Citrus Sinensis ID: 040569

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-----
Protein Sequence
MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLTSCSSASAKERIRQLIGEGSSEMVNWAWDETWVTVRSKEPGGIGSQLDCNLSSAAANVVPIGGGASRISAAEECDMDIHIIIPDPDDQFFST
Secondary Structure (PSIPRED)
cccEEccccccccccEEEEEEEcccccEEEEEEEEcccHHHHHHHHHHHccccccccEEEEccEEccccccEEEEEEEEEcccccHHHHHHccccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccccEEEEEccccEEcccccccccccccccccccccHHcccccccccccHHHHHHHHHHHHcccccccccccHHHHHHHHccccccccccccccHHHHHHHHHHHcccccccccHHHHHccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHcccccccccccccccEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccHHHEEEccccccEEEEEEEcccccEEEEEEEcHHHHHHHHHHHHHHHHHccccEEEEEEEEccHHHHHHHEHHHHHHcccHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccccEEEccccccEEEEEcccccEEcccccHHHHcHHHHHcccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHEHccccccccccccHHHHHHHHHHHcccHHHcccHHHHHccccHHccccHHHHccccccccccccccccccHcccHHHcccccccccccccHHHHHHHcHccccccHHHHHHccccccccccHHHHHHHHHcccccccccccccccccccccccccccccccHHHccccc
Coil and Loop (DISEMBL)
mdwtrgqtigrgstATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALAcpqivaykgcdiseenGKILYNLFLeyapggtltdairsgtcleegrirsHTRAVLLGLQYLhsngivhcdikgqnilvskdneqgakiadfgcarrarvneddegkpicgtpicmapevargeeqgfpadVWALGCTVlematgrppwpdvadpisalhrigfssdtpeipgymskQAQDFLSKclirnpgerwsasellehgfvkeqnfklstltepetynsesptsvlnqqlwdstltscssASAKERIRQLIGEGSSEMVNWAWDETWVTvrskepggigsqldcnlssaaanvvpigggasrisaaeecdmdihiiipdpddqffst
Flexible Loop (DISEMBL)
mdwtrgqtigrgstatvsigmsnrSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRArvneddegkpicGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLTSCSSASAKERIRQLigegssemvnWAWDETWVTVRSKEPGGIGSQLDCNLSSAAANVVPIGGGASRISAAEECDMDIHIIipdpddqffst
Low Complexity Region (SEG)
MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLTSCSSASAKERIRQLIGEGSSEMVNWAWDETWVTVRSKEPGGIGSQLDCNLSSAAANVVPIGGGASRISAAEECDMdihiiipdpddQFFST
Disordered region (IsUnstruct)
****************************************FLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE**EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS****IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK***********************W*****************QLIGEGSSEMVNWAWDETWVTVRSKEPGGIGSQLDCNLSSAAANVVPIGGGASRISAAEECDMDIHIIIP*********
Disordered Region (DISOPRED)
MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL*****LQR*QRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA**********ICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK***********************************************************AWDETWVT*******************************************************F**
Disordered Region (DISEMBL)
*********GRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTE***********VLNQQLWDSTLTSCSSASAKERIRQLIGEGSSEMVNWAWDETWVTVRSKEPGGIGSQLDCNLSSAAANVVPIGGGASRISAAEECDMDIHIIIPDPDDQFFST
Disordered Region (DISPRO)
MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLTSCSSASAKERIRQLIGEGSSEMVNWAWDETWVTVRSKEPGGIGSQLDCNLSSA*************ISAAEECDMDIHIIIPDPDDQFFST
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLTSCSSASAKERIRQLIGEGSSEMVNWAWDETWVTVRSKEPGGIGSQLDCNLSSAAANVVPIGGGASRISAAEECDMDIHIIIPDPDDQFFST
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	385	2.2.26 [Sep-21-2011]
Q9FZ36	651	Mitogen-activated protein	no	no	0.651	0.385	0.401	3e-49
O22040	666	Mitogen-activated protein	no	no	0.657	0.379	0.405	1e-48
Q54R82	942	Mitogen-activated protein	yes	no	0.683	0.279	0.351	3e-48
O22042	651	Mitogen-activated protein	no	no	0.651	0.385	0.390	7e-47
Q39008	608	Mitogen-activated protein	no	no	0.636	0.402	0.412	1e-41
P28829	659	Protein kinase byr2 OS=Sc	yes	no	0.651	0.380	0.385	1e-40
Q61084	626	Mitogen-activated protein	yes	no	0.659	0.405	0.377	1e-40
Q56UN5	1328	Mitogen-activated protein	no	no	0.649	0.188	0.380	4e-40
Q99759	626	Mitogen-activated protein	no	no	0.659	0.405	0.370	4e-40
Q9Y6R4	1608	Mitogen-activated protein	no	no	0.646	0.154	0.356	1e-39

>sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1

 Score =  196 bits (497), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 108/269 (40%), Positives = 156/269 (57%), Gaps = 18/269 (6%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----------EFLQREQRILSA 51
           W +GQ IGRG+  TV +GM+  S E+ AVK   ++++           + L+ E ++L  
Sbjct: 68  WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLITSNCASKEKTQAHIQELEEEVKLLKN 127

Query: 52  LACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLG 111
           L+ P IV Y G    +E      N+ LE+ PGG+++  +       E  +R++T  +LLG
Sbjct: 128 LSHPNIVRYLGTVREDET----LNILLEFVPGGSISSLLEKFGAFPESVVRTYTNQLLLG 183

Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR-ARVNEDDEGKPICGTPICMA 170
           L+YLH++ I+H DIKG NILV  DN+   K+ADFG +++ A +      K + GTP  MA
Sbjct: 184 LEYLHNHAIMHRDIKGANILV--DNQGCIKLADFGASKQVAELATISGAKSMKGTPYWMA 241

Query: 171 PEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK 230
           PEV       F AD+W++GCTV+EM TG+ PW      I+A+  IG +   P IP  +S 
Sbjct: 242 PEVILQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEIAAIFHIGTTKSHPPIPDNISS 301

Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGFV 259
            A DFL KCL + P  R +ASELL+H FV
Sbjct: 302 DANDFLLKCLQQEPNLRPTASELLKHPFV 330

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5

>sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2

 Score =  194 bits (492), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 110/271 (40%), Positives = 160/271 (59%), Gaps = 18/271 (6%)

Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVK----SAELSNSEF-------LQREQRIL 49
           + W +GQ IGRG+  TV +GM+  S E+ AVK    +A  ++ E        L+ E ++L
Sbjct: 67  ISWRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLL 126

Query: 50  SALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVL 109
             L+ P IV Y G  + E++     N+ LE+ PGG+++  +       E  +R++TR +L
Sbjct: 127 KNLSHPNIVRYLGT-VREDD---TLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLL 182

Query: 110 LGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR-ARVNEDDEGKPICGTPIC 168
           LGL+YLH++ I+H DIKG NILV  DN+   K+ADFG +++ A +      K + GTP  
Sbjct: 183 LGLEYLHNHAIMHRDIKGANILV--DNKGCIKLADFGASKQVAELATMTGAKSMKGTPYW 240

Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           MAPEV       F AD+W++GCTV+EM TG+ PW      ++A+  IG +   P IP  +
Sbjct: 241 MAPEVILQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTL 300

Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFV 259
           S  A+DFL KCL   P  R +ASELL+H FV
Sbjct: 301 SSDAKDFLLKCLQEVPNLRPTASELLKHPFV 331

May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2

 Score =  192 bits (489), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 99/282 (35%), Positives = 165/282 (58%), Gaps = 19/282 (6%)

Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSE--------FLQREQRILS 50
           + W +GQ +GRG   +V +G++  + E+FAVK  E+   NS+           +E  ++ 
Sbjct: 168 IKWQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMR 227

Query: 51  ALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL 110
           +L    IV Y G  + +       ++FLEY PGG+++  +       E  I+ +T+ +L 
Sbjct: 228 SLRHDNIVRYLGTSLDQS----FLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQ 283

Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMA 170
           GL +LH+N I+H DIKG NIL+  D +   K++DFGC++ +      + K + GTP  MA
Sbjct: 284 GLSFLHANSIIHRDIKGANILI--DTKGIVKLSDFGCSK-SFSGIVSQFKSMQGTPYWMA 340

Query: 171 PEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK 230
           PEV +    G  +D+W+LGC ++EMAT +PPW ++ +  + ++ I  S+  P IP +MS+
Sbjct: 341 PEVIKQTGHGRSSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQ 400

Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGFVK--EQNFKLSTLT 270
           +A DFL+ C  R+P ER  A++LL+H F+   + N +L T++
Sbjct: 401 EAFDFLNLCFKRDPKERPDANQLLKHPFIMNLDDNIQLPTIS 442

Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1

 Score =  188 bits (477), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 105/269 (39%), Positives = 157/269 (58%), Gaps = 18/269 (6%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF-----------LQREQRILSA 51
           W +G+ IG G+   V +GM+  S E+ A+K   ++ S             L+ E ++L  
Sbjct: 68  WRKGELIGCGAFGRVYMGMNLDSGELLAIKQVLIAPSSASKEKTQGHIRELEEEVQLLKN 127

Query: 52  LACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLG 111
           L+ P IV Y G  + E +     N+ +E+ PGG+++  +       E  I  +T+ +LLG
Sbjct: 128 LSHPNIVRYLGT-VRESDS---LNILMEFVPGGSISSLLEKFGSFPEPVIIMYTKQLLLG 183

Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA-RVNEDDEGKPICGTPICMA 170
           L+YLH+NGI+H DIKG NILV  DN+   ++ADFG +++   +   +  K + GTP  MA
Sbjct: 184 LEYLHNNGIMHRDIKGANILV--DNKGCIRLADFGASKKVVELATVNGAKSMKGTPYWMA 241

Query: 171 PEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK 230
           PEV       F AD+W++GCTV+EMATG+PPW +     +A+  IG +   P IP  +S 
Sbjct: 242 PEVILQTGHSFSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPPIPEDLSP 301

Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGFV 259
           +A+DFL KCL + P  R SA+ELL+H FV
Sbjct: 302 EAKDFLMKCLHKEPSLRLSATELLQHPFV 330

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2

 Score =  170 bits (431), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 111/269 (41%), Positives = 156/269 (57%), Gaps = 24/269 (8%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS--------EFLQREQRILSALAC 54
           W +GQ +GRGS  +V  G+S    + FAVK   L +         + L+ E ++LS L  
Sbjct: 333 WQKGQLLGRGSFGSVYEGISG-DGDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQLQH 391

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
             IV Y+G   + ++G  LY +FLE    G+L   +     L +  +  +TR +L GL+Y
Sbjct: 392 QNIVRYRG---TAKDGSNLY-IFLELVTQGSLL-KLYQRYQLRDSVVSLYTRQILDGLKY 446

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           LH  G +H DIK  NILV  D     K+ADFG A+ ++ N+    K   GTP  MAPEV 
Sbjct: 447 LHDKGFIHRDIKCANILV--DANGAVKLADFGLAKVSKFNDIKSCK---GTPFWMAPEVI 501

Query: 175 -RGEEQGF--PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQ 231
            R +  G+  PAD+W+LGCTVLEM TG+ P+ D+ +P+ AL RIG  +  PE+P  +S  
Sbjct: 502 NRKDSDGYGSPADIWSLGCTVLEMCTGQIPYSDL-EPVQALFRIGRGT-LPEVPDTLSLD 559

Query: 232 AQDFLSKCLIRNPGERWSASELLEHGFVK 260
           A+ F+ KCL  NP ER +A+ELL H FV+
Sbjct: 560 ARLFILKCLKVNPEERPTAAELLNHPFVR 588

Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|P28829|BYR2_SCHPO Protein kinase byr2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=byr2 PE=1 SV=1

 Score =  167 bits (424), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 106/275 (38%), Positives = 147/275 (53%), Gaps = 24/275 (8%)

Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQREQRILSALA------ 53
           + W RG  IG GS   V +GM+  S E+ AVK   L S SE   R  ++L ALA      
Sbjct: 392 IKWIRGALIGSGSFGQVYLGMNASSGELMAVKQVILDSVSESKDRHAKLLDALAGEIALL 451

Query: 54  ----CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVL 109
                  IV Y G +++ ++     N+FLEY PGG++   +      EE  +++  +  L
Sbjct: 452 QELSHEHIVQYLGSNLNSDH----LNIFLEYVPGGSVAGLLTMYGSFEETLVKNFIKQTL 507

Query: 110 LGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE----GKP-ICG 164
            GL+YLHS GIVH DIKG NILV  DN+   KI+DFG +++  +N         +P   G
Sbjct: 508 KGLEYLHSRGIVHRDIKGANILV--DNKGKIKISDFGISKKLELNSTSTKTGGARPSFQG 565

Query: 165 TPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI 224
           +   MAPEV +        D+W+LGC V+EM T + P+P+  D + A+ RIG  +  PE 
Sbjct: 566 SSFWMAPEVVKQTMHTEKTDIWSLGCLVIEMLTSKHPYPN-CDQMQAIFRIG-ENILPEF 623

Query: 225 PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV 259
           P  +S  A DFL K    +   R +ASELL H FV
Sbjct: 624 PSNISSSAIDFLEKTFAIDCNLRPTASELLSHPFV 658

Serine/threonine protein kinase involved in conjugation and sporulation. It is thought that it phosphorylates the byr1 protein kinase which itself phosphorylate the spk1 kinase.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q61084|M3K3_MOUSE Mitogen-activated protein kinase kinase kinase 3 OS=Mus musculus GN=Map3k3 PE=1 SV=1

 Score =  167 bits (423), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 102/270 (37%), Positives = 155/270 (57%), Gaps = 16/270 (5%)

Query: 1   MDWTRGQTIGRGSTATVSI------GMSNRSSEV-FAVKSAELSNS-EFLQREQRILSAL 52
           ++W RG+ +G+G+   V +      G    S +V F   S E S     L+ E ++L  L
Sbjct: 360 INWRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALECEIQLLKNL 419

Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGL 112
              +IV Y GC + +   KIL  +F+EY PGG++ D +++   L E   R +TR +L G+
Sbjct: 420 QHERIVQYYGC-LRDRAEKIL-TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGM 477

Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR-VNEDDEG-KPICGTPICMA 170
            YLHSN IVH DIKG NIL  +D+    K+ DFG ++R + +     G + + GTP  M+
Sbjct: 478 SYLHSNMIVHRDIKGANIL--RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 535

Query: 171 PEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK 230
           PEV  GE  G  ADVW+LGCTV+EM T +PPW +  + ++A+ +I      P++P ++S+
Sbjct: 536 PEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY-EAMAAIFKIATQPTNPQLPSHISE 594

Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGFVK 260
             +DFL +  +    +R SA ELL H F +
Sbjct: 595 HGRDFLRRIFV-EARQRPSAEELLTHHFAQ 623

Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q56UN5|M3K19_HUMAN Mitogen-activated protein kinase kinase kinase 19 OS=Homo sapiens GN=MAP3K19 PE=2 SV=1

 Score =  166 bits (419), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 104/273 (38%), Positives = 152/273 (55%), Gaps = 23/273 (8%)

Query: 3    WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-------EF--LQREQRILSALA 53
            WT+G+ +G+G+  TV  G++++  ++ AVK   L  S       E+  LQ E  +L AL 
Sbjct: 1061 WTKGEILGKGAYGTVYCGLTSQG-QLIAVKQVALDTSNKLAAEKEYRKLQEEVDLLKALK 1119

Query: 54   CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
               IVAY G  + E    I    F+E+ PGG+++  I     L E     +T+ +L G+ 
Sbjct: 1120 HVNIVAYLGTCLQENTVSI----FMEFVPGGSISSIINRFGPLPEMVFCKYTKQILQGVA 1175

Query: 114  YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR---ARVN--EDDEGKPICGTPIC 168
            YLH N +VH DIKG N+++        K+ DFGCARR   A +N    D  K + GTP  
Sbjct: 1176 YLHENCVVHRDIKGNNVMLMPTG--IIKLIDFGCARRLAWAGLNGTHSDMLKSMHGTPYW 1233

Query: 169  MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSD-TPEIPGY 227
            MAPEV      G  +D+W++GCTV EMATG+PP   + D ++A+  IG      P +P +
Sbjct: 1234 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM-DRMAAMFYIGAHRGLMPPLPDH 1292

Query: 228  MSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
             S+ A DF+  CL R+  ER SA +LL+H F++
Sbjct: 1293 FSENAADFVRMCLTRDQHERPSALQLLKHSFLE 1325

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q99759|M3K3_HUMAN Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens GN=MAP3K3 PE=1 SV=2

 Score =  166 bits (419), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 100/270 (37%), Positives = 152/270 (56%), Gaps = 16/270 (5%)

Query: 1   MDWTRGQTIGRGSTATVSI------GMSNRSSEV-FAVKSAELSNS-EFLQREQRILSAL 52
           ++W RG+ +G+G+   V +      G    S +V F   S E S     L+ E ++L  L
Sbjct: 360 INWRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALECEIQLLKNL 419

Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGL 112
              +IV Y GC + +   K L  +F+EY PGG++ D +++   L E   R +TR +L G+
Sbjct: 420 QHERIVQYYGC-LRDRAEKTL-TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGM 477

Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV--NEDDEGKPICGTPICMA 170
            YLHSN IVH DIKG NIL  +D+    K+ DFG ++R +         + + GTP  M+
Sbjct: 478 SYLHSNMIVHRDIKGANIL--RDSAGNVKLGDFGASKRLQTICMSGTGMRSVTGTPYWMS 535

Query: 171 PEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK 230
           PEV  GE  G  ADVW+LGCTV+EM T +PPW +  + ++A+ +I      P++P ++S+
Sbjct: 536 PEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY-EAMAAIFKIATQPTNPQLPSHISE 594

Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGFVK 260
             +DFL +  +    +R SA ELL H F +
Sbjct: 595 HGRDFLRRIFV-EARQRPSAEELLTHHFAQ 623

Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q9Y6R4|M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens GN=MAP3K4 PE=1 SV=2

 Score =  164 bits (414), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 96/269 (35%), Positives = 140/269 (52%), Gaps = 20/269 (7%)

Query: 3    WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF-----LQREQRILSALACPQI 57
            W RG  IG G    V   +S  + E+ A+K      ++         E +I   +  P +
Sbjct: 1343 WQRGNKIGEGQYGKVYTCISVDTGELMAMKEIRFQPNDHKTIKETADELKIFEGIKHPNL 1402

Query: 58   VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
            V Y G ++  E   I    F+EY   GTL +  R G  L+E  IR +++ + + +  LH 
Sbjct: 1403 VRYFGVELHREEMYI----FMEYCDEGTLEEVSRLG--LQEHVIRLYSKQITIAINVLHE 1456

Query: 118  NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD---EGKPICGTPICMAPEV- 173
            +GIVH DIKG NI ++       K+ DFGC+ + + N      E     GT   MAPEV 
Sbjct: 1457 HGIVHRDIKGANIFLTSSG--LIKLGDFGCSVKLKNNAQTMPGEVNSTLGTAAYMAPEVI 1514

Query: 174  --ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQ 231
              A+GE  G  AD+W+LGC V+EM TG+ PW +       ++++G     P IP  +S +
Sbjct: 1515 TRAKGEGHGRAADIWSLGCVVIEMVTGKRPWHEYEHNFQIMYKVGMGHKPP-IPERLSPE 1573

Query: 232  AQDFLSKCLIRNPGERWSASELLEHGFVK 260
             +DFLS CL  +P  RW+AS+LL+H FVK
Sbjct: 1574 GKDFLSHCLESDPKMRWTASQLLDHSFVK 1602

Component of a protein kinase signal transduction cascade. Activates the CSBP2, P38 and JNK MAPK pathways, but not the ERK pathway. Specifically phosphorylates and activates MAP2K4 and MAP2K6.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	385
224115790	340	predicted protein [Populus trichocarpa]	0.836	0.947	0.619	1e-115
255554817	344	ATP binding protein, putative [Ricinus c	0.831	0.930	0.621	1e-113
224118034	339	predicted protein [Populus trichocarpa]	0.841	0.955	0.613	1e-112
356532301	422	PREDICTED: mitogen-activated protein kin	0.812	0.741	0.596	1e-101
225447061	420	PREDICTED: mitogen-activated protein kin	0.831	0.761	0.572	1e-101
147841887	420	hypothetical protein VITISV_024689 [Viti	0.831	0.761	0.569	1e-100
302144106	1122	unnamed protein product [Vitis vinifera]	0.815	0.279	0.563	4e-97
359483393	367	PREDICTED: mitogen-activated protein kin	0.815	0.855	0.563	1e-96
359483395	367	PREDICTED: mitogen-activated protein kin	0.815	0.855	0.560	2e-96
359494145	454	PREDICTED: mitogen-activated protein kin	0.828	0.702	0.538	4e-95

>gi|224115790|ref|XP_002317125.1| predicted protein [Populus trichocarpa] gi|222860190|gb|EEE97737.1| predicted protein [Populus trichocarpa]

 Score =  419 bits (1078), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 215/347 (61%), Positives = 257/347 (74%), Gaps = 25/347 (7%)

Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           MDWTRG+TIG GS+ATVS+  +NRS +VFAVKSAEL  SE LQREQ ILS L CPQIV Y
Sbjct: 1   MDWTRGRTIGHGSSATVSMAKANRSGQVFAVKSAELLKSESLQREQSILSTLKCPQIVVY 60

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLGLQYLHSNG 119
           KGCDI+ ENGK+ YNLFLEY  GGTL DAIR G  CL+E  IR + R +LLGL+YLH NG
Sbjct: 61  KGCDITNENGKLFYNLFLEYISGGTLIDAIREGGGCLDEAMIRLYARTILLGLEYLHCNG 120

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGK------PICGTPICMAPEV 173
           IVHCDIKG NILV+ D   GAKIAD GCA+R  V+E   G       PI GTP+ MAPEV
Sbjct: 121 IVHCDIKGHNILVTGD---GAKIADLGCAKR--VDEVSGGTALKTTAPIAGTPLYMAPEV 175

Query: 174 ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           ARGE QGFPAD+W++GCTV+EMATG+ PW +V+DP+SAL++IGFS + PEIP +MSKQA+
Sbjct: 176 ARGEHQGFPADIWSVGCTVVEMATGQAPWVNVSDPVSALYQIGFSGNVPEIPSFMSKQAK 235

Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQ-NFKLSTLTEPETYNSESPTSVLNQQLWDST 292
           DFLSKCL R+PGERWSASELL+H F+ E+ N  L  +    + N ++PT VL+Q LWDS 
Sbjct: 236 DFLSKCLKRDPGERWSASELLKHDFITEEPNSALKEII--SSTNVDTPTCVLDQVLWDSI 293

Query: 293 LT---------SCSSASAKERIRQLIGEGSSEMVNWAWDETWVTVRS 330
                         S S  ERI+QL  EG  E+ NW+WD+TW+TVRS
Sbjct: 294 EALETTWDLSQESHSVSPVERIKQLT-EGHGEVPNWSWDDTWITVRS 339

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255554817|ref|XP_002518446.1| ATP binding protein, putative [Ricinus communis] gi|223542291|gb|EEF43833.1| ATP binding protein, putative [Ricinus communis]

 Score =  416 bits (1069), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 212/341 (62%), Positives = 258/341 (75%), Gaps = 21/341 (6%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKG 62
           WTRGQ +G+GS ATVSI    +S   FAVKSAELS SE LQ+EQRILS L+CPQI+AY+G
Sbjct: 4   WTRGQILGQGSQATVSIATVQQSGLAFAVKSAELSQSELLQKEQRILSTLSCPQIIAYEG 63

Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            D++ E+GK+L+N+FLEYAPGGTL D IR  G  L+EG IRS+ R +LLGL +LHSNGIV
Sbjct: 64  YDVTREDGKLLFNIFLEYAPGGTLIDTIRKHGGFLDEGMIRSYARDILLGLHHLHSNGIV 123

Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF 181
           HCDIKG NILV+ D   GAKIAD GCAR+  VN+  +  PI GTP+ MAPEVARGE QGF
Sbjct: 124 HCDIKGHNILVTSD---GAKIADLGCARK--VNQVSK-TPIAGTPVYMAPEVARGEHQGF 177

Query: 182 PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLI 241
           PADVWALGCT++EMATGRPPW  ++DP+SAL++IG+S   PEIP +MSKQA DF+SKCL 
Sbjct: 178 PADVWALGCTIIEMATGRPPWTTISDPVSALYQIGYSGMVPEIPSFMSKQAIDFVSKCLK 237

Query: 242 RNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWD----------S 291
           R+P ERWSASELL H FV E+    S L    + N E+PTSVL+Q LW+          S
Sbjct: 238 RDPVERWSASELLRHAFVTEE--ACSVLKGNTSSNVETPTSVLDQGLWESREELEATWKS 295

Query: 292 TLTSCSSASAKERIRQLIGEGSSEMVNWAWDETWVTVRSKE 332
           T  +CS  S  ERIRQL  +G++ + NWAWD++WVTVRSK+
Sbjct: 296 THKNCSR-SPTERIRQL-AQGTARVPNWAWDDSWVTVRSKD 334

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224118034|ref|XP_002331541.1| predicted protein [Populus trichocarpa] gi|222873765|gb|EEF10896.1| predicted protein [Populus trichocarpa]

 Score =  410 bits (1054), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 211/344 (61%), Positives = 260/344 (75%), Gaps = 20/344 (5%)

Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           MDWTRGQTIGRGS+ATVS+  +N+S +VFAVKSAELS SE LQ+EQ +LS L CPQIVAY
Sbjct: 1   MDWTRGQTIGRGSSATVSMARANQSGKVFAVKSAELSKSESLQKEQIVLSTLRCPQIVAY 60

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLGLQYLHSNG 119
           KGCDI+ ENGK+LYNLFLEYA GGTL DAIR G  CL+E  IR + R +LLGL+YLH NG
Sbjct: 61  KGCDITNENGKVLYNLFLEYASGGTLIDAIREGGGCLDEDMIRLYARTILLGLEYLHCNG 120

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRA-RVNEDDEGKP--ICGTPICMAPEVARG 176
           IVHCDIKG NILV+ D   GAKIAD GCA+R   V+E D G    I GTP+ MAPEVAR 
Sbjct: 121 IVHCDIKGHNILVTSD---GAKIADLGCAKRVDEVSEADWGTTTTIAGTPLYMAPEVARA 177

Query: 177 EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL 236
           E QGFPAD+WA+GCT++EMATG+ PW +V+DP+SAL++IGFS + PEIP +MSKQA+DFL
Sbjct: 178 EHQGFPADIWAVGCTIVEMATGQAPWVNVSDPVSALYQIGFSGNAPEIPSFMSKQARDFL 237

Query: 237 SKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDS----- 291
           SKCL R+P ERWSASELL+H F+ E+   +  L E  +  +++PT VL+Q LWDS     
Sbjct: 238 SKCLKRDPMERWSASELLKHDFIIEEPNLI--LKENNSSKADTPTCVLDQVLWDSMEKLE 295

Query: 292 ----TLTSCSSASAKERIRQLIGEGSSEMVNWA-WDETWVTVRS 330
               +  + S  S  ERI+QL  EG+ +  +W+ W + WVT+RS
Sbjct: 296 TTWDSTHNTSLVSPIERIKQLT-EGNGKAHSWSTWGDAWVTIRS 338

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356532301|ref|XP_003534712.1| PREDICTED: mitogen-activated protein kinase kinase kinase A-like [Glycine max]

 Score =  376 bits (965), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 201/337 (59%), Positives = 238/337 (70%), Gaps = 24/337 (7%)

Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           MDWTRG T+GRGSTA V IG S+RS EVFAVKSAEL  SEFL+RE+RILS L CPQIVAY
Sbjct: 1   MDWTRGHTLGRGSTAAVYIGESHRSGEVFAVKSAELHRSEFLKREERILSTLKCPQIVAY 60

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           +GCD + ENG   +N+F+EYAP GTL +    G  +EE  + S TR +L GL YLHSNGI
Sbjct: 61  RGCDNTFENGVQWFNMFMEYAPHGTLAE---RGGGMEEAVVGSCTRQILQGLNYLHSNGI 117

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           VHCD+KGQN+LV+   EQG KIADFGCARR     ++    I GTP  MAPEVARGE+QG
Sbjct: 118 VHCDVKGQNVLVT---EQGVKIADFGCARRV----EESSSVIAGTPRFMAPEVARGEQQG 170

Query: 181 FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCL 240
           FPADVWALGCTVLEM TG PPW    DP + ++RIGFS ++PEIPGY+S+Q +DFL KCL
Sbjct: 171 FPADVWALGCTVLEMITGTPPWQGGGDPAAVVYRIGFSGESPEIPGYVSEQGRDFLGKCL 230

Query: 241 IRNPGERWSASELLEHGFVKE-QNFKLSTLTEPETYNSESPTSVLNQQLWDSTLTSCSSA 299
            R PGERWS  ELL HGFVKE    KL  L      +S++PT VL +  WDS  T+   A
Sbjct: 231 KREPGERWSVEELLGHGFVKECTELKLLVL------DSDTPTGVLERGFWDSLETAQHEA 284

Query: 300 ----SAKERIRQLIGEGSSEMVNWAWDETWVTVRSKE 332
               S ++RIR+L    S E V  + D+ WVTVR  E
Sbjct: 285 LDCPSPRDRIRRLF---SDEPVWASNDDEWVTVRGNE 318

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225447061|ref|XP_002269660.1| PREDICTED: mitogen-activated protein kinase kinase kinase A [Vitis vinifera] gi|297739169|emb|CBI28820.3| unnamed protein product [Vitis vinifera]

 Score =  376 bits (965), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 194/339 (57%), Positives = 243/339 (71%), Gaps = 19/339 (5%)

Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           MDWTRG T+G GS+ATVS+  S RS +VFAVKS ELS SE LQRE+RILS+L  P IV Y
Sbjct: 1   MDWTRGHTLGSGSSATVSLANSLRSGDVFAVKSVELSRSESLQREERILSSLRSPYIVGY 60

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTC-LEEGRIRSHTRAVLLGLQYLHSNG 119
           KGCDI+ EN K++YNLF+EY PGGTL DAIR G   L E  I  + R ++ GL Y+HS G
Sbjct: 61  KGCDITRENKKLMYNLFIEYMPGGTLGDAIRRGGGQLHESMIGIYARQIVQGLDYIHSRG 120

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           +VHCDIKGQN+L+ +D   GAKIADFGCA+     +DD   PI GTP  MAPEVARGE+Q
Sbjct: 121 LVHCDIKGQNVLIGED---GAKIADFGCAKWTN-GKDDRKVPIAGTPFFMAPEVARGEDQ 176

Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
           G+P+DVWALGCT++EMATG  PWP+VA+ ++AL+RIGFS + P IP ++S QA+DFLSKC
Sbjct: 177 GYPSDVWALGCTIIEMATGGAPWPNVANAVAALYRIGFSEELPWIPSFLSDQAKDFLSKC 236

Query: 240 LIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLTSCS-- 297
           L R+P ERW+AS+LL+H FV E N +   +   E+Y S+SPTS+L+Q  W S   S +  
Sbjct: 237 LRRDPKERWTASQLLKHPFVGELNPQAKQVQ--ESY-SDSPTSILDQNFWSSLEESEAQG 293

Query: 298 -------SASAKERIRQLIGEGSSEMVNWAWDETWVTVR 329
                  S S  ERIR+L     S + NW  D+ WVT+R
Sbjct: 294 YLKQASFSNSPAERIRKLW--TFSRVENWTRDDNWVTIR 330

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147841887|emb|CAN65217.1| hypothetical protein VITISV_024689 [Vitis vinifera]

 Score =  373 bits (957), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 193/339 (56%), Positives = 242/339 (71%), Gaps = 19/339 (5%)

Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           MDWTRG T+G GS+ATVS+  S RS +VFAVKS ELS SE LQRE+RILS+L  P IV Y
Sbjct: 1   MDWTRGHTLGSGSSATVSLANSLRSGDVFAVKSVELSRSESLQREERILSSLRSPYIVGY 60

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTC-LEEGRIRSHTRAVLLGLQYLHSNG 119
           KGCDI+ EN K++YNLF+EY PGGTL DAIR G   L E  I  + R ++ GL Y+HS G
Sbjct: 61  KGCDITRENKKLMYNLFIEYMPGGTLGDAIRRGGGQLHESMIGIYARQIVQGLDYIHSRG 120

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           +VHCDIKGQN+L+ +D   GAKIADFGCA+     +DD    I GTP  MAPEVARGE+Q
Sbjct: 121 LVHCDIKGQNVLIGED---GAKIADFGCAKWTN-GKDDRKVQIAGTPFFMAPEVARGEDQ 176

Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
           G+P+DVWALGCT++EMATG  PWP+VA+ ++AL+RIGFS + P IP ++S QA+DFLSKC
Sbjct: 177 GYPSDVWALGCTIIEMATGGAPWPNVANAVAALYRIGFSEELPWIPSFLSDQAKDFLSKC 236

Query: 240 LIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLTSCS-- 297
           L R+P ERW+AS+LL+H FV E N +   +   E+Y S+SPTS+L+Q  W S   S +  
Sbjct: 237 LRRDPKERWTASQLLKHPFVGELNPQAKQVQ--ESY-SDSPTSILDQNFWSSLEESEAQG 293

Query: 298 -------SASAKERIRQLIGEGSSEMVNWAWDETWVTVR 329
                  S S  ERIR+L     S + NW  D+ WVT+R
Sbjct: 294 YLKQASFSNSPAERIRKLW--TFSRVENWTRDDNWVTIR 330

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302144106|emb|CBI23211.3| unnamed protein product [Vitis vinifera]

 Score =  361 bits (926), Expect = 4e-97,   Method: Compositional matrix adjust.
 Identities = 191/339 (56%), Positives = 236/339 (69%), Gaps = 25/339 (7%)

Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           MDWTRG T+GRGS+ATVSI  S+ S ++FAVKS ELS S+ L+REQRILS +    ++ Y
Sbjct: 1   MDWTRGCTLGRGSSATVSIATSHLSGDIFAVKSTELSQSKLLKREQRILSTVRSAHVIEY 60

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           +G +++ ENGK +YNL +EYA GGTL    +    L E  IR++TRA+L GLQYLHSN I
Sbjct: 61  RGWNVTCENGKQMYNLCMEYAAGGTL----KQRGSLGEAAIRANTRAILQGLQYLHSNCI 116

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           VHCDIK +NIL++ D   G KI D GCAR A    DD    +CGTP  MAPEVARGEEQG
Sbjct: 117 VHCDIKSENILITGD---GLKIGDLGCARLA----DDFSDSVCGTPAFMAPEVARGEEQG 169

Query: 181 FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCL 240
           F ADVWALGCT++EMATGR PW DV+DP+SA++RIGFS D PEIPG++S+ A+DFL KCL
Sbjct: 170 FAADVWALGCTIIEMATGRAPWTDVSDPVSAVYRIGFSGDVPEIPGWVSEDAKDFLGKCL 229

Query: 241 IRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYN--SESPTSVLNQQLWDSTLTSC-- 296
           +R+P +RWS  ELL H FV E     + +   E Y   S SPTSVL+Q+ W S++     
Sbjct: 230 VRDPVQRWSVGELLGHPFVNE-----ACVFSKEVYGSSSSSPTSVLDQRFWSSSIEELYP 284

Query: 297 ----SSASAKERIRQLIGEGS-SEMVNWAWDETWVTVRS 330
               S  S +ERI  L    S S + NW WDE WVTVRS
Sbjct: 285 FHKKSWNSPRERIHFLANSNSNSGLPNWGWDENWVTVRS 323

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483393|ref|XP_003632947.1| PREDICTED: mitogen-activated protein kinase kinase kinase A-like [Vitis vinifera]

 Score =  359 bits (922), Expect = 1e-96,   Method: Compositional matrix adjust.
 Identities = 191/339 (56%), Positives = 236/339 (69%), Gaps = 25/339 (7%)

Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           MDWTRG T+GRGS+ATVSI  S+ S ++FAVKS ELS S+ L+REQRILS +    ++ Y
Sbjct: 1   MDWTRGCTLGRGSSATVSIATSHLSGDIFAVKSTELSQSKLLKREQRILSTVRSAHVIEY 60

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           +G +++ ENGK +YNL +EYA GGTL    +    L E  IR++TRA+L GLQYLHSN I
Sbjct: 61  RGWNVTCENGKQMYNLCMEYAAGGTL----KQRGSLGEAAIRANTRAILQGLQYLHSNCI 116

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           VHCDIK +NIL++ D   G KI D GCAR A    DD    +CGTP  MAPEVARGEEQG
Sbjct: 117 VHCDIKSENILITGD---GLKIGDLGCARLA----DDFSDSVCGTPAFMAPEVARGEEQG 169

Query: 181 FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCL 240
           F ADVWALGCT++EMATGR PW DV+DP+SA++RIGFS D PEIPG++S+ A+DFL KCL
Sbjct: 170 FAADVWALGCTIIEMATGRAPWTDVSDPVSAVYRIGFSGDVPEIPGWVSEDAKDFLGKCL 229

Query: 241 IRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYN--SESPTSVLNQQLWDSTLTSC-- 296
           +R+P +RWS  ELL H FV E     + +   E Y   S SPTSVL+Q+ W S++     
Sbjct: 230 VRDPVQRWSVGELLGHPFVNE-----ACVFSKEVYGSSSSSPTSVLDQRFWSSSIEELYP 284

Query: 297 ----SSASAKERIRQLIGEGS-SEMVNWAWDETWVTVRS 330
               S  S +ERI  L    S S + NW WDE WVTVRS
Sbjct: 285 FHKKSWNSPRERIHFLANSNSNSGLPNWGWDENWVTVRS 323

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483395|ref|XP_003632948.1| PREDICTED: mitogen-activated protein kinase kinase kinase A-like [Vitis vinifera]

 Score =  358 bits (920), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 190/339 (56%), Positives = 238/339 (70%), Gaps = 25/339 (7%)

Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           MDWTRG T+GRGS+ATVSI  S+ S ++FAVKS ELS S+ L+REQRILS +    ++ Y
Sbjct: 1   MDWTRGCTLGRGSSATVSIATSHLSGDIFAVKSTELSQSKLLKREQRILSTVRSAHVIEY 60

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           +G +++ ENGK +YNL +EYA GGTL    +    L E  IR++TRA+L GLQYLHSN I
Sbjct: 61  RGWNVTCENGKQMYNLCMEYAAGGTL----KQRGSLGEAAIRANTRAILQGLQYLHSNCI 116

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           VHCDIK +NIL++    +G KI D GCAR A    DD    +CGTP  MAPEVARGEEQG
Sbjct: 117 VHCDIKSENILITG---EGLKIGDLGCARLA----DDFSDSVCGTPAFMAPEVARGEEQG 169

Query: 181 FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCL 240
           F ADVWALGCT++EMATGR PW DV+DP+SA++RIGFS D PEIPG++S++A+DFL KCL
Sbjct: 170 FAADVWALGCTIIEMATGRAPWTDVSDPVSAVYRIGFSGDVPEIPGWVSEEAKDFLGKCL 229

Query: 241 IRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYN--SESPTSVLNQQLWDSTLTSC-- 296
           +R+P +RWS  ELL H FV E     + +   E Y   S SPTSVL+Q+ W S++     
Sbjct: 230 VRDPVKRWSVGELLGHPFVNE-----ACVFSKEVYGSSSSSPTSVLDQRFWSSSIEELYP 284

Query: 297 ----SSASAKERIRQLIGEGS-SEMVNWAWDETWVTVRS 330
               S  S +ERI+ L    S S + NW WDE WVTVRS
Sbjct: 285 FHKKSWNSPRERIQFLANSNSNSGLPNWGWDENWVTVRS 323

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359494145|ref|XP_003634728.1| PREDICTED: mitogen-activated protein kinase kinase kinase 2-like [Vitis vinifera]

 Score =  354 bits (908), Expect = 4e-95,   Method: Compositional matrix adjust.
 Identities = 187/347 (53%), Positives = 238/347 (68%), Gaps = 28/347 (8%)

Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           MDWTRG TIGRG++AT+S+ + + S E+FAVKS ELS S+ LQREQ  LS L+  +IV Y
Sbjct: 1   MDWTRGPTIGRGASATISLAIVSTSGELFAVKSTELSRSKLLQREQSFLSQLSSERIVKY 60

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNG 119
            G + + E   +LYN+F+EY PGG L+D IR  G  L+E  IR +TR ++LGL+YL  NG
Sbjct: 61  LGSNTTCEGDTMLYNVFMEYVPGGALSDEIRRRGNRLDEDWIRLYTRQIVLGLEYLQFNG 120

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           +VHCDIK +N+L+ +D   GA IAD GCA+   V+ +  G    GTP+ MAPEVARGEEQ
Sbjct: 121 LVHCDIKSENVLIRED---GAVIADLGCAKS--VHGNGGGSVFSGTPVFMAPEVARGEEQ 175

Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
           GFPADVWALGCTV+EMATGR PWP+V DP+SAL+RIGFS D PE P ++S+  +DFL KC
Sbjct: 176 GFPADVWALGCTVIEMATGRNPWPEVDDPVSALYRIGFSGDVPEFPMWLSENGRDFLDKC 235

Query: 240 LIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQ-LWDS------- 291
           L RNP ERW+A ELLEH F++  + +L      + +  +SPTSVL+ Q  WDS       
Sbjct: 236 LRRNPRERWTAKELLEHPFLEPNSKQL------KEFPVKSPTSVLDDQGFWDSLEAPVTP 289

Query: 292 ---TLTSCSSASAKERIRQLIGEGS----SEMVNWAWDETWVTVRSK 331
                   SS S  ERI++L  EG+    S + NW WDE WVTVRS 
Sbjct: 290 SVLMHIGSSSNSPAERIQRL-NEGALSSGSNLPNWTWDEDWVTVRSN 335

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	385
TAIR|locus:2161690	448	MAPKKK15 "mitogen-activated pr	0.8	0.687	0.504	3.2e-81
TAIR|locus:2060246	372	MAPKKK17 "mitogen-activated pr	0.737	0.763	0.506	2.4e-76
TAIR|locus:2205523	339	MAPKKK18 "mitogen-activated pr	0.825	0.938	0.477	1.7e-75
TAIR|locus:2116417	444	MAPKKK16 "mitogen-activated pr	0.740	0.641	0.501	3.2e-72
TAIR|locus:2074835	342	MAPKKK20 "mitogen-activated pr	0.836	0.941	0.389	3e-53
TAIR|locus:2155568	344	MAPKKK19 "mitogen-activated pr	0.831	0.930	0.390	1.7e-52
TAIR|locus:2114990	336	MAPKKK21 "mitogen-activated pr	0.820	0.940	0.404	5.6e-52
TAIR|locus:2007337	499	MAPKKK13 "mitogen-activated pr	0.685	0.529	0.402	6e-48
TAIR|locus:2035989	666	NP1 "NPK1-related protein kina	0.685	0.396	0.399	9.8e-48
TAIR|locus:2045658	463	MAPKKK14 "mitogen-activated pr	0.812	0.676	0.377	3.3e-47

TAIR|locus:2161690 MAPKKK15 "mitogen-activated protein kinase kinase kinase 15" [Arabidopsis thaliana (taxid:3702)]

 Score = 795 (284.9 bits), Expect = 3.2e-81, Sum P(2) = 3.2e-81
 Identities = 163/323 (50%), Positives = 222/323 (68%)

Query:     2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
             +W RG  IGRGSTATVS+G++N S + FAVKSAE S+S FLQREQ ILS L+ P IV Y 
Sbjct:     5 NWIRGPIIGRGSTATVSLGITN-SGDFFAVKSAEFSSSAFLQREQSILSKLSSPYIVKYI 63

Query:    62 GCDISEENGKILYNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
             G ++++EN K++YNL +EY  GG+L D I+ SG  L E  IRS+TR +L GL YLH  GI
Sbjct:    64 GSNVTKENDKLMYNLLMEYVSGGSLHDLIKNSGGKLPEPLIRSYTRQILKGLMYLHDQGI 123

Query:   121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
             VHCD+K QN+++  +    AKI D GCA+    NE+ E     GTP  M+PEVARGEEQ 
Sbjct:   124 VHCDVKSQNVMIGGEI---AKIVDLGCAKTVEENENLE---FSGTPAFMSPEVARGEEQS 177

Query:   181 FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCL 240
             FPADVWALGCTV+EMATG  PWP++ D ++A+++IGF+ ++P IP ++S++ QDFL KCL
Sbjct:   178 FPADVWALGCTVIEMATGSSPWPELNDVVAAIYKIGFTGESPVIPVWLSEKGQDFLRKCL 237

Query:   241 IRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLTSCSSAS 300
              ++P +RW+  ELL+H F+ E++   S  T     NS SP++VL+Q+ WD   TS S   
Sbjct:   238 RKDPKQRWTVEELLQHPFLDEEDND-SDQTG-NCLNSSSPSTVLDQRFWDLCETSRSRF- 294

Query:   301 AKERIRQLIGEGSSEMVNWAWDE 323
                 I++   +  +   N+ WD+
Sbjct:   295 ----IKEDHEDPFANSTNFLWDD 313

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2060246 MAPKKK17 "mitogen-activated protein kinase kinase kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 769 (275.8 bits), Expect = 2.4e-76, P = 2.4e-76
 Identities = 150/296 (50%), Positives = 208/296 (70%)

Query:     1 MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
             M+WTRG+ +GRGSTATV     + S E+ AVKS+E+  SEFLQRE +ILS+L+ P ++ Y
Sbjct:     1 MEWTRGRILGRGSTATVYAAAGHNSDEILAVKSSEVHRSEFLQREAKILSSLSSPYVIGY 60

Query:    61 KGCDISEE-NGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
             +G +   E NG ++YNL +EYAP GTLTDA  + G  ++E R+  +TR +L GL+Y+HS 
Sbjct:    61 RGSETKRESNGVVMYNLLMEYAPYGTLTDAAAKDGGRVDETRVVKYTRDILKGLEYIHSK 120

Query:   119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
             GIVHCD+KG N+++S+  E  AKIADFGCA+R  V+   E  P+ GTP  MAPEVARGE+
Sbjct:   121 GIVHCDVKGSNVVISEKGE--AKIADFGCAKR--VDPVFES-PVMGTPAFMAPEVARGEK 175

Query:   179 QGFPADVWALGCTVLEMATGRPPWPDV---ADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
             QG  +D+WA+GCT++EM TG PPW       DP+S L+R+G+SS+TPE+P  ++++A+DF
Sbjct:   176 QGKESDIWAVGCTMIEMVTGSPPWTKADSREDPVSVLYRVGYSSETPELPCLLAEEAKDF 235

Query:   236 LSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDS 291
             L KCL R   ERW+A++LL H F+  +   +  +  P    S SPTSV +Q  W S
Sbjct:   236 LEKCLKREANERWTATQLLNHPFLTTKP-DIEPVLVPGLI-SNSPTSVTDQTFWRS 289

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2205523 MAPKKK18 "mitogen-activated protein kinase kinase kinase 18" [Arabidopsis thaliana (taxid:3702)]

 Score = 761 (272.9 bits), Expect = 1.7e-75, P = 1.7e-75
 Identities = 166/348 (47%), Positives = 221/348 (63%)

Query:     1 MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
             M+WTRG+T+GRGSTATVS    + S E  AVKSAE   SEFLQRE +ILS+L  P ++ Y
Sbjct:     1 MNWTRGKTLGRGSTATVSAATCHESGETLAVKSAEFHRSEFLQREAKILSSLNSPYVIGY 60

Query:    61 KGCDISEE----NGKIL-YNLFLEYAPGGTLTD-AIRSGTCLEEGRIRSHTRAVLLGLQY 114
             +GC+I+ E    NG+   Y+L +EYAP GTLTD A ++G  ++E R+  +TR +LLGL+Y
Sbjct:    61 RGCEITREPFHNNGEATTYSLLMEYAPYGTLTDVATKNGGFIDEARVVKYTRQILLGLEY 120

Query:   115 LH-SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
             +H S GI HCDIKG N+LV ++ E  AKIADFGCA+     E +  +P+ GTP  MAPE 
Sbjct:   121 IHNSKGIAHCDIKGSNVLVGENGE--AKIADFGCAKWV---EPEITEPVRGTPAFMAPEA 175

Query:   174 ARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRIGFSSDTPEIPGYMSKQ 231
             ARGE QG  +D+WA+GCTV+EM TG  PW   D  DP+S L+R+G+  + PE+P  +++Q
Sbjct:   176 ARGERQGKESDIWAVGCTVIEMVTGSQPWIGADFTDPVSVLYRVGYLGELPELPCSLTEQ 235

Query:   232 AQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDS 291
             A+DFL KCL +   ERW+AS+LL H F+  +  +L T        + SPTSV +Q  W S
Sbjct:   236 AKDFLGKCLKKEATERWTASQLLNHPFLVNKEPELVT-----GLVTNSPTSVTDQMFWRS 290

Query:   292 TLTSCSSASAK-------ERIRQLIGEGSSEMVNWAWD---ETWVTVR 329
                  S   +        ERI  L   G   +V   WD   E W+TVR
Sbjct:   291 VEEEVSEDRSSWWECHEDERIGVLSWIGHV-VVESTWDLDGEDWITVR 337

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2116417 MAPKKK16 "mitogen-activated protein kinase kinase kinase 16" [Arabidopsis thaliana (taxid:3702)]

 Score = 730 (262.0 bits), Expect = 3.2e-72, P = 3.2e-72
 Identities = 150/299 (50%), Positives = 204/299 (68%)

Query:     1 MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
             ++WTRG  IGRGSTATVSI +S+ S E+FAVKSA+LS+S  LQ+EQ ILS L+ P +V Y
Sbjct:     3 INWTRGPIIGRGSTATVSIAISS-SGELFAVKSADLSSSSLLQKEQSILSTLSSPHMVKY 61

Query:    61 KGCDISEENGKILYNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
              G  ++ E+  ++YN+ +EY  GG L D I+ SG  L E  IRS+TR +L GL YLH  G
Sbjct:    62 IGTGLTRESNGLVYNILMEYVSGGNLHDLIKNSGGKLPEPEIRSYTRQILNGLVYLHERG 121

Query:   120 IVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
             IVHCD+K  N+LV    E G  KIAD GCA+    +E        GTP  MAPEVARGEE
Sbjct:   122 IVHCDLKSHNVLVE---ENGVLKIADMGCAKSVDKSE------FSGTPAFMAPEVARGEE 172

Query:   179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK 238
             Q FPADVWALGCT++EM TG  PWP++ D ++A+++IGFS ++P IP ++S +A+DFL  
Sbjct:   173 QRFPADVWALGCTMIEMMTGSSPWPELNDVVAAMYKIGFSGESPAIPAWISDKAKDFLKN 232

Query:   239 CLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLTSCS 297
             CL  +  +RW+  ELL+H F+ +   + S  ++     + SP++VL+Q+ WDS  +S S
Sbjct:   233 CLKEDQKQRWTVEELLKHPFLDDD--EESQTSDCLKNKTSSPSTVLDQRFWDSCESSKS 289

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2074835 MAPKKK20 "mitogen-activated protein kinase kinase kinase 20" [Arabidopsis thaliana (taxid:3702)]

 Score = 551 (199.0 bits), Expect = 3.0e-53, P = 3.0e-53
 Identities = 136/349 (38%), Positives = 193/349 (55%)

Query:     1 MDWTRGQTIGRGSTATVSIGMSNRSSEVF----AVKSAELSNSEFLQREQRILSALA-CP 55
             M+W RG+TIG G+ +TVS    +R+S  F    AVKS +   +  L  E+ +L +L  CP
Sbjct:     1 MEWVRGETIGFGTFSTVSTATKSRNSGDFPALIAVKSTDAYGAASLSNEKSVLDSLGDCP 60

Query:    56 QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQ 113
             +I+   G D + ENG+ ++NL LEYA  G+L   ++   G  L E  +R HT +VL GL+
Sbjct:    61 EIIRCYGEDSTVENGEEMHNLLLEYASRGSLASYMKKLGGEGLPESTVRRHTGSVLRGLR 120

Query:   114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR--VNEDDEGKPICGTPICMAP 171
             ++H+ G  HCDIK  NIL+  D     KIADFG A R    +    +   I GTP+ MAP
Sbjct:   121 HIHAKGFAHCDIKLANILLFNDGS--VKIADFGLAMRVDGDLTALRKSVEIRGTPLYMAP 178

Query:   172 EVARGEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMS 229
             E     E G  ADVWALGC V+EM +G+  W   + +  +S L RIG   + P+IP  +S
Sbjct:   179 ECVNDNEYGSAADVWALGCAVVEMFSGKTAWSVKEGSHFMSLLIRIGVGDELPKIPEMLS 238

Query:   230 KQAQDFLSKCLIRNPGERWSASELLEHGFVK-------EQNFKLSTLTEPETYNSESPTS 282
             ++ +DFLSKC +++P +RW+A  LL H FV         +NF +    E +   S  P  
Sbjct:   239 EEGKDFLSKCFVKDPAKRWTAEMLLNHSFVTIDLEDDHRENFVVKVKDEDKVLMS--PKC 296

Query:   283 VLNQQLWDS-TLTSCSSA-SAKERIRQLIGEGSSEMVNWAWDETWVTVR 329
                   WDS TL S  S  S  ER+  L+   S  + +W+   +W+TVR
Sbjct:   297 PFEFDDWDSFTLDSNPSFDSPVERLGSLV---SGSIPDWSVGGSWLTVR 342

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0048235 "pollen sperm cell differentiation" evidence=IEP

GO:0000302 "response to reactive oxygen species" evidence=IEP

GO:0009409 "response to cold" evidence=IEP

GO:0009414 "response to water deprivation" evidence=IMP

GO:0009651 "response to salt stress" evidence=IMP

TAIR|locus:2155568 MAPKKK19 "mitogen-activated protein kinase kinase kinase 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 544 (196.6 bits), Expect = 1.7e-52, P = 1.7e-52
 Identities = 138/353 (39%), Positives = 199/353 (56%)

Query:     1 MDWTRGQTIGRGSTATVSIGM-SNRSSEVF----AVKSAELSNSEFLQREQRILSALA-- 53
             M+W RG+TIG G+ +TVS+   SN  S  F    AVKSA+   +  L  E+ +L  L   
Sbjct:     1 MEWIRGETIGYGTFSTVSLATRSNNDSGEFPPLMAVKSADSYGAASLANEKSVLDNLGDD 60

Query:    54 CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLG 111
             C +IV   G D + ENG+ ++NLFLEYA  G+L   ++  +G  + E  +R HT +VL G
Sbjct:    61 CNEIVRCFGEDRTVENGEEMHNLFLEYASRGSLESYLKKLAGEGVPESTVRRHTGSVLRG 120

Query:   112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR-ARVNEDDEGKPICGTPICMA 170
             L+++H+NG  HCD+K  NIL+  D     KIADFG A+R   +   + G  I GTP+ MA
Sbjct:   121 LRHIHANGFAHCDLKLGNILLFGDG--AVKIADFGLAKRIGDLTALNYGVQIRGTPLYMA 178

Query:   171 PEVARGEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYM 228
             PE     E G   DVWALGC V+EM +G+  W   + ++ +S L RIG   + P IP  +
Sbjct:   179 PESVNDNEYGSEGDVWALGCVVVEMFSGKTAWSLKEGSNFMSLLLRIGVGDEVPMIPEEL 238

Query:   229 SKQAQDFLSKCLIRNPGERWSASELLEHGFV----------KEQNFKLSTLTEPETYNSE 278
             S+Q +DFLSKC +++P +RW+A  LL H FV          KE++F ++  TE     S 
Sbjct:   239 SEQGRDFLSKCFVKDPKKRWTAEMLLNHPFVTVDVDHDVLVKEEDFVVNMKTEDV---ST 295

Query:   279 SPTSVLNQQLWDSTLTSCSSA-SAKERIRQLIGEGSSEMV-NWAWDETWVTVR 329
             SP        W S  +   +  S  ER+  L+    ++M+ +W+   +WVTVR
Sbjct:   296 SPRCPFEFPDWVSVSSGSQTIDSPDERVASLV----TDMIPDWSVTNSWVTVR 344

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009737 "response to abscisic acid stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

TAIR|locus:2114990 MAPKKK21 "mitogen-activated protein kinase kinase kinase 21" [Arabidopsis thaliana (taxid:3702)]

 Score = 539 (194.8 bits), Expect = 5.6e-52, P = 5.6e-52
 Identities = 141/349 (40%), Positives = 201/349 (57%)

Query:     1 MDWTRGQTIGRGSTATVSIGM-SNRSSEVF----AVKSAELSNSEFLQREQRILSALA-C 54
             M+W R +TIG GS +TVS+   S  SS+ F    AVKS+ +  S  L+ E+ +L  L  C
Sbjct:     1 MEWIRRETIGHGSFSTVSLATTSGSSSKAFPSLMAVKSSGVVCSAALRNERDVLDDLGDC 60

Query:    55 PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQ 113
              +IV   G   + ENG+ +YNLFLEYA GG+L D I+S G  L E  +R  TR+++ GL 
Sbjct:    61 SEIVRCFGEGRTVENGEEIYNLFLEYASGGSLADRIKSSGEALPEFEVRRFTRSIVKGLC 120

Query:   114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPE- 172
             ++H NG  HCDIK +N+LV  D +   KI+DFG A+R R  E      I GTP+ MAPE 
Sbjct:   121 HIHGNGFTHCDIKLENVLVFGDGD--VKISDFGLAKR-RSGE--VCVEIRGTPLYMAPES 175

Query:   173 VARGEEQGFPADVWALGCTVLEMATGRPPW--PD--VADPISALHRIGFSSDTPEIPGYM 228
             V  GE +  PAD+WALGC+V+EM++G+  W   D  + + +S L RIG   + P IP  +
Sbjct:   176 VNHGEFES-PADIWALGCSVVEMSSGKTAWCLEDGVMNNVMSLLVRIGSGDEVPRIPVEL 234

Query:   229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQL 288
             S++ +DF+SKC ++N  ERW+A  LL+H F+   +    +  E E   S SP +  +   
Sbjct:   235 SEEGKDFVSKCFVKNAAERWTAEMLLDHPFLAVDD---ESGEEDEAC-SVSPRNPFDFPG 290

Query:   289 W--------DSTLTSCSSASAKERIRQLIGEGSSEMVNWAWDETWVTVR 329
             W        DS +      S +ERI  L+ E   ++ +W+    WV VR
Sbjct:   291 WNSVQSPVNDSVMFGSLVGSPEERISGLVSE---KVPDWSVSCDWVNVR 336

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2007337 MAPKKK13 "mitogen-activated protein kinase kinase kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 501 (181.4 bits), Expect = 6.0e-48, P = 6.0e-48
 Identities = 111/276 (40%), Positives = 159/276 (57%)

Query:     3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----EFLQREQRILSALAC-PQ 56
             W RG  IGRG    VS  +S  + EVFAVKS +L+ S     E L+ E  +  +L   P 
Sbjct:    23 WVRGACIGRGCFGAVSTAISKTNGEVFAVKSVDLATSLPTQSESLENEISVFRSLKPHPY 82

Query:    57 IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
             IV + G  +S+E      NL+LEY P G +      G   +E  ++ +T  ++  L+++H
Sbjct:    83 IVKFLGDGVSKEGTTTFRNLYLEYLPNGDVASHRAGGKIEDETLLQRYTACLVSALRHVH 142

Query:   117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
             S G VHCD+K +NILVS+ +    K+ADFG A   R++         G+P+ MAPEV R 
Sbjct:   143 SQGFVHCDVKARNILVSQSSM--VKLADFGSA--FRIHTPRALITPRGSPLWMAPEVIRR 198

Query:   177 EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL 236
             E QG  +DVW+LGCT++EM TG+P W D    I +L RI FS + P  P  +S+  +DFL
Sbjct:   199 EYQGPESDVWSLGCTIIEMFTGKPAWEDHG--IDSLSRISFSDELPVFPSKLSEIGRDFL 256

Query:   237 SKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEP 272
              KCL R+P +RWS  +LL+H F+ + +    T + P
Sbjct:   257 EKCLKRDPNQRWSCDQLLQHPFLSQCHNSSPTESSP 292

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2035989 NP1 "NPK1-related protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 477 (173.0 bits), Expect = 9.8e-48, Sum P(2) = 9.8e-48
 Identities = 113/283 (39%), Positives = 166/283 (58%)

Query:     1 MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVK----SAELSNSEF-------LQREQRIL 49
             + W +GQ IGRG+  TV +GM+  S E+ AVK    +A  ++ E        L+ E ++L
Sbjct:    67 ISWRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLL 126

Query:    50 SALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVL 109
               L+ P IV Y G  + E++     N+ LE+ PGG+++  +       E  +R++TR +L
Sbjct:   127 KNLSHPNIVRYLGT-VREDD---TLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLL 182

Query:   110 LGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR-ARVNEDDEGKPICGTPIC 168
             LGL+YLH++ I+H DIKG NILV  DN+   K+ADFG +++ A +      K + GTP  
Sbjct:   183 LGLEYLHNHAIMHRDIKGANILV--DNKGCIKLADFGASKQVAELATMTGAKSMKGTPYW 240

Query:   169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
             MAPEV       F AD+W++GCTV+EM TG+ PW      ++A+  IG +   P IP  +
Sbjct:   241 MAPEVILQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTL 300

Query:   229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTE 271
             S  A+DFL KCL   P  R +ASELL+H FV  ++ K S  T+
Sbjct:   301 SSDAKDFLLKCLQEVPNLRPTASELLKHPFVMGKH-KESASTD 342

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IDA

GO:0009908 "flower development" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS

TAIR|locus:2045658 MAPKKK14 "mitogen-activated protein kinase kinase kinase 14" [Arabidopsis thaliana (taxid:3702)]

 Score = 494 (179.0 bits), Expect = 3.3e-47, P = 3.3e-47
 Identities = 126/334 (37%), Positives = 177/334 (52%)

Query:     3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-----SNSEFLQREQRILSALAC-PQ 56
             W RG  +GRG   TVS  +S     +FAVKS +L     S +E L+ E  IL ++   P 
Sbjct:    17 WIRGSCVGRGCFGTVSKALSKIDGGLFAVKSIDLATCLPSQAESLENEIVILRSMKSHPN 76

Query:    57 IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
             IV + G D+S+E      NL LEY+P G     + +G  + E  +R +   ++  L ++H
Sbjct:    77 IVRFLGDDVSKEGTASFRNLHLEYSPEGD----VANGGIVNETLLRRYVWCLVSALSHVH 132

Query:   117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
             SNGIVHCD+K +N+LV        K+ADFG A            P  G+P+ MAPEV R 
Sbjct:   133 SNGIVHCDVKSKNVLVFNGGSS-VKLADFGSAVEFE-KSTIHVSPR-GSPLWMAPEVVRR 189

Query:   177 EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL 236
             E QG  +DVW+LGCTV+EM TG+P W D      +L RIGFS+D P IP  +S+  +DFL
Sbjct:   190 EYQGPESDVWSLGCTVIEMLTGKPAWEDHG--FDSLSRIGFSNDLPFIPVGLSELGRDFL 247

Query:   237 SKCLIRNPGERWSASELLEHGFV-KEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLTS 295
              KCL R+  +RWS  +LL+H F+ ++ +    T + P     +   S  +++        
Sbjct:   248 EKCLKRDRSQRWSCDQLLQHPFLCQDHHDSFFTESSPRCV-LDWVNSEFDEEEESDEWRP 306

Query:   296 CSSASAKERIRQLIGEGSSEMVNWAWDETWVTVR 329
              S  SA  RI +L   G +   NW     W  VR
Sbjct:   307 ESMVSAMARISKLAITGGA---NWE-SNGWTEVR 336

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IMP

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IMP

GO:0009737 "response to abscisic acid stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	385
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-129
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-79
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-78
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-72
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-69
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-65
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-63
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-61
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-59
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-59
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-58
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-58
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-57
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-55
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-53
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-53
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-52
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-51
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-49
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-47
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-47
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-46
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-46
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-45
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-44
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-44
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-43
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-43
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-42
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-41
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-41
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-40
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-40
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-40
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-40
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-40
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-39
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-38
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-38
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-38
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-38
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-37
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-36
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-35
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-34
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-34
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-34
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-34
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	9e-34
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	8e-33
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-32
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-32
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-31
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-31
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-31
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-31
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-31
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-31
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-31
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-30
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-30
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-29
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-29
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-29
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-29
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-29
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-29
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-29
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-29
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-29
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-29
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-28
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-28
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-28
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-28
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-28
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-28
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-27
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-27
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-27
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-26
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-26
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-26
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-26
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-26
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-26
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-26
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-26
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-26
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-25
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-25
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-25
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-24
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-24
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-24
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-24
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-24
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-24
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-24
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-23
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-23
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-23
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-22
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-22
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-22
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-22
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-21
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-21
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-21
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-21
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-21
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-21
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-21
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-20
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-20
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-20
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-20
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-20
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-20
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-20
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-20
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-20
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-19
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-19
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-19
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-19
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-19
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-19
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-19
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-19
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-18
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-18
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-18
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-18
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-18
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-18
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-18
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-18
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-17
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-17
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-17
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-17
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-17
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	9e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-16
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-16
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-16
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-16
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-16
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-16
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-16
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-16
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-16
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-16
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	8e-16
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-15
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-15
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-15
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-15
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-15
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-15
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-15
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-15
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	8e-15
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	9e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-15
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-14
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-14
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-14
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-14
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-14
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-14
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-14
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-14
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-13
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-13
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-13
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-12
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-12
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-12
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-12
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	4e-12
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-12
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-12
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-11
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-11
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-11
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-11
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-11
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	9e-11
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-10
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-10
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-10
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-10
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-10
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	9e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-09
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-09
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	9e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-08
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-08
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-08
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-08
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-08
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-07
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-07
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-07
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-07
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	8e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	8e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-06
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	1e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-06
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-06
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-06
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	2e-06
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-06
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-06
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-06
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-06
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-06
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-05
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	1e-05
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-05
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-05
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-05
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-05
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-05
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-05
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	7e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	9e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-05
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-04
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-04
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-04
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-04
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-04
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.001
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	0.002

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  370 bits (953), Expect = e-129
 Identities = 132/264 (50%), Positives = 179/264 (67%), Gaps = 10/264 (3%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQ 56
           +WTRG+ +GRGS  +V + +   + E+ AVKS ELS       E L+RE RILS+L  P 
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV Y G +  EE      N+FLEY  GG+L+  ++    L E  IR +TR +L GL YLH
Sbjct: 61  IVRYYGSERDEEKN--TLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR-ARVNEDDEGKPICGTPICMAPEVAR 175
           SNGIVH DIKG NILV  D++   K+ADFGCA+R   +   +    + GTP  MAPEV R
Sbjct: 119 SNGIVHRDIKGANILV--DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
           GEE G  AD+W+LGCTV+EMATG+PPW ++ +P++AL++IG S + PEIP ++S++A+DF
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236

Query: 236 LSKCLIRNPGERWSASELLEHGFV 259
           L KCL R+P +R +A ELL+H F+
Sbjct: 237 LRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  243 bits (624), Expect = 2e-79
 Identities = 87/262 (33%), Positives = 135/262 (51%), Gaps = 13/262 (4%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK----SAELSNSEFLQREQRILSALACPQIV 58
           +   + +G GS   V +    ++ ++ A+K         + E + RE +IL  L  P IV
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
                    E+   LY L +EY  GG L D ++    L E   R + R +L  L+YLHS 
Sbjct: 61  RLYD---VFEDEDKLY-LVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK 116

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           GIVH D+K +NIL+ +D     K+ADFG AR  +++  ++     GTP  MAPEV  G+ 
Sbjct: 117 GIVHRDLKPENILLDEDGH--VKLADFGLAR--QLDPGEKLTTFVGTPEYMAPEVLLGKG 172

Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG-FSSDTPEIPGYMSKQAQDFLS 237
            G   D+W+LG  + E+ TG+PP+P     +    +IG      P     +S +A+D + 
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIR 232

Query: 238 KCLIRNPGERWSASELLEHGFV 259
           K L+++P +R +A E L+H F 
Sbjct: 233 KLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  242 bits (620), Expect = 1e-78
 Identities = 113/266 (42%), Positives = 157/266 (59%), Gaps = 18/266 (6%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF--------LQREQRILSALAC 54
           W +G+ +G GS  +V  G++    + FAVK   L++           L++E  +LS L  
Sbjct: 2   WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
           P IV Y G +  E+N      +FLE  PGG+L   ++      E  IR +TR +LLGL+Y
Sbjct: 62  PNIVQYLGTEREEDN----LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEY 117

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           LH    VH DIKG NILV  D     K+ADFG A+  +V E    K   G+P  MAPEV 
Sbjct: 118 LHDRNTVHRDIKGANILV--DTNGVVKLADFGMAK--QVVEFSFAKSFKGSPYWMAPEVI 173

Query: 175 RGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
             +   G  AD+W+LGCTVLEMATG+PPW  + + ++A+ +IG S + P IP ++S +A+
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPPWSQL-EGVAAVFKIGRSKELPPIPDHLSDEAK 232

Query: 234 DFLSKCLIRNPGERWSASELLEHGFV 259
           DF+ KCL R+P  R +A+ELLEH FV
Sbjct: 233 DFILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  226 bits (579), Expect = 1e-72
 Identities = 91/263 (34%), Positives = 146/263 (55%), Gaps = 16/263 (6%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIV 58
            +   + IG+G    V      R+ +  A+K  +L +    E +  E +IL     P IV
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHS 117
            Y G  + ++   I+    +E+  GG+L D ++S    L E +I    + +L GL+YLHS
Sbjct: 61  KYYGSYLKKDELWIV----MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
           NGI+H DIK  NIL++ D E   K+ DFG +  A++++      + GTP  MAPEV  G+
Sbjct: 117 NGIIHRDIKAANILLTSDGE--VKLIDFGLS--AQLSDTKARNTMVGTPYWMAPEVINGK 172

Query: 178 EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPG--YMSKQAQDF 235
              + AD+W+LG T +E+A G+PP+ ++  P+ AL +I  ++  P +      S + +DF
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPYSEL-PPMKALFKIA-TNGPPGLRNPEKWSDEFKDF 230

Query: 236 LSKCLIRNPGERWSASELLEHGF 258
           L KCL +NP +R +A +LL+H F
Sbjct: 231 LKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  217 bits (555), Expect = 6e-69
 Identities = 91/268 (33%), Positives = 135/268 (50%), Gaps = 19/268 (7%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQ---REQRILSALACPQI 57
           +   + +G GS  TV       + ++ AVK        S+  Q   RE RIL  L+ P I
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V     D  E+   +   L +EY  GG L D +  G  L E   +     +L GL+YLHS
Sbjct: 61  VRLI--DAFEDKDHLY--LVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHS 116

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV-ARG 176
           NGI+H D+K +NIL+ ++     KIADFG A +  +          GTP  MAPEV   G
Sbjct: 117 NGIIHRDLKPENILLDENGV--VKIADFGLA-KKLLKSSSSLTTFVGTPWYMAPEVLLGG 173

Query: 177 EEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIG---FSSDTPEIPGYMSKQ 231
              G   DVW+LG  + E+ TG+PP+   ++ D +  + RI       D P+     S++
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWS-SGSEE 232

Query: 232 AQDFLSKCLIRNPGERWSASELLEHGFV 259
           A+D + KCL ++P +R +A E+L+H + 
Sbjct: 233 AKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  207 bits (529), Expect = 4e-65
 Identities = 95/259 (36%), Positives = 137/259 (52%), Gaps = 14/259 (5%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFL---QREQRILSALACPQIVAY 60
           G  IGRG+   V  G++  + +  A+K   L     E L    +E  +L  L  P IV Y
Sbjct: 5   GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
            G     E    LY + LEYA  G+L   I+      E  +  +   VL GL YLH  G+
Sbjct: 65  IGS---IETSDSLY-IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           +H DIK  NIL +KD     K+ADFG A +      D+   + GTP  MAPEV       
Sbjct: 121 IHRDIKAANILTTKDGV--VKLADFGVATKLNDVSKDDASVV-GTPYWMAPEVIEMSGAS 177

Query: 181 FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCL 240
             +D+W+LGCTV+E+ TG PP+ D+ +P++AL RI    D P +P  +S + +DFL +C 
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDL-NPMAALFRIV-QDDHPPLPEGISPELKDFLMQCF 235

Query: 241 IRNPGERWSASELLEHGFV 259
            ++P  R +A +LL+H ++
Sbjct: 236 QKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  204 bits (520), Expect = 1e-63
 Identities = 101/270 (37%), Positives = 147/270 (54%), Gaps = 20/270 (7%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKS-----AELSNSEFLQREQRILSALACPQI 57
           W RG  IG G+   V   ++  + E+ AVK       +    + +  E ++L  L  P +
Sbjct: 2   WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNL 61

Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V Y G ++  E       +F+EY  GGTL + +  G  L+E  IR +T  +L GL YLHS
Sbjct: 62  VKYYGVEVHREK----VYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS 117

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED---DEGKPICGTPICMAPEVA 174
           +GIVH DIK  NI +  +     K+ DFGCA + + N     +E + + GTP  MAPEV 
Sbjct: 118 HGIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175

Query: 175 RGEE---QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPG--YMS 229
            G +    G  AD+W+LGC VLEMATG+ PW ++ +    +  +G     P IP    +S
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLS 234

Query: 230 KQAQDFLSKCLIRNPGERWSASELLEHGFV 259
            + +DFL +CL  +P +R +ASELL+H FV
Sbjct: 235 PEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  197 bits (503), Expect = 5e-61
 Identities = 97/267 (36%), Positives = 142/267 (53%), Gaps = 25/267 (9%)

Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE----FLQREQRILSALACPQIVA 59
           T  + IG+GS   V   +  R+++V A+K  +L  +E     +Q+E + LS    P I  
Sbjct: 4   TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITK 63

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           Y G  +      I+    +EY  GG+  D ++ G  L+E  I    R VLLGL+YLH  G
Sbjct: 64  YYGSFLKGSKLWII----MEYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYLHEEG 118

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCA-----RRARVNEDDEGKPICGTPICMAPEVA 174
            +H DIK  NIL+S++ +   K+ADFG +       ++ N         GTP  MAPEV 
Sbjct: 119 KIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKRNT------FVGTPFWMAPEVI 170

Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM-SKQAQ 233
           +       AD+W+LG T +E+A G PP  D+  P+  L  I   ++ P + G   SK  +
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEPPLSDL-HPMRVLFLIP-KNNPPSLEGNKFSKPFK 228

Query: 234 DFLSKCLIRNPGERWSASELLEHGFVK 260
           DF+S CL ++P ER SA ELL+H F+K
Sbjct: 229 DFVSLCLNKDPKERPSAKELLKHKFIK 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  193 bits (493), Expect = 1e-59
 Identities = 98/268 (36%), Positives = 152/268 (56%), Gaps = 17/268 (6%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK-------SAELSNS-EFLQREQRILSALA 53
           +W RG+ +G+G+   V +     +    AVK       S E       L+ E ++L  L 
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
             +IV Y GC    ++  +  ++F+EY PGG++ D +++   L E   R +TR +L G++
Sbjct: 63  HERIVQYYGCL--RDDETL--SIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVE 118

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV--NEDDEGKPICGTPICMAP 171
           YLHSN IVH DIKG NIL  +D+    K+ DFG ++R +   +     K + GTP  M+P
Sbjct: 119 YLHSNMIVHRDIKGANIL--RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Query: 172 EVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQ 231
           EV  GE  G  ADVW++GCTV+EM T +PPW +  + ++A+ +I      P++P ++S  
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF-EAMAAIFKIATQPTNPQLPSHVSPD 235

Query: 232 AQDFLSKCLIRNPGERWSASELLEHGFV 259
           A++FL +  + N  +R SA ELL H FV
Sbjct: 236 ARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  193 bits (491), Expect = 2e-59
 Identities = 104/274 (37%), Positives = 154/274 (56%), Gaps = 25/274 (9%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS------------EFLQREQRILS 50
           W +G  IG GS  +V +GM+  S E+ AVK  EL +             + L RE  +L 
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 51  ALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL 110
            L    IV Y G  +  ++     N+FLEY PGG++   + +    EE  +R+  R +L 
Sbjct: 62  ELQHENIVQYLGSSLDADH----LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILK 117

Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN----EDDEGKP-ICGT 165
           GL YLH+ GI+H DIKG NILV  DN+ G KI+DFG +++   N    + +  +P + G+
Sbjct: 118 GLNYLHNRGIIHRDIKGANILV--DNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175

Query: 166 PICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP 225
              MAPEV +       AD+W+LGC V+EM TG+ P+PD    + A+ +IG  + +PEIP
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC-TQLQAIFKIG-ENASPEIP 233

Query: 226 GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV 259
             +S +A DFL K    +  +R +A+ELL+H F+
Sbjct: 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  190 bits (485), Expect = 1e-58
 Identities = 99/272 (36%), Positives = 149/272 (54%), Gaps = 23/272 (8%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS---------EFLQREQRILSALA 53
           WT+G+ +G+G+  TV  G++N   ++ AVK  EL  S         E LQ E  +L +L 
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
              IV Y G  + ++N     ++F+E+ PGG+++  +     L E     +T+ +L G+ 
Sbjct: 61  HVNIVQYLGTCL-DDN---TISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA 116

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR-----ARVNEDDEGKPICGTPIC 168
           YLH+N +VH DIKG N+++  +     K+ DFGCARR           +  K + GTP  
Sbjct: 117 YLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG-FSSDTPEIPGY 227
           MAPEV      G  +D+W++GCTV EMATG+PP   + D ++A+  IG      P +P  
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM-DRLAAMFYIGAHRGLMPRLPDS 233

Query: 228 MSKQAQDFLSKCLIRNPGERWSASELLEHGFV 259
            S  A DF++ CL R+  ER SA +LL H F+
Sbjct: 234 FSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  187 bits (477), Expect = 7e-58
 Identities = 79/254 (31%), Positives = 115/254 (45%), Gaps = 46/254 (18%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVK----SAELSNSEFLQREQRILSALACPQIVAYKGCD 64
           +G G   TV +    ++ +  A+K        S  E L RE  IL  L  P IV   G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
             E +      L +EY  GG+L D ++     L E  I      +L GL+YLHSNGI+H 
Sbjct: 61  EDENH----LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116

Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE-EQGFP 182
           D+K +NIL+  DN +  K+ADFG ++    ++    K I GTP  MAPEV  G+      
Sbjct: 117 DLKPENILLDSDNGK-VKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 183 ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIR 242
           +D+W+LG  + E+                                   + +D + K L +
Sbjct: 175 SDIWSLGVILYEL----------------------------------PELKDLIRKMLQK 200

Query: 243 NPGERWSASELLEH 256
           +P +R SA E+LEH
Sbjct: 201 DPEKRPSAKEILEH 214

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  188 bits (480), Expect = 1e-57
 Identities = 97/276 (35%), Positives = 144/276 (52%), Gaps = 27/276 (9%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALAC-------- 54
           W +G+ IG+G+   V + ++  + E+ AVK  EL  +   + + R    +          
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 55  -----PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVL 109
                  IV Y G     E  +   ++FLEY PGG++   +R+    EE  +R  T  VL
Sbjct: 63  KDLDHLNIVQYLGF----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL 118

Query: 110 LGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR-ARVNEDDEGKPICGTPIC 168
            GL YLHS GI+H D+K  N+LV  D +   KI+DFG +++   + ++D+   + G+   
Sbjct: 119 EGLAYLHSKGILHRDLKADNLLV--DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176

Query: 169 MAPEVARGEEQGFPA--DVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP- 225
           MAPEV     QG+ A  D+W+LGC VLEM  GR PW D  + I+A+ ++G     P IP 
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE-EAIAAMFKLGNKRSAPPIPP 235

Query: 226 ---GYMSKQAQDFLSKCLIRNPGERWSASELLEHGF 258
                +S  A DFL+ C   NP  R +A ELL+H F
Sbjct: 236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  181 bits (461), Expect = 6e-55
 Identities = 87/256 (33%), Positives = 137/256 (53%), Gaps = 15/256 (5%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSN-SEFLQREQRILSALACPQIVAYKGCDISE 67
           +G GS  +V   +   + +V A+K   +    + + +E  IL     P IV Y G     
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKN 70

Query: 68  ENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIK 126
            +  I+    +EY   G+++D ++     L E  I +     L GL+YLHSN  +H DIK
Sbjct: 71  TDLWIV----MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIK 126

Query: 127 GQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF--PAD 184
             NIL++++ +  AK+ADFG + +   +   +   + GTP  MAPEV   +E G+   AD
Sbjct: 127 AGNILLNEEGQ--AKLADFGVSGQL-TDTMAKRNTVIGTPFWMAPEVI--QEIGYNNKAD 181

Query: 185 VWALGCTVLEMATGRPPWPDVADPISALHRIGFS-SDTPEIPGYMSKQAQDFLSKCLIRN 243
           +W+LG T +EMA G+PP+ D+  P+ A+  I      T   P   S +  DF+ KCL+++
Sbjct: 182 IWSLGITAIEMAEGKPPYSDI-HPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKD 240

Query: 244 PGERWSASELLEHGFV 259
           P ER SA +LL+H F+
Sbjct: 241 PEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  177 bits (450), Expect = 3e-53
 Identities = 97/261 (37%), Positives = 145/261 (55%), Gaps = 18/261 (6%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ---REQRILSALACPQIVAYKGCDI 65
           +G+G+   V       +    A+K     +S ++Q    E  + S L    IV Y G D 
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 66  SEENGKILYNLFLEYAPGGTLTDAIRSG---TCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
             ENG     +F+E  PGG+L+  +RS        E  I  +T+ +L GL+YLH N IVH
Sbjct: 76  --ENGFFK--IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131

Query: 123 CDIKGQNILVSKDNEQGA-KIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
            DIKG N+LV  +   G  KI+DFG   R A +N   E     GT   MAPEV     +G
Sbjct: 132 RDIKGDNVLV--NTYSGVVKISDFGTSKRLAGINPCTE--TFTGTLQYMAPEVIDKGPRG 187

Query: 181 F--PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK 238
           +  PAD+W+LGCT++EMATG+PP+ ++ +P +A+ ++G     PEIP  +S +A++F+ +
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR 247

Query: 239 CLIRNPGERWSASELLEHGFV 259
           C   +P +R SA +LL+  F+
Sbjct: 248 CFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  175 bits (447), Expect = 8e-53
 Identities = 83/260 (31%), Positives = 133/260 (51%), Gaps = 14/260 (5%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKS-AELSNSEFLQ---REQRILSALACPQIVAYKGCD 64
           +G+GS+  V       + +++A+K      + EF +   RE + L +   P +V   G  
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG-- 66

Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN-GIVHC 123
              + G+I  ++ LEY  GG+L D ++    + E  +    R +L GL YLH+   I+H 
Sbjct: 67  AFYKEGEI--SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHR 124

Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPA 183
           DIK  N+L++   E   KIADFG ++    N  D+     GT   M+PE  +GE   + A
Sbjct: 125 DIKPSNLLINSKGE--VKIADFGISKVLE-NTLDQCNTFVGTVTYMSPERIQGESYSYAA 181

Query: 184 DVWALGCTVLEMATGRPPW--PDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLI 241
           D+W+LG T+LE A G+ P+  P        +  I             S + +DF+S CL 
Sbjct: 182 DIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQ 241

Query: 242 RNPGERWSASELLEHGFVKE 261
           ++P +R SA+ELL+H F+K+
Sbjct: 242 KDPKKRPSAAELLQHPFIKK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  174 bits (443), Expect = 6e-52
 Identities = 94/262 (35%), Positives = 138/262 (52%), Gaps = 20/262 (7%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS--EFLQREQRILSALACPQIVAYKGCD 64
           + IG G++  V       + +  A+K   L     E +  E  I+     P IV Y    
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSY 84

Query: 65  ISEENGKILYNLFL--EYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
           +  +       L++  EY  GG+LTD I  +   + E +I    R VL GL+YLHS  ++
Sbjct: 85  LVGDE------LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVI 138

Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVN-EDDEGKPICGTPICMAPEVARGEEQG 180
           H DIK  NIL+SKD     K+ADFG A  A++  E  +   + GTP  MAPEV + ++ G
Sbjct: 139 HRDIKSDNILLSKDGS--VKLADFGFA--AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG 194

Query: 181 FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMSKQAQDFLSK 238
              D+W+LG   +EMA G PP+     P+ AL  I  +   P +  P   S + +DFL+K
Sbjct: 195 PKVDIWSLGIMCIEMAEGEPPYLRE-PPLRALFLIT-TKGIPPLKNPEKWSPEFKDFLNK 252

Query: 239 CLIRNPGERWSASELLEHGFVK 260
           CL+++P +R SA ELL+H F+K
Sbjct: 253 CLVKDPEKRPSAEELLQHPFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  171 bits (435), Expect = 5e-51
 Identities = 77/264 (29%), Positives = 133/264 (50%), Gaps = 22/264 (8%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----EFLQREQRILSALACPQIVAYK 61
           + IG+GS   V +       +++ +K  +LSN      E    E +IL  L  P I+ Y 
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS----GTCLEEGRIRSHTRAVLLGLQYLHS 117
                EE GK+   + +EYA GG L+  I+     G    E +I      + L L+YLHS
Sbjct: 66  ES--FEEKGKL--CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPEVARG 176
             I+H DIK QNI ++ +     K+ DFG ++   ++   +  K + GTP  ++PE+ + 
Sbjct: 122 RKILHRDIKPQNIFLTSNGL--VKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPELCQN 177

Query: 177 EEQGFPADVWALGCTVLEMATGRPPWPDVADPISAL-HRIGFSSDTPEIPGYMSKQAQDF 235
           +   + +D+W+LGC + E+ T + P+    + +  L  +I      P IP   S + ++ 
Sbjct: 178 KPYNYKSDIWSLGCVLYELCTLKHPF--EGENLLELALKI-LKGQYPPIPSQYSSELRNL 234

Query: 236 LSKCLIRNPGERWSASELLEHGFV 259
           +S  L ++P ER S +++L+  F+
Sbjct: 235 VSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  166 bits (420), Expect = 8e-49
 Identities = 100/270 (37%), Positives = 153/270 (56%), Gaps = 16/270 (5%)

Query: 1   MDWTRGQTIGRGSTATVSI------GMSNRSSEV-FAVKSAELSNS-EFLQREQRILSAL 52
           ++W RG+ +G+G+   V +      G    + +V F  +S E S     L+ E ++L  L
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGL 112
              +IV Y GC    +  +    +F+EY PGG++ D +++   L E   R +TR +L G+
Sbjct: 62  QHERIVQYYGC--LRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGM 119

Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR-VNEDDEG-KPICGTPICMA 170
            YLHSN IVH DIKG NIL  +D+    K+ DFG ++R + +     G + + GTP  M+
Sbjct: 120 SYLHSNMIVHRDIKGANIL--RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177

Query: 171 PEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK 230
           PEV  GE  G  ADVW+LGCTV+EM T +PPW +  + ++A+ +I      P++P ++S+
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY-EAMAAIFKIATQPTNPQLPSHISE 236

Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGFVK 260
            A+DFL  C+      R SA ELL H F +
Sbjct: 237 HARDFL-GCIFVEARHRPSAEELLRHPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  160 bits (408), Expect = 4e-47
 Identities = 85/260 (32%), Positives = 127/260 (48%), Gaps = 21/260 (8%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAV----KSAELSNSEFLQ--REQRILSALACPQIVAYKG 62
           +G+GS   V +     + +++A+    K   +   E      E+ ILS +  P IV    
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
              +EE    LY L LEYAPGG L   +       E R R +   ++L L+YLHS GI++
Sbjct: 61  AFQTEEK---LY-LVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIY 116

Query: 123 CDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF 181
            D+K +NIL+   +  G  K+ DFG A+    +E       CGTP  +APEV  G+  G 
Sbjct: 117 RDLKPENILL---DADGHIKLTDFGLAKEL-SSEGSRTNTFCGTPEYLAPEVLLGKGYGK 172

Query: 182 PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLI 241
             D W+LG  + EM TG+PP+    D      +I    D    P ++S +A+D +S  L 
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKI--LKDPLRFPEFLSPEARDLISGLLQ 229

Query: 242 RNPGER---WSASELLEHGF 258
           ++P +R     A E+  H F
Sbjct: 230 KDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  160 bits (406), Expect = 8e-47
 Identities = 98/268 (36%), Positives = 149/268 (55%), Gaps = 16/268 (5%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK-------SAELSNS-EFLQREQRILSALA 53
           +W  G+ +G+G+   V +     +    AVK       S E S     L+ E ++L  L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
             +IV Y GC + +   + L ++F+E+ PGG++ D ++S   L E   R +TR +L G+ 
Sbjct: 63  HERIVQYYGC-LRDPMERTL-SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS 120

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR-VNEDDEG-KPICGTPICMAP 171
           YLHSN IVH DIKG NIL  +D+    K+ DFG ++R + +     G K + GTP  M+P
Sbjct: 121 YLHSNMIVHRDIKGANIL--RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178

Query: 172 EVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQ 231
           EV  GE  G  AD+W++GCTV+EM T +PPW +  + ++A+ +I      P +P ++S  
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF-EAMAAIFKIATQPTNPVLPPHVSDH 237

Query: 232 AQDFLSKCLIRNPGERWSASELLEHGFV 259
            +DFL +  +     R SA ELL H FV
Sbjct: 238 CRDFLKRIFVEAK-LRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  160 bits (406), Expect = 1e-46
 Identities = 89/271 (32%), Positives = 144/271 (53%), Gaps = 23/271 (8%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---------SAELSNSEFLQREQRILSAL 52
           +W +GQ +G G+ ++       ++  + AVK         S +    E L++E R+++ L
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGL 112
             P I+   G    + +    +NLF+E+  GG+++  +      +E  I ++T  +L GL
Sbjct: 61  NHPHIIRMLGATCEDSH----FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGL 116

Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR--ARVNEDDEGK-PICGTPICM 169
            YLH N I+H D+KG N+L+     Q  +IADFG A R  A+     E +  + GT   M
Sbjct: 117 SYLHENQIIHRDVKGANLLIDSTG-QRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175

Query: 170 APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS----ALHRIGFSSDTPEIP 225
           APEV RGE+ G   DVW++GC ++EMAT +PPW   A+  S     + +I  ++  P IP
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN--AEKHSNHLALIFKIASATTAPSIP 233

Query: 226 GYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
            ++S   +D   +CL   P +R  + ELL+H
Sbjct: 234 EHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  159 bits (403), Expect = 4e-46
 Identities = 101/294 (34%), Positives = 148/294 (50%), Gaps = 35/294 (11%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF----LQREQRILSAL---ACP 55
           + R + IGRG+   V  G    +  V A+K   L   +     +QRE  +LS L     P
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I  Y G  +    G  L+ + +EYA GG++   +++G  + E  I    R VL+ L+Y+
Sbjct: 63  NITKYYGSYL---KGPRLW-IIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYI 117

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGK-PICGTPICMAPEVA 174
           H  G++H DIK  NILV+  N    K+ DFG A  A +N++   +    GTP  MAPEV 
Sbjct: 118 HKVGVIHRDIKAANILVT--NTGNVKLCDFGVA--ALLNQNSSKRSTFVGTPYWMAPEVI 173

Query: 175 R-GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPG-YMSKQA 232
             G+     AD+W+LG T+ EMATG PP+ DV D   A+  I   S  P +     SK  
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDV-DAFRAMMLIP-KSKPPRLEDNGYSKLL 231

Query: 233 QDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQ 286
           ++F++ CL   P ER SA ELL+  ++K                S++P S+L +
Sbjct: 232 REFVAACLDEEPKERLSAEELLKSKWIKAH--------------SKTPVSILKE 271

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  155 bits (393), Expect = 7e-45
 Identities = 95/271 (35%), Positives = 135/271 (49%), Gaps = 36/271 (13%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE---FLQREQRILSALACPQIVAYKGC 63
           Q IG G+   V       + E+ A+K  +L   +    +Q+E  +L     P IVAY G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTC--LEEGRIRSHTRAVLLGLQYLHSNGIV 121
            +  +   I+    +EY  GG+L D I   T   L E +I    R  L GL YLH  G +
Sbjct: 69  YLRRDKLWIV----MEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHETGKI 123

Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCA--------RRARVNEDDEGKPICGTPICMAPEV 173
           H DIKG NIL+++D +   K+ADFG +        +R         K   GTP  MAPEV
Sbjct: 124 HRDIKGANILLTEDGD--VKLADFGVSAQLTATIAKR---------KSFIGTPYWMAPEV 172

Query: 174 ARGEEQG---FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP---EIPGY 227
           A  E +G      D+WALG T +E+A  +PP  D+  P+ AL  I  S+  P   +    
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQPPMFDL-HPMRALFLISKSNFPPPKLKDKEK 231

Query: 228 MSKQAQDFLSKCLIRNPGERWSASELLEHGF 258
            S    DF+ KCL ++P +R +A++LL+H F
Sbjct: 232 WSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  154 bits (391), Expect = 2e-44
 Identities = 105/274 (38%), Positives = 149/274 (54%), Gaps = 16/274 (5%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF----LQREQRILSALACPQIV 58
           +T+ + IG+GS   V  G+ NR+ EV A+K  +L  +E     +Q+E  +LS    P I 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
            Y G   S   G  L+ + +EY  GG+  D ++ G  LEE  I +  R +L GL YLHS 
Sbjct: 66  RYYG---SYLKGTKLW-IIMEYLGGGSALDLLKPGP-LEETYIATILREILKGLDYLHSE 120

Query: 119 GIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
             +H DIK  N+L+S   EQG  K+ADFG A +   +   +     GTP  MAPEV +  
Sbjct: 121 RKIHRDIKAANVLLS---EQGDVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIKQS 176

Query: 178 EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
              F AD+W+LG T +E+A G PP  D+  P+  L  I  +S  P + G  SK  ++F+ 
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNS-PPTLEGQYSKPFKEFVE 234

Query: 238 KCLIRNPGERWSASELLEHGFVKEQNFKLSTLTE 271
            CL ++P  R +A ELL+H F+     K S LTE
Sbjct: 235 ACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTE 268

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  156 bits (395), Expect = 3e-44
 Identities = 86/306 (28%), Positives = 129/306 (42%), Gaps = 30/306 (9%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ---REQRILSALA-CPQI 57
            +   + +G GS   V +    +   +  +     S S+ ++   RE +IL++L   P I
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60

Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSG---TCLEEGRIRSHTRAVLLGLQY 114
           V        E +      L +EY  GG+L D ++       L E         +L  L+Y
Sbjct: 61  VKLYDFFQDEGS----LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG-----KPICGTPICM 169
           LHS GI+H DIK +NIL+ +D     K+ DFG A+                   GTP  M
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRV-VKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 170 APEVARG---EEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTP-- 222
           APEV  G         +D+W+LG T+ E+ TG PP+     +   S   +I     TP  
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235

Query: 223 ------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYN 276
                   P  +SK A D L K L ++P  R S+S  L H  +     K S L++    +
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPD 295

Query: 277 SESPTS 282
             +P  
Sbjct: 296 DSAPLR 301

Length = 384

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  152 bits (385), Expect = 1e-43
 Identities = 98/268 (36%), Positives = 145/268 (54%), Gaps = 16/268 (5%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK-------SAELSNS-EFLQREQRILSALA 53
           +W  G+ +GRG+   V +     +    AVK       S E S     L+ E ++L  L 
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
             +IV Y GC    E  K+  ++F+EY PGG++ D +++   L E   R +TR +L G+ 
Sbjct: 63  HDRIVQYYGCLRDPEEKKL--SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS 120

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR-VNEDDEG-KPICGTPICMAP 171
           YLHSN IVH DIKG NIL  +D+    K+ DFG ++R + +     G K + GTP  M+P
Sbjct: 121 YLHSNMIVHRDIKGANIL--RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 172 EVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQ 231
           EV  GE  G  ADVW++ CTV+EM T +PPW +  + ++A+ +I      P +P  +S  
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY-EAMAAIFKIATQPTKPMLPDGVSDA 237

Query: 232 AQDFLSKCLIRNPGERWSASELLEHGFV 259
            +DFL +  +     R +A  LL H FV
Sbjct: 238 CRDFLKQIFVEEK-RRPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  152 bits (385), Expect = 2e-43
 Identities = 96/275 (34%), Positives = 150/275 (54%), Gaps = 20/275 (7%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS---EFLQREQRILSALACPQIVA 59
           +TR + IG+G++ TV   +   + +  A+K   L      E +  E  ++     P IV 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80

Query: 60  Y-KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
           Y     + +E    L+ + +EY  GG+LTD + + TC++EG+I +  R  L  L++LHSN
Sbjct: 81  YLDSYLVGDE----LW-VVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSN 134

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGE 177
            ++H DIK  NIL+  D     K+ DFG CA+     E  +   + GTP  MAPEV   +
Sbjct: 135 QVIHRDIKSDNILLGMDGS--VKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPEVVTRK 190

Query: 178 EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPG--YMSKQAQDF 235
             G   D+W+LG   +EM  G PP+ +  +P+ AL+ I  ++ TPE+     +S   +DF
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIA-TNGTPELQNPEKLSAIFRDF 248

Query: 236 LSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLT 270
           L++CL  +  +R SA ELL+H F+K     LS+LT
Sbjct: 249 LNRCLEMDVEKRGSAKELLQHPFLKIAK-PLSSLT 282

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  148 bits (376), Expect = 4e-42
 Identities = 90/261 (34%), Positives = 138/261 (52%), Gaps = 21/261 (8%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNS---EFLQREQRILSALACPQIVA-YKGCD 64
           IG GST  V I     +    AVK  +L      E L  E  I+     P IV  Y    
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           + +E    L+ + +E+  GG LTD I + T + E +I +   AVL  L +LH+ G++H D
Sbjct: 87  VGDE----LW-VVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRD 140

Query: 125 IKGQNILVSKDNEQGAKIADFG-CARRARVNED-DEGKPICGTPICMAPEVARGEEQGFP 182
           IK  +IL++ D     K++DFG CA+   V+++    K + GTP  MAPEV      G  
Sbjct: 141 IKSDSILLTSDGR--VKLSDFGFCAQ---VSKEVPRRKSLVGTPYWMAPEVISRLPYGTE 195

Query: 183 ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMSKQAQDFLSKCL 240
            D+W+LG  V+EM  G PP+ +   P+ A+ RI   +  P++     +S + + FL + L
Sbjct: 196 VDIWSLGIMVIEMVDGEPPYFNEP-PLQAMKRIR-DNLPPKLKNLHKVSPRLRSFLDRML 253

Query: 241 IRNPGERWSASELLEHGFVKE 261
           +R+P +R +A+ELL H F+ +
Sbjct: 254 VRDPAQRATAAELLNHPFLAK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  146 bits (369), Expect = 3e-41
 Identities = 99/274 (36%), Positives = 150/274 (54%), Gaps = 16/274 (5%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF----LQREQRILSALACPQIV 58
           +T+ + IG+GS   V  G+ NR+ +V A+K  +L  +E     +Q+E  +LS    P + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
            Y G   S   G  L+ + +EY  GG+  D +R+G   +E +I +  + +L GL YLHS 
Sbjct: 66  KYYG---SYLKGTKLW-IIMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYLHSE 120

Query: 119 GIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
             +H DIK  N+L+S   EQG  K+ADFG A +   +   +     GTP  MAPEV +  
Sbjct: 121 KKIHRDIKAANVLLS---EQGDVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIQQS 176

Query: 178 EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
                AD+W+LG T +E+A G PP  D+  P+  L  I   ++ P + G  SK  ++F+ 
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDM-HPMRVLFLIP-KNNPPTLTGEFSKPFKEFID 234

Query: 238 KCLIRNPGERWSASELLEHGFVKEQNFKLSTLTE 271
            CL ++P  R +A ELL+H F+ +   K S LTE
Sbjct: 235 ACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTE 268

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  145 bits (369), Expect = 3e-41
 Identities = 90/273 (32%), Positives = 134/273 (49%), Gaps = 38/273 (13%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAEL----SNSEFLQREQRILSALACPQIVAYKGCD 64
           IG G+TA V   +   ++E  A+K  +L    ++ + L++E + +S    P +V Y    
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY-TS 67

Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRSG---TCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
               +   L+ L + Y  GG+L D ++S      L+E  I +  + VL GL+YLHSNG +
Sbjct: 68  FVVGD--ELW-LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124

Query: 122 HCDIKGQNILVSKDNEQGAKIADFG----------CARRARVNEDDEGKPICGTPICMAP 171
           H DIK  NIL+ +D     KIADFG            R+ R       K   GTP  MAP
Sbjct: 125 HRDIKAGNILLGEDG--SVKIADFGVSASLADGGDRTRKVR-------KTFVGTPCWMAP 175

Query: 172 EV-ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP----- 225
           EV  +     F AD+W+ G T +E+ATG  P+     P+  L      +D P +      
Sbjct: 176 EVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP-PMKVLMLT-LQNDPPSLETGADY 233

Query: 226 GYMSKQAQDFLSKCLIRNPGERWSASELLEHGF 258
              SK  +  +S CL ++P +R +A ELL+H F
Sbjct: 234 KKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  144 bits (365), Expect = 1e-40
 Identities = 95/269 (35%), Positives = 136/269 (50%), Gaps = 31/269 (11%)

Query: 8   TIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQIVAYKGC 63
            +G G++  VS  +   + ++ AVK+  L  +E +Q    RE  IL     P IV + G 
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSH-----TRAVLLGLQYLHSN 118
             +  NG I  ++ +EY  GG+L D I       +GRI          AVL GL YLH  
Sbjct: 68  FYN--NGDI--SICMEYMDGGSL-DKILK---EVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 119 -GIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
             I+H D+K  NILV   N +G  K+ DFG + +     +   K   GT   MAPE  +G
Sbjct: 120 HKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQL---VNSLAKTFVGTSSYMAPERIQG 173

Query: 177 EEQGFPADVWALGCTVLEMATGRPPWPDVAD----PISALHRIGFSSDTPEIPGYM-SKQ 231
            +    +D+W+LG +++E+ATGR P+P   D        L  I  +   P +P    S  
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI-VNEPPPRLPSGKFSPD 232

Query: 232 AQDFLSKCLIRNPGERWSASELLEHGFVK 260
            QDF++ CLI++P ER S  ELLEH F+K
Sbjct: 233 FQDFVNLCLIKDPRERPSYKELLEHPFIK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  144 bits (365), Expect = 1e-40
 Identities = 94/275 (34%), Positives = 138/275 (50%), Gaps = 23/275 (8%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALAC-PQIV 58
            +   + IG G+   V      ++ ++ A+K         E ++ E  IL   +  P I 
Sbjct: 7   IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIA 66

Query: 59  AYKGCDI---SEENGKILYNLFLEYAPGGTLTDAIRS----GTCLEEGRIRSHTRAVLLG 111
            + G  I      N   L+ L +E   GG++TD ++     G  L+E  I    R  L G
Sbjct: 67  TFYGAFIKKNPPGNDDQLW-LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125

Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAP 171
           L YLH N ++H DIKGQNIL++K+ E   K+ DFG + +           I GTP  MAP
Sbjct: 126 LAYLHENKVIHRDIKGQNILLTKNAE--VKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAP 182

Query: 172 EVARGEEQGFP-----ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI-- 224
           EV   +EQ        +DVW+LG T +E+A G+PP  D+  P+ AL +I   +  P +  
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM-HPMRALFKI-PRNPPPTLKS 240

Query: 225 PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV 259
           P   SK+  DF+S+CLI+N  +R    ELLEH F+
Sbjct: 241 PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  144 bits (363), Expect = 2e-40
 Identities = 95/273 (34%), Positives = 145/273 (53%), Gaps = 14/273 (5%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF----LQREQRILSALACPQIV 58
           +T+ + IG+GS   V  G+ NR+ +V A+K  +L  +E     +Q+E  +LS    P + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
            Y G  + +    I+    +EY  GG+  D +  G  L+E +I +  R +L GL YLHS 
Sbjct: 66  KYYGSYLKDTKLWII----MEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSE 120

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
             +H DIK  N+L+S+  E   K+ADFG A +   +   +     GTP  MAPEV +   
Sbjct: 121 KKIHRDIKAANVLLSEHGE--VKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK 238
               AD+W+LG T +E+A G PP  ++  P+  L  I   ++ P + G  SK  ++F+  
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSEL-HPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEA 235

Query: 239 CLIRNPGERWSASELLEHGFVKEQNFKLSTLTE 271
           CL + P  R +A ELL+H F+     K S LTE
Sbjct: 236 CLNKEPSFRPTAKELLKHKFIVRFAKKTSYLTE 268

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  144 bits (365), Expect = 2e-40
 Identities = 80/252 (31%), Positives = 120/252 (47%), Gaps = 19/252 (7%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKS------AELSNSEFLQREQRILSALACP 55
           D+   +T+G GS   V +     S + +A+K        +L   E +  E+RIL ++  P
Sbjct: 2   DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHP 61

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            +V   G    + N   LY L +EY PGG L   +R      E   R +   V+L L+YL
Sbjct: 62  FLVNLYGSFQDDSN---LY-LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYL 117

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  IV+ D+K +N+L+  D++   KI DFG A+R           +CGTP  +APE+  
Sbjct: 118 HSLDIVYRDLKPENLLL--DSDGYIKITDFGFAKR----VKGRTYTLCGTPEYLAPEIIL 171

Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +  G   D WALG  + EM  G PP+ D  +PI    +I         P + S  A+D 
Sbjct: 172 SKGYGKAVDWWALGILIYEMLAGYPPFFDD-NPIQIYEKI--LEGKVRFPSFFSPDAKDL 228

Query: 236 LSKCLIRNPGER 247
           +   L  +  +R
Sbjct: 229 IRNLLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  141 bits (359), Expect = 7e-40
 Identities = 78/261 (29%), Positives = 125/261 (47%), Gaps = 22/261 (8%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKS------AELSNSEFLQREQRILSALACPQIVA-YK 61
           +G G    V +      +  FA+K        E    E +  E+ IL     P IV  Y+
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
               + ++ K +Y L  EY  GG L   +R     +E   R +   V+L  +YLH+ GI+
Sbjct: 61  ----TFKDKKYIYMLM-EYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGII 115

Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF 181
           + D+K +N+L+  D+    K+ DFG A++ +  +  +    CGTP  +APE+   +   F
Sbjct: 116 YRDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTPEYVAPEIILNKGYDF 171

Query: 182 PADVWALGCTVLEMATGRPPWP-DVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCL 240
             D W+LG  + E+ TGRPP+  D  DP+   + I   +   E P Y+ K A+D + + L
Sbjct: 172 SVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLL 231

Query: 241 IRNPGERW-----SASELLEH 256
            RNP ER         ++ +H
Sbjct: 232 RRNPEERLGNLKGGIKDIKKH 252

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  140 bits (354), Expect = 4e-39
 Identities = 84/285 (29%), Positives = 129/285 (45%), Gaps = 51/285 (17%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKS---AELSNSEFLQR---EQRILSALACPQIVAYKG 62
           I +G+   V +     + +++A+K    A++     + +   E+ ILS    P +V    
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
               ++N   LY L +EY PGG L   + +   L+E   R +   ++L L+YLHSNGI+H
Sbjct: 61  SFQGKKN---LY-LVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIH 116

Query: 123 CDIKGQNILVSKDNEQGAKIADFG-----CARRA--RVNEDDEGKPICGTPICMAPEVAR 175
            D+K  NIL+  +     K+ DFG       RR     +++ E K I GTP  +APEV  
Sbjct: 117 RDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174

Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE----------IP 225
           G+      D W+LGC + E   G PP               F  +TPE          I 
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIPP---------------FHGETPEEIFQNILNGKIE 219

Query: 226 ----GYMSKQAQDFLSKCLIRNPGER---WSASELLEHGFVKEQN 263
                 +S +A D +SK L+ +P +R    S  E+  H F K  +
Sbjct: 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  138 bits (349), Expect = 3e-38
 Identities = 98/274 (35%), Positives = 150/274 (54%), Gaps = 18/274 (6%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS---EFLQREQRILSALACPQIVA 59
           +TR + IG+G++ TV   M   + +  A++   L      E +  E  ++     P IV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           Y     S   G  L+ + +EY  GG+LTD + + TC++EG+I +  R  L  L++LHSN 
Sbjct: 82  YLD---SYLVGDELW-VVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           ++H DIK  NIL+  D     K+ DFG CA+     E  +   + GTP  MAPEV   + 
Sbjct: 137 VIHRDIKSDNILLGMDGS--VKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPEVVTRKA 192

Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMSKQAQDFL 236
            G   D+W+LG   +EM  G PP+ +  +P+ AL+ I  ++ TPE+  P  +S   +DFL
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIA-TNGTPELQNPEKLSAIFRDFL 250

Query: 237 SKCLIRNPGERWSASELLEHGFVKEQNFKLSTLT 270
           ++CL  +  +R SA ELL+H F+K     LS+LT
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQFLKIAK-PLSSLT 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  137 bits (348), Expect = 4e-38
 Identities = 84/253 (33%), Positives = 132/253 (52%), Gaps = 23/253 (9%)

Query: 23  NRSSEVF-AVKSAELSNSEFLQR---EQRILSALACPQIVAYKGCDISEENGKILYNLFL 78
           ++ + +F A K  ++ + E L+    E  ILS    P IV        E    IL    +
Sbjct: 26  HKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL----I 81

Query: 79  EYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN 136
           E+  GG L D+I       L E +IR   R +L  L +LHS+ ++H D+K  NIL++ D 
Sbjct: 82  EFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG 140

Query: 137 EQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ-----GFPADVWALGCT 191
           +   K+ADFG + + + +   +     GTP  MAPEV   E        + AD+W+LG T
Sbjct: 141 D--VKLADFGVSAKNK-STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGIT 197

Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMSKQAQDFLSKCLIRNPGERWS 249
           ++E+A   PP  ++ +P+  L +I   S+ P +  P   S    DFL  CL+++P +R +
Sbjct: 198 LIELAQMEPPHHEL-NPMRVLLKI-LKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPT 255

Query: 250 ASELLEHGFVKEQ 262
           A+ELL+H FV +Q
Sbjct: 256 AAELLKHPFVSDQ 268

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  138 bits (348), Expect = 5e-38
 Identities = 98/274 (35%), Positives = 148/274 (54%), Gaps = 18/274 (6%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS---EFLQREQRILSALACPQIVA 59
           +TR + IG+G++ TV   +   + +  A+K   L      E +  E  ++     P IV 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           Y     S   G  L+ + +EY  GG+LTD + + TC++EG+I +  R  L  L +LHSN 
Sbjct: 81  YLD---SYLVGDELW-VVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALDFLHSNQ 135

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           ++H DIK  NIL+  D     K+ DFG CA+     E  +   + GTP  MAPEV   + 
Sbjct: 136 VIHRDIKSDNILLGMDGS--VKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMSKQAQDFL 236
            G   D+W+LG   +EM  G PP+ +  +P+ AL+ I  ++ TPE+  P  +S   +DFL
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIA-TNGTPELQNPERLSAVFRDFL 249

Query: 237 SKCLIRNPGERWSASELLEHGFVKEQNFKLSTLT 270
           ++CL  +   R SA ELL+H F+K     LS+LT
Sbjct: 250 NRCLEMDVDRRGSAKELLQHPFLKLAK-PLSSLT 282

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  136 bits (345), Expect = 6e-38
 Identities = 80/257 (31%), Positives = 123/257 (47%), Gaps = 20/257 (7%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQ-----RILSALACPQIVAYKGC 63
           +G+GS  +V        ++ +A+K  +L +    +RE      RIL+++  P I++YK  
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67

Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIR----SGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
            +   +G  L  + +EYAP G L+ AI         + E  I      +L GLQ LH   
Sbjct: 68  FL---DGNKLC-IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK 123

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           I+H D+K  NIL+   N+   KI D G ++  + N     K   GTP  MAPEV +G   
Sbjct: 124 ILHRDLKSANILLV-ANDL-VKIGDLGISKVLKKNM---AKTQIGTPHYMAPEVWKGRPY 178

Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
            + +D+W+LGC + EMAT  PP+   A  +  L         P IP   S+  Q+F+   
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFE--ARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSM 236

Query: 240 LIRNPGERWSASELLEH 256
           L   P  R +  ++L  
Sbjct: 237 LQVKPKLRPNCDKILAS 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  136 bits (346), Expect = 1e-37
 Identities = 84/283 (29%), Positives = 128/283 (45%), Gaps = 39/283 (13%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSE----FLQREQRILSALAC-PQIV 58
           G+ IG GS +TV +     +++ +A+K         E    +++ E+ +L+ L   P I+
Sbjct: 6   GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGII 65

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
                   EEN   LY   LEYAP G L   IR    L+E   R +   +LL L+YLHS 
Sbjct: 66  KLYYTFQDEEN---LY-FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK 121

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCAR-----------RARVNEDDEGKPI----- 162
           GI+H D+K +NIL+ KD     KI DFG A+           +      D          
Sbjct: 122 GIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179

Query: 163 ---CGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS 219
               GT   ++PE+   +  G  +D+WALGC + +M TG+PP+    + ++   +I    
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-FQKI--LK 236

Query: 220 DTPEIPGYMSKQAQDFLSKCLIRNPGER----WSASELLEHGF 258
                P      A+D + K L+ +P +R        EL  H F
Sbjct: 237 LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  134 bits (337), Expect = 2e-36
 Identities = 94/274 (34%), Positives = 150/274 (54%), Gaps = 18/274 (6%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS---EFLQREQRILSALACPQIVA 59
           +TR + IG+G++ TV   +   + +  A+K   L      E +  E  ++  L  P IV 
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           +     S   G  L+ + +EY  GG+LTD + + TC++E +I +  R  L  L++LH+N 
Sbjct: 81  FLD---SFLVGDELF-VVMEYLAGGSLTDVV-TETCMDEAQIAAVCRECLQALEFLHANQ 135

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           ++H DIK  N+L+    +   K+ DFG CA+     E  +   + GTP  MAPEV   + 
Sbjct: 136 VIHRDIKSDNVLLGM--DGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMSKQAQDFL 236
            G   D+W+LG   +EM  G PP+ +  +P+ AL+ I  ++ TPE+  P  +S   +DFL
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIA-TNGTPELQNPEKLSPIFRDFL 249

Query: 237 SKCLIRNPGERWSASELLEHGFVKEQNFKLSTLT 270
           ++CL  +  +R SA ELL+H F+K     LS+LT
Sbjct: 250 NRCLEMDVEKRGSAKELLQHPFLKLAK-PLSSLT 282

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  128 bits (324), Expect = 8e-35
 Identities = 80/263 (30%), Positives = 118/263 (44%), Gaps = 22/263 (8%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSA------ELSNSEFLQREQRILSALACPQIVA- 59
           + IG+G+   V I     + ++FA+K        E  +   +  E+RIL  L  P +V  
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 60  -YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
            Y   D  EEN   +Y L ++   GG L   +       E +++     ++L L+YLHS 
Sbjct: 66  WYSFQD--EEN---MY-LVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119

Query: 119 GIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
           GI+H DIK  NIL+   +EQG   I DF  A +  V  D       GTP  MAPEV   +
Sbjct: 120 GIIHRDIKPDNILL---DEQGHVHITDFNIATK--VTPDTLTTSTSGTPGYMAPEVLCRQ 174

Query: 178 EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
                 D W+LG T  E   G+ P+   +  I    R    +     P   S +A D ++
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAIN 234

Query: 238 KCLIRNPGERWS--ASELLEHGF 258
           K L R+P +R      +L  H +
Sbjct: 235 KLLERDPQKRLGDNLKDLKNHPY 257

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  128 bits (322), Expect = 1e-34
 Identities = 74/254 (29%), Positives = 118/254 (46%), Gaps = 16/254 (6%)

Query: 8   TIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQ-----RILSALACPQIVAYKG 62
            IG+GS   V   +      V+A+K  +LS     +RE+     R+L+ L    I+ Y  
Sbjct: 7   KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66

Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
             +  + GK+  N+ +EYA  G L   ++   G  L E ++      +LLGL +LHS  I
Sbjct: 67  SFL--DKGKL--NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKI 122

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           +H DIK  N+ +   +    KI D G A+    N  +    I GTP  ++PE+   +   
Sbjct: 123 LHRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDN-TNFANTIVGTPYYLSPELCEDKPYN 179

Query: 181 FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCL 240
             +DVWALG  + E  TG+ P+   A+   AL         P +    S+Q    + +CL
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFD--ANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCL 237

Query: 241 IRNPGERWSASELL 254
            ++  +R    +LL
Sbjct: 238 TKDYRQRPDTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  128 bits (324), Expect = 2e-34
 Identities = 95/258 (36%), Positives = 134/258 (51%), Gaps = 19/258 (7%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNS---EFLQREQRILSALACPQIVA-YKGCD 64
           IG GST  V I     S    AVK  +L      E L  E  I+       +V  YK   
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           + EE    L+ + +E+  GG LTD I S T L E +I +   +VL  L YLHS G++H D
Sbjct: 89  VGEE----LW-VLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRD 142

Query: 125 IKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPA 183
           IK  +IL++ D     K++DFG CA+ ++  +  + K + GTP  MAPEV      G   
Sbjct: 143 IKSDSILLTLDGR--VKLSDFGFCAQISK--DVPKRKSLVGTPYWMAPEVISRTPYGTEV 198

Query: 184 DVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY--MSKQAQDFLSKCLI 241
           D+W+LG  V+EM  G PP+     P+ A+ R+   S  P++     +S   +DFL + L 
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLR-DSPPPKLKNAHKISPVLRDFLERMLT 256

Query: 242 RNPGERWSASELLEHGFV 259
           R P ER +A ELL+H F+
Sbjct: 257 REPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  127 bits (321), Expect = 4e-34
 Identities = 89/275 (32%), Positives = 134/275 (48%), Gaps = 32/275 (11%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQIVAYKGCD 64
           +G G+  +V+      +  +FA+K+     +  LQ    RE  I  +   P IV Y G  
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68

Query: 65  ISEENGKILYNLFLEYAPGGTLTDAI------RSGTCLEE--GRIRSHTRAVLLGLQYLH 116
           + E +  I   + +EY  GG+L D+I      R G   E+  G+I     +VL GL YLH
Sbjct: 69  LDESSSSI--GIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAE---SVLKGLSYLH 122

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
           S  I+H DIK  NIL+++  +   K+ DFG +    VN         GT   MAPE  +G
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGEL-VNSLA--GTFTGTSFYMAPERIQG 177

Query: 177 EEQGFPADVWALGCTVLEMATGRPPWP----DVADPISALHRIGFSS-----DTPEIPGY 227
           +     +DVW+LG T+LE+A  R P+P        PI  L  I         D P     
Sbjct: 178 KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK 237

Query: 228 MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ 262
            S++ +DF+ +CL ++P  R +  ++LEH ++K Q
Sbjct: 238 WSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  127 bits (321), Expect = 7e-34
 Identities = 78/267 (29%), Positives = 123/267 (46%), Gaps = 26/267 (9%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKS------AELSNSEFLQREQRILS-ALACPQIVAYK 61
           +G+GS   V +     + E++AVK        +  + E    E+R+L+ A   P +    
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 62  GCDISEENGKILYNLF--LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
            C  +++       LF  +EY  GG L   I+     +E R R +   ++LGLQ+LH  G
Sbjct: 63  SCFQTKDR------LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG 116

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           I++ D+K  N+L+  D+E   KIADFG  +   +         CGTP  +APE+   +  
Sbjct: 117 IIYRDLKLDNVLL--DSEGHIKIADFGMCKEG-ILGGVTTSTFCGTPDYIAPEILSYQPY 173

Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
           G   D WALG  + EM  G+ P+    D       I    D    P ++SK+A+  L   
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFEGD-DEDELFQSI--LEDEVRYPRWLSKEAKSILKSF 230

Query: 240 LIRNPGERWSAS-----ELLEHGFVKE 261
           L +NP +R         ++  H F +E
Sbjct: 231 LTKNPEKRLGCLPTGEQDIKGHPFFRE 257

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  127 bits (320), Expect = 9e-34
 Identities = 88/263 (33%), Positives = 131/263 (49%), Gaps = 27/263 (10%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVK----SAELSNSEF--LQREQRILSALACPQIVAYKG 62
           IG GS   V      R++EV A+K    S + SN ++  + +E R L  L  P  + YKG
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 63  CDISEENGKILYNLFLEYAPGGT--LTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           C + E        L +EY  G    + +  +    L+E  I +     L GL YLHS+  
Sbjct: 83  CYLREHTAW----LVMEYCLGSASDILEVHKKP--LQEVEIAAICHGALQGLAYLHSHER 136

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           +H DIK  NIL+++      K+ADFG A               GTP  MAPEV    ++G
Sbjct: 137 IHRDIKAGNILLTEPGT--VKLADFGSASLV-----SPANSFVGTPYWMAPEVILAMDEG 189

Query: 181 F---PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI-PGYMSKQAQDFL 236
                 DVW+LG T +E+A  +PP  ++ + +SAL+ I   +D+P +     S   ++F+
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIA-QNDSPTLSSNDWSDYFRNFV 247

Query: 237 SKCLIRNPGERWSASELLEHGFV 259
             CL + P +R S+ ELL+H FV
Sbjct: 248 DSCLQKIPQDRPSSEELLKHRFV 270

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  123 bits (312), Expect = 8e-33
 Identities = 81/308 (26%), Positives = 122/308 (39%), Gaps = 81/308 (26%)

Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE--FLQ---REQRILSALACPQIV 58
            + + +G G+   V      ++ E+ A+K   L N E        RE  +L  L  P IV
Sbjct: 2   EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIV 61

Query: 59  AYKGCDISEENGKIL-------YNL--FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVL 109
                D+     K+         +L  +L+  PG            L    I+S    +L
Sbjct: 62  KLL--DVIHTERKLYLVFEYCDMDLKKYLDKRPGP-----------LSPNLIKSIMYQLL 108

Query: 110 LGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-C 168
            GL Y HS+ I+H D+K QNIL+++D     K+ADFG AR              G P+  
Sbjct: 109 RGLAYCHSHRILHRDLKPQNILINRDGV--LKLADFGLAR------------AFGIPLRT 154

Query: 169 M----------APEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI-- 215
                      APE+  G +      D+W++GC   EM TG+P +P  ++ I  L +I  
Sbjct: 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE-IDQLFKIFQ 213

Query: 216 -----------------GFSSDTPEIPG--------YMSKQAQDFLSKCLIRNPGERWSA 250
                             +    P+ P          +  +  D LSK L  NP +R SA
Sbjct: 214 ILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISA 273

Query: 251 SELLEHGF 258
            E L+H +
Sbjct: 274 KEALKHPY 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  122 bits (306), Expect = 6e-32
 Identities = 91/264 (34%), Positives = 137/264 (51%), Gaps = 29/264 (10%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEE 68
           IG GST  V I     + +  AVK  +L      +++QR    L   ++V  +  D   E
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDL------RKQQR--RELLFNEVVIMR--DYHHE 79

Query: 69  NGKILYNLFL---------EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           N   +YN +L         E+  GG LTD I + T + E +I +   +VL  L YLH+ G
Sbjct: 80  NVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQG 138

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           ++H DIK  +IL++ D     K++DFG CA+ ++  E  + K + GTP  MAPEV     
Sbjct: 139 VIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSK--EVPKRKSLVGTPYWMAPEVISRLP 194

Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY--MSKQAQDFL 236
            G   D+W+LG  V+EM  G PP+ +   P+ A+ RI   +  P +     +S   + FL
Sbjct: 195 YGTEVDIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIR-DNLPPRVKDSHKVSSVLRGFL 252

Query: 237 SKCLIRNPGERWSASELLEHGFVK 260
              L+R P +R +A ELL+H F+K
Sbjct: 253 DLMLVREPSQRATAQELLQHPFLK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  121 bits (305), Expect = 9e-32
 Identities = 87/286 (30%), Positives = 123/286 (43%), Gaps = 41/286 (14%)

Query: 8   TIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----EFLQREQRILSALACPQIVAYKG 62
            +G G+   V    +  + E+ A+K  + S       +   RE ++L  L    IV  K 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK- 66

Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
            +     G+ LY L  EY     L     S   L    +RS+   +L  + Y HS+ I+H
Sbjct: 67  -EAFRRKGR-LY-LVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIH 123

Query: 123 CDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ-GF 181
            DIK +NILVS+      K+ DFG AR  R            T    APE+  G+   G 
Sbjct: 124 RDIKPENILVSESGV--LKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGK 181

Query: 182 PADVWALGCTVLEMATGRPPWPDVAD------------PISALHRIGFSSD-------TP 222
           P DVWA+GC + E+  G P +P  +D            P+   H+  FSS+        P
Sbjct: 182 PVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFP 241

Query: 223 EI----------PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGF 258
           E           PG +S  A DFL  CL  +P ER +  ELL+H +
Sbjct: 242 EPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  120 bits (301), Expect = 2e-31
 Identities = 94/277 (33%), Positives = 141/277 (50%), Gaps = 30/277 (10%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS--EFLQREQRILSALA-CPQIVA 59
           W   +TIG+G+   V   ++ ++    AVK  +  +   E ++ E  IL AL+  P +V 
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVK 79

Query: 60  YKGCDISEE--NGKILYNLFLEYAPGGTLTDAIRS----GTCLEEGRIRSHTRAVLLGLQ 113
           + G    ++  NG  L+ L LE   GG++TD ++     G  +EE  I       L+GLQ
Sbjct: 80  FYGMYYKKDVKNGDQLW-LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA-----RRARVNEDDEGKPICGTPIC 168
           +LH N  +H D+KG NIL++   E G K+ DFG +      R R N         GTP  
Sbjct: 139 HLHVNKTIHRDVKGNNILLT--TEGGVKLVDFGVSAQLTSTRLRRNTS------VGTPFW 190

Query: 169 MAPEVARGEEQ-----GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS-SDTP 222
           MAPEV   E+Q         DVW+LG T +E+  G PP  D+  P+ AL +I  +   T 
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL-HPMRALFKIPRNPPPTL 249

Query: 223 EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV 259
             P   S +  DF+ KCL ++  +R + S+LL+H F+
Sbjct: 250 HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  121 bits (304), Expect = 2e-31
 Identities = 80/268 (29%), Positives = 134/268 (50%), Gaps = 22/268 (8%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSA------ELSNSEFLQREQRILS-ALACPQIVAYK 61
           +G+GS   V +     ++E FA+K+       E  + E    E+R+L+ A   P  + + 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHP-FLTHL 61

Query: 62  GCDISEENGKILYNLF--LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
            C    +      +LF  +EY  GG L   I+S    +E R R +   ++ GLQ+LH  G
Sbjct: 62  FCTFQTKE-----HLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           I++ D+K  N+L+ KD     KIADFG  +   +N + +    CGTP  +APE+ +G++ 
Sbjct: 117 IIYRDLKLDNVLLDKDGH--IKIADFGMCKE-NMNGEGKASTFCGTPDYIAPEILKGQKY 173

Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
               D W+ G  + EM  G+ P+    D       I   +D P  P ++SK+A+D LSK 
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSI--LNDRPHFPRWISKEAKDCLSKL 230

Query: 240 LIRNPGERW-SASELLEHGFVKEQNFKL 266
             R+P +R     ++ +H F +  +++ 
Sbjct: 231 FERDPTKRLGVDGDIRQHPFFRGIDWER 258

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  121 bits (305), Expect = 3e-31
 Identities = 88/270 (32%), Positives = 135/270 (50%), Gaps = 31/270 (11%)

Query: 5   RGQTIGRGSTATVSIGMSNRSSEVFAVK----SAELSNSEFLQREQRILSALACPQIVAY 60
           R   IG G+  TV   +   +  ++A+K    + E +    + RE  IL  +  P +V  
Sbjct: 78  RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVV-- 135

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCL-EEGRIRSHTRAVLLGLQYLHSNG 119
           K  D+ + NG+I   + LE+  GG+L      GT + +E  +    R +L G+ YLH   
Sbjct: 136 KCHDMFDHNGEI--QVLLEFMDGGSL-----EGTHIADEQFLADVARQILSGIAYLHRRH 188

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPE-----VA 174
           IVH DIK  N+L+  ++ +  KIADFG +R      D     + GT   M+PE     + 
Sbjct: 189 IVHRDIKPSNLLI--NSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLN 245

Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWP-----DVADPISALHRIGFSSDTPEIPGYMS 229
            G   G+  D+W+LG ++LE   GR P+      D A  + A+      S  PE P   S
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI----CMSQPPEAPATAS 301

Query: 230 KQAQDFLSKCLIRNPGERWSASELLEHGFV 259
           ++ + F+S CL R P +RWSA +LL+H F+
Sbjct: 302 REFRHFISCCLQREPAKRWSAMQLLQHPFI 331

Length = 353

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  118 bits (297), Expect = 5e-31
 Identities = 76/260 (29%), Positives = 126/260 (48%), Gaps = 15/260 (5%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR-----EQRILSALACPQIVAYK 61
           + +G+GS   VS+       + + +K   L N+   +R     E ++LS L  P IVAY+
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNG 119
               S E    L  + + +  GG L   ++   G  L E ++      + + LQYLH   
Sbjct: 66  E---SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           I+H D+K QN+ +++ N    K+ D G AR    N+ D    + GTP  M+PE+   +  
Sbjct: 123 ILHRDLKTQNVFLTRTNI--IKVGDLGIARVLE-NQCDMASTLIGTPYYMSPELFSNKPY 179

Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
            + +DVWALGC V EMAT +  + +  D  S ++RI      P +P   S +  + ++  
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAF-NAKDMNSLVYRI-IEGKLPPMPKDYSPELGELIATM 237

Query: 240 LIRNPGERWSASELLEHGFV 259
           L + P +R S   +L   ++
Sbjct: 238 LSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  119 bits (299), Expect = 5e-31
 Identities = 95/278 (34%), Positives = 140/278 (50%), Gaps = 30/278 (10%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE-LSN-SEFLQREQRILSALAC-PQIVA 59
           W   +TIG+G+   V    + +   + AVK  + +S+  E ++ E  IL +L   P +V 
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVK 83

Query: 60  YKGCDISEEN--GKILYNLFLEYAPGGTLTDAI----RSGTCLEEGRIRSHTRAVLLGLQ 113
           + G     +   G  L+ L LE   GG++T+ +      G  L+E  I       LLGLQ
Sbjct: 84  FYGMFYKADKLVGGQLW-LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ 142

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGC-----ARRARVNEDDEGKPICGTPIC 168
           +LH+N I+H D+KG NIL++   E G K+ DFG      + R R N         GTP  
Sbjct: 143 HLHNNRIIHRDVKGNNILLT--TEGGVKLVDFGVSAQLTSTRLRRNTS------VGTPFW 194

Query: 169 MAPEVARGEEQ---GFPA--DVWALGCTVLEMATGRPPWPDVADPISALHRIGFS-SDTP 222
           MAPEV   E+Q    + A  DVW+LG T +E+  G PP  D+  P+  L +I  +   T 
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM-HPVKTLFKIPRNPPPTL 253

Query: 223 EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
             P    +    F+S+CLI++   R S + LLEH F+K
Sbjct: 254 LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  119 bits (299), Expect = 6e-31
 Identities = 89/263 (33%), Positives = 138/263 (52%), Gaps = 29/263 (11%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEE 68
           IG GST  V I     S ++ AVK  +L      +++QR    L   ++V  +  D   E
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDL------RKQQR--RELLFNEVVIMR--DYQHE 77

Query: 69  NGKILYNLFL---------EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           N   +YN +L         E+  GG LTD I + T + E +I +   AVL  L  LH+ G
Sbjct: 78  NVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQG 136

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           ++H DIK  +IL++ D     K++DFG CA+ ++  E    K + GTP  MAPE+     
Sbjct: 137 VIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPELISRLP 192

Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY--MSKQAQDFL 236
            G   D+W+LG  V+EM  G PP+ +   P+ A+  I   +  P++     +S   + FL
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIR-DNLPPKLKNLHKVSPSLKGFL 250

Query: 237 SKCLIRNPGERWSASELLEHGFV 259
            + L+R+P +R +A+ELL+H F+
Sbjct: 251 DRLLVRDPAQRATAAELLKHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  119 bits (301), Expect = 6e-31
 Identities = 88/309 (28%), Positives = 135/309 (43%), Gaps = 41/309 (13%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE----LSNSEF--LQREQRILSALAC---PQIVA 59
           +GRG    V +    ++ E++A+K+ +    ++  E   L  E+RI         P +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
              C  +E++   +    +EYA GG L   I +     E R   +   V+LGLQYLH N 
Sbjct: 67  LFACFQTEDH---VC-FVMEYAAGGDLMMHIHTDV-FSEPRAVFYAACVVLGLQYLHENK 121

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           IV+ D+K  N+L+  D E   KIADFG  +   +   D     CGTP  +APEV      
Sbjct: 122 IVYRDLKLDNLLL--DTEGFVKIADFGLCKEG-MGFGDRTSTFCGTPEFLAPEVLTETSY 178

Query: 180 GFPADVWALGCTVLEMATGRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQD 234
               D W LG  + EM  G  P+P     +V D I         +D    P ++S++A  
Sbjct: 179 TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI--------VNDEVRYPRFLSREAIS 230

Query: 235 FLSKCLIRNPGERWSASE-----LLEHGFVKEQNF---KLSTLTEPETYNSESPTSVLNQ 286
            + + L RNP  R  + E     + +  F ++ N+       +  P     + P  V N 
Sbjct: 231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSN- 289

Query: 287 QLWDSTLTS 295
             +D   TS
Sbjct: 290 --FDEEFTS 296

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  117 bits (296), Expect = 2e-30
 Identities = 84/291 (28%), Positives = 126/291 (43%), Gaps = 52/291 (17%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSE--FLQ---REQRILSALACPQIVAYKGC 63
           IG G+   V    + ++ E+ A+K   + N +  F     RE ++L  L  P IV  K  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
             S+  G I   +  EY     LT  + S      E +I+ + + +L GLQYLHSNGI+H
Sbjct: 67  VTSKGKGSIY--MVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILH 123

Query: 123 CDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM----APEVARGEE 178
            DIKG NIL+  +N+   K+ADFG AR                 +       PE+  G  
Sbjct: 124 RDIKGSNILI--NNDGVLKLADFGLAR----PYTKRNSADYTNRVITLWYRPPELLLGAT 177

Query: 179 Q-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS---SDTPEI-PG------- 226
           + G   D+W++GC + E+  G+P +   +  +  L +I F    S T E  PG       
Sbjct: 178 RYGPEVDMWSVGCILAELFLGKPIFQG-STELEQLEKI-FELCGSPTDENWPGVSKLPWF 235

Query: 227 -------------------YMSKQAQDFLSKCLIRNPGERWSASELLEHGF 258
                               +   A D L K L  +P +R SA + L+H +
Sbjct: 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  117 bits (293), Expect = 5e-30
 Identities = 86/264 (32%), Positives = 130/264 (49%), Gaps = 23/264 (8%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRI------LSALACPQIVAYKG 62
           IG GS   V    ++ ++EV AVK    S  +  ++ Q I      L  L  P  + YKG
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
           C + E        L +EY  G            L+E  I + T   L GL YLHS+ ++H
Sbjct: 89  CYLKEHTAW----LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIH 144

Query: 123 CDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG-- 180
            DIK  NIL+++  +   K+ADFG A ++            GTP  MAPEV    ++G  
Sbjct: 145 RDIKAGNILLTEPGQ--VKLADFGSASKS-----SPANSFVGTPYWMAPEVILAMDEGQY 197

Query: 181 -FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI-PGYMSKQAQDFLSK 238
               DVW+LG T +E+A  +PP  ++ + +SAL+ I   +D+P +     +   + F+  
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIA-QNDSPTLQSNEWTDSFRGFVDY 255

Query: 239 CLIRNPGERWSASELLEHGFVKEQ 262
           CL + P ER +++ELL H FV+  
Sbjct: 256 CLQKIPQERPASAELLRHDFVRRD 279

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  114 bits (287), Expect = 2e-29
 Identities = 93/268 (34%), Positives = 128/268 (47%), Gaps = 21/268 (7%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALACPQ--IV 58
           D+   Q +G G+   V    +  + E+ AVK  +L    +F   +Q I     C    IV
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
           AY G  +S E   I     +EY  GG+L D       L E +I    R  L GL YLHS 
Sbjct: 70  AYFGSYLSREKLWIC----MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           G +H DIKG NIL++ + +   K+ADFG A +         K   GTP  MAPEVA  E+
Sbjct: 126 GKMHRDIKGANILLTDNGD--VKLADFGVAAKITATIAKR-KSFIGTPYWMAPEVAAVEK 182

Query: 179 QG---FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA--- 232
            G      D+WA+G T +E+A  +PP  D+  P+ AL  +  S+  P  P    K     
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPPMFDL-HPMRALFLMSKSNFQP--PKLKDKTKWSS 239

Query: 233 --QDFLSKCLIRNPGERWSASELLEHGF 258
              +F+   L +NP +R +A  LL H F
Sbjct: 240 TFHNFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  115 bits (288), Expect = 2e-29
 Identities = 89/267 (33%), Positives = 133/267 (49%), Gaps = 22/267 (8%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR---EQRILSALACPQIVAYKGCDI 65
           +G G+   V    +  +  + A K  E  + E L+    E  IL+    P IV   G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 66  SEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
            +  GK+   + +E+ PGG + DAI       L E +I+   R +L  LQYLHS  I+H 
Sbjct: 80  WD--GKLW--IMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHR 134

Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ---- 179
           D+K  N+L++ D +   K+ADFG + +  V          GTP  MAPEV   E      
Sbjct: 135 DLKAGNVLLTLDGD--IKLADFGVSAK-NVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191

Query: 180 -GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMSKQAQDFL 236
             + AD+W+LG T++EMA   PP  ++ +P+  L +I   S+ P +  P   S + +DFL
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIA-KSEPPTLSQPSKWSMEFRDFL 249

Query: 237 SKCLIRNPGERWSASELLEHGFVKEQN 263
              L ++P  R SA++LLEH FV    
Sbjct: 250 KTALDKHPETRPSAAQLLEHPFVSSVT 276

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  114 bits (286), Expect = 2e-29
 Identities = 79/272 (29%), Positives = 126/272 (46%), Gaps = 32/272 (11%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR------EQRILSALACPQIVA--Y 60
           I +G+  +V +     + + FA+K  + S+     +      E+ I+        VA  Y
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
                S ++   LY L +EY  GG     I++   L E   + +   V+LG++ LH  GI
Sbjct: 64  ----YSFQSKDYLY-LVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGI 118

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           +H DIK +N+L+  D     K+ DFG +R    N+        GTP  +APE   G    
Sbjct: 119 IHRDIKPENLLI--DQTGHLKLTDFGLSRNGLENKK-----FVGTPDYLAPETILGVGDD 171

Query: 181 FPADVWALGCTVLEMATGRPPW----PD-VADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
             +D W+LGC + E   G PP+    PD V D I +  RI +  +  E   + S +A D 
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS-RRINWPEEVKE---FCSPEAVDL 227

Query: 236 LSKCLIRNPGERWSAS---ELLEHGFVKEQNF 264
           +++ L  +P +R  A+   E+  H F K  N+
Sbjct: 228 INRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  114 bits (287), Expect = 2e-29
 Identities = 76/270 (28%), Positives = 120/270 (44%), Gaps = 31/270 (11%)

Query: 4   TRGQTIGRGSTATVSIG-----MSNRSSEVFAVK-----SAELSNSEFLQREQRILSALA 53
             G+ +G G+   V  G          ++V AVK     ++E    EFL  E  I+  L+
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKV-AVKTLKEGASEEEREEFL-EEASIMKKLS 59

Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGL 112
            P IV   G     +   +   +  EY PGG L D +R  G  L    +      +  G+
Sbjct: 60  HPNIVRLLGV--CTQGEPLY--IVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115

Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PIC-M 169
           +YL S   VH D+  +N LV+++     KI+DFG +R   + EDD  +   G   PI  M
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLV--VKISDFGLSR--DIYEDDYYRKRGGGKLPIKWM 171

Query: 170 APEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRI--GFSSDTPEIPG 226
           APE  +  +    +DVW+ G  + E+ T G  P+P +      L  +  G+    PE   
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM-SNEEVLELLEDGYRLPRPE--- 227

Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLEH 256
               +  + + +C   +P +R + SEL+E 
Sbjct: 228 NCPDELYELMLQCWAYDPEDRPTFSELVED 257

Length = 258

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  114 bits (288), Expect = 3e-29
 Identities = 81/295 (27%), Positives = 119/295 (40%), Gaps = 60/295 (20%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQRE---QRILSALACPQIVA- 59
           IG G+  TV       +    A+K   +  SE        RE    + L +   P IV  
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 60  YKGCDISEENGKILYNLFLEYAP---GGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
              C     + ++   L  E+        L+   + G  L    I+   R +L G+ +LH
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG--LPPETIKDLMRQLLRGVDFLH 124

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM-----AP 171
           S+ IVH D+K QNILV+ D +   KIADFG AR   +   +    +  T + +     AP
Sbjct: 125 SHRIVHRDLKPQNILVTSDGQ--VKIADFGLAR---IYSFE----MALTSVVVTLWYRAP 175

Query: 172 EVARGEEQGFPADVWALGCTVLEMA---------------------TGRPP---WP-DVA 206
           EV        P D+W++GC   E+                       G P    WP +V+
Sbjct: 176 EVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235

Query: 207 DPISALH---RIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGF 258
            P S+        F S  PE    + ++  D L K L  NP +R SA E L+H +
Sbjct: 236 LPRSSFPSYTPRSFKSFVPE----ICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  115 bits (289), Expect = 3e-29
 Identities = 88/282 (31%), Positives = 131/282 (46%), Gaps = 40/282 (14%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILSALAC--PQ 56
           + +G+GS   V +     + EV+A+K   L     LQ         E+RIL ALA   P 
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRIL-ALAAKHPF 57

Query: 57  IVAYKGCDISEENGKILYNLF--LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
           + A   C  +++       LF  +EY  GG L   I+     +E R R +   V L L +
Sbjct: 58  LTALHCCFQTKDR------LFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMF 111

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           LH +G+++ D+K  NIL+  D E   K+ADFG  +   +         CGTP  +APE+ 
Sbjct: 112 LHRHGVIYRDLKLDNILL--DAEGHCKLADFGMCKEG-ILNGVTTTTFCGTPDYIAPEIL 168

Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPW-PDVADPI--SALHRIGFSSDTPEIPGYMSKQ 231
           +  E G   D WALG  + EM  G+PP+  D  D +  S LH      D    P ++SK+
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH------DDVLYPVWLSKE 222

Query: 232 AQDFLSKCLIRNPGERWSA-------SELLEHGFVKEQNFKL 266
           A   L   + +NP +R            + +H F KE ++ L
Sbjct: 223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVL 264

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  113 bits (284), Expect = 4e-29
 Identities = 89/261 (34%), Positives = 129/261 (49%), Gaps = 17/261 (6%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-FLQREQRILSALAC--PQIVAYKGC 63
           Q IG G+   V    +  + E+ A+K  +L   E F   +Q I+    C    IVAY G 
Sbjct: 15  QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74

Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
            +  +   I     +E+  GG+L D       L E +I   +R  L GL YLHS G +H 
Sbjct: 75  YLRRDKLWIC----MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHR 130

Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF-- 181
           DIKG NIL++ +     K+ADFG + +         K   GTP  MAPEVA  E +G   
Sbjct: 131 DIKGANILLTDNGH--VKLADFGVSAQITATIAKR-KSFIGTPYWMAPEVAAVERKGGYN 187

Query: 182 -PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS-DTPEIPGYM--SKQAQDFLS 237
              D+WA+G T +E+A  +PP  D+  P+ AL  +  S+   P++   M  S     F+ 
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDL-HPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVK 246

Query: 238 KCLIRNPGERWSASELLEHGF 258
             L +NP +R +A +LL+H F
Sbjct: 247 MALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  112 bits (283), Expect = 7e-29
 Identities = 71/268 (26%), Positives = 107/268 (39%), Gaps = 25/268 (9%)

Query: 8   TIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQ-------RILSALACPQIVAY 60
           TIG+GS  TV         ++   K  E+      ++E+        IL  L  P IV Y
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWK--EIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY 64

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAI----RSGTCLEEGRIRSHTRAVLLGLQYLH 116
               I   N  +   + +EY  GG L   I    +    +EE  I      +LL L   H
Sbjct: 65  YDRIIDRSNQTL--YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122

Query: 117 -----SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAP 171
                 N ++H D+K  NI +  +N    K+ DFG A+    ++    K   GTP  M+P
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAKILG-HDSSFAKTYVGTPYYMSP 179

Query: 172 EVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQ 231
           E          +D+W+LGC + E+    PP+   A     L           IP   S +
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPPFT--ARNQLQLASKIKEGKFRRIPYRYSSE 237

Query: 232 AQDFLSKCLIRNPGERWSASELLEHGFV 259
             + +   L  +P +R S  ELL+   +
Sbjct: 238 LNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  113 bits (284), Expect = 7e-29
 Identities = 82/288 (28%), Positives = 123/288 (42%), Gaps = 49/288 (17%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQREQRILSALACPQIVAYKGC 63
           IG G+   V       + E  A+K   L   E        RE + L A   P +V     
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL-- 65

Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
           D+       +  L +EY P   L++ +R     L E +++S+ R +L G+ Y+H+NGI+H
Sbjct: 66  DVFPHGSGFV--LVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMH 122

Query: 123 CDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI---CGTPICMAPEVARGEEQ 179
            D+K  N+L+S D     KIADFG    AR+  ++E +       T    APE+  G  +
Sbjct: 123 RDLKPANLLISADGV--LKIADFGL---ARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177

Query: 180 GFPA-DVWALGCTVLEMATGRPPWPDVADPISALHRI--GFSSDTPEI-PGY-------- 227
             P  D+WA+GC   E+  G P +P   D I  L  +     +   E  PG         
Sbjct: 178 YDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236

Query: 228 -----------------MSKQAQDFLSKCLIRNPGERWSASELLEHGF 258
                             S +A D L   L+ +P +R SA+E L H +
Sbjct: 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  113 bits (283), Expect = 9e-29
 Identities = 90/270 (33%), Positives = 132/270 (48%), Gaps = 24/270 (8%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR---EQRILSALACPQIVA 59
           W     +G G+   V    +  +  + A K  +  + E L+    E  IL++   P IV 
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 66

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHS 117
                  E N  IL    +E+  GG + DA+       L E +IR   +  L  L YLH 
Sbjct: 67  LLDAFYYENNLWIL----IEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGC-ARRARVNEDDEGKPICGTPICMAPEVARG 176
           N I+H D+K  NIL + D +   K+ADFG  A+  R  +  +     GTP  MAPEV   
Sbjct: 122 NKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMC 177

Query: 177 EEQ-----GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMS 229
           E        + ADVW+LG T++EMA   PP  ++ +P+  L +I   S+ P +  P   S
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL-NPMRVLLKIA-KSEPPTLAQPSRWS 235

Query: 230 KQAQDFLSKCLIRNPGERWSASELLEHGFV 259
            + +DFL KCL +N   RW+ ++LL+H FV
Sbjct: 236 SEFKDFLKKCLEKNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  113 bits (283), Expect = 2e-28
 Identities = 86/263 (32%), Positives = 133/263 (50%), Gaps = 23/263 (8%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK----SAELSNSEF--LQREQRILSALACPQIVAY 60
           + IG GS   V      R++EV A+K    S + SN ++  + +E + L  +  P  + Y
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           KGC + E        L +EY  G            L+E  I + T   L GL YLHS+ +
Sbjct: 91  KGCYLREHTAW----LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           +H DIK  NIL+++  +   K+ADFG A  A            GTP  MAPEV    ++G
Sbjct: 147 IHRDIKAGNILLTEPGQ--VKLADFGSASIA-----SPANSFVGTPYWMAPEVILAMDEG 199

Query: 181 ---FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY-MSKQAQDFL 236
                 DVW+LG T +E+A  +PP  ++ + +SAL+ I   +++P +     S   ++F+
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIA-QNESPTLQSNEWSDYFRNFV 257

Query: 237 SKCLIRNPGERWSASELLEHGFV 259
             CL + P +R ++ ELL+H FV
Sbjct: 258 DSCLQKIPQDRPTSEELLKHMFV 280

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  111 bits (279), Expect = 2e-28
 Identities = 77/260 (29%), Positives = 131/260 (50%), Gaps = 16/260 (6%)

Query: 3   WTRGQTIGRGS--TATVSIGMSNRSSEVFA-VKSAELSNSE--FLQREQRILSALACPQI 57
           +   + +G+G+   AT+     + S  V+  V    LS  E      E  ILS L  P I
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61

Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYL 115
           +AY       ++  +L  +  EYA GGTL D I  + G   EE  +  +   ++  + Y+
Sbjct: 62  IAYYNH--FMDDNTLLIEM--EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYI 117

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           H  GI+H DIK  NI ++K      K+ DFG ++    +E    + + GTP  M+PE+ +
Sbjct: 118 HKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILG-SEYSMAETVVGTPYYMSPELCQ 174

Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
           G +  F +D+WALGC + E+ T +  + D  +P++ + +I   + TP +  Y S +    
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTF-DATNPLNLVVKIVQGNYTPVVSVY-SSELISL 232

Query: 236 LSKCLIRNPGERWSASELLE 255
           +   L ++P +R +A E+L+
Sbjct: 233 VHSLLQQDPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  111 bits (278), Expect = 4e-28
 Identities = 87/269 (32%), Positives = 128/269 (47%), Gaps = 27/269 (10%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR----EQRILSALACPQIVAYKG 62
           + +G G+  TV       +  + AVK   L  +  LQ+    E  IL     P I+ + G
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
               E    I      E+  GG+L D  R       GRI     AV+ GL YL S  I+H
Sbjct: 67  AFFVENRISIC----TEFMDGGSL-DVYRKIPEHVLGRI---AVAVVKGLTYLWSLKILH 118

Query: 123 CDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF 181
            D+K  N+LV   N +G  K+ DFG + +  VN     K   GT   MAPE   GE+ G 
Sbjct: 119 RDVKPSNMLV---NTRGQVKLCDFGVSTQL-VNSI--AKTYVGTNAYMAPERISGEQYGI 172

Query: 182 PADVWALGCTVLEMATGRPPWPDVAD------PISALHRIGFSSDTPEIP-GYMSKQAQD 234
            +DVW+LG + +E+A GR P+P +        P+  L  I    D P +P G  S++   
Sbjct: 173 HSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI-VDEDPPVLPVGQFSEKFVH 231

Query: 235 FLSKCLIRNPGERWSASELLEHGFVKEQN 263
           F+++C+ + P ER +   L++H F+ + N
Sbjct: 232 FITQCMRKQPKERPAPENLMDHPFIVQYN 260

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  110 bits (276), Expect = 6e-28
 Identities = 81/265 (30%), Positives = 138/265 (52%), Gaps = 16/265 (6%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALACPQ-IVAYKGC 63
           + +G G+   V  G   ++ ++ A+K  +++    E +++E  +L   +  + I  Y G 
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 64  DISEENGKILYNLFL--EYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNG 119
            I +    +   L+L  E+   G++TD I++  G  L+E  I    R +L GL +LH + 
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK 131

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           ++H DIKGQN+L++++ E   K+ DFG + +           I GTP  MAPEV   +E 
Sbjct: 132 VIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDEN 188

Query: 180 -----GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD 234
                 F +D+W+LG T +EMA G PP  D+  P+ AL  I  +          SK+ Q 
Sbjct: 189 PDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNPAPRLKSKKWSKKFQS 247

Query: 235 FLSKCLIRNPGERWSASELLEHGFV 259
           F+  CL++N  +R +  +L++H F+
Sbjct: 248 FIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  110 bits (278), Expect = 6e-28
 Identities = 74/257 (28%), Positives = 120/257 (46%), Gaps = 29/257 (11%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKS------AELSNSEFLQREQRILSALACP 55
           D  R +T+G G+   V +     S   +A+K         L   + +  E+R+L  ++ P
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+       +E + + LY L  EY PGG L   +R+           +   ++  L+YL
Sbjct: 62  FIIRLFW---TEHDQRFLYMLM-EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYL 117

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  IV+ D+K +NIL+ K+     K+ DFG A++ R    D    +CGTP  +APEV +
Sbjct: 118 HSKEIVYRDLKPENILLDKEGH--IKLTDFGFAKKLR----DRTWTLCGTPEYLAPEVIQ 171

Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPD-----VADPISALHRIGFSSDTPEIPGYMSK 230
            +      D WALG  + EM  G PP+ D     + + I A  ++ F       P ++  
Sbjct: 172 SKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA-GKLEF-------PRHLDL 223

Query: 231 QAQDFLSKCLIRNPGER 247
            A+D + K L+ +   R
Sbjct: 224 YAKDLIKKLLVVDRTRR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  111 bits (280), Expect = 7e-28
 Identities = 79/305 (25%), Positives = 126/305 (41%), Gaps = 70/305 (22%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQ---REQRILSALACPQIVAYKGC 63
           IG G+   V   +  R+    A+K  S    +    +   RE ++L  L    I+     
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL-- 65

Query: 64  DI----SEENGKILYNLFLEYAPGGTLTD---AIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           DI    S E+   +Y +  E       TD    I+S   L +  I+     +L GL+YLH
Sbjct: 66  DILRPPSPEDFNDVY-IVTELME----TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM------- 169
           S  ++H D+K  NILV+ + +   KI DFG AR   V+ D++ K        +       
Sbjct: 121 SANVIHRDLKPSNILVNSNCD--LKICDFGLARG--VDPDEDEKGF------LTEYVVTR 170

Query: 170 ---APEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI---------- 215
              APE+     +     D+W++GC   E+ T +P +P   D I  L+ I          
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPG-RDYIDQLNLIVEVLGTPSEE 229

Query: 216 ---GFSSDT--------PEIPG--------YMSKQAQDFLSKCLIRNPGERWSASELLEH 256
                +S+         P+ P           S +A D L K L+ +P +R +A E L H
Sbjct: 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289

Query: 257 GFVKE 261
            ++ +
Sbjct: 290 PYLAQ 294

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  110 bits (275), Expect = 1e-27
 Identities = 81/266 (30%), Positives = 138/266 (51%), Gaps = 18/266 (6%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF--LQREQRILSALACPQ-IVAYKGC 63
           + +G G+   V  G   ++ ++ A+K  +++  E   ++ E  +L   +  + I  Y G 
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 64  DISEE---NGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSN 118
            I +    +   L+ L +E+   G++TD +++  G  L+E  I    R +L GL +LH++
Sbjct: 82  FIKKSPPGHDDQLW-LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
            ++H DIKGQN+L++++ E   K+ DFG + +           I GTP  MAPEV   +E
Sbjct: 141 KVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDE 197

Query: 179 Q-----GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
                  + +D+W+LG T +EMA G PP  D+  P+ AL  I  +          SK+  
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNPPPKLKSKKWSKKFI 256

Query: 234 DFLSKCLIRNPGERWSASELLEHGFV 259
           DF+  CL++N   R S  +LL+H F+
Sbjct: 257 DFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  110 bits (276), Expect = 2e-27
 Identities = 76/267 (28%), Positives = 126/267 (47%), Gaps = 20/267 (7%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAY 60
           + +G+GS   V +     +++ FA+K+ +        + E    E+R+LS       + +
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 61  KGCDISEENGKILYNLF--LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
             C    +      NLF  +EY  GG L   I+S    +  R   +   ++ GLQ+LHS 
Sbjct: 61  LYCTFQTKE-----NLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           GIV+ D+K  NIL+  D     KIADFG  +   +  D +    CGTP  +APE+  G++
Sbjct: 116 GIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLG-DAKTCTFCGTPDYIAPEILLGQK 172

Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK 238
                D W+ G  + EM  G+ P+    D       I    D P  P +++++A+D L K
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGH-DEEELFQSI--RMDNPCYPRWLTREAKDILVK 229

Query: 239 CLIRNPGERWSA-SELLEHGFVKEQNF 264
             +R P  R     ++ +H F +E ++
Sbjct: 230 LFVREPERRLGVKGDIRQHPFFREIDW 256

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  107 bits (270), Expect = 5e-27
 Identities = 80/267 (29%), Positives = 118/267 (44%), Gaps = 27/267 (10%)

Query: 4   TRGQTIGRGSTATVSIGM-----SNRSSEVFAVKSA-----ELSNSEFLQREQRILSALA 53
           T G+ +G G+   V  G        +  EV AVK+      E    EFL RE RI+  L 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEV-AVKTLKEDASEQQIEEFL-REARIMRKLD 59

Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLG 111
            P IV   G    EE   I+    +EY PGG L D +R      L    + S    +  G
Sbjct: 60  HPNIVKLLGVCTEEEPLMIV----MEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARG 115

Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT-PI-CM 169
           ++YL S   +H D+  +N LV ++     KI+DFG +R   + +DD  K   G  PI  M
Sbjct: 116 MEYLESKNFIHRDLAARNCLVGENL--VVKISDFGLSR--DLYDDDYYKVKGGKLPIRWM 171

Query: 170 APEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           APE  +  +    +DVW+ G  + E+ T G  P+P +      L  +         P   
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM-SNAEVLEYLK-KGYRLPKPPNC 229

Query: 229 SKQAQDFLSKCLIRNPGERWSASELLE 255
             +    + +C   +P +R + SEL+E
Sbjct: 230 PPELYKLMLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 2e-26
 Identities = 78/284 (27%), Positives = 122/284 (42%), Gaps = 42/284 (14%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQ----REQRILSALACPQIVAYKGC 63
           IG G+   V       + E+ A+K  +L   SE +     RE ++L  L  P I+     
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL-- 64

Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
           D+    G  LY L  E+     L   I+     L E  I+S+   +L GL + HS+GI+H
Sbjct: 65  DVFRHKGD-LY-LVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILH 121

Query: 123 CDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ-GF 181
            D+K +N+L++ +     K+ADFG AR               T    APE+  G++    
Sbjct: 122 RDLKPENLLINTEGV--LKLADFGLARSFGSPVRPY-THYVVTRWYRAPELLLGDKGYST 178

Query: 182 PADVWALGCTVLEMATGRPPWPDVA--DPISALHRI----------GFSS----DTPEIP 225
           P D+W++GC   E+ + RP +P  +  D +  + R            F+S         P
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP 238

Query: 226 GY-----------MSKQAQDFLSKCLIRNPGERWSASELLEHGF 258
                         S QA D LS+ L  +P +R +A + L H +
Sbjct: 239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  107 bits (268), Expect = 2e-26
 Identities = 80/265 (30%), Positives = 123/265 (46%), Gaps = 42/265 (15%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSE----FLQREQRIL-SALACPQIVA 59
           + IGRGS A V +    ++  ++A+K    EL N +    ++Q E+ +   A   P +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
              C  +E   ++ +   +EY  GG L   ++    L E   R ++  + L L YLH  G
Sbjct: 61  LHSCFQTES--RLFF--VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 116

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           I++ D+K  N+L+  D+E   K+ D+G  +   +   D     CGTP  +APE+ RGE+ 
Sbjct: 117 IIYRDLKLDNVLL--DSEGHIKLTDYGMCKEG-LRPGDTTSTFCGTPNYIAPEILRGEDY 173

Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------------- 223
           GF  D WALG  + EM  GR P+  V            SSD P+                
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVG-----------SSDNPDQNTEDYLFQVILEKQI 222

Query: 224 -IPGYMSKQAQDFLSKCLIRNPGER 247
            IP  +S +A   L   L ++P ER
Sbjct: 223 RIPRSLSVKAASVLKSFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  105 bits (264), Expect = 3e-26
 Identities = 71/271 (26%), Positives = 112/271 (41%), Gaps = 36/271 (13%)

Query: 4   TRGQTIGRGSTATVSIG---MSNRSSEVF-AVK----SAELSNSEFLQREQRILSALACP 55
           T G+ +G G+   V  G         +V  AVK     A     E   RE RI+  L  P
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL----- 110
            +V   G    EE   I+    +EY  GG L   +R        ++      +L      
Sbjct: 62  NVVKLLGVCTEEEPLYIV----MEYMEGGDLLSYLRK----NRPKL--SLSDLLSFALQI 111

Query: 111 --GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE--DDEGKPICGTP 166
             G++YL S   +H D+  +N LV ++     KI+DFG +R    ++     G  +   P
Sbjct: 112 ARGMEYLESKNFIHRDLAARNCLVGENL--VVKISDFGLSRDLYDDDYYRKRGGKL---P 166

Query: 167 I-CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEI 224
           I  MAPE  +  +    +DVW+ G  + E+ T G  P+P +      L  +  +      
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM-SNEEVLEYLK-NGYRLPQ 224

Query: 225 PGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
           P     +  D + +C   +P +R + SEL+E
Sbjct: 225 PPNCPPELYDLMLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 3e-26
 Identities = 74/269 (27%), Positives = 116/269 (43%), Gaps = 32/269 (11%)

Query: 9   IGRGSTATVSIGM----SNRSSEVFAVKSAELSNS-----EFLQREQRILSALACPQIVA 59
           +G G+   V  G       +++EV AVK+ +   S     +FL +E R++  L  P +V 
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEV-AVKTLKEDASEEERKDFL-KEARVMKKLGHPNVVR 60

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTC-LEEGRIRSHTRAVLL-------- 110
             G     E   +   L LEY  GG L D +R            + +   LL        
Sbjct: 61  LLGV--CTEEEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CM 169
           G++YL S   VH D+  +N LV +D     KI+DFG +R    ++    K     PI  M
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLV--VKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174

Query: 170 APEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEIPGY 227
           APE  +       +DVW+ G  + E+ T G  P+P +  + +    R G+       P Y
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY---RLPKPEY 231

Query: 228 MSKQAQDFLSKCLIRNPGERWSASELLEH 256
              +  + +  C   +P +R + SEL+E 
Sbjct: 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  105 bits (265), Expect = 4e-26
 Identities = 73/246 (29%), Positives = 105/246 (42%), Gaps = 40/246 (16%)

Query: 44  REQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRS 103
           RE R+L  L  P +V     ++     K+  +L  EY     L +  ++   + E  I+ 
Sbjct: 49  REIRMLKQLKHPNLVNLI--EVFRRKRKL--HLVFEYCDHTVLNELEKNPRGVPEHLIKK 104

Query: 104 HTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPIC 163
                L  + + H +  +H D+K +NIL++K  +   K+ DFG A R      D+     
Sbjct: 105 IIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ--IKLCDFGFA-RILTGPGDDYTDYV 161

Query: 164 GTPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI------- 215
            T    APE+  G+ Q G P DVWA+GC   E+ TG+P WP  +D +  L+ I       
Sbjct: 162 ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD-VDQLYLIRKTLGDL 220

Query: 216 ---------------GFSSDTPE--------IPGYMSKQAQDFLSKCLIRNPGERWSASE 252
                          G S   PE         P   S  A  FL  CL  +P ER S  E
Sbjct: 221 IPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNI-SSPALSFLKGCLQMDPTERLSCEE 279

Query: 253 LLEHGF 258
           LLEH +
Sbjct: 280 LLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  106 bits (265), Expect = 4e-26
 Identities = 85/265 (32%), Positives = 129/265 (48%), Gaps = 21/265 (7%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK----SAELSNSEF--LQREQRILSALACPQIVAY 60
           + IG GS   V      R+SEV A+K    S + SN ++  + +E R L  L  P  + Y
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           +GC + E        L +EY  G            L+E  I + T   L GL YLHS+ +
Sbjct: 81  RGCYLREHTAW----LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           +H D+K  NIL+S+      K+ DFG A               GTP  MAPEV    ++G
Sbjct: 137 IHRDVKAGNILLSEPGL--VKLGDFGSASIM-----APANXFVGTPYWMAPEVILAMDEG 189

Query: 181 ---FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
                 DVW+LG T +E+A  +PP  ++ + +SAL+ I  +       G+ S+  ++F+ 
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFRNFVD 248

Query: 238 KCLIRNPGERWSASELLEHGFVKEQ 262
            CL + P +R ++  LL+H FV  +
Sbjct: 249 SCLQKIPQDRPTSEVLLKHRFVLRE 273

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  105 bits (264), Expect = 5e-26
 Identities = 84/273 (30%), Positives = 128/273 (46%), Gaps = 36/273 (13%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSA--ELSNSEFLQ--REQRILSALACPQIVAYKGCD 64
           +G+G+  +V   +   +    A+K    EL  S+F Q   E  IL     P IV + G  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRSGTC----LEEGRIRSHTRAVLLGLQYL-HSNG 119
             E  G +     +EY   G+L D + +G      + E  +R  T AV+ GL++L   + 
Sbjct: 69  FIE--GAVYM--CMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGC-----ARRARVNEDDEGKPICGTPICMAPEVA 174
           I+H D+K  N+LV+ + +   K+ DFG      A  A+ N         G    MAPE  
Sbjct: 124 IIHRDVKPTNVLVNGNGQ--VKLCDFGVSGNLVASLAKTN--------IGCQSYMAPERI 173

Query: 175 RGEEQG------FPADVWALGCTVLEMATGRPPWP-DVADPISALHRIGFSSDTPEIPGY 227
           +             +DVW+LG ++LEMA GR P+P +    I A        D P +P  
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG 233

Query: 228 MSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
            S  AQDF++KCL + P  R + ++LLEH ++ 
Sbjct: 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLV 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  106 bits (266), Expect = 5e-26
 Identities = 81/284 (28%), Positives = 124/284 (43%), Gaps = 52/284 (18%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVK--SAELSNSE----FLQREQRIL-SALACPQIVAYK 61
           IGRGS A V +    ++  ++A+K    EL N +    ++Q E+ +  +A   P +V   
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 62  GCDISEENGKILYNLFL--EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
            C  +E        LF   E+  GG L   ++    L E   R ++  + L L +LH  G
Sbjct: 63  SCFQTESR------LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG 116

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           I++ D+K  N+L+  D E   K+ D+G  +   +   D     CGTP  +APE+ RGE+ 
Sbjct: 117 IIYRDLKLDNVLL--DAEGHIKLTDYGMCKEG-IRPGDTTSTFCGTPNYIAPEILRGEDY 173

Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------------- 223
           GF  D WALG  + EM  GR P+  V             SD P+                
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGM-----------SDNPDQNTEDYLFQVILEKQI 222

Query: 224 -IPGYMSKQAQDFLSKCLIRNPGERWSA------SELLEHGFVK 260
            IP  +S +A   L   L ++P ER          ++  H F +
Sbjct: 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  104 bits (261), Expect = 7e-26
 Identities = 78/265 (29%), Positives = 127/265 (47%), Gaps = 18/265 (6%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKS---AELSNSEFLQ--REQRILSALACPQI 57
           + + + IG GS     +  S    + + +K    +++S  E  +  +E  +LS +  P I
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYL 115
           V Y+  +  EENG  LY + ++Y  GG L   I  + G    E +I      + L L+++
Sbjct: 62  VQYQ--ESFEENGN-LY-IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHV 117

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPIC-GTPICMAPEVA 174
           H   I+H DIK QNI ++KD     K+ DFG AR   +N   E    C GTP  ++PE+ 
Sbjct: 118 HDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARV--LNSTVELARTCIGTPYYLSPEIC 173

Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD 234
                   +D+WALGC + EM T +  +   A  +  L         P +  + S   ++
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCTLKHAFE--AGNMKNLVLKIIRGSYPPVSSHYSYDLRN 231

Query: 235 FLSKCLIRNPGERWSASELLEHGFV 259
            +S+   RNP +R S + +LE  F+
Sbjct: 232 LVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  105 bits (263), Expect = 1e-25
 Identities = 76/270 (28%), Positives = 126/270 (46%), Gaps = 22/270 (8%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAY 60
           + +G+GS   V +       E FAVK+ +        + E    E+R+L+       + +
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 61  KGCDISEENGKILYNLF--LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
             C    +      +LF  +E+  GG L   I+     +  R   +   ++ GLQ+LHS 
Sbjct: 61  LYCTFQTKE-----HLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK 115

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           GI++ D+K  N+++ +D     KIADFG  +   V  D+     CGTP  +APE+ +G +
Sbjct: 116 GIIYRDLKLDNVMLDRDGH--IKIADFGMCKE-NVFGDNRASTFCGTPDYIAPEILQGLK 172

Query: 179 QGFPADVWALGCTVLEMATGRPPW-PDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
             F  D W+ G  + EM  G+ P+  D  D +    R+    DTP  P +++K+++D L 
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV----DTPHYPRWITKESKDILE 228

Query: 238 KCLIRNPGERWSAS-ELLEHGFVKEQNFKL 266
           K   R+P  R      +  H F K  N+  
Sbjct: 229 KLFERDPTRRLGVVGNIRGHPFFKTINWTA 258

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  104 bits (261), Expect = 2e-25
 Identities = 81/277 (29%), Positives = 131/277 (47%), Gaps = 24/277 (8%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAEL----SNSEFLQREQRIL-SALACPQIVA 59
           + IGRGS A V +    ++ +++A+K    EL     + +++Q E+ +   A + P +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
              C  +      L+ L +EY  GG L   ++    L E   R +   + + L +LH  G
Sbjct: 61  LHSCFQTTSR---LF-LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG 116

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           I++ D+K  N+L+  D     K+ D+G  +   +   D     CGTP  +APE+ RGEE 
Sbjct: 117 IIYRDLKLDNVLLDADGH--IKLTDYGMCKEG-LGPGDTTSTFCGTPNYIAPEILRGEEY 173

Query: 180 GFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSS--DTP-EIPGYMSKQAQDF 235
           GF  D WALG  + EM  GR P+  + D P        F    + P  IP ++S +A   
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHV 233

Query: 236 LSKCLIRNPGERWSA------SELLEHGFVKEQNFKL 266
           L   L ++P ER         S++  H F +  ++ L
Sbjct: 234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDL 270

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  102 bits (256), Expect = 6e-25
 Identities = 71/242 (29%), Positives = 108/242 (44%), Gaps = 42/242 (17%)

Query: 45  EQRILSALACPQIV--AY------KGCDISE--ENGKILYNLFLEYAPGGTLTDAIRSGT 94
           E++IL  ++   IV  AY        C +      G + Y+++    PG           
Sbjct: 43  EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG----------- 91

Query: 95  CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN 154
              E R   +   ++ GL++LH   IV+ D+K +N+L+  D+    +I+D G A      
Sbjct: 92  -FPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL--DDHGNVRISDLGLAV----- 143

Query: 155 EDDEGKPI---CGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISA 211
           E   GK I    GTP  MAPEV +GE   F  D +ALGCT+ EM  GR P+    + +  
Sbjct: 144 ELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK 203

Query: 212 L---HRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGER-----WSASELLEHGFVKEQN 263
                R        E P   S +A+D     L ++P +R      SA E+ EH   K+ N
Sbjct: 204 EELKRRT--LEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261

Query: 264 FK 265
           ++
Sbjct: 262 WR 263

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  101 bits (254), Expect = 1e-24
 Identities = 76/280 (27%), Positives = 114/280 (40%), Gaps = 53/280 (18%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKS-AELSNSEFLQREQRILSAL-------ACPQIVAY 60
           IG G+   V      ++  V AVK      N E     +RIL  L        CP IV  
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE---ENKRILMDLDVVLKSHDCPYIVKC 79

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSH-----------TRAVL 109
            G  I++ +  I   L                 TCL++   R             T A++
Sbjct: 80  YGYFITDSDVFICMELM---------------STCLDKLLKRIQGPIPEDILGKMTVAIV 124

Query: 110 LGLQYLHSN-GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC 168
             L YL    G++H D+K  NIL+  D     K+ DFG +   R+ +        G    
Sbjct: 125 KALHYLKEKHGVIHRDVKPSNILL--DASGNVKLCDFGIS--GRLVDSKAKTRSAGCAAY 180

Query: 169 MAPEVARGE-EQGFP-----ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP 222
           MAPE  R +     P     ADVW+LG +++E+ATG+ P+ +       L +I    + P
Sbjct: 181 MAPE--RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI-LQEEPP 237

Query: 223 EIPGYM--SKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
            +P     S     F+  CL ++  +R    ELL+H F++
Sbjct: 238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  101 bits (252), Expect = 2e-24
 Identities = 65/200 (32%), Positives = 97/200 (48%), Gaps = 16/200 (8%)

Query: 75  NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSK 134
           +L L+Y  GG L   +       E  +R +   ++L L +LH  GI++ DIK +NIL+  
Sbjct: 81  HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL-- 138

Query: 135 DNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF--PADVWALGCTV 192
           D+E    + DFG ++     E++     CGT   MAPEV RG   G     D W+LG   
Sbjct: 139 DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLT 198

Query: 193 LEMATGRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGER 247
            E+ TG  P+      +    IS   RI  S   P  P  MS +A+DF+ K L ++P +R
Sbjct: 199 FELLTGASPFTVDGEQNSQSEIS--RRILKSK--PPFPKTMSAEARDFIQKLLEKDPKKR 254

Query: 248 W---SASELLEHGFVKEQNF 264
                A E+  H F +  ++
Sbjct: 255 LGANGADEIKNHPFFQGIDW 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 3e-24
 Identities = 82/294 (27%), Positives = 124/294 (42%), Gaps = 62/294 (21%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKS--AELSN-SEFLQ-REQRILSAL-ACPQIVAYKGC 63
           +G G+  +V +  +  + E+ A+K    +  +  E +  RE + L  L   P IV  K  
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK-- 64

Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
           ++  EN + LY +F EY  G  L   ++   G    E  IRS    +L GL ++H +G  
Sbjct: 65  EVFRENDE-LYFVF-EYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFF 121

Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP----ICGTPICMAPEVA-RG 176
           H D+K +N+LVS    +  KIADFG AR  R       +P       T    APE+  R 
Sbjct: 122 HRDLKPENLLVS--GPEVVKIADFGLAREIR------SRPPYTDYVSTRWYRAPEILLRS 173

Query: 177 EEQGFPADVWALGCTVLEMATGRP------------------------PWPDVADPISAL 212
                P D+WALGC + E+ T RP                         WP   +     
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWP---EGYKLA 230

Query: 213 HRIGFSSDTPEIPGYMSKQ--------AQDFLSKCLIRNPGERWSASELLEHGF 258
            ++GF    P+       Q        A D +   L  +P +R +AS+ L+H +
Sbjct: 231 SKLGFRF--PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  101 bits (252), Expect = 3e-24
 Identities = 76/266 (28%), Positives = 126/266 (47%), Gaps = 19/266 (7%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE----LSNSEFLQR--EQRILSALACPQIVAYKG 62
           IG+GS   V       +  ++A+K+      +S SE      E+ +L+ + CP IV  K 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59

Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
              S ++ + LY L L +  GG L   ++     +  R R +T  +L  L+ LH   +++
Sbjct: 60  --FSFQSPEKLY-LVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIY 116

Query: 123 CDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFP 182
            D+K +NIL+  D +    + DFG  +   + +DD+    CGTP  +APE+  G      
Sbjct: 117 RDLKPENILL--DYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173

Query: 183 ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIR 242
            D W LG  + EM TG PP+ D  + ++ ++R     +    P    + A+D L   L R
Sbjct: 174 VDWWTLGVLLYEMLTGLPPFYD--ENVNEMYR-KILQEPLRFPDGFDRDAKDLLIGLLSR 230

Query: 243 NPGERW---SASELLEHGFVKEQNFK 265
           +P  R     A E+  H F  + ++K
Sbjct: 231 DPTRRLGYNGAQEIKNHPFFSQLSWK 256

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 4e-24
 Identities = 89/315 (28%), Positives = 123/315 (39%), Gaps = 83/315 (26%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQ--------RILSALA 53
           D+   + IGRG+   V +     + +V+A+K   L  S+ ++R Q         IL+   
Sbjct: 2   DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMK--VLRKSDMIKRNQIAHVRAERDILADAD 59

Query: 54  CPQIV-AYKGCDISEENGKILYNLFLEYAPGGTLTDA-IRSGTCLEEGRIRSHTRAVLLG 111
            P IV  Y     S ++ + LY L +EY PGG L +  IR      E   R +   ++L 
Sbjct: 60  SPWIVKLY----YSFQDEEHLY-LVMEYMPGGDLMNLLIRKD-VFPEETARFYIAELVLA 113

Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG-CAR--------------------- 149
           L  +H  G +H DIK  NIL+  D     K+ADFG C +                     
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171

Query: 150 RARVNEDDEGKPIC------GTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWP 203
              V   D  +         GTP  +APEV RG   G   D W+LG  + EM  G PP  
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP-- 229

Query: 204 DVADPISALHRIGFSSDT-----------------PEIPGYMSKQAQDFLSKCLIRNPGE 246
                        F SDT                 P  P   S +A D + + L   P +
Sbjct: 230 -------------FYSDTLQETYNKIINWKESLRFPPDPPV-SPEAIDLICRLLCD-PED 274

Query: 247 RW-SASELLEHGFVK 260
           R  S  E+  H F K
Sbjct: 275 RLGSFEEIKSHPFFK 289

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  100 bits (252), Expect = 4e-24
 Identities = 79/307 (25%), Positives = 120/307 (39%), Gaps = 67/307 (21%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ--------REQRILSALAC 54
           + +G+ +G G+ A V       +  + A+K  +L   +  +        RE ++L  L  
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTC-LEEGRIRSHTRAVLLGLQ 113
           P I+        + N     NL  E+     L   I+  +  L    I+S+    L GL+
Sbjct: 62  PNIIGLLDVFGHKSN----INLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGLE 116

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTP----ICM 169
           YLHSN I+H D+K  N+L++ D     K+ADFG AR              G+P       
Sbjct: 117 YLHSNWILHRDLKPNNLLIASDGV--LKLADFGLARS------------FGSPNRKMTHQ 162

Query: 170 -------APEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDT 221
                  APE+  G    G   D+W++GC   E+    P  P  +D I  L +I  +  T
Sbjct: 163 VVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIFEALGT 221

Query: 222 P------------------EIPGYMSKQ--------AQDFLSKCLIRNPGERWSASELLE 255
           P                    P    KQ        A D L + L  NP +R +A + LE
Sbjct: 222 PTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281

Query: 256 HGFVKEQ 262
           H +    
Sbjct: 282 HPYFSND 288

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 99.3 bits (247), Expect = 5e-24
 Identities = 77/265 (29%), Positives = 130/265 (49%), Gaps = 25/265 (9%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYK 61
           + IG GS   + +  +   SE   +K  +L+       E  ++E  +L+ +  P IV + 
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
                +ENG++   + +EY  GG L   I  + G    E +I S    + LGL+++H   
Sbjct: 66  AS--FQENGRLF--IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK 121

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPIC-GTPICMAPEVARGEE 178
           I+H DIK QNI +SK N   AK+ DFG AR  ++N+  E    C GTP  ++PE+ +   
Sbjct: 122 ILHRDIKSQNIFLSK-NGMVAKLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEICQNRP 178

Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALH----RIGFSSDTPEIPGYMSKQAQD 234
                D+W+LGC + E+ T + P+       + LH    +I      P  P + S+  + 
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPFEG-----NNLHQLVLKICQGYFAPISPNF-SRDLRS 232

Query: 235 FLSKCLIRNPGERWSASELLEHGFV 259
            +S+    +P +R S + +L+  F+
Sbjct: 233 LISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 99.4 bits (248), Expect = 1e-23
 Identities = 77/256 (30%), Positives = 115/256 (44%), Gaps = 51/256 (19%)

Query: 44  REQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEE---GR 100
           RE ++L     P IV + G   S  +G+I  ++ +E+  GG+L   ++    + E   G+
Sbjct: 48  RELKVLHECNSPYIVGFYGAFYS--DGEI--SICMEHMDGGSLDQVLKKAGRIPENILGK 103

Query: 101 IRSHTRAVLLGLQYLHSN-GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG 159
           I   + AVL GL YL     I+H D+K  NILV+   E   K+ DFG + +     D   
Sbjct: 104 I---SIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI---DSMA 155

Query: 160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWP---------------- 203
               GT   M+PE  +G      +D+W+LG +++EMA GR P P                
Sbjct: 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVS 215

Query: 204 DVADPISALHRIGFSSDT------------------PEIP-GYMSKQAQDFLSKCLIRNP 244
           +     S     G   D+                  P++P G  S + QDF+ KCL +NP
Sbjct: 216 EGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNP 275

Query: 245 GERWSASELLEHGFVK 260
            ER    EL +H F+K
Sbjct: 276 KERADLKELTKHPFIK 291

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 99.5 bits (248), Expect = 2e-23
 Identities = 73/254 (28%), Positives = 118/254 (46%), Gaps = 23/254 (9%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ--------REQRILSALA 53
           D+  G+T+G GS   V I     + E +A+K   L   E L+        +E+ IL  L+
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKC--LKKREILKMKQVQHVAQEKSILMELS 76

Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
            P IV    C   +EN   +Y   LE+  GG L   +R          + +   ++L  +
Sbjct: 77  HPFIVNMM-CSFQDENR--VY-FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE 132

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
           YLHS  I++ D+K +N+L+  DN+   K+ DFG A++      D    +CGTP  +APEV
Sbjct: 133 YLHSKDIIYRDLKPENLLL--DNKGHVKVTDFGFAKKVP----DRTFTLCGTPEYLAPEV 186

Query: 174 ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
            + +  G   D W +G  + E   G PP+ D   P     +I   +   + P +   +A+
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKI--LAGRLKFPNWFDGRAR 243

Query: 234 DFLSKCLIRNPGER 247
           D +   L  +  +R
Sbjct: 244 DLVKGLLQTDHTKR 257

Length = 329

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 97.5 bits (243), Expect = 5e-23
 Identities = 68/214 (31%), Positives = 95/214 (44%), Gaps = 51/214 (23%)

Query: 78  LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE 137
           LE  P G           L+E R+R +   +L G+++ HS+ I+H DIK +NILVS+   
Sbjct: 90  LEKYPNG-----------LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV 138

Query: 138 QGAKIADFGCARR-ARVNED--DEGKPICGTPICMAPEVARGEEQ-GFPADVWALGCTVL 193
              K+ DFG AR  A   E   D       T    APE+  G+ + G   D+WA+GC V 
Sbjct: 139 --VKLCDFGFARTLAAPGEVYTD----YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVT 192

Query: 194 EMATGRPPWPDVADPISALHRI-----GFSSDTPEI----PGY----------------- 227
           EM TG P +P  +D I  L+ I            EI    P +                 
Sbjct: 193 EMLTGEPLFPGDSD-IDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKR 251

Query: 228 ---MSKQAQDFLSKCLIRNPGERWSASELLEHGF 258
              +S    D   +CL  +P +R S+S+LL H F
Sbjct: 252 FPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 96.0 bits (239), Expect = 1e-22
 Identities = 71/267 (26%), Positives = 122/267 (45%), Gaps = 28/267 (10%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQIVAYKG 62
             +G G+  +VS      +  V A K   +     ++    RE +I+     P IV++ G
Sbjct: 11  SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70

Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS-NGIV 121
             ++E N      + +E+   G+L    + G  +    +     AV+ GL YL++ + I+
Sbjct: 71  AFLNENN----ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIM 126

Query: 122 HCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           H DIK  NILV   N +G  K+ DFG +    +N         GT   M+PE  +G +  
Sbjct: 127 HRDIKPSNILV---NSRGQIKLCDFGVSGEL-INS--IADTFVGTSTYMSPERIQGGKYT 180

Query: 181 FPADVWALGCTVLEMATGRPPWPD-------VADPISA---LHRIGFSSDTPEIP-GYMS 229
             +DVW+LG +++E+A G+ P+           DP+     L +I      P +P     
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI-VQEPPPRLPSSDFP 239

Query: 230 KQAQDFLSKCLIRNPGERWSASELLEH 256
           +  +DF+  CL+++P ER +  +L   
Sbjct: 240 EDLRDFVDACLLKDPTERPTPQQLCAM 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 94.8 bits (236), Expect = 3e-22
 Identities = 81/294 (27%), Positives = 129/294 (43%), Gaps = 51/294 (17%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQREQRILSALACPQ 56
           D+T+ + IG G+   V  G + ++ ++ A+K   L + E        RE  +L  L  P 
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV  +   + +E+   L   FL       L D++  G  ++   ++S+   +L G+ + H
Sbjct: 61  IVCLQDV-LMQESRLYLIFEFLSMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFCH 118

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR------RARVNEDDEGKPICGTPICMA 170
           S  ++H D+K QN+L+  DN+   K+ADFG AR      R   +E         T    A
Sbjct: 119 SRRVLHRDLKPQNLLI--DNKGVIKLADFGLARAFGIPVRVYTHE-------VVTLWYRA 169

Query: 171 PEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP------- 222
           PEV  G  +   P D+W++G    EMAT +P +   ++ I  L RI     TP       
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE-IDQLFRIFRILGTPTEDVWPG 228

Query: 223 --EIPGY------------------MSKQAQDFLSKCLIRNPGERWSASELLEH 256
              +P Y                  + +   D L K LI +P +R SA + L H
Sbjct: 229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 95.4 bits (237), Expect = 4e-22
 Identities = 85/317 (26%), Positives = 135/317 (42%), Gaps = 43/317 (13%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRIL---SALACPQI 57
           IG+G+   V       +  ++A+K   LS  E + +        E+ IL        P I
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMK--VLSKKEIVAKKEVAHTIGERNILVRTLLDESPFI 58

Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V  K    S +    LY L  +Y  GG L   ++      E R + +   ++L L++LH 
Sbjct: 59  VGLK---FSFQTDSDLY-LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK 114

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
             IV+ D+K +NIL+         + DFG + +A + ++      CGT   +APEV   +
Sbjct: 115 YDIVYRDLKPENILLDATGH--IALCDFGLS-KANLTDNKTTNTFCGTTEYLAPEVLL-D 170

Query: 178 EQGFP--ADVWALGCTVLEMATGRPPW--PDVADPIS--ALHRIGFSSDTPEIPGYMSKQ 231
           E+G+    D W+LG  V EM  G  P+   D        A  ++ F  +       +S +
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNV------LSDE 224

Query: 232 AQDFLSKCLIRNPGERWSA----SELLEHGFVKEQNFKL---STLTEPETYNSESPTSVL 284
            + F+   L RNP  R  A     EL EH F  + ++ L     +T P     +S   V 
Sbjct: 225 GRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVS 284

Query: 285 NQQLWDSTLTSCSSASA 301
           N   +D   T+ S  +A
Sbjct: 285 N---FDPEFTNSSLLNA 298

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 94.0 bits (234), Expect = 7e-22
 Identities = 85/287 (29%), Positives = 134/287 (46%), Gaps = 47/287 (16%)

Query: 8   TIGRGSTATVSIGMSNRSSE-VFAVKSAELS-NSEFLQREQRILSAL-------ACPQIV 58
            +GRG+   V   M +  +  + AVK    + NS   Q ++R+L  L        CP  V
Sbjct: 8   ELGRGAYGVVD-KMRHVPTGTIMAVKRIRATVNS---QEQKRLLMDLDISMRSVDCPYTV 63

Query: 59  AYKGCDISEENGKI--------LYNLFLE-YAPGGTLTDAIRSGTCLEEGRIRSHTRAVL 109
            + G    E +  I        L   + + Y  G T+ + I        G+I     +++
Sbjct: 64  TFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDIL-------GKI---AVSIV 113

Query: 110 LGLQYLHSN-GIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPI-CGTP 166
             L+YLHS   ++H D+K  N+L+   N  G  K+ DFG +       D   K I  G  
Sbjct: 114 KALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYL---VDSVAKTIDAGCK 167

Query: 167 ICMAPEVARGE--EQGFP--ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP 222
             MAPE    E  ++G+   +DVW+LG T++E+ATGR P+     P   L ++     +P
Sbjct: 168 PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV-VEEPSP 226

Query: 223 EIP-GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLST 268
           ++P    S + QDF++KCL +N  ER +  ELL+H F +    K + 
Sbjct: 227 QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTD 273

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 93.3 bits (232), Expect = 1e-21
 Identities = 69/259 (26%), Positives = 118/259 (45%), Gaps = 20/259 (7%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSA---ELSNSEFLQR---EQRILSALACPQIVAYKG 62
           IG+G  + V   +      V A+K     E+ +++  Q    E  +L  L  P ++ Y  
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIR----SGTCLEEGRIRSHTRAVLLGLQYLHSN 118
             I E N     N+ LE A  G L+  I+        + E  I  +   +   L+++HS 
Sbjct: 70  SFI-ENN---ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK 125

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
            I+H DIK  N+ ++       K+ D G  R    ++      + GTP  M+PE      
Sbjct: 126 RIMHRDIKPANVFITATGV--VKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIHENG 182

Query: 179 QGFPADVWALGCTVLEMATGRPP-WPDVADPISALHRIGFSSDTPEIPG-YMSKQAQDFL 236
             F +D+W+LGC + EMA  + P + D  +  S   +I    D P +P  + S++ +D +
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-KCDYPPLPADHYSEELRDLV 241

Query: 237 SKCLIRNPGERWSASELLE 255
           S+C+  +P +R   S +L+
Sbjct: 242 SRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 79/309 (25%), Positives = 125/309 (40%), Gaps = 57/309 (18%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILSALACPQIVAY 60
           +G+G    V +     + ++FA+K   L   E ++R        EQ IL+ L  P +   
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKV--LDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
                S +    L  L ++Y PGG L   +  + G CL E   R +   VLL L+YLH  
Sbjct: 67  YA---SFQTETYLC-LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL 122

Query: 119 GIVHCDIKGQNILVSKD--------------NEQGAKIADFGCARRARVNEDDEGKPI-- 162
           GIV+ D+K +NIL+ +               + +   ++        R + +        
Sbjct: 123 GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182

Query: 163 ----------CGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISAL 212
                      GT   +APEV  G+  G   D W LG  + EM  G  P+        + 
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK------GSN 236

Query: 213 HRIGFS---SDTPEIPGY--MSKQAQDFLSKCLIRNP----GERWSASELLEHGFVKEQN 263
               FS         PG   +S  A+D + K L+++P    G +  A+E+ +H F +  N
Sbjct: 237 RDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296

Query: 264 FKLSTLTEP 272
           + L   T P
Sbjct: 297 WALIRHTTP 305

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 93.3 bits (232), Expect = 2e-21
 Identities = 71/266 (26%), Positives = 115/266 (43%), Gaps = 26/266 (9%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILSALACPQ-IVA 59
           +G+GS   V +     + E++A+K   L     +Q         E+R+L+    P  +  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKI--LKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQ 65

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
              C  + +    LY   +EY  GG L   I+     +E     +   + +GL +LHS G
Sbjct: 66  LHSCFQTMDR---LY-FVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           I++ D+K  N+++  D E   KIADFG  +   +      +  CGTP  +APE+   +  
Sbjct: 122 IIYRDLKLDNVML--DAEGHIKIADFGMCKE-NIFGGKTTRTFCGTPDYIAPEIIAYQPY 178

Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
           G   D WA G  + EM  G+PP+ D  D       I         P  +SK+A       
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQSI--MEHNVSYPKSLSKEAVSICKGL 235

Query: 240 LIRNPGERWSAS-----ELLEHGFVK 260
           L ++P +R         ++ EH F +
Sbjct: 236 LTKHPAKRLGCGPTGERDIREHAFFR 261

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 93.4 bits (232), Expect = 2e-21
 Identities = 78/278 (28%), Positives = 122/278 (43%), Gaps = 33/278 (11%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILSALAC--PQ 56
           + +G+GS   V +     S  ++AVK   L     LQ         E+RILS LA   P 
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILS-LARNHPF 57

Query: 57  IVAYKGCDISEENGKILYNLF--LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
           +     C  + +       LF  +E+  GG L   I+     +E R R +   +   L +
Sbjct: 58  LTQLYCCFQTPDR------LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMF 111

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           LH  GI++ D+K  N+L+  D+E   K+ADFG  +   +         CGTP  +APE+ 
Sbjct: 112 LHDKGIIYRDLKLDNVLL--DHEGHCKLADFGMCKEG-IFNGKTTSTFCGTPDYIAPEIL 168

Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD 234
           +    G   D WA+G  + EM  G  P+   A+    L      +D    P ++S+ A D
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPFE--AENEDDLFE-AILNDEVVYPTWLSQDAVD 225

Query: 235 FLSKCLIRNPGERWSA------SELLEHGFVKEQNFKL 266
            L   + +NP  R  +        +L H F KE +++ 
Sbjct: 226 ILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEK 263

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 93.2 bits (231), Expect = 3e-21
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 18/228 (7%)

Query: 78  LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE 137
           +EY  GG L   +       E R R +   ++  L YLHS  IV+ D+K +N+++ KD  
Sbjct: 74  MEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH 133

Query: 138 QGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT 197
              KI DFG  +   + +    K  CGTP  +APEV    + G   D W LG  + EM  
Sbjct: 134 --IKITDFGLCKEG-ITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 190

Query: 198 GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERW-----SASE 252
           GR P+ +       L  +    D  + P  +S  A+  LS  LI++P +R       A E
Sbjct: 191 GRLPFYN--QDHEKLFELILMEDI-KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKE 247

Query: 253 LLEHGFVKEQNF------KLSTLTEPETYNSESPTSVLNQQLWDSTLT 294
           ++ H F    N+      KL    +P+   SE+ T   +++    T+T
Sbjct: 248 IMRHSFFTGVNWQDVYDKKLVPPFKPQV-TSETDTRYFDEEFTAQTIT 294

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 91.5 bits (227), Expect = 3e-21
 Identities = 60/202 (29%), Positives = 108/202 (53%), Gaps = 14/202 (6%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEFL--QREQRILSALACPQI 57
           + + + +GRG+   V +       ++  +K     +++  E L  Q E ++L  L+ P I
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61

Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYL 115
           + Y    + ++   I+    +EYAPGGTL + I  R  + L+E  I      +LL L ++
Sbjct: 62  IEYYENFLEDKALMIV----MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV 117

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           H+  I+H D+K QNIL+ K ++   KI DFG ++   ++   +   + GTP  ++PE+  
Sbjct: 118 HTKLILHRDLKTQNILLDK-HKMVVKIGDFGISK--ILSSKSKAYTVVGTPCYISPELCE 174

Query: 176 GEEQGFPADVWALGCTVLEMAT 197
           G+     +D+WALGC + E+A+
Sbjct: 175 GKPYNQKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 92.7 bits (230), Expect = 4e-21
 Identities = 64/198 (32%), Positives = 100/198 (50%), Gaps = 11/198 (5%)

Query: 75  NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSK 134
           +L L+Y  GG +   +       E  +R ++  ++L L++LH  GIV+ DIK +NIL+  
Sbjct: 81  HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL-- 138

Query: 135 DNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCTVL 193
           D+E    + DFG ++     E +     CGT   MAPE+ RG+   G   D W+LG  + 
Sbjct: 139 DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIF 198

Query: 194 EMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGER---- 247
           E+ TG  P+      +  S + R     D P  P ++  +AQD L K L ++P +R    
Sbjct: 199 ELLTGASPFTLEGERNTQSEVSRRILKCD-PPFPSFIGPEAQDLLHKLLRKDPKKRLGAG 257

Query: 248 -WSASELLEHGFVKEQNF 264
              ASE+ EH F K  ++
Sbjct: 258 PQGASEIKEHPFFKGLDW 275

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 91.3 bits (227), Expect = 1e-20
 Identities = 74/320 (23%), Positives = 122/320 (38%), Gaps = 67/320 (20%)

Query: 9   IGRG--STATVSIGMSNRSSEVFAVK--SAELSNSE---FLQREQRILSALACPQIVAYK 61
           IG+       V +     ++ + AVK  + +  + E    LQ+E      L  P I+ Y 
Sbjct: 6   IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65

Query: 62  GCDISEENGKILYNL--FLEYAPGGTLTDAIRSGTC--LEEGRIRSHTRAVLLGLQYLHS 117
              I       LY +   + Y   G+  D +++     L E  I    + VL  L Y+HS
Sbjct: 66  TSFI---VDSELYVVSPLMAY---GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS 119

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR--VNEDDEGKPICGTPIC------- 168
            G +H  +K  +IL+S D      ++     R +   +      + +   P         
Sbjct: 120 KGFIHRSVKASHILLSGDG--KVVLSGL---RYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174

Query: 169 MAPEVARGEEQGFPA--DVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS----DTP 222
           ++PEV +   QG+    D++++G T  E+A G  P+ D+      L ++  +     D  
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKS 234

Query: 223 EIPGYMSKQAQD---------------------------FLSKCLIRNPGERWSASELLE 255
             P Y    +Q                            F+  CL R+P  R SAS+LL 
Sbjct: 235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294

Query: 256 HGF---VKEQNFKLSTLTEP 272
           H F    K +N  L  L +P
Sbjct: 295 HSFFKQCKRRNTSLLDLLKP 314

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 86/309 (27%), Positives = 131/309 (42%), Gaps = 61/309 (19%)

Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFL-----QREQRILSALACP 55
            D+     +G G+   V      ++  V A+K   + N +        RE +IL  L  P
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHP 67

Query: 56  QIV-----AYKGCDISEENGKILYNLF--LEYAPGGTLTD-AIRSGTCLEEGRIRSHTRA 107
            +V     A +  D S+     +Y +   +++   G L + +++    L E +I+ +   
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK----LTESQIKCYMLQ 123

Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG--- 164
           +L G+ YLH N I+H DIK  NIL+  DN+   KIADFG AR       +      G   
Sbjct: 124 LLEGINYLHENHILHRDIKAANILI--DNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181

Query: 165 --TPICM-----APEVARGEEQGFPA-DVWALGCTVLEMATGRPPWPDVADPISALHRIG 216
             T + +      PE+  GE +   A D+W +GC   EM T RP     +D I  LH I 
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD-IDQLHLI- 239

Query: 217 FS---SDTPE-------IPGY-------------------MSKQAQDFLSKCLIRNPGER 247
           F    + T E       +PG                    +  +  D LSK L  +P +R
Sbjct: 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKR 299

Query: 248 WSASELLEH 256
            +AS+ LEH
Sbjct: 300 LTASDALEH 308

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 91.0 bits (226), Expect = 2e-20
 Identities = 58/189 (30%), Positives = 89/189 (47%), Gaps = 17/189 (8%)

Query: 78  LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE 137
           +EYA GG L   +       E R R +   ++  L YLHS  +V+ D+K +N+++ KD  
Sbjct: 74  MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH 133

Query: 138 QGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT 197
              KI DFG  +   +++    K  CGTP  +APEV    + G   D W LG  + EM  
Sbjct: 134 --IKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 190

Query: 198 GRPPWPDVADPISALHRIGFS---SDTPEIPGYMSKQAQDFLSKCLIRNPGERW-----S 249
           GR P+       +  H   F     +    P  +S +A+  L+  L ++P +R       
Sbjct: 191 GRLPF------YNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPED 244

Query: 250 ASELLEHGF 258
           A E++EH F
Sbjct: 245 AKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 89.6 bits (222), Expect = 2e-20
 Identities = 72/265 (27%), Positives = 124/265 (46%), Gaps = 22/265 (8%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKS------AELSNSEFLQ--REQRILSALACPQIV 58
           Q +G+GS  TV +    ++     +K        EL+ +E +Q  +E ++LS L  P IV
Sbjct: 6   QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIR----SGTCLEEGRIRSHTRAVLLGLQY 114
            +    +  +     + +  EY  G  L   +     +G  L E ++      +LLG+ Y
Sbjct: 66  KFHASFLERDA----FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           +H   I+H D+K +NI +  +     KI DFG +R   +   D      GTP  M+PE  
Sbjct: 122 MHQRRILHRDLKAKNIFLKNNL---LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEAL 177

Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD 234
           + +     +D+W+LGC + EM      + +  + +S + RI     TP +P   S+Q   
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHAF-EGQNFLSVVLRI-VEGPTPSLPETYSRQLNS 235

Query: 235 FLSKCLIRNPGERWSASELLEHGFV 259
            +   L ++P  R SA+E+L + F+
Sbjct: 236 IMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 89.8 bits (223), Expect = 2e-20
 Identities = 65/212 (30%), Positives = 95/212 (44%), Gaps = 28/212 (13%)

Query: 7   QTIGRGSTATVSIG----MSNRSSEVFAVKSAELSNSEF----LQREQRILSALACPQIV 58
           + +G G    V +     + + + E  AVKS   S  E      +RE  IL  L    IV
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHS 117
            YKG    E+ G     L +EY P G+L D ++     +   R+   +  +  G+ YL S
Sbjct: 70  KYKGV--CEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA-------RVNEDDEGKPICGTPI-CM 169
              +H D+  +NILV  ++E   KI+DFG A+          V E  E      +PI   
Sbjct: 128 QRYIHRDLAARNILV--ESEDLVKISDFGLAKVLPEDKDYYYVKEPGE------SPIFWY 179

Query: 170 APEVARGEEQGFPADVWALGCTVLEMAT-GRP 200
           APE  R  +    +DVW+ G T+ E+ T G P
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFTYGDP 211

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 89.7 bits (223), Expect = 5e-20
 Identities = 74/296 (25%), Positives = 120/296 (40%), Gaps = 48/296 (16%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALACPQIVAYK 61
           + IG G+   V   +  RS +  A+K         + ++   RE +IL       I+A +
Sbjct: 11  ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70

Query: 62  GCDI---SEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
             DI      + K +Y + ++      L   I S   L E  IR     +L GL+Y+HS 
Sbjct: 71  --DILRPPGADFKDVY-VVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA 126

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI---CGTPICMAPEVAR 175
            ++H D+K  N+LV++D E   +I DFG AR    +  +    +     T    APE+  
Sbjct: 127 NVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184

Query: 176 GEEQGFPA-DVWALGCTVLEMATGRPPWPDVADPISALHRI------------------- 215
              +   A D+W++GC   EM   R  +P   + +  L  I                   
Sbjct: 185 SLPEYTTAIDMWSVGCIFAEMLGRRQLFPG-KNYVHQLKLILSVLGSPSEEVLNRIGSDR 243

Query: 216 ------GFSSDTP----EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                       P    +I    S +A D LS+ L  +P ER +  + L+H F+ +
Sbjct: 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 88.9 bits (220), Expect = 5e-20
 Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 12/199 (6%)

Query: 75  NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSK 134
           +L L+Y  GG L   +      +E  ++ ++  ++L L++LH  GI++ DIK +NIL+  
Sbjct: 81  HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL-- 138

Query: 135 DNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF--PADVWALGCTV 192
           D+     + DFG ++    +E +     CGT   MAP++ RG + G     D W++G  +
Sbjct: 139 DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLM 198

Query: 193 LEMATGRPPWPDVADPISA--LHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERW-- 248
            E+ TG  P+    +  S   + R    S+ P  P  MS  A+D + + L+++P +R   
Sbjct: 199 YELLTGASPFTVDGEKNSQAEISRRILKSEPP-YPQEMSALAKDIIQRLLMKDPKKRLGC 257

Query: 249 ---SASELLEHGFVKEQNF 264
               A E+ +H F ++ N+
Sbjct: 258 GPSDADEIKKHPFFQKINW 276

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 89.5 bits (222), Expect = 5e-20
 Identities = 73/231 (31%), Positives = 112/231 (48%), Gaps = 27/231 (11%)

Query: 45  EQRILSALACPQIV--AYKGCDISEENGKILYNLFLEYAPGGTL-TDAIRSGTCLEEGRI 101
           E+ IL A+  P IV   Y     + + G  LY L LEY  GG L     R G  +E+   
Sbjct: 50  ERNILEAVKHPFIVDLIY-----AFQTGGKLY-LILEYLSGGELFMHLEREGIFMED-TA 102

Query: 102 RSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGK 160
             +   + L L++LH  GI++ D+K +NIL+   + QG  K+ DFG  + + ++E     
Sbjct: 103 CFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKES-IHEGTVTH 158

Query: 161 PICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRIGFS 218
             CGT   MAPE+      G   D W+LG  + +M TG PP+   +    I  + +   +
Sbjct: 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN 218

Query: 219 SDTPEIPGYMSKQAQDFLSKCLIRNPGERW-----SASELLEHGFVKEQNF 264
                +P Y++ +A+D L K L RNP  R       A+E+  H F +  N+
Sbjct: 219 -----LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 87.7 bits (217), Expect = 6e-20
 Identities = 73/267 (27%), Positives = 123/267 (46%), Gaps = 31/267 (11%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAEL----SNSEFLQREQRILSALACPQIVAYKG 62
           + +G GS     +     S + +A+K   L    S  E  ++E  +L+ +  P IVA+K 
Sbjct: 6   RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65

Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
              S E    LY + +EY  GG L   I+   G    E  I      + LG+Q++H   +
Sbjct: 66  ---SFEADGHLY-IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV 121

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPIC---GTPICMAPEVARGE 177
           +H DIK +NI ++++ +   K+ DFG AR         G   C   GTP  + PE+    
Sbjct: 122 LHRDIKSKNIFLTQNGK--VKLGDFGSARLL----TSPGAYACTYVGTPYYVPPEIWENM 175

Query: 178 EQGFPADVWALGCTVLEMATGRPP-----WPDVADPISALHRIGFSSDTPEIPGYMSKQA 232
                +D+W+LGC + E+ T + P     W ++      + ++   S  P +P + S + 
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------ILKVCQGSYKP-LPSHYSYEL 228

Query: 233 QDFLSKCLIRNPGERWSASELLEHGFV 259
           +  + +   RNP  R SA+ +L  G +
Sbjct: 229 RSLIKQMFKRNPRSRPSATTILSRGSL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 89.2 bits (222), Expect = 7e-20
 Identities = 88/300 (29%), Positives = 129/300 (43%), Gaps = 57/300 (19%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSA--ELSNSEFLQREQR---ILSALA-CPQIVAY 60
           Q +G+G+   V   +  R+ EV A+K       N+   QR  R    L  L   P IV  
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIV-- 70

Query: 61  KGCD-ISEENGKILYNLFLEYAPGGTLTD---AIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           K  + I  EN K +Y +F EY      TD    IR+   LE+   R     +L  L+Y+H
Sbjct: 71  KLLNVIKAENDKDIYLVF-EYME----TDLHAVIRANI-LEDVHKRYIMYQLLKALKYIH 124

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI----CGTPICMAPE 172
           S  ++H D+K  NIL+  +++   K+ADFG AR     E++   P+      T    APE
Sbjct: 125 SGNVIHRDLKPSNILL--NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPE 182

Query: 173 VARGEEQ-GFPADVWALGCTVLEMATGRP------------------PWPDVADPISALH 213
           +  G  +     D+W++GC + EM  G+P                    P   D I ++ 
Sbjct: 183 ILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED-IESIK 241

Query: 214 RIGFS----SDTPEIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
              F+       P  P           S  A D L K L+ NP +R +A E LEH +V +
Sbjct: 242 S-PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 90.3 bits (224), Expect = 1e-19
 Identities = 75/264 (28%), Positives = 121/264 (45%), Gaps = 26/264 (9%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQ---------RILSALACPQI 57
           +G G+T TV         E FAVK  ++   +     R Q            S + C + 
Sbjct: 40  LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99

Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGR-IRSHTRA-----VLLG 111
            A K  D       ++  L L+YA  G L   I+S    +  R  R H        VLL 
Sbjct: 100 FAKK--DPRNPENVLMIALVLDYANAGDLRQEIKSRA--KTNRTFREHEAGLLFIQVLLA 155

Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR-ARVNEDDEGKPICGTPICMA 170
           + ++HS  ++H DIK  NIL+  +     K+ DFG ++  A    DD G+  CGTP  +A
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGL--VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213

Query: 171 PEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK 230
           PE+ R +     AD+++LG  + E+ T + P+ D  +    +H+   +     +P  +S 
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPF-DGENMEEVMHKT-LAGRYDPLPPSISP 271

Query: 231 QAQDFLSKCLIRNPGERWSASELL 254
           + Q+ ++  L  +P  R S+S+LL
Sbjct: 272 EMQEIVTALLSSDPKRRPSSSKLL 295

Length = 496

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 88.6 bits (219), Expect = 1e-19
 Identities = 71/264 (26%), Positives = 117/264 (44%), Gaps = 53/264 (20%)

Query: 44  REQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRS 103
           RE ++L     P IV + G   S+  G+I  ++ +E+  GG+L   ++    + E  +  
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSD--GEI--SICMEHMDGGSLDQVLKKAGRIPEQILGK 107

Query: 104 HTRAVLLGLQYL-HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI 162
            + AV+ GL YL   + I+H D+K  NILV+   E   K+ DFG + +     D      
Sbjct: 108 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI---DSMANSF 162

Query: 163 CGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWP------------------- 203
            GT   M+PE  +G      +D+W++G +++EMA GR P P                   
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDP 222

Query: 204 ---------------------DVADPISALHRIGF--SSDTPEIP-GYMSKQAQDFLSKC 239
                                D   P++    + +  +   P++P G    + QDF++KC
Sbjct: 223 AESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKC 282

Query: 240 LIRNPGERWSASELLEHGFVKEQN 263
           LI+NP ER    +L+ H F+K   
Sbjct: 283 LIKNPAERADLKQLMVHAFIKRSE 306

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 86.8 bits (215), Expect = 3e-19
 Identities = 76/293 (25%), Positives = 109/293 (37%), Gaps = 51/293 (17%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQREQRILSALA-CPQIVAYKG 62
           IG G+   V       + ++ A+K   L   E        RE  +L  L+    IV    
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 63  CD-ISEENGKILYNLFLEYAPGG--TLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHS 117
            + + E+NGK    L  EY         D+     G  L    I+S    +L G+ + H 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
           +G++H D+K QN+LV K      KIAD G  R   +        I  T    APEV  G 
Sbjct: 129 HGVMHRDLKPQNLLVDKQKGL-LKIADLGLGRAFSIPVKSYTHEIV-TLWYRAPEVLLGS 186

Query: 178 EQ-GFPADVWALGCTVLEMATGRP------------------------PWPDVAD----- 207
                P D+W++GC   EM+  +P                         WP V+      
Sbjct: 187 THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWH 246

Query: 208 --PISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGF 258
             P         S   P+    +S +  D L K L  +P +R SA   L H +
Sbjct: 247 EFPQ--WKPQDLSRAVPD----LSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 87.4 bits (216), Expect = 3e-19
 Identities = 68/231 (29%), Positives = 105/231 (45%), Gaps = 24/231 (10%)

Query: 78  LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE 137
           +EYA GG L   +       E R R +   ++  L+YLHS  +V+ DIK +N+++ KD  
Sbjct: 74  MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH 133

Query: 138 QGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT 197
              KI DFG  +   +++    K  CGTP  +APEV    + G   D W LG  + EM  
Sbjct: 134 --IKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 190

Query: 198 GRPPWPDVADPISALHRIGFSSDTPE---IPGYMSKQAQDFLSKCLIRNPGERW-----S 249
           GR P+       +  H   F     E    P  +S +A+  L+  L ++P +R       
Sbjct: 191 GRLPF------YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 244

Query: 250 ASELLEHGFVKEQNF------KLSTLTEPETYNSESPTSVLNQQLWDSTLT 294
           A E++EH F    N+      KL    +P+   SE  T   + +    ++T
Sbjct: 245 AKEVMEHRFFLSINWQDVVQKKLLPPFKPQV-TSEVDTRYFDDEFTAQSIT 294

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 62/233 (26%), Positives = 93/233 (39%), Gaps = 54/233 (23%)

Query: 71  KILY------NLFL--EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
           K+LY       L+L  EY PGG     + +   L E   R +   +   +  LH  G +H
Sbjct: 65  KLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIH 124

Query: 123 CDIKGQNILVSKDNEQGAKIADFGCARR--ARVNEDDEGKPICGTPICMAPEVARGEEQG 180
            D+K +N L+        K+ DFG ++      N       + G+P  MAPEV RG+   
Sbjct: 125 RDLKPENFLIDASGH--IKLTDFGLSKGIVTYANS------VVGSPDYMAPEVLRGKGYD 176

Query: 181 FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP------------------ 222
           F  D W+LGC + E   G PP               FS  TP                  
Sbjct: 177 FTVDYWSLGCMLYEFLCGFPP---------------FSGSTPNETWENLKYWKETLQRPV 221

Query: 223 -EIPGY-MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF-KLSTLTEP 272
            + P + +S +A D ++K +        S  ++  H F KE ++ +L  L  P
Sbjct: 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELRELKPP 274

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 86.0 bits (213), Expect = 4e-19
 Identities = 54/177 (30%), Positives = 80/177 (45%), Gaps = 14/177 (7%)

Query: 97  EEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED 156
           +E R   +   +  GL+ LH   IV+ D+K +NIL+  D+    +I+D G A      E 
Sbjct: 100 DEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL--DDYGHIRISDLGLAVEIPEGET 157

Query: 157 DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPI---SALH 213
             G+   GT   MAPEV + E   F  D W LGC + EM  G+ P+    + +       
Sbjct: 158 IRGR--VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER 215

Query: 214 RIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERW-----SASELLEHGFVKEQNFK 265
           R+    D  E     S+ A+    + L ++PG R       A E+  H F +  NFK
Sbjct: 216 RV--KEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 6e-19
 Identities = 75/308 (24%), Positives = 118/308 (38%), Gaps = 62/308 (20%)

Query: 9   IGRGSTATV--SIGMSNRSSEVFAVKSAELSNSE---FLQ---REQRILSALACPQIVAY 60
           IGRG+   V  +   + +  + +A+K  +    +     Q   RE  +L  L    +V+ 
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 61  KGCDISEENGKILYNLFLEYAP---GGTLTDAIRSGTC-LEEGRIRSHTRAVLLGLQYLH 116
               +   +  + Y LF +YA       +    ++    +    ++S    +L G+ YLH
Sbjct: 68  VEVFLEHADKSV-YLLF-DYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH 125

Query: 117 SNGIVHCDIKGQNILVSKD-NEQGA-KIADFGCAR--RARVNEDDEGKPICGTPICMAPE 172
           SN ++H D+K  NILV  +  E+G  KI D G AR   A +    +  P+  T    APE
Sbjct: 126 SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPE 185

Query: 173 VARGEEQGFPA-DVWALGCTVLEMATGRPP------------------------------ 201
           +  G      A D+WA+GC   E+ T  P                               
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPT 245

Query: 202 ---WPDVAD-PISALHRIGFS---SDTPEIPGYM------SKQAQDFLSKCLIRNPGERW 248
              WPD+   P        F      +  +  +M        Q  D L K L  +P +R 
Sbjct: 246 EKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRI 305

Query: 249 SASELLEH 256
           +A E LEH
Sbjct: 306 TAEEALEH 313

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 85.5 bits (211), Expect = 8e-19
 Identities = 58/176 (32%), Positives = 78/176 (44%), Gaps = 10/176 (5%)

Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
            EEGR   +   +  GL+ LH   IV+ D+K +NIL+  D+    +I+D G A    V E
Sbjct: 99  FEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL--DDHGHIRISDLGLA--VHVPE 154

Query: 156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI 215
               K   GT   MAPEV + E   F  D WALGC + EM  G+ P+      I      
Sbjct: 155 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 214

Query: 216 GFSSDTP-EIPGYMSKQAQDFLSKCLIRNPGERW-----SASELLEHGFVKEQNFK 265
               +   E     S  A+      L ++P ER       A E+ EH   K+ NFK
Sbjct: 215 RLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK 270

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 84.9 bits (210), Expect = 2e-18
 Identities = 76/269 (28%), Positives = 113/269 (42%), Gaps = 23/269 (8%)

Query: 8   TIGRGSTATVSIGMSNRSSEVFAVK----SAELSNSE--FLQREQRILSALACPQIVAYK 61
            +GRG    V +     + +++A+K    S  L+     F + E+ ILS    P I   +
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
                ++N   LY L +EY PGG L   + R     +E   + +   ++L +  +H  G 
Sbjct: 68  YAFQDKDN---LY-LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY 123

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV------A 174
           VH DIK +N+L+  D     K+ADFG A R   N+    K   GTP  +APEV       
Sbjct: 124 VHRDIKPENVLI--DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGD 181

Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPD--VADPISALHRIGFSSDTPEIPGYMSKQA 232
                G   D W+LG    EM  GR P+ +   A   + +         PE P  +S   
Sbjct: 182 GKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK-VSSDF 240

Query: 233 QDFLSKCLIRNPGERWSASELLEHGFVKE 261
            D +   L+    ER     L  H F  +
Sbjct: 241 LDLIQS-LLCGQKERLGYEGLCCHPFFSK 268

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 84.5 bits (209), Expect = 3e-18
 Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 19/221 (8%)

Query: 45  EQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSH 104
           E+ IL+ +  P IV       +E  GK LY L L++  GG L   +       E  ++ +
Sbjct: 48  ERDILAEVNHPFIVKLHYAFQTE--GK-LY-LILDFLRGGDLFTRLSKEVMFTEEDVKFY 103

Query: 105 TRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG 164
              + L L +LHS GI++ D+K +NIL+  D E   K+ DFG ++ + ++ + +    CG
Sbjct: 104 LAELALALDHLHSLGIIYRDLKPENILL--DEEGHIKLTDFGLSKES-IDHEKKAYSFCG 160

Query: 165 TPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRIGFSSDTP 222
           T   MAPEV         AD W+ G  + EM TG  P+   D  + ++ + +        
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG---- 216

Query: 223 EIPGYMSKQAQDFLSKCLIRNPGERWSAS-----ELLEHGF 258
            +P ++S +AQ  L     RNP  R  A      E+  H F
Sbjct: 217 -MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPF 256

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 84.3 bits (208), Expect = 4e-18
 Identities = 75/271 (27%), Positives = 118/271 (43%), Gaps = 25/271 (9%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQR---------ILSALACPQI 57
           + IG+GS   V +         +AVK   L     L+++++         +L  L  P +
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKEQNHIMAERNVLLKNLKHPFL 58

Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V   G   S +  + LY   L+Y  GG L   ++   C  E R R +   V   + YLHS
Sbjct: 59  V---GLHYSFQTAEKLY-FVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHS 114

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
             I++ D+K +NIL+  D++    + DFG  +   V  ++     CGTP  +APEV R E
Sbjct: 115 LNIIYRDLKPENILL--DSQGHVVLTDFGLCKEG-VEPEETTSTFCGTPEYLAPEVLRKE 171

Query: 178 EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
                 D W LG  + EM  G PP+   +  +S ++         ++PG  +  A D L 
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPF--YSRDVSQMYD-NILHKPLQLPGGKTVAACDLLV 228

Query: 238 KCLIRNPGERWSAS----ELLEHGFVKEQNF 264
             L ++   R  A     E+  H F    N+
Sbjct: 229 GLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 83.7 bits (207), Expect = 4e-18
 Identities = 83/302 (27%), Positives = 121/302 (40%), Gaps = 65/302 (21%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQREQRILSALACPQIVAYK-- 61
           IG G+   V       + E+ A+K   L N +        RE +IL  L    IV  K  
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74

Query: 62  ------GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTC-LEEGRIRSHTRAVLLGLQY 114
                   D  ++ G   + L  EY     L   + SG     E  I+S  + +L GL Y
Sbjct: 75  VTDKQDALDFKKDKGA--FYLVFEYM-DHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNY 131

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---AP 171
            H    +H DIK  NIL+  +N+   K+ADFG    AR+   +E +P     I +    P
Sbjct: 132 CHKKNFLHRDIKCSNILL--NNKGQIKLADFGL---ARLYNSEESRPYTNKVITLWYRPP 186

Query: 172 EVARGEEQGFPA-DVWALGCTVLEMATGRP--------------------P----WPDVA 206
           E+  GEE+  PA DVW+ GC + E+ T +P                    P    WPDV 
Sbjct: 187 ELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDV- 245

Query: 207 DPISALHRIGFSSDTP---------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHG 257
                +    F++  P         E   ++   A D L   L  +P +R +A E L   
Sbjct: 246 -----IKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSP 300

Query: 258 FV 259
           ++
Sbjct: 301 WL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 84.4 bits (209), Expect = 4e-18
 Identities = 86/296 (29%), Positives = 129/296 (43%), Gaps = 46/296 (15%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR-------EQRILSALA- 53
           D+   + IGRG+   V +     S +V+A+K   LS  E ++R       E+R + A A 
Sbjct: 44  DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMK--LLSKFEMIKRSDSAFFWEERDIMAHAN 101

Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
              IV        ++  K LY + +EY PGG L + + S   + E   R +T  V+L L 
Sbjct: 102 SEWIVQLH-YAFQDD--KYLY-MVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALD 156

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPIC----GTPIC 168
            +HS G +H D+K  N+L+ K      K+ADFG C +      D  G   C    GTP  
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKM-----DANGMVRCDTAVGTPDY 209

Query: 169 MAPEVARGE----EQGFPADVWALGCTVLEMATGRPPWPDVADPISAL------HRIGFS 218
           ++PEV + +      G   D W++G  + EM  G  P+   AD +         H+   +
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF--YADSLVGTYSKIMDHKNSLT 267

Query: 219 -SDTPEIPGYMSKQAQDFLSKCLIRNPGE--RWSASELLEHGFVKEQNFKLSTLTE 271
             D  EI    SKQA+D +   L        R    E+  H F K   +    + E
Sbjct: 268 FPDDIEI----SKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRE 319

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 83.5 bits (206), Expect = 6e-18
 Identities = 70/268 (26%), Positives = 121/268 (45%), Gaps = 30/268 (11%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQIVAY-K 61
           +G+GS   V +     + E++A+K        +  + E    E+R+L+    P  +    
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            C  + +    LY   +EY  GG L   I+     +E     +   + +GL +LHS GI+
Sbjct: 68  SCFQTMDR---LY-FVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGII 123

Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF 181
           + D+K  N+++  D+E   KIADFG  +   + +    K  CGTP  +APE+   +  G 
Sbjct: 124 YRDLKLDNVML--DSEGHIKIADFGMCKE-NMWDGVTTKTFCGTPDYIAPEIIAYQPYGK 180

Query: 182 PADVWALGCTVLEMATGRPPW--PDVADPISAL--HRIGFSSDTPEIPGYMSKQAQDFLS 237
             D WA G  + EM  G+ P+   D  +   ++  H + +       P  MSK+A     
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY-------PKSMSKEAVAICK 233

Query: 238 KCLIRNPGERWSAS-----ELLEHGFVK 260
             + ++PG+R         ++ EH F +
Sbjct: 234 GLMTKHPGKRLGCGPEGERDIKEHAFFR 261

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 82.9 bits (205), Expect = 6e-18
 Identities = 81/304 (26%), Positives = 124/304 (40%), Gaps = 82/304 (26%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQREQRILSALACPQIVAYKGC 63
           IG G+  TV    +  + E+ A+K   L + +        RE  +L  L    IV     
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY-- 65

Query: 64  DISEENGKILYNLFLEY----------APGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
           D+   + K+   L  EY          +  G +   I          ++S    +L GL 
Sbjct: 66  DVLHSDKKL--TLVFEYCDQDLKKYFDSCNGDIDPEI----------VKSFMFQLLKGLA 113

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMAPE 172
           + HS+ ++H D+K QN+L++K+ E   K+ADFG AR              G P+ C + E
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAF------------GIPVRCYSAE 159

Query: 173 VA----RGEEQGFPA-------DVWALGCTVLEMAT-GRPPWP--DVADPISALHRI--- 215
           V     R  +  F A       D+W+ GC   E+A  GRP +P  DV D +  + R+   
Sbjct: 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 219

Query: 216 -------GFS--SDTPEIPGY------------MSKQAQDFLSKCLIRNPGERWSASELL 254
                  G S   D    P Y            ++   +D L   L+ NP +R SA E L
Sbjct: 220 PTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEAL 279

Query: 255 EHGF 258
           +H +
Sbjct: 280 QHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 83.1 bits (205), Expect = 7e-18
 Identities = 66/231 (28%), Positives = 105/231 (45%), Gaps = 23/231 (9%)

Query: 78  LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN-GIVHCDIKGQNILVSKDN 136
           +EYA GG L   +       E R R +   ++  L YLHS   +V+ D+K +N+++ KD 
Sbjct: 74  MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG 133

Query: 137 EQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMA 196
               KI DFG  +   + +    K  CGTP  +APEV    + G   D W LG  + EM 
Sbjct: 134 H--IKITDFGLCKEG-IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 190

Query: 197 TGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERW-----SAS 251
            GR P+ +       L  +    +    P  +S +A+  LS  L ++P +R       A 
Sbjct: 191 CGRLPFYN--QDHEKLFELILMEEI-RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAK 247

Query: 252 ELLEHGF--------VKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLT 294
           E+++H F        V E+  KL    +P+   SE+ T   +++     +T
Sbjct: 248 EIMQHKFFAGIVWQDVYEK--KLVPPFKPQV-TSETDTRYFDEEFTAQMIT 295

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 59/192 (30%), Positives = 85/192 (44%), Gaps = 44/192 (22%)

Query: 101 IRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR------RARVN 154
           I+S+   +L G+ Y HS+ ++H D+K QN+L+  D E   K+ADFG AR      R   +
Sbjct: 101 IKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI--DREGALKLADFGLARAFGVPVRTYTH 158

Query: 155 EDDEGKPICGTPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALH 213
           E         T    APE+  G  Q   P D+W++GC   EM   RP +P  ++ I  L 
Sbjct: 159 E-------VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE-IDQLF 210

Query: 214 RIGFSSDTP---------EIPGYMSK------------------QAQDFLSKCLIRNPGE 246
           RI  +  TP          +P Y                        D LSK L+ +P +
Sbjct: 211 RIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAK 270

Query: 247 RWSASELLEHGF 258
           R SA   L+H +
Sbjct: 271 RISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 73/263 (27%), Positives = 117/263 (44%), Gaps = 55/263 (20%)

Query: 44  REQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRS 103
           RE ++L     P IV + G   S+  G+I  ++ +E+  GG+L   ++    + E  +  
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSD--GEI--SICMEHMDGGSLDQVLKEAKRIPEEILGK 107

Query: 104 HTRAVLLGLQYL-HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI 162
            + AVL GL YL   + I+H D+K  NILV+   E   K+ DFG + +     D      
Sbjct: 108 VSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI---DSMANSF 162

Query: 163 CGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWP------------------D 204
            GT   M+PE  +G      +D+W++G +++E+A GR P P                  +
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGE 222

Query: 205 VADPISALHR--------IGFSSDT------------------PEIP-GYMSKQAQDFLS 237
             +P S   R         G   D+                  P++P G  +   Q+F++
Sbjct: 223 EGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVN 282

Query: 238 KCLIRNPGERWSASELLEHGFVK 260
           KCLI+NP ER     L+ H F+K
Sbjct: 283 KCLIKNPAERADLKMLMNHTFIK 305

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 65/255 (25%), Positives = 119/255 (46%), Gaps = 24/255 (9%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSA---ELSNSEFLQ---REQRILSALACPQIVAY 60
           + IGRG  + V         +  A+K     E+ +++  Q   +E  +L  L  P ++ Y
Sbjct: 8   KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY 67

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAI----RSGTCLEEGRIRSHTRAVLLGLQYLH 116
              D   E+ ++  N+ LE A  G L+  I    +    + E  +  +   +   ++++H
Sbjct: 68  --LDSFIEDNEL--NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
           S  ++H DIK  N+ ++       K+ D G  R    ++      + GTP  M+PE  R 
Sbjct: 124 SRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPE--RI 178

Query: 177 EEQG--FPADVWALGCTVLEMATGRPP-WPDVADPISALHRIGFSSDTPEIPG-YMSKQA 232
            E G  F +D+W+LGC + EMA  + P + D  +  S   +I    D P +P  + S++ 
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE-QCDYPPLPTEHYSEKL 237

Query: 233 QDFLSKCLIRNPGER 247
           ++ +S C+  +P +R
Sbjct: 238 RELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 59/188 (31%), Positives = 87/188 (46%), Gaps = 41/188 (21%)

Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI 167
           +L GL+Y+HS GI+H D+K  NI V++D E   KI DFG AR      DDE      T  
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLARHT----DDEMTGYVATRW 180

Query: 168 CMAPEVA---RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI----GFSSD 220
             APE+        Q    D+W++GC + E+ TG+  +P  +D I  L RI    G   +
Sbjct: 181 YRAPEIMLNWMHYNQ--TVDIWSVGCIMAELLTGKTLFPG-SDHIDQLKRIMNLVGTPDE 237

Query: 221 T-----------------PEIP--------GYMSKQAQDFLSKCLIRNPGERWSASELLE 255
                             P++P           +  A D L K L+ +P +R +A+E L 
Sbjct: 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297

Query: 256 HGFVKEQN 263
           H ++ E +
Sbjct: 298 HPYLAEYH 305

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 78/297 (26%), Positives = 117/297 (39%), Gaps = 82/297 (27%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQR--------ILSALACPQIVAY 60
           IGRG+  TV+  +   S  + AVK    +  E   +EQ+        ++ +  CP IV +
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE---KEQKRLLMDLDVVMRSSDCPYIVKF 68

Query: 61  KG----------C----DISEEN-GKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSH- 104
            G          C    DIS +   K +Y                   + + E  I    
Sbjct: 69  YGALFREGDCWICMELMDISLDKFYKYVYE---------------VLKSVIPE-EILGKI 112

Query: 105 TRAVLLGLQYLHSN-GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPIC 163
             A +  L YL     I+H D+K  NIL+  D     K+ DFG               I 
Sbjct: 113 AVATVKALNYLKEELKIIHRDVKPSNILL--DRNGNIKLCDFG---------------IS 155

Query: 164 GTPI----------C---MAPE-VARGEEQGFP--ADVWALGCTVLEMATGRPPWPDVAD 207
           G  +          C   MAPE +      G+   +DVW+LG T+ E+ATG+ P+P    
Sbjct: 156 GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS 215

Query: 208 PISALHRIGFSSDTPEIP---GYM-SKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
               L ++    D P +        S    +F++ CLI++  +R    ELLEH F+K
Sbjct: 216 VFDQLTQV-VKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 81.1 bits (200), Expect = 2e-17
 Identities = 50/178 (28%), Positives = 88/178 (49%), Gaps = 16/178 (8%)

Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           LE  R+  ++  +  G+ +LHS  IV+ D+K +N+L+  D++   +++D G A   +   
Sbjct: 92  LEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL--DDQGNCRLSDLGLAVELK--- 146

Query: 156 DDEGKPI---CGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISA- 211
             +GK I    GT   MAPE+ + E   +P D +A+GC++ EM  GR P+ D  + ++  
Sbjct: 147 --DGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE 204

Query: 212 -LHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNP----GERWSASELLEHGFVKEQNF 264
            L R     +        +++++D     L + P    G R    +  +H F K  NF
Sbjct: 205 ELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 81.1 bits (200), Expect = 3e-17
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 25/206 (12%)

Query: 7   QTIGRGSTATVSI----GMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQIV 58
           + +G G    VS+      ++ + E+ AVK+ +    +       +E  IL  L    IV
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
            YKGC  SE+ GK L  L +EY P G+L D +     L   ++    + +  G+ YLHS 
Sbjct: 70  KYKGC-CSEQGGKGL-QLIMEYVPLGSLRDYLPKHK-LNLAQLLLFAQQICEGMAYLHSQ 126

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRA-------RVNEDDEGKPICGTPICMAP 171
             +H D+  +N+L+  DN++  KI DFG A+         RV ED +  P+       A 
Sbjct: 127 HYIHRDLAARNVLL--DNDRLVKIGDFGLAKAVPEGHEYYRVREDGD-SPV----FWYAV 179

Query: 172 EVARGEEQGFPADVWALGCTVLEMAT 197
           E  +  +  + +DVW+ G T+ E+ T
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 80.4 bits (198), Expect = 4e-17
 Identities = 52/178 (29%), Positives = 83/178 (46%), Gaps = 14/178 (7%)

Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
            EE R   +   +L GL+ LH    V+ D+K +NIL+  D+    +I+D G A   ++ E
Sbjct: 99  FEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL--DDYGHIRISDLGLA--VKIPE 154

Query: 156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI 215
            +  +   GT   MAPEV   +      D W LGC + EM  G+ P+    + +      
Sbjct: 155 GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD 214

Query: 216 GFSSDTPEIPGYMSKQAQDFLSKC---LIRNPGERW-----SASELLEHGFVKEQNFK 265
               +T E+  Y +K +++  S C   L ++P +R       A E+  H F +  NFK
Sbjct: 215 RRVLETEEV--YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 79.5 bits (196), Expect = 7e-17
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 14/198 (7%)

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS----GTCLEEGRIRSHTRAVLL 110
           P IV Y       EN + LY + ++   G  L +   S         E RI +    ++L
Sbjct: 69  PNIVRYY--KTFLENDR-LY-IVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124

Query: 111 GLQYLHSNG-IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM 169
            L+YLH    IVH D+   NI++ +D++    I DFG A++     + +   + GT +  
Sbjct: 125 ALRYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDFGLAKQK--QPESKLTSVVGTILYS 180

Query: 170 APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS 229
            PE+ + E  G  ADVWA GC + +M T +PP+    + +S   +I  +   P   G  S
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPEGMYS 239

Query: 230 KQAQDFLSKCLIRNPGER 247
           +   D ++ CL  +   R
Sbjct: 240 EDVTDVITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 79.8 bits (197), Expect = 9e-17
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 23/208 (11%)

Query: 76  LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKD 135
           + +EY  GG     +++   L     R +    +L L+YLH+ GIVH D+K  N+L++  
Sbjct: 78  MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM 137

Query: 136 NEQGAKIADFGCARRARVNEDD---EG-----------KPICGTPICMAPEVARGEEQGF 181
                K+ DFG ++   ++      EG           K +CGTP  +APEV   +  G 
Sbjct: 138 GH--IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGK 195

Query: 182 PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDT--PEIPGYMSKQAQDFLSKC 239
           P D WA+G  + E   G  P+    D    L     S D   PE    +   AQD +S+ 
Sbjct: 196 PVDWWAMGIILYEFLVGCVPF--FGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRL 253

Query: 240 LIRNPGERW---SASELLEHGFVKEQNF 264
           L +NP ER     A E+ +H F    ++
Sbjct: 254 LRQNPLERLGTGGAFEVKQHRFFLGLDW 281

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 71/224 (31%), Positives = 113/224 (50%), Gaps = 20/224 (8%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAYKGCD 64
           QTIG+G    V +G   R ++V AVK    + +   FL  E  +++ L    +V   G  
Sbjct: 12  QTIGKGEFGDVMLG-DYRGNKV-AVKCIKNDATAQAFLA-EASVMTQLRHSNLVQLLGV- 67

Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
           I EE G  LY +  EY   G+L D +RS   + L    +   +  V   ++YL +N  VH
Sbjct: 68  IVEEKGG-LY-IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVH 125

Query: 123 CDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFP 182
            D+  +N+LVS+DN   AK++DFG  + A   +D    P+  T    APE  R ++    
Sbjct: 126 RDLAARNVLVSEDNV--AKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 179

Query: 183 ADVWALGCTVLEMAT-GRPPWPDVA--DPISALHRIGFSSDTPE 223
           +DVW+ G  + E+ + GR P+P +   D +  + + G+  D P+
Sbjct: 180 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPD 222

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 76/269 (28%), Positives = 114/269 (42%), Gaps = 39/269 (14%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR-EQR--------ILSALACPQI 57
           + IG+GS   V +       + +AVK   L     L++ EQ+        +L  +  P +
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKV--LQKKAILKKKEQKHIMAERNVLLKNVKHPFL 58

Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V   G   S +    LY   L+Y  GG L   ++      E R R +   +   L YLHS
Sbjct: 59  V---GLHYSFQTADKLY-FVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
             I++ D+K +NIL+  D++    + DFG  +   +         CGTP  +APEV R +
Sbjct: 115 LNIIYRDLKPENILL--DSQGHVVLTDFGLCKEG-IEHSKTTSTFCGTPEYLAPEVLRKQ 171

Query: 178 EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
                 D W LG  + EM  G PP+              +S DT E+  Y      + L+
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPF--------------YSRDTAEM--Y-----DNILN 210

Query: 238 KCLIRNPGERWSASELLEHGFVKEQNFKL 266
           K L   P    SA  LLE    K++  +L
Sbjct: 211 KPLRLKPNISVSARHLLEGLLQKDRTKRL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 79.1 bits (195), Expect = 1e-16
 Identities = 81/287 (28%), Positives = 120/287 (41%), Gaps = 52/287 (18%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQIVAYKGCD 64
           +G G+ ATV  G +  + E+ A+K   L   E       RE  ++  L    IV     D
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLH--D 65

Query: 65  ISEENGKILYNLFLEYAPGG--TLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
           +     K++  L  EY         D       L+   ++S T  +L G+ + H N ++H
Sbjct: 66  VIHTENKLM--LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123

Query: 123 CDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG------TPICMAPEVARG 176
            D+K QN+L++K  E   K+ADFG AR         G P+        T    AP+V  G
Sbjct: 124 RDLKPQNLLINKRGE--LKLADFGLARAF-------GIPVNTFSNEVVTLWYRAPDVLLG 174

Query: 177 EEQ-GFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFS---------SDTPEI 224
                   D+W++GC + EM TGRP +P  +  D +  + RI  +         S  PE 
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234

Query: 225 ----PGYMSKQAQ-----------DFLSKCLIRNPGERWSASELLEH 256
               P Y  +  Q           D L + L  NP  R SA + L+H
Sbjct: 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 79.6 bits (196), Expect = 1e-16
 Identities = 83/323 (25%), Positives = 128/323 (39%), Gaps = 46/323 (14%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---NSEFLQ----REQRILSALACP 55
           +T  + +G G+  +V   +  R+ E  A+K  +LS    SE       RE  +L  +   
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIK--KLSRPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            ++       S  +G    + +L      T    I  G  L E +++     +L GL+Y+
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM-GHPLSEDKVQYLVYQMLCGLKYI 133

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS GI+H D+K  N+ V++D E   KI DFG AR A    D E      T    APEV  
Sbjct: 134 HSAGIIHRDLKPGNLAVNEDCE--LKILDFGLARHA----DAEMTGYVVTRWYRAPEVIL 187

Query: 176 G-EEQGFPADVWALGCTVLEMATGRP--------------------PWPDVADPISALHR 214
                    D+W++GC + EM TG+                     P P+    +     
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA 247

Query: 215 IGFSSDTPEIPG--------YMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKL 266
             +    P+ P           S QA D L K L  +  +R +A+E LEH +  +     
Sbjct: 248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF-DSFRDA 306

Query: 267 STLTEPETYNSESPTSVLNQQLW 289
              TE + Y+       L+   W
Sbjct: 307 DEETEQQPYDDSLENEKLSVDEW 329

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 55/202 (27%), Positives = 78/202 (38%), Gaps = 58/202 (28%)

Query: 95  CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN 154
            L E R++S+   +L  L ++H NGI H DIK +NIL+  D     K+ADFG  R     
Sbjct: 96  PLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDI---LKLADFGSCR----- 147

Query: 155 EDDEGKPICGTP-----ICM----APE-VARGEEQGFPADVWALGCTVLEMATGRPPWP- 203
                  I   P     I      APE +      G   D+WA+GC   E+ +  P +P 
Sbjct: 148 ------GIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG 201

Query: 204 -DVADPISALHRI----------------------------GFSSDTPEIPGYMSKQAQD 234
            +  D I+ +H +                            G     P      S +  D
Sbjct: 202 TNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPN----ASAEGLD 257

Query: 235 FLSKCLIRNPGERWSASELLEH 256
            L K L  +P ER +A + L H
Sbjct: 258 LLKKLLAYDPDERITAKQALRH 279

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 72/269 (26%), Positives = 114/269 (42%), Gaps = 39/269 (14%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQR---------ILSALACPQI 57
           + IG+GS   V +       + +AVK   L     L R+++         +L  +  P +
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKV--LQKKIVLNRKEQKHIMAERNVLLKNVKHPFL 58

Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V   G   S +  + LY   L++  GG L   ++      E R R +   +   L YLHS
Sbjct: 59  V---GLHYSFQTTEKLY-FVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
             IV+ D+K +NIL+  D++    + DFG  +   + + D     CGTP  +APEV R +
Sbjct: 115 INIVYRDLKPENILL--DSQGHVVLTDFGLCKEG-IAQSDTTTTFCGTPEYLAPEVIRKQ 171

Query: 178 EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
                 D W LG  + EM  G PP+              +  D  E+         + L 
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPF--------------YCRDVAEM-------YDNILH 210

Query: 238 KCLIRNPGERWSASELLEHGFVKEQNFKL 266
           K L+  PG   +A  +LE    K++  +L
Sbjct: 211 KPLVLRPGASLTAWSILEELLEKDRQRRL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 83/302 (27%), Positives = 126/302 (41%), Gaps = 68/302 (22%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQREQRILSALACPQIVAYKGC 63
           IG G+   V       S E+ A+K   + N          RE  +L  L  P IV  K  
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 64  DISEENGKILYNLFL--EYAPG--GTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
            +    GK L ++FL  EY      +L D +   T   E +++     +L GLQYLH N 
Sbjct: 75  VV----GKHLDSIFLVMEYCEQDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF 128

Query: 120 IVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICM-----APEV 173
           I+H D+K  N+L+    ++G  KIADFG AR          KP+  TP  +     APE+
Sbjct: 129 IIHRDLKVSNLLL---TDKGCLKIADFGLARTY----GLPAKPM--TPKVVTLWYRAPEL 179

Query: 174 ARG-EEQGFPADVWALGCTVLEMATGRP--------------------P----WPDVADP 208
             G        D+WA+GC + E+   +P                    P    WP  +D 
Sbjct: 180 LLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD- 238

Query: 209 ISALHRIGFSSDTPEIP--------GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
           +  + +       P+ P         ++S+     L+  L+ +P +R +A E LE  + K
Sbjct: 239 LPLVGKFTL----PKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294

Query: 261 EQ 262
           E+
Sbjct: 295 EK 296

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 27/216 (12%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR-------EQRILSALAC 54
           D+   + IGRG+   V +     S +V+A+K   LS  E ++R       E+R + A A 
Sbjct: 44  DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKL--LSKFEMIKRSDSAFFWEERDIMAFAN 101

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
              V    C   ++  K LY + +EY PGG L + + S   + E   + +T  V+L L  
Sbjct: 102 SPWVVQLFCAFQDD--KYLY-MVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDA 157

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPIC----GTPICMA 170
           +HS G++H D+K  N+L+ K      K+ADFG   +     D+ G   C    GTP  ++
Sbjct: 158 IHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKM----DETGMVRCDTAVGTPDYIS 211

Query: 171 PEVARGE----EQGFPADVWALGCTVLEMATGRPPW 202
           PEV + +      G   D W++G  + EM  G  P+
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 78.1 bits (192), Expect = 5e-16
 Identities = 69/269 (25%), Positives = 119/269 (44%), Gaps = 22/269 (8%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ-IVAYK 61
           +G+GS   V +     + E++A+K        +  + E    E+R+L+    P  +    
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            C  + +    LY   +EY  GG L   I+     +E +   +   + +GL +LH  GI+
Sbjct: 68  SCFQTVDR---LY-FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGII 123

Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF 181
           + D+K  N+++  D+E   KIADFG  +   V +    +  CGTP  +APE+   +  G 
Sbjct: 124 YRDLKLDNVML--DSEGHIKIADFGMCKEHMV-DGVTTRTFCGTPDYIAPEIIAYQPYGK 180

Query: 182 PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLI 241
             D WA G  + EM  G+PP+ D  D       I         P  +SK+A       + 
Sbjct: 181 SVDWWAYGVLLYEMLAGQPPF-DGEDEDELFQSI--MEHNVSYPKSLSKEAVSICKGLMT 237

Query: 242 RNPGERWSAS-----ELLEHGFVKEQNFK 265
           ++P +R         ++ EH F +  ++ 
Sbjct: 238 KHPSKRLGCGPEGERDIREHAFFRRIDWD 266

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 77.6 bits (191), Expect = 5e-16
 Identities = 55/195 (28%), Positives = 84/195 (43%), Gaps = 43/195 (22%)

Query: 101 IRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR------RARVN 154
           I+++   +L G+ Y HS+ ++H D+K QN+L+ +      K+ADFG AR      R   +
Sbjct: 104 IKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNA-LKLADFGLARAFGIPVRTFTH 162

Query: 155 EDDEGKPICGTPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALH 213
           E         T    APE+  G      P D+W++GC   EM   +P +P  ++ I  L 
Sbjct: 163 E-------VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE-IDELF 214

Query: 214 RIGFSSDTPE---------IPGYMS------------------KQAQDFLSKCLIRNPGE 246
           +I     TP          +P Y S                      D LSK L  +P +
Sbjct: 215 KIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSK 274

Query: 247 RWSASELLEHGFVKE 261
           R +A   LEH + K+
Sbjct: 275 RITARAALEHEYFKD 289

Length = 294

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 76.7 bits (189), Expect = 6e-16
 Identities = 72/270 (26%), Positives = 117/270 (43%), Gaps = 41/270 (15%)

Query: 2   DWTRGQTIGRGSTATVSIGM-SNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           +   G TIG+G    V +G    +   V  +K    +   FL  E  +++ L  P +V  
Sbjct: 7   ELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLA-EASVMTTLRHPNLVQL 65

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSH-TRAVLL--------G 111
            G  +  +   +   +  EY   G+L D +RS       R R+  T A  L        G
Sbjct: 66  LG--VVLQGNPLY--IVTEYMAKGSLVDYLRS-------RGRAVITLAQQLGFALDVCEG 114

Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAP 171
           ++YL     VH D+  +N+LVS+D    AK++DFG A+ A   +D    P+  T    AP
Sbjct: 115 MEYLEEKNFVHRDLAARNVLVSEDLV--AKVSDFGLAKEASQGQDSGKLPVKWT----AP 168

Query: 172 EVARGEEQGFPADVWALGCTVLEM-ATGRPPWP-----DVADPISALHRIGFSSDTPEIP 225
           E  R ++    +DVW+ G  + E+ + GR P+P     DV   +   +R+       E P
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRM-------EAP 221

Query: 226 GYMSKQAQDFLSKCLIRNPGERWSASELLE 255
                +    +  C   +P +R +  +L E
Sbjct: 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 76.8 bits (189), Expect = 7e-16
 Identities = 51/178 (28%), Positives = 87/178 (48%), Gaps = 13/178 (7%)

Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
             E R   +T  ++ GL++LH   I++ D+K +N+L+  DN+   +I+D G A   +  +
Sbjct: 94  FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL--DNDGNVRISDLGLAVELKDGQ 151

Query: 156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPI---SAL 212
             + K   GTP  MAPE+ +GEE  F  D +ALG T+ EM   R P+    + +      
Sbjct: 152 S-KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 210

Query: 213 HRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERW-----SASELLEHGFVKEQNFK 265
            RI   +D+   P   S  ++ F    L ++P +R      +   L  H   ++ N++
Sbjct: 211 QRI--LNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 77.4 bits (191), Expect = 8e-16
 Identities = 66/225 (29%), Positives = 95/225 (42%), Gaps = 38/225 (16%)

Query: 69  NGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQ 128
           N   LY   +E      L   IRSG  L +   +S    +L GL+Y+HS  ++H D+K  
Sbjct: 79  NELYLYEELMEA----DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPG 134

Query: 129 NILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG---TPICMAPEVARGEEQGFPA-D 184
           N+LV+ D E   KI DFG AR    N  +    +     T    APE+    +    A D
Sbjct: 135 NLLVNADCE--LKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAID 192

Query: 185 VWALGCTVLEMATGRPPWP--DVADPIS------------ALHRIG------FSSDTPEI 224
           VW++GC + E+   +P +   D  D ++             L RIG      +    P I
Sbjct: 193 VWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNI 252

Query: 225 PG--------YMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
           P           +  A D L K L  +P +R S  E LEH ++  
Sbjct: 253 PKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 76.3 bits (188), Expect = 8e-16
 Identities = 74/277 (26%), Positives = 113/277 (40%), Gaps = 56/277 (20%)

Query: 9   IGRGSTATVSIGM-SNRSSEVFAV-----KSAELSN--SEFLQREQRILSALACPQIVAY 60
           +G GS   V  G  S    +V  V     KS +LS+   +FL +E  I+ +L    ++  
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL-KEAAIMHSLDHENLIR- 60

Query: 61  KGCDISEENGKILYNLFL--------EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-- 110
                       LY + L        E AP G+L D       L +  +     + L   
Sbjct: 61  ------------LYGVVLTHPLMMVTELAPLGSLLD------RLRKDALGHFLISTLCDY 102

Query: 111 ------GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED----DEGK 160
                 G++YL S   +H D+  +NIL++ D++   KI DFG  R    NED    +E  
Sbjct: 103 AVQIANGMRYLESKRFIHRDLAARNILLASDDK--VKIGDFGLMRALPQNEDHYVMEEHL 160

Query: 161 PICGTPIC-MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFS 218
            +   P    APE  R       +DVW  G T+ EM T G  PW  ++     L +I   
Sbjct: 161 KV---PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-SQILKKIDKE 216

Query: 219 SDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
            +  E P    +   + + +C   NP +R + + L E
Sbjct: 217 GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 76.5 bits (188), Expect = 1e-15
 Identities = 75/287 (26%), Positives = 116/287 (40%), Gaps = 42/287 (14%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQIVAYKG 62
           + +G GS ATV  G+S  + ++ A+K   +   E +     RE  +L  L    IV    
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLH- 69

Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
            DI      + +    EY         I+    L    +R     +L GL Y+H   I+H
Sbjct: 70  -DIIHTKETLTF--VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126

Query: 123 CDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE-EQGF 181
            D+K QN+L+S   E   K+ADFG AR   +        +  T     P+V  G  +   
Sbjct: 127 RDLKPQNLLISYLGE--LKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSS 183

Query: 182 PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP---------EIPGYMSK-- 230
             D+W  GC  +EM  G+P +P V+D    L +I      P         ++P Y  +  
Sbjct: 184 ALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF 243

Query: 231 -------------------QAQDFLSKCLIRNPGERWSASELLEHGF 258
                              +A+D  S+ L+  P +R SA + L H +
Sbjct: 244 LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 76.3 bits (187), Expect = 1e-15
 Identities = 82/307 (26%), Positives = 118/307 (38%), Gaps = 56/307 (18%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQIVAYKG 62
           + +G GS ATV  G S  + ++ A+K   L   E       RE  +L  L    IV    
Sbjct: 11  EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70

Query: 63  CDISEENGKILYNL-------FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
              ++E   +++         +++  PGG           L    ++     +L GL Y+
Sbjct: 71  IIHTKETLTLVFEYVHTDLCQYMDKHPGG-----------LHPENVKLFLFQLLRGLSYI 119

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           H   I+H D+K QN+L+S   E   K+ADFG AR   V        +  T     P+V  
Sbjct: 120 HQRYILHRDLKPQNLLISDTGE--LKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLL 176

Query: 176 GE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---IPG----- 226
           G  E     D+W +GC  +EM  G   +P + D    L RI     TP     PG     
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236

Query: 227 ---------YMSK-------------QAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
                    Y  K              A+D  SK L   P  R SA   L H +  +   
Sbjct: 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296

Query: 265 KLSTLTE 271
           +L  LT+
Sbjct: 297 RLWELTD 303

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 76.0 bits (187), Expect = 1e-15
 Identities = 71/244 (29%), Positives = 106/244 (43%), Gaps = 48/244 (19%)

Query: 7   QTIGRGSTATVSI----GMSNRSSEVFAVKSAELSNSEFL---QREQRILSALACPQIVA 59
           Q +G+G+  +V +     + + + EV AVK  + S +E L   +RE  IL +L    IV 
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------GL 112
           YKG  +    G+    L +EY P G+L D       L++ R R   R +LL       G+
Sbjct: 70  YKG--VCYSAGRRNLRLVMEYLPYGSLRDY------LQKHRERLDHRKLLLYASQICKGM 121

Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR-------RARVNEDDEGKPICGT 165
           +YL S   VH D+  +NILV  ++E   KI DFG  +         +V E  E      +
Sbjct: 122 EYLGSKRYVHRDLATRNILV--ESENRVKIGDFGLTKVLPQDKEYYKVREPGE------S 173

Query: 166 PI-CMAPEVARGEEQGFPADVWALGCTVLEMAT----GRPPWPDVADPISALHRIGFSSD 220
           PI   APE     +    +DVW+ G  + E+ T       P      P   +  +G    
Sbjct: 174 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSP------PAEFMRMMGNDKQ 227

Query: 221 TPEI 224
              I
Sbjct: 228 GQMI 231

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 74/267 (27%), Positives = 111/267 (41%), Gaps = 35/267 (13%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK----SAELSNSE---FLQREQRILSALACPQIVA 59
           + IG+GS   V +       + +AVK     A L   E    +     +L  +  P +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV- 59

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
             G   S +    LY   L+Y  GG L   ++   C  E R R +   +   L YLHS  
Sbjct: 60  --GLHFSFQTADKLY-FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN 116

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           IV+ D+K +NIL+  D++    + DFG  +   +  +      CGTP  +APEV   +  
Sbjct: 117 IVYRDLKPENILL--DSQGHIVLTDFGLCKE-NIEHNGTTSTFCGTPEYLAPEVLHKQPY 173

Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
               D W LG  + EM  G PP+              +S +T E+         + L+K 
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPF--------------YSRNTAEM-------YDNILNKP 212

Query: 240 LIRNPGERWSASELLEHGFVKEQNFKL 266
           L   P    SA  LLE    K++  +L
Sbjct: 213 LQLKPNITNSARHLLEGLLQKDRTKRL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 83/302 (27%), Positives = 127/302 (42%), Gaps = 74/302 (24%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQIVAYK 61
           + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P IV  K
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV--K 63

Query: 62  GCDISEENGKILYNLF----------LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLG 111
             D+     K LY +F          ++ +P   +   +          I+S+   +L G
Sbjct: 64  LLDVIHTENK-LYLVFEFLHQDLKKFMDASPLSGIPLPL----------IKSYLFQLLQG 112

Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGA-KIADFGCAR------RARVNEDDEGKPICG 164
           L + HS+ ++H D+K QN+L+   N +GA K+ADFG AR      R   +E         
Sbjct: 113 LAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHE-------VV 162

Query: 165 TPICMAPEVARGEE-QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP- 222
           T    APE+  G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP 
Sbjct: 163 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPD 221

Query: 223 --------EIPGY------------------MSKQAQDFLSKCLIRNPGERWSASELLEH 256
                    +P Y                  + +  +D LS+ L  +P +R SA   L H
Sbjct: 222 EVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281

Query: 257 GF 258
            F
Sbjct: 282 PF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 61/198 (30%), Positives = 83/198 (41%), Gaps = 43/198 (21%)

Query: 98  EGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNED 156
              I+   + +L GL Y+H N I+H D+K  NIL++KD   G  K+ADFG AR   +++ 
Sbjct: 118 LSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD---GILKLADFGLARAFSLSK- 173

Query: 157 DEGKPICGTPICM-----APEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPIS 210
              KP   T   +      PE+  GE   G P D+W  GC + EM T R P         
Sbjct: 174 -NSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQH 231

Query: 211 ALHRIGF--SSDTPEI-PG--------------------------YMSKQ-AQDFLSKCL 240
            L  I     S TPE+ PG                          Y+    A D + K L
Sbjct: 232 QLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLL 291

Query: 241 IRNPGERWSASELLEHGF 258
           + +P +R  A   L H F
Sbjct: 292 VLDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 79/298 (26%), Positives = 122/298 (40%), Gaps = 41/298 (13%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQIVAYKG 62
           + +G G+ ATV  G S  +  + A+K   L + E       RE  +L  L    IV    
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH- 70

Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
            DI   +  +   L  EY            G  +    ++     +L GL Y H   ++H
Sbjct: 71  -DIVHTDKSL--TLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLH 127

Query: 123 CDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE-EQG 180
            D+K QN+L+   NE+G  K+ADFG AR   V        +  T     P+V  G  E  
Sbjct: 128 RDLKPQNLLI---NERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYS 183

Query: 181 FPADVWALGCTVLEMATGRPPWP--DVADPISALHRI----------GFSSDTP----EI 224
              D+W +GC   EMA+GRP +P   V D +  + R+          G SS+        
Sbjct: 184 TQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243

Query: 225 PGY-----------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTE 271
           P Y           +  +  + L+K L     +R SA E ++H + +    ++ +L E
Sbjct: 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIHSLPE 301

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 75/290 (25%), Positives = 120/290 (41%), Gaps = 42/290 (14%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQ----REQRILSALACPQIVAYK 61
           + +G G+  TV   +  R+    A+K       SE       RE R+L  +    ++   
Sbjct: 21  KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
                + +    ++ +L     GT    +     L E RI+     +L GL+Y+H+ GI+
Sbjct: 81  DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGII 140

Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQG 180
           H D+K  N+ V++D E   KI DFG AR+     D E      T    APEV        
Sbjct: 141 HRDLKPGNLAVNEDCE--LKILDFGLARQT----DSEMTGYVVTRWYRAPEVILNWMHYT 194

Query: 181 FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP-----------EIPGYMS 229
              D+W++GC + EM TG+P +    D +  L  I   + TP           +   Y+ 
Sbjct: 195 QTVDIWSVGCIMAEMLTGKPLFKG-HDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVK 253

Query: 230 K----QAQDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
           K    + +DF              L K L+ +   R +A+E L H + +E
Sbjct: 254 KLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 75.2 bits (185), Expect = 4e-15
 Identities = 83/315 (26%), Positives = 122/315 (38%), Gaps = 67/315 (21%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFA---VKSAELSN--SEFLQ------------REQRI 48
           G  +G G+   V       + ++ A   VK  E+SN  ++  Q            RE +I
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 49  LSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAV 108
           ++ +    I+     D+  E   I  NL ++      L   +     L E +++     +
Sbjct: 74  MNEIKHENIMGLV--DVYVEGDFI--NLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQI 128

Query: 109 LLGLQYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGCARR------ARVNEDDEGK- 160
           L GL  LH    +H D+   NI +   N +G  KIADFG ARR      +     DE   
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFI---NSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185

Query: 161 ------PICGTPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALH 213
                     T    APE+  G E+  F  D+W++GC   E+ TG+P +P   + I  L 
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG-ENEIDQLG 244

Query: 214 RIGFSSDTPE---------IPGY-----MSKQ------------AQDFLSKCLIRNPGER 247
           RI     TP          +P Y        +            A D L   L  NP ER
Sbjct: 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLER 304

Query: 248 WSASELLEHGFVKEQ 262
            SA E L+H + K  
Sbjct: 305 ISAKEALKHEYFKSD 319

Length = 335

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 75.6 bits (186), Expect = 5e-15
 Identities = 86/369 (23%), Positives = 139/369 (37%), Gaps = 80/369 (21%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQ--------RILSALACPQIV 58
           +TIG G+   V +     ++ ++A+K+  L  ++ L R Q         IL+      +V
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKT--LRKADVLMRNQAAHVKAERDILAEADNEWVV 64

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTL-TDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
                   ++N   LY   ++Y PGG + +  IR G   EE   R +   +   ++ +H 
Sbjct: 65  KLYYSFQDKDN---LY-FVMDYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIESVHK 119

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFG-CA---------------------------- 148
            G +H DIK  NIL+ +D     K+ DFG C                             
Sbjct: 120 MGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177

Query: 149 -------------RRARVNEDDEGKPICGTPICMAPEV-AR-GEEQGFPADVWALGCTVL 193
                        RR R ++      + GTP  +APEV  R G  Q    D W++G  + 
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL--CDWWSVGVILY 235

Query: 194 EMATGRPPWPDVADPISALHRIGFSSDTPEIP--GYMSKQAQDFLSKCLIRNPGERW--- 248
           EM  G+PP+     P     ++     T  IP    +S++A D + + L     +R    
Sbjct: 236 EMLVGQPPFLA-DTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKN 293

Query: 249 SASELLEHGFVKEQNFKLSTLTEPETYNSE--SPTSVLN------QQLWDSTLT-SCSSA 299
            A E+  H F K  +F      +   Y  +   PT   N      ++L       S    
Sbjct: 294 GADEIKAHPFFKGIDFASLIRRQKAPYIPKITHPTDTSNFDPVDPEKLRSDDSGESSPDR 353

Query: 300 SAKERIRQL 308
           + K   R+ 
Sbjct: 354 NVKPNNRKR 362

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 75.1 bits (184), Expect = 6e-15
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 25/215 (11%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACP 55
           D+   + IGRG+   V +     + +V+A+K        + S+S F   E+ I++    P
Sbjct: 44  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            +V       + ++ + LY + +EY PGG L + + S   + E   R +T  V+L L  +
Sbjct: 104 WVVQLF---YAFQDDRYLY-MVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAI 158

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPIC----GTPICMAP 171
           HS G +H D+K  N+L+ K      K+ADFG   +     + EG   C    GTP  ++P
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKM----NKEGMVRCDTAVGTPDYISP 212

Query: 172 EVARGE----EQGFPADVWALGCTVLEMATGRPPW 202
           EV + +      G   D W++G  + EM  G  P+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 74.0 bits (182), Expect = 8e-15
 Identities = 82/292 (28%), Positives = 113/292 (38%), Gaps = 56/292 (19%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQIVAYKGCD 64
           +G GS ATV  G S  + ++ A+K   L + E       RE  +L  L    IV     D
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLH--D 70

Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           I   + K    L  EY            G  L    +R     +L GL Y H   ++H D
Sbjct: 71  II--HTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRD 128

Query: 125 IKGQNILVSKDNEQGA-KIADFGCARRARV------NEDDEGKPICGTPICMAPEVARGE 177
           +K QN+L+   +E+G  K+ADFG AR   V      NE         T     P+V  G 
Sbjct: 129 LKPQNLLI---SERGELKLADFGLARAKSVPSKTYSNE-------VVTLWYRPPDVLLGS 178

Query: 178 -EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP---------EIPGY 227
            E     D+W +GC   EMATGRP +P   D    LH+I     TP           P +
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238

Query: 228 MS---------------------KQAQDFLSKCLIRNPGERWSASELLEHGF 258
                                     ++   K L   P +R SA+E ++H +
Sbjct: 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 73.8 bits (181), Expect = 9e-15
 Identities = 84/292 (28%), Positives = 110/292 (37%), Gaps = 54/292 (18%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQREQRILSALAC---PQIVAY 60
           IG G+  TV       S    A+KS  +  +E        RE  +L  L     P IV  
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 61  KG-CDISEENGKILYNLFLEYAPG---GTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
              C  S  + +    L  E+        L      G   E   I+   R  L GL +LH
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAE--TIKDLMRQFLRGLDFLH 125

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
           +N IVH D+K +NILV+   +   K+ADFG AR           P+  T    APEV   
Sbjct: 126 ANCIVHRDLKPENILVTSGGQ--VKLADFGLARIYSCQM--ALTPVVVTLWYRAPEVLLQ 181

Query: 177 EEQGFPADVWALGCTVLEM---------------------ATGRPP---WP-DVADPISA 211
                P D+W++GC   EM                       G PP   WP DV  P  A
Sbjct: 182 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGA 241

Query: 212 LHRIGFSSDTPE-----IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGF 258
                FS   P      +P  + +     L + L  NP +R SA   L+H F
Sbjct: 242 -----FSPRGPRPVQSVVPE-IEESGAQLLLEMLTFNPHKRISAFRALQHPF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 73.8 bits (182), Expect = 9e-15
 Identities = 52/193 (26%), Positives = 82/193 (42%), Gaps = 59/193 (30%)

Query: 109 LLGLQYLHSNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPI 167
           L G+ +LH N I+H D+K  N+L+   N +G  KI DFG AR              G+P+
Sbjct: 116 LSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLARE------------YGSPL 160

Query: 168 -----------CMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI 215
                        APE+  G ++     D+W++GC   E+ T +P +P  ++ I  L++I
Sbjct: 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE-IDQLNKI 219

Query: 216 -------------GFSS------DTPEIPGY-----------MSKQAQDFLSKCLIRNPG 245
                        GFS        T     Y           +S    D L++ L  +P 
Sbjct: 220 FKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPA 279

Query: 246 ERWSASELLEHGF 258
           +R SA + L+H +
Sbjct: 280 KRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 64/201 (31%), Positives = 88/201 (43%), Gaps = 14/201 (6%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQIVAYKGCD 64
           +G G+ ATV  G S  +  + A+K   L + E       RE  +L  L    IV     D
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLH--D 70

Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           I      +   L  EY            G  +    ++     +L GL Y H   I+H D
Sbjct: 71  IIHTERCL--TLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRD 128

Query: 125 IKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE-EQGFP 182
           +K QN+L+   NE+G  K+ADFG AR   V        +  T     P+V  G  E   P
Sbjct: 129 LKPQNLLI---NEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTP 184

Query: 183 ADVWALGCTVLEMATGRPPWP 203
            D+W +GC + EMATGRP +P
Sbjct: 185 IDMWGVGCILYEMATGRPMFP 205

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 75.6 bits (186), Expect = 1e-14
 Identities = 78/295 (26%), Positives = 118/295 (40%), Gaps = 67/295 (22%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKS--AELSNSEFLQ----REQRILSALACPQIV-AYK 61
           IG+G    V +      S   A+K    +LS +  L+    RE +I + L  P IV  Y 
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS-------GTCLEEG-RIRSHTR---AVLL 110
            C   +    + Y +   Y  G TL   ++S          L E   + +       +  
Sbjct: 70  ICSDGD---PVYYTM--PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124

Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG----------- 159
            ++Y+HS G++H D+K  NIL+    E    I D+G A   ++ E+D             
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 160 ----KP--ICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW----------- 202
                P  I GTP  MAPE   G       D++ALG  + +M T   P+           
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR 242

Query: 203 PDVADPIS-ALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERW-SASELLE 255
             +  PI  A +R        EIP ++S+ A     K L  +P ER+ S  EL +
Sbjct: 243 DVILSPIEVAPYR--------EIPPFLSQIAM----KALAVDPAERYSSVQELKQ 285

Length = 932

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 41/225 (18%)

Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGK--PICGT 165
           +L GL+Y+HS  ++H D+K  N+L++ + +   KI DFG AR A    D  G       T
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPEHDHTGFLTEYVAT 172

Query: 166 PICMAPEVARGEEQGFPA-DVWALGCTVLEMATGRPPWP--DVADPIS-ALHRIGFSSD- 220
               APE+    +    A D+W++GC + EM + RP +P  D    ++  L  +G  S  
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE 232

Query: 221 -------------------TPEIP-----GYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
                               P++P          +A D L K L  NP +R +  E L H
Sbjct: 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292

Query: 257 GFVKEQNFKLS---TLTEPETYNSES----PTSVLNQQLWDSTLT 294
            ++ EQ    S      EP  ++ E     P   L + +++  + 
Sbjct: 293 PYL-EQYHDPSDEPVAEEPFPFDFELFDDLPKEKLKELIFEEIMR 336

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 66/260 (25%), Positives = 105/260 (40%), Gaps = 33/260 (12%)

Query: 23  NRSSEVFAVKSAELSNSEF----LQREQRILSALACPQIVAYKGCDISEENGKILYNLFL 78
           + + E  AVKS +  +       L++E  IL  L    IV YKG  I  E+G     L +
Sbjct: 30  DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKG--ICTEDGGNGIKLIM 87

Query: 79  EYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE 137
           E+ P G+L + + R+   +   +   +   +  G+ YL S   VH D+  +N+LV  ++E
Sbjct: 88  EFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV--ESE 145

Query: 138 QGAKIADFGCARRARVNE------DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCT 191
              KI DFG  +    ++      DD   P+       APE     +    +DVW+ G T
Sbjct: 146 HQVKIGDFGLTKAIETDKEYYTVKDDLDSPV----FWYAPECLIQSKFYIASDVWSFGVT 201

Query: 192 VLEMAT----GRPPWPDVADPISALH---------RIGFSSDTPEIPGYMSKQAQDFLSK 238
           + E+ T       P       I   H         R+         P    ++    + K
Sbjct: 202 LYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRK 261

Query: 239 CLIRNPGERWSASELLEHGF 258
           C    P +R +   L+E GF
Sbjct: 262 CWEFQPSKRTTFQNLIE-GF 280

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 54/193 (27%), Positives = 78/193 (40%), Gaps = 44/193 (22%)

Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI 167
           +L G+++LHS GI+H D+K  NI+V  D     KI DFG AR A         P   T  
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA--GTSFMMTPYVVTRY 182

Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWP--DVAD------------PISALH 213
             APEV  G       D+W++GC + EM  G   +P  D  D                + 
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242

Query: 214 RIG--------------------------FSSDTPEIPGYMSKQAQDFLSKCLIRNPGER 247
           R+                           F  D+       + QA+D LSK L+ +P +R
Sbjct: 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKR 302

Query: 248 WSASELLEHGFVK 260
            S  + L+H ++ 
Sbjct: 303 ISVDDALQHPYIN 315

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 71.8 bits (177), Expect = 3e-14
 Identities = 46/171 (26%), Positives = 73/171 (42%), Gaps = 17/171 (9%)

Query: 76  LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKD 135
           L ++Y   G L D ++    L E  ++   R ++  L  LH + I+H DIK +N+L  + 
Sbjct: 86  LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRA 145

Query: 136 NEQGAKIADFGCARRARVNEDDEGKPIC--GTPICMAPEVARGEEQGFPADVWALGCTVL 193
            ++   + D+G  +         G P C  GT    +PE  +G       D WA+G    
Sbjct: 146 KDR-IYLCDYGLCKI-------IGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTY 197

Query: 194 EMATGRPPWP----DVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCL 240
           E+ TG+ P+     +  D  S L R             +SK A DF+   L
Sbjct: 198 ELLTGKHPFKEDEDEELDLESLLKRQ---QKKLPFIKNVSKNANDFVQSML 245

Length = 267

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 74.1 bits (182), Expect = 3e-14
 Identities = 58/169 (34%), Positives = 77/169 (45%), Gaps = 16/169 (9%)

Query: 42  LQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRI 101
            +RE  + + L  P IVA    D  E    +L+ +F EY PG TL + + +   L  G  
Sbjct: 25  FRRETALCARLYHPNIVAL--LDSGEAPPGLLFAVF-EYVPGRTLREVLAADGALPAGET 81

Query: 102 RSHTRAVLLGLQYLHSNGIVHCDIKGQNILVS-KDNEQGAKIADFGC---------ARRA 151
                 VL  L   H+ GIVH D+K QNI+VS       AK+ DFG          A  A
Sbjct: 82  GRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVA 141

Query: 152 RVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRP 200
            +    E   + GTP   APE  RGE     +D++A G   LE  TG+ 
Sbjct: 142 TLTRTTE---VLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 71.9 bits (176), Expect = 3e-14
 Identities = 53/178 (29%), Positives = 79/178 (44%), Gaps = 14/178 (7%)

Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
            +E R   +   +  GL+ L    IV+ D+K +NIL+  D+    +I+D G A +    E
Sbjct: 99  FDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL--DDRGHIRISDLGLAVQIPEGE 156

Query: 156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPI---SAL 212
              G+   GT   MAPEV   E+  F  D W LGC + EM  G+ P+    + +      
Sbjct: 157 TVRGR--VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD 214

Query: 213 HRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERW-----SASELLEHGFVKEQNFK 265
            R+    D  E     S+ A+      L +NP ER       A+ + +H   K  NFK
Sbjct: 215 RRV--KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK 270

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 55/181 (30%), Positives = 78/181 (43%), Gaps = 37/181 (20%)

Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI 167
           +L GL+Y+HS  I+H D+K  N+ V++D E   KI DFG AR    + DDE      T  
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRW 182

Query: 168 CMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE--- 223
             APE+           D+W++GC + E+ TGR  +P   D I  L  I     TP    
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG-TDHIDQLKLILRLVGTPGAEL 241

Query: 224 ---IPG-----------YMSK------------QAQDFLSKCLIRNPGERWSASELLEHG 257
              I              M K             A D L K L+ +  +R +A++ L H 
Sbjct: 242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301

Query: 258 F 258
           +
Sbjct: 302 Y 302

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 72.4 bits (178), Expect = 5e-14
 Identities = 79/304 (25%), Positives = 124/304 (40%), Gaps = 64/304 (21%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQ--------RILSALACPQIVAY 60
           IGRG+   V +     +  ++A+K   L  SE L++EQ         IL+    P +V  
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKK--LRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66

Query: 61  KGCDISEENGKILYNLFLEYAPGGTL-TDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
                S ++   LY L +EY PGG + T  ++  T  EE   R +    +L +  +H  G
Sbjct: 67  Y---YSFQDENYLY-LIMEYLPGGDMMTLLMKKDTFTEEE-TRFYIAETILAIDSIHKLG 121

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CA--RRARVNE--------------DDEGKPI 162
            +H DIK  N+L+  D +   K++DFG C   +++   E              D   KP+
Sbjct: 122 YIHRDIKPDNLLL--DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPM 179

Query: 163 --------------------CGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW 202
                                GTP  +APEV          D W+LG  + EM  G PP+
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239

Query: 203 PDVADPISALHRIGFSSDT----PEIPGYMSKQAQDFLSK--CLIRNPGERWSASELLEH 256
               +P     +I    +T     E+P  +S +A+D + +  C           +E+  H
Sbjct: 240 CS-DNPQETYRKIINWKETLQFPDEVP--LSPEAKDLIKRLCCEAERRLGNNGVNEIKSH 296

Query: 257 GFVK 260
            F K
Sbjct: 297 PFFK 300

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 71.6 bits (175), Expect = 5e-14
 Identities = 72/292 (24%), Positives = 117/292 (40%), Gaps = 60/292 (20%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQ---REQRILSALACPQIVAYKGC 63
           +G G+   V       + E+ A+K  + S  N E  +   RE ++L  L    IV  K  
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELK-- 66

Query: 64  DISEENGKILYNLF----------LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
           +     GK LY +F          LE  P G   +           ++RS+   ++  + 
Sbjct: 67  EAFRRRGK-LYLVFEYVEKNMLELLEEMPNGVPPE-----------KVRSYIYQLIKAIH 114

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
           + H N IVH DIK +N+L+S ++    K+ DFG AR      +        T    +PE+
Sbjct: 115 WCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANYTEYVATRWYRSPEL 172

Query: 174 ARGEEQGFPADVWALGCTVLEMATGRPPWP------------DVADPISA---------- 211
             G   G   D+W++GC + E++ G+P +P             V  P+ A          
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232

Query: 212 -LHRIGFSSDT-PEI-----PGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
             H + F +   P+       G +S    D +   L  NP +R+   + L H
Sbjct: 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 72.0 bits (176), Expect = 6e-14
 Identities = 72/284 (25%), Positives = 116/284 (40%), Gaps = 40/284 (14%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKS-----AELSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      R  +  AVK        L ++    RE R+L  +    ++     
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +    ++L     G   + I     L +  ++     +L GL+Y+HS GI+H 
Sbjct: 83  FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHR 142

Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   +I DFG AR+A    DDE      T    APE+          
Sbjct: 143 DLKPSNVAVNEDCE--LRILDFGLARQA----DDEMTGYVATRWYRAPEIMLNWMHYNQT 196

Query: 183 ADVWALGCTVLEMATGR--------------------PPWPDVADPISALHRIGFSSDTP 222
            D+W++GC + E+  G+                     P P+V   IS+ H   +    P
Sbjct: 197 VDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLP 256

Query: 223 EIPGYMSKQ--------AQDFLSKCLIRNPGERWSASELLEHGF 258
            +P    K+        A D L K L+ +  +R SASE L H +
Sbjct: 257 HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 37/183 (20%)

Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI 167
           +L GL+Y+HS G+VH D+K  NIL++++ +   KI DFG AR     +D +      T  
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILINENCD--LKICDFGLARI----QDPQMTGYVSTRY 170

Query: 168 CMAPEVA-RGEEQGFPADVWALGCTVLEMATGRPPWP--------------------DVA 206
             APE+    ++     D+W+ GC   EM  G+P +P                    DV 
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230

Query: 207 DPISALHRIGFSSDTPE---------IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHG 257
           + I + + + F    P+                 A D L K L+ +P +R SA+E L H 
Sbjct: 231 NTICSENTLRFVQSLPKREPVPFSEKFKN-ADPSAIDLLEKMLVFDPQKRISAAEALAHP 289

Query: 258 FVK 260
           ++ 
Sbjct: 290 YLA 292

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 52/210 (24%), Positives = 95/210 (45%), Gaps = 14/210 (6%)

Query: 44  REQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIR----SGTCLEEG 99
           +E  +L  L  P ++ Y    I +       N+ LE A  G L+  I+        + E 
Sbjct: 51  KEIDLLKQLNHPNVIKYYASFIEDNE----LNIVLELADAGDLSRMIKHFKKQKRLIPEK 106

Query: 100 RIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG 159
            +  +   +   L+++HS  ++H DIK  N+ ++       K+ D G  R    ++    
Sbjct: 107 TVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFS-SKTTAA 163

Query: 160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPP-WPDVADPISALHRIGFS 218
             + GTP  M+PE        F +D+W+LGC + EMA  + P + D  +  S   +I   
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-Q 222

Query: 219 SDTPEIPG-YMSKQAQDFLSKCLIRNPGER 247
            D P +P  + S++ +  ++ C+  +P +R
Sbjct: 223 CDYPPLPSDHYSEELRQLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 73/296 (24%), Positives = 122/296 (41%), Gaps = 41/296 (13%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQIVAYKGCD 64
           +G G+ ATV  G S  +  + A+K   L + E       RE  +L  L    IV      
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
            +E++  +++  +L+      L D    G  +    ++     +L GL Y H   ++H D
Sbjct: 74  HTEKSLTLVFE-YLDKDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRD 129

Query: 125 IKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE-EQGFP 182
           +K QN+L+   NE+G  K+ADFG AR   +        +  T     P++  G  +    
Sbjct: 130 LKPQNLLI---NERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQ 185

Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQ--------- 231
            D+W +GC   EM+TGRP +P   V + +  + RI  +      PG +S +         
Sbjct: 186 IDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPK 245

Query: 232 ----------------AQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTE 271
                             + LSK L     +R SA E ++H +      ++  L +
Sbjct: 246 YRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIHKLPD 301

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 68.8 bits (168), Expect = 3e-13
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 28/199 (14%)

Query: 70  GKILYN---LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------GLQYLHSNG 119
           G IL+N   + +E    G L + +R+      GR       +L        G++YL S  
Sbjct: 66  GVILHNGLYIVMELMSKGNLVNFLRT-----RGRALVSVIQLLQFSLDVAEGMEYLESKK 120

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           +VH D+  +NILVS+D    AK++DFG AR   +  D+   P+  T    APE  + ++ 
Sbjct: 121 LVHRDLAARNILVSEDGV--AKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKF 174

Query: 180 GFPADVWALGCTVLEM-ATGRPPWPDVA-DPISALHRIGFSSDTPE-IPGYMSKQAQDFL 236
              +DVW+ G  + E+ + GR P+P ++   +      G+  + PE  P          +
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPA----DVYVLM 230

Query: 237 SKCLIRNPGERWSASELLE 255
           + C    P +R S  +L E
Sbjct: 231 TSCWETEPKKRPSFHKLRE 249

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 36/221 (16%)

Query: 5   RGQTIGRGSTATVSIGM---SNRSSEV-FAVK-----SAELSNSEFLQREQRILSALACP 55
           + + +G G+  TV  G+        ++  A+K     ++  +N E L  E  +++++  P
Sbjct: 11  KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEIL-DEAYVMASVDHP 69

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHT-----RAVLL 110
            +V   G  +S +       L  +  P G L D +R+        I S         +  
Sbjct: 70  HVVRLLGICLSSQ-----VQLITQLMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAK 120

Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED----DEGKPICGTP 166
           G+ YL    +VH D+  +N+LV        KI DFG A+   V+E     + GK     P
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDVDEKEYHAEGGK----VP 174

Query: 167 I-CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
           I  MA E          +DVW+ G TV E+ T G  P+  +
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 53/194 (27%), Positives = 80/194 (41%), Gaps = 38/194 (19%)

Query: 101 IRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGK 160
           ++     +L GL+YLHS GI+H DIK  N+LV+ +     KI DFG    ARV E DE K
Sbjct: 105 VKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV--LKICDFGL---ARVEEPDESK 159

Query: 161 PICG---TPICMAPEVARGEEQGFPA-DVWALGCTVLEMATGR----------------- 199
            +     T    APE+  G      A D+W++GC   E+   R                 
Sbjct: 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD 219

Query: 200 ----PPWPD--------VADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGER 247
               P             A  +   H+         +    + +A   L + L+ +P +R
Sbjct: 220 LLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKR 279

Query: 248 WSASELLEHGFVKE 261
            SA++ L H ++ E
Sbjct: 280 ISAADALAHPYLDE 293

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 68.4 bits (167), Expect = 4e-13
 Identities = 69/273 (25%), Positives = 119/273 (43%), Gaps = 49/273 (17%)

Query: 4   TRGQTIGRGSTATVSIG--MSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           T  Q IG G    V +G  +  R   +  ++   +S  +F++ E +++  L+ P++V   
Sbjct: 7   TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIE-EAQVMMKLSHPKLVQLY 65

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS-----------GTCLEEGRIRSHTRAVLL 110
           G  +  E   I   L  E+   G L+D +R+           G CL+          V  
Sbjct: 66  G--VCTERSPIC--LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLD----------VCE 111

Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM- 169
           G+ YL S+ ++H D+  +N LV ++  Q  K++DFG     R   DD+     GT   + 
Sbjct: 112 GMAYLESSNVIHRDLAARNCLVGEN--QVVKVSDFG---MTRFVLDDQYTSSTGTKFPVK 166

Query: 170 --APEVARGEEQGFPADVWALGCTVLEM-ATGRPPW-----PDVADPISALHRIGFSSDT 221
             +PEV    +    +DVW+ G  + E+ + G+ P+      +V + I+A  R+      
Sbjct: 167 WSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL------ 220

Query: 222 PEIPGYMSKQAQDFLSKCLIRNPGERWSASELL 254
              P   S+   + +  C    P +R S S LL
Sbjct: 221 -YKPRLASQSVYELMQHCWKERPEDRPSFSLLL 252

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 17/203 (8%)

Query: 7   QTIGRGSTATVSIGM-SNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVA 59
           +T+G GS   V +    N      A+K  E S        + +  E++IL+ +  P  V 
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
             G   S ++   LY L LE+  GG     +R            +   ++L  +YL S  
Sbjct: 96  LYG---SFKDESYLY-LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN 151

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           IV+ D+K +N+L+ KD     K+ DFG A+      D     +CGTP  +APE+      
Sbjct: 152 IVYRDLKPENLLLDKDG--FIKMTDFGFAKVV----DTRTYTLCGTPEYIAPEILLNVGH 205

Query: 180 GFPADVWALGCTVLEMATGRPPW 202
           G  AD W LG  + E+  G PP+
Sbjct: 206 GKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 70/209 (33%), Positives = 101/209 (48%), Gaps = 30/209 (14%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKS---AELSNSEFLQREQRILSALACPQIVA-YKGCD 64
           +G G    V +G  N +++V AVK+     +S   FLQ E +I+  L   ++V  Y  C 
Sbjct: 14  LGAGQFGEVWMGTWNGTTKV-AVKTLKPGTMSPEAFLQ-EAQIMKKLRHDKLVQLYAVCS 71

Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL------GLQYLHSN 118
             E     +Y +  EY   G+L D ++SG    EG+     + V +      G+ YL S 
Sbjct: 72  EEEP----IY-IVTEYMSKGSLLDFLKSG----EGKKLRLPQLVDMAAQIAEGMAYLESR 122

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PI-CMAPEVAR 175
             +H D+  +NILV ++     KIADFG    AR+ EDDE     G   PI   APE A 
Sbjct: 123 NYIHRDLAARNILVGENL--VCKIADFGL---ARLIEDDEYTAREGAKFPIKWTAPEAAN 177

Query: 176 GEEQGFPADVWALGCTVLEMAT-GRPPWP 203
                  +DVW+ G  + E+ T GR P+P
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVTYGRVPYP 206

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 69/279 (24%), Positives = 118/279 (42%), Gaps = 36/279 (12%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALA----CPQIV- 58
           IGRG    V       + +++A+K  +     +   E L   +RI+ +L     CP IV 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 59  ---AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
              A+   D      K+ +   L+   GG L   +       E  +R +   ++LGL+++
Sbjct: 62  MSYAFHTPD------KLSF--ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHM 113

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEV 173
           H+  +V+ D+K  NIL+  D     +I+D G A      +  + KP    GT   MAPEV
Sbjct: 114 HNRFVVYRDLKPANILL--DEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMAPEV 166

Query: 174 -ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA 232
             +G      AD ++LGC + ++  G  P+                +   E+P   S + 
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 226

Query: 233 QDFLSKCLIRNPGER-----WSASELLEHGFVKEQNFKL 266
           +  L   L R+   R       A E+ EH F +  ++++
Sbjct: 227 RSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 57/203 (28%), Positives = 80/203 (39%), Gaps = 43/203 (21%)

Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L+  R+      +L G+++LHS GI+H D+K  NI+V  D     KI DFG AR A  N 
Sbjct: 120 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNF 177

Query: 156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGR---------PPWPDVA 206
                P   T    APEV  G       D+W++GC + E+  G            W  V 
Sbjct: 178 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVI 235

Query: 207 DPIS----------------------ALHRIGFSSDTP--------EIPGYMSKQAQDFL 236
           + +                           I F    P        E     + QA+D L
Sbjct: 236 EQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLL 295

Query: 237 SKCLIRNPGERWSASELLEHGFV 259
           SK L+ +P +R S  E L H ++
Sbjct: 296 SKMLVIDPDKRISVDEALRHPYI 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 65.6 bits (160), Expect = 3e-12
 Identities = 64/249 (25%), Positives = 111/249 (44%), Gaps = 28/249 (11%)

Query: 17  VSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL 76
           V + M  R+ + F +K   L  S    RE+  +     P +V      +SE++      L
Sbjct: 9   VLLVMDTRTQQTFILKG--LRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDS----VFL 62

Query: 77  FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN 136
            L++A GG L   I     + E  ++     +++ L  LH  GIV  D+   NIL+   +
Sbjct: 63  VLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---D 119

Query: 137 EQG-AKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEM 195
           ++G  ++  F   R + V +  +G+ +    +  APEV    E+    D W+LG  + E+
Sbjct: 120 DRGHIQLTYFS--RWSEVEDSCDGEAV--ENMYCAPEVGGISEETEACDWWSLGAILFEL 175

Query: 196 ATGRPPWPDVADPISALHRIGFSSDTP-EIPGYMSKQAQDFLSKCLIRNPGERWSA---- 250
            TG+         +   H  G ++ T   IP ++S++A+  L + L  NP ER  A    
Sbjct: 176 LTGK--------TLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAG 227

Query: 251 -SELLEHGF 258
             ++  H F
Sbjct: 228 VEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 65.4 bits (160), Expect = 4e-12
 Identities = 68/262 (25%), Positives = 110/262 (41%), Gaps = 33/262 (12%)

Query: 9   IGRGSTATVSIGM----SNRSSEVFAVK----SAELSN-SEFLQREQRILSALACPQIVA 59
           +G G+  +V  G+    S +  EV AVK        +   EFL RE  +++ L  P IV 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEV-AVKTLKQEHIAAGKKEFL-REASVMAQLDHPCIVR 60

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
             G  + +    +L    +E AP G L   ++    +    ++     V +G+ YL S  
Sbjct: 61  LIG--VCKGEPLML---VMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH 115

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT-PI-CMAPEVARGE 177
            VH D+  +N+L+   N   AKI+DFG +R      D       G  P+   APE     
Sbjct: 116 FVHRDLAARNVLLV--NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173

Query: 178 EQGFPADVWALGCTVLEMAT-GRPPW-----PDVADPISALHRIGFSSDTPEIPGYMSKQ 231
           +    +DVW+ G T+ E  + G  P+      +V   + +  R+    + P+   Y    
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQ-EIY---- 228

Query: 232 AQDFLSKCLIRNPGERWSASEL 253
               +  C    P +R + SEL
Sbjct: 229 --SIMLSCWKYRPEDRPTFSEL 248

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 64.0 bits (156), Expect = 4e-12
 Identities = 41/191 (21%), Positives = 62/191 (32%), Gaps = 30/191 (15%)

Query: 84  GTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKI 142
            +L D +   G  L E  I +     L  L+ LH        +   + L+  D     K 
Sbjct: 1   VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSVAFKT 60

Query: 143 ADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW 202
                       E          P  MAPEV +G+     AD+++LG T+ E      P 
Sbjct: 61  P-----------EQSRP-----DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP- 103

Query: 203 PDVADPISA-LHRIGFSSDTPEIPGYMSK---------QAQDFLSKCLIRNPGERWSASE 252
            +    +SA L  +   +  P                   +DF+  C  R P  R +A+ 
Sbjct: 104 YNEERELSAILEIL--LNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANH 161

Query: 253 LLEHGFVKEQN 263
            L H       
Sbjct: 162 YLAHCRALFAE 172

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 65.2 bits (159), Expect = 5e-12
 Identities = 64/271 (23%), Positives = 117/271 (43%), Gaps = 37/271 (13%)

Query: 1   MDWTRGQTIGRGSTATVSIGM--SNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIV 58
            + T  + +G G    V +G         +  ++   +S  +F++ E +++  L+ P +V
Sbjct: 4   SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE-EAKVMMKLSHPNLV 62

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHT-----RAVLLGLQ 113
              G  +  +   I   +  EY   G L + +R      +G++ +         V   ++
Sbjct: 63  QLYG--VCTKQRPIF--IVTEYMANGCLLNYLRE----RKGKLGTEWLLDMCSDVCEAME 114

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PICMA- 170
           YL SNG +H D+  +N LV +DN    K++DFG AR      DD+     GT  P+  A 
Sbjct: 115 YLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVL---DDQYTSSQGTKFPVKWAP 169

Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEI 224
           PEV         +DVW+ G  + E+ + G+ P+      +V + +SA    G+    P++
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA----GYRLYRPKL 225

Query: 225 PGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
                 +    +  C    P +R +  +LL 
Sbjct: 226 ---APTEVYTIMYSCWHEKPEDRPAFKKLLS 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 64.7 bits (157), Expect = 7e-12
 Identities = 71/252 (28%), Positives = 113/252 (44%), Gaps = 31/252 (12%)

Query: 9   IGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +G+G    V +G  N ++ V    +K   +S   FLQ E +++  L   ++V      +S
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYAV-VS 71

Query: 67  EENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           EE   I+     EY   G+L D ++   G  L   ++      +  G+ Y+     VH D
Sbjct: 72  EEPIYIV----TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127

Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PI-CMAPEVARGEEQGF 181
           ++  NILV ++     K+ADFG AR   + ED+E     G   PI   APE A       
Sbjct: 128 LRAANILVGEN--LVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 182 PADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +DVW+ G  + E+ T GR P+P     +V D +   +R+    + PE          D 
Sbjct: 183 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE-------SLHDL 235

Query: 236 LSKCLIRNPGER 247
           + +C  + P ER
Sbjct: 236 MCQCWRKEPEER 247

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 72/286 (25%), Positives = 123/286 (43%), Gaps = 45/286 (15%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSN-------SEFLQREQRILSALACPQIVAYK 61
           IGRG+   V    ++ ++E  A+K  +++N       ++   RE ++L  L    ++A K
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIK--KIANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70

Query: 62  GCDISEENGKILYN-LFLEYAPGGT-LTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
             DI     +  +N +++ Y    T L   IRS   L +   +     +L GL+Y+HS  
Sbjct: 71  --DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN 128

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA-RGEE 178
           ++H D+K  N+L++ + +   KI DFG AR      D   + +  T    APE+     E
Sbjct: 129 VLHRDLKPSNLLLNANCD--LKICDFGLARTTSEKGDFMTEYVV-TRWYRAPELLLNCSE 185

Query: 179 QGFPADVWALGCTVLEMATGRPPWP--DVADPISALHR-IGFSSDT-------------- 221
                DVW++GC   E+   +P +P  D    +  +   +G  S+               
Sbjct: 186 YTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYI 245

Query: 222 ---PEIPG--------YMSKQAQDFLSKCLIRNPGERWSASELLEH 256
              P  P         + +  A D L K L+ +P +R +  E L H
Sbjct: 246 RSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 59/210 (28%), Positives = 86/210 (40%), Gaps = 57/210 (27%)

Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L+  R+      +L G+++LHS GI+H D+K  NI+V  D     KI DFG AR A    
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA---- 169

Query: 156 DDEGKPICGTPICM-----APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS 210
              G     TP  +     APEV  G       D+W++GC + EM   +  +P   D I 
Sbjct: 170 ---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG-RDYID 225

Query: 211 ALHRIGFSSDTPEIPGYMSK---------------------------------------- 230
             +++     TP  P +M K                                        
Sbjct: 226 QWNKVIEQLGTP-CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKA 284

Query: 231 -QAQDFLSKCLIRNPGERWSASELLEHGFV 259
            QA+D LSK L+ +P +R S  E L+H ++
Sbjct: 285 SQARDLLSKMLVIDPAKRISVDEALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 72/258 (27%), Positives = 114/258 (44%), Gaps = 39/258 (15%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVAYKGCD 64
           + +G G    V +G  N +++V    +K   +S   FL+ E +I+  L   ++V      
Sbjct: 12  KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE-EAQIMKKLRHDKLVQLYAV- 69

Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGR------IRSHTRAVLLGLQYLHSN 118
           +SEE   I+     EY   G+L D ++ G    EGR      +      V  G+ Y+   
Sbjct: 70  VSEEPIYIV----TEYMSKGSLLDFLKDG----EGRALKLPNLVDMAAQVAAGMAYIERM 121

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PI-CMAPEVAR 175
             +H D++  NILV   +    KIADFG    AR+ ED+E     G   PI   APE A 
Sbjct: 122 NYIHRDLRSANILVG--DGLVCKIADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAAL 176

Query: 176 GEEQGFPADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMS 229
                  +DVW+ G  + E+ T GR P+P     +V + +   +R+    D P       
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCP------- 229

Query: 230 KQAQDFLSKCLIRNPGER 247
               + + +C  ++P ER
Sbjct: 230 ISLHELMLQCWKKDPEER 247

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 64.1 bits (156), Expect = 1e-11
 Identities = 72/252 (28%), Positives = 110/252 (43%), Gaps = 31/252 (12%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKS---AELSNSEFLQREQRILSALACPQIVAYKGCDI 65
           +G G    V +G  N  ++V A+KS     +S   FL  E  ++  L  P++V       
Sbjct: 14  LGAGQFGEVWMGYYNGHTKV-AIKSLKQGSMSPEAFLA-EANLMKQLQHPRLVRLYAVVT 71

Query: 66  SEENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
            E     +Y +  EY   G+L D +++  G  L   ++      +  G+ ++     +H 
Sbjct: 72  QEP----IY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126

Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNE--DDEGK--PICGTPICMAPEVARGEEQ 179
           D++  NILVS+      KIADFG AR    NE    EG   PI  T    APE       
Sbjct: 127 DLRAANILVSE--TLCCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINYGTF 180

Query: 180 GFPADVWALGCTVLEMAT-GRPPWPDVADP--ISALHRIGFSSDTPE-IPGYMSKQAQDF 235
              +DVW+ G  + E+ T GR P+P + +P  I  L R G+    P+  P     +  + 
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER-GYRMPRPDNCPE----ELYEL 235

Query: 236 LSKCLIRNPGER 247
           +  C    P ER
Sbjct: 236 MRLCWKEKPEER 247

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 70/258 (27%), Positives = 117/258 (45%), Gaps = 31/258 (12%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYK 61
           + IG+GS   V   +   + E  A+K        +S++  + RE ++L  L  P IV  K
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65

Query: 62  GCDI--SEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
              +  S    K +Y +F E      L   I++   L     +     +L  L+Y+H+  
Sbjct: 66  HIMLPPSRREFKDIYVVF-ELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN 123

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI-----CGTPICMAPEVA 174
           + H D+K +NIL + D +   KI DFG    ARV  +D    I       T    APE+ 
Sbjct: 124 VFHRDLKPKNILANADCK--LKICDFGL---ARVAFNDTPTAIFWTDYVATRWYRAPELC 178

Query: 175 RGEEQGF-PA-DVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSD-----TPE-IPG 226
                 + PA D+W++GC   E+ TG+P +P      + +H++   +D     +PE I  
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK----NVVHQLDLITDLLGTPSPETISR 234

Query: 227 YMSKQAQDFLSKCLIRNP 244
             +++A+ +LS    + P
Sbjct: 235 VRNEKARRYLSSMRKKQP 252

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 72/298 (24%), Positives = 123/298 (41%), Gaps = 48/298 (16%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ---REQRILSALACPQIV----- 58
           + +G GS   V   + +   +  AVK   L++ + ++   RE +I+  L    IV     
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70

Query: 59  -AYKGCDISEENGKI-----LYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGL 112
               G D++E+ G +     +Y +  EY     L + +  G   EE   R     +L GL
Sbjct: 71  LGPSGSDLTEDVGSLTELNSVY-IVQEYMET-DLANVLEQGPLSEE-HARLFMYQLLRGL 127

Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG--TPICMA 170
           +Y+HS  ++H D+K  N+ ++ ++    KI DFG AR    +   +G    G  T    +
Sbjct: 128 KYIHSANVLHRDLKPANVFINTEDLV-LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS 186

Query: 171 PEVARGEEQGFPA-DVWALGCTVLEMATGRPPWPD---------VADPISALHRIGFSSD 220
           P +         A D+WA GC   EM TG+P +           + + +  +     +  
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNEL 246

Query: 221 TPEIPGYMSK------------------QAQDFLSKCLIRNPGERWSASELLEHGFVK 260
              IP ++                    +A DFL + L  NP +R +A E L H ++ 
Sbjct: 247 LNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 57/186 (30%), Positives = 78/186 (41%), Gaps = 40/186 (21%)

Query: 101 IRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGK 160
           I+     +L GL +LHS+ +VH D+K QNILV+   +   K+ADFG AR           
Sbjct: 112 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQM--ALT 167

Query: 161 PICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRP-------------------- 200
            +  T    APEV        P D+W++GC   EM   +P                    
Sbjct: 168 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 227

Query: 201 ----PWP-DVADPISALHRIGFSSDTPE-----IPGYMSKQAQDFLSKCLIRNPGERWSA 250
                WP DVA P  A     F S + +     +   + +  +D L KCL  NP +R SA
Sbjct: 228 PGEEDWPRDVALPRQA-----FHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRISA 281

Query: 251 SELLEH 256
              L H
Sbjct: 282 YSALSH 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 78/312 (25%), Positives = 129/312 (41%), Gaps = 41/312 (13%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILSALACPQIVAY 60
           IGRG+   V++     + +V+A+K   L+  E L+R        E+ +L       I   
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKI--LNKWEMLKRAETACFREERDVLVNGDRRWITNL 66

Query: 61  KGCDISEENGKILYNLFLEYAPGGT-LTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
                 E N   LY L ++Y  GG  LT   +    L E   R +   ++L +  +H  G
Sbjct: 67  HYAFQDENN---LY-LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
            VH DIK  N+L+ K+     ++ADFG   R   +   +     GTP  ++PE+ +  E 
Sbjct: 123 YVHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180

Query: 180 GF-----PADVWALGCTVLEMATGRPPWPDVADPISALH--------RIGFSSDTPEIPG 226
           G        D W+LG  + EM  G  P+   A+ +   +           F  D  ++  
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPF--YAESLVETYGKIMNHKEHFQFPPDVTDVS- 237

Query: 227 YMSKQAQDFLSKCLIRNPGERW---SASELLEHGFVKEQNFK-LSTLTEPETYNSESPTS 282
              ++A+D + + LI +P  R       +  +H F +  ++  +   T P      SPT 
Sbjct: 238 ---EEAKDLIRR-LICSPETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTD 293

Query: 283 VLNQQLWDSTLT 294
             N  + D  L 
Sbjct: 294 TSNFDVDDDDLR 305

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 56/204 (27%), Positives = 85/204 (41%), Gaps = 45/204 (22%)

Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L+  R+      +L G+++LHS GI+H D+K  NI+V  D     KI DFG AR A  + 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSF 180

Query: 156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI 215
                P   T    APEV  G       D+W++GC + EM  G   +P   D I   +++
Sbjct: 181 MMT--PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG-TDHIDQWNKV 237

Query: 216 --------------------GFSSDTPEIPGY--------------------MSKQAQDF 235
                                +  + P+  GY                     + QA+D 
Sbjct: 238 IEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 297

Query: 236 LSKCLIRNPGERWSASELLEHGFV 259
           LSK L+ +  +R S  E L+H ++
Sbjct: 298 LSKMLVIDASKRISVDEALQHPYI 321

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 72/295 (24%), Positives = 122/295 (41%), Gaps = 32/295 (10%)

Query: 9   IGRGST--ATVSIGMSNRSSEVFA--VKSAELSNSEFLQREQRILSALACPQIVAYKGCD 64
           +GR  T  A V+   S+   +V A  V   +   + + + E   L+A  C      K  D
Sbjct: 75  VGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAA--CDHFGIVKHFD 132

Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHT-----------RAVLLGLQ 113
             + + K+L  L +EY  GG L   I+        R++ H              ++L L 
Sbjct: 133 DFKSDDKLL--LIMEYGSGGDLNKQIKQ-------RLKEHLPFQEYEVGLLFYQIVLALD 183

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED-DEGKPICGTPICMAPE 172
            +HS  ++H D+K  NI +        K+ DFG +++   +   D     CGTP  +APE
Sbjct: 184 EVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241

Query: 173 VARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA 232
           +   +     AD+W+LG  + E+ T   P+   +     + ++ +    P  P  +S   
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-EIMQQVLYGKYDP-FPCPVSSGM 299

Query: 233 QDFLSKCLIRNPGERWSASELLEHGFVKE-QNFKLSTLTEPETYNSESPTSVLNQ 286
           +  L   L +NP  R +  +LL   F+K   N     +   ET +      +L Q
Sbjct: 300 KALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIVRHSETISPHDREEILRQ 354

Length = 478

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 82/316 (25%), Positives = 123/316 (38%), Gaps = 72/316 (22%)

Query: 9   IGRG--STATVSIGMSNRSSEVFAVKSAEL---SNS--EFLQREQRILSALACPQIVAYK 61
           IGRG     TV++     + E   V+   L   +N    FLQ E  +      P IV Y+
Sbjct: 6   IGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYR 65

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTC------LEEGRIRSHTRAVLLGLQYL 115
              I++ N   +   F+ Y   G+  D I    C      + E  I    + VL  L Y+
Sbjct: 66  ATFIAD-NELWVVTSFMAY---GSAKDLI----CTHFMDGMSELAIAYILQGVLKALDYI 117

Query: 116 HSNGIVHCDIKGQNILVSKDNE---QGAK--IADFGCARRARVNEDDEGKPICGTPICMA 170
           H  G VH  +K  +IL+S D +    G +  ++     +R RV  D     +   P  ++
Sbjct: 118 HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP-WLS 176

Query: 171 PEVARGEEQGFPA--DVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS----DTPEI 224
           PEV +   QG+ A  D++++G T  E+A G  P+ D+      L ++  +     DT  I
Sbjct: 177 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236

Query: 225 PG---------------------------------------YMSKQAQDFLSKCLIRNPG 245
           P                                          S     F+ +CL RNP 
Sbjct: 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPD 296

Query: 246 ERWSASELLEHGFVKE 261
            R SAS LL H F K+
Sbjct: 297 ARPSASTLLNHSFFKQ 312

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 18/211 (8%)

Query: 6   GQTIGRGSTATV--SIGMSNRSSEVFAVKSAELSN-SEFLQREQRILSALACPQIVAYKG 62
           G  +GRG+   V  +     +    +A+K  E +  S    RE  +L  L  P +++ + 
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQK 65

Query: 63  CDISEENGKILYNLFLEYAPGG--------TLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
             +S  + K+   L  +YA             + A +    L  G ++S    +L G+ Y
Sbjct: 66  VFLSHADRKVW--LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123

Query: 115 LHSNGIVHCDIKGQNILVSKDN-EQG-AKIADFGCAR--RARVNEDDEGKPICGTPICMA 170
           LH+N ++H D+K  NILV  +  E+G  KIAD G AR   + +    +  P+  T    A
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 171 PEVARGEEQGFPA-DVWALGCTVLEMATGRP 200
           PE+  G      A D+WA+GC   E+ T  P
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 71/274 (25%), Positives = 119/274 (43%), Gaps = 38/274 (13%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALA----CPQIV- 58
           IGRG    V       + +++A+K  +     +   E L   +RI+ +L     CP IV 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 59  ---AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
              A+   D      K+ +   L+   GG L   +       E  +R +   ++LGL+++
Sbjct: 62  MTYAFHTPD------KLCF--ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHM 113

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEV 173
           H+  +V+ D+K  NIL+  D     +I+D G A      +  + KP    GT   MAPEV
Sbjct: 114 HNRFVVYRDLKPANILL--DEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMAPEV 166

Query: 174 -ARGEEQGFPADVWALGCTVLEMATGRPPW-PDVADPISALHRIGFSSDTPEIPGYMSKQ 231
             +G      AD ++LGC + ++  G  P+          + R+  + +  E+P   S +
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNV-ELPDSFSPE 225

Query: 232 AQDFLSKCLIRNPGERW-----SASELLEHGFVK 260
            +  L   L R+  +R       A E+ EH F K
Sbjct: 226 LKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFK 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 62.1 bits (151), Expect = 6e-11
 Identities = 71/269 (26%), Positives = 117/269 (43%), Gaps = 42/269 (15%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYK 61
           + IG+G+   V  G+   ++EV AVK+   +       +FLQ E  IL     P IV   
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEV-AVKTCRSTLPPDLKRKFLQ-EAEILKQYDHPNIVKLI 58

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           G  +  +   I   + +E  PGG+L   +R     L   ++   +     G++YL S   
Sbjct: 59  G--VCVQKQPIY--IVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC 114

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGK----------PICGTPICMA 170
           +H D+  +N LV ++N    KI+DFG +R     E++ G           PI  T    A
Sbjct: 115 IHRDLAARNCLVGENNV--LKISDFGMSR-----EEEGGIYTVSDGLKQIPIKWT----A 163

Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRI--GFSSDTPEI-PG 226
           PE          +DVW+ G  + E  + G  P+P +++      RI  G+    P++ P 
Sbjct: 164 PEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-QTRERIESGYRMPAPQLCPE 222

Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLE 255
            + +     + +C   +P  R S SE+  
Sbjct: 223 EIYR----LMLQCWAYDPENRPSFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 62.0 bits (150), Expect = 6e-11
 Identities = 72/252 (28%), Positives = 113/252 (44%), Gaps = 26/252 (10%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKS---AELSNSEFLQREQRILSALACPQIVAYKGC 63
           + +G G    V +G  N S++V AVK+     +S   FL+ E  ++  L   ++V     
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSVQAFLE-EANLMKTLQHDKLVRLYAV 69

Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
              EE   I+     EY   G+L D ++S  G  +   ++   +  +  G+ Y+     +
Sbjct: 70  VTKEEPIYII----TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 125

Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PI-CMAPEVARGEE 178
           H D++  N+LVS+      KIADFG    ARV ED+E     G   PI   APE      
Sbjct: 126 HRDLRAANVLVSE--SLMCKIADFGL---ARVIEDNEYTAREGAKFPIKWTAPEAINFGS 180

Query: 179 QGFPADVWALGCTVLEMAT-GRPPWPDV--ADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
               +DVW+ G  + E+ T G+ P+P +  +D +SAL R G+     E       +  D 
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR-GYRMPRME---NCPDELYDI 236

Query: 236 LSKCLIRNPGER 247
           +  C      ER
Sbjct: 237 MKTCWKEKAEER 248

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 63.2 bits (153), Expect = 9e-11
 Identities = 80/295 (27%), Positives = 131/295 (44%), Gaps = 55/295 (18%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQ-------RILSALACPQIVA 59
           + IG G    V +    R+ E F  K+  +S     +RE+        ++  L    IV 
Sbjct: 19  KKIGNGRFGEVFLVKHKRTQEFFCWKA--ISYRGLKEREKSQLVIEVNVMRELKHKNIVR 76

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEE-GRIRSH-----TRAVLLGLQ 113
           Y    +++ N K LY + +E+   G L+  I+   C +  G+I  H     TR +L  L 
Sbjct: 77  YIDRFLNKANQK-LY-ILMEFCDAGDLSRNIQK--CYKMFGKIEEHAIVDITRQLLHALA 132

Query: 114 YLHS-----NG--IVHCDIKGQNILVSK------------DNEQG---AKIADFGCARRA 151
           Y H+     NG  ++H D+K QNI +S             +N  G   AKI DFG ++  
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192

Query: 152 RVNEDDEGKPICGTPICMAPEVARGEEQGF--PADVWALGCTVLEMATGRPPW---PDVA 206
            +  +       GTP   +PE+   E + +   +D+WALGC + E+ +G+ P+    + +
Sbjct: 193 GI--ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250

Query: 207 DPISALHRIGFSSDTPEIP-GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
             IS L R       P++P    SK+    +   L  +  ER SA + L +  +K
Sbjct: 251 QLISELKR------GPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299

Length = 1021

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 18/211 (8%)

Query: 6   GQTIGRGSTATV--SIGMSNRSSEVFAVKSAELSN-SEFLQREQRILSALACPQIVAYKG 62
           G  +GRG+   V  +     +  + +A+K  E +  S    RE  +L  L  P ++A + 
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65

Query: 63  CDISEENGKILYNLFLEYAPGG--------TLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
             +S  + K+   L  +YA             + A +    L    ++S    +L G+ Y
Sbjct: 66  VFLSHSDRKVW--LLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123

Query: 115 LHSNGIVHCDIKGQNILVSKDN-EQG-AKIADFGCAR--RARVNEDDEGKPICGTPICMA 170
           LH+N ++H D+K  NILV  +  E+G  KIAD G AR   + +    +  P+  T    A
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 171 PEVARGEEQGFPA-DVWALGCTVLEMATGRP 200
           PE+  G      A D+WA+GC   E+ T  P
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 12/203 (5%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDI 65
           G  IG GS   V   +   +SE  A+K   L + ++  RE  I+  L    I+  K    
Sbjct: 71  GNIIGNGSFGVVYEAICIDTSEKVAIKKV-LQDPQYKNRELLIMKNLNHINIIFLKDYYY 129

Query: 66  SE---ENGK-ILYNLFLEYAPGGT---LTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
           +E   +N K I  N+ +E+ P      +    R+   L    ++ ++  +   L Y+HS 
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK 189

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
            I H D+K QN+L+   N    K+ DFG A+     +      IC +    APE+  G  
Sbjct: 190 FICHRDLKPQNLLIDP-NTHTLKLCDFGSAKNLLAGQRSVSY-IC-SRFYRAPELMLGAT 246

Query: 179 Q-GFPADVWALGCTVLEMATGRP 200
                 D+W+LGC + EM  G P
Sbjct: 247 NYTTHIDLWSLGCIIAEMILGYP 269

Length = 440

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 4/90 (4%)

Query: 106 RAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT 165
           + +L GL+YLH+  I+H D+K +NI +  ++     I D G A+   V     G  + GT
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFI--NDVDQVCIGDLGAAQFPVVAPAFLG--LAGT 219

Query: 166 PICMAPEVARGEEQGFPADVWALGCTVLEM 195
               APEV   ++    AD+W+ G  + EM
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 73/279 (26%), Positives = 113/279 (40%), Gaps = 44/279 (15%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +       EFL +E  ++  +  P +V
Sbjct: 7   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 65

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E    I+     E+   G L D +R          R    AV+L        
Sbjct: 66  QLLGVCTREPPFYII----TEFMTYGNLLDYLRECN-------RQEVNAVVLLYMATQIS 114

Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PI 167
             ++YL     +H D+  +N LV +++    K+ADFG +R       D      G   PI
Sbjct: 115 SAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMT---GDTYTAHAGAKFPI 169

Query: 168 -CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWP--DVADPISALHRIGFSSDTPE 223
              APE     +    +DVWA G  + E+AT G  P+P  D++     L + G+  + PE
Sbjct: 170 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-GYRMERPE 228

Query: 224 -IPGYMSKQAQDFLSKCLIRNPGERWSASEL---LEHGF 258
             P     +  + +  C   NP +R S +E+    E  F
Sbjct: 229 GCP----PKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 3e-10
 Identities = 68/254 (26%), Positives = 115/254 (45%), Gaps = 34/254 (13%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEFLQREQRILSALACPQIVA-YKGCD 64
           +G G    V  G+ N ++ V AVK      +   +FL  E +I+  L  P+++  Y  C 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPV-AVKTLKPGTMDPKDFL-AEAQIMKKLRHPKLIQLYAVCT 71

Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
           + E     +Y +  E    G+L + ++  +G  L+  ++      V  G+ YL +   +H
Sbjct: 72  LEEP----IY-IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIH 126

Query: 123 CDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PI-CMAPEVARGEEQ 179
            D+  +N+LV ++N    K+ADFG    ARV ++D  +   G   PI   APE A     
Sbjct: 127 RDLAARNVLVGENNI--CKVADFGL---ARVIKEDIYEAREGAKFPIKWTAPEAALYNRF 181

Query: 180 GFPADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
              +DVW+ G  + E+ T GR P+P     +V   +   +R+      P       K+  
Sbjct: 182 SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCP-------KELY 234

Query: 234 DFLSKCLIRNPGER 247
           D +  C   +P +R
Sbjct: 235 DIMLDCWKEDPDDR 248

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 59.3 bits (143), Expect = 5e-10
 Identities = 68/252 (26%), Positives = 113/252 (44%), Gaps = 27/252 (10%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIVAYKGC 63
           + +G G    V +   N+ ++V AVK+ +   +S   FL  E  ++  L   ++V     
Sbjct: 12  KKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAFLA-EANVMKTLQHDKLVKLHAV 69

Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
              E     +Y +  E+   G+L D ++S  G+     ++   +  +  G+ ++     +
Sbjct: 70  VTKEP----IY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 124

Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PI-CMAPEVARGEE 178
           H D++  NILVS       KIADFG    ARV ED+E     G   PI   APE      
Sbjct: 125 HRDLRAANILVSA--SLVCKIADFGL---ARVIEDNEYTAREGAKFPIKWTAPEAINFGS 179

Query: 179 QGFPADVWALGCTVLEMAT-GRPPWPDVADP--ISALHRIGFSSDTPEIPGYMSKQAQDF 235
               +DVW+ G  ++E+ T GR P+P +++P  I AL R          P    ++  + 
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP----EELYNI 235

Query: 236 LSKCLIRNPGER 247
           + +C    P ER
Sbjct: 236 MMRCWKNRPEER 247

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 58.9 bits (143), Expect = 8e-10
 Identities = 66/280 (23%), Positives = 107/280 (38%), Gaps = 47/280 (16%)

Query: 6   GQTIGRGSTATVSIGMSNR--SSEVF---AVKSAELSNS-----EFLQREQRILSALACP 55
            + +G+GS   V  G++      E     A+K+   + S     EFL  E  ++    C 
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN-EASVMKEFNCH 69

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEE--------GRIRSHTRA 107
            +V   G  +S     ++    +E    G L   +RS     E           +    A
Sbjct: 70  HVVRLLGV-VSTGQPTLV---VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125

Query: 108 VLL--GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT 165
             +  G+ YL +   VH D+  +N +V++D     KI DFG  R   + E D  +     
Sbjct: 126 AEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTR--DIYETDYYRKGGKG 181

Query: 166 --PI-CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIG 216
             P+  MAPE  +       +DVW+ G  + EMAT    P+      +V   +      G
Sbjct: 182 LLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID----G 237

Query: 217 FSSDTPE-IPGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
              D PE  P  +     + +  C   NP  R +  E++ 
Sbjct: 238 GHLDLPENCPDKL----LELMRMCWQYNPKMRPTFLEIVS 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 59.5 bits (144), Expect = 9e-10
 Identities = 72/318 (22%), Positives = 127/318 (39%), Gaps = 71/318 (22%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQ--------RILSALACPQIV 58
           + IG+G+   V +     + +++A+K+  L  SE  +++Q         +L+    P +V
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKT--LLKSEMFKKDQLAHVKAERDVLAESDSPWVV 64

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTL-TDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           +      S ++ + LY L +E+ PGG L T  I+  T   E   R +    +L ++ +H 
Sbjct: 65  SLY---YSFQDAQYLY-LIMEFLPGGDLMTMLIKYDT-FSEDVTRFYMAECVLAIEAVHK 119

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGC----------ARRARVNEDDEGKP------ 161
            G +H DIK  NIL+ +      K++DFG           A   ++ +    K       
Sbjct: 120 LGFIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177

Query: 162 ------------------------------ICGTPICMAPEVARGEEQGFPADVWALGCT 191
                                           GTP  +APE+   +  G   D W+LG  
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237

Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEIPG--YMSKQAQDFLSKCLIRNPGE--- 246
           + E   G PP+    +      +I    +T   P   ++S +A+D + + LI N      
Sbjct: 238 MFECLIGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRR-LITNAENRLG 295

Query: 247 RWSASELLEHGFVKEQNF 264
           R  A E+  H F +  ++
Sbjct: 296 RGGAHEIKSHPFFRGVDW 313

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 68/252 (26%), Positives = 112/252 (44%), Gaps = 31/252 (12%)

Query: 9   IGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +G+G    V +G  N +++V    +K   +    FLQ E +I+  L   ++V      +S
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQ-EAQIMKKLRHDKLVPLYAV-VS 71

Query: 67  EENGKILYNLFLEYAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           EE   I+     E+   G+L D ++ G    L+  ++      +  G+ Y+     +H D
Sbjct: 72  EEPIYIV----TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127

Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PI-CMAPEVARGEEQGF 181
           ++  NILV  +     KIADFG    AR+ ED+E     G   PI   APE A       
Sbjct: 128 LRAANILVGDN--LVCKIADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 182 PADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +DVW+ G  + E+ T GR P+P     +V + +   +R+      PE          + 
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPE-------SLHEL 235

Query: 236 LSKCLIRNPGER 247
           +  C  ++P ER
Sbjct: 236 MKLCWKKDPDER 247

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 57.9 bits (140), Expect = 1e-09
 Identities = 65/266 (24%), Positives = 113/266 (42%), Gaps = 43/266 (16%)

Query: 9   IGRGSTATVSIG--MSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +G G    V +G   +     + A+    +S  +F++ E +++  L+ P++V   G    
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE-EAKVMMKLSHPKLVQLYGVCTQ 70

Query: 67  EENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL--------GLQYLHSN 118
           +   K LY +  E+   G L + +R      +G++    + +LL        G++YL  N
Sbjct: 71  Q---KPLY-IVTEFMENGCLLNYLRQ----RQGKLS---KDMLLSMCQDVCEGMEYLERN 119

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PI-CMAPEVAR 175
             +H D+  +N LVS  +    K++DFG  R      DDE     G   P+    PEV  
Sbjct: 120 SFIHRDLAARNCLVS--STGVVKVSDFGMTRYVL---DDEYTSSSGAKFPVKWSPPEVFN 174

Query: 176 GEEQGFPADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMS 229
             +    +DVW+ G  + E+ T G+ P+      +V + IS   R+         P   S
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL-------YRPKLAS 227

Query: 230 KQAQDFLSKCLIRNPGERWSASELLE 255
               + +  C    P  R + +ELL 
Sbjct: 228 MTVYEVMYSCWHEKPEGRPTFAELLR 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 47/149 (31%), Positives = 73/149 (48%), Gaps = 16/149 (10%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEFLQREQRILSALA---CPQIVA--Y 60
           I RG+   V +G    +S+++AVK    A++ N   + + Q    ALA    P IV   Y
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
                S ++   +Y L +EY  GG +   +      +E     +   V L L YLH +GI
Sbjct: 72  -----SLQSANNVY-LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGI 125

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCAR 149
           +H D+K  N+L+S  NE   K+ DFG ++
Sbjct: 126 IHRDLKPDNMLIS--NEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 73/277 (26%), Positives = 125/277 (45%), Gaps = 35/277 (12%)

Query: 6   GQTIGRGSTATV------SIGMSNRSSEVFAVK----SAELSNSEFLQREQRILSALACP 55
           G+T+G G+   V       +  S+   +V AVK    +A  S  E L  E +I+S L   
Sbjct: 40  GKTLGAGAFGKVVEATAYGLSKSDAVMKV-AVKMLKPTAHSSEREALMSELKIMSHLGNH 98

Query: 56  Q-IVAYKG-CDISEENGKILYNLFLEYAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLG 111
           + IV   G C I    G IL  +  EY   G L + +R    + L    + S +  V  G
Sbjct: 99  ENIVNLLGACTIG---GPIL--VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153

Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + +L S   +H D+  +N+L++  + +  KI DFG AR    + +   K     P+  MA
Sbjct: 154 MAFLASKNCIHRDLAARNVLLT--HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMA 211

Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISA----LHRIGFSSDTPEIP 225
           PE        F +DVW+ G  + E+ + G  P+P +  P+ +    L + G+    PE  
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM--PVDSKFYKLIKEGYRMAQPE-- 267

Query: 226 GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ 262
            +   +  D +  C   +P +R +  ++++   + +Q
Sbjct: 268 -HAPAEIYDIMKTCWDADPLKRPTFKQIVQ--LIGKQ 301

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 66/278 (23%), Positives = 113/278 (40%), Gaps = 51/278 (18%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           D+   + IGRG+   V +     +  ++A+K   L  ++ L++EQ          +V   
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKI--LRKADMLEKEQVAHIRAERDILVEAD 59

Query: 62  GCDI-----SEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           G  +     S ++ + LY L +E+ PGG +   +     L E   + +    +L +  +H
Sbjct: 60  GAWVVKMFYSFQDKRNLY-LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH 118

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFG-CA--------------------------- 148
             G +H DIK  N+L+  D +   K++DFG C                            
Sbjct: 119 QLGFIHRDIKPDNLLL--DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176

Query: 149 ---RRA---RVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW 202
              R+A   + N         GTP  +APEV          D W+LG  + EM  G PP+
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 203 PDVADPISALHRIGFSSDT----PEIPGYMSKQAQDFL 236
                P     ++    +T    PE+P  +S++A+D +
Sbjct: 237 CS-ETPQETYRKVMNWKETLVFPPEVP--ISEKAKDLI 271

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 13/104 (12%)

Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE-----DDEGKPICGT 165
           G+ YLH  G++H DI  +N ++  D E   KI D   +R     +     D+E +P+   
Sbjct: 129 GMSYLHKRGVIHKDIAARNCVI--DEELQVKITDNALSRDLFPMDYHCLGDNENRPV--- 183

Query: 166 PICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADP 208
              MA E    +E    +DVW+ G  + E+ T G+ P+ ++ DP
Sbjct: 184 -KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI-DP 225

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 20/209 (9%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILSALACPQIV 58
           + IGRG+   V++     +  ++A+K   L+  E L+R        E+ +L    C  I 
Sbjct: 7   KVIGRGAFGEVAVVKMKHTERIYAMKI--LNKWEMLKRAETACFREERNVLVNGDCQWIT 64

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
                   +EN   LY +   Y  G  LT   +    L E   R +   ++L +  +H  
Sbjct: 65  TLHYA-FQDEN--YLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL 121

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
             VH DIK  N+L+  D     ++ADFG   +   +   +     GTP  ++PE+ +  E
Sbjct: 122 HYVHRDIKPDNVLL--DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAME 179

Query: 179 QGF-----PADVWALGCTVLEMATGRPPW 202
            G        D W+LG  + EM  G  P+
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 56.9 bits (137), Expect = 6e-09
 Identities = 59/248 (23%), Positives = 91/248 (36%), Gaps = 53/248 (21%)

Query: 78  LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE 137
           ++Y PGG +   +       E   R +   + L ++ +H  G +H DIK  NIL+  D  
Sbjct: 80  MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH 139

Query: 138 QGAKIADFG--------------------------------------CARRARVNEDDEG 159
              K+ DFG                                      C  R +  E    
Sbjct: 140 --IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRAT 197

Query: 160 K--------PICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISA 211
           K         + GTP  +APEV   +      D W++G  + EM  G+PP+       + 
Sbjct: 198 KQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQ 257

Query: 212 LHRIGFSSDTPEIPGY--MSKQAQDFLSK--CLIRNPGERWSASELLEHGFVKEQNFKLS 267
           L  I + + T  IP    +S +A D ++K  C       R  A ++  H F  E +F   
Sbjct: 258 LKVINWEN-TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSD 316

Query: 268 TLTEPETY 275
             T+P  Y
Sbjct: 317 IRTQPAPY 324

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 24/199 (12%)

Query: 76  LFLEYAPGGTLTDAIRS----------GTC------LEEGRIRSHTRAVLLGLQYLHSNG 119
           + +EYA  G L + +R+           TC      L    + S    V  G++YL S  
Sbjct: 95  VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK 154

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT-PI-CMAPEVARGE 177
            +H D+  +N+LV++DN    KIADFG AR    N D   K   G  P+  MAPE     
Sbjct: 155 CIHRDLAARNVLVTEDNVM--KIADFGLARDVH-NIDYYKKTTNGRLPVKWMAPEALFDR 211

Query: 178 EQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL 236
                +DVW+ G  + E+ T G  P+P +  P+  L ++       + P   + +    +
Sbjct: 212 VYTHQSDVWSFGVLLWEIFTLGGSPYPGI--PVEELFKLLKEGHRMDKPANCTHELYMIM 269

Query: 237 SKCLIRNPGERWSASELLE 255
            +C    P +R +  +L+E
Sbjct: 270 RECWHAVPSQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 55.8 bits (135), Expect = 9e-09
 Identities = 73/280 (26%), Positives = 117/280 (41%), Gaps = 57/280 (20%)

Query: 18  SIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALACPQIVAYKG--------CD 64
           +   +  +  + AVK     +++ +  +FL +E +ILS L+ P I    G        C 
Sbjct: 38  AENDNADAPVLVAVKVLRPDASDNAREDFL-KEVKILSRLSDPNIARLLGVCTVDPPLCM 96

Query: 65  ISE--ENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL--------GLQY 114
           I E  ENG +  N FL+     T   A  S         +S + + LL        G++Y
Sbjct: 97  IMEYMENGDL--NQFLQKHVAETSGLACNS---------KSLSFSTLLYMATQIASGMRY 145

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE--DDEGKPICGTPI-CMAP 171
           L S   VH D+  +N LV K      KIADFG +R    ++    +G+     PI  MA 
Sbjct: 146 LESLNFVHRDLATRNCLVGK--NYTIKIADFGMSRNLYSSDYYRVQGRAP--LPIRWMAW 201

Query: 172 EVARGEEQGFPADVWALGCTVLEMAT--GRPPWPDVADP--ISALHRIGFSSDTPEIPGY 227
           E     +    +DVWA G T+ E+ T     P+  + D   I       F  D  +I  Y
Sbjct: 202 ESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHF-FRDDGRQI--Y 258

Query: 228 MSKQAQ------DFLSKCLIRNPGERWSASELLEHGFVKE 261
           + +         + + +C  R+  +R +  E+  H F++ 
Sbjct: 259 LPRPPNCPKDIYELMLECWRRDEEDRPTFREI--HLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 56.2 bits (135), Expect = 9e-09
 Identities = 32/94 (34%), Positives = 47/94 (50%), Gaps = 2/94 (2%)

Query: 106 RAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT 165
           R+VL  +QYLH N I+H DIK +NI ++   +    + DFG A        ++     GT
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINANKYYGWAGT 246

Query: 166 PICMAPEVARGEEQGFPADVWALGCTVLEMATGR 199
               APE+   +  G   D+W+ G  + EMAT  
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 42/149 (28%), Positives = 73/149 (48%), Gaps = 10/149 (6%)

Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG-TPI-C 168
           G+++L S   +H D+  +N+LV++D+    KIADFG AR    + D   K   G  P+  
Sbjct: 144 GMEFLASKKCIHRDLAARNVLVTEDHVM--KIADFGLARDIH-HIDYYRKTTNGRLPVKW 200

Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADP-ISALHRIGFSSDTPEIPG 226
           MAPE          +DVW+ G  + E+ T G  P+P +    +  L + G+  + P+   
Sbjct: 201 MAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQ--- 257

Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLE 255
             +++    +  C    P +R +  +L+E
Sbjct: 258 NCTQELYHLMRDCWHEVPSQRPTFKQLVE 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 65/262 (24%), Positives = 108/262 (41%), Gaps = 31/262 (11%)

Query: 9   IGRGSTATVSIGM--SNRSSEVFAVK-----SAELSNSEFLQREQRILSALACPQIVAYK 61
           +G G+  TV  GM    +S +  AVK     + + +  + L RE  ++  L  P IV   
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
           G  I E      + L +E A  G L   ++    + E  I      V +G++YL     V
Sbjct: 63  G--ICEAES---WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFV 117

Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT-PI-CMAPEVARGEEQ 179
           H D+  +N+L+    +  AKI+DFG ++    +E+       G  P+   APE     + 
Sbjct: 118 HRDLAARNVLLV--TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175

Query: 180 GFPADVWALGCTVLE-MATGRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
              +DVW+ G  + E  + G+ P+      +V   I +  R+      P        +  
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCP-------PEMY 228

Query: 234 DFLSKCLIRNPGER--WSASEL 253
           D +  C      ER  ++  EL
Sbjct: 229 DLMKLCWTYGVDERPGFAVVEL 250

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 68/284 (23%), Positives = 114/284 (40%), Gaps = 63/284 (22%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           D+   + IGRG+   V +     +  V+A+K   L  ++ L++EQ          I A +
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKI--LRKADMLEKEQ-------VGHIRAER 52

Query: 62  GCDISEEN---GKILY------NLFL--EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL 110
              +  ++    K+ Y      NL+L  E+ PGG +   +     L E   + +    +L
Sbjct: 53  DILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVL 112

Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG-CA--------------------- 148
            +  +H  G +H DIK  N+L+  D++   K++DFG C                      
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLL--DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD 170

Query: 149 ---------RRARV---NEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMA 196
                    R+A     N         GTP  +APEV          D W+LG  + EM 
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Query: 197 TGRPPWPDVADPISALHRIGFSSDT----PEIPGYMSKQAQDFL 236
            G PP+     P     ++    +T    PE+P  +S++A+D +
Sbjct: 231 IGYPPFCS-ETPQETYKKVMNWKETLIFPPEVP--ISEKAKDLI 271

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 58/227 (25%), Positives = 88/227 (38%), Gaps = 38/227 (16%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILS------ALACPQIVAY 60
             IG G    V +G ++R      V   EL  S     +   L        L  P ++  
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRA-------VLLGLQ 113
            G  I      I Y L LE+ P G L + +RS          +           V  GL 
Sbjct: 61  LGQCIE----SIPYLLVLEFCPLGDLKNYLRS--NRGMVAQMAQKDVLQRMACEVASGLL 114

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED----DEGKPICGTPI-C 168
           +LH    +H D+  +N  ++ D     KI D+G A   +  ED     +   +   P+  
Sbjct: 115 WLHQADFIHSDLALRNCQLTAD--LSVKIGDYGLA-LEQYPEDYYITKDCHAV---PLRW 168

Query: 169 MAPEVARGEEQGF-PAD------VWALGCTVLEMAT-GRPPWPDVAD 207
           +APE+     Q   P D      +W+LG T+ E+ T    P+PD++D
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD 215

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 45/151 (29%), Positives = 70/151 (46%), Gaps = 5/151 (3%)

Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI 167
           V  G+++L S   +H D+  +NIL+S++N    KI DFG AR    + D   K     P+
Sbjct: 188 VAKGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLPL 245

Query: 168 -CMAPEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVADPISALHRIGFSSDTPEIP 225
             MAPE          +DVW+ G  + E+ + G  P+P V        R+   +     P
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAP 304

Query: 226 GYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
            Y + +    +  C    P +R + SEL+EH
Sbjct: 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 60/254 (23%), Positives = 92/254 (36%), Gaps = 57/254 (22%)

Query: 75  NLF--LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           NL+  ++Y PGG +   +       E   R +   +   ++ +H  G +H DIK  NIL+
Sbjct: 75  NLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI 134

Query: 133 SKDNEQGAKIADFGCARRARVNED------------------------------DEGKPI 162
            +D     K+ DFG     R   D                              D  KP+
Sbjct: 135 DRDGH--IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPL 192

Query: 163 ----------------CGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVA 206
                            GTP  +APEV          D W++G  + EM  G+PP+    
Sbjct: 193 ERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFL-AQ 251

Query: 207 DPISALHRIGFSSDTPEIP--GYMSKQAQDFLSKCLIRNPGERW---SASELLEHGFVKE 261
            P+    ++     +  IP    +S +A D + K L R P +R     A E+  H F K 
Sbjct: 252 TPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGADEIKAHPFFKT 310

Query: 262 QNFKLSTLTEPETY 275
            +F      +   Y
Sbjct: 311 IDFSSDLRQQSAPY 324

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 8/156 (5%)

Query: 103 SHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI 162
           S T  V  G++YL S   +H D+  +N+LV+++N    KIADFG AR    N D   K  
Sbjct: 141 SCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVM--KIADFGLARDVN-NIDYYKKTT 197

Query: 163 CGT-PI-CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSS 219
            G  P+  MAPE          +DVW+ G  + E+ T G  P+P +  P+  L ++    
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEG 255

Query: 220 DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
              + P   + +    +  C    P  R +  +L+E
Sbjct: 256 HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 51/229 (22%), Positives = 87/229 (37%), Gaps = 39/229 (17%)

Query: 38  NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLE 97
           +S        ++S L+   +V   G  + +EN      +  EY   G L   +      E
Sbjct: 44  DSLAFFETASLMSQLSHKHLVKLYGVCVRDEN-----IMVEEYVKFGPLDVFLHR----E 94

Query: 98  EGRIRSHTRAVLL-----GLQYLHSNGIVHCDIKGQNILVSKDNEQG-----AKIADFGC 147
           +  +  H +  +       L YL    +VH ++ G+NILV++           K++D G 
Sbjct: 95  KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154

Query: 148 ARRA-RVNEDDEGKPICGTPICMAPEVARGEEQGFP---ADVWALGCTVLEMATGRPPWP 203
                   E  E  P       +APE  R   Q      AD W+ G T+LE+ +      
Sbjct: 155 PITVLSREERVERIP------WIAPECIRN-GQASLTIAADKWSFGTTLLEICSNGE--- 204

Query: 204 DVADPISALHR---IGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWS 249
              +P+S L       F  D   +P     +  + +++C   +P +R S
Sbjct: 205 ---EPLSTLSSSEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPS 250

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 46/151 (30%), Positives = 72/151 (47%), Gaps = 8/151 (5%)

Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT-P 166
           V  G++YL S   +H D+  +N+LV++DN    KIADFG AR    + D   K   G  P
Sbjct: 149 VARGMEYLASKKCIHRDLAARNVLVTEDNVM--KIADFGLARDIH-HIDYYKKTTNGRLP 205

Query: 167 I-CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEI 224
           +  MAPE          +DVW+ G  + E+ T G  P+P V  P+  L ++       + 
Sbjct: 206 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDK 263

Query: 225 PGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
           P   + +    +  C    P +R +  +L+E
Sbjct: 264 PSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 31/222 (13%)

Query: 76  LFLEYAPGGTLTDAIRS-----------GTCLEEGRIR-----SHTRAVLLGLQYLHSNG 119
           + +EYA  G L + +R+            T + E ++      S    V  G++YL S  
Sbjct: 95  VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR 154

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG--TPI-CMAPEVARG 176
            +H D+  +N+LV++DN    KIADFG AR   V++ D  K       P+  MAPE    
Sbjct: 155 CIHRDLAARNVLVTEDNVM--KIADFGLAR--GVHDIDYYKKTSNGRLPVKWMAPEALFD 210

Query: 177 EEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
                 +DVW+ G  + E+ T G  P+P +  P+  L ++       + P   + +    
Sbjct: 211 RVYTHQSDVWSFGILMWEIFTLGGSPYPGI--PVEELFKLLREGHRMDKPSNCTHELYML 268

Query: 236 LSKCLIRNPGERWSASELLEH-----GFVKEQNFKLSTLTEP 272
           + +C    P +R +  +L+E        V E+   LS   E 
Sbjct: 269 MRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLDLSMPFEQ 310

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 53.3 bits (128), Expect = 4e-08
 Identities = 55/237 (23%), Positives = 102/237 (43%), Gaps = 33/237 (13%)

Query: 31  VKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL--EYAPGGTLTD 88
           +K   +S  EF++ E +++  L+  ++V   G    +        +++  EY   G L +
Sbjct: 36  IKEGSMSEDEFIE-EAKVMMKLSHEKLVQLYGVCTKQ------RPIYIVTEYMSNGCLLN 88

Query: 89  AIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFG 146
            +R  G   +  ++    + V  G+ YL S   +H D+  +N LV   ++QG  K++DFG
Sbjct: 89  YLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFG 145

Query: 147 CARRARVNEDDEGKPICGTPICM---APEVARGEEQGFPADVWALGCTVLEMAT-GRPPW 202
            +R      DDE     G+   +    PEV    +    +DVWA G  + E+ + G+ P+
Sbjct: 146 LSRYVL---DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPY 202

Query: 203 -----PDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELL 254
                 +  + +S   R+         P   S++    +  C      ER +  +LL
Sbjct: 203 ERFNNSETVEKVSQGLRL-------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 68/274 (24%), Positives = 122/274 (44%), Gaps = 50/274 (18%)

Query: 10  GRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVA-YKGCDISEE 68
           GR    TV++ M   ++      S+EL +   L  E  +L  +  P ++  Y  C    +
Sbjct: 26  GRAGYTTVAVKMLKENAS-----SSELRD---LLSEFNLLKQVNHPHVIKLYGAC---SQ 74

Query: 69  NGKILYNLFLEYA----------------PGGTLTDAIRSGTCLEEGRIRSHTRAVLL-- 110
           +G +L  L +EYA                P    +D  R+ + L+    R+ T   L+  
Sbjct: 75  DGPLL--LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISF 132

Query: 111 ------GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE--GKPI 162
                 G+QYL    +VH D+  +N+LV++  +   KI+DFG +R   V E+D    +  
Sbjct: 133 AWQISRGMQYLAEMKLVHRDLAARNVLVAEGRK--MKISDFGLSR--DVYEEDSYVKRSK 188

Query: 163 CGTPI-CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVA-DPISALHRIGFSS 219
              P+  MA E          +DVW+ G  + E+ T G  P+P +A + +  L + G+  
Sbjct: 189 GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRM 248

Query: 220 DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASEL 253
           + PE     S++  + +  C  + P +R + +++
Sbjct: 249 ERPE---NCSEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 53.3 bits (128), Expect = 8e-08
 Identities = 59/203 (29%), Positives = 87/203 (42%), Gaps = 31/203 (15%)

Query: 61  KGCDISEEN--GKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
           K     EE+  G  LY   L      TL D I            S++  V  G+++L S 
Sbjct: 151 KSLSDVEEDEEGDELYKEPL------TLEDLI------------SYSFQVARGMEFLASR 192

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMAPEVARGE 177
             +H D+  +NIL+S++N    KI DFG AR    + D   K     P+  MAPE    +
Sbjct: 193 KCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDK 250

Query: 178 EQGFPADVWALGCTVLEMAT-GRPPWPDV---ADPISALHRIGFSSDTPEIPGYMSKQAQ 233
                +DVW+ G  + E+ + G  P+P V    +    L   G     PE   Y + +  
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE-GTRMRAPE---YATPEIY 306

Query: 234 DFLSKCLIRNPGERWSASELLEH 256
             +  C   NP +R + SEL+E 
Sbjct: 307 SIMLDCWHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 59/224 (26%), Positives = 91/224 (40%), Gaps = 61/224 (27%)

Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGC----ARR 150
           + E  I +     L GL YLH NG +H +IK  +IL+S D     + ++         ++
Sbjct: 98  MSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157

Query: 151 ARVNEDDEGKPICGTPIC--MAPEVARGEEQGF--PADVWALGCTVLEMATGRPPWPDV- 205
           A+V  D    P   T +   ++PE+ R +  G+   +D++++G T  E+ATGR P+ D+ 
Sbjct: 158 AKVVYD---FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214

Query: 206 ----------ADPISALHRIGFSSD----------------------------------T 221
                       P S L    F  +                                  T
Sbjct: 215 RTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRT 274

Query: 222 PEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGF---VKEQ 262
           P      S   Q+ +  CL ++P +R SAS LL H F   VKEQ
Sbjct: 275 PS-SKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 50/191 (26%), Positives = 79/191 (41%), Gaps = 40/191 (20%)

Query: 31  VKSAELSNSEFLQREQRILSALACPQIVA-YKGCDISEENGKILYNLFLEYAPGGTLTDA 89
           +KS +L   +  Q+E + L  L    +++ +  C + E              P   +T+ 
Sbjct: 38  LKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE--------------PVYIITEL 83

Query: 90  IRSGTCLE-----EGRIRSHTRAVLL--------GLQYLHSNGIVHCDIKGQNILVSKDN 136
           +  G+ L      EG+      A L+        G+ YL     +H D+  +NILV    
Sbjct: 84  MEKGSLLAFLRSPEGQ--VLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV--GE 139

Query: 137 EQGAKIADFGCARRAR---VNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVL 193
           +   K+ADFG AR  +       D+  P   T    APE A        +DVW+ G  + 
Sbjct: 140 DLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----APEAASHGTFSTKSDVWSFGILLY 195

Query: 194 EMAT-GRPPWP 203
           EM T G+ P+P
Sbjct: 196 EMFTYGQVPYP 206

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.8 bits (126), Expect = 1e-07
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 18/208 (8%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR-------EQRILSALACPQIVA 59
           + IGRG+   V++     + +VFA+K   L+  E L+R       E+R +      Q + 
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDNQWIT 64

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
                  +EN   LY +   Y  G  LT   +    L E   R +   +++ +  +H   
Sbjct: 65  TLHYAFQDENN--LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
            VH DIK  NIL+  D     ++ADFG   +   +   +     GTP  ++PE+ +  E 
Sbjct: 123 YVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 180 GF-----PADVWALGCTVLEMATGRPPW 202
           G        D W+LG  + EM  G  P+
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 75/290 (25%), Positives = 113/290 (38%), Gaps = 61/290 (21%)

Query: 4   TRGQTIGRGSTATV----SIGMSNRSSEV-FAVKS-----AELSNSEFLQREQRILSALA 53
           T  + +G G+   V      G    + E+  AVK+     +E   S+FL  E  I+S   
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLM-EALIMSKFN 67

Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSH--------- 104
              IV   G        ++   + LE   GG L   +R      E R R           
Sbjct: 68  HQNIVRLIGVSFE----RLPRFILLELMAGGDLKSFLR------ENRPRPERPSSLTMKD 117

Query: 105 ----TRAVLLGLQYLHSNGIVHCDIKGQNILVS-KDNEQGAKIADFGCAR---RA---RV 153
                R V  G +YL  N  +H DI  +N L++ K   + AKIADFG AR   RA   R 
Sbjct: 118 LLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177

Query: 154 NEDDEGKPICGTPI-CMAPEVARGEEQGFPADVWALGCTVLE-MATGRPPWP-----DVA 206
                G+ +   PI  M PE           DVW+ G  + E  + G  P+P     +V 
Sbjct: 178 G----GRAM--LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231

Query: 207 DPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
           + ++   R+         PG + +     ++ C    P +R + + +LE 
Sbjct: 232 EFVTGGGRLDPP---KGCPGPVYR----IMTDCWQHTPEDRPNFATILER 274

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 50.0 bits (119), Expect = 6e-07
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 23/213 (10%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYK 61
           + IGRG+   V  G     +   AVKS   +      ++FLQ E RIL   + P IV   
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQ-EARILKQYSHPNIVRLI 59

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           G    ++   I+    +E   GG     +R+ G  L+   +         G++YL S   
Sbjct: 60  GVCTQKQPIYIV----MELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC 115

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG----TPI-CMAPEVAR 175
           +H D+  +N LV++ N    KI+DFG +R     E+D      G     P+   APE   
Sbjct: 116 IHRDLAARNCLVTEKN--VLKISDFGMSRE----EEDGVYASTGGMKQIPVKWTAPEALN 169

Query: 176 GEEQGFPADVWALGCTVLE-MATGRPPWPDVAD 207
                  +DVW+ G  + E  + G  P+ ++++
Sbjct: 170 YGRYSSESDVWSFGILLWEAFSLGAVPYANLSN 202

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 64/244 (26%), Positives = 96/244 (39%), Gaps = 26/244 (10%)

Query: 28  VFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLT 87
           V A+K   L+  +  QRE  +L+ L    IV + G      +G  L  +F EY   G L 
Sbjct: 40  VKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG---DGDPLIMVF-EYMKHGDLN 95

Query: 88  DAIRS----GTCLEEGRIRSHTRAVLL------------GLQYLHSNGIVHCDIKGQNIL 131
             +R+       L +G+ R     + L            G+ YL S   VH D+  +N L
Sbjct: 96  KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 155

Query: 132 VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMAPEVARGEEQGFPADVWALGC 190
           V        KI DFG +R     +          PI  M PE     +    +DVW+ G 
Sbjct: 156 VG--ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 213

Query: 191 TVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWS 249
            + E+ T G+ PW  ++     +  I       E P    K+  D +  C  R P +R +
Sbjct: 214 ILWEIFTYGKQPWFQLS-NTEVIECIT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLN 271

Query: 250 ASEL 253
             E+
Sbjct: 272 IKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 49.8 bits (119), Expect = 7e-07
 Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 39/222 (17%)

Query: 7   QTIGRGSTATVSIGM---SNRSSEVFAVKS----AELSNSEFLQREQRILSALACPQIVA 59
           + IG+G    V  G    S+      AVKS     +L   E   +E  I+   + P +++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL--------G 111
             G  +  E   ++    L Y   G L + IRS T        + T   L+        G
Sbjct: 61  LLGICLPSEGSPLV---VLPYMKHGDLRNFIRSET-------HNPTVKDLIGFGLQVAKG 110

Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA------RVNEDDEGKPICGT 165
           ++YL S   VH D+  +N ++  D     K+ADFG AR         V+     K     
Sbjct: 111 MEYLASKKFVHRDLAARNCML--DESFTVKVADFGLARDIYDKEYYSVHNHTGAK----L 164

Query: 166 PI-CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
           P+  MA E  + ++    +DVW+ G  + E+ T G PP+PDV
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 206

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 49.8 bits (119), Expect = 8e-07
 Identities = 56/216 (25%), Positives = 81/216 (37%), Gaps = 32/216 (14%)

Query: 10  GRGSTATVSIGMSNRSSEVFAVK----SAELSNSEFLQREQRILSALACPQIVAYKGCDI 65
           G+               E+ AVK    +A     +  +RE  +L+      IV + G   
Sbjct: 19  GKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT 78

Query: 66  SEENGKILYNLFLEYAPGGTLTDAIRS------------GTCLEEGRIRSHTRAVLL--G 111
             +       +F EY   G L   +RS                E    +    AV +  G
Sbjct: 79  EGDP---PIMVF-EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASG 134

Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT---PI- 167
           + YL S   VH D+  +N LV  D     KI DFG +R   V   D  + + G    PI 
Sbjct: 135 MVYLASQHFVHRDLATRNCLVGYD--LVVKIGDFGMSR--DVYTTDYYR-VGGHTMLPIR 189

Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPW 202
            M PE     +    +DVW+ G  + E+ T G+ PW
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 49.6 bits (118), Expect = 8e-07
 Identities = 42/157 (26%), Positives = 69/157 (43%), Gaps = 17/157 (10%)

Query: 76  LFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSK 134
           L  + +P G+L D +R     L+  R+ +    +  G+ YL  + +VH ++  +NIL+  
Sbjct: 85  LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKS 144

Query: 135 DNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMAPEVARGEEQGFPADVWALGCTVL 193
           D+    +IADFG A     ++         TPI  MA E          +DVW+ G TV 
Sbjct: 145 DSI--VQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVW 202

Query: 194 EMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK 230
           EM +        A+P + +          E+P  + K
Sbjct: 203 EMMSYG------AEPYAGMR-------PHEVPDLLEK 226

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 9/152 (5%)

Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI 167
           V  G+++L S   +H D+  +NIL+S++N    KI DFG AR    + D   K     P+
Sbjct: 183 VARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGSARLPL 240

Query: 168 -CMAPEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVADPISALHRI--GFSSDTPE 223
             MAPE    +     +DVW+ G  + E+ + G  P+P V        R+  G     PE
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPE 300

Query: 224 IPGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
                + +    +  C   +P ER + S L+E
Sbjct: 301 ---NATPEIYRIMLACWQGDPKERPTFSALVE 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 48.4 bits (116), Expect = 1e-06
 Identities = 36/121 (29%), Positives = 48/121 (39%), Gaps = 30/121 (24%)

Query: 44  REQRILSAL-----ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSG---TC 95
           RE RIL+         P +      D+  +NG I+    +EY  G  L DA+        
Sbjct: 48  REARILAKAREAGVPVPIVY-----DVDPDNGLIV----MEYIEGELLKDALEEARPDLL 98

Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
            E GR        L+G   LH  GIVH D+   NI++S          DFG    +   E
Sbjct: 99  REVGR--------LVGK--LHKAGIVHGDLTTSNIILSGGR---IYFIDFGLGEFSDEVE 145

Query: 156 D 156
           D
Sbjct: 146 D 146

Length = 204

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 51/177 (28%), Positives = 74/177 (41%), Gaps = 27/177 (15%)

Query: 37  SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCL 96
           +N E L  E  +++ +  P +    G  ++         L  +  P G L D +R     
Sbjct: 52  ANKEILD-EAYVMAGVGSPYVCRLLGICLTST-----VQLVTQLMPYGCLLDYVRE---- 101

Query: 97  EEGRIRSH-----TRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA 151
            + RI S         +  G+ YL    +VH D+  +N+LV   N    KI DFG AR  
Sbjct: 102 NKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLL 159

Query: 152 RVNED----DEGKPICGTPI-CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPW 202
            ++E     D GK     PI  MA E          +DVW+ G TV E+ T G  P+
Sbjct: 160 DIDETEYHADGGK----VPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 46/153 (30%), Positives = 67/153 (43%), Gaps = 24/153 (15%)

Query: 68  ENGKILYNLFLEYAPGGTLTDAIRSGTCLEE--GRIRSHTRAVLL--------------G 111
           E+   LY L +EYAP G L D +R    LE       +++ A  L              G
Sbjct: 66  EHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 124

Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL     +H D+  +NILV ++    AKIADFG +R   V      K +   P+  MA
Sbjct: 125 MDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSRGQEVYVK---KTMGRLPVRWMA 179

Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPW 202
            E          +DVW+ G  + E+ + G  P+
Sbjct: 180 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 41/227 (18%)

Query: 4   TRGQTIGRGSTATV---SIGMSNRSSEVFAVKS-----AELSNSEFLQREQRILSALACP 55
           T+ + IG G    V    + M  R     A+K+      E    +FL  E  I+   +  
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-EASIMGQFSHH 66

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHT-----RAVLL 110
            I+  +G     +   I+     EY   G L   +R      +G   S+      R +  
Sbjct: 67  NIIRLEGVVTKFKPAMII----TEYMENGALDKYLRD----HDGEFSSYQLVGMLRGIAA 118

Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE--------GK-P 161
           G++YL     VH D+  +NILV+ + E   K++DFG    +RV EDD         GK P
Sbjct: 119 GMKYLSDMNYVHRDLAARNILVNSNLE--CKVSDFGL---SRVLEDDPEGTYTTSGGKIP 173

Query: 162 ICGTPICMAPEVARGEEQGFPADVWALGCTVLE-MATGRPPWPDVAD 207
           I  T    APE     +    +DVW+ G  + E M+ G  P+ D+++
Sbjct: 174 IRWT----APEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 47.6 bits (114), Expect = 2e-06
 Identities = 34/120 (28%), Positives = 50/120 (41%), Gaps = 25/120 (20%)

Query: 44  REQRILSALA-----CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEE 98
           RE RI+S         P +       +  EN  I+    +EY  G  L D I S      
Sbjct: 48  REARIMSRARKAGVNVPAVY-----FVDPENFIIV----MEYIEGEPLKDLINSN----G 94

Query: 99  GRIRSHTRAV--LLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED 156
                 +R +  L+G   LHS GI+H D+   N+++S        + DFG A  ++  ED
Sbjct: 95  MEELELSREIGRLVGK--LHSAGIIHGDLTTSNMILSGGKIY---LIDFGLAEFSKDLED 149

Length = 211

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 46/153 (30%), Positives = 67/153 (43%), Gaps = 24/153 (15%)

Query: 68  ENGKILYNLFLEYAPGGTLTDAIRSGTCLEE--GRIRSHTRAVLL--------------G 111
           EN   LY + +EYAP G L D +R    LE      + H  A  L              G
Sbjct: 73  ENRGYLY-IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATG 131

Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           +QYL     +H D+  +N+LV ++    +KIADFG +R   V      K +   P+  MA
Sbjct: 132 MQYLSEKQFIHRDLAARNVLVGEN--LASKIADFGLSRGEEVYVK---KTMGRLPVRWMA 186

Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPW 202
            E          +DVW+ G  + E+ + G  P+
Sbjct: 187 IESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 15/180 (8%)

Query: 35  ELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT 94
           E S  + + RE  I+  L  P IV   G   +E        L +E A GG L   +    
Sbjct: 35  EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEA-----LMLVMEMASGGPLNKFLSGKK 89

Query: 95  -CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV 153
             +    +      V +G++YL     VH D+  +N+L+   N+  AKI+DFG ++   +
Sbjct: 90  DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV--NQHYAKISDFGLSK--AL 145

Query: 154 NEDD---EGKPICGTPI-CMAPEVARGEEQGFPADVWALGCTVLE-MATGRPPWPDVADP 208
             DD   + +     P+   APE     +    +DVW+ G T+ E  + G+ P+  +  P
Sbjct: 146 GADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP 205

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 49/188 (26%), Positives = 80/188 (42%), Gaps = 18/188 (9%)

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDA-IRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           K  DI   N +  Y+ +L  AP  T  D  I     L    +   +  V  G+++L S  
Sbjct: 200 KYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN 259

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMAPEVARGEE 178
            VH D+  +N+L+ +   +  KI DFG AR    + +   K     P+  MAPE      
Sbjct: 260 CVHRDLAARNVLICEG--KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL 317

Query: 179 QGFPADVWALGCTVLEMAT-GRPPWPDVA------DPISALHRIGFSSDTPEIPGYMSKQ 231
               +DVW+ G  + E+ T G  P+P++       + I   +R+         P + S +
Sbjct: 318 YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA-------KPAHASDE 370

Query: 232 AQDFLSKC 239
             + + KC
Sbjct: 371 IYEIMQKC 378

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 25/48 (52%), Positives = 31/48 (64%), Gaps = 2/48 (4%)

Query: 101 IRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA 148
           I+   R VL GL+ LH  GIVH DIK +N+LV+ D +   KI DFG A
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFGAA 356

Length = 507

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 34/105 (32%), Positives = 50/105 (47%), Gaps = 9/105 (8%)

Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L   ++ +  R +L  + Y+H  GI+H DIK +N+LV  +  +   + DFG A  AR   
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV--NGPEDICLGDFGAACFAR--- 311

Query: 156 DDEGKP----ICGTPICMAPEVARGEEQGFPADVWALGCTVLEMA 196
                P    I GT    APEV  G+      D+W+ G  + E A
Sbjct: 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 48.7 bits (116), Expect = 4e-06
 Identities = 36/103 (34%), Positives = 49/103 (47%), Gaps = 4/103 (3%)

Query: 158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF 217
           EG+ I GTP  +APE+  G+  G   D WALG  + E  TG PP+ D   P      I  
Sbjct: 536 EGERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFND-ETPQQVFQNI-L 593

Query: 218 SSDT--PEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGF 258
           + D   PE    +S  AQ+ +   L  +P +R    EL +H  
Sbjct: 594 NRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 19/162 (11%)

Query: 103 SHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQG--AKIADFGCARRARVNEDDEGK 160
           S +  V  G+ +L S   +H D+  +NIL++     G   KI DFG AR  R + +   K
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLT----HGRITKICDFGLARDIRNDSNYVVK 273

Query: 161 PICGTPI-CMAPEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVADPISA----LHR 214
                P+  MAPE        F +DVW+ G  + E+ + G  P+P +  P+ +    + +
Sbjct: 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM--PVDSKFYKMIK 331

Query: 215 IGFSSDTPEI-PGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
            G+   +PE  P  M     D +  C   +P +R +  ++++
Sbjct: 332 EGYRMLSPECAPSEM----YDIMKSCWDADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 47.8 bits (113), Expect = 4e-06
 Identities = 56/213 (26%), Positives = 88/213 (41%), Gaps = 29/213 (13%)

Query: 5   RGQTIGRGSTATVSIGMSNRSSEVFAVKSA---------ELSNSEFLQREQRILSALACP 55
           R + +G G+  TV  G+     E   +  A           +N EF+  E  I++++  P
Sbjct: 11  RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMD-EALIMASMDHP 69

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS-----GTCLEEGRIRSHTRAVLL 110
            +V   G  +S         L  +  P G L D +       G+ L    + +    +  
Sbjct: 70  HLVRLLGVCLSPT-----IQLVTQLMPHGCLLDYVHEHKDNIGSQL----LLNWCVQIAK 120

Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CM 169
           G+ YL    +VH D+  +N+LV   N    KI DFG AR    +E +        PI  M
Sbjct: 121 GMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEKEYNADGGKMPIKWM 178

Query: 170 APEVARGEEQGFPADVWALGCTVLEMAT--GRP 200
           A E     +    +DVW+ G T+ E+ T  G+P
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 47.0 bits (112), Expect = 5e-06
 Identities = 63/218 (28%), Positives = 89/218 (40%), Gaps = 32/218 (14%)

Query: 2   DWTRGQTIGRGSTATVSIG--MSNRSSEV-FAVKS----AELSNSEFLQREQRILSALAC 54
           D T G+ IG G    V  G  MS  + ++  AVK+       S  E   +E  I+     
Sbjct: 7   DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH 66

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIR-SHTRAVLLGLQ 113
           P IV   G  I+E    I+    +E AP G L       + L+  +        +L   Q
Sbjct: 67  PHIVKLIGV-ITENPVWIV----MELAPLGEL------RSYLQVNKYSLDLASLILYSYQ 115

Query: 114 ------YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT-P 166
                 YL S   VH DI  +N+LVS  +    K+ DFG +R   + ++   K   G  P
Sbjct: 116 LSTALAYLESKRFVHRDIAARNVLVS--SPDCVKLGDFGLSR--YLEDESYYKASKGKLP 171

Query: 167 I-CMAPEVARGEEQGFPADVWALGCTVLE-MATGRPPW 202
           I  MAPE          +DVW  G  + E +  G  P+
Sbjct: 172 IKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF 209

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 47.5 bits (113), Expect = 6e-06
 Identities = 31/100 (31%), Positives = 47/100 (47%), Gaps = 9/100 (9%)

Query: 106 RAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPIC-- 163
           R +L  L YLH  GI+H D+K +NI +  D  + A + DFG A +   + D    P C  
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTENIFL--DEPENAVLGDFGAACKLDAHPD---TPQCYG 246

Query: 164 --GTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPP 201
             GT    +PE+   +      D+W+ G  + EM+     
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 47.1 bits (112), Expect = 6e-06
 Identities = 37/151 (24%), Positives = 70/151 (46%), Gaps = 10/151 (6%)

Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT-- 165
           + LG+ +L +   VH D+  +N LVS   E   K++    ++      + E   +     
Sbjct: 126 IALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSLLSLSKDVY---NSEYYKLRNALI 180

Query: 166 PI-CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPE 223
           P+  +APE  + ++    +DVW+ G  + E+ T G  P+  ++D    L+R+        
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-EVLNRLQAGKLELP 239

Query: 224 IPGYMSKQAQDFLSKCLIRNPGERWSASELL 254
           +P     +    +++C   NP +R S SEL+
Sbjct: 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 47.1 bits (112), Expect = 6e-06
 Identities = 66/274 (24%), Positives = 116/274 (42%), Gaps = 32/274 (11%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVF---AVKSAELSNSEFLQREQRILSALAC------PQ 56
           G+ +G G   +V  G  ++        AVK+ +L    + + E+  LS  AC      P 
Sbjct: 4   GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEE-FLSEAACMKDFDHPN 62

Query: 57  IVAYKG-CDISEENGKILYNL-FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVL----- 109
           ++   G C  +    KI   +  L +   G L   +     L     +   + +L     
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSR-LGGLPEKLPLQTLLKFMVD 121

Query: 110 --LGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED--DEGKPICGT 165
             LG++YL +   +H D+  +N ++ +D      +ADFG +++   + D   +G+ I   
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLRED--MTVCVADFGLSKKI-YSGDYYRQGR-IAKM 177

Query: 166 PI-CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVAD-PISALHRIGFSSDTP 222
           P+  +A E          +DVWA G T+ E+AT G+ P+P V +  I    R G     P
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP 237

Query: 223 EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
           E       +  D +  C   +P +R + ++L E 
Sbjct: 238 E---DCLDELYDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 46.9 bits (111), Expect = 6e-06
 Identities = 71/263 (26%), Positives = 109/263 (41%), Gaps = 35/263 (13%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYK 61
           + +G+G+   V  G     + V AVK+ +         +FL  E RIL     P IV   
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPV-AVKTCKEDLPQELKIKFLS-EARILKQYDHPNIVKLI 58

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVL---LGLQYLHSN 118
           G     +   I+    +E  PGG     +R     +E + +   +  L    G+ YL S 
Sbjct: 59  GVCTQRQPIYIV----MELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESK 112

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG---TPI-CMAPEVA 174
             +H D+  +N LV ++N    KI+DFG +R+    EDD      G    PI   APE  
Sbjct: 113 NCIHRDLAARNCLVGENN--VLKISDFGMSRQ----EDDGIYSSSGLKQIPIKWTAPEAL 166

Query: 175 RGEEQGFPADVWALGCTVLE-MATGRPPWPDVADPISALHRI--GFSSDTPE-IPGYMSK 230
                   +DVW+ G  + E  + G  P+P + +   A  ++  G+    P+  P  + K
Sbjct: 167 NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-QAREQVEKGYRMSCPQKCPDDVYK 225

Query: 231 QAQDFLSKCLIRNPGERWSASEL 253
             Q    +C    P  R   SEL
Sbjct: 226 VMQ----RCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 13/153 (8%)

Query: 103 SHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQG--AKIADFGCARRARVNEDDEGK 160
           S T  V  G+++L S   VH D+  +N+L++    QG   KI DFG AR    + +   K
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLA----QGKIVKICDFGLARDIMHDSNYVSK 296

Query: 161 PICGTPI-CMAPEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVADPISALHRI--G 216
                P+  MAPE          +DVW+ G  + E+ + G  P+P +    +  ++I  G
Sbjct: 297 GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSG 356

Query: 217 FSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWS 249
           +    P+   + +++  D + KC    P +R S
Sbjct: 357 YRMAKPD---HATQEVYDIMVKCWNSEPEKRPS 386

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 35/121 (28%), Positives = 48/121 (39%), Gaps = 30/121 (24%)

Query: 44  REQRILSALA-----CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSG---TC 95
            E R+LS         P +      D+  +N  I+    +EY  G  L D I  G     
Sbjct: 46  NEARLLSRARKAGVNTPVVY-----DVDPDNKTIV----MEYIEGKPLKDVIEEGNDELL 96

Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
            E GR+        +G   LH  GIVH D+   NI+V  D      + DFG  + +   E
Sbjct: 97  REIGRL--------VGK--LHKAGIVHGDLTTSNIIVRDDK---LYLIDFGLGKYSDEIE 143

Query: 156 D 156
           D
Sbjct: 144 D 144

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 57/226 (25%), Positives = 92/226 (40%), Gaps = 38/226 (16%)

Query: 76  LFLEYAPGGTLTDAIRSGTCLE----------------EGRIRSHTRAVLLGLQYLHSNG 119
           L +EYAP G L D +R    LE                  ++      V  G+ YL    
Sbjct: 85  LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 144

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMAPEVARGEE 178
            +H D+  +NILV ++    AKIADFG +R   V      K +   P+  MA E      
Sbjct: 145 FIHRDLAARNILVGENYV--AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSV 199

Query: 179 QGFPADVWALGCTVLEMAT-GRPPW-----PDVADPISALHRIGFSSDTPEIPGYMSKQA 232
               +DVW+ G  + E+ + G  P+      ++ + +   +R+       E P     + 
Sbjct: 200 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL-------EKPLNCDDEV 252

Query: 233 QDFLSKCLIRNPGERWSASEL---LEHGFVKEQNFKLSTLTEPETY 275
            D + +C    P ER S +++   L     + + +  +TL E  TY
Sbjct: 253 YDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTY 298

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 36/104 (34%), Positives = 52/104 (50%), Gaps = 13/104 (12%)

Query: 106 RAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD----EGK- 160
           R +  G++YL     VH D+  +NILV+  +    K++DFG +RR   +E       GK 
Sbjct: 113 RGIASGMKYLSEMNYVHRDLAARNILVN--SNLVCKVSDFGLSRRLEDSEATYTTKGGKI 170

Query: 161 PICGTPICMAPEVARGEEQGFPADVWALGCTVLE-MATG-RPPW 202
           PI  T    APE     +    +DVW+ G  + E M+ G RP W
Sbjct: 171 PIRWT----APEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 63/244 (25%), Positives = 96/244 (39%), Gaps = 27/244 (11%)

Query: 28  VFAVKSAELSNSEFLQREQRILSALACPQIVAYKG-CDISEENGKILYNLFLEYAPGGTL 86
           V A+K A  S  +  QRE  +L+ L    IV + G C      G+ L  +F EY   G L
Sbjct: 40  VKALKEASESARQDFQREAELLTVLQHQHIVRFYGVC----TEGRPLLMVF-EYMRHGDL 94

Query: 87  TDAIRS----GTCLEEGRIRSHTRAVL-----------LGLQYLHSNGIVHCDIKGQNIL 131
              +RS       L  G   +  +  L            G+ YL S   VH D+  +N L
Sbjct: 95  NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCL 154

Query: 132 VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMAPEVARGEEQGFPADVWALGC 190
           V +      KI DFG +R     +          PI  M PE     +    +D+W+ G 
Sbjct: 155 VGQG--LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGV 212

Query: 191 TVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWS 249
            + E+ T G+ PW  +++   A+  I    +  E P     +    +  C  R P +R  
Sbjct: 213 VLWEIFTYGKQPWYQLSN-TEAIECITQGREL-ERPRTCPPEVYAIMQGCWQREPQQRMV 270

Query: 250 ASEL 253
             ++
Sbjct: 271 IKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.9 bits (104), Expect = 2e-05
 Identities = 33/144 (22%), Positives = 53/144 (36%), Gaps = 25/144 (17%)

Query: 20  GMSNR------SSEVFAVK-SAELSNSEFLQREQRILSALA-----CPQIVAYKGCDISE 67
           G++NR        E + +K +         +RE  IL  LA      P+++A        
Sbjct: 9   GLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG------ 62

Query: 68  ENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKG 127
                   L +E+  G TL +     +  E+  I      +L  L  L    + H D+  
Sbjct: 63  -ESDGWSYLLMEWIEGETLDEV----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHP 117

Query: 128 QNILVSKDNEQGAKIADFGCARRA 151
            NILV  D+ +   I D+  A   
Sbjct: 118 GNILV--DDGKILGIIDWEYAGYG 139

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 66/273 (24%), Positives = 109/273 (39%), Gaps = 52/273 (19%)

Query: 9   IGRGS-------TATVSIGMSNRSSEVFAVKS-----AELSNSEFLQREQRILSALACPQ 56
           +G G+       TAT  +G  +    V AVK+      +    EFL+ E  ++S    P 
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRV-AVKTLRKGATDQEKKEFLK-EAHLMSNFNHPN 60

Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL------ 110
           IV   G  +   N      + +E   GG L   +R      + R+      +L       
Sbjct: 61  IVKLLG--VCLLNEPQ--YIIMELMEGGDLLSYLR------DARVERFGPPLLTLKELLD 110

Query: 111 -------GLQYLHSNGIVHCDIKGQNILVSK---DNEQGAKIADFGCARRARVNE----D 156
                  G  YL     +H D+  +N LVS+   D ++  KI DFG AR    ++    +
Sbjct: 111 ICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKE 170

Query: 157 DEGKPICGTPI-CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHR 214
            EG      P+  MAPE     +    +DVW+ G  + E+ T G+ P+P + +    L  
Sbjct: 171 GEGL----LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-QEVLQH 225

Query: 215 IGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGER 247
           +  +    + P     +    ++ C  ++P ER
Sbjct: 226 VT-AGGRLQKPENCPDKIYQLMTNCWAQDPSER 257

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 45/150 (30%), Positives = 64/150 (42%), Gaps = 14/150 (9%)

Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CM 169
           G+ YL    +VH D+  +N+LV     Q  KI DFG A+    +E +        PI  M
Sbjct: 121 GMNYLEERRLVHRDLAARNVLVK--TPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178

Query: 170 APEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTP---EI 224
           A E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P    I
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI 238

Query: 225 PGYMSKQAQDFLSKCLIRNPGERWSASELL 254
             YM       + KC + +   R    EL+
Sbjct: 239 DVYM------IMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 45.1 bits (106), Expect = 3e-05
 Identities = 50/190 (26%), Positives = 78/190 (41%), Gaps = 21/190 (11%)

Query: 28  VFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLT 87
           V  +K A  +  +   RE  +L+ L    IV + G  +    G  L  +F EY   G L 
Sbjct: 40  VKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE---GDPLIMVF-EYMKHGDLN 95

Query: 88  DAIRSG-------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSK 134
             +R+                L + ++    + +  G+ YL S   VH D+  +N LV +
Sbjct: 96  KFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 155

Query: 135 DNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMAPEVARGEEQGFPADVWALGCTVL 193
           +     KI DFG +R     +          PI  M PE     +    +DVW+LG  + 
Sbjct: 156 N--LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLW 213

Query: 194 EMAT-GRPPW 202
           E+ T G+ PW
Sbjct: 214 EIFTYGKQPW 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 51/177 (28%), Positives = 78/177 (44%), Gaps = 31/177 (17%)

Query: 39  SEFLQREQRILSALACPQIVAYKG--------CDISE--ENGKILYNLFL-EYAPGGTLT 87
           ++FL +E +I+S L  P I+            C I+E  ENG +  N FL  + P     
Sbjct: 64  NDFL-KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL--NQFLSRHEPQEAAE 120

Query: 88  DAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGC 147
            A      +    +      +  G++YL S   VH D+  +N LV K+     KIADFG 
Sbjct: 121 KA--DVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT--IKIADFGM 176

Query: 148 ARRA------RVNEDDEGKPICGTPI-CMAPEVARGEEQGFPADVWALGCTVLEMAT 197
           +R        R+    +G+ +   PI  M+ E     +    +DVWA G T+ E+ T
Sbjct: 177 SRNLYSGDYYRI----QGRAV--LPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 45/132 (34%), Positives = 62/132 (46%), Gaps = 24/132 (18%)

Query: 106 RAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE------- 158
           R +  G++YL   G VH D+  +NILV+ +     K++DFG    +RV EDD        
Sbjct: 113 RGIASGMKYLSDMGYVHRDLAARNILVNSN--LVCKVSDFGL---SRVLEDDPEAAYTTR 167

Query: 159 -GK-PICGTPICMAPEVARGEEQGFPADVWALGCTVLE-MATG-RPPWP----DVADPIS 210
            GK PI  T    APE     +    +DVW+ G  + E M+ G RP W     DV   I 
Sbjct: 168 GGKIPIRWT----APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE 223

Query: 211 ALHRIGFSSDTP 222
             +R+    D P
Sbjct: 224 EGYRLPAPMDCP 235

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.4 bits (105), Expect = 7e-05
 Identities = 24/53 (45%), Positives = 30/53 (56%), Gaps = 1/53 (1%)

Query: 101 IRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV 153
           I++  R +L  L  LHS GIVH D+K QNI+ S +     KI D G A   RV
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFS-EGSGSFKIIDLGAAADLRV 308

Length = 566

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 43.4 bits (102), Expect = 9e-05
 Identities = 59/182 (32%), Positives = 81/182 (44%), Gaps = 36/182 (19%)

Query: 37  SNSEFLQREQRILSALACPQIVAYKG--------CDISE--ENGKILYNLFLEYAPGGTL 86
           + ++FL +E +I+S L  P I+   G        C I+E  ENG +  N FL        
Sbjct: 60  ARNDFL-KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL--NQFLS------- 109

Query: 87  TDAIRSGTCLEEGRIRSHTRAVLL--------GLQYLHSNGIVHCDIKGQNILVSKDNEQ 138
              I S T      I S + A LL        G++YL S   VH D+  +N LV   N  
Sbjct: 110 QREIES-TFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV--GNHY 166

Query: 139 GAKIADFGCARRARVNE--DDEGKPICGTPI-CMAPEVARGEEQGFPADVWALGCTVLEM 195
             KIADFG +R     +    +G+ +   PI  MA E     +    +DVWA G T+ EM
Sbjct: 167 TIKIADFGMSRNLYSGDYYRIQGRAV--LPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224

Query: 196 AT 197
            T
Sbjct: 225 FT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 43.7 bits (103), Expect = 9e-05
 Identities = 31/104 (29%), Positives = 52/104 (50%), Gaps = 10/104 (9%)

Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT-- 165
           V  G+ +L S   +H D+  +N+L++  + + AKI DFG AR      +D    + G   
Sbjct: 221 VAQGMDFLASKNCIHRDVAARNVLLT--DGRVAKICDFGLARDI---MNDSNYVVKGNAR 275

Query: 166 -PI-CMAPEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVA 206
            P+  MAPE          +DVW+ G  + E+ + G+ P+P + 
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 41/130 (31%), Positives = 59/130 (45%), Gaps = 18/130 (13%)

Query: 106 RAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI--- 162
           R +  G++YL     VH D+  +NILV+ +     K++DFG +R     EDD   P    
Sbjct: 113 RGIAAGMKYLSEMNYVHRDLAARNILVNSN--LVCKVSDFGLSRFL---EDDTSDPTYTS 167

Query: 163 ---CGTPI-CMAPEVARGEEQGFPADVWALGCTVLE-MATG-RPPW----PDVADPISAL 212
                 PI   APE     +    +DVW+ G  + E M+ G RP W     DV + I   
Sbjct: 168 SLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD 227

Query: 213 HRIGFSSDTP 222
           +R+    D P
Sbjct: 228 YRLPPPMDCP 237

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 64/281 (22%), Positives = 109/281 (38%), Gaps = 45/281 (16%)

Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVF--AVKSAEL-----SNSEFLQREQRILSALACPQ 56
             G+T+G G   +V  G  N+   +   AVK+ ++     S  E    E   +     P 
Sbjct: 2   ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61

Query: 57  IVAYKGCDI--SEENGKILYNLFLEYAPGGTLTDAI---RSGTC---LEEGRIRSHTRAV 108
           ++   G  +   E  G     + L +   G L   +   R G C   L    +      +
Sbjct: 62  VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121

Query: 109 LLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI- 167
             G++YL S   +H D+  +N +++++      +ADFG +++    +      I   P+ 
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLNEN--MNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179

Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPG 226
            +A E          +DVW+ G T+ E+AT G+ P+P V              +  EI  
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV--------------ENSEIYD 225

Query: 227 YMS-----KQAQD-------FLSKCLIRNPGERWSASELLE 255
           Y+      KQ  D        +S C + NP +R S   L  
Sbjct: 226 YLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC 266

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 34/129 (26%), Positives = 56/129 (43%), Gaps = 16/129 (12%)

Query: 95  CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN 154
           C  +  I++  + +L  L+Y+H +GI H DIK +NI+V  +N     I D+G A    ++
Sbjct: 122 CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR--GYIIDYGIASHFIIH 179

Query: 155 EDDEGKPIC----------GTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPD 204
               GK I           GT      +   G       D+ +LG  +L+ A  + PW  
Sbjct: 180 ----GKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG 235

Query: 205 VADPISALH 213
                + +H
Sbjct: 236 FGHNGNLIH 244

Length = 294

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 50/179 (27%), Positives = 75/179 (41%), Gaps = 27/179 (15%)

Query: 37  SNSEFLQREQRILSALACPQIVAYKG--------CDISE--ENGKILYNLFLEY------ 80
           + ++FL +E +ILS L  P I+   G        C I+E  ENG +  N FL        
Sbjct: 62  ARNDFL-KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL--NQFLSSHHLDDK 118

Query: 81  -APGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQG 139
              G            +    +      +  G++YL S   VH D+  +N LV +     
Sbjct: 119 EENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGE--NLT 176

Query: 140 AKIADFGCARRARVNE--DDEGKPICGTPI-CMAPEVARGEEQGFPADVWALGCTVLEM 195
            KIADFG +R     +    +G+ +   PI  MA E     +    +DVWA G T+ E+
Sbjct: 177 IKIADFGMSRNLYAGDYYRIQGRAV--LPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 64/266 (24%), Positives = 105/266 (39%), Gaps = 47/266 (17%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACP----QIVAYKG 62
           + IG G    V +G  N       V   EL  S  +Q + + L   A P    Q      
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEE-AQPYRSLQHSNLLQ 59

Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSG------TCLEEGRIRSHTRAVLLGLQYLH 116
           C + +      Y L +E+ P G L   +RS       T  +   ++     + LGL +LH
Sbjct: 60  C-LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP-DPTTLQRMACEIALGLLHLH 117

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR-----VNEDDEGKPICGTPICMAP 171
            N  +H D+  +N L++ D     KI D+G +         V  D    P+      +AP
Sbjct: 118 KNNFIHSDLALRNCLLTAD--LTVKIGDYGLSHNKYKEDYYVTPDQLWVPL----RWIAP 171

Query: 172 EV---ARGE----EQGFPADVWALGCTVLEM-ATGRPPWPDVADPISALHRIGFSSDTPE 223
           E+     G     +Q   ++VW+LG T+ E+   G  P+  ++D               +
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD--------------EQ 217

Query: 224 IPGYMSKQAQDFLSKCLIRNP-GERW 248
           +  Y  ++ Q  L K  ++ P  +RW
Sbjct: 218 VLTYTVREQQLKLPKPRLKLPLSDRW 243

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 41.1 bits (96), Expect = 5e-04
 Identities = 43/172 (25%), Positives = 75/172 (43%), Gaps = 24/172 (13%)

Query: 42  LQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTD--AIRSG------ 93
            Q+E  +++ L  P IV   G    E+   +L+    EY   G L +   +RS       
Sbjct: 54  FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF----EYLNQGDLHEFLIMRSPHSDVGC 109

Query: 94  TCLEEGRIRSHTR---------AVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIAD 144
           +  E+G ++S             +  G++YL S+  VH D+  +NIL+ +  +   KI+D
Sbjct: 110 SSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE--QLHVKISD 167

Query: 145 FGCARRARVNEDDEGKPICGTPI-CMAPEVARGEEQGFPADVWALGCTVLEM 195
            G +R     +    +P    PI  M PE     +    +D+W+ G  + E+
Sbjct: 168 LGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 41.1 bits (96), Expect = 6e-04
 Identities = 33/147 (22%), Positives = 66/147 (44%), Gaps = 10/147 (6%)

Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI--- 167
           G++YL S   +H D+  +N +++++      +ADFG ++  ++   D  +  C + +   
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNEN--MTVCVADFGLSK--KIYSGDYYRQGCASKLPVK 180

Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPG 226
            +A E          +DVWA G T+ E+ T G+ P+  V +  S ++      +  + P 
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKGNRLKQPP 238

Query: 227 YMSKQAQDFLSKCLIRNPGERWSASEL 253
              +   + + +C    P  R S   L
Sbjct: 239 DCLEDVYELMCQCWSPEPKCRPSFQHL 265

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 40.8 bits (95), Expect = 6e-04
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 11/92 (11%)

Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE----GKPICGTP 166
           G+ YL++N  VH D+  +N +V++D     KI DFG  R   + E D     GK +   P
Sbjct: 131 GMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDFGMTR--DIYETDYYRKGGKGL--LP 184

Query: 167 I-CMAPEVARGEEQGFPADVWALGCTVLEMAT 197
           +  M+PE  +       +DVW+ G  + E+AT
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 40.6 bits (95), Expect = 8e-04
 Identities = 33/109 (30%), Positives = 48/109 (44%), Gaps = 18/109 (16%)

Query: 94  TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA-- 151
           +C E+  I    + V  G+ YL     VH D+  +N LV ++     KIADFG +R    
Sbjct: 128 SCTEQLCI---AKQVAAGMAYLSERKFVHRDLATRNCLVGEN--MVVKIADFGLSRNIYS 182

Query: 152 ----RVNEDDEGKPICGTPI-CMAPEVARGEEQGFPADVWALGCTVLEM 195
               + +E+D        PI  M PE          +DVWA G  + E+
Sbjct: 183 ADYYKASEND------AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 54/247 (21%), Positives = 98/247 (39%), Gaps = 34/247 (13%)

Query: 30  AVKSAELSNS-----EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGG 84
           AVK+   S S     EFL  E  ++    C  +V   G  +S+    ++    + +    
Sbjct: 40  AVKTVNESASLRERIEFLN-EASVMKGFTCHHVVRLLGV-VSKGQPTLVVMELMAHGDLK 97

Query: 85  TLTDAIRSGTCLEEGRIRSHTRAVLL-------GLQYLHSNGIVHCDIKGQNILVSKDNE 137
           +   ++R       GR     + ++        G+ YL++   VH D+  +N +V+ D  
Sbjct: 98  SYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT 157

Query: 138 QGAKIADFGCARRARVNEDDE----GK---PICGTPICMAPEVARGEEQGFPADVWALGC 190
              KI DFG  R   + E D     GK   P+      MAPE  +       +D+W+ G 
Sbjct: 158 --VKIGDFGMTR--DIYETDYYRKGGKGLLPVRW----MAPESLKDGVFTTSSDMWSFGV 209

Query: 191 TVLEMAT-GRPPWPDVA-DPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERW 248
            + E+ +    P+  ++ + +      G   D P+      ++  D +  C   NP  R 
Sbjct: 210 VLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD---NCPERVTDLMRMCWQFNPKMRP 266

Query: 249 SASELLE 255
           +  E++ 
Sbjct: 267 TFLEIVN 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 33/135 (24%), Positives = 54/135 (40%), Gaps = 24/135 (17%)

Query: 32  KSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTL----- 86
           ++AE    +  ++E  ++S L  P IV   G    E+   +L+    EY   G L     
Sbjct: 45  ENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF----EYLAHGDLHEFLV 100

Query: 87  -----------TDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKD 135
                      +      + L+          +  G++YL S+  VH D+  +N LV   
Sbjct: 101 RNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV--- 157

Query: 136 NEQ-GAKIADFGCAR 149
            E    KI+DFG +R
Sbjct: 158 GEGLTVKISDFGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	385
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
PRK10345	210	hypothetical protein; Provisional	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.87
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.86
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.86
smart00090	237	RIO RIO-like kinase.	99.85
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.78
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.74
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.61
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.55
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.52
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.52
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.49
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.48
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.47
KOG1243	690	consensus Protein kinase [General function predict	99.44
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.35
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.28
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.25
KOG3087	229	consensus Serine/threonine protein kinase [General	99.19
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.16
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.12
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.08
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.99
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.99
COG4248	637	Uncharacterized protein with protein kinase and he	98.97
PRK09902	216	hypothetical protein; Provisional	98.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.9
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.76
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.67
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.54
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.52
PF01636	239	APH: Phosphotransferase enzyme family This family	98.49
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.4
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.36
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.34
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.33
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.29
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.29
PLN02876	822	acyl-CoA dehydrogenase	98.16
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.05
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.96
PRK10593	297	hypothetical protein; Provisional	97.92
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.84
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.72
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.68
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.68
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.64
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.49
KOG2270	520	consensus Serine/threonine protein kinase involved	97.48
PRK05231	319	homoserine kinase; Provisional	97.47
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.45
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.35
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.32
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.05
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.94
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.61
PRK12396	409	5-methylribose kinase; Reviewed	96.5
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.45
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.35
PLN02236	344	choline kinase	96.34
PLN02756	418	S-methyl-5-thioribose kinase	96.27
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.04
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.97
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.91
PRK06148	1013	hypothetical protein; Provisional	95.71
COG2334	331	Putative homoserine kinase type II (protein kinase	95.58
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.5
PRK11768	325	serine/threonine protein kinase; Provisional	95.47
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.37
PTZ00384	383	choline kinase; Provisional	95.18
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.2
PTZ00296	442	choline kinase; Provisional	93.59

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-61  Score=448.96  Aligned_cols=252  Identities=34%  Similarity=0.534  Sum_probs=226.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +.+.++.||+|..|+||+++|+.|++.||+|.+...    -..++.+|++|+++.+|||||+|||.|+....   -.+|+
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~---~isI~  156 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE---EISIC  156 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc---eEEee
Confidence            346788999999999999999999999999999433    24577899999999999999999999988764   25699


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~-~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      ||||.||||+++++..++++|..+..++.+|++||.|||+ ++||||||||+||||+..++  |||||||.++.....  
T Consensus       157 mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe--VKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  157 MEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE--VKICDFGVSGILVNS--  232 (364)
T ss_pred             hhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC--EEeccccccHHhhhh--
Confidence            9999999999999988999999999999999999999995 99999999999999999887  999999999876433  


Q ss_pred             CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCC----CChHHHHHHhcCCCCCCCCCCc-CCHH
Q 040569          157 DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDV----ADPISALHRIGFSSDTPEIPGY-MSKQ  231 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~----~~~~~~~~~~~~~~~~~~~~~~-~s~~  231 (385)
                       ...+++||..|||||.+++..|+.++||||||++++||++|+.||...    .+...++..| .....|.+|.. +|++
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I-v~~ppP~lP~~~fS~e  310 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI-VDEPPPRLPEGEFSPE  310 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH-hcCCCCCCCcccCCHH
Confidence             456789999999999999999999999999999999999999999763    3556666666 45677888886 9999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          232 AQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +++||.+||++||.+|||+.|+|+|||++..
T Consensus       311 f~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~  341 (364)
T KOG0581|consen  311 FRSFVSCCLRKDPSERPSAKQLLQHPFIKKF  341 (364)
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence            9999999999999999999999999999854

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-59  Score=442.09  Aligned_cols=259  Identities=47%  Similarity=0.806  Sum_probs=228.6

Q ss_pred             CCceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            1 MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         1 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      ++|..++.||+|+||+||++.+..+|..+|||.+...+   .+.+++|+.+|++++|||||+++|.....+.  ..|+++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~--~~~~i~   94 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN--DEYNIF   94 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC--eeeEee
Confidence            47999999999999999999999999999999998766   5668999999999999999999997544443  458899


Q ss_pred             EeecCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeec-CCCCCeEEeecCceeeecc--
Q 040569           78 LEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSK-DNEQGAKIADFGCARRARV--  153 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~-~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~-~~~~~~kL~DFG~a~~~~~--  153 (385)
                      |||++||+|.+++++.+ .|+|..++.+++||++||+|||++||+||||||+|||++. ++.  +||+|||+++....  
T Consensus        95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~--~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD--VKLADFGLAKKLESKG  172 (313)
T ss_pred             eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe--EEeccCcccccccccc
Confidence            99999999999999644 7999999999999999999999999999999999999997 455  99999999987653  


Q ss_pred             cCCCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHH
Q 040569          154 NEDDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA  232 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  232 (385)
                      ..........|||.|||||++.++ ..++++|||||||+++||+||++||.........+..++.....|.+|..+|+++
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a  252 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA  252 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence            222334567899999999999953 4456999999999999999999999875566677778877888899999999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          233 QDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      ++||++||.+||.+|||+.++|+|||+....
T Consensus       253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             HHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            9999999999999999999999999987653

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-59  Score=442.80  Aligned_cols=254  Identities=31%  Similarity=0.470  Sum_probs=220.5

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----------SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      |.+.+.||+|+||.|-+|..+.||+.||||++.+..          ...+++|++||++|+|||||+++++|...+.   
T Consensus       174 yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds---  250 (475)
T KOG0615|consen  174 YIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS---  250 (475)
T ss_pred             eEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc---
Confidence            778999999999999999999999999999886432          2346799999999999999999999876654   


Q ss_pred             EEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCC-CeEEeecCceeee
Q 040569           73 LYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQ-GAKIADFGCARRA  151 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~-~~kL~DFG~a~~~  151 (385)
                       +|+||||+.||+|.+.+...+.+.|...+.+++|++.|+.|||++||+||||||+|||++.+.+. .+||+|||+|+..
T Consensus       251 -~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  251 -SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             -eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence             67999999999999999988899999999999999999999999999999999999999876433 3699999999987


Q ss_pred             cccCCCCCCccccCCcccChhhhcCCCC---CCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC--CCCCCCCC
Q 040569          152 RVNEDDEGKPICGTPICMAPEVARGEEQ---GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS--SDTPEIPG  226 (385)
Q Consensus       152 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~---~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~  226 (385)
                      .  ....+.+.||||.|.|||++.+..+   ..++|||||||++|.+++|.+||.+.........+|...  ...|....
T Consensus       330 g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~  407 (475)
T KOG0615|consen  330 G--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD  407 (475)
T ss_pred             c--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh
Confidence            4  4556788999999999999976643   348899999999999999999998766655555555333  22334456


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          227 YMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       227 ~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      .+|+++++||.+||..||++|||+.|+|+||||+..
T Consensus       408 ~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  408 RISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence            699999999999999999999999999999999854

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-58  Score=451.05  Aligned_cols=250  Identities=32%  Similarity=0.539  Sum_probs=226.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      .|.+++.||+|||+.||.+++..+|++||+|++.+.      ..+.+.+|++|.++|+|||||+|+++|.+..+    .|
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~n----VY   94 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNN----VY   94 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCc----eE
Confidence            499999999999999999999999999999998752      35788899999999999999999999988776    77


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      ||+|+|..++|..++++.+.++|.+++.+++||+.||.|||+++|+|||||..|+|++++.+  |||+|||+|...... 
T Consensus        95 ivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~--VKIgDFGLAt~le~~-  171 (592)
T KOG0575|consen   95 IVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN--VKIGDFGLATQLEYD-  171 (592)
T ss_pred             EEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc--EEecccceeeeecCc-
Confidence            99999999999999998889999999999999999999999999999999999999998766  999999999988533 


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                      .....+.||||.|.|||++.....++.+||||+||++|.|+.|++||... +......+|..  ....+|..+|.++++|
T Consensus       172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-~vkety~~Ik~--~~Y~~P~~ls~~A~dL  248 (592)
T KOG0575|consen  172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-TVKETYNKIKL--NEYSMPSHLSAEAKDL  248 (592)
T ss_pred             ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-hHHHHHHHHHh--cCcccccccCHHHHHH
Confidence            34567889999999999999999999999999999999999999999863 45555555533  3455677899999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      |.++|++||.+|||++++|.|+||..
T Consensus       249 I~~lL~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  249 IRKLLRPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             HHHHhcCCcccCCCHHHHhcCHhhhC
Confidence            99999999999999999999999943

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-57  Score=419.47  Aligned_cols=255  Identities=33%  Similarity=0.522  Sum_probs=225.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+|+.++.+.|++.||+|++++.      ..+....|..||.+++||.||+++..|++.+.    .|
T Consensus        26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k----Ly  101 (357)
T KOG0598|consen   26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK----LY  101 (357)
T ss_pred             heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe----EE
Confidence            689999999999999999999999999999988653      34677889999999999999999888776655    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      ||+||+.||.|...|++.+.++|..++.|+..|+.||.|||++|||||||||+|||++.+|.  ++|+|||+++..- ..
T Consensus       102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH--i~LtDFgL~k~~~-~~  178 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH--IKLTDFGLCKEDL-KD  178 (357)
T ss_pred             EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc--EEEeccccchhcc-cC
Confidence            99999999999999999999999999999999999999999999999999999999998877  9999999999653 22


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                      .....++|||+.|||||++.+..|+.++|.||||+++|||++|.+||... +.......+.. ...+..|..+|.++++|
T Consensus       179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-~~~~~~~~I~~-~k~~~~p~~ls~~ardl  256 (357)
T KOG0598|consen  179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-DVKKMYDKILK-GKLPLPPGYLSEEARDL  256 (357)
T ss_pred             CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-cHHHHHHHHhc-CcCCCCCccCCHHHHHH
Confidence            33456689999999999999999999999999999999999999999874 44444444432 33466677799999999


Q ss_pred             HHHhhhcCCCCCC----CHHHHHhCccccccccc
Q 040569          236 LSKCLIRNPGERW----SASELLEHGFVKEQNFK  265 (385)
Q Consensus       236 l~~cL~~dP~~Rp----s~~elL~hp~~~~~~~~  265 (385)
                      |+++|++||++|.    ++.++-+||||...+++
T Consensus       257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~  290 (357)
T KOG0598|consen  257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE  290 (357)
T ss_pred             HHHHhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence            9999999999996    68899999999998765

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-56  Score=418.78  Aligned_cols=254  Identities=34%  Similarity=0.544  Sum_probs=224.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|...+.||+|+||+||+|+++.++..+|||.+.+..     .+.+..|+.||+.++|||||.++++....+.    +||
T Consensus        11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~----i~l   86 (429)
T KOG0595|consen   11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF----IYL   86 (429)
T ss_pred             cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe----EEE
Confidence            6889999999999999999999999999999997652     4667899999999999999999998766553    779


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecC-CC---CCeEEeecCceeeec
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKD-NE---QGAKIADFGCARRAR  152 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~-~~---~~~kL~DFG~a~~~~  152 (385)
                      |||||.||+|.++|++.++++|..++.++.||+.||++||+++||||||||+||||+.. +.   ..+||+|||+|+...
T Consensus        87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            99999999999999988899999999999999999999999999999999999999875 33   246999999999885


Q ss_pred             ccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC-CCCCCCCCcCCHH
Q 040569          153 VNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS-SDTPEIPGYMSKQ  231 (385)
Q Consensus       153 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~  231 (385)
                        ......+.||+|.|||||+++...|+.|+|+||+|+++|+|++|++||... ....++..+... ...+.++..+++.
T Consensus       167 --~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~-t~~eL~~~~~k~~~~~~~~~~~~s~~  243 (429)
T KOG0595|consen  167 --PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE-TPKELLLYIKKGNEIVPVLPAELSNP  243 (429)
T ss_pred             --chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc-CHHHHHHHHhccccccCchhhhccCc
Confidence              333456789999999999999999999999999999999999999999874 455555555443 4566677888999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          232 AQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ..+++...|+++|..|.+..+-+.|+++...
T Consensus       244 ~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~  274 (429)
T KOG0595|consen  244 LRELLISLLQRNPKDRISFEDFFDHPFLAAN  274 (429)
T ss_pred             hhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence            9999999999999999999999999998754

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-55  Score=425.53  Aligned_cols=255  Identities=31%  Similarity=0.552  Sum_probs=225.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      ||..++.||.|+|++|++|+.+.+++.||||++++..      ...+.+|-.+|.+| .||.|++++-.|.+...    +
T Consensus        74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s----L  149 (604)
T KOG0592|consen   74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES----L  149 (604)
T ss_pred             hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc----e
Confidence            7999999999999999999999999999999887532      35677899999999 89999999988877766    6


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      |+|+||+++|+|.++|++.+.|+|..++.|+.+|+.||+|||++|||||||||+|||++.++.  +||+|||.|+.+...
T Consensus       150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSPS  227 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc--EEEeeccccccCChh
Confidence            789999999999999999999999999999999999999999999999999999999998877  999999999976432


Q ss_pred             CCC----------C--CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCC
Q 040569          155 EDD----------E--GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP  222 (385)
Q Consensus       155 ~~~----------~--~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  222 (385)
                      ...          .  ...++||..|.+||++.+...++.+|||+||||+|+|+.|++||... +.....++|.  ....
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~-NeyliFqkI~--~l~y  304 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA-NEYLIFQKIQ--ALDY  304 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc-cHHHHHHHHH--Hhcc
Confidence            221          1  25689999999999999999999999999999999999999999885 4455555542  2234


Q ss_pred             CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccc
Q 040569          223 EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK  265 (385)
Q Consensus       223 ~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~~~  265 (385)
                      .+|..+++.+++||+++|.+||++|+|+.||.+||||...+|.
T Consensus       305 ~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~  347 (604)
T KOG0592|consen  305 EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE  347 (604)
T ss_pred             cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence            5677789999999999999999999999999999999988764

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-53  Score=416.38  Aligned_cols=252  Identities=32%  Similarity=0.534  Sum_probs=222.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--------CHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--------NSEFLQREQRILSALA-CPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--------~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~   72 (385)
                      .|.+++.||+|+||+|++|.+..++..+|+|+++..        ..+.+.||+.+++++. ||||+++++++.....   
T Consensus        18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~---   94 (370)
T KOG0583|consen   18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK---   94 (370)
T ss_pred             ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe---
Confidence            589999999999999999999999999999977653        2456779999999998 9999999999876654   


Q ss_pred             EEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           73 LYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                       +++|||||.||+|.+++.+.+++.|..++.+++||+.|++|||++||+||||||+|||++.+. ..+||+|||++....
T Consensus        95 -~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~-~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   95 -IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE-GNLKLSDFGLSAISP  172 (370)
T ss_pred             -EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC-CCEEEeccccccccC
Confidence             779999999999999999888999999999999999999999999999999999999999872 349999999999764


Q ss_pred             ccCCCCCCccccCCcccChhhhcCCC-C-CCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcC-C
Q 040569          153 VNEDDEGKPICGTPICMAPEVARGEE-Q-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM-S  229 (385)
Q Consensus       153 ~~~~~~~~~~~Gt~~y~aPE~~~~~~-~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-s  229 (385)
                       .......+.||||.|+|||++.+.. | +.++||||||+++|.|++|+.||.+. +.......+  ......+|..+ |
T Consensus       173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-~~~~l~~ki--~~~~~~~p~~~~S  248 (370)
T KOG0583|consen  173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-NVPNLYRKI--RKGEFKIPSYLLS  248 (370)
T ss_pred             -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-cHHHHHHHH--hcCCccCCCCcCC
Confidence             3344567889999999999999877 7 58999999999999999999999884 444444443  34456678888 9


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          230 KQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       230 ~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +++++|+.+||..||.+|+|+.++++||||+..
T Consensus       249 ~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  249 PEARSLIEKMLVPDPSTRITLLEILEHPWFQKE  281 (370)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence            999999999999999999999999999999873

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-54  Score=388.58  Aligned_cols=251  Identities=31%  Similarity=0.544  Sum_probs=224.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      ||++.++||.|+||.|.+++++.+|..||+|++++..      .+...+|.++|+.+.||.++++++.+.+...    .+
T Consensus        45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~----ly  120 (355)
T KOG0616|consen   45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN----LY  120 (355)
T ss_pred             hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe----EE
Confidence            6899999999999999999999999999999987654      3566789999999999999999988766554    77


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++||.|..++++.++++|..++.|+.||+.||+|||+++|++|||||+|||++.+|.  +||+|||+|+...   
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~--iKitDFGFAK~v~---  195 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH--IKITDFGFAKRVS---  195 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc--EEEEeccceEEec---
Confidence            99999999999999999999999999999999999999999999999999999999998887  9999999999874   


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                       ...-+.||||.|+|||++....|+.++|.||||+++|||+.|.+||... ++.....+|.  ...-.+|..+++++++|
T Consensus       196 -~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~-~~~~iY~KI~--~~~v~fP~~fs~~~kdL  271 (355)
T KOG0616|consen  196 -GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD-NPIQIYEKIL--EGKVKFPSYFSSDAKDL  271 (355)
T ss_pred             -CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC-ChHHHHHHHH--hCcccCCcccCHHHHHH
Confidence             2356789999999999999999999999999999999999999999874 5555555552  33456788899999999


Q ss_pred             HHHhhhcCCCCCC-----CHHHHHhCccccccccc
Q 040569          236 LSKCLIRNPGERW-----SASELLEHGFVKEQNFK  265 (385)
Q Consensus       236 l~~cL~~dP~~Rp-----s~~elL~hp~~~~~~~~  265 (385)
                      |+++|+.|-.+|.     ...++..||||+...+.
T Consensus       272 l~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~  306 (355)
T KOG0616|consen  272 LKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE  306 (355)
T ss_pred             HHHHHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence            9999999999995     56789999999987654

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-54  Score=424.72  Aligned_cols=249  Identities=31%  Similarity=0.514  Sum_probs=225.0

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      |+.+++||+|+.|.|.+|++..||+.+|||++.+.      ....+++|+-||+.+.||||+++|+++.....    +|+
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~----lyl   89 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH----LYL   89 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce----EEE
Confidence            89999999999999999999999999999999754      13567899999999999999999998766554    779


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |+||++||.|++++...++++|.++.++++||+.|+.|||..+|+||||||+|+|++..++  +||+|||+|....  ..
T Consensus        90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~--~g  165 (786)
T KOG0588|consen   90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLEV--PG  165 (786)
T ss_pred             EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC--Eeeeccceeeccc--CC
Confidence            9999999999999998899999999999999999999999999999999999999998877  9999999998753  33


Q ss_pred             CCCCccccCCcccChhhhcCCCC-CCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          157 DEGKPICGTPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                      .-..+.||+|.|.|||++.|..| +.++||||+|||||.|+||+.||.+ ++...++.++  ..+..++|..+|.++++|
T Consensus       166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV--~~G~f~MPs~Is~eaQdL  242 (786)
T KOG0588|consen  166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKV--QRGVFEMPSNISSEAQDL  242 (786)
T ss_pred             ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHH--HcCcccCCCcCCHHHHHH
Confidence            34567899999999999999988 7899999999999999999999986 4666666665  445677889999999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      |.+||..||.+|+|.+|+++|||+...
T Consensus       243 Lr~ml~VDp~~RiT~~eI~kHP~l~g~  269 (786)
T KOG0588|consen  243 LRRMLDVDPSTRITTEEILKHPFLSGY  269 (786)
T ss_pred             HHHHhccCccccccHHHHhhCchhhcC
Confidence            999999999999999999999999865

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.2e-53  Score=410.03  Aligned_cols=278  Identities=27%  Similarity=0.446  Sum_probs=229.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      ||..++.||+|+||.||+|+-+.||.+||+|++.++      +.+.++.|-.||....+|+||++|..|.+.+.    +|
T Consensus       142 DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~----LY  217 (550)
T KOG0605|consen  142 DFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY----LY  217 (550)
T ss_pred             cchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe----eE
Confidence            689999999999999999999999999999998764      34567789999999999999999988877665    78


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc-
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN-  154 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~-  154 (385)
                      |||||++||++..+|.+.+.|+|..++.|+.+++.|++-||++|+|||||||+|+||+..|.  +||+|||++..+... 
T Consensus       218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH--iKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH--IKLSDFGLSTGLDKKH  295 (550)
T ss_pred             EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC--Eeeccccccchhhhhh
Confidence            99999999999999999999999999999999999999999999999999999999998877  999999998532110 


Q ss_pred             ----------------C---C-CC-------------------------CCccccCCcccChhhhcCCCCCCCCChHHHH
Q 040569          155 ----------------E---D-DE-------------------------GKPICGTPICMAPEVARGEEQGFPADVWALG  189 (385)
Q Consensus       155 ----------------~---~-~~-------------------------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG  189 (385)
                                      .   . ..                         ....+|||.|||||++.+..|+..+|+||||
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG  375 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG  375 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence                            0   0 00                         0135799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCC--CcCCHHHHHHHHHhhhcCCCCCC---CHHHHHhCcccccccc
Q 040569          190 CTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP--GYMSKQAQDFLSKCLIRNPGERW---SASELLEHGFVKEQNF  264 (385)
Q Consensus       190 ~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~ll~~cL~~dP~~Rp---s~~elL~hp~~~~~~~  264 (385)
                      ||+||||.|.+||.. +++.....++......-.+|  ..++++++|||.+||. ||.+|.   +++|+.+||||+..+|
T Consensus       376 ~ImyEmLvGyPPF~s-~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W  453 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCS-ETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDW  453 (550)
T ss_pred             HHHHHHHhCCCCCCC-CCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence            999999999999987 45666555553333222222  2378999999999999 999999   5899999999999876


Q ss_pred             c-ccccCCCCCCCCCCCCcccccc
Q 040569          265 K-LSTLTEPETYNSESPTSVLNQQ  287 (385)
Q Consensus       265 ~-~~~~~~~~~~~~~~p~~~~~~~  287 (385)
                      . +-....|..+...++..+.+..
T Consensus       454 ~~l~~~~apfvP~v~~~~DT~yFd  477 (550)
T KOG0605|consen  454 DHLREMPAPFVPQVNSELDTQYFD  477 (550)
T ss_pred             chhhcCCCCCCCCCCCcccccccc
Confidence            4 4444444444555555444443

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-53  Score=403.27  Aligned_cols=252  Identities=38%  Similarity=0.606  Sum_probs=226.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      .|+..+.||+|+||.||+|+++.+++.||+|+++.+.    .+.+++|+.+|.++++|||.++|+.+.....    ++++
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~----Lwii   89 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK----LWII   89 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc----HHHH
Confidence            4888999999999999999999999999999998654    4678999999999999999999999887654    6799


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      ||||.||++.++++.++.++|..+..++++++.||.|||+++.+|||||+.|||+..++.  +||+|||.+.+.......
T Consensus        90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~--vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD--VKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc--EEEEecceeeeeechhhc
Confidence            999999999999999888899999999999999999999999999999999999998866  999999999988655444


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      . .+++|||.|||||++++..|+.++||||||++.+||++|.+||... .+...+..|. ...+|.+...+|+.+++|+.
T Consensus       168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~-hPmrvlflIp-k~~PP~L~~~~S~~~kEFV~  244 (467)
T KOG0201|consen  168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKL-HPMRVLFLIP-KSAPPRLDGDFSPPFKEFVE  244 (467)
T ss_pred             c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCccc-CcceEEEecc-CCCCCccccccCHHHHHHHH
Confidence            4 7889999999999999999999999999999999999999999875 4444444443 34567777789999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCcccccc
Q 040569          238 KCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      .||++||+.||||.+||+|+|++..
T Consensus       245 ~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  245 ACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             HHhhcCcccCcCHHHHhhhHHHHhc
Confidence            9999999999999999999999864

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.7e-52  Score=379.30  Aligned_cols=252  Identities=28%  Similarity=0.450  Sum_probs=208.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      .|+.+..+|+|+||+||+++++.||++||||++-.+.     .+-..||+++|++|+|||+|.++++|.-...    ++|
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk----lhL   78 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK----LHL   78 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce----eEE
Confidence            4899999999999999999999999999999885443     2345699999999999999999998865443    679


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |+|||+..-|.++-+....+++..+..|++|++.|+.|+|++++|||||||+||||+.++.  +||||||+|+.... ..
T Consensus        79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv--vKLCDFGFAR~L~~-pg  155 (396)
T KOG0593|consen   79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV--VKLCDFGFARTLSA-PG  155 (396)
T ss_pred             EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc--EEeccchhhHhhcC-Cc
Confidence            9999988445544445556999999999999999999999999999999999999998776  89999999998753 33


Q ss_pred             CCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC-----------------
Q 040569          157 DEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS-----------------  218 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-----------------  218 (385)
                      ...+-++.|.+|.|||.+.+ ..|+.++||||+||++.||++|.+.|++.++..+ ++.|...                 
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ-Ly~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ-LYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH-HHHHHHHHcccCHHHHHHhccCCc
Confidence            34456678999999999988 6899999999999999999999999998765443 3322100                 


Q ss_pred             ---CCCCCC--C-------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          219 ---SDTPEI--P-------GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       219 ---~~~~~~--~-------~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                         ...|+.  +       ..++.-+.||+.+||+.||.+|++++|+|.||||..
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence               001111  1       125778899999999999999999999999999954

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-52  Score=403.27  Aligned_cols=250  Identities=35%  Similarity=0.617  Sum_probs=224.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC---CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~---~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      .|+..+.||+|+.|.||.|+...+++.||||.+++.   ..+.+.+|+.+|+..+|+|||.+++.|...+.    +++||
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de----LWVVM  349 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE----LWVVM  349 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce----eEEEE
Confidence            377788999999999999999999999999999864   35778899999999999999999998877644    67999


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      ||++||+|.+.+... .++|.++..+++.+++||+|||.+||+|||||.+|||+..++.  +||+|||++..+...... 
T Consensus       350 Eym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~K-  425 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQSK-  425 (550)
T ss_pred             eecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc--EEEeeeeeeeccccccCc-
Confidence            999999999998855 4999999999999999999999999999999999999998877  999999999988655443 


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCC--CCCcCCHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE--IPGYMSKQAQDFL  236 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~ll  236 (385)
                      ..+.+|||.|||||++....|++++||||||++++||+-|.+||-. .++...++.+... ..|+  .+..+|+.+++||
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln-E~PlrAlyLIa~n-g~P~lk~~~klS~~~kdFL  503 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATN-GTPKLKNPEKLSPELKDFL  503 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC-CChHHHHHHHhhc-CCCCcCCccccCHHHHHHH
Confidence            4566899999999999999999999999999999999999999976 6788888887543 3343  4677999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHhCccccc
Q 040569          237 SKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      .+||+.|+.+|+++.|||+||||+.
T Consensus       504 ~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  504 DRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             HHHhhcchhcCCCHHHHhcChhhhh
Confidence            9999999999999999999999854

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.7e-53  Score=380.36  Aligned_cols=242  Identities=26%  Similarity=0.423  Sum_probs=209.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++++.||+|+||+||++++..+|+.+|.|.+....     .+.+..|+.+|++|+|||||++++.....++  ...+|
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~--evlni   97 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN--EVLNI   97 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc--hhhHH
Confidence            5889999999999999999999999999999886432     3567789999999999999999985444333  23679


Q ss_pred             EEeecCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCCEEeecCCCCCeEEeecCce
Q 040569           77 FLEYAPGGTLTDAIR----SGTCLEEGRIRSHTRAVLLGLQYLHS--NG--IVHCDIKGQNILVSKDNEQGAKIADFGCA  148 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~----~~~~l~e~~~~~i~~qil~gL~yLH~--~g--ivHrDlKp~NILi~~~~~~~~kL~DFG~a  148 (385)
                      |||||.+|+|.++|+    .+..++|..++.++.|++.||.++|+  ..  |+||||||.||+|+.++.  +||+|||++
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv--vKLGDfGL~  175 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV--VKLGDFGLG  175 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc--eeeccchhH
Confidence            999999999999997    35679999999999999999999999  44  999999999999997765  999999999


Q ss_pred             eeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCC-Cc
Q 040569          149 RRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP-GY  227 (385)
Q Consensus       149 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~  227 (385)
                      +.+.... ......+|||.||+||.+.+..|++++||||+||++|||+.-++||.+. +..++-.+|. .++.|.+| ..
T Consensus       176 r~l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-n~~~L~~KI~-qgd~~~~p~~~  252 (375)
T KOG0591|consen  176 RFLSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-NLLSLCKKIE-QGDYPPLPDEH  252 (375)
T ss_pred             hHhcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-cHHHHHHHHH-cCCCCCCcHHH
Confidence            9885332 2345678999999999999999999999999999999999999999875 5566656664 34666667 77


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCH
Q 040569          228 MSKQAQDFLSKCLIRNPGERWSA  250 (385)
Q Consensus       228 ~s~~~~~ll~~cL~~dP~~Rps~  250 (385)
                      +|.++..+|..|+..||..||+.
T Consensus       253 YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  253 YSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             hhhHHHHHHHHHccCCcccCCCc
Confidence            99999999999999999999986

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.1e-52  Score=404.47  Aligned_cols=250  Identities=32%  Similarity=0.484  Sum_probs=221.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH-----HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----EFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~-----~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|.+.+.||+|+||+||+|+.+.+.++||+|.+.+...     ..+++|++|+++|+|||||.+++.|....+    +++
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~----~~v   78 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH----LWV   78 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce----EEE
Confidence            68999999999999999999999999999999986543     358899999999999999999998876655    779


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |.|||.| +|..++...+.++|+.++.++.|++.||.|||+++|+|||+||+|||+..++.  +|+||||+|+....+. 
T Consensus        79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t-  154 (808)
T KOG0597|consen   79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT--LKLCDFGLARAMSTNT-  154 (808)
T ss_pred             Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc--eeechhhhhhhcccCc-
Confidence            9999987 99999999999999999999999999999999999999999999999987766  9999999999875432 


Q ss_pred             CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          157 DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      .....+.|||.|||||++.+..|+..+|+|||||++|||.+|++||.. .........|.  .+....|...|..+++||
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~--~d~v~~p~~~S~~f~nfl  231 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSIL--KDPVKPPSTASSSFVNFL  231 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHh--cCCCCCcccccHHHHHHH
Confidence            234566799999999999999999999999999999999999999975 24444455553  334455668999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          237 SKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ..+|.+||.+|.|..+++.|||.+..
T Consensus       232 ~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  232 QGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             HHHhhcChhhcccHHHHhcChHHhhh
Confidence            99999999999999999999998764

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-52  Score=370.20  Aligned_cols=254  Identities=28%  Similarity=0.457  Sum_probs=215.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC-----CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-----SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~-----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++-+.||+|.|+.|+++.++.||+.||+|+++.     ...+.+++|++|-+.|+||||+++++.+.+.    .+.||
T Consensus        12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~----~~~yl   87 (355)
T KOG0033|consen   12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE----SFHYL   87 (355)
T ss_pred             hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc----ceeEE
Confidence            47788999999999999999999999999998864     3457899999999999999999998765333    24679


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCC-CeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQ-GAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~-~~kL~DFG~a~~~~~~~  155 (385)
                      |+|++.|++|..-|.+.-.++|..+..+++||+++|.|+|.+||||||+||+|+|+-+...+ .+||+|||+|....  .
T Consensus        88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~  165 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--D  165 (355)
T ss_pred             EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--C
Confidence            99999999998888765668999999999999999999999999999999999999554333 37999999999886  3


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh---cCCCCCCCCCCcCCHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI---GFSSDTPEIPGYMSKQA  232 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~~  232 (385)
                      ........|||.|||||+++..+|+..+|||+.|+++|.|+.|++||.+. +......+|   .+....|+ ...+++++
T Consensus       166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~-~~~rlye~I~~g~yd~~~~~-w~~is~~A  243 (355)
T KOG0033|consen  166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-DQHRLYEQIKAGAYDYPSPE-WDTVTPEA  243 (355)
T ss_pred             ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc-cHHHHHHHHhccccCCCCcc-cCcCCHHH
Confidence            34456678999999999999999999999999999999999999999863 333333333   23333333 34589999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          233 QDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      ++|+++||..||.+|+|+.|+|+|||+.+..
T Consensus       244 k~LvrrML~~dP~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  244 KSLIRRMLTVNPKKRITADEALKHPWICNRE  274 (355)
T ss_pred             HHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence            9999999999999999999999999998653

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.4e-51  Score=391.88  Aligned_cols=254  Identities=29%  Similarity=0.455  Sum_probs=217.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      .|+.++.||+|.||.||+|++..+|++||+|++..+.     .-...||+.||++|.||||+++.+...+...+.  +||
T Consensus       118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s--iYl  195 (560)
T KOG0600|consen  118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS--IYL  195 (560)
T ss_pred             HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce--EEE
Confidence            4788999999999999999999999999999987654     235679999999999999999999887764433  569


Q ss_pred             EEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |+|||+. +|.-++.. +-.|++.++..|++||+.||+|||++||+|||||.+||||+.++.  +||+|||+|+++....
T Consensus       196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV--LKIADFGLARFYTPSG  272 (560)
T ss_pred             EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC--EEeccccceeeccCCC
Confidence            9999987 99999985 557999999999999999999999999999999999999997776  9999999999887666


Q ss_pred             CCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCC--------CCC-
Q 040569          156 DDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP--------EIP-  225 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------~~~-  225 (385)
                      ....+..+-|.+|.|||.+.|. .|+.++|+||+||||.||++|++.|++..+ ..+++.|..-...|        .+| 
T Consensus       273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE-veQl~kIfklcGSP~e~~W~~~kLP~  351 (560)
T KOG0600|consen  273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE-VEQLHKIFKLCGSPTEDYWPVSKLPH  351 (560)
T ss_pred             CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH-HHHHHHHHHHhCCCChhccccccCCc
Confidence            6666777889999999999886 689999999999999999999999998644 44444442111111        111 


Q ss_pred             ------------------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          226 ------------------GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       226 ------------------~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                                        ..+++.+.+|+..||..||.+|.|+.++|+|+||..
T Consensus       352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence                              236889999999999999999999999999999954

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-50  Score=402.74  Aligned_cols=273  Identities=30%  Similarity=0.502  Sum_probs=231.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|+..+.||+|+||+|+++..+.+++.||||.++++      +.+.+..|.+|+... +||.++.++.+|.+.++    +
T Consensus       369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~----l  444 (694)
T KOG0694|consen  369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH----L  444 (694)
T ss_pred             ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe----E
Confidence            689999999999999999999999999999988754      467888999999988 59999999999988776    7


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      |+||||+.||++..++ ..+.++|..++.|+..|+.||+|||++|||+||||.+|||++.+|.  +||+|||+++..-. 
T Consensus       445 ~fvmey~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m~-  520 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGMG-  520 (694)
T ss_pred             EEEEEecCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc--EEecccccccccCC-
Confidence            7999999999944433 4456999999999999999999999999999999999999998887  99999999997532 


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                      ......++||||.|||||++.+..|+.++|.|||||++|||+.|+.||++. +.......|  ..+.+.+|.++|.++.+
T Consensus       521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd-dEee~FdsI--~~d~~~yP~~ls~ea~~  597 (694)
T KOG0694|consen  521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD-DEEEVFDSI--VNDEVRYPRFLSKEAIA  597 (694)
T ss_pred             CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHH--hcCCCCCCCcccHHHHH
Confidence            333567899999999999999999999999999999999999999999874 334444444  34567789999999999


Q ss_pred             HHHHhhhcCCCCCCC-----HHHHHhCccccccccccc---ccCCCCCCCCCCCCcccc
Q 040569          235 FLSKCLIRNPGERWS-----ASELLEHGFVKEQNFKLS---TLTEPETYNSESPTSVLN  285 (385)
Q Consensus       235 ll~~cL~~dP~~Rps-----~~elL~hp~~~~~~~~~~---~~~~~~~~~~~~p~~~~~  285 (385)
                      +++++|.++|.+|..     +.++..||||+..+|..-   ...+|..+...+|..+.|
T Consensus       598 il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~sn  656 (694)
T KOG0694|consen  598 IMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSN  656 (694)
T ss_pred             HHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhcc
Confidence            999999999999995     578999999999876422   233344444555555444

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-51  Score=391.96  Aligned_cols=252  Identities=27%  Similarity=0.426  Sum_probs=209.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHH--HHHHHHHHHHhcC-CCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSE--FLQREQRILSALA-CPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~--~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      .|+..+.||.|.||.||+|+.+.+|++||||.+...  ..+  .-.||+.-|++|+ |||||++++++.+...   .+++
T Consensus        11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~---~L~f   87 (538)
T KOG0661|consen   11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR---ILYF   87 (538)
T ss_pred             HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc---eEee
Confidence            488999999999999999999999999999988642  122  2348999999998 9999999999877654   3679


Q ss_pred             EEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |||||+. +|.++++ ++..|+|..++.|++||++||+|+|.+|+.|||+||+||||....-  +||+|||+|+.+..  
T Consensus        88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~--iKiaDFGLARev~S--  162 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDV--IKIADFGLAREVRS--  162 (538)
T ss_pred             eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccce--eEeccccccccccc--
Confidence            9999976 9999998 5667999999999999999999999999999999999999985433  89999999998742  


Q ss_pred             CCCCCccccCCcccChhhhc-CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC-----------------
Q 040569          156 DDEGKPICGTPICMAPEVAR-GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF-----------------  217 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-----------------  217 (385)
                      ....+.++.|.+|.|||++. .+.|+.+.||||+|||++|+.+-++.|++.++. .++.+|-.                 
T Consensus       163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~-Dqi~KIc~VLGtP~~~~~~eg~~La  241 (538)
T KOG0661|consen  163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI-DQIYKICEVLGTPDKDSWPEGYNLA  241 (538)
T ss_pred             CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH-HHHHHHHHHhCCCccccchhHHHHH
Confidence            23345678899999999984 567899999999999999999999999986443 33333310                 


Q ss_pred             ---CCCCC--------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          218 ---SSDTP--------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       218 ---~~~~~--------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                         ....|        .+....++++.++|.+||..||.+|||+.|+|+||||+..
T Consensus       242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~  297 (538)
T KOG0661|consen  242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG  297 (538)
T ss_pred             HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence               00111        1112378999999999999999999999999999999865

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-50  Score=381.05  Aligned_cols=256  Identities=32%  Similarity=0.521  Sum_probs=217.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|+..+.||.|..++||+|+...++++||||+++.+.    .+.+++|+..|+.+.||||++++..|+....    +++|
T Consensus        27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~----LWvV  102 (516)
T KOG0582|consen   27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE----LWVV  102 (516)
T ss_pred             ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce----eEEe
Confidence            6899999999999999999999999999999998643    4688999999999999999999999988766    7899


Q ss_pred             EeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           78 LEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |.||.+||+.++++.  ...++|..+..+++++++||.|||.+|.||||||+.||||+.+|.  |||+|||.........
T Consensus       103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~--VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT--VKLADFGVSASLFDSG  180 (516)
T ss_pred             ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc--EEEcCceeeeeecccC
Confidence            999999999999983  334999999999999999999999999999999999999998887  9999999876543332


Q ss_pred             CC---CCCccccCCcccChhhhcC--CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCC---C---
Q 040569          156 DD---EGKPICGTPICMAPEVARG--EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---I---  224 (385)
Q Consensus       156 ~~---~~~~~~Gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~---  224 (385)
                      ..   ...+++|||+|||||++..  ..|+.|+||||||++..||++|..||........++..+......+.   +   
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d  260 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKD  260 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChH
Confidence            11   1256789999999999643  47999999999999999999999999887555555555533332221   1   


Q ss_pred             -CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          225 -PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       225 -~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                       ...++..++.+|..||++||++|||++++|+|+||+...
T Consensus       261 ~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  261 EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence             123677899999999999999999999999999998653

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=8.1e-50  Score=386.42  Aligned_cols=250  Identities=26%  Similarity=0.492  Sum_probs=216.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+|+++.+++.+|+|.+...      ..+.+.+|+.+|++++||||+++++++.....    ++
T Consensus        19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~----~~   94 (329)
T PTZ00263         19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR----VY   94 (329)
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE----EE
Confidence            689999999999999999999999999999988642      23467789999999999999999998765443    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....  
T Consensus        95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~--  170 (329)
T PTZ00263         95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVPD--  170 (329)
T ss_pred             EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC--EEEeeccCceEcCC--
Confidence            99999999999999998888999999999999999999999999999999999999987766  99999999987532  


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                        .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+.  .....+|..++..+++|
T Consensus       171 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~--~~~~~~p~~~~~~~~~l  245 (329)
T PTZ00263        171 --RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD-TPFRIYEKIL--AGRLKFPNWFDGRARDL  245 (329)
T ss_pred             --CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC-CHHHHHHHHh--cCCcCCCCCCCHHHHHH
Confidence              223457999999999999999999999999999999999999999764 3444444432  23345677799999999


Q ss_pred             HHHhhhcCCCCCCC-----HHHHHhCcccccccc
Q 040569          236 LSKCLIRNPGERWS-----ASELLEHGFVKEQNF  264 (385)
Q Consensus       236 l~~cL~~dP~~Rps-----~~elL~hp~~~~~~~  264 (385)
                      |.+||++||.+||+     ++++++||||...++
T Consensus       246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~  279 (329)
T PTZ00263        246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANW  279 (329)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence            99999999999997     799999999987543

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-51  Score=361.37  Aligned_cols=248  Identities=30%  Similarity=0.483  Sum_probs=221.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|.+++.||+|.||.||+|+.+.++-++|+|++.+++      ..+++||++|-+.|+||||+++|++|.+...    .|
T Consensus        23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r----iy   98 (281)
T KOG0580|consen   23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR----IY   98 (281)
T ss_pred             hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce----eE
Confidence            6899999999999999999999999999999997654      3578899999999999999999999988766    77


Q ss_pred             EEEeecCCCCHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           76 LFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~--~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      |++||.++|+|...+.  ...+++|..+..|++|++.||.|+|.++|+||||||+|+|++..+.  +||+|||.+.... 
T Consensus        99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen   99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-  175 (281)
T ss_pred             EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC--eeccCCCceeecC-
Confidence            9999999999999999  6678999999999999999999999999999999999999987776  9999999998753 


Q ss_pred             cCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHH
Q 040569          154 NEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ  233 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  233 (385)
                        .....+.|||..|.|||+..+..++..+|+|++|++.||++.|.+||.... ......++..  ..-.+|..+|.+++
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k--~~~~~p~~is~~a~  250 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRK--VDLKFPSTISGGAA  250 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHH--ccccCCcccChhHH
Confidence              344577899999999999999999999999999999999999999998754 3344444422  22345678999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          234 DFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       234 ~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      |+|.+||.++|.+|.+..|++.|||+..
T Consensus       251 dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  251 DLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHHHHHhccCccccccHHHHhhhHHHHh
Confidence            9999999999999999999999999864

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.6e-50  Score=385.57  Aligned_cols=248  Identities=28%  Similarity=0.455  Sum_probs=211.4

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +.||+|+||+||+|.++.+|+.||+|.+...      ....+.+|+.+|++++||||+++++++.....    +++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~----~~lv~e~   76 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDR----LCFVMEY   76 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCE----EEEEEeC
Confidence            4799999999999999999999999988642      12456689999999999999999988765443    6799999


Q ss_pred             cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCC
Q 040569           81 APGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGK  160 (385)
Q Consensus        81 ~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~  160 (385)
                      ++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++..... .....
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DfG~a~~~~~~-~~~~~  153 (323)
T cd05571          77 ANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISD-GATMK  153 (323)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEeeCCCCcccccC-CCccc
Confidence            999999999998888999999999999999999999999999999999999987665  999999998754221 22234


Q ss_pred             ccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhh
Q 040569          161 PICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCL  240 (385)
Q Consensus       161 ~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL  240 (385)
                      ..+||+.|||||++.+..++.++|||||||++|||++|+.||... +.......+.  .....+|..+++++++||.+||
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~-~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L  230 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELIL--MEEIRFPRTLSPEAKSLLAGLL  230 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC-CHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHc
Confidence            567999999999999999999999999999999999999999764 3333333332  2234567789999999999999


Q ss_pred             hcCCCCCC-----CHHHHHhCcccccccc
Q 040569          241 IRNPGERW-----SASELLEHGFVKEQNF  264 (385)
Q Consensus       241 ~~dP~~Rp-----s~~elL~hp~~~~~~~  264 (385)
                      ++||++||     ++.++++||||...++
T Consensus       231 ~~dP~~R~~~~~~~~~~ll~h~~f~~~~~  259 (323)
T cd05571         231 KKDPKQRLGGGPEDAKEIMEHRFFASINW  259 (323)
T ss_pred             cCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence            99999999     8999999999987644

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-49  Score=386.49  Aligned_cols=244  Identities=30%  Similarity=0.435  Sum_probs=214.8

Q ss_pred             eeeceeeccCceEEEEEEECCCCcE-EEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            4 TRGQTIGRGSTATVSIGMSNRSSEV-FAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~~-~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      ...+.||+|+||+||+|.++  |.. +|||.+....     .+.+.+|+.+|++++|||||+|+|++.....   .++||
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~---~~~iV  118 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG---SLCIV  118 (362)
T ss_pred             hhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC---ceEEE
Confidence            45667999999999999998  556 9999987543     4588999999999999999999999876652   26799


Q ss_pred             EeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           78 LEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNG-IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~g-ivHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      |||+++|+|.+++..  +..++...+..++.||++|+.|||+++ ||||||||+|||++.+. ..+||||||+++.....
T Consensus       119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-KTLKIADFGLSREKVIS  197 (362)
T ss_pred             EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC-CEEEECCCccceeeccc
Confidence            999999999999986  678999999999999999999999999 99999999999999775 23999999999976433


Q ss_pred             CCCCCCccccCCcccChhhhc--CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHH
Q 040569          155 EDDEGKPICGTPICMAPEVAR--GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA  232 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  232 (385)
                      . .......||+.|||||++.  ...|+.++||||||+++|||+||+.||.+... ......+......|.+|...++.+
T Consensus       198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~~p~~~~~~l  275 (362)
T KOG0192|consen  198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPPIPKECPPHL  275 (362)
T ss_pred             c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCCCCccCCHHH
Confidence            2 2334467999999999999  56999999999999999999999999998765 777777778888999999999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHh
Q 040569          233 QDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ..++.+||..||.+||++.+++.
T Consensus       276 ~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  276 SSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHhCCCCCCcCCCHHHHHH
Confidence            99999999999999999999875

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-50  Score=380.05  Aligned_cols=250  Identities=28%  Similarity=0.500  Sum_probs=214.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+|+++.+++.+|+|.+...      ..+.+.+|+.+|+++.||||+++++++....    .++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~~   77 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR----FLY   77 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC----eEE
Confidence            689999999999999999999999999999988643      2345778999999999999999998765433    367


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....  
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~--~kl~Dfg~~~~~~~--  153 (291)
T cd05612          78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH--IKLTDFGFAKKLRD--  153 (291)
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEEecCcchhccC--
Confidence            99999999999999998888999999999999999999999999999999999999987665  99999999986532  


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                        .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+.  .....++..+++.+++|
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~-~~~~~~~~i~--~~~~~~~~~~~~~~~~l  228 (291)
T cd05612         154 --RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD-NPFGIYEKIL--AGKLEFPRHLDLYAKDL  228 (291)
T ss_pred             --CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHH--hCCcCCCccCCHHHHHH
Confidence              223457999999999999999999999999999999999999999764 3333333332  22345667789999999


Q ss_pred             HHHhhhcCCCCCCC-----HHHHHhCcccccccc
Q 040569          236 LSKCLIRNPGERWS-----ASELLEHGFVKEQNF  264 (385)
Q Consensus       236 l~~cL~~dP~~Rps-----~~elL~hp~~~~~~~  264 (385)
                      |.+||++||.+||+     ++++++||||....+
T Consensus       229 i~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  262 (291)
T cd05612         229 IKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW  262 (291)
T ss_pred             HHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence            99999999999995     999999999986543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=8.8e-50  Score=357.27  Aligned_cols=252  Identities=31%  Similarity=0.417  Sum_probs=212.4

Q ss_pred             CCceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH-----HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            1 MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----EFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         1 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~-----~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +.|...+.||+|.||+||+|++..||+.||||++...+.     -...||++.|+.++||||+.++++|....+    ..
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~----l~   77 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN----LS   77 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc----eE
Confidence            368999999999999999999999999999999986543     356799999999999999999999877666    77


Q ss_pred             EEEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           76 LFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ||+||++. +|...|+ +...++...++.|+.++++||+|||++.|+||||||.|+||++++.  +||+|||+|+.+...
T Consensus        78 lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   78 LVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSP  154 (318)
T ss_pred             EEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc--EEeecccchhccCCC
Confidence            99999986 9999998 5667999999999999999999999999999999999999998887  999999999987543


Q ss_pred             CCCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCC---------CC
Q 040569          155 EDDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP---------EI  224 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---------~~  224 (385)
                      ... ....+-|.+|.|||.+.|. .|+..+||||.|||+.||+.|.+-|++.++..+ +..+......|         .+
T Consensus       155 ~~~-~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ-L~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  155 NRI-QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ-LSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             Ccc-cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH-HHHHHHHcCCCCcccCcccccc
Confidence            322 2233679999999999876 689999999999999999999988888655433 33321111111         11


Q ss_pred             -----------------CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          225 -----------------PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       225 -----------------~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                                       -...++++.||+.+||..||.+|+|+.|+|+|+||.+
T Consensus       233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~  286 (318)
T KOG0659|consen  233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS  286 (318)
T ss_pred             ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence                             1125788899999999999999999999999999985

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-50  Score=383.08  Aligned_cols=255  Identities=30%  Similarity=0.477  Sum_probs=210.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----------------HHHHHHHHHHHHhcCCCCeeeeeeee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----------------SEFLQREQRILSALACPQIVAYKGCD   64 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----------------~~~~~~E~~il~~l~hpnIv~~~~~~   64 (385)
                      +|++++.||+|.||.|-+|++..+++.||||++.+..                 .+..++|+.||++|.|||||+++++.
T Consensus        98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL  177 (576)
T KOG0585|consen   98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL  177 (576)
T ss_pred             heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence            6999999999999999999999999999999886421                 25788999999999999999999987


Q ss_pred             eeccCCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEee
Q 040569           65 ISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIAD  144 (385)
Q Consensus        65 ~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~D  144 (385)
                      -+.....  +|||+|||..|.+...-..+.-+++.++++|+++++.||+|||.+|||||||||+|+||+.++.  +||+|
T Consensus       178 DDP~s~~--~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~--VKIsD  253 (576)
T KOG0585|consen  178 DDPESDK--LYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT--VKISD  253 (576)
T ss_pred             cCcccCc--eEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc--EEeec
Confidence            6655444  5699999999988754433334999999999999999999999999999999999999998876  99999


Q ss_pred             cCceeeecccCCC----CCCccccCCcccChhhhcCCC----CCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc
Q 040569          145 FGCARRARVNEDD----EGKPICGTPICMAPEVARGEE----QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG  216 (385)
Q Consensus       145 FG~a~~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~  216 (385)
                      ||.+..+......    ......|||.|||||.+.++.    .+.+.||||+||+||.|+.|+.||-+. ....+..+|.
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~-~~~~l~~KIv  332 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD-FELELFDKIV  332 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc-hHHHHHHHHh
Confidence            9999876333221    123367999999999997742    367899999999999999999999763 3333444442


Q ss_pred             -CCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          217 -FSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       217 -~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                       .....|+.| .+.+.++|||.+||++||.+|++..++..|||+...
T Consensus       333 n~pL~fP~~p-e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  333 NDPLEFPENP-EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             cCcccCCCcc-cccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence             222333333 378999999999999999999999999999998754

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-49  Score=380.28  Aligned_cols=246  Identities=28%  Similarity=0.458  Sum_probs=208.7

Q ss_pred             eeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecC
Q 040569            9 IGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAP   82 (385)
Q Consensus         9 LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (385)
                      ||+|+||+||+|+++.+++.||+|.+...      ....+.+|+.+|++++||||+++++.+.....    +++||||++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~e~~~   76 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEK----LYLVLAFIN   76 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCe----EEEEEcCCC
Confidence            79999999999999999999999988632      23456789999999999999999988765432    679999999


Q ss_pred             CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCCcc
Q 040569           83 GGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI  162 (385)
Q Consensus        83 ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~  162 (385)
                      ||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..... .......
T Consensus        77 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~-~~~~~~~  153 (312)
T cd05585          77 GGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH--IALCDFGLCKLNMKD-DDKTNTF  153 (312)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc--EEEEECcccccCccC-CCccccc
Confidence            9999999988788999999999999999999999999999999999999987766  999999999854222 2223456


Q ss_pred             ccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhc
Q 040569          163 CGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIR  242 (385)
Q Consensus       163 ~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~  242 (385)
                      +||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+.  .....++..+++++++||.+||.+
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~  230 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE-NVNEMYRKIL--QEPLRFPDGFDRDAKDLLIGLLSR  230 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC-CHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHcCC
Confidence            7999999999999999999999999999999999999999764 3333333332  234456777999999999999999


Q ss_pred             CCCCCC---CHHHHHhCcccccccc
Q 040569          243 NPGERW---SASELLEHGFVKEQNF  264 (385)
Q Consensus       243 dP~~Rp---s~~elL~hp~~~~~~~  264 (385)
                      ||.+||   ++.|+|+||||...++
T Consensus       231 dp~~R~~~~~~~e~l~hp~~~~~~~  255 (312)
T cd05585         231 DPTRRLGYNGAQEIKNHPFFSQLSW  255 (312)
T ss_pred             CHHHcCCCCCHHHHHcCCCcCCCCH
Confidence            999997   5799999999987643

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7e-49  Score=371.93  Aligned_cols=255  Identities=26%  Similarity=0.393  Sum_probs=212.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      .|+..+.||+|+||+||+|.++.+++.||+|.+....      ...+.+|+.+|+++.||||+++++.+.....    ++
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~----~~   76 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDA----LC   76 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCe----EE
Confidence            4889999999999999999999999999999876432      2346689999999999999999988765443    67


Q ss_pred             EEEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           76 LFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      +||||+++|+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||++.....
T Consensus        77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~  154 (285)
T cd05631          77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH--IRISDLGLAVQIPE  154 (285)
T ss_pred             EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeCCCcEEcCC
Confidence            99999999999988863  346899999999999999999999999999999999999987665  99999999987532


Q ss_pred             cCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChH--HHHHHhcCCCCCCCCCCcCCHH
Q 040569          154 NEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPI--SALHRIGFSSDTPEIPGYMSKQ  231 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~  231 (385)
                      .  .......||+.|||||++.+..++.++|||||||++|+|++|+.||.......  ...... .......++..++++
T Consensus       155 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~  231 (285)
T cd05631         155 G--ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR-VKEDQEEYSEKFSED  231 (285)
T ss_pred             C--CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH-hhcccccCCccCCHH
Confidence            2  12234579999999999999999999999999999999999999997643321  111111 123334556678999


Q ss_pred             HHHHHHHhhhcCCCCCCC-----HHHHHhCccccccccc
Q 040569          232 AQDFLSKCLIRNPGERWS-----ASELLEHGFVKEQNFK  265 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps-----~~elL~hp~~~~~~~~  265 (385)
                      +.+||++||++||.+||+     ++++++||||...+++
T Consensus       232 ~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05631         232 AKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK  270 (285)
T ss_pred             HHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence            999999999999999997     8999999999887544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.3e-48  Score=383.05  Aligned_cols=257  Identities=23%  Similarity=0.338  Sum_probs=210.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|+..+.||+|+||+||+|.++.+++.||+|++...      ....+++|+.++.+++||||+++++.+.....    ++
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~----~~   77 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLN----LY   77 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCe----EE
Confidence            699999999999999999999999999999998642      22467789999999999999999988765443    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus        78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~--vkL~DFGla~~~~~~~  155 (363)
T cd05628          78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH--VKLSDFGLCTGLKKAH  155 (363)
T ss_pred             EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC--EEEeeccCcccccccc
Confidence            99999999999999998888999999999999999999999999999999999999987765  9999999987542110


Q ss_pred             C----------------------------------CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCC
Q 040569          156 D----------------------------------DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPP  201 (385)
Q Consensus       156 ~----------------------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~P  201 (385)
                      .                                  ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            0                                  001245799999999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHHHhcCCCCCCCCC--CcCCHHHHHHHHHhhhc--CCCCCCCHHHHHhCccccccccc
Q 040569          202 WPDVADPISALHRIGFSSDTPEIP--GYMSKQAQDFLSKCLIR--NPGERWSASELLEHGFVKEQNFK  265 (385)
Q Consensus       202 f~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~ll~~cL~~--dP~~Rps~~elL~hp~~~~~~~~  265 (385)
                      |... +......++........+|  ..+++++++||.+|+..  ++..||+++|+++||||+..++.
T Consensus       236 f~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~  302 (363)
T cd05628         236 FCSE-TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWE  302 (363)
T ss_pred             CCCC-CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHH
Confidence            9764 3334344432222222222  23789999999997652  23356899999999999987554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.3e-49  Score=372.07  Aligned_cols=252  Identities=24%  Similarity=0.350  Sum_probs=207.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++.+.||+|+||+||+|+++.+++.+|+|.+...     ..+.+.+|+.++++++||||+++++++.....    +++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~l   77 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGK----LYL   77 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCE----EEE
Confidence            699999999999999999999999999999988643     23567789999999999999999988765432    679


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      ||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++........
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSN  155 (287)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccCccccccccc
Confidence            9999999887776666667999999999999999999999999999999999999987665  99999999987643333


Q ss_pred             CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC-----------------
Q 040569          157 DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS-----------------  219 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-----------------  219 (385)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|++||.................                 
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            333445799999999999998999999999999999999999999986533222111000000                 


Q ss_pred             --CCC----------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          220 --DTP----------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       220 --~~~----------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                        ..+          .....+|.++++||.+||++||.+|||++|+|+||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence              000          0112368899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.7e-49  Score=372.96  Aligned_cols=263  Identities=30%  Similarity=0.466  Sum_probs=223.9

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH------HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS------EFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~------~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      |+.++.||+|.-|+||++..+.++..+|+|++++...      ..++.|.+||+.+.||.++.+|..+.+..    ++|+
T Consensus        79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~----~~cl  154 (459)
T KOG0610|consen   79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK----YSCL  154 (459)
T ss_pred             HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc----eeEE
Confidence            6778999999999999999999999999999986542      34567999999999999999999876654    4889


Q ss_pred             EEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc-
Q 040569           77 FLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV-  153 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~-  153 (385)
                      +||||+||+|..+.++  +++++|..++.|+..++.||+|||-.|||.|||||+||||.++|.  +.|.||.++..... 
T Consensus       155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH--IMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH--IMLSDFDLSLRCPVS  232 (459)
T ss_pred             EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc--EEeeeccccccCCCC
Confidence            9999999999999984  568999999999999999999999999999999999999998887  99999987643210 


Q ss_pred             --------------------------------c-C---------------------CCCCCccccCCcccChhhhcCCCC
Q 040569          154 --------------------------------N-E---------------------DDEGKPICGTPICMAPEVARGEEQ  179 (385)
Q Consensus       154 --------------------------------~-~---------------------~~~~~~~~Gt~~y~aPE~~~~~~~  179 (385)
                                                      . .                     ......++||-.|+|||++.|...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                     011234679999999999999999


Q ss_pred             CCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCC----HHHHHh
Q 040569          180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWS----ASELLE  255 (385)
Q Consensus       180 ~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps----~~elL~  255 (385)
                      +.++|+|+||+.+|||+.|..||.+.++.......+......|..+ .+|..++|||+++|.+||++|..    ++|+.+
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence            9999999999999999999999999766555555454444555555 57899999999999999999998    999999


Q ss_pred             CcccccccccccccCCC
Q 040569          256 HGFVKEQNFKLSTLTEP  272 (385)
Q Consensus       256 hp~~~~~~~~~~~~~~~  272 (385)
                      ||||+..+|.+-....|
T Consensus       392 HpFF~gVnWaLir~~~P  408 (459)
T KOG0610|consen  392 HPFFEGVNWALIRCARP  408 (459)
T ss_pred             CccccCCChhheeccCC
Confidence            99999998876554443

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-49  Score=370.93  Aligned_cols=256  Identities=28%  Similarity=0.385  Sum_probs=210.7

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEecc--CC---CHHHHHHHHHHHHhcCCCCeeeeeeeeee-ccCCeEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE--LS---NSEFLQREQRILSALACPQIVAYKGCDIS-EENGKILYNL   76 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~--~~---~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~~~~~l   76 (385)
                      |...+.||+|+||.|+.|.++.+|+.||||++.  ..   ..+...||+.+|+.++|+||+.+++++.. ......-+|+
T Consensus        24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYi  103 (359)
T KOG0660|consen   24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYL  103 (359)
T ss_pred             ecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEE
Confidence            445789999999999999999999999999886  22   23456689999999999999999998866 2222223669


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc-C
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN-E  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~-~  155 (385)
                      |+|+|+ -+|.+.|+.+..|++.++..+++||++||+|+|+.||+||||||+|+|++.+..  +||||||+|+..... .
T Consensus       104 V~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~~~~~~~  180 (359)
T KOG0660|consen  104 VFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARYLDKFFE  180 (359)
T ss_pred             ehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC--EEeccccceeeccccCc
Confidence            999994 599999999888999999999999999999999999999999999999998877  899999999987533 1


Q ss_pred             CCCCCccccCCcccChhhh-cCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCC--------------
Q 040569          156 DDEGKPICGTPICMAPEVA-RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSD--------------  220 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--------------  220 (385)
                      ....+..+-|.+|.|||++ ....|+.+.||||+|||+.||++|++.|++. +...++..+....+              
T Consensus       181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~-d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK-DYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC-chHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence            2234667889999999997 4568999999999999999999999999875 33333332211111              


Q ss_pred             -------CCC--------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          221 -------TPE--------IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       221 -------~~~--------~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                             .|.        +-...++.+.+|+.+||..||.+|+|++|+|+|||+...
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~  316 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY  316 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence                   111        113578999999999999999999999999999999864

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-49  Score=384.33  Aligned_cols=253  Identities=30%  Similarity=0.449  Sum_probs=219.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcC-CCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALA-CPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      .|++++.||+|.||+||+++++.||+.+|+|.+.+..      .+.+.+|++||+++. |||||.+++.+.+...    +
T Consensus        36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~----~  111 (382)
T KOG0032|consen   36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS----V  111 (382)
T ss_pred             cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe----E
Confidence            4889999999999999999999999999999987543      368899999999998 9999999999877664    7


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCC--CCeEEeecCceeeec
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE--QGAKIADFGCARRAR  152 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~--~~~kL~DFG~a~~~~  152 (385)
                      ++|||+|.||.|.+.|... .++|..+..+++||+.+++|||+.||+||||||+|+|+.....  ..+|++|||++....
T Consensus       112 ~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~  190 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK  190 (382)
T ss_pred             EEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence            7999999999999999866 4999999999999999999999999999999999999976543  359999999999875


Q ss_pred             ccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh--cCCCCCCCCCCcCCH
Q 040569          153 VNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI--GFSSDTPEIPGYMSK  230 (385)
Q Consensus       153 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~s~  230 (385)
                      .  .......+|||.|+|||++.+..|+..+||||+|+++|.|++|.+||....+........  .+....+. ...+|.
T Consensus       191 ~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~-w~~is~  267 (382)
T KOG0032|consen  191 P--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEP-WDDISE  267 (382)
T ss_pred             C--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCC-ccccCH
Confidence            4  445677899999999999999999999999999999999999999998765443333221  22222333 344799


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      .+++||++||..||.+|+|+.++|+|||+...
T Consensus       268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            99999999999999999999999999998764

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=7.4e-49  Score=381.67  Aligned_cols=250  Identities=26%  Similarity=0.420  Sum_probs=213.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCC-cEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSS-EVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~-~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++.+.||+|+||.||+|.++.++ ..+|+|.+...      ..+.+.+|+.+++.++||||+++++++.....    +
T Consensus        31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~----~  106 (340)
T PTZ00426         31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY----L  106 (340)
T ss_pred             hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE----E
Confidence            5899999999999999999876654 78999987532      23567789999999999999999998765543    6


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... 
T Consensus       107 ~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--ikL~DFG~a~~~~~-  183 (340)
T PTZ00426        107 YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAKVVDT-  183 (340)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEecCCCCeecCC-
Confidence            799999999999999998888999999999999999999999999999999999999987665  99999999987532 


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                         .....+||+.|||||++.+..++.++|||||||++|+|++|+.||... +.......+.  .....+|..+++.+++
T Consensus       184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~-~~~~~~~~i~--~~~~~~p~~~~~~~~~  257 (340)
T PTZ00426        184 ---RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN-EPLLIYQKIL--EGIIYFPKFLDNNCKH  257 (340)
T ss_pred             ---CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC-CHHHHHHHHh--cCCCCCCCCCCHHHHH
Confidence               223557999999999999999999999999999999999999999864 3333333332  2234457778999999


Q ss_pred             HHHHhhhcCCCCCC-----CHHHHHhCcccccccc
Q 040569          235 FLSKCLIRNPGERW-----SASELLEHGFVKEQNF  264 (385)
Q Consensus       235 ll~~cL~~dP~~Rp-----s~~elL~hp~~~~~~~  264 (385)
                      +|++||++||.+|+     +++++++||||...++
T Consensus       258 li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~  292 (340)
T PTZ00426        258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW  292 (340)
T ss_pred             HHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence            99999999999996     8999999999987643

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-48  Score=378.67  Aligned_cols=252  Identities=25%  Similarity=0.430  Sum_probs=213.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||.||+|+++.+++.||+|++...      ....+.+|+.+++.++||||+++++++.....    ++
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~----~~   77 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEY----LY   77 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCE----EE
Confidence            699999999999999999999999999999988643      23456789999999999999999988765432    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.....  
T Consensus        78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~--  153 (333)
T cd05600          78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT--  153 (333)
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEEEeCcCCccccc--
Confidence            99999999999999998888999999999999999999999999999999999999987765  99999999986532  


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC---CCCCCCCC---CcCC
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF---SSDTPEIP---GYMS  229 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~---~~~~~~~~---~~~s  229 (385)
                        .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+..   ....+...   ..++
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~s  230 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS-TPNETWENLKYWKETLQRPVYDDPRFNLS  230 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC-CHHHHHHHHHhccccccCCCCCccccccC
Confidence              234557999999999999999999999999999999999999999764 33333222211   11122211   2468


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHhCcccccccc
Q 040569          230 KQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF  264 (385)
Q Consensus       230 ~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~~  264 (385)
                      +++.+||.+||..+|.+||++.++++||||....+
T Consensus       231 ~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         231 DEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             HHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence            99999999999999999999999999999987543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.8e-48  Score=384.46  Aligned_cols=256  Identities=25%  Similarity=0.381  Sum_probs=209.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      .|+.++.||+|+||+||+|+++.+++.||+|++....      .+.+.+|+.+|++++||||+++++++.....    ++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~----~~   77 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDN----LY   77 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCE----EE
Confidence            5899999999999999999999999999999986422      3457789999999999999999998765443    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.  +||+|||+++......
T Consensus        78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~--~kL~DFGl~~~~~~~~  155 (381)
T cd05626          78 FVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH--IKLTDFGLCTGFRWTH  155 (381)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCC--EEEeeCcCCccccccc
Confidence            99999999999999998778999999999999999999999999999999999999987665  9999999976431100


Q ss_pred             C----------------------------------------------CCCCccccCCcccChhhhcCCCCCCCCChHHHH
Q 040569          156 D----------------------------------------------DEGKPICGTPICMAPEVARGEEQGFPADVWALG  189 (385)
Q Consensus       156 ~----------------------------------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG  189 (385)
                      .                                              ......+||+.|||||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                              001235799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCC--CcCCHHHHHHHHHhh--hcCCCCCCCHHHHHhCcccccccc
Q 040569          190 CTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP--GYMSKQAQDFLSKCL--IRNPGERWSASELLEHGFVKEQNF  264 (385)
Q Consensus       190 ~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~ll~~cL--~~dP~~Rps~~elL~hp~~~~~~~  264 (385)
                      |++|||++|+.||............+. ......+|  ..+++++++||.+|+  ..+|.+|+++.++++||||....+
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQLKVIN-WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHHHHHHc-cccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence            999999999999976543333222221 11122222  247999999999955  556666999999999999987644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-48  Score=383.05  Aligned_cols=255  Identities=25%  Similarity=0.399  Sum_probs=212.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+|+++.+++.||||++...      ....+++|+.+|+.++||||+++++.+.....    ++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~----~~   77 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENY----LY   77 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCe----EE
Confidence            699999999999999999999999999999998642      23457789999999999999999998765443    77


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus        78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSH  155 (364)
T ss_pred             EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEeecccceeccccc
Confidence            99999999999999998778999999999999999999999999999999999999987766  9999999987643211


Q ss_pred             CC-------------------------------------CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhC
Q 040569          156 DD-------------------------------------EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATG  198 (385)
Q Consensus       156 ~~-------------------------------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG  198 (385)
                      ..                                     .....+||+.|||||++.+..++.++|||||||++|+|++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            00                                     01134699999999999999999999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHhcCCCCCCCCC--CcCCHHHHHHHHHhhhcCCCCCCC---HHHHHhCcccccccc
Q 040569          199 RPPWPDVADPISALHRIGFSSDTPEIP--GYMSKQAQDFLSKCLIRNPGERWS---ASELLEHGFVKEQNF  264 (385)
Q Consensus       199 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~ll~~cL~~dP~~Rps---~~elL~hp~~~~~~~  264 (385)
                      +.||.... .......+........++  ..+++++++||.+||. +|.+|++   +.|+|+||||+...+
T Consensus       236 ~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~  304 (364)
T cd05599         236 YPPFCSDN-PQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDW  304 (364)
T ss_pred             CCCCCCCC-HHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            99997643 333333332211112222  2478999999999996 8999998   999999999987654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.1e-49  Score=363.48  Aligned_cols=254  Identities=28%  Similarity=0.411  Sum_probs=213.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHH-----HHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~-----~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|+++..|++|+||.||+|+++.|+++||+|+++.+...     ...||+.+|.+++|||||.+..+.+...-..  +|+
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~--iy~  154 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK--IYI  154 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce--eee
Confidence            488899999999999999999999999999999765432     3468999999999999999999877665544  569


Q ss_pred             EEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |||||+. +|..++.. ..++.+.+++-++.|++.||+|||.+.|+||||||+|+|++..|.  +||||||+|+.+... 
T Consensus       155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~--lKiaDFGLAR~ygsp-  230 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI--LKIADFGLAREYGSP-  230 (419)
T ss_pred             eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc--EEecccchhhhhcCC-
Confidence            9999987 99999984 458999999999999999999999999999999999999987766  999999999988533 


Q ss_pred             CCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCC---------C---
Q 040569          156 DDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDT---------P---  222 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~---------~---  222 (385)
                      ....++.+-|.+|.|||.+.+. .|+.+.|+||+|||+.||+++++.|++..+..+ +.+|......         .   
T Consensus       231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ-l~~If~llGtPte~iwpg~~~lp  309 (419)
T KOG0663|consen  231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ-LDKIFKLLGTPSEAIWPGYSELP  309 (419)
T ss_pred             cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH-HHHHHHHhCCCccccCCCccccc
Confidence            3345666789999999999876 689999999999999999999999998654433 3332110000         0   


Q ss_pred             -----------------CCCCc-CCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          223 -----------------EIPGY-MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       223 -----------------~~~~~-~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                       .++.. +|+...+|+..+|..||.+|.|+.|.|+|.||.+.
T Consensus       310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence                             11111 67999999999999999999999999999999874

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.4e-48  Score=376.95  Aligned_cols=248  Identities=29%  Similarity=0.456  Sum_probs=210.0

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +.||+|+||+||+++++.+|+.||+|.+...      ....+.+|++++++++||||+++++.+.....    +++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~----~~lv~E~   76 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR----LCFVMEY   76 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCE----EEEEEeC
Confidence            5799999999999999999999999988642      22456689999999999999999988765543    6799999


Q ss_pred             cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCC
Q 040569           81 APGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGK  160 (385)
Q Consensus        81 ~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~  160 (385)
                      ++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++..... .....
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~-~~~~~  153 (323)
T cd05595          77 ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISD-GATMK  153 (323)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC--EEecccHHhccccCC-CCccc
Confidence            999999999988788999999999999999999999999999999999999987765  999999998753211 12233


Q ss_pred             ccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhh
Q 040569          161 PICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCL  240 (385)
Q Consensus       161 ~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL  240 (385)
                      ..+||+.|||||++.+..++.++|||||||++|+|++|+.||... +.......+.  .....+|..+++++++||.+||
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~-~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L  230 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHERLFELIL--MEEIRFPRTLSPEAKSLLAGLL  230 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHc
Confidence            457999999999999999999999999999999999999999764 3333333332  2233466778999999999999


Q ss_pred             hcCCCCCC-----CHHHHHhCcccccccc
Q 040569          241 IRNPGERW-----SASELLEHGFVKEQNF  264 (385)
Q Consensus       241 ~~dP~~Rp-----s~~elL~hp~~~~~~~  264 (385)
                      ++||.+|+     ++.++++||||....+
T Consensus       231 ~~dP~~R~~~~~~~~~~~l~h~~~~~~~~  259 (323)
T cd05595         231 KKDPKQRLGGGPSDAKEVMEHRFFLSINW  259 (323)
T ss_pred             cCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            99999998     8999999999987643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.5e-48  Score=377.46  Aligned_cols=248  Identities=29%  Similarity=0.467  Sum_probs=210.6

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +.||+|+||+||++.++.+++.||+|.+...      ....+.+|+++|+.+.||||+++++++.....    +++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~----~~lv~Ey   76 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDR----LCFVMEY   76 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCE----EEEEEeC
Confidence            4799999999999999999999999988642      23456789999999999999999988765443    6799999


Q ss_pred             cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCC
Q 040569           81 APGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGK  160 (385)
Q Consensus        81 ~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~  160 (385)
                      +++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++..... .....
T Consensus        77 ~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DfG~~~~~~~~-~~~~~  153 (328)
T cd05593          77 VNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITD-AATMK  153 (328)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc--EEEecCcCCccCCCc-ccccc
Confidence            999999999988778999999999999999999999999999999999999987766  999999998754221 12234


Q ss_pred             ccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhh
Q 040569          161 PICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCL  240 (385)
Q Consensus       161 ~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL  240 (385)
                      ..+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+.  .....+|..+++++.+||.+||
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~-~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L  230 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELIL--MEDIKFPRTLSADAKSLLSGLL  230 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC-CHHHHHHHhc--cCCccCCCCCCHHHHHHHHHHc
Confidence            457999999999999999999999999999999999999999764 3333333332  2334567779999999999999


Q ss_pred             hcCCCCCC-----CHHHHHhCcccccccc
Q 040569          241 IRNPGERW-----SASELLEHGFVKEQNF  264 (385)
Q Consensus       241 ~~dP~~Rp-----s~~elL~hp~~~~~~~  264 (385)
                      ++||.+|+     ++.|+++||||...++
T Consensus       231 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~  259 (328)
T cd05593         231 IKDPNKRLGGGPDDAKEIMRHSFFTGVNW  259 (328)
T ss_pred             CCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            99999997     8999999999987543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.2e-50  Score=373.19  Aligned_cols=256  Identities=33%  Similarity=0.435  Sum_probs=214.1

Q ss_pred             CCceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCC-eEEEEEEEe
Q 040569            1 MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENG-KILYNLFLE   79 (385)
Q Consensus         1 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~-~~~~~lv~E   79 (385)
                      |.|.-.+.+|+|+||.||.|+...+++.+|||++-.+ ...-.+|++||+.+.|||||++.-+|....+. ..+.++|||
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d-~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle  102 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD-KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE  102 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCC-CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence            4678899999999999999999999999999988543 33445899999999999999999888776665 567889999


Q ss_pred             ecCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           80 YAPGGTLTDAIRS----GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        80 y~~ggsL~~~l~~----~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |++. +|.+.++.    +.+++...++.|++||++||.|||+.||+||||||+|+|++.+. +.+||||||.|+....++
T Consensus       103 ymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~t-g~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  103 YMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDT-GVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             hchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCC-CeEEeccCCcceeeccCC
Confidence            9986 99999983    67799999999999999999999999999999999999999773 348999999999985444


Q ss_pred             CCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCC-------------
Q 040569          156 DDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDT-------------  221 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~-------------  221 (385)
                      .  .....-|..|.|||.+.|. .|+.+.||||.||++.||+.|++-|++.+ ...++..+..-.+.             
T Consensus       181 p--niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik~lG~Pt~e~I~~mn~~y  257 (364)
T KOG0658|consen  181 P--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIKVLGTPTREDIKSMNPNY  257 (364)
T ss_pred             C--ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence            3  3556679999999999775 78999999999999999999999999853 33333322110000             


Q ss_pred             -----C---------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          222 -----P---------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       222 -----~---------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                           |         -+....++++.+|+.++|+.+|.+|.++.|+|.||||.+.
T Consensus       258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel  312 (364)
T KOG0658|consen  258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL  312 (364)
T ss_pred             ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence                 1         1334578999999999999999999999999999999864

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.8e-48  Score=380.89  Aligned_cols=255  Identities=27%  Similarity=0.416  Sum_probs=211.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+|+++.+++.+|+|.+...      ..+.+.+|+.+++.++||||+++++++.....    ++
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~----~~  119 (370)
T cd05596          44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY----LY  119 (370)
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE----EE
Confidence            589999999999999999999999999999988532      23457789999999999999999987765432    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||++.......
T Consensus       120 lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~  196 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANG  196 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCC
Confidence            999999999999998754 5899999999999999999999999999999999999987766  9999999998764332


Q ss_pred             CCCCCccccCCcccChhhhcCC----CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCC--cCC
Q 040569          156 DDEGKPICGTPICMAPEVARGE----EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPG--YMS  229 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~s  229 (385)
                      .......+||+.|||||++.+.    .++.++|||||||++|+|++|+.||.... .......+........+|.  .+|
T Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s  275 (370)
T cd05596         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-LVGTYSKIMDHKNSLTFPDDIEIS  275 (370)
T ss_pred             cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC-HHHHHHHHHcCCCcCCCCCcCCCC
Confidence            2233456799999999998654    37889999999999999999999998643 3333333322222223333  479


Q ss_pred             HHHHHHHHHhhhcCCCC--CCCHHHHHhCcccccccc
Q 040569          230 KQAQDFLSKCLIRNPGE--RWSASELLEHGFVKEQNF  264 (385)
Q Consensus       230 ~~~~~ll~~cL~~dP~~--Rps~~elL~hp~~~~~~~  264 (385)
                      .++++||.+||+.+|.+  |+|+.++++||||+...+
T Consensus       276 ~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             HHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence            99999999999999988  999999999999987543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.7e-48  Score=370.85  Aligned_cols=253  Identities=30%  Similarity=0.412  Sum_probs=205.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++.+.||+|+||+||+|+++.+++.+|+|.+....    ...+.+|+.+++.++||||+++++++.....    +++|
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~lv   81 (303)
T cd07869           6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKET----LTLV   81 (303)
T ss_pred             cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCe----EEEE
Confidence            6999999999999999999999999999999886432    2456789999999999999999998765432    6799


Q ss_pred             EeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           78 LEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |||+. ++|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++..... .
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~-~  157 (303)
T cd07869          82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE--LKLADFGLARAKSVP-S  157 (303)
T ss_pred             EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECCCCcceeccCC-C
Confidence            99996 57877776 4567999999999999999999999999999999999999987665  999999999764322 1


Q ss_pred             CCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCC-------------
Q 040569          157 DEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP-------------  222 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-------------  222 (385)
                      .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....+....+..+......+             
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence            22234568999999999875 4578899999999999999999999987655544433321100000             


Q ss_pred             ---C-----CC---------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          223 ---E-----IP---------GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       223 ---~-----~~---------~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                         .     .+         ...++.+++||.+||++||++|||+.|+|+||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence               0     00         1245789999999999999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.1e-48  Score=383.05  Aligned_cols=255  Identities=24%  Similarity=0.377  Sum_probs=210.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+|+++.+++.||+|.+...      ....+++|+++|+++.||||+++++.+.....    ++
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~----~~   77 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDN----LY   77 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCE----EE
Confidence            699999999999999999999999999999988642      23567789999999999999999988765433    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|.......
T Consensus        78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~  155 (376)
T cd05598          78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTH  155 (376)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC--EEEEeCCCCccccccc
Confidence            99999999999999998888999999999999999999999999999999999999987766  9999999975321000


Q ss_pred             ------------------------------------------CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHH
Q 040569          156 ------------------------------------------DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVL  193 (385)
Q Consensus       156 ------------------------------------------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  193 (385)
                                                                .......+||+.|||||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                      00012357999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCChHHHHHHhcCCCCCCCC--CCcCCHHHHHHHHHhhhcCCCCCC---CHHHHHhCcccccccc
Q 040569          194 EMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMSKQAQDFLSKCLIRNPGERW---SASELLEHGFVKEQNF  264 (385)
Q Consensus       194 elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~ll~~cL~~dP~~Rp---s~~elL~hp~~~~~~~  264 (385)
                      +|++|+.||.... .......+........+  ...+++++.+||.+|+ .+|.+|+   ++.++++||||.....
T Consensus       236 ell~G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~  309 (376)
T cd05598         236 EMLVGQPPFLADT-PAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDF  309 (376)
T ss_pred             ehhhCCCCCCCCC-HHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence            9999999998753 33332332211111122  2357999999999976 5999999   9999999999987543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.7e-48  Score=383.23  Aligned_cols=255  Identities=24%  Similarity=0.383  Sum_probs=210.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      .|+.++.||+|+||+||+|+++.+++.+|+|.+....      ...+.+|+.+++++.||||+++++.+.....    ++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~----~~   77 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN----LY   77 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCE----EE
Confidence            5899999999999999999999999999999886432      3467789999999999999999998875443    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++.......
T Consensus        78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~  155 (382)
T cd05625          78 FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTH  155 (382)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEeECCCCccccccc
Confidence            99999999999999987778999999999999999999999999999999999999987766  9999999975321000


Q ss_pred             ----------------------------------------------CCCCCccccCCcccChhhhcCCCCCCCCChHHHH
Q 040569          156 ----------------------------------------------DDEGKPICGTPICMAPEVARGEEQGFPADVWALG  189 (385)
Q Consensus       156 ----------------------------------------------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG  189 (385)
                                                                    .......+||+.|||||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                          0001235799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCC--CCcCCHHHHHHHHHhhhcCCCCCCC---HHHHHhCcccccccc
Q 040569          190 CTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMSKQAQDFLSKCLIRNPGERWS---ASELLEHGFVKEQNF  264 (385)
Q Consensus       190 ~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~ll~~cL~~dP~~Rps---~~elL~hp~~~~~~~  264 (385)
                      |++|||++|+.||..... ......+.........  ...++++++++|.+|+ .+|.+|++   +.++++||||+...+
T Consensus       236 vil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~  313 (382)
T cd05625         236 VILYEMLVGQPPFLAQTP-LETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDF  313 (382)
T ss_pred             HHHHHHHhCCCCCCCCCH-HHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence            999999999999987533 3333332221111222  2357999999999976 59999997   999999999987643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-48  Score=378.80  Aligned_cols=255  Identities=29%  Similarity=0.458  Sum_probs=214.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+|+++.+++.||+|.+...      ....+.+|+.++..+.||||+++++++.....    ++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~----~~   77 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEH----LY   77 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCe----EE
Confidence            699999999999999999999999999999988642      23567889999999999999999988765433    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++.......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAK  155 (350)
T ss_pred             EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEeecCCCCccCcccC
Confidence            99999999999999997788999999999999999999999999999999999999987766  9999999998654332


Q ss_pred             ----------------------------CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCC
Q 040569          156 ----------------------------DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVAD  207 (385)
Q Consensus       156 ----------------------------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~  207 (385)
                                                  ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~-  234 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT-  234 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC-
Confidence                                        112234579999999999999999999999999999999999999998754 


Q ss_pred             hHHHHHHhcCCCCCCCCCC--cCCHHHHHHHHHhhhcCCCCCCC-HHHHHhCcccccccc
Q 040569          208 PISALHRIGFSSDTPEIPG--YMSKQAQDFLSKCLIRNPGERWS-ASELLEHGFVKEQNF  264 (385)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~--~~s~~~~~ll~~cL~~dP~~Rps-~~elL~hp~~~~~~~  264 (385)
                      ......++........+|.  .+++++.+||.+||. ||.+||+ +.++|+||||....+
T Consensus       235 ~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~  293 (350)
T cd05573         235 LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW  293 (350)
T ss_pred             HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence            3333333322111122222  269999999999997 9999999 999999999987644

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.3e-48  Score=374.30  Aligned_cols=254  Identities=29%  Similarity=0.488  Sum_probs=211.0

Q ss_pred             CceeeceeeccCceEEEEEEEC---CCCcEEEEEeccCC-------CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCC
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN---RSSEVFAVKSAELS-------NSEFLQREQRILSAL-ACPQIVAYKGCDISEENG   70 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~---~~~~~~AvK~~~~~-------~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~   70 (385)
                      +|++++.||+|+||+||++++.   .+++.+|+|++...       ..+.+.+|+.+++++ .||||+++++++..... 
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~-   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK-   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE-
Confidence            6999999999999999999864   57899999988532       124567899999999 59999999987755432 


Q ss_pred             eEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569           71 KILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus        71 ~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                         +++||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.
T Consensus        80 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~  154 (332)
T cd05614          80 ---LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKE  154 (332)
T ss_pred             ---EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC--EEEeeCcCCcc
Confidence               6799999999999999987778999999999999999999999999999999999999987765  99999999986


Q ss_pred             ecccCCCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCC--ChHH-HHHHhcCCCCCCCCCC
Q 040569          151 ARVNEDDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVA--DPIS-ALHRIGFSSDTPEIPG  226 (385)
Q Consensus       151 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~--~~~~-~~~~~~~~~~~~~~~~  226 (385)
                      ............+||+.|||||++.+. .++.++|||||||++|+|++|+.||....  .... ....+  ....+.++.
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~  232 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--LKCDPPFPS  232 (332)
T ss_pred             ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH--hcCCCCCCC
Confidence            543333333456799999999999875 47889999999999999999999996432  1122 22222  223355667


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCccccccc
Q 040569          227 YMSKQAQDFLSKCLIRNPGERW-----SASELLEHGFVKEQN  263 (385)
Q Consensus       227 ~~s~~~~~ll~~cL~~dP~~Rp-----s~~elL~hp~~~~~~  263 (385)
                      .+++.+++||.+||++||++||     +++++++||||....
T Consensus       233 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  274 (332)
T cd05614         233 FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD  274 (332)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            7899999999999999999999     888999999998654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8.1e-48  Score=371.46  Aligned_cols=253  Identities=26%  Similarity=0.461  Sum_probs=213.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCC-CeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACP-QIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hp-nIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++.+.||+|+||+||+|.++.+++.||+|++...      ..+.+.+|.+++..+.|+ +|+++++++.....    +
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~----~   76 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR----L   76 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCE----E
Confidence            699999999999999999999999999999988642      234567899999999764 57888887755443    6


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus        77 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~  154 (324)
T cd05587          77 YFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFG  154 (324)
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC--EEEeecCcceecCCC
Confidence            799999999999999988778999999999999999999999999999999999999987765  999999998754221


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                       .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+.  ...+.+|..+++++.+
T Consensus       155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~-~~~~~~~~i~--~~~~~~~~~~~~~~~~  230 (324)
T cd05587         155 -GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE-DEDELFQSIM--EHNVSYPKSLSKEAVS  230 (324)
T ss_pred             -CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHH--cCCCCCCCCCCHHHHH
Confidence             22234557999999999999999999999999999999999999999764 3333333332  2334567779999999


Q ss_pred             HHHHhhhcCCCCCCCH-----HHHHhCcccccccc
Q 040569          235 FLSKCLIRNPGERWSA-----SELLEHGFVKEQNF  264 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~-----~elL~hp~~~~~~~  264 (385)
                      |+.+||.+||.+|++.     .++++||||...++
T Consensus       231 li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         231 ICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            9999999999999976     89999999987644

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=8.1e-48  Score=378.56  Aligned_cols=254  Identities=26%  Similarity=0.413  Sum_probs=209.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+++++.+++.+|+|.+.+.      ..+.+.+|+.+++.+.||||+++++++.....    ++
T Consensus        44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~----~~  119 (370)
T cd05621          44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY----LY  119 (370)
T ss_pred             HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE----EE
Confidence            589999999999999999999999999999987531      23457789999999999999999988765432    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++.......
T Consensus       120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~  196 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETG  196 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEEecccceecccCC
Confidence            999999999999999754 5899999999999999999999999999999999999987766  9999999998764332


Q ss_pred             CCCCCccccCCcccChhhhcCCC----CCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCC--cCC
Q 040569          156 DDEGKPICGTPICMAPEVARGEE----QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPG--YMS  229 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~s  229 (385)
                      .......+||+.|||||++.+..    ++.++|||||||++|+|++|+.||.... .......+........+|.  .++
T Consensus       197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~~~~s  275 (370)
T cd05621         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS-LVGTYSKIMDHKNSLNFPEDVEIS  275 (370)
T ss_pred             ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCcccCCCCcccCC
Confidence            22334567999999999997643    7789999999999999999999997643 3333344332222233333  469


Q ss_pred             HHHHHHHHHhhhcCCCC--CCCHHHHHhCccccccc
Q 040569          230 KQAQDFLSKCLIRNPGE--RWSASELLEHGFVKEQN  263 (385)
Q Consensus       230 ~~~~~ll~~cL~~dP~~--Rps~~elL~hp~~~~~~  263 (385)
                      ..+++++.+||..++.+  |+++.|+++||||+...
T Consensus       276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~  311 (370)
T cd05621         276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ  311 (370)
T ss_pred             HHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence            99999999999865544  89999999999998643

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.1e-48  Score=371.94  Aligned_cols=248  Identities=28%  Similarity=0.483  Sum_probs=209.7

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +.||+|+||+||+|+++.+++.||+|.+...      ..+.+.+|..+++.+ .||||+++++++.....    +++|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~----~~iv~E   76 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDR----LFFVME   76 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCE----EEEEEc
Confidence            4799999999999999999999999988642      234556788888877 79999999998765443    679999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      |++||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++..... ....
T Consensus        77 y~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~--~kL~DfG~~~~~~~~-~~~~  153 (320)
T cd05590          77 FVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIFN-GKTT  153 (320)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeeCCCCeecCcC-CCcc
Confidence            9999999999988788999999999999999999999999999999999999987766  999999998764222 1223


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHh
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC  239 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~c  239 (385)
                      ...+||+.|||||++.+..++.++|||||||++|+|++|+.||... +.......+.  .....++..+++++++||.+|
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~  230 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE-NEDDLFEAIL--NDEVVYPTWLSQDAVDILKAF  230 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC-CHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHH
Confidence            4457999999999999999999999999999999999999999764 3333333332  233456677899999999999


Q ss_pred             hhcCCCCCCCH------HHHHhCcccccccc
Q 040569          240 LIRNPGERWSA------SELLEHGFVKEQNF  264 (385)
Q Consensus       240 L~~dP~~Rps~------~elL~hp~~~~~~~  264 (385)
                      |++||.+||++      +++++||||....+
T Consensus       231 L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         231 MTKNPTMRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             cccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence            99999999998      89999999987543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=9.7e-48  Score=369.88  Aligned_cols=248  Identities=30%  Similarity=0.524  Sum_probs=208.3

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +.||+|+||+||+|.++.+++.||+|.+...      ..+...+|..++..+ .||||+++++++....    .+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~----~~~lv~e   76 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE----HLFFVME   76 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC----EEEEEEc
Confidence            4799999999999999999999999988642      233455677777755 8999999998875543    2679999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      |++||+|.++++..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...... ...
T Consensus        77 ~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~a~~~~~~~-~~~  153 (316)
T cd05592          77 YLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGE-GKA  153 (316)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC--EEEccCcCCeECCCCC-Ccc
Confidence            9999999999988778999999999999999999999999999999999999987765  9999999998653222 233


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHh
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC  239 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~c  239 (385)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+  ....+.+|..++.++.+||.+|
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~-~~~~~~~i--~~~~~~~~~~~~~~~~~ll~~~  230 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED-EDELFDSI--LNDRPHFPRWISKEAKDCLSKL  230 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-HHHHHHHH--HcCCCCCCCCCCHHHHHHHHHH
Confidence            45679999999999999999999999999999999999999998643 33333333  2345567778999999999999


Q ss_pred             hhcCCCCCCCHH-HHHhCcccccccc
Q 040569          240 LIRNPGERWSAS-ELLEHGFVKEQNF  264 (385)
Q Consensus       240 L~~dP~~Rps~~-elL~hp~~~~~~~  264 (385)
                      |++||.+||++. ++++||||...++
T Consensus       231 l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05592         231 FERDPTKRLGVDGDIRQHPFFRGIDW  256 (316)
T ss_pred             ccCCHHHcCCChHHHHcCcccCCCCH
Confidence            999999999864 8889999987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-48  Score=381.28  Aligned_cols=254  Identities=24%  Similarity=0.401  Sum_probs=208.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+||++.++.+++.||||.+...      ..+.+++|+++++++.||||+++++++.....    +|
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~----~~   77 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQY----LY   77 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCe----eE
Confidence            699999999999999999999999999999987542      13457789999999999999999998765443    77


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus        78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~--~kl~DfGla~~~~~~~  155 (377)
T cd05629          78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQH  155 (377)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEEeeccccccccccc
Confidence            99999999999999998788999999999999999999999999999999999999987665  9999999986321100


Q ss_pred             C-------------C---------------------------------CCCccccCCcccChhhhcCCCCCCCCChHHHH
Q 040569          156 D-------------D---------------------------------EGKPICGTPICMAPEVARGEEQGFPADVWALG  189 (385)
Q Consensus       156 ~-------------~---------------------------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG  189 (385)
                      .             .                                 .....+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            0             0                                 00124699999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCC--cCCHHHHHHHHHhhhcCCCCC---CCHHHHHhCccccccc
Q 040569          190 CTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPG--YMSKQAQDFLSKCLIRNPGER---WSASELLEHGFVKEQN  263 (385)
Q Consensus       190 ~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~ll~~cL~~dP~~R---ps~~elL~hp~~~~~~  263 (385)
                      |++|||++|+.||... +.......+........+|.  .++.++++||.+||. +|.+|   +++.|+++||||...+
T Consensus       236 vil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~  312 (377)
T cd05629         236 AIMFECLIGWPPFCSE-NSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD  312 (377)
T ss_pred             hhhhhhhcCCCCCCCC-CHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence            9999999999999764 33333333322222222332  478999999999998 66665   5999999999998654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.8e-48  Score=373.92  Aligned_cols=247  Identities=28%  Similarity=0.446  Sum_probs=209.2

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +.||+|+||+||++.++.+++.+|+|.+...      ....+.+|+++++.+.||||+++++++.....    +++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~----~~lv~E~   76 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR----LCFVMEY   76 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCE----EEEEEeC
Confidence            4799999999999999999999999988642      22455689999999999999999987765443    6799999


Q ss_pred             cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           81 APGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        81 ~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~-~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      ++||+|.+++...+.+++..+..++.||+.||+|||+ +||+||||||+|||++.++.  +||+|||+++..... ....
T Consensus        77 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~--~kL~Dfg~~~~~~~~-~~~~  153 (325)
T cd05594          77 ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKD-GATM  153 (325)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC--EEEecCCCCeecCCC-Cccc
Confidence            9999999999887889999999999999999999997 79999999999999987766  999999998764222 1223


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHh
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC  239 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~c  239 (385)
                      ...+||+.|||||++.+..++.++|||||||++|+|++|+.||... +.......+.  .....+|..+++++.+||.+|
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~-~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~  230 (325)
T cd05594         154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELIL--MEEIRFPRTLSPEAKSLLSGL  230 (325)
T ss_pred             ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC-CHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHH
Confidence            3457999999999999999999999999999999999999999764 3333333332  233456677899999999999


Q ss_pred             hhcCCCCCC-----CHHHHHhCccccccc
Q 040569          240 LIRNPGERW-----SASELLEHGFVKEQN  263 (385)
Q Consensus       240 L~~dP~~Rp-----s~~elL~hp~~~~~~  263 (385)
                      |++||++|+     ++.++++||||....
T Consensus       231 L~~dP~~R~~~~~~~~~~il~h~~~~~~~  259 (325)
T cd05594         231 LKKDPKQRLGGGPDDAKEIMQHKFFAGIV  259 (325)
T ss_pred             hhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence            999999997     899999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=9.1e-48  Score=364.83  Aligned_cols=249  Identities=30%  Similarity=0.429  Sum_probs=202.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++.+.||+|+||+||+|+++.+++.||+|.+....    ...+.+|++++++++||||+++++++....    .+++|
T Consensus         6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv   81 (288)
T cd07871           6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTER----CLTLV   81 (288)
T ss_pred             cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC----eEEEE
Confidence            5999999999999999999999999999999886432    346678999999999999999999876543    36799


Q ss_pred             EeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           78 LEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |||+++ +|.+++.. +..+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...... 
T Consensus        82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~-  157 (288)
T cd07871          82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPT-  157 (288)
T ss_pred             EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEECcCcceeeccCCC-
Confidence            999985 99998874 446899999999999999999999999999999999999987766  9999999998653222 


Q ss_pred             CCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC--CC--------------
Q 040569          157 DEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF--SS--------------  219 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~--------------  219 (385)
                      .......|++.|+|||++.+ ..++.++|||||||++|+|++|++||..... ...+..+..  ..              
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV-KEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChHHhhccccchh
Confidence            22234568999999999875 5688999999999999999999999976432 222211100  00              


Q ss_pred             ----CCC--------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          220 ----DTP--------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       220 ----~~~--------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                          ..+        .....+++++++||.+||++||.+|||++|+|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                000        0112468899999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1e-47  Score=370.32  Aligned_cols=249  Identities=30%  Similarity=0.504  Sum_probs=210.5

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +.||+|+||+||+|.++.+++.||+|.+...      ..+.+.+|.++++.+ +||||+++++++.....    +++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~----~~lv~E   76 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDR----LFFVME   76 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCe----EEEEEe
Confidence            4799999999999999999999999988642      223456789999876 89999999998866543    679999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      |++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..... ....
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~--~kL~Dfg~~~~~~~~-~~~~  153 (321)
T cd05591          77 YVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH--CKLADFGMCKEGILN-GVTT  153 (321)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeecccceecccC-Cccc
Confidence            9999999999988788999999999999999999999999999999999999987766  999999998864322 2223


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHh
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC  239 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~c  239 (385)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+.  ......|..+++++.+||.+|
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~-~~~~~~~~i~--~~~~~~p~~~~~~~~~ll~~~  230 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD-NEDDLFESIL--HDDVLYPVWLSKEAVSILKAF  230 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC-CHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHH
Confidence            4567999999999999999999999999999999999999999864 3344444432  223445667899999999999


Q ss_pred             hhcCCCCCC-------CHHHHHhCccccccccc
Q 040569          240 LIRNPGERW-------SASELLEHGFVKEQNFK  265 (385)
Q Consensus       240 L~~dP~~Rp-------s~~elL~hp~~~~~~~~  265 (385)
                      |++||.+||       ++.++++||||...++.
T Consensus       231 L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~  263 (321)
T cd05591         231 MTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV  263 (321)
T ss_pred             hccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence            999999999       89999999999876443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1e-47  Score=371.77  Aligned_cols=250  Identities=28%  Similarity=0.520  Sum_probs=208.4

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +.||+|+||+||+|.++.+++.||+|.+...      ....+++|..+++++ +||||+++++++.....    +++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~----~~lv~e   76 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESR----LFFVIE   76 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCE----EEEEEe
Confidence            4799999999999999999999999988642      124577899999998 79999999998765443    679999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      |++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... .....
T Consensus        77 ~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~-~~~~~  153 (329)
T cd05588          77 FVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGIR-PGDTT  153 (329)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEECcCcccccccc-CCCcc
Confidence            9999999999987788999999999999999999999999999999999999987765  99999999875321 12223


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCC-------ChHHHHHHhcCCCCCCCCCCcCCHHH
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVA-------DPISALHRIGFSSDTPEIPGYMSKQA  232 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~s~~~  232 (385)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||....       .....+.... ......+|..++.++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~p~~~~~~~  232 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI-LEKQIRIPRSLSVKA  232 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH-HcCCCCCCCCCCHHH
Confidence            45679999999999999999999999999999999999999996321       1111122211 123345677899999


Q ss_pred             HHHHHHhhhcCCCCCCC------HHHHHhCcccccccc
Q 040569          233 QDFLSKCLIRNPGERWS------ASELLEHGFVKEQNF  264 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps------~~elL~hp~~~~~~~  264 (385)
                      +++|.+||++||.+|++      ++++++||||....+
T Consensus       233 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             HHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            99999999999999997      789999999987544

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-49  Score=389.19  Aligned_cols=250  Identities=36%  Similarity=0.615  Sum_probs=222.9

Q ss_pred             eeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecCCC
Q 040569            8 TIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGG   84 (385)
Q Consensus         8 ~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~gg   84 (385)
                      .||+|.||+||-|++..|....|||.+....   .+.+..|+.+-++|.|.|||+++|.+.  ++|  ++-|+||-++||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s--enG--f~kIFMEqVPGG  657 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVS--ENG--FFKIFMEQVPGG  657 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccC--CCC--eEEEEeecCCCC
Confidence            6999999999999999999999999997544   345778999999999999999999853  333  356899999999


Q ss_pred             CHHHHHH-cCCCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCCc
Q 040569           85 TLTDAIR-SGTCL--EEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP  161 (385)
Q Consensus        85 sL~~~l~-~~~~l--~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~~  161 (385)
                      ||.++++ +=+++  +|..+..|.+||++||.|||++.|||||||.+||||+.-. +.+||.|||.++... .-+.-..+
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTyS-GvlKISDFGTsKRLA-ginP~TET  735 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYS-GVLKISDFGTSKRLA-GINPCTET  735 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeecc-ceEEecccccchhhc-cCCccccc
Confidence            9999998 44667  8999999999999999999999999999999999998653 336999999998764 22334567


Q ss_pred             cccCCcccChhhhcCC--CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHh
Q 040569          162 ICGTPICMAPEVARGE--EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC  239 (385)
Q Consensus       162 ~~Gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~c  239 (385)
                      +.||..|||||++..+  .|+.++|||||||++.||+||++||....++...+.++++-.-.|.+|..+|.+++.||.+|
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc  815 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC  815 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence            7899999999999765  68999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhcCCCCCCCHHHHHhCccccccc
Q 040569          240 LIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       240 L~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      +.+||.+||++.++|..||++..+
T Consensus       816 Fepd~~~R~sA~~LL~DpFlq~~~  839 (1226)
T KOG4279|consen  816 FEPDPCDRPSAKDLLQDPFLQHNN  839 (1226)
T ss_pred             cCCCcccCccHHHhccCcccccCC
Confidence            999999999999999999998653

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4e-48  Score=374.23  Aligned_cols=255  Identities=27%  Similarity=0.417  Sum_probs=211.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+|+++.+++.+|+|.+...      ....+++|+.+++.+.||||+++++++.....    ++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~----~~   77 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDN----LY   77 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCe----EE
Confidence            699999999999999999999999999999988643      23467889999999999999999988765432    67


Q ss_pred             EEEeecCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           76 LFLEYAPGGTLTDAIRSG-TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~-~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +||||++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~  155 (330)
T cd05601          78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH--IKLADFGSAARLTAN  155 (330)
T ss_pred             EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC--EEeccCCCCeECCCC
Confidence            999999999999999864 67999999999999999999999999999999999999987766  999999999876433


Q ss_pred             CCCCCCccccCCcccChhhhc------CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCC--C
Q 040569          155 EDDEGKPICGTPICMAPEVAR------GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP--G  226 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~  226 (385)
                      .........||+.|+|||++.      +..++.++|||||||++|+|++|+.||.... .......+........+|  .
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~  234 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT-SAKTYNNIMNFQRFLKFPEDP  234 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC-HHHHHHHHHcCCCccCCCCCC
Confidence            322233457999999999987      4567889999999999999999999997643 333333332111112222  2


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccccc
Q 040569          227 YMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF  264 (385)
Q Consensus       227 ~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~~  264 (385)
                      .+++++++||.+||. +|.+|||+.++++||||...++
T Consensus       235 ~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~  271 (330)
T cd05601         235 KVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW  271 (330)
T ss_pred             CCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence            478999999999998 9999999999999999987543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.6e-49  Score=355.33  Aligned_cols=251  Identities=29%  Similarity=0.468  Sum_probs=213.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----------HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccC
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----------SEFLQREQRILSAL-ACPQIVAYKGCDISEEN   69 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----------~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~   69 (385)
                      .|...+.||+|..++|-++.++.+|+.+|+|++....           .+.-.+|+.||+++ .||+|+++.+++.+.. 
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s-   96 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA-   96 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc-
Confidence            4677889999999999999999999999999886421           13445799999998 8999999999876543 


Q ss_pred             CeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCcee
Q 040569           70 GKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR  149 (385)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~  149 (385)
                         +.++|+|.|+.|.|.|++...-.++|...+.+++|+++|+.|||.++||||||||+|||++.+.+  +||+|||+|.
T Consensus        97 ---F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~--i~isDFGFa~  171 (411)
T KOG0599|consen   97 ---FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN--IKISDFGFAC  171 (411)
T ss_pred             ---hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc--eEEeccceee
Confidence               36799999999999999998888999999999999999999999999999999999999987766  9999999999


Q ss_pred             eecccCCCCCCccccCCcccChhhhcCC------CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc---CCCC
Q 040569          150 RARVNEDDEGKPICGTPICMAPEVARGE------EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG---FSSD  220 (385)
Q Consensus       150 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~---~~~~  220 (385)
                      .+..+  ......||||+|+|||.+...      .|+..+|+||+|+|+|.|+.|.+||... .....+..|.   +...
T Consensus       172 ~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-kQmlMLR~ImeGkyqF~  248 (411)
T KOG0599|consen  172 QLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-KQMLMLRMIMEGKYQFR  248 (411)
T ss_pred             ccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-HHHHHHHHHHhcccccC
Confidence            88543  344667999999999999643      5788999999999999999999999764 3333344332   2222


Q ss_pred             CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          221 TPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       221 ~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      .|+ ...+|...+|||.+||+.||.+|+|++|+|.||||.+.
T Consensus       249 spe-Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  249 SPE-WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             Ccc-hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            333 34589999999999999999999999999999999764

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-47  Score=369.10  Aligned_cols=248  Identities=28%  Similarity=0.445  Sum_probs=208.9

Q ss_pred             eceeeccCceEEEEEEEC---CCCcEEEEEeccCC-------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            6 GQTIGRGSTATVSIGMSN---RSSEVFAVKSAELS-------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~---~~~~~~AvK~~~~~-------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      .+.||+|+||+||++++.   .+++.+|+|.+...       ....+.+|+.+|++++||||+++++.+.....    ++
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~----~~   76 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGK----LY   76 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCe----EE
Confidence            368999999999999863   57899999988642       12356789999999999999999988765432    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++..... 
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~-  153 (323)
T cd05584          77 LILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH--VKLTDFGLCKESIHE-  153 (323)
T ss_pred             EEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEeeCcCCeecccC-
Confidence            99999999999999998888999999999999999999999999999999999999987765  999999998754322 


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                      .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+.  .....+|..+++++.+|
T Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~-~~~~~~~~~--~~~~~~~~~~~~~~~~l  230 (323)
T cd05584         154 GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN-RKKTIDKIL--KGKLNLPPYLTPEARDL  230 (323)
T ss_pred             CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC-HHHHHHHHH--cCCCCCCCCCCHHHHHH
Confidence            222344579999999999999889999999999999999999999997643 333333332  22345667789999999


Q ss_pred             HHHhhhcCCCCCC-----CHHHHHhCccccccc
Q 040569          236 LSKCLIRNPGERW-----SASELLEHGFVKEQN  263 (385)
Q Consensus       236 l~~cL~~dP~~Rp-----s~~elL~hp~~~~~~  263 (385)
                      |.+||+++|.+||     ++.++++||||....
T Consensus       231 i~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~  263 (323)
T cd05584         231 LKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN  263 (323)
T ss_pred             HHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence            9999999999999     899999999998653

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.1e-47  Score=369.33  Aligned_cols=257  Identities=24%  Similarity=0.322  Sum_probs=206.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccC-CeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEEN-GKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~~~~~   75 (385)
                      +|++.+.||+|+||.||+|+++.+++.||||.+...     ....+.+|+++|++++||||+++++++..... ....++
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            589999999999999999999999999999987532     23457789999999999999999998764432 222367


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDT  157 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEccCcccccccccc
Confidence            9999995 699999988778999999999999999999999999999999999999987766  9999999998643221


Q ss_pred             C--CCCCccccCCcccChhhhcC--CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHH-----------------
Q 040569          156 D--DEGKPICGTPICMAPEVARG--EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHR-----------------  214 (385)
Q Consensus       156 ~--~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~-----------------  214 (385)
                      .  .......||+.|+|||++.+  ..++.++|||||||++|+|++|++||...... ..+..                 
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhh
Confidence            1  11234579999999999876  57899999999999999999999999764321 11100                 


Q ss_pred             ----------hcCCCCC--CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          215 ----------IGFSSDT--PEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       215 ----------~~~~~~~--~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                +......  ......+++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~  296 (338)
T cd07859         237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL  296 (338)
T ss_pred             hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence                      0000000  00112367889999999999999999999999999999764

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.5e-49  Score=367.90  Aligned_cols=247  Identities=28%  Similarity=0.472  Sum_probs=215.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH------HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS------EFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~------~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      .|++.++||+|.||+|.+|.....|+.||||.+.++..      -.++||++||+.|+||||+.+|++|.....    +.
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK----Iv  129 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK----IV  129 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce----EE
Confidence            48889999999999999999999999999999976532      357899999999999999999999755443    55


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |||||..+|.|.+|+...+.|+|.+++.+++||+.|+.|+|.++++|||||.+|||++.+++  +||+|||++..+.  .
T Consensus       130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~--~  205 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYA--D  205 (668)
T ss_pred             EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC--eeeeccchhhhhc--c
Confidence            89999999999999998889999999999999999999999999999999999999998887  9999999998763  3


Q ss_pred             CCCCCccccCCcccChhhhcCCCC-CCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                      .....++||+|.|.+||+++|..| ++.+|.||||+++|.|+.|.+||.+. +...++.+|..... .+ | ..+..+.-
T Consensus       206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-Dhk~lvrQIs~GaY-rE-P-~~PSdA~g  281 (668)
T KOG0611|consen  206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-DHKRLVRQISRGAY-RE-P-ETPSDASG  281 (668)
T ss_pred             ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-hHHHHHHHhhcccc-cC-C-CCCchHHH
Confidence            334578899999999999999988 78999999999999999999999875 45555555533221 11 1 24678999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccc
Q 040569          235 FLSKCLIRNPGERWSASELLEHGFVK  260 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~hp~~~  260 (385)
                      ||+.||..||.+|-|.+++-.|=|++
T Consensus       282 LIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  282 LIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             HHHHHHhcCcccchhHHHHhhhheee
Confidence            99999999999999999999998876

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.4e-47  Score=368.16  Aligned_cols=250  Identities=31%  Similarity=0.508  Sum_probs=209.2

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHH---HhcCCCCeeeeeeeeeeccCCeEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRIL---SALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il---~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      |++.+.||+|+||+||+|.++.+++.||||.+...      ..+.+.+|.+++   +.+.||||+++++++.....    
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~----   76 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDH----   76 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCE----
Confidence            78899999999999999999999999999988632      234566777665   45689999999998765443    


Q ss_pred             EEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           74 YNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      +++||||++||+|..++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus        77 ~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~  153 (324)
T cd05589          77 VCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMG  153 (324)
T ss_pred             EEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc--EEeCcccCCccCCC
Confidence            6799999999999988875 46999999999999999999999999999999999999987766  99999999875422


Q ss_pred             cCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHH
Q 040569          154 NEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ  233 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  233 (385)
                      . .......+||+.|||||++.+..++.++|||||||++|+|++|+.||... +.......+.  ...+..|..+++.+.
T Consensus       154 ~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~-~~~~~~~~i~--~~~~~~p~~~~~~~~  229 (324)
T cd05589         154 F-GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD-DEEEVFDSIV--NDEVRYPRFLSREAI  229 (324)
T ss_pred             C-CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC-CHHHHHHHHH--hCCCCCCCCCCHHHH
Confidence            1 22234567999999999999999999999999999999999999999764 3333333332  223446677899999


Q ss_pred             HHHHHhhhcCCCCCC-----CHHHHHhCccccccc
Q 040569          234 DFLSKCLIRNPGERW-----SASELLEHGFVKEQN  263 (385)
Q Consensus       234 ~ll~~cL~~dP~~Rp-----s~~elL~hp~~~~~~  263 (385)
                      +||.+||++||.+||     ++.++++||||....
T Consensus       230 ~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         230 SIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             HHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence            999999999999999     699999999998754

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3e-47  Score=366.50  Aligned_cols=248  Identities=29%  Similarity=0.505  Sum_probs=209.5

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +.||+|+||+||+|.++.+++.||+|.+...      ..+...+|..++..+ .||||+++++++.....    +++|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~----~~lv~E   76 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEH----LFFVME   76 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCE----EEEEEC
Confidence            5799999999999999999999999988642      234566788888765 89999999988765432    679999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      |++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++..... ....
T Consensus        77 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~-~~~~  153 (316)
T cd05620          77 FLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFG-DNRA  153 (316)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEeCccCCCeecccC-CCce
Confidence            9999999999988778999999999999999999999999999999999999987765  999999998753211 2223


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHh
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC  239 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~c  239 (385)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+.  ...+.++..++.++++||.+|
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~  230 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD-DEDELFESIR--VDTPHYPRWITKESKDILEKL  230 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHH
Confidence            4567999999999999999999999999999999999999999764 3333333332  334666778999999999999


Q ss_pred             hhcCCCCCCCH-HHHHhCcccccccc
Q 040569          240 LIRNPGERWSA-SELLEHGFVKEQNF  264 (385)
Q Consensus       240 L~~dP~~Rps~-~elL~hp~~~~~~~  264 (385)
                      |++||.+||++ +++++||||...++
T Consensus       231 l~~dP~~R~~~~~~~~~h~~f~~~~~  256 (316)
T cd05620         231 FERDPTRRLGVVGNIRGHPFFKTINW  256 (316)
T ss_pred             ccCCHHHcCCChHHHHcCCCcCCCCH
Confidence            99999999998 58899999987643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.4e-47  Score=368.03  Aligned_cols=253  Identities=26%  Similarity=0.446  Sum_probs=213.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++.+.||+|+||+||+|+++.+++.+|+|.+....      .+...+|..++..+ .||+|+++++++.....    +
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~----~   76 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDR----L   76 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCE----E
Confidence            6899999999999999999999999999999886431      23456788888887 68999999888765443    6


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus        77 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~  154 (323)
T cd05616          77 YFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENMWD  154 (323)
T ss_pred             EEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc--EEEccCCCceecCCC
Confidence            799999999999999987778999999999999999999999999999999999999987766  999999999864322


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                       .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+.  .....+|..+++++.+
T Consensus       155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-~~~~~~~~i~--~~~~~~p~~~s~~~~~  230 (323)
T cd05616         155 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-DEDELFQSIM--EHNVAYPKSMSKEAVA  230 (323)
T ss_pred             -CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC-CHHHHHHHHH--hCCCCCCCcCCHHHHH
Confidence             12234567999999999999999999999999999999999999999764 3344444432  2234466779999999


Q ss_pred             HHHHhhhcCCCCCCCH-----HHHHhCcccccccc
Q 040569          235 FLSKCLIRNPGERWSA-----SELLEHGFVKEQNF  264 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~-----~elL~hp~~~~~~~  264 (385)
                      |+.+||++||.+|+++     .++++||||+..++
T Consensus       231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~  265 (323)
T cd05616         231 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  265 (323)
T ss_pred             HHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence            9999999999999984     89999999987654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.8e-47  Score=366.75  Aligned_cols=249  Identities=30%  Similarity=0.516  Sum_probs=209.7

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +.||+|+||+||+|+++.+++.||+|.+...      ..+...+|..+++.+ .||||+++++++.....    +++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~----~~lv~e   76 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKEN----LFFVME   76 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCE----EEEEEe
Confidence            4799999999999999999999999988642      234456788888765 99999999998765543    679999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      |++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..... ....
T Consensus        77 y~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~-~~~~  153 (316)
T cd05619          77 YLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLG-DAKT  153 (316)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEccCCcceECCCC-CCce
Confidence            9999999999987778999999999999999999999999999999999999987765  999999998754221 1223


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHh
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC  239 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~c  239 (385)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+..  ..+.+|..++.++++||.+|
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~-~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~  230 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH-DEEELFQSIRM--DNPCYPRWLTREAKDILVKL  230 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHh--CCCCCCccCCHHHHHHHHHH
Confidence            3457999999999999999999999999999999999999999764 34444444422  23456677899999999999


Q ss_pred             hhcCCCCCCCHH-HHHhCccccccccc
Q 040569          240 LIRNPGERWSAS-ELLEHGFVKEQNFK  265 (385)
Q Consensus       240 L~~dP~~Rps~~-elL~hp~~~~~~~~  265 (385)
                      |++||.+||++. ++++||||...++.
T Consensus       231 l~~~P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05619         231 FVREPERRLGVKGDIRQHPFFREIDWS  257 (316)
T ss_pred             hccCHhhcCCChHHHHcCcccCCCCHH
Confidence            999999999996 89999999886543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.1e-47  Score=369.72  Aligned_cols=250  Identities=29%  Similarity=0.530  Sum_probs=208.1

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +.||+|+||+||+|+++.+++.+|+|.+...      ....+++|..++.++ +||||+++++++.....    +++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~----~~lv~E   76 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR----LFFVIE   76 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCE----EEEEEe
Confidence            5799999999999999999999999988642      124567899998887 89999999998766443    679999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      |+++|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++..... ....
T Consensus        77 ~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~--~kL~DfG~~~~~~~~-~~~~  153 (329)
T cd05618          77 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRP-GDTT  153 (329)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC--EEEeeCCccccccCC-CCcc
Confidence            9999999999988788999999999999999999999999999999999999987766  999999998754211 2223


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCC-------ChHHHHHHhcCCCCCCCCCCcCCHHH
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVA-------DPISALHRIGFSSDTPEIPGYMSKQA  232 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~s~~~  232 (385)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||....       .....+.... ......+|..++.++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i-~~~~~~~p~~~~~~~  232 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-LEKQIRIPRSLSVKA  232 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH-hcCCCCCCCCCCHHH
Confidence            45679999999999999999999999999999999999999995311       1111222211 123345677899999


Q ss_pred             HHHHHHhhhcCCCCCCC------HHHHHhCcccccccc
Q 040569          233 QDFLSKCLIRNPGERWS------ASELLEHGFVKEQNF  264 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps------~~elL~hp~~~~~~~  264 (385)
                      ++||.+||++||.+||+      +.++++||||...++
T Consensus       233 ~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             HHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            99999999999999998      579999999987654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.5e-47  Score=384.86  Aligned_cols=256  Identities=25%  Similarity=0.365  Sum_probs=205.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcCCCCeeeeeeeeeecc----CCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEE----NGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----~~~~~~~lv   77 (385)
                      +|++++.||+|+||+||+|++..+++.||||.+... .....+|+.+|+.++||||+++++++....    ....++++|
T Consensus        67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv  145 (440)
T PTZ00036         67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV  145 (440)
T ss_pred             eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence            589999999999999999999999999999988643 344568999999999999999988765432    223456799


Q ss_pred             EeecCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           78 LEYAPGGTLTDAIR----SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~----~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      |||+++ +|.+++.    .+..+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||+|+....
T Consensus       146 mE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~-~~vkL~DFGla~~~~~  223 (440)
T PTZ00036        146 MEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT-HTLKLCDFGSAKNLLA  223 (440)
T ss_pred             EecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC-CceeeeccccchhccC
Confidence            999986 7777764    456799999999999999999999999999999999999997543 2389999999987632


Q ss_pred             cCCCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC-------------
Q 040569          154 NEDDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS-------------  219 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-------------  219 (385)
                      .  .......||+.|||||++.+. .++.++|||||||++|||++|++||............+....             
T Consensus       224 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~  301 (440)
T PTZ00036        224 G--QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPN  301 (440)
T ss_pred             C--CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchh
Confidence            2  223345789999999998764 689999999999999999999999986543322211110000             


Q ss_pred             ----CC---------CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          220 ----DT---------PEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       220 ----~~---------~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                          ..         ..+|...++++++||.+||++||.+|||+.|+|+||||...
T Consensus       302 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        302 YADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             hhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence                00         11344578899999999999999999999999999999864

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.9e-47  Score=367.86  Aligned_cols=251  Identities=29%  Similarity=0.498  Sum_probs=209.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++.+.||+|+||+||+++++.++..+|+|.+....    .+.+.+|+++|++++||||+++++++.....    +++|
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv   81 (331)
T cd06649           6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE----ISIC   81 (331)
T ss_pred             cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE----EEEE
Confidence            6899999999999999999999999999999886542    2467899999999999999999998766443    6699


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN-GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~-givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |||++||+|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.  +||+|||++......  
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS--  157 (331)
T ss_pred             eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc--EEEccCccccccccc--
Confidence            99999999999999877899999999999999999999986 6999999999999987766  999999999865321  


Q ss_pred             CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc--------------------
Q 040569          157 DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG--------------------  216 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~--------------------  216 (385)
                       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+.                    
T Consensus       158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (331)
T cd06649         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD-AKELEAIFGRPVVDGEEGEPHSISPRPRP  235 (331)
T ss_pred             -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHhcccccccccCCccccCccccc
Confidence             2234579999999999999999999999999999999999999996532 111111110                    


Q ss_pred             -------------------------CCCCCCCC-CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          217 -------------------------FSSDTPEI-PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       217 -------------------------~~~~~~~~-~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                               .....+.. ...+++++++||.+||++||++|||+.|+|+|||++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                                     00111111 12468899999999999999999999999999999754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.3e-47  Score=357.58  Aligned_cols=257  Identities=32%  Similarity=0.441  Sum_probs=212.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH-----HHHHHHHHHHHhcCCCC-eeeeeeeeeeccC--CeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----EFLQREQRILSALACPQ-IVAYKGCDISEEN--GKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~-----~~~~~E~~il~~l~hpn-Iv~~~~~~~~~~~--~~~~   73 (385)
                      +|..++.||+|+||+||+|+++.+|+.||+|++..+..     ....||+.+|+.|+|+| |+++++++...+.  ....
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            57888999999999999999999999999999976533     35679999999999999 9999999887652  2233


Q ss_pred             EEEEEeecCCCCHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCcee
Q 040569           74 YNLFLEYAPGGTLTDAIRSGT----CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR  149 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~~----~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~  149 (385)
                      .++|+||+.- +|.+++....    .++...++.+++||+.||+|||++||+||||||+||||++++.  +||+|||+|+
T Consensus        92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~--lKlaDFGlAr  168 (323)
T KOG0594|consen   92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV--LKLADFGLAR  168 (323)
T ss_pred             EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc--EeeeccchHH
Confidence            6699999965 9999998433    5788999999999999999999999999999999999998766  9999999999


Q ss_pred             eecccCCCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCC------
Q 040569          150 RARVNEDDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP------  222 (385)
Q Consensus       150 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~------  222 (385)
                      ....... ...+.++|.+|.|||++.+. .|+...||||+|||+.||+++++.|++..+ ..++.+|......|      
T Consensus       169 a~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~~lGtP~e~~Wp  246 (323)
T KOG0594|consen  169 AFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFRLLGTPNEKDWP  246 (323)
T ss_pred             HhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHHHcCCCCccCCC
Confidence            6643222 24556799999999999887 789999999999999999999999998655 44444432111111      


Q ss_pred             ----------CCC------------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          223 ----------EIP------------GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       223 ----------~~~------------~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                                .++            ...++.+.+++.+||+.+|.+|.|+..+|.||||....
T Consensus       247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP  309 (323)
T ss_pred             CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence                      011            11345899999999999999999999999999998653

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.4e-47  Score=375.19  Aligned_cols=256  Identities=23%  Similarity=0.373  Sum_probs=211.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|+..+.||+|+||+||+|.++.+++.+|+|.+...      ....+++|..++..++||||+++++.+.....    ++
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~----~~   77 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRN----LY   77 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE----EE
Confidence            689999999999999999999999999999988532      23467789999999999999999988765443    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus        78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~--vkL~DfG~~~~~~~~~  155 (360)
T cd05627          78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH--VKLSDFGLCTGLKKAH  155 (360)
T ss_pred             EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEeeccCCccccccc
Confidence            99999999999999998888999999999999999999999999999999999999987665  9999999987542110


Q ss_pred             C----------------------------------CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCC
Q 040569          156 D----------------------------------DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPP  201 (385)
Q Consensus       156 ~----------------------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~P  201 (385)
                      .                                  ......+||+.|||||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            0                                  001235799999999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHHHhcCCCCCCCCCC--cCCHHHHHHHHHhhhcCCCCCC---CHHHHHhCccccccccc
Q 040569          202 WPDVADPISALHRIGFSSDTPEIPG--YMSKQAQDFLSKCLIRNPGERW---SASELLEHGFVKEQNFK  265 (385)
Q Consensus       202 f~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~ll~~cL~~dP~~Rp---s~~elL~hp~~~~~~~~  265 (385)
                      |... +.......+........+|.  .+++++++||.+|+ .||.+|+   ++.++++||||...++.
T Consensus       236 f~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~  302 (360)
T cd05627         236 FCSE-TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDWG  302 (360)
T ss_pred             CCCC-CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCHH
Confidence            9764 33333333322122222222  37899999999977 4999998   48999999999987543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-47  Score=365.80  Aligned_cols=256  Identities=23%  Similarity=0.357  Sum_probs=208.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+++++.+++.||+|.+.+.      ..+.+.+|..+++.++||||+++++++.....    ++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~----~~   77 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENN----LY   77 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCe----EE
Confidence            699999999999999999999999999999998632      23457789999999999999999988765443    67


Q ss_pred             EEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           76 LFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +||||++||+|.+++.+ +..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++......
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~  155 (331)
T cd05597          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH--IRLADFGSCLRLLAD  155 (331)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC--EEEEECCceeecCCC
Confidence            99999999999999975 567999999999999999999999999999999999999987766  999999999765433


Q ss_pred             CCCCCCccccCCcccChhhhcC-----CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC---CCCCCCCC
Q 040569          155 EDDEGKPICGTPICMAPEVARG-----EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS---SDTPEIPG  226 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~---~~~~~~~~  226 (385)
                      ........+||+.|||||++.+     ..++.++|||||||++|+|++|+.||... +.......+...   ...+....
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~  234 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYGKIMNHKEHFQFPPDVT  234 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC-CHHHHHHHHHcCCCcccCCCccC
Confidence            3222334579999999999973     45688999999999999999999999764 333333333211   12222233


Q ss_pred             cCCHHHHHHHHHhhhcCCCC--CCCHHHHHhCcccccccc
Q 040569          227 YMSKQAQDFLSKCLIRNPGE--RWSASELLEHGFVKEQNF  264 (385)
Q Consensus       227 ~~s~~~~~ll~~cL~~dP~~--Rps~~elL~hp~~~~~~~  264 (385)
                      .+++++++||++||..++.+  |+++.++++||||...++
T Consensus       235 ~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~  274 (331)
T cd05597         235 DVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW  274 (331)
T ss_pred             CCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence            47999999999988764444  789999999999987644

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5e-47  Score=365.11  Aligned_cols=248  Identities=29%  Similarity=0.518  Sum_probs=210.2

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +.||+|+||+||+|.++.+++.||+|.+...      ....+.+|..+++.+ .||||+++++++.....    +++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~----~~lv~e   76 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDR----LFFVME   76 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCE----EEEEEc
Confidence            4799999999999999999999999988642      234566899999888 79999999998765443    679999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      |++||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..... ....
T Consensus        77 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~-~~~~  153 (318)
T cd05570          77 YVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH--IKIADFGMCKEGILG-GVTT  153 (318)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--EEecccCCCeecCcC-CCcc
Confidence            9999999999998878999999999999999999999999999999999999987766  999999998753222 2223


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHh
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC  239 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~c  239 (385)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+.  ...+.++..+++++.+||.+|
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~-~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~  230 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDELFQSIL--EDEVRYPRWLSKEAKSILKSF  230 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC-CHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHH
Confidence            4457999999999999999999999999999999999999999764 3333333332  223455677899999999999


Q ss_pred             hhcCCCCCCCH-----HHHHhCcccccccc
Q 040569          240 LIRNPGERWSA-----SELLEHGFVKEQNF  264 (385)
Q Consensus       240 L~~dP~~Rps~-----~elL~hp~~~~~~~  264 (385)
                      |++||.+|||+     .++++|||+....+
T Consensus       231 l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         231 LTKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             ccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            99999999999     99999999987644

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.9e-47  Score=367.42  Aligned_cols=248  Identities=26%  Similarity=0.408  Sum_probs=205.0

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHH-HHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQR-ILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~-il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +.||+|+||+||+|+++.+++.+|+|.+....      ...+.+|.. +++.++||||+++++.+.....    +++|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~----~~lv~e   76 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADK----LYFVLD   76 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCE----EEEEEc
Confidence            47999999999999999999999999886421      223344444 5678999999999988765433    679999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      |++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... .....
T Consensus        77 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~--~kl~Dfg~~~~~~~-~~~~~  153 (323)
T cd05575          77 YVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGIE-HSKTT  153 (323)
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeccCCCccccc-CCCcc
Confidence            9999999999998888999999999999999999999999999999999999987765  99999999875422 12233


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHh
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC  239 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~c  239 (385)
                      ...+||+.|||||++.+..++.++|||||||++|+|++|+.||... +.......+..  ....++..+++.+.+||.+|
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~-~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~  230 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-DTAEMYDNILN--KPLRLKPNISVSARHLLEGL  230 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC-CHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHH
Confidence            4567999999999999999999999999999999999999999764 33333333321  22344556799999999999


Q ss_pred             hhcCCCCCCCH----HHHHhCcccccccc
Q 040569          240 LIRNPGERWSA----SELLEHGFVKEQNF  264 (385)
Q Consensus       240 L~~dP~~Rps~----~elL~hp~~~~~~~  264 (385)
                      |++||.+||++    .++++||||....+
T Consensus       231 l~~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         231 LQKDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             hhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            99999999987    69999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8.4e-47  Score=371.48  Aligned_cols=254  Identities=26%  Similarity=0.405  Sum_probs=208.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+++++.+++.+|+|.+...      ....+.+|..+++.++||||+++++.+....    .++
T Consensus        44 ~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~----~~~  119 (371)
T cd05622          44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR----YLY  119 (371)
T ss_pred             hcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC----EEE
Confidence            589999999999999999999999999999987531      2345678999999999999999998876543    267


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++||+|.++++.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus       120 lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~~~  196 (371)
T cd05622         120 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEG  196 (371)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCcCC
Confidence            999999999999999754 4899999999999999999999999999999999999987766  9999999998764333


Q ss_pred             CCCCCccccCCcccChhhhcCCC----CCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCC--CcCC
Q 040569          156 DDEGKPICGTPICMAPEVARGEE----QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP--GYMS  229 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~s  229 (385)
                      .......+||+.|||||++.+..    ++.++|||||||++|+|++|+.||... +.......+........+|  ..++
T Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s  275 (371)
T cd05622         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-SLVGTYSKIMNHKNSLTFPDDNDIS  275 (371)
T ss_pred             cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCcccCCCcCCCC
Confidence            32334567999999999997643    788999999999999999999999764 3333344442222222222  3589


Q ss_pred             HHHHHHHHHhhhcCCCC--CCCHHHHHhCccccccc
Q 040569          230 KQAQDFLSKCLIRNPGE--RWSASELLEHGFVKEQN  263 (385)
Q Consensus       230 ~~~~~ll~~cL~~dP~~--Rps~~elL~hp~~~~~~  263 (385)
                      .++++||.+||..++.+  |++++++++||||....
T Consensus       276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence            99999999999854443  78999999999998653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.9e-47  Score=366.71  Aligned_cols=251  Identities=29%  Similarity=0.533  Sum_probs=209.5

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +.||+|+||+||+|.++.+++.+|+|.+....      .+.+.+|..++.++ .||||+++++++.....    +++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~----~~lv~e   76 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSR----LFLVIE   76 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCE----EEEEEe
Confidence            47999999999999999999999999987431      24577899999988 69999999998765443    679999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      |++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... .....
T Consensus        77 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~-~~~~~  153 (327)
T cd05617          77 YVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLG-PGDTT  153 (327)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--EEEeccccceeccC-CCCce
Confidence            9999999999987778999999999999999999999999999999999999987766  99999999875321 12223


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCC-----ChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVA-----DPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||....     +....+..... .....+|..++..+++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~  232 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL-EKPIRIPRFLSVKASH  232 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH-hCCCCCCCCCCHHHHH
Confidence            45679999999999999999999999999999999999999995321     12222222212 2234567779999999


Q ss_pred             HHHHhhhcCCCCCCC------HHHHHhCccccccccc
Q 040569          235 FLSKCLIRNPGERWS------ASELLEHGFVKEQNFK  265 (385)
Q Consensus       235 ll~~cL~~dP~~Rps------~~elL~hp~~~~~~~~  265 (385)
                      +|.+||++||.+|++      +.++++||||...++.
T Consensus       233 li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~  269 (327)
T cd05617         233 VLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD  269 (327)
T ss_pred             HHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence            999999999999998      5799999999886543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-49  Score=415.30  Aligned_cols=255  Identities=38%  Similarity=0.711  Sum_probs=227.3

Q ss_pred             CCceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            1 MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         1 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      |+|.++..||.|.||.||.|.+..+|+..|+|.+....     ...+.+|+.+|..|+|||+|++||+-...+.    .+
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek----v~ 1310 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK----VY 1310 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH----HH
Confidence            68999999999999999999999999999999776433     3467789999999999999999999777665    66


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |+||||+||+|.++++.++..+|...+.|..|++.|+.|||++|||||||||.|||++.++-  +|++|||.|..+..+.
T Consensus      1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~--iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL--IKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc--EEeecccceeEecCch
Confidence            89999999999999999998999999999999999999999999999999999999997774  8999999999876543


Q ss_pred             CC---CCCccccCCcccChhhhcCC---CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCC
Q 040569          156 DD---EGKPICGTPICMAPEVARGE---EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS  229 (385)
Q Consensus       156 ~~---~~~~~~Gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s  229 (385)
                      ..   ......|||.|||||++.+.   ..+-++|||||||++.||+||+.||...++....++.++. +..|.+|..+|
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~-gh~Pq~P~~ls 1467 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA-GHKPQIPERLS 1467 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc-cCCCCCchhhh
Confidence            21   22356799999999999764   4577999999999999999999999999888888888854 56788899999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          230 KQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       230 ~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ++.++||.+||..||++||++.|+|+|.|-+..
T Consensus      1468 ~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1468 SEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred             HhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence            999999999999999999999999999997643

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-50  Score=364.03  Aligned_cols=252  Identities=34%  Similarity=0.547  Sum_probs=220.3

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeec
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYA   81 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (385)
                      |.++++||+|+||.||+|+|+.+|.++|||.+..+ +.+.+.+|+.||+++.+|++|++||.++-...    +++|||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD----LWIVMEYC  110 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD----LWIVMEYC  110 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc----eEeehhhc
Confidence            66789999999999999999999999999999764 46778899999999999999999999876554    77999999


Q ss_pred             CCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCC
Q 040569           82 PGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGK  160 (385)
Q Consensus        82 ~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~  160 (385)
                      ..||+.+.++ +...|+|.++..+++..+.||+|||...-+|||||..|||++.++.  .||+|||.|.++.... ....
T Consensus       111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~--AKLADFGVAGQLTDTM-AKRN  187 (502)
T KOG0574|consen  111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI--AKLADFGVAGQLTDTM-AKRN  187 (502)
T ss_pred             CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch--hhhhhccccchhhhhH-HhhC
Confidence            9999999998 6778999999999999999999999999999999999999998776  8999999998875332 2345


Q ss_pred             ccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC-CCCCCCCCcCCHHHHHHHHHh
Q 040569          161 PICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS-SDTPEIPGYMSKQAQDFLSKC  239 (385)
Q Consensus       161 ~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~ll~~c  239 (385)
                      +..|||.|||||++..-.|+.++||||||++.+||+.|++||.+. .+...+..+... .....-|..+|.++.||+++|
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI-HPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C  266 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI-HPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC  266 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc-cccceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence            678999999999999999999999999999999999999999876 344444444322 222234666899999999999


Q ss_pred             hhcCCCCCCCHHHHHhCcccccc
Q 040569          240 LIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       240 L~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      |.+.|++|-|+.++++|||++..
T Consensus       267 LiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  267 LIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             hcCCHHHHHHHHHHhhhhhhcCC
Confidence            99999999999999999999854

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.5e-47  Score=356.75  Aligned_cols=247  Identities=28%  Similarity=0.416  Sum_probs=204.7

Q ss_pred             eeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecC
Q 040569            9 IGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAP   82 (385)
Q Consensus         9 LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (385)
                      ||+|+||+||++.++.+++.+|+|.+....      .+.+.+|++++++++||||+++++++.....    +++||||++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~----~~lv~e~~~   76 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTD----LCLVMTIMN   76 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCe----EEEEEeCCC
Confidence            799999999999999999999999886432      2345689999999999999999887655433    679999999


Q ss_pred             CCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           83 GGTLTDAIR----SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        83 ggsL~~~l~----~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      ||+|.+++.    ....+++..+..++.||+.||+|||++||+||||||+||+++.++.  +||+|||++........ .
T Consensus        77 ~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~-~  153 (280)
T cd05608          77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN--VRISDLGLAVELKDGQS-K  153 (280)
T ss_pred             CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCccceecCCCCc-c
Confidence            999998874    3456899999999999999999999999999999999999987655  99999999986543222 2


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChH---HHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPI---SALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   .....+  ......++..+++++.+|
T Consensus       154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l  231 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI--LNDSVTYPDKFSPASKSF  231 (280)
T ss_pred             ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh--cccCCCCcccCCHHHHHH
Confidence            334579999999999999999999999999999999999999997543221   111222  122334566789999999


Q ss_pred             HHHhhhcCCCCCC-----CHHHHHhCcccccccc
Q 040569          236 LSKCLIRNPGERW-----SASELLEHGFVKEQNF  264 (385)
Q Consensus       236 l~~cL~~dP~~Rp-----s~~elL~hp~~~~~~~  264 (385)
                      +.+||+.||.+||     +++++++||||+...+
T Consensus       232 i~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~  265 (280)
T cd05608         232 CEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNW  265 (280)
T ss_pred             HHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence            9999999999999     8899999999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=7.1e-47  Score=369.21  Aligned_cols=249  Identities=32%  Similarity=0.511  Sum_probs=203.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|+.++.||+|+||+||+|+++.+++.||||.+....    ...+.+|+++|++++||||+++++++.....    +++|
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv  150 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE----IQVL  150 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe----EEEE
Confidence            4778899999999999999999999999999885432    3467899999999999999999998755433    6699


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |||+++|+|.+.    ...++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...... .
T Consensus       151 ~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DfG~~~~~~~~~-~  223 (353)
T PLN00034        151 LEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTM-D  223 (353)
T ss_pred             EecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEcccccceeccccc-c
Confidence            999999998653    34678889999999999999999999999999999999987765  9999999998764221 1


Q ss_pred             CCCccccCCcccChhhhcC-----CCCCCCCChHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          158 EGKPICGTPICMAPEVARG-----EEQGFPADVWALGCTVLEMATGRPPWPDVA--DPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      ......||+.|+|||++..     ...+.++|||||||++|||++|+.||....  +.......+ .....+..+..++.
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  302 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI-CMSQPPEAPATASR  302 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH-hccCCCCCCCccCH
Confidence            2234579999999999853     234578999999999999999999997422  222222222 22334555667899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ++++||.+||+.||.+|||+.|+|+||||...
T Consensus       303 ~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence            99999999999999999999999999999865

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.9e-47  Score=375.52  Aligned_cols=251  Identities=24%  Similarity=0.285  Sum_probs=203.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeec
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYA   81 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (385)
                      +|++.+.||+|+||.||+|+++.+++.+|+|...   ...+.+|+++|++|+||||+++++++.....    .++++||+
T Consensus        93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~----~~lv~e~~  165 (391)
T PHA03212         93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---RGGTATEAHILRAINHPSIIQLKGTFTYNKF----TCLILPRY  165 (391)
T ss_pred             CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---hhhhHHHHHHHHhCCCCCCCCEeEEEEECCe----eEEEEecC
Confidence            5999999999999999999999999999999754   3456789999999999999999998765433    66899999


Q ss_pred             CCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCCc
Q 040569           82 PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP  161 (385)
Q Consensus        82 ~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~~  161 (385)
                      . ++|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+............
T Consensus       166 ~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~--vkL~DFG~a~~~~~~~~~~~~~  242 (391)
T PHA03212        166 K-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINANKYYG  242 (391)
T ss_pred             C-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC--EEEEeCCccccccccccccccc
Confidence            5 699999987778999999999999999999999999999999999999987766  9999999997543222223345


Q ss_pred             cccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCC------hHHHHHHh----cC--------------
Q 040569          162 ICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVAD------PISALHRI----GF--------------  217 (385)
Q Consensus       162 ~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~------~~~~~~~~----~~--------------  217 (385)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||.....      ....+..+    +.              
T Consensus       243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~  322 (391)
T PHA03212        243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD  322 (391)
T ss_pred             ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence            6799999999999999999999999999999999999988743210      00111100    00              


Q ss_pred             ----------CCCCCCCC-----CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          218 ----------SSDTPEIP-----GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       218 ----------~~~~~~~~-----~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                .......+     ..++.++.+||.+||++||.+|||+.|+|+||||+..
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence                      00000001     1246789999999999999999999999999999753

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-46  Score=349.84  Aligned_cols=251  Identities=38%  Similarity=0.683  Sum_probs=215.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--------SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|+.++.||+|++|.||+|.+..+++.+|+|.+....        ...+++|+++++++.||||+++++++....    .
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~   78 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE----T   78 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC----e
Confidence            6899999999999999999999999999999875421        245778999999999999999999876554    3


Q ss_pred             EEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           74 YNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      .++++||++|++|.+++...+.+++..+..++.|++.||.|||+.|++||||||+||+++.++.  +||+|||+++....
T Consensus        79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~--~~l~dfg~~~~~~~  156 (263)
T cd06625          79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQT  156 (263)
T ss_pred             EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceeccc
Confidence            6799999999999999997778999999999999999999999999999999999999987665  99999999986532


Q ss_pred             cCCCCC--CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHH
Q 040569          154 NEDDEG--KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQ  231 (385)
Q Consensus       154 ~~~~~~--~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  231 (385)
                      ......  ....|++.|+|||++.+..++.++|||||||++|+|++|+.||.... ..............+.++..++..
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  235 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE-AMAAIFKIATQPTNPQLPSHVSPD  235 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc-hHHHHHHHhccCCCCCCCccCCHH
Confidence            221111  34568899999999999999999999999999999999999997653 333334444444556677789999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          232 AQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      +.+||.+||.++|.+|||+.++++||||
T Consensus       236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         236 ARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            9999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.7e-46  Score=363.54  Aligned_cols=256  Identities=22%  Similarity=0.338  Sum_probs=209.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+++++.+++.+|+|.+.+.      ....+.+|..++..+.||||+++++++.....    ++
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~----~~   77 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENN----LY   77 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCE----EE
Confidence            699999999999999999999999999999988532      22357789999999999999999988765443    67


Q ss_pred             EEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           76 LFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +||||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++......
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~  155 (332)
T cd05623          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMED  155 (332)
T ss_pred             EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEeecchheecccC
Confidence            99999999999999985 567999999999999999999999999999999999999987665  999999999765333


Q ss_pred             CCCCCCccccCCcccChhhhc-----CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC---CCCCCCC
Q 040569          155 EDDEGKPICGTPICMAPEVAR-----GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS---DTPEIPG  226 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~---~~~~~~~  226 (385)
                      ........+||+.|||||++.     ...++.++|||||||++|||++|+.||... +.......+....   ..+....
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~  234 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYGKIMNHKERFQFPAQVT  234 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC-CHHHHHHHHhCCCccccCCCccc
Confidence            222233457999999999986     345788999999999999999999999764 3344444432222   2233334


Q ss_pred             cCCHHHHHHHHHhhhcCCCC--CCCHHHHHhCcccccccc
Q 040569          227 YMSKQAQDFLSKCLIRNPGE--RWSASELLEHGFVKEQNF  264 (385)
Q Consensus       227 ~~s~~~~~ll~~cL~~dP~~--Rps~~elL~hp~~~~~~~  264 (385)
                      .+++++++||++||..++.+  |++++|+++||||...++
T Consensus       235 ~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~  274 (332)
T cd05623         235 DVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW  274 (332)
T ss_pred             cCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence            57999999999999665544  789999999999987643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-46  Score=356.19  Aligned_cols=255  Identities=27%  Similarity=0.410  Sum_probs=212.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      .|++.+.||+|+||+||++.+..+++.||+|.+....      ...+.+|+.++++++||||+++++.+.....    .+
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~   76 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA----LC   76 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe----EE
Confidence            5899999999999999999999999999999886432      2345689999999999999999988755432    67


Q ss_pred             EEEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           76 LFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      +||||++||+|.+++..  ...+++..+..++.||+.||.|||++|++||||||+||+++.++.  ++|+|||++.....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~  154 (285)
T cd05605          77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH--IRISDLGLAVEIPE  154 (285)
T ss_pred             EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC--EEEeeCCCceecCC
Confidence            99999999999998863  346899999999999999999999999999999999999987655  99999999987532


Q ss_pred             cCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHH--HHHHhcCCCCCCCCCCcCCHH
Q 040569          154 NEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS--ALHRIGFSSDTPEIPGYMSKQ  231 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~s~~  231 (385)
                      ..  .....+|++.|+|||++.+..++.++||||+||++|+|++|+.||........  .+... .....+.++..+++.
T Consensus       155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  231 (285)
T cd05605         155 GE--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR-VKEDQEEYSEKFSEA  231 (285)
T ss_pred             CC--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH-hhhcccccCcccCHH
Confidence            21  22344789999999999998999999999999999999999999976433211  11111 123334456668999


Q ss_pred             HHHHHHHhhhcCCCCCC-----CHHHHHhCccccccccc
Q 040569          232 AQDFLSKCLIRNPGERW-----SASELLEHGFVKEQNFK  265 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rp-----s~~elL~hp~~~~~~~~  265 (385)
                      +++||.+||..||.+||     +++++++||||...+++
T Consensus       232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05605         232 ARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK  270 (285)
T ss_pred             HHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence            99999999999999999     89999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-47  Score=371.48  Aligned_cols=252  Identities=28%  Similarity=0.479  Sum_probs=222.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|..++.+|+|+||.+++++++..++.+++|.++...     .....+|+.+++++.|||||.+++.++.+..   +.+|
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~---~l~I   81 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ---LLCI   81 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCc---eEEE
Confidence            6889999999999999999999999999999987543     3466789999999999999999998876543   4779


Q ss_pred             EEeecCCCCHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           77 FLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~--~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ||+||+||+|.+.|+  ++..++|+.+..|+.|++.|+.|||+++|+|||||+.|||++.++.  +||+|||+|+.....
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPE  159 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc--eeecchhhhhhcCCc
Confidence            999999999999997  4457899999999999999999999999999999999999998877  899999999987533


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                      . ....+.+|||.||.||++.+.+|+.++|||||||++|||++-+++|... +......++.. .....+|...|.+++.
T Consensus       160 ~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-~m~~Li~ki~~-~~~~Plp~~ys~el~~  236 (426)
T KOG0589|consen  160 D-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-NMSELILKINR-GLYSPLPSMYSSELRS  236 (426)
T ss_pred             h-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-chHHHHHHHhh-ccCCCCCccccHHHHH
Confidence            3 2456788999999999999999999999999999999999999999873 55555555533 3356678889999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          235 FLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      +|..||.++|..||++.++|.+|.+..
T Consensus       237 lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  237 LVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             HHHHHhhcCCccCCCHHHHhhChhhhh
Confidence            999999999999999999999998763

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.8e-47  Score=365.03  Aligned_cols=249  Identities=27%  Similarity=0.431  Sum_probs=208.9

Q ss_pred             eceeeccCceEEEEEEE---CCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            6 GQTIGRGSTATVSIGMS---NRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~---~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      ++.||+|+||+||++++   +.+|+.+|+|++...     ....+.+|+++|++++||||+++++++.....    +++|
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~lv   76 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGK----LYLI   76 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCE----EEEE
Confidence            36899999999999976   467899999988642     22346689999999999999999988765432    6799


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |||++||+|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...... .
T Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~-~  153 (318)
T cd05582          77 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHE-K  153 (318)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc--EEEeeccCCcccCCCC-C
Confidence            999999999999987778999999999999999999999999999999999999987765  9999999998653221 2


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+.  .....+|..+++++++||+
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-~~~~~~~~i~--~~~~~~p~~~~~~~~~li~  230 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK-DRKETMTMIL--KAKLGMPQFLSPEAQSLLR  230 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC-CHHHHHHHHH--cCCCCCCCCCCHHHHHHHH
Confidence            233457999999999999988999999999999999999999999764 3333333332  2233456678999999999


Q ss_pred             HhhhcCCCCCCC-----HHHHHhCcccccccc
Q 040569          238 KCLIRNPGERWS-----ASELLEHGFVKEQNF  264 (385)
Q Consensus       238 ~cL~~dP~~Rps-----~~elL~hp~~~~~~~  264 (385)
                      +||++||.+||+     ..++++||||....+
T Consensus       231 ~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~  262 (318)
T cd05582         231 ALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW  262 (318)
T ss_pred             HHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence            999999999999     778999999987543

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.8e-46  Score=362.18  Aligned_cols=253  Identities=26%  Similarity=0.452  Sum_probs=211.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALA-CPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|+..+.||+|+||+||+|.++.+++.||+|.+...      ..+.+.+|..+++.+. ||+|+++++++.....    +
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~----~   76 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDR----L   76 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCE----E
Confidence            588999999999999999999999999999988642      2245667899998885 5778888887655443    6


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus        77 ~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~  154 (323)
T cd05615          77 YFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVD  154 (323)
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeccccccccCCC
Confidence            799999999999999998788999999999999999999999999999999999999987765  999999998864322


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                      . ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+.  .....+|..++.++.+
T Consensus       155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~-~~~~~~~~i~--~~~~~~p~~~~~~~~~  230 (323)
T cd05615         155 G-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE-DEDELFQSIM--EHNVSYPKSLSKEAVS  230 (323)
T ss_pred             C-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHH--hCCCCCCccCCHHHHH
Confidence            1 1234457999999999999999999999999999999999999999764 3333333332  2233456778999999


Q ss_pred             HHHHhhhcCCCCCCC-----HHHHHhCcccccccc
Q 040569          235 FLSKCLIRNPGERWS-----ASELLEHGFVKEQNF  264 (385)
Q Consensus       235 ll~~cL~~dP~~Rps-----~~elL~hp~~~~~~~  264 (385)
                      ++.+||+++|.+|++     ..++++||||...++
T Consensus       231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         231 ICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             HHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence            999999999999997     578999999987654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.3e-46  Score=362.65  Aligned_cols=256  Identities=21%  Similarity=0.362  Sum_probs=209.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+++++.+++.+|+|.+...      ....+.+|..++..+.||||+++++++.....    .+
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~----~~   77 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENY----LY   77 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE----EE
Confidence            699999999999999999999999999999988642      12356789999999999999999988765432    67


Q ss_pred             EEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           76 LFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus        78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~  155 (331)
T cd05624          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQD  155 (331)
T ss_pred             EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC--EEEEeccceeeccCC
Confidence            99999999999999985 567999999999999999999999999999999999999987665  999999999876433


Q ss_pred             CCCCCCccccCCcccChhhhcC-----CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCC---CCCCCC
Q 040569          155 EDDEGKPICGTPICMAPEVARG-----EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSD---TPEIPG  226 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~  226 (385)
                      ........+||+.|||||++.+     ..++.++|||||||++|+|++|+.||... +.......+.....   .+....
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~  234 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYGKIMNHEERFQFPSHIT  234 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC-CHHHHHHHHHcCCCcccCCCccc
Confidence            2222334579999999999976     45788999999999999999999999764 33333333322222   222233


Q ss_pred             cCCHHHHHHHHHhhhcCCCC--CCCHHHHHhCcccccccc
Q 040569          227 YMSKQAQDFLSKCLIRNPGE--RWSASELLEHGFVKEQNF  264 (385)
Q Consensus       227 ~~s~~~~~ll~~cL~~dP~~--Rps~~elL~hp~~~~~~~  264 (385)
                      .+++++++||.+||..++++  |++++++++||||...++
T Consensus       235 ~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~  274 (331)
T cd05624         235 DVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW  274 (331)
T ss_pred             cCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence            47899999999999876654  569999999999987644

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.1e-46  Score=353.66  Aligned_cols=252  Identities=27%  Similarity=0.360  Sum_probs=200.8

Q ss_pred             CceeeceeeccCceEEEEEEECC-CCcEEEEEeccCCC-----HHHHHHHHHHHHhc---CCCCeeeeeeeeeecc-CCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNR-SSEVFAVKSAELSN-----SEFLQREQRILSAL---ACPQIVAYKGCDISEE-NGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~-~~~~~AvK~~~~~~-----~~~~~~E~~il~~l---~hpnIv~~~~~~~~~~-~~~   71 (385)
                      +|++.+.||+|+||+||+|++.. +++.+|+|.+....     ...+.+|+.+++.+   .||||+++++++.... ...
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            69999999999999999999854 47889999875321     23556788887776   6999999999875322 122


Q ss_pred             EEEEEEEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCcee
Q 040569           72 ILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR  149 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~  149 (385)
                      ..+++||||+. ++|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~~  158 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLAR  158 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccceE
Confidence            23669999997 599999874  345899999999999999999999999999999999999987766  9999999998


Q ss_pred             eecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC------C---
Q 040569          150 RARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS------D---  220 (385)
Q Consensus       150 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~------~---  220 (385)
                      .....  .......||+.|+|||++.+..++.++|||||||++|+|++|++||....+.. .+..+....      .   
T Consensus       159 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         159 IYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             eccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhchh
Confidence            76422  23345579999999999998899999999999999999999999998654322 222211000      0   


Q ss_pred             ----------------CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          221 ----------------TPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       221 ----------------~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                                      ...+...+++.+++|+.+||++||++|||+.|+|+||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                            001113468889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2e-46  Score=368.52  Aligned_cols=257  Identities=25%  Similarity=0.333  Sum_probs=209.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccC-CeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEEN-GKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~~~~~   75 (385)
                      +|++++.||+|+||+||+|.+..+++.||+|.+...     ....+.+|+++|+.++||||+++++++..... .....+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            688999999999999999999999999999988542     23467789999999999999999998765441 112367


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +|+||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDE  157 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC--EEeccccceeecccCc
Confidence            9999996 589999987788999999999999999999999999999999999999987765  9999999998764333


Q ss_pred             CCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc------------------
Q 040569          156 DDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG------------------  216 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~------------------  216 (385)
                      ........||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+..+.                  
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~~  236 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP-IQQLDLITDLLGTPSLEAMRSACEGA  236 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence            3333445689999999999875 478999999999999999999999976432 22221110                  


Q ss_pred             ------CCCCCC------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          217 ------FSSDTP------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       217 ------~~~~~~------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                            .....+      .+....++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                  000011      1233468899999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.9e-46  Score=362.33  Aligned_cols=251  Identities=29%  Similarity=0.488  Sum_probs=208.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++.+.||+|+||+||++.++.++..+|+|.+....    .+.+.+|+++|++++||||+++++++.....    +++|
T Consensus         6 ~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv   81 (333)
T cd06650           6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE----ISIC   81 (333)
T ss_pred             hhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCE----EEEE
Confidence            6899999999999999999999999999999886532    2467899999999999999999999876543    6799


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN-GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~-givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |||++||+|.+++...+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.  +||+|||++......  
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS--  157 (333)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--EEEeeCCcchhhhhh--
Confidence            99999999999999777899999999999999999999985 7999999999999987665  999999998765321  


Q ss_pred             CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHH----------------------
Q 040569          157 DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHR----------------------  214 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~----------------------  214 (385)
                       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....                      
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (333)
T cd06650         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK-ELELMFGCPVEGDPAESETSPRPRPPG  235 (333)
T ss_pred             -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh-HHHHHhcCcccCCccccccCcccCCcc
Confidence             223457999999999999988999999999999999999999999643211 11000                      


Q ss_pred             ---------------------hcCCCCCCCCC-CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          215 ---------------------IGFSSDTPEIP-GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       215 ---------------------~~~~~~~~~~~-~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                           .......+.++ ...+.++++||.+||++||++|||+.|+++||||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                                 00011112222 2367899999999999999999999999999999753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.5e-46  Score=361.99  Aligned_cols=248  Identities=28%  Similarity=0.438  Sum_probs=204.7

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHH-HHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQ-RILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~-~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +.||+|+||+||+|+++.+++.+|+|.+....      ...+.+|. .+++.++||||+++++.+.....    +++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~----~~lv~e   76 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEK----LYFVLD   76 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCE----EEEEEc
Confidence            47999999999999999999999999886421      22334444 46788999999999987755433    679999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      |++||+|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..... ....
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~-~~~~  153 (321)
T cd05603          77 YVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGVEP-EETT  153 (321)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEccCCCCccCCCC-CCcc
Confidence            9999999999988778999999999999999999999999999999999999987766  999999998753211 2223


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHh
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC  239 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~c  239 (385)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+.  .....++...+..+.++|.+|
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~  230 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR-DVSQMYDNIL--HKPLQLPGGKTVAACDLLVGL  230 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC-CHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHH
Confidence            4457999999999999989999999999999999999999999764 3333333332  223455667899999999999


Q ss_pred             hhcCCCCCCCH----HHHHhCcccccccc
Q 040569          240 LIRNPGERWSA----SELLEHGFVKEQNF  264 (385)
Q Consensus       240 L~~dP~~Rps~----~elL~hp~~~~~~~  264 (385)
                      |++||.+||++    .++++|+||...++
T Consensus       231 l~~~p~~R~~~~~~~~~~~~~~~~~~~~~  259 (321)
T cd05603         231 LHKDQRRRLGAKADFLEIKNHVFFSPINW  259 (321)
T ss_pred             ccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence            99999999975    59999999986543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.7e-46  Score=362.39  Aligned_cols=247  Identities=27%  Similarity=0.394  Sum_probs=203.6

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHH-HHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQR-ILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~-il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +.||+|+||+||+|+++.+|+.+|+|++...      ....+.+|.. +++.++||||+++++.+.....    +++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~----~~lv~e   76 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEK----LYFVLD   76 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCE----EEEEEc
Confidence            4799999999999999999999999988642      1223444544 5677899999999988765443    679999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      |++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++..... ....
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~--~kL~DfG~~~~~~~~-~~~~  153 (325)
T cd05604          77 FVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH--VVLTDFGLCKEGIAQ-SDTT  153 (325)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEeecCCcccCCCC-CCCc
Confidence            9999999999988888999999999999999999999999999999999999987766  999999998754221 2223


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHh
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC  239 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~c  239 (385)
                      ...+||+.|||||++.+..++.++|||||||++|+|++|+.||... +.......+.. . ...++...+..+.++|.+|
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~-~~~~~~~~~~~-~-~~~~~~~~~~~~~~ll~~l  230 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR-DVAEMYDNILH-K-PLVLRPGASLTAWSILEEL  230 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC-CHHHHHHHHHc-C-CccCCCCCCHHHHHHHHHH
Confidence            4567999999999999999999999999999999999999999764 33333333321 1 2233445899999999999


Q ss_pred             hhcCCCCCCCH----HHHHhCccccccc
Q 040569          240 LIRNPGERWSA----SELLEHGFVKEQN  263 (385)
Q Consensus       240 L~~dP~~Rps~----~elL~hp~~~~~~  263 (385)
                      |.++|.+||++    .++++||||....
T Consensus       231 l~~~p~~R~~~~~~~~~i~~h~~f~~~~  258 (325)
T cd05604         231 LEKDRQRRLGAKEDFLEIQEHPFFESLS  258 (325)
T ss_pred             hccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence            99999999976    5999999998653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.8e-46  Score=360.84  Aligned_cols=248  Identities=25%  Similarity=0.412  Sum_probs=203.7

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHH-HHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQ-RILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~-~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +.||+|+||+||+|+++.+++.+|+|.+....      ...+.+|. .+++.+.||||+++++.+.....    +++|||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~----~~lv~e   76 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK----LYFVLD   76 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCe----EEEEEe
Confidence            47999999999999999999999999886421      12233343 45678899999999988765443    679999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      |++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... .....
T Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~--~kl~DfG~a~~~~~-~~~~~  153 (325)
T cd05602          77 YINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIE-HNGTT  153 (325)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEEccCCCCccccc-CCCCc
Confidence            9999999999998788999999999999999999999999999999999999987665  99999999975422 12223


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHh
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC  239 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~c  239 (385)
                      ...+||+.|||||++.+..++.++|||||||++|+|++|+.||... +.......+..  ....++..+++.++++|.+|
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~  230 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-NTAEMYDNILN--KPLQLKPNITNSARHLLEGL  230 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC-CHHHHHHHHHh--CCcCCCCCCCHHHHHHHHHH
Confidence            4567999999999999999999999999999999999999999764 33333333311  12334456899999999999


Q ss_pred             hhcCCCCCCCHH----HHHhCcccccccc
Q 040569          240 LIRNPGERWSAS----ELLEHGFVKEQNF  264 (385)
Q Consensus       240 L~~dP~~Rps~~----elL~hp~~~~~~~  264 (385)
                      |++||.+|+++.    ++++|+|+...++
T Consensus       231 l~~~p~~R~~~~~~~~~i~~~~~~~~~~~  259 (325)
T cd05602         231 LQKDRTKRLGAKDDFMEIKNHIFFSPINW  259 (325)
T ss_pred             cccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence            999999999876    8999999976543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.4e-46  Score=363.20  Aligned_cols=252  Identities=26%  Similarity=0.343  Sum_probs=202.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccC--CeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEEN--GKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~~~~   74 (385)
                      +|++.+.||+|+||+||++.++.+|+.+|+|.+...     ....+.+|+.+++.++||||+++++++.....  ....+
T Consensus        22 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  101 (359)
T cd07876          22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV  101 (359)
T ss_pred             ceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccccee
Confidence            689999999999999999999999999999988542     23456789999999999999999998764432  11235


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||||+.+ +|.+.+..  .+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... 
T Consensus       102 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~~~~-  175 (359)
T cd07876         102 YLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACT-  175 (359)
T ss_pred             EEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCcccccc-
Confidence            799999976 67777653  3899999999999999999999999999999999999987766  99999999976432 


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh-------------------
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI-------------------  215 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~-------------------  215 (385)
                       ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .+..+                   
T Consensus       176 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  253 (359)
T cd07876         176 -NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGTPSAEFMNRLQPTV  253 (359)
T ss_pred             -CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCcHHHHHHHHHHH
Confidence             222344578999999999999999999999999999999999999997643211 11000                   


Q ss_pred             ----cCCCC-----------------CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          216 ----GFSSD-----------------TPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       216 ----~~~~~-----------------~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                          .....                 ........++++++||.+||..||++|||+.|+|+|||+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence                00000                 00111234678999999999999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-47  Score=364.00  Aligned_cols=255  Identities=25%  Similarity=0.404  Sum_probs=219.9

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH-----HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~-----~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      |...++||+|.|++|.+|+|..||+.||||++++...     ..+.+|++-|+.++|||||++|++......    +|||
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK----lyLi   95 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK----LYLI   95 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccce----EEEE
Confidence            7788999999999999999999999999999987543     467789999999999999999998644433    6699


Q ss_pred             EeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           78 LEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      +|.-.+|+|.++|. ....++|..+++|++||+.|+.|+|+..+|||||||+||.+.+.- +-|||.|||++..+...  
T Consensus        96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKl-GlVKLTDFGFSNkf~PG--  172 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKL-GLVKLTDFGFSNKFQPG--  172 (864)
T ss_pred             EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeec-CceEeeeccccccCCCc--
Confidence            99999999999986 455699999999999999999999999999999999999887553 34899999999877433  


Q ss_pred             CCCCccccCCcccChhhhcCCCCC-CCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          157 DEGKPICGTPICMAPEVARGEEQG-FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                      ....+.||+..|-|||++.|..|+ +++||||||+|+|-|++|++||...++...+ ..|  ......+|..+|.++++|
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL-TmI--mDCKYtvPshvS~eCrdL  249 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL-TMI--MDCKYTVPSHVSKECRDL  249 (864)
T ss_pred             chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh-hhh--hcccccCchhhhHHHHHH
Confidence            345678999999999999999885 7899999999999999999999886554443 333  233456788899999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCccccccccccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVKEQNFKLS  267 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~~~~~~~~  267 (385)
                      |..||.+||++|.|.+++..|+|++..+..++
T Consensus       250 I~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~s  281 (864)
T KOG4717|consen  250 IQSMLVRDPKKRASLEEIVSTSWLQAGDRGLS  281 (864)
T ss_pred             HHHHHhcCchhhccHHHHhccccccCCCCCcc
Confidence            99999999999999999999999987754443

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=9.7e-46  Score=350.55  Aligned_cols=255  Identities=28%  Similarity=0.410  Sum_probs=210.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      .|++.+.||+|+||+||++.++.+++.+|+|.+....      ...+.+|+.++++++|+||+++++.+....    .++
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~----~~~   76 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD----ALC   76 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC----EEE
Confidence            4889999999999999999999999999999876431      234668999999999999999998875543    267


Q ss_pred             EEEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           76 LFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      +||||++|++|.+++..  ...+++..+..++.|++.||.|||++||+||||||+||+++.++.  ++|+|||++.....
T Consensus        77 lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~  154 (285)
T cd05630          77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPE  154 (285)
T ss_pred             EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeccceeecCC
Confidence            99999999999999863  335899999999999999999999999999999999999987665  99999999976532


Q ss_pred             cCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChH--HHHHHhcCCCCCCCCCCcCCHH
Q 040569          154 NEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPI--SALHRIGFSSDTPEIPGYMSKQ  231 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~  231 (385)
                      ..  ......|++.|+|||++.+..++.++|||||||++|+|++|+.||....+..  ....... .......+..++++
T Consensus       155 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  231 (285)
T cd05630         155 GQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPD  231 (285)
T ss_pred             Cc--cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHH
Confidence            22  2233479999999999999999999999999999999999999997643321  1111111 11223345668999


Q ss_pred             HHHHHHHhhhcCCCCCCC-----HHHHHhCccccccccc
Q 040569          232 AQDFLSKCLIRNPGERWS-----ASELLEHGFVKEQNFK  265 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps-----~~elL~hp~~~~~~~~  265 (385)
                      +++|+.+||+.||.+|||     +.|+++||||.+.++.
T Consensus       232 ~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05630         232 ARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK  270 (285)
T ss_pred             HHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence            999999999999999999     8999999999875443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-46  Score=363.78  Aligned_cols=245  Identities=28%  Similarity=0.428  Sum_probs=201.2

Q ss_pred             eeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhc---CCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            9 IGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSAL---ACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         9 LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l---~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      ||+|+||+||+|+++.+++.+|+|++....      .....+|..++..+   .||||+++++.+.....    +++|||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~----~~lv~e   76 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSD----LYLVTD   76 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCe----EEEEEc
Confidence            799999999999999999999999886421      12334577777765   69999999988765543    679999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      |++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++..... ....
T Consensus        77 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~a~~~~~~-~~~~  153 (330)
T cd05586          77 YMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH--IALCDFGLSKANLTD-NKTT  153 (330)
T ss_pred             CCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEecCCcCcCCCCC-CCCc
Confidence            9999999999998888999999999999999999999999999999999999987766  999999998754222 2223


Q ss_pred             CccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCC-CcCCHHHHHHHH
Q 040569          160 KPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP-GYMSKQAQDFLS  237 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~ll~  237 (385)
                      ...+||+.|||||++.+. .++.++|||||||++|+|++|+.||... +.......+....  ..++ ..+++++++||.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~-~~~~~~~~i~~~~--~~~~~~~~~~~~~~li~  230 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE-DTQQMYRNIAFGK--VRFPKNVLSDEGRQFVK  230 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC-CHHHHHHHHHcCC--CCCCCccCCHHHHHHHH
Confidence            456799999999999765 4789999999999999999999999764 3333334432221  2222 347999999999


Q ss_pred             HhhhcCCCCCC----CHHHHHhCccccccc
Q 040569          238 KCLIRNPGERW----SASELLEHGFVKEQN  263 (385)
Q Consensus       238 ~cL~~dP~~Rp----s~~elL~hp~~~~~~  263 (385)
                      +||++||.+||    ++.++++||||....
T Consensus       231 ~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         231 GLLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             HHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence            99999999998    799999999998654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=9.8e-46  Score=349.63  Aligned_cols=253  Identities=27%  Similarity=0.364  Sum_probs=202.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhc---CCCCeeeeeeeeeecc-CCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSAL---ACPQIVAYKGCDISEE-NGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l---~hpnIv~~~~~~~~~~-~~~~   72 (385)
                      +|++.+.||+|+||+||+|+++.+++.+|+|.+....     .....+|+.+++.+   .||||+++++++.... ....
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5899999999999999999999999999999886421     23456788887766   6999999999876432 2233


Q ss_pred             EEEEEEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569           73 LYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                      .++++|||+++ +|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~  157 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARI  157 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccCcccc
Confidence            46799999985 89998874  345899999999999999999999999999999999999987766  99999999987


Q ss_pred             ecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh---cCCC--------
Q 040569          151 ARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI---GFSS--------  219 (385)
Q Consensus       151 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---~~~~--------  219 (385)
                      ....  .......||+.|+|||++.+..++.++|||||||++|+|++|++||.............   +...        
T Consensus       158 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         158 YSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             ccCc--ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            5322  22234568999999999999899999999999999999999999997643322211111   0000        


Q ss_pred             ---------C----CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          220 ---------D----TPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       220 ---------~----~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                               .    .......+++.+++||.+||++||.+|||+.|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                     0    001112467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.2e-45  Score=348.26  Aligned_cols=248  Identities=25%  Similarity=0.407  Sum_probs=201.3

Q ss_pred             eeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecC
Q 040569            9 IGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAP   82 (385)
Q Consensus         9 LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (385)
                      ||+|+||+||++.++.+|+.||+|.+....      ...+..|++++++++||||+++++.+.....    +++||||++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~----~~lv~e~~~   76 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTH----LCLVMSLMN   76 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCe----EEEEEecCC
Confidence            799999999999999999999999886321      2345579999999999999999888755432    679999999


Q ss_pred             CCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCC
Q 040569           83 GGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGK  160 (385)
Q Consensus        83 ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~  160 (385)
                      |++|.+++..  ...+++..+..++.||+.||+|||++||+||||||+||+++.++.  +||+|||++.......  ...
T Consensus        77 g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~--~~~  152 (277)
T cd05607          77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN--CRLSDLGLAVELKDGK--TIT  152 (277)
T ss_pred             CCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC--EEEeeceeeeecCCCc--eee
Confidence            9999998863  235889999999999999999999999999999999999987665  9999999998763221  223


Q ss_pred             ccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChH--HHHHHhcCCCCCCCCCCcCCHHHHHHHHH
Q 040569          161 PICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPI--SALHRIGFSSDTPEIPGYMSKQAQDFLSK  238 (385)
Q Consensus       161 ~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~~ll~~  238 (385)
                      ...|++.|+|||++.+..++.++|||||||++|+|++|+.||.......  ............+.....+++++++||.+
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  232 (277)
T cd05607         153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRL  232 (277)
T ss_pred             ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHH
Confidence            3468999999999999889999999999999999999999997543221  11111111222222234579999999999


Q ss_pred             hhhcCCCCCCCH----HHHHhCcccccccc
Q 040569          239 CLIRNPGERWSA----SELLEHGFVKEQNF  264 (385)
Q Consensus       239 cL~~dP~~Rps~----~elL~hp~~~~~~~  264 (385)
                      ||++||.+||++    ++++.||||+..++
T Consensus       233 ~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~  262 (277)
T cd05607         233 FLAKKPEDRLGSREKNDDPRKHEFFKTINF  262 (277)
T ss_pred             HhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence            999999999999    67889999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=9.8e-46  Score=358.54  Aligned_cols=248  Identities=24%  Similarity=0.332  Sum_probs=200.5

Q ss_pred             CceeeceeeccCceEEEEEEE-----CCCCcEEEEEeccCCC----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMS-----NRSSEVFAVKSAELSN----SEFLQREQRILSAL-ACPQIVAYKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~   71 (385)
                      +|++++.||+|+||+||+|.+     +.+++.||||.+....    ...+.+|+.+|+++ +||||+++++++.....  
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~--   85 (338)
T cd05102           8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG--   85 (338)
T ss_pred             HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC--
Confidence            588999999999999999975     2446789999886432    24577899999999 89999999998654332  


Q ss_pred             EEEEEEEeecCCCCHHHHHHcC----------------------------------------------------------
Q 040569           72 ILYNLFLEYAPGGTLTDAIRSG----------------------------------------------------------   93 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~~----------------------------------------------------------   93 (385)
                       .++++|||+++|+|.+++...                                                          
T Consensus        86 -~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          86 -PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             -ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             256899999999999999742                                                          


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC-CCCccccCCcc
Q 040569           94 ----TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD-EGKPICGTPIC  168 (385)
Q Consensus        94 ----~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~Gt~~y  168 (385)
                          ..+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++........ ......+++.|
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc--EEEeecccccccccCcchhcccCCCCCccc
Confidence                24778889999999999999999999999999999999987665  999999999865322111 12233467889


Q ss_pred             cChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCC
Q 040569          169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGER  247 (385)
Q Consensus       169 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~R  247 (385)
                      ||||++.+..++.++|||||||++|||++ |..||............+ .....+..+..+++.+.+|+.+||..||.+|
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  321 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL-KDGTRMRAPENATPEIYRIMLACWQGDPKER  321 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH-hcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence            99999999999999999999999999997 999998754333332222 2233445567789999999999999999999


Q ss_pred             CCHHHHHh
Q 040569          248 WSASELLE  255 (385)
Q Consensus       248 ps~~elL~  255 (385)
                      ||+.|+++
T Consensus       322 Ps~~el~~  329 (338)
T cd05102         322 PTFSALVE  329 (338)
T ss_pred             cCHHHHHH
Confidence            99999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.4e-45  Score=344.39  Aligned_cols=251  Identities=37%  Similarity=0.638  Sum_probs=210.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---------SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|++++.||+|+||+||+|.. .+++.+|+|.+....         ...+++|+++|++++||||+++++++....    
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   75 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN----   75 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC----
Confidence            699999999999999999986 478999999876432         245788999999999999999999876543    


Q ss_pred             EEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           73 LYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      .+++++||++|++|.+++.+.+.+++..+..++.||+.||+|||+.|++|+||||+||+++.++.  +||+|||++....
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~  153 (265)
T cd06631          76 TISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLA  153 (265)
T ss_pred             eEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe--EEeccchhhHhhh
Confidence            36799999999999999987777999999999999999999999999999999999999987665  9999999987642


Q ss_pred             ccC-----CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCc
Q 040569          153 VNE-----DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY  227 (385)
Q Consensus       153 ~~~-----~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (385)
                      ...     ........|+..|+|||++.+..++.++|+|||||++|+|++|+.||...................+.++..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDS  233 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCC
Confidence            111     111234568999999999999889999999999999999999999997654333222222222345567777


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          228 MSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       228 ~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      ++.++.+||.+||.++|.+||++.|+|+||||
T Consensus       234 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         234 FSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            89999999999999999999999999999996

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-45  Score=374.75  Aligned_cols=252  Identities=24%  Similarity=0.366  Sum_probs=212.5

Q ss_pred             ceeeceeeccCceEEEEEEECCC-CcEEEEEeccCCCH---HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRS-SEVFAVKSAELSNS---EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~-~~~~AvK~~~~~~~---~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      |.+.+.||+|+||+||+|....+ ++.+|+|.+.....   ..+++|+.+|+.++||||+++++++.....    ++|||
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~----~~lv~  144 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK----LLLIM  144 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE----EEEEE
Confidence            88999999999999999998877 78889997765442   456789999999999999999998866543    67999


Q ss_pred             eecCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           79 EYAPGGTLTDAIR----SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        79 Ey~~ggsL~~~l~----~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ||++||+|.+++.    ....+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~  222 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDS  222 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc--EEEEeCcCceecCCc
Confidence            9999999998875    2456899999999999999999999999999999999999987765  999999999876432


Q ss_pred             CC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHH
Q 040569          155 ED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ  233 (385)
Q Consensus       155 ~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  233 (385)
                      .. ......+||+.|||||++.+..++.++|||||||++|+|++|+.||... +....+..+.. ...+..+..++++++
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~-~~~~~~~~~~~-~~~~~~~~~~s~~~~  300 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP-SQREIMQQVLY-GKYDPFPCPVSSGMK  300 (478)
T ss_pred             cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHh-CCCCCCCccCCHHHH
Confidence            21 1234567999999999999999999999999999999999999999764 33344444322 233445667899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          234 DFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       234 ~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +||.+||.+||.+||++.++|.|+|++..
T Consensus       301 ~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        301 ALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             HHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            99999999999999999999999998643

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-47  Score=374.51  Aligned_cols=252  Identities=32%  Similarity=0.526  Sum_probs=217.7

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH---HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS---EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~---~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      |.++..||-|+||.||+|.++.++-..|.|+++....   +.+.-|++||..+.||+||++++.|+....    ++++.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk----LwiliE  109 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK----LWILIE  109 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc----eEEEEe
Confidence            7889999999999999999999999999999986554   455579999999999999999998877665    678999


Q ss_pred             ecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           80 YAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        80 y~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      ||.||-+...+- -+..|+|.++..+++|++.||.|||+++|||||||..|||++.+|.  ++|+|||.+.... .....
T Consensus       110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd--irLADFGVSAKn~-~t~qk  186 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD--IRLADFGVSAKNK-STRQK  186 (1187)
T ss_pred             ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc--Eeeecccccccch-hHHhh
Confidence            999999999886 5667999999999999999999999999999999999999999888  9999999876432 22233


Q ss_pred             CCccccCCcccChhhhc-----CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC-CCCCCCCCcCCHHH
Q 040569          159 GKPICGTPICMAPEVAR-----GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS-SDTPEIPGYMSKQA  232 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~  232 (385)
                      ...+.|||.|||||+..     ..+|++++||||||++++||+.+.+|.... ++...+.++..+ +...--|..+|..+
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-npMRVllKiaKSePPTLlqPS~Ws~~F  265 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLLQPSHWSRSF  265 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-chHHHHHHHhhcCCCcccCcchhhhHH
Confidence            45678999999999974     457999999999999999999999999876 566666565443 22333477889999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          233 QDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      .|||.+||.+||..||+++|+|+||||...
T Consensus       266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             HHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence            999999999999999999999999999854

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.5e-45  Score=343.45  Aligned_cols=254  Identities=37%  Similarity=0.674  Sum_probs=213.3

Q ss_pred             CCceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            1 MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--------SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         1 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      .+|+.++.||+|+||.||+|.+..++..+|+|.+....        .+.+++|+.++++++||||+++++++......  
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~--   79 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEK--   79 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCC--
Confidence            37999999999999999999999999999999875321        24577899999999999999999987643322  


Q ss_pred             EEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           73 LYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      .+++++||+++++|.+++...+.+++..+..++.||+.||+|||++|++||||||+||+++.++.  +||+|||+++...
T Consensus        80 ~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~  157 (266)
T cd06651          80 TLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCCCccccc
Confidence            35689999999999999987777999999999999999999999999999999999999987665  9999999987653


Q ss_pred             ccC--CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          153 VNE--DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       153 ~~~--~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      ...  ........|+..|+|||.+.+..++.++|||||||++|+|++|+.||..... .............+.++..+++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~  236 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-MAAIFKIATQPTNPQLPSHISE  236 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-HHHHHHHhcCCCCCCCchhcCH
Confidence            211  1112334688999999999998899999999999999999999999986533 3333344344455677778899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLEHGFVK  260 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~hp~~~  260 (385)
                      .+++|+ +||..+|++||+++|+++||||+
T Consensus       237 ~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         237 HARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            999999 67788999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-45  Score=375.85  Aligned_cols=257  Identities=27%  Similarity=0.385  Sum_probs=214.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccC----CeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEEN----GKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~----~~~   72 (385)
                      +|++.+.||+|+||+||+|++..+++.||||.+....     ...+++|+.+|..+.|+||++++..+.....    ...
T Consensus        33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~  112 (496)
T PTZ00283         33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL  112 (496)
T ss_pred             CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence            6999999999999999999999999999999886432     2456789999999999999999877654322    223


Q ss_pred             EEEEEEeecCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCce
Q 040569           73 LYNLFLEYAPGGTLTDAIRS----GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA  148 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~----~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a  148 (385)
                      ++++||||+++|+|.++++.    ...+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||++
T Consensus       113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL~DFGls  190 (496)
T PTZ00283        113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKLGDFGFS  190 (496)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEEEecccC
Confidence            46799999999999999863    346899999999999999999999999999999999999987765  999999999


Q ss_pred             eeecccC-CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCc
Q 040569          149 RRARVNE-DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY  227 (385)
Q Consensus       149 ~~~~~~~-~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (385)
                      +...... .......+||+.|||||++.+..++.++|||||||++|+|++|+.||... +....+..+. ......++..
T Consensus       191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-~~~~~~~~~~-~~~~~~~~~~  268 (496)
T PTZ00283        191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-NMEEVMHKTL-AGRYDPLPPS  268 (496)
T ss_pred             eeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHh-cCCCCCCCCC
Confidence            8754322 12234567999999999999999999999999999999999999999764 3333333332 2333446677


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          228 MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       228 ~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +++++.+|+.+||..||.+||++.++++|||++..
T Consensus       269 ~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        269 ISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            89999999999999999999999999999997653

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.3e-45  Score=353.31  Aligned_cols=254  Identities=27%  Similarity=0.441  Sum_probs=204.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++.+.||+|+||+||+|+++.+++.+|+|.+....    ...+.+|++++++++||||+++++++.....    +++|
T Consensus         7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv   82 (309)
T cd07872           7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKS----LTLV   82 (309)
T ss_pred             ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCe----EEEE
Confidence            5999999999999999999999999999999886432    2456789999999999999999998766543    6799


Q ss_pred             EeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           78 LEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |||+++ +|.+++.. +..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.......
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSVPTK  159 (309)
T ss_pred             EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECccccceecCCCcc
Confidence            999976 88888864 456899999999999999999999999999999999999987665  99999999986532221


Q ss_pred             CCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHH--HHHHh-c----------------
Q 040569          157 DEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPIS--ALHRI-G----------------  216 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~~~~-~----------------  216 (385)
                       ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........  ...+. +                
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence             2233468999999999865 4578899999999999999999999976432111  11110 0                


Q ss_pred             ----CCCCCC----CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          217 ----FSSDTP----EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       217 ----~~~~~~----~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                          +....+    .....+++++++||.+||+.||.+|||+.|+|+||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence                000000    01124788999999999999999999999999999998653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.4e-45  Score=342.93  Aligned_cols=254  Identities=33%  Similarity=0.624  Sum_probs=214.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---------SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|++++.||+|+||.||++.+..+++.+|+|.+....         .+.+.+|+.++++++||||+++++++.....   
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---   77 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSH---   77 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCe---
Confidence            5999999999999999999999999999999886432         3567889999999999999999998765443   


Q ss_pred             EEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           73 LYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                       +++|+||++|++|.+++...+.+++..+..++.||+.||.|||++|++|+||||+||+++.++. .+||+|||.+....
T Consensus        78 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~  155 (268)
T cd06630          78 -FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLA  155 (268)
T ss_pred             -EEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEcccccccccc
Confidence             6799999999999999987778999999999999999999999999999999999999975532 38999999987764


Q ss_pred             ccCCC---CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHhcCCCCCCCCCCc
Q 040569          153 VNEDD---EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVA--DPISALHRIGFSSDTPEIPGY  227 (385)
Q Consensus       153 ~~~~~---~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~  227 (385)
                      .....   ......|+..|+|||++.+..++.++|+|||||++++|++|..||....  .......++......+.++..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH  235 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchh
Confidence            32111   1223468899999999998889999999999999999999999996432  223333344344556677778


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 040569          228 MSKQAQDFLSKCLIRNPGERWSASELLEHGFVK  260 (385)
Q Consensus       228 ~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~  260 (385)
                      +++++.+++.+||..+|.+||++.++++||||+
T Consensus       236 ~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         236 LSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             hCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            899999999999999999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.2e-45  Score=373.92  Aligned_cols=252  Identities=19%  Similarity=0.256  Sum_probs=198.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcCCC------CeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALACP------QIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~hp------nIv~~~~~~~~~~~~~~~   73 (385)
                      +|++.+.||+|+||+||+|.+..+++.||||++....  ....++|+.+++.+.|.      +++++++++.....   .
T Consensus       130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~---~  206 (467)
T PTZ00284        130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG---H  206 (467)
T ss_pred             cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc---e
Confidence            4889999999999999999999999999999986422  33456788888887554      58888877654322   3


Q ss_pred             EEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEeecCCC--------------C
Q 040569           74 YNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSKDNE--------------Q  138 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~-~givHrDlKp~NILi~~~~~--------------~  138 (385)
                      +++|||++ |++|.+++.+.+.+++..+..++.||+.||+|||+ .||+||||||+|||++.++.              .
T Consensus       207 ~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~  285 (467)
T PTZ00284        207 MCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC  285 (467)
T ss_pred             EEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence            67899998 77999999877789999999999999999999998 59999999999999976542              1


Q ss_pred             CeEEeecCceeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC-
Q 040569          139 GAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF-  217 (385)
Q Consensus       139 ~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-  217 (385)
                      .+||+|||.+....    ......+||+.|||||++.+..++.++|||||||++|||++|+.||....+. ..+..+.. 
T Consensus       286 ~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~  360 (467)
T PTZ00284        286 RVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL-EHLHLMEKT  360 (467)
T ss_pred             eEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHH
Confidence            38999999876432    2234568999999999999999999999999999999999999999764332 21111100 


Q ss_pred             CCC------------------------CCCC---------------CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 040569          218 SSD------------------------TPEI---------------PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGF  258 (385)
Q Consensus       218 ~~~------------------------~~~~---------------~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~  258 (385)
                      ...                        .+..               ....++.+.+||.+||++||.+|||++|+|+|||
T Consensus       361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~  440 (467)
T PTZ00284        361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY  440 (467)
T ss_pred             cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence            000                        0000               0012456789999999999999999999999999


Q ss_pred             cccc
Q 040569          259 VKEQ  262 (385)
Q Consensus       259 ~~~~  262 (385)
                      |...
T Consensus       441 ~~~~  444 (467)
T PTZ00284        441 VLKY  444 (467)
T ss_pred             cccc
Confidence            9864

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.2e-45  Score=341.31  Aligned_cols=250  Identities=40%  Similarity=0.702  Sum_probs=212.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccC
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------------SEFLQREQRILSALACPQIVAYKGCDISEEN   69 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~   69 (385)
                      .|.+++.||+|++|.||+|.+..+++.+|+|.+....            .+.+++|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            5899999999999999999999999999999875421            1457789999999999999999998765443


Q ss_pred             CeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCcee
Q 040569           70 GKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR  149 (385)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~  149 (385)
                          .++++||+++++|.+++...+.+++..+..++.|++.||+|||++|++||||||+||+++.++.  +||+|||+++
T Consensus        81 ----~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~  154 (267)
T cd06628          81 ----LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISK  154 (267)
T ss_pred             ----cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC--EEecccCCCc
Confidence                6689999999999999998778999999999999999999999999999999999999987665  9999999998


Q ss_pred             eecccCC-----CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCC
Q 040569          150 RARVNED-----DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI  224 (385)
Q Consensus       150 ~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  224 (385)
                      .......     .......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...... .....+.. ...+.+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~-~~~~~~  232 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-QAIFKIGE-NASPEI  232 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-HHHHHHhc-cCCCcC
Confidence            7642211     1112346889999999999888999999999999999999999999865333 33333322 344566


Q ss_pred             CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          225 PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       225 ~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      +..++..+.++|.+||++||.+||++.|+++||||
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         233 PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             CcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            77789999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-47  Score=370.04  Aligned_cols=244  Identities=36%  Similarity=0.560  Sum_probs=213.6

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH------HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS------EFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~------~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      |.-++.||.|+||.||.|++..+.++||||.+..+..      ..+.+|++.|+++.|||+|.+.|||.-...    .+|
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T----aWL  103 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT----AWL  103 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch----HHH
Confidence            5667899999999999999999999999999876532      356789999999999999999999876654    669


Q ss_pred             EEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |||||-| |-.|++. ...++-|.++..|+.+.+.||+|||+++.||||||..|||++..+.  |||+|||.|....   
T Consensus       104 VMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~--VKLaDFGSAsi~~---  177 (948)
T KOG0577|consen  104 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL--VKLADFGSASIMA---  177 (948)
T ss_pred             HHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe--eeeccccchhhcC---
Confidence            9999965 9999987 5567999999999999999999999999999999999999997776  9999999998753   


Q ss_pred             CCCCCccccCCcccChhhhc---CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCC-CcCCHH
Q 040569          156 DDEGKPICGTPICMAPEVAR---GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP-GYMSKQ  231 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~  231 (385)
                        ....++|||.|||||++.   .+.|+-++||||||++.+||+-.++|..++ +..+.++.|.. ++.|.++ ..+|+.
T Consensus       178 --PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-NAMSALYHIAQ-NesPtLqs~eWS~~  253 (948)
T KOG0577|consen  178 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQ-NESPTLQSNEWSDY  253 (948)
T ss_pred             --chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-hHHHHHHHHHh-cCCCCCCCchhHHH
Confidence              345678999999999984   567899999999999999999999999876 66777777753 3445443 457999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 040569          232 AQDFLSKCLIRNPGERWSASELLEHGFVK  260 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~hp~~~  260 (385)
                      +++|+..||++-|.+|||.+++|.|+|+.
T Consensus       254 F~~Fvd~CLqKipqeRptse~ll~H~fv~  282 (948)
T KOG0577|consen  254 FRNFVDSCLQKIPQERPTSEELLKHRFVL  282 (948)
T ss_pred             HHHHHHHHHhhCcccCCcHHHHhhcchhc
Confidence            99999999999999999999999999985

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.8e-45  Score=359.27  Aligned_cols=253  Identities=26%  Similarity=0.352  Sum_probs=202.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccC--CeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEEN--GKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~~~~   74 (385)
                      +|++.+.||+|+||+||++.+..+++.+|+|.+...     ....+.+|+.+++.++||||+++++++.....  ....+
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   97 (355)
T cd07874          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV   97 (355)
T ss_pred             ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence            589999999999999999999999999999988642     13456689999999999999999998754332  12235


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||||+++ +|.+.+..  .+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... 
T Consensus        98 ~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~~~~-  171 (355)
T cd07874          98 YLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGT-  171 (355)
T ss_pred             EEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC--EEEeeCcccccCCC-
Confidence            799999976 77777764  3899999999999999999999999999999999999987766  99999999986532 


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh----cC-------------
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI----GF-------------  217 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~----~~-------------  217 (385)
                       ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+    +.             
T Consensus       172 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  249 (355)
T cd07874         172 -SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_pred             -ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHhhcHHH
Confidence             22234557999999999999999999999999999999999999999764321 111100    00             


Q ss_pred             ------C-----------------CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          218 ------S-----------------SDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       218 ------~-----------------~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                            .                 ......+...+.++++||.+||+.||++|||+.|+|+|||+...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                  0                 00011122346788999999999999999999999999999743

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.9e-45  Score=358.29  Aligned_cols=252  Identities=26%  Similarity=0.353  Sum_probs=202.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccC--CeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEEN--GKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~~~~   74 (385)
                      +|++.+.||+|+||+||++.++.+++.+|||.+...     ....+.+|+.+++.++||||+++++++.....  ....+
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~  104 (364)
T cd07875          25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV  104 (364)
T ss_pred             ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence            689999999999999999999999999999988642     23456789999999999999999987654321  12236


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||||+++ +|.+.+..  .+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... 
T Consensus       105 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~-  178 (364)
T cd07875         105 YIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGT-  178 (364)
T ss_pred             EEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCccccCC-
Confidence            799999975 78887764  3889999999999999999999999999999999999987765  99999999986532 


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC--CC-------------
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF--SS-------------  219 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~-------------  219 (385)
                       ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+..  ..             
T Consensus       179 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (364)
T cd07875         179 -SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLGTPCPEFMKKLQPTV  256 (364)
T ss_pred             -CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence             2223445799999999999999999999999999999999999999976432 221111100  00             


Q ss_pred             -----CC--------------------CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          220 -----DT--------------------PEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       220 -----~~--------------------~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                           ..                    +......++++++||.+||+.||.+|||+.|+|+||||..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                 00                    0111123568999999999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.8e-46  Score=347.08  Aligned_cols=250  Identities=32%  Similarity=0.505  Sum_probs=206.1

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHH-----HHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF-----LQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~-----~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      |+.++.||+|+||+||++++..+++.+|+|.+.......     ..+|+.+++++.||||+++++++.....    .+++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~----~~~v   76 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNY----LYIV   76 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSE----EEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccc----cccc
Confidence            789999999999999999999999999999998776432     2359999999999999999998876433    5699


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |||+++++|.+++...+.+++..+..++.||++||++||++|++|+||||+||+++.++.  ++|+|||.+.... ....
T Consensus        77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~-~~~~  153 (260)
T PF00069_consen   77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE--VKLIDFGSSVKLS-ENNE  153 (260)
T ss_dssp             EEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE--EEESSGTTTEEST-STTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccc-cccc
Confidence            999999999999997777999999999999999999999999999999999999997666  9999999998641 2222


Q ss_pred             CCCccccCCcccChhhhc-CCCCCCCCChHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHhcCCCCCCCC--CCcCCHHH
Q 040569          158 EGKPICGTPICMAPEVAR-GEEQGFPADVWALGCTVLEMATGRPPWPDVA--DPISALHRIGFSSDTPEI--PGYMSKQA  232 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~--~~~~s~~~  232 (385)
                      ......|++.|+|||++. +..++.++||||||+++++|++|..||....  +.................  ....++.+
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEEL  233 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHH
Confidence            334557899999999998 8889999999999999999999999998651  112222111111000000  11124899


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          233 QDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      .++|.+||+.||++|||+.++++||||
T Consensus       234 ~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  234 RDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.6e-45  Score=342.02  Aligned_cols=250  Identities=32%  Similarity=0.464  Sum_probs=205.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+....   ...+++|+.+++.++||||+++++.+.....    ++++|
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~----~~lv~   85 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDK----LWICM   85 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE----EEEEE
Confidence            5888999999999999999999999999999886543   3457789999999999999999998765433    67999


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      ||+++++|.+++...+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.  +||+|||++...... ...
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~-~~~  162 (267)
T cd06645          86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGVSAQITAT-IAK  162 (267)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECcceeeeEccCc-ccc
Confidence            99999999999987778999999999999999999999999999999999999987665  999999998765322 222


Q ss_pred             CCccccCCcccChhhhc---CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCC--CCcCCHHHH
Q 040569          159 GKPICGTPICMAPEVAR---GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMSKQAQ  233 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~  233 (385)
                      .....|++.|+|||++.   ...++.++|+|||||++|+|++|+.||...................+..  ...++..+.
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH  242 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence            33457999999999984   4557889999999999999999999996543222221111111111111  224688999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcc
Q 040569          234 DFLSKCLIRNPGERWSASELLEHGF  258 (385)
Q Consensus       234 ~ll~~cL~~dP~~Rps~~elL~hp~  258 (385)
                      +||.+||.++|.+|||+.++++|||
T Consensus       243 ~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         243 HFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHccCCchhCcCHHHHhcCCC
Confidence            9999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=7.4e-45  Score=344.35  Aligned_cols=255  Identities=25%  Similarity=0.384  Sum_probs=211.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      .|+..+.||+|+||+||+|.+..+++.+|+|.+....      ...+.+|+++|++++|+||+++++.+.....    .+
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~----~~   76 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDA----LC   76 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCE----EE
Confidence            4889999999999999999999999999999886432      2346789999999999999999888765432    67


Q ss_pred             EEEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           76 LFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      ++|||+++++|.+++..  ...+++..+..++.|++.||.|||++||+||||||+||+++.++.  +||+|||++.....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~--~kl~Dfg~~~~~~~  154 (285)
T cd05632          77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH--IRISDLGLAVKIPE  154 (285)
T ss_pred             EEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC--EEEecCCcceecCC
Confidence            99999999999988863  346999999999999999999999999999999999999987655  99999999976532


Q ss_pred             cCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHH--HHHHhcCCCCCCCCCCcCCHH
Q 040569          154 NEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS--ALHRIGFSSDTPEIPGYMSKQ  231 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~s~~  231 (385)
                      .  .......|++.|+|||++.+..++.++|+|||||++|+|++|+.||....+...  ..... .......++..++++
T Consensus       155 ~--~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  231 (285)
T cd05632         155 G--ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR-VLETEEVYSAKFSEE  231 (285)
T ss_pred             C--CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-hhccccccCccCCHH
Confidence            2  122345799999999999999999999999999999999999999976533221  11111 122233455668899


Q ss_pred             HHHHHHHhhhcCCCCCCC-----HHHHHhCccccccccc
Q 040569          232 AQDFLSKCLIRNPGERWS-----ASELLEHGFVKEQNFK  265 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps-----~~elL~hp~~~~~~~~  265 (385)
                      +.+|+.+||++||.+||+     +.++++|+||.....+
T Consensus       232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05632         232 AKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK  270 (285)
T ss_pred             HHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence            999999999999999999     8899999999876443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-45  Score=356.87  Aligned_cols=252  Identities=26%  Similarity=0.367  Sum_probs=203.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCC--eEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENG--KILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~--~~~~   74 (385)
                      +|++.+.||+|+||+||+|.+..+++.||||.+....     ...+.+|+++|++++||||+++++++......  ...+
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07878          16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV   95 (343)
T ss_pred             hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence            5889999999999999999999999999999886432     24566899999999999999999887543221  1235


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++++|++ +++|.++++.+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... 
T Consensus        96 ~~~~~~~-~~~l~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~-  170 (343)
T cd07878          96 YLVTNLM-GADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQADD-  170 (343)
T ss_pred             EEEeecC-CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceecCC-
Confidence            6899998 77999888754 5999999999999999999999999999999999999987766  99999999987532 


Q ss_pred             CCCCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC----------------
Q 040569          155 EDDEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF----------------  217 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~----------------  217 (385)
                         ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ...+..+..                
T Consensus       171 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07878         171 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-IDQLKRIMEVVGTPSPEVLKKISSE  246 (343)
T ss_pred             ---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHhcchh
Confidence               2344579999999999977 5688999999999999999999999976422 211111100                


Q ss_pred             -----CCCCCCC--------CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          218 -----SSDTPEI--------PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       218 -----~~~~~~~--------~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                           ....+..        ....++.+.+||.+||..||.+|||+.|+|+||||...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~  304 (343)
T cd07878         247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY  304 (343)
T ss_pred             hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence                 0001111        12356788999999999999999999999999999764

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.3e-44  Score=338.26  Aligned_cols=253  Identities=36%  Similarity=0.628  Sum_probs=212.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--------SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|++++.||+|+||+||+|.++.+++.+|+|.+....        .+.+.+|+.+++++.||||+++++++......  .
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~--~   80 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMER--T   80 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCc--e
Confidence            7999999999999999999999999999999875321        24677899999999999999999986554332  3


Q ss_pred             EEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           74 YNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      ++++|||++|++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.  +||+|||++.....
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~  158 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQT  158 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC--EEECcCcccccccc
Confidence            5689999999999999987777999999999999999999999999999999999999987665  99999999886532


Q ss_pred             cC--CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHH
Q 040569          154 NE--DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQ  231 (385)
Q Consensus       154 ~~--~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  231 (385)
                      ..  ........|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ............+..|..++..
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  237 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-AAIFKIATQPTNPVLPPHVSDH  237 (265)
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-HHHHHHhcCCCCCCCchhhCHH
Confidence            11  11223456899999999998888999999999999999999999999765333 3333443344456667778999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 040569          232 AQDFLSKCLIRNPGERWSASELLEHGFVK  260 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~hp~~~  260 (385)
                      +.++|.+|+. +|++||+++++++|||+.
T Consensus       238 ~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         238 CRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            9999999995 899999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-46  Score=388.63  Aligned_cols=277  Identities=26%  Similarity=0.384  Sum_probs=234.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      ||.+++.||+|+||.|.+++++.|+++||+|++++      .....|..|-.||---+++.|+.++-.|.+..+    +|
T Consensus        76 DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~----LY  151 (1317)
T KOG0612|consen   76 DFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY----LY  151 (1317)
T ss_pred             hhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc----eE
Confidence            69999999999999999999999999999998865      345678889999999999999999888776654    77


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++||+|-.++.+..+++|..++.|+..|+.||+-||+.|+|||||||+||||+..|.  +||+|||.+.....+.
T Consensus       152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH--ikLADFGsClkm~~dG  229 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH--IKLADFGSCLKMDADG  229 (1317)
T ss_pred             EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc--EeeccchhHHhcCCCC
Confidence            99999999999999997779999999999999999999999999999999999999998877  9999999998776666


Q ss_pred             CCCCCccccCCcccChhhhc----C-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCC--CcC
Q 040569          156 DDEGKPICGTPICMAPEVAR----G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP--GYM  228 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~----~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~  228 (385)
                      .-.+...+|||.|.+||+++    + +.|++.+|.||+||++|||+.|..||... .......+|........+|  ..+
T Consensus       230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-slveTY~KIm~hk~~l~FP~~~~V  308 (1317)
T KOG0612|consen  230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-SLVETYGKIMNHKESLSFPDETDV  308 (1317)
T ss_pred             cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-HHHHHHHHHhchhhhcCCCccccc
Confidence            66677789999999999995    3 57899999999999999999999999753 3333333332222223333  348


Q ss_pred             CHHHHHHHHHhhhcCCCCCCC---HHHHHhCcccccccc-cccccCCCCCCCCCCCCccccc
Q 040569          229 SKQAQDFLSKCLIRNPGERWS---ASELLEHGFVKEQNF-KLSTLTEPETYNSESPTSVLNQ  286 (385)
Q Consensus       229 s~~~~~ll~~cL~~dP~~Rps---~~elL~hp~~~~~~~-~~~~~~~~~~~~~~~p~~~~~~  286 (385)
                      |+++++||.+++. +|..|..   ++++..||||...+| .+....+|..+..++|..+.|.
T Consensus       309 SeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DTsnF  369 (1317)
T KOG0612|consen  309 SEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTSNF  369 (1317)
T ss_pred             CHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCccccc
Confidence            9999999999887 5788887   999999999999876 3555566666777777766665

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=9.6e-45  Score=344.08  Aligned_cols=250  Identities=31%  Similarity=0.505  Sum_probs=215.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+...      ..+.+.+|+++++++.||||+++++++.....    ++
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~   77 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN----LY   77 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCe----EE
Confidence            689999999999999999999999999999987532      23567789999999999999999998765433    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      ++|||+++++|.+++...+.+++..+..++.||+.||.|||++|++|+||+|+|||++.++.  +||+|||+++..... 
T Consensus        78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~-  154 (290)
T cd05580          78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR-  154 (290)
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEeeCCCccccCCC-
Confidence            99999999999999998788999999999999999999999999999999999999987765  999999999876432 


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                         .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||.... .......+.  .....++..+++.++++
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~--~~~~~~~~~~~~~l~~l  228 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYEKIL--EGKVRFPSFFSPDAKDL  228 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHh--cCCccCCccCCHHHHHH
Confidence               234568999999999988888999999999999999999999997643 333333332  23345667789999999


Q ss_pred             HHHhhhcCCCCCC-----CHHHHHhCcccccccc
Q 040569          236 LSKCLIRNPGERW-----SASELLEHGFVKEQNF  264 (385)
Q Consensus       236 l~~cL~~dP~~Rp-----s~~elL~hp~~~~~~~  264 (385)
                      |.+||..||.+|+     +++|+++||||....+
T Consensus       229 i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  262 (290)
T cd05580         229 IRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW  262 (290)
T ss_pred             HHHHccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence            9999999999999     9999999999987653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.4e-45  Score=350.55  Aligned_cols=251  Identities=27%  Similarity=0.401  Sum_probs=193.6

Q ss_pred             eceeeccCceEEEEEEEC--CCCcEEEEEeccCCC-HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecC
Q 040569            6 GQTIGRGSTATVSIGMSN--RSSEVFAVKSAELSN-SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAP   82 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~--~~~~~~AvK~~~~~~-~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (385)
                      ++.||+|+||+||+|+++  .+++.+|+|.+.... ...+.+|+++|++++||||+++++++......  .+++++||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADR--KVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCc--EEEEEEeccC
Confidence            678999999999999975  467899999886543 45678999999999999999999987654433  3669999996


Q ss_pred             CCCHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecC--CCCCeEEeecCceeee
Q 040569           83 GGTLTDAIRS---------GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKD--NEQGAKIADFGCARRA  151 (385)
Q Consensus        83 ggsL~~~l~~---------~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~--~~~~~kL~DFG~a~~~  151 (385)
                      + +|.+++..         ...+++..++.++.||+.||+|||++||+||||||+|||+..+  ....+||+|||+++..
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence            5 88888752         2258999999999999999999999999999999999999532  2234899999999876


Q ss_pred             cccCC--CCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHHh----c
Q 040569          152 RVNED--DEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADP--------ISALHRI----G  216 (385)
Q Consensus       152 ~~~~~--~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--------~~~~~~~----~  216 (385)
                      .....  .......||+.|||||++.+. .++.++|||||||++|+|++|++||....+.        ...+.++    +
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (317)
T cd07868         163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG  242 (317)
T ss_pred             CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcC
Confidence            43221  123456789999999999774 5899999999999999999999999643211        0111100    0


Q ss_pred             CCC--------CCC------------------------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          217 FSS--------DTP------------------------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       217 ~~~--------~~~------------------------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      ...        ..+                        ......+.++.+||.+||++||.+|||++|+|+||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            000        000                        0011235678999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2e-44  Score=334.59  Aligned_cols=250  Identities=29%  Similarity=0.499  Sum_probs=210.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++.+.||+|++|.||++.++.+++.+|+|.+....     .+.+.+|++++++++|||++++++.+....   ..+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~l   77 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED---GLLYI   77 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC---CEEEE
Confidence            5899999999999999999999999999999886432     345778999999999999999988654322   23679


Q ss_pred             EEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           77 FLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +|||+++++|.+++..  +..+++..+..++.|++.||+|||++|++||||||+||+++.++.  ++|+|||++......
T Consensus        78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~--~~l~df~~~~~~~~~  155 (257)
T cd08223          78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQ  155 (257)
T ss_pred             EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc--EEEecccceEEeccc
Confidence            9999999999999974  456899999999999999999999999999999999999987665  999999999876432


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                      . .......|++.|+|||++.+..++.++|+|||||++++|++|+.||... +.......+ .....+..+..+++++.+
T Consensus       156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~  232 (257)
T cd08223         156 C-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-DMNSLVYRI-IEGKLPPMPKDYSPELGE  232 (257)
T ss_pred             C-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CHHHHHHHH-HhcCCCCCccccCHHHHH
Confidence            2 2234456899999999999999999999999999999999999999754 333333332 223344556678999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          235 FLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      |+.+||+++|.+|||+.++++||||
T Consensus       233 li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         233 LIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.6e-44  Score=334.79  Aligned_cols=249  Identities=29%  Similarity=0.451  Sum_probs=212.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++.+.||+|++|+||+|.++.+++.+++|.+...     ....+.+|++++++++||||+++++.+....    .+++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~l   76 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG----KLNI   76 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC----EEEE
Confidence            689999999999999999999999999999987642     2456778999999999999999999876543    2679


Q ss_pred             EEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           77 FLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +|||++|++|.+++..  +..+++..+..++.||+.||.|||++|++|+||||+||+++.++.  +||+|||+++.....
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~--~~l~df~~~~~~~~~  154 (256)
T cd08529          77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDN  154 (256)
T ss_pred             EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC--EEEcccccceeccCc
Confidence            9999999999999974  467899999999999999999999999999999999999987665  999999999876432


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                      .. ......|++.|+|||++.+..++.++|+|||||++++|++|+.||.... .......+ .....+.++..++.++.+
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~  231 (256)
T cd08529         155 TN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-QGALILKI-IRGVFPPVSQMYSQQLAQ  231 (256)
T ss_pred             cc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHH-HcCCCCCCccccCHHHHH
Confidence            22 2234568999999999999999999999999999999999999997643 33333333 233445566678999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          235 FLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      ++.+||+.+|++||++.++++|||+
T Consensus       232 ~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         232 LIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHHccCCcccCcCHHHHhhCCCC
Confidence            9999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=8.1e-45  Score=340.31  Aligned_cols=254  Identities=30%  Similarity=0.503  Sum_probs=208.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCC--eEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSAL-ACPQIVAYKGCDISEENG--KILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~--~~~~~l   76 (385)
                      .|+..+.||+|+||+||+|.++.+++.+|+|.+...  ....+.+|+.+++++ .||||+++++.+......  ...+++
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i   86 (272)
T cd06637           7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL   86 (272)
T ss_pred             hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence            478889999999999999999999999999988654  345678899999999 799999999988654321  224679


Q ss_pred             EEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           77 FLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +|||+++++|.+++..  ...+++..+..++.||+.||+|||++||+||||||+||+++.++.  +||+|||++......
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~~~~  164 (272)
T cd06637          87 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRT  164 (272)
T ss_pred             EEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--EEEccCCCceecccc
Confidence            9999999999999984  346899999999999999999999999999999999999987765  999999999865322


Q ss_pred             CCCCCCccccCCcccChhhhc-----CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCC
Q 040569          155 EDDEGKPICGTPICMAPEVAR-----GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS  229 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s  229 (385)
                      . .......|++.|+|||++.     +..++.++|||||||++|+|++|+.||..... ................+..++
T Consensus       165 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~  242 (272)
T cd06637         165 V-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-MRALFLIPRNPAPRLKSKKWS  242 (272)
T ss_pred             c-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-HHHHHHHhcCCCCCCCCCCcC
Confidence            2 2234457999999999986     33578899999999999999999999976432 222222222222233344578


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          230 KQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       230 ~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      .++.+|+.+||..+|.+|||+.++++||||
T Consensus       243 ~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         243 KKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=8.1e-45  Score=339.68  Aligned_cols=249  Identities=34%  Similarity=0.467  Sum_probs=205.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC---CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~---~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|++.+.||+|+||+||+|+++.+++.+|+|.+...   ....+++|+.+++++.||||+++++.+.....    +++||
T Consensus        10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~----~~iv~   85 (267)
T cd06646          10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREK----LWICM   85 (267)
T ss_pred             hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE----EEEEE
Confidence            699999999999999999999999999999988643   24567889999999999999999998765432    67999


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      ||+++++|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++.++.  +||+|||++....... ..
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~-~~  162 (267)
T cd06646          86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGVAAKITATI-AK  162 (267)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEECcCccceeecccc-cc
Confidence            99999999999987778999999999999999999999999999999999999987665  9999999998763221 12


Q ss_pred             CCccccCCcccChhhhc---CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC---CCCCCCCCCcCCHHH
Q 040569          159 GKPICGTPICMAPEVAR---GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF---SSDTPEIPGYMSKQA  232 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~~  232 (385)
                      .....|++.|+|||.+.   ...++.++|+|||||++|+|++|+.||...... .....+..   .......+..++..+
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-RALFLMSKSNFQPPKLKDKTKWSSTF  241 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-hhheeeecCCCCCCCCccccccCHHH
Confidence            23456899999999985   344678999999999999999999999654322 21111111   111111223478999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCcc
Q 040569          233 QDFLSKCLIRNPGERWSASELLEHGF  258 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~hp~  258 (385)
                      .+||.+||..+|.+|||++++|+|+|
T Consensus       242 ~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         242 HNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            99999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.2e-44  Score=341.69  Aligned_cols=252  Identities=32%  Similarity=0.505  Sum_probs=208.0

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH---HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS---EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~---~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      |++.+.||+|+||.||+|.+..++..+++|.+.....   +.+.+|+++++.+.||||+++++.+.....    +++|+|
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~----~~~v~e   82 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENN----LWILIE   82 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCE----EEEEEE
Confidence            6788999999999999999999999999999875443   456789999999999999999998765432    669999


Q ss_pred             ecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           80 YAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        80 y~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      |+++++|..++.+ ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.  +||+|||++...... ...
T Consensus        83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~-~~~  159 (282)
T cd06643          83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRT-IQR  159 (282)
T ss_pred             ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC--EEEcccccccccccc-ccc
Confidence            9999999998763 567999999999999999999999999999999999999987765  999999998765322 122


Q ss_pred             CCccccCCcccChhhhc-----CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh-cCCCCCCCCCCcCCHHH
Q 040569          159 GKPICGTPICMAPEVAR-----GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI-GFSSDTPEIPGYMSKQA  232 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~  232 (385)
                      .....|++.|+|||++.     +..++.++|||||||++|+|++|++||..... ......+ .........+..++.++
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSEPPTLAQPSRWSSEF  238 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-HHHHHHHhhcCCCCCCCccccCHHH
Confidence            23456899999999984     34567899999999999999999999976533 3332222 21222223455688999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          233 QDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ++||.+||++||.+||++.++++|||+...
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         239 KDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            999999999999999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=9.9e-45  Score=336.19  Aligned_cols=251  Identities=32%  Similarity=0.522  Sum_probs=211.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +|+..+.||+|+||.||+|+++.+++.+++|.+.... .+.+.+|++++++++||||+++++.+.....    +++++||
T Consensus         4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~----~~l~~e~   79 (256)
T cd06612           4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTD----LWIVMEY   79 (256)
T ss_pred             cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCc----EEEEEec
Confidence            5889999999999999999999989999999887543 5678899999999999999999998876543    6799999


Q ss_pred             cCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           81 APGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        81 ~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      +++++|.+++.. +..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.  +||+|||++........ ..
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~-~~  156 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQLTDTMA-KR  156 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc--EEEcccccchhcccCcc-cc
Confidence            999999999974 567899999999999999999999999999999999999987765  99999999987643221 22


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHh
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC  239 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~c  239 (385)
                      ....|+..|+|||++.+..++.++||||||+++++|++|+.||......................+..++.++.+||.+|
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  236 (256)
T cd06612         157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC  236 (256)
T ss_pred             ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHH
Confidence            33458899999999999999999999999999999999999997653332222111111122223445788999999999


Q ss_pred             hhcCCCCCCCHHHHHhCccc
Q 040569          240 LIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       240 L~~dP~~Rps~~elL~hp~~  259 (385)
                      |+.||.+|||+.|+|+||||
T Consensus       237 l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         237 LVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HhcChhhCcCHHHHhcCCCC
Confidence            99999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-46  Score=339.77  Aligned_cols=255  Identities=26%  Similarity=0.404  Sum_probs=212.8

Q ss_pred             cee-eceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            3 WTR-GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         3 y~~-~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      |++ -+.||-|-.|.|-.+.++.|++.||+|++.  +....+||+++--.. .|||||.++++|...-.+..++.+|||.
T Consensus        63 Y~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~--Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~  140 (400)
T KOG0604|consen   63 YSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL--DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC  140 (400)
T ss_pred             heehhhhhccccCCceEEEEeccchhhhHHHHHh--cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence            444 468999999999999999999999999875  456667899875555 8999999999998777777778899999


Q ss_pred             cCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCC-CeEEeecCceeeecccCCC
Q 040569           81 APGGTLTDAIRSGT--CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQ-GAKIADFGCARRARVNEDD  157 (385)
Q Consensus        81 ~~ggsL~~~l~~~~--~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~-~~kL~DFG~a~~~~~~~~~  157 (385)
                      ++||.|...|+..+  .++|.++..|++||..|+.|||+.+|.||||||+|+|....+.. .+||+|||+|+....  ..
T Consensus       141 meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~--~~  218 (400)
T KOG0604|consen  141 MEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE--PG  218 (400)
T ss_pred             ccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC--Cc
Confidence            99999999998544  59999999999999999999999999999999999999755433 359999999998643  34


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHh---cCCCCCCCCCCcCCHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVAD---PISALHRI---GFSSDTPEIPGYMSKQ  231 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~---~~~~~~~~---~~~~~~~~~~~~~s~~  231 (385)
                      ...+.|-||.|.|||++..+.|+..+|+||+||++|.|++|.+||.....   .--...+|   .+....++ ...+|+.
T Consensus       219 ~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE-Ws~VSe~  297 (400)
T KOG0604|consen  219 DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE-WSCVSEA  297 (400)
T ss_pred             cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh-HhHHHHH
Confidence            45677899999999999999999999999999999999999999975321   11111222   12222233 2458999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          232 AQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ++++|+++|+.+|.+|.|.+|+++|||+.+.
T Consensus       298 aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  298 AKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             HHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence            9999999999999999999999999999764

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-44  Score=347.41  Aligned_cols=261  Identities=28%  Similarity=0.447  Sum_probs=213.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|+..+.||+|+||+||+|.+..+++.+|+|.+....      ...+.+|+++++.++||||+++++.+....    ..+
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~   77 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET----YLC   77 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC----EEE
Confidence            6899999999999999999999999999999886543      245778999999999999999998875433    267


Q ss_pred             EEEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           76 LFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      ++|||+.|++|.+++..  +..+++..+..++.||+.||+|||+.|++|+||||+||+++.++.  ++|+|||++.....
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~  155 (316)
T cd05574          78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH--IMLSDFDLSKQSDV  155 (316)
T ss_pred             EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC--EEEeecchhhcccc
Confidence            99999999999999974  357999999999999999999999999999999999999987765  99999999875432


Q ss_pred             cCC----------------------------CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCC
Q 040569          154 NED----------------------------DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDV  205 (385)
Q Consensus       154 ~~~----------------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~  205 (385)
                      ...                            .......||..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            111                            0112346899999999999988999999999999999999999999765


Q ss_pred             CChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCC----HHHHHhCccccccccccccc
Q 040569          206 ADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWS----ASELLEHGFVKEQNFKLSTL  269 (385)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps----~~elL~hp~~~~~~~~~~~~  269 (385)
                      ... .....+............+++++++||.+||.+||.+|||    ++|+|+||||++..+.....
T Consensus       236 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~  302 (316)
T cd05574         236 NRD-ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRH  302 (316)
T ss_pred             chH-HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhccc
Confidence            433 3333322111111112227899999999999999999999    99999999999876554443

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.8e-44  Score=334.59  Aligned_cols=249  Identities=44%  Similarity=0.764  Sum_probs=214.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--------SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      .|+..+.||+|+||+||+|..+.+++.+++|.+....        .+.+.+|+.++++++||||+++++++.....    
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~----   76 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN----   76 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCe----
Confidence            5889999999999999999999899999999875432        2467789999999999999999998655432    


Q ss_pred             EEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           74 YNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      +++++||+++++|.+++.+.+.+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.  +||+|||++.....
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~  154 (258)
T cd06632          77 LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVE  154 (258)
T ss_pred             EEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccceeccc
Confidence            6799999999999999987777999999999999999999999999999999999999987665  99999999887533


Q ss_pred             cCCCCCCccccCCcccChhhhcCCC-CCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHH
Q 040569          154 NEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA  232 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  232 (385)
                      ..  ......|++.|+|||.+.... ++.++|+|||||++|+|++|+.||.... .......+......+.++..+++.+
T Consensus       155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  231 (258)
T cd06632         155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-GVAAVFKIGRSKELPPIPDHLSDEA  231 (258)
T ss_pred             cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-HHHHHHHHHhcccCCCcCCCcCHHH
Confidence            22  223456899999999997776 8999999999999999999999997654 4444444444455666777889999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          233 QDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      ++|+.+||..+|.+||++.+++.|||+
T Consensus       232 ~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         232 KDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            999999999999999999999999995

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.8e-44  Score=340.28  Aligned_cols=247  Identities=30%  Similarity=0.501  Sum_probs=204.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++.+.||+|+||+||+|++..+++.+|+|.+....    ...+.+|+++++++.||||+++++.+.....    +++|
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv   77 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENR----ISIC   77 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCE----EEEE
Confidence            6888999999999999999999999999999886432    2457789999999999999999998876543    6699


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |||+++++|..+    ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.  +||+|||++......   
T Consensus        78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~~---  148 (279)
T cd06619          78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVNS---  148 (279)
T ss_pred             EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC--EEEeeCCcceecccc---
Confidence            999999999765    24789999999999999999999999999999999999987766  999999999865322   


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCCh------HHHHHHhcCCCCCCCC-CCcCCH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADP------ISALHRIGFSSDTPEI-PGYMSK  230 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~------~~~~~~~~~~~~~~~~-~~~~s~  230 (385)
                      .....+||+.|+|||++.+..++.++|+|||||++|+|++|+.||......      ......+ .....+.. ....++
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  227 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI-VDEDPPVLPVGQFSE  227 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH-hccCCCCCCCCcCCH
Confidence            223457999999999999999999999999999999999999999643211      1111111 11122222 334788


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ++++|+.+||+++|.+||++.++++|||+...
T Consensus       228 ~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         228 KFVHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             HHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            99999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2e-44  Score=343.44  Aligned_cols=252  Identities=33%  Similarity=0.571  Sum_probs=210.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|+..+.||+|+||+||+|+++.+++.+|+|.+....   .+.+.+|+.+++.+.||||+++++.+.....    .++||
T Consensus        21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~----~~lv~   96 (296)
T cd06654          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDE----LWVVM   96 (296)
T ss_pred             ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCE----EEEee
Confidence            6899999999999999999999999999999886533   4567889999999999999999998765432    67999


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      ||++|++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.  +||+|||++........ .
T Consensus        97 e~~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~--~kl~dfg~~~~~~~~~~-~  172 (296)
T cd06654          97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS-K  172 (296)
T ss_pred             cccCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEECccccchhcccccc-c
Confidence            999999999998754 5899999999999999999999999999999999999987665  99999999876532221 1


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC-CCCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF-SSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~ll~  237 (385)
                      .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||..... ...+..+.. .......+..++..+.+|+.
T Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  251 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-LRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (296)
T ss_pred             cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-HHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence            2334689999999999988899999999999999999999999976432 222222211 11122235568899999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCcccccc
Q 040569          238 KCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +||.++|.+|||+.++++|||+...
T Consensus       252 ~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         252 RCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             HHCcCCcccCcCHHHHhhChhhhcc
Confidence            9999999999999999999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-46  Score=343.17  Aligned_cols=254  Identities=28%  Similarity=0.454  Sum_probs=221.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|..++.||+|.||+|-+++.+.+++.||+|+++++      ....-..|-++|+...||.+..+...|.....    +|
T Consensus       169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr----lC  244 (516)
T KOG0690|consen  169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR----LC  244 (516)
T ss_pred             hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce----EE
Confidence            688899999999999999999999999999988653      23344579999999999999998877766554    78


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||+.||.|.-.+.+...++|..++.|-..|+.||.|||+++||.||||.+|+|++.++.  +||+|||+++..-. .
T Consensus       245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~-~  321 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIK-Y  321 (516)
T ss_pred             EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc--eEeeecccchhccc-c
Confidence            99999999999999998888999999999999999999999999999999999999999887  99999999986532 2


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                      ....+++||||.|+|||++....|+.++|.|.+|+++|||++|+.||.+.+ ...+...|  ....-.+|..+|++++.|
T Consensus       322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d-h~kLFeLI--l~ed~kFPr~ls~eAktL  398 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD-HEKLFELI--LMEDLKFPRTLSPEAKTL  398 (516)
T ss_pred             cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc-hhHHHHHH--HhhhccCCccCCHHHHHH
Confidence            334678999999999999999999999999999999999999999998753 33333333  223456788899999999


Q ss_pred             HHHhhhcCCCCCC-----CHHHHHhCccccccccc
Q 040569          236 LSKCLIRNPGERW-----SASELLEHGFVKEQNFK  265 (385)
Q Consensus       236 l~~cL~~dP~~Rp-----s~~elL~hp~~~~~~~~  265 (385)
                      +..+|.+||.+|.     .+.|+.+|+||...++.
T Consensus       399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~  433 (516)
T KOG0690|consen  399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE  433 (516)
T ss_pred             HHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence            9999999999998     58899999999988764

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.9e-44  Score=345.48  Aligned_cols=250  Identities=31%  Similarity=0.503  Sum_probs=207.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++.+.||+|+||+||++.+..++..+|+|.+....    ...+.+|++++++++||||+++++++.....    ++++
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv   77 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGE----ISIC   77 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCE----EEEE
Confidence            6999999999999999999999999999999886542    2457789999999999999999998866543    6799


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~-~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |||++|++|.+++++.+.+++..+..++.||+.||.|||+ .+++||||||+|||++.++.  +||+|||++......  
T Consensus        78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~--  153 (308)
T cd06615          78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS--  153 (308)
T ss_pred             eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc--EEEccCCCccccccc--
Confidence            9999999999999877889999999999999999999997 59999999999999987665  999999998765321  


Q ss_pred             CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc--------------------
Q 040569          157 DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG--------------------  216 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~--------------------  216 (385)
                       ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||.... .......+.                    
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccccccCCcccccCCCC
Confidence             2234578999999999988889999999999999999999999996432 111111110                    


Q ss_pred             ---------------CCCCCCCCCC-cCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          217 ---------------FSSDTPEIPG-YMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       217 ---------------~~~~~~~~~~-~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                                     .....+..|. .++.++++|+.+||.++|++|||+.|+++||||..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  292 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR  292 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence                           0111122221 36789999999999999999999999999999964

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.5e-44  Score=340.90  Aligned_cols=241  Identities=15%  Similarity=0.170  Sum_probs=201.7

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      ...||+|+++.||+|..  +|+.||||.+....      .+.+.+|+.+|++++||||+++++++.....+...+++|||
T Consensus        25 ~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             CeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence            37899999999999997  58999999886532      25567999999999999999999998763222233679999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN-GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~-givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      |++||+|.+++.+.+.+++.....++.|++.||.|||+. +++||||||+|||++.++.  +||+|||+++.....    
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~--~kl~dfg~~~~~~~~----  176 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK--LKIICHGLEKILSSP----  176 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc--EEEcccchHhhhccc----
Confidence            999999999999877899999999999999999999984 9999999999999987765  999999998865321    


Q ss_pred             CCccccCCcccChhhhcC--CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARG--EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      .....|++.|+|||++.+  ..++.++|||||||++|||++|+.||.... .......+......+.++...++++++|+
T Consensus       177 ~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~l~~li  255 (283)
T PHA02988        177 PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-TKEIYDLIINKNNSLKLPLDCPLEIKCIV  255 (283)
T ss_pred             cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHhcCCCCCCCCcCcHHHHHHH
Confidence            123468999999999976  678999999999999999999999998653 33333444333344556666899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 040569          237 SKCLIRNPGERWSASELLE  255 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~  255 (385)
                      .+||++||.+|||+.++++
T Consensus       256 ~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        256 EACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHhcCCcccCcCHHHHHH
Confidence            9999999999999999986

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-44  Score=340.22  Aligned_cols=253  Identities=32%  Similarity=0.521  Sum_probs=209.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH---HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS---EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~---~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|++.+.||+|+||+||++.++.+++.+|+|.+.....   +.+.+|++++++++||||+++++.+.....    +++||
T Consensus         6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~   81 (280)
T cd06611           6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENK----LWILI   81 (280)
T ss_pred             HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCe----EEEEe
Confidence            58899999999999999999998999999999875443   456789999999999999999998765432    67999


Q ss_pred             eecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           79 EYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        79 Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      ||+++++|.+++.. +..+++..++.++.|++.||.|||++||+|+||||+||+++.++.  +||+|||++...... ..
T Consensus        82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~--~~l~d~g~~~~~~~~-~~  158 (280)
T cd06611          82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGVSAKNKST-LQ  158 (280)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC--EEEccCccchhhccc-cc
Confidence            99999999999974 457999999999999999999999999999999999999987766  999999998765322 12


Q ss_pred             CCCccccCCcccChhhhcC-----CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC-CCCCCCCCcCCHH
Q 040569          158 EGKPICGTPICMAPEVARG-----EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS-SDTPEIPGYMSKQ  231 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~  231 (385)
                      ......|++.|+|||++..     ..++.++|+|||||++|+|++|+.||.... .......+... ......+..++.+
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  237 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN-PMRVLLKILKSEPPTLDQPSKWSSS  237 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC-HHHHHHHHhcCCCCCcCCcccCCHH
Confidence            2234568999999999853     346778999999999999999999997653 33333333221 1122234568899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          232 AQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +.+||.+||+.+|.+||++.++|+|||+...
T Consensus       238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         238 FNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            9999999999999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.4e-44  Score=349.09  Aligned_cols=252  Identities=26%  Similarity=0.372  Sum_probs=200.2

Q ss_pred             eeceeecc--CceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            5 RGQTIGRG--STATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         5 ~~~~LG~G--~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +++.||+|  +|++||+++++.+|+.||+|.+....     .+.+++|+++++.++||||+++++++.....    +++|
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~----~~lv   77 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE----LWVV   77 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCE----EEEE
Confidence            56889999  77899999999999999999987532     2567889999999999999999998876543    6799


Q ss_pred             EeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           78 LEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |||+++|+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.  ++++|||.+.......
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~  155 (327)
T cd08227          78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMINHG  155 (327)
T ss_pred             EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc--EEEcccchhhcccccc
Confidence            999999999999963  345899999999999999999999999999999999999987765  9999998754332111


Q ss_pred             C------CCCCccccCCcccChhhhcC--CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCC-------
Q 040569          156 D------DEGKPICGTPICMAPEVARG--EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSD-------  220 (385)
Q Consensus       156 ~------~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-------  220 (385)
                      .      .......++..|+|||++.+  ..++.++|||||||++|+|++|+.||..................       
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (327)
T cd08227         156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT  235 (327)
T ss_pred             ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccc
Confidence            0      01122356788999999976  45889999999999999999999999764333222221110000       


Q ss_pred             ------------------------------------CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          221 ------------------------------------TPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       221 ------------------------------------~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                                          .......+++++++||.+||+.||.+|||++|+|+||||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                                                000112357889999999999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.8e-44  Score=340.12  Aligned_cols=253  Identities=32%  Similarity=0.479  Sum_probs=207.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH---HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS---EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~---~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      .|++++.||+|+||.||+|.++.+++.+|+|.+.....   +.+.+|+.+++.++||||+++++.+.....    +++||
T Consensus        13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~   88 (292)
T cd06644          13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGK----LWIMI   88 (292)
T ss_pred             hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCe----EEEEE
Confidence            48899999999999999999999999999999876543   456789999999999999999998765442    67999


Q ss_pred             eecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           79 EYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        79 Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      ||++|++|..++. ....+++..+..++.||+.+|.|||++|++||||||+||+++.++.  +||+|||++...... ..
T Consensus        89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~-~~  165 (292)
T cd06644          89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD--IKLADFGVSAKNVKT-LQ  165 (292)
T ss_pred             ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC--EEEccCccceecccc-cc
Confidence            9999999998876 3556899999999999999999999999999999999999987665  999999998764222 12


Q ss_pred             CCCccccCCcccChhhhc-----CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC-CCCCCCCCCcCCHH
Q 040569          158 EGKPICGTPICMAPEVAR-----GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF-SSDTPEIPGYMSKQ  231 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~  231 (385)
                      ......|++.|+|||++.     ...++.++|+|||||++|+|++|..||.... .......+.. .......+..++.+
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  244 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLSQPSKWSME  244 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-HHHHHHHHhcCCCccCCCCcccCHH
Confidence            223456889999999985     3446788999999999999999999997643 3333323211 11122234567899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          232 AQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +.+||.+||..+|++||+++++++|||+...
T Consensus       245 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  275 (292)
T cd06644         245 FRDFLKTALDKHPETRPSAAQLLEHPFVSSV  275 (292)
T ss_pred             HHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            9999999999999999999999999998754

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=7e-45  Score=360.99  Aligned_cols=251  Identities=27%  Similarity=0.412  Sum_probs=207.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcC-C-----CCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALA-C-----PQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~-h-----pnIv~~~~~~~~~~~~~~~   73 (385)
                      .|.+.+.||+|+||.|-+|.+..|++.||||+++...  ..+.+.|+.||..|+ |     -|+|+++++|....+    
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H----  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH----  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc----
Confidence            4789999999999999999999999999999997543  345567999999996 4     589999999988777    


Q ss_pred             EEEEEeecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           74 YNLFLEYAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      .|||+|.+. .+|.++|+..  ..|+-..++.++.||+.||.+||+.|||||||||+|||+..-+...+||+|||.|...
T Consensus       263 lciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  263 LCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            889999995 4999999943  3589999999999999999999999999999999999998777778999999999976


Q ss_pred             cccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh-cCCCC----------
Q 040569          152 RVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI-GFSSD----------  220 (385)
Q Consensus       152 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~-~~~~~----------  220 (385)
                      ..    ...+.+-+..|.|||++.|..|+.+.||||||||+.||++|.+.|++.++ ..++.+| ..-+.          
T Consensus       342 ~q----~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne-~DQl~~I~e~lG~Pp~~mL~~~~  416 (586)
T KOG0667|consen  342 SQ----RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE-YDQLARIIEVLGLPPPKMLDTAK  416 (586)
T ss_pred             CC----cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH-HHHHHHHHHHhCCCCHHHHHhcc
Confidence            32    22256778899999999999999999999999999999999999987533 3322222 00000          


Q ss_pred             -----------CC----------------------------CCC-----------CcCCHHHHHHHHHhhhcCCCCCCCH
Q 040569          221 -----------TP----------------------------EIP-----------GYMSKQAQDFLSKCLIRNPGERWSA  250 (385)
Q Consensus       221 -----------~~----------------------------~~~-----------~~~s~~~~~ll~~cL~~dP~~Rps~  250 (385)
                                 .+                            ..|           ..-...+.+||.+||..||.+|+|+
T Consensus       417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp  496 (586)
T KOG0667|consen  417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP  496 (586)
T ss_pred             ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence                       00                            011           0112457899999999999999999


Q ss_pred             HHHHhCcccccc
Q 040569          251 SELLEHGFVKEQ  262 (385)
Q Consensus       251 ~elL~hp~~~~~  262 (385)
                      .|+|+|||+...
T Consensus       497 ~qal~Hpfl~~~  508 (586)
T KOG0667|consen  497 AQALNHPFLTGT  508 (586)
T ss_pred             HHHhcCcccccc
Confidence            999999999854

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.9e-44  Score=338.35  Aligned_cols=254  Identities=33%  Similarity=0.518  Sum_probs=206.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhc-CCCCeeeeeeeeeecc-CCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSAL-ACPQIVAYKGCDISEE-NGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~-~~~~~~~lv   77 (385)
                      +|++.+.||+|+||+||+|.++.+++.+|+|......  ...+.+|+.+++++ +||||+++++++.... .....++++
T Consensus        19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv   98 (286)
T cd06638          19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV   98 (286)
T ss_pred             ceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence            6899999999999999999999999999999876432  35678899999999 7999999999875432 122346799


Q ss_pred             EeecCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           78 LEYAPGGTLTDAIR----SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~----~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      |||++|++|.+++.    .+..+++..+..++.|++.||.|||+++++||||||+||+++.++.  +||+|||+++....
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~  176 (286)
T cd06638          99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTS  176 (286)
T ss_pred             EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC--EEEccCCceeeccc
Confidence            99999999999875    3456899999999999999999999999999999999999987765  99999999987632


Q ss_pred             cCCCCCCccccCCcccChhhhcC-----CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC-CCCCCCCc
Q 040569          154 NEDDEGKPICGTPICMAPEVARG-----EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS-DTPEIPGY  227 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~  227 (385)
                      .. .......|++.|+|||++..     ..++.++|||||||++|+|++|+.||..... ...+....... .....+..
T Consensus       177 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~  254 (286)
T cd06638         177 TR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-MRALFKIPRNPPPTLHQPEL  254 (286)
T ss_pred             CC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-hHHHhhccccCCCcccCCCC
Confidence            21 12234469999999999853     3478899999999999999999999976533 22222221111 11223455


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          228 MSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       228 ~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      ++.++.+||.+||+.||++|||+.|+++|+|+
T Consensus       255 ~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         255 WSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            78899999999999999999999999999996

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.5e-44  Score=333.99  Aligned_cols=251  Identities=40%  Similarity=0.757  Sum_probs=212.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|+..+.||+|+||.||+|++..+++.+|+|.+....     ...+.+|+.++++++||||+++++.+.....    +++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~----~~l   76 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREK----VYI   76 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCE----EEE
Confidence            5899999999999999999999999999999886543     3467899999999999999999998654432    679


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |+||+++++|.+++..+..+++..+..++.|++.||.|||++|++|+||||+||+++.++.  +||+|||++........
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          77 FMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             EEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEcccccccccCCCCC
Confidence            9999999999999998777999999999999999999999999999999999999987655  99999999987643322


Q ss_pred             CCC---CccccCCcccChhhhcCCC---CCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcC--
Q 040569          157 DEG---KPICGTPICMAPEVARGEE---QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM--  228 (385)
Q Consensus       157 ~~~---~~~~Gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--  228 (385)
                      ...   ....|++.|+|||++.+..   .+.++||||||+++++|++|+.||....+.......+.. ...+.+|...  
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~  233 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQL  233 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCccccc
Confidence            211   1346889999999998776   788999999999999999999999765454444444433 3344455544  


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          229 SKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       229 s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      ++.+.+||.+||+++|.+|||+.+++.|||+
T Consensus       234 ~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         234 SPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            8999999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.3e-44  Score=339.48  Aligned_cols=250  Identities=27%  Similarity=0.422  Sum_probs=202.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++.+.||+|++|+||+|.++.+++.+|+|.+....     ...+.+|+.+++++.||||+++++++.....    +++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~~   76 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESR----LYL   76 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCe----EEE
Confidence            6999999999999999999999999999999876432     3567889999999999999999998765433    679


Q ss_pred             EEeecCCCCHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           77 FLEYAPGGTLTDAIRS---GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~---~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      ||||++ ++|.+++..   +..+++..+..++.||+.||.|||++|++||||||+|||++.++.  +||+|||++.....
T Consensus        77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~  153 (285)
T cd07861          77 IFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGI  153 (285)
T ss_pred             EEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc--EEECcccceeecCC
Confidence            999997 589888863   356899999999999999999999999999999999999987766  99999999986532


Q ss_pred             cCCCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc----------------
Q 040569          154 NEDDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG----------------  216 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~----------------  216 (385)
                      .. .......|++.|+|||++.+. .++.++|||||||++|+|++|++||..............                
T Consensus       154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         154 PV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             Cc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence            21 112233578999999998754 468899999999999999999999975432221111000                


Q ss_pred             ------C----CCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          217 ------F----SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       217 ------~----~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                            .    ..........+++++++||.+||+.||.+|||+.++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                  0    000011123478999999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.7e-44  Score=334.09  Aligned_cols=250  Identities=35%  Similarity=0.548  Sum_probs=207.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++++.||.|+||+||+|....++..+|+|.+....    ...+.+|+.+|+.+.||||+++++.+.....    ++++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~iv   77 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDE----LWLV   77 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCE----EEEE
Confidence            6999999999999999999998899999999886432    4567899999999999999999988765433    6799


Q ss_pred             EeecCCCCHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           78 LEYAPGGTLTDAIRSG---TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~---~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +||++|++|.+++...   ..+++..++.++.||+.||.|||++|++||||||+||+++.++.  +||+|||++......
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~  155 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADG  155 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccchHHHhccC
Confidence            9999999999999753   45899999999999999999999999999999999999987655  999999998765432


Q ss_pred             CCC---CCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCC-----
Q 040569          155 EDD---EGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP-----  225 (385)
Q Consensus       155 ~~~---~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-----  225 (385)
                      ...   ......|++.|+|||++... .++.++|+|||||++++|++|+.||...............  ..+.++     
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~  233 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--DPPSLETGADY  233 (267)
T ss_pred             ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC--CCCCcCCcccc
Confidence            221   12344689999999999877 7889999999999999999999999765433222222211  112121     


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          226 GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       226 ~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      ..+++++++|+.+||.+||++|||+.++++||||
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         234 KKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            2578999999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.1e-44  Score=338.64  Aligned_cols=254  Identities=30%  Similarity=0.489  Sum_probs=207.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccC--CeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSAL-ACPQIVAYKGCDISEEN--GKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~--~~~~~~l   76 (385)
                      .|++.+.||+|+||+||+|.++.+++.+|+|.+....  ...+.+|+.+++++ .||||+++++++.....  ....+++
T Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i   96 (282)
T cd06636          17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL   96 (282)
T ss_pred             hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEE
Confidence            4788899999999999999999999999999886543  34677899999999 79999999998764321  1234679


Q ss_pred             EEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           77 FLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +|||+++|+|.+++..  +..+++..+..++.||+.||.|||++|++|+||||+||+++.++.  ++|+|||++......
T Consensus        97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~~~~~  174 (282)
T cd06636          97 VMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRT  174 (282)
T ss_pred             EEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCcchhhhhcc
Confidence            9999999999999974  445889999999999999999999999999999999999987765  999999998765322


Q ss_pred             CCCCCCccccCCcccChhhhc-----CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCC
Q 040569          155 EDDEGKPICGTPICMAPEVAR-----GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS  229 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s  229 (385)
                      . .......|++.|+|||++.     +..++.++|+|||||++|+|++|+.||..... ......+............++
T Consensus       175 ~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~  252 (282)
T cd06636         175 V-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP-MRALFLIPRNPPPKLKSKKWS  252 (282)
T ss_pred             c-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH-HhhhhhHhhCCCCCCcccccC
Confidence            1 1233457899999999986     34577899999999999999999999976532 232222222222223344578


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          230 KQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       230 ~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      .++.+||.+||..||.+|||+.|+|+||||
T Consensus       253 ~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         253 KKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             HHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=9.5e-44  Score=328.36  Aligned_cols=254  Identities=52%  Similarity=0.872  Sum_probs=222.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|+..+.||+|++|.||+|.++.+++.+++|.+....     .+.+.+|+.++++++||||+++++.+.....  ..+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~~~l   78 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEK--NTLNI   78 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCC--CeEEE
Confidence            5899999999999999999999999999999887654     5678899999999999999999988765521  23669


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      ++||+++++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.  +||+|||.+........
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV--VKLADFGCAKRLGDIET  156 (260)
T ss_pred             EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEcccccEEecccccc
Confidence            9999999999999987778999999999999999999999999999999999999987655  99999999987754322


Q ss_pred             C-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          157 D-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       157 ~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                      . ......++..|+|||.+.+...+.++||||||+++++|++|+.||....+.......+......+.++..++..+++|
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  236 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF  236 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHH
Confidence            1 123456899999999999888999999999999999999999999876656666666655556677788889999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      |.+||..+|++||++.++++||||
T Consensus       237 i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         237 LRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHhCcCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-44  Score=334.45  Aligned_cols=254  Identities=35%  Similarity=0.545  Sum_probs=208.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccC--CeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSAL-ACPQIVAYKGCDISEEN--GKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~--~~~~~~l   76 (385)
                      +|++.+.||+|++|+||+|.++.+++.+++|.+....  .+.+.+|+.+++++ .||||+++++++.....  ....+++
T Consensus         7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~l   86 (275)
T cd06608           7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWL   86 (275)
T ss_pred             heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEE
Confidence            5899999999999999999999999999999887544  35788999999999 79999999999876542  2344679


Q ss_pred             EEeecCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           77 FLEYAPGGTLTDAIRS----GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~----~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      ||||+++++|.+++..    +..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.  +||+|||++....
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~  164 (275)
T cd06608          87 VMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE--VKLVDFGVSAQLD  164 (275)
T ss_pred             EEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe--EEECCCccceecc
Confidence            9999999999999863    457999999999999999999999999999999999999987665  9999999998653


Q ss_pred             ccCCCCCCccccCCcccChhhhcCC-----CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCC-CCCCCC
Q 040569          153 VNEDDEGKPICGTPICMAPEVARGE-----EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSD-TPEIPG  226 (385)
Q Consensus       153 ~~~~~~~~~~~Gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~  226 (385)
                      .... ......|++.|+|||++...     .++.++|||||||++|+|++|+.||..... ...+..+..... ....+.
T Consensus       165 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~  242 (275)
T cd06608         165 STLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-MRALFKIPRNPPPTLKSPE  242 (275)
T ss_pred             cchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-HHHHHHhhccCCCCCCchh
Confidence            2222 22345689999999998543     467789999999999999999999976433 333333322211 111223


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          227 YMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       227 ~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      .+++.+++||.+||..||.+|||+.|+++|||+
T Consensus       243 ~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         243 NWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             hcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            368899999999999999999999999999995

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=7.7e-44  Score=337.63  Aligned_cols=255  Identities=33%  Similarity=0.507  Sum_probs=207.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccC-CeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSAL-ACPQIVAYKGCDISEEN-GKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~-~~~~~~lv   77 (385)
                      +|++.+.||+|+||.||++.++.+++.+|+|.+...  ..+.+.+|+.+++++ +|||++++++++...+. ....+++|
T Consensus        23 ~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv  102 (291)
T cd06639          23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV  102 (291)
T ss_pred             CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence            589999999999999999999999999999988653  245677899999999 89999999998765432 11236699


Q ss_pred             EeecCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           78 LEYAPGGTLTDAIR----SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~----~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      +||++||+|.++++    .+..+++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||++.....
T Consensus       103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~~~~  180 (291)
T cd06639         103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTS  180 (291)
T ss_pred             EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEeecccchhccc
Confidence            99999999999885    3567899999999999999999999999999999999999987665  99999999886532


Q ss_pred             cCCCCCCccccCCcccChhhhcCCC-----CCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC-CCCCCCCCc
Q 040569          154 NEDDEGKPICGTPICMAPEVARGEE-----QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS-SDTPEIPGY  227 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~~-----~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~  227 (385)
                      ... ......|+..|+|||++....     ++.++|||||||++|+|++|+.||..... ...+..+... ......+..
T Consensus       181 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~  258 (291)
T cd06639         181 TRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-VKTLFKIPRNPPPTLLHPEK  258 (291)
T ss_pred             ccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-HHHHHHHhcCCCCCCCcccc
Confidence            221 223346899999999986543     57899999999999999999999976533 2333332211 111122445


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 040569          228 MSKQAQDFLSKCLIRNPGERWSASELLEHGFVK  260 (385)
Q Consensus       228 ~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~  260 (385)
                      .+..+++||.+||+++|.+||++.|+++||||+
T Consensus       259 ~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         259 WCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             cCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            678899999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.7e-44  Score=334.35  Aligned_cols=249  Identities=36%  Similarity=0.608  Sum_probs=206.7

Q ss_pred             eeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeec
Q 040569            5 RGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYA   81 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (385)
                      ....||+|+||+||+|+++.++..+|+|.+....   .+.+.+|+.++++++||||+++++++....    .+++++||+
T Consensus        12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~   87 (268)
T cd06624          12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG----FFKIFMEQV   87 (268)
T ss_pred             ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC----EEEEEEecC
Confidence            4468999999999999999999999999887543   346789999999999999999999876543    267999999


Q ss_pred             CCCCHHHHHHcC-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           82 PGGTLTDAIRSG-TCL--EEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        82 ~ggsL~~~l~~~-~~l--~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      ++++|.+++... ..+  ++..+..++.||+.||.|||++||+||||||+||+++.+. ..+||+|||++....... ..
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~~~-~~  165 (268)
T cd06624          88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS-GVVKISDFGTSKRLAGIN-PC  165 (268)
T ss_pred             CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CeEEEecchhheecccCC-Cc
Confidence            999999999853 445  8889999999999999999999999999999999997532 238999999987653221 22


Q ss_pred             CCccccCCcccChhhhcCCC--CCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEE--QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      .....|++.|+|||++.+..  ++.++|+||||+++|+|++|+.||...................+.++..+++++++|+
T Consensus       166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  245 (268)
T cd06624         166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFI  245 (268)
T ss_pred             cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHH
Confidence            23346899999999986643  7889999999999999999999997654444433333333445667778999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHhCccc
Q 040569          237 SKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      .+||..+|.+|||+.|++.||||
T Consensus       246 ~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         246 LRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHcCCCchhCCCHHHHHhCCCC
Confidence            99999999999999999999996

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-44  Score=336.45  Aligned_cols=251  Identities=38%  Similarity=0.616  Sum_probs=213.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|+..+.||.|+||.||+|++..+++.+|+|.+....    ...+.+|++++++++||||+++++.+....    ..++|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v   77 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS----KLWII   77 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC----eEEEE
Confidence            5889999999999999999999999999999886543    346778999999999999999999876553    36799


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      +||+++++|.+++... ++++..+..++.||+.||.|||+++++||||+|+||+++.++.  ++|+|||+++...... .
T Consensus        78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~-~  153 (274)
T cd06609          78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTM-S  153 (274)
T ss_pred             EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEcccccceeecccc-c
Confidence            9999999999999865 7999999999999999999999999999999999999988766  9999999998775332 2


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCc-CCHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY-MSKQAQDFL  236 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~ll  236 (385)
                      ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+.. ...+.++.. +++++.+++
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  231 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH-PMRVLFLIPK-NNPPSLEGNKFSKPFKDFV  231 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc-hHHHHHHhhh-cCCCCCcccccCHHHHHHH
Confidence            2334568999999999998889999999999999999999999997643 3333333322 234444444 889999999


Q ss_pred             HHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          237 SKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      .+||..+|++|||++++++|||+...
T Consensus       232 ~~~l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         232 SLCLNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             HHHhhCChhhCcCHHHHhhChhhcCC
Confidence            99999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.6e-44  Score=341.96  Aligned_cols=252  Identities=27%  Similarity=0.406  Sum_probs=203.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|+..+.||+|+||+||+|+++.+++.+|+|.+....    ...+.+|+.++++++||||+++++++.....    +++|
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~----~~lv   82 (301)
T cd07873           7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS----LTLV   82 (301)
T ss_pred             ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCe----EEEE
Confidence            5899999999999999999999999999999886432    3456789999999999999999998765433    6799


Q ss_pred             EeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           78 LEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |||++ ++|.+++.. +..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++....... 
T Consensus        83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~-  158 (301)
T cd07873          83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPT-  158 (301)
T ss_pred             Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc--EEECcCcchhccCCCC-
Confidence            99997 499988874 556899999999999999999999999999999999999987765  9999999997643221 


Q ss_pred             CCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh---cC---------------
Q 040569          157 DEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI---GF---------------  217 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---~~---------------  217 (385)
                      .......+++.|+|||++.+. .++.++|||||||++|+|++|++||.... .......+   ..               
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST-VEEQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHcCCCChhhchhhhcccc
Confidence            122234578999999998764 57889999999999999999999997643 22211111   00               


Q ss_pred             --CCCCCC--------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          218 --SSDTPE--------IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       218 --~~~~~~--------~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                        ....+.        ....+++.+++||.+||+.||.+|||+.|+|+||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence              000111        123478899999999999999999999999999999754

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.9e-44  Score=340.83  Aligned_cols=252  Identities=32%  Similarity=0.576  Sum_probs=211.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC---CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~---~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|++.+.||.|+||+||+|++..+++.+|+|.+...   ..+.+.+|+.+++.++||||+++++.+.....    +++|+
T Consensus        20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~   95 (296)
T cd06655          20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDE----LFVVM   95 (296)
T ss_pred             eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCce----EEEEE
Confidence            489999999999999999999999999999988643   24567889999999999999999998765433    67999


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      ||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.  +||+|||++........ .
T Consensus        96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~-~  171 (296)
T cd06655          96 EYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQS-K  171 (296)
T ss_pred             EecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccchhcccccc-c
Confidence            999999999998754 5899999999999999999999999999999999999987665  99999999886533222 1


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC-CCCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF-SSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~ll~  237 (385)
                      .....|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.... .......+.. .......+..+++.+++||.
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  250 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN-PLRALYLIATNGTPELQNPEKLSPIFRDFLN  250 (296)
T ss_pred             CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCcccCCcccCCHHHHHHHH
Confidence            233468999999999998889999999999999999999999997643 3333322221 12222345568899999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCcccccc
Q 040569          238 KCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +||..||.+|||+.+++.|||++..
T Consensus       251 ~~l~~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         251 RCLEMDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             HHhhcChhhCCCHHHHhhChHhhhc
Confidence            9999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-44  Score=333.21  Aligned_cols=253  Identities=36%  Similarity=0.634  Sum_probs=213.6

Q ss_pred             CCceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            1 MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--------NSEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         1 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      .+|++++.||+|+||.||+|.+..+++.+|+|.+...        ....+++|++++++++||||+++++++.....+  
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~--   79 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEK--   79 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCC--
Confidence            3799999999999999999999999999999987432        124677899999999999999999987554333  


Q ss_pred             EEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           73 LYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      .+++++||+++++|.+++...+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.  ++|+|||+++...
T Consensus        80 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~  157 (264)
T cd06653          80 KLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECccccccccc
Confidence            25589999999999999987777999999999999999999999999999999999999987665  9999999998653


Q ss_pred             ccCC--CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          153 VNED--DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       153 ~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      ....  .......|+..|+|||++.+...+.++|+|||||++++|++|+.||..... ......+......+.+|..+++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~p~~~~~  236 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-MAAIFKIATQPTKPMLPDGVSD  236 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-HHHHHHHHcCCCCCCCCcccCH
Confidence            2111  112345689999999999988899999999999999999999999987533 3334444444555677888999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      ++++||.+||+ +|.+||++.++++|||+
T Consensus       237 ~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         237 ACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            99999999999 47999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3e-44  Score=380.18  Aligned_cols=255  Identities=26%  Similarity=0.377  Sum_probs=209.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++++.||+|+||+||+|.++.+++.+|+|.+....     ...+.+|+.+|++|.|||||++++++......  .++|
T Consensus        14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~--~lyI   91 (1021)
T PTZ00266         14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ--KLYI   91 (1021)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC--EEEE
Confidence            6999999999999999999999999999999886432     34677899999999999999999988765443  3669


Q ss_pred             EEeecCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCCEEeecC----------
Q 040569           77 FLEYAPGGTLTDAIRS----GTCLEEGRIRSHTRAVLLGLQYLHSN-------GIVHCDIKGQNILVSKD----------  135 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~----~~~l~e~~~~~i~~qil~gL~yLH~~-------givHrDlKp~NILi~~~----------  135 (385)
                      ||||+++|+|.++|..    .+.+++..++.|+.||+.||.|||+.       +|+||||||+||||+.+          
T Consensus        92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            9999999999999964    35699999999999999999999984       49999999999999642          


Q ss_pred             -----CCCCeEEeecCceeeecccCCCCCCccccCCcccChhhhcC--CCCCCCCChHHHHHHHHHHHhCCCCCCCCCCh
Q 040569          136 -----NEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG--EEQGFPADVWALGCTVLEMATGRPPWPDVADP  208 (385)
Q Consensus       136 -----~~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~  208 (385)
                           +...+||+|||++.......  .....+||+.|+|||++.+  ..++.++||||||||+|+|++|+.||......
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~  249 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF  249 (1021)
T ss_pred             ccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence                 22347999999998653221  2234579999999999965  45788999999999999999999999875554


Q ss_pred             HHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          209 ISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ...+..+......+  ....+.++.+||.+||.++|.+||++.|+|.|||+...
T Consensus       250 ~qli~~lk~~p~lp--i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        250 SQLISELKRGPDLP--IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             HHHHHHHhcCCCCC--cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            44444432222111  23468999999999999999999999999999999755

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.4e-44  Score=341.97  Aligned_cols=252  Identities=33%  Similarity=0.570  Sum_probs=210.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|++.+.||+|+||+||+|.+..+++.+|+|.+....   .+.+.+|+.+++.+.||||+++++.+.....    +++||
T Consensus        20 ~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~----~~lv~   95 (297)
T cd06656          20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDE----LWVVM   95 (297)
T ss_pred             hceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCE----EEEee
Confidence            6899999999999999999999999999999886432   3567789999999999999999998765432    67999


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      ||++|++|.+++.+. .+++..+..++.|++.||.|||+.|++||||||+|||++.++.  +||+|||++........ .
T Consensus        96 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~-~  171 (297)
T cd06656          96 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS-K  171 (297)
T ss_pred             cccCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEECcCccceEccCCcc-C
Confidence            999999999999754 5899999999999999999999999999999999999987665  99999999886532221 2


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC-CCCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF-SSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~ll~  237 (385)
                      .....|++.|+|||.+.+..++.++|+|||||++|+|++|+.||..... ...+..+.. .......+..++..+++|+.
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  250 (297)
T cd06656         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-LRALYLIATNGTPELQNPERLSAVFRDFLN  250 (297)
T ss_pred             cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc-chheeeeccCCCCCCCCccccCHHHHHHHH
Confidence            2334689999999999998899999999999999999999999965432 222222211 12222345668899999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCcccccc
Q 040569          238 KCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +||.++|.+||++.++++||||...
T Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~  275 (297)
T cd06656         251 RCLEMDVDRRGSAKELLQHPFLKLA  275 (297)
T ss_pred             HHccCChhhCcCHHHHhcCchhccc
Confidence            9999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.4e-44  Score=333.79  Aligned_cols=247  Identities=28%  Similarity=0.509  Sum_probs=210.5

Q ss_pred             eeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecC
Q 040569            9 IGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAP   82 (385)
Q Consensus         9 LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (385)
                      ||+|+||.||+|+++.+++.+|+|.+....      .+.+.+|+.+++.++||||+++++.+.....    +++++||++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~   76 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKY----IYMLMEYCL   76 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCc----cEEEEecCC
Confidence            799999999999999999999999886422      3567899999999999999999998765433    679999999


Q ss_pred             CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCCcc
Q 040569           83 GGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI  162 (385)
Q Consensus        83 ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~  162 (385)
                      +++|.+++.+...+++..+..++.||+.||+|||++|++|+||||+||+++.++.  +||+|||++.......  .....
T Consensus        77 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~--~~l~df~~~~~~~~~~--~~~~~  152 (262)
T cd05572          77 GGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY--VKLVDFGFAKKLKSGQ--KTWTF  152 (262)
T ss_pred             CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC--EEEeeCCcccccCccc--ccccc
Confidence            9999999987777999999999999999999999999999999999999987665  9999999998764322  22334


Q ss_pred             ccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCC-hHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhh
Q 040569          163 CGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLI  241 (385)
Q Consensus       163 ~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~  241 (385)
                      .|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... .......+......+..|...++++++||.+||.
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  232 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLR  232 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHcc
Confidence            689999999999888899999999999999999999999976542 3333444433344556666679999999999999


Q ss_pred             cCCCCCCC-----HHHHHhCccccccc
Q 040569          242 RNPGERWS-----ASELLEHGFVKEQN  263 (385)
Q Consensus       242 ~dP~~Rps-----~~elL~hp~~~~~~  263 (385)
                      ++|.+||+     +.|+++||||.+..
T Consensus       233 ~~p~~R~~~~~~~~~~l~~~~~~~~~~  259 (262)
T cd05572         233 RNPEERLGNLKGGIKDIKKHKWFNGFD  259 (262)
T ss_pred             CChhhCcCCcccCHHHHhcChhhhCCC
Confidence            99999999     99999999998643

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.8e-44  Score=340.31  Aligned_cols=250  Identities=27%  Similarity=0.378  Sum_probs=201.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|+..+.||+|+||+||+|+++.+|+.+|+|.+....     ...+.+|+.++++++||||+++++++.....    +++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~----~~l   76 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKK----LTL   76 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCc----eEE
Confidence            5899999999999999999999999999999886432     2456789999999999999999998765443    679


Q ss_pred             EEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      ++||+.+ +|.+++. ..+.+++..++.++.||++||.|||++|++||||||+||+++.++.  +||+|||+++......
T Consensus        77 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~  153 (284)
T cd07839          77 VFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPV  153 (284)
T ss_pred             EEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc--EEECccchhhccCCCC
Confidence            9999975 8888876 4567999999999999999999999999999999999999987765  9999999998653222


Q ss_pred             CCCCCccccCCcccChhhhcCCC-CCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc------------------
Q 040569          156 DDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG------------------  216 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~------------------  216 (385)
                      . ......+++.|+|||++.+.. ++.++|||||||++|+|++|..|+....+....+..+.                  
T Consensus       154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence            1 123345789999999987754 68899999999999999999988644333332222210                  


Q ss_pred             CCCCCC---------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          217 FSSDTP---------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       217 ~~~~~~---------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      .....+         .....+++++++||.+||+.||.+|||++++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            000000         1122478999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-44  Score=358.20  Aligned_cols=252  Identities=21%  Similarity=0.245  Sum_probs=202.7

Q ss_pred             CceeeceeeccCceEEEEEEEC--CCCcEEEEEeccCCCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN--RSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~--~~~~~~AvK~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|.+++.||+|+||+||++...  .+++.+|+|.+...  ....+|+++|++++||||+++++++.....    ++++||
T Consensus        93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l~h~~iv~~~~~~~~~~~----~~lv~e  166 (392)
T PHA03207         93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTISHRAIINLIHAYRWKST----VCMVMP  166 (392)
T ss_pred             ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhcCCCCccceeeeEeeCCE----EEEEeh
Confidence            6999999999999999999764  45688999987643  345689999999999999999988765432    679999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC-C
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD-E  158 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~-~  158 (385)
                      |+. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++........ .
T Consensus       167 ~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~~~~  243 (392)
T PHA03207        167 KYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPDTPQ  243 (392)
T ss_pred             hcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEccCccccccCccccccc
Confidence            996 589999987778999999999999999999999999999999999999987765  999999999765432221 2


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHh----cCC--------------
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADP--ISALHRI----GFS--------------  218 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--~~~~~~~----~~~--------------  218 (385)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......  ...+..+    +..              
T Consensus       244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~  323 (392)
T PHA03207        244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK  323 (392)
T ss_pred             ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence            23457999999999999999999999999999999999999999653211  1111110    000              


Q ss_pred             -------CCCC--CCC-----CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          219 -------SDTP--EIP-----GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       219 -------~~~~--~~~-----~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                             ...+  ..+     ..++.++++||.+||..||.+|||+.|+|.||||...
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             HHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence                   0000  011     2356789999999999999999999999999999764

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6e-44  Score=337.25  Aligned_cols=248  Identities=25%  Similarity=0.394  Sum_probs=199.8

Q ss_pred             eeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHh---cCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            8 TIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSA---LACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         8 ~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~---l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      .||+|+||.||++.+..+++.+|+|.+....      .....+|..+++.   ..||||+.+++.+.....    +++||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~----~~lv~   76 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK----LCFIL   76 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe----EEEEE
Confidence            4899999999999999999999999875421      1233445544444   479999999888765443    66899


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      ||++||+|.+++...+.+++..+..++.||+.||+|||++|++||||||+|||++.++.  +||+|||++......   .
T Consensus        77 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~--~~l~dfg~~~~~~~~---~  151 (279)
T cd05633          77 DLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK---K  151 (279)
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC--EEEccCCcceecccc---C
Confidence            99999999999987778999999999999999999999999999999999999987665  999999998765322   1


Q ss_pred             CCccccCCcccChhhhc-CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          159 GKPICGTPICMAPEVAR-GEEQGFPADVWALGCTVLEMATGRPPWPDVADP-ISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      .....|++.|+|||.+. +..++.++|||||||++|+|++|+.||...... ...+.... ......++..+++++++||
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li  230 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTVNVELPDSFSPELKSLL  230 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-hcCCcCCccccCHHHHHHH
Confidence            22346899999999986 456789999999999999999999999653221 12222221 1223455667899999999


Q ss_pred             HHhhhcCCCCCC-----CHHHHHhCccccccccc
Q 040569          237 SKCLIRNPGERW-----SASELLEHGFVKEQNFK  265 (385)
Q Consensus       237 ~~cL~~dP~~Rp-----s~~elL~hp~~~~~~~~  265 (385)
                      .+||++||.+||     |+.++++||||+..++.
T Consensus       231 ~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~  264 (279)
T cd05633         231 EGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQ  264 (279)
T ss_pred             HHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHh
Confidence            999999999999     69999999999986543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.9e-44  Score=333.88  Aligned_cols=251  Identities=38%  Similarity=0.674  Sum_probs=206.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-------------HHHHHHHHHHHHhcCCCCeeeeeeeeeecc
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-------------SEFLQREQRILSALACPQIVAYKGCDISEE   68 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-------------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~   68 (385)
                      +|...+.||+|+||.||+|.+..+++.+|+|.+....             .+.+.+|+.++++++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            6999999999999999999999999999999875321             135678999999999999999999875543


Q ss_pred             CCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCce
Q 040569           69 NGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA  148 (385)
Q Consensus        69 ~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a  148 (385)
                      .    +++||||++|++|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++.  +||+|||++
T Consensus        82 ~----~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~--~~l~d~~~~  155 (272)
T cd06629          82 Y----LSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI--CKISDFGIS  155 (272)
T ss_pred             c----eEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe--EEEeecccc
Confidence            2    6689999999999999987778999999999999999999999999999999999999987665  999999999


Q ss_pred             eeecccCC-CCCCccccCCcccChhhhcCCC--CCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCC---
Q 040569          149 RRARVNED-DEGKPICGTPICMAPEVARGEE--QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP---  222 (385)
Q Consensus       149 ~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---  222 (385)
                      +....... .......|+..|+|||++....  ++.++|+||||+++++|++|..||...... .....+......+   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~  234 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-AAMFKLGNKRSAPPIP  234 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-HHHHHhhccccCCcCC
Confidence            76532211 1123446899999999997755  788999999999999999999999754332 2222221122122   


Q ss_pred             -CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          223 -EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       223 -~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                       .....++.++++||.+||.++|.+|||+.++|+|||+
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         235 PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence             2223468999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-44  Score=352.79  Aligned_cols=248  Identities=23%  Similarity=0.282  Sum_probs=196.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeec
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYA   81 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (385)
                      +|++.+.||+|+||+||+|+++.+++.+|+|.....   ...+|+.++++++||||+++++++.....    .++||||+
T Consensus        67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~e~~  139 (357)
T PHA03209         67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---TTLIEAMLLQNVNHPSVIRMKDTLVSGAI----TCMVLPHY  139 (357)
T ss_pred             CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---ccHHHHHHHHhCCCCCCcChhheEEeCCe----eEEEEEcc
Confidence            589999999999999999999999999999976433   33569999999999999999998776443    66899999


Q ss_pred             CCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCC
Q 040569           82 PGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGK  160 (385)
Q Consensus        82 ~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~  160 (385)
                      . ++|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++....  .....
T Consensus       140 ~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~--~~~~~  214 (357)
T PHA03209        140 S-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVV--APAFL  214 (357)
T ss_pred             C-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEecCcccccccc--Ccccc
Confidence            6 48888886 4567999999999999999999999999999999999999987665  99999999975421  11223


Q ss_pred             ccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCC-CCCCCh--------HHHHHH-hc-CCCCCCCCC----
Q 040569          161 PICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW-PDVADP--------ISALHR-IG-FSSDTPEIP----  225 (385)
Q Consensus       161 ~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf-~~~~~~--------~~~~~~-~~-~~~~~~~~~----  225 (385)
                      ...||+.|+|||++.+..++.++|||||||++|||+++..|+ ......        ...+.. +. .......++    
T Consensus       215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  294 (357)
T PHA03209        215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG  294 (357)
T ss_pred             cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence            456999999999999999999999999999999999855444 321110        000110 00 000000011    


Q ss_pred             --------------------------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          226 --------------------------GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       226 --------------------------~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                                                ..++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                      135678889999999999999999999999999974

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-44  Score=332.86  Aligned_cols=249  Identities=36%  Similarity=0.525  Sum_probs=208.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+....   .+.+.+|++++++++||||+++++.+.....    ++++|
T Consensus         4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~----~~l~~   79 (262)
T cd06613           4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDK----LWIVM   79 (262)
T ss_pred             ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCE----EEEEE
Confidence            6899999999999999999999999999999887543   4578899999999999999999998765443    67999


Q ss_pred             eecCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           79 EYAPGGTLTDAIRSG-TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~-~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      ||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.  +||+|||++....... .
T Consensus        80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~-~  156 (262)
T cd06613          80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD--VKLADFGVSAQLTATI-A  156 (262)
T ss_pred             eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC--EEECccccchhhhhhh-h
Confidence            999999999999854 67999999999999999999999999999999999999987665  9999999988654321 1


Q ss_pred             CCCccccCCcccChhhhcCC---CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC---CCCCCCCCcCCHH
Q 040569          158 EGKPICGTPICMAPEVARGE---EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS---SDTPEIPGYMSKQ  231 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~---~~~~~~~~~~s~~  231 (385)
                      ......|+..|+|||.+.+.   .++.++|+|||||++|+|++|+.||...... .........   ......+...+.+
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  235 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-RALFLISKSNFPPPKLKDKEKWSPV  235 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCccccchhhhhHH
Confidence            22345689999999999776   7889999999999999999999999765432 222222111   1112223346788


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 040569          232 AQDFLSKCLIRNPGERWSASELLEHGF  258 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~hp~  258 (385)
                      +++|+.+||.++|.+|||+.+++.|+|
T Consensus       236 ~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         236 FHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=7.7e-44  Score=330.94  Aligned_cols=251  Identities=29%  Similarity=0.435  Sum_probs=212.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++.+.||+|+||+||+|.++.+++.+|+|.+....     .+.+.+|++++++++||||+++++.+......  ..++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~--~~~~   78 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ--TLYI   78 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC--EEEE
Confidence            6899999999999999999999999999999875432     34577899999999999999999877654433  3568


Q ss_pred             EEeecCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCCEEeecCCCCCeEEeecCc
Q 040569           77 FLEYAPGGTLTDAIRS----GTCLEEGRIRSHTRAVLLGLQYLH-----SNGIVHCDIKGQNILVSKDNEQGAKIADFGC  147 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~----~~~l~e~~~~~i~~qil~gL~yLH-----~~givHrDlKp~NILi~~~~~~~~kL~DFG~  147 (385)
                      +|||+++++|.+++..    ...+++..+..++.||+.||.|||     +.+++|+||||+||+++.++.  +||+|||+
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~--~kl~d~g~  156 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGL  156 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC--EEEecccc
Confidence            9999999999999974    467999999999999999999999     899999999999999987665  99999999


Q ss_pred             eeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCc
Q 040569          148 ARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY  227 (385)
Q Consensus       148 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (385)
                      +........ ......|++.|+|||++.+..++.++|+||||+++++|++|+.||.... .......+ .....+.++..
T Consensus       157 ~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~-~~~~~~~~~~~  233 (265)
T cd08217         157 AKILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-QLQLASKI-KEGKFRRIPYR  233 (265)
T ss_pred             cccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-HHHHHHHH-hcCCCCCCccc
Confidence            987643322 1234568999999999998889999999999999999999999997653 33333333 23344566778


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          228 MSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       228 ~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      ++.++.+++.+||..+|.+||++.++++|||+
T Consensus       234 ~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         234 YSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            89999999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-45  Score=349.45  Aligned_cols=255  Identities=26%  Similarity=0.404  Sum_probs=217.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      .|+.-+.||+|+||.||-++-+.||+.||.|.+++..      .....+|..||+++++|.||.+-..|.+.+.    +|
T Consensus       186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~----LC  261 (591)
T KOG0986|consen  186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA----LC  261 (591)
T ss_pred             ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc----eE
Confidence            3677899999999999999999999999999776432      2355689999999999999999777766655    88


Q ss_pred             EEEeecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           76 LFLEYAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      |||..|+||+|.-.|-+-  +.++|..++.|+.+|+.||++||+.+||.|||||+|||++..|.  ++|+|+|+|..+..
T Consensus       262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~~  339 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH--VRISDLGLAVEIPE  339 (591)
T ss_pred             EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC--eEeeccceEEecCC
Confidence            999999999999988743  37999999999999999999999999999999999999998877  99999999998754


Q ss_pred             cCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHH--HHHhcCCCCCCCCCCcCCHH
Q 040569          154 NEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISA--LHRIGFSSDTPEIPGYMSKQ  231 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~s~~  231 (385)
                      ..  .....+||.+|||||+++++.|+...|.|||||++|||+.|+.||....+....  +.+. ......+++..+|++
T Consensus       340 g~--~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr-~~~~~~ey~~kFS~e  416 (591)
T KOG0986|consen  340 GK--PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRR-TLEDPEEYSDKFSEE  416 (591)
T ss_pred             CC--ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHH-HhcchhhcccccCHH
Confidence            33  334458999999999999999999999999999999999999999754332221  2222 123455677889999


Q ss_pred             HHHHHHHhhhcCCCCCC-----CHHHHHhCccccccccc
Q 040569          232 AQDFLSKCLIRNPGERW-----SASELLEHGFVKEQNFK  265 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rp-----s~~elL~hp~~~~~~~~  265 (385)
                      +++|.+.+|.+||.+|.     .++++.+||||+..+++
T Consensus       417 akslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~  455 (591)
T KOG0986|consen  417 AKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR  455 (591)
T ss_pred             HHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence            99999999999999998     46699999999998775

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=352.60  Aligned_cols=243  Identities=27%  Similarity=0.377  Sum_probs=201.4

Q ss_pred             eeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeec
Q 040569            4 TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYA   81 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (385)
                      +..+.||+|-||+|++|.++.+ ..+|+|.+...  ..+.+.+|++||++|+|+|||++++++...+.    ++|||||+
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p----iyIVtE~m  283 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP----IYIVTEYM  283 (468)
T ss_pred             HHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCc----eEEEEEec
Confidence            4578999999999999999733 46799987642  34667799999999999999999999877654    67999999


Q ss_pred             CCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           82 PGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        82 ~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      +.|+|.++++.  +..+.-.+...++.||++|++||+++++|||||-.+||||+.+.-  +||+|||+|+....+.....
T Consensus       284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~--vKIsDFGLAr~~~d~~Y~~~  361 (468)
T KOG0197|consen  284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV--VKISDFGLARLIGDDEYTAS  361 (468)
T ss_pred             ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce--EEEcccccccccCCCceeec
Confidence            99999999985  677999999999999999999999999999999999999987765  89999999996543332222


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHH
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK  238 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~  238 (385)
                      ....--..|.|||.++.+.++.+|||||||++|+||+| |+.||+.+.+ ...+..+.. +..-.-|..+|+++.+++..
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-~ev~~~le~-GyRlp~P~~CP~~vY~lM~~  439 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-EEVLELLER-GYRLPRPEGCPDEVYELMKS  439 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-HHHHHHHhc-cCcCCCCCCCCHHHHHHHHH
Confidence            21112346999999999999999999999999999999 9999998754 344444432 33333466699999999999


Q ss_pred             hhhcCCCCCCCHHHHHh
Q 040569          239 CLIRNPGERWSASELLE  255 (385)
Q Consensus       239 cL~~dP~~Rps~~elL~  255 (385)
                      ||+.+|++|||++.+..
T Consensus       440 CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  440 CWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HhhCCcccCCCHHHHHH
Confidence            99999999999996653

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.7e-44  Score=334.43  Aligned_cols=248  Identities=28%  Similarity=0.410  Sum_probs=212.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||.||+|.++.+++.+|+|.+...      ..+.+.+|++++++++||||+++++.+.....    .+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~   76 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEEN----MY   76 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCe----EE
Confidence            589999999999999999999999999999988642      23567889999999999999999988654332    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +|+||++|++|.+++.....+++..+..++.||++||.|||++|++|+||||+||+++.++.  ++|+|||++.......
T Consensus        77 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~  154 (258)
T cd05578          77 LVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDT  154 (258)
T ss_pred             EEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC--EEEeecccccccCCCc
Confidence            99999999999999987778999999999999999999999999999999999999987766  9999999988764322


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHhcCCCCCCCCCCcCCHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVAD--PISALHRIGFSSDTPEIPGYMSKQAQ  233 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~  233 (385)
                        ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||.....  ........  ....+..+..++.++.
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  230 (258)
T cd05578         155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ--ETADVLYPATWSTEAI  230 (258)
T ss_pred             --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh--ccccccCcccCcHHHH
Confidence              22345688999999999988899999999999999999999999986543  22222222  2245566777899999


Q ss_pred             HHHHHhhhcCCCCCCCH--HHHHhCccc
Q 040569          234 DFLSKCLIRNPGERWSA--SELLEHGFV  259 (385)
Q Consensus       234 ~ll~~cL~~dP~~Rps~--~elL~hp~~  259 (385)
                      ++|.+||.+||.+||++  .|+++||||
T Consensus       231 ~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         231 DAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            99999999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=9.5e-44  Score=339.81  Aligned_cols=256  Identities=27%  Similarity=0.397  Sum_probs=210.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|+..+.||+|+||.||++.++.+++.||+|.+....      .+.+.+|+++++.++||||+++++.+....    .++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~   77 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR----HLC   77 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC----EEE
Confidence            6899999999999999999999999999999886532      245678999999999999999998875443    267


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      ++|||++|++|.++++..+.+++..+..++.|++.||.|||++|++||||||+||+++.++.  +||+|||+++......
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~--~~l~dfg~~~~~~~~~  155 (305)
T cd05609          78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSL  155 (305)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC--EEEeeCCCccccCcCc
Confidence            99999999999999987778999999999999999999999999999999999999987665  9999999987421110


Q ss_pred             C--------------CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC-CC
Q 040569          156 D--------------DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS-SD  220 (385)
Q Consensus       156 ~--------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~  220 (385)
                      .              .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||... ............ ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~-~~~~~~~~~~~~~~~  234 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-TPEELFGQVISDDIE  234 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcccC
Confidence            0              0112346788999999998888999999999999999999999999764 333333332211 12


Q ss_pred             CCCCCCcCCHHHHHHHHHhhhcCCCCCCC---HHHHHhCcccccccc
Q 040569          221 TPEIPGYMSKQAQDFLSKCLIRNPGERWS---ASELLEHGFVKEQNF  264 (385)
Q Consensus       221 ~~~~~~~~s~~~~~ll~~cL~~dP~~Rps---~~elL~hp~~~~~~~  264 (385)
                      .+..+..++.++++||.+||+++|++||+   +.++|+||||....+
T Consensus       235 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~  281 (305)
T cd05609         235 WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW  281 (305)
T ss_pred             CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence            23333357899999999999999999997   789999999976543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.2e-44  Score=343.27  Aligned_cols=251  Identities=27%  Similarity=0.385  Sum_probs=192.2

Q ss_pred             eceeeccCceEEEEEEECC--CCcEEEEEeccCCC-HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecC
Q 040569            6 GQTIGRGSTATVSIGMSNR--SSEVFAVKSAELSN-SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAP   82 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~--~~~~~AvK~~~~~~-~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (385)
                      +..||+|+||+||+|+++.  ++..+|+|.+.... ...+.+|+.+|++++||||+++++++.......  +++++||+.
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~--~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRK--VWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCe--EEEEEeeeC
Confidence            5689999999999999754  56899999886543 456779999999999999999999876544333  568999997


Q ss_pred             CCCHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC--CCCeEEeecCceeee
Q 040569           83 GGTLTDAIRS---------GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRA  151 (385)
Q Consensus        83 ggsL~~~l~~---------~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~--~~~~kL~DFG~a~~~  151 (385)
                      + +|.+++..         ...+++..++.++.||+.||.|||++||+||||||+|||+..++  ...+||+|||+++..
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence            5 88887752         12488999999999999999999999999999999999995321  234899999999876


Q ss_pred             cccCC--CCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChH--------HHHHH----hc
Q 040569          152 RVNED--DEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPI--------SALHR----IG  216 (385)
Q Consensus       152 ~~~~~--~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--------~~~~~----~~  216 (385)
                      .....  .......||+.|+|||++.+. .++.++|||||||++|+|+||++||....+..        ..+.+    .+
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (317)
T cd07867         163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG  242 (317)
T ss_pred             CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence            43221  123345789999999999764 57899999999999999999999996432110        00000    00


Q ss_pred             CC-----------C---------------------CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          217 FS-----------S---------------------DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       217 ~~-----------~---------------------~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      ..           .                     .........+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            00           0                     0000111245678899999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.4e-43  Score=328.43  Aligned_cols=249  Identities=26%  Similarity=0.453  Sum_probs=209.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|+..+.||+|+||.||++.+..+++.+|+|.+....     ...+.+|+++|++++||||+++++.+....    .+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~l   76 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDK----ALMI   76 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCC----EEEE
Confidence            5899999999999999999999999999999886432     356788999999999999999998765433    2679


Q ss_pred             EEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           77 FLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      |+||++|++|.+++..  +..+++..+..++.|++.||+|||++|++|+||||+||+++.++. .+||+|||++......
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~  155 (256)
T cd08220          77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM-VVKIGDFGISKILSSK  155 (256)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEccCCCceecCCC
Confidence            9999999999999974  345899999999999999999999999999999999999975432 3799999999876432


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                      .  ......|++.|+|||.+.+..++.++||||||+++++|++|+.||...... .....+. ......++..+++++++
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~l~~  231 (256)
T cd08220         156 S--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-ALVLKIM-SGTFAPISDRYSPDLRQ  231 (256)
T ss_pred             c--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-HHHHHHH-hcCCCCCCCCcCHHHHH
Confidence            2  223356899999999999888899999999999999999999999765333 3333332 23334456678999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          235 FLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      ++.+||.++|.+|||+.|+++|||+
T Consensus       232 li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         232 LILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHHHccCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-45  Score=362.23  Aligned_cols=250  Identities=30%  Similarity=0.455  Sum_probs=217.1

Q ss_pred             eeceeeccCceEEEEEEECCCCcEEEEEec---cC--C--CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            5 RGQTIGRGSTATVSIGMSNRSSEVFAVKSA---EL--S--NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~---~~--~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      ....||+|+|-+||+|.+..+|..||.-.+   +.  .  ..+.+..|+.+|+.|+||||++||..+.+..+  ..+++|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n--~~in~i  121 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN--KTINFI  121 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC--ceeeee
Confidence            357899999999999999999999985332   22  1  23677889999999999999999999887766  346689


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG--IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~g--ivHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +|.+..|+|..|+++.++++...++.|++||++||.|||++.  |||||||.+||||+.+ .+.|||+|+|+|.....  
T Consensus       122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~-~G~VKIGDLGLAtl~r~--  198 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN-LGEVKIGDLGLATLLRK--  198 (632)
T ss_pred             eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC-cCceeecchhHHHHhhc--
Confidence            999999999999999999999999999999999999999994  9999999999999855 45699999999987642  


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                       ...+..+|||.|||||++. +.|+..+||||||++++||+|+..||....++.....++..+..+..+...-.+++++|
T Consensus       199 -s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~f  276 (632)
T KOG0584|consen  199 -SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREF  276 (632)
T ss_pred             -cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHH
Confidence             2344578999999999988 88999999999999999999999999998888777777755554445556668999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      |.+||.. .++|+|+.|||+||||...
T Consensus       277 IekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  277 IEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHhcC-chhccCHHHHhhChhhccc
Confidence            9999999 9999999999999999875

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-45  Score=335.41  Aligned_cols=252  Identities=26%  Similarity=0.401  Sum_probs=209.1

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEEeec
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFLEYA   81 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (385)
                      .+.||+|+|+.|..+++..+|..||||++++..   ...+.||++++.++ .|+||++++++|.++.+    +|||||.+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~----FYLVfEKm  158 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR----FYLVFEKM  158 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce----EEEEEecc
Confidence            578999999999999999999999999998754   45677999999999 79999999999877665    77999999


Q ss_pred             CCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCC-CeEEeecCceeeecccCC----
Q 040569           82 PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQ-GAKIADFGCARRARVNED----  156 (385)
Q Consensus        82 ~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~-~~kL~DFG~a~~~~~~~~----  156 (385)
                      .||+|...|.+...++|.++.+++++|+.||+|||.+||.||||||+|||...-+.- .+|||||.+......+..    
T Consensus       159 ~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa  238 (463)
T KOG0607|consen  159 RGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA  238 (463)
T ss_pred             cCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence            999999999988899999999999999999999999999999999999998544332 369999998875433222    


Q ss_pred             --CCCCccccCCcccChhhhc-----CCCCCCCCChHHHHHHHHHHHhCCCCCCCC---------CCh-----HHHHHHh
Q 040569          157 --DEGKPICGTPICMAPEVAR-----GEEQGFPADVWALGCTVLEMATGRPPWPDV---------ADP-----ISALHRI  215 (385)
Q Consensus       157 --~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~Pf~~~---------~~~-----~~~~~~~  215 (385)
                        ....+.+|+..|||||+..     ...|+.++|.||||+|+|.|++|++||.+.         .+.     ..+...|
T Consensus       239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI  318 (463)
T KOG0607|consen  239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI  318 (463)
T ss_pred             CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence              2334678999999999973     236899999999999999999999999643         111     1222222


Q ss_pred             cCCCCCCCCC----CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          216 GFSSDTPEIP----GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       216 ~~~~~~~~~~----~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      .  ....++|    ..+|.+++++++.+|.+|+.+|.++.++++|||++...
T Consensus       319 Q--EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~  368 (463)
T KOG0607|consen  319 Q--EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA  368 (463)
T ss_pred             h--ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence            1  1222333    45899999999999999999999999999999998653

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-45  Score=356.77  Aligned_cols=237  Identities=28%  Similarity=0.480  Sum_probs=204.6

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecCCCC
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGT   85 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggs   85 (385)
                      ++-||+|+.|.||+|+.+  ++.||||+++    +.-+.+++-|++|+||||+.|.|++....    +||||||||..|.
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~----elkETdIKHLRkLkH~NII~FkGVCtqsP----cyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVR----ELKETDIKHLRKLKHPNIITFKGVCTQSP----CYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHh----hhhhhhHHHHHhccCcceeeEeeeecCCc----eeEEeeecccccc
Confidence            566999999999999987  8899999874    23346788899999999999999986554    4999999999999


Q ss_pred             HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCCccccC
Q 040569           86 LTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT  165 (385)
Q Consensus        86 L~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt  165 (385)
                      |...++.+..++......|..+|+.|+.|||.++|||||||.-||||+.+.-  |||+|||.++.....  .....++||
T Consensus       199 L~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~--VKIsDFGTS~e~~~~--STkMSFaGT  274 (904)
T KOG4721|consen  199 LYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV--VKISDFGTSKELSDK--STKMSFAGT  274 (904)
T ss_pred             HHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce--EEeccccchHhhhhh--hhhhhhhhh
Confidence            9999999999999999999999999999999999999999999999987655  899999999876422  334567999


Q ss_pred             CcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCC
Q 040569          166 PICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPG  245 (385)
Q Consensus       166 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~  245 (385)
                      ..|||||+++.+..+.++|||||||+||||+||..||.+.+. ...+.-++.......+|..+++.++=||+.||+..|.
T Consensus       275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds-sAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpR  353 (904)
T KOG4721|consen  275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS-SAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPR  353 (904)
T ss_pred             HhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch-heeEEeccCCcccccCcccCchHHHHHHHHHHhcCCC
Confidence            999999999999999999999999999999999999987532 2223333333334456778899999999999999999


Q ss_pred             CCCCHHHHHhCc
Q 040569          246 ERWSASELLEHG  257 (385)
Q Consensus       246 ~Rps~~elL~hp  257 (385)
                      .|||+.|+|.|-
T Consensus       354 NRPSFrqil~Hl  365 (904)
T KOG4721|consen  354 NRPSFRQILLHL  365 (904)
T ss_pred             CCccHHHHHHHH
Confidence            999999999984

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.6e-44  Score=359.47  Aligned_cols=250  Identities=22%  Similarity=0.269  Sum_probs=198.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeec
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYA   81 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (385)
                      .|.+.+.||+|+||.||+|.+..+++.||||...   ...+.+|+++|++|+||||+++++++.....    .++||||+
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~----~~lv~e~~  242 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---YASSVHEARLLRRLSHPAVLALLDVRVVGGL----TCLVLPKY  242 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---ccCHHHHHHHHHHCCCCCCCcEEEEEEECCE----EEEEEEcc
Confidence            5899999999999999999999999999999643   2345689999999999999999998765432    56899999


Q ss_pred             CCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC-CC
Q 040569           82 PGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD-EG  159 (385)
Q Consensus        82 ~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~-~~  159 (385)
                      . ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.  +||+|||+++........ ..
T Consensus       243 ~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~~~~  319 (461)
T PHA03211        243 R-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED--ICLGDFGAACFARGSWSTPFH  319 (461)
T ss_pred             C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC--EEEcccCCceecccccccccc
Confidence            5 688888864 456999999999999999999999999999999999999987665  999999999875322211 12


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCC-C------hHH---HHHHhcCC-CCCC------
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVA-D------PIS---ALHRIGFS-SDTP------  222 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-~------~~~---~~~~~~~~-~~~~------  222 (385)
                      ....||+.|||||++.+..++.++|||||||++|||++|..|+.... .      ...   .+...... ...+      
T Consensus       320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~  399 (461)
T PHA03211        320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR  399 (461)
T ss_pred             cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence            24579999999999999999999999999999999999876543211 1      011   11111100 0000      


Q ss_pred             ---------------C-----CC--CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          223 ---------------E-----IP--GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       223 ---------------~-----~~--~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                                     .     +.  ..++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                           0     00  124668999999999999999999999999999964

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=8.2e-44  Score=335.66  Aligned_cols=251  Identities=30%  Similarity=0.418  Sum_probs=204.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++.+.||+|+||.||+|.+..+|+.+|+|.+....     .+.+.+|+.++++++||||+++++++....    .+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~~   76 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS----GFVL   76 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC----eeEE
Confidence            6899999999999999999999999999999886433     356789999999999999999999876533    2679


Q ss_pred             EEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |+||+ +++|.+++. ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.  ++|+|||++.......
T Consensus        77 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~--~~l~dfg~~~~~~~~~  153 (286)
T cd07832          77 VMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV--LKIADFGLARLFSEEE  153 (286)
T ss_pred             Eeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc--EEEeeeeecccccCCC
Confidence            99999 999999997 3456999999999999999999999999999999999999987655  9999999998764333


Q ss_pred             CCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC----------------
Q 040569          156 DDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS----------------  218 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~----------------  218 (385)
                      ........|+..|+|||++.+. .++.++|||||||++++|++|++||....+. ..+..+...                
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCChHHHhhccCcc
Confidence            2223445789999999998654 4688999999999999999998888654332 222111000                


Q ss_pred             --------CCC----CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 040569          219 --------SDT----PEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK  260 (385)
Q Consensus       219 --------~~~----~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~  260 (385)
                              ...    .......+..+.+||.+||.++|.+|||++++|+||||.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                    000    011124578999999999999999999999999999973

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.8e-45  Score=357.28  Aligned_cols=250  Identities=29%  Similarity=0.449  Sum_probs=219.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      .|.+.++||+|.|++|.+|++..|+..||||.++++.     ...+.+|+++|+.|+|||||+++.+......    +|+
T Consensus        57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~----lyl  132 (596)
T KOG0586|consen   57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT----LYL  132 (596)
T ss_pred             ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce----eEE
Confidence            4889999999999999999999999999999998754     2457799999999999999999998776654    779


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      ||||+.+|.+++++.+.+++.|..++.++.|++.+++|||+++|+|||||++|||++.+.+  +||+|||++..+.  ..
T Consensus       133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~--~~  208 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN--IKIADFGFSTFFD--YG  208 (596)
T ss_pred             EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc--eeeeccccceeec--cc
Confidence            9999999999999999999999999999999999999999999999999999999997766  9999999999885  33


Q ss_pred             CCCCccccCCcccChhhhcCCCC-CCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          157 DEGKPICGTPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                      ....++||++.|.|||++++..| ++.+|+||+|+++|.|+.|..||.+.. ......+.  -.....+|..+|.+++++
T Consensus       209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~-lk~Lr~rv--l~gk~rIp~~ms~dce~l  285 (596)
T KOG0586|consen  209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN-LKELRPRV--LRGKYRIPFYMSCDCEDL  285 (596)
T ss_pred             ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-cccccchh--eeeeecccceeechhHHH
Confidence            44577899999999999999877 789999999999999999999998642 22222222  122345677799999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      |+++|..+|.+|++++++++|.|....
T Consensus       286 Lrk~lvl~Pskr~~~dqim~~~W~n~~  312 (596)
T KOG0586|consen  286 LRKFLVLNPSKRGPCDQIMKDRWRNDL  312 (596)
T ss_pred             HHHhhccCccccCCHHHhhhhcccchh
Confidence            999999999999999999999998754

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.4e-43  Score=334.03  Aligned_cols=251  Identities=30%  Similarity=0.450  Sum_probs=204.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|+..+.||+|+||.||+|+++.+++.+|+|.+....     .+.+.+|+.++++++||||+++++++.....    +++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~----~~~   77 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK----LHL   77 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE----EEE
Confidence            5899999999999999999999999999999875321     2456789999999999999999998765433    679


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      ||||+++++|..++.....+++..+..++.||+.||.|||++|++||||||+||+++.++.  +||+|||++........
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ--IKLCDFGFARILTGPGD  155 (286)
T ss_pred             EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc--EEECccccceecCCCcc
Confidence            9999999999988887777999999999999999999999999999999999999987765  99999999987643221


Q ss_pred             CCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc-C-----------------
Q 040569          157 DEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG-F-----------------  217 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~-~-----------------  217 (385)
                       ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||....+......... .                 
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF  234 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence             2233457889999999876 4578899999999999999999999986543322111100 0                 


Q ss_pred             ---CCCCCC-------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          218 ---SSDTPE-------IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       218 ---~~~~~~-------~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                         ....+.       ....++..+.+|+.+||+++|++||++.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence               000000       012468889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-45  Score=352.19  Aligned_cols=249  Identities=26%  Similarity=0.466  Sum_probs=202.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEecc-CC----CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE-LS----NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~-~~----~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      .|++++.||+||.+.||+++.... ..||+|.+. ..    ....+.+|+..|.+| .|.+||+++++-+.+    .++|
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d----~~lY  436 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD----GYLY  436 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC----ceEE
Confidence            589999999999999999987544 555655443 21    235678999999999 789999999986553    3477


Q ss_pred             EEEeecCCCCHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           76 LFLEYAPGGTLTDAIRSGTC-LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~-l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +||||-+. +|..+|+++.. ++.-.++.|..|++.++.++|.+||||.||||.|+|+-.   +.+||+|||.|..+..+
T Consensus       437 mvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk---G~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  437 MVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK---GRLKLIDFGIANAIQPD  512 (677)
T ss_pred             EEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe---eeEEeeeechhcccCcc
Confidence            99999854 99999986554 344689999999999999999999999999999999973   33899999999987654


Q ss_pred             CCC-CCCccccCCcccChhhhcCCC-----------CCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC---
Q 040569          155 EDD-EGKPICGTPICMAPEVARGEE-----------QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS---  219 (385)
Q Consensus       155 ~~~-~~~~~~Gt~~y~aPE~~~~~~-----------~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~---  219 (385)
                      ... .....+||+.||+||.+....           .+.++||||||||||+|+-|++||....+....+..|....   
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~I  592 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEI  592 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccc
Confidence            433 234568999999999985432           45789999999999999999999988877777777774432   


Q ss_pred             CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          220 DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       220 ~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      +.|.++.+  .++.++++.||.+||++|||+.+||+|||++.
T Consensus       593 efp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  593 EFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             cccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            34444432  33999999999999999999999999999875

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.6e-44  Score=337.03  Aligned_cols=251  Identities=30%  Similarity=0.475  Sum_probs=208.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++++.||+|+||+||+++++.+++.+|+|.+....    ...+.+|+.++++++||||+++++.+.....    +++|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~----~~lv   77 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGA----VYMC   77 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCe----EEEE
Confidence            6899999999999999999999999999999876431    2467789999999999999999998765433    6799


Q ss_pred             EeecCCCCHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           78 LEYAPGGTLTDAIRSG---TCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~---~~l~e~~~~~i~~qil~gL~yLH~-~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      |||++|++|..++..+   ..+++..+..++.||+.||.|||+ .|++||||||+||+++.++.  +||+|||++.....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~  155 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ--VKLCDFGVSGNLVA  155 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC--EEEeecCCcccccC
Confidence            9999999999998753   368999999999999999999997 59999999999999987655  99999999876532


Q ss_pred             cCCCCCCccccCCcccChhhhcCCC------CCCCCChHHHHHHHHHHHhCCCCCCCCCChH--HHHHHhcCCCCCCCCC
Q 040569          154 NEDDEGKPICGTPICMAPEVARGEE------QGFPADVWALGCTVLEMATGRPPWPDVADPI--SALHRIGFSSDTPEIP  225 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~  225 (385)
                      .   ......|++.|+|||++.+..      ++.++|+|||||++|+|++|+.||.......  ..+..+ .....+.++
T Consensus       156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~  231 (286)
T cd06622         156 S---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI-VDGDPPTLP  231 (286)
T ss_pred             C---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHH-hhcCCCCCC
Confidence            2   223346889999999986543      4789999999999999999999996532211  122222 233445666


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          226 GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       226 ~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ..+++++.+||.+||.++|.+||++.++++|||+...
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             cccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence            6789999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.3e-43  Score=332.24  Aligned_cols=246  Identities=18%  Similarity=0.268  Sum_probs=200.9

Q ss_pred             CceeeceeeccCceEEEEEEEC---CCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN---RSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~---~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++.+.||+|+||.||+|.++   ..+..+|+|.+....    ...+.+|+.++++++||||+++++++.....    .
T Consensus         6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~   81 (266)
T cd05064           6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT----M   81 (266)
T ss_pred             HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC----c
Confidence            5889999999999999999875   456789999887542    2357789999999999999999998765433    6


Q ss_pred             EEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      ++||||+++|+|.+++.. ...+++..++.++.||+.||+|||++|++||||||+|||++.++.  +|++|||.+.....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~--~~l~dfg~~~~~~~  159 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKS  159 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc--EEECCCcccccccc
Confidence            699999999999999975 457999999999999999999999999999999999999987655  89999998765422


Q ss_pred             cCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHH
Q 040569          154 NEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA  232 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  232 (385)
                      ..........++..|+|||.+.+..++.++|||||||++|||++ |..||..... ...+..+.. ...+..+..++..+
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~  237 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-QDVIKAVED-GFRLPAPRNCPNLL  237 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-HHHHHHHHC-CCCCCCCCCCCHHH
Confidence            21111222345678999999999999999999999999999775 9999976533 333333322 22334566789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHh
Q 040569          233 QDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .+++.+||+++|.+||++.++++
T Consensus       238 ~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         238 HQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHcCCCchhCCCHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.1e-43  Score=328.51  Aligned_cols=253  Identities=33%  Similarity=0.552  Sum_probs=217.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|.+.+.||+|++|.||+|.++.+++.+|+|.+....    ...+.+|+.++++++||||+++++++.....    .+++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~lv   77 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGE----ISIV   77 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCe----EEEE
Confidence            6899999999999999999999999999999887653    4578899999999999999999998766533    6799


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~-~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      +||+++++|.+++.....+++..+..++.||+.||.|||+ .|++||||+|+||+++.++.  ++|+|||++........
T Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~  155 (264)
T cd06623          78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE--VKIADFGISKVLENTLD  155 (264)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC--EEEccCccceecccCCC
Confidence            9999999999999877789999999999999999999999 99999999999999987665  99999999987643222


Q ss_pred             CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHhcCCCCCCCCCCc-CCHHHH
Q 040569          157 DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVA--DPISALHRIGFSSDTPEIPGY-MSKQAQ  233 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~-~s~~~~  233 (385)
                       ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||....  ........+. ....+..+.. ++..+.
T Consensus       156 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~  233 (264)
T cd06623         156 -QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFR  233 (264)
T ss_pred             -cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHH
Confidence             2224568999999999999989999999999999999999999997764  4444444443 3344555555 899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          234 DFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       234 ~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ++|.+||.++|++|||+.++++|||++..
T Consensus       234 ~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         234 DFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            99999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=9.1e-44  Score=350.38  Aligned_cols=248  Identities=25%  Similarity=0.318  Sum_probs=199.6

Q ss_pred             CceeeceeeccCceEEEEEEE-----CCCCcEEEEEeccCC----CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMS-----NRSSEVFAVKSAELS----NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~~AvK~~~~~----~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~   71 (385)
                      +|++++.||+|+||+||+|.+     ..++..||||.+...    ..+.+.+|+.+|+.+ .||||+++++++.....  
T Consensus        36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~--  113 (375)
T cd05104          36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP--  113 (375)
T ss_pred             HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc--
Confidence            488899999999999999974     346778999988643    234677899999999 89999999998765543  


Q ss_pred             EEEEEEEeecCCCCHHHHHHcC----------------------------------------------------------
Q 040569           72 ILYNLFLEYAPGGTLTDAIRSG----------------------------------------------------------   93 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~~----------------------------------------------------------   93 (385)
                        .++||||++||+|.+++...                                                          
T Consensus       114 --~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         114 --TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             --ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence              56899999999999998632                                                          


Q ss_pred             -----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           94 -----------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        94 -----------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                                       ..+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIRNDSN  269 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc--EEEecCccceeccCccc
Confidence                             14678889999999999999999999999999999999986654  89999999987543221


Q ss_pred             CC-CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          157 DE-GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       157 ~~-~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                      .. .....++..|||||++.+..++.++|||||||++|+|++ |..||............+ .....+..+...+.++++
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~  348 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI-KEGYRMLSPECAPSEMYD  348 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH-HhCccCCCCCCCCHHHHH
Confidence            11 112335678999999999999999999999999999998 899997654333322222 222233445567899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhC
Q 040569          235 FLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      |+.+||++||++|||+.|+++.
T Consensus       349 li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         349 IMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHccCChhHCcCHHHHHHH
Confidence            9999999999999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.1e-44  Score=333.99  Aligned_cols=250  Identities=34%  Similarity=0.552  Sum_probs=211.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|+..+.||+|+||.||++.++.+++.+|+|.+....    ...+.+|+++++++.||||+++++.+.....    ++++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~----~~lv   77 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGD----ISIC   77 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCE----EEEE
Confidence            5888999999999999999999999999999886542    2457789999999999999999998766532    7799


Q ss_pred             EeecCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           78 LEYAPGGTLTDAIRSG-TCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~-~~l~e~~~~~i~~qil~gL~yLH~-~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||+++++|.+++... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.  +||+|||.+.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~--~~l~d~g~~~~~~~~~  155 (265)
T cd06605          78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ--IKLCDFGVSGQLVNSL  155 (265)
T ss_pred             EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC--EEEeecccchhhHHHH
Confidence            9999999999999854 779999999999999999999999 99999999999999987665  9999999987653221


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCC----ChHHHHHHhcCCCCCCCCCCc-CCH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVA----DPISALHRIGFSSDTPEIPGY-MSK  230 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~----~~~~~~~~~~~~~~~~~~~~~-~s~  230 (385)
                      .   ....|+..|+|||.+.+..++.++|||||||++++|++|+.||....    .....+..+ .....+..+.. +++
T Consensus       156 ~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  231 (265)
T cd06605         156 A---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI-VNEPPPRLPSGKFSP  231 (265)
T ss_pred             h---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH-hcCCCCCCChhhcCH
Confidence            1   12568999999999999999999999999999999999999997542    223333332 22333444444 899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      ++++||.+||..||.+|||+.+++.||||+.
T Consensus       232 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         232 DFQDFVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence            9999999999999999999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.5e-43  Score=325.58  Aligned_cols=249  Identities=26%  Similarity=0.448  Sum_probs=211.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|+..+.||.|+||.||.++...+++.+++|.+....     ...+.+|+.++++++||||+++++++.....    .++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~----~~~   76 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNT----LLI   76 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCe----EEE
Confidence            5899999999999999999999999999999876432     3457789999999999999999999866432    668


Q ss_pred             EEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           77 FLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +|||+++++|.+++..  +..+++..+..++.|++.||.|||+.|++||||||+||+++.++.  +||+|||++......
T Consensus        77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~  154 (256)
T cd08221          77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSE  154 (256)
T ss_pred             EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC--EEECcCcceEEcccc
Confidence            9999999999999975  356899999999999999999999999999999999999987765  999999999876433


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                      .. ......|++.|+|||++.+..++.++|+|||||++++|++|..||... +.......+.. ...+..+..++.++.+
T Consensus       155 ~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~  231 (256)
T cd08221         155 YS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT-NPLNLVVKIVQ-GNYTPVVSVYSSELIS  231 (256)
T ss_pred             cc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHc-CCCCCCccccCHHHHH
Confidence            22 234456899999999998888899999999999999999999999763 34444444422 2333345668999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          235 FLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      ++.+||.++|.+||++.++|+|||+
T Consensus       232 ~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         232 LVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHHcccCcccCCCHHHHhhCcCC
Confidence            9999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.2e-44  Score=350.60  Aligned_cols=247  Identities=24%  Similarity=0.297  Sum_probs=198.9

Q ss_pred             CceeeceeeccCceEEEEEEECCC-----CcEEEEEeccCCC----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRS-----SEVFAVKSAELSN----SEFLQREQRILSAL-ACPQIVAYKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~~AvK~~~~~~----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~   71 (385)
                      +|++++.||+|+||.||+|++..+     +..||+|.+....    .+.+.+|+.+++.+ .||||+++++.+.....  
T Consensus        39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~--  116 (374)
T cd05106          39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP--  116 (374)
T ss_pred             HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC--
Confidence            488999999999999999986544     3579999886432    34577899999999 89999999998765543  


Q ss_pred             EEEEEEEeecCCCCHHHHHHcC----------------------------------------------------------
Q 040569           72 ILYNLFLEYAPGGTLTDAIRSG----------------------------------------------------------   93 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~~----------------------------------------------------------   93 (385)
                        +++||||+++|+|.+++...                                                          
T Consensus       117 --~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         117 --VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             --eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence              67999999999999998532                                                          


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC-CCC
Q 040569           94 ------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD-EGK  160 (385)
Q Consensus        94 ------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~-~~~  160 (385)
                                  .++++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++........ ...
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~--~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV--AKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe--EEEeeceeeeeccCCcceeecc
Confidence                        24788899999999999999999999999999999999986655  899999999865322211 111


Q ss_pred             ccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHh
Q 040569          161 PICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC  239 (385)
Q Consensus       161 ~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~c  239 (385)
                      ...+++.|||||++.+..++.++|||||||++|+|++ |+.||............+ .....+..+..+++++++++.+|
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~c  351 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV-KRGYQMSRPDFAPPEIYSIMKMC  351 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH-HcccCccCCCCCCHHHHHHHHHH
Confidence            2235668999999998899999999999999999997 999997654322222222 22233445566799999999999


Q ss_pred             hhcCCCCCCCHHHHHh
Q 040569          240 LIRNPGERWSASELLE  255 (385)
Q Consensus       240 L~~dP~~Rps~~elL~  255 (385)
                      |+.||.+|||+.++++
T Consensus       352 l~~dp~~RPs~~~l~~  367 (374)
T cd05106         352 WNLEPTERPTFSQISQ  367 (374)
T ss_pred             cCCChhhCcCHHHHHH
Confidence            9999999999999976

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.1e-43  Score=327.80  Aligned_cols=249  Identities=28%  Similarity=0.476  Sum_probs=210.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++.+.||+|+||+||++.+..+++.+|+|.+...     ....+.+|+.++++++||||+++++++.....    .++
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~l   76 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGN----LYI   76 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCe----EEE
Confidence            589999999999999999999999999999987532     23467889999999999999999998755432    679


Q ss_pred             EEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           77 FLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      |+||+++++|.+++..  ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.  ++|+|||++......
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~  154 (256)
T cd08218          77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARVLNST  154 (256)
T ss_pred             EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEEeeccceeecCcc
Confidence            9999999999999974  335899999999999999999999999999999999999987665  999999999865322


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                      . .......|++.|+|||++.+..++.++|+|||||++++|++|+.||... +.......+. ....+..+..++.++.+
T Consensus       155 ~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~  231 (256)
T cd08218         155 V-ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-NMKNLVLKII-RGSYPPVSSHYSYDLRN  231 (256)
T ss_pred             h-hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-CHHHHHHHHh-cCCCCCCcccCCHHHHH
Confidence            1 1123346889999999999888999999999999999999999999764 3333333332 33445566778999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          235 FLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      +|.+||+++|.+||++.++++||||
T Consensus       232 li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         232 LVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHHhhCChhhCcCHHHHhhCcCC
Confidence            9999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-43  Score=335.33  Aligned_cols=251  Identities=27%  Similarity=0.444  Sum_probs=209.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++.+.||+|+||+||++.+..+++.+|+|.+....    .+.+.+|+++++.++||||+++++.+.....    +++|
T Consensus         6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~lv   81 (284)
T cd06620           6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENN----ICMC   81 (284)
T ss_pred             HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCE----EEEE
Confidence            5888999999999999999999999999999875432    3567899999999999999999998766532    6799


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~-~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |||+++++|.+++.+.+.+++..+..++.|++.||.|||+ +|++||||||+||+++.++.  ++|+|||++......  
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~d~gl~~~~~~~--  157 (284)
T cd06620          82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ--IKLCDFGVSGELINS--  157 (284)
T ss_pred             EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCc--EEEccCCcccchhhh--
Confidence            9999999999999887789999999999999999999997 69999999999999987665  999999998754221  


Q ss_pred             CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCCh----------HHHHHHhcCCCCCCCCCC
Q 040569          157 DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADP----------ISALHRIGFSSDTPEIPG  226 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~----------~~~~~~~~~~~~~~~~~~  226 (385)
                       ......|+..|+|||++.+..++.++|||||||++|+|++|+.||......          ......+ .....+.++.
T Consensus       158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  235 (284)
T cd06620         158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI-VQEPPPRLPS  235 (284)
T ss_pred             -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH-hhccCCCCCc
Confidence             123457899999999998888999999999999999999999999754321          1122222 1222333333


Q ss_pred             c-CCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          227 Y-MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       227 ~-~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      . ++.++.+|+.+||++||.+|||+.|+++|+|+.+.
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            2 78899999999999999999999999999998653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-43  Score=333.73  Aligned_cols=252  Identities=31%  Similarity=0.435  Sum_probs=207.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++.+.||+|+||+||+|.++.+++.+|+|.+...     ..+.+.+|++++++++||||+++++++.....    +++
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~i   77 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR----LYL   77 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCE----EEE
Confidence            689999999999999999999999999999987642     23578899999999999999999999866432    679


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      +|||++++.+..++.+...+++..+..++.||+.||.|||++|++||||||+||+++.++.  +||+|||++........
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~--~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFGFARALRARPA  155 (288)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEEeeecccccCCCcc
Confidence            9999999778777777677999999999999999999999999999999999999987665  99999999987654332


Q ss_pred             CCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc------------C------
Q 040569          157 DEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG------------F------  217 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~------------~------  217 (385)
                      .......|+..|+|||++.+. .++.++||||||+++|+|++|++||..............            .      
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence            233445789999999999888 789999999999999999999999976433222111000            0      


Q ss_pred             CC-CC----------CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          218 SS-DT----------PEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       218 ~~-~~----------~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      .. ..          ...+..+++++++||.+||..+|++|||++++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            00 00          01233458999999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.2e-43  Score=332.50  Aligned_cols=251  Identities=27%  Similarity=0.453  Sum_probs=202.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHH-HHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRI-LSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~i-l~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++.+.||+|+||.||+|+++.+|+.||+|.+....    ...+.+|..+ ++.+.||||+++++++.....    .++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~----~~l   77 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGD----VWI   77 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc----EEE
Confidence            6899999999999999999999999999999886532    2234456665 566799999999998765443    669


Q ss_pred             EEeecCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           77 FLEYAPGGTLTDAIRS----GTCLEEGRIRSHTRAVLLGLQYLHSN-GIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~----~~~l~e~~~~~i~~qil~gL~yLH~~-givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      +|||++ |+|.+++..    +..+++..+..++.||+.||+|||++ +++||||||+||+++.++.  +||+|||++...
T Consensus        78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~--~kl~dfg~~~~~  154 (283)
T cd06617          78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGYL  154 (283)
T ss_pred             Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeeccccccc
Confidence            999997 588887752    34689999999999999999999997 9999999999999987765  999999999865


Q ss_pred             cccCCCCCCccccCCcccChhhhcC----CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCC-C
Q 040569          152 RVNEDDEGKPICGTPICMAPEVARG----EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP-G  226 (385)
Q Consensus       152 ~~~~~~~~~~~~Gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~  226 (385)
                      ...  .......|+..|+|||++.+    ..++.++|+|||||++|+|++|+.||.........+.... ....+.++ .
T Consensus       155 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~  231 (283)
T cd06617         155 VDS--VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAE  231 (283)
T ss_pred             ccc--cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCCCCCcc
Confidence            321  11223468899999999865    4468899999999999999999999976544444443332 22223333 3


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          227 YMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       227 ~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      .+|+++.+||.+||..+|.+||++.++++||||...
T Consensus       232 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         232 KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence            578999999999999999999999999999999865

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.3e-43  Score=332.28  Aligned_cols=248  Identities=29%  Similarity=0.430  Sum_probs=204.8

Q ss_pred             eeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecC
Q 040569            9 IGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAP   82 (385)
Q Consensus         9 LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (385)
                      ||+|+||+||+|.++.+|+.+|+|.+....      ...+.+|+++|++++||||+++++.+.....    +++||||++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~lv~e~~~   76 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDD----LCLVMTLMN   76 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCe----EEEEEecCC
Confidence            699999999999999999999999885421      3345689999999999999999988755432    679999999


Q ss_pred             CCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCC
Q 040569           83 GGTLTDAIRSGT--CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGK  160 (385)
Q Consensus        83 ggsL~~~l~~~~--~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~  160 (385)
                      |++|.+++.+..  .+++..+..++.|++.||.|||++|++||||+|+||+++.++.  +||+|||.+.....  .....
T Consensus        77 ~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~--~~l~dfg~~~~~~~--~~~~~  152 (277)
T cd05577          77 GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKG--GKKIK  152 (277)
T ss_pred             CCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEccCcchhhhcc--CCccc
Confidence            999999997544  6999999999999999999999999999999999999987665  99999999876532  22223


Q ss_pred             ccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHhcCCCCCCCCCCcCCHHHHHHHHH
Q 040569          161 PICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADP--ISALHRIGFSSDTPEIPGYMSKQAQDFLSK  238 (385)
Q Consensus       161 ~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~  238 (385)
                      ...|+..|+|||++.+..++.++|||||||++|+|++|+.||......  ...+... ........+..+++.+.+||.+
T Consensus       153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~  231 (277)
T cd05577         153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR-TLEMAVEYPDKFSPEAKDLCEA  231 (277)
T ss_pred             cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc-cccccccCCccCCHHHHHHHHH
Confidence            446788999999998888999999999999999999999999764321  1112111 1223344566689999999999


Q ss_pred             hhhcCCCCCC-----CHHHHHhCccccccccc
Q 040569          239 CLIRNPGERW-----SASELLEHGFVKEQNFK  265 (385)
Q Consensus       239 cL~~dP~~Rp-----s~~elL~hp~~~~~~~~  265 (385)
                      ||+.+|.+||     ++.++++||||...++.
T Consensus       232 ~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~  263 (277)
T cd05577         232 LLQKDPEKRLGCRGGSADEVREHPLFKDLNWR  263 (277)
T ss_pred             HccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence            9999999999     88899999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.1e-43  Score=325.94  Aligned_cols=246  Identities=25%  Similarity=0.430  Sum_probs=207.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++.+.||+|+||.||++.++.+++.+|+|.+...    ..+.+.+|+.+++.++||||+++++.+.....    ++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv   76 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGH----LYIV   76 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCE----EEEE
Confidence            689999999999999999999999999999987542    23567789999999999999999998765433    6799


Q ss_pred             EeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           78 LEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |||+++|+|.+++..  +..+++..+..++.||+.||.|||++||+|+||||+||+++.++.  ++|+|||++...... 
T Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~-  153 (255)
T cd08219          77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSP-  153 (255)
T ss_pred             EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc--EEEcccCcceeeccc-
Confidence            999999999999863  456899999999999999999999999999999999999987665  999999999865322 


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                      ........|++.|+|||++.+..++.++|+||||+++|+|++|+.||... +.......+. ....+.++..++..+++|
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~l  231 (255)
T cd08219         154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN-SWKNLILKVC-QGSYKPLPSHYSYELRSL  231 (255)
T ss_pred             ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC-CHHHHHHHHh-cCCCCCCCcccCHHHHHH
Confidence            12223456899999999999988999999999999999999999999763 3333333332 233444566789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhC
Q 040569          236 LSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~h  256 (385)
                      |.+||++||.+|||+.++++-
T Consensus       232 i~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         232 IKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHhCCcccCCCHHHHhhc
Confidence            999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.2e-43  Score=328.63  Aligned_cols=246  Identities=23%  Similarity=0.338  Sum_probs=204.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++.+.||+|+||+||+|.++.+++.+|+|.+..+.  .+.+.+|+++++++.||||+++++++.....    ++++||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e   82 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP----FYIITE   82 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCC----cEEEEE
Confidence            5788999999999999999999999999999887543  3567889999999999999999998765443    669999


Q ss_pred             ecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           80 YAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        80 y~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |+++++|.+++..  ...+++..+..++.|++.||+|||++|++||||||+|||++.++.  +||+|||++.........
T Consensus        83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc--EEeCCCccccccccceee
Confidence            9999999999974  345899999999999999999999999999999999999987665  999999999876432222


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||... +.......+. ....+..+..++.++.+++
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~li  238 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLE-KGYRMERPEGCPPKVYELM  238 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHH-CCCCCCCCCCCCHHHHHHH
Confidence            2222234678999999999999999999999999999998 99999764 3333333332 2234455677899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 040569          237 SKCLIRNPGERWSASELLE  255 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~  255 (385)
                      .+||+.+|++|||+.++++
T Consensus       239 ~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         239 RACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHccCCcccCCCHHHHHH
Confidence            9999999999999999976

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.1e-43  Score=337.71  Aligned_cols=251  Identities=32%  Similarity=0.511  Sum_probs=207.1

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      |.....||+|+||.||++.+..++..+|||.+....   .+.+.+|+.++++++||||+++++.+.....    +++|||
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~----~~lv~e   99 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE----LWVVME   99 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCe----EEEEEe
Confidence            455778999999999999999999999999886533   3467799999999999999999998765433    679999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      |+++++|.+++..+ .+++..+..++.||+.||.|||++|++||||||+||+++.++.  +||+|||++....... ...
T Consensus       100 ~~~~~~L~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~~-~~~  175 (292)
T cd06658         100 FLEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSKEV-PKR  175 (292)
T ss_pred             CCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEccCcchhhccccc-ccC
Confidence            99999999988754 5899999999999999999999999999999999999987765  9999999987653222 222


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC-CCCCCCCCcCCHHHHHHHHH
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS-SDTPEIPGYMSKQAQDFLSK  238 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~ll~~  238 (385)
                      ....|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ....+..+... .........++..+++|+.+
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  254 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP-PLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL  254 (292)
T ss_pred             ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence            34568999999999998889999999999999999999999997643 33322222111 11112233478999999999


Q ss_pred             hhhcCCCCCCCHHHHHhCcccccc
Q 040569          239 CLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       239 cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ||.+||.+|||++++++||||...
T Consensus       255 ~l~~~P~~Rpt~~~il~~~~~~~~  278 (292)
T cd06658         255 MLVREPSQRATAQELLQHPFLKLA  278 (292)
T ss_pred             HccCChhHCcCHHHHhhChhhhcc
Confidence            999999999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.1e-43  Score=331.74  Aligned_cols=247  Identities=20%  Similarity=0.296  Sum_probs=204.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCC-----cEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSS-----EVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~-----~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|++.+.||+|+||.||+|.+...+     ..+|+|.+....    ...+.+|+.++++++||||+++++++.....   
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~---   82 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP---   82 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc---
Confidence            5889999999999999999986555     789999886432    2457789999999999999999998765433   


Q ss_pred             EEEEEEeecCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC
Q 040569           73 LYNLFLEYAPGGTLTDAIRSG----------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN  136 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~----------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~  136 (385)
                       .+++|||+++|+|.+++...                ..+++..+..++.||+.||.|||++|++||||||+||+++.++
T Consensus        83 -~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          83 -TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             -eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence             66899999999999999743                4578899999999999999999999999999999999998766


Q ss_pred             CCCeEEeecCceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHH
Q 040569          137 EQGAKIADFGCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHR  214 (385)
Q Consensus       137 ~~~~kL~DFG~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~  214 (385)
                      .  +||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||.... .......
T Consensus       162 ~--~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~-~~~~~~~  238 (283)
T cd05048         162 T--VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS-NQEVIEM  238 (283)
T ss_pred             c--EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHH
Confidence            5  99999999986532221 12233457889999999998899999999999999999998 999997643 3333333


Q ss_pred             hcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          215 IGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       215 ~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      +. ....+..+..+++++.+|+.+||++||.+||++.|++++
T Consensus       239 i~-~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         239 IR-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HH-cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            32 333455677789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.9e-43  Score=342.32  Aligned_cols=258  Identities=27%  Similarity=0.352  Sum_probs=208.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++.+.||+|+||.||+|+++.+++.||+|.+...     ....+.+|+.+|++++||||+++++++..........++
T Consensus         6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l   85 (334)
T cd07855           6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV   85 (334)
T ss_pred             ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence            689999999999999999999999999999987643     235667899999999999999999887654433345679


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |+||+. ++|.+++...+.+++..+..++.||+.||.|||++|++||||||+||+++.++.  +||+|||++........
T Consensus        86 v~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          86 VMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEecccccceeecccCc
Confidence            999996 599999987777999999999999999999999999999999999999987766  99999999986543222


Q ss_pred             CC---CCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh-----------------
Q 040569          157 DE---GKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI-----------------  215 (385)
Q Consensus       157 ~~---~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~-----------------  215 (385)
                      ..   .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ +..+                 
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~-~~~~~~~~g~~~~~~~~~~~~  241 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ-LKLILSVLGSPSEEVLNRIGS  241 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH-HHHHHHHhCCChhHhhhhhch
Confidence            11   224478999999999865 4578999999999999999999999976432111 1100                 


Q ss_pred             -------cCCCCCCC-----CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          216 -------GFSSDTPE-----IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       216 -------~~~~~~~~-----~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                             ........     +....++++++||.+||+++|.+|||+.+++.||||.+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~  301 (334)
T cd07855         242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH  301 (334)
T ss_pred             hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence                   00000011     1134689999999999999999999999999999998653

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=9e-44  Score=334.82  Aligned_cols=250  Identities=37%  Similarity=0.609  Sum_probs=209.6

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      |+..+.||+|+||.||+|.+..+++.+|+|.+....    .+.+.+|+.+++++.||||+++++++.....    +++||
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~   81 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTK----LWIIM   81 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCc----eEEEE
Confidence            677889999999999999999999999999886433    2467899999999999999999998765443    67999


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      ||+++++|.+++.. +.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.  +||+|||++....... ..
T Consensus        82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~-~~  157 (277)
T cd06642          82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQ-IK  157 (277)
T ss_pred             EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC--EEEccccccccccCcc-hh
Confidence            99999999999875 45899999999999999999999999999999999999987665  9999999997654221 12


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK  238 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~  238 (385)
                      .....|+..|+|||++.+..++.++|+|||||++++|++|+.||.... .......+ .....+.++...+.++.++|.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~  235 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH-PMRVLFLI-PKNSPPTLEGQYSKPFKEFVEA  235 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc-hhhHHhhh-hcCCCCCCCcccCHHHHHHHHH
Confidence            233468899999999999889999999999999999999999997542 22222222 1223445556688999999999


Q ss_pred             hhhcCCCCCCCHHHHHhCcccccc
Q 040569          239 CLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       239 cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ||+.+|.+||++.++++|||+...
T Consensus       236 ~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         236 CLNKDPRFRPTAKELLKHKFITRY  259 (277)
T ss_pred             HccCCcccCcCHHHHHHhHHHHHH
Confidence            999999999999999999998754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.7e-43  Score=330.84  Aligned_cols=252  Identities=35%  Similarity=0.596  Sum_probs=212.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      .|+..+.||+|+||.||+|.++.++..+|+|.+....    .+.+.+|+.+++++.||||+++++++.....    +++|
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv   80 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTK----LWII   80 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE----EEEE
Confidence            3788899999999999999999999999999887543    3467789999999999999999998766443    6799


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |||++||+|.+++..+ ++++..+..++.|++.||+|||+.+++|+||+|+||+++.++.  ++|+|||++....... .
T Consensus        81 ~e~~~~~~L~~~i~~~-~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~-~  156 (277)
T cd06640          81 MEYLGGGSALDLLRAG-PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQ-I  156 (277)
T ss_pred             EecCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC--EEEcccccceeccCCc-c
Confidence            9999999999999854 5899999999999999999999999999999999999987665  9999999998764322 1


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      ......++..|+|||++.+..++.++|+|||||++|+|++|..||.... +......+ .....+.++..++..+.+|+.
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~li~  234 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH-PMRVLFLI-PKNNPPTLTGEFSKPFKEFID  234 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC-hHhHhhhh-hcCCCCCCchhhhHHHHHHHH
Confidence            2233468889999999998889999999999999999999999997643 33322222 223345566668899999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCccccccc
Q 040569          238 KCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      +||+++|.+||++.++++|||+....
T Consensus       235 ~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         235 ACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             HHcccCcccCcCHHHHHhChHhhhcc
Confidence            99999999999999999999987543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.8e-43  Score=325.33  Aligned_cols=245  Identities=23%  Similarity=0.319  Sum_probs=201.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++.+.||+|+||.||++..+ .+..+|+|.+....  .+.+.+|+.+|++++||||+++++++.....    ++++||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~iv~e   79 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKP----LYIVTE   79 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCC----EEEEEE
Confidence            4889999999999999999886 45678999876432  4577889999999999999999998755443    679999


Q ss_pred             ecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           80 YAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        80 y~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      |+++|+|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+||+++.++.  +||+|||+++.........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV--VKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe--EEECCCCCccccCCCceec
Confidence            9999999999974 456899999999999999999999999999999999999987655  8999999988653222222


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      .....++..|+|||++.+..++.++||||||+++|+|++ |+.||.... .......+.. ...+..+...+..+.+|+.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~-~~~~~~~i~~-~~~~~~~~~~~~~~~~li~  235 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-NYEVVEMISR-GFRLYRPKLASMTVYEVMY  235 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHC-CCCCCCCCCCCHHHHHHHH
Confidence            222345668999999998889999999999999999999 999997643 3333333322 2233445667899999999


Q ss_pred             HhhhcCCCCCCCHHHHHh
Q 040569          238 KCLIRNPGERWSASELLE  255 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~  255 (385)
                      +||+.+|.+|||+.++++
T Consensus       236 ~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         236 SCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHccCCcccCcCHHHHHH
Confidence            999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1e-42  Score=320.10  Aligned_cols=247  Identities=36%  Similarity=0.623  Sum_probs=209.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|+..+.||+|++|.||++.++.+++.+++|.+....   ...+.+|+++++++.||||+++++++.....    .++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~l~~   76 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE----LWIVM   76 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe----EEEEE
Confidence            6899999999999999999999999999999987543   4678899999999999999999998766533    66899


Q ss_pred             eecCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           79 EYAPGGTLTDAIRSG-TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~-~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      ||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.  +||+|||.+........ 
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe--EEEeecccccccccccc-
Confidence            999999999999864 57999999999999999999999999999999999999987665  99999999987643321 


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCc--CCHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY--MSKQAQDF  235 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~s~~~~~l  235 (385)
                       .....|+..|+|||.+.+..++.++|+||||+++++|++|+.||...... ..+..... ...+..+..  ++..+.+|
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~  230 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-KALFKIAT-NGPPGLRNPEKWSDEFKDF  230 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHHh-cCCCCcCcccccCHHHHHH
Confidence             34456899999999999888999999999999999999999999765332 22222222 223333333  38999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcc
Q 040569          236 LSKCLIRNPGERWSASELLEHGF  258 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~  258 (385)
                      |.+||+.||++|||+.|+|+|||
T Consensus       231 i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         231 LKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHHccCChhhCCCHHHHhcCCC
Confidence            99999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=324.66  Aligned_cols=249  Identities=26%  Similarity=0.411  Sum_probs=206.0

Q ss_pred             eeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-HH---HHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            4 TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-SE---FLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-~~---~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      ..+..||+|+-|+|++++.+.+|.++|||.+.... .+   .+.+.+.++.+. .+|+||+++|+|+.+..    .+++|
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d----V~IcM  170 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD----VFICM  170 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch----HHHHH
Confidence            45678999999999999999999999999987543 33   344556665555 58999999999988765    55889


Q ss_pred             eecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           79 EYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        79 Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~-~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |.|.. -+..+++ -+++++|..+-++...++.||.||.. +||+|||+||+|||++..++  +||||||.+....... 
T Consensus       171 elMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn--iKlCDFGIsGrlvdSk-  246 (391)
T KOG0983|consen  171 ELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN--IKLCDFGISGRLVDSK-  246 (391)
T ss_pred             HHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC--EEeecccccceeeccc-
Confidence            99843 5666666 45679999999999999999999986 59999999999999998887  9999999998763222 


Q ss_pred             CCCCccccCCcccChhhhcC---CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCC--cCCHH
Q 040569          157 DEGKPICGTPICMAPEVARG---EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPG--YMSKQ  231 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~  231 (385)
                       ..+...|.+.|||||.+.-   ..|+..+||||||++++||+||+.||.........+..+.. .++|.++.  .+|++
T Consensus       247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~gFSp~  324 (391)
T KOG0983|consen  247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMGFSPD  324 (391)
T ss_pred             -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccCcCHH
Confidence             2233469999999999954   46889999999999999999999999987777777766644 44565553  37999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          232 AQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +++|+..||.+|+.+||...++|+|||+...
T Consensus       325 F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  325 FQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY  355 (391)
T ss_pred             HHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence            9999999999999999999999999998643

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=6.4e-43  Score=329.92  Aligned_cols=248  Identities=24%  Similarity=0.386  Sum_probs=200.0

Q ss_pred             eeeccCceEEEEEEECCCCcEEEEEeccCCC-----H-HHHHHHHH---HHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            8 TIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----S-EFLQREQR---ILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         8 ~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~-~~~~~E~~---il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      .||+|+||+||+|++..+++.||+|.+....     . .....|..   +++...||||+++++.+.....    +++||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~----~~~v~   76 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK----LSFIL   76 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE----EEEEE
Confidence            4899999999999999999999999876432     1 12333433   4445689999999887765443    67899


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      ||++||+|.+++...+.+++..+..++.|++.||.|||+.+++||||||+||+++.++.  +||+|||++......   .
T Consensus        77 e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~--~kl~dfg~~~~~~~~---~  151 (278)
T cd05606          77 DLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK---K  151 (278)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC--EEEccCcCccccCcc---C
Confidence            99999999999987778999999999999999999999999999999999999987665  999999998765321   2


Q ss_pred             CCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChH-HHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPI-SALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      .....|+..|+|||++.++ .++.++||||+||++|+|++|+.||....... ...... .....+.++..+|.++.+++
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li  230 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTMAVELPDSFSPELRSLL  230 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH-hhccCCCCCCcCCHHHHHHH
Confidence            2344799999999999754 68899999999999999999999997542211 111111 12234556667899999999


Q ss_pred             HHhhhcCCCCCC-----CHHHHHhCccccccccc
Q 040569          237 SKCLIRNPGERW-----SASELLEHGFVKEQNFK  265 (385)
Q Consensus       237 ~~cL~~dP~~Rp-----s~~elL~hp~~~~~~~~  265 (385)
                      .+||..+|.+||     ++.++++||||+...+.
T Consensus       231 ~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~  264 (278)
T cd05606         231 EGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ  264 (278)
T ss_pred             HHHhhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence            999999999999     99999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.8e-43  Score=325.73  Aligned_cols=250  Identities=26%  Similarity=0.434  Sum_probs=208.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|+..+.||+|+||.||++.++.++..+|+|.+...     ..+.+.+|+.++++++||||+++++.+.....    .++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~----~~l   76 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGR----LFI   76 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCe----EEE
Confidence            589999999999999999999999999999988643     34567899999999999999999988755432    679


Q ss_pred             EEeecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           77 FLEYAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||+++++|.+++...  ..+++..+..++.||+.||.|||+++++|+||||+||+++.++. .+||+|||.+......
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~  155 (257)
T cd08225          77 VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDS  155 (257)
T ss_pred             EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCC
Confidence            99999999999999743  35799999999999999999999999999999999999986543 3699999998866422


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                      . .......|++.|+|||++.+..++.++|+||||+++++|++|+.||.... .......+ .....+..+..++.++++
T Consensus       156 ~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~  232 (257)
T cd08225         156 M-ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVLKI-CQGYFAPISPNFSRDLRS  232 (257)
T ss_pred             c-ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHH-hcccCCCCCCCCCHHHHH
Confidence            2 12233468999999999988889999999999999999999999997543 33333332 223334455567899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          235 FLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      +|.+||..+|++|||+.++++||||
T Consensus       233 ~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         233 LISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHHhccChhhCcCHHHHhhCCCC
Confidence            9999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.2e-43  Score=334.37  Aligned_cols=247  Identities=23%  Similarity=0.270  Sum_probs=195.4

Q ss_pred             CceeeceeeccCceEEEEEEECC----------------CCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNR----------------SSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYK   61 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~----------------~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~   61 (385)
                      +|++.+.||+|+||+||+|.++.                ++..+|+|.+....    ...+.+|+.+|++++||||++++
T Consensus         6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~   85 (304)
T cd05096           6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL   85 (304)
T ss_pred             hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence            58899999999999999998643                34579999886532    24577899999999999999999


Q ss_pred             eeeeeccCCeEEEEEEEeecCCCCHHHHHHcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 040569           62 GCDISEENGKILYNLFLEYAPGGTLTDAIRSG-------------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVH  122 (385)
Q Consensus        62 ~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~-------------------~~l~e~~~~~i~~qil~gL~yLH~~givH  122 (385)
                      +++.....    .+++|||+++|+|.+++...                   ..+++..+..++.||+.||.|||++||+|
T Consensus        86 ~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH  161 (304)
T cd05096          86 GVCVDEDP----LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH  161 (304)
T ss_pred             EEEecCCc----eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            98876543    67999999999999998642                   23577889999999999999999999999


Q ss_pred             ccCCCCCEEeecCCCCCeEEeecCceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh--CC
Q 040569          123 CDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT--GR  199 (385)
Q Consensus       123 rDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--G~  199 (385)
                      |||||+|||++.++.  +||+|||+++........ ......++..|||||++.+..++.++|||||||++|+|++  +.
T Consensus       162 ~dlkp~Nill~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         162 RDLATRNCLVGENLT--IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             cCcchhheEEcCCcc--EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            999999999987665  999999999865322211 1223346788999999998899999999999999999986  66


Q ss_pred             CCCCCCCChHHHHHHh------cCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          200 PPWPDVADPISALHRI------GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       200 ~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .||...... ..+..+      .........+..+++.+.+|+.+||..||.+|||+.|+.+
T Consensus       240 ~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         240 QPYGELTDE-QVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCCcCCHH-HHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            788764322 221111      0111122234457899999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.8e-43  Score=329.01  Aligned_cols=244  Identities=23%  Similarity=0.324  Sum_probs=198.2

Q ss_pred             ceeecee--eccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            3 WTRGQTI--GRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         3 y~~~~~L--G~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      |++.+.+  |+|+||.||++.++.+++.+|+|.+.......  .|..+...+ .||||+++++.+.....    +++|||
T Consensus        16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~e~~~~~~~~~h~~iv~~~~~~~~~~~----~~iv~e   89 (267)
T PHA03390         16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--IEPMVHQLMKDNPNFIKLYYSVTTLKG----HVLIMD   89 (267)
T ss_pred             hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--hhHHHHHHhhcCCCEEEEEEEEecCCe----eEEEEE
Confidence            4555565  99999999999999999999999986543222  133333323 79999999998866542    779999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      |++|++|.+++.....+++..+..++.||+.||.|||+.|++||||||+||+++.++ ..++|+|||++......     
T Consensus        90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~~-----  163 (267)
T PHA03390         90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK-DRIYLCDYGLCKIIGTP-----  163 (267)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC-CeEEEecCccceecCCC-----
Confidence            999999999998777899999999999999999999999999999999999998776 13999999998865321     


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChH---HHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPI---SALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      ....|++.|+|||++.+..++.++|||||||++|+|++|+.||.......   ..+....  ......+..+++.+++||
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li  241 (267)
T PHA03390        164 SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNVSKNANDFV  241 (267)
T ss_pred             ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccccCHHHHHHH
Confidence            23468999999999999899999999999999999999999997543221   1111111  223344556899999999


Q ss_pred             HHhhhcCCCCCCC-HHHHHhCcccc
Q 040569          237 SKCLIRNPGERWS-ASELLEHGFVK  260 (385)
Q Consensus       237 ~~cL~~dP~~Rps-~~elL~hp~~~  260 (385)
                      .+||+++|.+||+ ++|+|+||||.
T Consensus       242 ~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        242 QSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             HHHhccChhhCCchHHHHhcCCccc
Confidence            9999999999996 69999999985

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5e-43  Score=332.95  Aligned_cols=252  Identities=29%  Similarity=0.414  Sum_probs=204.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--------SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|++.+.||+|+||.||+|.++.+++.+|+|.+....        ...+.+|++++++++||||+++++++....    .
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~   76 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS----N   76 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC----E
Confidence            5889999999999999999999999999999886432        234668999999999999999999886633    2


Q ss_pred             EEEEEeecCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           74 YNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~~-~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      .++||||+ +|+|.+++.... .+++..+..++.||++||.|||++|++|+||||+||+++.++.  +||+|||++....
T Consensus        77 ~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~  153 (298)
T cd07841          77 INLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV--LKLADFGLARSFG  153 (298)
T ss_pred             EEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC--EEEccceeeeecc
Confidence            66999999 889999998655 7999999999999999999999999999999999999997766  9999999998764


Q ss_pred             ccCCCCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC------------
Q 040569          153 VNEDDEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS------------  219 (385)
Q Consensus       153 ~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~------------  219 (385)
                      ... .......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||....+. ..+..+....            
T Consensus       154 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         154 SPN-RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             CCC-ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhcc
Confidence            322 12233357889999999865 45788999999999999999998888654332 2111110000            


Q ss_pred             --------------CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          220 --------------DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       220 --------------~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                    .........+.++.+||.+||.++|++|||+.|+|+||||.+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~  288 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND  288 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence                          0001123457899999999999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=349.45  Aligned_cols=249  Identities=27%  Similarity=0.401  Sum_probs=214.9

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      .+.||+|.||+||-|+++++|+.||||++++.     ..+++++|+.||+++.||.||.+--.+...+.    .++|||.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er----vFVVMEK  644 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER----VFVVMEK  644 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce----EEEEehh
Confidence            47899999999999999999999999998753     35789999999999999999999777655544    6689999


Q ss_pred             cCCCCHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCC-CCeEEeecCceeeecccCCC
Q 040569           81 APGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE-QGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        81 ~~ggsL~~~l~--~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~-~~~kL~DFG~a~~~~~~~~~  157 (385)
                      +.| +..+.|-  ..++|+|.....++.||+.||.|||-+||+|+||||+|||+..... ..+||||||+|+.+.  +..
T Consensus       645 l~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg--Eks  721 (888)
T KOG4236|consen  645 LHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG--EKS  721 (888)
T ss_pred             hcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecc--hhh
Confidence            966 6666653  6778999999999999999999999999999999999999965422 247999999999984  333


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      -....+|||.|+|||+++...|+..-|+||.|+|+|.-++|..||....+...+++...+.. ++.....+|+++.|||.
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMy-Pp~PW~eis~~AidlIn  800 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMY-PPNPWSEISPEAIDLIN  800 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcccccc-CCCchhhcCHHHHHHHH
Confidence            44667899999999999999999999999999999999999999988777777766654433 34445669999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCcccccc
Q 040569          238 KCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      .+|+..-++|+|..+.|.|||++..
T Consensus       801 ~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  801 NLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             HHHHHHHHHhcchHhhccchhhhcc
Confidence            9999999999999999999999865

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.6e-43  Score=335.96  Aligned_cols=251  Identities=34%  Similarity=0.533  Sum_probs=208.3

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCC---CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~---~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      |.....||+|+||.||+|.+..+++.+|+|.+...   ..+.+.+|+.+++.+.||||+++++++.....    +++++|
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~----~~iv~e   98 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE----LWVLME   98 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCe----EEEEEe
Confidence            34556899999999999999999999999988542   34567899999999999999999998765443    679999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      |+++++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.  +||+|||++....... ...
T Consensus        99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~--~kL~dfg~~~~~~~~~-~~~  174 (297)
T cd06659          99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDV-PKR  174 (297)
T ss_pred             cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc--EEEeechhHhhccccc-ccc
Confidence            9999999998865 45899999999999999999999999999999999999987765  9999999987553222 122


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC-CCCCCCCCcCCHHHHHHHHH
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS-SDTPEIPGYMSKQAQDFLSK  238 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~ll~~  238 (385)
                      ....|++.|+|||++.+..++.++|||||||++|+|++|+.||... +....+..+... ......+..+++.+.+||.+
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~  253 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRDSPPPKLKNAHKISPVLRDFLER  253 (297)
T ss_pred             cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhccCCCCccccCCCCHHHHHHHHH
Confidence            3457899999999999889999999999999999999999999754 333333333221 12223344578999999999


Q ss_pred             hhhcCCCCCCCHHHHHhCcccccc
Q 040569          239 CLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       239 cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ||+.+|.+||++.++++|||+.+.
T Consensus       254 ~l~~~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         254 MLTREPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             HhcCCcccCcCHHHHhhChhhccC
Confidence            999999999999999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6e-43  Score=331.54  Aligned_cols=250  Identities=28%  Similarity=0.402  Sum_probs=199.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++.+.||+|+||.||+|.++.+++.+|+|.+....    ...+.+|+.+++.+.|+||+++++++....    ..++|
T Consensus         6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~~lv   81 (291)
T cd07870           6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKE----TLTFV   81 (291)
T ss_pred             eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC----eEEEE
Confidence            5899999999999999999999999999999886432    235678999999999999999999876443    26689


Q ss_pred             EeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           78 LEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      +||+. ++|.+++. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.  +||+|||+++...... 
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~-  157 (291)
T cd07870          82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE--LKLADFGLARAKSIPS-  157 (291)
T ss_pred             Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc--EEEeccccccccCCCC-
Confidence            99996 57777665 4456889999999999999999999999999999999999987765  9999999987643221 


Q ss_pred             CCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC--C---------------
Q 040569          157 DEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF--S---------------  218 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~---------------  218 (385)
                      .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||....+....+..+..  .               
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence            122334579999999998764 5788999999999999999999999765544333322100  0               


Q ss_pred             -------CCCC----CCC--CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          219 -------SDTP----EIP--GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       219 -------~~~~----~~~--~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                             ...+    ...  ...+..+.+|+.+||+.||.+|||+.|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                   0000    000  0136789999999999999999999999999996

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=8e-43  Score=328.56  Aligned_cols=250  Identities=36%  Similarity=0.608  Sum_probs=211.4

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      |+..+.||+|+||.||+|.++.+++.+|+|.+....    ...+.+|+.+++++.||||+++++.+.....    +++||
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~   81 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK----LWIIM   81 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCe----EEEEE
Confidence            678899999999999999999999999999876433    2467789999999999999999998765443    67999


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      ||+++++|.+++..+ .+++..+..++.|++.+|.|||++|++|+||||+||+++.++.  ++|+|||++....... ..
T Consensus        82 e~~~~~~l~~~i~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~-~~  157 (277)
T cd06641          82 EYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQ-IK  157 (277)
T ss_pred             EeCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC--EEEeecccceecccch-hh
Confidence            999999999999754 5899999999999999999999999999999999999987665  9999999987654221 12


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK  238 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~  238 (385)
                      .....|+..|+|||.+.+..++.++|+|||||++++|++|..||.... .......+ .....+.++..++.++.+++.+
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~  235 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH-PMKVLFLI-PKNNPPTLEGNYSKPLKEFVEA  235 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc-hHHHHHHH-hcCCCCCCCcccCHHHHHHHHH
Confidence            233468899999999998888999999999999999999999997643 33333332 2334555666789999999999


Q ss_pred             hhhcCCCCCCCHHHHHhCcccccc
Q 040569          239 CLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       239 cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ||.++|.+||++.++++|||+...
T Consensus       236 ~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         236 CLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             HccCChhhCcCHHHHHhCHHHhhh
Confidence            999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.6e-43  Score=331.52  Aligned_cols=250  Identities=30%  Similarity=0.423  Sum_probs=203.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|+..+.||+|+||+||+|.++.+++.+|+|.+...     ..+.+.+|+++++.++||||+++++++.....    +++
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~l   77 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR----LYL   77 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe----EEE
Confidence            689999999999999999999999999999987532     13467789999999999999999998754432    679


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |+||+++++|..+......+++..+..++.||+.||+|||+.|++||||+|+||+++.++.  +||+|||++....... 
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~-  154 (286)
T cd07846          78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPG-  154 (286)
T ss_pred             EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc--EEEEeeeeeeeccCCc-
Confidence            9999999999998877667999999999999999999999999999999999999987665  9999999998764322 


Q ss_pred             CCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC------------------
Q 040569          157 DEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF------------------  217 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~------------------  217 (385)
                      .......|+..|+|||++.+. .++.++|||||||++++|++|++||...... .....+..                  
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07846         155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPRHQEIFQKNPL  233 (286)
T ss_pred             cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCCCchhhHHHhccchH
Confidence            222345688999999998764 4678999999999999999999999753321 11111100                  


Q ss_pred             --CCCCC---------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          218 --SSDTP---------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       218 --~~~~~---------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                        ....+         .....++..+.+|+.+||..+|.+||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence              00001         1123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-43  Score=327.83  Aligned_cols=251  Identities=36%  Similarity=0.579  Sum_probs=208.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC----CHHHHHHHHHHHHhcC---CCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS----NSEFLQREQRILSALA---CPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~----~~~~~~~E~~il~~l~---hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      .|+..+.||+|+||.||+|.++.+++.+|+|.+...    ..+.+++|+.+++++.   |||++++++++....    .+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~----~~   77 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP----RL   77 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC----EE
Confidence            488899999999999999999999999999987643    2356788999999996   999999999876543    26


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +++|||++|++|.+++..+ .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.  ++|+|||++......
T Consensus        78 ~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~  154 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVAALLNQN  154 (277)
T ss_pred             EEEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCC--EEEccCCceeecCCC
Confidence            7999999999999999765 6999999999999999999999999999999999999987655  999999999876433


Q ss_pred             CCCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCc-CCHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY-MSKQA  232 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~  232 (385)
                      . .......|+..|+|||.+.+. .++.++|+|||||++|+|++|+.||.... .......+. ....+.++.. .+.++
T Consensus       155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~  231 (277)
T cd06917         155 S-SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD-AFRAMMLIP-KSKPPRLEDNGYSKLL  231 (277)
T ss_pred             c-cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC-hhhhhhccc-cCCCCCCCcccCCHHH
Confidence            2 222344689999999998754 46889999999999999999999997643 222222221 1223344433 78899


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          233 QDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      .+|+.+||+.||.+||++.++++|||++..
T Consensus       232 ~~~i~~~l~~~p~~R~~~~~il~~~~~~~~  261 (277)
T cd06917         232 REFVAACLDEEPKERLSAEELLKSKWIKAH  261 (277)
T ss_pred             HHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence            999999999999999999999999999653

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-42  Score=328.74  Aligned_cols=253  Identities=31%  Similarity=0.516  Sum_probs=207.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|+..+.||.|++|.||++.+..+++.+|+|.+....    ...+.+|++++++++||||+++++++.....+.  +++|
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~--~~lv   79 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSS--IGIA   79 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCe--EEEE
Confidence            5889999999999999999999999999999887532    346789999999999999999999886654433  5699


Q ss_pred             EeecCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           78 LEYAPGGTLTDAIR----SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~----~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      |||++|++|.+++.    ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.  +||+|||++.....
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~  157 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVN  157 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe--EEEeeccccccccc
Confidence            99999999998875    3456899999999999999999999999999999999999987665  99999999876532


Q ss_pred             cCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCC----ChHHHHHHhcCCCCCCCCC----
Q 040569          154 NEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVA----DPISALHRIGFSSDTPEIP----  225 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~----~~~~~~~~~~~~~~~~~~~----  225 (385)
                      ..   .....++..|+|||.+.+..++.++|||||||++|+|++|+.||....    ........+.. ...+.++    
T Consensus       158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  233 (287)
T cd06621         158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPELKDEPG  233 (287)
T ss_pred             cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhhccCCC
Confidence            21   123457889999999999999999999999999999999999997541    22222222211 1111111    


Q ss_pred             --CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          226 --GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       226 --~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                        ...++.+.+||.+||.++|.+|||+.|+++|||+...
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence              2356889999999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=9e-43  Score=333.50  Aligned_cols=254  Identities=29%  Similarity=0.410  Sum_probs=203.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++.+.||+|+||+||+|.++.+|+.||+|.+....     ...+.+|+.++++++||||+++++++......  .+++
T Consensus         8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~--~~~l   85 (309)
T cd07845           8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLD--SIFL   85 (309)
T ss_pred             ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC--eEEE
Confidence            6899999999999999999999999999999886432     22456899999999999999999987654332  2568


Q ss_pred             EEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      ||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.  +||+|||++.......
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~kL~dfg~~~~~~~~~  162 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPA  162 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccceeeecCCcc
Confidence            9999975 89888874 467899999999999999999999999999999999999987665  9999999998764322


Q ss_pred             CCCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC---------------
Q 040569          156 DDEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS---------------  219 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~---------------  219 (385)
                       .......+++.|+|||++.+ ..++.++|||||||++|+|++|++||..... ...+..+....               
T Consensus       163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07845         163 -KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE-IEQLDLIIQLLGTPNESIWPGFSDLP  240 (309)
T ss_pred             -CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCChhhchhhhccc
Confidence             12233356888999999875 4578999999999999999999999976533 22222211000               


Q ss_pred             -----CCCC--------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          220 -----DTPE--------IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       220 -----~~~~--------~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                           ..+.        .....++++.+||.+||++||++|||+.|+|+||||...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence                 0000        012358899999999999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.1e-43  Score=333.19  Aligned_cols=253  Identities=33%  Similarity=0.565  Sum_probs=209.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC---CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~---~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|++.+.||+|+||+||++.+..++..+|+|.+...   ..+.+.+|+.++++++||||+++++.+...+.    +++|+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~----~~lv~   95 (293)
T cd06647          20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDE----LWVVM   95 (293)
T ss_pred             hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc----EEEEE
Confidence            688999999999999999999989999999988643   23567889999999999999999998766543    67999


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      ||+++++|.+++.+. .+++..+..++.|++.||.|||++|++||||||+||+++.++.  +||+|||++........ .
T Consensus        96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~--~kL~dfg~~~~~~~~~~-~  171 (293)
T cd06647          96 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS-K  171 (293)
T ss_pred             ecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC--EEEccCcceeccccccc-c
Confidence            999999999999854 4889999999999999999999999999999999999987665  99999999876543222 2


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC-CCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS-SDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~ll~  237 (385)
                      .....|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...... ..+..+... ......+..++..+++||.
T Consensus       172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-RALYLIATNGTPELQNPEKLSAIFRDFLN  250 (293)
T ss_pred             cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-hheeehhcCCCCCCCCccccCHHHHHHHH
Confidence            23346899999999998888999999999999999999999999764322 222222111 1111123457889999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCccccccc
Q 040569          238 KCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      +||..+|.+||++.+++.||||+...
T Consensus       251 ~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         251 RCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHccCChhhCcCHHHHhcCHHHhcCc
Confidence            99999999999999999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-43  Score=330.69  Aligned_cols=250  Identities=30%  Similarity=0.425  Sum_probs=199.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++.+.||+|++|+||+|.++.+++.||+|.+....    ...+.+|++++++++||||+++++++.....    .++|
T Consensus         6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~lv   81 (291)
T cd07844           6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKT----LTLV   81 (291)
T ss_pred             ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCe----EEEE
Confidence            5899999999999999999999999999999886432    2346689999999999999999998765432    6799


Q ss_pred             EeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           78 LEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |||+.+ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.......
T Consensus        82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSK  158 (291)
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC--EEECccccccccCCCCc
Confidence            999985 99998874 456899999999999999999999999999999999999987765  99999999876432211


Q ss_pred             CCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC--CC--------------
Q 040569          157 DEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF--SS--------------  219 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~--------------  219 (385)
                       ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.........+..+..  ..              
T Consensus       159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence             1122347889999999876 45788999999999999999999999765433322221100  00              


Q ss_pred             --------CC-C---CCCCcCC--HHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          220 --------DT-P---EIPGYMS--KQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       220 --------~~-~---~~~~~~s--~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                              .. .   .....++  .++.+++.+||.++|.+|||+.++|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                    00 0   0001234  788999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.4e-43  Score=330.88  Aligned_cols=250  Identities=27%  Similarity=0.377  Sum_probs=201.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|+..+.||+|++|+||+|+++.+++.+|||.+....     ...+.+|++++++++||||+++++++.....    +++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~~   76 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK----LYL   76 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCc----EEE
Confidence            5899999999999999999999999999999886432     2467789999999999999999998754433    679


Q ss_pred             EEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           77 FLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +|||+. ++|.+++..  +..+++..+..++.||+.||+|||++|++||||+|+||+++.++.  +||+|||++......
T Consensus        77 v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~  153 (284)
T cd07860          77 VFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVP  153 (284)
T ss_pred             Eeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEeeccchhhcccC
Confidence            999996 589998863  456899999999999999999999999999999999999987766  999999998765322


Q ss_pred             CCCCCCccccCCcccChhhhcCCC-CCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC--------------
Q 040569          155 EDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS--------------  219 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--------------  219 (385)
                      .. ......+++.|+|||++.+.. ++.++|||||||++|+|+||+.||....+.......+....              
T Consensus       154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         154 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             cc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence            11 122335788999999987654 58889999999999999999999976433222111110000              


Q ss_pred             ------------CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          220 ------------DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       220 ------------~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                                  ....+...++++++++|.+||++||.+|||++++|+||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                        0001123478899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.4e-42  Score=328.71  Aligned_cols=250  Identities=33%  Similarity=0.548  Sum_probs=208.2

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      |...+.||+|++|.||++.++.+++.+++|.+....   .+.+.+|+.+++.+.||||+++++++.....    .++++|
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~----~~~v~e   96 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE----LWVVME   96 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe----EEEEEe
Confidence            556789999999999999999999999999886433   3457789999999999999999998765433    678999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      |++|++|.+++.. +++++..+..++.||+.||+|||++|++||||||+||+++.++.  +||+|||++........ ..
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~d~g~~~~~~~~~~-~~  172 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFGFCAQVSKEVP-RR  172 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc--EEEcccccchhhccCCc-cc
Confidence            9999999999987 56999999999999999999999999999999999999987765  99999998876532221 22


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCC--CCCcCCHHHHHHHH
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE--IPGYMSKQAQDFLS  237 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~ll~  237 (385)
                      ....|++.|+|||.+.+..++.++|||||||++|+|++|+.||... ++......+... ..+.  .+..++..+.+|+.
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~  250 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE-PPLQAMKRIRDN-LPPKLKNLHKVSPRLRSFLD  250 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC-CHHHHHHHHHhc-CCCCCcccccCCHHHHHHHH
Confidence            3346899999999999888999999999999999999999999763 333333333222 1222  23337899999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCcccccc
Q 040569          238 KCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +||.++|++|||+.++++|||++..
T Consensus       251 ~~l~~~p~~Rpt~~~il~~~~~~~~  275 (285)
T cd06648         251 RMLVRDPAQRATAAELLNHPFLAKA  275 (285)
T ss_pred             HHcccChhhCcCHHHHccCcccccC
Confidence            9999999999999999999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=7.5e-43  Score=326.10  Aligned_cols=248  Identities=23%  Similarity=0.386  Sum_probs=204.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC---C---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---N---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~---~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||.||+|+++.+++.+|||.+...   .   ...+.+|++++++++||||+++++++.....    ++
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~   78 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNE----LN   78 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCe----EE
Confidence            689999999999999999999999999999976431   1   2356789999999999999999998765432    66


Q ss_pred             EEEeecCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           76 LFLEYAPGGTLTDAIR----SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~----~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      +++||+++|+|.+++.    +...+++..+..++.||+.||.|||++|++|+||||+||+++.++.  ++|+|||++...
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~  156 (267)
T cd08228          79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFF  156 (267)
T ss_pred             EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC--EEECccccceec
Confidence            9999999999999885    2345899999999999999999999999999999999999987665  999999998876


Q ss_pred             cccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          152 RVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVA-DPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       152 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      ..... ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.... +.......+......+..+...+.
T Consensus       157 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08228         157 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSE  235 (267)
T ss_pred             cchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCH
Confidence            42221 1223468899999999998889999999999999999999999996533 223333333322233333445788


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      .+++++.+||+.+|.+||++.++++.
T Consensus       236 ~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         236 KLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            99999999999999999999999973

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-42  Score=323.75  Aligned_cols=247  Identities=21%  Similarity=0.315  Sum_probs=201.6

Q ss_pred             CCceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            1 MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         1 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      ++|++.+.||+|+||.||+|.++ ++..+|+|.+...  ....+.+|++++++++||||+++++++.....    .++||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~lv~   78 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRP----IFIVT   78 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc----eEEEE
Confidence            47899999999999999999886 5678999988643  34567789999999999999999988654432    66899


Q ss_pred             eecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           79 EYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        79 Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      ||++|++|.+++.. ...+++..+..++.||+.||+|||++|++||||||+||+++.++.  +||+|||+++........
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc--EEECCcccceeccccccc
Confidence            99999999999974 457899999999999999999999999999999999999987665  999999999865322111


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      ......++..|+|||.+.+..++.++|||||||++|+|++ |+.||.... .......+.. ......+...++++.+++
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~li  234 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS-NSEVVESVSA-GYRLYRPKLAPTEVYTIM  234 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHHHc-CCcCCCCCCCCHHHHHHH
Confidence            1112223457999999999999999999999999999999 899997643 3333333322 223344566899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHhC
Q 040569          237 SKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~h  256 (385)
                      .+||..+|++|||+.|+++.
T Consensus       235 ~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         235 YSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHhcCChhhCcCHHHHHHH
Confidence            99999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.1e-42  Score=329.99  Aligned_cols=255  Identities=28%  Similarity=0.390  Sum_probs=202.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccC-CeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSAL-ACPQIVAYKGCDISEEN-GKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~-~~~~~   74 (385)
                      +|++.+.||+|+||+||+|.+..+++.||+|.+....     ...+.+|+.+++++ +||||+++++++..... +...+
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            6899999999999999999999999999999876432     24677899999999 56999999998765443 33446


Q ss_pred             EEEEeecCCCCHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeec-CCCCCeEEeecCce
Q 040569           75 NLFLEYAPGGTLTDAIRS-----GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSK-DNEQGAKIADFGCA  148 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~-----~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~-~~~~~~kL~DFG~a  148 (385)
                      +++|||+++ +|.+++..     +..+++..++.++.||+.||.|||++|++||||||+||+++. ++.  +||+|||++
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~--~kl~dfg~~  158 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL--LKIADLGLG  158 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCe--EEEeecccc
Confidence            799999986 89888863     235899999999999999999999999999999999999987 433  899999999


Q ss_pred             eeecccCCCCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC---CC-----
Q 040569          149 RRARVNEDDEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF---SS-----  219 (385)
Q Consensus       149 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~---~~-----  219 (385)
                      +....... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||....+..........   ..     
T Consensus       159 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (295)
T cd07837         159 RAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP  237 (295)
T ss_pred             eecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            86532211 1222357889999999865 45789999999999999999999999865443322211100   00     


Q ss_pred             -------------CC----CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 040569          220 -------------DT----PEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK  260 (385)
Q Consensus       220 -------------~~----~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~  260 (385)
                                   ..    ......+++++.+||.+||.+||.+||++.|+|.|||++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                         00    001124788999999999999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1e-42  Score=339.80  Aligned_cols=252  Identities=26%  Similarity=0.366  Sum_probs=202.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccC--CeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEEN--GKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~~~~   74 (385)
                      +|+..+.||+|+||+||+|++..+++.+|+|.+...     ....+.+|+.++++++||||+++++++.....  .....
T Consensus        17 ~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   96 (353)
T cd07850          17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV   96 (353)
T ss_pred             ceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcE
Confidence            589999999999999999999999999999988532     23456789999999999999999998764432  11235


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||||+.+ +|.+.+...  +++..+..++.||+.||+|||++||+||||||+||+++.++.  +||+|||+++.....
T Consensus        97 ~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~  171 (353)
T cd07850          97 YLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTS  171 (353)
T ss_pred             EEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeCCCC
Confidence            699999965 899888754  899999999999999999999999999999999999987766  999999999875322


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc----C-------------
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG----F-------------  217 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~----~-------------  217 (385)
                        .......|++.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+.    .             
T Consensus       172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  248 (353)
T cd07850         172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEFMSRLQPTV  248 (353)
T ss_pred             --CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHHhhhhh
Confidence              2233456899999999999999999999999999999999999999754321 1111100    0             


Q ss_pred             ------CC------------------CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          218 ------SS------------------DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       218 ------~~------------------~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                            ..                  .....+...++.+++||.+||+.||++|||+.|+|+|||++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence                  00                  000002234677999999999999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.3e-42  Score=323.70  Aligned_cols=246  Identities=21%  Similarity=0.312  Sum_probs=201.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++.+.||+|+||+||+|.++. +..+|+|.+....  .+.+.+|+.++++++||||+++++++.....    ++++||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e   79 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRP----IYIVTE   79 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCC----cEEEEE
Confidence            58899999999999999998753 4569999887543  4567899999999999999999998755433    569999


Q ss_pred             ecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           80 YAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        80 y~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      |+++|+|.+++.. ...+++..+..++.||+.||+|||++|++|+||||+||+++.++.  +||+|||+++.........
T Consensus        80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC--VKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC--EEECCCccceecCCCceee
Confidence            9999999999975 446899999999999999999999999999999999999987665  9999999988653322212


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      .....++..|+|||++.+..++.++|||||||++|+|++ |+.||...... .....+. ....+..+...++.+++++.
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~li~  235 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-ETVEKVS-QGLRLYRPHLASEKVYAIMY  235 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-HHHHHHh-cCCCCCCCCCCCHHHHHHHH
Confidence            222335678999999998889999999999999999998 99999765432 2222222 22233345567899999999


Q ss_pred             HhhhcCCCCCCCHHHHHhC
Q 040569          238 KCLIRNPGERWSASELLEH  256 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~h  256 (385)
                      +||+.+|.+||++.+++.+
T Consensus       236 ~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         236 SCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHcCCCcccCCCHHHHHHh
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-42  Score=319.25  Aligned_cols=249  Identities=35%  Similarity=0.616  Sum_probs=213.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++.+.||+|++|.||++.++.+++.+|+|.+....     .+.+.+|+++++++.|||++++++++....    .+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~   76 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD----SLYI   76 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC----EEEE
Confidence            5899999999999999999999999999999886543     356789999999999999999998876543    2679


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      ++||+++++|.+++.....+++..+..++.|++.||.|||++|++||||||+||+++.++.  +||+|||++........
T Consensus        77 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          77 ILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV--VKLADFGVATKLNDVSK  154 (254)
T ss_pred             EEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCC--EEEeccccceecCCCcc
Confidence            9999999999999987778999999999999999999999999999999999999987655  99999999987643322


Q ss_pred             CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          157 DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                       ......|+..|+|||.+.+..++.++||||||+++++|++|+.||..... ........ ....+.++..+++.+.+++
T Consensus       155 -~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~i  231 (254)
T cd06627         155 -DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-MAALFRIV-QDDHPPLPEGISPELKDFL  231 (254)
T ss_pred             -cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHh-ccCCCCCCCCCCHHHHHHH
Confidence             12345689999999999888889999999999999999999999976543 23232322 2344556777899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHhCccc
Q 040569          237 SKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      .+||..+|++|||+.+++.||||
T Consensus       232 ~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         232 MQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHHhCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999996

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.8e-42  Score=320.18  Aligned_cols=249  Identities=29%  Similarity=0.514  Sum_probs=212.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|+..+.||+|+||.||++.+..+++.+|+|.+...     ....+.+|++++++++|||++++.+.+....    ..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~----~~~l   76 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKG----KLCI   76 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCC----EEEE
Confidence            689999999999999999999999999999988653     2356788999999999999999998876542    3669


Q ss_pred             EEeecCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           77 FLEYAPGGTLTDAIRS----GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~----~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      ++||+++++|.+++..    +..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.  ++|+|||++....
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~  154 (258)
T cd08215          77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLS  154 (258)
T ss_pred             EEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc--EEECCccceeecc
Confidence            9999999999999975    377999999999999999999999999999999999999987655  9999999998764


Q ss_pred             ccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHH
Q 040569          153 VNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA  232 (385)
Q Consensus       153 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  232 (385)
                      ... .......|++.|+|||.+.+..++.++|+||+|+++++|++|+.||.... ........ .....+.++..++.++
T Consensus       155 ~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~  231 (258)
T cd08215         155 STV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELALKI-LKGQYPPIPSQYSSEL  231 (258)
T ss_pred             cCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-HHHHHHHH-hcCCCCCCCCCCCHHH
Confidence            332 12234578999999999998889999999999999999999999997643 33333332 2334555666789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          233 QDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      .+++.+||..+|++|||+.++|+||||
T Consensus       232 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         232 RNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=5.4e-43  Score=328.52  Aligned_cols=249  Identities=33%  Similarity=0.550  Sum_probs=211.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALA-CPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|...+.||+|+||.||+|.++.+++.+|+|.+...      ....+.+|..+++++. ||||+++++++.....    +
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~----~   77 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEEN----L   77 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCce----E
Confidence            699999999999999999999999999999988642      1346778999999998 9999999988754432    6


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +++|||+++++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.  ++|+|||++......
T Consensus        78 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~  155 (280)
T cd05581          78 YFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPN  155 (280)
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEecCCccccccCCc
Confidence            799999999999999998878999999999999999999999999999999999999987665  999999998865432


Q ss_pred             CC-------------------CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh
Q 040569          155 ED-------------------DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI  215 (385)
Q Consensus       155 ~~-------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~  215 (385)
                      ..                   .......|+..|+|||++.+..++.++|+||||+++++|++|+.||..... ......+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~  234 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-YLTFQKI  234 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-HHHHHHH
Confidence            21                   122344678999999999888899999999999999999999999986543 2222222


Q ss_pred             cCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCH----HHHHhCccc
Q 040569          216 GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSA----SELLEHGFV  259 (385)
Q Consensus       216 ~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~----~elL~hp~~  259 (385)
                      .  .....++..+++.+.+||.+||+.+|.+|||+    .++|+||||
T Consensus       235 ~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         235 L--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             H--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            1  22334556679999999999999999999999    999999996

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=8.4e-43  Score=323.97  Aligned_cols=246  Identities=32%  Similarity=0.531  Sum_probs=204.3

Q ss_pred             eeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecC
Q 040569            9 IGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAP   82 (385)
Q Consensus         9 LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (385)
                      ||+|+||.||++.+..+++.+|+|.+....      .+.+.+|+++++++.||||+++++.+....    .+++++||++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~~~lv~e~~~   76 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK----NLYLVMEYLP   76 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc----EEEEEEecCC
Confidence            689999999999999999999999886532      346778999999999999999988765433    2679999999


Q ss_pred             CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC------
Q 040569           83 GGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED------  156 (385)
Q Consensus        83 ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~------  156 (385)
                      |++|.+++.+.+.+++..+..++.||++||.|||++|++|+||+|+||+++.++.  +||+|||++........      
T Consensus        77 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          77 GGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC--EEEEecccchhcccCcccccccc
Confidence            9999999987678999999999999999999999999999999999999988766  99999999876532211      


Q ss_pred             -CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCc--CCHHHH
Q 040569          157 -DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY--MSKQAQ  233 (385)
Q Consensus       157 -~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~s~~~~  233 (385)
                       .......+++.|+|||.+.+...+.++|+||||+++|+|++|..||.... .......+....  ...+..  ++..+.
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~  231 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-PEEIFQNILNGK--IEWPEDVEVSDEAI  231 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcCC--cCCCccccCCHHHH
Confidence             12234468899999999998889999999999999999999999997643 333333332211  222333  489999


Q ss_pred             HHHHHhhhcCCCCCCCH---HHHHhCccccccc
Q 040569          234 DFLSKCLIRNPGERWSA---SELLEHGFVKEQN  263 (385)
Q Consensus       234 ~ll~~cL~~dP~~Rps~---~elL~hp~~~~~~  263 (385)
                      +|+.+||+.+|.+|||+   .++|+||||+..+
T Consensus       232 ~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~  264 (265)
T cd05579         232 DLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID  264 (265)
T ss_pred             HHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence            99999999999999999   9999999997653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.7e-42  Score=326.25  Aligned_cols=249  Identities=24%  Similarity=0.306  Sum_probs=202.4

Q ss_pred             CceeeceeeccCceEEEEEEECC-----CCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNR-----SSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|++.+.||+|+||+||+|.+..     ++..+|+|.+....    ...+.+|+.++++++||||+++++++.....   
T Consensus         7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---   83 (277)
T cd05036           7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP---   83 (277)
T ss_pred             HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC---
Confidence            48889999999999999999987     78899999886432    2457789999999999999999998766543   


Q ss_pred             EEEEEEeecCCCCHHHHHHcCC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCC-CCeEEee
Q 040569           73 LYNLFLEYAPGGTLTDAIRSGT-------CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE-QGAKIAD  144 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~~-------~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~-~~~kL~D  144 (385)
                       ++++|||++|++|.+++...+       .+++..+..++.||+.||+|||++|++||||||+||+++.++. ..+||+|
T Consensus        84 -~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          84 -RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             -cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence             568999999999999997432       4889999999999999999999999999999999999986543 2379999


Q ss_pred             cCceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCC
Q 040569          145 FGCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTP  222 (385)
Q Consensus       145 FG~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  222 (385)
                      ||+++........ ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...... .....+ .....+
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-~~~~~~-~~~~~~  240 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-EVMEFV-TGGGRL  240 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHH-HcCCcC
Confidence            9999865221111 1112233567999999998999999999999999999997 99999764332 222222 223344


Q ss_pred             CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          223 EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       223 ~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ..+..++..+.+|+.+||+++|++|||+.++++|
T Consensus       241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            5567789999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.5e-42  Score=328.01  Aligned_cols=254  Identities=35%  Similarity=0.567  Sum_probs=211.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      .|+..+.||+|+||.||+|.++.++..+|+|.+....  .+.+.+|++++++++||||+++++.+.....    .++++|
T Consensus        20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~lv~e   95 (286)
T cd06614          20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDE----LWVVME   95 (286)
T ss_pred             cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCE----EEEEEe
Confidence            4778899999999999999999899999999987654  5677899999999999999999998776533    679999


Q ss_pred             ecCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           80 YAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        80 y~~ggsL~~~l~~~~-~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      |++|++|.+++.... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++.  +||+|||++........ .
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~-~  172 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKS-K  172 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC--EEECccchhhhhccchh-h
Confidence            999999999998655 7999999999999999999999999999999999999987665  99999998875532211 2


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCC-CCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSD-TPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~ll~  237 (385)
                      .....|++.|+|||++.+..++.++|+|||||++|+|++|+.||..... ......+..... ....+..++..+++||.
T Consensus       173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  251 (286)
T cd06614         173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-LRALFLITTKGIPPLKNPEKWSPEFKDFLN  251 (286)
T ss_pred             hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence            2334588999999999988899999999999999999999999976433 333223221111 11122337899999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCccccccc
Q 040569          238 KCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      +||+.+|.+|||+.++++|||+....
T Consensus       252 ~~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         252 KCLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             HHhccChhhCcCHHHHhhChHhhccC
Confidence            99999999999999999999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1e-42  Score=334.46  Aligned_cols=246  Identities=22%  Similarity=0.318  Sum_probs=200.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcE----EEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEV----FAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~----~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|+..+.||+|+||+||+|++..+++.    +|+|.+....    .+.+.+|+.+++.+.||||+++++++....     
T Consensus         8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~-----   82 (316)
T cd05108           8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-----   82 (316)
T ss_pred             hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC-----
Confidence            689999999999999999998766664    8999886432    346778999999999999999999876532     


Q ss_pred             EEEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           74 YNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      .++++||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~  160 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLG  160 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc--EEEcccccccccc
Confidence            4589999999999999985 456899999999999999999999999999999999999987665  9999999998764


Q ss_pred             ccCCCC-CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          153 VNEDDE-GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       153 ~~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      ...... .....++..|||||++.+..++.++|||||||++|||++ |+.||.... ... +..+.........+...+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~-~~~-~~~~~~~~~~~~~~~~~~~  238 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASE-ISSILEKGERLPQPPICTI  238 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-HHH-HHHHHhCCCCCCCCCCCCH
Confidence            322211 112234678999999999999999999999999999998 999997642 222 2222222223334556789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ++.+++.+||..+|.+||++.+++.+
T Consensus       239 ~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         239 DVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-42  Score=323.10  Aligned_cols=246  Identities=28%  Similarity=0.446  Sum_probs=200.1

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEeccCCCH------HHHHHHHHHHH-hcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS------EFLQREQRILS-ALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~------~~~~~E~~il~-~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      ++.||+|+||.||+|.++.+++.+|+|.+.....      ..+..|..++. .+.||||+++++++.....    +++++
T Consensus         1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~----~~lv~   76 (260)
T cd05611           1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDY----LYLVM   76 (260)
T ss_pred             CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCe----EEEEE
Confidence            3679999999999999999999999998865321      12334555444 4589999999998765432    67999


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      ||++|++|.++++..+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.  +||+|||+++....     
T Consensus        77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~-----  149 (260)
T cd05611          77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH--LKLTDFGLSRNGLE-----  149 (260)
T ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEeecccceeccc-----
Confidence            99999999999997778999999999999999999999999999999999999987665  99999999886532     


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC--CCCCCCCCcCCHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS--SDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~ll  236 (385)
                      .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.... .......+...  ...+.....+++++.+|+
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  228 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET-PDAVFDNILSRRINWPEEVKEFCSPEAVDLI  228 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHhcccCCCCcccccCCHHHHHHH
Confidence            233468899999999988888999999999999999999999997643 33333332111  112233445799999999


Q ss_pred             HHhhhcCCCCCC---CHHHHHhCccccccc
Q 040569          237 SKCLIRNPGERW---SASELLEHGFVKEQN  263 (385)
Q Consensus       237 ~~cL~~dP~~Rp---s~~elL~hp~~~~~~  263 (385)
                      .+||.++|++||   +++|+|+||||...+
T Consensus       229 ~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         229 NRLLCMDPAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             HHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence            999999999999   557999999997653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.1e-42  Score=322.27  Aligned_cols=245  Identities=23%  Similarity=0.315  Sum_probs=200.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++.+.||+|+||+||+|... ++..+|+|.+....  .+.+.+|+.++++++||||+++++.+.....    .+++||
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e   81 (261)
T cd05072           7 SIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP----IYIITE   81 (261)
T ss_pred             HeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----cEEEEe
Confidence            5889999999999999999875 56778999876433  4678899999999999999999988654433    569999


Q ss_pred             ecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           80 YAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        80 y~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |+++|+|.++++.  +..+++..+..++.||+.||+|||++|++||||||+||+++.++.  +||+|||++.........
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM--CKIADFGLARVIEDNEYT  159 (261)
T ss_pred             cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc--EEECCCccceecCCCcee
Confidence            9999999999973  456899999999999999999999999999999999999987665  899999999876432222


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      ......++..|+|||++.+..++.++|||||||++|+|++ |+.||.... .......+.... ....+..++.++.+|+
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~li  237 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS-NSDVMSALQRGY-RMPRMENCPDELYDIM  237 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC-HHHHHHHHHcCC-CCCCCCCCCHHHHHHH
Confidence            2223345678999999998889999999999999999998 999997643 333333332222 2223445889999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 040569          237 SKCLIRNPGERWSASELLE  255 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~  255 (385)
                      .+||..+|++||+++++++
T Consensus       238 ~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         238 KTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHccCCcccCcCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.4e-42  Score=326.54  Aligned_cols=246  Identities=24%  Similarity=0.362  Sum_probs=202.4

Q ss_pred             CceeeceeeccCceEEEEEEECC-----CCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNR-----SSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|.+.+.||+|+||.||+|.+..     +++.+|+|.+....    .+.+.+|+++|+++.||||+++++++.....   
T Consensus         6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---   82 (280)
T cd05049           6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP---   82 (280)
T ss_pred             HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC---
Confidence            47889999999999999998753     46889999886432    3567899999999999999999998766543   


Q ss_pred             EEEEEEeecCCCCHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCC
Q 040569           73 LYNLFLEYAPGGTLTDAIRSG--------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQ  138 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~--------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~  138 (385)
                       .+++|||++|++|.+++...              ..+++..+..++.||+.||.|||++|++||||||+||+++.++. 
T Consensus        83 -~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~-  160 (280)
T cd05049          83 -PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV-  160 (280)
T ss_pred             -eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe-
Confidence             67999999999999999743              24788999999999999999999999999999999999987765 


Q ss_pred             CeEEeecCceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhc
Q 040569          139 GAKIADFGCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIG  216 (385)
Q Consensus       139 ~~kL~DFG~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~  216 (385)
                       +||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.... .......+.
T Consensus       161 -~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~-~~~~~~~~~  238 (280)
T cd05049         161 -VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS-NEEVIECIT  238 (280)
T ss_pred             -EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHH
Confidence             99999999986532211 11223346788999999999999999999999999999998 999997643 333333332


Q ss_pred             CCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          217 FSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       217 ~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                       ....+..+..++..+++|+.+||++||.+||++.|+++
T Consensus       239 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         239 -QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             -cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence             23334455678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=8.2e-43  Score=329.90  Aligned_cols=250  Identities=28%  Similarity=0.417  Sum_probs=201.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcC-CCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALA-CPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|...+.||+|+||+||++.++.+++.+|+|.+....    ...+.+|+.++.++. ||||+++++++.....    .++
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~----~~~   80 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD----CWI   80 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc----EEE
Confidence            4677889999999999999999999999999886532    345678999999995 9999999998765433    558


Q ss_pred             EEeecCCCCHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569           77 FLEYAPGGTLTDAIR-----SGTCLEEGRIRSHTRAVLLGLQYLHSN-GIVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~-----~~~~l~e~~~~~i~~qil~gL~yLH~~-givHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                      +|||+.+ +|.++..     ....+++..+..++.|++.||+|||+. |++||||||+||+++.++.  +||+|||+++.
T Consensus        81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~  157 (288)
T cd06616          81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQ  157 (288)
T ss_pred             EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc--EEEeecchhHH
Confidence            9999864 6655432     346799999999999999999999975 9999999999999987665  99999999976


Q ss_pred             ecccCCCCCCccccCCcccChhhhcCC---CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCC---
Q 040569          151 ARVNEDDEGKPICGTPICMAPEVARGE---EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI---  224 (385)
Q Consensus       151 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---  224 (385)
                      .....  ......|++.|+|||++.+.   .++.++|||||||++|+|++|+.||.........+.++.. ...+.+   
T Consensus       158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~  234 (288)
T cd06616         158 LVDSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK-GDPPILSNS  234 (288)
T ss_pred             hccCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcC-CCCCcCCCc
Confidence            53221  12334689999999999776   6889999999999999999999999765443344333321 222222   


Q ss_pred             -CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          225 -PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       225 -~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                       +..++.++.+||.+||+++|.+|||++++++||||+.
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  272 (288)
T cd06616         235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD  272 (288)
T ss_pred             CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence             2347899999999999999999999999999999975

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-42  Score=321.91  Aligned_cols=247  Identities=22%  Similarity=0.309  Sum_probs=201.4

Q ss_pred             CceeeceeeccCceEEEEEEECCC---CcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRS---SEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~---~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++.+.||+|+||+||+|.++.+   ...+|+|.+....    ...+.+|+.++++++||||+++++.+.....    .
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~   80 (266)
T cd05033           5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP----V   80 (266)
T ss_pred             HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc----e
Confidence            589999999999999999998654   4689999886432    2456789999999999999999998755433    6


Q ss_pred             EEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      +++|||+++++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~  158 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLED  158 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC--EEECccchhhcccc
Confidence            689999999999999974 457899999999999999999999999999999999999987665  99999999987641


Q ss_pred             cCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHH
Q 040569          154 NEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQ  231 (385)
Q Consensus       154 ~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  231 (385)
                      .... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... .....+.. ......+...++.
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~  236 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-DVIKAVED-GYRLPPPMDCPSA  236 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-HHHHHHHc-CCCCCCCCCCCHH
Confidence            1111 1112235678999999999899999999999999999998 99999765332 23333322 2222345568999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          232 AQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      +.+|+.+||+.+|++||++.+++++
T Consensus       237 l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         237 LYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHHH
Confidence            9999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.9e-42  Score=319.52  Aligned_cols=246  Identities=26%  Similarity=0.443  Sum_probs=203.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+...      ..+.+.+|++++++++|+||+++++.+.....    ++
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~----~~   78 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNE----LN   78 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe----EE
Confidence            589999999999999999999999999999977531      24567899999999999999999998766432    67


Q ss_pred             EEEeecCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           76 LFLEYAPGGTLTDAIRS----GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~----~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      ++|||+++|+|.+++..    +..+++..+..++.||+.||.|||+.|++||||||+||+++.++.  ++|+|||++...
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~  156 (267)
T cd08224          79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFF  156 (267)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc--EEEeccceeeec
Confidence            99999999999999863    345899999999999999999999999999999999999987665  999999998865


Q ss_pred             cccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChH-HHHHHhcCCCCCCCCCC-cCC
Q 040569          152 RVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPI-SALHRIGFSSDTPEIPG-YMS  229 (385)
Q Consensus       152 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~-~~s  229 (385)
                      ..... ......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||....... .....+. ....+..+. ..+
T Consensus       157 ~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  234 (267)
T cd08224         157 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-KCDYPPLPADHYS  234 (267)
T ss_pred             cCCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh-cCCCCCCChhhcC
Confidence            43221 2233468999999999998889999999999999999999999996543222 2222221 222333333 678


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          230 KQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       230 ~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .++.++|.+||..+|++|||+.++++
T Consensus       235 ~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         235 EELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            89999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.4e-42  Score=325.58  Aligned_cols=250  Identities=28%  Similarity=0.426  Sum_probs=202.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++.+.||.|++|+||+|+++.+++.+|+|.+....    .+.+.+|+.++++++||||+++++++...+.    +++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~lv   76 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENK----LMLV   76 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc----EEEE
Confidence            6899999999999999999999999999999886532    3566789999999999999999998876544    6799


Q ss_pred             EeecCCCCHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           78 LEYAPGGTLTDAIRSG---TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~---~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      |||+++ +|.+++...   ..+++..+..++.||+.||+|||++|++||||||+||+++.++.  +||+|||++......
T Consensus        77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~  153 (284)
T cd07836          77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIP  153 (284)
T ss_pred             EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc--EEEeecchhhhhcCC
Confidence            999985 898888642   46899999999999999999999999999999999999987665  999999999765322


Q ss_pred             CCCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC----------------
Q 040569          155 EDDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF----------------  217 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~----------------  217 (385)
                      .. ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||...............                
T Consensus       154 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07836         154 VN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP  232 (284)
T ss_pred             cc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence            21 12334578999999998664 5688999999999999999999999765432221111000                


Q ss_pred             --CCCCC--------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          218 --SSDTP--------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       218 --~~~~~--------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                        ....+        .+...+++.++++|.+||++||.+||++.|+++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence              00000        0112357889999999999999999999999999997

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=348.00  Aligned_cols=242  Identities=25%  Similarity=0.378  Sum_probs=205.8

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      ..+++.||+|+||+||+|++.   -.||||.++...     .+.|++|+.+|++-+|.||+-|.|++....     +.||
T Consensus       394 v~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~-----~AIi  465 (678)
T KOG0193|consen  394 VLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP-----LAII  465 (678)
T ss_pred             hhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc-----eeee
Confidence            457899999999999999987   357999887543     467889999999999999999999976554     4689


Q ss_pred             EeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc-cC
Q 040569           78 LEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV-NE  155 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~-~~  155 (385)
                      +.+|+|-+|+.+++ ....|.....+.|++||++|+.|||.++|||||||..|||+.+++.  |||+|||++..... ..
T Consensus       466 TqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k--VkIgDFGLatvk~~w~g  543 (678)
T KOG0193|consen  466 TQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK--VKIGDFGLATVKTRWSG  543 (678)
T ss_pred             ehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc--EEEecccceeeeeeecc
Confidence            99999999999998 4456999999999999999999999999999999999999997766  99999999976432 33


Q ss_pred             CCCCCccccCCcccChhhhcCC---CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCC---CCCCCCcCC
Q 040569          156 DDEGKPICGTPICMAPEVARGE---EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSD---TPEIPGYMS  229 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~s  229 (385)
                      ........|...|||||+++.+   +|++.+|||||||++|||+||..||. ..+..+.+.+++.+..   ...+....+
T Consensus       544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~s~~p  622 (678)
T KOG0193|consen  544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIRSNCP  622 (678)
T ss_pred             ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchhhhccCH
Confidence            3344566789999999999754   68999999999999999999999998 5677777777765533   333445577


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          230 KQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       230 ~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .++++|+..||.+++++||.+.+||.
T Consensus       623 k~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  623 KAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHHHHhcCcccCccHHHHHH
Confidence            89999999999999999999999986

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3e-42  Score=324.48  Aligned_cols=247  Identities=21%  Similarity=0.317  Sum_probs=198.7

Q ss_pred             CceeeceeeccCceEEEEEEECC-----CCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNR-----SSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|++.+.||+|+||+||+|.++.     ++..+|+|.+....    ...+.+|+.+++.++||||+++++++.....   
T Consensus         7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~---   83 (277)
T cd05062           7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP---   83 (277)
T ss_pred             HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC---
Confidence            58899999999999999998652     35789999875432    2356789999999999999999988654433   


Q ss_pred             EEEEEEeecCCCCHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEE
Q 040569           73 LYNLFLEYAPGGTLTDAIRSG----------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKI  142 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~----------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL  142 (385)
                       .++||||+++|+|.+++.+.          ..++...+..++.|++.||.|||+.|++||||||+||+++.++.  +||
T Consensus        84 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~--~~l  160 (277)
T cd05062          84 -TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKI  160 (277)
T ss_pred             -eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC--EEE
Confidence             66899999999999999742          23567788999999999999999999999999999999987665  999


Q ss_pred             eecCceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCC
Q 040569          143 ADFGCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSD  220 (385)
Q Consensus       143 ~DFG~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  220 (385)
                      +|||+++........ ......+++.|||||++.+..++.++|||||||++|+|++ |..||..... ......+ ....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-~~~~~~~-~~~~  238 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-EQVLRFV-MEGG  238 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHH-HcCC
Confidence            999998764322111 1122346788999999999899999999999999999999 7899976533 2333222 2233


Q ss_pred             CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          221 TPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       221 ~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      .+..+...++.+++|+.+||+.+|++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            445566789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.7e-42  Score=326.02  Aligned_cols=253  Identities=21%  Similarity=0.301  Sum_probs=201.7

Q ss_pred             CceeeceeeccCceEEEEEEECC-----CCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNR-----SSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|++.+.||+|+||.||+|..+.     .+..+|+|.+....    ...+.+|+.+++.+.||||+++++++.....   
T Consensus         7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---   83 (288)
T cd05061           7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP---   83 (288)
T ss_pred             HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC---
Confidence            58999999999999999997652     35689999876433    2346689999999999999999998755443   


Q ss_pred             EEEEEEeecCCCCHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEE
Q 040569           73 LYNLFLEYAPGGTLTDAIRSG----------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKI  142 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~----------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL  142 (385)
                       .+++|||+++|+|.+++.+.          ..++...+..++.||+.||.|||++||+||||||+|||++.++.  +||
T Consensus        84 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~--~~L  160 (288)
T cd05061          84 -TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKI  160 (288)
T ss_pred             -cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc--EEE
Confidence             56999999999999999742          23456788999999999999999999999999999999987665  999


Q ss_pred             eecCceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCC
Q 040569          143 ADFGCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSD  220 (385)
Q Consensus       143 ~DFG~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  220 (385)
                      +|||+++........ ......++..|+|||.+.+..++.++|+|||||++|||++ |..||.... .......+ ....
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-~~~~~~~~-~~~~  238 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-NEQVLKFV-MDGG  238 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHH-HcCC
Confidence            999998865322111 1122345678999999998889999999999999999998 789997643 22332222 2333


Q ss_pred             CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh------Ccccccc
Q 040569          221 TPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE------HGFVKEQ  262 (385)
Q Consensus       221 ~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~------hp~~~~~  262 (385)
                      .+..+...++.+++++.+||+.||++|||+.++++      ||||...
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         239 YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence            44556667899999999999999999999999987      7777654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-42  Score=319.14  Aligned_cols=245  Identities=24%  Similarity=0.344  Sum_probs=200.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++.+.||+|++|.||+|.++ +++.+|+|.+....  .+.+.+|+.++++++||||+++++++.....    .+++||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e   81 (261)
T cd05068           7 SIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP----IYIVTE   81 (261)
T ss_pred             heeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCC----eeeeee
Confidence            4788999999999999999975 45789999886543  4678899999999999999999998655443    568999


Q ss_pred             ecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           80 YAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        80 y~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.  +||+|||+++........
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC--EEECCcceEEEccCCccc
Confidence            99999999999753  36899999999999999999999999999999999999987765  999999999876422211


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      ......++..|+|||++.+..++.++|||||||++|+|++ |+.||.... ....+..+... .....+...++.+.+++
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~li  237 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT-NAEVLQQVDQG-YRMPCPPGCPKELYDIM  237 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHcC-CCCCCCCcCCHHHHHHH
Confidence            1112223457999999999899999999999999999999 999997643 33333333222 22334556789999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 040569          237 SKCLIRNPGERWSASELLE  255 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~  255 (385)
                      .+||+.+|.+||++.++++
T Consensus       238 ~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         238 LDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHhhcCcccCCCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.8e-42  Score=336.40  Aligned_cols=249  Identities=27%  Similarity=0.345  Sum_probs=200.0

Q ss_pred             CceeeceeeccCceEEEEEEEC-----CCCcEEEEEeccCCC----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN-----RSSEVFAVKSAELSN----SEFLQREQRILSAL-ACPQIVAYKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~~AvK~~~~~~----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~   71 (385)
                      +|++++.||+|+||.||+|...     .+++.||+|.+....    .+.+.+|+.+++++ .||||+++++++.....  
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~--   85 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG--   85 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC--
Confidence            4889999999999999999753     345899999886432    23566899999999 89999999997764432  


Q ss_pred             EEEEEEEeecCCCCHHHHHHcC----------------------------------------------------------
Q 040569           72 ILYNLFLEYAPGGTLTDAIRSG----------------------------------------------------------   93 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~~----------------------------------------------------------   93 (385)
                       .++++|||+++|+|.+++...                                                          
T Consensus        86 -~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          86 -PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             -CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence             256899999999999998631                                                          


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC-CCCccccCCccc
Q 040569           94 ---TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD-EGKPICGTPICM  169 (385)
Q Consensus        94 ---~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~Gt~~y~  169 (385)
                         ..+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++........ ......++..||
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~--vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc--EEEeccccchhcccCcchhhccCCCCCcccc
Confidence               25788999999999999999999999999999999999987665  999999999875322211 122334677899


Q ss_pred             ChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCC
Q 040569          170 APEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERW  248 (385)
Q Consensus       170 aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rp  248 (385)
                      |||++.+..++.++|||||||++|+|++ |..||............+ .....+..+...++++.+++.+||+.+|.+||
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP  321 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL-KEGTRMRAPEYATPEIYSIMLDCWHNNPEDRP  321 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH-hccCCCCCCccCCHHHHHHHHHHccCChhhCc
Confidence            9999999999999999999999999998 999997643322222222 12233444566889999999999999999999


Q ss_pred             CHHHHHhC
Q 040569          249 SASELLEH  256 (385)
Q Consensus       249 s~~elL~h  256 (385)
                      ++.|+++|
T Consensus       322 s~~ell~~  329 (337)
T cd05054         322 TFSELVEI  329 (337)
T ss_pred             CHHHHHHH
Confidence            99999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.1e-42  Score=319.52  Aligned_cols=241  Identities=24%  Similarity=0.358  Sum_probs=196.0

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecC
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAP   82 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (385)
                      +.||+|+||+||+|+++.+++.+|+|.+....    ...+.+|++++++++||||+++++++.....    +++||||++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~   76 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP----IYIVMELVQ   76 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCC----eEEEEeecc
Confidence            47999999999999999999999999875332    3467889999999999999999998765443    679999999


Q ss_pred             CCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC-CC
Q 040569           83 GGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GK  160 (385)
Q Consensus        83 ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~-~~  160 (385)
                      +++|.+++.. +..+++..+..++.|++.||.|||++|++||||||+|||++.++.  +||+|||++.......... ..
T Consensus        77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV--LKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc--EEECccccCcccccccccccCC
Confidence            9999999974 456899999999999999999999999999999999999987665  9999999987643211111 11


Q ss_pred             ccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHh
Q 040569          161 PICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC  239 (385)
Q Consensus       161 ~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~c  239 (385)
                      ...++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ......+. .......+...+..+.+|+.+|
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~  232 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-QQTREAIE-QGVRLPCPELCPDAVYRLMERC  232 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-HHHHHHHH-cCCCCCCcccCCHHHHHHHHHH
Confidence            1123456999999999899999999999999999998 9999975432 22222222 2223345666899999999999


Q ss_pred             hhcCCCCCCCHHHHHh
Q 040569          240 LIRNPGERWSASELLE  255 (385)
Q Consensus       240 L~~dP~~Rps~~elL~  255 (385)
                      |+++|.+|||+.++++
T Consensus       233 l~~~p~~Rps~~~~~~  248 (252)
T cd05084         233 WEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             cCCChhhCcCHHHHHH
Confidence            9999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.1e-42  Score=325.74  Aligned_cols=246  Identities=24%  Similarity=0.374  Sum_probs=201.6

Q ss_pred             CceeeceeeccCceEEEEEEE-----CCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMS-----NRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|.+.+.||+|+||+||++..     ..++..+|+|.+....   .+.+.+|+.++++++||||+++++++.....    
T Consensus         6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----   81 (288)
T cd05093           6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP----   81 (288)
T ss_pred             HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc----
Confidence            588999999999999999985     3356779999886543   3467899999999999999999998765443    


Q ss_pred             EEEEEeecCCCCHHHHHHcCC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCe
Q 040569           74 YNLFLEYAPGGTLTDAIRSGT-------------CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGA  140 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~~-------------~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~  140 (385)
                      ++++|||+++++|.+++...+             .+++..+..++.||+.||+|||++|++||||||+|||++.++.  +
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~--~  159 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--V  159 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--E
Confidence            679999999999999997432             4899999999999999999999999999999999999987665  9


Q ss_pred             EEeecCceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCC
Q 040569          141 KIADFGCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFS  218 (385)
Q Consensus       141 kL~DFG~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~  218 (385)
                      ||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.... .......+. .
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~-~~~~~~~i~-~  237 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-NNEVIECIT-Q  237 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHH-c
Confidence            9999999986532211 11223346788999999999999999999999999999998 999997653 333333332 2


Q ss_pred             CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          219 SDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       219 ~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ...+..+...+.++.+|+.+||++||.+|||+.+++.
T Consensus       238 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         238 GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            2334455668899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.4e-42  Score=322.75  Aligned_cols=247  Identities=23%  Similarity=0.372  Sum_probs=203.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||.||+|+++.+++.+|||.+...      ....+.+|+.+++.+.||||+++++++.....    ++
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~----~~   78 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE----LN   78 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCe----EE
Confidence            588999999999999999999999999999977532      12466789999999999999999998766443    66


Q ss_pred             EEEeecCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           76 LFLEYAPGGTLTDAIRS----GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~----~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      ++|||++|++|.+++..    ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.  ++|+|||++...
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~  156 (267)
T cd08229          79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFF  156 (267)
T ss_pred             EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEECcchhhhcc
Confidence            99999999999999862    456899999999999999999999999999999999999987665  999999998865


Q ss_pred             cccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHhcCCCCCCCCCCcCCH
Q 040569          152 RVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADP-ISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       152 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      ..... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ......+......+..+...++
T Consensus       157 ~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08229         157 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE  235 (267)
T ss_pred             ccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccH
Confidence            43221 123446899999999999988999999999999999999999999654322 2222232222222233445889


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .+++|+.+||+.+|.+|||+.++++
T Consensus       236 ~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         236 ELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHHH
Confidence            9999999999999999999998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.8e-42  Score=322.44  Aligned_cols=244  Identities=24%  Similarity=0.324  Sum_probs=204.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|++++.||+|+||+||+|.++. +..+|+|.+....   ...+.+|+.+++.++||||+++++++.....    ++++|
T Consensus         7 ~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~lv~   81 (261)
T cd05148           7 EFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP----VYIIT   81 (261)
T ss_pred             HHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCC----eEEEE
Confidence            68899999999999999999987 8999999987543   3577899999999999999999988765543    67999


Q ss_pred             eecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           79 EYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        79 Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      ||+++++|.+++..  +..+++..+..++.||+.||.|||++|++||||||+||+++.++.  +||+|||.+........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVY  159 (261)
T ss_pred             eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce--EEEccccchhhcCCccc
Confidence            99999999999984  456899999999999999999999999999999999999987765  99999999976532211


Q ss_pred             CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          157 DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                       ......++..|+|||++.+..++.++||||||+++|+|++ |+.||.... .......+. ....+..+..+++.+.++
T Consensus       160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~  236 (261)
T cd05148         160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQIT-AGYRMPCPAKCPQEIYKI  236 (261)
T ss_pred             -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-HHHHHHHHH-hCCcCCCCCCCCHHHHHH
Confidence             1123345678999999998889999999999999999998 899997643 333333332 223344556789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHh
Q 040569          236 LSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~  255 (385)
                      +.+||++||.+|||+.++++
T Consensus       237 i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         237 MLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999976

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.8e-42  Score=327.30  Aligned_cols=251  Identities=25%  Similarity=0.390  Sum_probs=202.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++.+.||+|+||+||+|.++.+++.+|+|.+....     ...+.+|+.+++++.||||+++++++......  ..++
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~--~~~l   83 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLD--KIYM   83 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCC--cEEE
Confidence            5888999999999999999999999999999886432     23456899999999999999999987665322  3669


Q ss_pred             EEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |+||+++ +|.+++.. ...+++..+..++.||+.||+|||++|++|+||||+|||++.++.  +||+|||++.......
T Consensus        84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~  160 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSPL  160 (293)
T ss_pred             EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc--EEEeecCceeeccCCc
Confidence            9999975 99999874 445899999999999999999999999999999999999987665  9999999998764322


Q ss_pred             CCCCCccccCCcccChhhhcCCC-CCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc------------------
Q 040569          156 DDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG------------------  216 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~------------------  216 (385)
                       .......+++.|+|||.+.+.. ++.++|+||||+++++|++|.+||....... ...++.                  
T Consensus       161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchHHHHHhhccc
Confidence             1223345789999999987654 6889999999999999999999997643321 111110                  


Q ss_pred             -----------CCCCCCCCCCc-CCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          217 -----------FSSDTPEIPGY-MSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       217 -----------~~~~~~~~~~~-~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                                 .......++.. +++.+++||.+||+.+|++|||+.|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                       00001122333 58899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.2e-42  Score=325.26  Aligned_cols=247  Identities=19%  Similarity=0.278  Sum_probs=201.1

Q ss_pred             CceeeceeeccCceEEEEEEEC----CCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN----RSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~----~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|++.+.||+|+||+||+|...    .+++.+|+|.+....    ...+++|+.+++++.||||+++++++.....    
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----   81 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP----   81 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc----
Confidence            4788999999999999999853    456889999886422    2457889999999999999999998765543    


Q ss_pred             EEEEEeecCCCCHHHHHHcC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC
Q 040569           74 YNLFLEYAPGGTLTDAIRSG-----------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN  136 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~-----------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~  136 (385)
                      .+++|||+++++|.+++...                 ..+++..+..++.||+.||+|||++|++||||||+|||++.++
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence            67999999999999998522                 2378889999999999999999999999999999999998766


Q ss_pred             CCCeEEeecCceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHH
Q 040569          137 EQGAKIADFGCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHR  214 (385)
Q Consensus       137 ~~~~kL~DFG~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~  214 (385)
                      .  +||+|||+++....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.... .......
T Consensus       162 ~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-~~~~~~~  238 (283)
T cd05090         162 H--VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-NQEVIEM  238 (283)
T ss_pred             c--EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-HHHHHHH
Confidence            5  99999999986532221 11233346778999999998889999999999999999998 999997643 3333333


Q ss_pred             hcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          215 IGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       215 ~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      +.. ...+..+..+++.+++++.+||++||.+||++.+++++
T Consensus       239 ~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         239 VRK-RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            322 22344566789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.2e-42  Score=326.35  Aligned_cols=255  Identities=25%  Similarity=0.460  Sum_probs=209.6

Q ss_pred             CceeeceeeccCceEEEEEEEC---CCCcEEEEEeccCC-------CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCC
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN---RSSEVFAVKSAELS-------NSEFLQREQRILSAL-ACPQIVAYKGCDISEENG   70 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~---~~~~~~AvK~~~~~-------~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~   70 (385)
                      +|++.+.||+|+||.||+|.+.   .+|+.||+|.+...       ..+.+.+|+++|+++ +||||+++++++....  
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~--   78 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT--   78 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC--
Confidence            5899999999999999999875   47899999988642       135677899999999 6999999998765543  


Q ss_pred             eEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569           71 KILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus        71 ~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                        .+++|+||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+|||++.++.  +||+|||++..
T Consensus        79 --~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~  154 (290)
T cd05613          79 --KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKE  154 (290)
T ss_pred             --eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCC--EEEeeCcccee
Confidence              26699999999999999987778999999999999999999999999999999999999987765  99999999987


Q ss_pred             ecccCCCCCCccccCCcccChhhhcCC--CCCCCCChHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHhcCCCCCCCCC
Q 040569          151 ARVNEDDEGKPICGTPICMAPEVARGE--EQGFPADVWALGCTVLEMATGRPPWPDVADP---ISALHRIGFSSDTPEIP  225 (385)
Q Consensus       151 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~---~~~~~~~~~~~~~~~~~  225 (385)
                      .............|+..|+|||.+.+.  .++.++||||||+++|+|++|..||......   ......+  ....+.++
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~  232 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPYP  232 (290)
T ss_pred             cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh--hccCCCCC
Confidence            643333333345689999999998753  4678999999999999999999999643221   1222221  12234456


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCcccccccc
Q 040569          226 GYMSKQAQDFLSKCLIRNPGERW-----SASELLEHGFVKEQNF  264 (385)
Q Consensus       226 ~~~s~~~~~ll~~cL~~dP~~Rp-----s~~elL~hp~~~~~~~  264 (385)
                      ..+++.+.+|+.+||..||.+||     ++.++++||||...++
T Consensus       233 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  276 (290)
T cd05613         233 QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW  276 (290)
T ss_pred             ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence            67899999999999999999997     8999999999987654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.4e-42  Score=320.50  Aligned_cols=244  Identities=24%  Similarity=0.360  Sum_probs=199.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++.+.||+|+||+||+|++..++ .+|+|.+...  ..+.+.+|++++++++||||+++++.+.. .  .  .++|||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~--~--~~lv~e   80 (262)
T cd05071           7 SLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E--P--IYIVTE   80 (262)
T ss_pred             HeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-C--C--cEEEEE
Confidence            5899999999999999999987654 5899988743  24678899999999999999999887532 2  1  569999


Q ss_pred             ecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           80 YAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        80 y~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |+++|+|.+++..  +..+++..+..++.|++.||+|||+.|++||||||+||+++.++.  +||+|||.++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYT  158 (262)
T ss_pred             cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc--EEeccCCceeeccccccc
Confidence            9999999999974  345899999999999999999999999999999999999987665  999999999876433222


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      ......++..|+|||++.+..++.++|||||||++|+|++ |..||..... ......+... .....+..++..+.+|+
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~l~~li  236 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERG-YRMPCPPECPESLHDLM  236 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh-HHHHHHHhcC-CCCCCccccCHHHHHHH
Confidence            2223346778999999998899999999999999999999 8889976533 2333333222 22233456889999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 040569          237 SKCLIRNPGERWSASELLE  255 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~  255 (385)
                      .+||+++|++||++.++++
T Consensus       237 ~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         237 CQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHccCCcccCCCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.5e-42  Score=319.00  Aligned_cols=244  Identities=25%  Similarity=0.344  Sum_probs=199.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++.+.||+|+||+||+|.++ .+..+|+|.+...  ..+.+.+|+.++++++||||+++++++.. .  .  .+++||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~--~--~~lv~e   80 (260)
T cd05070           7 SLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-E--P--IYIVTE   80 (260)
T ss_pred             HhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC-C--C--cEEEEE
Confidence            5889999999999999999876 5667899988643  34678899999999999999999987532 2  2  459999


Q ss_pred             ecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           80 YAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        80 y~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |+++++|.+++..  ...+++..+..++.|++.||.|||++|++||||||+||+++.++.  +||+|||++.........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~--~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV--CKIADFGLARLIEDNEYT  158 (260)
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce--EEeCCceeeeeccCcccc
Confidence            9999999999974  345899999999999999999999999999999999999987655  899999999875432222


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      ......++..|+|||++.+..++.++||||||+++|+|++ |..||.... .......+.. ...+..+...+..+++|+
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~li  236 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-NREVLEQVER-GYRMPCPQDCPISLHELM  236 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHc-CCCCCCCCcCCHHHHHHH
Confidence            2222335667999999998889999999999999999999 899997643 3333333322 233445667899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 040569          237 SKCLIRNPGERWSASELLE  255 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~  255 (385)
                      .+||.++|++|||+.++++
T Consensus       237 ~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         237 LQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHcccCcccCcCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-42  Score=334.18  Aligned_cols=256  Identities=25%  Similarity=0.336  Sum_probs=202.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccC-CeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS----NSEFLQREQRILSALACPQIVAYKGCDISEEN-GKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~~~~~l   76 (385)
                      +|++.+.||+|+||+||+|+++.+|+.||+|.+...    ....+.+|+.++++++||||+++++++..... .....++
T Consensus         6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   85 (336)
T cd07849           6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI   85 (336)
T ss_pred             ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence            699999999999999999999999999999988532    12456689999999999999999987654321 2223568


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      ++||+.+ +|.+++..+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.......
T Consensus        86 v~e~~~~-~l~~~~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~  161 (336)
T cd07849          86 VQELMET-DLYKLIKTQ-HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPEHD  161 (336)
T ss_pred             Eehhccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEECcccceeecccccc
Confidence            9999975 888888654 5999999999999999999999999999999999999987666  99999999987533221


Q ss_pred             C--CCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh----c-------------
Q 040569          157 D--EGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI----G-------------  216 (385)
Q Consensus       157 ~--~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~----~-------------  216 (385)
                      .  ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ......+    +             
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
T cd07849         162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-LHQLNLILGVLGTPSQEDLNCIISL  240 (336)
T ss_pred             ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCCHHHHHHhhch
Confidence            1  1233578999999998754 4678999999999999999999999975321 1111100    0             


Q ss_pred             -------CCCCCCC-----CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          217 -------FSSDTPE-----IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       217 -------~~~~~~~-----~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                             .....+.     .....++++.+||.+||+.+|.+|||+.|+++||||...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence                   0000000     112357889999999999999999999999999999864

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.3e-42  Score=326.14  Aligned_cols=254  Identities=26%  Similarity=0.399  Sum_probs=201.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|+..+.||+|++|+||+|.++.+++.+|+|.+....     .+.+.+|+++++++.||||+++++++.....    +++
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~l   78 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR----LYL   78 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCe----EEE
Confidence            5899999999999999999999999999999886432     2567789999999999999999998765443    779


Q ss_pred             EEeecCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           77 FLEYAPGGTLTDAIRSGT--CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~--~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ||||++ ++|.+.+....  .+++..+..++.||+.||+|||++|++||||||+||+++.++ ..+||+|||++......
T Consensus        79 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~-~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         79 VFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT-NALKLADFGLARAFGIP  156 (294)
T ss_pred             EEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC-CEEEEcccccccccCCC
Confidence            999996 48888886433  358889999999999999999999999999999999998543 23899999999765322


Q ss_pred             CCCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC-CC-------------
Q 040569          155 EDDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF-SS-------------  219 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-~~-------------  219 (385)
                      . .......|++.|+|||++.+. .++.++|||||||++|+|++|++||............... ..             
T Consensus       157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (294)
T PLN00009        157 V-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP  235 (294)
T ss_pred             c-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence            1 112334578999999998764 5688999999999999999999999764332222111100 00             


Q ss_pred             ----CCCC--------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          220 ----DTPE--------IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       220 ----~~~~--------~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                          ..+.        ....+++++.+|+.+||+.+|.+||++.++++||||...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence                0000        123468899999999999999999999999999999753

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-42  Score=317.25  Aligned_cols=242  Identities=27%  Similarity=0.397  Sum_probs=204.3

Q ss_pred             ceeeccCceEEEEEEECCC---CcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            7 QTIGRGSTATVSIGMSNRS---SEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~---~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +.||+|+||.||+|.+...   +..+|+|.+....    .+.+.+|+++++.++||||+++++++....    .++++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~lv~e   76 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEE----PLYLVLE   76 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCC----ceEEEEE
Confidence            5799999999999999866   8999999887543    457789999999999999999999876533    2679999


Q ss_pred             ecCCCCHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569           80 YAPGGTLTDAIRSG---------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus        80 y~~ggsL~~~l~~~---------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                      |+++++|.+++...         ..+++..+..++.||+.||+|||++|++||||||+||+++.++.  +||+|||.+..
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~  154 (262)
T cd00192          77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV--VKISDFGLSRD  154 (262)
T ss_pred             eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc--EEEcccccccc
Confidence            99999999999864         77999999999999999999999999999999999999987765  99999999987


Q ss_pred             ecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcC
Q 040569          151 ARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYM  228 (385)
Q Consensus       151 ~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (385)
                      ...... .......+++.|+|||.+....++.++|||||||++|+|++ |..||... ........+.. ......+..+
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~-~~~~~~~~~~  232 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRK-GYRLPKPEYC  232 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHc-CCCCCCCccC
Confidence            643321 12334467889999999998889999999999999999999 69999875 33333333322 3445566778


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          229 SKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       229 s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      |+++.+++.+||+.+|.+|||+.|++++
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         233 PDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             ChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            9999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3e-42  Score=334.40  Aligned_cols=256  Identities=25%  Similarity=0.364  Sum_probs=205.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccC-CeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEEN-GKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~~~~~   75 (385)
                      +|.+.+.||+|+||+||+|++..+++.+|||.+...     ....+.+|+.+++.++||||+++++++..... .....+
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   85 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY   85 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence            589999999999999999999999999999987532     23456689999999999999999998754322 112367


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +++||+. ++|.+++...+.+++..+..++.||+.||.|||++|++||||||+||+++.++.  +||+|||+++......
T Consensus        86 lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~  162 (337)
T cd07858          86 IVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTSEKG  162 (337)
T ss_pred             EEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccCCCc
Confidence            9999996 699999988788999999999999999999999999999999999999987665  9999999998764321


Q ss_pred             CCCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHH--------------------
Q 040569          156 DDEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHR--------------------  214 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~--------------------  214 (385)
                       .......|+..|+|||++.+ ..++.++|||||||++|+|++|++||..... ......                    
T Consensus       163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07858         163 -DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITELLGSPSEEDLGFIRNEK  240 (337)
T ss_pred             -ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHHhhhcCchh
Confidence             22334568999999999865 4688999999999999999999999965321 110000                    


Q ss_pred             -------hcCCC--CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          215 -------IGFSS--DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       215 -------~~~~~--~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                             .....  ........+++++++||.+||+.+|.+|||+.++|+||||...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                   00000  0011123578999999999999999999999999999999754

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5.5e-42  Score=319.18  Aligned_cols=240  Identities=25%  Similarity=0.352  Sum_probs=197.4

Q ss_pred             ceeeccCceEEEEEEE--CCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            7 QTIGRGSTATVSIGMS--NRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~--~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +.||+|+||+||+|.+  +.++..+|+|.+....     .+.+.+|+.+++++.||||+++++++... .    +++|||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~----~~lv~e   75 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE-S----WMLVME   75 (257)
T ss_pred             CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-C----cEEEEe
Confidence            3699999999999964  5678999999886432     34678899999999999999999875322 1    568999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC--
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD--  157 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~--  157 (385)
                      |+++|+|.+++.....+++..+..++.|++.||+|||++|++||||||+||+++.++.  +||+|||+++........  
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~--~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY--AKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCe--EEECCCccccccCCCCCeee
Confidence            9999999999987778999999999999999999999999999999999999987655  999999999865332211  


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      ......+++.|+|||.+....++.++|||||||++|||++ |+.||... +.......+. ....+..|..+++++++||
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~i~-~~~~~~~~~~~~~~l~~li  231 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM-KGNEVTQMIE-SGERMECPQRCPPEMYDLM  231 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHH-CCCCCCCCCCCCHHHHHHH
Confidence            1122234678999999988889999999999999999998 99999764 3333444443 2334556777999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 040569          237 SKCLIRNPGERWSASELLE  255 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~  255 (385)
                      .+||++||++||++.++..
T Consensus       232 ~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         232 KLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHHhccCchhCcCHHHHHH
Confidence            9999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=8e-42  Score=318.39  Aligned_cols=244  Identities=24%  Similarity=0.372  Sum_probs=200.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++++.||+|+||.||+|..+ +++.+|+|.+....  .+.+.+|+.++++++||||+++++++.. ..    ++++||
T Consensus         7 ~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~----~~~v~e   80 (260)
T cd05067           7 TLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EP----IYIITE   80 (260)
T ss_pred             HceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEcc-CC----cEEEEE
Confidence            5889999999999999999865 57889999887533  4678899999999999999999987532 22    569999


Q ss_pred             ecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           80 YAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        80 y~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |+++++|.+++..  +..+++..+..++.|++.||+|||++|++||||||+||+++.++.  ++|+|||++.........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC--CKIADFGLARLIEDNEYT  158 (260)
T ss_pred             cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC--EEEccCcceeecCCCCcc
Confidence            9999999999873  446899999999999999999999999999999999999987665  999999999876422222


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      ......++..|+|||++.+..++.++||||||+++|+|++ |+.||...... .....+. .......+...+.++.+++
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~li  236 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-EVIQNLE-RGYRMPRPDNCPEELYELM  236 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-HHHHHHH-cCCCCCCCCCCCHHHHHHH
Confidence            2223346778999999999999999999999999999999 99999865432 3333322 2223345566889999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 040569          237 SKCLIRNPGERWSASELLE  255 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~  255 (385)
                      .+||+++|++||+++++++
T Consensus       237 ~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         237 RLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHccCChhhCCCHHHHHH
Confidence            9999999999999999876

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-42  Score=319.89  Aligned_cols=250  Identities=21%  Similarity=0.307  Sum_probs=201.9

Q ss_pred             ceeeceeeccCceEEEEEEECCC---CcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccC--CeE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRS---SEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEEN--GKI   72 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~---~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~~   72 (385)
                      |++++.||+|+||+||+|....+   +..+|+|.+....     .+.+.+|+.+++.++||||+++++++.....  ...
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            67899999999999999987653   4889999886432     2467889999999999999999987654332  223


Q ss_pred             EEEEEEeecCCCCHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecC
Q 040569           73 LYNLFLEYAPGGTLTDAIRS------GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG  146 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~------~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG  146 (385)
                      ..++++||+++|+|..++..      ...+++..+..++.|++.||.|||++|++||||||+||+++.++.  +||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT--VCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe--EEECCcc
Confidence            46689999999999999852      235899999999999999999999999999999999999987655  9999999


Q ss_pred             ceeeecccCCCC-CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCC
Q 040569          147 CARRARVNEDDE-GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEI  224 (385)
Q Consensus       147 ~a~~~~~~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  224 (385)
                      +++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||....+ ......+. ....+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-~~~~~~~~-~~~~~~~  236 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HEIYDYLR-HGNRLKQ  236 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHH-cCCCCCC
Confidence            998764322111 112235678999999988889999999999999999999 9999976543 33333332 2344556


Q ss_pred             CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          225 PGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       225 ~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      +...++++.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         237 PEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            77789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.4e-42  Score=318.14  Aligned_cols=247  Identities=31%  Similarity=0.476  Sum_probs=209.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++.+.||+|+||.||++.++.+++.+|+|.+....     ...+.+|++++++++||||+++++++....    .+++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~   76 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGN----KLCI   76 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCC----EEEE
Confidence            5899999999999999999999999999999886432     235668999999999999999998876542    2679


Q ss_pred             EEeecCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           77 FLEYAPGGTLTDAIRS----GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~----~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      |+||+++++|.+++..    +..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.  +||+|||++....
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~--~kl~d~g~~~~~~  154 (256)
T cd08530          77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL--VKIGDLGISKVLK  154 (256)
T ss_pred             EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc--EEEeeccchhhhc
Confidence            9999999999999865    456899999999999999999999999999999999999987655  9999999998764


Q ss_pred             ccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHH
Q 040569          153 VNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA  232 (385)
Q Consensus       153 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  232 (385)
                      ..   ......|++.|+|||.+.+..++.++|+||||+++++|++|+.||.... .......+ .....+..+..++.++
T Consensus       155 ~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~  229 (256)
T cd08530         155 KN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS-MQDLRYKV-QRGKYPPIPPIYSQDL  229 (256)
T ss_pred             cC---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHH-hcCCCCCCchhhCHHH
Confidence            33   2233468999999999999889999999999999999999999997653 33333333 2334455566789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          233 QDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      ++++.+||.++|.+|||+.++++||++
T Consensus       230 ~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         230 QNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=6.3e-42  Score=327.51  Aligned_cols=247  Identities=34%  Similarity=0.519  Sum_probs=203.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      .|+..+.||+|+||+||+|.+..+++.+|+|.+....      ...+.+|+++++.++||||+++++++.....    .+
T Consensus        16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~----~~   91 (307)
T cd06607          16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHT----AW   91 (307)
T ss_pred             hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCe----EE
Confidence            4788999999999999999999999999999875321      2357789999999999999999998876543    66


Q ss_pred             EEEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           76 LFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +|+||+.| +|.+++. ....+++..+..++.||+.||.|||+.|++||||+|+||+++.++.  +||+|||++..... 
T Consensus        92 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~~-  167 (307)
T cd06607          92 LVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVSP-  167 (307)
T ss_pred             EEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC--EEEeecCcceecCC-
Confidence            99999974 7777775 4557999999999999999999999999999999999999987765  99999999876532 


Q ss_pred             CCCCCCccccCCcccChhhhc---CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHH
Q 040569          155 EDDEGKPICGTPICMAPEVAR---GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQ  231 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  231 (385)
                          .....|++.|+|||++.   ...++.++||||||+++|+|++|+.||... +.......+.........+..++..
T Consensus       168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  242 (307)
T cd06607         168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNDSPTLSSNDWSDY  242 (307)
T ss_pred             ----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc-cHHHHHHHHhcCCCCCCCchhhCHH
Confidence                12346889999999984   356788999999999999999999999764 3333333332222222223347889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          232 AQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      ++++|.+||..+|.+||++.+++.|||+..
T Consensus       243 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  272 (307)
T cd06607         243 FRNFVDSCLQKIPQDRPSSEELLKHRFVLR  272 (307)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence            999999999999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.2e-42  Score=321.27  Aligned_cols=250  Identities=21%  Similarity=0.323  Sum_probs=199.3

Q ss_pred             ceeeceeeccCceEEEEEEECCCCc--EEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccC--CeEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSE--VFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEEN--GKIL   73 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~--~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~~~   73 (385)
                      +.+++.||+|+||.||+|.++.++.  .+|+|.+...     ..+.+.+|+.+++.++||||+++++.+.....  ....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4678999999999999999887775  5899987643     23467789999999999999999987643321  1223


Q ss_pred             EEEEEeecCCCCHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCc
Q 040569           74 YNLFLEYAPGGTLTDAIRS------GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGC  147 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~------~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~  147 (385)
                      .+++|||+++|+|.+++..      ...+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC--EEECCCCc
Confidence            5689999999999998741      234789999999999999999999999999999999999987665  99999999


Q ss_pred             eeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCC
Q 040569          148 ARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIP  225 (385)
Q Consensus       148 a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  225 (385)
                      ++........ ......+++.|+|||++.+..++.++|||||||++|+|++ |+.||.... .......+. ....+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~~~-~~~~~~~~  236 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE-NSEIYDYLR-QGNRLKQP  236 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHH-cCCCCCCC
Confidence            9875432211 1123346778999999999999999999999999999999 899997643 333333332 22333445


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          226 GYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       226 ~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ..++..++++|.+||++||.+|||+.+++++
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            5688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.4e-42  Score=322.54  Aligned_cols=245  Identities=22%  Similarity=0.324  Sum_probs=199.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcE----EEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEV----FAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~----~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|+..+.||+|+||+||+|.+..++..    ||+|.+....    ...+.+|..+++.+.||||+++++++....     
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----   82 (279)
T cd05109           8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTST-----   82 (279)
T ss_pred             heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCC-----
Confidence            588999999999999999998777764    7999876432    346778999999999999999999875432     


Q ss_pred             EEEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           74 YNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      .++++||+++|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+..++.  +||+|||+++...
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~  160 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLD  160 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCCCceeecc
Confidence            4489999999999999975 456999999999999999999999999999999999999986655  9999999998764


Q ss_pred             ccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          153 VNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       153 ~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      ..... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.... .......+. ....+..+...+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~~~~~~-~~~~~~~~~~~~~  238 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-AREIPDLLE-KGERLPQPPICTI  238 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHH-CCCcCCCCccCCH
Confidence            32221 1112235678999999998899999999999999999998 999997542 222222222 2233344566899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ++.+++.+||..||.+||++.++++
T Consensus       239 ~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         239 DVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-42  Score=320.77  Aligned_cols=246  Identities=22%  Similarity=0.312  Sum_probs=203.1

Q ss_pred             CceeeceeeccCceEEEEEEECCC-----CcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRS-----SEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|++.+.||+|+||.||+|.++..     +..+|+|.+....    ...+.+|+.+|+.++||||+++++++.....   
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~---   83 (277)
T cd05032           7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP---   83 (277)
T ss_pred             HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC---
Confidence            588999999999999999988654     4889999886443    2356789999999999999999998765533   


Q ss_pred             EEEEEEeecCCCCHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEE
Q 040569           73 LYNLFLEYAPGGTLTDAIRSG----------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKI  142 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~----------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL  142 (385)
                       .++||||+++|+|.+++...          ..+++..+..++.||+.||.|||++|++||||||+|||++.++.  +||
T Consensus        84 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~--~kl  160 (277)
T cd05032          84 -TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKI  160 (277)
T ss_pred             -cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--EEE
Confidence             66899999999999999632          23678899999999999999999999999999999999988766  999


Q ss_pred             eecCceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCC
Q 040569          143 ADFGCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSD  220 (385)
Q Consensus       143 ~DFG~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  220 (385)
                      +|||+++....... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||... +.......+. ...
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-~~~~~~~~~~-~~~  238 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL-SNEEVLKFVI-DGG  238 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC-CHHHHHHHHh-cCC
Confidence            99999876532221 12233457889999999988889999999999999999998 99999764 3333333333 344


Q ss_pred             CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          221 TPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       221 ~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .+..|...+.++.+|+.+||+.+|++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            55667778999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.1e-42  Score=327.12  Aligned_cols=255  Identities=27%  Similarity=0.392  Sum_probs=199.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccC----CeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEEN----GKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~----~~~   72 (385)
                      +|++.+.||+|+||+||+|+++.+++.+|||.+....     ...+.+|++++++++||||+++++++.....    ...
T Consensus        13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   92 (310)
T cd07865          13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG   92 (310)
T ss_pred             heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence            5899999999999999999999999999999875322     2345689999999999999999998765432    123


Q ss_pred             EEEEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           73 LYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      .+++||||+.+ +|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.  +||+|||++...
T Consensus        93 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~  169 (310)
T cd07865          93 SFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI--LKLADFGLARAF  169 (310)
T ss_pred             eEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc--EEECcCCCcccc
Confidence            45799999965 88888874 346899999999999999999999999999999999999987665  999999999865


Q ss_pred             cccCCC---CCCccccCCcccChhhhcCCC-CCCCCChHHHHHHHHHHHhCCCCCCCCCChHHH--HHHhcCCCC-----
Q 040569          152 RVNEDD---EGKPICGTPICMAPEVARGEE-QGFPADVWALGCTVLEMATGRPPWPDVADPISA--LHRIGFSSD-----  220 (385)
Q Consensus       152 ~~~~~~---~~~~~~Gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~--~~~~~~~~~-----  220 (385)
                      ......   ......++..|+|||++.+.. ++.++||||||+++|+|++|+.||.........  +..+.....     
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (310)
T cd07865         170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP  249 (310)
T ss_pred             cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            432221   122345788999999987654 688999999999999999999999764322111  111100000     


Q ss_pred             ------------CCC----------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          221 ------------TPE----------IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       221 ------------~~~----------~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                                  .+.          .+...++.+++||.+||.+||.+|||++|+|+||||
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                        000          011236778999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1e-41  Score=321.77  Aligned_cols=248  Identities=22%  Similarity=0.323  Sum_probs=197.1

Q ss_pred             ceeeceeeccCceEEEEEE----ECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            3 WTRGQTIGRGSTATVSIGM----SNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~----~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      |+..+.||+|+||+||++.    ...++..+|+|.+....    .+.+.+|+++|+++.||||+++++++......  .+
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~--~~   83 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK--GL   83 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc--eE
Confidence            3889999999999998865    34578899999886532    35677899999999999999999986554332  35


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +++|||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+|||++.++.  +||+|||+++.....
T Consensus        84 ~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~  160 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEG  160 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc--EEEeecccccccCCc
Confidence            6999999999999999864 4999999999999999999999999999999999999987655  999999999865432


Q ss_pred             CCC--CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHH-------------HHhcCCC
Q 040569          155 EDD--EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISAL-------------HRIGFSS  219 (385)
Q Consensus       155 ~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~-------------~~~~~~~  219 (385)
                      ...  ......++..|+|||.+.+..++.++|||||||++|+|++|..||..........             .......
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG  240 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence            211  1122345677999999998889999999999999999999999986432211110             0000111


Q ss_pred             CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          220 DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       220 ~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ..+..+...+.++.+|+.+||+.+|++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            222345667899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=6.9e-42  Score=339.49  Aligned_cols=247  Identities=24%  Similarity=0.315  Sum_probs=198.4

Q ss_pred             CceeeceeeccCceEEEEEEECCC-----CcEEEEEeccCCC----HHHHHHHHHHHHhcC-CCCeeeeeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRS-----SEVFAVKSAELSN----SEFLQREQRILSALA-CPQIVAYKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~~AvK~~~~~~----~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~   71 (385)
                      +|++++.||+|+||+||+|.+...     +..||||.+....    .+.+.+|+++|+++. ||||+++++++.....  
T Consensus        38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~--  115 (400)
T cd05105          38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP--  115 (400)
T ss_pred             ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc--
Confidence            477899999999999999987433     3579999886432    356788999999995 9999999998765443  


Q ss_pred             EEEEEEEeecCCCCHHHHHHcC----------------------------------------------------------
Q 040569           72 ILYNLFLEYAPGGTLTDAIRSG----------------------------------------------------------   93 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~~----------------------------------------------------------   93 (385)
                        .+||||||++|+|.+++.+.                                                          
T Consensus       116 --~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         116 --IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             --eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence              67999999999999988631                                                          


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecC
Q 040569           94 --------------------------------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKD  135 (385)
Q Consensus        94 --------------------------------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~  135 (385)
                                                            ..+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~  273 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG  273 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence                                                  237788889999999999999999999999999999999876


Q ss_pred             CCCCeEEeecCceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 040569          136 NEQGAKIADFGCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALH  213 (385)
Q Consensus       136 ~~~~~kL~DFG~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~  213 (385)
                      +.  +||+|||+++....... .......+++.|||||++.+..++.++|||||||++|+|++ |..||...........
T Consensus       274 ~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~  351 (400)
T cd05105         274 KI--VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN  351 (400)
T ss_pred             CE--EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence            55  99999999986532221 11223356788999999999999999999999999999997 9999976533222222


Q ss_pred             HhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          214 RIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       214 ~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .+. ....+..+..++.++.+++.+||+.||++|||+.++.+
T Consensus       352 ~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         352 KIK-SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHh-cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            222 22234455668999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6.3e-42  Score=322.13  Aligned_cols=248  Identities=27%  Similarity=0.388  Sum_probs=196.8

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--C--HHHHHHHHHHHHhcC-CCCeeeeeeeeeeccCCeEEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--N--SEFLQREQRILSALA-CPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~--~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      |++.+.||+|+||.||+|.++.+++.+|+|.+...  .  .....+|+.+++++. ||||+++++++.+...+.  +++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~--~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGR--LALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCc--EEEE
Confidence            78899999999999999999999999999987642  1  123347899999985 999999999887653333  5699


Q ss_pred             EeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           78 LEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      +||+++ +|.+.+.. ...+++..+..++.||+.||.|||++|++||||||+||+++. +  .+||+|||+++...... 
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~--~~kl~dfg~~~~~~~~~-  153 (282)
T cd07831          79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D--ILKLADFGSCRGIYSKP-  153 (282)
T ss_pred             EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C--CeEEEecccccccccCC-
Confidence            999975 88888874 457899999999999999999999999999999999999987 4  39999999998763222 


Q ss_pred             CCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc---------------CC--
Q 040569          157 DEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG---------------FS--  218 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~---------------~~--  218 (385)
                       ......+++.|+|||++.. ..++.++|||||||++|+|++|..||...... .....+.               ..  
T Consensus       154 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         154 -PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL-DQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             -CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH-HHHHHHHHHcCCCCHHHHHhhccccc
Confidence             2233468999999998754 45788999999999999999999999764321 1111110               00  


Q ss_pred             --CCCC--------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          219 --SDTP--------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       219 --~~~~--------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                        ...+        .....++..+.+||.+||.++|.+||++.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence              0000        0112468999999999999999999999999999996

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.6e-42  Score=328.93  Aligned_cols=245  Identities=25%  Similarity=0.322  Sum_probs=197.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcE--EEEEeccCCC----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEV--FAVKSAELSN----SEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~--~AvK~~~~~~----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++.+.||+|+||+||+|.++.++..  +|+|.+....    ...+.+|+.++.++ +||||+++++++.....    +
T Consensus         8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~----~   83 (303)
T cd05088           8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY----L   83 (303)
T ss_pred             hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC----c
Confidence            588899999999999999999877754  5777665321    24577899999999 89999999998755433    6


Q ss_pred             EEEEeecCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCC
Q 040569           75 NLFLEYAPGGTLTDAIRSG----------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQ  138 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~----------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~  138 (385)
                      +++|||+++|+|.+++...                ..+++..+..++.||+.||+|||++|++||||||+|||++.++. 
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~-  162 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-  162 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc-
Confidence            7999999999999999743                25789999999999999999999999999999999999987665 


Q ss_pred             CeEEeecCceeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcC
Q 040569          139 GAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGF  217 (385)
Q Consensus       139 ~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~  217 (385)
                       +||+|||+++......  ......++..|+|||++.+..++.++|||||||++|+|+| |..||..... ......+. 
T Consensus       163 -~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~~~-  237 (303)
T cd05088         163 -AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLP-  237 (303)
T ss_pred             -EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-HHHHHHHh-
Confidence             9999999986432111  1112234667999999988889999999999999999998 9999975432 23232321 


Q ss_pred             CCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          218 SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       218 ~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      .......+...++++.+|+.+||+.+|++||++.++|.+
T Consensus       238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            222333455678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-41  Score=315.99  Aligned_cols=240  Identities=25%  Similarity=0.353  Sum_probs=197.0

Q ss_pred             ceeeccCceEEEEEEECCCC---cEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            7 QTIGRGSTATVSIGMSNRSS---EVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~---~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +.||+|+||.||+|+...++   ..+|+|.+....    .+.+.+|+.+++++.||||+++++++... .    +++|||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~----~~~v~e   75 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE-P----LMLVME   75 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC-c----eEEEEE
Confidence            57999999999999876555   889999887443    34677899999999999999999875422 1    568999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      |+++|+|.+++.....+++..+..++.|++.||+|||++|++||||||+|||++.++.  +||+|||+++..........
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc--EEeccccccceeecCCcccc
Confidence            9999999999987778999999999999999999999999999999999999987665  99999999987643322111


Q ss_pred             --CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          160 --KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       160 --~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                        ....++..|+|||.+.+..++.++|||||||++|+|++ |+.||..... ......+. .......+..++..++++|
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~l~~li  231 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-AEVIAMLE-SGERLPRPEECPQEIYSIM  231 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-HHHHHHHH-cCCcCCCCCCCCHHHHHHH
Confidence              11223567999999999999999999999999999998 9999976533 33333332 2233345667899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 040569          237 SKCLIRNPGERWSASELLE  255 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~  255 (385)
                      .+||.++|++||++.++++
T Consensus       232 ~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         232 LSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHhcCChhhCcCHHHHHH
Confidence            9999999999999999976

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-42  Score=324.16  Aligned_cols=248  Identities=30%  Similarity=0.452  Sum_probs=200.5

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      |++.+.||+|++|+||+|.++.+|+.||+|.+....     .+.+.+|++++++++|||++++++++....    ..+++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~----~~~iv   76 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN----KLYLV   76 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC----eEEEE
Confidence            778999999999999999999999999999886432     346778999999999999999999876543    26799


Q ss_pred             EeecCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           78 LEYAPGGTLTDAIRSGT--CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~--~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||++ ++|.+++....  .+++..+..++.||+.||+|||+++++||||+|+||+++.++.  +||+|||++.......
T Consensus        77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~  153 (283)
T cd07835          77 FEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA--LKLADFGLARAFGVPV  153 (283)
T ss_pred             EeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCc--EEEeecccccccCCCc
Confidence            99995 69999997554  6899999999999999999999999999999999999987655  9999999997653222


Q ss_pred             CCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc------------------
Q 040569          156 DDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG------------------  216 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~------------------  216 (385)
                      . ......+++.|+|||++.+. .++.++||||||+++|+|++|+.||...... ..+..+.                  
T Consensus       154 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         154 R-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             c-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhhhhhch
Confidence            1 12233578899999988764 4688999999999999999999999764322 1111110                  


Q ss_pred             -----CC----CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          217 -----FS----SDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       217 -----~~----~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                           +.    .........++..+.++|.+||+++|.+|||+.|+++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                 00    00111234477899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.3e-41  Score=322.62  Aligned_cols=247  Identities=23%  Similarity=0.295  Sum_probs=199.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCC----------------cEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSS----------------EVFAVKSAELSN----SEFLQREQRILSALACPQIVAYK   61 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~----------------~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~   61 (385)
                      +|++++.||+|+||.||+|.+..++                ..+|+|.+....    .+.+.+|++++++++||||++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~   85 (296)
T cd05051           6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL   85 (296)
T ss_pred             hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            6899999999999999999876544                568999887543    35677899999999999999999


Q ss_pred             eeeeeccCCeEEEEEEEeecCCCCHHHHHHcCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCE
Q 040569           62 GCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-----------CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNI  130 (385)
Q Consensus        62 ~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~~-----------~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NI  130 (385)
                      +++.....    ++++|||+++++|.+++....           .+++..+..++.|++.||+|||++|++||||||+||
T Consensus        86 ~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni  161 (296)
T cd05051          86 GVCTVDPP----LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC  161 (296)
T ss_pred             EEEecCCC----cEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence            98765533    668999999999999997544           689999999999999999999999999999999999


Q ss_pred             EeecCCCCCeEEeecCceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh--CCCCCCCCCC
Q 040569          131 LVSKDNEQGAKIADFGCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT--GRPPWPDVAD  207 (385)
Q Consensus       131 Li~~~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--G~~Pf~~~~~  207 (385)
                      +++.++.  ++|+|||+++....... .......+++.|||||++.+..++.++|||||||++|+|++  |..||.....
T Consensus       162 li~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         162 LVGKNYT--IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             eecCCCc--eEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            9987755  99999999986532221 11223456788999999998889999999999999999998  7788876433


Q ss_pred             hHHHHHHhcC------CCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          208 PISALHRIGF------SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       208 ~~~~~~~~~~------~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .. .+.....      .......+...+.++.+++.+||+.||.+|||+.|+++
T Consensus       240 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         240 QQ-VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HH-HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            22 2222211      11112234457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=8.2e-42  Score=325.00  Aligned_cols=249  Identities=31%  Similarity=0.514  Sum_probs=205.4

Q ss_pred             eeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            4 TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      .....||+|+||.||++.++.+++.+|+|.+....   ...+.+|+.+++.+.||||+++++.+...+.    .+++|||
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~e~   98 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE----LWVVMEF   98 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCE----EEEEEec
Confidence            34567999999999999999999999999876432   3467789999999999999999998766543    6799999


Q ss_pred             cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCC
Q 040569           81 APGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGK  160 (385)
Q Consensus        81 ~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~  160 (385)
                      +++++|.+++..+ .+++..+..++.|++.||+|||++|++||||||+||+++.++.  ++|+|||++....... ....
T Consensus        99 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~--~~l~dfg~~~~~~~~~-~~~~  174 (292)
T cd06657          99 LEGGALTDIVTHT-RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEV-PRRK  174 (292)
T ss_pred             CCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEcccccceeccccc-cccc
Confidence            9999999988654 5899999999999999999999999999999999999987765  9999999987654322 2223


Q ss_pred             ccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc--CCCCCCCCCCcCCHHHHHHHHH
Q 040569          161 PICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG--FSSDTPEIPGYMSKQAQDFLSK  238 (385)
Q Consensus       161 ~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~~ll~~  238 (385)
                      ...|++.|+|||.+.+..++.++|+||+|+++|+|++|..||... +.......+.  ...... ....+++.+.+++.+
T Consensus       175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~  252 (292)
T cd06657         175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-PPLKAMKMIRDNLPPKLK-NLHKVSPSLKGFLDR  252 (292)
T ss_pred             ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhhCCcccC-CcccCCHHHHHHHHH
Confidence            456899999999998888899999999999999999999999753 3333222221  111111 223478999999999


Q ss_pred             hhhcCCCCCCCHHHHHhCcccccc
Q 040569          239 CLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       239 cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ||+++|.+||++.++++||||...
T Consensus       253 ~l~~~P~~R~~~~~ll~~~~~~~~  276 (292)
T cd06657         253 LLVRDPAQRATAAELLKHPFLAKA  276 (292)
T ss_pred             HHhCCcccCcCHHHHhcChHHhcc
Confidence            999999999999999999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.2e-42  Score=324.66  Aligned_cols=247  Identities=24%  Similarity=0.340  Sum_probs=200.4

Q ss_pred             CceeeceeeccCceEEEEEEECCC-----CcEEEEEeccCCC----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRS-----SEVFAVKSAELSN----SEFLQREQRILSAL-ACPQIVAYKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~~AvK~~~~~~----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~   71 (385)
                      +|+..+.||+|+||.||++.++..     ...+|+|.+....    ...+.+|+.+++++ +||||+++++++.....  
T Consensus        13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~--   90 (293)
T cd05053          13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP--   90 (293)
T ss_pred             HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC--
Confidence            588899999999999999988644     3789999886432    23467899999999 89999999998755433  


Q ss_pred             EEEEEEEeecCCCCHHHHHHc----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecC
Q 040569           72 ILYNLFLEYAPGGTLTDAIRS----------------GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKD  135 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~----------------~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~  135 (385)
                        ++++|||+++|+|.+++..                ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus        91 --~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~  168 (293)
T cd05053          91 --LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED  168 (293)
T ss_pred             --eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence              6799999999999999953                3468899999999999999999999999999999999999876


Q ss_pred             CCCCeEEeecCceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 040569          136 NEQGAKIADFGCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALH  213 (385)
Q Consensus       136 ~~~~~kL~DFG~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~  213 (385)
                      +.  +||+|||+++........ ......++..|+|||++.+..++.++|||||||++|+|++ |..||.... ......
T Consensus       169 ~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~  245 (293)
T cd05053         169 HV--MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEELFK  245 (293)
T ss_pred             Ce--EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC-HHHHHH
Confidence            65  999999999865432211 1112235678999999998899999999999999999997 999997643 222222


Q ss_pred             HhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          214 RIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       214 ~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      .+ .....+..+...+..+.+|+.+||..||.+|||+.|++++
T Consensus       246 ~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         246 LL-KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HH-HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            22 2233445566788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=6.2e-42  Score=331.53  Aligned_cols=253  Identities=27%  Similarity=0.398  Sum_probs=201.8

Q ss_pred             ce-eeceeeccCceEEEEEEECCCCcEEEEEeccCCCH-----------------HHHHHHHHHHHhcCCCCeeeeeeee
Q 040569            3 WT-RGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----------------EFLQREQRILSALACPQIVAYKGCD   64 (385)
Q Consensus         3 y~-~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~-----------------~~~~~E~~il~~l~hpnIv~~~~~~   64 (385)
                      |. +.+.||+|+||+||+|+++.+++.+|+|.+.....                 ..+.+|++++++++||||+++++++
T Consensus        10 y~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   89 (335)
T PTZ00024         10 YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVY   89 (335)
T ss_pred             hhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEE
Confidence            44 45779999999999999999999999998754321                 1366899999999999999999987


Q ss_pred             eeccCCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEee
Q 040569           65 ISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIAD  144 (385)
Q Consensus        65 ~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~D  144 (385)
                      ....    ..+++|||+. |+|.+++.....+++..+..++.||+.||+|||++|++||||||+||+++.++.  +||+|
T Consensus        90 ~~~~----~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~d  162 (335)
T PTZ00024         90 VEGD----FINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIAD  162 (335)
T ss_pred             ecCC----cEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC--EEECC
Confidence            6544    2679999997 599999988778999999999999999999999999999999999999987765  99999


Q ss_pred             cCceeeecccC-------------CCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHH
Q 040569          145 FGCARRARVNE-------------DDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPIS  210 (385)
Q Consensus       145 FG~a~~~~~~~-------------~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~  210 (385)
                      ||++.......             ........+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||....+.. 
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-  241 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID-  241 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence            99998653110             1111233578899999999765 46889999999999999999999997654322 


Q ss_pred             HHHHhcC--C-CC-----------------------CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          211 ALHRIGF--S-SD-----------------------TPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       211 ~~~~~~~--~-~~-----------------------~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      .+..+..  . ..                       ........+.++.+||.+||+++|++|||++|+|.||||+...
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~  320 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP  320 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence            2211100  0 00                       0011224578899999999999999999999999999998653

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.4e-41  Score=320.69  Aligned_cols=245  Identities=22%  Similarity=0.293  Sum_probs=197.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcE----EEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEV----FAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~----~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|++.+.||+|+||+||+|.+..++..    +++|.+....    ...+.+|+.+++++.||||+++++++...   .  
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~---~--   82 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA---S--   82 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC---c--
Confidence            688999999999999999999877764    6778775332    23456788889999999999999975322   1  


Q ss_pred             EEEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           74 YNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      .++++||+++|+|.+++.. .+.+++..+..++.||+.||+|||++|++||||||+|||++.++.  +||+|||+++...
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~--~kl~Dfg~~~~~~  160 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI--VQIADFGVADLLY  160 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEEcCCccceecc
Confidence            4579999999999999974 567899999999999999999999999999999999999987655  9999999998753


Q ss_pred             ccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          153 VNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       153 ~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      ..... ......|+..|+|||++.+..++.++|||||||++|||++ |+.||.... .......+ .....+..+...+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-~~~~~~~~-~~~~~~~~~~~~~~  238 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR-PHEVPDLL-EKGERLAQPQICTI  238 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHH-HCCCcCCCCCCCCH
Confidence            22211 1233457778999999998899999999999999999998 999997643 22222222 22333444555788


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .+.+++.+||..+|.+|||+.|+++
T Consensus       239 ~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         239 DVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHHH
Confidence            9999999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-42  Score=327.56  Aligned_cols=253  Identities=28%  Similarity=0.382  Sum_probs=199.7

Q ss_pred             CceeeceeeccCceEEEEEEECC--CCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNR--SSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~--~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      .|++.+.||+|+||.||+|.++.  +++.+|+|.+....      .+.+.+|+.++++++||||+++++++......  .
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~--~   78 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADK--S   78 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCc--e
Confidence            48899999999999999999988  89999999887522      35677899999999999999999988765322  3


Q ss_pred             EEEEEeecCCCCHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeec----CCCCCeEEee
Q 040569           74 YNLFLEYAPGGTLTDAIRS-----GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSK----DNEQGAKIAD  144 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~-----~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~----~~~~~~kL~D  144 (385)
                      +++||||+++ +|.+++..     ...+++..++.++.||+.||.|||++||+||||||+||+++.    ++.  +||+|
T Consensus        79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~--~kl~D  155 (316)
T cd07842          79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGV--VKIGD  155 (316)
T ss_pred             EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccce--EEECC
Confidence            6699999975 77777642     236899999999999999999999999999999999999987    444  89999


Q ss_pred             cCceeeecccCC--CCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChH--------HHHH
Q 040569          145 FGCARRARVNED--DEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPI--------SALH  213 (385)
Q Consensus       145 FG~a~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--------~~~~  213 (385)
                      ||++........  .......+++.|+|||++.+. .++.++|||||||++++|++|++||.......        ..+.
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            999986532221  123345789999999998764 57889999999999999999999997543211        0000


Q ss_pred             H----hcC--------------------CCCCCCCC-----------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 040569          214 R----IGF--------------------SSDTPEIP-----------GYMSKQAQDFLSKCLIRNPGERWSASELLEHGF  258 (385)
Q Consensus       214 ~----~~~--------------------~~~~~~~~-----------~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~  258 (385)
                      .    +..                    .......+           ...+.++.++|.+||..||.+|||+.|+++|||
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~  315 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY  315 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence            0    000                    00001111           146788999999999999999999999999999


Q ss_pred             c
Q 040569          259 V  259 (385)
Q Consensus       259 ~  259 (385)
                      |
T Consensus       316 f  316 (316)
T cd07842         316 F  316 (316)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=7.1e-42  Score=322.66  Aligned_cols=247  Identities=19%  Similarity=0.256  Sum_probs=201.2

Q ss_pred             CceeeceeeccCceEEEEEEECCC-----CcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRS-----SEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|++.+.||+|+||+||+|.+..+     ++.+|+|.+....    .+.+.+|+.+++.++||||+++++++.....   
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~---   82 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP---   82 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc---
Confidence            477889999999999999987543     5789999987543    2457789999999999999999998765544   


Q ss_pred             EEEEEEeecCCCCHHHHHHc----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC
Q 040569           73 LYNLFLEYAPGGTLTDAIRS----------------GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN  136 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~----------------~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~  136 (385)
                       .++++||+++++|.+++..                ...+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus        83 -~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          83 -LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             -eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence             5689999999999999852                23478888999999999999999999999999999999998766


Q ss_pred             CCCeEEeecCceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHH
Q 040569          137 EQGAKIADFGCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHR  214 (385)
Q Consensus       137 ~~~~kL~DFG~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~  214 (385)
                      .  +||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||... ........
T Consensus       162 ~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~~~~  238 (283)
T cd05091         162 N--VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY-SNQDVIEM  238 (283)
T ss_pred             c--eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHH
Confidence            5  99999999886532221 11223346789999999998889999999999999999998 88899764 33333433


Q ss_pred             hcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          215 IGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       215 ~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      +. .......+..++..+.+|+.+||+++|.+||++.+++..
T Consensus       239 i~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         239 IR-NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HH-cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            32 233344567789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1e-41  Score=323.39  Aligned_cols=246  Identities=24%  Similarity=0.361  Sum_probs=201.7

Q ss_pred             CceeeceeeccCceEEEEEEEC-----CCCcEEEEEeccCCCH---HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN-----RSSEVFAVKSAELSNS---EFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~~AvK~~~~~~~---~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|...+.||+|+||.||+|.+.     .++..+++|.+.....   ..+++|++++++++||||+++++++.....    
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----   81 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP----   81 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc----
Confidence            5888999999999999999854     3456789998865443   468899999999999999999998765433    


Q ss_pred             EEEEEeecCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCC
Q 040569           74 YNLFLEYAPGGTLTDAIRSG----------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE  137 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~----------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~  137 (385)
                      .++||||+++++|.+++...                +.+++..+..++.||+.||+|||++|++||||||+|||++.++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence            67999999999999999743                23789999999999999999999999999999999999987665


Q ss_pred             CCeEEeecCceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHh
Q 040569          138 QGAKIADFGCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRI  215 (385)
Q Consensus       138 ~~~kL~DFG~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~  215 (385)
                        +||+|||++........ .......|++.|+|||++.+..++.++|||||||++|+|++ |+.||.... .......+
T Consensus       162 --~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-~~~~~~~~  238 (291)
T cd05094         162 --VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS-NTEVIECI  238 (291)
T ss_pred             --EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHH
Confidence              99999999976532221 11233457889999999999999999999999999999999 999997643 33333333


Q ss_pred             cCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          216 GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       216 ~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                       .....+..+...+..+.+++.+||+++|.+|||+.++++
T Consensus       239 -~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         239 -TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             -hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence             223344455668899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.5e-42  Score=330.87  Aligned_cols=257  Identities=26%  Similarity=0.353  Sum_probs=209.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeecc-CCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEE-NGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~~~~~   75 (385)
                      +|++.+.||+|++|.||+|++..+++.+|+|.+...     ..+.+.+|+.+++.++||||+++++++.... .....++
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            589999999999999999999999999999987642     2356788999999999999999999876654 1222367


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      ++|||+++ +|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++.++.  ++|+|||++.......
T Consensus        81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~--~~L~dfg~~~~~~~~~  157 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDE  157 (330)
T ss_pred             EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccCceEeecccc
Confidence            99999974 89999988778999999999999999999999999999999999999987755  9999999998764332


Q ss_pred             C--CCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC-------------
Q 040569          156 D--DEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS-------------  219 (385)
Q Consensus       156 ~--~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-------------  219 (385)
                      .  .......|++.|+|||++.+. .++.++|+|||||++|+|++|++||..... ......+....             
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~  236 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY-IDQLNLIVEVLGTPSEEDLKFITS  236 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHhcCCCChhHhhhccc
Confidence            1  123344689999999999887 789999999999999999999999976432 21111110000             


Q ss_pred             ----------------CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          220 ----------------DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       220 ----------------~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                      ........++.++.+||.+||+++|.+|||++++++||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence                            0001123368899999999999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.8e-41  Score=315.33  Aligned_cols=241  Identities=26%  Similarity=0.382  Sum_probs=199.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +|++.+.||+|+||+||++..+  +..+|+|.+.... .+.+.+|+.++++++|||++++++++.....   ..+++|||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~lv~e~   81 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG---GLYIVTEY   81 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC---ceEEEEEC
Confidence            5889999999999999999865  7889999886543 4567899999999999999999987654332   25689999


Q ss_pred             cCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           81 APGGTLTDAIRSGT--CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        81 ~~ggsL~~~l~~~~--~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      +++++|.++++..+  .+++..+..++.||+.||+|||++|++||||||+||+++.++.  +||+|||+++......   
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc--EEecCCccceeccccC---
Confidence            99999999997432  4889999999999999999999999999999999999987765  9999999988653221   


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                       ....++..|+|||++.+..++.++|||||||++|+|++ |+.||... +.......+. ....+..+..+++.+++|+.
T Consensus       157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~  233 (256)
T cd05082         157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVE-KGYKMDAPDGCPPVVYDVMK  233 (256)
T ss_pred             -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHh-cCCCCCCCCCCCHHHHHHHH
Confidence             22345678999999998889999999999999999998 99999754 3333333332 22344556678999999999


Q ss_pred             HhhhcCCCCCCCHHHHHh
Q 040569          238 KCLIRNPGERWSASELLE  255 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~  255 (385)
                      +||..+|++|||+.++++
T Consensus       234 ~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         234 QCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHhcCChhhCcCHHHHHH
Confidence            999999999999999976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.3e-42  Score=327.15  Aligned_cols=254  Identities=29%  Similarity=0.415  Sum_probs=199.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCC----eE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENG----KI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~----~~   72 (385)
                      +|++.+.||+|+||.||+|.++.+++.+|+|.+....     ...+.+|++++++++||||+++++++......    ..
T Consensus         9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   88 (311)
T cd07866           9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG   88 (311)
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence            6899999999999999999999999999999875321     23567899999999999999999887654321    23


Q ss_pred             EEEEEEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           73 LYNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      .+++++||+.+ +|...+. ....+++..+..++.||++||.|||++|++||||||+||+++.++.  +||+|||++...
T Consensus        89 ~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~  165 (311)
T cd07866          89 SVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLARPY  165 (311)
T ss_pred             eEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECcCccchhc
Confidence            46799999975 7777766 4557999999999999999999999999999999999999987766  999999999865


Q ss_pred             cccCCC----------CCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh-cCCC
Q 040569          152 RVNEDD----------EGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI-GFSS  219 (385)
Q Consensus       152 ~~~~~~----------~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~-~~~~  219 (385)
                      ......          ......|++.|+|||.+.+. .++.++|||||||++|+|++|++||...... .....+ ....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~~~~~~  244 (311)
T cd07866         166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLIFKLCG  244 (311)
T ss_pred             cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhC
Confidence            322211          11234578899999998654 5789999999999999999999999764332 211111 0000


Q ss_pred             C-----------CC---------CC-------CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          220 D-----------TP---------EI-------PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       220 ~-----------~~---------~~-------~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      .           .+         ..       ...+++.+.+||.+||..||.+|||+.|+++||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            0           00         00       02245788999999999999999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.9e-41  Score=316.10  Aligned_cols=244  Identities=23%  Similarity=0.345  Sum_probs=199.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|.+.+.||+|+||+||+|.+..++ .+|+|.+....  .+.+.+|+++++++.|||++++++++..  . .  .+++||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~-~--~~~v~e   80 (260)
T cd05069           7 SLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE--E-P--IYIVTE   80 (260)
T ss_pred             HeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC--C-C--cEEEEE
Confidence            4788999999999999999886554 58999876432  4567889999999999999999887532  1 1  458999


Q ss_pred             ecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           80 YAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        80 y~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |+++|+|.+++..  ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++.  +||+|||+++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNEYT  158 (260)
T ss_pred             cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe--EEECCCccceEccCCccc
Confidence            9999999999974  335789999999999999999999999999999999999987665  999999999876433222


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||....+ ......+.. ...+..+...+..+++|+
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~li  236 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-REVLEQVER-GYRMPCPQGCPESLHELM  236 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHc-CCCCCCCcccCHHHHHHH
Confidence            2223346778999999998899999999999999999999 9999987533 333333322 223344566889999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 040569          237 SKCLIRNPGERWSASELLE  255 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~  255 (385)
                      .+||.+||.+||+++++++
T Consensus       237 ~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         237 KLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHccCCcccCcCHHHHHH
Confidence            9999999999999999876

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.2e-41  Score=330.95  Aligned_cols=257  Identities=25%  Similarity=0.328  Sum_probs=201.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCe-------
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGK-------   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~-------   71 (385)
                      +|++.+.||.|+||+||+|.++.+++.+|+|.+....   .+.+.+|++++++++||||+++++++.......       
T Consensus         6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (342)
T cd07854           6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL   85 (342)
T ss_pred             ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence            5899999999999999999999999999999886533   456788999999999999999998765433211       


Q ss_pred             ---EEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCce
Q 040569           72 ---ILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA  148 (385)
Q Consensus        72 ---~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a  148 (385)
                         ..++++|||++ ++|.+++..+ .+++..++.++.||+.||.|||++||+||||||+||+++.++ ..+||+|||++
T Consensus        86 ~~~~~~~lv~e~~~-~~L~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~-~~~kl~dfg~~  162 (342)
T cd07854          86 TELNSVYIVQEYME-TDLANVLEQG-PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED-LVLKIGDFGLA  162 (342)
T ss_pred             cccceEEEEeeccc-ccHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-ceEEECCcccc
Confidence               23679999997 4999888754 599999999999999999999999999999999999997543 23799999999


Q ss_pred             eeecccCCC--CCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC--------
Q 040569          149 RRARVNEDD--EGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF--------  217 (385)
Q Consensus       149 ~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--------  217 (385)
                      +........  ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...............        
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (342)
T cd07854         163 RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED  242 (342)
T ss_pred             eecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            865321111  1122357889999998754 56788999999999999999999999754322221111000        


Q ss_pred             --------------CCCCC-----CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          218 --------------SSDTP-----EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       218 --------------~~~~~-----~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                                    ....+     .....++.++++||.+||+.||.+|||+.++|+||||+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         243 RNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             hhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence                          00000     112347889999999999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.5e-41  Score=318.92  Aligned_cols=248  Identities=23%  Similarity=0.326  Sum_probs=202.1

Q ss_pred             CceeeceeeccCceEEEEEEECC-----CCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNR-----SSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|+..+.||+|+||+||+|+.+.     +.+.+++|.+....    .+.+.+|++++++++||||+++++++.....   
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---   82 (275)
T cd05046           6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP---   82 (275)
T ss_pred             hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc---
Confidence            58899999999999999999754     35789999886543    2467899999999999999999997654432   


Q ss_pred             EEEEEEeecCCCCHHHHHHcCC---------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEe
Q 040569           73 LYNLFLEYAPGGTLTDAIRSGT---------CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIA  143 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~~---------~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~  143 (385)
                       .++||||+++|+|.+++....         .+++..+..++.||+.||+|||++||+||||||+|||++.++.  ++|+
T Consensus        83 -~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~  159 (275)
T cd05046          83 -HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVS  159 (275)
T ss_pred             -ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc--EEEc
Confidence             679999999999999998544         6899999999999999999999999999999999999987765  9999


Q ss_pred             ecCceeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCC
Q 040569          144 DFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTP  222 (385)
Q Consensus       144 DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  222 (385)
                      |||+++..............+++.|+|||.+.+...+.++||||||+++|+|++ |..||....+. .....+.......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-~~~~~~~~~~~~~  238 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-EVLNRLQAGKLEL  238 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-HHHHHHHcCCcCC
Confidence            999987543222223334457788999999988888999999999999999998 88999765332 3333332222222


Q ss_pred             CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          223 EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       223 ~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ..+..++..+.+++.+||..+|.+|||+.|++..
T Consensus       239 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         239 PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            2345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.5e-41  Score=320.62  Aligned_cols=246  Identities=24%  Similarity=0.359  Sum_probs=200.1

Q ss_pred             CceeeceeeccCceEEEEEEE-----CCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMS-----NRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|+..+.||+|+||+||++..     ..++..+|+|.+....   .+.+.+|++++++++||||+++++++.....    
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----   81 (280)
T cd05092           6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP----   81 (280)
T ss_pred             hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc----
Confidence            578899999999999999974     3357789999876543   3568899999999999999999988765443    


Q ss_pred             EEEEEeecCCCCHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCC
Q 040569           74 YNLFLEYAPGGTLTDAIRSG---------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQ  138 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~---------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~  138 (385)
                      ++++|||+++|+|.+++...               ..+++..+..++.||+.||+|||++|++||||||+|||++.++. 
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~-  160 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV-  160 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC-
Confidence            67999999999999999753               24789999999999999999999999999999999999987655 


Q ss_pred             CeEEeecCceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhc
Q 040569          139 GAKIADFGCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIG  216 (385)
Q Consensus       139 ~~kL~DFG~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~  216 (385)
                       +||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |.+||..... ......+.
T Consensus       161 -~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~~~~  238 (280)
T cd05092         161 -VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN-TEAIECIT  238 (280)
T ss_pred             -EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH-HHHHHHHH
Confidence             99999999976532211 11122345788999999999999999999999999999998 9999976433 23333332


Q ss_pred             CCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          217 FSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       217 ~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      . ...+..+..+++.+.+||.+||++||.+||++.++++
T Consensus       239 ~-~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         239 Q-GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             c-CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            2 2234455678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-41  Score=331.12  Aligned_cols=253  Identities=26%  Similarity=0.367  Sum_probs=204.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCC--eEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENG--KILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~--~~~~   74 (385)
                      +|++.+.||+|+||+||+|.+..++..||||.+....     .+.+.+|+.+|++++||||+++++++......  ...+
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07880          16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF   95 (343)
T ss_pred             ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence            5899999999999999999999999999999885421     24577899999999999999999987654321  1236


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||||+ |++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.  +||+|||++..... 
T Consensus        96 ~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~--~kl~dfg~~~~~~~-  170 (343)
T cd07880          96 YLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQTDS-  170 (343)
T ss_pred             EEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeccccccccc-
Confidence            7999999 7799988875 45999999999999999999999999999999999999987665  99999999986532 


Q ss_pred             CCCCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC--------------
Q 040569          155 EDDEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS--------------  219 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--------------  219 (385)
                         ......+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||.................              
T Consensus       171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07880         171 ---EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED  247 (343)
T ss_pred             ---CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh
Confidence               2233467999999999876 4578899999999999999999999976432211111100000              


Q ss_pred             --------------CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          220 --------------DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       220 --------------~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                    ....+...+++++.++|.+||++||.+|||+.+++.||||+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence                          0011224578899999999999999999999999999999865

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.3e-41  Score=315.53  Aligned_cols=239  Identities=23%  Similarity=0.334  Sum_probs=193.9

Q ss_pred             eeeccCceEEEEEEEC--CCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeec
Q 040569            8 TIGRGSTATVSIGMSN--RSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYA   81 (385)
Q Consensus         8 ~LG~G~~g~Vy~a~~~--~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (385)
                      .||+|+||.||+|.++  ..+..+|+|.+....    .+.+.+|+.++++++||||+++++++...     .+++||||+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~-----~~~lv~e~~   76 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE-----ALMLVMEMA   76 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC-----CeEEEEEeC
Confidence            4899999999999775  445679999886543    24577999999999999999999876322     256899999


Q ss_pred             CCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC--
Q 040569           82 PGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE--  158 (385)
Q Consensus        82 ~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~--  158 (385)
                      ++|+|.+++. ....+++..+..++.||+.||.|||++|++||||||+|||++.++.  +||+|||++..........  
T Consensus        77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--AKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc--EEeccCCccccccCCccceec
Confidence            9999999997 3557999999999999999999999999999999999999987655  9999999998653222211  


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      .....+++.|+|||++.+..++.++|||||||++|+|++ |..||..... ......+. ....+..+...++++.++|.
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~l~~li~  232 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-PEVMSFIE-QGKRLDCPAECPPEMYALMK  232 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-HHHHHHHH-CCCCCCCCCCCCHHHHHHHH
Confidence            111223578999999998889999999999999999996 9999976533 33333332 23345566778999999999


Q ss_pred             HhhhcCCCCCCCHHHHHh
Q 040569          238 KCLIRNPGERWSASELLE  255 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~  255 (385)
                      +||.++|++||++.++++
T Consensus       233 ~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         233 DCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.2e-41  Score=312.06  Aligned_cols=240  Identities=23%  Similarity=0.329  Sum_probs=196.3

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecC
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAP   82 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (385)
                      +.||+|+||.||+|... ++..+|+|.+....    ...+.+|+++++++.||||+++++++.....    +++||||++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~   75 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQP----IYIVMELVP   75 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCc----cEEEEECCC
Confidence            47999999999999865 68899999876532    2357789999999999999999998765443    669999999


Q ss_pred             CCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCCc
Q 040569           83 GGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP  161 (385)
Q Consensus        83 ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~~  161 (385)
                      +++|.+++.. ...+++..+..++.|++.+|.|||++|++||||||+||+++.++.  +||+|||++.............
T Consensus        76 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          76 GGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe--EEECCCccceeccccccccCCC
Confidence            9999999874 456899999999999999999999999999999999999987665  9999999997653222212222


Q ss_pred             cccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhh
Q 040569          162 ICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCL  240 (385)
Q Consensus       162 ~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL  240 (385)
                      ..+++.|+|||++.+..++.++||||||+++|+|++ |..||..... ......+. .......+..++..+.+|+.+||
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l  231 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-QQAREQVE-KGYRMSCPQKCPDDVYKVMQRCW  231 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHc
Confidence            234677999999998889999999999999999998 9999976533 23333332 22333455668999999999999


Q ss_pred             hcCCCCCCCHHHHHh
Q 040569          241 IRNPGERWSASELLE  255 (385)
Q Consensus       241 ~~dP~~Rps~~elL~  255 (385)
                      .++|.+||++.++++
T Consensus       232 ~~~p~~Rp~~~~l~~  246 (250)
T cd05085         232 DYKPENRPKFSELQK  246 (250)
T ss_pred             ccCcccCCCHHHHHH
Confidence            999999999999976

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-42  Score=352.33  Aligned_cols=249  Identities=26%  Similarity=0.384  Sum_probs=200.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH---HHHHHHHHHHHhcC-CCCeeeeeee-eeec--cCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS---EFLQREQRILSALA-CPQIVAYKGC-DISE--ENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~---~~~~~E~~il~~l~-hpnIv~~~~~-~~~~--~~~~~~~   74 (385)
                      ++++.+.|.+|||+.||+|.+...|..||+|++-..+.   ..+.+|+++|++|+ |||||.|++. ....  .++..-+
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            46789999999999999999998889999998865444   46779999999995 9999999993 3222  2223446


Q ss_pred             EEEEeecCCCCHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569           75 NLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNG--IVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~--~~~~l~e~~~~~i~~qil~gL~yLH~~g--ivHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                      .|+||||+||+|-|++.  -..+|+|.++.+|++|+++|+.+||..+  |||||||-+||||+.++.  .||||||.|..
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFGSatt  195 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFGSATT  195 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC--EEeCccccccc
Confidence            69999999999999997  3456999999999999999999999997  999999999999998876  99999999875


Q ss_pred             ecccCCCC--------CCccccCCcccChhhh---cCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC
Q 040569          151 ARVNEDDE--------GKPICGTPICMAPEVA---RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS  219 (385)
Q Consensus       151 ~~~~~~~~--------~~~~~Gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~  219 (385)
                      ........        .-...-|+.|+|||++   .+...+.|+|||+|||+||-||....||...... . +  +.-..
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-a-I--lng~Y  271 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-A-I--LNGNY  271 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-e-E--Eeccc
Confidence            43222110        0112359999999998   4667899999999999999999999999865321 1 1  11112


Q ss_pred             CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCc
Q 040569          220 DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHG  257 (385)
Q Consensus       220 ~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp  257 (385)
                      ..|.. ..+|..+++||+.||+.||.+||++.|++.+-
T Consensus       272 ~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~  308 (738)
T KOG1989|consen  272 SFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI  308 (738)
T ss_pred             cCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence            23333 24799999999999999999999999998753

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1e-41  Score=331.63  Aligned_cols=249  Identities=25%  Similarity=0.352  Sum_probs=199.5

Q ss_pred             CceeeceeeccCceEEEEEEE-----CCCCcEEEEEeccCCC----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMS-----NRSSEVFAVKSAELSN----SEFLQREQRILSAL-ACPQIVAYKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~   71 (385)
                      +|++++.||+|+||+||+|++     ..+++.||||.+....    ...+.+|+.+|.++ +||||+++++++.....  
T Consensus         8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~--   85 (343)
T cd05103           8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG--   85 (343)
T ss_pred             HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC--
Confidence            488999999999999999984     3567899999986532    23567899999999 78999999987754433  


Q ss_pred             EEEEEEEeecCCCCHHHHHHcC----------------------------------------------------------
Q 040569           72 ILYNLFLEYAPGGTLTDAIRSG----------------------------------------------------------   93 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~~----------------------------------------------------------   93 (385)
                       .++++|||+++|+|.+++...                                                          
T Consensus        86 -~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          86 -PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             -ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence             256899999999999998632                                                          


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC-CCCCccc
Q 040569           94 ---------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED-DEGKPIC  163 (385)
Q Consensus        94 ---------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~  163 (385)
                               ..++...+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||++........ .......
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc--EEEEecccccccccCcchhhcCCCC
Confidence                     23677788899999999999999999999999999999987665  99999999986532211 1112234


Q ss_pred             cCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhc
Q 040569          164 GTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIR  242 (385)
Q Consensus       164 Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~  242 (385)
                      +++.|+|||++.+..++.++|||||||++|+|++ |..||............+ .....+..|...++++.+++.+||+.
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~cl~~  321 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGTRMRAPDYTTPEMYQTMLDCWHG  321 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHH-hccCCCCCCCCCCHHHHHHHHHHccC
Confidence            5678999999998899999999999999999997 999997654333332222 22233445666889999999999999


Q ss_pred             CCCCCCCHHHHHhC
Q 040569          243 NPGERWSASELLEH  256 (385)
Q Consensus       243 dP~~Rps~~elL~h  256 (385)
                      +|.+|||+.++++|
T Consensus       322 ~p~~Rps~~eil~~  335 (343)
T cd05103         322 EPSQRPTFSELVEH  335 (343)
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.8e-41  Score=324.09  Aligned_cols=247  Identities=23%  Similarity=0.305  Sum_probs=199.4

Q ss_pred             CceeeceeeccCceEEEEEEE-----CCCCcEEEEEeccCCC----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMS-----NRSSEVFAVKSAELSN----SEFLQREQRILSAL-ACPQIVAYKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~   71 (385)
                      +|.+.+.||+|+||.||++.+     ..++..+|+|.+....    .+.+.+|+.+++++ +||||+++++++.....  
T Consensus        36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~--  113 (302)
T cd05055          36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP--  113 (302)
T ss_pred             HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc--
Confidence            578899999999999999975     3456689999886432    24578899999999 89999999998765543  


Q ss_pred             EEEEEEEeecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCcee
Q 040569           72 ILYNLFLEYAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR  149 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~  149 (385)
                        .+++|||+++|+|.+++...  ..+++..+..++.||+.||.|||++|++|+||||+|||++.++.  +||+|||+++
T Consensus       114 --~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~dfg~~~  189 (302)
T cd05055         114 --ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKI--VKICDFGLAR  189 (302)
T ss_pred             --eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCe--EEECCCcccc
Confidence              66999999999999999743  34899999999999999999999999999999999999986554  8999999998


Q ss_pred             eecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCc
Q 040569          150 RARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY  227 (385)
Q Consensus       150 ~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (385)
                      ........ ......+++.|+|||++.+..++.++|||||||++|+|++ |..||............+ .....+..+..
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~  268 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI-KEGYRMAQPEH  268 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH-HcCCcCCCCCC
Confidence            65322211 1122346788999999999999999999999999999998 999997654332222222 12222334556


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          228 MSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       228 ~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .++++.+|+.+||.++|++|||+.|+++
T Consensus       269 ~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         269 APAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            7899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2e-41  Score=317.22  Aligned_cols=246  Identities=20%  Similarity=0.282  Sum_probs=199.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCC---cEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSS---EVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~---~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++++.||+|+||.||+|.++.++   ..+|+|.+....    .+.+.+|+.++++++||||+++++++.....    .
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~   80 (267)
T cd05066           5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP----V   80 (267)
T ss_pred             HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc----c
Confidence            5889999999999999999986554   379999886432    3467889999999999999999998754432    6


Q ss_pred             EEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      +++|||++|++|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+|||++.++.  +||+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~~l~dfg~~~~~~~  158 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSRVLED  158 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCe--EEeCCCCccccccc
Confidence            689999999999999974 456899999999999999999999999999999999999987655  99999999987643


Q ss_pred             cCCCCC--CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          154 NEDDEG--KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       154 ~~~~~~--~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      ......  ....++..|+|||.+.+..++.++|+|||||++|+|++ |..||.... .......+... ..+..+..+++
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~-~~~~~~~~~~~-~~~~~~~~~~~  236 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS-NQDVIKAIEEG-YRLPAPMDCPA  236 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC-HHHHHHHHhCC-CcCCCCCCCCH
Confidence            222111  11223568999999998899999999999999999886 999997653 23333333222 22334456789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .+.+++.+||+++|.+||++.++++
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         237 ALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHHHcccCchhCCCHHHHHH
Confidence            9999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.4e-41  Score=313.24  Aligned_cols=245  Identities=28%  Similarity=0.397  Sum_probs=203.9

Q ss_pred             ceeeceeeccCceEEEEEEECCCC----cEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSS----EVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~----~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +++.+.||+|+||.||++.+..++    ..+|+|.+....    .+.+.+|+.+++.+.||||+++++++.....    +
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~   76 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP----L   76 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe----e
Confidence            467899999999999999998776    999999987543    4578899999999999999999998766532    6


Q ss_pred             EEEEeecCCCCHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           75 NLFLEYAPGGTLTDAIRSGTC--LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~--l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      +++|||+++++|.+++.....  +++..+..++.||+.||+|||++|++||||||+||+++.++.  ++|+|||++....
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~--~~l~dfg~~~~~~  154 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV--VKISDFGLSRDLY  154 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe--EEEcccCCceecc
Confidence            799999999999999985443  999999999999999999999999999999999999987765  9999999998764


Q ss_pred             ccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHH
Q 040569          153 VNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQ  231 (385)
Q Consensus       153 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  231 (385)
                      ...........+++.|+|||.+.+..++.++|||||||++++|++ |++||... +.......+. ....+..+...+.+
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~  232 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-SNEEVLEYLK-KGYRLPKPENCPPE  232 (258)
T ss_pred             cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHh-cCCCCCCCCcCCHH
Confidence            332222212337789999999988889999999999999999998 88998763 3333333332 22334455668999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          232 AQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      +.+++.+||..+|++|||+.|+++
T Consensus       233 ~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      233 IYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHCcCChhhCcCHHHHHh
Confidence            999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.2e-41  Score=359.01  Aligned_cols=248  Identities=25%  Similarity=0.289  Sum_probs=197.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+|.+..+++.||+|.+....      .+.+.+|+++++++.||||+++++++.....    .+
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~----ly   78 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDP----VY   78 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCE----EE
Confidence            6999999999999999999999999999999886431      2457789999999999999999988765432    66


Q ss_pred             EEEeecCCCCHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEee
Q 040569           76 LFLEYAPGGTLTDAIRSG-----------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIAD  144 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~-----------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~D  144 (385)
                      ++|||++||+|.+++...           ..++...+..++.||+.||+|||++||+||||||+|||++.++.  +||+|
T Consensus        79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--vKLiD  156 (932)
T PRK13184         79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILD  156 (932)
T ss_pred             EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC--EEEEe
Confidence            899999999999998631           23456678899999999999999999999999999999987766  99999


Q ss_pred             cCceeeecccCC-----------------CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCC
Q 040569          145 FGCARRARVNED-----------------DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVAD  207 (385)
Q Consensus       145 FG~a~~~~~~~~-----------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~  207 (385)
                      ||+++.......                 ......+||+.|||||++.+..++.++|||||||++|||+||+.||.....
T Consensus       157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~  236 (932)
T PRK13184        157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG  236 (932)
T ss_pred             cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence            999986521110                 011234699999999999999999999999999999999999999976322


Q ss_pred             hHHHHHHhcCCCCCC-CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          208 PISALHRIGFSSDTP-EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       208 ~~~~~~~~~~~~~~~-~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      . ............. .....+++.+.+++.+||..||++||+..+.+.+
T Consensus       237 ~-ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        237 R-KISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             h-hhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            1 1111111111111 1123578999999999999999999987766644

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7.5e-42  Score=330.29  Aligned_cols=250  Identities=24%  Similarity=0.340  Sum_probs=196.4

Q ss_pred             ceeecc--CceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            7 QTIGRG--STATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         7 ~~LG~G--~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      ..||+|  +||+||+|.+..+++.||+|.+....     .+.+++|+.+++.++||||+++++++.....    +++|+|
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~----~~~v~e   79 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW----LWVISP   79 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCc----eEEEEe
Confidence            467777  99999999999999999999886432     3567899999999999999999999876443    679999


Q ss_pred             ecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           80 YAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        80 y~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |+.+++|.+++.+.  ..+++..+..++.||+.||+|||++|++||||||+|||++.++.  +|++||+.+.........
T Consensus        80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~--~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL--VSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc--EEEechHHHhhhhccCcc
Confidence            99999999999853  35899999999999999999999999999999999999987665  999999865432111110


Q ss_pred             C------CCccccCCcccChhhhcCC--CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCC---------
Q 040569          158 E------GKPICGTPICMAPEVARGE--EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSD---------  220 (385)
Q Consensus       158 ~------~~~~~Gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~---------  220 (385)
                      .      .....++..|||||++.+.  .++.++|||||||++|+|++|+.||..................         
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP  237 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc
Confidence            0      1112356679999999764  4688999999999999999999999765433333222211000         


Q ss_pred             -----------------------------------CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          221 -----------------------------------TPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       221 -----------------------------------~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                                         ....+..+++.+++||++||+.||.+|||+.|+|+||||...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                                               000122356789999999999999999999999999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.5e-41  Score=323.41  Aligned_cols=245  Identities=23%  Similarity=0.320  Sum_probs=197.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCc--EEEEEeccCC-C---HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSE--VFAVKSAELS-N---SEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~--~~AvK~~~~~-~---~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++.+.||+|+||.||+|..+.++.  .+++|.+... .   .+.+.+|+.+++++ .||||+++++++.....    +
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~----~   78 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY----L   78 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc----c
Confidence            68999999999999999999887765  4688877532 1   24577899999999 79999999998755433    6


Q ss_pred             EEEEeecCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCC
Q 040569           75 NLFLEYAPGGTLTDAIRSG----------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQ  138 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~----------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~  138 (385)
                      ++++||+++|+|.+++...                ..+++..+..++.||+.||+|||++|++||||||+|||++.++. 
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~-  157 (297)
T cd05089          79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA-  157 (297)
T ss_pred             eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe-
Confidence            7999999999999999743                24788999999999999999999999999999999999987655 


Q ss_pred             CeEEeecCceeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcC
Q 040569          139 GAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGF  217 (385)
Q Consensus       139 ~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~  217 (385)
                       +||+|||++.......  .......+..|+|||++.+..++.++|||||||++|+|++ |..||... ........+. 
T Consensus       158 -~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~-~~~~~~~~~~-  232 (297)
T cd05089         158 -SKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM-TCAELYEKLP-  232 (297)
T ss_pred             -EEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHh-
Confidence             9999999986432111  1111223457999999998889999999999999999997 99999764 3333333332 


Q ss_pred             CCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          218 SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       218 ~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ....+..+..++..+++|+.+||+.+|.+|||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         233 QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            222344566789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.2e-41  Score=322.07  Aligned_cols=255  Identities=28%  Similarity=0.490  Sum_probs=206.9

Q ss_pred             CceeeceeeccCceEEEEEEEC---CCCcEEEEEeccCCC-------HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCC
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN---RSSEVFAVKSAELSN-------SEFLQREQRILSAL-ACPQIVAYKGCDISEENG   70 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~---~~~~~~AvK~~~~~~-------~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~   70 (385)
                      +|++.+.||+|+||+||++.+.   .+++.+|||.+....       .+.+.+|+.+++++ +||||+++++.+....  
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~--   78 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT--   78 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC--
Confidence            5899999999999999999864   467899999876321       24567899999999 6999999998765433  


Q ss_pred             eEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569           71 KILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus        71 ~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                        .+++||||+++|+|.+++.....+++..++.++.|++.||.|||+.|++||||||+||+++.++.  ++|+|||+++.
T Consensus        79 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~--~~l~dfg~~~~  154 (288)
T cd05583          79 --KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKE  154 (288)
T ss_pred             --EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEEECccccc
Confidence              26699999999999999987777999999999999999999999999999999999999987665  99999999887


Q ss_pred             ecccCCCCCCccccCCcccChhhhcCCC--CCCCCChHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHhcCCCCCCCCC
Q 040569          151 ARVNEDDEGKPICGTPICMAPEVARGEE--QGFPADVWALGCTVLEMATGRPPWPDVAD---PISALHRIGFSSDTPEIP  225 (385)
Q Consensus       151 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltG~~Pf~~~~~---~~~~~~~~~~~~~~~~~~  225 (385)
                      .............|++.|+|||.+.+..  .+.++|+||||+++|+|++|..||.....   .......+  ....+..+
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~  232 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI--LKSKPPFP  232 (288)
T ss_pred             cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH--HccCCCCC
Confidence            5433222233456899999999987765  68899999999999999999999964221   11111121  12234456


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCC---HHHHHhCcccccccc
Q 040569          226 GYMSKQAQDFLSKCLIRNPGERWS---ASELLEHGFVKEQNF  264 (385)
Q Consensus       226 ~~~s~~~~~ll~~cL~~dP~~Rps---~~elL~hp~~~~~~~  264 (385)
                      ..++..+++||.+||+.||++|||   +.++|+|||++...+
T Consensus       233 ~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         233 KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence            668899999999999999999998   567899999987654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.6e-41  Score=316.13  Aligned_cols=248  Identities=28%  Similarity=0.471  Sum_probs=204.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC--------CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL--------SNSEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~--------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      .|.+.+.||+|+||+||++++..++..+++|.+..        .....+.+|..++++++||||+++++.+.....    
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----   76 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDA----   76 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCc----
Confidence            48899999999999999999988777666665432        122356689999999999999999988765443    


Q ss_pred             EEEEEeecCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCcee
Q 040569           74 YNLFLEYAPGGTLTDAIR----SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR  149 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~----~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~  149 (385)
                      +++++||+++++|.+++.    .+..+++..+..++.|++.||.|||++|++|+||||+||+++. +  .+||+|||+++
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~--~~~l~d~g~~~  153 (260)
T cd08222          77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-N--LLKIGDFGVSR  153 (260)
T ss_pred             eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-C--CEeecccCcee
Confidence            679999999999999885    3456899999999999999999999999999999999999974 2  39999999998


Q ss_pred             eecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCC
Q 040569          150 RARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS  229 (385)
Q Consensus       150 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s  229 (385)
                      ...... .......|++.|+|||.+.+..++.++|+||||+++++|++|..||... ........+ .....+..+..++
T Consensus       154 ~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~  230 (260)
T cd08222         154 LLMGSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-NFLSVVLRI-VEGPTPSLPETYS  230 (260)
T ss_pred             ecCCCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHH-HcCCCCCCcchhc
Confidence            753222 2223456899999999998888899999999999999999999999754 333333333 2344556677789


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          230 KQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       230 ~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      .++.++|.+||..+|++||++.++++||||
T Consensus       231 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         231 RQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.8e-41  Score=322.59  Aligned_cols=254  Identities=29%  Similarity=0.400  Sum_probs=201.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccC------C
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEEN------G   70 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~------~   70 (385)
                      +|++.+.||+|+||+||+|.++.+++.+|+|.+....     ...+.+|++++++++||||+++++++.....      .
T Consensus         8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~   87 (302)
T cd07864           8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD   87 (302)
T ss_pred             hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence            6899999999999999999999999999999886432     2456789999999999999999998765441      1


Q ss_pred             eEEEEEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCcee
Q 040569           71 KILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR  149 (385)
Q Consensus        71 ~~~~~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~  149 (385)
                      ...+++++||+++ +|.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.  +||+|||++.
T Consensus        88 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~  164 (302)
T cd07864          88 KGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFGLAR  164 (302)
T ss_pred             CCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCcccccc
Confidence            1146799999986 77777764 446899999999999999999999999999999999999987665  9999999998


Q ss_pred             eecccCCCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC---CCCC---C
Q 040569          150 RARVNEDDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF---SSDT---P  222 (385)
Q Consensus       150 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~---~~~~---~  222 (385)
                      ..............++..|+|||++.+. .++.++|||||||++++|++|++||...... ..+..+..   ....   +
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  243 (302)
T cd07864         165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELISRLCGSPCPAVWP  243 (302)
T ss_pred             cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhhcc
Confidence            7643322222223468889999998654 5688999999999999999999999764332 22211100   0000   0


Q ss_pred             ----------------------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          223 ----------------------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       223 ----------------------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                                            .....++..+.++|.+||..+|.+|||+.+++.||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                  0122368999999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.8e-42  Score=349.48  Aligned_cols=254  Identities=21%  Similarity=0.205  Sum_probs=190.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCc-EEEEE------------------eccCC--CHHHHHHHHHHHHhcCCCCeeee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSE-VFAVK------------------SAELS--NSEFLQREQRILSALACPQIVAY   60 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~-~~AvK------------------~~~~~--~~~~~~~E~~il~~l~hpnIv~~   60 (385)
                      +|++++.||+|+||+||++..+.... ..++|                  .+...  ....+++|+.+|++++||||+++
T Consensus       149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l  228 (501)
T PHA03210        149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI  228 (501)
T ss_pred             ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence            59999999999999999987654322 22222                  11111  13457899999999999999999


Q ss_pred             eeeeeeccCCeEEEEEEEeecCCCCHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecC
Q 040569           61 KGCDISEENGKILYNLFLEYAPGGTLTDAIRSG-----TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKD  135 (385)
Q Consensus        61 ~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~-----~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~  135 (385)
                      ++++.....    .++++|++. ++|.+++..+     .......++.++.||+.||+|||++||+||||||+|||++.+
T Consensus       229 ~~~~~~~~~----~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        229 EEILRSEAN----TYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             eEEEEECCe----eEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence            998766543    568999985 5787777532     234567788999999999999999999999999999999877


Q ss_pred             CCCCeEEeecCceeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCC-CCCCCC-ChHHHHH
Q 040569          136 NEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRP-PWPDVA-DPISALH  213 (385)
Q Consensus       136 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~-Pf~~~~-~~~~~~~  213 (385)
                      +.  +||+|||+++.............+||+.|+|||++.+..++.++|||||||++|||++|.. ||.... +....+.
T Consensus       304 ~~--vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        304 GK--IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CC--EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            66  9999999998764333333345679999999999999999999999999999999999875 443221 2222221


Q ss_pred             HhcC--C---CCCC--------------------CC-----CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          214 RIGF--S---SDTP--------------------EI-----PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       214 ~~~~--~---~~~~--------------------~~-----~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      .+..  .   ...+                    .+     ...++.++.++|.+||++||.+|||+.|+|.||||...
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            1100  0   0000                    00     01256778889999999999999999999999999754

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.7e-41  Score=320.20  Aligned_cols=246  Identities=24%  Similarity=0.359  Sum_probs=198.8

Q ss_pred             CceeeceeeccCceEEEEEEECC-----CCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNR-----SSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|++.+.||+|+||+||+|.+..     ....+|+|.+....    .+.+.+|+.+++++.||||+++++.+.....   
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP---   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC---
Confidence            68899999999999999998753     23678999876432    2467789999999999999999998755433   


Q ss_pred             EEEEEEeecCCCCHHHHHHcC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 040569           73 LYNLFLEYAPGGTLTDAIRSG------------------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQ  128 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~------------------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~  128 (385)
                       .++++||+.+|+|.+++...                        ..+++..+..++.|++.||.|||++|++||||||+
T Consensus        78 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~  156 (290)
T cd05045          78 -LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR  156 (290)
T ss_pred             -cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence             56899999999999998632                        24788899999999999999999999999999999


Q ss_pred             CEEeecCCCCCeEEeecCceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCC
Q 040569          129 NILVSKDNEQGAKIADFGCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVA  206 (385)
Q Consensus       129 NILi~~~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~  206 (385)
                      |||++.++.  +||+|||+++........ ......++..|+|||++.+..++.++|||||||++++|++ |..||... 
T Consensus       157 nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-  233 (290)
T cd05045         157 NVLVAEGRK--MKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI-  233 (290)
T ss_pred             eEEEcCCCc--EEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC-
Confidence            999987655  999999999865322211 1223345778999999988889999999999999999998 99999764 


Q ss_pred             ChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          207 DPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .+........ .......+..++.++.+|+.+||+.+|.+||++.++++
T Consensus       234 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         234 APERLFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            3333333322 22233456678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.5e-41  Score=324.86  Aligned_cols=247  Identities=24%  Similarity=0.329  Sum_probs=199.0

Q ss_pred             CceeeceeeccCceEEEEEEECC-------CCcEEEEEeccCCC----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccC
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNR-------SSEVFAVKSAELSN----SEFLQREQRILSAL-ACPQIVAYKGCDISEEN   69 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~-------~~~~~AvK~~~~~~----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~   69 (385)
                      +|.+++.||+|+||+||+|++..       ++..+|+|.+....    ...+.+|+.+++++ +||||+++++++.....
T Consensus        19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   98 (307)
T cd05098          19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP   98 (307)
T ss_pred             HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            48899999999999999998643       23579999887532    23567899999999 79999999998765443


Q ss_pred             CeEEEEEEEeecCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEee
Q 040569           70 GKILYNLFLEYAPGGTLTDAIRSG----------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVS  133 (385)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~l~~~----------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~  133 (385)
                          +++||||+++|+|.+++...                ..++...+..++.||+.||+|||++|++||||||+|||++
T Consensus        99 ----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  174 (307)
T cd05098          99 ----LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  174 (307)
T ss_pred             ----eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence                66999999999999999743                2478889999999999999999999999999999999998


Q ss_pred             cCCCCCeEEeecCceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHH
Q 040569          134 KDNEQGAKIADFGCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISA  211 (385)
Q Consensus       134 ~~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~  211 (385)
                      .++.  +||+|||+++........ ......+++.|||||++.+..++.++|||||||++|+|++ |..||... .....
T Consensus       175 ~~~~--~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-~~~~~  251 (307)
T cd05098         175 EDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEEL  251 (307)
T ss_pred             CCCc--EEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-CHHHH
Confidence            7765  999999998765321111 1112234578999999999889999999999999999998 88999653 33333


Q ss_pred             HHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          212 LHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       212 ~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ...+ ........+...+.++++|+.+||..+|.+|||+.+++++
T Consensus       252 ~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         252 FKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHH-HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            3332 2233445666789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.6e-41  Score=328.99  Aligned_cols=254  Identities=31%  Similarity=0.421  Sum_probs=203.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC-----CCHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-----SNSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~-----~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||.||+|.++.+++.+|+|.+..     .....+.+|+.+++++ +||||+++++++.....  ..++
T Consensus         8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~--~~~~   85 (337)
T cd07852           8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND--KDIY   85 (337)
T ss_pred             HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC--ceEE
Confidence            58899999999999999999999999999997743     1234566899999999 99999999998755432  2356


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||+++ +|.+++..+ .+++..+..++.||+.||.|||++||+||||||+||+++.++.  +||+|||++.......
T Consensus        86 lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~~  161 (337)
T cd07852          86 LVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSELE  161 (337)
T ss_pred             EEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhcccccc
Confidence            99999975 999999866 7899999999999999999999999999999999999987766  9999999998654322


Q ss_pred             C----CCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh-cC------------
Q 040569          156 D----DEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI-GF------------  217 (385)
Q Consensus       156 ~----~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~-~~------------  217 (385)
                      .    .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ..++ ..            
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07852         162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAEDIESI  240 (337)
T ss_pred             ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHHH
Confidence            2    12233568999999998765 4578899999999999999999999975432211 1110 00            


Q ss_pred             ----------------CCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          218 ----------------SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       218 ----------------~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                      ..........++.++.+||.+||+.||.+|||+.++++|||++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                            000111122378999999999999999999999999999999865

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-41  Score=320.51  Aligned_cols=249  Identities=22%  Similarity=0.332  Sum_probs=198.4

Q ss_pred             ceeeceeeccCceEEEEEEE----CCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMS----NRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~----~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      |++.+.||+|+||+||+++.    +.++..+|+|.+....    .+.+.+|+.+++++.||||+++++++......  .+
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~--~~   83 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN--GI   83 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC--ce
Confidence            68899999999999999984    4678999999986432    35678999999999999999999987654222  25


Q ss_pred             EEEEeecCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIRSG-TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~-~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      ++||||++|++|.+++.+. ..+++..+..++.||+.||+|||++|++||||||+||+++.++.  +||+|||+++....
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~  161 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC--EEECCCcccccccc
Confidence            6999999999999999743 46899999999999999999999999999999999999987665  99999999986543


Q ss_pred             cCCC--CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCC--------------hHHHHHHhcC
Q 040569          154 NEDD--EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVAD--------------PISALHRIGF  217 (385)
Q Consensus       154 ~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~--------------~~~~~~~~~~  217 (385)
                      ....  ......|+..|+|||++.+..++.++|||||||++|+|++++.|+.....              .......+. 
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  240 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE-  240 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH-
Confidence            2211  12234577789999999888899999999999999999998776532111              011111111 


Q ss_pred             CCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          218 SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       218 ~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      .......+..+++.+.+|+.+||+++|.+|||+.+++++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            122233455689999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-41  Score=313.06  Aligned_cols=245  Identities=26%  Similarity=0.364  Sum_probs=201.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++.+.||+|+||+||+|.++ +++.+|+|.+...  ..+.+.+|+.++++++||||+++++++.....    ++++||
T Consensus         7 ~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~~v~e   81 (261)
T cd05034           7 SLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEP----IYIVTE   81 (261)
T ss_pred             heeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCc----eEEEEe
Confidence            5899999999999999999976 5578999988643  34678899999999999999999988654333    679999


Q ss_pred             ecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           80 YAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        80 y~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |+++++|.+++...  ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.  +||+|||++.........
T Consensus        82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLARLIEDDEYT  159 (261)
T ss_pred             ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC--EEECccccceeccchhhh
Confidence            99999999999743  46899999999999999999999999999999999999987765  999999999876432211


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      ......++..|+|||.+.+..++.++|+|||||++++|++ |+.||.... ....+..+.. ......+...+.++.+++
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~i  237 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT-NREVLEQVER-GYRMPRPPNCPEELYDLM  237 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHc-CCCCCCCCCCCHHHHHHH
Confidence            1122234668999999999899999999999999999998 999997643 3334444322 222333455689999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 040569          237 SKCLIRNPGERWSASELLE  255 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~  255 (385)
                      .+||+.+|.+||++.++++
T Consensus       238 ~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         238 LQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHcccCcccCCCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.4e-41  Score=315.15  Aligned_cols=246  Identities=25%  Similarity=0.332  Sum_probs=200.1

Q ss_pred             CceeeceeeccCceEEEEEEECCC---CcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRS---SEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~---~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++.+.||+|+||.||+|.+...   ...+|+|......    .+.+.+|+.+++++.||||+++++++....     .
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~   81 (270)
T cd05056           7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENP-----V   81 (270)
T ss_pred             hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCC-----c
Confidence            588999999999999999987544   4578999876433    346788999999999999999998765322     4


Q ss_pred             EEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      +++|||+++|+|.+++.. ...+++..+..++.||+.||+|||++|++||||||+||+++.++.  +||+|||+++....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~  159 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLED  159 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC--eEEccCceeeeccc
Confidence            589999999999999985 446899999999999999999999999999999999999987665  99999999987643


Q ss_pred             cCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHH
Q 040569          154 NEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA  232 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  232 (385)
                      ..........+++.|+|||.+....++.++|||||||++|+|++ |..||...... .....+.. ......+..++..+
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~  237 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-DVIGRIEN-GERLPMPPNCPPTL  237 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHc-CCcCCCCCCCCHHH
Confidence            32212222334568999999988889999999999999999996 99999765433 22333322 22334566789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          233 QDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      .+++.+||..+|.+|||+.+++..
T Consensus       238 ~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         238 YSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.7e-42  Score=321.54  Aligned_cols=244  Identities=29%  Similarity=0.415  Sum_probs=197.0

Q ss_pred             eeeceeeccCceEEEEEEEC----CCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            4 TRGQTIGRGSTATVSIGMSN----RSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~----~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +..+.||.|+||.||+|.++    ..+..|+||.+....    .+.+.+|++++++++||||++++|++.....    ++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~----~~   77 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP----LF   77 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS----EE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc----cc
Confidence            46789999999999999987    457889999995432    3577899999999999999999999884443    66


Q ss_pred             EEEeecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           76 LFLEYAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      +|+||+++|+|.+++...  ..+++..+..++.||+.||.|||+++++|++|+++|||++.++.  +||+|||++.....
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~--~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ--VKLSDFGLSRPISE  155 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE--EEEESTTTGEETTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc
Confidence            899999999999999864  77999999999999999999999999999999999999998765  99999999987621


Q ss_pred             cCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHH
Q 040569          154 NED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQ  231 (385)
Q Consensus       154 ~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  231 (385)
                      ... .......+...|+|||.+.+..++.++||||||+++|||++ |+.||.+. +.......+ .....+..+..++..
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~  233 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKL-KQGQRLPIPDNCPKD  233 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHH-HTTEETTSBTTSBHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc-cccccceeccchhHH
Confidence            111 11223346778999999999999999999999999999999 78999876 444444444 334445566778999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          232 AQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      +.++|.+||..+|.+|||+.++++
T Consensus       234 ~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  234 IYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHh
Confidence            999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.7e-41  Score=317.92  Aligned_cols=250  Identities=26%  Similarity=0.350  Sum_probs=197.1

Q ss_pred             CceeeceeeccCceEEEEEE----ECCCCcEEEEEeccCCCH---HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGM----SNRSSEVFAVKSAELSNS---EFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~----~~~~~~~~AvK~~~~~~~---~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++.+.||+|+||+||++.    +..+++.+|+|.+.....   +.+.+|++++++++||||+++++++......  .+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~--~~   82 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR--NL   82 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC--ce
Confidence            58889999999999999997    446789999999865443   4677999999999999999999976544332  26


Q ss_pred             EEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      ++|+||+++|+|.+++.. ...+++..+..++.||+.||+|||++|++||||||+||+++.++.  +||+|||++.....
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~  160 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe--EEECCCcccccccC
Confidence            699999999999999974 456899999999999999999999999999999999999987665  99999999987643


Q ss_pred             cCCCC--CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHH--------------HHHHhcC
Q 040569          154 NEDDE--GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS--------------ALHRIGF  217 (385)
Q Consensus       154 ~~~~~--~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--------------~~~~~~~  217 (385)
                      .....  .....++..|+|||++.+..++.++|||||||+++||++|..|+........              .+.....
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            22111  1112234569999999988899999999999999999998877643211100              0001111


Q ss_pred             CCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          218 SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       218 ~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .......+..++.++.+|+.+||..+|++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            11222334567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.5e-42  Score=331.80  Aligned_cols=252  Identities=26%  Similarity=0.397  Sum_probs=203.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccC--CeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEEN--GKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~~~~   74 (385)
                      +|++.+.||+|++|+||+|++..+++.+|+|.+...     ....+.+|+.+++++.||||+++++++.....  ....+
T Consensus        16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07851          16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV   95 (343)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence            588999999999999999999999999999987642     22456789999999999999999887654332  12236


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++|+||+ +++|.+++..+ .+++..+..++.||++||.|||++||+||||||+||+++.++.  +||+|||++......
T Consensus        96 ~lv~e~~-~~~L~~~~~~~-~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~  171 (343)
T cd07851          96 YLVTHLM-GADLNNIVKCQ-KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLARHTDDE  171 (343)
T ss_pred             EEEEecC-CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEcccccccccccc
Confidence            6999999 66999999864 5999999999999999999999999999999999999987665  999999999865322


Q ss_pred             CCCCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC-CCC------------
Q 040569          155 EDDEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF-SSD------------  220 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-~~~------------  220 (385)
                          .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ...+..+.. ...            
T Consensus       172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~  246 (343)
T cd07851         172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-IDQLKRIMNLVGTPDEELLQKISSE  246 (343)
T ss_pred             ----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHHHhhccch
Confidence                334468899999999865 3678899999999999999999999976433 222221100 000            


Q ss_pred             ----------------CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          221 ----------------TPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       221 ----------------~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                      ........++.+.+||.+||+++|.+|||+.++++||||.+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~  304 (343)
T cd07851         247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY  304 (343)
T ss_pred             hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence                            001112358999999999999999999999999999999864

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=319.92  Aligned_cols=248  Identities=29%  Similarity=0.433  Sum_probs=202.3

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      |++.+.||+|++|.||+|.++.+++.+++|.+....     ...+.+|+++|++++||||+++++++.....    .+++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~~v   76 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGD----LYLV   76 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCC----EEEE
Confidence            678899999999999999999999999999886432     3467789999999999999999998765533    6699


Q ss_pred             EeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           78 LEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      +||+++ +|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.  +||+|||.+....... 
T Consensus        77 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~df~~~~~~~~~~-  152 (283)
T cd05118          77 FEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV--LKLADFGLARSFGSPV-  152 (283)
T ss_pred             EeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc--EEEeeeeeeEecCCCc-
Confidence            999976 88888874 467999999999999999999999999999999999999987655  9999999998764332 


Q ss_pred             CCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC--C--------------
Q 040569          157 DEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS--S--------------  219 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~--------------  219 (385)
                      .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||..... ...+..+...  .              
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE-IDQLFKIFRTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCchHhcccchhhhh
Confidence            122234588899999999876 788999999999999999999999976433 2222111000  0              


Q ss_pred             ------------CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          220 ------------DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       220 ------------~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                                  ..+.....++.++++||.+||.+||.+||++.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                        0001122468899999999999999999999999999996

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-41  Score=312.51  Aligned_cols=240  Identities=26%  Similarity=0.406  Sum_probs=200.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++.+.||+|+||.||+|...  |+.+|+|.+....  .+.+.+|+.++++++||||+++++++.....    .++|||
T Consensus         7 ~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~~v~e   80 (256)
T cd05039           7 ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNP----LYIVTE   80 (256)
T ss_pred             hccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCC----eEEEEE
Confidence            5889999999999999999875  8899999987553  3567789999999999999999998765333    668999


Q ss_pred             ecCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           80 YAPGGTLTDAIRSGT--CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        80 y~~ggsL~~~l~~~~--~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |+++++|.++++...  .+++..+..++.|++.||.|||++|++||||||+||+++.++.  +||+|||.++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~--~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV--AKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC--EEEcccccccccccccc-
Confidence            999999999998544  6899999999999999999999999999999999999987665  89999999987632211 


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                         ...++..|+|||++.+..++.++||||||+++++|++ |+.||... ........+. ....+..+...++++.+||
T Consensus       158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~li  232 (256)
T cd05039         158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPHVE-KGYRMEAPEGCPPEVYKVM  232 (256)
T ss_pred             ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHh-cCCCCCCccCCCHHHHHHH
Confidence               2234567999999998889999999999999999997 99999764 3333333332 2223445666899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 040569          237 SKCLIRNPGERWSASELLE  255 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~  255 (385)
                      .+||.++|.+|||+.++++
T Consensus       233 ~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         233 KDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHhccChhhCcCHHHHHH
Confidence            9999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.2e-41  Score=326.06  Aligned_cols=252  Identities=24%  Similarity=0.338  Sum_probs=195.3

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      |.+++.+|.  +|.||+++.+.+++.+|+|++...     ..+.+++|++++++++||||+++++++.....    .+++
T Consensus         4 ~~i~~~~~~--~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~----~~~~   77 (314)
T cd08216           4 TLIGKCFED--LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE----LYVV   77 (314)
T ss_pred             hhhhHhhcC--CceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCe----EEEE
Confidence            344444444  455666666778999999987643     23578899999999999999999998765543    6789


Q ss_pred             EeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           78 LEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |||+++|+|.+++..  ...+++..+..+++||+.||+|||++||+||||||+||+++.++.  +||+|||.+.......
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~--~kl~d~~~~~~~~~~~  155 (314)
T cd08216          78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHG  155 (314)
T ss_pred             EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc--eEEecCccceeecccc
Confidence            999999999999974  346899999999999999999999999999999999999987665  9999999887553221


Q ss_pred             C------CCCCccccCCcccChhhhcCC--CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC--------
Q 040569          156 D------DEGKPICGTPICMAPEVARGE--EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS--------  219 (385)
Q Consensus       156 ~------~~~~~~~Gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--------  219 (385)
                      .      .......++..|+|||++.+.  .++.++|+|||||++++|++|+.||............+....        
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (314)
T cd08216         156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKST  235 (314)
T ss_pred             ccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCc
Confidence            1      112234578889999999763  578899999999999999999999986544333332221000        


Q ss_pred             -----------------------CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          220 -----------------------DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       220 -----------------------~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                             .....+..++.++.+|+.+||..||++|||+.|+|+||||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~  301 (314)
T cd08216         236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC  301 (314)
T ss_pred             hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence                                   0001112245788999999999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.2e-41  Score=311.73  Aligned_cols=246  Identities=23%  Similarity=0.330  Sum_probs=200.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++.+.||+|+||.||+|.+. ++..+|+|.+...  ....+.+|+++++++.||||+++++++.....    ++++||
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~~v~e   79 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSP----ICLVFE   79 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCc----eEEEEE
Confidence            5889999999999999999885 4678999988643  24678899999999999999999988655433    678999


Q ss_pred             ecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           80 YAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        80 y~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      |+++++|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+||+++.++.  +||+|||++..........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV--VKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCe--EEECCCcceeecccCcccc
Confidence            9999999999974 456899999999999999999999999999999999999986655  9999999998653222211


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      .....++..|+|||++.+..++.++||||||+++|+|++ |+.||.... .......+.. ...+..+...+..+.+|+.
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~  235 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-NSEVVETINA-GFRLYKPRLASQSVYELMQ  235 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-HHHHHHHHhC-CCCCCCCCCCCHHHHHHHH
Confidence            222335678999999998889999999999999999998 999997542 3333333321 2223335557899999999


Q ss_pred             HhhhcCCCCCCCHHHHHhC
Q 040569          238 KCLIRNPGERWSASELLEH  256 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~h  256 (385)
                      +||+.+|.+|||+.+++++
T Consensus       236 ~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         236 HCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHcccChhhCCCHHHHHHh
Confidence            9999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-41  Score=318.33  Aligned_cols=251  Identities=31%  Similarity=0.467  Sum_probs=202.2

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      |++.+.||+|+||.||+|.+..+++.+|+|.+....     ...+.+|+++++++.|||++++++++.....+  ..++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~--~~~lv   78 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKG--SIYMV   78 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCC--cEEEE
Confidence            788999999999999999999999999999987542     34577899999999999999999987655212  26699


Q ss_pred             EeecCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           78 LEYAPGGTLTDAIRSG-TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~-~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      +||+++ +|.+++... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.  +||+|||++........
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNS  155 (287)
T ss_pred             eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC--EEEccccceeeccCCCc
Confidence            999975 999998754 57999999999999999999999999999999999999987766  99999999987644332


Q ss_pred             CCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC-CC-----CCC-------
Q 040569          157 DEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF-SS-----DTP-------  222 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-~~-----~~~-------  222 (385)
                      .......++..|+|||.+.+. .++.++||||||+++++|++|+.||...... ..+..+.. ..     ..+       
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhccccccchh
Confidence            223334578899999987654 5788999999999999999999999764332 22211100 00     000       


Q ss_pred             ----------------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          223 ----------------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       223 ----------------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                                      .+...+++.+.+++.+||..+|.+||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                            0111138899999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=295.10  Aligned_cols=251  Identities=29%  Similarity=0.426  Sum_probs=206.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH-----HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----EFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~-----~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|...++||+|.||+||+|+++.++++||+|.+..++.     ....||+-+|+.|+|.|||+++++..++..    .-+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkk----ltl   78 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK----LTL   78 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCce----eEE
Confidence            58889999999999999999999999999999876542     467799999999999999999998766544    558


Q ss_pred             EEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |+|||.. +|..+.. -.+.++.+.++.++.|+++||.|+|++++.|||+||+|.||+.+++  +||+|||+|+.+....
T Consensus        79 vfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge--lkladfglarafgipv  155 (292)
T KOG0662|consen   79 VFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPV  155 (292)
T ss_pred             eHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc--EEecccchhhhcCCce
Confidence            9999965 8988887 4667999999999999999999999999999999999999998887  9999999999764332


Q ss_pred             CCCCCccccCCcccChhhhcCCC-CCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCC-----------
Q 040569          156 DDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTP-----------  222 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~-----------  222 (385)
                      .-.+ .-+-|.+|.+|.++.+.. |+...|+||-|||+.|+.. |++.|++. +...++.+|......|           
T Consensus       156 rcys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~-dvddqlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  156 RCYS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             Eeee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC-cHHHHHHHHHHHhCCCccccCCccccC
Confidence            2211 224688999999998764 7889999999999999996 88888874 5555555542111111           


Q ss_pred             -------CCC---------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          223 -------EIP---------GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       223 -------~~~---------~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                             .+|         ..++...+++++++|.-+|.+|++++++|+||||..
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d  288 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD  288 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence                   111         124566899999999999999999999999999875

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-41  Score=327.69  Aligned_cols=252  Identities=24%  Similarity=0.358  Sum_probs=201.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccC--CeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEEN--GKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~~~~   74 (385)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....     .+.+.+|+.++++++||||+++++++.....  ....+
T Consensus        18 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   97 (345)
T cd07877          18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV   97 (345)
T ss_pred             ceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccE
Confidence            6899999999999999999999999999999886432     3456789999999999999999988754321  11235


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +++++++ |++|.++++.. .+++..+..++.||++||+|||++||+||||||+||+++.++.  +||+|||+++.... 
T Consensus        98 ~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~~~~~-  172 (345)
T cd07877          98 YLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTDD-  172 (345)
T ss_pred             EEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC--EEEecccccccccc-
Confidence            6788887 78999888754 5999999999999999999999999999999999999987765  99999999886421 


Q ss_pred             CCCCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC--C-------------
Q 040569          155 EDDEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF--S-------------  218 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~-------------  218 (385)
                         ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ..+..+..  .             
T Consensus       173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  248 (345)
T cd07877         173 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELLKKISSE  248 (345)
T ss_pred             ---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHhhcccH
Confidence               2234568999999999866 56788999999999999999999999754322 11111000  0             


Q ss_pred             ---------CCCC-----CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          219 ---------SDTP-----EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       219 ---------~~~~-----~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                               ...+     ......++++++||.+||++||.+||++.++++||||.+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~  306 (345)
T cd07877         249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  306 (345)
T ss_pred             hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence                     0000     1112358889999999999999999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.1e-41  Score=322.51  Aligned_cols=247  Identities=34%  Similarity=0.547  Sum_probs=201.9

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      |...+.||+|+||+||+|++..+++.+++|.+....      ...+.+|+++++.++|||++++++++.....    .++
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~l   98 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHT----AWL   98 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE----EEE
Confidence            445678999999999999999999999999886422      2356789999999999999999998766543    669


Q ss_pred             EEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +|||+.| +|.+++. ....+++..+..++.||+.+|.|||++|++|+||||+||+++.++.  +||+|||++....   
T Consensus        99 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~--~kL~dfg~~~~~~---  172 (313)
T cd06633          99 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASKSS---  172 (313)
T ss_pred             EEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC--EEEeecCCCcccC---
Confidence            9999965 7877776 4557899999999999999999999999999999999999987665  9999999986432   


Q ss_pred             CCCCCccccCCcccChhhhc---CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHH
Q 040569          156 DDEGKPICGTPICMAPEVAR---GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA  232 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  232 (385)
                        ......|+..|+|||++.   ...++.++|||||||++|+|++|..||... +.......+............++..+
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l  249 (313)
T cd06633         173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNDSPTLQSNEWTDSF  249 (313)
T ss_pred             --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCCCCCccccCHHH
Confidence              123456899999999984   456788999999999999999999999765 33333333322222222334577889


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          233 QDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ++|+.+||+++|.+||++.++++|||+...
T Consensus       250 ~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         250 RGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            999999999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.8e-41  Score=326.82  Aligned_cols=257  Identities=27%  Similarity=0.372  Sum_probs=203.9

Q ss_pred             CceeeceeeccCceEEEEEEECCC--CcEEEEEeccCC-----CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRS--SEVFAVKSAELS-----NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~--~~~~AvK~~~~~-----~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|++.+.||+|+||.||++.+..+  +..+|+|.+...     ..+.+.+|+.+++++ .||||+++++...........
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            589999999999999999999888  999999987532     134567899999999 699999999876543233334


Q ss_pred             EEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           74 YNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      +++++||+. ++|.+++.....+++..++.++.||+.||.|||++|++||||||+|||++.++.  +||+|||+++....
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~  157 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSE  157 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceeccc
Confidence            568899986 599999988788999999999999999999999999999999999999987765  99999999986543


Q ss_pred             cCCC---CCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHH---------------
Q 040569          154 NEDD---EGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHR---------------  214 (385)
Q Consensus       154 ~~~~---~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~---------------  214 (385)
                      ....   ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||..... ...+..               
T Consensus       158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~  236 (332)
T cd07857         158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-VDQLNQILQVLGTPDEETLSR  236 (332)
T ss_pred             ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-HHHHHHHHHHhCCCCHHHHHh
Confidence            2211   1233578999999998866 4678999999999999999999999975321 111110               


Q ss_pred             hc----------C-C---CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          215 IG----------F-S---SDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       215 ~~----------~-~---~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +.          . .   ...+......+..+.+|+.+||+.||.+|||+.+++.|||+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence            00          0 0   00011122357899999999999999999999999999999754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=8.4e-41  Score=312.67  Aligned_cols=246  Identities=20%  Similarity=0.289  Sum_probs=200.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCc---EEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSE---VFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~---~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|+..+.||+|+||.||+|+++.++.   .+|+|.+....    .+.+.+|+++++++.||||+++.+++.....    .
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~   81 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP----A   81 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC----c
Confidence            58889999999999999999876654   79999886542    3457789999999999999999998765543    5


Q ss_pred             EEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      +++|||+++++|.+++.. .+.+++..+..++.|++.||+|||+.|++||||||+||+++.++.  +||+|||++.....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~  159 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE--CKVSDFGLSRVLED  159 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCc--EEECCCccceeccc
Confidence            699999999999999974 467899999999999999999999999999999999999987655  99999999986643


Q ss_pred             cCCCCCC--ccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          154 NEDDEGK--PICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       154 ~~~~~~~--~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      .......  ....++.|+|||++.+..++.++|||||||++|+|++ |+.||.... .......+... .....+...+.
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~-~~~~~~~i~~~-~~~~~~~~~~~  237 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS-NHEVMKAINDG-FRLPAPMDCPS  237 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC-HHHHHHHHhcC-CCCCCCCCCCH
Confidence            2221111  1123457999999998889999999999999999997 999997643 33333343222 22233445789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .+.+|+.+||..+|++||++.++++
T Consensus       238 ~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         238 AVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHHH
Confidence            9999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-41  Score=316.14  Aligned_cols=251  Identities=29%  Similarity=0.372  Sum_probs=201.0

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhc---CCCCeeeeeeeeeeccC-CeEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSAL---ACPQIVAYKGCDISEEN-GKIL   73 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l---~hpnIv~~~~~~~~~~~-~~~~   73 (385)
                      |++.+.||+|+||.||+|.++.+++.+|+|.+....     ...+.+|+.+++++   .||||+++++++..... +...
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            788999999999999999999899999999886421     23456788887776   59999999999876543 3344


Q ss_pred             EEEEEeecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           74 YNLFLEYAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      ++++|||+.+ +|.+++...  ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.  +||+|||++...
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~--~~l~dfg~~~~~  157 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ--VKIADFGLARIY  157 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCC--EEEeccCcceec
Confidence            6799999975 899988753  35899999999999999999999999999999999999988755  999999999876


Q ss_pred             cccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC----CC--------
Q 040569          152 RVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF----SS--------  219 (385)
Q Consensus       152 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~----~~--------  219 (385)
                      ....  ......+++.|+|||++.+..++.++|+|||||++|+|++|++||...... ..+.++..    ..        
T Consensus       158 ~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07838         158 SFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEEEWPRNV  234 (287)
T ss_pred             cCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChHhcCCCc
Confidence            4322  222345788999999999999999999999999999999999999764332 22221100    00        


Q ss_pred             ---------C----CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          220 ---------D----TPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       220 ---------~----~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                               .    .......+++.+.+||.+||+.||.+||++.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                     0    000112356888999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=8.1e-41  Score=321.58  Aligned_cols=246  Identities=34%  Similarity=0.532  Sum_probs=203.5

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      |+..+.||+|+||+||+|++..++..+|+|.+....      ...+.+|++++++++|||++++++++.....    .++
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~l  102 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT----AWL  102 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe----EEE
Confidence            678889999999999999999999999999886431      2357789999999999999999998766543    669


Q ss_pred             EEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      ||||++| +|.+.+. ....+++..+..++.||+.||.|||++|++||||+|+||+++.++.  +||+|||++.....  
T Consensus       103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~--~kl~dfg~~~~~~~--  177 (317)
T cd06635         103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASIASP--  177 (317)
T ss_pred             EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC--EEEecCCCccccCC--
Confidence            9999975 7877775 4567999999999999999999999999999999999999987655  99999999875421  


Q ss_pred             CCCCCccccCCcccChhhhc---CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHH
Q 040569          156 DDEGKPICGTPICMAPEVAR---GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA  232 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  232 (385)
                         .....|++.|+|||++.   ...++.++|||||||++|+|++|+.||... +.......+......+..+..+++.+
T Consensus       178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l  253 (317)
T cd06635         178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPTLQSNEWSDYF  253 (317)
T ss_pred             ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHhccCCCCCCccccHHH
Confidence               22346899999999984   456788999999999999999999999764 33333333333332333344578899


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          233 QDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      ++|+.+||+++|.+||++.++++|+|+..
T Consensus       254 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         254 RNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             HHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence            99999999999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.2e-40  Score=310.75  Aligned_cols=244  Identities=22%  Similarity=0.332  Sum_probs=198.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|+..+.||+|+||.||++.++ .+..+|+|.+....  .+.+.+|++++++++|+||+++++.+.. ..    ++++||
T Consensus         7 ~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~----~~~v~e   80 (260)
T cd05073           7 SLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EP----IYIITE   80 (260)
T ss_pred             ceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CC----eEEEEE
Confidence            5889999999999999999865 45679999876543  3567889999999999999999988654 22    568999


Q ss_pred             ecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           80 YAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        80 y~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |+++++|.+++.+  +..+++..+..++.||+.||.|||++|++||||||+||+++.++.  +||+|||++.........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYT  158 (260)
T ss_pred             eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCCcceeeccCCCcc
Confidence            9999999999974  446788899999999999999999999999999999999987665  999999999876432222


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      ......++..|+|||++.+..++.++|+|||||++|+|++ |+.||..... ......+.. ......+...+.++.+++
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~i  236 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-PEVIRALER-GYRMPRPENCPEELYNIM  236 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHhC-CCCCCCcccCCHHHHHHH
Confidence            2222345678999999998889999999999999999999 9999986533 223333322 222334456889999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 040569          237 SKCLIRNPGERWSASELLE  255 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~  255 (385)
                      .+||+++|++||++.++++
T Consensus       237 ~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         237 MRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHcccCcccCcCHHHHHH
Confidence            9999999999999998875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-41  Score=310.71  Aligned_cols=241  Identities=33%  Similarity=0.533  Sum_probs=205.4

Q ss_pred             eeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecC
Q 040569            9 IGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAP   82 (385)
Q Consensus         9 LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (385)
                      ||+|+||.||++.+..+++.+|+|.+....      .+.+.+|+.+++++.||||+++++.+....    ..+++|||++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v~e~~~   76 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE----KLYLVLEYAP   76 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC----eeEEEEecCC
Confidence            799999999999999899999999886532      346788999999999999999998765433    2679999999


Q ss_pred             CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCCcc
Q 040569           83 GGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI  162 (385)
Q Consensus        83 ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~  162 (385)
                      +++|.+++.....+++..+..++.||+.||.|||+.+++|+||||+||+++.++.  ++|+|||++....... ......
T Consensus        77 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~-~~~~~~  153 (250)
T cd05123          77 GGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLAKELSSEG-SRTNTF  153 (250)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc--EEEeecCcceecccCC-CcccCC
Confidence            9999999997778999999999999999999999999999999999999987765  9999999998764321 223445


Q ss_pred             ccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhc
Q 040569          163 CGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIR  242 (385)
Q Consensus       163 ~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~  242 (385)
                      .|+..|+|||...+...+.++|+||||+++|+|++|+.||.... .......+..  ....++..++..+.+||.+||..
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~  230 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKILK--DPLRFPEFLSPEARDLISGLLQK  230 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcC
Confidence            68999999999998888999999999999999999999997643 3333333322  34556777899999999999999


Q ss_pred             CCCCCCCH---HHHHhCccc
Q 040569          243 NPGERWSA---SELLEHGFV  259 (385)
Q Consensus       243 dP~~Rps~---~elL~hp~~  259 (385)
                      ||++||++   .++++||||
T Consensus       231 ~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         231 DPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             CHhhCCCcccHHHHHhCCCC
Confidence            99999999   999999997

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.1e-41  Score=320.67  Aligned_cols=247  Identities=23%  Similarity=0.338  Sum_probs=199.6

Q ss_pred             CceeeceeeccCceEEEEEEEC-------CCCcEEEEEeccCCC----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccC
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN-------RSSEVFAVKSAELSN----SEFLQREQRILSAL-ACPQIVAYKGCDISEEN   69 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~-------~~~~~~AvK~~~~~~----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~   69 (385)
                      +|++++.||+|+||.||+|+..       ..+..+|+|.+....    ...+.+|+.+++.+ .||||+++++++.....
T Consensus        16 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   95 (304)
T cd05101          16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP   95 (304)
T ss_pred             HeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCc
Confidence            5889999999999999999752       234579999886422    34678999999999 89999999998765433


Q ss_pred             CeEEEEEEEeecCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEee
Q 040569           70 GKILYNLFLEYAPGGTLTDAIRSG----------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVS  133 (385)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~l~~~----------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~  133 (385)
                          .+++|||+++|+|.+++...                ..++...+..++.||+.||.|||++|++||||||+|||++
T Consensus        96 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~  171 (304)
T cd05101          96 ----LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT  171 (304)
T ss_pred             ----eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence                66999999999999999743                2467788999999999999999999999999999999998


Q ss_pred             cCCCCCeEEeecCceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHH
Q 040569          134 KDNEQGAKIADFGCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISA  211 (385)
Q Consensus       134 ~~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~  211 (385)
                      .++.  +||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|+|++ |..||... .....
T Consensus       172 ~~~~--~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~  248 (304)
T cd05101         172 ENNV--MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEEL  248 (304)
T ss_pred             CCCc--EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-CHHHH
Confidence            7665  999999999876432211 1222346778999999998889999999999999999998 88888764 33333


Q ss_pred             HHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          212 LHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       212 ~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ...+. .......+...+.++++|+.+||.++|.+|||+.|+++.
T Consensus       249 ~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         249 FKLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            33332 223344566789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.5e-41  Score=313.12  Aligned_cols=229  Identities=26%  Similarity=0.358  Sum_probs=191.4

Q ss_pred             cCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecCCCCHHHHHH
Q 040569           12 GSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIR   91 (385)
Q Consensus        12 G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~   91 (385)
                      |.||.||+++++.+++.||+|.+....  ...+|...+....||||+++++++.....    ++++|||++||+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~~~~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPHCVPNMVCLHKYIVSEDS----VFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhcCCCceeehhhheecCCe----EEEEEecCCCCCHHHHHH
Confidence            899999999999999999999987543  33456666667789999999998765443    679999999999999998


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCCccccCCcccCh
Q 040569           92 SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAP  171 (385)
Q Consensus        92 ~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aP  171 (385)
                      +...+++..+..++.|++.||+|||++|++||||||+||+++.++.  ++|+|||.+......    .....++..|+||
T Consensus        78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~df~~~~~~~~~----~~~~~~~~~y~aP  151 (237)
T cd05576          78 KFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--IQLTYFSRWSEVEDS----CDGEAVENMYCAP  151 (237)
T ss_pred             HhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEecccchhccccc----cccCCcCccccCC
Confidence            7777999999999999999999999999999999999999987766  999999987655321    2233567889999


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCH-
Q 040569          172 EVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSA-  250 (385)
Q Consensus       172 E~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~-  250 (385)
                      |.+.+..++.++|+||+||++|+|++|+.|+.......       .......+|..+++.+++||.+||++||++||++ 
T Consensus       152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             cccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence            99988889999999999999999999999875432110       0111223566789999999999999999999985 


Q ss_pred             ----HHHHhCccc
Q 040569          251 ----SELLEHGFV  259 (385)
Q Consensus       251 ----~elL~hp~~  259 (385)
                          +++++||||
T Consensus       225 ~~~~~~~~~h~~~  237 (237)
T cd05576         225 VAGVEDIKSHPFF  237 (237)
T ss_pred             ccchHHHHcCCCC
Confidence                999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=8e-41  Score=310.67  Aligned_cols=241  Identities=26%  Similarity=0.408  Sum_probs=197.7

Q ss_pred             ceeeccCceEEEEEEECC-CCc--EEEEEeccCCCH----HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            7 QTIGRGSTATVSIGMSNR-SSE--VFAVKSAELSNS----EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~-~~~--~~AvK~~~~~~~----~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +.||+|++|+||+|.+.. +++  .+|+|.+.....    +.+.+|+.++++++||||+++++.+.. .    .+++++|
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~----~~~~v~e   75 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-H----PLMMVTE   75 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-C----eEEEEEE
Confidence            478999999999999865 333  689998876443    467789999999999999999998765 2    2669999


Q ss_pred             ecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           80 YAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        80 y~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |+++|+|.+++...  ..+++..+..++.|++.||+|||++|++||||||+||+++.++.  +||+|||+++........
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK--VKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE--EEeccccccccccccccc
Confidence            99999999999754  36899999999999999999999999999999999999988765  999999999876432211


Q ss_pred             --CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          158 --EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       158 --~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                        ......++..|+|||++.+..++.++|||||||++|+|++ |+.||... ........+.........+...+..+.+
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKIDKEGERLERPEACPQDIYN  232 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCCcCCCCccCCHHHHH
Confidence              1123457789999999999999999999999999999999 99999754 3333333333233334455567899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHh
Q 040569          235 FLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ++.+||+++|.+|||+.++++
T Consensus       233 li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         233 VMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHCCCCcccCCCHHHHHH
Confidence            999999999999999999986

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.6e-41  Score=333.62  Aligned_cols=248  Identities=24%  Similarity=0.309  Sum_probs=199.5

Q ss_pred             CceeeceeeccCceEEEEEEEC-----CCCcEEEEEeccCCC----HHHHHHHHHHHHhcC-CCCeeeeeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN-----RSSEVFAVKSAELSN----SEFLQREQRILSALA-CPQIVAYKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~   71 (385)
                      +|.+++.||+|+||.||+|+++     .+++.||+|.+....    .+.+.+|+++|.++. ||||+++++.+.....  
T Consensus        38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~--  115 (401)
T cd05107          38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP--  115 (401)
T ss_pred             HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC--
Confidence            3677899999999999999964     356789999987542    235778999999997 9999999998766543  


Q ss_pred             EEEEEEEeecCCCCHHHHHHcCC---------------------------------------------------------
Q 040569           72 ILYNLFLEYAPGGTLTDAIRSGT---------------------------------------------------------   94 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~~~---------------------------------------------------------   94 (385)
                        .++||||+++|+|.+++...+                                                         
T Consensus       116 --~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         116 --IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             --cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence              669999999999999996321                                                         


Q ss_pred             -----------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEee
Q 040569           95 -----------------------------------------CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVS  133 (385)
Q Consensus        95 -----------------------------------------~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~  133 (385)
                                                               .++...+..++.||+.||.|||+.|++||||||+|||++
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~  273 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC  273 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence                                                     256677888999999999999999999999999999998


Q ss_pred             cCCCCCeEEeecCceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHH
Q 040569          134 KDNEQGAKIADFGCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISA  211 (385)
Q Consensus       134 ~~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~  211 (385)
                      .++.  +||+|||+++....... .......|++.|||||.+.+..++.++|||||||++|||++ |..||.........
T Consensus       274 ~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~  351 (401)
T cd05107         274 EGKL--VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF  351 (401)
T ss_pred             CCCE--EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence            7654  89999999986532211 11223357889999999998889999999999999999998 89999765433322


Q ss_pred             HHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          212 LHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       212 ~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ...+ .....+..|..++.++.+|+.+||.++|.+||++.++++.
T Consensus       352 ~~~~-~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         352 YNAI-KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHH-HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2222 2233344566789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=345.06  Aligned_cols=255  Identities=33%  Similarity=0.561  Sum_probs=218.3

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhc-CCCCeeeeeeeeeecc-CCeEEEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSAL-ACPQIVAYKGCDISEE-NGKILYNLFL   78 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~-~~~~~~~lv~   78 (385)
                      |.+.+.||.|.+|.||+++++.+++..|+|+....  ..+.++-|.+||+.+ .|||++.+||++.-.. .....++|||
T Consensus        21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM  100 (953)
T KOG0587|consen   21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM  100 (953)
T ss_pred             cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence            88999999999999999999999999999988653  456788899999998 7999999999986433 2233467999


Q ss_pred             eecCCCCHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           79 EYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        79 Ey~~ggsL~~~l~--~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |||.|||..|+++  .+.++.|..+..|++.++.||.|||.+.++|||||-.|||++.++.  |||+|||++.+.... .
T Consensus       101 EfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~--VKLvDFGvSaQldsT-~  177 (953)
T KOG0587|consen  101 EFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDST-V  177 (953)
T ss_pred             eccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc--EEEeeeeeeeeeecc-c
Confidence            9999999999998  5778999999999999999999999999999999999999998877  999999999887533 3


Q ss_pred             CCCCccccCCcccChhhhcCC-----CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCC--CCCcCC
Q 040569          157 DEGKPICGTPICMAPEVARGE-----EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE--IPGYMS  229 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~s  229 (385)
                      ....+.+|||.|||||++...     .|+..+|+||||+|.+||.-|.+|+.++ .+...+..|.. ..+|.  -|...+
T Consensus       178 grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm-HPmraLF~IpR-NPPPkLkrp~kWs  255 (953)
T KOG0587|consen  178 GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPR-NPPPKLKRPKKWS  255 (953)
T ss_pred             ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc-chhhhhccCCC-CCCccccchhhHH
Confidence            344567899999999999654     3677899999999999999999999887 44555555532 22333  366789


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          230 KQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       230 ~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +++.+||..||.+|..+||+..++|+|||+..+
T Consensus       256 ~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  256 KKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             HHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence            999999999999999999999999999999744

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-41  Score=315.39  Aligned_cols=248  Identities=28%  Similarity=0.404  Sum_probs=198.9

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcC-CCCeeeeeeeeeeccCCeEEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALA-CPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      |++.+.||+|++|+||+|+...+++.+|+|.+....    .....+|+..++++. ||||+++++++.....    .++|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~----~~lv   76 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDE----LYFV   76 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCc----EEEE
Confidence            788999999999999999999999999999876432    224457999999998 9999999998766433    6699


Q ss_pred             EeecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           78 LEYAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |||+ +|+|.+++...  ..+++..+..++.|++.+|.|||++|++|+||||+||+++.++.  ++|+|||++.......
T Consensus        77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~  153 (283)
T cd07830          77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRP  153 (283)
T ss_pred             EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC--EEEeecccceeccCCC
Confidence            9999 77999998754  37899999999999999999999999999999999999987665  9999999998763221


Q ss_pred             CCCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC-----------------
Q 040569          156 DDEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF-----------------  217 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-----------------  217 (385)
                        ......|+..|+|||++.+ ..++.++|+||||+++++|++|++||...............                 
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         154 --PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             --CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence              2234568899999998854 45789999999999999999999999765332221111000                 


Q ss_pred             --C--------CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          218 --S--------SDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       218 --~--------~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                        .        ..........+..+++||++||+.+|++|||+.|++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence              0        00001111236889999999999999999999999999996

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=9.7e-41  Score=320.46  Aligned_cols=246  Identities=24%  Similarity=0.328  Sum_probs=197.6

Q ss_pred             CceeeceeeccCceEEEEEEECC-------CCcEEEEEeccCCC----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccC
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNR-------SSEVFAVKSAELSN----SEFLQREQRILSAL-ACPQIVAYKGCDISEEN   69 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~-------~~~~~AvK~~~~~~----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~   69 (385)
                      +|++++.||+|+||.||+|.+..       ....+|+|.+....    ...+.+|+++++++ .||||+++++++.....
T Consensus        13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   92 (314)
T cd05099          13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP   92 (314)
T ss_pred             HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCc
Confidence            47899999999999999998632       35678999876432    23567899999999 69999999998755432


Q ss_pred             CeEEEEEEEeecCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEee
Q 040569           70 GKILYNLFLEYAPGGTLTDAIRSG----------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVS  133 (385)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~l~~~----------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~  133 (385)
                          ++++|||+++|+|.+++...                ..++...+..++.||+.||.|||++|++||||||+|||++
T Consensus        93 ----~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  168 (314)
T cd05099          93 ----LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT  168 (314)
T ss_pred             ----eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence                67999999999999999642                3478889999999999999999999999999999999998


Q ss_pred             cCCCCCeEEeecCceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHH
Q 040569          134 KDNEQGAKIADFGCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISA  211 (385)
Q Consensus       134 ~~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~  211 (385)
                      .++.  +||+|||+++........ ......+++.|||||++.+..++.++|||||||++|+|++ |..||... .....
T Consensus       169 ~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~-~~~~~  245 (314)
T cd05099         169 EDNV--MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEEL  245 (314)
T ss_pred             CCCc--EEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC-CHHHH
Confidence            7665  999999999865322111 1112234568999999998889999999999999999999 89999764 33333


Q ss_pred             HHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          212 LHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       212 ~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ...+. .......+..++.++++++.+||..+|.+|||+.++++
T Consensus       246 ~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         246 FKLLR-EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            33332 22334456678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-41  Score=327.63  Aligned_cols=252  Identities=28%  Similarity=0.386  Sum_probs=200.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCC--eEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENG--KILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~--~~~~   74 (385)
                      +|.+.+.||+|+||+||+|++..+|+.+|+|.+....     ...+.+|+.+++++.||||+++++++......  ...+
T Consensus        16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   95 (342)
T cd07879          16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF   95 (342)
T ss_pred             ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence            5889999999999999999999999999999886421     24567899999999999999999987654321  1235


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++++||+.+ +|.+++.  ..+++..+..++.|++.||+|||++|++||||||+|||++.++.  +||+|||+++.... 
T Consensus        96 ~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~--~kL~dfg~~~~~~~-  169 (342)
T cd07879          96 YLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE--LKILDFGLARHADA-  169 (342)
T ss_pred             EEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCCCCcCCCC-
Confidence            799999964 7777653  35899999999999999999999999999999999999987765  99999999876421 


Q ss_pred             CCCCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC---------------
Q 040569          155 EDDEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS---------------  218 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~---------------  218 (385)
                         ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ....+..+...               
T Consensus       170 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (342)
T cd07879         170 ---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-YLDQLTQILKVTGVPGPEFVQKLEDK  245 (342)
T ss_pred             ---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCCHHHHHHhccc
Confidence               2234468999999999876 467889999999999999999999997643 22211111000               


Q ss_pred             ------CCCCCC--------CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          219 ------SDTPEI--------PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       219 ------~~~~~~--------~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                            ...+..        ....++.+.+||.+||+.||.+||++.+++.||||....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                  000111        123678899999999999999999999999999998753

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=325.99  Aligned_cols=257  Identities=27%  Similarity=0.448  Sum_probs=220.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      ||..+..||+|+||+|-+|..+.+.++||||++.++      +.+--..|-++|... +-|.+++++.+|..-+.    +
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR----L  425 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR----L  425 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh----e
Confidence            688899999999999999999999999999988653      334445688888777 56889999998877665    6


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      |+||||+.||+|--.|++-+++.|..+..|+..|+-||-+||++||+.||||.+||+++.++.  +||+|||+++.-- .
T Consensus       426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH--iKi~DFGmcKEni-~  502 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENI-F  502 (683)
T ss_pred             eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc--eEeeecccccccc-c
Confidence            789999999999999999999999999999999999999999999999999999999998777  9999999998642 2


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                      ......++||||.|+|||++...+|+.++|.||+|+++|||+.|++||.+. +...+...|.  ...-.+|..+|.++.+
T Consensus       503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe-DE~elF~aI~--ehnvsyPKslSkEAv~  579 (683)
T KOG0696|consen  503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE-DEDELFQAIM--EHNVSYPKSLSKEAVA  579 (683)
T ss_pred             CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHH--HccCcCcccccHHHHH
Confidence            233467889999999999999999999999999999999999999999874 4444444442  2234568889999999


Q ss_pred             HHHHhhhcCCCCCCCH-----HHHHhCcccccccccccc
Q 040569          235 FLSKCLIRNPGERWSA-----SELLEHGFVKEQNFKLST  268 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~-----~elL~hp~~~~~~~~~~~  268 (385)
                      +....|.+.|.+|..+     .++-.||||+..+|....
T Consensus       580 ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E  618 (683)
T KOG0696|consen  580 ICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLE  618 (683)
T ss_pred             HHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHh
Confidence            9999999999999854     489999999988765433

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-42  Score=340.97  Aligned_cols=242  Identities=26%  Similarity=0.339  Sum_probs=208.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +|.....+|.|+|++|..+.+..+++.+++|++... ....++|+.++... +||||+++++++.+..+    .++|||+
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~----~~~v~e~  397 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKE----IYLVMEL  397 (612)
T ss_pred             hhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecCCce----eeeeehh
Confidence            477788899999999999999999999999999865 44556788777776 89999999998765544    6799999


Q ss_pred             cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEee-cCCCCCeEEeecCceeeecccCCCCC
Q 040569           81 APGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVS-KDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        81 ~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~-~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      +.|+.|.+.+.....+. .++.+|+++|+.++.|||++|+|||||||+|||+. ..+.  ++|+|||.++.....    .
T Consensus       398 l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~--lrltyFG~a~~~~~~----~  470 (612)
T KOG0603|consen  398 LDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGH--LRLTYFGFWSELERS----C  470 (612)
T ss_pred             ccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCc--EEEEEechhhhCchh----h
Confidence            99999999998766555 88899999999999999999999999999999995 4444  999999999987433    3


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHh
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC  239 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~c  239 (385)
                      .+.|-|..|.|||++...+|++++||||||++||+|++|+.||...........+++.    +.+...+|+.+++||+.|
T Consensus       471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~----~~~s~~vS~~AKdLl~~L  546 (612)
T KOG0603|consen  471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM----PKFSECVSDEAKDLLQQL  546 (612)
T ss_pred             cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC----CccccccCHHHHHHHHHh
Confidence            4456788999999999999999999999999999999999999865555455555533    333477999999999999


Q ss_pred             hhcCCCCCCCHHHHHhCccc
Q 040569          240 LIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       240 L~~dP~~Rps~~elL~hp~~  259 (385)
                      |+.||.+|+++.+++.|||+
T Consensus       547 L~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  547 LQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ccCChhhCcChhhhccCcch
Confidence            99999999999999999998

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.7e-41  Score=352.67  Aligned_cols=142  Identities=29%  Similarity=0.445  Sum_probs=128.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+|.+..+++.||||++....      ...+.+|+.+++.++||||+++++++.....    ++
T Consensus         5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~----~~   80 (669)
T cd05610           5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANN----VY   80 (669)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCE----EE
Confidence            6999999999999999999999999999999986432      2567889999999999999999987655432    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCcee
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR  149 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~  149 (385)
                      +||||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.  +||+|||+++
T Consensus        81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~--vkL~DFGls~  152 (669)
T cd05610          81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGH--IKLTDFGLSK  152 (669)
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCC--EEEEeCCCCc
Confidence            99999999999999987778999999999999999999999999999999999999987665  9999999876

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.1e-40  Score=319.39  Aligned_cols=246  Identities=34%  Similarity=0.528  Sum_probs=201.5

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCC---C---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---N---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~---~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      |+..+.||+|+||+||+|+++.+++.+|+|.+...   .   ...+.+|+++++.++|||++++++++.....    +++
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~l   92 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT----AWL   92 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCe----eEE
Confidence            66788999999999999999999999999987532   1   2356689999999999999999998766433    669


Q ss_pred             EEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      ||||+. |+|.+++. ....+++..+..++.|++.||.|||++|++||||||+||+++.++.  +||+|||++.....  
T Consensus        93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~--  167 (308)
T cd06634          93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP--  167 (308)
T ss_pred             EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCc--EEECCcccceeecC--
Confidence            999997 58888775 4556899999999999999999999999999999999999987655  99999999886532  


Q ss_pred             CCCCCccccCCcccChhhhc---CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHH
Q 040569          156 DDEGKPICGTPICMAPEVAR---GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA  232 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  232 (385)
                         .....|++.|+|||++.   ...++.++|||||||++|+|++|+.||.... .......+.........+..++..+
T Consensus       168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  243 (308)
T cd06634         168 ---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPALQSGHWSEYF  243 (308)
T ss_pred             ---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc-HHHHHHHHhhcCCCCcCcccccHHH
Confidence               12346889999999985   3457889999999999999999999997643 2333333322222222244578999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          233 QDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      ++||.+||.++|.+||++.++++|||+..
T Consensus       244 ~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             HHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence            99999999999999999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-41  Score=314.21  Aligned_cols=239  Identities=25%  Similarity=0.333  Sum_probs=192.1

Q ss_pred             ceeeccCceEEEEEEECCCCcE--EEEEeccCC----CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            7 QTIGRGSTATVSIGMSNRSSEV--FAVKSAELS----NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~--~AvK~~~~~----~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +.||+|+||.||+|.++.++..  +|+|.+...    ..+.+.+|+++++++ .||||+++++++.....    ++++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~----~~lv~e   76 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY----LYLAIE   76 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCC----ceEEEE
Confidence            4699999999999999888764  588877632    134677899999999 89999999998765443    669999


Q ss_pred             ecCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEe
Q 040569           80 YAPGGTLTDAIRSGT----------------CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIA  143 (385)
Q Consensus        80 y~~ggsL~~~l~~~~----------------~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~  143 (385)
                      |+++|+|.+++....                .+++..+..++.|++.||+|||++|++||||||+|||++.++.  +||+
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~--~kl~  154 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIA  154 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe--EEEC
Confidence            999999999997432                4789999999999999999999999999999999999987665  9999


Q ss_pred             ecCceeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCC
Q 040569          144 DFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTP  222 (385)
Q Consensus       144 DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  222 (385)
                      |||++.......  .......+..|+|||++.+..++.++|||||||++|+|++ |..||.... .......+. .....
T Consensus       155 dfgl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-~~~~~~~~~-~~~~~  230 (270)
T cd05047         155 DFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLP-QGYRL  230 (270)
T ss_pred             CCCCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-HHHHHHHHh-CCCCC
Confidence            999986432111  1112234567999999998889999999999999999997 999997643 223333331 22233


Q ss_pred             CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          223 EIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       223 ~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ..+..++.++.+++.+||..+|.+|||+.+++.
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         231 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            445568899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.1e-40  Score=312.21  Aligned_cols=246  Identities=20%  Similarity=0.291  Sum_probs=198.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCc---EEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSE---VFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~---~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++.+.||+|+||.||+|.++.+++   .+|+|.+....    ...+.+|+.+++++.||||+++++++.....    +
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~----~   80 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP----V   80 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc----e
Confidence            58899999999999999999887765   69999886532    3467889999999999999999998755443    6


Q ss_pred             EEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      ++||||+++|+|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+||+++.++.  +||+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~  158 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLED  158 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCc--EEECCCcccccccc
Confidence            689999999999999974 556899999999999999999999999999999999999986655  99999999876532


Q ss_pred             cCCCC--CCccc--cCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcC
Q 040569          154 NEDDE--GKPIC--GTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYM  228 (385)
Q Consensus       154 ~~~~~--~~~~~--Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (385)
                      .....  .....  ++..|+|||++.+..++.++|||||||++|||++ |..||.... .......+... .....+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~-~~~~~~~i~~~-~~~~~~~~~  236 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-NQDVINAIEQD-YRLPPPMDC  236 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC-HHHHHHHHHcC-CcCCCcccC
Confidence            22111  11111  2457999999999999999999999999999886 999997643 33333333222 222234457


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          229 SKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       229 s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      +..+.+++.+||.++|.+||++.+++.
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         237 PTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-41  Score=328.57  Aligned_cols=247  Identities=29%  Similarity=0.405  Sum_probs=194.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|.....||+|+||+||+|..... ..+|||++....   ...+.+|+.+|.+++|||+|+++|++.+.+. .  .+||+
T Consensus        76 ~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~--~~LVY  151 (361)
T KOG1187|consen   76 NFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE-H--RLLVY  151 (361)
T ss_pred             CCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc-e--EEEEE
Confidence            567778999999999999998644 899999887543   4569999999999999999999999887653 1  45899


Q ss_pred             eecCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           79 EYAPGGTLTDAIRSGT--CLEEGRIRSHTRAVLLGLQYLHSNG---IVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~--~l~e~~~~~i~~qil~gL~yLH~~g---ivHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      ||+++|+|.+.+....  .+++....+|+.++++||+|||...   ||||||||+|||++++.+  +||+|||+|+....
T Consensus       152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~~  229 (361)
T KOG1187|consen  152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGPE  229 (361)
T ss_pred             EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC--EEccCccCcccCCc
Confidence            9999999999998443  8999999999999999999999853   999999999999997776  99999999976542


Q ss_pred             cCCCCCCcc-ccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCC--ChHHHHH----HhcC----CCCCC
Q 040569          154 NEDDEGKPI-CGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVA--DPISALH----RIGF----SSDTP  222 (385)
Q Consensus       154 ~~~~~~~~~-~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~--~~~~~~~----~~~~----~~~~~  222 (385)
                      . ....... .||.+|+|||++..+..+.++||||||+++.||+||+.|.....  .......    .+..    ..-.|
T Consensus       230 ~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~  308 (361)
T KOG1187|consen  230 G-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDP  308 (361)
T ss_pred             c-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCC
Confidence            1 2222222 79999999999999999999999999999999999998876431  1111111    1110    11122


Q ss_pred             CCC-CcCC--HH---HHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          223 EIP-GYMS--KQ---AQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       223 ~~~-~~~s--~~---~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .+. ...+  .+   +..+..+|++.+|.+||++.|+++
T Consensus       309 ~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  309 RLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             CccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            222 2233  23   445667999999999999999864

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.2e-40  Score=315.24  Aligned_cols=246  Identities=22%  Similarity=0.291  Sum_probs=199.5

Q ss_pred             CceeeceeeccCceEEEEEEEC-----CCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN-----RSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|+..+.||+|+||.||+|.++     .++..+|+|.+....    ...+.+|+.+++++.||||+++++++.....   
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~---   82 (288)
T cd05050           6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP---   82 (288)
T ss_pred             hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc---
Confidence            6889999999999999999875     367899999886543    3457789999999999999999998765443   


Q ss_pred             EEEEEEeecCCCCHHHHHHcC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCE
Q 040569           73 LYNLFLEYAPGGTLTDAIRSG----------------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNI  130 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~----------------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NI  130 (385)
                       +++++||+++|+|.+++...                      ..+++..+..++.||+.||.|||++|++||||||+||
T Consensus        83 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni  161 (288)
T cd05050          83 -MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC  161 (288)
T ss_pred             -cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence             56999999999999999732                      2367888999999999999999999999999999999


Q ss_pred             EeecCCCCCeEEeecCceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCCh
Q 040569          131 LVSKDNEQGAKIADFGCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADP  208 (385)
Q Consensus       131 Li~~~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~  208 (385)
                      |++.++.  +||+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||... ..
T Consensus       162 l~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~-~~  238 (288)
T cd05050         162 LVGENMV--VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM-AH  238 (288)
T ss_pred             EecCCCc--eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-CH
Confidence            9987665  99999999876532211 11122234667999999998999999999999999999998 88898654 33


Q ss_pred             HHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          209 ISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ......+. .......+..++.++.+|+.+||+.+|.+|||+.|+++
T Consensus       239 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         239 EEVIYYVR-DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            33333332 22333445668899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9.6e-41  Score=322.97  Aligned_cols=251  Identities=27%  Similarity=0.363  Sum_probs=201.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++.+.||+|+||+||+|.++.+++.+|+|.+...     ..+.+.+|+++++++.||||+++++++.....   ..++
T Consensus        11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~---~~~l   87 (328)
T cd07856          11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE---DIYF   87 (328)
T ss_pred             ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC---cEEE
Confidence            589999999999999999999999999999987532     24567789999999999999999998765332   2568


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      ++||+ +++|.++++.+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.  +||+|||++.....   
T Consensus        88 v~e~~-~~~L~~~~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~--~~l~dfg~~~~~~~---  160 (328)
T cd07856          88 VTELL-GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD--LKICDFGLARIQDP---  160 (328)
T ss_pred             Eeehh-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC--EEeCccccccccCC---
Confidence            99998 56999888754 5899999999999999999999999999999999999987655  99999999875421   


Q ss_pred             CCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHH--HH--------------------
Q 040569          157 DEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISA--LH--------------------  213 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~--~~--------------------  213 (385)
                       ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.........  +.                    
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd07856         161 -QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL  239 (328)
T ss_pred             -CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence             2233467889999999866 56889999999999999999999999754221100  00                    


Q ss_pred             ----HhcCCCCC--CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          214 ----RIGFSSDT--PEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       214 ----~~~~~~~~--~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                          ........  ......+++.+.++|.+||+.+|++|||+++++.|||+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~  295 (328)
T cd07856         240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH  295 (328)
T ss_pred             HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence                00000000  011124688999999999999999999999999999997543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=9.1e-41  Score=317.72  Aligned_cols=251  Identities=26%  Similarity=0.427  Sum_probs=200.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++.+.||+|+||+||+|.++.+++.+|||.+....    ...+.+|+.++.++ .||||+++++++.....    .++
T Consensus        16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~----~~~   91 (296)
T cd06618          16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD----VFI   91 (296)
T ss_pred             hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe----EEE
Confidence            6889999999999999999999999999999986432    23455677767666 59999999998766443    679


Q ss_pred             EEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           77 FLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~-~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +|||+.+ +|.+++.. ...+++..+..++.||+.||+|||+ .||+||||+|+||+++.++.  +||+|||++......
T Consensus        92 v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~--~kL~dfg~~~~~~~~  168 (296)
T cd06618          92 CMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN--VKLCDFGISGRLVDS  168 (296)
T ss_pred             EeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCC--EEECccccchhccCC
Confidence            9999854 88888764 5579999999999999999999997 59999999999999987655  999999998765322


Q ss_pred             CCCCCCccccCCcccChhhhcCCC----CCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCC--CcC
Q 040569          155 EDDEGKPICGTPICMAPEVARGEE----QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP--GYM  228 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~  228 (385)
                      .  ......|++.|+|||.+.+..    ++.++||||||+++|+|++|+.||.........+..+.. ...+.++  ..+
T Consensus       169 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  245 (296)
T cd06618         169 K--AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ-EEPPSLPPNEGF  245 (296)
T ss_pred             C--cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc-CCCCCCCCCCCC
Confidence            1  122335788999999997654    788999999999999999999999764333333333322 2222222  246


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       229 s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ++++.+|+.+||.+||.+||++.++++|||+...
T Consensus       246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence            8999999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.5e-41  Score=315.08  Aligned_cols=237  Identities=17%  Similarity=0.321  Sum_probs=190.7

Q ss_pred             ceeeccCceEEEEEEECCCCcE-------EEEEeccCCCH---HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            7 QTIGRGSTATVSIGMSNRSSEV-------FAVKSAELSNS---EFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~-------~AvK~~~~~~~---~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +.||+|+||+||+|.++.++..       +|+|.+.....   +.+.+|..+++.+.||||+++++++.....    .++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~----~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDE----SIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCC----cEE
Confidence            4799999999999998665443       88888765432   456789999999999999999998876544    568


Q ss_pred             EEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCC------CeEEeecCcee
Q 040569           77 FLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQ------GAKIADFGCAR  149 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~------~~kL~DFG~a~  149 (385)
                      ||||+++|+|.+++.. +..+++..+..++.||+.||+|||++||+||||||+||+++.++..      .+|++|||++.
T Consensus        77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            9999999999999975 4468999999999999999999999999999999999999876542      26999999987


Q ss_pred             eecccCCCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCC-CCCCCCCChHHHHHHhcCCCCCCCCCCc
Q 040569          150 RARVNEDDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGR-PPWPDVADPISALHRIGFSSDTPEIPGY  227 (385)
Q Consensus       150 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (385)
                      ....     .....|++.|+|||++.+. .++.++|||||||++|+|++|. .||... +........   .....+|..
T Consensus       157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~-~~~~~~~~~---~~~~~~~~~  227 (258)
T cd05078         157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL-DSQKKLQFY---EDRHQLPAP  227 (258)
T ss_pred             ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc-cHHHHHHHH---HccccCCCC
Confidence            5421     2234688899999999864 5789999999999999999985 666543 332222211   123345556


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          228 MSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       228 ~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      .+.++.+|+.+||++||++|||++++++.
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         228 KWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             CcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            77899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-40  Score=306.88  Aligned_cols=240  Identities=24%  Similarity=0.359  Sum_probs=196.4

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecC
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAP   82 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (385)
                      +.||+|+||.||++.+.. ++.+|+|.+....    .+.+.+|+++++++.||||+++++++.....    .++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~~v~e~~~   75 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQP----IYIVMELVP   75 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCC----eEEEEEcCC
Confidence            479999999999999987 9999999876532    3467889999999999999999998766544    668999999


Q ss_pred             CCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC-C
Q 040569           83 GGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG-K  160 (385)
Q Consensus        83 ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~-~  160 (385)
                      |++|.+++.. ...+++..+..++.|++.+|+|||++|++||||||+|||++.++.  +||+|||++........... .
T Consensus        76 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc--EEEeeccccccccCCcceeccc
Confidence            9999999974 456899999999999999999999999999999999999987665  99999999986532111111 1


Q ss_pred             ccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHh
Q 040569          161 PICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC  239 (385)
Q Consensus       161 ~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~c  239 (385)
                      ...++..|+|||.+.+..++.++|+|||||++|+|++ |..||..... ......+.. ......+...+.++.+|+.+|
T Consensus       154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~  231 (251)
T cd05041         154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-QQTRERIES-GYRMPAPQLCPEEIYRLMLQC  231 (251)
T ss_pred             cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-HHHHHHHhc-CCCCCCCccCCHHHHHHHHHH
Confidence            2234567999999998889999999999999999999 8999976532 222223321 223334566889999999999


Q ss_pred             hhcCCCCCCCHHHHHh
Q 040569          240 LIRNPGERWSASELLE  255 (385)
Q Consensus       240 L~~dP~~Rps~~elL~  255 (385)
                      |..+|.+|||+.|+++
T Consensus       232 l~~~p~~Rp~~~ell~  247 (251)
T cd05041         232 WAYDPENRPSFSEIYN  247 (251)
T ss_pred             hccChhhCcCHHHHHH
Confidence            9999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=316.83  Aligned_cols=247  Identities=21%  Similarity=0.259  Sum_probs=194.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCC--------------cEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSS--------------EVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGC   63 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~--------------~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~   63 (385)
                      +|++.+.||+|+||.||++.+..++              ..+|+|.+....    .+.+.+|++++++++||||++++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~   85 (295)
T cd05097           6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV   85 (295)
T ss_pred             hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence            5889999999999999999875432              358999886532    3467889999999999999999998


Q ss_pred             eeeccCCeEEEEEEEeecCCCCHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEE
Q 040569           64 DISEENGKILYNLFLEYAPGGTLTDAIRSG------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNIL  131 (385)
Q Consensus        64 ~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NIL  131 (385)
                      +.....    .++||||+++++|.+++...            ..+++..+..++.||+.||+|||++|++||||||+||+
T Consensus        86 ~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          86 CVSDDP----LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EcCCCc----cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            765443    66999999999999998632            13678899999999999999999999999999999999


Q ss_pred             eecCCCCCeEEeecCceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh--CCCCCCCCCCh
Q 040569          132 VSKDNEQGAKIADFGCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT--GRPPWPDVADP  208 (385)
Q Consensus       132 i~~~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--G~~Pf~~~~~~  208 (385)
                      ++.++.  +||+|||++......... ......+++.|+|||++.+..++.++|||||||++|+|++  |..||......
T Consensus       162 l~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~  239 (295)
T cd05097         162 VGNHYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE  239 (295)
T ss_pred             EcCCCc--EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence            987655  999999999765322111 1122345678999999998889999999999999999988  66788654322


Q ss_pred             HHHHHHh------cCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          209 ISALHRI------GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       209 ~~~~~~~------~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      . .+..+      .........+...++.+++|+.+||..+|.+|||+.++++
T Consensus       240 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         240 Q-VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             H-HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            2 11111      0111122234457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.3e-40  Score=309.16  Aligned_cols=239  Identities=25%  Similarity=0.361  Sum_probs=197.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +|++.+.||+|+||.||++..  +++.+|+|.+... ..+.+.+|+.++++++||||+++++++....     .+++|||
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~v~e~   79 (254)
T cd05083           7 KLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-----LYIVMEL   79 (254)
T ss_pred             HceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-----cEEEEEC
Confidence            589999999999999999864  6889999988654 3457789999999999999999999875422     4689999


Q ss_pred             cCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           81 APGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        81 ~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      +++++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.  +||+|||+++.....    
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~--~kl~Dfg~~~~~~~~----  153 (254)
T cd05083          80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV--AKVSDFGLARVGSMG----  153 (254)
T ss_pred             CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc--EEECCCccceecccc----
Confidence            9999999999743  35899999999999999999999999999999999999987665  999999999864321    


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      ......+..|+|||.+.+..++.++|+|||||++|+|++ |+.||.... .......+.. ...+..+..+++.+.+|+.
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~li~  231 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-LKEVKECVEK-GYRMEPPEGCPADVYVLMT  231 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-HHHHHHHHhC-CCCCCCCCcCCHHHHHHHH
Confidence            112234568999999998899999999999999999998 999997643 3333333322 2233345568899999999


Q ss_pred             HhhhcCCCCCCCHHHHHh
Q 040569          238 KCLIRNPGERWSASELLE  255 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~  255 (385)
                      +||+++|.+||++.++++
T Consensus       232 ~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         232 SCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999986

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.6e-40  Score=321.74  Aligned_cols=247  Identities=24%  Similarity=0.336  Sum_probs=198.8

Q ss_pred             CceeeceeeccCceEEEEEEECCC-------CcEEEEEeccCCC----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccC
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRS-------SEVFAVKSAELSN----SEFLQREQRILSAL-ACPQIVAYKGCDISEEN   69 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~-------~~~~AvK~~~~~~----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~   69 (385)
                      +|++++.||+|+||.||+|.+...       +..+|+|.+....    .+.+.+|+++++++ .||||+++++++.....
T Consensus        13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   92 (334)
T cd05100          13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP   92 (334)
T ss_pred             HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence            488999999999999999986432       2368999876432    34677899999999 89999999998765433


Q ss_pred             CeEEEEEEEeecCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEee
Q 040569           70 GKILYNLFLEYAPGGTLTDAIRSG----------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVS  133 (385)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~l~~~----------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~  133 (385)
                          .++++||+++|+|.+++...                ..++...+..++.||+.||.|||++|++||||||+|||++
T Consensus        93 ----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~  168 (334)
T cd05100          93 ----LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT  168 (334)
T ss_pred             ----eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence                56999999999999999742                2367788899999999999999999999999999999998


Q ss_pred             cCCCCCeEEeecCceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHH
Q 040569          134 KDNEQGAKIADFGCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISA  211 (385)
Q Consensus       134 ~~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~  211 (385)
                      .++.  +||+|||+++........ ......++..|||||++.+..++.++|||||||++|+|++ |..||... +....
T Consensus       169 ~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~  245 (334)
T cd05100         169 EDNV--MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEEL  245 (334)
T ss_pred             CCCc--EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHH
Confidence            7765  999999999865322111 1122234567999999999999999999999999999998 89999764 33333


Q ss_pred             HHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          212 LHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       212 ~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ...+. ....+..+...+.++.+|+.+||+.+|.+|||+.|++++
T Consensus       246 ~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         246 FKLLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            33332 233444566788999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=7e-42  Score=303.78  Aligned_cols=252  Identities=24%  Similarity=0.331  Sum_probs=200.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccC-CeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEEN-GKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~~~~~lv   77 (385)
                      .|++.+.||.|||+-||++.+-.++..||+|++....   .+...+|++..++++|||+++++++...... +....||+
T Consensus        22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll  101 (302)
T KOG2345|consen   22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLL  101 (302)
T ss_pred             eEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEE
Confidence            5899999999999999999999999999999886544   4567799999999999999999887654433 55667899


Q ss_pred             EeecCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           78 LEYAPGGTLTDAIR----SGTCLEEGRIRSHTRAVLLGLQYLHSNG--IVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~----~~~~l~e~~~~~i~~qil~gL~yLH~~g--ivHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      +.|...|||.+.+.    ++..++|.++..|+.+|++||++||+..  ++||||||.|||++.++.  ++|.|||.+...
T Consensus       102 ~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~--~vl~D~GS~~~a  179 (302)
T KOG2345|consen  102 LPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL--PVLMDLGSATQA  179 (302)
T ss_pred             eehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc--eEEEeccCcccc
Confidence            99999999999986    4557999999999999999999999998  999999999999987665  999999998765


Q ss_pred             cccCCCC--------CCccccCCcccChhhhcCC---CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHH-HhcC-C
Q 040569          152 RVNEDDE--------GKPICGTPICMAPEVARGE---EQGFPADVWALGCTVLEMATGRPPWPDVADPISALH-RIGF-S  218 (385)
Q Consensus       152 ~~~~~~~--------~~~~~Gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~-~~~~-~  218 (385)
                      .......        ...-..|..|.|||.+.-.   ..+.++|||||||++|.|+.|..||.........+. .+.. .
T Consensus       180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q  259 (302)
T KOG2345|consen  180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQ  259 (302)
T ss_pred             ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccc
Confidence            3222111        1122358899999999654   457899999999999999999999963211100000 0000 0


Q ss_pred             CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          219 SDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       219 ~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ...|.- ..+|+.+.+||+.||+.||.+||++.+++.+
T Consensus       260 ~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  260 ISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             cccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            111221 2289999999999999999999999999874

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-40  Score=309.08  Aligned_cols=235  Identities=20%  Similarity=0.275  Sum_probs=190.3

Q ss_pred             ceeeccCceEEEEEEECCCC----------cEEEEEeccCCC--HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            7 QTIGRGSTATVSIGMSNRSS----------EVFAVKSAELSN--SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~----------~~~AvK~~~~~~--~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +.||+|+||.||+|.+..++          ..+++|......  ...+.+|+.++++++||||+++++++.. ..    .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~----~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DE----N   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CC----c
Confidence            47999999999999998777          357888776443  4577889999999999999999998766 22    4


Q ss_pred             EEEEeecCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCC-----CeEEeecCce
Q 040569           75 NLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQ-----GAKIADFGCA  148 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~-~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~-----~~kL~DFG~a  148 (385)
                      ++||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++..     .+||+|||++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            68999999999999998554 78999999999999999999999999999999999999876522     3899999999


Q ss_pred             eeecccCCCCCCccccCCcccChhhhcCC--CCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCC
Q 040569          149 RRARVNEDDEGKPICGTPICMAPEVARGE--EQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIP  225 (385)
Q Consensus       149 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  225 (385)
                      .....     .....++..|+|||++.+.  .++.++|||||||++++|++ |..||.... ..........   ....+
T Consensus       156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~~---~~~~~  226 (259)
T cd05037         156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQD---QHRLP  226 (259)
T ss_pred             ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHhc---CCCCC
Confidence            87532     2234577889999999877  78899999999999999999 688886653 2222221111   11222


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          226 GYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       226 ~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ...+..+.+|+.+||..+|.+|||+.++++
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         227 MPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            233489999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.4e-40  Score=311.06  Aligned_cols=243  Identities=23%  Similarity=0.350  Sum_probs=195.4

Q ss_pred             ceeeccCceEEEEEEECCCC------cEEEEEeccCC----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            7 QTIGRGSTATVSIGMSNRSS------EVFAVKSAELS----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~------~~~AvK~~~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +.||+|+||.||+|.++...      +.+|+|.+...    ....+.+|+.+++.+.||||+++++++.....    .++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~~   76 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP----QYI   76 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCC----eEE
Confidence            46999999999999986544      78999987543    24567789999999999999999998765443    668


Q ss_pred             EEeecCCCCHHHHHHc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC---CCCeEEeecC
Q 040569           77 FLEYAPGGTLTDAIRS-------GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN---EQGAKIADFG  146 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~-------~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~---~~~~kL~DFG  146 (385)
                      +|||+++++|.+++..       ...+++..+..++.||+.||.|||+++++|+||||+||+++.++   ...+||+|||
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            9999999999999963       13478899999999999999999999999999999999998765   1138999999


Q ss_pred             ceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCC
Q 040569          147 CARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEI  224 (385)
Q Consensus       147 ~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  224 (385)
                      +++........ ......++..|+|||++.+..++.++|||||||++|+|++ |+.||....+ ......+. .......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-~~~~~~~~-~~~~~~~  234 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-QEVLQHVT-AGGRLQK  234 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-HHHHHHHh-cCCccCC
Confidence            99765322111 1122345788999999999999999999999999999998 9999976433 33333332 2234445


Q ss_pred             CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          225 PGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       225 ~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      +..+|+.+.+||.+||.++|.+||++.++++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            6668999999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.1e-40  Score=315.54  Aligned_cols=248  Identities=21%  Similarity=0.256  Sum_probs=191.9

Q ss_pred             CceeeceeeccCceEEEEEEECCC---CcEEEEEeccCCCH----HH----------HHHHHHHHHhcCCCCeeeeeeee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRS---SEVFAVKSAELSNS----EF----------LQREQRILSALACPQIVAYKGCD   64 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~---~~~~AvK~~~~~~~----~~----------~~~E~~il~~l~hpnIv~~~~~~   64 (385)
                      +|++.+.||+|+||+||+|.+..+   +..+|+|.......    +.          ...+...++.+.|+||++++++.
T Consensus        13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~   92 (294)
T PHA02882         13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG   92 (294)
T ss_pred             ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence            599999999999999999999877   77888886543221    10          11233445567899999999877


Q ss_pred             eeccCCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEee
Q 040569           65 ISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIAD  144 (385)
Q Consensus        65 ~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~D  144 (385)
                      ........+.++++|++.. ++.+.++.....++..+..++.||+.||+|||+++|+||||||+|||++.++.  +||+|
T Consensus        93 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~--~~l~D  169 (294)
T PHA02882         93 SFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR--GYIID  169 (294)
T ss_pred             eEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc--EEEEE
Confidence            6555444456688898854 78888876666789999999999999999999999999999999999987655  99999


Q ss_pred             cCceeeecccCC------CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHH------
Q 040569          145 FGCARRARVNED------DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISAL------  212 (385)
Q Consensus       145 FG~a~~~~~~~~------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~------  212 (385)
                      ||+|+.......      .......||+.|+|||++.+..++.++|||||||+++||++|+.||..........      
T Consensus       170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~  249 (294)
T PHA02882        170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCD  249 (294)
T ss_pred             cCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHH
Confidence            999987642221      11233469999999999999999999999999999999999999997653322211      


Q ss_pred             --HHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          213 --HRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       213 --~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                        .++..  ... .....++++.++++.|+..+|.+||++.++++
T Consensus       250 ~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        250 FIKRLHE--GKI-KIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHhhh--hhh-ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence              22211  111 12345789999999999999999999999975

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.3e-40  Score=314.90  Aligned_cols=247  Identities=23%  Similarity=0.281  Sum_probs=194.4

Q ss_pred             CceeeceeeccCceEEEEEEECC----------------CCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNR----------------SSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYK   61 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~----------------~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~   61 (385)
                      +|++.+.||+|+||+||++.+..                ++..+|+|.+....    ...+.+|+.+|++++||||++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~   85 (296)
T cd05095           6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL   85 (296)
T ss_pred             hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence            58999999999999999986432                34579999886432    34678999999999999999999


Q ss_pred             eeeeeccCCeEEEEEEEeecCCCCHHHHHHcCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCE
Q 040569           62 GCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-----------CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNI  130 (385)
Q Consensus        62 ~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~~-----------~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NI  130 (385)
                      +++.....    .+++|||+++|+|.+++....           .+++..+..++.||+.||+|||++|++||||||+||
T Consensus        86 ~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni  161 (296)
T cd05095          86 AVCITSDP----LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC  161 (296)
T ss_pred             EEEecCCc----cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence            98766543    679999999999999997432           366778999999999999999999999999999999


Q ss_pred             EeecCCCCCeEEeecCceeeecccCCCC-CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh--CCCCCCCCCC
Q 040569          131 LVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT--GRPPWPDVAD  207 (385)
Q Consensus       131 Li~~~~~~~~kL~DFG~a~~~~~~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--G~~Pf~~~~~  207 (385)
                      |++.++.  +||+|||+++......... .....+++.|+|||+..+..++.++|||||||++|||++  |..||.....
T Consensus       162 li~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         162 LVGKNYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             EEcCCCC--EEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            9987655  9999999998653222111 112234678999999988889999999999999999998  7788865432


Q ss_pred             hHHHHHHh------cCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          208 PISALHRI------GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       208 ~~~~~~~~------~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .. .....      .........+..+++.+.+|+.+||++||.+||++.++++
T Consensus       240 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         240 EQ-VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HH-HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            22 11111      0011112234457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-40  Score=310.90  Aligned_cols=245  Identities=23%  Similarity=0.332  Sum_probs=200.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCc----EEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSE----VFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~----~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|++++.||+|+||+||+|.++.+++    .+|+|......    ...+.+|+.++++++||||+++++++.. ..    
T Consensus         8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~----   82 (279)
T cd05057           8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ----   82 (279)
T ss_pred             HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc----
Confidence            58899999999999999999877665    58999876543    2467789999999999999999998765 22    


Q ss_pred             EEEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           74 YNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      .++++||+++|+|.+++.. ...+++..+..++.||+.||+|||++|++||||||+||+++.++.  +||+|||+++...
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~  160 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLD  160 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe--EEECCCccccccc
Confidence            5689999999999999985 456999999999999999999999999999999999999987665  9999999998764


Q ss_pred             ccCCCC-CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          153 VNEDDE-GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       153 ~~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      ...... .....++..|+|||.+....++.++|+|||||++|||++ |+.||... ........+. .......+...+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~-~~~~~~~~~~~~~  238 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLE-KGERLPQPPICTI  238 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHh-CCCCCCCCCCCCH
Confidence            222111 111223568999999988889999999999999999998 99999764 3333333332 2333344556789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .+.+++.+||..+|.+||++.++++
T Consensus       239 ~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         239 DVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-42  Score=332.18  Aligned_cols=280  Identities=28%  Similarity=0.421  Sum_probs=240.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +..++-+||-|+||.|-++..+.....+|+|.+++      .+.+.+..|-+||..+.+|.||++|..|.+..    +.|
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k----yvY  496 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK----YVY  496 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch----hhh
Confidence            45678899999999999999887766799997764      23567788999999999999999998765543    366


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      ++||-|-||.|...+...+.+++..++.|+..+++|++|||++|||.|||||+|.+++.++.  +||.|||+|+.+..+ 
T Consensus       497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--~KLVDFGFAKki~~g-  573 (732)
T KOG0614|consen  497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--LKLVDFGFAKKIGSG-  573 (732)
T ss_pred             hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--eEEeehhhHHHhccC-
Confidence            89999999999999999899999999999999999999999999999999999999998777  999999999988543 


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                       ...-++||||.|.|||++.+...+.++|.||||+++|||++|.+||... +++.....|....+.-.+|..++..+.++
T Consensus       574 -~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~-dpmktYn~ILkGid~i~~Pr~I~k~a~~L  651 (732)
T KOG0614|consen  574 -RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV-DPMKTYNLILKGIDKIEFPRRITKTATDL  651 (732)
T ss_pred             -CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC-chHHHHHHHHhhhhhhhcccccchhHHHH
Confidence             3345789999999999999999999999999999999999999999885 67777777777777788899999999999


Q ss_pred             HHHhhhcCCCCCCC-----HHHHHhCccccccccc---ccccCCCCCCCCCCCCccccccccc
Q 040569          236 LSKCLIRNPGERWS-----ASELLEHGFVKEQNFK---LSTLTEPETYNSESPTSVLNQQLWD  290 (385)
Q Consensus       236 l~~cL~~dP~~Rps-----~~elL~hp~~~~~~~~---~~~~~~~~~~~~~~p~~~~~~~~~~  290 (385)
                      |+++...+|.+|..     ..++-+|.||...++.   ...+++|-.....+|+.+.+...+.
T Consensus       652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~~p  714 (732)
T KOG0614|consen  652 IKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDNFP  714 (732)
T ss_pred             HHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccCCC
Confidence            99999999999995     7899999999987653   4445555555666777666654443

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.6e-40  Score=308.98  Aligned_cols=242  Identities=23%  Similarity=0.337  Sum_probs=188.2

Q ss_pred             ceeeccCceEEEEEEEC--CCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            7 QTIGRGSTATVSIGMSN--RSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~--~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +.||+|+||.||+|...  .++..+|+|.+....    ...+.+|+.++++++||||+++++.+.....    +++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTP----YLLVMEF   76 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCC----cEEEEEC
Confidence            46999999999999764  456789999886532    2357789999999999999999998765443    5689999


Q ss_pred             cCCCCHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           81 APGGTLTDAIRSG-----TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        81 ~~ggsL~~~l~~~-----~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +++|+|.+++...     ..+++..+..++.|++.||+|||++|++||||||+||+++.++.  +||+|||+++......
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~--~kL~dfg~~~~~~~~~  154 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT--VKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEECCccccccccCcc
Confidence            9999999999632     23567788899999999999999999999999999999987655  9999999987542211


Q ss_pred             C-CCCCccccCCcccChhhhcCC-------CCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHh---cCCCCCCC
Q 040569          156 D-DEGKPICGTPICMAPEVARGE-------EQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRI---GFSSDTPE  223 (385)
Q Consensus       156 ~-~~~~~~~Gt~~y~aPE~~~~~-------~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~---~~~~~~~~  223 (385)
                      . .......|++.|+|||++.+.       .++.++|||||||++|+|++ |+.||............+   ......+.
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR  234 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence            1 112234578899999998643       35789999999999999996 999997654433222222   11222334


Q ss_pred             CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          224 IPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       224 ~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      +....++.+.+++.+|+ .+|.+|||+++++.
T Consensus       235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             cCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            44457889999999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.6e-40  Score=309.50  Aligned_cols=237  Identities=18%  Similarity=0.271  Sum_probs=186.5

Q ss_pred             ceeeccCceEEEEEEECCC------------CcEEEEEeccCCCH---HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCe
Q 040569            7 QTIGRGSTATVSIGMSNRS------------SEVFAVKSAELSNS---EFLQREQRILSALACPQIVAYKGCDISEENGK   71 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~------------~~~~AvK~~~~~~~---~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   71 (385)
                      +.||+|+||+||+|+....            ...+|+|.+.....   ..+.+|+.+++.++||||+++++++.....  
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~--   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE--   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC--
Confidence            4689999999999985422            33588998765432   356789999999999999999998765543  


Q ss_pred             EEEEEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCC-----CeEEeec
Q 040569           72 ILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQ-----GAKIADF  145 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~-----~~kL~DF  145 (385)
                        .+++|||+++|+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++..     .+|++||
T Consensus        79 --~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          79 --NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             --CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence              5689999999999999874 5569999999999999999999999999999999999999755421     2799999


Q ss_pred             CceeeecccCCCCCCccccCCcccChhhhc-CCCCCCCCChHHHHHHHHHHH-hCCCCCCCCCChHHHHHHhcCCCCCCC
Q 040569          146 GCARRARVNEDDEGKPICGTPICMAPEVAR-GEEQGFPADVWALGCTVLEMA-TGRPPWPDVADPISALHRIGFSSDTPE  223 (385)
Q Consensus       146 G~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell-tG~~Pf~~~~~~~~~~~~~~~~~~~~~  223 (385)
                      |++.....     .....|+..|||||.+. +..++.++|||||||++|+|+ +|..||........  .... .. ...
T Consensus       157 g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~-~~-~~~  227 (262)
T cd05077         157 GIPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--ERFY-EG-QCM  227 (262)
T ss_pred             CCCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--HHHH-hc-Ccc
Confidence            99875421     12345788999999987 466889999999999999998 58888865422111  1111 11 111


Q ss_pred             CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          224 IPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       224 ~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      .....++++.+||.+||+.||.+||++.+++++
T Consensus       228 ~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         228 LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            223356889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.2e-40  Score=307.46  Aligned_cols=243  Identities=26%  Similarity=0.349  Sum_probs=192.0

Q ss_pred             ceeeccCceEEEEEEECC---CCcEEEEEeccCC-C---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            7 QTIGRGSTATVSIGMSNR---SSEVFAVKSAELS-N---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~---~~~~~AvK~~~~~-~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +.||+|+||+||+|.+..   .+..+|+|.+... .   .+.+.+|+.+++.++||||+++++++...+.   ..+++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG---SPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCC---CcEEEEe
Confidence            479999999999998643   3467999987532 2   3466789999999999999999997654332   2558999


Q ss_pred             ecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC--
Q 040569           80 YAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED--  156 (385)
Q Consensus        80 y~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~--  156 (385)
                      |+++|+|.+++.+ ...+++..+..++.||+.||.|||+.|++||||||+|||++.++.  +||+|||+++.......  
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCccccccccCCccee
Confidence            9999999999974 445678888999999999999999999999999999999987665  99999999975432111  


Q ss_pred             -CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          157 -DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       157 -~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                       .......+++.|+|||.+.+..++.++|||||||++|||++ |.+||... +.......+ .....+..+..+++.+.+
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~  233 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DSFDITVYL-LQGRRLLQPEYCPDPLYE  233 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHH-hcCCCCCCCCcCCHHHHH
Confidence             11123346778999999988889999999999999999999 46667654 333333333 223344445667899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhC
Q 040569          235 FLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ++.+||..+|++||++.++++.
T Consensus       234 li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         234 VMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.8e-40  Score=317.00  Aligned_cols=246  Identities=23%  Similarity=0.317  Sum_probs=198.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCc----EEEEEeccCCCH----HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSE----VFAVKSAELSNS----EFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~----~~AvK~~~~~~~----~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|+..+.||+|+||.||+|.++.++.    .+|+|.+.....    ..+.+|+.+++++.||||+++++++....     
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-----   82 (303)
T cd05110           8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT-----   82 (303)
T ss_pred             hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC-----
Confidence            68899999999999999999987776    468887764432    35678999999999999999999875432     


Q ss_pred             EEEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           74 YNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      .++++||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~  160 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLE  160 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc--eEEcccccccccc
Confidence            3479999999999999975 446899999999999999999999999999999999999987655  9999999998653


Q ss_pred             ccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          153 VNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       153 ~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      ..... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.... .......+ .....+..+...+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-~~~~~~~~-~~~~~~~~~~~~~~  238 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-TREIPDLL-EKGERLPQPPICTI  238 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHH-HCCCCCCCCCCCCH
Confidence            22211 1222345778999999998899999999999999999997 999997542 22222222 22223333455788


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      .+.+++.+||..+|++||++.++++.
T Consensus       239 ~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         239 DVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999999874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=312.05  Aligned_cols=260  Identities=29%  Similarity=0.521  Sum_probs=223.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      ||..++.||+|+|++|-+++++.|.+.||+|+++++      +...++.|..+..+- +||.+|.++.+|..+..    +
T Consensus       251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr----l  326 (593)
T KOG0695|consen  251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR----L  326 (593)
T ss_pred             cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce----E
Confidence            689999999999999999999999999999988643      245678899998887 89999999999876654    5


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++|.||++||+|--.++++.+++|+.++.|...|+.||.|||++||+.||||.+|+|++..+.  +||.|+|+++.-- .
T Consensus       327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh--ikltdygmcke~l-~  403 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGL-G  403 (593)
T ss_pred             EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc--eeecccchhhcCC-C
Confidence            689999999999999999999999999999999999999999999999999999999998776  9999999998643 3


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCC------CChHHHHHHhcCCCCCCCCCCcC
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDV------ADPISALHRIGFSSDTPEIPGYM  228 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~------~~~~~~~~~~~~~~~~~~~~~~~  228 (385)
                      ......++||||.|.|||++++..|++.+|.|+||++++||+.|+.||.-.      .+....+.++.... .-.+|..+
T Consensus       404 ~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek-qiriprsl  482 (593)
T KOG0695|consen  404 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK-QIRIPRSL  482 (593)
T ss_pred             CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh-ccccccee
Confidence            334467889999999999999999999999999999999999999999632      23444555553332 34577889


Q ss_pred             CHHHHHHHHHhhhcCCCCCCC------HHHHHhCccccccccccccc
Q 040569          229 SKQAQDFLSKCLIRNPGERWS------ASELLEHGFVKEQNFKLSTL  269 (385)
Q Consensus       229 s~~~~~ll~~cL~~dP~~Rps------~~elL~hp~~~~~~~~~~~~  269 (385)
                      |-.+..+++..|++||.+|..      ..++-.|+||+..++....+
T Consensus       483 svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leq  529 (593)
T KOG0695|consen  483 SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQ  529 (593)
T ss_pred             ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhh
Confidence            999999999999999999984      56899999999887754443

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=311.25  Aligned_cols=248  Identities=31%  Similarity=0.448  Sum_probs=201.7

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      |+..+.||+|+||.||+|++..+++.+|+|.+....     .+.+.+|+.++++++||||+++++++.....    +++|
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~----~~~v   76 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERK----LYLV   76 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCc----eEEE
Confidence            678899999999999999999999999999887532     2456789999999999999999998765533    6799


Q ss_pred             EeecCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           78 LEYAPGGTLTDAIRSG-TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~-~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      +||+++ +|.+++.+. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.  +||+|||+++.......
T Consensus        77 ~e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          77 FEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV--LKLADFGLARAFGIPLR  153 (282)
T ss_pred             ecCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC--EEEecCCcccccCCCcc
Confidence            999984 999999865 57999999999999999999999999999999999999987655  99999999987643222


Q ss_pred             CCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc-------------------
Q 040569          157 DEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG-------------------  216 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~-------------------  216 (385)
                       ......++..|+|||.+.+. .++.++|||||||++++|++|++||....... .+.++.                   
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID-QLFKIFQILGTPTEESWPGVTKLPD  231 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHHHhCCCcHHHHHhhccccc
Confidence             22334567889999999776 78999999999999999999999997643221 111110                   


Q ss_pred             CCCCCCC--------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          217 FSSDTPE--------IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       217 ~~~~~~~--------~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      .....+.        ....++..+.+||.+||..+|++||++.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            0000010        111247889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.4e-40  Score=310.72  Aligned_cols=247  Identities=21%  Similarity=0.283  Sum_probs=199.8

Q ss_pred             CceeeceeeccCceEEEEEEECC----CCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNR----SSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~----~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|++.+.||+|+||.||+|.+..    ++..+++|.+....    .+.+.+|+.++++++||||++++++......   .
T Consensus         7 ~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~---~   83 (280)
T cd05043           7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE---P   83 (280)
T ss_pred             heEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC---C
Confidence            58899999999999999999876    36889999876432    3457789999999999999999998665422   2


Q ss_pred             EEEEEeecCCCCHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeec
Q 040569           74 YNLFLEYAPGGTLTDAIRSG--------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADF  145 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~--------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DF  145 (385)
                      .++++||+++|+|.+++...        ..+++..+..++.||+.||+|||++|++||||||+||+++.++.  +||+||
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kl~d~  161 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ--VKITDN  161 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc--EEECCC
Confidence            55899999999999999642        45899999999999999999999999999999999999987655  999999


Q ss_pred             CceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCC
Q 040569          146 GCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPE  223 (385)
Q Consensus       146 G~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  223 (385)
                      |+++........ ......++..|+|||++.+..++.++|||||||++|+|++ |+.||... +.......+.. .....
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~-~~~~~  239 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI-DPFEMAAYLKD-GYRLA  239 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC-CHHHHHHHHHc-CCCCC
Confidence            999865322111 1122345678999999998889999999999999999999 99999764 44443333322 22233


Q ss_pred             CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          224 IPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       224 ~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .+..+++++.+++.+||..||++|||+.++++
T Consensus       240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         240 QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            45557899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.6e-40  Score=308.81  Aligned_cols=242  Identities=25%  Similarity=0.363  Sum_probs=187.1

Q ss_pred             ceeeccCceEEEEEEECC--CCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            7 QTIGRGSTATVSIGMSNR--SSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~--~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +.||+|+||+||+|....  ....+|+|.+....    ...+.+|+.+++.++||||+++++.+.....    +++||||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~----~~lv~e~   76 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIP----YLLVLEF   76 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCc----eEEEEEe
Confidence            469999999999996532  45678999775432    2356789999999999999999998765443    6799999


Q ss_pred             cCCCCHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           81 APGGTLTDAIRSGT-----CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        81 ~~ggsL~~~l~~~~-----~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +++|+|.+++....     ..++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||++.......
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~  154 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPED  154 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc--EEEeccccccccccch
Confidence            99999999997432     2467788999999999999999999999999999999987766  9999999987532211


Q ss_pred             C-CCCCccccCCcccChhhhcC-------CCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHh---cCCCCCCC
Q 040569          156 D-DEGKPICGTPICMAPEVARG-------EEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRI---GFSSDTPE  223 (385)
Q Consensus       156 ~-~~~~~~~Gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~---~~~~~~~~  223 (385)
                      . .......+++.|+|||++..       ..++.++|||||||++|+|++ |..||....+.......+   ......+.
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ  234 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence            1 11123346778999999753       346789999999999999999 888997654333222211   11223344


Q ss_pred             CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          224 IPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       224 ~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ++..+++.+.+++..|+ .||.+|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            55678999999999998 59999999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-43  Score=313.66  Aligned_cols=248  Identities=26%  Similarity=0.369  Sum_probs=204.6

Q ss_pred             eeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH----HHHHHHHHHHHh-cCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            4 TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSA-LACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~----~~~~~E~~il~~-l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +-+..||.|+||+|++..++.+|+++|||.+.....    ..+..|.+...+ -++||||+|||..+.+..    .+++|
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd----cWiCM  142 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD----CWICM  142 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc----eeeeH
Confidence            346789999999999999999999999999875432    345567765444 489999999999776655    67999


Q ss_pred             eecCCCCHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           79 EYAPGGTLTDAIR-----SGTCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        79 Ey~~ggsL~~~l~-----~~~~l~e~~~~~i~~qil~gL~yLH~-~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      |.|. .||..+.+     ++..++|+.+-.++...+.||.||.. .+|||||+||+|||++..|.  +||||||.+..+.
T Consensus       143 ELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~--vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  143 ELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD--VKLCDFGICGQLV  219 (361)
T ss_pred             HHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC--EeeecccchHhHH
Confidence            9995 48877764     45679999999999999999999986 59999999999999998777  9999999987753


Q ss_pred             ccCCCCCCccccCCcccChhhhcC--CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCC--C---
Q 040569          153 VNEDDEGKPICGTPICMAPEVARG--EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--P---  225 (385)
Q Consensus       153 ~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~---  225 (385)
                      ..-  ..+.-.|...|||||.+..  ..|+.++|+||||+++||++||+.|+....+...++.++... ..|.+  +   
T Consensus       220 ~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g-dpp~l~~~~~~  296 (361)
T KOG1006|consen  220 DSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG-DPPILLFDKEC  296 (361)
T ss_pred             HHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC-CCCeecCcccc
Confidence            221  1223368999999999953  468999999999999999999999999887778887777543 33332  2   


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          226 GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       226 ~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      ..+|..++.||..||.+|-+.||...+++++||++-
T Consensus       297 ~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~  332 (361)
T KOG1006|consen  297 VHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM  332 (361)
T ss_pred             cccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence            237899999999999999999999999999999864

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.9e-40  Score=308.28  Aligned_cols=246  Identities=25%  Similarity=0.425  Sum_probs=200.1

Q ss_pred             CceeeceeeccCceEEEEEEECC-CCcEEEEEeccCCC-------------HHHHHHHHHHHHh-cCCCCeeeeeeeeee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNR-SSEVFAVKSAELSN-------------SEFLQREQRILSA-LACPQIVAYKGCDIS   66 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~-~~~~~AvK~~~~~~-------------~~~~~~E~~il~~-l~hpnIv~~~~~~~~   66 (385)
                      +|++.+.||+|+||.||+|+++. +++.+|+|.+....             ...+.+|+.++++ +.||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            58999999999999999999987 78999999775321             1335578888875 699999999998765


Q ss_pred             ccCCeEEEEEEEeecCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEeecCCCCCeE
Q 040569           67 EENGKILYNLFLEYAPGGTLTDAIR----SGTCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSKDNEQGAK  141 (385)
Q Consensus        67 ~~~~~~~~~lv~Ey~~ggsL~~~l~----~~~~l~e~~~~~i~~qil~gL~yLH~-~givHrDlKp~NILi~~~~~~~~k  141 (385)
                      ...    .+++|||++|++|.+++.    .+..+++..+..++.|++.||.|||+ .|++|+||||+|||++.++.  +|
T Consensus        81 ~~~----~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~--~~  154 (269)
T cd08528          81 NDR----LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK--VT  154 (269)
T ss_pred             CCe----EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc--EE
Confidence            432    679999999999999874    35568999999999999999999996 78999999999999987665  99


Q ss_pred             EeecCceeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCC
Q 040569          142 IADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDT  221 (385)
Q Consensus       142 L~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~  221 (385)
                      |+|||++.......  ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||... +.......+......
T Consensus       155 l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~~~~~~  231 (269)
T cd08528         155 ITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-NMLSLATKIVEAVYE  231 (269)
T ss_pred             Eecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc-CHHHHHHHHhhccCC
Confidence            99999998764332  234456899999999999888999999999999999999999999654 333333333222222


Q ss_pred             CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          222 PEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       222 ~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      +.....+++.+.+||.+||+.||++||++.|+..+
T Consensus       232 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         232 PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            22233578999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.8e-41  Score=350.94  Aligned_cols=253  Identities=25%  Similarity=0.411  Sum_probs=203.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH----HHHHHHHHHHHhcCCCCeeeeeeeeeecc---------
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQIVAYKGCDISEE---------   68 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~----~~~~~E~~il~~l~hpnIv~~~~~~~~~~---------   68 (385)
                      ||+.++.||+||||.||+++++-+|+.||||++.....    ..+.||+..|.+|+|||||+++..+++..         
T Consensus       480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~  559 (1351)
T KOG1035|consen  480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIV  559 (1351)
T ss_pred             hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccc
Confidence            67889999999999999999999999999999976532    35678999999999999999986543000         


Q ss_pred             --------------------------------------------------------------------------------
Q 040569           69 --------------------------------------------------------------------------------   68 (385)
Q Consensus        69 --------------------------------------------------------------------------------   68 (385)
                                                                                                      
T Consensus       560 ~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~  639 (1351)
T KOG1035|consen  560 ASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGS  639 (1351)
T ss_pred             ccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCc
Confidence                                                                                            


Q ss_pred             ------------------CCe--------EEEEEEEeecCCCCHHHHHHcCCCC-CHHHHHHHHHHHHHHHHHHHHCCce
Q 040569           69 ------------------NGK--------ILYNLFLEYAPGGTLTDAIRSGTCL-EEGRIRSHTRAVLLGLQYLHSNGIV  121 (385)
Q Consensus        69 ------------------~~~--------~~~~lv~Ey~~ggsL~~~l~~~~~l-~e~~~~~i~~qil~gL~yLH~~giv  121 (385)
                                        ...        .+.||=||||+.-+|.+++..+... ....++.++++|++||.|+|++|||
T Consensus       640 ~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giI  719 (1351)
T KOG1035|consen  640 VILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGII  719 (1351)
T ss_pred             cccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCcee
Confidence                              001        4567889999998888888866544 4778999999999999999999999


Q ss_pred             eccCCCCCEEeecCCCCCeEEeecCceeeecc-----------------cCCCCCCccccCCcccChhhhcCCC---CCC
Q 040569          122 HCDIKGQNILVSKDNEQGAKIADFGCARRARV-----------------NEDDEGKPICGTPICMAPEVARGEE---QGF  181 (385)
Q Consensus       122 HrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~-----------------~~~~~~~~~~Gt~~y~aPE~~~~~~---~~~  181 (385)
                      ||||||.|||+++++.  |||+|||+|.....                 ......+..+||..|+|||++.+..   |+.
T Consensus       720 HRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~  797 (1351)
T KOG1035|consen  720 HRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS  797 (1351)
T ss_pred             eccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence            9999999999997766  99999999987210                 0011334568999999999997654   999


Q ss_pred             CCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCC---CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 040569          182 PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI---PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGF  258 (385)
Q Consensus       182 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~  258 (385)
                      |+||||||++++||+   .||....+....+..+. .+..|..   ...--+.-..+|++||++||.+|||+.|+|++-|
T Consensus       798 KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR-~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~l  873 (1351)
T KOG1035|consen  798 KIDMYSLGIVLFEML---YPFGTSMERASILTNLR-KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSEL  873 (1351)
T ss_pred             hhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcc-cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccC
Confidence            999999999999998   56877666666666654 3333332   2333345678999999999999999999999988


Q ss_pred             cc
Q 040569          259 VK  260 (385)
Q Consensus       259 ~~  260 (385)
                      +-
T Consensus       874 lp  875 (1351)
T KOG1035|consen  874 LP  875 (1351)
T ss_pred             CC
Confidence            76

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-41  Score=331.20  Aligned_cols=244  Identities=26%  Similarity=0.390  Sum_probs=201.2

Q ss_pred             eeeceeeccCceEEEEEEECCCCc---E-EEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            4 TRGQTIGRGSTATVSIGMSNRSSE---V-FAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~---~-~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      ...+.||+|+||.||+|..+..+.   . ||||....+.      ...+.+|+++|++++|||||+|||+....+.    
T Consensus       160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P----  235 (474)
T KOG0194|consen  160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP----  235 (474)
T ss_pred             cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc----
Confidence            456899999999999998876532   3 8999876421      2456689999999999999999999888877    


Q ss_pred             EEEEEeecCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           74 YNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~~-~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      ++||||+|+||+|.++|++.+ .++..+...++.+.++||+|||+++++||||-.+|+|++.++.  +||+|||+++...
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~--vKISDFGLs~~~~  313 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV--VKISDFGLSRAGS  313 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe--EEeCccccccCCc
Confidence            779999999999999999655 5999999999999999999999999999999999999987654  7999999988653


Q ss_pred             ccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHH
Q 040569          153 VNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQ  231 (385)
Q Consensus       153 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  231 (385)
                      ...... ....--..|+|||.++...|++++|||||||++||+.+ |..||.+.. ......++.........|...+.+
T Consensus       314 ~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~-~~~v~~kI~~~~~r~~~~~~~p~~  391 (474)
T KOG0194|consen  314 QYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK-NYEVKAKIVKNGYRMPIPSKTPKE  391 (474)
T ss_pred             ceeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC-HHHHHHHHHhcCccCCCCCCCHHH
Confidence            111111 01112357999999999999999999999999999998 899999864 344445553444445556678899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          232 AQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      +..++.+|+..+|.+|||+.++.+
T Consensus       392 ~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  392 LAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHHHhccCChhhccCHHHHHH
Confidence            999999999999999999999876

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.6e-40  Score=309.92  Aligned_cols=236  Identities=19%  Similarity=0.269  Sum_probs=186.2

Q ss_pred             eeeccCceEEEEEEECCC------------------------CcEEEEEeccCCCH---HHHHHHHHHHHhcCCCCeeee
Q 040569            8 TIGRGSTATVSIGMSNRS------------------------SEVFAVKSAELSNS---EFLQREQRILSALACPQIVAY   60 (385)
Q Consensus         8 ~LG~G~~g~Vy~a~~~~~------------------------~~~~AvK~~~~~~~---~~~~~E~~il~~l~hpnIv~~   60 (385)
                      .||+|+||.||+|....+                        ...+|+|.+.....   ..+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            599999999999985422                        24578898865432   356678999999999999999


Q ss_pred             eeeeeeccCCeEEEEEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCC--
Q 040569           61 KGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE--  137 (385)
Q Consensus        61 ~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~--  137 (385)
                      ++++.....    .++||||+++|+|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++..+.  
T Consensus        82 ~~~~~~~~~----~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGSE----NIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCCc----eEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence            998766543    5689999999999999974 567899999999999999999999999999999999999975432  


Q ss_pred             ---CCeEEeecCceeeecccCCCCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHH-hCCCCCCCCCChHHHH
Q 040569          138 ---QGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMA-TGRPPWPDVADPISAL  212 (385)
Q Consensus       138 ---~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell-tG~~Pf~~~~~~~~~~  212 (385)
                         ..+|++|||++.....     .....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||....... ..
T Consensus       158 ~~~~~~kl~d~g~~~~~~~-----~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-~~  231 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALS-----REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-KE  231 (274)
T ss_pred             CccceeeecCCcccccccc-----ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-HH
Confidence               1379999998865421     122357888999999875 56799999999999999995 6999997643222 11


Q ss_pred             HHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          213 HRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       213 ~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ....   .....+...++.+.++|.+||+.+|.+|||+.++|++
T Consensus       232 ~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         232 RFYE---KKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHH---hccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            1111   1122334457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.6e-40  Score=307.65  Aligned_cols=250  Identities=20%  Similarity=0.289  Sum_probs=198.1

Q ss_pred             ceeeceeeccCceEEEEEEEC---CCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCC--eE
Q 040569            3 WTRGQTIGRGSTATVSIGMSN---RSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENG--KI   72 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~---~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~--~~   72 (385)
                      |++.+.||+|+||+||+|..+   .+++.+|||.+....     .+.+.+|++++++++||||+++++++......  ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678999999999999999864   357899999886431     34577899999999999999999987654322  22


Q ss_pred             EEEEEEeecCCCCHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecC
Q 040569           73 LYNLFLEYAPGGTLTDAIRSG------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG  146 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG  146 (385)
                      +.++++||+++|+|.+++...      ..+++..+..++.||+.||+|||++||+||||||+||+++.+..  +||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~--~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT--VCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC--EEECccc
Confidence            346889999999999887521      24788999999999999999999999999999999999986655  9999999


Q ss_pred             ceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCC
Q 040569          147 CARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEI  224 (385)
Q Consensus       147 ~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  224 (385)
                      +++........ ......+++.|++||.+.+..++.++|||||||++|+|++ |++||.... .......+. .......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~-~~~~~~~~~-~~~~~~~  236 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-NSEIYNYLI-KGNRLKQ  236 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC-HHHHHHHHH-cCCcCCC
Confidence            99865322211 1223345678999999999889999999999999999999 899997643 333222222 2222334


Q ss_pred             CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          225 PGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       225 ~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      +...++.+.+++.+||+++|++|||+.+++++
T Consensus       237 ~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         237 PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            45678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-41  Score=327.84  Aligned_cols=277  Identities=25%  Similarity=0.379  Sum_probs=220.8

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      |..++.||-|+||.|.+++...|..+||+|.+.+.+      ...++-|-.||..-..+.||++|-.|.+.++    +|+
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn----LYF  706 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN----LYF  706 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc----eEE
Confidence            788999999999999999999999999999886533      3566779999999999999999988877766    778


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      ||||++||++-.+|-+.+.|.|..++.|+..+.+|++++|..|+|||||||+||||+.+|.  +||.|||++.-+....+
T Consensus       707 VMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  707 VMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             EEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc--eeeeeccccccceeccc
Confidence            9999999999999988888999999999999999999999999999999999999999887  99999999875432211


Q ss_pred             C-----------------------------------------CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHH
Q 040569          157 D-----------------------------------------EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEM  195 (385)
Q Consensus       157 ~-----------------------------------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el  195 (385)
                      .                                         .....+||+.|+|||++....|+..+|.||.|||||||
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM  864 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence            0                                         00134699999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCChHHHHHHhcCCCCCCC--CCCcCCHHHHHHHHHhhhcCCCCCC---CHHHHHhCccccccccc-cccc
Q 040569          196 ATGRPPWPDVADPISALHRIGFSSDTPE--IPGYMSKQAQDFLSKCLIRNPGERW---SASELLEHGFVKEQNFK-LSTL  269 (385)
Q Consensus       196 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~ll~~cL~~dP~~Rp---s~~elL~hp~~~~~~~~-~~~~  269 (385)
                      +.|++||-.......+...+++. ....  .-..+|+++.++|.++.. +++.|.   .++|+..||||+..++. +..+
T Consensus       865 ~~g~~pf~~~tp~~tq~kv~nw~-~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfsslRkq  942 (1034)
T KOG0608|consen  865 LVGQPPFLADTPGETQYKVINWR-NFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSSLRKQ  942 (1034)
T ss_pred             hhCCCCccCCCCCcceeeeeehh-hccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHhhhhc
Confidence            99999997643222222222222 1222  234689999999987654 578888   46689999999988653 3333


Q ss_pred             CCCCCCCCCCCCcccccc
Q 040569          270 TEPETYNSESPTSVLNQQ  287 (385)
Q Consensus       270 ~~~~~~~~~~p~~~~~~~  287 (385)
                      ..+..+....|+.+.|..
T Consensus       943 ~ApYIP~ItHptDTSNFd  960 (1034)
T KOG0608|consen  943 RAPYIPRITHPTDTSNFD  960 (1034)
T ss_pred             cCCcCccccCCCccccCC
Confidence            344444455565555443

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.8e-40  Score=308.33  Aligned_cols=250  Identities=26%  Similarity=0.362  Sum_probs=198.5

Q ss_pred             CceeeceeeccCceEEEEEEEC----CCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN----RSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~----~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|+..+.||+|+||+||+|...    .+++.+|+|.+....    .+.+++|+++++++.||||+++++++.....  ..
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~--~~   82 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGG--RS   82 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCC--Cc
Confidence            4778899999999999999864    348999999887543    3578899999999999999999987655332  23


Q ss_pred             EEEEEeecCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           74 YNLFLEYAPGGTLTDAIRSG-TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~-~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      .+++|||+++++|.+++... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.  +||+|||++....
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~  160 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL--VKISDFGLAKVLP  160 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccccccccc
Confidence            66899999999999999753 36999999999999999999999999999999999999987755  9999999998764


Q ss_pred             ccCCC--CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChH-------------HHHHHhcC
Q 040569          153 VNEDD--EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPI-------------SALHRIGF  217 (385)
Q Consensus       153 ~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-------------~~~~~~~~  217 (385)
                      .....  ......++..|+|||.+.+..++.++|||||||++++|++|+.|+.......             ..+.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            22111  1112234567999999998889999999999999999999999986432111             11111111


Q ss_pred             CCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          218 SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       218 ~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .......+...+.++.+|+.+||+++|.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            22222334557889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-41  Score=335.06  Aligned_cols=243  Identities=29%  Similarity=0.427  Sum_probs=191.8

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccC----CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCC--eEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL----SNSEFLQREQRILSALACPQIVAYKGCDISEENG--KILYNL   76 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~--~~~~~l   76 (385)
                      |..-+.||+|+||.||+++++.+|+.+|||.++.    ...+..-+|+++|++|+|||||+++++-.....+  ...-.+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            6778899999999999999999999999998875    3456777999999999999999998874433300  112338


Q ss_pred             EEeecCCCCHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC--CCCeEEeecCceeee
Q 040569           77 FLEYAPGGTLTDAIR---SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRA  151 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~---~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~--~~~~kL~DFG~a~~~  151 (385)
                      |||||.||||...+.   +...|+|.++..++.++..||.|||++||+||||||.||++-...  ....||+|||+|+..
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            999999999999997   344699999999999999999999999999999999999985443  333499999999988


Q ss_pred             cccCCCCCCccccCCcccChhhhc-CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChH---HHHHHhc-----------
Q 040569          152 RVNEDDEGKPICGTPICMAPEVAR-GEEQGFPADVWALGCTVLEMATGRPPWPDVADPI---SALHRIG-----------  216 (385)
Q Consensus       152 ~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~---~~~~~~~-----------  216 (385)
                      ..+  .......||+.|++||++. ...|+..+|.|||||++|+++||..||-....+.   .....+.           
T Consensus       175 ~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~  252 (732)
T KOG4250|consen  175 DDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGA  252 (732)
T ss_pred             CCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEee
Confidence            533  3556778999999999998 4888999999999999999999999996433331   1222211           


Q ss_pred             ---------CCCCCCCCCCcCCHHH----HHHHHHhhhcCCCCCC
Q 040569          217 ---------FSSDTPEIPGYMSKQA----QDFLSKCLIRNPGERW  248 (385)
Q Consensus       217 ---------~~~~~~~~~~~~s~~~----~~ll~~cL~~dP~~Rp  248 (385)
                               +....| .|..++..+    -..+..+|..+|++|+
T Consensus       253 ~~~eNgpv~~s~~lP-~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  253 QEEENGPVEWSSTLP-QPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             ecccCCceeeeccCC-CcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                     111112 244455443    4567788999999999

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=6.1e-41  Score=306.09  Aligned_cols=257  Identities=30%  Similarity=0.410  Sum_probs=202.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCc----EEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSE----VFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~----~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      .|+..+.||+|.||.||+|..+.++.    .||+|.++-+.     +...-||+.+++.++||||+.+..++...+.   
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~---  101 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK---  101 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc---
Confidence            47889999999999999997665543    78999887541     3566799999999999999999999887532   


Q ss_pred             EEEEEEeecCCCCHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC--CCCeEEeec
Q 040569           73 LYNLFLEYAPGGTLTDAIR-----SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADF  145 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~-----~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~--~~~~kL~DF  145 (385)
                      ..++++||++. +|...|+     +...++...++.+++||+.|+.|||++=|+||||||.||||..++  .+.|||+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            26699999987 9999996     244689999999999999999999999999999999999997662  234899999


Q ss_pred             CceeeecccCC--CCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCC------h--HHHHHH
Q 040569          146 GCARRARVNED--DEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVAD------P--ISALHR  214 (385)
Q Consensus       146 G~a~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~------~--~~~~~~  214 (385)
                      |+++.+...-.  ......+-|.+|.|||.+.|. .|+++.||||+|||+.||+|-.+.|.+...      +  ..++.+
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            99998743221  134566789999999999886 589999999999999999999888864311      1  112222


Q ss_pred             hcCCCCCC---------CCCC--------------------------cCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          215 IGFSSDTP---------EIPG--------------------------YMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       215 ~~~~~~~~---------~~~~--------------------------~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      |..-...|         .+|.                          .-++.+.+|+.+||..||.+|+|++|+|+|+||
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF  340 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF  340 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence            21111111         1111                          125568899999999999999999999999999


Q ss_pred             ccc
Q 040569          260 KEQ  262 (385)
Q Consensus       260 ~~~  262 (385)
                      ...
T Consensus       341 ~~d  343 (438)
T KOG0666|consen  341 TED  343 (438)
T ss_pred             ccC
Confidence            864

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-40  Score=343.74  Aligned_cols=245  Identities=24%  Similarity=0.355  Sum_probs=202.7

Q ss_pred             ceeeceeeccCceEEEEEEECCC-Cc----EEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRS-SE----VFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~-~~----~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      -+.++.||+|+||.||.|..... |.    .||||.+....    ...|.+|..+|++++|||||+++|++.....    
T Consensus       694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~----  769 (1025)
T KOG1095|consen  694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP----  769 (1025)
T ss_pred             eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC----
Confidence            35788999999999999976543 33    38999887542    3567799999999999999999999888554    


Q ss_pred             EEEEEeecCCCCHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecC
Q 040569           74 YNLFLEYAPGGTLTDAIRSG-------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG  146 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~-------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG  146 (385)
                      ++|++|||+||+|..+|++.       ..++......++.||++|+.||+++++|||||..+|+|++....  +||+|||
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~--VKIaDFG  847 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRV--VKIADFG  847 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCc--EEEcccc
Confidence            66899999999999999843       45899999999999999999999999999999999999997744  9999999


Q ss_pred             ceeeecccCCCCCCcc-ccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCC
Q 040569          147 CARRARVNEDDEGKPI-CGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEI  224 (385)
Q Consensus       147 ~a~~~~~~~~~~~~~~-~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  224 (385)
                      +|+.+........... .--..|||||.+..+.++.++|||||||++||++| |..||++..+......-.  ....-..
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~--~ggRL~~  925 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL--EGGRLDP  925 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH--hCCccCC
Confidence            9995422211111111 11247999999999999999999999999999999 999999976655544332  2335666


Q ss_pred             CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          225 PGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       225 ~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      |.++++.+.++|..||+.+|.+||++..+++
T Consensus       926 P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  926 PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            8889999999999999999999999999987

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.9e-39  Score=302.20  Aligned_cols=241  Identities=21%  Similarity=0.318  Sum_probs=185.6

Q ss_pred             ceeeccCceEEEEEEECCC--CcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            7 QTIGRGSTATVSIGMSNRS--SEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~--~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +.||+|+||+||++.....  ...+++|.+....    .+.+.+|+.+++.++||||+++++.+.....    +++||||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~----~~lv~e~   76 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIP----YLLVFEY   76 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCc----cEEEEec
Confidence            4699999999999975433  3456788765432    3467789999999999999999998765443    6799999


Q ss_pred             cCCCCHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC-
Q 040569           81 APGGTLTDAIRSG----TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE-  155 (385)
Q Consensus        81 ~~ggsL~~~l~~~----~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~-  155 (385)
                      +++|+|.+++.+.    ..+++..+..++.||+.||+|||+++++||||||+|||++.++.  +||+|||++....... 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~--~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc--EEecccccccccCcchh
Confidence            9999999999743    34567788899999999999999999999999999999987665  9999999986432111 


Q ss_pred             CCCCCccccCCcccChhhhcC-------CCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHh----cCCCCCCC
Q 040569          156 DDEGKPICGTPICMAPEVARG-------EEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRI----GFSSDTPE  223 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~----~~~~~~~~  223 (385)
                      .......+|++.|+|||++..       ..++.++|||||||++|||++ |..||....+. ..+..+    ......+.
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~  233 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVIKDQQVKLFKPQ  233 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhhcccccCCCc
Confidence            112234568899999999853       235778999999999999997 57788654332 222221    12223345


Q ss_pred             CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          224 IPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       224 ~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ++..+++.+.+++.+|| .+|++||++.++++
T Consensus       234 ~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         234 LELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            55568899999999999 67999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.4e-39  Score=334.99  Aligned_cols=258  Identities=22%  Similarity=0.236  Sum_probs=177.0

Q ss_pred             CceeeceeeccCceEEEEEEECCC----CcEEEEEeccCCCHHHHHHHHHHHHhcCCCCeeeeeeeeeec--cCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRS----SEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISE--ENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~----~~~~AvK~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+|++..+    +..+|+|.+..........+. .++...+.++..+...+...  ......++
T Consensus       133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  211 (566)
T PLN03225        133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE-RVRRACPNSCADFVYGFLEPVSSKKEDEYW  211 (566)
T ss_pred             CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH-HHHhhchhhHHHHHHhhhcccccccCCceE
Confidence            689999999999999999999988    999999987643322111111 12222333333332221110  01122366


Q ss_pred             EEEeecCCCCHHHHHHcCCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecC
Q 040569           76 LFLEYAPGGTLTDAIRSGTC--------------------LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKD  135 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~--------------------l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~  135 (385)
                      +|+||+.+++|.+++.....                    ..+..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus       212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~  291 (566)
T PLN03225        212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEG  291 (566)
T ss_pred             EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCC
Confidence            99999999999999874321                    1234567899999999999999999999999999999853


Q ss_pred             CCCCeEEeecCceeeecccCCCCCCccccCCcccChhhhcCCC----------------------CCCCCChHHHHHHHH
Q 040569          136 NEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE----------------------QGFPADVWALGCTVL  193 (385)
Q Consensus       136 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~----------------------~~~~~DiwSlG~il~  193 (385)
                      . ..+||+|||+|+.............+||+.|||||++....                      ++.++|||||||++|
T Consensus       292 ~-~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~  370 (566)
T PLN03225        292 S-GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL  370 (566)
T ss_pred             C-CcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHH
Confidence            2 23999999999866444333445678999999999764332                      334569999999999


Q ss_pred             HHHhCCCCCCCCCChHHHHHHhcC-------------CCCCC------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 040569          194 EMATGRPPWPDVADPISALHRIGF-------------SSDTP------EIPGYMSKQAQDFLSKCLIRNPGERWSASELL  254 (385)
Q Consensus       194 elltG~~Pf~~~~~~~~~~~~~~~-------------~~~~~------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL  254 (385)
                      ||+++..|+..  +.......+..             ....+      .+....+..+.+||.+||++||++|||+.|+|
T Consensus       371 el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L  448 (566)
T PLN03225        371 QMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAAL  448 (566)
T ss_pred             HHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHh
Confidence            99998776542  11111111100             00000      01111234566999999999999999999999


Q ss_pred             hCccccccc
Q 040569          255 EHGFVKEQN  263 (385)
Q Consensus       255 ~hp~~~~~~  263 (385)
                      +||||....
T Consensus       449 ~Hpff~~~~  457 (566)
T PLN03225        449 AHPYFDREG  457 (566)
T ss_pred             CCcCcCCCC
Confidence            999998653

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.9e-40  Score=335.19  Aligned_cols=244  Identities=23%  Similarity=0.338  Sum_probs=202.3

Q ss_pred             ceeeceeeccCceEEEEEEEC-----CCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSN-----RSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~-----~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      -+..+.||+|+||+||+|.-.     .....||||.++...    .+.|+||+++|..|+|||||+++|++...+.    
T Consensus       488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P----  563 (774)
T KOG1026|consen  488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP----  563 (774)
T ss_pred             eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe----
Confidence            356789999999999999754     234779999886433    3579999999999999999999999988776    


Q ss_pred             EEEEEeecCCCCHHHHHHc----------CCC----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCC
Q 040569           74 YNLFLEYAPGGTLTDAIRS----------GTC----LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQG  139 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~----------~~~----l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~  139 (385)
                      +++|+|||..|+|.++|..          +..    |+..+...++.||+.|+.||-++.+|||||-.+|+||+++..  
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~--  641 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV--  641 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE--
Confidence            7799999999999999962          223    889999999999999999999999999999999999987655  


Q ss_pred             eEEeecCceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcC
Q 040569          140 AKIADFGCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGF  217 (385)
Q Consensus       140 ~kL~DFG~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~  217 (385)
                      |||+|||+++..-..... ......--.+|||||.+..++|+.++||||+||+|||+++ |+.||.+..+. +.+..+..
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-EVIe~i~~  720 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-EVIECIRA  720 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-HHHHHHHc
Confidence            899999999975322211 1111122458999999999999999999999999999998 99999987554 44444433


Q ss_pred             CCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 040569          218 SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELL  254 (385)
Q Consensus       218 ~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL  254 (385)
                      +.. -.-|...|.++.+|+..||+.+|++||++.||-
T Consensus       721 g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  721 GQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             CCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            333 556788999999999999999999999999984

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=4e-40  Score=289.58  Aligned_cols=253  Identities=25%  Similarity=0.381  Sum_probs=207.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALA-CPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +|++.+.+|+|.|+.||.|++..+++.++||+++.-..+.+.||+.||+.|. ||||++++++..+.....  ..|++||
T Consensus        39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt--paLiFE~  116 (338)
T KOG0668|consen   39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT--PSLIFEY  116 (338)
T ss_pred             hHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC--chhHhhh
Confidence            6889999999999999999999999999999999888899999999999995 999999999876655433  5689999


Q ss_pred             cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCC
Q 040569           81 APGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGK  160 (385)
Q Consensus        81 ~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~  160 (385)
                      +.+.+...+..   .|+...++.++.+++.||.|||++||.|||+||.|++|+... ..++|+|+|+|.+.....  ...
T Consensus       117 v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~-rkLrlIDWGLAEFYHp~~--eYn  190 (338)
T KOG0668|consen  117 VNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHEL-RKLRLIDWGLAEFYHPGK--EYN  190 (338)
T ss_pred             hccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhh-ceeeeeecchHhhcCCCc--eee
Confidence            99887777654   488899999999999999999999999999999999998653 458999999999875333  333


Q ss_pred             ccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc--------------CCCC-CC--
Q 040569          161 PICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG--------------FSSD-TP--  222 (385)
Q Consensus       161 ~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~--------------~~~~-~~--  222 (385)
                      ..+.+..|--||.+.. ..|+..-|+|||||++..|+..+.||-.-.+...++.+|.              +... .|  
T Consensus       191 VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~  270 (338)
T KOG0668|consen  191 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQF  270 (338)
T ss_pred             eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhH
Confidence            4456778999999865 4679999999999999999999999864444333333321              0000 00  


Q ss_pred             ------------------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          223 ------------------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       223 ------------------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                        +-..-.++++.|||.++|..|-.+|+|+.|++.||||...
T Consensus       271 ~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  271 EDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             hhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence                              0111257999999999999999999999999999999864

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=9.6e-38  Score=284.80  Aligned_cols=239  Identities=35%  Similarity=0.571  Sum_probs=200.5

Q ss_pred             CceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecCCCCHHH
Q 040569           13 STATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTD   88 (385)
Q Consensus        13 ~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~   88 (385)
                      +||.||+|.+..+++.+|+|.+....    .+.+.+|++.+++++|+||+++++.+.....    .++++||+++++|.+
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~----~~l~~e~~~~~~L~~   76 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDK----LYLVMEYCDGGDLFD   76 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCE----EEEEEeCCCCCCHHH
Confidence            68999999999899999999987543    4678899999999999999999998765432    678999999999999


Q ss_pred             HHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCCccccCCcc
Q 040569           89 AIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC  168 (385)
Q Consensus        89 ~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y  168 (385)
                      ++.....+++..+..++.+++.+|.|||+.|++|+||+|+||+++.++.  ++|+|||.+.......  ......|+..|
T Consensus        77 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~--~~l~d~~~~~~~~~~~--~~~~~~~~~~~  152 (244)
T smart00220       77 LLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGH--VKLADFGLARQLDPGG--LLTTFVGTPEY  152 (244)
T ss_pred             HHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCc--EEEccccceeeecccc--ccccccCCcCC
Confidence            9987666899999999999999999999999999999999999987755  9999999998764332  33445689999


Q ss_pred             cChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCc-CCHHHHHHHHHhhhcCCCCC
Q 040569          169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY-MSKQAQDFLSKCLIRNPGER  247 (385)
Q Consensus       169 ~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~ll~~cL~~dP~~R  247 (385)
                      +|||.+.+..++.++||||||+++++|++|..||....+.................... ++.++.+++.+||..+|++|
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R  232 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR  232 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence            99999998888999999999999999999999997644444444433222211111111 78999999999999999999


Q ss_pred             CCHHHHHhCccc
Q 040569          248 WSASELLEHGFV  259 (385)
Q Consensus       248 ps~~elL~hp~~  259 (385)
                      |++.++++||||
T Consensus       233 p~~~~~~~~~~~  244 (244)
T smart00220      233 LTAEEALQHPFF  244 (244)
T ss_pred             cCHHHHhhCCCC
Confidence            999999999996

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-40  Score=293.00  Aligned_cols=256  Identities=27%  Similarity=0.390  Sum_probs=204.1

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCe----EE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGK----IL   73 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~----~~   73 (385)
                      |.....||+|.||.||+|+.+.+|+.||+|++-.+.     .....||+.||..|+|+|++.+++++.......    ..
T Consensus        19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t   98 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT   98 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence            667889999999999999999999999998764322     245678999999999999999988876544322    23


Q ss_pred             EEEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           74 YNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      +|+|+.+|+. +|.-++.. ..+++..++..++.++++||.|+|...|+|||+||.|+||+.++.  +||+|||+++.+.
T Consensus        99 ~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi--lklADFGlar~fs  175 (376)
T KOG0669|consen   99 FYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI--LKLADFGLARAFS  175 (376)
T ss_pred             eeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce--EEeecccccccee
Confidence            7799999987 99999984 368999999999999999999999999999999999999998776  8999999998775


Q ss_pred             ccCCCC---CCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc--CCCCC-----
Q 040569          153 VNEDDE---GKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG--FSSDT-----  221 (385)
Q Consensus       153 ~~~~~~---~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~--~~~~~-----  221 (385)
                      ...+..   .+..+-|.+|.+||.+.|. .|+++.|||.-||++.||.||.+-+.+..+. ..+..|.  ...-.     
T Consensus       176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq-qql~~Is~LcGs~tkevWP  254 (376)
T KOG0669|consen  176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ-QQLHLISQLCGSITKEVWP  254 (376)
T ss_pred             cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH-HHHHHHHHHhccCCcccCC
Confidence            443322   2334569999999999875 6899999999999999999999988765433 2222221  01111     


Q ss_pred             -------------CCCC-------------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          222 -------------PEIP-------------GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       222 -------------~~~~-------------~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                   +.++             -.-.+++.+|+.++|..||.+|+++.++|+|.||...
T Consensus       255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence                         1011             1124578999999999999999999999999998753

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-39  Score=304.45  Aligned_cols=256  Identities=23%  Similarity=0.325  Sum_probs=208.2

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccC--CCH--------HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL--SNS--------EFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~--~~~--------~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      |-.++.||+|+|+.||+|.+....+.+|||+-..  +..        +..-||.+|-+.|.||.||++|++|.-+...  
T Consensus       465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds--  542 (775)
T KOG1151|consen  465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS--  542 (775)
T ss_pred             HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc--
Confidence            5668899999999999999999999999997643  221        2345899999999999999999998665443  


Q ss_pred             EEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCCEEeecCCC-CCeEEeecCcee
Q 040569           73 LYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN--GIVHCDIKGQNILVSKDNE-QGAKIADFGCAR  149 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~--givHrDlKp~NILi~~~~~-~~~kL~DFG~a~  149 (385)
                       +|-|+|||+|.+|.-+++...-++|.+++.|+.||+.||.||...  -|||-||||.|||+..... +.+||.|||+++
T Consensus       543 -FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK  621 (775)
T KOG1151|consen  543 -FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK  621 (775)
T ss_pred             -ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence             778999999999999999888899999999999999999999986  5999999999999964433 237999999999


Q ss_pred             eecccCCC------CCCccccCCcccChhhhcCC----CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc--C
Q 040569          150 RARVNEDD------EGKPICGTPICMAPEVARGE----EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG--F  217 (385)
Q Consensus       150 ~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~--~  217 (385)
                      ........      ......||.+|++||.+.-+    ..+.++||||+|||+|.++.|+.||.........+....  .
T Consensus       622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk  701 (775)
T KOG1151|consen  622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK  701 (775)
T ss_pred             hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc
Confidence            76433222      23456799999999998533    457899999999999999999999987544444443221  1


Q ss_pred             --CCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          218 --SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       218 --~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                        ....|.-| .+|+++++||++||++.-++|..+.|+-.||||...
T Consensus       702 AtEVqFP~KP-vVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  702 ATEVQFPPKP-VVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             ceeccCCCCC-ccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence              11223222 489999999999999999999999999999999764

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-39  Score=325.64  Aligned_cols=253  Identities=27%  Similarity=0.348  Sum_probs=199.1

Q ss_pred             eeeceeeccCce-EEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEEeec
Q 040569            4 TRGQTIGRGSTA-TVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFLEYA   81 (385)
Q Consensus         4 ~~~~~LG~G~~g-~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (385)
                      .-.+.+|.|+.| .||+|...  |+.||||++-.+.....+||+..|+.- .|||||++|+...    +..+.||++|.|
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~----d~qF~YIalELC  585 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQ----DRQFLYIALELC  585 (903)
T ss_pred             ccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeecc----CCceEEEEehHh
Confidence            345788999998 68999976  889999999777778899999999998 8999999987533    233577999999


Q ss_pred             CCCCHHHHHHcCC-C---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeec---CCCCCeEEeecCceeeeccc
Q 040569           82 PGGTLTDAIRSGT-C---LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSK---DNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        82 ~ggsL~~~l~~~~-~---l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~---~~~~~~kL~DFG~a~~~~~~  154 (385)
                      .. +|.++++..+ .   ......+..+.|++.||+|||+.+||||||||+||||..   ++...++|+|||+++....+
T Consensus       586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            87 9999998631 1   112456888999999999999999999999999999976   34445799999999987544


Q ss_pred             CCC--CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhC-CCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHH
Q 040569          155 EDD--EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATG-RPPWPDVADPISALHRIGFSSDTPEIPGYMSKQ  231 (385)
Q Consensus       155 ~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  231 (385)
                      ...  ......||-+|+|||++.......++||+||||++|..++| .+||.+.......+..-.+..  -.+......+
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L--~~L~~~~d~e  742 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTL--VHLEPLPDCE  742 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccce--eeeccCchHH
Confidence            432  34566799999999999999999999999999999999985 999976433333222211111  1111111228


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCccccccccc
Q 040569          232 AQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK  265 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~~~  265 (385)
                      +++||.+||+++|..||++.++|.||||-....+
T Consensus       743 A~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekr  776 (903)
T KOG1027|consen  743 AKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKR  776 (903)
T ss_pred             HHHHHHHhcCCCcccCCCHHHHhCCCccCChHHH
Confidence            9999999999999999999999999999765433

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.5e-37  Score=311.06  Aligned_cols=258  Identities=22%  Similarity=0.226  Sum_probs=182.9

Q ss_pred             CceeeceeeccCceEEEEEEEC----------------CCCcEEEEEeccCCCH-----------------HHHHHHHHH
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN----------------RSSEVFAVKSAELSNS-----------------EFLQREQRI   48 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~----------------~~~~~~AvK~~~~~~~-----------------~~~~~E~~i   48 (385)
                      +|++.+.||+|+||+||+|...                ..++.||||.+.....                 +....|+.+
T Consensus       146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~  225 (507)
T PLN03224        146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM  225 (507)
T ss_pred             CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence            6899999999999999999752                3456799998864321                 122347777


Q ss_pred             HHhcCCCCe-----eeeeeeeeeccC----CeEEEEEEEeecCCCCHHHHHHcC------------------------CC
Q 040569           49 LSALACPQI-----VAYKGCDISEEN----GKILYNLFLEYAPGGTLTDAIRSG------------------------TC   95 (385)
Q Consensus        49 l~~l~hpnI-----v~~~~~~~~~~~----~~~~~~lv~Ey~~ggsL~~~l~~~------------------------~~   95 (385)
                      +.+++|.++     +++++++.....    .....+|||||+++|+|.+++...                        ..
T Consensus       226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~  305 (507)
T PLN03224        226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK  305 (507)
T ss_pred             HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence            777866554     566666543211    011256999999999999998631                        12


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCCccccCCcccChhhhc
Q 040569           96 LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR  175 (385)
Q Consensus        96 l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~  175 (385)
                      +++..++.++.|++.||.|||+++|+||||||+|||++.++.  +||+|||++...............+|+.|+|||++.
T Consensus       306 ~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~  383 (507)
T PLN03224        306 RDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV  383 (507)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc--EEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence            345678899999999999999999999999999999987765  999999999765332222222234589999999985


Q ss_pred             CCC--------------------CC--CCCChHHHHHHHHHHHhCCC-CCCCCCChHHHH----------HHhcCCCCCC
Q 040569          176 GEE--------------------QG--FPADVWALGCTVLEMATGRP-PWPDVADPISAL----------HRIGFSSDTP  222 (385)
Q Consensus       176 ~~~--------------------~~--~~~DiwSlG~il~elltG~~-Pf~~~~~~~~~~----------~~~~~~~~~~  222 (385)
                      ...                    ++  .+.||||+||++|+|++|.. ||.........+          ..+.......
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~  463 (507)
T PLN03224        384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDF  463 (507)
T ss_pred             CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCc
Confidence            432                    11  24799999999999999875 775321111111          1110011111


Q ss_pred             CCCCcCCHHHHHHHHHhhhcCC---CCCCCHHHHHhCccccc
Q 040569          223 EIPGYMSKQAQDFLSKCLIRNP---GERWSASELLEHGFVKE  261 (385)
Q Consensus       223 ~~~~~~s~~~~~ll~~cL~~dP---~~Rps~~elL~hp~~~~  261 (385)
                      ......++.+++|+.+||.++|   .+|+|++|+|+||||..
T Consensus       464 ~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        464 SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            1234578999999999999876   68999999999999964

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-39  Score=298.89  Aligned_cols=249  Identities=24%  Similarity=0.331  Sum_probs=197.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhcC-C-C----CeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALA-C-P----QIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l~-h-p----nIv~~~~~~~~~~~~~~~   73 (385)
                      .|.+..++|+|.||.|-.+.++.++..+|||++..-  -.+...-|+++|+++. + |    -+|++.++|.-...    
T Consensus        90 Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh----  165 (415)
T KOG0671|consen   90 RYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH----  165 (415)
T ss_pred             ceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc----
Confidence            488999999999999999999999999999988632  2355567999999993 2 2    25666665544444    


Q ss_pred             EEEEEeecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC---------------
Q 040569           74 YNLFLEYAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN---------------  136 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~---------------  136 (385)
                      .|||+|.+ |-|+.++++.+  .+++-..++.+.+|++++++|||+.+++|-||||+|||+.+..               
T Consensus       166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r  244 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR  244 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceec
Confidence            77999998 66999999854  4688999999999999999999999999999999999984321               


Q ss_pred             ---CCCeEEeecCceeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHH--
Q 040569          137 ---EQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISA--  211 (385)
Q Consensus       137 ---~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~--  211 (385)
                         ...+||+|||.|.....    ...+.+.|..|.|||++.+-+.+.++||||+||||+||.||...|+...+...+  
T Consensus       245 ~~ks~~I~vIDFGsAtf~~e----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaM  320 (415)
T KOG0671|consen  245 PLKSTAIKVIDFGSATFDHE----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAM  320 (415)
T ss_pred             cCCCcceEEEecCCcceecc----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHH
Confidence               12379999999987632    235667899999999999999999999999999999999999999876654433  


Q ss_pred             HHHhcCCCCCC------------------CCCCc-------------------------CCHHHHHHHHHhhhcCCCCCC
Q 040569          212 LHRIGFSSDTP------------------EIPGY-------------------------MSKQAQDFLSKCLIRNPGERW  248 (385)
Q Consensus       212 ~~~~~~~~~~~------------------~~~~~-------------------------~s~~~~~ll~~cL~~dP~~Rp  248 (385)
                      +.++  -+..|                  .++..                         --.++.|||++||..||.+|+
T Consensus       321 MerI--lGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri  398 (415)
T KOG0671|consen  321 MERI--LGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI  398 (415)
T ss_pred             HHHh--hCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence            2222  11111                  00000                         123477999999999999999


Q ss_pred             CHHHHHhCccccc
Q 040569          249 SASELLEHGFVKE  261 (385)
Q Consensus       249 s~~elL~hp~~~~  261 (385)
                      |+.|+|.||||+.
T Consensus       399 Tl~EAL~HpFF~~  411 (415)
T KOG0671|consen  399 TLREALSHPFFAR  411 (415)
T ss_pred             cHHHHhcCHHhhc
Confidence            9999999999974

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=307.19  Aligned_cols=247  Identities=28%  Similarity=0.388  Sum_probs=207.0

Q ss_pred             eeeceeeccCceEEEEEEECCC-C--cEEEEEeccCC----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            4 TRGQTIGRGSTATVSIGMSNRS-S--EVFAVKSAELS----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~-~--~~~AvK~~~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      ++.+.||+|+||+|++|.++.. |  ..||||.+...    ....|.+|+.+|.+|+|||++++||+..+. .    ..+
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q-p----~mM  187 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ-P----AMM  187 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc-h----hhH
Confidence            4678999999999999998654 3  45799988643    346788999999999999999999997763 2    458


Q ss_pred             EEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           77 FLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      |+|.+++|||.+.+.+  ...|--.....|+.||+.|+.||.++++|||||-..|+|+.....  |||||||+.+.+..+
T Consensus       188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprt--VKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRT--VKICDFGLMRALGEN  265 (1039)
T ss_pred             HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccce--eeeecccceeccCCC
Confidence            9999999999999974  556888899999999999999999999999999999999976444  999999999987544


Q ss_pred             CCCC-CCc-cccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHH
Q 040569          155 EDDE-GKP-ICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQ  231 (385)
Q Consensus       155 ~~~~-~~~-~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  231 (385)
                      .... +.. .---..|+|||.++...++.++|+|++||++|||+| |..||.+. .....++++. ..+...-|..+|+.
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~-~g~qIL~~iD-~~erLpRPk~csed  343 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC-RGIQILKNID-AGERLPRPKYCSED  343 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC-CHHHHHHhcc-ccccCCCCCCChHH
Confidence            3321 111 112336999999999999999999999999999999 89999985 5677777776 66666778889999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          232 AQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      +.+++..||..+|.+|||+..|.+.-+.
T Consensus       344 IY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  344 IYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             HHHHHHHhccCCccccccHHHHHHhHHH
Confidence            9999999999999999999988654433

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=314.26  Aligned_cols=253  Identities=36%  Similarity=0.522  Sum_probs=217.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|.....+|+|.||.||+|+++.++++.|+|+++...   ...++.|+-+++.++|||||.++|.+.-...    .+++|
T Consensus        16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk----lwicM   91 (829)
T KOG0576|consen   16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK----LWICM   91 (829)
T ss_pred             chhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC----cEEEE
Confidence            6889999999999999999999999999999998654   4567899999999999999999999876665    66999


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      |||.||+|.+.....++++|.++....+..++||+|||++|-+|||||..|||++..++  +|++|||.+..+...-. .
T Consensus        92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD--vklaDfgvsaqitati~-K  168 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD--VKLADFGVSAQITATIA-K  168 (829)
T ss_pred             EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc--eeecccCchhhhhhhhh-h
Confidence            99999999999998889999999999999999999999999999999999999998877  99999999887643322 3


Q ss_pred             CCccccCCcccChhhh---cCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCC-CC--CCCCcCCHHH
Q 040569          159 GKPICGTPICMAPEVA---RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSD-TP--EIPGYMSKQA  232 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~--~~~~~~s~~~  232 (385)
                      .+.+.|||.|||||+.   +.+.|...+|||++|++..|+..-++|-.+. .+...+.....+.. .|  +-+...++.+
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl-hpmr~l~LmTkS~~qpp~lkDk~kws~~f  247 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL-HPMRALFLMTKSGFQPPTLKDKTKWSEFF  247 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc-chHHHHHHhhccCCCCCcccCCccchHHH
Confidence            4567899999999997   4567899999999999999999888886554 34444444433322 22  2345679999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          233 QDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      .+|++.+|.++|++||+++.+|.|||+.+.
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            999999999999999999999999998754

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=285.92  Aligned_cols=250  Identities=28%  Similarity=0.377  Sum_probs=202.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC-----CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccC--CeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-----SNSEFLQREQRILSALACPQIVAYKGCDISEEN--GKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~-----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~~~~   74 (385)
                      .|.-++.+|.|.- .|..|.+..+++.+|+|....     .......||...+..++|+||++++.+|.-...  ...-+
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            4677889999999 899999999999999997643     234567899999999999999999998854332  11226


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      |+||||+.. +|.+.+..  .++-..++.++.|+++|++|||+.||+||||||+||+++.+..  +||+|||+|+.....
T Consensus        97 y~v~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~ar~e~~~  171 (369)
T KOG0665|consen   97 YLVMELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGLARTEDTD  171 (369)
T ss_pred             HHHHHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh--eeeccchhhcccCcc
Confidence            699999965 99999883  3788999999999999999999999999999999999998776  899999999976433


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc------------------
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG------------------  216 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~------------------  216 (385)
                        ...++++.|..|.|||++.+-.+...+||||+||++.||++|+..|++. +...+..++.                  
T Consensus       172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~-d~idQ~~ki~~~lgtpd~~F~~qL~~~~  248 (369)
T KOG0665|consen  172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK-DHIDQWNKIIEQLGTPDPSFMKQLQPTV  248 (369)
T ss_pred             --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc-hHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence              4677889999999999999988999999999999999999999999753 2222222110                  


Q ss_pred             --------------CCCCCC--------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 040569          217 --------------FSSDTP--------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK  260 (385)
Q Consensus       217 --------------~~~~~~--------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~  260 (385)
                                    +....|        +.+..-+..+++++.+||..||++|.|+.++|+|||++
T Consensus       249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                          000000        01111345789999999999999999999999999998

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=268.92  Aligned_cols=211  Identities=27%  Similarity=0.401  Sum_probs=175.1

Q ss_pred             eeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            5 RGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      .+..||+|+||.|-+.++..+|.+.|+|.+...-    ...+.+|+.+..+. .+|.+|.|||.......    .+++||
T Consensus        50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd----vwIcME  125 (282)
T KOG0984|consen   50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD----VWICME  125 (282)
T ss_pred             hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc----EEEeHH
Confidence            4678999999999999999999999999886432    23455788876655 89999999998765544    679999


Q ss_pred             ecCCCCHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           80 YAPGGTLTDAI----RSGTCLEEGRIRSHTRAVLLGLQYLHSN-GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        80 y~~ggsL~~~l----~~~~~l~e~~~~~i~~qil~gL~yLH~~-givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      .|.. ||..+.    ++++.++|..+-+++..++.||.|||++ .++|||+||+||||+.+++  +|+||||.+-.+...
T Consensus       126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq--VKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ--VKICDFGISGYLVDS  202 (282)
T ss_pred             Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc--EEEcccccceeehhh
Confidence            9965 887765    4688899999999999999999999986 9999999999999999888  999999999876422


Q ss_pred             CCCCCCccccCCcccChhhhcC----CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCC
Q 040569          155 EDDEGKPICGTPICMAPEVARG----EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP  225 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  225 (385)
                      -.  .+.-.|...|||||.+..    ..|+.++||||||++++||++++.||+.-..+..++.++.. ...|.+|
T Consensus       203 iA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe-ep~P~Lp  274 (282)
T KOG0984|consen  203 IA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE-EPSPQLP  274 (282)
T ss_pred             hH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc-CCCCCCc
Confidence            21  122468899999999854    36889999999999999999999999998899999988843 3344444

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-37  Score=301.50  Aligned_cols=242  Identities=25%  Similarity=0.326  Sum_probs=199.6

Q ss_pred             eeeceeeccCceEEEEEEECCC----CcEEEEEeccC----CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            4 TRGQTIGRGSTATVSIGMSNRS----SEVFAVKSAEL----SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~----~~~~AvK~~~~----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +..+.||.|.||.||.|.....    .--||||..+.    +..+.+..|..+|+.+.|||||+++|++.+..     .+
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-----~W  466 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-----MW  466 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-----ee
Confidence            3467899999999999976422    33478898765    34577888999999999999999999976543     66


Q ss_pred             EEEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           76 LFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ||||.++-|.|..+++ +...|+-.....|+.||+.+|.|||++++|||||-.+|||+.+..  .+||+|||+++.....
T Consensus       467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~--CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ--CVKLADFGLSRYLEDD  544 (974)
T ss_pred             EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc--eeeecccchhhhcccc
Confidence            9999999999999998 556799999999999999999999999999999999999998653  3899999999987544


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ  233 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  233 (385)
                      .........-..-|||||.++-..++.++|||-||+++||++. |..||.+..+..... .+ -.++.+..|..+++.+.
T Consensus       545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-~i-EnGeRlP~P~nCPp~LY  622 (974)
T KOG4257|consen  545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-HI-ENGERLPCPPNCPPALY  622 (974)
T ss_pred             chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-Ee-cCCCCCCCCCCCChHHH
Confidence            3333222222346999999999999999999999999999987 999998875543332 22 23556667888999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHH
Q 040569          234 DFLSKCLIRNPGERWSASELL  254 (385)
Q Consensus       234 ~ll~~cL~~dP~~Rps~~elL  254 (385)
                      .|+.+||.++|.+||.+.|+.
T Consensus       623 slmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  623 SLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             HHHHHHhccCcccCCcHHHHH
Confidence            999999999999999988764

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=288.32  Aligned_cols=248  Identities=26%  Similarity=0.360  Sum_probs=201.5

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhc--CCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL--ACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l--~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      -+..+.||+|.||.||+|+++  |+.||||++...+.....||.+|.+..  +|+||+.|++......+.....+||.+|
T Consensus       213 I~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdY  290 (513)
T KOG2052|consen  213 IVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDY  290 (513)
T ss_pred             eEEEEEecCccccceeecccc--CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeec
Confidence            467899999999999999998  999999999988889999999999985  9999999999988777777788899999


Q ss_pred             cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           81 APGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN--------GIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        81 ~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~--------givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      .+.|||.|++.+ ..++.+...+++..++.||+|||..        .|.|||||..||||..++.  .-|+|+|+|....
T Consensus       291 He~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~--C~IADLGLAv~h~  367 (513)
T KOG2052|consen  291 HEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHD  367 (513)
T ss_pred             ccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc--EEEeeceeeEEec
Confidence            999999999997 4599999999999999999999953        3999999999999998877  8999999998765


Q ss_pred             ccCCC---CCCccccCCcccChhhhcCCC------CCCCCChHHHHHHHHHHHhC----------CCCCCCCC---ChHH
Q 040569          153 VNEDD---EGKPICGTPICMAPEVARGEE------QGFPADVWALGCTVLEMATG----------RPPWPDVA---DPIS  210 (385)
Q Consensus       153 ~~~~~---~~~~~~Gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~elltG----------~~Pf~~~~---~~~~  210 (385)
                      ...+.   ...+.+||.+|||||++...-      .-..+||||||.++||++..          ++||.+..   ....
T Consensus       368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e  447 (513)
T KOG2052|consen  368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFE  447 (513)
T ss_pred             ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHH
Confidence            44322   345678999999999996542      23469999999999999763          47876542   2233


Q ss_pred             HHHHh-cCCCCCCCCCCcCC-H----HHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          211 ALHRI-GFSSDTPEIPGYMS-K----QAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       211 ~~~~~-~~~~~~~~~~~~~s-~----~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .+..+ -.....|.+|.... .    .+..+++.||..+|.-|.|+--+.+
T Consensus       448 eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  448 EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            33332 23344555554432 2    3567899999999999999876643

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.4e-37  Score=299.95  Aligned_cols=251  Identities=26%  Similarity=0.374  Sum_probs=202.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH--HHHHHHHHHHHhcCC------CCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS--EFLQREQRILSALAC------PQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~--~~~~~E~~il~~l~h------pnIv~~~~~~~~~~~~~~~   73 (385)
                      .|.+....|+|-|++|.+|.+..-|..||||++.....  ..=.+|++||++|+.      -|+++++..|....+    
T Consensus       433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH----  508 (752)
T KOG0670|consen  433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH----  508 (752)
T ss_pred             eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce----
Confidence            47888899999999999999999999999999975443  223479999999953      578888887776665    


Q ss_pred             EEEEEeecCCCCHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569           74 YNLFLEYAPGGTLTDAIRSGT---CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~~---~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                      +|||+|-+. .+|.+.+++.+   .|....++.|+.|++.||.+|...||+|+||||+||||++... .+||||||.|..
T Consensus       509 LClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~  586 (752)
T KOG0670|consen  509 LCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASF  586 (752)
T ss_pred             eEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCccccc
Confidence            889999985 59999998533   5889999999999999999999999999999999999997654 379999999998


Q ss_pred             ecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCC--------
Q 040569          151 ARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP--------  222 (385)
Q Consensus       151 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------  222 (385)
                      ...+   ..+++.-+..|.|||++.|..|+...|+||.||+||||.||+..|++..+...+.......+..|        
T Consensus       587 ~~en---eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgq  663 (752)
T KOG0670|consen  587 ASEN---EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQ  663 (752)
T ss_pred             cccc---cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcc
Confidence            7433   33455667789999999999999999999999999999999999998755443322221111111        


Q ss_pred             ----------------------------------------------CCCCc---CCHHHHHHHHHhhhcCCCCCCCHHHH
Q 040569          223 ----------------------------------------------EIPGY---MSKQAQDFLSKCLIRNPGERWSASEL  253 (385)
Q Consensus       223 ----------------------------------------------~~~~~---~s~~~~~ll~~cL~~dP~~Rps~~el  253 (385)
                                                                    .+|..   +-.++++||.+||..||.+|.|+.|+
T Consensus       664 F~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqA  743 (752)
T KOG0670|consen  664 FKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQA  743 (752)
T ss_pred             hhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHH
Confidence                                                          00000   11357899999999999999999999


Q ss_pred             HhCccccc
Q 040569          254 LEHGFVKE  261 (385)
Q Consensus       254 L~hp~~~~  261 (385)
                      |.||||..
T Consensus       744 L~HpFi~~  751 (752)
T KOG0670|consen  744 LKHPFITE  751 (752)
T ss_pred             hcCCcccC
Confidence            99999864

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.1e-36  Score=330.07  Aligned_cols=238  Identities=22%  Similarity=0.311  Sum_probs=184.4

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecC
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAP   82 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (385)
                      |+..+.||+|+||+||+|+++.+++.||||.+..... ...+|++++++++|||||++++++.....    +++||||++
T Consensus       692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l~HpnIv~~~~~~~~~~~----~~lv~Ey~~  766 (968)
T PLN00113        692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKLQHPNIVKLIGLCRSEKG----AYLIHEYIE  766 (968)
T ss_pred             CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhCCCCCcceEEEEEEcCCC----CEEEEeCCC
Confidence            4566789999999999999999999999998864332 23467999999999999999999876543    569999999


Q ss_pred             CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           83 GGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH---SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        83 ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH---~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      +|+|.++++.   +++..+..++.||+.||+|||   +.+|+||||||+||+++.+..  .++. ||.+.....     .
T Consensus       767 ~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~--~~~~-~~~~~~~~~-----~  835 (968)
T PLN00113        767 GKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE--PHLR-LSLPGLLCT-----D  835 (968)
T ss_pred             CCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc--eEEE-ecccccccc-----C
Confidence            9999999974   789999999999999999999   669999999999999986655  5554 665543311     1


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHhcCCC------CCCCC------
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVAD---PISALHRIGFSS------DTPEI------  224 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~---~~~~~~~~~~~~------~~~~~------  224 (385)
                      ....||+.|||||++.+..++.++|||||||++|||+||+.||.....   ......+.....      ..+.+      
T Consensus       836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (968)
T PLN00113        836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV  915 (968)
T ss_pred             CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence            223689999999999999999999999999999999999999853211   111111110100      00111      


Q ss_pred             CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          225 PGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       225 ~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      +.....++.+++.+||+.||++|||+.|+++.
T Consensus       916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        916 NQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            11122356789999999999999999999874

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=294.06  Aligned_cols=245  Identities=24%  Similarity=0.266  Sum_probs=197.8

Q ss_pred             eeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            4 TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      .++++||+|-||.|.++.-. .+..+|||++....    ...|.+|+++|.+|+||||+.++|++..++.    +++++|
T Consensus       541 ~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP----icmI~E  615 (807)
T KOG1094|consen  541 RFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP----LCMITE  615 (807)
T ss_pred             ehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc----hHHHHH
Confidence            56899999999999999875 36899999987543    3567899999999999999999999988887    889999


Q ss_pred             ecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           80 YAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        80 y~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |++.|+|.+++.+.  ..+.......++.||+.|++||.+.++|||||.+.|+|++.+.+  +||+|||+++.+-.....
T Consensus       616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~--iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT--IKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc--EEecCcccccccccCCce
Confidence            99999999999854  22345566679999999999999999999999999999987766  999999999965332222


Q ss_pred             CCC-ccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh--CCCCCCCCCChHHHHHHhcCC-----CCCCCCCCcCC
Q 040569          158 EGK-PICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT--GRPPWPDVADPISALHRIGFS-----SDTPEIPGYMS  229 (385)
Q Consensus       158 ~~~-~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--G~~Pf~~~~~~~~~~~~~~~~-----~~~~~~~~~~s  229 (385)
                      ... ..+-..+|||||.+..++++.++|+|+||+++||+++  ...||....+....-..-.+.     ...+..|.-++
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp  773 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACP  773 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCc
Confidence            111 1123468999999999999999999999999999865  788998764433222221111     12334566789


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          230 KQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       230 ~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ..+.++|.+||.++..+|||++++-.
T Consensus       774 ~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  774 QGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             HHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            99999999999999999999999865

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-38  Score=282.96  Aligned_cols=258  Identities=26%  Similarity=0.331  Sum_probs=206.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC-----CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCe-EEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-----SNSEFLQREQRILSALACPQIVAYKGCDISEENGK-ILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~-----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~-~~~~   75 (385)
                      |.+..+.||-|+||+||.+.+..+|+.+|+|++..     ...+.+.+|+.+|..++|.|++..++...-..-+. .-+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            44567899999999999999999999999998742     23456778999999999999998877654322111 0144


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +++|.+.. +|..+|.....++...+.-+++||++||+|||+.||.||||||.|.|++++.-  +||||||+|+......
T Consensus       134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCv--LKICDFGLARvee~d~  210 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCI--LKICDFGLARTWDQRD  210 (449)
T ss_pred             HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCce--EEecccccccccchhh
Confidence            78888865 89999998888999999999999999999999999999999999999987654  7999999999887666


Q ss_pred             CCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC---------------
Q 040569          156 DDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS---------------  219 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~---------------  219 (385)
                      ..+++.-+-|..|.|||++.|. .|+.+.||||.|||+.||+..+..|... ++..++..|..-.               
T Consensus       211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq-~PiqQL~lItdLLGTPs~EaMr~ACEGA  289 (449)
T KOG0664|consen  211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA-GPIEQLQMIIDLLGTPSQEAMKYACEGA  289 (449)
T ss_pred             hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc-ChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence            6666767789999999999876 6899999999999999999999998764 4444444331111               


Q ss_pred             ---------CCCCCC--------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          220 ---------DTPEIP--------GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       220 ---------~~~~~~--------~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                               ..|.++        ..-..+..+++.++|..||++|.+.++++.|++.....
T Consensus       290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence                     111111        12234678899999999999999999999999987543

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-36  Score=293.05  Aligned_cols=243  Identities=22%  Similarity=0.305  Sum_probs=200.4

Q ss_pred             eeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeec
Q 040569            4 TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYA   81 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (385)
                      +-.++||-|.||.||.|.+++-.-.+|||.++.+.  .+.|..|+.+|+.++|||+|+++|++..+..    +|||+|||
T Consensus       270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP----FYIiTEfM  345 (1157)
T KOG4278|consen  270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP----FYIITEFM  345 (1157)
T ss_pred             eeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC----eEEEEecc
Confidence            44678999999999999999999999999987654  5678899999999999999999999877666    77999999


Q ss_pred             CCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           82 PGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        82 ~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      ..|+|.+|++..  .-++.....+++.||..|++||..+++|||||-..|+|+.++.-  +|++|||+++....+.....
T Consensus       346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi--VKvADFGLsRlMtgDTYTAH  423 (1157)
T KOG4278|consen  346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI--VKVADFGLSRLMTGDTYTAH  423 (1157)
T ss_pred             cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce--EEeeccchhhhhcCCceecc
Confidence            999999999843  34677788899999999999999999999999999999987655  89999999998643332211


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHH
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK  238 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~  238 (385)
                      ...--..-|.|||.+-...++.++|||+||++|||++| |-.||++.+-  .+.+.+.-....-.-|..+++.+.+|++.
T Consensus       424 AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl--SqVY~LLEkgyRM~~PeGCPpkVYeLMra  501 (1157)
T KOG4278|consen  424 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYGLLEKGYRMDGPEGCPPKVYELMRA  501 (1157)
T ss_pred             cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH--HHHHHHHhccccccCCCCCCHHHHHHHHH
Confidence            11112346999999999999999999999999999999 9999998632  22222222223334456789999999999


Q ss_pred             hhhcCCCCCCCHHHHH
Q 040569          239 CLIRNPGERWSASELL  254 (385)
Q Consensus       239 cL~~dP~~Rps~~elL  254 (385)
                      ||+.+|.+||+++|+-
T Consensus       502 CW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  502 CWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             HhcCCcccCccHHHHH
Confidence            9999999999998764

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-36  Score=302.93  Aligned_cols=245  Identities=20%  Similarity=0.321  Sum_probs=203.8

Q ss_pred             eeeceeeccCceEEEEEEECCCC---cEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            4 TRGQTIGRGSTATVSIGMSNRSS---EVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~---~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      ++.+.||.|.||.|++|+.+..|   ..||||.++...    ...|..|+.||-++.||||+++.|+......    .+|
T Consensus       632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P----vMI  707 (996)
T KOG0196|consen  632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP----VMI  707 (996)
T ss_pred             EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce----eEE
Confidence            57899999999999999998777   568999887543    3356679999999999999999998655444    668


Q ss_pred             EEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |.|||++|+|+.+|+ +.+.|+..++..+++.|+.|++||-++|+|||||..+||||+.+--  .|++|||+++....+.
T Consensus       708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv--CKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDP  785 (996)
T ss_pred             EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE--EEeccccceeecccCC
Confidence            999999999999998 5677999999999999999999999999999999999999986533  6999999999875554


Q ss_pred             CCCCCcccc--CCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHH
Q 040569          156 DDEGKPICG--TPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA  232 (385)
Q Consensus       156 ~~~~~~~~G--t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  232 (385)
                      ....++..|  -.+|.|||.+....++.++||||+|+++||.++ |..||.++.+.. .++.+......| -|..++..+
T Consensus       786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-VIkaIe~gyRLP-pPmDCP~aL  863 (996)
T KOG0196|consen  786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-VIKAIEQGYRLP-PPMDCPAAL  863 (996)
T ss_pred             CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-HHHHHHhccCCC-CCCCCcHHH
Confidence            333333333  247999999999999999999999999999887 999999886543 344443222222 355689999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          233 QDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      .+|+..||++|-.+||.+.|++.+
T Consensus       864 ~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  864 YQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHHHhhcCCCHHHHHHH
Confidence            999999999999999999999863

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=284.22  Aligned_cols=244  Identities=25%  Similarity=0.320  Sum_probs=191.4

Q ss_pred             eeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhc--CCCCeeeeeeeeeeccCCeEEEEEEEeec
Q 040569            4 TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL--ACPQIVAYKGCDISEENGKILYNLFLEYA   81 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l--~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (385)
                      +..+.||+|.||+||+|...  ++.||||++...+.+.+++|-+|.+..  +|+||++|++...-......-|+||+||.
T Consensus       213 ~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh  290 (534)
T KOG3653|consen  213 QLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH  290 (534)
T ss_pred             hhHHHhhcCccceeehhhcc--CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence            45678999999999999876  699999999999999999999998865  89999999987543332233478999999


Q ss_pred             CCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           82 PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN---------GIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        82 ~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~---------givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      +.|||.++++... ++.....+++..+++||+|||+.         .|+|||||..||||..|..  ..|+|||+|..+.
T Consensus       291 ~kGsL~dyL~~nt-isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT--ccIaDFGLAl~~~  367 (534)
T KOG3653|consen  291 PKGSLCDYLKANT-ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT--CCIADFGLALRLE  367 (534)
T ss_pred             cCCcHHHHHHhcc-ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc--EEeeccceeEEec
Confidence            9999999999654 89999999999999999999963         4999999999999998777  9999999999886


Q ss_pred             ccCCCC-CCccccCCcccChhhhcCCC-C-----CCCCChHHHHHHHHHHHhCCC------------CCCC---CCC-hH
Q 040569          153 VNEDDE-GKPICGTPICMAPEVARGEE-Q-----GFPADVWALGCTVLEMATGRP------------PWPD---VAD-PI  209 (385)
Q Consensus       153 ~~~~~~-~~~~~Gt~~y~aPE~~~~~~-~-----~~~~DiwSlG~il~elltG~~------------Pf~~---~~~-~~  209 (385)
                      ...... ....+||.+|||||++.+.- +     -.+.||||+|.++|||++...            ||..   ... ..
T Consensus       368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e  447 (534)
T KOG3653|consen  368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE  447 (534)
T ss_pred             CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence            544332 33468999999999997642 1     236899999999999998642            2320   011 11


Q ss_pred             HHHHHhcCCCCCCCCCCc-----CCHHHHHHHHHhhhcCCCCCCCHHH
Q 040569          210 SALHRIGFSSDTPEIPGY-----MSKQAQDFLSKCLIRNPGERWSASE  252 (385)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~-----~s~~~~~ll~~cL~~dP~~Rps~~e  252 (385)
                      .....+......|.+|..     -..-+++.+..||+.||+.|.|+.=
T Consensus       448 ~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C  495 (534)
T KOG3653|consen  448 EMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC  495 (534)
T ss_pred             HHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence            122222334456665543     2345789999999999999999863

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=277.38  Aligned_cols=131  Identities=23%  Similarity=0.322  Sum_probs=114.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcC-----C---CCeeeeeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALA-----C---PQIVAYKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~-----h---pnIv~~~~~~~~~~~~~   71 (385)
                      .|.+.++||-|-|+|||++-+..+.+.||+|+++...  .+....|+++|+++.     |   .+||++++.|.....+.
T Consensus        79 RY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG  158 (590)
T KOG1290|consen   79 RYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNG  158 (590)
T ss_pred             eEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCC
Confidence            4889999999999999999999999999999987433  355668999999982     2   57999999998777666


Q ss_pred             EEEEEEEeecCCCCHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEee
Q 040569           72 ILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSN-GIVHCDIKGQNILVS  133 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~--~~~~l~e~~~~~i~~qil~gL~yLH~~-givHrDlKp~NILi~  133 (385)
                      .-+|+|+|++ |-+|..+|+  ..+.++-..+++|++||+.||.|||.. ||||-||||+|||+.
T Consensus       159 ~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  159 QHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             cEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            6688999999 669999998  455699999999999999999999975 999999999999984

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-34  Score=295.98  Aligned_cols=245  Identities=28%  Similarity=0.383  Sum_probs=199.3

Q ss_pred             eeeceeeccCceEEEEEEEC---C----CCcEEEEEeccCC----CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCe
Q 040569            4 TRGQTIGRGSTATVSIGMSN---R----SSEVFAVKSAELS----NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGK   71 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~---~----~~~~~AvK~~~~~----~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~   71 (385)
                      .+.+.||+|.||.|++|..+   .    ....+|||.....    +.+.+..|+++|+.+ .||||+.++|++.....  
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~--  376 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP--  376 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc--
Confidence            35669999999999999743   1    1467899987643    346788999999999 79999999998776333  


Q ss_pred             EEEEEEEeecCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecC
Q 040569           72 ILYNLFLEYAPGGTLTDAIRSGT----------------CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKD  135 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~~~----------------~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~  135 (385)
                        .++|+||+..|+|.++++..+                .++......++.||+.|++||++.+++||||-.+|||+..+
T Consensus       377 --~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~  454 (609)
T KOG0200|consen  377 --LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKN  454 (609)
T ss_pred             --eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCC
Confidence              568999999999999998443                48899999999999999999999999999999999999876


Q ss_pred             CCCCeEEeecCceeeecccCCCCCCccccCC--cccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHH
Q 040569          136 NEQGAKIADFGCARRARVNEDDEGKPICGTP--ICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISAL  212 (385)
Q Consensus       136 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~--~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~  212 (385)
                      ..  +||+|||+|+..........+...|+.  .|||||.+....|+.++||||+|+++||++| |..||++........
T Consensus       455 ~~--~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~  532 (609)
T KOG0200|consen  455 KV--IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL  532 (609)
T ss_pred             CE--EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence            54  899999999965332222212222222  4999999999999999999999999999998 999999854344443


Q ss_pred             HHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          213 HRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       213 ~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      . ....+.....|...++++.++++.||+.+|.+||++.++.+
T Consensus       533 ~-~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  533 E-FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             H-HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            3 33455566778889999999999999999999999999876

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=1e-32  Score=245.09  Aligned_cols=208  Identities=37%  Similarity=0.568  Sum_probs=182.7

Q ss_pred             eeccCceEEEEEEECCCCcEEEEEeccCCCH----HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecCCC
Q 040569            9 IGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGG   84 (385)
Q Consensus         9 LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~----~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~gg   84 (385)
                      ||+|++|.||++....+++.+++|.+.....    +.+.+|++.++.+.|++|+++++++....    ..++++||++|+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~~~~e~~~~~   76 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDEN----HLYLVMEYCEGG   76 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC----eEEEEEecCCCC
Confidence            6899999999999988899999999986654    67889999999999999999999876542    266899999999


Q ss_pred             CHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeec-CCCCCeEEeecCceeeecccCCCCCCcc
Q 040569           85 TLTDAIRSG-TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSK-DNEQGAKIADFGCARRARVNEDDEGKPI  162 (385)
Q Consensus        85 sL~~~l~~~-~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~-~~~~~~kL~DFG~a~~~~~~~~~~~~~~  162 (385)
                      +|.+++... ..+++..+..++.+++.+|.+||++|++|+||+|.||+++. ++.  ++|+|||.+........ .....
T Consensus        77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~--~~l~d~~~~~~~~~~~~-~~~~~  153 (215)
T cd00180          77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK--VKLADFGLSKLLTSDKS-LLKTI  153 (215)
T ss_pred             cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCc--EEEecCCceEEccCCcc-hhhcc
Confidence            999999865 56899999999999999999999999999999999999987 444  99999999987643221 12334


Q ss_pred             ccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhh
Q 040569          163 CGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLI  241 (385)
Q Consensus       163 ~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~  241 (385)
                      .+...|++||.+... .++.++|+|+||+++++|                                  ..+.+++.+|+.
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~l~  199 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKMLQ  199 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHHhh
Confidence            578899999999887 788999999999999999                                  688999999999


Q ss_pred             cCCCCCCCHHHHHhCc
Q 040569          242 RNPGERWSASELLEHG  257 (385)
Q Consensus       242 ~dP~~Rps~~elL~hp  257 (385)
                      .+|.+||++.++++|+
T Consensus       200 ~~p~~R~~~~~l~~~~  215 (215)
T cd00180         200 KDPEKRPSAKEILEHL  215 (215)
T ss_pred             CCcccCcCHHHHhhCC
Confidence            9999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=7.1e-34  Score=269.40  Aligned_cols=254  Identities=29%  Similarity=0.396  Sum_probs=197.7

Q ss_pred             CceeeceeeccCceEEEEEEECC---CCcEEEEEeccCC-CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNR---SSEVFAVKSAELS-NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~---~~~~~AvK~~~~~-~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      .|...++||.|+|++||++.+..   ..+.||+|.+... ....+.+|+++|..+ .+.||+++.+++...+.    ..+
T Consensus        37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~----v~i  112 (418)
T KOG1167|consen   37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ----VAI  112 (418)
T ss_pred             hhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCe----eEE
Confidence            47889999999999999999877   7899999988754 456788999999999 79999999988765544    568


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC-
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE-  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~-  155 (385)
                      ||||.+.-+..+++..   ++-..++.|++.++.||+++|.+|||||||||+|+|.+...+ .-.|+|||+|....... 
T Consensus       113 vlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~-rg~LvDFgLA~~~d~~~~  188 (418)
T KOG1167|consen  113 VLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ-RGVLVDFGLAQRYDGYQQ  188 (418)
T ss_pred             EecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC-CceEEechhHHHHHhhhh
Confidence            9999999888888775   678899999999999999999999999999999999986543 36899999997211000 


Q ss_pred             ------------CC------------------------------CCCccccCCcccChhhhcC-CCCCCCCChHHHHHHH
Q 040569          156 ------------DD------------------------------EGKPICGTPICMAPEVARG-EEQGFPADVWALGCTV  192 (385)
Q Consensus       156 ------------~~------------------------------~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il  192 (385)
                                  ..                              ......||++|.|||++.. ..+++++||||.|+|+
T Consensus       189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~  268 (418)
T KOG1167|consen  189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL  268 (418)
T ss_pred             hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence                        00                              0012359999999999854 5679999999999999


Q ss_pred             HHHHhCCCCCCCCCChHHHHHHh----------------cC-------------------CCC--------------CCC
Q 040569          193 LEMATGRPPWPDVADPISALHRI----------------GF-------------------SSD--------------TPE  223 (385)
Q Consensus       193 ~elltG~~Pf~~~~~~~~~~~~~----------------~~-------------------~~~--------------~~~  223 (385)
                      ..+++++.||-...+....+..+                +.                   ...              ...
T Consensus       269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~  348 (418)
T KOG1167|consen  269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI  348 (418)
T ss_pred             ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence            99999999985332211111100                00                   000              000


Q ss_pred             CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          224 IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       224 ~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      .....+..+.+|+++||..||.+|+|++++|+||||....
T Consensus       349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  349 GSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             ccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence            1122456889999999999999999999999999998653

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-34  Score=278.81  Aligned_cols=194  Identities=28%  Similarity=0.399  Sum_probs=172.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH-----------HHHHHHHHHHHhcC---CCCeeeeeeeeeec
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----------EFLQREQRILSALA---CPQIVAYKGCDISE   67 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~-----------~~~~~E~~il~~l~---hpnIv~~~~~~~~~   67 (385)
                      +|+..+.+|.|+||.|++|+++.+...|+||.+.++..           ..+-.|++||..|+   |+||++++++|.+.
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            69999999999999999999999999999999976542           12335999999996   99999999998766


Q ss_pred             cCCeEEEEEEEeec-CCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecC
Q 040569           68 ENGKILYNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG  146 (385)
Q Consensus        68 ~~~~~~~~lv~Ey~-~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG  146 (385)
                      +.    |||+||-- +|.+|.++|....+++|.++..|++||+.|+++||+.||||||||-+||.++.+|-  +||+|||
T Consensus       642 d~----yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~--~klidfg  715 (772)
T KOG1152|consen  642 DY----YYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF--VKLIDFG  715 (772)
T ss_pred             Ce----eEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe--EEEeecc
Confidence            54    88999985 67799999999999999999999999999999999999999999999999987776  9999999


Q ss_pred             ceeeecccCCCCCCccccCCcccChhhhcCCCC-CCCCChHHHHHHHHHHHhCCCCCCC
Q 040569          147 CARRARVNEDDEGKPICGTPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPD  204 (385)
Q Consensus       147 ~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~  204 (385)
                      .|.....+   ....++||..|.|||++.|..| +..-|||+||+++|.++....||.+
T Consensus       716 saa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  716 SAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             chhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            99876433   3456789999999999999987 7889999999999999998888854

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=282.97  Aligned_cols=244  Identities=24%  Similarity=0.328  Sum_probs=198.9

Q ss_pred             ceeeceeeccCceEEEEEEECCCCc----EEEEEeccCC----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSE----VFAVKSAELS----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~----~~AvK~~~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      .+..+.||+|+||+||+|.+-..|+    +||+|++...    ....+..|+-+|.+|.|||+++++++.....     .
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-----~  772 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-----L  772 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----H
Confidence            3567899999999999999866554    4678876532    2456778999999999999999999987654     4


Q ss_pred             EEEEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      .||++|+++|+|.++++ ....+-......|..||++|+.|||.++++||||-.+||||.+-+.  +||.|||+|+....
T Consensus       773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h--vkitdfgla~ll~~  850 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH--VKITDFGLAKLLAP  850 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe--EEEEecchhhccCc
Confidence            48999999999999998 5567889999999999999999999999999999999999987666  99999999998765


Q ss_pred             cCCCCCCcc-ccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHH
Q 040569          154 NEDDEGKPI-CGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQ  231 (385)
Q Consensus       154 ~~~~~~~~~-~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  231 (385)
                      ......... .--+-|||=|.+....|+.++||||+||++||++| |..|+.++.  ...+......++...-|...+-+
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~--~~eI~dlle~geRLsqPpiCtiD  928 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP--AEEIPDLLEKGERLSQPPICTID  928 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC--HHHhhHHHhccccCCCCCCccHH
Confidence            544332221 12446999999999999999999999999999998 999998752  22222222233334446668999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          232 AQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      +.-++.+||-.|+..||+++++-.
T Consensus       929 Vy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  929 VYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHhccCcccCccHHHHHH
Confidence            999999999999999999988754

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=8.4e-32  Score=243.65  Aligned_cols=207  Identities=35%  Similarity=0.482  Sum_probs=175.6

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCC----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      |+..+.||+|++|+||++.+..+++.+|+|.+...    ..+.+.+|++.++++.|+|++++++.+.....    +++++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~----~~~v~   76 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP----LYLVM   76 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc----eEEEE
Confidence            67889999999999999999988999999998765    35678899999999999999999988655433    66899


Q ss_pred             eecCCCCHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           79 EYAPGGTLTDAIRSGTC-LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~-l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      ||+++++|.+++..... +++..+..++.+++.+|.+||+++++|+||+|.||+++.++.  ++|+|||.+.........
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~--~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGL--VKLADFGLARFIHRDLAA  154 (225)
T ss_pred             eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeCceeeEecCcccc
Confidence            99999999999987666 899999999999999999999999999999999999987654  999999999887433211


Q ss_pred             CCCccccCCcccChhhh-cCCCCCCCCChHHHHHHHHHHHhCCCCCCC-CCChHHHHHHh
Q 040569          158 EGKPICGTPICMAPEVA-RGEEQGFPADVWALGCTVLEMATGRPPWPD-VADPISALHRI  215 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltG~~Pf~~-~~~~~~~~~~~  215 (385)
                      ......++..|++||.+ ....++.++|+|+||+++++|++|+.||.. ..+.......+
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~  214 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW  214 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence            23445688899999999 666778899999999999999999999976 33333444444

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-33  Score=251.40  Aligned_cols=253  Identities=20%  Similarity=0.332  Sum_probs=200.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      .|++.+.||+|.||.+-++.|+.++..+++|.+...  ....+.||...--.| .|.||+.-|++-.....   +|.+++
T Consensus        25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d---~YvF~q  101 (378)
T KOG1345|consen   25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD---AYVFVQ  101 (378)
T ss_pred             hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc---eEEEee
Confidence            488999999999999999999999999999988754  356788898887777 68999988776433222   477899


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      ||++-|+|..-+...| +.|.....++.|++.||.|||++++||||||.+||||.......+||||||..+........ 
T Consensus       102 E~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~-  179 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY-  179 (378)
T ss_pred             ccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceehh-
Confidence            9999999999887544 89999999999999999999999999999999999997665667999999998765322111 


Q ss_pred             CCccccCCcccChhhhcC---C--CCCCCCChHHHHHHHHHHHhCCCCCCCC---CChHHHHHHh--cCCCCCCCCCCcC
Q 040569          159 GKPICGTPICMAPEVARG---E--EQGFPADVWALGCTVLEMATGRPPWPDV---ADPISALHRI--GFSSDTPEIPGYM  228 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~---~--~~~~~~DiwSlG~il~elltG~~Pf~~~---~~~~~~~~~~--~~~~~~~~~~~~~  228 (385)
                         .--+-.|.+||.+..   +  ...+.+|+|.||+++|.++||.+||...   ..+.....+.  +.....|..-..+
T Consensus       180 ---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~f  256 (378)
T KOG1345|consen  180 ---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPF  256 (378)
T ss_pred             ---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhccc
Confidence               123556999998742   2  2478899999999999999999999732   2222222222  2334455555678


Q ss_pred             CHHHHHHHHHhhhcCCCCC---CCHHHHHhCcccccc
Q 040569          229 SKQAQDFLSKCLIRNPGER---WSASELLEHGFVKEQ  262 (385)
Q Consensus       229 s~~~~~ll~~cL~~dP~~R---ps~~elL~hp~~~~~  262 (385)
                      |+.+..+.++-|.++|++|   +++.......|....
T Consensus       257 s~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~  293 (378)
T KOG1345|consen  257 SEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL  293 (378)
T ss_pred             CHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence            9999999999999999999   777777777786543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=2.5e-32  Score=293.11  Aligned_cols=206  Identities=19%  Similarity=0.205  Sum_probs=148.2

Q ss_pred             hcCC-CCeeeeeeeeeecc---CCeEEEEEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 040569           51 ALAC-PQIVAYKGCDISEE---NGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDI  125 (385)
Q Consensus        51 ~l~h-pnIv~~~~~~~~~~---~~~~~~~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDl  125 (385)
                      .++| +||+.+++.+....   .....+.+++||+ +++|.+++.. ...+++..+..+++||+.||+|||++||+||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            3444 46666666541111   1111244688988 5699999974 456999999999999999999999999999999


Q ss_pred             CCCCEEeecC-----------------CCCCeEEeecCceeeecccCC---------------CCCCccccCCcccChhh
Q 040569          126 KGQNILVSKD-----------------NEQGAKIADFGCARRARVNED---------------DEGKPICGTPICMAPEV  173 (385)
Q Consensus       126 Kp~NILi~~~-----------------~~~~~kL~DFG~a~~~~~~~~---------------~~~~~~~Gt~~y~aPE~  173 (385)
                      ||+||||+..                 ....+||+|||+++.......               ......+||+.|||||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            9999999642                 223368888888764321000               00112468999999999


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHH
Q 040569          174 ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASEL  253 (385)
Q Consensus       174 ~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~el  253 (385)
                      +.+..++.++|||||||++|||++|.+|+.........+...   ...+... ...+...+++.+||+++|.+||++.|+
T Consensus       187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~---~~~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~~ei  262 (793)
T PLN00181        187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHR---VLPPQIL-LNWPKEASFCLWLLHPEPSCRPSMSEL  262 (793)
T ss_pred             hccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHh---hcChhhh-hcCHHHHHHHHHhCCCChhhCcChHHH
Confidence            999999999999999999999999999886432222222211   1111111 124567899999999999999999999


Q ss_pred             HhCccccc
Q 040569          254 LEHGFVKE  261 (385)
Q Consensus       254 L~hp~~~~  261 (385)
                      |+||||..
T Consensus       263 l~h~~~~~  270 (793)
T PLN00181        263 LQSEFINE  270 (793)
T ss_pred             hhchhhhh
Confidence            99999964

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=8.3e-31  Score=230.14  Aligned_cols=162  Identities=27%  Similarity=0.307  Sum_probs=128.9

Q ss_pred             CCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCCcc
Q 040569           84 GTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI  162 (385)
Q Consensus        84 gsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~  162 (385)
                      |+|.+++.. +..+++..++.++.||+.||+|||+++      ||+|||++.++.  +|+  ||+++.....      ..
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~~------~~   64 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTPE------QS   64 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeeccc------cC
Confidence            699999985 566999999999999999999999999      999999987665  788  9999876322      12


Q ss_pred             ccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC--CCCCC---CCCCcCCH--HHHHH
Q 040569          163 CGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF--SSDTP---EIPGYMSK--QAQDF  235 (385)
Q Consensus       163 ~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~---~~~~~~s~--~~~~l  235 (385)
                      .||+.|||||++.+..++.++|||||||++|||++|+.||.........+..+..  ....+   ..+..++.  ++++|
T Consensus        65 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (176)
T smart00750       65 RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF  144 (176)
T ss_pred             CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence            6899999999999999999999999999999999999999754332222222211  11101   11222344  69999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      |.+||..+|.+||++.|+++|+|+..
T Consensus       145 i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      145 MRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHHhcccccccCHHHHHHHHHHHH
Confidence            99999999999999999999999753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.1e-29  Score=261.71  Aligned_cols=252  Identities=24%  Similarity=0.365  Sum_probs=199.8

Q ss_pred             eeceeeccCceEEEEEEECCCCcEEEEEecc----CCC-H----HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            5 RGQTIGRGSTATVSIGMSNRSSEVFAVKSAE----LSN-S----EFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~----~~~-~----~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      ..+.+|.|++|.|+.+......+.++.|...    ... .    ..+..|.-+-.+|.|||++...........    +.
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~----~~  397 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG----IL  397 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc----ch
Confidence            5788999999999999888788888877543    111 1    124457777888899999887665544332    22


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      -+||||++ +|..++...+.++..++..+++|++.|++|||+.||.|||+||+|+++..++.  +||+|||.+.......
T Consensus       398 ~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  398 QSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI--LKIIDFGAASVFRYPW  474 (601)
T ss_pred             hhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc--eEEeecCcceeeccCc
Confidence            34999999 99999998888999999999999999999999999999999999999998775  9999999998876544


Q ss_pred             CC---CCCccccCCcccChhhhcCCCCCC-CCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh------cCCCCCCCCC
Q 040569          156 DD---EGKPICGTPICMAPEVARGEEQGF-PADVWALGCTVLEMATGRPPWPDVADPISALHRI------GFSSDTPEIP  225 (385)
Q Consensus       156 ~~---~~~~~~Gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~------~~~~~~~~~~  225 (385)
                      ..   .....+|+..|+|||++.+.+|++ ..||||.|++++.|++|+.||.............      ....+...+.
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~  554 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL  554 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence            42   355678999999999999999976 6899999999999999999997432221111111      1112222334


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          226 GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       226 ~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      ..++...+.+|.+||+.||.+|.|++++++.+|++...
T Consensus       555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             HhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            45788899999999999999999999999999998753

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=1.2e-26  Score=217.75  Aligned_cols=251  Identities=32%  Similarity=0.443  Sum_probs=199.2

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCC-CeeeeeeeeeeccCCeEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACP-QIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hp-nIv~~~~~~~~~~~~~~~~~   75 (385)
                      |...+.||.|+||.||++.+.   ..+++|.+...      ....+.+|..++..+.|+ +|+++++.+.....    .+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~----~~   74 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS----LY   74 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE----EE
Confidence            678899999999999999987   78888877532      245678999999999888 79999998843332    56


Q ss_pred             EEEeecCCCCHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           76 LFLEYAPGGTLTDAIRSGT---CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~---~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      ++++|+.++++.+++....   .+++..+..++.|++.++.|+|+.|++|||+||+||+++..+. .++++|||.++...
T Consensus        75 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~  153 (384)
T COG0515          75 LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLP  153 (384)
T ss_pred             EEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecC
Confidence            8999999999998887654   7999999999999999999999999999999999999986651 38999999998654


Q ss_pred             ccCCC-----CCCccccCCcccChhhhcC---CCCCCCCChHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHhcCCCC-
Q 040569          153 VNEDD-----EGKPICGTPICMAPEVARG---EEQGFPADVWALGCTVLEMATGRPPWPDVAD---PISALHRIGFSSD-  220 (385)
Q Consensus       153 ~~~~~-----~~~~~~Gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltG~~Pf~~~~~---~~~~~~~~~~~~~-  220 (385)
                      .....     ......||..|+|||.+.+   ..+....|+||+|++++++++|..||.....   .......+..... 
T Consensus       154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  233 (384)
T COG0515         154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP  233 (384)
T ss_pred             CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence            33221     2356689999999999988   5788999999999999999999999876543   2233322222211 


Q ss_pred             --CCCCCCcC----CHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          221 --TPEIPGYM----SKQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       221 --~~~~~~~~----s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                        ........    ...+.+++.+|+..+|..|.+..+...+++...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence              11111111    257899999999999999999999998866554

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.95  E-value=9e-28  Score=225.64  Aligned_cols=245  Identities=18%  Similarity=0.278  Sum_probs=190.5

Q ss_pred             eeeceeeccCceEEEEEEECCCC-----cEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            4 TRGQTIGRGSTATVSIGMSNRSS-----EVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~-----~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +....+-+|.||.||.|+++...     +.+-+|.+.-..    ...+..|.-.|..+.|||+.++.++.+.....   -
T Consensus       287 ~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~---P  363 (563)
T KOG1024|consen  287 RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT---P  363 (563)
T ss_pred             echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc---c
Confidence            34456778999999999876432     334456554222    23455788889999999999999988765443   3


Q ss_pred             EEEEeecCCCCHHHHHH--c------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecC
Q 040569           75 NLFLEYAPGGTLTDAIR--S------GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG  146 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~--~------~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG  146 (385)
                      ++++.+..-|+|..++.  +      .+.++..++..++.|+..|++|||++|+||.||..+|.+|++.-+  +||+|=.
T Consensus       364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq--VkltDsa  441 (563)
T KOG1024|consen  364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ--VKLTDSA  441 (563)
T ss_pred             eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee--EEeccch
Confidence            36788888899999997  1      123677788899999999999999999999999999999986544  8999999


Q ss_pred             ceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCC
Q 040569          147 CARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEI  224 (385)
Q Consensus       147 ~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  224 (385)
                      +++........ -...--....||+||.+....|+.++|+||||+++|||+| |+.|+.+. ++......+. .+..-.-
T Consensus       442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI-DPfEm~~ylk-dGyRlaQ  519 (563)
T KOG1024|consen  442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI-DPFEMEHYLK-DGYRLAQ  519 (563)
T ss_pred             hccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc-CHHHHHHHHh-ccceecC
Confidence            99875432211 0011112447999999999999999999999999999998 99999886 6666655543 3444455


Q ss_pred             CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          225 PGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       225 ~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      |.++++++..++..||...|++||+.+|+..
T Consensus       520 P~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  520 PFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            7789999999999999999999999999864

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-26  Score=223.35  Aligned_cols=251  Identities=20%  Similarity=0.217  Sum_probs=192.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCC-cEEEEEeccCCC---HHHHHHHHHHHHhcC----CCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSS-EVFAVKSAELSN---SEFLQREQRILSALA----CPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~-~~~AvK~~~~~~---~~~~~~E~~il~~l~----hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|++.+.||+|+||.||++.+..++ +.+|+|......   ...+..|..+|..+.    .+++..+++...   ....+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~---~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR---STEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc---CCCce
Confidence            5999999999999999999998774 678888665432   126889999999996    368888877654   12224


Q ss_pred             EEEEEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC-C--CCeEEeecCce
Q 040569           74 YNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN-E--QGAKIADFGCA  148 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~-~--~~~kL~DFG~a  148 (385)
                      .++||+.+ |.+|.++.+.  .+.++...+..++.|++.+|++||+.|++||||||+|+++.... .  ..++|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            56899998 7899999863  36799999999999999999999999999999999999997653 1  34899999999


Q ss_pred             eeec--ccCCC------C-CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHhcC
Q 040569          149 RRAR--VNEDD------E-GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADP--ISALHRIGF  217 (385)
Q Consensus       149 ~~~~--~~~~~------~-~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--~~~~~~~~~  217 (385)
                      +...  .....      . .....||..|+++....+.+.+.+.|+||++.++.+|..|..||......  .........
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            9322  11111      1 23456999999999999999999999999999999999999999765432  222222211


Q ss_pred             CCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          218 SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       218 ~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ...........+.++..+...+-..+...+|....+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            111111333456788888888888899999999887653

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=2.5e-27  Score=230.32  Aligned_cols=160  Identities=24%  Similarity=0.233  Sum_probs=125.4

Q ss_pred             CceeeceeeccCceEEEEEEECC-CCcEEEEEeccCC--------CHHHHHHHHHHHHhcCCCCeee-eeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNR-SSEVFAVKSAELS--------NSEFLQREQRILSALACPQIVA-YKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~-~~~~~AvK~~~~~--------~~~~~~~E~~il~~l~hpnIv~-~~~~~~~~~~~~   71 (385)
                      +|+.++.||+|+||+||+|+++. +++++|||.....        ..+.+.+|+++|++++|+|+++ +++.    ..  
T Consensus        19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~--   92 (365)
T PRK09188         19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK--   92 (365)
T ss_pred             CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC--
Confidence            59999999999999999999876 6888899986422        1356889999999999999985 4331    22  


Q ss_pred             EEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCCEEeecCCCCCeEEeecCceee
Q 040569           72 ILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDI-KGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDl-Kp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                        .+|||||++|++|... ...   .   ...++.|++++|.|||++||+|||| ||+|||++.++.  +||+|||+|+.
T Consensus        93 --~~LVmE~~~G~~L~~~-~~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~--ikLiDFGlA~~  161 (365)
T PRK09188         93 --DGLVRGWTEGVPLHLA-RPH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE--AAVIDFQLASV  161 (365)
T ss_pred             --cEEEEEccCCCCHHHh-Ccc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC--EEEEECcccee
Confidence              5699999999999732 211   1   1467899999999999999999999 999999976654  99999999997


Q ss_pred             ecccCCC-------CCCccccCCcccChhhhcCCC
Q 040569          151 ARVNEDD-------EGKPICGTPICMAPEVARGEE  178 (385)
Q Consensus       151 ~~~~~~~-------~~~~~~Gt~~y~aPE~~~~~~  178 (385)
                      .......       ......|++.|+|||.+...+
T Consensus       162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~  196 (365)
T PRK09188        162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE  196 (365)
T ss_pred             cccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence            6432211       113557889999999986543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.93  E-value=7e-27  Score=232.03  Aligned_cols=238  Identities=25%  Similarity=0.405  Sum_probs=198.9

Q ss_pred             eeeccCceEEEEEEE---CCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcC-CCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            8 TIGRGSTATVSIGMS---NRSSEVFAVKSAELSN-----SEFLQREQRILSALA-CPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         8 ~LG~G~~g~Vy~a~~---~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      .+|.|+||.|++++-   ...+..||+|+..+..     ......|..++...+ ||.+++++..+.....    .++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~k----l~l~l   76 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGK----LYLIL   76 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccc----hhHhh
Confidence            479999999988753   3558889999776432     123346888899985 9999999887766554    56899


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      +|..||.|...+.+...+.+...+.+...++-+++++|+.||+|||+|++||+++.+|.  +|+.|||+++..-..... 
T Consensus        77 d~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh--i~~tdfglske~v~~~~~-  153 (612)
T KOG0603|consen   77 DFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH--IKLTDFGLSKEAVKEKIA-  153 (612)
T ss_pred             hhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc--cccCCchhhhHhHhhhhc-
Confidence            99999999999998888999999999999999999999999999999999999998776  999999999876322222 


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK  238 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~  238 (385)
                          |||..|||||+++  ....++|.||+|++.++|+||..||..     ....+|  ....+.+|..++..+++++..
T Consensus       154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~I--l~~~~~~p~~l~~~a~~~~~~  220 (612)
T KOG0603|consen  154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRI--LKAELEMPRELSAEARSLFRQ  220 (612)
T ss_pred             ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHH--hhhccCCchhhhHHHHHHHHH
Confidence                9999999999998  677899999999999999999999976     223333  122455677899999999999


Q ss_pred             hhhcCCCCCCC-----HHHHHhCccccccccc
Q 040569          239 CLIRNPGERWS-----ASELLEHGFVKEQNFK  265 (385)
Q Consensus       239 cL~~dP~~Rps-----~~elL~hp~~~~~~~~  265 (385)
                      ++.++|.+|.-     +.|+++|+|++.+++.
T Consensus       221 l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  221 LFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             HHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence            99999999985     4699999999988665

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-24  Score=201.40  Aligned_cols=245  Identities=22%  Similarity=0.283  Sum_probs=193.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEecc-CCCHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE-LSNSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~-~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      .|+++++||.|+||+.+.|.+--+++.||||.-. +++..+++-|.+..+.| ..+.|...|-+..+  . . +-.||+|
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqe--G-~-~NiLVid  104 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQE--G-K-YNILVID  104 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccc--c-c-hhhhhhh
Confidence            6999999999999999999999999999999654 56678999999999999 56888887654322  2 2 1237999


Q ss_pred             ecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCC---CeEEeecCceeeecccC
Q 040569           80 YAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQ---GAKIADFGCARRARVNE  155 (385)
Q Consensus        80 y~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~---~~kL~DFG~a~~~~~~~  155 (385)
                      .+ |-||.|+.. ++.+|+-..+..++.|++.-++|+|++.+|.|||||+|+||..-+..   .+.|+|||+|+......
T Consensus       105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~  183 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK  183 (449)
T ss_pred             hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence            98 889999998 88899999999999999999999999999999999999999654332   36999999999875443


Q ss_pred             CC------CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHhcCCCC---CCCC
Q 040569          156 DD------EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVAD--PISALHRIGFSSD---TPEI  224 (385)
Q Consensus       156 ~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~--~~~~~~~~~~~~~---~~~~  224 (385)
                      ..      ..+...||..||+--...|.+++...|+=|||-++...+.|..||.+..-  ......+|+....   ...+
T Consensus       184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~L  263 (449)
T KOG1165|consen  184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVL  263 (449)
T ss_pred             ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHH
Confidence            32      23456799999999999999999999999999999999999999987532  2223334432221   1123


Q ss_pred             CCcCCHHHHHHHHHhhhcCCCCCCCHH
Q 040569          225 PGYMSKQAQDFLSKCLIRNPGERWSAS  251 (385)
Q Consensus       225 ~~~~s~~~~~ll~~cL~~dP~~Rps~~  251 (385)
                      -..+|.++..-|+..-..+-.+-|..+
T Consensus       264 c~g~P~efa~Yl~yvR~L~F~E~PDYd  290 (449)
T KOG1165|consen  264 CEGFPEEFATYLRYVRRLDFFETPDYD  290 (449)
T ss_pred             HhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence            344677777777666666666677655

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=9.1e-25  Score=194.12  Aligned_cols=245  Identities=19%  Similarity=0.253  Sum_probs=189.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhcCC-CCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALAC-PQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|..++.||+|+||.+|+|.+..+|+.||||.-... .-.++..|..+.+.|++ ..|+.++.+..+...    -.+|||
T Consensus        16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y----nvlVMd   91 (341)
T KOG1163|consen   16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY----NVLVMD   91 (341)
T ss_pred             ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhcccccc----ceeeee
Confidence            588999999999999999999999999999975433 23577889999999965 556655544333222    338999


Q ss_pred             ecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCC-CeEEeecCceeeecccCCC
Q 040569           80 YAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQ-GAKIADFGCARRARVNEDD  157 (385)
Q Consensus        80 y~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~-~~kL~DFG~a~~~~~~~~~  157 (385)
                      .. |.||.++.. ....++...+.-++-|++.-++|+|.++++||||||+|+|..-+... .+.|+|||+|+........
T Consensus        92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~  170 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR  170 (341)
T ss_pred             cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence            98 789999998 66679999999999999999999999999999999999998543322 2799999999976433322


Q ss_pred             ------CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHH-----HHHHhcCCCCCCCCCC
Q 040569          158 ------EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS-----ALHRIGFSSDTPEIPG  226 (385)
Q Consensus       158 ------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~~  226 (385)
                            ......||..|.+--...+.+++...|+-|+|.++..+..|..||.+......     .+.....+.....+-.
T Consensus       171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~  250 (341)
T KOG1163|consen  171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCK  250 (341)
T ss_pred             ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhC
Confidence                  23445799999998888888999999999999999999999999987632211     1111222222333445


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCCCHH
Q 040569          227 YMSKQAQDFLSKCLIRNPGERWSAS  251 (385)
Q Consensus       227 ~~s~~~~~ll~~cL~~dP~~Rps~~  251 (385)
                      .+|.++.-.+..|-..--.+-|...
T Consensus       251 G~P~EF~myl~Y~R~L~F~E~Pdy~  275 (341)
T KOG1163|consen  251 GFPAEFAMYLNYCRGLGFEEKPDYM  275 (341)
T ss_pred             CCcHHHHHHHHHHhhcCCCCCCcHH
Confidence            6788898999999777777778754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.91  E-value=1.4e-24  Score=225.25  Aligned_cols=223  Identities=30%  Similarity=0.469  Sum_probs=169.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeec
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYA   81 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (385)
                      +|..+++|..|+||.||+++|+.+.+.||+| +++. .-.+++   ||.....|.+|                       
T Consensus        84 df~~IklisngAygavylvrh~~trqrfa~k-iNkq-~lilRn---ilt~a~npfvv-----------------------  135 (1205)
T KOG0606|consen   84 DFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQ-NLILRN---ILTFAGNPFVV-----------------------  135 (1205)
T ss_pred             ccceeEeeccCCCCceeeeeccccccchhhc-cccc-chhhhc---cccccCCccee-----------------------
Confidence            6899999999999999999999999999995 4332 111222   22222333322                       


Q ss_pred             CCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC-----
Q 040569           82 PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED-----  156 (385)
Q Consensus        82 ~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~-----  156 (385)
                        |+=..+++.-+.++-..        +.+++|||+.||+|||+||+|.+|+.-+.  +|+.|||+.+.......     
T Consensus       136 --gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGh--iKlTDfgLsk~GLms~atnl~e  203 (1205)
T KOG0606|consen  136 --GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKKGLMSLATNLKE  203 (1205)
T ss_pred             --chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeeccc--ccccchhhhhhhhhhccchhhh
Confidence              45556666555555444        78899999999999999999999997766  99999999875321111     


Q ss_pred             ---------CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHH-hcCCCCCCCCCC
Q 040569          157 ---------DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHR-IGFSSDTPEIPG  226 (385)
Q Consensus       157 ---------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~  226 (385)
                               ...+..||||.|.|||++..+.|+..+|+|++|+|+||.+-|..||.+. .+..++.. +......++-..
T Consensus       204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd-tpeelfg~visd~i~wpE~de  282 (1205)
T KOG0606|consen  204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-TPEELFGQVISDDIEWPEEDE  282 (1205)
T ss_pred             cchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC-CHHHHHhhhhhhhccccccCc
Confidence                     1235679999999999999999999999999999999999999999773 34444333 233344444455


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCC---CHHHHHhCccccccccc
Q 040569          227 YMSKQAQDFLSKCLIRNPGERW---SASELLEHGFVKEQNFK  265 (385)
Q Consensus       227 ~~s~~~~~ll~~cL~~dP~~Rp---s~~elL~hp~~~~~~~~  265 (385)
                      .++++++++|.++|+.+|..|.   .+-++.+|+||+..+++
T Consensus       283 a~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  283 ALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             CCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            5889999999999999999998   56688999999877655

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=7.5e-25  Score=227.49  Aligned_cols=233  Identities=20%  Similarity=0.291  Sum_probs=177.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-------SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      ++...+-||++.|=+|.+|+++. | +++||++-+..       ..+..+|++ ...+++||+++|.-+......    .
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kA----A   96 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKA----A   96 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHH----H
Confidence            46678899999999999999863 3 48889774332       223334555 555699999999776444433    5


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      |||-+|... +|.|.+...+.+...+.+.|+.||+.||.-+|..||+|||||.+||||+.-+-  +.|+||...+..-..
T Consensus        97 ylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW--~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen   97 YLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW--LYLTDFASFKPTYLP  173 (1431)
T ss_pred             HHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech--hhhhcccccCCccCC
Confidence            589999977 99999998888999999999999999999999999999999999999987655  899999877654322


Q ss_pred             CCCCC------CccccCCcccChhhhcCCC-----------CCCCCChHHHHHHHHHHHh-CCCCCCC----------CC
Q 040569          155 EDDEG------KPICGTPICMAPEVARGEE-----------QGFPADVWALGCTVLEMAT-GRPPWPD----------VA  206 (385)
Q Consensus       155 ~~~~~------~~~~Gt~~y~aPE~~~~~~-----------~~~~~DiwSlG~il~ellt-G~~Pf~~----------~~  206 (385)
                      .+...      .+...-.+|.|||.+....           .+++-||||+||++.||++ |++||.-          ..
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~  253 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNAD  253 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCcc
Confidence            22211      1222345799999985421           4678899999999999998 8999952          11


Q ss_pred             ChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          207 DPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ++...+.+|            -+..++++|..|+++||.+|.|+++.|+.
T Consensus       254 ~~e~~Le~I------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  254 DPEQLLEKI------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             CHHHHHHhC------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            222222222            23478999999999999999999999985

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=5.6e-24  Score=190.05  Aligned_cols=136  Identities=20%  Similarity=0.174  Sum_probs=108.4

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEeccCCCH-----------------------------HHHHHHHHHHHhcCCCC
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----------------------------EFLQREQRILSALACPQ   56 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~-----------------------------~~~~~E~~il~~l~hpn   56 (385)
                      .+.||+|+||+||+|.+. +|+.||||++.....                             ...++|.++|.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            578999999999999997 899999998864311                             12245999999998777


Q ss_pred             eeeeeeeeeeccCCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCCEEeecC
Q 040569           57 IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL-HSNGIVHCDIKGQNILVSKD  135 (385)
Q Consensus        57 Iv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yL-H~~givHrDlKp~NILi~~~  135 (385)
                      +.......  ...    .+|||||++|+++...+...+.+++..+..++.|++.+|.|| |+.||+||||||+|||++. 
T Consensus        81 v~~p~~~~--~~~----~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-  153 (190)
T cd05147          81 IPCPEPIL--LKS----HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-  153 (190)
T ss_pred             CCCCcEEE--ecC----CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-
Confidence            64332221  112    248999999988876654456799999999999999999999 7999999999999999983 


Q ss_pred             CCCCeEEeecCceeee
Q 040569          136 NEQGAKIADFGCARRA  151 (385)
Q Consensus       136 ~~~~~kL~DFG~a~~~  151 (385)
                      +  .++|+|||+|...
T Consensus       154 ~--~v~LiDFG~a~~~  167 (190)
T cd05147         154 G--KLYIIDVSQSVEH  167 (190)
T ss_pred             C--cEEEEEccccccC
Confidence            3  3999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=2.7e-23  Score=185.66  Aligned_cols=137  Identities=23%  Similarity=0.201  Sum_probs=110.4

Q ss_pred             eeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----------------------------HHHHHHHHHHHHhcCCC
Q 040569            5 RGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----------------------------SEFLQREQRILSALACP   55 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----------------------------~~~~~~E~~il~~l~hp   55 (385)
                      +.+.||+|++|+||+|.+. +|+.||||.+....                             ...+++|.+.+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3678999999999999987 89999999876431                             12346899999999999


Q ss_pred             CeeeeeeeeeeccCCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEeec
Q 040569           56 QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSK  134 (385)
Q Consensus        56 nIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~-~givHrDlKp~NILi~~  134 (385)
                      ++.....+...  .    .+|||||++|+++.........+++..+..++.|++.+|.+||+ +||+||||||+|||++ 
T Consensus        80 ~i~~p~~~~~~--~----~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-  152 (190)
T cd05145          80 GVPVPEPILLK--K----NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCCCceEEEec--C----CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-
Confidence            87544333222  1    24899999998665443334568899999999999999999999 9999999999999998 


Q ss_pred             CCCCCeEEeecCceeee
Q 040569          135 DNEQGAKIADFGCARRA  151 (385)
Q Consensus       135 ~~~~~~kL~DFG~a~~~  151 (385)
                      ++.  ++|+|||++...
T Consensus       153 ~~~--~~liDFG~a~~~  167 (190)
T cd05145         153 DGK--PYIIDVSQAVEL  167 (190)
T ss_pred             CCC--EEEEEcccceec
Confidence            444  999999999875

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10345 hypothetical protein; Provisional

Probab=99.90  E-value=4.5e-23  Score=186.47  Aligned_cols=141  Identities=22%  Similarity=0.279  Sum_probs=113.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC---CHHHHHHHHHHHHhc-----CCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---NSEFLQREQRILSAL-----ACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~---~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +....+.||+|+||.||.  +..++.. +||++...   ..+.+.+|+.+++++     .||||+++++++.+......+
T Consensus         3 ~L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          3 RLSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             ecCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            456678999999999995  7666655 79988754   456789999999999     579999999998776543444


Q ss_pred             EEEEEee--cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHH-HHHHHCCceeccCCCCCEEeecCC--CCCeEEeecCce
Q 040569           74 YNLFLEY--APGGTLTDAIRSGTCLEEGRIRSHTRAVLLGL-QYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCA  148 (385)
Q Consensus        74 ~~lv~Ey--~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL-~yLH~~givHrDlKp~NILi~~~~--~~~~kL~DFG~a  148 (385)
                      +.+|+||  +.+|+|.++++++ .+++.  ..+++|++.++ +|||+++|+||||||+|||++..+  ...++|+||+.+
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            5689999  6689999999875 47766  35688888888 999999999999999999997533  335899995443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=3.9e-23  Score=188.01  Aligned_cols=169  Identities=16%  Similarity=0.211  Sum_probs=128.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC---CHH---------HHHHHHHHHHhcCCCCeeeeeeeeeeccC
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---NSE---------FLQREQRILSALACPQIVAYKGCDISEEN   69 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~---~~~---------~~~~E~~il~~l~hpnIv~~~~~~~~~~~   69 (385)
                      +|+..+.||.|+||.||++..  ++..+|+|.+...   ...         .+++|++.+.++.||+|.....++.....
T Consensus        32 ~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~  109 (232)
T PRK10359         32 NIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER  109 (232)
T ss_pred             ceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence            588999999999999999654  4678999988532   111         26789999999999999999887665432


Q ss_pred             Ce----EEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeec
Q 040569           70 GK----ILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADF  145 (385)
Q Consensus        70 ~~----~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DF  145 (385)
                      ..    ...+|+|||++|.+|.++..    +++.    ...+++.+|..||+.|++|||+||+||+++.++   ++|+||
T Consensus       110 ~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~liDf  178 (232)
T PRK10359        110 KTLRYAHTYIMLIEYIEGVELNDMPE----ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRIIDL  178 (232)
T ss_pred             ccccccCCeEEEEEEECCccHHHhhh----ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEEEEC
Confidence            11    12568999999999988732    3442    456999999999999999999999999998654   999999


Q ss_pred             CceeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHH
Q 040569          146 GCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMA  196 (385)
Q Consensus       146 G~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell  196 (385)
                      |..+........             ..+.....++.++|+||||+++..+.
T Consensus       179 g~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        179 SGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            988765211100             11344445678999999999987765

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.89  E-value=6.7e-23  Score=191.87  Aligned_cols=231  Identities=27%  Similarity=0.306  Sum_probs=144.5

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCC----------CCeeeeeeeee-
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALAC----------PQIVAYKGCDI-   65 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~h----------pnIv~~~~~~~-   65 (385)
                      ..+++.||.|+++.||.+.+..||+.+|+|+.-...      .+.+++|......+.+          -.++..++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            467899999999999999999999999999774321      3455555544433221          11111111111 


Q ss_pred             -------eccCCeEE-----EEEEEeecCCCCHHHHHH---c-CCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 040569           66 -------SEENGKIL-----YNLFLEYAPGGTLTDAIR---S-GTC---LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIK  126 (385)
Q Consensus        66 -------~~~~~~~~-----~~lv~Ey~~ggsL~~~l~---~-~~~---l~e~~~~~i~~qil~gL~yLH~~givHrDlK  126 (385)
                             ....+...     ++++|+-+. ++|.+++.   . ...   +.-.....++.|+++.+++||++|++|+|||
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~  172 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK  172 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence                   11111111     356777775 48888875   1 211   2222335666999999999999999999999


Q ss_pred             CCCEEeecCCCCCeEEeecCceeeecccCCCCCCccccCCcccChhhhcCC--------CCCCCCChHHHHHHHHHHHhC
Q 040569          127 GQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE--------EQGFPADVWALGCTVLEMATG  198 (385)
Q Consensus       127 p~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~--------~~~~~~DiwSlG~il~elltG  198 (385)
                      |+|+|++.+|.  ++|+||+...........    ...+..|.+||.....        .++.+.|.|+||+++|.|.+|
T Consensus       173 ~~nfll~~~G~--v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  173 PENFLLDQDGG--VFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             GGGEEE-TTS---EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             eeeEEEcCCCC--EEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            99999998876  999999988765322111    2345779999987442        467889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCC
Q 040569          199 RPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGER  247 (385)
Q Consensus       199 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~R  247 (385)
                      ..||...........  .+..    -. .+|+.++.||..+|++||.+|
T Consensus       247 ~lPf~~~~~~~~~~~--~f~~----C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPEW--DFSR----CR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSGG--GGTT----SS----HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCccccccc--cchh----cC-CcCHHHHHHHHHHccCCcccC
Confidence            999975421111000  1111    11 478999999999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=3.5e-22  Score=178.53  Aligned_cols=182  Identities=20%  Similarity=0.186  Sum_probs=138.0

Q ss_pred             eeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH--H-----HHHHHHHHHHhcC-CCCeeeeeeeeeeccCCeEEEE
Q 040569            4 TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS--E-----FLQREQRILSALA-CPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~--~-----~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      .....|++|+||+||++..  .+..++.+.+.....  .     .+++|+++|++|. |++|++++++    ..    .+
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~----~~   74 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DG----RH   74 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cC----EE
Confidence            3567899999999997765  577888777654332  2     5789999999994 5889988774    12    45


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDI-KGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDl-Kp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++|||+.|.+|.+.+..+       ...++.|++.+|.+||++||+|||| ||+|||++.++.  ++|+|||+|......
T Consensus        75 lvmeyI~G~~L~~~~~~~-------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~--i~LIDFG~A~~~~~~  145 (218)
T PRK12274         75 LDRSYLAGAAMYQRPPRG-------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS--PAVIDFQLAVRGNPR  145 (218)
T ss_pred             EEEeeecCccHHhhhhhh-------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC--EEEEECCCceecCCc
Confidence            899999999997654321       1357889999999999999999999 799999987665  999999999865422


Q ss_pred             CCC----C--------CCccccCCcccChhhhcCC-CCC-CCCChHHHHHHHHHHHhCCCCCCC
Q 040569          155 EDD----E--------GKPICGTPICMAPEVARGE-EQG-FPADVWALGCTVLEMATGRPPWPD  204 (385)
Q Consensus       155 ~~~----~--------~~~~~Gt~~y~aPE~~~~~-~~~-~~~DiwSlG~il~elltG~~Pf~~  204 (385)
                      ...    .        ..-..+++.|++|+...-. ..+ ...+.++.|+-+|.++|++.|+..
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            210    0        0011368899999876543 233 567899999999999999988754

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.6e-21  Score=184.20  Aligned_cols=195  Identities=24%  Similarity=0.327  Sum_probs=147.1

Q ss_pred             CCCCeeeeeeeeeecc------------------------CCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHH
Q 040569           53 ACPQIVAYKGCDISEE------------------------NGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAV  108 (385)
Q Consensus        53 ~hpnIv~~~~~~~~~~------------------------~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qi  108 (385)
                      .|||||++.+.|.+.-                        ++. ..|+||.-.+. +|.+++.... .+....+-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~-tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPK-TLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCc-eEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHH
Confidence            6999999988875321                        122 25588887765 9999998543 6788889999999


Q ss_pred             HHHHHHHHHCCceeccCCCCCEEeecCC--CCCeEEeecCceeeecccC-----CCCCCccccCCcccChhhhcCCC---
Q 040569          109 LLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNE-----DDEGKPICGTPICMAPEVARGEE---  178 (385)
Q Consensus       109 l~gL~yLH~~givHrDlKp~NILi~~~~--~~~~kL~DFG~a~~~~~~~-----~~~~~~~~Gt~~y~aPE~~~~~~---  178 (385)
                      ++|+.|||.+||.|||+|.+||||--+.  -..+.|+||||+-......     ........|.-.-||||+.....   
T Consensus       351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~  430 (598)
T KOG4158|consen  351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN  430 (598)
T ss_pred             HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence            9999999999999999999999995443  3235999999986532211     11112234777899999986432   


Q ss_pred             ---CCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHH
Q 040569          179 ---QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS  251 (385)
Q Consensus       179 ---~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~  251 (385)
                         -..++|.|+.|.+.||+++...||....+....... -.....|.+|..+++.+++++..+|++||++|+|..
T Consensus       431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             eeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence               134899999999999999999999864332221111 234667888999999999999999999999999854

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=9.3e-22  Score=207.63  Aligned_cols=237  Identities=23%  Similarity=0.303  Sum_probs=169.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcC---CCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALA---CPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~---hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      .|.+.+.||+|+||+||+|.+.. |+.||+|.-.....=.+.--.+++.+|+   -+-|..+..+++..+.    -.||+
T Consensus       699 ~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~----S~lv~  773 (974)
T KOG1166|consen  699 KFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA----SVLVS  773 (974)
T ss_pred             eEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc----ceeee
Confidence            57889999999999999999987 9999999765433211111233444554   2334444444333333    33899


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeec-----CCCCCeEEeecCceeeecc
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSK-----DNEQGAKIADFGCARRARV  153 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~-----~~~~~~kL~DFG~a~~~~~  153 (385)
                      ||.+-|+|.+++...+.++|..+..++.|++..+++||..||||+||||+|+||..     .+..+++|+|||.+-....
T Consensus       774 ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~l  853 (974)
T KOG1166|consen  774 EYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKL  853 (974)
T ss_pred             eccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeE
Confidence            99999999999998778999999999999999999999999999999999999942     2344589999999876543


Q ss_pred             cCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC-CCCCCCCCcCCH-
Q 040569          154 NEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS-SDTPEIPGYMSK-  230 (385)
Q Consensus       154 ~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~-  230 (385)
                      -... ..+..++|-.+-.+|+..|...++.+|.|.|+.+++.|+.|+.--          ..-+.. .....++.+.-. 
T Consensus       854 fp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q----------~~~g~~~~~~~~~~Ry~~~~  923 (974)
T KOG1166|consen  854 FPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME----------VKNGSSWMVKTNFPRYWKRD  923 (974)
T ss_pred             cCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH----------hcCCcceeccccchhhhhHH
Confidence            3332 345567899999999999999999999999999999999987422          000000 111112333323 


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHH
Q 040569          231 QAQDFLSKCLIRNPGERWSASEL  253 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~el  253 (385)
                      -.-+|...+|+.|-..=|...++
T Consensus       924 ~W~~~F~~lLN~~~~~~p~l~~l  946 (974)
T KOG1166|consen  924 MWNKFFDLLLNPDCDTLPNLQEL  946 (974)
T ss_pred             HHHHHHHHHhCcCcccchhHHHH
Confidence            34578888998444444444443

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.86  E-value=6.9e-22  Score=178.58  Aligned_cols=234  Identities=18%  Similarity=0.309  Sum_probs=185.3

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      ..+|.....|..|+|++..+  -+++|++...     -...+..|.--|+-+.||||+++++.+.+..+    ..++..|
T Consensus       195 ~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn----lv~isq~  268 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN----LVIISQY  268 (448)
T ss_pred             hhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC----ceEeeee
Confidence            44667788899999999743  4555655432     23567788888999999999999998877654    5578999


Q ss_pred             cCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           81 APGGTLTDAIRSGT--CLEEGRIRSHTRAVLLGLQYLHSNG--IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        81 ~~ggsL~~~l~~~~--~l~e~~~~~i~~qil~gL~yLH~~g--ivHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      ++-|||...+..+.  ..+..++..++.+|++|++|||+..  |----|....++|+++-...+-.+|--++-+.     
T Consensus       269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe-----  343 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE-----  343 (448)
T ss_pred             ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec-----
Confidence            99999999998554  3578899999999999999999974  44446888899998776644444554333221     


Q ss_pred             CCCCccccCCcccChhhhcCCCCC---CCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHH
Q 040569          157 DEGKPICGTPICMAPEVARGEEQG---FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ  233 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~~---~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  233 (385)
                         ....-.|.||+||.++..+-+   .++|+|||.++++||.|...||.+. .+...-.++...+..+.+|..+|..+.
T Consensus       344 ---~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadl-spmecgmkialeglrv~ippgis~hm~  419 (448)
T KOG0195|consen  344 ---VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADL-SPMECGMKIALEGLRVHIPPGISRHMN  419 (448)
T ss_pred             ---cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccC-CchhhhhhhhhccccccCCCCccHHHH
Confidence               122358899999999877543   4799999999999999999999875 456666677778888999999999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHH
Q 040569          234 DFLSKCLIRNPGERWSASELL  254 (385)
Q Consensus       234 ~ll~~cL~~dP~~Rps~~elL  254 (385)
                      .|+.-|++-||.+||.+.+++
T Consensus       420 klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  420 KLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHhcCCCCcCCCcceeh
Confidence            999999999999999988764

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=4.3e-21  Score=177.17  Aligned_cols=139  Identities=23%  Similarity=0.190  Sum_probs=111.8

Q ss_pred             CceeeceeeccCceEEEEEE-ECCCCcEEEEEeccCCCH---------------------------HHHHHHHHHHHhcC
Q 040569            2 DWTRGQTIGRGSTATVSIGM-SNRSSEVFAVKSAELSNS---------------------------EFLQREQRILSALA   53 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~-~~~~~~~~AvK~~~~~~~---------------------------~~~~~E~~il~~l~   53 (385)
                      -|.+.+.||+|+||.||+|. +..+|+.||+|.+.....                           ..+++|..+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            37788999999999999999 777999999998764320                           23568999999997


Q ss_pred             CC--CeeeeeeeeeeccCCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCCE
Q 040569           54 CP--QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG-IVHCDIKGQNI  130 (385)
Q Consensus        54 hp--nIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~g-ivHrDlKp~NI  130 (385)
                      +.  .++++++.    ..    .++||||++|++|...+.....+.+..+..++.||+.+|.+||++| ++||||||+||
T Consensus       109 ~~~i~~p~~~~~----~~----~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NI  180 (237)
T smart00090      109 EAGVPVPKPIAW----RR----NVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNI  180 (237)
T ss_pred             hcCCCCCeeeEe----cC----ceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhE
Confidence            53  33444432    11    3589999999998877654555777788999999999999999999 99999999999


Q ss_pred             EeecCCCCCeEEeecCceeee
Q 040569          131 LVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus       131 Li~~~~~~~~kL~DFG~a~~~  151 (385)
                      +++ ++.  ++|+|||.+...
T Consensus       181 li~-~~~--i~LiDFg~a~~~  198 (237)
T smart00090      181 LVH-DGK--VVIIDVSQSVEL  198 (237)
T ss_pred             EEE-CCC--EEEEEChhhhcc
Confidence            998 434  999999998754

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.84  E-value=7.4e-22  Score=193.00  Aligned_cols=245  Identities=23%  Similarity=0.312  Sum_probs=162.0

Q ss_pred             eceeeccCceEEEEEEECCC---CcEEEEEeccCCC---HHHHHHHHHHHHhcC-CCCeeeee--e--eeeeccCC---e
Q 040569            6 GQTIGRGSTATVSIGMSNRS---SEVFAVKSAELSN---SEFLQREQRILSALA-CPQIVAYK--G--CDISEENG---K   71 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~---~~~~AvK~~~~~~---~~~~~~E~~il~~l~-hpnIv~~~--~--~~~~~~~~---~   71 (385)
                      .+..++.+++.+.......+   .+.++-|..+.+.   .....+++-.+.... |+..+.+-  .  .-....+.   .
T Consensus       249 ~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~  328 (516)
T KOG1033|consen  249 SKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKK  328 (516)
T ss_pred             cccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccccccccc
Confidence            34455555555555443322   3444444444333   123334555555544 44443321  0  11111111   2


Q ss_pred             EEEEEEEeecCCCCHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCce
Q 040569           72 ILYNLFLEYAPGGTLTDAIRSG---TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA  148 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~~---~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a  148 (385)
                      .+.||.|++|.-.+|.++|...   ...+......++.|+..|++|   +|.+|+|+||.||+...+..  +||+|||+.
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q--~kIgDFgl~  403 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ--LKIGDFGLV  403 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh--hhhhhhhhe
Confidence            2467999999999999999743   235667889999999999999   99999999999999986665  899999998


Q ss_pred             eeecccC-----CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCC
Q 040569          149 RRARVNE-----DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE  223 (385)
Q Consensus       149 ~~~~~~~-----~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  223 (385)
                      .......     ........||..||+||++.+..|+.++||||||++++||+.   +|....+....+..+....-+|.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g~ip~~  480 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRDGIIPPE  480 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcCCCChH
Confidence            8764333     223455679999999999999999999999999999999996   23222223333333322222222


Q ss_pred             CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          224 IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       224 ~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      +... -++-..|+..+|.+.|.+||++.+.-.|.|.
T Consensus       481 ~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  481 FLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             Hhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            2222 2345689999999999999988777767664

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=6e-22  Score=204.46  Aligned_cols=255  Identities=29%  Similarity=0.402  Sum_probs=201.5

Q ss_pred             CceeeceeeccCceEEEEEEEC-CCCcEEEEEeccCCC-----HHHHHHHHHHHHhcC-CCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN-RSSEVFAVKSAELSN-----SEFLQREQRILSALA-CPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~-~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      .|...+.||+|+|+.|-+.... .+...+|+|.+....     .+....|..+-+.+. |+|++.+++.....+.    +
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~----~   96 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS----Y   96 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcc----c
Confidence            5788899999999999998774 445666777665432     234446888888886 9999999887554443    6


Q ss_pred             EEEEeecCCCCHHHHH-HcCC-CCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           75 NLFLEYAPGGTLTDAI-RSGT-CLEEGRIRSHTRAVLLGLQYLH-SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l-~~~~-~l~e~~~~~i~~qil~gL~yLH-~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      +++++|..|+++.+.+ .... ..+...+..++.|+..++.|+| ..++.|+|+||+|.+++..+. .+|++|||+|..+
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~  175 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAY  175 (601)
T ss_pred             ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhccc
Confidence            7899999999999999 5444 6788889999999999999999 999999999999999987773 3899999999987


Q ss_pred             cc--cCCCCCCcccc-CCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHH-hcCC-CCCCCCC
Q 040569          152 RV--NEDDEGKPICG-TPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHR-IGFS-SDTPEIP  225 (385)
Q Consensus       152 ~~--~~~~~~~~~~G-t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~-~~~~-~~~~~~~  225 (385)
                      ..  +........+| ++.|+|||...+. ...+..|+||+|+++.-|++|..||............ .... .......
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW  255 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence            54  22233445678 9999999999885 5688999999999999999999999754322211111 1111 1123345


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          226 GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       226 ~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      ..++....+++.+++..+|..|.+.+++-.+||+..
T Consensus       256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  256 NSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ccCChhhhhcccccccCCchhccccccccccccccc
Confidence            668899999999999999999999999999999987

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=2.5e-19  Score=162.03  Aligned_cols=132  Identities=27%  Similarity=0.300  Sum_probs=107.2

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEeccCCC-----------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----------SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      .+.||+|++|.||+|.+  .|..+++|......           ...+.+|+.++..+.|++|+....++.....    .
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~----~   74 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN----F   74 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC----C
Confidence            36899999999999987  57788888654211           1346789999999999988766555444433    4


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                      +++|||++|++|.+++.....    ....++.+++.+|.+||+.|++|||++|.|||++ ++.  ++|+|||++..
T Consensus        75 ~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~--~~liDf~~a~~  143 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGK--IYLIDFGLAEF  143 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCC--EEEEECCcccC
Confidence            589999999999999875432    7889999999999999999999999999999998 333  99999998875

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=4.2e-19  Score=159.19  Aligned_cols=128  Identities=27%  Similarity=0.360  Sum_probs=100.4

Q ss_pred             eeeccCceEEEEEEECCCCcEEEEEeccCC-----C------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            8 TIGRGSTATVSIGMSNRSSEVFAVKSAELS-----N------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         8 ~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      .||+|+||+||+|..  ++..+++|.....     .      .+.+.+|+++++.+.|+++.....++.....    .++
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~----~~l   74 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN----KTI   74 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC----CEE
Confidence            489999999999985  4678888874321     1      1456689999999988775544333333332    458


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      +|||++|++|.+++.....       .++.|++.+|.+||+.|++|||++|.||+++ ++.  ++++|||++...
T Consensus        75 v~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~--~~liDfg~a~~~  139 (199)
T TIGR03724        75 VMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDK--LYLIDFGLGKYS  139 (199)
T ss_pred             EEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCc--EEEEECCCCcCC
Confidence            9999999999998865321       8899999999999999999999999999998 433  999999998763

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=6.9e-19  Score=158.05  Aligned_cols=132  Identities=22%  Similarity=0.208  Sum_probs=105.2

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-------------------------HHHHHHHHHHHHhcCCCC-
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-------------------------SEFLQREQRILSALACPQ-   56 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-------------------------~~~~~~E~~il~~l~hpn-   56 (385)
                      |.+.+.||+|+||.||++... +|+.+|||++....                         .....+|..++.++.+++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            778899999999999999875 79999999765422                         113567999999997774 


Q ss_pred             -eeeeeeeeeeccCCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecC
Q 040569           57 -IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKD  135 (385)
Q Consensus        57 -Iv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~  135 (385)
                       ++..++    ...    .+++|||++|++|.+....      .....++.+|+.++.++|+.|++||||||+||+++.+
T Consensus        96 ~v~~~~~----~~~----~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~  161 (198)
T cd05144          96 PVPKPID----WNR----HAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD  161 (198)
T ss_pred             CCCceee----cCC----ceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC
Confidence             444432    122    3589999999999875431      3456788999999999999999999999999999876


Q ss_pred             CCCCeEEeecCceeee
Q 040569          136 NEQGAKIADFGCARRA  151 (385)
Q Consensus       136 ~~~~~kL~DFG~a~~~  151 (385)
                      +.  ++|+|||++...
T Consensus       162 ~~--~~liDfg~~~~~  175 (198)
T cd05144         162 EK--IYIIDWPQMVST  175 (198)
T ss_pred             Cc--EEEEECCccccC
Confidence            55  999999999655

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=1.6e-18  Score=178.44  Aligned_cols=134  Identities=25%  Similarity=0.312  Sum_probs=104.2

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCC---------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---------NSEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~---------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      |...+.||+|+||+||++.+......+.++.....         ..+.+.+|+++++.++|++++....+......    
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~----  410 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE----  410 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC----
Confidence            34578999999999999987644333332222111         12456789999999999999876655554333    


Q ss_pred             EEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           74 YNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      .++||||++|++|.+++.        ....++.|++.+|.|||+.|++||||||+|||++ ++  .++|+|||+++..
T Consensus       411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~--~~~liDFGla~~~  477 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD--RLYLIDFGLGKYS  477 (535)
T ss_pred             CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC--cEEEEeCcccccC
Confidence            458999999999999886        3577899999999999999999999999999994 33  3999999999764

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.78  E-value=7.7e-19  Score=174.47  Aligned_cols=201  Identities=24%  Similarity=0.336  Sum_probs=153.7

Q ss_pred             HHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCc-eeccCC
Q 040569           49 LSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGI-VHCDIK  126 (385)
Q Consensus        49 l~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~gi-vHrDlK  126 (385)
                      |+.+.|.|+.+|+|.......    .++|.+||.-|+|.+.+.. ...++......++++|+.||.|||+.-| .|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~----~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPE----MIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCc----eEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeec
Confidence            467899999999999887633    5689999999999999985 5568888899999999999999998755 999999


Q ss_pred             CCCEEeecCCCCCeEEeecCceeeecc-cCCCCCCccccCCcccChhhhcCCC-------CCCCCChHHHHHHHHHHHhC
Q 040569          127 GQNILVSKDNEQGAKIADFGCARRARV-NEDDEGKPICGTPICMAPEVARGEE-------QGFPADVWALGCTVLEMATG  198 (385)
Q Consensus       127 p~NILi~~~~~~~~kL~DFG~a~~~~~-~~~~~~~~~~Gt~~y~aPE~~~~~~-------~~~~~DiwSlG~il~elltG  198 (385)
                      ..|.+++..-.  +||.|||+...... ..........-...|.|||.+.+..       .+.+.||||+|++++|+++.
T Consensus        77 s~nClvd~~w~--lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   77 SSNCLVDSRWV--LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             cccceeeeeEE--EEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            99999986654  89999999876532 1111112223455799999997642       35679999999999999999


Q ss_pred             CCCCCCCC---ChHHHHHHhcC---CCCCCCCCC--cCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          199 RPPWPDVA---DPISALHRIGF---SSDTPEIPG--YMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       199 ~~Pf~~~~---~~~~~~~~~~~---~~~~~~~~~--~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      +.||....   ++...+.++..   ....|.+..  ...+++..++.+||..+|.+||+++++-.
T Consensus       155 ~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  155 SGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             cCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            99997532   22233444322   122333321  34567999999999999999999998754

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.74  E-value=4.2e-17  Score=150.80  Aligned_cols=137  Identities=16%  Similarity=0.193  Sum_probs=104.2

Q ss_pred             eceee-ccCceEEEEEEECCCCcEEEEEeccCC----------------CHHHHHHHHHHHHhcCCCCe--eeeeeeeee
Q 040569            6 GQTIG-RGSTATVSIGMSNRSSEVFAVKSAELS----------------NSEFLQREQRILSALACPQI--VAYKGCDIS   66 (385)
Q Consensus         6 ~~~LG-~G~~g~Vy~a~~~~~~~~~AvK~~~~~----------------~~~~~~~E~~il~~l~hpnI--v~~~~~~~~   66 (385)
                      +..|| .|+.|+||.+...  +..++||.+...                ....+.+|++++.+|.|++|  +..+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            45788 8999999999775  778899877421                12356789999999988775  556555433


Q ss_pred             ccCCeEEEEEEEeecCC-CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeec
Q 040569           67 EENGKILYNLFLEYAPG-GTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADF  145 (385)
Q Consensus        67 ~~~~~~~~~lv~Ey~~g-gsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DF  145 (385)
                      ........++||||++| .+|.+++... .+++..    +.||+.+|.+||++||+||||||.|||++.++.  ++|+||
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~--v~LIDf  186 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEA-PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGK--FWLIDF  186 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcC-CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCC--EEEEEC
Confidence            22211112489999998 6899988754 466543    578999999999999999999999999987654  999999


Q ss_pred             Cceeee
Q 040569          146 GCARRA  151 (385)
Q Consensus       146 G~a~~~  151 (385)
                      |.+...
T Consensus       187 g~~~~~  192 (239)
T PRK01723        187 DRGELR  192 (239)
T ss_pred             CCcccC
Confidence            988763

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=2.9e-17  Score=145.69  Aligned_cols=132  Identities=24%  Similarity=0.288  Sum_probs=96.2

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEeccCCCH------HH---------------------HHHHHHHHHhcCCCC--
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS------EF---------------------LQREQRILSALACPQ--   56 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~------~~---------------------~~~E~~il~~l~hpn--   56 (385)
                      ++.||+|+||+||+|.+. +++.||||.+.....      ..                     ...|...+.++.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            578999999999999986 899999998764321      11                     135666676664432  


Q ss_pred             eeeeeeeeeeccCCeEEEEEEEeecCCCCHHH-HHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEeec
Q 040569           57 IVAYKGCDISEENGKILYNLFLEYAPGGTLTD-AIRSGTCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSK  134 (385)
Q Consensus        57 Iv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~-~l~~~~~l~e~~~~~i~~qil~gL~yLH~-~givHrDlKp~NILi~~  134 (385)
                      +.+.+++    ..    .+++|||++|+.+.. .+.... . ...++.++.+++.++.++|+ .||+||||||+||+++ 
T Consensus        81 ~~~~~~~----~~----~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-  149 (187)
T cd05119          81 VPKPIDL----NR----HVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-  149 (187)
T ss_pred             CCceEec----CC----CEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-
Confidence            3444432    11    358999999954432 122111 1 16788999999999999999 9999999999999998 


Q ss_pred             CCCCCeEEeecCceeee
Q 040569          135 DNEQGAKIADFGCARRA  151 (385)
Q Consensus       135 ~~~~~~kL~DFG~a~~~  151 (385)
                      ++.  ++|+|||.+...
T Consensus       150 ~~~--~~liDfg~a~~~  164 (187)
T cd05119         150 DGK--VYIIDVPQAVEI  164 (187)
T ss_pred             CCc--EEEEECcccccc
Confidence            444  999999999765

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.68  E-value=2.8e-17  Score=171.51  Aligned_cols=256  Identities=24%  Similarity=0.346  Sum_probs=201.3

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +.+.+.+-+|+++.++.+.-..+|-.++.|+..+.      +.+...++-.++-...+|-++...--+....+    .+|
T Consensus       806 ~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP----~~L  881 (1205)
T KOG0606|consen  806 FEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP----LPL  881 (1205)
T ss_pred             ceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC----cch
Confidence            45667888999999999998888877777755432      23444556666666677888866544333333    568


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc--
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN--  154 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~--  154 (385)
                      +++|..|++|...+++-++.+++.++.++..+.++++|||+..+.|+|++|.|+|+..++.  .++.|||.......-  
T Consensus       882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~~p  959 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLIPP  959 (1205)
T ss_pred             hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC--cccCccccccccccccC
Confidence            9999999999999998888999999999999999999999999999999999999988776  899999844322110  


Q ss_pred             ------CC----------------------CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCC
Q 040569          155 ------ED----------------------DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVA  206 (385)
Q Consensus       155 ------~~----------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~  206 (385)
                            ..                      .......||+.|.+||...+...+..+|+|++|++++|.++|.+||....
T Consensus       960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen  960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred             cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence                  00                      00123469999999999999999999999999999999999999997643


Q ss_pred             ChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHH---HHHhCcccccccc
Q 040569          207 DPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS---ELLEHGFVKEQNF  264 (385)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~---elL~hp~~~~~~~  264 (385)
                      .........+.....+..+...+.++++++.+.|..+|.+|..+.   ++-.|+||+...+
T Consensus      1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred             hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence            322222233344556667778899999999999999999999888   8999999998754

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=3.8e-16  Score=131.84  Aligned_cols=131  Identities=23%  Similarity=0.201  Sum_probs=106.9

Q ss_pred             eeceeeccCceEEEEEEECCCCcEEEEEeccCCC-HHHHHHHHHHHHhcCC--CCeeeeeeeeeeccCCeEEEEEEEeec
Q 040569            5 RGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-SEFLQREQRILSALAC--PQIVAYKGCDISEENGKILYNLFLEYA   81 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-~~~~~~E~~il~~l~h--pnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (385)
                      +.+.||+|.++.||++....  ..+++|...... ...+.+|..+++.+.+  +++++++.......    ..+++|||+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~----~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDG----WSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC----ccEEEEEec
Confidence            46789999999999999863  789999886543 3578899999999976  58888877654332    256899999


Q ss_pred             CCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569           82 PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN---GIVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus        82 ~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~---givHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                      +|+++..+       +......++.+++.+|++||..   +++|+|++|.||+++..+.  +++.|||.+..
T Consensus        76 ~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~--~~l~Df~~~~~  138 (155)
T cd05120          76 EGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI--LGIIDWEYAGY  138 (155)
T ss_pred             CCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcE--EEEEecccccC
Confidence            99877754       5566778899999999999985   7999999999999987444  99999998865

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.61  E-value=6.6e-16  Score=153.89  Aligned_cols=250  Identities=23%  Similarity=0.205  Sum_probs=188.0

Q ss_pred             ceeeceeec--cCceEEEEEEE--CCCCcEEEEEeccCCC-----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeE
Q 040569            3 WTRGQTIGR--GSTATVSIGMS--NRSSEVFAVKSAELSN-----SEFLQREQRILSAL-ACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         3 y~~~~~LG~--G~~g~Vy~a~~--~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +.+.+.+|+  |.+|.||.+..  ..++..+|+|.-...-     ...-.+|....+++ .|+|.++.+..+.....   
T Consensus       116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~---  192 (524)
T KOG0601|consen  116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI---  192 (524)
T ss_pred             cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc---
Confidence            445678999  99999999998  8899999999743211     12223566666666 68999986655433322   


Q ss_pred             EEEEEEeecCCCCHHHHHHcCC-CCCHHHHHHHHHHHHH----HHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCc
Q 040569           73 LYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLL----GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGC  147 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~~-~l~e~~~~~i~~qil~----gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~  147 (385)
                       .++-+|+|. .+|.++...-. .+++..++..+.+...    ||.++|+.+++|-|+||.||++..+. ...+++|||+
T Consensus       193 -lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~-~s~~~~df~~  269 (524)
T KOG0601|consen  193 -LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW-TSCKLTDFGL  269 (524)
T ss_pred             -ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc-ceeecCCcce
Confidence             457788884 79999988544 4899999999999999    99999999999999999999998773 2379999999


Q ss_pred             eeeecccCCCC----CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCC-CChHHHHHHhcCCCCCC
Q 040569          148 ARRARVNEDDE----GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDV-ADPISALHRIGFSSDTP  222 (385)
Q Consensus       148 a~~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~-~~~~~~~~~~~~~~~~~  222 (385)
                      ...+.......    .....|...|++||..++. ++...|+|+||.++.+-.+|..+.... .+....+.+.   ....
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~---~ip~  345 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG---YIPL  345 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc---cCch
Confidence            98875443221    1222578889999998754 788999999999999999987665432 2222222221   1233


Q ss_pred             CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          223 EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       223 ~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ++-...+..+...+..|++.+|..|++++.+++|+++...
T Consensus       346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            4444567777779999999999999999999999998754

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.55  E-value=4.3e-14  Score=141.71  Aligned_cols=138  Identities=22%  Similarity=0.204  Sum_probs=95.2

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEeccCCCHHH-------------------------------------------H
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF-------------------------------------------L   42 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~-------------------------------------------~   42 (385)
                      .+.||+|++|.||+|+.+ +|+.||||+....-.+.                                           +
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            368999999999999975 78999999876543222                                           2


Q ss_pred             HHHHHHHHhc----CCCCeeeeeeeeeeccCCeEEEEEEEeecCCCCHHHHHHcC-CCCCHHHHHHHHHHHHH-HHHHHH
Q 040569           43 QREQRILSAL----ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSG-TCLEEGRIRSHTRAVLL-GLQYLH  116 (385)
Q Consensus        43 ~~E~~il~~l----~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~-~~l~e~~~~~i~~qil~-gL~yLH  116 (385)
                      .+|++.+.++    ++.+-+.+-.++..... .  .+|||||++|++|.++.... ...+   ...++.+++. .+..+|
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~-~--~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~  274 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTS-E--RVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL  274 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcC-C--ceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH
Confidence            3455555554    22222333233322222 1  34899999999999887521 1122   3345555655 467899


Q ss_pred             HCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569          117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus       117 ~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      ..|++|+|+||.||++..++.  ++++|||++....
T Consensus       275 ~~g~~H~D~hPgNilv~~~g~--i~liDfG~~~~l~  308 (437)
T TIGR01982       275 RDGFFHADLHPGNIFVLKDGK--IIALDFGIVGRLS  308 (437)
T ss_pred             hCCceeCCCCcccEEECCCCc--EEEEeCCCeeECC
Confidence            999999999999999987765  9999999998763

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.52  E-value=7e-14  Score=142.28  Aligned_cols=139  Identities=20%  Similarity=0.198  Sum_probs=95.1

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHH------------------------------------------
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE------------------------------------------   40 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~------------------------------------------   40 (385)
                      |+. +.||+|++|.||+|+.+.+|+.||||+....-.+                                          
T Consensus       122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E  200 (537)
T PRK04750        122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE  200 (537)
T ss_pred             cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence            455 7899999999999999988999999988643111                                          


Q ss_pred             -HHHHHHHHHHhc----CCCCeeeeeeeeeeccCCeEEEEEEEeecCCCCHHHH--HHcCC----CCCHHHHHHHHHHHH
Q 040569           41 -FLQREQRILSAL----ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDA--IRSGT----CLEEGRIRSHTRAVL  109 (385)
Q Consensus        41 -~~~~E~~il~~l----~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~--l~~~~----~l~e~~~~~i~~qil  109 (385)
                       .+.+|+..+.++    .+.+.+.+-.++.+-.. .  -+|||||+.|+++.++  +...+    .+.+..+..++.|++
T Consensus       201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st-~--~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif  277 (537)
T PRK04750        201 LDLMREAANASQLRRNFEDSDMLYVPEVYWDYCS-E--TVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF  277 (537)
T ss_pred             hCHHHHHHHHHHHHHHccCCCCeecceeecccCC-C--ceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence             123455555544    23333333333332222 1  2389999999999875  33332    255555666666665


Q ss_pred             HHHHHHHHCCceeccCCCCCEEeecCC--CCCeEEeecCceeeec
Q 040569          110 LGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRAR  152 (385)
Q Consensus       110 ~gL~yLH~~givHrDlKp~NILi~~~~--~~~~kL~DFG~a~~~~  152 (385)
                             ..|++|+|+||.||+++.++  ...++++|||++....
T Consensus       278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                   58999999999999998765  1138999999998763

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.52  E-value=1.3e-14  Score=144.71  Aligned_cols=244  Identities=25%  Similarity=0.234  Sum_probs=181.4

Q ss_pred             CceeeceeeccCceEEEEEEEC-CCCcEEEEEeccCCCHH-----HHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN-RSSEVFAVKSAELSNSE-----FLQREQRILSAL-ACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~-~~~~~~AvK~~~~~~~~-----~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|..+..||.|.|+.|+....+ .++..|++|.+......     .-..|+.+...+ .|.+++.+...+....+    .
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~----~  341 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ----G  341 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc----c
Confidence            5777889999999999988655 78999999977543221     123577777777 78999987776666555    3


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++=.|||.++++...+.-...+++...+.+..|++.++.++|++.++|+|+||+||++..++ ..-++.|||++......
T Consensus       342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhcccccccccccee
Confidence            37789999999888776555689999999999999999999999999999999999998654 33599999998753211


Q ss_pred             CCCCCCccccCCccc--ChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHH
Q 040569          155 EDDEGKPICGTPICM--APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA  232 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~--aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  232 (385)
                          .....+.-+++  +|+......+..++|++|||..+.+.+++...-.. ..   ....+ .....+..+... .++
T Consensus       421 ----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-~~---~~~~i-~~~~~p~~~~~~-~~~  490 (524)
T KOG0601|consen  421 ----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-GV---QSLTI-RSGDTPNLPGLK-LQL  490 (524)
T ss_pred             ----cccccccccccccchhhccccccccccccccccccccccccCcccCcc-cc---cceee-ecccccCCCchH-Hhh
Confidence                11122333445  55555667788999999999999999998643221 11   11122 234455555544 889


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 040569          233 QDFLSKCLIRNPGERWSASELLEHGFVK  260 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~hp~~~  260 (385)
                      ..+...++.+++..|+.+.++..|+-+.
T Consensus       491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  491 QVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             hhhhhhhcCCccccchhhhhhcccchhh
Confidence            9999999999999999999998876543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.49  E-value=3.6e-14  Score=131.96  Aligned_cols=235  Identities=19%  Similarity=0.228  Sum_probs=155.3

Q ss_pred             EEEEEEECCCCcEEEEEeccC-------CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccC-CeEEEEEEEeecCCCCHH
Q 040569           16 TVSIGMSNRSSEVFAVKSAEL-------SNSEFLQREQRILSALACPQIVAYKGCDISEEN-GKILYNLFLEYAPGGTLT   87 (385)
Q Consensus        16 ~Vy~a~~~~~~~~~AvK~~~~-------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~~~~~lv~Ey~~ggsL~   87 (385)
                      .||++.++..|..+..-.+..       .+.+..+.-...|-.+.|.|||+++.++.+... ...-..++.||+..|+|.
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~  160 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK  160 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence            456666666666655332211       112222223344566789999999988755432 222244689999999999


Q ss_pred             HHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCCEEeecCCCCCeEEeecCceeeeccc----CCC
Q 040569           88 DAIR----SGTCLEEGRIRSHTRAVLLGLQYLHSN--GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN----EDD  157 (385)
Q Consensus        88 ~~l~----~~~~l~e~~~~~i~~qil~gL~yLH~~--givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~----~~~  157 (385)
                      ++|+    .+..+.+....+|+-||+.||.|||+.  -|+|+++..+.|++..++-  +|++---.. .+...    ...
T Consensus       161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngL--Ikig~~ap~-s~h~s~~~~~~~  237 (458)
T KOG1266|consen  161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGL--IKIGSVAPD-STHPSVNSTREA  237 (458)
T ss_pred             HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCce--EEecccCcc-ccchhhhhhhHh
Confidence            9997    355688999999999999999999998  4999999999999985543  565321111 11000    001


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVAD---PISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                      ......|-++|.+||.=.....+-++|||++|....+|..+..--.+...   ....+.+..+...        ...-++
T Consensus       238 Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le--------n~lqr~  309 (458)
T KOG1266|consen  238 EKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE--------NGLQRG  309 (458)
T ss_pred             hhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc--------CccccC
Confidence            11223577899999986666677799999999999999987654322111   1112222111111        122357


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          235 FLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      ++.+||+..|..||++.++|-||.+-+
T Consensus       310 ~i~kcl~~eP~~rp~ar~llfHpllfe  336 (458)
T KOG1266|consen  310 SITKCLEGEPNGRPDARLLLFHPLLFE  336 (458)
T ss_pred             cCcccccCCCCCCcchhhhhcCceeee
Confidence            999999999999999999999997543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.48  E-value=1.7e-13  Score=119.28  Aligned_cols=126  Identities=18%  Similarity=0.095  Sum_probs=95.1

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcCCCCe-eeeeeeeeeccCCeEEEEEEEeecC
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALACPQI-VAYKGCDISEENGKILYNLFLEYAP   82 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~hpnI-v~~~~~~~~~~~~~~~~~lv~Ey~~   82 (385)
                      .+.|+.|.++.||++...  ++.+++|......  ...+++|+.+++.+.+.++ ++++...  ...    .++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~----~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PET----GVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCC----CeEEEEecC
Confidence            568899999999999865  7889999876543  2456789999999965444 3444432  222    237999999


Q ss_pred             CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569           83 GGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI-----VHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus        83 ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~gi-----vHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                      |.++.+.        ......++.+++.+|+.||+.++     +|+|++|.||+++ ++  .++++|||.+..
T Consensus        75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~--~~~liDf~~a~~  136 (170)
T cd05151          75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG--RLWLIDWEYAGM  136 (170)
T ss_pred             CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC--eEEEEecccccC
Confidence            9888653        11123457899999999999885     9999999999998 33  399999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.47  E-value=9.8e-13  Score=117.34  Aligned_cols=135  Identities=13%  Similarity=0.128  Sum_probs=98.2

Q ss_pred             eceeeccCceEEEEEEECC------CCcEEEEEeccCCC-------------------------HHHH----HHHHHHHH
Q 040569            6 GQTIGRGSTATVSIGMSNR------SSEVFAVKSAELSN-------------------------SEFL----QREQRILS   50 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~------~~~~~AvK~~~~~~-------------------------~~~~----~~E~~il~   50 (385)
                      ...||.|.-+.||.|....      .+..+|||+...+.                         ...+    ++|.+.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4689999999999998653      35789999653210                         1122    38999999


Q ss_pred             hcCC--CCeeeeeeeeeeccCCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCC
Q 040569           51 ALAC--PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL-HSNGIVHCDIKG  127 (385)
Q Consensus        51 ~l~h--pnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yL-H~~givHrDlKp  127 (385)
                      ++..  -++++.+.+   ..     -+|||||+.+..+..-.-+...+++..+..+..+++.+|..| |+.|++|+||++
T Consensus        82 rl~~~Gv~vP~pi~~---~~-----~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~  153 (197)
T cd05146          82 RMQKAGIPCPEVVVL---KK-----HVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSE  153 (197)
T ss_pred             HHHHcCCCCCeEEEe---cC-----CEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence            9832  445555443   22     338999997754432222233466777888899999999999 899999999999


Q ss_pred             CCEEeecCCCCCeEEeecCceeee
Q 040569          128 QNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus       128 ~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      .|||+..   +.++|+|||.+...
T Consensus       154 ~NIL~~~---~~v~iIDF~qav~~  174 (197)
T cd05146         154 YNMLWHD---GKVWFIDVSQSVEP  174 (197)
T ss_pred             HHEEEEC---CcEEEEECCCceeC
Confidence            9999973   23999999988765

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.44  E-value=2.5e-12  Score=129.87  Aligned_cols=166  Identities=21%  Similarity=0.305  Sum_probs=126.7

Q ss_pred             EEEECCCCcEEEEEeccCCCH---HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecCCCCHHHHHHcCCC
Q 040569           19 IGMSNRSSEVFAVKSAELSNS---EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTC   95 (385)
Q Consensus        19 ~a~~~~~~~~~AvK~~~~~~~---~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~~~   95 (385)
                      .|..+.++..+.|.....+..   +...+-++-|+.++||||++++..+.....    .|||+|-+.  .|..+++.-  
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~----~ylvTErV~--Pl~~~lk~l--  101 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGT----LYLVTERVR--PLETVLKEL--  101 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCc----eEEEeeccc--cHHHHHHHh--
Confidence            567778888888887765554   567788999999999999999988766553    679999985  788888863  


Q ss_pred             CCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCCccccCCcccChhhh
Q 040569           96 LEEGRIRSHTRAVLLGLQYLH-SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA  174 (385)
Q Consensus        96 l~e~~~~~i~~qil~gL~yLH-~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~  174 (385)
                       .+..+...+.||+.||.||| +.+++|++|.-+.|+|+..++  .||++|.++........ ......--..|..|+.+
T Consensus       102 -~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~  177 (690)
T KOG1243|consen  102 -GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEI  177 (690)
T ss_pred             -HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEEeeeEEEeccccCCc-ccccchhhhcccChhhc
Confidence             47788889999999999998 568999999999999998887  99999998865421111 01111111235566554


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHhC
Q 040569          175 RGEEQGFPADVWALGCTVLEMATG  198 (385)
Q Consensus       175 ~~~~~~~~~DiwSlG~il~elltG  198 (385)
                      ....  -..|.|-|||++++++.|
T Consensus       178 ~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  178 DPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             Cccc--cchhhhhHHHHHHHHhCc
Confidence            3222  346999999999999998

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.35  E-value=4e-11  Score=118.01  Aligned_cols=212  Identities=20%  Similarity=0.178  Sum_probs=155.1

Q ss_pred             eEEEEEEECCCCcEEEEEeccCCCH---HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecCC-CCHHHHH
Q 040569           15 ATVSIGMSNRSSEVFAVKSAELSNS---EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPG-GTLTDAI   90 (385)
Q Consensus        15 g~Vy~a~~~~~~~~~AvK~~~~~~~---~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~g-gsL~~~l   90 (385)
                      .+.|++.++.+|..|++|++.-.+.   ...-.-+++++++.|+|||+|.+++.....+..-+++|++|.++ ++|.++.
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            5899999999999999999843221   12234688899999999999999998766666667899999886 5777765


Q ss_pred             H---------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           91 R---------------SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        91 ~---------------~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      -               .+...+|..++.|+.|+..||.+||+.|+..+-|.|.+||+..+..  ++|.--|....+..+.
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~R--IriS~C~i~Dvl~~d~  447 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMR--IRISGCGIMDVLQEDP  447 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcce--EEEecccceeeecCCC
Confidence            2               1335789999999999999999999999999999999999985543  6665555544442221


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHH-HHHhcCCCCCCCCCCcCCHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISA-LHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                              +       |.+.   .-.+-|.=.||.+++.|.||..--......... +.++         ...+|.++++
T Consensus       448 --------~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I---------~~~yS~D~rn  500 (655)
T KOG3741|consen  448 --------T-------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI---------TTTYSTDLRN  500 (655)
T ss_pred             --------C-------cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh---------hhhhhHHHHH
Confidence                    0       1111   122558889999999999996432111222222 2222         2347899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhC
Q 040569          235 FLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      +|..+..-++++ -+..+++.+
T Consensus       501 ~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  501 VVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHhcCccc-ccHHHHHHH
Confidence            999999998886 578888865

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.28  E-value=4.9e-11  Score=103.69  Aligned_cols=127  Identities=26%  Similarity=0.267  Sum_probs=91.8

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEE-eccCCC----------HHHHHHHHHHHHhcCC--CCeeeeeeeeeeccCCeEE
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVK-SAELSN----------SEFLQREQRILSALAC--PQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK-~~~~~~----------~~~~~~E~~il~~l~h--pnIv~~~~~~~~~~~~~~~   73 (385)
                      ..+++|+-+.+|.+...  |..+++| .+.+.-          .+.-.+|++++.++.-  =+.+.++.+  +..+    
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~~~----   73 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DPDN----   73 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cCCC----
Confidence            46889999999999664  4456666 232211          2344579999999843  333334433  2333    


Q ss_pred             EEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           74 YNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      ..|+|||++|-.|.+.+...       ...+++.+-.-+.-||..||+|+||.++||++..++   +.++|||++...
T Consensus        74 ~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~---i~~IDfGLg~~s  141 (204)
T COG3642          74 GLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR---IYFIDFGLGEFS  141 (204)
T ss_pred             CEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc---EEEEECCccccc
Confidence            23899999999999888865       255667777778889999999999999999997443   999999999864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.25  E-value=4.8e-11  Score=108.01  Aligned_cols=142  Identities=20%  Similarity=0.188  Sum_probs=103.7

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCC--CCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALAC--PQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~h--pnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      .+.|+.|.++.||++... +|+.+++|......    ...+.+|.++++.+.+  ..+++++.+...... ....+++||
T Consensus         3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~-~~~~~~v~e   80 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSV-LGTPFYVME   80 (223)
T ss_pred             ceecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCc-cCCceEEEE
Confidence            467899999999999875 36899999876533    4577899999999965  334555554332210 012458999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS------------------------------------------  117 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~------------------------------------------  117 (385)
                      |++|.++.+.+.. ..+++.....++.+++.+|..||+                                          
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9999988876542 347777777888888888888874                                          


Q ss_pred             --------------CCceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569          118 --------------NGIVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus       118 --------------~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                                    ..++|+|++|.||+++.+....+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          236999999999999864222368999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.19  E-value=3.9e-10  Score=97.83  Aligned_cols=139  Identities=24%  Similarity=0.277  Sum_probs=99.3

Q ss_pred             eeceeeccCceEEEEEEECCCCcEEEEEe-ccCCC----------HHHHHHHHHHHHhcCCCCe--eeeeeeeeeccCCe
Q 040569            5 RGQTIGRGSTATVSIGMSNRSSEVFAVKS-AELSN----------SEFLQREQRILSALACPQI--VAYKGCDISEENGK   71 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~-~~~~~----------~~~~~~E~~il~~l~hpnI--v~~~~~~~~~~~~~   71 (385)
                      ....|-+|+-+.|+++...  |+.++||. +.+.-          .....+|+++|.++.--.|  ++++  +.+...  
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~--~~D~~~--   84 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI--FIDTYG--   84 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE--EEecCC--
Confidence            4567889999999999875  88988883 22211          2344579999998832222  2232  223333  


Q ss_pred             EEEEEEEeecCC-CCHHHHHHc-CCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCC-eEEeecCc
Q 040569           72 ILYNLFLEYAPG-GTLTDAIRS-GTC-LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGC  147 (385)
Q Consensus        72 ~~~~lv~Ey~~g-gsL~~~l~~-~~~-l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~-~kL~DFG~  147 (385)
                        -.|+|||++| .++.+++.. ... ........++++|-+.+.-||..+|+|+||..+||++.+++... +.++|||+
T Consensus        85 --~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgl  162 (229)
T KOG3087|consen   85 --GQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGL  162 (229)
T ss_pred             --CeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecc
Confidence              2378999987 478888863 222 23333478999999999999999999999999999998776653 48999999


Q ss_pred             eeee
Q 040569          148 ARRA  151 (385)
Q Consensus       148 a~~~  151 (385)
                      +...
T Consensus       163 s~~s  166 (229)
T KOG3087|consen  163 SSVS  166 (229)
T ss_pred             hhcc
Confidence            8754

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.16  E-value=2.9e-11  Score=122.72  Aligned_cols=154  Identities=21%  Similarity=0.241  Sum_probs=114.3

Q ss_pred             HHHHHHHHHHHC-CceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC--------CCCccccCCcccChhhhcCC
Q 040569          107 AVLLGLQYLHSN-GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD--------EGKPICGTPICMAPEVARGE  177 (385)
Q Consensus       107 qil~gL~yLH~~-givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~--------~~~~~~Gt~~y~aPE~~~~~  177 (385)
                      ++..||.|+|.. ++||++|.|++|.++..+.  .||+.|+++.........        ......-...|.|||++.+.
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            344999999976 9999999999999998776  999999987654321110        01112345689999999998


Q ss_pred             CCCCCCChHHHHHHHHHHH-hCCCCCCCCCChHHHH-HHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          178 EQGFPADVWALGCTVLEMA-TGRPPWPDVADPISAL-HRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       178 ~~~~~~DiwSlG~il~ell-tG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ..++++|++||||++|.+. .|+.-+...+.....- .+.............+++++++=|.++|..++..||++.+++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence            8899999999999999999 4555554332222221 1111222333445678999999999999999999999999999


Q ss_pred             Ccccccc
Q 040569          256 HGFVKEQ  262 (385)
Q Consensus       256 hp~~~~~  262 (385)
                      -|||...
T Consensus       265 ~~ff~D~  271 (700)
T KOG2137|consen  265 IPFFSDP  271 (700)
T ss_pred             ccccCCc
Confidence            9999865

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.12  E-value=3.2e-09  Score=99.69  Aligned_cols=132  Identities=16%  Similarity=0.031  Sum_probs=92.3

Q ss_pred             ceEEEEEEECCCCcEEEEEeccCCCH--------------HHHHHHHHHHHhcCC-----CCeeeeeeeeeeccCC-eEE
Q 040569           14 TATVSIGMSNRSSEVFAVKSAELSNS--------------EFLQREQRILSALAC-----PQIVAYKGCDISEENG-KIL   73 (385)
Q Consensus        14 ~g~Vy~a~~~~~~~~~AvK~~~~~~~--------------~~~~~E~~il~~l~h-----pnIv~~~~~~~~~~~~-~~~   73 (385)
                      ...|.+...  .|+.|.||.......              ....+|.+.+.+|..     |.+|-+   ......+ ...
T Consensus        35 ~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~---~e~~~~~~~~~  109 (268)
T PRK15123         35 GRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAF---GERGSNPATRT  109 (268)
T ss_pred             CceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEE---EEecCCCccce
Confidence            333555543  478899996643221              136789999888833     433333   2221111 122


Q ss_pred             EEEEEeecCCC-CHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeec-----CCCCCeEEeec
Q 040569           74 YNLFLEYAPGG-TLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSK-----DNEQGAKIADF  145 (385)
Q Consensus        74 ~~lv~Ey~~gg-sL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~-----~~~~~~kL~DF  145 (385)
                      .+||+|++++- +|.+++..  ....++.....++.+++..+.-||..||+|+|+++.|||+..     ++...+.|+||
T Consensus       110 s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl  189 (268)
T PRK15123        110 SFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDL  189 (268)
T ss_pred             eEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence            45899999885 89999863  344677788899999999999999999999999999999975     23345899999


Q ss_pred             Cceee
Q 040569          146 GCARR  150 (385)
Q Consensus       146 G~a~~  150 (385)
                      +.+..
T Consensus       190 ~r~~~  194 (268)
T PRK15123        190 HRAQI  194 (268)
T ss_pred             Ccccc
Confidence            98753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.08  E-value=1e-09  Score=97.47  Aligned_cols=122  Identities=27%  Similarity=0.302  Sum_probs=80.8

Q ss_pred             EEEEEEECCCCcEEEEEeccCCC-----------------------------HHHHHHHHHHHHhcCCC--Ceeeeeeee
Q 040569           16 TVSIGMSNRSSEVFAVKSAELSN-----------------------------SEFLQREQRILSALACP--QIVAYKGCD   64 (385)
Q Consensus        16 ~Vy~a~~~~~~~~~AvK~~~~~~-----------------------------~~~~~~E~~il~~l~hp--nIv~~~~~~   64 (385)
                      -||.|.. ..|..+|||......                             ....++|.+.|+++..-  ++++.+.+ 
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-   78 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-   78 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence            3899987 467899999654211                             12456899999999654  45666543 


Q ss_pred             eeccCCeEEEEEEEeecC--CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHH-HHHCCceeccCCCCCEEeecCCCCCeE
Q 040569           65 ISEENGKILYNLFLEYAP--GGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY-LHSNGIVHCDIKGQNILVSKDNEQGAK  141 (385)
Q Consensus        65 ~~~~~~~~~~~lv~Ey~~--ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~y-LH~~givHrDlKp~NILi~~~~~~~~k  141 (385)
                       . .+     .|||||++  |..+..+....  ++......++.+++..+.. +|+.||+|+||.+.|||++.+   .+.
T Consensus        79 -~-~~-----~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~---~~~  146 (188)
T PF01163_consen   79 -N-RN-----VIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG---KVY  146 (188)
T ss_dssp             -E-TT-----EEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT---CEE
T ss_pred             -e-CC-----EEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc---eEE
Confidence             2 22     38999998  65665544422  2255667788888885555 579999999999999999865   399


Q ss_pred             EeecCceeee
Q 040569          142 IADFGCARRA  151 (385)
Q Consensus       142 L~DFG~a~~~  151 (385)
                      |+|||.+...
T Consensus       147 iIDf~qav~~  156 (188)
T PF01163_consen  147 IIDFGQAVDS  156 (188)
T ss_dssp             E--GTTEEET
T ss_pred             EEecCcceec
Confidence            9999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.99  E-value=8.9e-09  Score=93.11  Aligned_cols=112  Identities=27%  Similarity=0.272  Sum_probs=83.6

Q ss_pred             HHHHHHHHHHHhcCCCCe--eeeeeeeeeccCCeEEEEEEEeecCCC-CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 040569           40 EFLQREQRILSALACPQI--VAYKGCDISEENGKILYNLFLEYAPGG-TLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH  116 (385)
Q Consensus        40 ~~~~~E~~il~~l~hpnI--v~~~~~~~~~~~~~~~~~lv~Ey~~gg-sL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH  116 (385)
                      ....+|...+..|..-.|  ++.+++...........+||+|+++|- +|.+++.....++......++.++...+.-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            356678888887733222  223333333222223356899999984 79999987555788888999999999999999


Q ss_pred             HCCceeccCCCCCEEeecCC-CCCeEEeecCceeee
Q 040569          117 SNGIVHCDIKGQNILVSKDN-EQGAKIADFGCARRA  151 (385)
Q Consensus       117 ~~givHrDlKp~NILi~~~~-~~~~kL~DFG~a~~~  151 (385)
                      ..||+|+|+++.|||++.++ ...+.++||+-++..
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999999999999998775 223899999987753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.99  E-value=3.7e-09  Score=97.27  Aligned_cols=130  Identities=24%  Similarity=0.267  Sum_probs=98.7

Q ss_pred             eeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-------------------------HHHHHHHHHHHHhcCCC--C
Q 040569            4 TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-------------------------SEFLQREQRILSALACP--Q   56 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-------------------------~~~~~~E~~il~~l~hp--n   56 (385)
                      .++..||-|.-|.||.|.+. .|..+|||.-....                         ....++|.++|++|...  .
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            46789999999999999986 78999999443211                         13467899999999655  6


Q ss_pred             eeeeeeeeeeccCCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC
Q 040569           57 IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN  136 (385)
Q Consensus        57 Iv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~  136 (385)
                      |++-++.    +.    -.+||||++|-.|...-     ++...+..++..|++-+..+-..|+||+|+++-||++++++
T Consensus       173 VP~P~~~----nR----HaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         173 VPKPIAW----NR----HAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCCcccc----cc----ceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC
Confidence            6665543    22    34899999997776432     24555666777777777777789999999999999999877


Q ss_pred             CCCeEEeecCcee
Q 040569          137 EQGAKIADFGCAR  149 (385)
Q Consensus       137 ~~~~kL~DFG~a~  149 (385)
                      .  ++++||--+.
T Consensus       240 ~--~~vIDwPQ~v  250 (304)
T COG0478         240 D--IVVIDWPQAV  250 (304)
T ss_pred             C--EEEEeCcccc
Confidence            6  9999995443

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.97  E-value=4.1e-08  Score=94.97  Aligned_cols=240  Identities=18%  Similarity=0.230  Sum_probs=151.9

Q ss_pred             eeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhc-CCCCeeeee----eeeeeccCCeEEEEEEEe
Q 040569            5 RGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL-ACPQIVAYK----GCDISEENGKILYNLFLE   79 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l-~hpnIv~~~----~~~~~~~~~~~~~~lv~E   79 (385)
                      .++.||+|+-+.+|-.-.-   .--+.|+........-.+-+..|-.. .||-+-.=+    ...+..+.+.. .-++|.
T Consensus        15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~-iGflmP   90 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV-IGFLMP   90 (637)
T ss_pred             CCccccCCccceeeecchh---hchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccce-eEEecc
Confidence            4788999999999976432   11244665543322222233444443 666553300    00111222222 457888


Q ss_pred             ecCCCC-HHHHHH------cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           80 YAPGGT-LTDAIR------SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        80 y~~ggs-L~~~l~------~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      .++|.. +..++.      ...-.....+.+.++.|+.+.+-||.+|.+-+|+.++|+|++.++.  +.|.|-..-....
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi~~  168 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQINA  168 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceeecc
Confidence            887753 333332      2234678889999999999999999999999999999999997776  8888765433321


Q ss_pred             ccCCCCCCccccCCcccChhhhc-----CCCCCCCCChHHHHHHHHHHHhC-CCCCCCCC------ChHH-HH-------
Q 040569          153 VNEDDEGKPICGTPICMAPEVAR-----GEEQGFPADVWALGCTVLEMATG-RPPWPDVA------DPIS-AL-------  212 (385)
Q Consensus       153 ~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG-~~Pf~~~~------~~~~-~~-------  212 (385)
                       + .......+|.+.|.+||..+     +..-+...|.|.||+++++|+.| ++||.+..      ++.. .+       
T Consensus       169 -n-g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y  246 (637)
T COG4248         169 -N-GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY  246 (637)
T ss_pred             -C-CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence             1 11223457999999999876     33456789999999999999986 99997541      1111 11       


Q ss_pred             ---HHhcCCCCCCCCC-CcCCHHHHHHHHHhhhcC--CCCCCCHHH
Q 040569          213 ---HRIGFSSDTPEIP-GYMSKQAQDFLSKCLIRN--PGERWSASE  252 (385)
Q Consensus       213 ---~~~~~~~~~~~~~-~~~s~~~~~ll~~cL~~d--P~~Rps~~e  252 (385)
                         .+.+.......+| .-+++.++.+..+|+...  +.-|||++-
T Consensus       247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence               1111111111222 237888999999998753  568999763

>PRK09902 hypothetical protein; Provisional

Probab=98.93  E-value=4.3e-08  Score=88.01  Aligned_cols=140  Identities=18%  Similarity=0.127  Sum_probs=102.7

Q ss_pred             eeccCceEEEEEEECCCCcEEEEEecc---------CCCHHHHHHHHHHHHhcCCCC--eeeeeeeeeeccCCeEEEEEE
Q 040569            9 IGRGSTATVSIGMSNRSSEVFAVKSAE---------LSNSEFLQREQRILSALACPQ--IVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         9 LG~G~~g~Vy~a~~~~~~~~~AvK~~~---------~~~~~~~~~E~~il~~l~hpn--Iv~~~~~~~~~~~~~~~~~lv   77 (385)
                      -|+||-+.|+.....  |+.|=+|...         .-....+.+|...|++|..-+  +++...............+||
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence            367899999997654  4467788654         223467889999999984322  333332222333344446689


Q ss_pred             EeecCC-CCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569           78 LEYAPG-GTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus        78 ~Ey~~g-gsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                      +|-+.| .+|.+++...  .+.++.....++.+|...+.-||+.|+.|+|+-+.|||++.++...++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            998865 5899988753  345788888999999999999999999999999999999865544589999986654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.90  E-value=2.2e-10  Score=115.30  Aligned_cols=238  Identities=21%  Similarity=0.208  Sum_probs=167.6

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcCCCC-eeeeeeeeeeccCCeEEEEEEEeecCCC
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQ-IVAYKGCDISEENGKILYNLFLEYAPGG   84 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~hpn-Iv~~~~~~~~~~~~~~~~~lv~Ey~~gg   84 (385)
                      .+-+++|+++++++.+...+.... .|.+...  ....-++++|.+++||| .+..++-    .....+..+.++|+.++
T Consensus       247 fh~fvK~altknpKkRptaeklL~-h~fvs~~--l~~rl~~eLLdK~n~P~~~v~~~~d----~~~E~~~~i~~~i~s~~  319 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--LSRRLAIELLDKVNNPNPVVRYLED----YDGEDYLWIPMRICSTG  319 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhhee-ceeeccc--hhhHHHHHHHHHccCCCCccccccc----CCcccccchhhhhhcCC
Confidence            455789999999999987666555 7766543  45556899999999999 4444332    33344567899999887


Q ss_pred             -CHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCCcc
Q 040569           85 -TLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI  162 (385)
Q Consensus        85 -sL~~~l-~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~  162 (385)
                       +-...+ ...-.+.+-+...+.+.=+++|+++|+.-=+|+|    ||+..+.   ..|..||+....+....  ...+.
T Consensus       320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~---~~~~~~~~v~~~L~~~~--~~~t~  390 (829)
T KOG0576|consen  320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE---EVKLLDFAVPPQLTRTM--KPRTA  390 (829)
T ss_pred             ccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc---ccccccccCCcccCccc--ccccC
Confidence             332222 2233355556667777788899999998778998    8887642   37999999988764322  34566


Q ss_pred             ccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCC---cCCHHHHHHHHHh
Q 040569          163 CGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPG---YMSKQAQDFLSKC  239 (385)
Q Consensus       163 ~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~~s~~~~~ll~~c  239 (385)
                      .+|+.++|||+.....+....|.|++|.--.+|.-|-+|-..   +......++.....+.+..   +-+..-.++...|
T Consensus       391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~---P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~  467 (829)
T KOG0576|consen  391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS---PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPC  467 (829)
T ss_pred             CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC---CccccCCCCCCCCccccchhhhcCcccccCCcccc
Confidence            799999999999999999999999999988889888887643   2333333322222221111   1112223588899


Q ss_pred             hhcCCCCCCCHHHHHhCcccccc
Q 040569          240 LIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       240 L~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +...|..|+....++-|.+|..+
T Consensus       468 ~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  468 LNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             cCCCCCCCcchhhHHHHHHhccC
Confidence            99999999999999988777654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.76  E-value=4.6e-08  Score=104.67  Aligned_cols=208  Identities=25%  Similarity=0.286  Sum_probs=144.0

Q ss_pred             HHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 040569           42 LQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV  121 (385)
Q Consensus        42 ~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~giv  121 (385)
                      .+.|+..+.++.|+|++.++.+............+..|||+.-++...+..-+.++-...+.+..++++||+|+|+....
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~  308 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE  308 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence            44677888899999999998876654443323346679999999999999888899999999999999999999998555


Q ss_pred             eccCCCCCEEe-ecCCCCCeEEe--ecCceeeecccCCCCCCccccCCcccChhhhcCCCCCCC--CChHHHHHHHHHHH
Q 040569          122 HCDIKGQNILV-SKDNEQGAKIA--DFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFP--ADVWALGCTVLEMA  196 (385)
Q Consensus       122 HrDlKp~NILi-~~~~~~~~kL~--DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~--~DiwSlG~il~ell  196 (385)
                      |.-+..+-..- +.++...+.+.  ||+..+........  ....-...+-+||......+..+  .|+|.+|.....+.
T Consensus       309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~  386 (1351)
T KOG1035|consen  309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS  386 (1351)
T ss_pred             eeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence            55444331111 11122224555  88877765332222  12223456778887766655544  79999999999999


Q ss_pred             hCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          197 TGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       197 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      .|..+-.....+...            ++........+++.+|+.-++++|+++.+++.|+|.+...
T Consensus       387 ~~~~i~~~~~~~~~~------------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~  441 (1351)
T KOG1035|consen  387 QGEDISEKSAVPVSL------------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT  441 (1351)
T ss_pred             hcCcccccccchhhh------------hccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence            876553221111111            1111122678899999999999999999999999987653

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.67  E-value=6.5e-07  Score=80.85  Aligned_cols=135  Identities=19%  Similarity=0.189  Sum_probs=83.2

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH------------HHHHHHHHHHHhcCC---CCeeeeeeeeeec
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS------------EFLQREQRILSALAC---PQIVAYKGCDISE   67 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~------------~~~~~E~~il~~l~h---pnIv~~~~~~~~~   67 (385)
                      |...+.+-.....-|.+..  ..|+.+++|.......            +...+++..+.++..   -....++.+..-.
T Consensus        33 ~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk  110 (229)
T PF06176_consen   33 YKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK  110 (229)
T ss_pred             ceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence            4445555555555555554  4578999997653321            123345555555522   2222322222111


Q ss_pred             cCC-eEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecC
Q 040569           68 ENG-KILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG  146 (385)
Q Consensus        68 ~~~-~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG  146 (385)
                      ... ...+.|+|||++|..|.+...    +++.    +...|.+++.-||+.|++|+|..|.|++++.+   +++++||+
T Consensus       111 ~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~---~i~iID~~  179 (229)
T PF06176_consen  111 IFRYTSSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN---GIRIIDTQ  179 (229)
T ss_pred             eccceeEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC---cEEEEECc
Confidence            111 122558999999988877543    3332    44567778899999999999999999999843   29999998


Q ss_pred             ceee
Q 040569          147 CARR  150 (385)
Q Consensus       147 ~a~~  150 (385)
                      ..+.
T Consensus       180 ~k~~  183 (229)
T PF06176_consen  180 GKRM  183 (229)
T ss_pred             cccc
Confidence            7654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.54  E-value=6.7e-07  Score=90.98  Aligned_cols=137  Identities=23%  Similarity=0.259  Sum_probs=89.8

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccCCCHH-------------------------------------------HHH
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-------------------------------------------FLQ   43 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~-------------------------------------------~~~   43 (385)
                      +.|+.++-|.||+|+.+ +|+.||||+....-.+                                           .+.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            67899999999999997 4999999976432110                                           244


Q ss_pred             HHHHHHHhc-----CCCCeeeeeeeeeeccCCeEEEEEEEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHH
Q 040569           44 REQRILSAL-----ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHS  117 (385)
Q Consensus        44 ~E~~il~~l-----~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~  117 (385)
                      +|...+.++     ..|++ .+-.++.+-.+..   .|+|||+.|-.+.+... +...++...+.....++.  +..+-.
T Consensus       210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~---VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~  283 (517)
T COG0661         210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRR---VLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLR  283 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCe-EeceeehhccCCc---EEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHh
Confidence            677777766     23443 2222332222221   27999999999998853 223355433332222221  122234


Q ss_pred             CCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569          118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus       118 ~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      .|++|+|..|.||++..++.  +.+.|||+.....
T Consensus       284 dgffHaDpHpGNi~v~~~g~--i~~lDfGi~g~l~  316 (517)
T COG0661         284 DGFFHADPHPGNILVRSDGR--IVLLDFGIVGRLD  316 (517)
T ss_pred             cCccccCCCccceEEecCCc--EEEEcCcceecCC
Confidence            89999999999999998866  9999999987763

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.52  E-value=1.2e-06  Score=80.18  Aligned_cols=133  Identities=24%  Similarity=0.234  Sum_probs=92.2

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEeccCCCH---------------------------HHHHHHHHHHHhcC--CCC
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS---------------------------EFLQREQRILSALA--CPQ   56 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~---------------------------~~~~~E~~il~~l~--hpn   56 (385)
                      ...|.+|.-+.||+|.. .++..+|+|+......                           .-..+|...|+++.  +=.
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            34677888889999986 4688999997753321                           12346888899883  333


Q ss_pred             eeeeeeeeeeccCCeEEEEEEEeecCCCC-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEeec
Q 040569           57 IVAYKGCDISEENGKILYNLFLEYAPGGT-LTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSK  134 (385)
Q Consensus        57 Iv~~~~~~~~~~~~~~~~~lv~Ey~~ggs-L~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~-~givHrDlKp~NILi~~  134 (385)
                      +++-+.+   ..+    . |||||+.... -.-.|+ .-.+...++..+..++++.+.-|-. .|+||+||+.-|||+. 
T Consensus       132 vP~Pi~~---~~n----V-LvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-  201 (268)
T COG1718         132 VPEPIAF---RNN----V-LVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-  201 (268)
T ss_pred             CCCceee---cCC----e-EEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-
Confidence            3443332   122    2 8999996531 111222 2224444788889999999988877 8999999999999998 


Q ss_pred             CCCCCeEEeecCceeee
Q 040569          135 DNEQGAKIADFGCARRA  151 (385)
Q Consensus       135 ~~~~~~kL~DFG~a~~~  151 (385)
                      ++.  +.|+|||-|...
T Consensus       202 ~~~--p~iID~~QaV~~  216 (268)
T COG1718         202 DGE--PYIIDVSQAVTI  216 (268)
T ss_pred             CCe--EEEEECcccccc
Confidence            333  999999988765

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.49  E-value=2.3e-06  Score=77.56  Aligned_cols=80  Identities=25%  Similarity=0.285  Sum_probs=56.7

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhcCCC--CeeeeeeeeeeccCCeEEEEEEEeecC
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALACP--QIVAYKGCDISEENGKILYNLFLEYAP   82 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l~hp--nIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (385)
                      ++.|+.|..+.||++....  ..+++|..... ....+.+|..+++.+...  .+++++......... ...+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~-~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFN-GFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEET-SEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccc-ccceEEEEEec
Confidence            5789999999999999864  58999987654 456788999999988432  345555533222221 22568999999


Q ss_pred             CCCHHH
Q 040569           83 GGTLTD   88 (385)
Q Consensus        83 ggsL~~   88 (385)
                      |.++..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            988877

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.40  E-value=4.4e-06  Score=76.65  Aligned_cols=72  Identities=14%  Similarity=0.070  Sum_probs=48.6

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhcCCCCe--eeeeeeeeeccCCeEEEEEEEeecC
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALACPQI--VAYKGCDISEENGKILYNLFLEYAP   82 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l~hpnI--v~~~~~~~~~~~~~~~~~lv~Ey~~   82 (385)
                      -..||+|..+.||+.    .+..+++|..... ....+++|.++++.+..-.+  ++.+++.....  .  +.++||+++
T Consensus         6 ~~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~--~--~glv~e~i~   77 (226)
T TIGR02172         6 WTQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGG--R--LGLIYELIV   77 (226)
T ss_pred             heeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCC--e--eeeeeeecC
Confidence            367899999999983    2556789987653 35668899999998853333  33443322222  1  457999999


Q ss_pred             CCC
Q 040569           83 GGT   85 (385)
Q Consensus        83 ggs   85 (385)
                      |.+
T Consensus        78 G~~   80 (226)
T TIGR02172        78 GKR   80 (226)
T ss_pred             Ccc
Confidence            963

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.36  E-value=5.1e-06  Score=76.80  Aligned_cols=78  Identities=21%  Similarity=0.121  Sum_probs=52.5

Q ss_pred             eceeeccCc-eEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccCCeEEEEEEEeecCC
Q 040569            6 GQTIGRGST-ATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALA-CPQIVAYKGCDISEENGKILYNLFLEYAPG   83 (385)
Q Consensus         6 ~~~LG~G~~-g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~g   83 (385)
                      .+.|-.|.+ +.||+....  +..+.+|.........+.+|+++++.+. +--+++++++....  +.  .++|||+++|
T Consensus         3 ~~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~--~~lv~e~i~G   76 (244)
T cd05150           3 WERVTEGQSGATVYRLDGK--NPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDD--GR--AWLLTSAVPG   76 (244)
T ss_pred             ceecCCCCCcCeEEEEcCC--CCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecC--Cc--cEEEEEeeCC
Confidence            345666766 799999754  4688899876544456778999999883 33344555544332  22  4489999999


Q ss_pred             CCHHHH
Q 040569           84 GTLTDA   89 (385)
Q Consensus        84 gsL~~~   89 (385)
                      .+|...
T Consensus        77 ~~l~~~   82 (244)
T cd05150          77 VPAAAL   82 (244)
T ss_pred             ccHhHh
Confidence            877643

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.34  E-value=4.6e-06  Score=72.46  Aligned_cols=127  Identities=27%  Similarity=0.336  Sum_probs=91.5

Q ss_pred             eeceeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhcCCCCeee-eeeeeeeccCCeEEEEEEEeecC
Q 040569            5 RGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALACPQIVA-YKGCDISEENGKILYNLFLEYAP   82 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l~hpnIv~-~~~~~~~~~~~~~~~~lv~Ey~~   82 (385)
                      ..+.||+|.+|.||++.++  |..+|+|+-..+ ....++.|+++|..++.-++.+ +|.+  ...      ++.|||+.
T Consensus        26 v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y--g~~------~i~me~i~   95 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY--GED------FIRMEYID   95 (201)
T ss_pred             hhhhhhcccccEEEEeecc--CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe--chh------hhhhhhhc
Confidence            3578999999999999986  668899977654 4678999999999998766644 4332  222      25699999


Q ss_pred             CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC-C-CCEEeecCCCCCeEEeecCceeee
Q 040569           83 GGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIK-G-QNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        83 ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlK-p-~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      |-+|.+.-..+   +    ++-+..+++.---|-..||-|+.|. | .||+++ ++.  +.|+||..|+..
T Consensus        96 G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~~--~~iIDFd~At~k  156 (201)
T COG2112          96 GRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN-DRD--VYIIDFDSATFK  156 (201)
T ss_pred             Ccchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEec-CCc--EEEEEccchhhc
Confidence            98887765432   2    3344556666555677899999987 3 455554 334  999999998743

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.33  E-value=3e-06  Score=86.18  Aligned_cols=137  Identities=18%  Similarity=0.135  Sum_probs=87.7

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEeccCCCH----------------------------------H------HHHHH
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----------------------------------E------FLQRE   45 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~----------------------------------~------~~~~E   45 (385)
                      -+.||.-+.|.||+|+.+. |+.||||+....-.                                  +      .+.+|
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            4678999999999999975 99999997543210                                  0      12245


Q ss_pred             HHHHHhc----CCCC------eeeeeeeeeeccCCeEEEEEEEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHH
Q 040569           46 QRILSAL----ACPQ------IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQY  114 (385)
Q Consensus        46 ~~il~~l----~hpn------Iv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~y  114 (385)
                      ++...+.    .|-+      |+++|..+   .. .  -.|+||||+|..+.|.-. ....++...+..   .+.++...
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~---st-~--RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~---~l~~~~~~  315 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWDL---ST-K--RVLTMEYVDGIKINDLDAIDKRGISPHDILN---KLVEAYLE  315 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhhc---Cc-c--eEEEEEecCCccCCCHHHHHHcCCCHHHHHH---HHHHHHHH
Confidence            5544443    4444      44444322   11 2  228999999988776643 222355554333   33332222


Q ss_pred             -HHHCCceeccCCCCCEEeecC--CCCCeEEeecCceeeec
Q 040569          115 -LHSNGIVHCDIKGQNILVSKD--NEQGAKIADFGCARRAR  152 (385)
Q Consensus       115 -LH~~givHrDlKp~NILi~~~--~~~~~kL~DFG~a~~~~  152 (385)
                       |=..|++|+|-.|.||++..+  +...+.+.|||+.....
T Consensus       316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             HHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence             335789999999999999854  24448999999988763

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.29  E-value=1.8e-05  Score=70.69  Aligned_cols=125  Identities=22%  Similarity=0.284  Sum_probs=89.2

Q ss_pred             CceeeceeeccCc-eEEEEEEECCCCcEEEEEecc---CCC---------------------HHHHHHHHHHHHhc---C
Q 040569            2 DWTRGQTIGRGST-ATVSIGMSNRSSEVFAVKSAE---LSN---------------------SEFLQREQRILSAL---A   53 (385)
Q Consensus         2 ~y~~~~~LG~G~~-g~Vy~a~~~~~~~~~AvK~~~---~~~---------------------~~~~~~E~~il~~l---~   53 (385)
                      +++.++.||.|.- |.|+++...  |+.||+|.+.   ...                     .+.+..|.+..-+|   .
T Consensus        38 ~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   38 DIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             cEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            5678999999999 999999876  8899999821   100                     12355677776666   4


Q ss_pred             CCCe--eeeeeeeeecc--------------CCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 040569           54 CPQI--VAYKGCDISEE--------------NGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS  117 (385)
Q Consensus        54 hpnI--v~~~~~~~~~~--------------~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~  117 (385)
                      +.++  |+++|+..-..              .....+.||-||++...         .+....    +.+|++-+..+|.
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~k  182 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILHK  182 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHHH
Confidence            5566  99999874331              22334668888887643         234444    4456667778999


Q ss_pred             CCceeccCCCCCEEeecCCCCCeEEeecCce
Q 040569          118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCA  148 (385)
Q Consensus       118 ~givHrDlKp~NILi~~~~~~~~kL~DFG~a  148 (385)
                      .||+-+|+|+.|..     +  -||+|||.+
T Consensus       183 ~gI~~~Dv~~~ny~-----~--G~lvDfs~~  206 (207)
T PF13095_consen  183 LGIVPRDVKPRNYR-----G--GKLVDFSSS  206 (207)
T ss_pred             CCeeeccCcccccc-----C--CEEEecccC
Confidence            99999999999994     2  599999864

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.29  E-value=2.5e-05  Score=70.03  Aligned_cols=129  Identities=21%  Similarity=0.246  Sum_probs=92.1

Q ss_pred             eeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-------------------HHHHHHHHHHHHhcC------CCCee
Q 040569            4 TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-------------------SEFLQREQRILSALA------CPQIV   58 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-------------------~~~~~~E~~il~~l~------hpnIv   58 (385)
                      .....||+|+.=.||.--   .+.-..||+.....                   ..+..+|+.....+.      +.+|.
T Consensus         4 ~~~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~   80 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP   80 (199)
T ss_pred             CCCcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence            345689999999999853   34556788776655                   466778888877776      78999


Q ss_pred             eeeeeeeeccCCeEEEEEEEeecCC------CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEe
Q 040569           59 AYKGCDISEENGKILYNLFLEYAPG------GTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV  132 (385)
Q Consensus        59 ~~~~~~~~~~~~~~~~~lv~Ey~~g------gsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi  132 (385)
                      +++|+..++..-    -+|+|.+.+      .+|.++++.+. +++ ...+.+.   +-.+||-+++|+.+|++|.||++
T Consensus        81 r~~G~veT~~G~----Glv~e~I~d~dG~~s~TL~~~l~~~~-~~~-~~~~~L~---~f~~~l~~~~Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   81 RFYGFVETNLGL----GLVVELIRDADGNISPTLEDYLKEGG-LTE-ELRQALD---EFKRYLLDHHIVIRDLNPHNIVV  151 (199)
T ss_pred             cEeEEEecCCce----EEEEEEEECCCCCcCccHHHHHHcCC-ccH-HHHHHHH---HHHHHHHHcCCeecCCCcccEEE
Confidence            999987766552    345555422      35888887654 666 4444444   44567889999999999999999


Q ss_pred             ecCCCCC--eEEee
Q 040569          133 SKDNEQG--AKIAD  144 (385)
Q Consensus       133 ~~~~~~~--~kL~D  144 (385)
                      .....+.  +.|+|
T Consensus       152 ~~~~~~~~~lvlID  165 (199)
T PF10707_consen  152 QRRDSGEFRLVLID  165 (199)
T ss_pred             EecCCCceEEEEEe
Confidence            7665544  56666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.16  E-value=2.1e-05  Score=85.43  Aligned_cols=80  Identities=13%  Similarity=0.150  Sum_probs=53.7

Q ss_pred             eeceeeccCceEEEEEEECCCC--cEEEEEeccCC----CHHHHHHHHHHHHhcC-CCCe--eeeeeeeeeccCCeEEEE
Q 040569            5 RGQTIGRGSTATVSIGMSNRSS--EVFAVKSAELS----NSEFLQREQRILSALA-CPQI--VAYKGCDISEENGKILYN   75 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~--~~~AvK~~~~~----~~~~~~~E~~il~~l~-hpnI--v~~~~~~~~~~~~~~~~~   75 (385)
                      ..+.|+.|.++.+|+......+  ..+++|+....    ....+.+|.++|+.+. |+++  ++++.++.+... ....+
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v-~G~~f  120 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV-IGTAF  120 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc-CCCce
Confidence            3677889999999998765432  46778876432    2457889999999995 6665  555554433211 11145


Q ss_pred             EEEeecCCCC
Q 040569           76 LFLEYAPGGT   85 (385)
Q Consensus        76 lv~Ey~~ggs   85 (385)
                      +||||++|..
T Consensus       121 lVME~v~G~~  130 (822)
T PLN02876        121 YIMEYLEGRI  130 (822)
T ss_pred             EEEEecCCcc
Confidence            8999999865

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.05  E-value=5.3e-07  Score=98.72  Aligned_cols=212  Identities=13%  Similarity=-0.034  Sum_probs=144.6

Q ss_pred             HHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecCCCCHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHC
Q 040569           43 QREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSG----TCLEEGRIRSHTRAVLLGLQYLHSN  118 (385)
Q Consensus        43 ~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~----~~l~e~~~~~i~~qil~gL~yLH~~  118 (385)
                      ..|...++...|+++...+.-....+...  .+..++|+.+|.+.+.|-++    ..+++..+.....+.+.+..-+|+.
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~e--e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTE--EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChH--HHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence            34555667779999987665433333322  34789999999999998643    3455555555555657777777865


Q ss_pred             -C----ceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHH
Q 040569          119 -G----IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVL  193 (385)
Q Consensus       119 -g----ivHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  193 (385)
                       +    .+|+++|+-|.+|..+-+  +|++++|+.+... ..........+++.|++|++.+.-.++.++|+|..|+-+|
T Consensus      1355 tnlg~T~v~~~Lkf~lpmIVtny~--v~~gk~gLdKIkn-p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYN--VKLGKGGLDKIKN-PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred             ccCCccchhhhhhhhccceecCCc--ccccccccccccC-chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence             2    699999999999986655  9999999999332 2222233446788999999999999998899999999999


Q ss_pred             HHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          194 EMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       194 elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      ++..|..+|-..  ....+..+.......+++...|.++-.....+|-..-..||.-...+.-+.+..
T Consensus      1432 ~rs~~n~~fi~f--lq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1432 LRSDGNAYFIFF--LQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred             HHhcccHHHHHH--HHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence            999988877321  111112222222233344444555555555555555678999888888777653

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.96  E-value=5.5e-05  Score=69.61  Aligned_cols=76  Identities=20%  Similarity=0.136  Sum_probs=46.5

Q ss_pred             eceeeccCce-EEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhcCCC---CeeeeeeeeeeccCCeEEEEEEEee
Q 040569            6 GQTIGRGSTA-TVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALACP---QIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         6 ~~~LG~G~~g-~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l~hp---nIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      .+.|+.|+.. .||+.     +..+++|..... ....+++|.++|+.|...   -+.+.++.....+ .....+++||+
T Consensus         2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~-~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGE-GYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEc-----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCcc-CCCcceEEEEe
Confidence            4567877776 69976     235778876653 345788999999888431   2333333221111 11123578999


Q ss_pred             cCCCCHH
Q 040569           81 APGGTLT   87 (385)
Q Consensus        81 ~~ggsL~   87 (385)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9997763

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=97.92  E-value=0.00015  Score=69.27  Aligned_cols=78  Identities=22%  Similarity=0.104  Sum_probs=54.0

Q ss_pred             eeceeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhcCC---CCeeeeeeeeeecc-CCeEEEEEEEe
Q 040569            5 RGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALAC---PQIVAYKGCDISEE-NGKILYNLFLE   79 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l~h---pnIv~~~~~~~~~~-~~~~~~~lv~E   79 (385)
                      ..+.||.|..+.||..... ++ .+.+|..... ....+.+|...|+.|.-   -.+++.++++.... .+.  .+||||
T Consensus        18 ~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~--~~LVmE   93 (297)
T PRK10593         18 RVECISEQPYAALWALYDS-QG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP--DVLLLE   93 (297)
T ss_pred             eeeecCCccceeEEEEEcC-CC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC--eEEEEe
Confidence            3568999999999998653 23 4677775442 45789999999999843   35666766543321 122  458999


Q ss_pred             ecCCCCH
Q 040569           80 YAPGGTL   86 (385)
Q Consensus        80 y~~ggsL   86 (385)
                      +++|+++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998765

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.84  E-value=0.00029  Score=62.72  Aligned_cols=99  Identities=18%  Similarity=0.162  Sum_probs=77.3

Q ss_pred             HHHHHHHHhcCC-CCeeeeeeeeeeccCCeEEEEEEEeecCCCCHHHH---HHcCCCCCHHHHHHHHHHHHHHHHHHHH-
Q 040569           43 QREQRILSALAC-PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDA---IRSGTCLEEGRIRSHTRAVLLGLQYLHS-  117 (385)
Q Consensus        43 ~~E~~il~~l~h-pnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~---l~~~~~l~e~~~~~i~~qil~gL~yLH~-  117 (385)
                      ..|.-+|+.+++ +++++++|.+   +.    + ++.||...+++...   +..-...+.....+++.++++.+.+++. 
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C---G~----~-~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~   78 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC---GR----F-YVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHG   78 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC---CC----E-EEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence            468888999965 7999999975   21    2 48899987766421   1111235888999999999999999997 


Q ss_pred             --CCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569          118 --NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus       118 --~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                        ..+..+|++|+|+-++.++.  +|++|...+...
T Consensus        79 ~~~~~~lcDv~~~nfgv~~~~~--lk~iDld~v~~~  112 (188)
T PF12260_consen   79 PLGFFYLCDVSPDNFGVNDDGR--LKLIDLDDVFVE  112 (188)
T ss_pred             CCCcEEEeecchHHeEEeCCCc--EEEEechhcchh
Confidence              35888999999999997766  999999877654

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.72  E-value=0.0004  Score=63.58  Aligned_cols=73  Identities=21%  Similarity=0.160  Sum_probs=47.9

Q ss_pred             eceeeccCceEEEEEEECC-CCcEEEEEeccCCCHH--HHHHHHHHHHhcCCCC-eeeeeeeeeeccCCeEEEEEEEeec
Q 040569            6 GQTIGRGSTATVSIGMSNR-SSEVFAVKSAELSNSE--FLQREQRILSALACPQ-IVAYKGCDISEENGKILYNLFLEYA   81 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~-~~~~~AvK~~~~~~~~--~~~~E~~il~~l~hpn-Iv~~~~~~~~~~~~~~~~~lv~Ey~   81 (385)
                      .+.|..|-...+|+..... .++.|++|........  ..++|..+++.+.... .+++++..   ..     .++|||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~---~~-----~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF---QN-----GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe---CC-----cEEEEee
Confidence            4677888888999987543 3578889977643322  3357999999984333 34444321   22     1699999


Q ss_pred             CCCCH
Q 040569           82 PGGTL   86 (385)
Q Consensus        82 ~ggsL   86 (385)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            99765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.68  E-value=0.00024  Score=66.19  Aligned_cols=130  Identities=23%  Similarity=0.205  Sum_probs=76.5

Q ss_pred             eeeccCceEEEEEEECCCCcEEEEEeccCCCHH---HHHHHHHHHHhcCCCCe-eeeeeeeeeccCCeEEEEEEEeecCC
Q 040569            8 TIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE---FLQREQRILSALACPQI-VAYKGCDISEENGKILYNLFLEYAPG   83 (385)
Q Consensus         8 ~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~---~~~~E~~il~~l~hpnI-v~~~~~~~~~~~~~~~~~lv~Ey~~g   83 (385)
                      .+..|-.+.+|+..  .+++.+++|........   ..++|.++++.+..-.+ ++++...   ..     .+|+||++|
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~---~~-----~~v~e~i~G   72 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN---EH-----WLLVEWLEG   72 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe---CC-----EEEEEeccC
Confidence            45667788999887  34778889976543222   35789999999954322 3333321   11     278999998


Q ss_pred             CCHHH--------------HHH---c----CCCCCH-HHHHHHHHHH---------HHHHHHHHH--------CCceecc
Q 040569           84 GTLTD--------------AIR---S----GTCLEE-GRIRSHTRAV---------LLGLQYLHS--------NGIVHCD  124 (385)
Q Consensus        84 gsL~~--------------~l~---~----~~~l~e-~~~~~i~~qi---------l~gL~yLH~--------~givHrD  124 (385)
                      ..+..              .++   .    +.+++. ..+..+..++         ...+..+-.        ..++|+|
T Consensus        73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D  152 (256)
T TIGR02721        73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD  152 (256)
T ss_pred             cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence            76532              111   1    111121 1222322222         111222222        1489999


Q ss_pred             CCCCCEEeecCCCCCeEEeecCceee
Q 040569          125 IKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus       125 lKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                      +.|.||+++.++   ++|+||+.|..
T Consensus       153 l~~~Nil~~~~~---~~lIDwE~a~~  175 (256)
T TIGR02721       153 VHAYNLVVTPQG---LKLIDWEYASD  175 (256)
T ss_pred             CCcCcEEEeCCC---CEEEeccccCc
Confidence            999999998543   79999988764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.68  E-value=0.00094  Score=66.22  Aligned_cols=74  Identities=19%  Similarity=0.057  Sum_probs=51.9

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEeccC----------CCHHHHHHHHHHHHhcC---CCCeeeeeeeeeeccCCeE
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAEL----------SNSEFLQREQRILSALA---CPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~----------~~~~~~~~E~~il~~l~---hpnIv~~~~~~~~~~~~~~   72 (385)
                      .+.||.|.+..||++.....++.++||....          -..+....|.+.|+.+.   ..++++++.+.  .+.   
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~---  105 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EEL---  105 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCC---
Confidence            4678999999999999864446899997531          13456677999998872   24567776653  222   


Q ss_pred             EEEEEEeecCCCC
Q 040569           73 LYNLFLEYAPGGT   85 (385)
Q Consensus        73 ~~~lv~Ey~~ggs   85 (385)
                       .++||||+++..
T Consensus       106 -~~lVME~L~~~~  117 (401)
T PRK09550        106 -AVTVMEDLSDHK  117 (401)
T ss_pred             -CEEEEecCCCcc
Confidence             448999998744

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.64  E-value=0.00063  Score=64.65  Aligned_cols=140  Identities=22%  Similarity=0.205  Sum_probs=82.0

Q ss_pred             eeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcCCCC--eeeeeee----eeeccCCeEEEEEEE
Q 040569            5 RGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQ--IVAYKGC----DISEENGKILYNLFL   78 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~hpn--Iv~~~~~----~~~~~~~~~~~~lv~   78 (385)
                      ..+.|..|....+|+....  +..+++|.......+.+..|.++++.|....  +++.+..    ......+.  .++++
T Consensus        18 ~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~--~~~l~   93 (296)
T cd05153          18 SFEGISAGIENTNYFVTTD--SGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK--PAALV   93 (296)
T ss_pred             heecccCccccceEEEEeC--CCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc--eEEEE
Confidence            4567778888899998643  4578999887655677888999999884322  3443321    11111122  45799


Q ss_pred             eecCCCCHHH-----------HHH---c-CCCCC--------HHHHH------------HHHHHHHHHHHHHHH------
Q 040569           79 EYAPGGTLTD-----------AIR---S-GTCLE--------EGRIR------------SHTRAVLLGLQYLHS------  117 (385)
Q Consensus        79 Ey~~ggsL~~-----------~l~---~-~~~l~--------e~~~~------------~i~~qil~gL~yLH~------  117 (385)
                      +|++|.++..           .+.   . ...+.        ..-..            .....+...+.++.+      
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9999976421           110   0 00000        00000            011112333444443      


Q ss_pred             -CCceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569          118 -NGIVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus       118 -~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                       .+++|+|+.|.|||++.++.  +.|+||+.+..
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~--~~iIDfe~a~~  205 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDEL--SGVIDFYFACT  205 (296)
T ss_pred             CCcCCccCcCcccEEEeCCce--EEEeehhhhcC
Confidence             47999999999999986432  47999987754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.49  E-value=0.00013  Score=69.32  Aligned_cols=129  Identities=17%  Similarity=0.199  Sum_probs=89.4

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---------H----------------HHHHHHHHHHHhcC-CCC
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---------S----------------EFLQREQRILSALA-CPQ   56 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---------~----------------~~~~~E~~il~~l~-hpn   56 (385)
                      +..++.||-|.-+-||.+.+. .|.++++|.-.+..         .                -...+|...|+.|. |-.
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            467899999999999999874 68899999543211         0                12347999999884 322


Q ss_pred             -eeeeeeeeeeccCCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecC
Q 040569           57 -IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKD  135 (385)
Q Consensus        57 -Iv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~  135 (385)
                       +++-+++    ..    .++|||++.|..|.+.-+-.   +   +..+...+..-+--|-.+|+||||..--||+|..+
T Consensus       173 pVPkpiD~----~R----H~Vvmelv~g~Pl~~v~~v~---d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd  238 (465)
T KOG2268|consen  173 PVPKPIDH----NR----HCVVMELVDGYPLRQVRHVE---D---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDD  238 (465)
T ss_pred             CCCCcccc----cc----eeeHHHhhcccceeeeeecC---C---hHHHHHHHHHHHHHHHHcCceecccchheeEEecC
Confidence             2222221    11    45899999998887654321   2   23344455555667888999999999999999876


Q ss_pred             CCCCeEEeecCce
Q 040569          136 NEQGAKIADFGCA  148 (385)
Q Consensus       136 ~~~~~kL~DFG~a  148 (385)
                      +.  ++++||--.
T Consensus       239 ~~--i~vIDFPQm  249 (465)
T KOG2268|consen  239 DK--IVVIDFPQM  249 (465)
T ss_pred             CC--EEEeechHh
Confidence            55  999999643

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.48  E-value=0.0009  Score=64.74  Aligned_cols=136  Identities=18%  Similarity=0.176  Sum_probs=92.5

Q ss_pred             eeceeeccCceEEEEEEECCCCcEEEEEeccCC------C-------------------H----HHHHHHHHHHHhcCCC
Q 040569            5 RGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------N-------------------S----EFLQREQRILSALACP   55 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~-------------------~----~~~~~E~~il~~l~hp   55 (385)
                      +-.+|..|.-+-||.|.. .+|..+|||+...+      .                   .    -..++|++.|.+|..-
T Consensus       148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            345777888899999876 47788999965421      0                   1    1345799999999544


Q ss_pred             CeeeeeeeeeeccCCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCCEEeec
Q 040569           56 QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH-SNGIVHCDIKGQNILVSK  134 (385)
Q Consensus        56 nIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH-~~givHrDlKp~NILi~~  134 (385)
                      .|+.- .-..-..     -.|||+|+..-....-.-+...++...++.+-.|++.-+.-|- ..++||.||.--|+|+. 
T Consensus       227 GIP~P-ePIlLk~-----hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-  299 (520)
T KOG2270|consen  227 GIPCP-EPILLKN-----HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-  299 (520)
T ss_pred             CCCCC-Cceeeec-----ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-
Confidence            43211 1111112     2389999954222222223445888889999999998888875 56999999999999998 


Q ss_pred             CCCCCeEEeecCceee
Q 040569          135 DNEQGAKIADFGCARR  150 (385)
Q Consensus       135 ~~~~~~kL~DFG~a~~  150 (385)
                        .+.+.|+|-+-+..
T Consensus       300 --dG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  300 --DGKLYIIDVSQSVE  313 (520)
T ss_pred             --CCEEEEEEcccccc
Confidence              33499999976644

>PRK05231 homoserine kinase; Provisional

Probab=97.47  E-value=0.0021  Score=61.83  Aligned_cols=77  Identities=19%  Similarity=0.169  Sum_probs=46.4

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcC-----CCCeeeee-eeeeeccCCeEEEEEEEe
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALA-----CPQIVAYK-GCDISEENGKILYNLFLE   79 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~-----hpnIv~~~-~~~~~~~~~~~~~~lv~E   79 (385)
                      .+.|+.|...++|+....  +..+++|+++....+.+..|..+++.|.     .|.+++-. |.......+.  .++++|
T Consensus        27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~--~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT--QGEYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGK--PAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeC--CCcEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCE--EEEEEE
Confidence            456677777899998754  3468999886434566667777777763     23333211 1111111222  458999


Q ss_pred             ecCCCCH
Q 040569           80 YAPGGTL   86 (385)
Q Consensus        80 y~~ggsL   86 (385)
                      |++|..+
T Consensus       103 ~l~G~~~  109 (319)
T PRK05231        103 FLEGKWP  109 (319)
T ss_pred             ecCCCCC
Confidence            9999753

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.45  E-value=0.0023  Score=61.36  Aligned_cols=140  Identities=18%  Similarity=0.206  Sum_probs=79.9

Q ss_pred             eeceeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhcCCCC--eeeeeee----eeeccCCeEEEEEE
Q 040569            5 RGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALACPQ--IVAYKGC----DISEENGKILYNLF   77 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l~hpn--Iv~~~~~----~~~~~~~~~~~~lv   77 (385)
                      ..+.++.|....+|+....  +..+++|..... ..+.+..|.++++.|....  +++++..    ......+.  .+++
T Consensus        26 ~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~--~~~l  101 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTTD--VGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK--PACL  101 (307)
T ss_pred             eccccCCccccceEEEEeC--CCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe--EEEE
Confidence            3566778878899998643  446888987543 3456778888888883222  3333221    11111222  4589


Q ss_pred             EeecCCCCHH-----------HHHH---c-CCCCC--------HHH-----HH----------HHHHHHHHHHHHHHH--
Q 040569           78 LEYAPGGTLT-----------DAIR---S-GTCLE--------EGR-----IR----------SHTRAVLLGLQYLHS--  117 (385)
Q Consensus        78 ~Ey~~ggsL~-----------~~l~---~-~~~l~--------e~~-----~~----------~i~~qil~gL~yLH~--  117 (385)
                      +||++|.++.           ..+.   . ...++        ...     ..          .....+...++++..  
T Consensus       102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~  181 (307)
T TIGR00938       102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW  181 (307)
T ss_pred             EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence            9999985531           1111   0 00010        000     00          001123344555542  


Q ss_pred             -----CCceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569          118 -----NGIVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus       118 -----~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                           .+++|+|+.+.||+++.++.  ..|+||+.+..
T Consensus       182 ~~~~~~~l~HgD~~~~Nvl~~~~~~--~~vIDfd~~~~  217 (307)
T TIGR00938       182 PRDLPRGVIHADLFPDNVLFDGDSV--KGVIDFYFACT  217 (307)
T ss_pred             hhcCCCccCCCCCCcCcEEEECCce--EEEeecccccC
Confidence                 58999999999999986542  58999987653

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.35  E-value=0.0014  Score=62.54  Aligned_cols=74  Identities=22%  Similarity=0.128  Sum_probs=48.4

Q ss_pred             eceeeccCceEEEEEEECC------CCcEEEEEeccCCC--HHHHHHHHHHHHhcCCCCe-eeeeeeeeeccCCeEEEEE
Q 040569            6 GQTIGRGSTATVSIGMSNR------SSEVFAVKSAELSN--SEFLQREQRILSALACPQI-VAYKGCDISEENGKILYNL   76 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~------~~~~~AvK~~~~~~--~~~~~~E~~il~~l~hpnI-v~~~~~~~~~~~~~~~~~l   76 (385)
                      .+.|..|-...+|+.....      +++.+++|......  .....+|.++++.+....+ +++++.+   ..+     +
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~---~~~-----~   74 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIF---PNG-----R   74 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEe---CCC-----c
Confidence            4566677777999987643      25789999876542  2456789999999843223 3444432   121     4


Q ss_pred             EEeecCCCCHH
Q 040569           77 FLEYAPGGTLT   87 (385)
Q Consensus        77 v~Ey~~ggsL~   87 (385)
                      |+||++|.++.
T Consensus        75 v~e~i~G~~l~   85 (302)
T cd05156          75 IEEFIPSRTLT   85 (302)
T ss_pred             hhheeCCCcCC
Confidence            78999987653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.32  E-value=0.00063  Score=68.24  Aligned_cols=167  Identities=22%  Similarity=0.260  Sum_probs=102.9

Q ss_pred             CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 040569           38 NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS  117 (385)
Q Consensus        38 ~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~  117 (385)
                      ...++.-...+++.+.|+|...++++.......   ..+|+|++ +.||.++++.+. +-....   .           .
T Consensus        25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r---~IVV~e~~-~~Sled~~~~~~-l~~~s~---~-----------~   85 (725)
T KOG1093|consen   25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHER---VIVVMEHY-TMSLEDILKTGN-LKDESL---L-----------A   85 (725)
T ss_pred             cHHHHhhhhHHHHhhcCccceeeEeeecCccce---EEEEehhh-ccchHHHHHhcc-cchhhh---c-----------c
Confidence            345566678899999999999998765443332   34799999 459999988654 211111   1           2


Q ss_pred             CCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh
Q 040569          118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT  197 (385)
Q Consensus       118 ~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt  197 (385)
                      +|+.|-     |+         .+++|    ...    +.. ...                .++++||||+|.++.++.-
T Consensus        86 ~~~~~~-----~~---------~~~td----~~~----t~~-~~~----------------~~pKsdVwsl~~i~~el~L  126 (725)
T KOG1093|consen   86 HGVLHL-----NI---------IYITD----HFL----TKY-PSP----------------IGPKSDVWSLGFIILELYL  126 (725)
T ss_pred             ccccee-----hh---------hhccc----ccc----ccC-CCC----------------CCcchhhhhHHHHHHHHHH
Confidence            222221     12         34444    000    000 111                1149999999999999999


Q ss_pred             CCCCCCCCCChHHH--HHHhcCCCCCCC-------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          198 GRPPWPDVADPISA--LHRIGFSSDTPE-------IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       198 G~~Pf~~~~~~~~~--~~~~~~~~~~~~-------~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      |...|....+....  +.+..+......       +-..++....+++.+|+-..|..||...++++++-|.+.
T Consensus       127 ~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  127 GISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             hhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            98877654332222  222211111110       111245667889999999999999999999999988754

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.05  E-value=0.0079  Score=58.69  Aligned_cols=79  Identities=18%  Similarity=0.077  Sum_probs=49.7

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccC-------C---CHHHHHHHHHHHHhcC--CC-CeeeeeeeeeeccCCeEE
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAEL-------S---NSEFLQREQRILSALA--CP-QIVAYKGCDISEENGKIL   73 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~-------~---~~~~~~~E~~il~~l~--hp-nIv~~~~~~~~~~~~~~~   73 (385)
                      +.||-|-..-||++.+...++-++||....       +   ..+....|.+.|+...  .| .++++|.+.  .+.    
T Consensus         1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D--~e~----   74 (370)
T TIGR01767         1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD--TEM----   74 (370)
T ss_pred             CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc--ccc----
Confidence            357899999999999864446899995431       1   1234456888887763  34 556666542  222    


Q ss_pred             EEEEEeecCCCC-HHHHHH
Q 040569           74 YNLFLEYAPGGT-LTDAIR   91 (385)
Q Consensus        74 ~~lv~Ey~~ggs-L~~~l~   91 (385)
                      ..+|||+++... |.+.+-
T Consensus        75 ~~~vMEdL~~~~ilR~~Li   93 (370)
T TIGR01767        75 AVTVMEDLSHHKIARKGLI   93 (370)
T ss_pred             ceehHhhCccchHHHHHHH
Confidence            347999996533 444443

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.94  E-value=0.0081  Score=56.80  Aligned_cols=31  Identities=26%  Similarity=0.396  Sum_probs=24.4

Q ss_pred             CceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569          119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus       119 givHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                      .++|+|++|.|||++.++. ..-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDAR-VTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCC-EEEEECcHhccc
Confidence            4899999999999985432 136999998865

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.61  E-value=0.019  Score=55.18  Aligned_cols=30  Identities=20%  Similarity=0.385  Sum_probs=26.0

Q ss_pred             ceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569          120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus       120 ivHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      ++|+|+.+.||+|..++.  +=+.||+++..-
T Consensus       200 lvHGD~~~gNlii~~~~~--~gVlDwe~~~lG  229 (321)
T COG3173         200 LVHGDYRPGNLIIDPGRP--TGVLDWELATLG  229 (321)
T ss_pred             eeeCCcccCCEEEeCCCe--eEEEeccccccC
Confidence            899999999999987655  788999988754

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.50  E-value=0.028  Score=55.65  Aligned_cols=80  Identities=19%  Similarity=0.130  Sum_probs=52.1

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEecc----C-----CCHHHHHHHHHHHHhcC--CC-CeeeeeeeeeeccCCeEE
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAE----L-----SNSEFLQREQRILSALA--CP-QIVAYKGCDISEENGKIL   73 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~----~-----~~~~~~~~E~~il~~l~--hp-nIv~~~~~~~~~~~~~~~   73 (385)
                      .+.||-|--.-||++.+...++-++||...    .     -..+....|.+.|+.+.  .| +++++|.+.  .+.    
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D--~e~----  107 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD--SVM----  107 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC--cHH----
Confidence            568899999999999985445678999543    1     12345567888888772  34 566676543  222    


Q ss_pred             EEEEEeecCCCC-HHHHHH
Q 040569           74 YNLFLEYAPGGT-LTDAIR   91 (385)
Q Consensus        74 ~~lv~Ey~~ggs-L~~~l~   91 (385)
                      ..+|||+++... |.+.+-
T Consensus       108 ~~~vMEdL~~~~ilR~~Li  126 (409)
T PRK12396        108 NCCVMEDLSDHTILRTALI  126 (409)
T ss_pred             hhHHHHhCcccHHHHHHHH
Confidence            347999996533 444443

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.45  E-value=0.068  Score=50.95  Aligned_cols=29  Identities=34%  Similarity=0.527  Sum_probs=24.3

Q ss_pred             CCceeccCCCCCEEeecCCCCCeEEeecCcee
Q 040569          118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCAR  149 (385)
Q Consensus       118 ~givHrDlKp~NILi~~~~~~~~kL~DFG~a~  149 (385)
                      .+++|+|+.+.||+++. +.  +.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~--i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NE--VYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-Cc--EEEEECcccc
Confidence            47899999999999985 33  8999998664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.35  E-value=0.016  Score=56.97  Aligned_cols=59  Identities=17%  Similarity=0.263  Sum_probs=43.9

Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCCEEeecC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH-SNGIVHCDIKGQNILVSKD  135 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH-~~givHrDlKp~NILi~~~  135 (385)
                      |+-+|..|.++..+++... .+|...+.++.--.+||.-+- -.+++|.|+.|.||++..+
T Consensus       322 l~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  322 LVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             eeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            6778999999999998433 456566666666666654443 4699999999999999543

>PLN02236 choline kinase

Probab=96.34  E-value=0.06  Score=52.58  Aligned_cols=136  Identities=18%  Similarity=0.122  Sum_probs=77.0

Q ss_pred             eceeeccCceEEEEEEECC----CCcEEEEEeccCCCHH--HHHHHHHHHHhcCCCCe-eeeeeeeeeccCCeEEEEEEE
Q 040569            6 GQTIGRGSTATVSIGMSNR----SSEVFAVKSAELSNSE--FLQREQRILSALACPQI-VAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~----~~~~~AvK~~~~~~~~--~~~~E~~il~~l~hpnI-v~~~~~~~~~~~~~~~~~lv~   78 (385)
                      ...|-.|-...+|++....    .++.+++|........  ...+|..+++.+..-++ +++++.+   .++     .|.
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~---~~g-----~v~  112 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF---PNG-----RVE  112 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE---CCc-----eEE
Confidence            3455557778999986432    3478899987654322  23579999998844333 3344433   222     368


Q ss_pred             eecCCCCHHHH--------------HH---cCC----C-C-CHHHHHHHHHHHH-----------------HHHHHH---
Q 040569           79 EYAPGGTLTDA--------------IR---SGT----C-L-EEGRIRSHTRAVL-----------------LGLQYL---  115 (385)
Q Consensus        79 Ey~~ggsL~~~--------------l~---~~~----~-l-~e~~~~~i~~qil-----------------~gL~yL---  115 (385)
                      ||++|.+|...              ++   +..    . . ....+..+..++.                 ..+..|   
T Consensus       113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~  192 (344)
T PLN02236        113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE  192 (344)
T ss_pred             EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence            89887665311              11   111    0 1 1223333332221                 111112   


Q ss_pred             -HH----CCceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569          116 -HS----NGIVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus       116 -H~----~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                       ..    ..++|+|+++.|||++.+. ..++++||..|..
T Consensus       193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~~  231 (344)
T PLN02236        193 LSGDDQEIGFCHNDLQYGNIMIDEET-RAITIIDYEYASY  231 (344)
T ss_pred             hcccCCCceEEeCCCCcCcEEEeCCC-CcEEEEeehhccc
Confidence             11    2589999999999997532 3499999987753

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.27  E-value=0.064  Score=53.34  Aligned_cols=70  Identities=20%  Similarity=0.130  Sum_probs=46.3

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEecc-----CC-----CHHHHHHHHHHHHhcC---CCCeeeeeeeeeeccCCeE
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAE-----LS-----NSEFLQREQRILSALA---CPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~-----~~-----~~~~~~~E~~il~~l~---hpnIv~~~~~~~~~~~~~~   72 (385)
                      .+.||-|....||+..+.  +..++||...     ..     ..+....|.+.|+.+.   ..++++++.++.  +.   
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~---  109 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TM---  109 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CC---
Confidence            567899999999998864  4568899765     11     2233345677776663   246777776543  22   


Q ss_pred             EEEEEEeecCC
Q 040569           73 LYNLFLEYAPG   83 (385)
Q Consensus        73 ~~~lv~Ey~~g   83 (385)
                       ..++|||+++
T Consensus       110 -~vlvME~L~~  119 (418)
T PLN02756        110 -ALIGMRYLEP  119 (418)
T ss_pred             -CEEEEeecCC
Confidence             3479999987

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.04  E-value=0.049  Score=52.87  Aligned_cols=73  Identities=16%  Similarity=0.123  Sum_probs=44.7

Q ss_pred             eceeeccCceEEEEEEECCC---CcEEEEEeccCCCHH--HHHHHHHHHHhcCCCCe-eeeeeeeeeccCCeEEEEEEEe
Q 040569            6 GQTIGRGSTATVSIGMSNRS---SEVFAVKSAELSNSE--FLQREQRILSALACPQI-VAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~---~~~~AvK~~~~~~~~--~~~~E~~il~~l~hpnI-v~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      .+.|..|-...+|+......   +..|++|........  ...+|..+++.+..-++ +++++++   .++     +|.+
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~---~~G-----~i~~   90 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVF---GNG-----MIQS   90 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEe---CCc-----Eeeh
Confidence            45555577778998865432   347889987643322  23579999999854333 3444433   222     4788


Q ss_pred             ecCCCCH
Q 040569           80 YAPGGTL   86 (385)
Q Consensus        80 y~~ggsL   86 (385)
                      |++|-+|
T Consensus        91 fi~g~~l   97 (330)
T PLN02421         91 FINARTL   97 (330)
T ss_pred             hhcCCCC
Confidence            9887665

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.97  E-value=0.062  Score=51.09  Aligned_cols=75  Identities=19%  Similarity=0.151  Sum_probs=46.9

Q ss_pred             eeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcC---CCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            4 TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALA---CPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~---hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +..+.|+.|....+|+..  .+++.+.||.-.......++.|.+-|+.|.   .-.+++.+++......    -+|+|||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~----~fLlle~   93 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD----AFLLLEF   93 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC----CEEEEE-
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC----ceEEEEe
Confidence            456788989999999987  668899999887555678889999999883   3345566665544333    2589999


Q ss_pred             cCCC
Q 040569           81 APGG   84 (385)
Q Consensus        81 ~~gg   84 (385)
                      ++.+
T Consensus        94 l~~~   97 (288)
T PF03881_consen   94 LEMG   97 (288)
T ss_dssp             ----
T ss_pred             ecCC
Confidence            9877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.91  E-value=0.021  Score=51.46  Aligned_cols=31  Identities=39%  Similarity=0.542  Sum_probs=19.8

Q ss_pred             CceeccCCCCCEEe-ecCCCCCeEEeecCceeee
Q 040569          119 GIVHCDIKGQNILV-SKDNEQGAKIADFGCARRA  151 (385)
Q Consensus       119 givHrDlKp~NILi-~~~~~~~~kL~DFG~a~~~  151 (385)
                      -++|+|+.|.|||+ ..++.  ++|+||..|..-
T Consensus       144 v~cHnDl~~~Nil~~~~~~~--~~lIDfEya~~n  175 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGE--VKLIDFEYAGYN  175 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSC--EEE--GTT-EEE
T ss_pred             eEeeccCccccEEeccCCCe--EEEecHHHHhhc
Confidence            48999999999999 44444  999999988753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK06148 hypothetical protein; Provisional

Probab=95.71  E-value=0.22  Score=55.58  Aligned_cols=142  Identities=20%  Similarity=0.311  Sum_probs=79.3

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccCCC-HHHHHHHHHHHHhc-------CCCCeeeee-eeee---eccCCeEEE
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-SEFLQREQRILSAL-------ACPQIVAYK-GCDI---SEENGKILY   74 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-~~~~~~E~~il~~l-------~hpnIv~~~-~~~~---~~~~~~~~~   74 (385)
                      +.|+ |..-.+|+... .+|..|++|+.+... ...+..|.++|..|       ..|.+++-. |-..   ....+...+
T Consensus        31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~  108 (1013)
T PRK06148         31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL  108 (1013)
T ss_pred             eecC-CcCCceEEEEe-CCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence            4554 34578888865 357789999997543 34555666677655       234544432 1111   112233235


Q ss_pred             EEEEeecCCCCHHHH-------H----------H---cC-------CCCC-----------------HHHHHHHHHHHHH
Q 040569           75 NLFLEYAPGGTLTDA-------I----------R---SG-------TCLE-----------------EGRIRSHTRAVLL  110 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~-------l----------~---~~-------~~l~-----------------e~~~~~i~~qil~  110 (385)
                      +-+++|++|..|.+.       +          .   ++       ..+.                 ....+.++.+++.
T Consensus       109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~  188 (1013)
T PRK06148        109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA  188 (1013)
T ss_pred             EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence            568999999877541       0          0   00       0000                 1112233333333


Q ss_pred             HHH-----HHHH--CCceeccCCCCCEEeecCCCCCeE-EeecCceee
Q 040569          111 GLQ-----YLHS--NGIVHCDIKGQNILVSKDNEQGAK-IADFGCARR  150 (385)
Q Consensus       111 gL~-----yLH~--~givHrDlKp~NILi~~~~~~~~k-L~DFG~a~~  150 (385)
                      ...     .+.+  +++||+|+.+.|||++.+....+. |+|||-+..
T Consensus       189 ~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        189 RFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            322     1222  479999999999999876532364 999997764

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.58  E-value=0.12  Score=50.21  Aligned_cols=139  Identities=22%  Similarity=0.261  Sum_probs=81.7

Q ss_pred             eeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhcC-C--CC---eeeeeeeeeeccCCeEEEEEEEee
Q 040569            8 TIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALA-C--PQ---IVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         8 ~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l~-h--pn---Iv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      .|.+ .-..||+....  +..+++|+.+.. ....+.-|...|+.|. +  |=   +...-|-....-.+.....-+.+|
T Consensus        33 ~l~s-~eN~~f~~~~~--~g~~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~  109 (331)
T COG2334          33 GLNS-EENSNFRVQTE--DGRYILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY  109 (331)
T ss_pred             cccc-ccCceEEEEec--CCCeEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence            3444 45578887764  334499999875 6778888999999882 2  11   333333332222220235578899


Q ss_pred             cCCCCHHH------------HH---H---cCCC---------CCHH----H---------HHHHHHHHHHHHHHHHH---
Q 040569           81 APGGTLTD------------AI---R---SGTC---------LEEG----R---------IRSHTRAVLLGLQYLHS---  117 (385)
Q Consensus        81 ~~ggsL~~------------~l---~---~~~~---------l~e~----~---------~~~i~~qil~gL~yLH~---  117 (385)
                      ++|..+..            .+   .   ++-+         ....    .         -.....++...++.+.+   
T Consensus       110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~  189 (331)
T COG2334         110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP  189 (331)
T ss_pred             cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence            99988772            11   0   0100         1111    0         01123344455555543   


Q ss_pred             -----CC--ceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569          118 -----NG--IVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus       118 -----~g--ivHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                           .+  +||+|+.|.|||++.+.. ...+.|||-+..
T Consensus       190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~~  228 (331)
T COG2334         190 AHLPALGDQIIHGDLHPDNVLFDDDTD-VSGFIDFDDAGY  228 (331)
T ss_pred             hhCCcccceeeecCCCccceeEcCCCC-eeeEEEcccccc
Confidence                 24  999999999999986654 368999997754

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.50  E-value=0.075  Score=51.74  Aligned_cols=105  Identities=15%  Similarity=0.250  Sum_probs=68.5

Q ss_pred             CCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEeecCCCCCeEEeecCc
Q 040569           69 NGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN-GIVHCDIKGQNILVSKDNEQGAKIADFGC  147 (385)
Q Consensus        69 ~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~-givHrDlKp~NILi~~~~~~~~kL~DFG~  147 (385)
                      .+..+.|++|++- |++|. .++.   -..+++..++++.+..++-+..+ .+-||++.-.||||+ +|+  +.|+||-|
T Consensus       296 de~~y~yl~~kdh-gt~is-~ik~---~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~Gn--vtLIDfkl  367 (488)
T COG5072         296 DETLYLYLHFKDH-GTPIS-IIKA---DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGN--VTLIDFKL  367 (488)
T ss_pred             CCceEEEEEEecC-Cceee-eeec---ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCc--eEEEEeee
Confidence            3345566888885 44544 2332   24667888889888887777654 789999999999998 445  99999999


Q ss_pred             eeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHH
Q 040569          148 ARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWAL  188 (385)
Q Consensus       148 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSl  188 (385)
                      ++.- .....     .--...--|-.++|.. +.+-+||-+
T Consensus       368 sRl~-~~q~~-----isy~rldhp~lF~G~d-d~QFeIYrl  401 (488)
T COG5072         368 SRLS-YSQGI-----ISYNRLDHPDLFNGVD-DYQFEIYRL  401 (488)
T ss_pred             eecc-cCCce-----eeccccCchhhhcCcc-ceeeeHHHH
Confidence            9942 12111     1111233455555443 667777764

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.47  E-value=0.53  Score=45.53  Aligned_cols=70  Identities=16%  Similarity=0.134  Sum_probs=41.5

Q ss_pred             CceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhcCCCC--eee---eeeeeeeccCCeEEEEEEEeecCCCC
Q 040569           13 STATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALACPQ--IVA---YKGCDISEENGKILYNLFLEYAPGGT   85 (385)
Q Consensus        13 ~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l~hpn--Iv~---~~~~~~~~~~~~~~~~lv~Ey~~ggs   85 (385)
                      .-..||+... .++..+++|.....  ..+.+..|.+.+..|....  ++.   .-|-......+  +++.++++++|..
T Consensus        37 ~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g--~~~~l~~~~~G~~  113 (325)
T PRK11768         37 YENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQG--FRFALFPRRGGRA  113 (325)
T ss_pred             ccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECC--EEEEEEeeeCCCC
Confidence            4457888865 34667999987643  4667788999988873211  121   12211111122  2457899998864

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.37  E-value=0.25  Score=47.28  Aligned_cols=30  Identities=17%  Similarity=0.175  Sum_probs=25.8

Q ss_pred             CceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569          119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus       119 givHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                      +++|+|+.+.|||++.++.  +.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRG--GYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCC--EEEEEhhhccc
Confidence            7999999999999986655  89999987764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PTZ00384 choline kinase; Provisional

Probab=95.18  E-value=0.12  Score=51.32  Aligned_cols=75  Identities=16%  Similarity=0.083  Sum_probs=43.9

Q ss_pred             eeceeeccCceEEEEEEECCC-Cc-----EEEEEeccCCCHH--HHHHHHHHHHhcCCCCe-eeeeeeeeeccCCeEEEE
Q 040569            5 RGQTIGRGSTATVSIGMSNRS-SE-----VFAVKSAELSNSE--FLQREQRILSALACPQI-VAYKGCDISEENGKILYN   75 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~-~~-----~~AvK~~~~~~~~--~~~~E~~il~~l~hpnI-v~~~~~~~~~~~~~~~~~   75 (385)
                      ..+.|..|-...+|++..... +.     .|.++........  ..++|.++++.+...++ .++++.+   .+     .
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f---~~-----g  125 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRF---GD-----F  125 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEec---CC-----E
Confidence            345666687889999865322 12     2444433222211  23569999999965544 4455543   22     2


Q ss_pred             EEEeecCCCCHH
Q 040569           76 LFLEYAPGGTLT   87 (385)
Q Consensus        76 lv~Ey~~ggsL~   87 (385)
                      ++.||++|-+|.
T Consensus       126 ~l~efIeGr~l~  137 (383)
T PTZ00384        126 TIQEWVEGNTMG  137 (383)
T ss_pred             EEEEEeccccCC
Confidence            688999987754

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.20  E-value=0.28  Score=44.80  Aligned_cols=88  Identities=23%  Similarity=0.294  Sum_probs=58.3

Q ss_pred             CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 040569           38 NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS  117 (385)
Q Consensus        38 ~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~  117 (385)
                      ....+.++.+++.++.  .|+++.-     +++.. |-+++|+|--...             ....++..=+..|.-.|+
T Consensus       101 ~~~~y~nky~v~Armh--GilrL~N-----Dn~~~-yGvIlE~Cy~~~i-------------~~~N~i~agi~~L~~fH~  159 (308)
T PF07387_consen  101 NDALYFNKYRVFARMH--GILRLKN-----DNNYK-YGVILERCYKIKI-------------NFSNFITAGIKDLMDFHS  159 (308)
T ss_pred             chhhhhhhhhHHHHhh--heeEeec-----CCCce-eEEEEeeccCccc-------------chhHHHHHhHHHHHHhhc
Confidence            3456788999998886  4677652     23232 5689999953111             111122222456777884


Q ss_pred             --CCceeccCCCCCEEeecCCCCCeEEeecCce
Q 040569          118 --NGIVHCDIKGQNILVSKDNEQGAKIADFGCA  148 (385)
Q Consensus       118 --~givHrDlKp~NILi~~~~~~~~kL~DFG~a  148 (385)
                        .+.+|+|..|+||+-+..+.  +||.|=++.
T Consensus       160 ~~~~~lHGD~np~NiM~D~~G~--lKlVDP~~L  190 (308)
T PF07387_consen  160 ENQHCLHGDCNPDNIMCDKFGY--LKLVDPVCL  190 (308)
T ss_pred             cCCCeecCCCChhheeecCCCC--EEecChhhh
Confidence              37999999999999987776  899887654

The function of this family is unknown.

>PTZ00296 choline kinase; Provisional

Probab=93.59  E-value=0.66  Score=46.93  Aligned_cols=74  Identities=15%  Similarity=0.031  Sum_probs=45.6

Q ss_pred             eeceeeccCceEEEEEEECCC--------CcEEEEEeccCCCHH--HHHHHHHHHHhcCCCCee-eeeeeeeeccCCeEE
Q 040569            5 RGQTIGRGSTATVSIGMSNRS--------SEVFAVKSAELSNSE--FLQREQRILSALACPQIV-AYKGCDISEENGKIL   73 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~--------~~~~AvK~~~~~~~~--~~~~E~~il~~l~hpnIv-~~~~~~~~~~~~~~~   73 (385)
                      ..+.|..|-.-.+|++.....        ++.|.+++.......  ...+|..+++.+..-.|- ++++.+   .++   
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f---~gg---  182 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTF---SGG---  182 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEe---CCC---
Confidence            355666677778888875421        567889987654333  234688888888543442 344432   222   


Q ss_pred             EEEEEeecCCCCH
Q 040569           74 YNLFLEYAPGGTL   86 (385)
Q Consensus        74 ~~lv~Ey~~ggsL   86 (385)
                        .|.||++|-+|
T Consensus       183 --~I~efi~g~~l  193 (442)
T PTZ00296        183 --RIEEWLYGDPL  193 (442)
T ss_pred             --EEEEeeCCccC
Confidence              47899988644

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	385
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-36
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-35
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-35
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-35
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-34
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-34
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-34
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-34
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-34
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-34
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-34
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-34
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		9e-34
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-30
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-29
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-28
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-28
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-27
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-27
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-27
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-27
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-27
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-27
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-27
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-27
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-26
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-26
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-26
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-26
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-26
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-26
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-26
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		9e-26
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-25
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-25
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-25
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-25
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-25
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-25
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-25
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-25
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-25
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-25
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-24
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-24
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-24
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-24
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-24
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-24
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-24
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-24
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-24
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-24
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-24
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-24
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-24
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-24
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-24
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-24
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-24
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-24
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-24
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-24
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-24
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-24
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-24
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-24
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		7e-24
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-24
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-24
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-24
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-23
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-23
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-23
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-23
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-23
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-23
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-23
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-23
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-23
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-23
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-23
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-23
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-23
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-23
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-23
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-23
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-23
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-23
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-23
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-23
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-23
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-23
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-23
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-23
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-23
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-23
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-23
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-23
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-23
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-23
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-23
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-23
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-23
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-23
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-23
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-23
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-23
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-23
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-23
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-23
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-23
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-23
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-23
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-23
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-23
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-23
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-23
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-23
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-23
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-23
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-23
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-23
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-23
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		7e-23
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-23
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-22
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-22
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-22
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-22
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-22
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-22
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-22
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-22
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-22
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-22
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-22
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-22
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-22
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-22
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-22
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-22
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-22
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-22
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-22
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-22
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-22
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-22
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-22
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-22
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-22
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-22
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-22
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-22
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-22
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-22
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-22
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-22
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-22
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-22
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-22
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-22
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-22
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-22
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-22
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-22
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-22
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-22
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-22
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-22
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-22
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-22
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-22
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-22
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-22
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-22
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-22
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-22
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-22
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-22
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-22
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-22
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-22
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		9e-22
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-22
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-21
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-21
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-21
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-21
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-21
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-21
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-21
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-21
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-21
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-21
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-21
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-21
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-21
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-21
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-21
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-21
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-21
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-21
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-21
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-21
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-21
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-21
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-20
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-20
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-20
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-20
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-20
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-20
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-20
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-20
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-20
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-20
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-20
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-20
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-20
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-20
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-20
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-20
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-20
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-20
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-20
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-20
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-20
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		7e-20
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-20
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		8e-20
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-20
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-20
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-19
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-19
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-19
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-19
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-19
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-19
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-19
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-19
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-19
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-19
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-19
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-19
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-19
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-19
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-19
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-19
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-19
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-19
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-19
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-19
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-19
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-19
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-19
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-19
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-19
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-19
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-19
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-19
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-19
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-19
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-19
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-19
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-19
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-19
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-19
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-19
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-19
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-19
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		6e-19
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-19
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-19
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-19
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-19
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-19
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-19
3soa_A	444	Full-Length Human Camkii Length = 444		8e-19
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-19
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		9e-19
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		9e-19
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-19
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-18
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-18
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-18
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-18
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-18
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-18
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-18
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-18
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-18
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-18
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-18
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-18
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-18
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-18
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-18
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-18
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-18
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-18
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-18
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-18
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		9e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-17
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-17
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-17
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-17
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-17
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-17
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-17
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-17
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-17
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-17
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-17
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-17
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-17
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-17
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-17
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-17
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-17
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		6e-17
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-17
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-17
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-17
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-17
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-17
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-17
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-17
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-17
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-17
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		8e-17
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-17
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		9e-17
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-16
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-16
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-16
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-16
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-16
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-16
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-16
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-16
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-16
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-16
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-16
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-16
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-16
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-16
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-16
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		6e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-16
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-16
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-16
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-15
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-15
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-15
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-15
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-15
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-15
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-15
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-15
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-15
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-15
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-15
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-15
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-15
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-15
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-15
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-15
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-15
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-15
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-15
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-15
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-15
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-15
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-15
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		9e-15
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		9e-15
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-14
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-14
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-14
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-14
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-14
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-14
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-14
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-14
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-14
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-14
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-14
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-14
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-14
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-14
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-14
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-14
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-14
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-14
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-14
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-14
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-14
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-14
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-14
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-14
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-14
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-14
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-14
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-14
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-14
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-14
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-14
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		7e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-14
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-14
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		9e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-14
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		9e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-13
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-13
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-13
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-13
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-13
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-13
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-13
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-13
3gni_B	389	Structure Of Strad And Mo25 Length = 389		1e-13
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-13
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-13
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-13
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-13
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-13
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-13
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-13
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-13
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-13
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		3e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-13
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-13
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-13
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-13
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-13
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-13
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-13
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-13
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		8e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-13
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-13
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-13
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-13
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		9e-13
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-12
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-12
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-12
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-12
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-12
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-12
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-12
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-12
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-12
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-12
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-12
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-12
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-12
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-12
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-12
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-12
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-12
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-12
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-12
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-12
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-12
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		8e-12
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		8e-12
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		8e-12
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		8e-12
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		8e-12
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-12
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-12
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-12
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		8e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		9e-12
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-12
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		9e-12
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-12
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		9e-12
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		9e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-12
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-11
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-11
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-11
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-11
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-11
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-11
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-11
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-11
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-11
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-11
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-11
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-11
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-11
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		5e-11
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-11
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-11
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-11
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-11
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-11
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		7e-11
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		8e-11
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		8e-11
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		8e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		9e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		9e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-11
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-10
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-10
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-10
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-10
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-10
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		7e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		8e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		8e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		9e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		9e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-09
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-09
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-09
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-09
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-09
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-09
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-09
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-09
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		9e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		9e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		9e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-08
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-08
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-08
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-08
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-08
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-08
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-08
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-08
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-08
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-08
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-08
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-08
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-08
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-08
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-08
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-08
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		3e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-08
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		3e-08
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		3e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-08
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		3e-08
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		3e-08
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		3e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-08
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		4e-08
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		4e-08
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		4e-08
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-08
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		4e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-08
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		4e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-08
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		6e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		6e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		6e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		7e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		8e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		9e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		9e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		9e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		9e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		9e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-07
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-07
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		3e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-07
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-07
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-07
2v62_A	345	Structure Of Vaccinia-Related Kinase 2 Length = 345		6e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-07
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		7e-07
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		7e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		8e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-07
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		8e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-07
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		9e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		9e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		9e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		9e-07
2chl_A	351	Structure Of Casein Kinase 1 Gamma 3 Length = 351		1e-06
2izr_A	330	Structure Of Casein Kinase Gamma 3 In Complex With		1e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-06
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-06
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		1e-06
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-06
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-06
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-06
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-06
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-06
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-06
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-06
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-06
2csn_A	297	Binary Complex Of Casein Kinase-1 With Cki7 Length		2e-06
1eh4_A	298	Binary Complex Of Casein Kinase-1 From S. Pombe Wit		2e-06
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-06
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-06
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-06
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-06
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-06
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-06
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-06
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-06
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-06
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		6e-06
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-06
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-06
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-06
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		7e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-06
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		8e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		8e-06
2lav_A	361	Nmr Solution Structure Of Human Vaccinia-Related Ki		8e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		9e-06
2kty_A	368	Solution Structure Of Human Vaccinia Related Kinase		9e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		9e-06
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		1e-05
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-05
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-05
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-05
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-05
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-05
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-05
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-05
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-05
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-05
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-05
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-05
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-05
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-05
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-05
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-05
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-05
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-05
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-05
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-05
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-05
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-05

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  147 bits (372), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 102/274 (37%), Positives = 144/274 (52%), Gaps = 16/274 (5%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFL----QREQRILSALACPQIV 58
           +T+   IG+GS   V  G+ N + EV A+K  +L  +E      Q+E  +LS    P I 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
            Y G  +      I+    +EY  GG+  D ++ G  LEE  I +  R +L GL YLHS 
Sbjct: 81  RYFGSYLKSTKLWII----MEYLGGGSALDLLKPGP-LEETYIATILREILKGLDYLHSE 135
Query: 119 GIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
             +H DIK  N+L+S   EQG  K+ADFG A +   +   +     GTP  MAPEV +  
Sbjct: 136 RKIHRDIKAANVLLS---EQGDVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIKQS 191
Query: 178 EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
              F AD+W+LG T +E+A G PP  D+  P+  L  I  +S  P + G  SK  ++F+ 
Sbjct: 192 AYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNS-PPTLEGQHSKPFKEFVE 249
Query: 238 KCLIRNPGERWSASELLEHGFVKEQNFKLSTLTE 271
            CL ++P  R +A ELL+H F+     K S LTE
Sbjct: 250 ACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTE 283

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 99/271 (36%), Positives = 149/271 (54%), Gaps = 18/271 (6%)
Query: 8   TIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF---LQREQRILSALACPQIVAYKGCD 64
            +G+G+   V  G    +    A+K     +S +   L  E  +   L    IV Y G  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS- 87
Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRS--GTCLE-EGRIRSHTRAVLLGLQYLHSNGIV 121
              ENG I   +F+E  PGG+L+  +RS  G   + E  I  +T+ +L GL+YLH N IV
Sbjct: 88  -FSENGFI--KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 122 HCDIKGQNILVSKDNEQGA-KIADFGCARR-ARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           H DIKG N+L+  +   G  KI+DFG ++R A +N   E     GT   MAPE+     +
Sbjct: 145 HRDIKGDNVLI--NTYSGVLKISDFGTSKRLAGINPCTE--TFTGTLQYMAPEIIDKGPR 200
Query: 180 GF--PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
           G+   AD+W+LGCT++EMATG+PP+ ++ +P +A+ ++G     PEIP  MS +A+ F+ 
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFIL 260
Query: 238 KCLIRNPGERWSASELLEHGFVKEQNFKLST 268
           KC   +P +R  A++LL   F+K  + K  T
Sbjct: 261 KCFEPDPDKRACANDLLVDEFLKVSSKKKKT 291

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 97/263 (36%), Positives = 146/263 (55%), Gaps = 18/263 (6%)
Query: 8   TIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF---LQREQRILSALACPQIVAYKGCD 64
            +G+G+   V  G    +    A+K     +S +   L  E  +   L    IV Y G  
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS- 73
Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRS--GTCLE-EGRIRSHTRAVLLGLQYLHSNGIV 121
              ENG I   +F+E  PGG+L+  +RS  G   + E  I  +T+ +L GL+YLH N IV
Sbjct: 74  -FSENGFI--KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 130
Query: 122 HCDIKGQNILVSKDNEQGA-KIADFGCARR-ARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           H DIKG N+L+  +   G  KI+DFG ++R A +N   E     GT   MAPE+     +
Sbjct: 131 HRDIKGDNVLI--NTYSGVLKISDFGTSKRLAGINPCTE--TFTGTLQYMAPEIIDKGPR 186
Query: 180 GF--PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
           G+   AD+W+LGCT++EMATG+PP+ ++ +P +A+ ++G     PEIP  MS +A+ F+ 
Sbjct: 187 GYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFIL 246
Query: 238 KCLIRNPGERWSASELLEHGFVK 260
           KC   +P +R  A++LL   F+K
Sbjct: 247 KCFEPDPDKRACANDLLVDEFLK 269

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  144 bits (363), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 95/273 (34%), Positives = 144/273 (52%), Gaps = 14/273 (5%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFL----QREQRILSALACPQIV 58
           +T+ + IG+GS   V  G+ NR+ +V A+K  +L  +E      Q+E  +LS    P + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
            Y G  + +    I+    +EY  GG+  D +  G  L+E +I +  R +L GL YLHS 
Sbjct: 89  KYYGSYLKDTKLWII----MEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSE 143
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
             +H DIK  N+L+S+  E   K+ADFG A +   +   +     GTP  MAPEV +   
Sbjct: 144 KKIHRDIKAANVLLSEHGE--VKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIKQSA 200
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK 238
               AD+W+LG T +E+A G PP  ++  P+  L  I   ++ P + G  SK  ++F+  
Sbjct: 201 YDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEA 258
Query: 239 CLIRNPGERWSASELLEHGFVKEQNFKLSTLTE 271
           CL + P  R +A ELL+H F+     K S LTE
Sbjct: 259 CLNKEPSFRPTAKELLKHKFILRNAKKTSYLTE 291

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 95/273 (34%), Positives = 144/273 (52%), Gaps = 14/273 (5%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFL----QREQRILSALACPQIV 58
           +T+ + IG+GS   V  G+ NR+ +V A+K  +L  +E      Q+E  +LS    P + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
            Y G  + +    I+    +EY  GG+  D +  G  L+E +I +  R +L GL YLHS 
Sbjct: 69  KYYGSYLKDTKLWII----MEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSE 123
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
             +H DIK  N+L+S+  E   K+ADFG A +   +   +     GTP  MAPEV +   
Sbjct: 124 KKIHRDIKAANVLLSEHGE--VKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIKQSA 180
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK 238
               AD+W+LG T +E+A G PP  ++  P+  L  I   ++ P + G  SK  ++F+  
Sbjct: 181 YDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEA 238
Query: 239 CLIRNPGERWSASELLEHGFVKEQNFKLSTLTE 271
           CL + P  R +A ELL+H F+     K S LTE
Sbjct: 239 CLNKEPSFRPTAKELLKHKFILRNAKKTSYLTE 271

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 95/273 (34%), Positives = 144/273 (52%), Gaps = 14/273 (5%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFL----QREQRILSALACPQIV 58
           +T+ + IG+GS   V  G+ NR+ +V A+K  +L  +E      Q+E  +LS    P + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
            Y G  + +    I+    +EY  GG+  D +  G  L+E +I +  R +L GL YLHS 
Sbjct: 84  KYYGSYLKDTKLWII----MEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSE 138
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
             +H DIK  N+L+S+  E   K+ADFG A +   +   +     GTP  MAPEV +   
Sbjct: 139 KKIHRDIKAANVLLSEHGE--VKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIKQSA 195
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK 238
               AD+W+LG T +E+A G PP  ++  P+  L  I   ++ P + G  SK  ++F+  
Sbjct: 196 YDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEA 253
Query: 239 CLIRNPGERWSASELLEHGFVKEQNFKLSTLTE 271
           CL + P  R +A ELL+H F+     K S LTE
Sbjct: 254 CLNKEPSFRPTAKELLKHKFILRNAKKTSYLTE 286

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 97/274 (35%), Positives = 149/274 (54%), Gaps = 16/274 (5%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFL----QREQRILSALACPQIV 58
           +T+ + IG+GS   V  G+ NR+ +V A+K  +L  +E      Q+E  +LS      + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
            Y G   S   G  L+ + +EY  GG+  D +R+G   +E +I +  + +L GL YLHS 
Sbjct: 85  KYYG---SYLKGSKLW-IIMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYLHSE 139
Query: 119 GIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
             +H DIK  N+L+S   EQG  K+ADFG A +   +   +     GTP  MAPEV +  
Sbjct: 140 KKIHRDIKAANVLLS---EQGDVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIQQS 195
Query: 178 EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
                AD+W+LG T +E+A G PP  D+  P+  L  I   ++ P + G  +K  ++F+ 
Sbjct: 196 AYDSKADIWSLGITAIELAKGEPPNSDM-HPMRVLFLIP-KNNPPTLVGDFTKSFKEFID 253
Query: 238 KCLIRNPGERWSASELLEHGFVKEQNFKLSTLTE 271
            CL ++P  R +A ELL+H F+ + + K S LTE
Sbjct: 254 ACLNKDPSFRPTAKELLKHKFIVKNSKKTSYLTE 287

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 95/273 (34%), Positives = 144/273 (52%), Gaps = 14/273 (5%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFL----QREQRILSALACPQIV 58
           +T+ + IG+GS   V  G+ NR+ +V A+K  +L  +E      Q+E  +LS    P + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
            Y G  + +    I+    +EY  GG+  D +  G  L+E +I +  R +L GL YLHS 
Sbjct: 69  KYYGSYLKDTKLWII----MEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSE 123
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
             +H DIK  N+L+S+  E   K+ADFG A +   +   +     GTP  MAPEV +   
Sbjct: 124 KKIHRDIKAANVLLSEHGE--VKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIKQSA 180
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK 238
               AD+W+LG T +E+A G PP  ++  P+  L  I   ++ P + G  SK  ++F+  
Sbjct: 181 YDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEA 238
Query: 239 CLIRNPGERWSASELLEHGFVKEQNFKLSTLTE 271
           CL + P  R +A ELL+H F+     K S LTE
Sbjct: 239 CLNKEPSFRPTAKELLKHKFILRNAKKTSYLTE 271

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 93/264 (35%), Positives = 145/264 (54%), Gaps = 17/264 (6%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---NSEFLQREQRILSALACPQIVA 59
           +TR + IG+G++ TV   M   + +  A++   L      E +  E  ++     P IV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           Y    +    G  L+ + +EY  GG+LTD + + TC++EG+I +  R  L  L++LHSN 
Sbjct: 82  YLDSYLV---GDELW-VVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           ++H DIK  NIL+  D     K+ DFG CA+     E  +   + GTP  MAPEV   + 
Sbjct: 137 VIHRDIKSDNILLGMDG--SVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMSKQAQDFL 236
            G   D+W+LG   +EM  G PP+ +  +P+ AL+ I  ++ TPE+  P  +S   +DFL
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIA-TNGTPELQNPEKLSAIFRDFL 250
Query: 237 SKCLIRNPGERWSASELLEHGFVK 260
           ++CL  +  +R SA ELL+H F+K
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 93/264 (35%), Positives = 145/264 (54%), Gaps = 17/264 (6%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---NSEFLQREQRILSALACPQIVA 59
           +TR + IG+G++ TV   M   + +  A++   L      E +  E  ++     P IV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           Y    +    G  L+ + +EY  GG+LTD + + TC++EG+I +  R  L  L++LHSN 
Sbjct: 82  YLDSYLV---GDELW-VVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           ++H DIK  NIL+  D     K+ DFG CA+     E  +   + GTP  MAPEV   + 
Sbjct: 137 VIHRDIKSDNILLGMDG--SVKLTDFGFCAQITP--EQSKRSEMVGTPYWMAPEVVTRKA 192
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMSKQAQDFL 236
            G   D+W+LG   +EM  G PP+ +  +P+ AL+ I  ++ TPE+  P  +S   +DFL
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIA-TNGTPELQNPEKLSAIFRDFL 250
Query: 237 SKCLIRNPGERWSASELLEHGFVK 260
           ++CL  +  +R SA ELL+H F+K
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 93/264 (35%), Positives = 145/264 (54%), Gaps = 17/264 (6%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---NSEFLQREQRILSALACPQIVA 59
           +TR + IG+G++ TV   M   + +  A++   L      E +  E  ++     P IV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           Y    +    G  L+ + +EY  GG+LTD + + TC++EG+I +  R  L  L++LHSN 
Sbjct: 82  YLDSYLV---GDELW-VVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           ++H DIK  NIL+  D     K+ DFG CA+     E  +   + GTP  MAPEV   + 
Sbjct: 137 VIHRDIKSDNILLGMDG--SVKLTDFGFCAQITP--EQSKRSXMVGTPYWMAPEVVTRKA 192
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMSKQAQDFL 236
            G   D+W+LG   +EM  G PP+ +  +P+ AL+ I  ++ TPE+  P  +S   +DFL
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIA-TNGTPELQNPEKLSAIFRDFL 250
Query: 237 SKCLIRNPGERWSASELLEHGFVK 260
           ++CL  +  +R SA ELL+H F+K
Sbjct: 251 NRCLEMDVEKRGSAKELLQHQFLK 274

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 92/264 (34%), Positives = 145/264 (54%), Gaps = 17/264 (6%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---NSEFLQREQRILSALACPQIVA 59
           +TR + IG+G++ TV   M   + +  A++   L      E +  E  ++     P IV 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           Y    +    G  L+ + +EY  GG+LTD + + TC++EG+I +  R  L  L++LHSN 
Sbjct: 83  YLDSYLV---GDELW-VVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           ++H DIK  NIL+  D     K+ DFG CA+     E  +   + GTP  MAPEV   + 
Sbjct: 138 VIHRDIKSDNILLGMDG--SVKLTDFGFCAQIT--PEQSKRSXMVGTPYWMAPEVVTRKA 193
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMSKQAQDFL 236
            G   D+W+LG   +EM  G PP+ +  +P+ AL+ I  ++ TPE+  P  +S   +DFL
Sbjct: 194 YGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIA-TNGTPELQNPEKLSAIFRDFL 251
Query: 237 SKCLIRNPGERWSASELLEHGFVK 260
           ++CL  +  +R SA EL++H F+K
Sbjct: 252 NRCLEMDVEKRGSAKELIQHQFLK 275

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  140 bits (354), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 91/264 (34%), Positives = 145/264 (54%), Gaps = 17/264 (6%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---NSEFLQREQRILSALACPQIVA 59
           +TR + IG+G++ TV   M   + +  A++   L      E +  E  ++     P IV 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           Y    +    G  L+ + +EY  GG+LTD + + TC++EG+I +  R  L  L++LHSN 
Sbjct: 83  YLDSYLV---GDELW-VVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           ++H +IK  NIL+  D     K+ DFG CA+     E  +   + GTP  MAPEV   + 
Sbjct: 138 VIHRNIKSDNILLGMDG--SVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKA 193
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMSKQAQDFL 236
            G   D+W+LG   +EM  G PP+ +  +P+ AL+ I  ++ TPE+  P  +S   +DFL
Sbjct: 194 YGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIA-TNGTPELQNPEKLSAIFRDFL 251
Query: 237 SKCLIRNPGERWSASELLEHGFVK 260
           ++CL  +  +R SA EL++H F+K
Sbjct: 252 NRCLEMDVEKRGSAKELIQHQFLK 275

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 83/257 (32%), Positives = 137/257 (53%), Gaps = 11/257 (4%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQREQRILSALACPQIVAYKGCDI 65
           + +G GS  +V   +   + ++ A+K   + S+ + + +E  I+     P +V Y G   
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 66  SEENGKILYNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
              +  I+    +EY   G+++D IR     L E  I +  ++ L GL+YLH    +H D
Sbjct: 95  KNTDLWIV----MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRD 150
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPAD 184
           IK  NIL+  + E  AK+ADFG A +   +   +   + GTP  MAPEV +       AD
Sbjct: 151 IKAGNILL--NTEGHAKLADFGVAGQL-TDXMAKRNXVIGTPFWMAPEVIQEIGYNCVAD 207
Query: 185 VWALGCTVLEMATGRPPWPDVADPISALHRIGFS-SDTPEIPGYMSKQAQDFLSKCLIRN 243
           +W+LG T +EMA G+PP+ D+  P+ A+  I  +   T   P   S    DF+ +CL+++
Sbjct: 208 IWSLGITAIEMAEGKPPYADI-HPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKS 266
Query: 244 PGERWSASELLEHGFVK 260
           P +R +A++LL+H FV+
Sbjct: 267 PEQRATATQLLQHPFVR 283

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 93/281 (33%), Positives = 141/281 (50%), Gaps = 21/281 (7%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNS---EFLQREQRILSALACPQIV-AYKGCD 64
           IG GST  V +     S    AVK  +L      E L  E  I+       +V  YK   
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           + EE       + +E+  GG LTD + S   L E +I +   AVL  L YLH+ G++H D
Sbjct: 113 VGEE-----LWVLMEFLQGGALTDIV-SQVRLNEEQIATVCEAVLQALAYLHAQGVIHRD 166
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPA 183
           IK  +IL++ D     K++DFG    A++++D  + K + GTP  MAPEV          
Sbjct: 167 IKSDSILLTLDGR--VKLSDFGFC--AQISKDVPKRKXLVGTPYWMAPEVISRSLYATEV 222
Query: 184 DVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPG--YMSKQAQDFLSKCL 240
           D+W+LG  V+EM  G PP+   +D P+ A+ R+   S  P++     +S   +DFL + L
Sbjct: 223 DIWSLGIMVIEMVDGEPPY--FSDSPVQAMKRLR-DSPPPKLKNSHKVSPVLRDFLERML 279
Query: 241 IRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPT 281
           +R+P ER +A ELL+H F+ +       +   + Y  ++ T
Sbjct: 280 VRDPQERATAQELLDHPFLLQTGLPECLVPLIQLYRKQTST 320

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 130/271 (47%), Gaps = 20/271 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACP 55
           D+   + +G+GS   V +    ++++ FA+K+ +        + E    E+R+LS     
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 56  QIVAYKGCDISEENGKILYNLF--LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
             + +  C    +      NLF  +EY  GG L   I+S    +  R   +   ++LGLQ
Sbjct: 78  PFLTHMFCTFQTKE-----NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 132
Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
           +LHS GIV+ D+K  NIL+ KD     KIADFG  +   +  D +    CGTP  +APE+
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLG-DAKTNXFCGTPDYIAPEI 189
Query: 174 ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
             G++     D W+ G  + EM  G+ P+    D     H I    D P  P ++ K+A+
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSI--RMDNPFYPRWLEKEAK 246
Query: 234 DFLSKCLIRNPGERWSAS-ELLEHGFVKEQN 263
           D L K  +R P +R     ++ +H   +E N
Sbjct: 247 DLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 130/271 (47%), Gaps = 20/271 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACP 55
           D+   + +G+GS   V +    ++++ FA+K+ +        + E    E+R+LS     
Sbjct: 19  DFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 78
Query: 56  QIVAYKGCDISEENGKILYNLF--LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
             + +  C    +      NLF  +EY  GG L   I+S    +  R   +   ++LGLQ
Sbjct: 79  PFLTHMFCTFQTKE-----NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 133
Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
           +LHS GIV+ D+K  NIL+ KD     KIADFG  +   +  D +    CGTP  +APE+
Sbjct: 134 FLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLG-DAKTNEFCGTPDYIAPEI 190
Query: 174 ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
             G++     D W+ G  + EM  G+ P+    D     H I    D P  P ++ K+A+
Sbjct: 191 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSI--RMDNPFYPRWLEKEAK 247
Query: 234 DFLSKCLIRNPGERWSAS-ELLEHGFVKEQN 263
           D L K  +R P +R     ++ +H   +E N
Sbjct: 248 DLLVKLFVREPEKRLGVRGDIRQHPLFREIN 278

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 137/263 (52%), Gaps = 29/263 (11%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEE 68
           IG GST  V I     S ++ AVK  +L      +++QR    L   ++V  +  D   E
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDL------RKQQR--RELLFNEVVIMR--DYQHE 77
Query: 69  NGKILYNLFL---------EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           N   +YN +L         E+  GG LTD + + T + E +I +   AVL  L  LH+ G
Sbjct: 78  NVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLQALSVLHAQG 136
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           ++H DIK  +IL++ D     K++DFG CA+ ++  E    K + GTP  MAPE+     
Sbjct: 137 VIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISRLP 192
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY--MSKQAQDFL 236
            G   D+W+LG  V+EM  G PP+ +   P+ A+  I   +  P +     +S   + FL
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIR-DNLPPRLKNLHKVSPSLKGFL 250
Query: 237 SKCLIRNPGERWSASELLEHGFV 259
            + L+R+P +R +A+ELL+H F+
Sbjct: 251 DRLLVRDPAQRATAAELLKHPFL 273

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 137/263 (52%), Gaps = 29/263 (11%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEE 68
           IG GST  V I     S ++ AVK  +L      +++QR    L   ++V  +  D   E
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDL------RKQQR--RELLFNEVVIMR--DYQHE 81
Query: 69  NGKILYNLFL---------EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           N   +YN +L         E+  GG LTD + + T + E +I +   AVL  L  LH+ G
Sbjct: 82  NVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLQALSVLHAQG 140
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           ++H DIK  +IL++ D     K++DFG CA+ ++  E    K + GTP  MAPE+     
Sbjct: 141 VIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISRLP 196
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY--MSKQAQDFL 236
            G   D+W+LG  V+EM  G PP+ +   P+ A+  I   +  P +     +S   + FL
Sbjct: 197 YGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIR-DNLPPRLKNLHKVSPSLKGFL 254
Query: 237 SKCLIRNPGERWSASELLEHGFV 259
            + L+R+P +R +A+ELL+H F+
Sbjct: 255 DRLLVRDPAQRATAAELLKHPFL 277

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 137/263 (52%), Gaps = 29/263 (11%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEE 68
           IG GST  V I     S ++ AVK  +L      +++QR    L   ++V  +  D   E
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDL------RKQQR--RELLFNEVVIMR--DYQHE 88
Query: 69  NGKILYNLFL---------EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           N   +YN +L         E+  GG LTD + + T + E +I +   AVL  L  LH+ G
Sbjct: 89  NVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLQALSVLHAQG 147
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           ++H DIK  +IL++ D     K++DFG CA+ ++  E    K + GTP  MAPE+     
Sbjct: 148 VIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISRLP 203
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY--MSKQAQDFL 236
            G   D+W+LG  V+EM  G PP+ +   P+ A+  I   +  P +     +S   + FL
Sbjct: 204 YGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIR-DNLPPRLKNLHKVSPSLKGFL 261
Query: 237 SKCLIRNPGERWSASELLEHGFV 259
            + L+R+P +R +A+ELL+H F+
Sbjct: 262 DRLLVRDPAQRATAAELLKHPFL 284

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 137/263 (52%), Gaps = 29/263 (11%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEE 68
           IG GST  V I     S ++ AVK  +L      +++QR    L   ++V  +  D   E
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDL------RKQQR--RELLFNEVVIMR--DYQHE 86
Query: 69  NGKILYNLFL---------EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           N   +YN +L         E+  GG LTD + + T + E +I +   AVL  L  LH+ G
Sbjct: 87  NVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLQALSVLHAQG 145
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           ++H DIK  +IL++ D     K++DFG CA+ ++  E    K + GTP  MAPE+     
Sbjct: 146 VIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISRLP 201
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY--MSKQAQDFL 236
            G   D+W+LG  V+EM  G PP+ +   P+ A+  I   +  P +     +S   + FL
Sbjct: 202 YGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIR-DNLPPRLKNLHKVSPSLKGFL 259
Query: 237 SKCLIRNPGERWSASELLEHGFV 259
            + L+R+P +R +A+ELL+H F+
Sbjct: 260 DRLLVRDPAQRATAAELLKHPFL 282

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 135/265 (50%), Gaps = 17/265 (6%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQ---RILSALACP 55
           D+  G  +G+GS A V    S  +    A+K  +   +  +  +QR Q   +I   L  P
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTC-LEEGRIRSHTRAVLLGLQY 114
            I+         E+   +Y L LE    G +   +++      E   R     ++ G+ Y
Sbjct: 72  SILELYN---YFEDSNYVY-LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127
Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           LHS+GI+H D+   N+L++++     KIADFG A + ++   ++   +CGTP  ++PE+A
Sbjct: 128 LHSHGILHRDLTLSNLLLTRN--MNIKIADFGLATQLKM-PHEKHYTLCGTPNYISPEIA 184
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD 234
                G  +DVW+LGC    +  GRPP+ D     + L+++  +    E+P ++S +A+D
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPF-DTDTVKNTLNKVVLAD--YEMPSFLSIEAKD 241
Query: 235 FLSKCLIRNPGERWSASELLEHGFV 259
            + + L RNP +R S S +L+H F+
Sbjct: 242 LIHQLLRRNPADRLSLSSVLDHPFM 266

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 87/263 (33%), Positives = 136/263 (51%), Gaps = 29/263 (11%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEE 68
           IG GST  V I     S ++ AVK  +L      QR + + +     ++V  +  D   E
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFN-----EVVIMR--DYQHE 131
Query: 69  NGKILYNLFL---------EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           N   +YN +L         E+  GG LTD + + T + E +I +   AVL  L  LH+ G
Sbjct: 132 NVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLQALSVLHAQG 190
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           ++H DIK  +IL++ D     K++DFG CA+ ++  E    K + GTP  MAPE+     
Sbjct: 191 VIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISRLP 246
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY--MSKQAQDFL 236
            G   D+W+LG  V+EM  G PP+ +   P+ A+  I   +  P +     +S   + FL
Sbjct: 247 YGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIR-DNLPPRLKNLHKVSPSLKGFL 304
Query: 237 SKCLIRNPGERWSASELLEHGFV 259
            + L+R+P +R +A+ELL+H F+
Sbjct: 305 DRLLVRDPAQRATAAELLKHPFL 327

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 136/264 (51%), Gaps = 29/264 (10%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEE 68
           IG GST  V I     + +  AVK  +L      +++QR    L   ++V  +  D   +
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDL------RKQQR--RELLFNEVVIMR--DYHHD 102
Query: 69  NGKILYNLFL---------EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           N   +Y+ +L         E+  GG LTD + + T + E +I +   +VL  L YLH+ G
Sbjct: 103 NVVDMYSSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIATVCLSVLRALSYLHNQG 161
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           ++H DIK  +IL++ D     K++DFG CA+ ++  E  + K + GTP  MAPEV     
Sbjct: 162 VIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSK--EVPKRKXLVGTPYWMAPEVISRLP 217
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY--MSKQAQDFL 236
            G   D+W+LG  V+EM  G PP+ +   P+ A+ RI   S  P +     +S   + FL
Sbjct: 218 YGTEVDIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIR-DSLPPRVKDLHKVSSVLRGFL 275
Query: 237 SKCLIRNPGERWSASELLEHGFVK 260
              L+R P +R +A ELL H F+K
Sbjct: 276 DLMLVREPSQRATAQELLGHPFLK 299

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 87/263 (33%), Positives = 136/263 (51%), Gaps = 29/263 (11%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEE 68
           IG GST  V I     S ++ AVK  +L      QR + + +     ++V  +  D   E
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFN-----EVVIMR--DYQHE 208
Query: 69  NGKILYNLFL---------EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           N   +YN +L         E+  GG LTD + + T + E +I +   AVL  L  LH+ G
Sbjct: 209 NVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLQALSVLHAQG 267
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           ++H DIK  +IL++ D     K++DFG CA+ ++  E    K + GTP  MAPE+     
Sbjct: 268 VIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISRLP 323
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY--MSKQAQDFL 236
            G   D+W+LG  V+EM  G PP+ +   P+ A+  I   +  P +     +S   + FL
Sbjct: 324 YGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIR-DNLPPRLKNLHKVSPSLKGFL 381
Query: 237 SKCLIRNPGERWSASELLEHGFV 259
            + L+R+P +R +A+ELL+H F+
Sbjct: 382 DRLLVRDPAQRATAAELLKHPFL 404

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 143/269 (53%), Gaps = 18/269 (6%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALACPQ-IVAYKGC 63
           + +G G+   V  G   ++ ++ A+K  +++    E +++E  +L   +  + I  Y G 
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 64  DISEENGKILYNLFL--EYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNG 119
            I +    +   L+L  E+   G++TD I++  G  L+E  I    R +L GL +LH + 
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK 149
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED-DEGKPICGTPICMAPEVARGEE 178
           ++H DIKGQN+L++++ E   K+ DFG +  A+++          GTP  MAPEV   +E
Sbjct: 150 VIHRDIKGQNVLLTENAE--VKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPEVIACDE 205
Query: 179 Q-----GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
                  F +D+W+LG T +EMA G PP  D+  P+ AL  I  +          SK+ Q
Sbjct: 206 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNPAPRLKSKKWSKKFQ 264
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQ 262
            F+  CL++N  +R +  +L++H F+++Q
Sbjct: 265 SFIESCLVKNHSQRPATEQLMKHPFIRDQ 293

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 90/263 (34%), Positives = 134/263 (50%), Gaps = 27/263 (10%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVK----SAELSNSEF--LQREQRILSALACPQIVAYKG 62
           IG GS   V      R+SEV A+K    S + SN ++  + +E R L  L  P  + Y+G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
           C + E        L +EY  G            L+E  I + T   L GL YLHS+ ++H
Sbjct: 83  CYLREHTAW----LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 138
Query: 123 CDIKGQNILVSKDNEQG-AKIADFGCAR-RARVNEDDEGKPICGTPICMAPEVARGEEQG 180
            D+K  NIL+S   E G  K+ DFG A   A  N         GTP  MAPEV    ++G
Sbjct: 139 RDVKAGNILLS---EPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVILAMDEG 189
Query: 181 F---PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI-PGYMSKQAQDFL 236
                 DVW+LG T +E+A  +PP  ++ + +SAL+ I   +++P +  G+ S+  ++F+
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIA-QNESPALQSGHWSEYFRNFV 247
Query: 237 SKCLIRNPGERWSASELLEHGFV 259
             CL + P +R ++  LL+H FV
Sbjct: 248 DSCLQKIPQDRPTSEVLLKHRFV 270

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/262 (33%), Positives = 130/262 (49%), Gaps = 25/262 (9%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVK----SAELSNSEF--LQREQRILSALACPQIVAYKG 62
           IG GS   V      R+SEV A+K    S + SN ++  + +E R L  L  P  + Y+G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
           C + E        L +EY  G            L+E  I + T   L GL YLHS+ ++H
Sbjct: 122 CYLREHTAW----LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 177
Query: 123 CDIKGQNILVSKDNEQG-AKIADFGCAR-RARVNEDDEGKPICGTPICMAPEVARGEEQG 180
            D+K  NIL+S   E G  K+ DFG A   A  N         GTP  MAPEV    ++G
Sbjct: 178 RDVKAGNILLS---EPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVILAMDEG 228
Query: 181 F---PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
                 DVW+LG T +E+A  +PP  ++ + +SAL+ I  +       G+ S+  ++F+ 
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFRNFVD 287
Query: 238 KCLIRNPGERWSASELLEHGFV 259
            CL + P +R ++  LL+H FV
Sbjct: 288 SCLQKIPQDRPTSEVLLKHRFV 309

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 90/270 (33%), Positives = 133/270 (49%), Gaps = 24/270 (8%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR---EQRILSALACPQIVA 59
           W     +G G+   V    +  +S + A K  +  + E L+    E  IL++   P IV 
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHS 117
                  E N  IL    +E+  GG + DA+       L E +I+   +  L  L YLH 
Sbjct: 99  LLDAFYYENNLWIL----IEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGC-ARRARVNEDDEGKPICGTPICMAPEV--- 173
           N I+H D+K  NIL + D +   K+ADFG  A+  R  +  +     GTP  MAPEV   
Sbjct: 154 NKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMC 209
Query: 174 --ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMS 229
             ++     + ADVW+LG T++EMA   PP  ++ +P+  L +I   S+ P +  P   S
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIA-KSEPPTLAQPSRWS 267
Query: 230 KQAQDFLSKCLIRNPGERWSASELLEHGFV 259
              +DFL KCL +N   RW+ S+LL+H FV
Sbjct: 268 SNFKDFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 89/292 (30%), Positives = 137/292 (46%), Gaps = 38/292 (13%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL----SNSEFLQREQRILSALACPQI 57
           D+   + IG G+TA V         E  A+K   L    ++ + L +E + +S    P I
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIR--------SGTCLEEGRIRSHTRAVL 109
           V+Y    + ++   ++  L      GG++ D I+            L+E  I +  R VL
Sbjct: 76  VSYYTSFVVKDELWLVMKLL----SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 110 LGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGC----ARRARVNEDDEGKPICGT 165
            GL+YLH NG +H D+K  NIL+ +D     +IADFG     A    +  +   K   GT
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDG--SVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 166 PICMAPEV---ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP 222
           P  MAPEV    RG +  F AD+W+ G T +E+ATG  P+     P+  L  +   +D P
Sbjct: 190 PCWMAPEVMEQVRGYD--FKADIWSFGITAIELATGAAPYHKYP-PMKVL-MLTLQNDPP 245
Query: 223 ---------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK 265
                    E+     K  +  +S CL ++P +R +A+ELL H F ++   K
Sbjct: 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 90/270 (33%), Positives = 133/270 (49%), Gaps = 24/270 (8%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR---EQRILSALACPQIVA 59
           W     +G G+   V    +  +S + A K  +  + E L+    E  IL++   P IV 
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHS 117
                  E N  IL    +E+  GG + DA+       L E +I+   +  L  L YLH 
Sbjct: 99  LLDAFYYENNLWIL----IEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGC-ARRARVNEDDEGKPICGTPICMAPEV--- 173
           N I+H D+K  NIL + D +   K+ADFG  A+  R  +  +     GTP  MAPEV   
Sbjct: 154 NKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRXIQRRDS--FIGTPYWMAPEVVMC 209
Query: 174 --ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMS 229
             ++     + ADVW+LG T++EMA   PP  ++ +P+  L +I   S+ P +  P   S
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIA-KSEPPTLAQPSRWS 267
Query: 230 KQAQDFLSKCLIRNPGERWSASELLEHGFV 259
              +DFL KCL +N   RW+ S+LL+H FV
Sbjct: 268 SNFKDFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 136/288 (47%), Gaps = 38/288 (13%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL----SNSEFLQREQRILSALACPQI 57
           D+   + IG G+TA V         E  A+K   L    ++ + L +E + +S    P I
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIR--------SGTCLEEGRIRSHTRAVL 109
           V+Y    + ++   ++  L      GG++ D I+            L+E  I +  R VL
Sbjct: 71  VSYYTSFVVKDELWLVMKLL----SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 126
Query: 110 LGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGC----ARRARVNEDDEGKPICGT 165
            GL+YLH NG +H D+K  NIL+ +D     +IADFG     A    +  +   K   GT
Sbjct: 127 EGLEYLHKNGQIHRDVKAGNILLGEDG--SVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 166 PICMAPEV---ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP 222
           P  MAPEV    RG +  F AD+W+ G T +E+ATG  P+     P+  L  +   +D P
Sbjct: 185 PCWMAPEVMEQVRGYD--FKADIWSFGITAIELATGAAPYHKYP-PMKVL-MLTLQNDPP 240
Query: 223 ---------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                    E+     K  +  +S CL ++P +R +A+ELL H F ++
Sbjct: 241 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 288

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 90/270 (33%), Positives = 133/270 (49%), Gaps = 24/270 (8%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR---EQRILSALACPQIVA 59
           W     +G G+   V    +  +S + A K  +  + E L+    E  IL++   P IV 
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHS 117
                  E N  IL    +E+  GG + DA+       L E +I+   +  L  L YLH 
Sbjct: 99  LLDAFYYENNLWIL----IEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGC-ARRARVNEDDEGKPICGTPICMAPEV--- 173
           N I+H D+K  NIL + D +   K+ADFG  A+  R  +  +     GTP  MAPEV   
Sbjct: 154 NKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRXIQRRDX--FIGTPYWMAPEVVMC 209
Query: 174 --ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMS 229
             ++     + ADVW+LG T++EMA   PP  ++ +P+  L +I   S+ P +  P   S
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIA-KSEPPTLAQPSRWS 267
Query: 230 KQAQDFLSKCLIRNPGERWSASELLEHGFV 259
              +DFL KCL +N   RW+ S+LL+H FV
Sbjct: 268 SNFKDFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 137/281 (48%), Gaps = 24/281 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNR----------SSEVFAVKSAELSNSEF-LQREQRILS 50
           ++   +T+G G+   V +    +          S   FA+ SA  ++    ++ E  IL 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 51  ALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL 110
            L  P I+  K    +E+     Y + LE   GG L D +     L+E   + +   +LL
Sbjct: 71  KLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICM 169
            +QYLH NGI+H D+K +N+L+S   E    KI DFG ++   + E    + +CGTP  +
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLCGTPTYL 183
Query: 170 APEVARGE-EQGF--PADVWALGCTVLEMATGRPPWPDVADPISALHRI--GFSSDTPEI 224
           APEV       G+    D W+LG  +    +G PP+ +    +S   +I  G  +  PE+
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243
Query: 225 PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK 265
              +S++A D + K L+ +P  R++  E L H ++++++ K
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 284

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 137/281 (48%), Gaps = 24/281 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNR----------SSEVFAVKSAELSNSEF-LQREQRILS 50
           ++   +T+G G+   V +    +          S   FA+ SA  ++    ++ E  IL 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 51  ALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL 110
            L  P I+  K    +E+     Y + LE   GG L D +     L+E   + +   +LL
Sbjct: 71  KLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICM 169
            +QYLH NGI+H D+K +N+L+S   E    KI DFG ++   + E    + +CGTP  +
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLCGTPTYL 183
Query: 170 APEVARGE-EQGF--PADVWALGCTVLEMATGRPPWPDVADPISALHRI--GFSSDTPEI 224
           APEV       G+    D W+LG  +    +G PP+ +    +S   +I  G  +  PE+
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243
Query: 225 PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK 265
              +S++A D + K L+ +P  R++  E L H ++++++ K
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 284

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 137/281 (48%), Gaps = 24/281 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNR----------SSEVFAVKSAELSNSEF-LQREQRILS 50
           ++   +T+G G+   V +    +          S   FA+ SA  ++    ++ E  IL 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 51  ALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL 110
            L  P I+  K    +E+     Y + LE   GG L D +     L+E   + +   +LL
Sbjct: 71  KLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICM 169
            +QYLH NGI+H D+K +N+L+S   E    KI DFG ++   + E    + +CGTP  +
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLCGTPTYL 183
Query: 170 APEVARGE-EQGF--PADVWALGCTVLEMATGRPPWPDVADPISALHRI--GFSSDTPEI 224
           APEV       G+    D W+LG  +    +G PP+ +    +S   +I  G  +  PE+
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243
Query: 225 PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK 265
              +S++A D + K L+ +P  R++  E L H ++++++ K
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 284

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 137/281 (48%), Gaps = 24/281 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNR----------SSEVFAVKSAELSNSEF-LQREQRILS 50
           ++   +T+G G+   V +    +          S   FA+ SA  ++    ++ E  IL 
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 69
Query: 51  ALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL 110
            L  P I+  K    +E+     Y + LE   GG L D +     L+E   + +   +LL
Sbjct: 70  KLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 124
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICM 169
            +QYLH NGI+H D+K +N+L+S   E    KI DFG ++   + E    + +CGTP  +
Sbjct: 125 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLCGTPTYL 182
Query: 170 APEVARGE-EQGF--PADVWALGCTVLEMATGRPPWPDVADPISALHRI--GFSSDTPEI 224
           APEV       G+    D W+LG  +    +G PP+ +    +S   +I  G  +  PE+
Sbjct: 183 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 242
Query: 225 PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK 265
              +S++A D + K L+ +P  R++  E L H ++++++ K
Sbjct: 243 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 283

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 82/256 (32%), Positives = 133/256 (51%), Gaps = 19/256 (7%)
Query: 7   QTIGRGSTATVSIG---MSNRSSEVFAVKSAELSNSEF--LQREQRILSALACPQIVAYK 61
           +TIG+G+ A V +    ++ +   V  +   +L++S    L RE RI+  L  P IV  K
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV--K 77
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
             ++ E   K LY L +EYA GG + D + +   ++E   R+  R ++  +QY H   IV
Sbjct: 78  LFEVIETE-KTLY-LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARV-NEDDEGKPICGTPICMAPEVARGEEQG 180
           H D+K +N+L+  D +   KIADFG +      N+ DE    CG+P   APE+ +G++  
Sbjct: 136 HRDLKAENLLL--DADMNIKIADFGFSNEFTFGNKLDE---FCGSPPYAAPELFQGKKYD 190
Query: 181 FP-ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
            P  DVW+LG  +  + +G  P+ D  +      R+        IP YMS   ++ L K 
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERV--LRGKYRIPFYMSTDCENLLKKF 247
Query: 240 LIRNPGERWSASELLE 255
           LI NP +R +  ++++
Sbjct: 248 LILNPSKRGTLEQIMK 263

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 137/281 (48%), Gaps = 24/281 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNR----------SSEVFAVKSAELSNSEF-LQREQRILS 50
           ++   +T+G G+   V +    +          S   FA+ SA  ++    ++ E  IL 
Sbjct: 150 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 209
Query: 51  ALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL 110
            L  P I+  K    +E+     Y + LE   GG L D +     L+E   + +   +LL
Sbjct: 210 KLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 264
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICM 169
            +QYLH NGI+H D+K +N+L+S   E    KI DFG ++   + E    + +CGTP  +
Sbjct: 265 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLCGTPTYL 322
Query: 170 APEVARGE-EQGF--PADVWALGCTVLEMATGRPPWPDVADPISALHRI--GFSSDTPEI 224
           APEV       G+    D W+LG  +    +G PP+ +    +S   +I  G  +  PE+
Sbjct: 323 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 382
Query: 225 PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK 265
              +S++A D + K L+ +P  R++  E L H ++++++ K
Sbjct: 383 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 423

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 137/281 (48%), Gaps = 24/281 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNR----------SSEVFAVKSAELSNSEF-LQREQRILS 50
           ++   +T+G G+   V +    +          S   FA+ SA  ++    ++ E  IL 
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 76
Query: 51  ALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL 110
            L  P I+  K    +E+     Y + LE   GG L D +     L+E   + +   +LL
Sbjct: 77  KLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 131
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICM 169
            +QYLH NGI+H D+K +N+L+S   E    KI DFG ++   + E    + +CGTP  +
Sbjct: 132 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLCGTPTYL 189
Query: 170 APEVARGE-EQGF--PADVWALGCTVLEMATGRPPWPDVADPISALHRI--GFSSDTPEI 224
           APEV       G+    D W+LG  +    +G PP+ +    +S   +I  G  +  PE+
Sbjct: 190 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 249
Query: 225 PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK 265
              +S++A D + K L+ +P  R++  E L H ++++++ K
Sbjct: 250 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 290

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 137/281 (48%), Gaps = 24/281 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNR----------SSEVFAVKSAELSNSEF-LQREQRILS 50
           ++   +T+G G+   V +    +          S   FA+ SA  ++    ++ E  IL 
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 51  ALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL 110
            L  P I+  K    +E+     Y + LE   GG L D +     L+E   + +   +LL
Sbjct: 196 KLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 250
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICM 169
            +QYLH NGI+H D+K +N+L+S   E    KI DFG ++   + E    + +CGTP  +
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLCGTPTYL 308
Query: 170 APEVARGE-EQGF--PADVWALGCTVLEMATGRPPWPDVADPISALHRI--GFSSDTPEI 224
           APEV       G+    D W+LG  +    +G PP+ +    +S   +I  G  +  PE+
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368
Query: 225 PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK 265
              +S++A D + K L+ +P  R++  E L H ++++++ K
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 409

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 125/270 (46%), Gaps = 42/270 (15%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSE----FLQREQRIL-SALAC 54
           D+   + IGRGS A V +    ++  ++A+K    EL N +    ++Q E+ +   A   
Sbjct: 21  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 80
Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
           P +V    C  +E   ++ +   +EY  GG L   ++    L E   R ++  + L L Y
Sbjct: 81  PFLVGLHSCFQTE--SRLFF--VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 136
Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           LH  GI++ D+K  N+L+  D+E   K+ D+G  +   +   D     CGTP  +APE+ 
Sbjct: 137 LHERGIIYRDLKLDNVLL--DSEGHIKLTDYGMCKEG-LRPGDTTSXFCGTPNYIAPEIL 193
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE----------- 223
           RGE+ GF  D WALG  + EM  GR P+  V            SSD P+           
Sbjct: 194 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG-----------SSDNPDQNTEDYLFQVI 242
Query: 224 ------IPGYMSKQAQDFLSKCLIRNPGER 247
                 IP  MS +A   L   L ++P ER
Sbjct: 243 LEKQIRIPRSMSVKAASVLKSFLNKDPKER 272

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 137/286 (47%), Gaps = 22/286 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 35  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 94
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 95  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 150
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A  +  D+   +CGT   + PE+  
Sbjct: 151 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPSSRRDD---LCGTLDYLPPEMIE 205
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 206 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 260
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSES 279
           D +S+ L  NP +R    E+LEH ++   + K S     E+ + +S
Sbjct: 261 DLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 306

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/258 (32%), Positives = 133/258 (51%), Gaps = 23/258 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQ---REQRILSALACPQIVAYK 61
           +TIG+G+ A V +     + +  AVK  + +  NS  LQ   RE RI+  L  P IV  K
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV--K 77
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
             ++ E   K LY L +EYA GG + D + +   ++E   R+  R ++  +QY H   IV
Sbjct: 78  LFEVIETE-KTLY-LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI---CGTPICMAPEVARGEE 178
           H D+K +N+L+  D +   KIADFG +     NE   G  +   CG+P   APE+ +G++
Sbjct: 136 HRDLKAENLLL--DADMNIKIADFGFS-----NEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 179 QGFP-ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
              P  DVW+LG  +  + +G  P+ D  +      R+        IP YMS   ++ L 
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERV--LRGKYRIPFYMSTDCENLLK 245
Query: 238 KCLIRNPGERWSASELLE 255
           K LI NP +R +  ++++
Sbjct: 246 KFLILNPSKRGTLEQIMK 263

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/258 (32%), Positives = 133/258 (51%), Gaps = 23/258 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQ---REQRILSALACPQIVAYK 61
           +TIG+G+ A V +     + +  AVK  + +  NS  LQ   RE RI+  L  P IV  K
Sbjct: 13  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV--K 70
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
             ++ E   K LY L +EYA GG + D + +   ++E   R+  R ++  +QY H   IV
Sbjct: 71  LFEVIETE-KTLY-LVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIV 128
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI---CGTPICMAPEVARGEE 178
           H D+K +N+L+  D +   KIADFG +     NE   G  +   CG+P   APE+ +G++
Sbjct: 129 HRDLKAENLLL--DADMNIKIADFGFS-----NEFTFGNKLDTFCGSPPYAAPELFQGKK 181
Query: 179 QGFP-ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
              P  DVW+LG  +  + +G  P+ D  +      R+        IP YMS   ++ L 
Sbjct: 182 YDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERV--LRGKYRIPFYMSTDCENLLK 238
Query: 238 KCLIRNPGERWSASELLE 255
           K LI NP +R +  ++++
Sbjct: 239 KFLILNPSKRGTLEQIMK 256

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/258 (32%), Positives = 133/258 (51%), Gaps = 23/258 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQ---REQRILSALACPQIVAYK 61
           +TIG+G+ A V +     + +  AVK  + +  NS  LQ   RE RI+  L  P IV  K
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV--K 77
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
             ++ E   K LY L +EYA GG + D + +   ++E   R+  R ++  +QY H   IV
Sbjct: 78  LFEVIETE-KTLY-LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI---CGTPICMAPEVARGEE 178
           H D+K +N+L+  D +   KIADFG +     NE   G  +   CG+P   APE+ +G++
Sbjct: 136 HRDLKAENLLL--DADMNIKIADFGFS-----NEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 179 QGFP-ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
              P  DVW+LG  +  + +G  P+ D  +      R+        IP YMS   ++ L 
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERV--LRGKYRIPFYMSTDCENLLK 245
Query: 238 KCLIRNPGERWSASELLE 255
           K LI NP +R +  ++++
Sbjct: 246 KFLILNPSKRGTLEQIMK 263

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/258 (31%), Positives = 133/258 (51%), Gaps = 23/258 (8%)
Query: 7   QTIGRGSTATVSIG---MSNRSSEVFAVKSAELSNSEF--LQREQRILSALACPQIVAYK 61
           +TIG+G+ A V +    ++ +   V  +   +L++S    L RE RI+  L  P IV  K
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV--K 77
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
             ++ E   K LY L +EYA GG + D + +   ++E   R+  R ++  +QY H   IV
Sbjct: 78  LFEVIETE-KTLY-LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI---CGTPICMAPEVARGEE 178
           H D+K +N+L+  D +   KIADFG +     NE   G  +   CG+P   APE+ +G++
Sbjct: 136 HRDLKAENLLL--DADMNIKIADFGFS-----NEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 179 QGFP-ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
              P  DVW+LG  +  + +G  P+ D  +      R+        IP YMS   ++ L 
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERV--LRGKYRIPFYMSTDCENLLK 245
Query: 238 KCLIRNPGERWSASELLE 255
           K LI NP +R +  ++++
Sbjct: 246 KFLILNPSKRGTLEQIMK 263

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 125/270 (46%), Gaps = 42/270 (15%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSE----FLQREQRIL-SALAC 54
           D+   + IGRGS A V +    ++  ++A+K    EL N +    ++Q E+ +   A   
Sbjct: 6   DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 65
Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
           P +V    C  +E   ++ +   +EY  GG L   ++    L E   R ++  + L L Y
Sbjct: 66  PFLVGLHSCFQTE--SRLFF--VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 121
Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           LH  GI++ D+K  N+L+  D+E   K+ D+G  +   +   D     CGTP  +APE+ 
Sbjct: 122 LHERGIIYRDLKLDNVLL--DSEGHIKLTDYGMCKEG-LRPGDTTSXFCGTPNYIAPEIL 178
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE----------- 223
           RGE+ GF  D WALG  + EM  GR P+  V            SSD P+           
Sbjct: 179 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG-----------SSDNPDQNTEDYLFQVI 227
Query: 224 ------IPGYMSKQAQDFLSKCLIRNPGER 247
                 IP  +S +A   L   L ++P ER
Sbjct: 228 LEKQIRIPRSLSVKAASVLKSFLNKDPKER 257

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 85/258 (32%), Positives = 132/258 (51%), Gaps = 23/258 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQ---REQRILSALACPQIVAYK 61
           +TIG+G+ A V +     + +  AVK  + +  NS  LQ   RE RI+  L  P IV  K
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV--K 77
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
             ++ E   K LY L +EYA GG + D + +   ++E   R+  R ++  +QY H   IV
Sbjct: 78  LFEVIETE-KTLY-LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI---CGTPICMAPEVARGEE 178
           H D+K +N+L+  D +   KIADFG +     NE   G  +   CG P   APE+ +G++
Sbjct: 136 HRDLKAENLLL--DADMNIKIADFGFS-----NEFTFGNKLDAFCGAPPYAAPELFQGKK 188
Query: 179 QGFP-ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
              P  DVW+LG  +  + +G  P+ D  +      R+        IP YMS   ++ L 
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERV--LRGKYRIPFYMSTDCENLLK 245
Query: 238 KCLIRNPGERWSASELLE 255
           K LI NP +R +  ++++
Sbjct: 246 KFLILNPSKRGTLEQIMK 263

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 129/266 (48%), Gaps = 22/266 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 72  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A  +  D+   +CGT   + PE+  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPSSRRDD---LCGTLDYLPPEMIE 182
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 237
Query: 234 DFLSKCLIRNPGERWSASELLEHGFV 259
           D +S+ L  NP +R    E+LEH ++
Sbjct: 238 DLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 125/270 (46%), Gaps = 42/270 (15%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSE----FLQREQRIL-SALAC 54
           D+   + IGRGS A V +    ++  ++A+K    EL N +    ++Q E+ +   A   
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
           P +V    C  +E   ++ +   +EY  GG L   ++    L E   R ++  + L L Y
Sbjct: 70  PFLVGLHSCFQTE--SRLFF--VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           LH  GI++ D+K  N+L+  D+E   K+ D+G  +   +   D     CGTP  +APE+ 
Sbjct: 126 LHERGIIYRDLKLDNVLL--DSEGHIKLTDYGMCKEG-LRPGDTTSXFCGTPNYIAPEIL 182
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE----------- 223
           RGE+ GF  D WALG  + EM  GR P+  V            SSD P+           
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG-----------SSDNPDQNTEDYLFQVI 231
Query: 224 ------IPGYMSKQAQDFLSKCLIRNPGER 247
                 IP  +S +A   L   L ++P ER
Sbjct: 232 LEKQIRIPRSLSVKAASVLKSFLNKDPKER 261

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 128/268 (47%), Gaps = 18/268 (6%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQR-----ILSALACPQI 57
           + R Q IG GS     +  S      + +K   +S     +RE+      +L+ +  P I
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYL 115
           V Y+  +  EENG +   + ++Y  GG L   I  + G   +E +I      + L L+++
Sbjct: 86  VQYR--ESFEENGSLY--IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPIC-GTPICMAPEVA 174
           H   I+H DIK QNI ++KD     ++ DFG AR   +N   E    C GTP  ++PE+ 
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARV--LNSTVELARACIGTPYYLSPEIC 197
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD 234
             +     +D+WALGC + E+ T +  +   A  +  L     S   P +  + S   + 
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHAFE--AGSMKNLVLKIISGSFPPVSLHYSYDLRS 255
Query: 235 FLSKCLIRNPGERWSASELLEHGFVKEQ 262
            +S+   RNP +R S + +LE GF+ ++
Sbjct: 256 LVSQLFKRNPRDRPSVNSILEKGFIAKR 283

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 136/286 (47%), Gaps = 22/286 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 69  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A  +   E   +CGT   + PE+  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPSSRRTE---LCGTLDYLPPEMIE 179
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 234
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSES 279
           D +S+ L  NP +R    E+LEH ++   + K S     E+ + +S
Sbjct: 235 DLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 280

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 125/270 (46%), Gaps = 42/270 (15%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSE----FLQREQRIL-SALAC 54
           D+   + IGRGS A V +    ++  ++A++    EL N +    ++Q E+ +   A   
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
           P +V    C  +E   ++ +   +EY  GG L   ++    L E   R ++  + L L Y
Sbjct: 113 PFLVGLHSCFQTE--SRLFF--VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           LH  GI++ D+K  N+L+  D+E   K+ D+G  +   +   D     CGTP  +APE+ 
Sbjct: 169 LHERGIIYRDLKLDNVLL--DSEGHIKLTDYGMCKEG-LRPGDTTSTFCGTPNYIAPEIL 225
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE----------- 223
           RGE+ GF  D WALG  + EM  GR P+  V            SSD P+           
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG-----------SSDNPDQNTEDYLFQVI 274
Query: 224 ------IPGYMSKQAQDFLSKCLIRNPGER 247
                 IP  +S +A   L   L ++P ER
Sbjct: 275 LEKQIRIPRSLSVKAASVLKSFLNKDPKER 304

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 76/247 (30%), Positives = 118/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +TIG GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY PGG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   K+ADFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIKVADFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 128/266 (48%), Gaps = 22/266 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 70  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A  +  D    +CGT   + PE+  
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPSSRRDT---LCGTLDYLPPEMIE 180
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 235
Query: 234 DFLSKCLIRNPGERWSASELLEHGFV 259
           D +S+ L  NP +R    E+LEH ++
Sbjct: 236 DLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 76/247 (30%), Positives = 118/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +TIG GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY PGG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   K+ADFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIKVADFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 76/247 (30%), Positives = 118/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +TIG GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY PGG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   K+ADFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIKVADFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 139/277 (50%), Gaps = 23/277 (8%)
Query: 7   QTIGRGSTATVSIG---MSNRSSEVFAVKSAELSNSEF--LQREQRILSALACPQIVAYK 61
           +TIG+G+ A V +    ++ R   +  +   +L+ +    L RE RI+  L  P IV  K
Sbjct: 18  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV--K 75
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
             ++ E   K LY L +EYA GG + D + +   ++E   RS  R ++  +QY H   IV
Sbjct: 76  LFEVIETE-KTLY-LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 133
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGK--PICGTPICMAPEVARGEEQ 179
           H D+K +N+L+  D +   KIADFG +    V     GK    CG+P   APE+ +G++ 
Sbjct: 134 HRDLKAENLLL--DADMNIKIADFGFSNEFTVG----GKLDTFCGSPPYAAPELFQGKKY 187
Query: 180 GFP-ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK 238
             P  DVW+LG  +  + +G  P+ D  +      R+        IP YMS   ++ L +
Sbjct: 188 DGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERV--LRGKYRIPFYMSTDCENLLKR 244
Query: 239 CLIRNPGERWSASELLEHGFVK--EQNFKLSTLTEPE 273
            L+ NP +R +  ++++  ++    +  +L    EPE
Sbjct: 245 FLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPE 281

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 90/331 (27%), Positives = 155/331 (46%), Gaps = 23/331 (6%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELS--------NSEFLQREQRILSALACPQIV 58
           + IG+G+ + V   ++  + + FAVK  +++        ++E L+RE  I   L  P IV
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAI----RSGTCLEEGRIRSHTRAVLLGLQY 114
                +    +G +LY +F E+  G  L   I     +G    E     + R +L  L+Y
Sbjct: 90  EL--LETYSSDG-MLYMVF-EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 115 LHSNGIVHCDIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
            H N I+H D+K +N+L+ SK+N    K+ DFG A +   +    G  + GTP  MAPEV
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRV-GTPHFMAPEV 204
Query: 174 ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
            + E  G P DVW  G  +  + +G  P+    + +      G     P    ++S+ A+
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAK 264
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTL 293
           D + + L+ +P ER +  E L H ++KE++     +  PET       +   ++L  + L
Sbjct: 265 DLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNA-RRKLKGAVL 323
Query: 294 TSCSSASAKERIRQLIGEGSSEMVNWAWDET 324
            + SS     +     G+   E+ +++ D T
Sbjct: 324 AAVSS----HKFNSFYGDPPEELPDFSEDPT 350

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 134/269 (49%), Gaps = 22/269 (8%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR---EQRILSALACPQIVA 59
           W     +G G+   V    +  +  + A K  E  + E L+    E  IL+    P IV 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHS 117
             G      +GK+   + +E+ PGG + DAI       L E +I+   R +L  L +LHS
Sbjct: 81  LLGA--YYHDGKLW--IMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
             I+H D+K  N+L++ + +   ++ADFG + +  +    +     GTP  MAPEV   E
Sbjct: 136 KRIIHRDLKAGNVLMTLEGD--IRLADFGVSAK-NLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 178 EQ-----GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMSK 230
                   + AD+W+LG T++EMA   PP  ++ +P+  L +I   SD P +  P   S 
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIA-KSDPPTLLTPSKWSV 250
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGFV 259
           + +DFL   L +NP  R SA++LLEH FV
Sbjct: 251 EFRDFLKIALDKNPETRPSAAQLLEHPFV 279

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 134/276 (48%), Gaps = 23/276 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQI 57
           D+ +   +G G+   V       S  V A K   L     ++    RE ++L     P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH- 116
           V + G   S  +G+I  ++ +E+  GG+L   ++    + E  +   + AV+ GL YL  
Sbjct: 67  VGFYGAFYS--DGEI--SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
            + I+H D+K  NILV+   E   K+ DFG + +     D       GT   M+PE  +G
Sbjct: 123 KHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQG 177
Query: 177 EEQGFPADVWALGCTVLEMATGRPPWP------DVADPISALHRIGF--SSDTPEIP-GY 227
                 +D+W++G +++EMA GR P P      D   P++    + +  +   P++P G 
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGV 237
Query: 228 MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            S + QDF++KCLI+NP ER    +L+ H F+K  +
Sbjct: 238 FSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 273

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 132/268 (49%), Gaps = 17/268 (6%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQI 57
           D+ +   +G G+   V       S  V A K   L     ++    RE ++L     P I
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 69
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH- 116
           V + G   S  +G+I  ++ +E+  GG+L   ++    + E  +   + AV+ GL YL  
Sbjct: 70  VGFYGAFYS--DGEI--SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 125
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
            + I+H D+K  NILV+   E   K+ DFG + +     D+      GT   M+PE  +G
Sbjct: 126 KHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI---DEMANEFVGTRSYMSPERLQG 180
Query: 177 EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP-GYMSKQAQDF 235
                 +D+W++G +++EMA GR P P +A  I  L     +   P++P    S + QDF
Sbjct: 181 THYSVQSDIWSMGLSLVEMAVGRYPRPPMA--IFELLDYIVNEPPPKLPSAVFSLEFQDF 238
Query: 236 LSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++KCLI+NP ER    +L+ H F+K  +
Sbjct: 239 VNKCLIKNPAERADLKQLMVHAFIKRSD 266

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 134/269 (49%), Gaps = 22/269 (8%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR---EQRILSALACPQIVA 59
           W     +G G+   V    +  +  + A K  E  + E L+    E  IL+    P IV 
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 72
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHS 117
             G      +GK+   + +E+ PGG + DAI       L E +I+   R +L  L +LHS
Sbjct: 73  LLGA--YYHDGKLW--IMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 127
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
             I+H D+K  N+L++ + +   ++ADFG + +  +    +     GTP  MAPEV   E
Sbjct: 128 KRIIHRDLKAGNVLMTLEGD--IRLADFGVSAK-NLKTLQKRDSFIGTPYWMAPEVVMCE 184
Query: 178 EQ-----GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMSK 230
                   + AD+W+LG T++EMA   PP  ++ +P+  L +I   SD P +  P   S 
Sbjct: 185 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIA-KSDPPTLLTPSKWSV 242
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGFV 259
           + +DFL   L +NP  R SA++LLEH FV
Sbjct: 243 EFRDFLKIALDKNPETRPSAAQLLEHPFV 271

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 76/247 (30%), Positives = 118/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RI  A+  P 
Sbjct: 44  FERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPF 103
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + LEYAPGG +   +R      E   R +   ++L  +YLH
Sbjct: 104 LVK---LEFSFKDNSNLY-MVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   K+ADFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 160 SLDLIYRDLKPENLLI--DQQGYIKVADFGFAKRVK------GRTWXLCGTPEYLAPEII 211
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 267
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 268 DLLRNLL 274

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 138/277 (49%), Gaps = 23/277 (8%)
Query: 7   QTIGRGSTATVSIG---MSNRSSEVFAVKSAELSNSEF--LQREQRILSALACPQIVAYK 61
           +TIG+G+ A V +    ++ R   +  +   +L+ +    L RE RI+  L  P IV  K
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV--K 78
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
             ++ E   K LY L +EYA GG + D + +   ++E   RS  R ++  +QY H   IV
Sbjct: 79  LFEVIETE-KTLY-LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 136
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGK--PICGTPICMAPEVARGEEQ 179
           H D+K +N+L+  D +   KIADFG +    V     GK    CG P   APE+ +G++ 
Sbjct: 137 HRDLKAENLLL--DADMNIKIADFGFSNEFTVG----GKLDAFCGAPPYAAPELFQGKKY 190
Query: 180 GFP-ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK 238
             P  DVW+LG  +  + +G  P+ D  +      R+        IP YMS   ++ L +
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERV--LRGKYRIPFYMSTDCENLLKR 247
Query: 239 CLIRNPGERWSASELLEHGFVK--EQNFKLSTLTEPE 273
            L+ NP +R +  ++++  ++    +  +L    EPE
Sbjct: 248 FLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPE 284

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 126/266 (47%), Gaps = 22/266 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +     S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G     ++ ++   L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 69  NILRLYG--YFHDSTRVY--LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A          +CGT   + PE+  
Sbjct: 125 HSKKVIHRDIKPENLLLGSAGE--LKIADFGWSVHA---PSSRRAALCGTLDYLPPEMIE 179
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      D    + R+ F+      P ++++ A+
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFT-----FPDFVTEGAR 234
Query: 234 DFLSKCLIRNPGERWSASELLEHGFV 259
           D +S+ L  NP +R    E+LEH ++
Sbjct: 235 DLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 118/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EYAPGG +   +R      E   R +   ++L  +YLH
Sbjct: 104 LVK---LEFSFKDNSNLY-MVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+++  D +   K+ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 160 SLDLIYRDLKPENLMI--DQQGYIKVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 211
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 267
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 268 DLLRNLL 274

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 128/267 (47%), Gaps = 22/267 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF------LQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    +  E       L+RE  I S L  P
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 73  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+  + E   KIADFG +  A  +  D    +CGT   + PE+  
Sbjct: 129 HSKRVIHRDIKPENLLLGSNGE--LKIADFGWSVHAPSSRRDT---LCGTLDYLPPEMIE 183
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G PP+      +    + R+ F+      P ++++ A+
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFT-----FPDFVTEGAR 238
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVK 260
           D +S+ L  N  +R + +E+LEH ++K
Sbjct: 239 DLISRLLKHNASQRLTLAEVLEHPWIK 265

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 129/271 (47%), Gaps = 20/271 (7%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFA---VKSAELSNS------EFLQREQRILSALA 53
           +  G+ +G G  A V       + + +A   +K   LS+S      E ++RE  IL  + 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
            P I+     DI E    ++  L LE   GG L D +     L E       + +L G+ 
Sbjct: 67  HPNIITLH--DIFENKTDVV--LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 122
Query: 114 YLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNEDDEGKPICGTPICMAP 171
           YLHS  I H D+K +NI++   N      K+ DFG A   ++   +E K I GTP  +AP
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH--KIEAGNEFKNIFGTPEFVAP 180
Query: 172 EVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRIGFSSDTPEIPGYMS 229
           E+   E  G  AD+W++G     + +G  P+      + ++ +  + +  D  E     S
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD-EEYFSNTS 239
Query: 230 KQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
           + A+DF+ + L+++P  R + ++ LEH ++K
Sbjct: 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 134/286 (46%), Gaps = 22/286 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 26  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 85
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 86  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 141
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A          +CGT   + PE+  
Sbjct: 142 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHA---PSSRRTTLCGTLDYLPPEMIE 196
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 197 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 251
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSES 279
           D +S+ L  NP +R    E+LEH ++   + K S     E+ + +S
Sbjct: 252 DLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 297

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 134/286 (46%), Gaps = 22/286 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 72  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A          +CGT   + PE+  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHA---PSSRRTTLCGTLDYLPPEMIE 182
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 237
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSES 279
           D +S+ L  NP +R    E+LEH ++   + K S     E+ + +S
Sbjct: 238 DLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 283

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 134/286 (46%), Gaps = 22/286 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 35  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 94
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 95  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 150
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A          +CGT   + PE+  
Sbjct: 151 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHA---PSSRRTTLCGTLDYLPPEMIE 205
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 206 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 260
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSES 279
           D +S+ L  NP +R    E+LEH ++   + K S     E+ + +S
Sbjct: 261 DLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 306

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 134/286 (46%), Gaps = 22/286 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 69  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A          +CGT   + PE+  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHA---PSSRRTTLCGTLDYLPPEMIE 179
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 234
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSES 279
           D +S+ L  NP +R    E+LEH ++   + K S     E+ + +S
Sbjct: 235 DLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 280

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 134/286 (46%), Gaps = 22/286 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 11  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 70
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 71  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 126
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A          +CGT   + PE+  
Sbjct: 127 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHA---PSSRRXXLCGTLDYLPPEMIE 181
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 182 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 236
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSES 279
           D +S+ L  NP +R    E+LEH ++   + K S     E+ + +S
Sbjct: 237 DLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 282

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 134/286 (46%), Gaps = 22/286 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 74  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 129
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A          +CGT   + PE+  
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHA---PSSRRTTLCGTLDYLPPEMIE 184
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 239
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSES 279
           D +S+ L  NP +R    E+LEH ++   + K S     E+ + +S
Sbjct: 240 DLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 285

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 118/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EYAPGG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+++  D +   K+ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLMI--DQQGYIKVTDFGLAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 118/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EYAPGG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+++  D +   K+ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLMI--DQQGYIKVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 134/286 (46%), Gaps = 22/286 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 72  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A          +CGT   + PE+  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHA---PSSRRAALCGTLDYLPPEMIE 182
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 237
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSES 279
           D +S+ L  NP +R    E+LEH ++   + K S     E+ + +S
Sbjct: 238 DLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 283

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 128/266 (48%), Gaps = 22/266 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 69  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A  +   +   +CGT   + PE+  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPSSRRTD---LCGTLDYLPPEMIE 179
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 234
Query: 234 DFLSKCLIRNPGERWSASELLEHGFV 259
           D +S+ L  NP +R    E+LEH ++
Sbjct: 235 DLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 118/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EYAPGG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+++  D +   K+ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLMI--DQQGYIKVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 128/266 (48%), Gaps = 22/266 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 70  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A  +   +   +CGT   + PE+  
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPSSRRTD---LCGTLDYLPPEMIE 180
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 235
Query: 234 DFLSKCLIRNPGERWSASELLEHGFV 259
           D +S+ L  NP +R    E+LEH ++
Sbjct: 236 DLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 128/266 (48%), Gaps = 22/266 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 74  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 129
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A  +   +   +CGT   + PE+  
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPSSRRTD---LCGTLDYLPPEMIE 184
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 239
Query: 234 DFLSKCLIRNPGERWSASELLEHGFV 259
           D +S+ L  NP +R    E+LEH ++
Sbjct: 240 DLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 128/271 (47%), Gaps = 20/271 (7%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFA---VKSAELSNS------EFLQREQRILSALA 53
           +  G+ +G G  A V       + + +A   +K   LS+S      E ++RE  IL  + 
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
            P I+     DI E    ++  L LE   GG L D +     L E       + +L G+ 
Sbjct: 74  HPNIITLH--DIFENKTDVV--LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 129
Query: 114 YLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNEDDEGKPICGTPICMAP 171
           YLHS  I H D+K +NI++   N      K+ DFG A   ++   +E K I GTP  +AP
Sbjct: 130 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH--KIEAGNEFKNIFGTPEFVAP 187
Query: 172 EVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRIGFSSDTPEIPGYMS 229
           E+   E  G  AD+W++G     + +G  P+      + ++ +  + +  D  E     S
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD-EEYFSNTS 246
Query: 230 KQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
           + A+DF+ + L+++P  R   ++ LEH ++K
Sbjct: 247 ELAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 133/286 (46%), Gaps = 22/286 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 74  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 129
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A          +CGT   + PE   
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHA---PSSRRTTLCGTLDYLPPEXIE 184
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 185 GRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 239
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSES 279
           D +S+ L  NP +R    E+LEH ++   + K S     E+ + +S
Sbjct: 240 DLISRLLKHNPSQRPXLREVLEHPWITANSSKPSNCQNKESASKQS 285

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 128/266 (48%), Gaps = 22/266 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 69  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A  +   +   +CGT   + PE+  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPSSRRTD---LCGTLDYLPPEMIE 179
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 234
Query: 234 DFLSKCLIRNPGERWSASELLEHGFV 259
           D +S+ L  NP +R    E+LEH ++
Sbjct: 235 DLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 117/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   FA+K        +L   E    E+RIL A+  P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY PGG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEYSFKDNSNLY-MVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 117/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   FA+K        +L   E    E+RIL A+  P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY PGG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEYSFKDNSNLY-MVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 117/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   FA+K        +L   E    E+RIL A+  P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY PGG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEYSFKDNSNLY-MVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 126/266 (47%), Gaps = 22/266 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 72  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A          +CGT   + PE+  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHA---PSSRRXXLCGTLDYLPPEMIE 182
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 237
Query: 234 DFLSKCLIRNPGERWSASELLEHGFV 259
           D +S+ L  NP +R    E+LEH ++
Sbjct: 238 DLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 126/266 (47%), Gaps = 22/266 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 8   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 67
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 68  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 123
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A          +CGT   + PE+  
Sbjct: 124 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHA---PSSRRTTLCGTLDYLPPEMIE 178
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 179 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 233
Query: 234 DFLSKCLIRNPGERWSASELLEHGFV 259
           D +S+ L  NP +R    E+LEH ++
Sbjct: 234 DLISRLLKHNPSQRPMLREVLEHPWI 259

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 126/266 (47%), Gaps = 22/266 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 72  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A          +CGT   + PE+  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHA---PSSRRTTLCGTLDYLPPEMIE 182
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 237
Query: 234 DFLSKCLIRNPGERWSASELLEHGFV 259
           D +S+ L  NP +R    E+LEH ++
Sbjct: 238 DLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 126/266 (47%), Gaps = 22/266 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 69  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A          +CGT   + PE+  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHA---PSSRRXXLCGTLDYLPPEMIE 179
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 234
Query: 234 DFLSKCLIRNPGERWSASELLEHGFV 259
           D +S+ L  NP +R    E+LEH ++
Sbjct: 235 DLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 126/266 (47%), Gaps = 22/266 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 69  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A          +CGT   + PE+  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHA---PSSRRTXLCGTLDYLPPEMIE 179
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 234
Query: 234 DFLSKCLIRNPGERWSASELLEHGFV 259
           D +S+ L  NP +R    E+LEH ++
Sbjct: 235 DLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 126/266 (47%), Gaps = 22/266 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 69  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A          +CGT   + PE+  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHA---PSSRRAALCGTLDYLPPEMIE 179
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 234
Query: 234 DFLSKCLIRNPGERWSASELLEHGFV 259
           D +S+ L  NP +R    E+LEH ++
Sbjct: 235 DLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 126/266 (47%), Gaps = 22/266 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 13  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 73  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 128
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A          +CGT   + PE+  
Sbjct: 129 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHA---PSSRRTTLCGTLDYLPPEMIE 183
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 238
Query: 234 DFLSKCLIRNPGERWSASELLEHGFV 259
           D +S+ L  NP +R    E+LEH ++
Sbjct: 239 DLISRLLKHNPSQRPMLREVLEHPWI 264

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 95
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY PGG +   +R      E   R +   ++L  +YLH
Sbjct: 96  LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 151
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 152 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 203
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 204 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 259
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 260 DLLRNLL 266

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 133/286 (46%), Gaps = 22/286 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP G +   ++  +  +E R  ++   +   L Y 
Sbjct: 74  NILRLYGYF---HDATRVY-LILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYC 129
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A          +CGT   + PE+  
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHA---PSSRRTTLCGTLDYLPPEMIE 184
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 239
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSES 279
           D +S+ L  NP +R    E+LEH ++   + K S     E+ + +S
Sbjct: 240 DLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 285

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY PGG +   +R      E   R +   ++L  +YLH
Sbjct: 104 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 160 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 211
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 267
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 268 DLLRNLL 274

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 95
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY PGG +   +R      E   R +   ++L  +YLH
Sbjct: 96  LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 151
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 152 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 203
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 204 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 259
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 260 DLLRNLL 266

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY PGG +   +R      E   R +   ++L  +YLH
Sbjct: 104 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 160 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 211
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 267
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 268 DLLRNLL 274

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY PGG +   +R      E   R +   ++L  +YLH
Sbjct: 104 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 160 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 211
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 267
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 268 DLLRNLL 274

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 118/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EYAPGG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+++  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLMI--DQQGYIQVTDFGLAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 118/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EYAPGG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+++  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLMI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 134/286 (46%), Gaps = 22/286 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 11  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 70
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 71  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 126
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIA+FG +  A          +CGT   + PE+  
Sbjct: 127 HSKRVIHRDIKPENLLLGSAGE--LKIANFGWSVHA---PSSRRTTLCGTLDYLPPEMIE 181
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 182 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 236
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSES 279
           D +S+ L  NP +R    E+LEH ++   + K S     E+ + +S
Sbjct: 237 DLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 282

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 117/224 (52%), Gaps = 13/224 (5%)
Query: 44  REQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRS 103
           RE ++L     P IV + G   S  +G+I  ++ +E+  GG+L   ++    + E  +  
Sbjct: 72  RELQVLHECNSPYIVGFYGAFYS--DGEI--SICMEHMDGGSLDQVLKKAGRIPEQILGK 127
Query: 104 HTRAVLLGLQYLH-SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI 162
            + AV+ GL YL   + I+H D+K  NILV+   E   K+ DFG + +     D      
Sbjct: 128 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI---DSMANSF 182
Query: 163 CGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP 222
            GT   M+PE  +G      +D+W++G +++EMA GR P    +  ++    + +  + P
Sbjct: 183 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEP 242
Query: 223 --EIP-GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
             ++P G  S + QDF++KCLI+NP ER    +L+ H F+K  +
Sbjct: 243 PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 286

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 126/267 (47%), Gaps = 22/267 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF------LQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    +  E       L+RE  I S L  P
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 73  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+  + E   KIADFG +  A          +CGT   + PE+  
Sbjct: 129 HSKRVIHRDIKPENLLLGSNGE--LKIADFGWSVHA---PSSRRTTLCGTLDYLPPEMIE 183
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G PP+      +    + R+ F+      P ++++ A+
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFT-----FPDFVTEGAR 238
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVK 260
           D +S+ L  N  +R + +E+LEH ++K
Sbjct: 239 DLISRLLKHNASQRLTLAEVLEHPWIK 265

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +      + S ++   LY + +EYAPGG +   +R      E   R +   ++L  +YLH
Sbjct: 104 LTK---LEFSFKDNSNLY-MVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 159
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+++  D +   K+ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 160 SLDLIYRDLKPENLMI--DQQGYIKVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 211
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 267
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 268 DLLRNLL 274

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +      + S ++   LY + +EYAPGG +   +R      E   R +   ++L  +YLH
Sbjct: 104 LTK---LEFSFKDNSNLY-MVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+++  D +   K+ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 160 SLDLIYRDLKPENLMI--DQQGYIKVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 211
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 267
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 268 DLLRNLL 274

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 127/271 (46%), Gaps = 20/271 (7%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFA---VKSAELSNS------EFLQREQRILSALA 53
           +  G+ +G G  A V       + + +A   +K   L +S      E ++RE  IL  + 
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
            P I+     DI E    ++  L LE   GG L D +     L E       + +L G+ 
Sbjct: 88  HPNIITLH--DIFENKTDVV--LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 143
Query: 114 YLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNEDDEGKPICGTPICMAP 171
           YLHS  I H D+K +NI++   N      K+ DFG A   ++   +E K I GTP  +AP
Sbjct: 144 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH--KIEAGNEFKNIFGTPEFVAP 201
Query: 172 EVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRIGFSSDTPEIPGYMS 229
           E+   E  G  AD+W++G     + +G  P+      + ++ +  + +  D  E     S
Sbjct: 202 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD-EEYFSNTS 260
Query: 230 KQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
           + A+DF+ + L+++P  R   ++ LEH ++K
Sbjct: 261 ELAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 291

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 64  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY PGG +   +R      E   R +   ++L  +YLH
Sbjct: 124 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 179
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 180 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 231
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 232 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 287
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 288 DLLRNLL 294

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +      + S ++   LY + +EYAPGG +   +R      E   R +   ++L  +YLH
Sbjct: 104 LTK---LEFSFKDNSNLY-MVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+++  D +   K+ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 160 SLDLIYRDLKPENLMI--DQQGYIKVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 211
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 267
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 268 DLLRNLL 274

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY PGG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY PGG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 29  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 88
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY PGG +   +R      E   R +   ++L  +YLH
Sbjct: 89  LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 144
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 145 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWTLCGTPEYLAPEII 196
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 197 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 252
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 253 DLLRNLL 259

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY PGG +   +R      E   R +   ++L  +YLH
Sbjct: 104 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 160 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWTLCGTPEYLAPEII 211
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 267
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 268 DLLRNLL 274

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY PGG +   +R      E   R +   ++L  +YLH
Sbjct: 104 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 160 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 211
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 267
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 268 DLLRNLL 274

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY PGG +   +R      E   R +   ++L  +YLH
Sbjct: 104 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 159
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 160 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 211
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 267
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 268 DLLRNLL 274

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY PGG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY PGG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY PGG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 126/266 (47%), Gaps = 22/266 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 72  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIA+FG +  A          +CGT   + PE+  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGE--LKIANFGWSVHA---PSSRRTTLCGTLDYLPPEMIE 182
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 237
Query: 234 DFLSKCLIRNPGERWSASELLEHGFV 259
           D +S+ L  NP +R    E+LEH ++
Sbjct: 238 DLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 117/264 (44%), Gaps = 24/264 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           DW   QT+G G+   V + ++  + E  AVK  ++  +    E +++E  I   L    +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G       G I Y LFLEY  GG L D I     + E   +     ++ G+ YLH 
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPE-VAR 175
            GI H DIK +N+L+  D     KI+DFG A   R N  +     +CGT   +APE + R
Sbjct: 123 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ-- 233
            E    P DVW+ G  +  M  G  PW   +D           SD  E   Y++   +  
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYLNPWKKID 234
Query: 234 ----DFLSKCLIRNPGERWSASEL 253
                 L K L+ NP  R +  ++
Sbjct: 235 SAPLALLHKILVENPSARITIPDI 258

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACP 55
           D+  G+ +G GS +TV +     +S  +A+K  E       +   ++ RE+ ++S L  P
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
             V    C   +++ K+ + L   YA  G L   IR     +E   R +T  ++  L+YL
Sbjct: 98  FFVKLYFC--FQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 153
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA-------RRARVNEDDEGKPICGTPIC 168
           H  GI+H D+K +NIL+++D     +I DFG A       ++AR N         GT   
Sbjct: 154 HGKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANX------FVGTAQY 205
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           ++PE+   +     +D+WALGC + ++  G PP+    + +     I    D PE     
Sbjct: 206 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE---KF 262
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
             +A+D + K L+ +  +R    E+  +G +K   F
Sbjct: 263 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 298

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 125/266 (46%), Gaps = 22/266 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +   + A+K    A+L  +     L+RE  I S L  P
Sbjct: 6   DFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 65
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 66  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 121
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A          +CGT   + PE+  
Sbjct: 122 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHA---PSSRRTTLCGTLDYLPPEMIE 176
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 177 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 231
Query: 234 DFLSKCLIRNPGERWSASELLEHGFV 259
           D +S+ L  NP +R    E+LEH ++
Sbjct: 232 DLISRLLKHNPSQRPMLREVLEHPWI 257

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 118/248 (47%), Gaps = 27/248 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     S   +A+K        +L   E    E+RIL A+  P 
Sbjct: 30  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 89
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY  GG +   +R      E   R +   ++L  +YLH
Sbjct: 90  LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 145
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKP--ICGTPICMAPEV 173
           S  +++ D+K +N+L+   +EQG  ++ DFG A+R +      G+   +CGTP  +APE+
Sbjct: 146 SLDLIYRDLKPENLLI---DEQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEI 196
Query: 174 ARGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQA 232
              +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   
Sbjct: 197 ILSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDL 252
Query: 233 QDFLSKCL 240
           +D L   L
Sbjct: 253 KDLLRNLL 260

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 118/264 (44%), Gaps = 24/264 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           DW   QT+G G+   V + ++  + E  AVK  ++  +    E +++E  I + L    +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENV 67
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G       G I Y LFLEY  GG L D I     + E   +     ++ G+ YLH 
Sbjct: 68  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPE-VAR 175
            GI H DIK +N+L+  D     KI+DFG A   R N  +     +CGT   +APE + R
Sbjct: 124 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ-- 233
            E    P DVW+ G  +  M  G  PW   +D           SD  E   Y++   +  
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYLNPWKKID 235
Query: 234 ----DFLSKCLIRNPGERWSASEL 253
                 L K L+ NP  R +  ++
Sbjct: 236 SAPLALLHKILVENPSARITIPDI 259

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     S   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY  GG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEALAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 117/264 (44%), Gaps = 24/264 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           DW   QT+G G+   V + ++  + E  AVK  ++  +    E +++E  I   L    +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G       G I Y LFLEY  GG L D I     + E   +     ++ G+ YLH 
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPE-VAR 175
            GI H DIK +N+L+  D     KI+DFG A   R N  +     +CGT   +APE + R
Sbjct: 123 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ-- 233
            E    P DVW+ G  +  M  G  PW   +D           SD  E   Y++   +  
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYLNPWKKID 234
Query: 234 ----DFLSKCLIRNPGERWSASEL 253
                 L K L+ NP  R +  ++
Sbjct: 235 SAPLALLHKILVENPSARITIPDI 258

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     S   +A+K        +L   E    E+RIL A+  P 
Sbjct: 38  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 97
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY  GG +   +R      E   R +   ++L  +YLH
Sbjct: 98  LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 153
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 154 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 205
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 206 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 261
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 262 DLLRNLL 268

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 117/264 (44%), Gaps = 24/264 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           DW   QT+G G+   V + ++  + E  AVK  ++  +    E +++E  I   L    +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G       G I Y LFLEY  GG L D I     + E   +     ++ G+ YLH 
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPE-VAR 175
            GI H DIK +N+L+  D     KI+DFG A   R N  +     +CGT   +APE + R
Sbjct: 123 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ-- 233
            E    P DVW+ G  +  M  G  PW   +D           SD  E   Y++   +  
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYLNPWKKID 234
Query: 234 ----DFLSKCLIRNPGERWSASEL 253
                 L K L+ NP  R +  ++
Sbjct: 235 SAPLALLHKILVENPSARITIPDI 258

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 117/264 (44%), Gaps = 24/264 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           DW   QT+G G+   V + ++  + E  AVK  ++  +    E +++E  I   L    +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G       G I Y LFLEY  GG L D I     + E   +     ++ G+ YLH 
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPE-VAR 175
            GI H DIK +N+L+  D     KI+DFG A   R N  +     +CGT   +APE + R
Sbjct: 123 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ-- 233
            E    P DVW+ G  +  M  G  PW   +D           SD  E   Y++   +  
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYLNPWKKID 234
Query: 234 ----DFLSKCLIRNPGERWSASEL 253
                 L K L+ NP  R +  ++
Sbjct: 235 SAPLALLHKILVENPSARITIPDI 258

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 117/264 (44%), Gaps = 24/264 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           DW   QT+G G+   V + ++  + E  AVK  ++  +    E +++E  I   L    +
Sbjct: 7   DWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G       G I Y LFLEY  GG L D I     + E   +     ++ G+ YLH 
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPE-VAR 175
            GI H DIK +N+L+  D     KI+DFG A   R N  +     +CGT   +APE + R
Sbjct: 123 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ-- 233
            E    P DVW+ G  +  M  G  PW   +D           SD  E   Y++   +  
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYLNPWKKID 234
Query: 234 ----DFLSKCLIRNPGERWSASEL 253
                 L K L+ NP  R +  ++
Sbjct: 235 SAPLALLHKILVENPSARITIPDI 258

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 117/264 (44%), Gaps = 24/264 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           DW   QT+G G+   V + ++  + E  AVK  ++  +    E +++E  I   L    +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G       G I Y LFLEY  GG L D I     + E   +     ++ G+ YLH 
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPE-VAR 175
            GI H DIK +N+L+  D     KI+DFG A   R N  +     +CGT   +APE + R
Sbjct: 123 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ-- 233
            E    P DVW+ G  +  M  G  PW   +D           SD  E   Y++   +  
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYLNPWKKID 234
Query: 234 ----DFLSKCLIRNPGERWSASEL 253
                 L K L+ NP  R +  ++
Sbjct: 235 SAPLALLHKILVENPSARITIPDI 258

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     S   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY  GG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     S   +A+K        +L   E    E+RIL A+  P 
Sbjct: 44  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY  GG +   +R      E   R +   ++L  +YLH
Sbjct: 104 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 160 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 211
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 267
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 268 DLLRNLL 274

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 117/264 (44%), Gaps = 24/264 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           DW   QT+G G+   V + ++  + E  AVK  ++  +    E +++E  I   L    +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G       G I Y LFLEY  GG L D I     + E   +     ++ G+ YLH 
Sbjct: 68  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPE-VAR 175
            GI H DIK +N+L+  D     KI+DFG A   R N  +     +CGT   +APE + R
Sbjct: 124 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ-- 233
            E    P DVW+ G  +  M  G  PW   +D           SD  E   Y++   +  
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYLNPWKKID 235
Query: 234 ----DFLSKCLIRNPGERWSASEL 253
                 L K L+ NP  R +  ++
Sbjct: 236 SAPLALLHKILVENPSARITIPDI 259

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 117/264 (44%), Gaps = 24/264 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           DW   QT+G G+   V + ++  + E  AVK  ++  +    E +++E  I   L    +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G       G I Y LFLEY  GG L D I     + E   +     ++ G+ YLH 
Sbjct: 68  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPE-VAR 175
            GI H DIK +N+L+  D     KI+DFG A   R N  +     +CGT   +APE + R
Sbjct: 124 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ-- 233
            E    P DVW+ G  +  M  G  PW   +D           SD  E   Y++   +  
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTYLNPWKKID 235
Query: 234 ----DFLSKCLIRNPGERWSASEL 253
                 L K L+ NP  R +  ++
Sbjct: 236 SAPLALLHKILVENPSARITIPDI 259

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     S   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY  GG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADEPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 117/264 (44%), Gaps = 24/264 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           DW   QT+G G+   V + ++  + E  AVK  ++  +    E +++E  I   L    +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G       G I Y LFLEY  GG L D I     + E   +     ++ G+ YLH 
Sbjct: 68  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPE-VAR 175
            GI H DIK +N+L+  D     KI+DFG A   R N  +     +CGT   +APE + R
Sbjct: 124 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ-- 233
            E    P DVW+ G  +  M  G  PW   +D           SD  E   Y++   +  
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYLNPWKKID 235
Query: 234 ----DFLSKCLIRNPGERWSASEL 253
                 L K L+ NP  R +  ++
Sbjct: 236 SAPLALLHKILVENPSARITIPDI 259

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     S   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY  GG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 117/264 (44%), Gaps = 24/264 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           DW   QT+G G+   V + ++  + E  AVK  ++  +    E +++E  I   L    +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G       G I Y LFLEY  GG L D I     + E   +     ++ G+ YLH 
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPE-VAR 175
            GI H DIK +N+L+  D     KI+DFG A   R N  +     +CGT   +APE + R
Sbjct: 123 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ-- 233
            E    P DVW+ G  +  M  G  PW   +D           SD  E   Y++   +  
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYLNPWKKID 234
Query: 234 ----DFLSKCLIRNPGERWSASEL 253
                 L K L+ NP  R +  ++
Sbjct: 235 SAPLALLHKILVENPSARITIPDI 258

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 117/264 (44%), Gaps = 24/264 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           DW   QT+G G+   V + ++  + E  AVK  ++  +    E +++E  I   L    +
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G       G I Y LFLEY  GG L D I     + E   +     ++ G+ YLH 
Sbjct: 66  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPE-VAR 175
            GI H DIK +N+L+  D     KI+DFG A   R N  +     +CGT   +APE + R
Sbjct: 122 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ-- 233
            E    P DVW+ G  +  M  G  PW   +D           SD  E   Y++   +  
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYLNPWKKID 233
Query: 234 ----DFLSKCLIRNPGERWSASEL 253
                 L K L+ NP  R +  ++
Sbjct: 234 SAPLALLHKILVENPSARITIPDI 257

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     S   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY  GG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     S   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY  GG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     S   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY  GG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 117/264 (44%), Gaps = 24/264 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           DW   QT+G G+   V + ++  + E  AVK  ++  +    E +++E  I   L    +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G       G I Y LFLEY  GG L D I     + E   +     ++ G+ YLH 
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPE-VAR 175
            GI H DIK +N+L+  D     KI+DFG A   R N  +     +CGT   +APE + R
Sbjct: 123 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ-- 233
            E    P DVW+ G  +  M  G  PW   +D           SD  E   Y++   +  
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYLNPWKKID 234
Query: 234 ----DFLSKCLIRNPGERWSASEL 253
                 L K L+ NP  R +  ++
Sbjct: 235 SAPLALLHKILVENPSARITIPDI 258

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 117/264 (44%), Gaps = 24/264 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           DW   QT+G G+   V + ++  + E  AVK  ++  +    E +++E  I   L    +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G       G I Y LFLEY  GG L D I     + E   +     ++ G+ YLH 
Sbjct: 68  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPE-VAR 175
            GI H DIK +N+L+  D     KI+DFG A   R N  +     +CGT   +APE + R
Sbjct: 124 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ-- 233
            E    P DVW+ G  +  M  G  PW   +D           SD  E   Y++   +  
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYLNPWKKID 235
Query: 234 ----DFLSKCLIRNPGERWSASEL 253
                 L K L+ NP  R +  ++
Sbjct: 236 SAPLALLHKILVENPSARITIPDI 259

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 117/264 (44%), Gaps = 24/264 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           DW   QT+G G+   V + ++  + E  AVK  ++  +    E +++E  I   L    +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G       G I Y LFLEY  GG L D I     + E   +     ++ G+ YLH 
Sbjct: 68  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPE-VAR 175
            GI H DIK +N+L+  D     KI+DFG A   R N  +     +CGT   +APE + R
Sbjct: 124 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ-- 233
            E    P DVW+ G  +  M  G  PW   +D           SD  E   Y++   +  
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYLNPWKKID 235
Query: 234 ----DFLSKCLIRNPGERWSASEL 253
                 L K L+ NP  R +  ++
Sbjct: 236 SAPLALLHKILVENPSARITIPDI 259

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 117/264 (44%), Gaps = 24/264 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           DW   QT+G G+   V + ++  + E  AVK  ++  +    E +++E  I   L    +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G       G I Y LFLEY  GG L D I     + E   +     ++ G+ YLH 
Sbjct: 68  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPE-VAR 175
            GI H DIK +N+L+  D     KI+DFG A   R N  +     +CGT   +APE + R
Sbjct: 124 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ-- 233
            E    P DVW+ G  +  M  G  PW   +D           SD  E   Y++   +  
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYLNPWKKID 235
Query: 234 ----DFLSKCLIRNPGERWSASEL 253
                 L K L+ NP  R +  ++
Sbjct: 236 SAPLALLHKILVENPSARITIPDI 259

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     S   +A+K        +L   E    E+RIL A+  P 
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY  GG +   +R      E   R +   ++L  +YLH
Sbjct: 124 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 179
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 180 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 231
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 232 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 287
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 288 DLLRNLL 294

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     S   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY  GG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     S   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY  GG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     S   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY  GG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACP 55
           D+  G+ +G GS +TV +     +S  +A+K  E       +   ++ RE+ ++S L  P
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
             V  K     +++ K+ + L   YA  G L   IR     +E   R +T  ++  L+YL
Sbjct: 93  FFV--KLYFTFQDDEKLYFGL--SYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYL 148
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA-------RRARVNEDDEGKPICGTPIC 168
           H  GI+H D+K +NIL+++D     +I DFG A       ++AR N         GT   
Sbjct: 149 HGKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANS------FVGTAQY 200
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           ++PE+   +     +D+WALGC + ++  G PP+    + +     I    D PE     
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE---KF 257
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
             +A+D + K L+ +  +R    E+  +G +K   F
Sbjct: 258 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 293

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 133/286 (46%), Gaps = 22/286 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 70  NILRLYGYF---HDATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A          + GT   + PE+  
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSCHA---PSSRRTTLSGTLDYLPPEMIE 180
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 235
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSES 279
           D +S+ L  NP +R    E+LEH ++   + K S     E+ + +S
Sbjct: 236 DLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNSQNKESASKQS 281

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACP 55
           D+  G+ +G GS +TV +     +S  +A+K  E       +   ++ RE+ ++S L  P
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
             V  K     +++ K+ + L   YA  G L   IR     +E   R +T  ++  L+YL
Sbjct: 93  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 148
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA-------RRARVNEDDEGKPICGTPIC 168
           H  GI+H D+K +NIL+++D     +I DFG A       ++AR N         GT   
Sbjct: 149 HGKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANX------FVGTAQY 200
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           ++PE+   +     +D+WALGC + ++  G PP+    + +     I    D PE     
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE---KF 257
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
             +A+D + K L+ +  +R    E+  +G +K   F
Sbjct: 258 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 293

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 114/245 (46%), Gaps = 21/245 (8%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     S   +A+K        +L   E    E+RIL A+  P 
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY  GG +   +R      E   R +   ++L  +YLH
Sbjct: 124 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 179
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
           S  +++ D+K +N+L+  D +   ++ DFG A+R +         +CGTP  +APE+   
Sbjct: 180 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK----GATWTLCGTPEYLAPEIILS 233
Query: 177 EEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQDF 235
           +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +D 
Sbjct: 234 KGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLKDL 289
Query: 236 LSKCL 240
           L   L
Sbjct: 290 LRNLL 294

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACP 55
           D+  G+ +G GS +TV +     +S  +A+K  E       +   ++ RE+ ++S L  P
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
             V  K     +++ K+ + L   YA  G L   IR     +E   R +T  ++  L+YL
Sbjct: 90  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 145
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA-------RRARVNEDDEGKPICGTPIC 168
           H  GI+H D+K +NIL+++D     +I DFG A       ++AR N         GT   
Sbjct: 146 HGKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANS------FVGTAQY 197
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           ++PE+   +     +D+WALGC + ++  G PP+    + +     I    D PE     
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK---F 254
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
             +A+D + K L+ +  +R    E+  +G +K   F
Sbjct: 255 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 290

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACP 55
           D+  G+ +G GS +TV +     +S  +A+K  E       +   ++ RE+ ++S L  P
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
             V  K     +++ K+ + L   YA  G L   IR     +E   R +T  ++  L+YL
Sbjct: 91  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 146
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA-------RRARVNEDDEGKPICGTPIC 168
           H  GI+H D+K +NIL+++D     +I DFG A       ++AR N         GT   
Sbjct: 147 HGKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANX------FVGTAQY 198
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           ++PE+   +     +D+WALGC + ++  G PP+    + +     I    D PE     
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE---KF 255
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
             +A+D + K L+ +  +R    E+  +G +K   F
Sbjct: 256 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACP 55
           D+  G+ +G GS +TV +     +S  +A+K  E       +   ++ RE+ ++S L  P
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
             V  K     +++ K+ + L   YA  G L   IR     +E   R +T  ++  L+YL
Sbjct: 91  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 146
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA-------RRARVNEDDEGKPICGTPIC 168
           H  GI+H D+K +NIL+++D     +I DFG A       ++AR N         GT   
Sbjct: 147 HGKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANX------FVGTAQY 198
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           ++PE+   +     +D+WALGC + ++  G PP+    + +     I    D PE     
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE---KF 255
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
             +A+D + K L+ +  +R    E+  +G +K   F
Sbjct: 256 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 116/247 (46%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     S   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY  GG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + +MA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYQMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACP 55
           D+  G+ +G GS +TV +     +S  +A+K  E  +        ++ RE+ ++S L  P
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
             V  K     +++ K+ + L   YA  G L   IR     +E   R +T  ++  L+YL
Sbjct: 90  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 145
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA-------RRARVNEDDEGKPICGTPIC 168
           H  GI+H D+K +NIL+++D     +I DFG A       ++AR N         GT   
Sbjct: 146 HGKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANX------FVGTAQY 197
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           ++PE+   +     +D+WALGC + ++  G PP+    + +     I    D PE     
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK---F 254
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
             +A+D + K L+ +  +R    E+  +G +K   F
Sbjct: 255 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 290

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 116/247 (46%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     S   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY  GG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+++  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLII--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 ISKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACP 55
           D+  G+ +G GS +TV +     +S  +A+K  E  +        ++ RE+ ++S L  P
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
             V  K     +++ K+ + L   YA  G L   IR     +E   R +T  ++  L+YL
Sbjct: 75  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 130
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA-------RRARVNEDDEGKPICGTPIC 168
           H  GI+H D+K +NIL+++D     +I DFG A       ++AR N         GT   
Sbjct: 131 HGKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANX------FVGTAQY 182
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           ++PE+   +     +D+WALGC + ++  G PP+    + +     I    D PE     
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE---KF 239
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
             +A+D + K L+ +  +R    E+  +G +K   F
Sbjct: 240 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 275

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACP 55
           D+  G+ +G GS +TV +     +S  +A+K  E       +   ++ RE+ ++S L  P
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
             V  K     +++ K+ + L   YA  G L   IR     +E   R +T  ++  L+YL
Sbjct: 94  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 149
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA-------RRARVNEDDEGKPICGTPIC 168
           H  GI+H D+K +NIL+++D     +I DFG A       ++AR N         GT   
Sbjct: 150 HGKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANS------FVGTAQY 201
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           ++PE+   +     +D+WALGC + ++  G PP+    + +     I    D PE     
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE---KF 258
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
             +A+D + K L+ +  +R    E+  +G +K   F
Sbjct: 259 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 294

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACP 55
           D+  G+ +G GS +TV +     +S  +A+K  E       +   ++ RE+ ++S L  P
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
             V  K     +++ K+ + L   YA  G L   IR     +E   R +T  ++  L+YL
Sbjct: 94  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 149
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA-------RRARVNEDDEGKPICGTPIC 168
           H  GI+H D+K +NIL+++D     +I DFG A       ++AR N         GT   
Sbjct: 150 HGKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANX------FVGTAQY 201
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           ++PE+   +     +D+WALGC + ++  G PP+    + +     I    D PE     
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE---KF 258
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
             +A+D + K L+ +  +R    E+  +G +K   F
Sbjct: 259 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 294

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACP 55
           D+  G+ +G GS +TV +     +S  +A+K  E       +   ++ RE+ ++S L  P
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
             V  K     +++ K+ + L   YA  G L   IR     +E   R +T  ++  L+YL
Sbjct: 93  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 148
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA-------RRARVNEDDEGKPICGTPIC 168
           H  GI+H D+K +NIL+++D     +I DFG A       ++AR N         GT   
Sbjct: 149 HGKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANX------FVGTAQY 200
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           ++PE+   +     +D+WALGC + ++  G PP+    + +     I    D PE     
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE---KF 257
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
             +A+D + K L+ +  +R    E+  +G +K   F
Sbjct: 258 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 293

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACP 55
           D+  G+ +G GS +TV +     +S  +A+K  E       +   ++ RE+ ++S L  P
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
             V  K     +++ K+ + L   YA  G L   IR     +E   R +T  ++  L+YL
Sbjct: 93  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 148
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA-------RRARVNEDDEGKPICGTPIC 168
           H  GI+H D+K +NIL+++D     +I DFG A       ++AR N         GT   
Sbjct: 149 HGKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANX------FVGTAQY 200
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           ++PE+   +     +D+WALGC + ++  G PP+    + +     I    D PE     
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE---KF 257
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
             +A+D + K L+ +  +R    E+  +G +K   F
Sbjct: 258 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 293

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACP 55
           D+  G+ +G GS +TV +     +S  +A+K  E  +        ++ RE+ ++S L  P
Sbjct: 8   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 67
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
             V  K     +++ K+ + L   YA  G L   IR     +E   R +T  ++  L+YL
Sbjct: 68  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 123
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA-------RRARVNEDDEGKPICGTPIC 168
           H  GI+H D+K +NIL+++D     +I DFG A       ++AR N         GT   
Sbjct: 124 HGKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANX------FVGTAQY 175
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           ++PE+   +     +D+WALGC + ++  G PP+    + +     I    D PE     
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE---KF 232
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
             +A+D + K L+ +  +R    E+  +G +K   F
Sbjct: 233 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 268

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACP 55
           D+  G+ +G GS +TV +     +S  +A+K  E  +        ++ RE+ ++S L  P
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
             V  K     +++ K+ + L   YA  G L   IR     +E   R +T  ++  L+YL
Sbjct: 69  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA-------RRARVNEDDEGKPICGTPIC 168
           H  GI+H D+K +NIL+++D     +I DFG A       ++AR N         GT   
Sbjct: 125 HGKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANX------FVGTAQY 176
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           ++PE+   +     +D+WALGC + ++  G PP+    + +     I    D PE     
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE---KF 233
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
             +A+D + K L+ +  +R    E+  +G +K   F
Sbjct: 234 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 132/286 (46%), Gaps = 22/286 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G      +   +Y L LEYAP G +   ++  +  +E R  ++   +   L Y 
Sbjct: 74  NILRLYGYF---HDATRVY-LILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYC 129
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A          + GT   + PE+  
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHA---PSSRRXXLXGTLDYLPPEMIE 184
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           G       D+W+LG    E   G+PP+      +    + R+ F+      P ++++ A+
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGAR 239
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSES 279
           D +S+ L  NP +R    E+LEH ++   + K S     E+ + +S
Sbjct: 240 DLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS 285

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACP 55
           D+  G+ +G GS +TV +     +S  +A+K  E       +   ++ RE+ ++S L  P
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
             V  K     +++ K+ + L   YA  G L   IR     +E   R +T  ++  L+YL
Sbjct: 93  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 148
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA-------RRARVNEDDEGKPICGTPIC 168
           H  GI+H D+K +NIL+++D     +I DFG A       ++AR N         GT   
Sbjct: 149 HGKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANX------FVGTAQY 200
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           ++PE+   +     +D+WALGC + ++  G PP+    + +     I    D PE     
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE---KF 257
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
             +A+D + K L+ +  +R    E+  +G +K   F
Sbjct: 258 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 293

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACP 55
           D+  G+ +G GS +TV +     +S  +A+K  E       +   ++ RE+ ++S L  P
Sbjct: 11  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 70
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
             V  K     +++ K+ + L   YA  G L   IR     +E   R +T  ++  L+YL
Sbjct: 71  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 126
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA-------RRARVNEDDEGKPICGTPIC 168
           H  GI+H D+K +NIL+++D     +I DFG A       ++AR N         GT   
Sbjct: 127 HGKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANX------FVGTAQY 178
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           ++PE+   +     +D+WALGC + ++  G PP+    + +     I    D PE     
Sbjct: 179 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE---KF 235
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
             +A+D + K L+ +  +R    E+  +G +K   F
Sbjct: 236 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 271

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACP 55
           D+  G+ +G GS +TV +     +S  +A+K  E  +        ++ RE+ ++S L  P
Sbjct: 10  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 69
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
             V  K     +++ K+ + L   YA  G L   IR     +E   R +T  ++  L+YL
Sbjct: 70  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 125
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA-------RRARVNEDDEGKPICGTPIC 168
           H  GI+H D+K +NIL+++D     +I DFG A       ++AR N         GT   
Sbjct: 126 HGKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANX------FVGTAQY 177
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           ++PE+   +     +D+WALGC + ++  G PP+    + +     I    D PE     
Sbjct: 178 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE---KF 234
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
             +A+D + K L+ +  +R    E+  +G +K   F
Sbjct: 235 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 270

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACP 55
           D+  G+ +G GS +TV +     +S  +A+K  E       +   ++ RE+ ++S L  P
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
             V  K     +++ K+ + L   YA  G L   IR     +E   R +T  ++  L+YL
Sbjct: 91  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 146
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA-------RRARVNEDDEGKPICGTPIC 168
           H  GI+H D+K +NIL+++D     +I DFG A       ++AR N         GT   
Sbjct: 147 HGKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARAN------AFVGTAQY 198
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           ++PE+   +     +D+WALGC + ++  G PP+    + +     I    D PE     
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE---KF 255
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
             +A+D + K L+ +  +R    E+  +G +K   F
Sbjct: 256 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACP 55
           D+  G+ +G GS +TV +     +S  +A+K  E       +   ++ RE+ ++S L  P
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
             V  K     +++ K+ + L   YA  G L   IR     +E   R +T  ++  L+YL
Sbjct: 93  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 148
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA-------RRARVNEDDEGKPICGTPIC 168
           H  GI+H D+K +NIL+++D     +I DFG A       ++AR N         GT   
Sbjct: 149 HGKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANX------FVGTAQY 200
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           ++PE+   +     +D+WALGC + ++  G PP+    + +     I    D PE     
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE---KF 257
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
             +A+D + K L+ +  +R    E+  +G +K   F
Sbjct: 258 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 293

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 116/247 (46%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     +   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY  GG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 84/256 (32%), Positives = 126/256 (49%), Gaps = 23/256 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQ---REQRILSALACPQIVAYK 61
           +TIG+G+ A V +     + +  AVK  + +  NS  LQ   RE RI   L  P IV  K
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIV--K 77
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
             ++ E   K LY L  EYA GG + D + +    +E   R+  R ++  +QY H   IV
Sbjct: 78  LFEVIETE-KTLY-LVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI---CGTPICMAPEVARGEE 178
           H D+K +N+L+  D +   KIADFG +     NE   G  +   CG P   APE+ +G++
Sbjct: 136 HRDLKAENLLL--DADXNIKIADFGFS-----NEFTFGNKLDAFCGAPPYAAPELFQGKK 188
Query: 179 QGFP-ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
              P  DVW+LG  +  + +G  P+ D  +      R+        IP Y S   ++ L 
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERV--LRGKYRIPFYXSTDCENLLK 245
Query: 238 KCLIRNPGERWSASEL 253
           K LI NP +R +  ++
Sbjct: 246 KFLILNPSKRGTLEQI 261

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 88/331 (26%), Positives = 151/331 (45%), Gaps = 23/331 (6%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELS--------NSEFLQREQRILSALACPQIV 58
           + IG+G  + V   ++  + + FAVK  +++        ++E L+RE  I   L  P IV
Sbjct: 32  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 91
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAI----RSGTCLEEGRIRSHTRAVLLGLQY 114
                +    +G +LY +F E+  G  L   I     +G    E     + R +L  L+Y
Sbjct: 92  EL--LETYSSDG-MLYMVF-EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 115 LHSNGIVHCDIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
            H N I+H D+K   +L+ SK+N    K+  FG A +   +    G  + GTP  MAPEV
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEV 206
Query: 174 ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
            + E  G P DVW  G  +  + +G  P+    + +      G     P    ++S+ A+
Sbjct: 207 VKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAK 266
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTL 293
           D + + L+ +P ER +  E L H ++KE++     +  PET       +   ++L  + L
Sbjct: 267 DLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNA-RRKLKGAVL 325
Query: 294 TSCSSASAKERIRQLIGEGSSEMVNWAWDET 324
            + SS     +     G+   E+ +++ D T
Sbjct: 326 AAVSS----HKFNSFYGDPPEELPDFSEDPT 352

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 18/280 (6%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK---SAELS--NSEFLQREQRILSALACPQIVAYK 61
           + +G+G+ + V   M   + + +A K   + +LS  + + L+RE RI   L  P IV   
Sbjct: 10  EELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 69
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
              ISEE     + L  +   GG L + I +     E       + +L  + + H NGIV
Sbjct: 70  D-SISEEG---FHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIV 125
Query: 122 HCDIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEG-KPICGTPICMAPEVARGEEQ 179
           H D+K +N+L+ SK      K+ADFG A    V  D +      GTP  ++PEV R +  
Sbjct: 126 HRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI---GFSSDTPEIPGYMSKQAQDFL 236
           G P D+WA G  +  +  G PP+ D  D      +I    +   +PE    ++ +A+D +
Sbjct: 184 GKPVDMWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDT-VTPEAKDLI 241
Query: 237 SKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYN 276
           +K L  NP +R +ASE L+H ++ +++   S +   ET +
Sbjct: 242 NKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVD 281

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 18/280 (6%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK---SAELS--NSEFLQREQRILSALACPQIVAYK 61
           + +G+G+ + V   M   + + +A K   + +LS  + + L+RE RI   L  P IV   
Sbjct: 10  EELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 69
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
              ISEE     + L  +   GG L + I +     E       + +L  + + H NGIV
Sbjct: 70  D-SISEEG---FHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIV 125
Query: 122 HCDIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEG-KPICGTPICMAPEVARGEEQ 179
           H D+K +N+L+ SK      K+ADFG A    V  D +      GTP  ++PEV R +  
Sbjct: 126 HRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI---GFSSDTPEIPGYMSKQAQDFL 236
           G P D+WA G  +  +  G PP+ D  D      +I    +   +PE    ++ +A+D +
Sbjct: 184 GKPVDMWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDT-VTPEAKDLI 241
Query: 237 SKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYN 276
           +K L  NP +R +ASE L+H ++ +++   S +   ET +
Sbjct: 242 NKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVD 281

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 88/331 (26%), Positives = 151/331 (45%), Gaps = 23/331 (6%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELS--------NSEFLQREQRILSALACPQIV 58
           + IG+G  + V   ++  + + FAVK  +++        ++E L+RE  I   L  P IV
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAI----RSGTCLEEGRIRSHTRAVLLGLQY 114
                +    +G +LY +F E+  G  L   I     +G    E     + R +L  L+Y
Sbjct: 90  EL--LETYSSDG-MLYMVF-EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 115 LHSNGIVHCDIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
            H N I+H D+K   +L+ SK+N    K+  FG A +   +    G  + GTP  MAPEV
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEV 204
Query: 174 ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
            + E  G P DVW  G  +  + +G  P+    + +      G     P    ++S+ A+
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAK 264
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTL 293
           D + + L+ +P ER +  E L H ++KE++     +  PET       +   ++L  + L
Sbjct: 265 DLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNA-RRKLKGAVL 323
Query: 294 TSCSSASAKERIRQLIGEGSSEMVNWAWDET 324
            + SS     +     G+   E+ +++ D T
Sbjct: 324 AAVSS----HKFNSFYGDPPEELPDFSEDPT 350

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 116/264 (43%), Gaps = 24/264 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           DW   QT+G G+   V + ++  + E  AVK  ++  +    E +++E  I   L    +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G       G I Y LFLEY  GG L D I     + E   +     ++ G+ YLH 
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPE-VAR 175
            GI H DIK +N+L+  D     KI+DFG A   R N  +     + GT   +APE + R
Sbjct: 123 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ-- 233
            E    P DVW+ G  +  M  G  PW   +D           SD  E   Y++   +  
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYLNPWKKID 234
Query: 234 ----DFLSKCLIRNPGERWSASEL 253
                 L K L+ NP  R +  ++
Sbjct: 235 SAPLALLHKILVENPSARITIPDI 258

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 129/276 (46%), Gaps = 28/276 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACP 55
           D+  G+ +G GS +TV +     +S  +A+K  E       +   ++ RE+ ++S L  P
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
             V  K     +++ K+ + L   YA  G L   IR     +E   R +T  ++  L+YL
Sbjct: 96  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 151
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA-------RRARVNEDDEGKPICGTPIC 168
           H  GI+H D+K +NIL+++D     +I DFG A       ++AR N         GT   
Sbjct: 152 HGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQARANX------FVGTAQY 203
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           ++PE+   +     +D+WALGC + ++  G PP+    + +     I    D    P   
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD---FPAAF 260
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
             +A+D + K L+ +  +R    E+  +G +K   F
Sbjct: 261 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 296

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 115/247 (46%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     S   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY  GG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   +CGTP  +AP + 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLCGTPEYLAPAII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 116/264 (43%), Gaps = 24/264 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           DW   QT+G G+   V + ++  + E  AVK  ++  +    E +++E  I   L    +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 67
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G       G I Y LFLEY  GG L D I     + E   +     ++ G+ YLH 
Sbjct: 68  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPE-VAR 175
            GI H DIK +N+L+  D     KI+DFG A   R N  +     + GT   +APE + R
Sbjct: 124 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 181
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ-- 233
            E    P DVW+ G  +  M  G  PW   +D           SD  E   Y++   +  
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYLNPWKKID 235
Query: 234 ----DFLSKCLIRNPGERWSASEL 253
                 L K L+ NP  R +  ++
Sbjct: 236 SAPLALLHKILVENPSARITIPDI 259

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 137/300 (45%), Gaps = 35/300 (11%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQR--------ILSALACPQIVAY 60
           +G+G  A         + EVFA K   +  S  L+  QR        I  +LA   +V +
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKI--VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
            G    E+N  +   + LE     +L +  +    L E   R + R ++LG QYLH N +
Sbjct: 83  HG--FFEDNDFVF--VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 138
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPEVARGEEQ 179
           +H D+K  N+ +++D E   KI DFG A   +V  D E  K +CGTP  +APEV   +  
Sbjct: 139 IHRDLKLGNLFLNEDLE--VKIGDFGLA--TKVEYDGERKKTLCGTPNYIAPEVLSKKGH 194
Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
            F  DVW++GC +  +  G+PP+       + L RI    +   IP +++  A   + K 
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-RI--KKNEYSIPKHINPVAASLIQKM 251
Query: 240 LIRNPGERWSASELLEHGFVKE----QNFKLSTLTEPETY---------NSESPTSVLNQ 286
           L  +P  R + +ELL   F           ++ LT P  +         ++  P +VLN+
Sbjct: 252 LQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVLNK 311

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 137/300 (45%), Gaps = 35/300 (11%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQR--------ILSALACPQIVAY 60
           +G+G  A         + EVFA K   +  S  L+  QR        I  +LA   +V +
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKI--VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 86
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
            G    E+N  +   + LE     +L +  +    L E   R + R ++LG QYLH N +
Sbjct: 87  HG--FFEDNDFVF--VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 142
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPEVARGEEQ 179
           +H D+K  N+ +++D E   KI DFG A   +V  D E  K +CGTP  +APEV   +  
Sbjct: 143 IHRDLKLGNLFLNEDLE--VKIGDFGLA--TKVEYDGERKKTLCGTPNYIAPEVLSKKGH 198
Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
            F  DVW++GC +  +  G+PP+       + L RI    +   IP +++  A   + K 
Sbjct: 199 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-RI--KKNEYSIPKHINPVAASLIQKM 255
Query: 240 LIRNPGERWSASELLEHGFVKE----QNFKLSTLTEPETY---------NSESPTSVLNQ 286
           L  +P  R + +ELL   F           ++ LT P  +         ++  P +VLN+
Sbjct: 256 LQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVLNK 315

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 129/276 (46%), Gaps = 28/276 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACP 55
           D+  G+ +G GS +T  +     +S  +A+K  E       +   ++ RE+ ++S L  P
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
             V  K     +++ K+ + L   YA  G L   IR     +E   R +T  ++  L+YL
Sbjct: 91  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 146
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA-------RRARVNEDDEGKPICGTPIC 168
           H  GI+H D+K +NIL+++D     +I DFG A       ++AR N         GT   
Sbjct: 147 HGKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANX------FVGTAQY 198
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           ++PE+   +     +D+WALGC + ++  G PP+    + +     I    D PE     
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE---KF 255
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
             +A+D + K L+ +  +R    E+  +G +K   F
Sbjct: 256 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 137/300 (45%), Gaps = 35/300 (11%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQR--------ILSALACPQIVAY 60
           +G+G  A         + EVFA K   +  S  L+  QR        I  +LA   +V +
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKI--VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
            G    E+N  +   + LE     +L +  +    L E   R + R ++LG QYLH N +
Sbjct: 83  HG--FFEDNDFVF--VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 138
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPEVARGEEQ 179
           +H D+K  N+ +++D E   KI DFG A   +V  D E  K +CGTP  +APEV   +  
Sbjct: 139 IHRDLKLGNLFLNEDLE--VKIGDFGLA--TKVEYDGERKKTLCGTPNYIAPEVLSKKGH 194
Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
            F  DVW++GC +  +  G+PP+       + L RI    +   IP +++  A   + K 
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-RI--KKNEYSIPKHINPVAASLIQKM 251
Query: 240 LIRNPGERWSASELLEHGFVKE----QNFKLSTLTEPETY---------NSESPTSVLNQ 286
           L  +P  R + +ELL   F           ++ LT P  +         ++  P +VLN+
Sbjct: 252 LQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPXFSIAPSSLDPSNRKPLTVLNK 311

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 137/300 (45%), Gaps = 35/300 (11%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQR--------ILSALACPQIVAY 60
           +G+G  A         + EVFA K   +  S  L+  QR        I  +LA   +V +
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKI--VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 104
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
            G    E+N  +   + LE     +L +  +    L E   R + R ++LG QYLH N +
Sbjct: 105 HG--FFEDNDFVF--VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 160
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI-CGTPICMAPEVARGEEQ 179
           +H D+K  N+ +++D E   KI DFG A   +V  D E K + CGTP  +APEV   +  
Sbjct: 161 IHRDLKLGNLFLNEDLE--VKIGDFGLA--TKVEYDGERKKVLCGTPNYIAPEVLSKKGH 216
Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
            F  DVW++GC +  +  G+PP+       + L RI    +   IP +++  A   + K 
Sbjct: 217 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-RI--KKNEYSIPKHINPVAASLIQKM 273
Query: 240 LIRNPGERWSASELLEHGFVKE----QNFKLSTLTEPETY---------NSESPTSVLNQ 286
           L  +P  R + +ELL   F           ++ LT P  +         ++  P +VLN+
Sbjct: 274 LQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVLNK 333

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 115/247 (46%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     S   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY  GG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   + GTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLAGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 137/300 (45%), Gaps = 35/300 (11%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQR--------ILSALACPQIVAY 60
           +G+G  A         + EVFA K   +  S  L+  QR        I  +LA   +V +
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKI--VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
            G    E+N  +   + LE     +L +  +    L E   R + R ++LG QYLH N +
Sbjct: 107 HG--FFEDNDFVF--VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 162
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI-CGTPICMAPEVARGEEQ 179
           +H D+K  N+ +++D E   KI DFG A   +V  D E K + CGTP  +APEV   +  
Sbjct: 163 IHRDLKLGNLFLNEDLE--VKIGDFGLA--TKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
            F  DVW++GC +  +  G+PP+       + L RI    +   IP +++  A   + K 
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-RI--KKNEYSIPKHINPVAASLIQKM 275
Query: 240 LIRNPGERWSASELLEHGFVKE----QNFKLSTLTEPETY---------NSESPTSVLNQ 286
           L  +P  R + +ELL   F           ++ LT P  +         ++  P +VLN+
Sbjct: 276 LQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVLNK 335

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/259 (30%), Positives = 123/259 (47%), Gaps = 22/259 (8%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQR--------ILSALACPQIVAY 60
           +G+G  A         + EVFA K   +  S  L+  QR        I  +LA   +V +
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKI--VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
            G    E+N  +   + LE     +L +  +    L E   R + R ++LG QYLH N +
Sbjct: 81  HG--FFEDNDFVF--VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 136
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI-CGTPICMAPEVARGEEQ 179
           +H D+K  N+ +++D E   KI DFG A   +V  D E K + CGTP  +APEV   +  
Sbjct: 137 IHRDLKLGNLFLNEDLE--VKIGDFGLA--TKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
            F  DVW++GC +  +  G+PP+       + L RI    +   IP +++  A   + K 
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-RI--KKNEYSIPKHINPVAASLIQKM 249
Query: 240 LIRNPGERWSASELLEHGF 258
           L  +P  R + +ELL   F
Sbjct: 250 LQTDPTARPTINELLNDEF 268

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 116/264 (43%), Gaps = 24/264 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           DW   QT+G G+   V + ++  + E  AVK  ++  +    E +++E  I   L    +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G       G I Y LFLEY  GG L D I     + E   +     ++ G+ YLH 
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPE-VAR 175
            GI H DIK +N+L+  D     KI+DFG A   R N  +     + GT   +APE + R
Sbjct: 123 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ-- 233
            E    P DVW+ G  +  M  G  PW   +D           SD  E   Y++   +  
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEY------SDWKEKKTYLNPWKKID 234
Query: 234 ----DFLSKCLIRNPGERWSASEL 253
                 L K L+ NP  R +  ++
Sbjct: 235 SAPLALLHKILVENPSARITIPDI 258

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 116/264 (43%), Gaps = 24/264 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           DW   QT+G G+   V + ++  + E  AVK  ++  +    E +++E  I   L    +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G       G I Y LFLEY  GG L D I     + E   +     ++ G+ YLH 
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPE-VAR 175
            GI H DIK +N+L+  D     KI+DFG A   R N  +     + GT   +APE + R
Sbjct: 123 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ-- 233
            E    P DVW+ G  +  M  G  PW   +D           SD  E   Y++   +  
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYLNPWKKID 234
Query: 234 ----DFLSKCLIRNPGERWSASEL 253
                 L K L+ NP  R +  ++
Sbjct: 235 SAPLALLHKILVENPSARITIPDI 258

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 115/247 (46%), Gaps = 25/247 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           + R +T+G GS   V +     S   +A+K        +L   E    E+RIL A+  P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V     + S ++   LY + +EY  GG +   +R      E   R +   ++L  +YLH
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA 174
           S  +++ D+K +N+L+  D +   ++ DFG A+R +      G+   + GTP  +APE+ 
Sbjct: 159 SLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK------GRTWXLXGTPEYLAPEII 210
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQ 233
             +      D WALG  + EMA G PP+   AD PI    +I   S     P + S   +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 234 DFLSKCL 240
           D L   L
Sbjct: 267 DLLRNLL 273

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 137/291 (47%), Gaps = 34/291 (11%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQR-------ILSALA-------C 54
           +GRG  A V   +S  + + +A K        FL++ +R       IL  +A       C
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAK--------FLKKRRRGQDCRAEILHEIAVLELAKSC 88
Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGL 112
           P+++     ++ E   +I+  L LEYA GG +           + E  +    + +L G+
Sbjct: 89  PRVINLH--EVYENTSEII--LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICMAP 171
            YLH N IVH D+K QNIL+S     G  KI DFG +R  ++    E + I GTP  +AP
Sbjct: 145 YYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR--KIGHACELREIMGTPEYLAP 202
Query: 172 EVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSD-TPEIPGYMSK 230
           E+   +      D+W +G     + T   P+    +  + L+    + D + E    +S+
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ 262
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPT 281
            A DF+   L++NP +R +A   L H ++++ +F+   L  PE  +S S T
Sbjct: 263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE--NLFHPEETSSSSQT 311

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 116/264 (43%), Gaps = 24/264 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           DW   QT+G G+   V + ++  + E  AVK  ++  +    E +++E  I   L    +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G       G I Y LFLEY  GG L D I     + E   +     ++ G+ YLH 
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPE-VAR 175
            GI H DIK +N+L+  D     KI+DFG A   R N  +     + GT   +APE + R
Sbjct: 123 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ-- 233
            E    P DVW+ G  +  M  G  PW   +D           SD  E   Y++   +  
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYLNPWKKID 234
Query: 234 ----DFLSKCLIRNPGERWSASEL 253
                 L K L+ NP  R +  ++
Sbjct: 235 SAPLALLHKILVENPSARITIPDI 258

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 121/264 (45%), Gaps = 20/264 (7%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQ 56
           + RG+ +G+G  A         + EVFA K    S        E +  E  I  +L  P 
Sbjct: 28  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 87
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V + G     E+   +Y + LE     +L +  +    + E   R   R  + G+QYLH
Sbjct: 88  VVGFHGF---FEDDDFVY-VVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 143
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
           +N ++H D+K  N+ ++ D +   KI DFG A +   +  +  K +CGTP  +APEV   
Sbjct: 144 NNRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFD-GERKKDLCGTPNYIAPEVLCK 200
Query: 177 EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHR--IGFSSDTPEIPGYMSKQAQD 234
           +   F  D+W+LGC +  +  G+PP+       S L    I    +   +P +++  A  
Sbjct: 201 KGHSFEVDIWSLGCILYTLLVGKPPF-----ETSCLKETYIRIKKNEYSVPRHINPVASA 255
Query: 235 FLSKCLIRNPGERWSASELLEHGF 258
            + + L  +P  R S +ELL   F
Sbjct: 256 LIRRMLHADPTLRPSVAELLTDEF 279

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 121/264 (45%), Gaps = 20/264 (7%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQ 56
           + RG+ +G+G  A         + EVFA K    S        E +  E  I  +L  P 
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V + G     E+   +Y + LE     +L +  +    + E   R   R  + G+QYLH
Sbjct: 104 VVGFHGF---FEDDDFVY-VVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
           +N ++H D+K  N+ ++ D +   KI DFG A +   +  +  K +CGTP  +APEV   
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFD-GERKKDLCGTPNYIAPEVLCK 216
Query: 177 EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHR--IGFSSDTPEIPGYMSKQAQD 234
           +   F  D+W+LGC +  +  G+PP+       S L    I    +   +P +++  A  
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVGKPPF-----ETSCLKETYIRIKKNEYSVPRHINPVASA 271
Query: 235 FLSKCLIRNPGERWSASELLEHGF 258
            + + L  +P  R S +ELL   F
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEF 295

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 121/264 (45%), Gaps = 20/264 (7%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQ 56
           + RG+ +G+G  A         + EVFA K    S        E +  E  I  +L  P 
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V + G     E+   +Y + LE     +L +  +    + E   R   R  + G+QYLH
Sbjct: 104 VVGFHGF---FEDDDFVY-VVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
           +N ++H D+K  N+ ++ D +   KI DFG A +   +  +  K +CGTP  +APEV   
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFD-GERKKTLCGTPNYIAPEVLCK 216
Query: 177 EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHR--IGFSSDTPEIPGYMSKQAQD 234
           +   F  D+W+LGC +  +  G+PP+       S L    I    +   +P +++  A  
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVGKPPF-----ETSCLKETYIRIKKNEYSVPRHINPVASA 271
Query: 235 FLSKCLIRNPGERWSASELLEHGF 258
            + + L  +P  R S +ELL   F
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEF 295

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 121/264 (45%), Gaps = 20/264 (7%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQ 56
           + RG+ +G+G  A         + EVFA K    S        E +  E  I  +L  P 
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +V + G     E+   +Y + LE     +L +  +    + E   R   R  + G+QYLH
Sbjct: 104 VVGFHGF---FEDDDFVY-VVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
           +N ++H D+K  N+ ++ D +   KI DFG A +   +  +  K +CGTP  +APEV   
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFD-GERKKXLCGTPNYIAPEVLCK 216
Query: 177 EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHR--IGFSSDTPEIPGYMSKQAQD 234
           +   F  D+W+LGC +  +  G+PP+       S L    I    +   +P +++  A  
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVGKPPF-----ETSCLKETYIRIKKNEYSVPRHINPVASA 271
Query: 235 FLSKCLIRNPGERWSASELLEHGF 258
            + + L  +P  R S +ELL   F
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEF 295

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 114/228 (50%), Gaps = 11/228 (4%)
Query: 40  EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEG 99
           E ++RE  IL  +  P ++     ++ E    ++  L LE   GG L D +     L E 
Sbjct: 59  EDIEREVSILKEIQHPNVITLH--EVYENKTDVI--LILELVAGGELFDFLAEKESLTEE 114
Query: 100 RIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNEDD 157
                 + +L G+ YLHS  I H D+K +NI++   N  +   KI DFG A +  ++  +
Sbjct: 115 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGN 172
Query: 158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRI 215
           E K I GTP  +APE+   E  G  AD+W++G     + +G  P+      + ++ +  +
Sbjct: 173 EFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232
Query: 216 GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            +  +  E     S  A+DF+ + L+++P +R +  + L+H ++K ++
Sbjct: 233 NYEFED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 114/228 (50%), Gaps = 11/228 (4%)
Query: 40  EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEG 99
           E ++RE  IL  +  P ++     ++ E    ++  L LE   GG L D +     L E 
Sbjct: 59  EDIEREVSILKEIQHPNVITLH--EVYENKTDVI--LILELVAGGELFDFLAEKESLTEE 114
Query: 100 RIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNEDD 157
                 + +L G+ YLHS  I H D+K +NI++   N  +   KI DFG A +  ++  +
Sbjct: 115 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGN 172
Query: 158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRI 215
           E K I GTP  +APE+   E  G  AD+W++G     + +G  P+      + ++ +  +
Sbjct: 173 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232
Query: 216 GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            +  +  E     S  A+DF+ + L+++P +R +  + L+H ++K ++
Sbjct: 233 NYEFED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 85/280 (30%), Positives = 142/280 (50%), Gaps = 19/280 (6%)
Query: 2   DWTRGQTIGRGSTATVSIG---MSNRSSEVFAVKSAELSNSEF--LQREQRILSALACPQ 56
           ++   +TIG+G+ A V +    ++ R   V  +   +L+ +    L RE RI+  L  P 
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV  K  ++ E   K LY L +EYA GG + D + +   ++E   R+  R ++  +QY H
Sbjct: 76  IV--KLFEVIETE-KTLY-LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH 131
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
              IVH D+K +N+L+  D +   KIADFG +    V   ++    CG+P   APE+ +G
Sbjct: 132 QKYIVHRDLKAENLLL--DGDMNIKIADFGFSNEFTVG--NKLDTFCGSPPYAAPELFQG 187
Query: 177 EEQGFP-ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
           ++   P  DVW+LG  +  + +G  P+ D  +      R+        IP YMS   ++ 
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERV--LRGKYRIPFYMSTDCENL 244
Query: 236 LSKCLIRNPGERWSASELLEHGF--VKEQNFKLSTLTEPE 273
           L K L+ NP +R S  ++++  +  V  +  +L   TEP+
Sbjct: 245 LKKLLVLNPIKRGSLEQIMKDRWMNVGHEEEELKPYTEPD 284

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 114/228 (50%), Gaps = 11/228 (4%)
Query: 40  EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEG 99
           E ++RE  IL  +  P ++     ++ E    ++  L LE   GG L D +     L E 
Sbjct: 59  EDIEREVSILKEIQHPNVITLH--EVYENKTDVI--LILELVAGGELFDFLAEKESLTEE 114
Query: 100 RIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNEDD 157
                 + +L G+ YLHS  I H D+K +NI++   N  +   KI DFG A +  ++  +
Sbjct: 115 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGN 172
Query: 158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRI 215
           E K I GTP  +APE+   E  G  AD+W++G     + +G  P+      + ++ +  +
Sbjct: 173 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232
Query: 216 GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            +  +  E     S  A+DF+ + L+++P +R +  + L+H ++K ++
Sbjct: 233 NYEFED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 114/228 (50%), Gaps = 11/228 (4%)
Query: 40  EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEG 99
           E ++RE  IL  +  P ++     ++ E    ++  L LE   GG L D +     L E 
Sbjct: 58  EDIEREVSILKEIQHPNVITLH--EVYENKTDVI--LILELVAGGELFDFLAEKESLTEE 113
Query: 100 RIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNEDD 157
                 + +L G+ YLHS  I H D+K +NI++   N  +   KI DFG A +  ++  +
Sbjct: 114 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGN 171
Query: 158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRI 215
           E K I GTP  +APE+   E  G  AD+W++G     + +G  P+      + ++ +  +
Sbjct: 172 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231
Query: 216 GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            +  +  E     S  A+DF+ + L+++P +R +  + L+H ++K ++
Sbjct: 232 NYEFED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 114/228 (50%), Gaps = 11/228 (4%)
Query: 40  EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEG 99
           E ++RE  IL  +  P ++     ++ E    ++  L LE   GG L D +     L E 
Sbjct: 59  EDIEREVSILKEIQHPNVITLH--EVYENKTDVI--LILELVAGGELFDFLAEKESLTEE 114
Query: 100 RIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNEDD 157
                 + +L G+ YLHS  I H D+K +NI++   N  +   KI DFG A +  ++  +
Sbjct: 115 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGN 172
Query: 158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRI 215
           E K I GTP  +APE+   E  G  AD+W++G     + +G  P+      + ++ +  +
Sbjct: 173 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232
Query: 216 GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            +  +  E     S  A+DF+ + L+++P +R +  + L+H ++K ++
Sbjct: 233 NYEFED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 114/228 (50%), Gaps = 11/228 (4%)
Query: 40  EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEG 99
           E ++RE  IL  +  P ++     ++ E    ++  L LE   GG L D +     L E 
Sbjct: 59  EDIEREVSILKEIQHPNVITLH--EVYENKTDVI--LILELVAGGELFDFLAEKESLTEE 114
Query: 100 RIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNEDD 157
                 + +L G+ YLHS  I H D+K +NI++   N  +   KI DFG A +  ++  +
Sbjct: 115 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGN 172
Query: 158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRI 215
           E K I GTP  +APE+   E  G  AD+W++G     + +G  P+      + ++ +  +
Sbjct: 173 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232
Query: 216 GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            +  +  E     S  A+DF+ + L+++P +R +  + L+H ++K ++
Sbjct: 233 NYEFED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 114/228 (50%), Gaps = 11/228 (4%)
Query: 40  EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEG 99
           E ++RE  IL  +  P ++     ++ E    ++  L LE   GG L D +     L E 
Sbjct: 58  EDIEREVSILKEIQHPNVITLH--EVYENKTDVI--LILELVAGGELFDFLAEKESLTEE 113
Query: 100 RIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNEDD 157
                 + +L G+ YLHS  I H D+K +NI++   N  +   KI DFG A +  ++  +
Sbjct: 114 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGN 171
Query: 158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRI 215
           E K I GTP  +APE+   E  G  AD+W++G     + +G  P+      + ++ +  +
Sbjct: 172 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231
Query: 216 GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            +  +  E     S  A+DF+ + L+++P +R +  + L+H ++K ++
Sbjct: 232 NYEFED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 114/228 (50%), Gaps = 11/228 (4%)
Query: 40  EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEG 99
           E ++RE  IL  +  P ++     ++ E    ++  L LE   GG L D +     L E 
Sbjct: 59  EDIEREVSILKEIQHPNVITLH--EVYENKTDVI--LILELVAGGELFDFLAEKESLTEE 114
Query: 100 RIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNEDD 157
                 + +L G+ YLHS  I H D+K +NI++   N  +   KI DFG A +  ++  +
Sbjct: 115 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGN 172
Query: 158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRI 215
           E K I GTP  +APE+   E  G  AD+W++G     + +G  P+      + ++ +  +
Sbjct: 173 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232
Query: 216 GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            +  +  E     S  A+DF+ + L+++P +R +  + L+H ++K ++
Sbjct: 233 NYEFED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 114/228 (50%), Gaps = 11/228 (4%)
Query: 40  EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEG 99
           E ++RE  IL  +  P ++     ++ E    ++  L LE   GG L D +     L E 
Sbjct: 59  EDIEREVSILKEIQHPNVITLH--EVYENKTDVI--LILELVAGGELFDFLAEKESLTEE 114
Query: 100 RIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNEDD 157
                 + +L G+ YLHS  I H D+K +NI++   N  +   KI DFG A +  ++  +
Sbjct: 115 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGN 172
Query: 158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRI 215
           E K I GTP  +APE+   E  G  AD+W++G     + +G  P+      + ++ +  +
Sbjct: 173 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232
Query: 216 GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            +  +  E     S  A+DF+ + L+++P +R +  + L+H ++K ++
Sbjct: 233 NYEFED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 114/228 (50%), Gaps = 11/228 (4%)
Query: 40  EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEG 99
           E ++RE  IL  +  P ++     ++ E    ++  L LE   GG L D +     L E 
Sbjct: 59  EDIEREVSILKEIQHPNVITLH--EVYENKTDVI--LILELVAGGELFDFLAEKESLTEE 114
Query: 100 RIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNEDD 157
                 + +L G+ YLHS  I H D+K +NI++   N  +   KI DFG A +  ++  +
Sbjct: 115 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGN 172
Query: 158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRI 215
           E K I GTP  +APE+   E  G  AD+W++G     + +G  P+      + ++ +  +
Sbjct: 173 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232
Query: 216 GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            +  +  E     S  A+DF+ + L+++P +R +  + L+H ++K ++
Sbjct: 233 NYEFED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 113/226 (50%), Gaps = 11/226 (4%)
Query: 42  LQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRI 101
           ++RE  IL  +  P ++     ++ E    ++  L LE   GG L D +     L E   
Sbjct: 61  IEREVSILKEIQHPNVITLH--EVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEA 116
Query: 102 RSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNEDDEG 159
               + +L G+ YLHS  I H D+K +NI++   N  +   KI DFG A +  ++  +E 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEF 174
Query: 160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRIGF 217
           K I GTP  +APE+   E  G  AD+W++G     + +G  P+      + ++ +  + +
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 234
Query: 218 SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
             +  E     S  A+DF+ + L+++P +R +  + L+H ++K ++
Sbjct: 235 EFED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 111/223 (49%), Gaps = 11/223 (4%)
Query: 42  LQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRI 101
           ++RE  IL  +  P ++     ++ E    ++  L LE   GG L D +     L E   
Sbjct: 61  IEREVSILKEIQHPNVITLH--EVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEA 116
Query: 102 RSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNEDDEG 159
               + +L G+ YLHS  I H D+K +NI++   N  +   KI DFG A +  ++  +E 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEF 174
Query: 160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRIGF 217
           K I GTP  +APE+   E  G  AD+W++G     + +G  P+      + ++ +  + +
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 234
Query: 218 SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
             +  E     S  A+DF+ + L+++P +R +  + L+H ++K
Sbjct: 235 EFED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 111/223 (49%), Gaps = 11/223 (4%)
Query: 42  LQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRI 101
           ++RE  IL  +  P ++     ++ E    ++  L LE   GG L D +     L E   
Sbjct: 61  IEREVSILKEIQHPNVITLH--EVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEA 116
Query: 102 RSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNEDDEG 159
               + +L G+ YLHS  I H D+K +NI++   N  +   KI DFG A +  ++  +E 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEF 174
Query: 160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRIGF 217
           K I GTP  +APE+   E  G  AD+W++G     + +G  P+      + ++ +  + +
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 234
Query: 218 SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
             +  E     S  A+DF+ + L+++P +R +  + L+H ++K
Sbjct: 235 EFED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 134/308 (43%), Gaps = 55/308 (17%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQI 57
           D+ +   +G G+   V       S  V A K   L     ++    RE ++L     P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH- 116
           V + G   S  +G+I  ++ +E+  GG+L   ++    + E  +   + AV+ GL YL  
Sbjct: 67  VGFYGAFYS--DGEI--SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
            + I+H D+K  NILV+   E   K+ DFG + +     D       GT   M+PE  +G
Sbjct: 123 KHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQG 177
Query: 177 EEQGFPADVWALGCTVLEMATGRPPWP--------------------------------- 203
                 +D+W++G +++EMA GR P P                                 
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 204 -----DVADPISALHRIGF--SSDTPEIP-GYMSKQAQDFLSKCLIRNPGERWSASELLE 255
                D   P++    + +  +   P++P G  S + QDF++KCLI+NP ER    +L+ 
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
Query: 256 HGFVKEQN 263
           H F+K  +
Sbjct: 298 HAFIKRSD 305

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 107/224 (47%), Gaps = 11/224 (4%)
Query: 40  EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEG 99
           E ++RE  IL  +  P I+     D+ E    ++  L LE   GG L D +     L E 
Sbjct: 60  EEIEREVSILRQVLHPNIITLH--DVYENRTDVV--LILELVSGGELFDFLAQKESLSEE 115
Query: 100 RIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNEDD 157
              S  + +L G+ YLH+  I H D+K +NI++   N      K+ DFG A    + +  
Sbjct: 116 EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGV 173
Query: 158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRI 215
           E K I GTP  +APE+   E  G  AD+W++G     + +G  P+      + ++ +  +
Sbjct: 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233
Query: 216 GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV 259
            +  D  E     S+ A+DF+ K L++   +R +  E L H ++
Sbjct: 234 SYDFD-EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 134/308 (43%), Gaps = 55/308 (17%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQI 57
           D+ +   +G G+   V       S  V A K   L     ++    RE ++L     P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH- 116
           V + G   S  +G+I  ++ +E+  GG+L   ++    + E  +   + AV+ GL YL  
Sbjct: 67  VGFYGAFYS--DGEI--SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
            + I+H D+K  NILV+   E   K+ DFG + +     D       GT   M+PE  +G
Sbjct: 123 KHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQG 177
Query: 177 EEQGFPADVWALGCTVLEMATGRPPWP--------------------------------- 203
                 +D+W++G +++EMA GR P P                                 
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 204 -----DVADPISALHRIGF--SSDTPEIP-GYMSKQAQDFLSKCLIRNPGERWSASELLE 255
                D   P++    + +  +   P++P G  S + QDF++KCLI+NP ER    +L+ 
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
Query: 256 HGFVKEQN 263
           H F+K  +
Sbjct: 298 HAFIKRSD 305

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 134/308 (43%), Gaps = 55/308 (17%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQI 57
           D+ +   +G G+   V       S  V A K   L     ++    RE ++L     P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH- 116
           V + G   S  +G+I  ++ +E+  GG+L   ++    + E  +   + AV+ GL YL  
Sbjct: 67  VGFYGAFYS--DGEI--SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
            + I+H D+K  NILV+   E   K+ DFG + +     D       GT   M+PE  +G
Sbjct: 123 KHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQG 177
Query: 177 EEQGFPADVWALGCTVLEMATGRPPWP--------------------------------- 203
                 +D+W++G +++EMA GR P P                                 
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 204 -----DVADPISALHRIGF--SSDTPEIP-GYMSKQAQDFLSKCLIRNPGERWSASELLE 255
                D   P++    + +  +   P++P G  S + QDF++KCLI+NP ER    +L+ 
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
Query: 256 HGFVKEQN 263
           H F+K  +
Sbjct: 298 HAFIKRSD 305

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 134/308 (43%), Gaps = 55/308 (17%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQI 57
           D+ +   +G G+   V       S  V A K   L     ++    RE ++L     P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH- 116
           V + G   S  +G+I  ++ +E+  GG+L   ++    + E  +   + AV+ GL YL  
Sbjct: 67  VGFYGAFYS--DGEI--SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
            + I+H D+K  NILV+   E   K+ DFG + +     D       GT   M+PE  +G
Sbjct: 123 KHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQG 177
Query: 177 EEQGFPADVWALGCTVLEMATGRPPWP--------------------------------- 203
                 +D+W++G +++EMA GR P P                                 
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 204 -----DVADPISALHRIGF--SSDTPEIP-GYMSKQAQDFLSKCLIRNPGERWSASELLE 255
                D   P++    + +  +   P++P G  S + QDF++KCLI+NP ER    +L+ 
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
Query: 256 HGFVKEQN 263
           H F+K  +
Sbjct: 298 HAFIKRSD 305

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 134/308 (43%), Gaps = 55/308 (17%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQI 57
           D+ +   +G G+   V       S  V A K   L     ++    RE ++L     P I
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH- 116
           V + G   S  +G+I  ++ +E+  GG+L   ++    + E  +   + AV+ GL YL  
Sbjct: 94  VGFYGAFYS--DGEI--SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
            + I+H D+K  NILV+   E   K+ DFG + +     D       GT   M+PE  +G
Sbjct: 150 KHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQG 204
Query: 177 EEQGFPADVWALGCTVLEMATGRPPWP--------------------------------- 203
                 +D+W++G +++EMA GR P P                                 
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264
Query: 204 -----DVADPISALHRIGF--SSDTPEIP-GYMSKQAQDFLSKCLIRNPGERWSASELLE 255
                D   P++    + +  +   P++P G  S + QDF++KCLI+NP ER    +L+ 
Sbjct: 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324
Query: 256 HGFVKEQN 263
           H F+K  +
Sbjct: 325 HAFIKRSD 332

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 147/320 (45%), Gaps = 41/320 (12%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS--EFLQREQRILSALACPQIVAYKGCD 64
           + IG G+     +    +S+E+ AVK  E      E ++RE     +L  P IV +K   
Sbjct: 24  KDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVI 83
Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           ++  +  I+    +EYA GG L + I +     E   R   + ++ G+ Y H+  + H D
Sbjct: 84  LTPTHLAIV----MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 139
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV-ARGEEQGFPA 183
           +K +N L+        KI DFG ++ + ++   + K   GTP  +APEV  + E  G  A
Sbjct: 140 LKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYDGKVA 197
Query: 184 DVWALGCTVLEMATGRPPWPDVADPIS---ALHRIGFSSDTPEIPGY--MSKQAQDFLSK 238
           DVW+ G T+  M  G  P+ D  +P +    +HRI   +    IP Y  +S + +  +S+
Sbjct: 198 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI--LNVQYAIPDYVHISPECRHLISR 255
Query: 239 CLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLTSCSS 298
             + +P +R S  E+  H                E +    P  ++N    D+T+T+  +
Sbjct: 256 IFVADPAKRISIPEIRNH----------------EWFLKNLPADLMN----DNTMTTQFA 295
Query: 299 ASAK-----ERIRQLIGEGS 313
           AS +     E I Q+I E +
Sbjct: 296 ASDQPGQSIEEIMQIIAEAT 315

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 130/280 (46%), Gaps = 19/280 (6%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF------LQREQRILSALACPQIVAY 60
           + +G G+   V   +   +  VF    A+  N+ +      ++ E  I++ L  P+++  
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFV---AKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNG 119
              D  E+  +++  L LE+  GG L D I +    + E  + ++ R    GL+++H + 
Sbjct: 114 H--DAFEDKYEMV--LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           IVH DIK +NI+         KI DFG A   ++N D+  K    T    APE+   E  
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLA--TKLNPDEIVKVTTATAEFAAPEIVDREPV 227
Query: 180 GFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
           GF  D+WA+G     + +G  P+   D  + +  + R  +  D       +S +A+DF+ 
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS-VSPEAKDFIK 286
Query: 238 KCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNS 277
             L + P +R +  + LEH ++K  +  L++      YN 
Sbjct: 287 NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNK 326

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 135/282 (47%), Gaps = 16/282 (5%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELS--NSEFLQREQRILSALACPQ 56
           D+   + +G+G+ + V   +    ++ +A K   + +LS  + + L+RE RI   L  P 
Sbjct: 32  DYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPN 91
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      ISEE     + L  +   GG L + I +     E         +L  + ++H
Sbjct: 92  IVRLHD-SISEEG---FHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIH 147
Query: 117 SNGIVHCDIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
            + IVH D+K +N+L+ SK      K+ADFG A   +  E        GTP  ++PEV R
Sbjct: 148 QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ-GEQQAWFGFAGTPGYLSPEVLR 206
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI---GFSSDTPEIPGYMSKQA 232
            +  G P D+WA G  +  +  G PP+ D  D      +I    +   +PE    ++ +A
Sbjct: 207 KDPYGKPVDIWACGVILYILLVGYPPFWD-EDQHKLYQQIKAGAYDFPSPEWDT-VTPEA 264
Query: 233 QDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPET 274
           ++ +++ L  NP +R +A + L+H +V +++   S +   ET
Sbjct: 265 KNLINQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQET 306

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 130/275 (47%), Gaps = 22/275 (8%)
Query: 2   DWTRGQ-TIGRGSTATVSIGMSNRSSEVFAVKS------AELSNSEFLQREQRILSALAC 54
           D  +GQ  +G+GS   V +     + +  AVK        + ++ E L RE ++L  L  
Sbjct: 32  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 91
Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
           P I+  K  +  E+ G   + L  E   GG L D I S     E       R VL G+ Y
Sbjct: 92  PNIM--KLYEFFEDKG--YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 147
Query: 115 LHSNGIVHCDIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
           +H N IVH D+K +N+L+ SK  +   +I DFG +     ++  + K   GT   +APEV
Sbjct: 148 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--IGTAYYIAPEV 205
Query: 174 ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY--MSKQ 231
             G       DVW+ G  +  + +G PP+ + A+    L ++     T E+P +  +S+ 
Sbjct: 206 LHGTYDE-KCDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKGKYTFELPQWKKVSES 263
Query: 232 AQDFLSKCLIRNPGERWSASELLEH----GFVKEQ 262
           A+D + K L   P  R SA + L+H     + KEQ
Sbjct: 264 AKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQ 298

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 86/320 (26%), Positives = 146/320 (45%), Gaps = 41/320 (12%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS--EFLQREQRILSALACPQIVAYKGCD 64
           + IG G+     +    +++E+ AVK  E      E ++RE     +L  P IV +K   
Sbjct: 25  KDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVI 84
Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           ++  +  I+    +EYA GG L + I +     E   R   + ++ G+ Y H+  + H D
Sbjct: 85  LTPTHLAIV----MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQVAHRD 140
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV-ARGEEQGFPA 183
           +K +N L+        KIADFG ++ + ++   + K   GTP  +APEV  + E  G  A
Sbjct: 141 LKLENTLLDGSPAPRLKIADFGYSKASVLHS--QPKSAVGTPAYIAPEVLLKKEYDGKVA 198
Query: 184 DVWALGCTVLEMATGRPPWPDVADPIS---ALHRIGFSSDTPEIPGY--MSKQAQDFLSK 238
           DVW+ G T+  M  G  P+ D  +P +    +HRI   +    IP Y  +S + +  +S+
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI--LNVQYAIPDYVHISPECRHLISR 256
Query: 239 CLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLTSCSS 298
             + +P +R S  E+  H                E +    P  ++N    D+T+T+   
Sbjct: 257 IFVADPAKRISIPEIRNH----------------EWFLKNLPADLMN----DNTMTTQFD 296
Query: 299 ASAK-----ERIRQLIGEGS 313
            S +     E I Q+I E +
Sbjct: 297 ESDQPGQSIEEIMQIIAEAT 316

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 125/282 (44%), Gaps = 35/282 (12%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSN--SEFLQ--REQRILSALACPQ 56
           +  G+ +G G  + V +    R     AVK   A+L+   S +L+  RE +  +AL  P 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IVA      +E     L  + +EY  G TL D + +   +   R           L + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV--NEDDEGKPICGTPICMAPEVA 174
            NGI+H D+K  NI++S  N    K+ DFG AR      N   +   + GT   ++PE A
Sbjct: 134 QNGIIHRDVKPANIMISATN--AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPW----PDVA-------DPI--SALHRIGFSSDT 221
           RG+     +DV++LGC + E+ TG PP+    PD         DPI  SA H  G S+D 
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPSARHE-GLSADL 250
Query: 222 PEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
             +           + K L +NP  R+  +  +    V+  N
Sbjct: 251 DAV-----------VLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 130/275 (47%), Gaps = 22/275 (8%)
Query: 2   DWTRGQ-TIGRGSTATVSIGMSNRSSEVFAVKS------AELSNSEFLQREQRILSALAC 54
           D  +GQ  +G+GS   V +     + +  AVK        + ++ E L RE ++L  L  
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
           P I+  K  +  E+ G   + L  E   GG L D I S     E       R VL G+ Y
Sbjct: 86  PNIM--KLYEFFEDKG--YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 141
Query: 115 LHSNGIVHCDIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
           +H N IVH D+K +N+L+ SK  +   +I DFG +     ++  + K   GT   +APEV
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPEV 199
Query: 174 ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY--MSKQ 231
             G       DVW+ G  +  + +G PP+ + A+    L ++     T E+P +  +S+ 
Sbjct: 200 LHGTYDE-KCDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKGKYTFELPQWKKVSES 257
Query: 232 AQDFLSKCLIRNPGERWSASELLEH----GFVKEQ 262
           A+D + K L   P  R SA + L+H     + KEQ
Sbjct: 258 AKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQ 292

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 120/265 (45%), Gaps = 18/265 (6%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF------LQREQRILSALACP 55
           D+  G+ +G+G    V +    ++  + A+K    S  E       L+RE  I S L  P
Sbjct: 16  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 75
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+  +  +   +  +I   L LE+AP G L   ++     +E R  +    +   L Y 
Sbjct: 76  NIL--RMYNYFHDRKRIY--LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYC 131
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           H   ++H DIK +N+L+    E   KIADFG +  A        + +CGT   + PE+  
Sbjct: 132 HERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHA---PSLRRRXMCGTLDYLPPEMIE 186
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
           G+      D+W  G    E   G PP+   +   +  HR   + D  + P ++S  ++D 
Sbjct: 187 GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--TETHRRIVNVDL-KFPPFLSDGSKDL 243
Query: 236 LSKCLIRNPGERWSASELLEHGFVK 260
           +SK L  +P +R     ++EH +VK
Sbjct: 244 ISKLLRYHPPQRLPLKGVMEHPWVK 268

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 129/279 (46%), Gaps = 16/279 (5%)
Query: 7   QTIGRGSTATVS-----IGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           + +G+G+ + V      +     ++++   K     + + L+RE RI   L  P IV   
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 87
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
              ISEE     + L  +   GG L + I +     E       + +L  + + H  G+V
Sbjct: 88  D-SISEEGH---HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVV 143
Query: 122 HCDIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           H D+K +N+L+ SK      K+ADFG A      E        GTP  ++PEV R +  G
Sbjct: 144 HRDLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGYLSPEVLRKDPYG 202
Query: 181 FPADVWALGCTVLEMATGRPPWPDVADPISALHRI---GFSSDTPEIPGYMSKQAQDFLS 237
            P D+WA G  +  +  G PP+ D  D      +I    +   +PE    ++ +A+D ++
Sbjct: 203 KPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDT-VTPEAKDLIN 260
Query: 238 KCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYN 276
           K L  NP +R +A+E L+H ++  ++   S +   ET +
Sbjct: 261 KMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVD 299

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 11/219 (5%)
Query: 42  LQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRI 101
           ++RE  IL  +    ++     D+ E    ++  L LE   GG L D +     L E   
Sbjct: 62  IEREVSILRQVLHHNVITLH--DVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEA 117
Query: 102 RSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNEDDEG 159
            S  + +L G+ YLH+  I H D+K +NI++   N      K+ DFG A    + +  E 
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEF 175
Query: 160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRIGF 217
           K I GTP  +APE+   E  G  AD+W++G     + +G  P+      + ++ +  + +
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY 235
Query: 218 SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
             D  E   + S+ A+DF+ K L++   +R +  E L H
Sbjct: 236 DFD-EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 11/219 (5%)
Query: 42  LQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRI 101
           ++RE  IL  +    ++     D+ E    ++  L LE   GG L D +     L E   
Sbjct: 62  IEREVSILRQVLHHNVITLH--DVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEA 117
Query: 102 RSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNEDDEG 159
            S  + +L G+ YLH+  I H D+K +NI++   N      K+ DFG A    + +  E 
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEF 175
Query: 160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRIGF 217
           K I GTP  +APE+   E  G  AD+W++G     + +G  P+      + ++ +  + +
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY 235
Query: 218 SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
             D  E   + S+ A+DF+ K L++   +R +  E L H
Sbjct: 236 DFD-EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 130/275 (47%), Gaps = 22/275 (8%)
Query: 2   DWTRGQ-TIGRGSTATVSIGMSNRSSEVFAVKS------AELSNSEFLQREQRILSALAC 54
           D  +GQ  +G+GS   V +     + +  AVK        + ++ E L RE ++L  L  
Sbjct: 49  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 108
Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
           P I+  K  +  E+ G   + L  E   GG L D I S     E       R VL G+ Y
Sbjct: 109 PNIM--KLYEFFEDKG--YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 164
Query: 115 LHSNGIVHCDIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
           +H N IVH D+K +N+L+ SK  +   +I DFG +     ++  + K   GT   +APEV
Sbjct: 165 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPEV 222
Query: 174 ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY--MSKQ 231
             G       DVW+ G  +  + +G PP+ + A+    L ++     T E+P +  +S+ 
Sbjct: 223 LHGTYDE-KCDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKGKYTFELPQWKKVSES 280
Query: 232 AQDFLSKCLIRNPGERWSASELLEH----GFVKEQ 262
           A+D + K L   P  R SA + L+H     + KEQ
Sbjct: 281 AKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQ 315

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 123/257 (47%), Gaps = 15/257 (5%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEF--LQREQRILSALACPQIVAYK 61
           + +G+G+ + V   +   +   FA K   + +LS  +F  L+RE RI   L  P IV   
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
              I EE+    + L  +   GG L + I +     E       + +L  + Y HSNGIV
Sbjct: 72  D-SIQEES---FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIV 127
Query: 122 HCDIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           H ++K +N+L+ SK      K+ADFG A    VN+ +      GTP  ++PEV + +   
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 181 FPADVWALGCTVLEMATGRPP-WPDVADPISALHRIG-FSSDTPEIPGYMSKQAQDFLSK 238
            P D+WA G  +  +  G PP W +    + A  + G +   +PE    ++ +A+  +  
Sbjct: 186 KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT-VTPEAKSLIDS 244
Query: 239 CLIRNPGERWSASELLE 255
            L  NP +R +A + L+
Sbjct: 245 MLTVNPKKRITADQALK 261

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 125/262 (47%), Gaps = 15/262 (5%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEF--LQREQRILSALACPQ 56
           ++   + +G+G+ + V   +   +   FA K   + +LS  +F  L+RE RI   L  P 
Sbjct: 30  NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 89
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I EE+    + L  +   GG L + I +     E       + +L  + Y H
Sbjct: 90  IVRLHDS-IQEES---FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 145
Query: 117 SNGIVHCDIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           SNGIVH ++K +N+L+ SK      K+ADFG A    VN+ +      GTP  ++PEV +
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLK 203
Query: 176 GEEQGFPADVWALGCTVLEMATGRPP-WPDVADPISALHRIG-FSSDTPEIPGYMSKQAQ 233
            +    P D+WA G  +  +  G PP W +    + A  + G +   +PE    ++ +A+
Sbjct: 204 KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW-DTVTPEAK 262
Query: 234 DFLSKCLIRNPGERWSASELLE 255
             +   L  NP +R +A + L+
Sbjct: 263 SLIDSMLTVNPKKRITADQALK 284

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 123/257 (47%), Gaps = 15/257 (5%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEF--LQREQRILSALACPQIVAYK 61
           + +G+G+ + V   +   +   FA K   + +LS  +F  L+RE RI   L  P IV   
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
              I EE+    + L  +   GG L + I +     E       + +L  + Y HSNGIV
Sbjct: 72  D-SIQEES---FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIV 127
Query: 122 HCDIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           H ++K +N+L+ SK      K+ADFG A    VN+ +      GTP  ++PEV + +   
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 181 FPADVWALGCTVLEMATGRPP-WPDVADPISALHRIG-FSSDTPEIPGYMSKQAQDFLSK 238
            P D+WA G  +  +  G PP W +    + A  + G +   +PE    ++ +A+  +  
Sbjct: 186 KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT-VTPEAKSLIDS 244
Query: 239 CLIRNPGERWSASELLE 255
            L  NP +R +A + L+
Sbjct: 245 MLTVNPKKRITADQALK 261

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/308 (25%), Positives = 133/308 (43%), Gaps = 55/308 (17%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQI 57
           D+ +   +G G+   V       S  V A K   L     ++    RE ++L     P I
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 128
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH- 116
           V + G   S  +G+I  ++ +E+  GG+L   ++    + E  +   + AV+ GL YL  
Sbjct: 129 VGFYGAFYS--DGEI--SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 184
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
            + I+H D+K  NILV+   E   K+ DFG + +     D       GT   M+PE  +G
Sbjct: 185 KHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQG 239
Query: 177 EEQGFPADVWALGCTVLEMATGRPPWP--------------------------------- 203
                 +D+W++G +++EMA GR P P                                 
Sbjct: 240 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 299
Query: 204 -----DVADPISALHRIGF--SSDTPEIP-GYMSKQAQDFLSKCLIRNPGERWSASELLE 255
                D   P++    + +  +   P++P    S + QDF++KCLI+NP ER    +L+ 
Sbjct: 300 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMV 359
Query: 256 HGFVKEQN 263
           H F+K  +
Sbjct: 360 HAFIKRSD 367

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 130/275 (47%), Gaps = 22/275 (8%)
Query: 2   DWTRGQ-TIGRGSTATVSIGMSNRSSEVFAVKS------AELSNSEFLQREQRILSALAC 54
           D  +GQ  +G+GS   V +     + +  AVK        + ++ E L RE ++L  L  
Sbjct: 50  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 109
Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
           P I+  K  +  E+ G   + L  E   GG L D I S     E       R VL G+ Y
Sbjct: 110 PNIM--KLYEFFEDKG--YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 165
Query: 115 LHSNGIVHCDIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
           +H N IVH D+K +N+L+ SK  +   +I DFG +     ++  + K   GT   +APEV
Sbjct: 166 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPEV 223
Query: 174 ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY--MSKQ 231
             G       DVW+ G  +  + +G PP+ + A+    L ++     T E+P +  +S+ 
Sbjct: 224 LHGTYDE-KCDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKGKYTFELPQWKKVSES 281
Query: 232 AQDFLSKCLIRNPGERWSASELLEH----GFVKEQ 262
           A+D + K L   P  R SA + L+H     + KEQ
Sbjct: 282 AKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQ 316

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           + IG GS +     +   ++  FAVK  + S  +  +  + +L     P I+  K     
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDV--- 84
Query: 67  EENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIK 126
            ++GK +Y +  E   GG L D I       E    +    +   ++YLH+ G+VH D+K
Sbjct: 85  YDDGKYVY-VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLK 143
Query: 127 GQNILVSKD--NEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPA- 183
             NIL   +  N +  +I DFG A++ R        P C T   +APEV   E QG+ A 
Sbjct: 144 PSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP-CYTANFVAPEVL--ERQGYDAA 200
Query: 184 -DVWALGCTVLEMATGRPPWPDVAD--PISALHRIGFSSDTPEIPGY---MSKQAQDFLS 237
            D+W+LG  +  M TG  P+ +  D  P   L RIG S       GY   +S  A+D +S
Sbjct: 201 CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG-SGKFSLSGGYWNSVSDTAKDLVS 259
Query: 238 KCLIRNPGERWSASELLEHGFV 259
           K L  +P +R +A+ +L H ++
Sbjct: 260 KMLHVDPHQRLTAALVLRHPWI 281

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 113/228 (49%), Gaps = 11/228 (4%)
Query: 40  EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEG 99
           E ++RE  IL  +  P ++     ++ E    ++  L  E   GG L D +     L E 
Sbjct: 59  EDIEREVSILKEIQHPNVITLH--EVYENKTDVI--LIGELVAGGELFDFLAEKESLTEE 114
Query: 100 RIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNEDD 157
                 + +L G+ YLHS  I H D+K +NI++   N  +   KI DFG A +  ++  +
Sbjct: 115 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGN 172
Query: 158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRI 215
           E K I GTP  +APE+   E  G  AD+W++G     + +G  P+      + ++ +  +
Sbjct: 173 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232
Query: 216 GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            +  +  E     S  A+DF+ + L+++P +R +  + L+H ++K ++
Sbjct: 233 NYEFED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 123/257 (47%), Gaps = 15/257 (5%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEF--LQREQRILSALACPQIVAYK 61
           + +G+G+ + V   +   +   FA K   + +LS  +F  L+RE RI   L  P IV   
Sbjct: 11  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 70
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
              I EE+    + L  +   GG L + I +     E       + +L  + Y HSNGIV
Sbjct: 71  D-SIQEES---FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIV 126
Query: 122 HCDIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           H ++K +N+L+ SK      K+ADFG A    VN+ +      GTP  ++PEV + +   
Sbjct: 127 HRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 184
Query: 181 FPADVWALGCTVLEMATGRPP-WPDVADPISALHRIG-FSSDTPEIPGYMSKQAQDFLSK 238
            P D+WA G  +  +  G PP W +    + A  + G +   +PE    ++ +A+  +  
Sbjct: 185 KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT-VTPEAKSLIDS 243
Query: 239 CLIRNPGERWSASELLE 255
            L  NP +R +A + L+
Sbjct: 244 MLTVNPKKRITADQALK 260

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 11/219 (5%)
Query: 42  LQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRI 101
           ++RE  IL  +    ++     D+ E    ++  L LE   GG L D +     L E   
Sbjct: 62  IEREVSILRQVLHHNVITLH--DVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEA 117
Query: 102 RSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNEDDEG 159
            S  + +L G+ YLH+  I H D+K +NI++   N      K+ DFG A    + +  E 
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEF 175
Query: 160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRIGF 217
           K I GTP  +APE+   E  G  AD+W++G     + +G  P+      + ++ +  + +
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY 235
Query: 218 SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
             D  E   + S+ A+DF+ K L++   +R +  E L H
Sbjct: 236 DFDE-EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 113/262 (43%), Gaps = 12/262 (4%)
Query: 9   IGRGSTATVSIGMSNRSSEVFA---VKSAELSNSEF--LQREQRILSALACPQIVAYKGC 63
           IGRGS  TV  G+   ++   A   ++  +L+ SE    + E   L  L  P IV +   
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG--IV 121
             S   GK    L  E    GTL   ++     +   +RS  R +L GLQ+LH+    I+
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF 181
           H D+K  NI ++       KI D G A   R +     K + GTP   APE    E+   
Sbjct: 154 HRDLKCDNIFITGPT-GSVKIGDLGLATLKRAS---FAKAVIGTPEFXAPEXYE-EKYDE 208
Query: 182 PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLI 241
             DV+A G   LE AT   P+ +  +      R+               + ++ +  C+ 
Sbjct: 209 SVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268
Query: 242 RNPGERWSASELLEHGFVKEQN 263
           +N  ER+S  +LL H F +E+ 
Sbjct: 269 QNKDERYSIKDLLNHAFFQEET 290

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 122/271 (45%), Gaps = 13/271 (4%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSN--SEFLQ--REQRILSALACPQ 56
           +  G+ +G G  + V +    R     AVK   A+L+   S +L+  RE +  +AL  P 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IVA      +E     L  + +EY  G TL D + +   +   R           L + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV--NEDDEGKPICGTPICMAPEVA 174
            NGI+H D+K  NIL+S  N    K+ DFG AR      N   +   + GT   ++PE A
Sbjct: 134 QNGIIHRDVKPANILISATN--AVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQA 191
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY--MSKQA 232
           RG+     +DV++LGC + E+ TG PP+   + P+S  ++       P    +  +S   
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-PVSVAYQHVREDPIPPSARHEGLSADL 250
Query: 233 QDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
              + K L +NP  R+  +  +    V+  N
Sbjct: 251 DAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 119/260 (45%), Gaps = 14/260 (5%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK----SAELSNSEFLQREQRILSALACPQIVAYKG 62
           +T+G G+ + V +     + ++FAVK     A       ++ E  +L  +    IVA + 
Sbjct: 28  ETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALE- 86
Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
            DI E    +   L ++   GG L D I       E    +  R VL  + YLH  GIVH
Sbjct: 87  -DIYESPNHLY--LVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVH 143
Query: 123 CDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF 181
            D+K +N+L  S+D E    I+DFG ++     + D     CGTP  +APEV   +    
Sbjct: 144 RDLKPENLLYYSQDEESKIMISDFGLSKME--GKGDVMSTACGTPGYVAPEVLAQKPYSK 201
Query: 182 PADVWALGCTVLEMATGRPPWPDVADP--ISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
             D W++G     +  G PP+ D  D      + +  +  D+P     +S  A+DF+   
Sbjct: 202 AVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDD-ISDSAKDFIRNL 260
Query: 240 LIRNPGERWSASELLEHGFV 259
           + ++P +R++  +   H ++
Sbjct: 261 MEKDPNKRYTCEQAARHPWI 280

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 125/267 (46%), Gaps = 16/267 (5%)
Query: 3   WTRGQTIGRGSTATV-----SIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQI 57
           + R + +G G+   V      +    R+ ++    S   S++  L  E  +L  L  P I
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           +  K  D  E+     Y L +E   GG L D I       E       + VL G+ YLH 
Sbjct: 99  M--KLYDFFEDKRN--YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK 154
Query: 118 NGIVHCDIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
           + IVH D+K +N+L+ SK+ +   KI DFG +  A      + K   GT   +APEV R 
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLS--AVFENQKKMKERLGTAYYIAPEVLR- 211
Query: 177 EEQGFPADVWALGCTVLEMATGRPPWPDVADP--ISALHRIGFSSDTPEIPGYMSKQAQD 234
           ++     DVW++G  +  +  G PP+    D   +  + +  ++ D+PE    +S+ A+D
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKN-VSEGAKD 270
Query: 235 FLSKCLIRNPGERWSASELLEHGFVKE 261
            + + L  +   R SA + LEH ++KE
Sbjct: 271 LIKQMLQFDSQRRISAQQALEHPWIKE 297

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 124/262 (47%), Gaps = 12/262 (4%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALACPQIVAYKGCDISE 67
           +GRG+T+ V       + + +A+K  + + + + ++ E  +L  L+ P I+  K  +I E
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLK--EIFE 118
Query: 68  ENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKG 127
              +I  +L LE   GG L D I       E       + +L  + YLH NGIVH D+K 
Sbjct: 119 TPTEI--SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKP 176
Query: 128 QNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVW 186
           +N+L +        KIADFG ++   V      K +CGTP   APE+ RG   G   D+W
Sbjct: 177 ENLLYATPAPDAPLKIADFGLSK--IVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMW 234
Query: 187 ALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY--MSKQAQDFLSKCLIRNP 244
           ++G     +  G  P+ D         RI         P +  +S  A+D + K ++ +P
Sbjct: 235 SVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDP 294
Query: 245 GERWSASELLEHGFV--KEQNF 264
            +R +  + L+H +V  K  NF
Sbjct: 295 KKRLTTFQALQHPWVTGKAANF 316

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 19/223 (8%)
Query: 43  QREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIR 102
           + E+ IL+ +  P +V       +E  GK+   L L++  GG L   +       E  ++
Sbjct: 78  KMERDILADVNHPFVVKLHYAFQTE--GKLY--LILDFLRGGDLFTRLSKEVMFTEEDVK 133
Query: 103 SHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI 162
            +   + LGL +LHS GI++ D+K +NIL+  D E   K+ DFG ++ A ++ + +    
Sbjct: 134 FYLAELALGLDHLHSLGIIYRDLKPENILL--DEEGHIKLTDFGLSKEA-IDHEKKAYSF 190
Query: 163 CGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRIGFSSD 220
           CGT   MAPEV   +     AD W+ G  + EM TG  P+   D  + ++ + +      
Sbjct: 191 CGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLG-- 248
Query: 221 TPEIPGYMSKQAQDFLSKCLIRNPGERW-----SASELLEHGF 258
              +P ++S +AQ  L     RNP  R       A E+  H F
Sbjct: 249 ---MPQFLSTEAQSLLRALFKRNPANRLGSGPDGAEEIKRHVF 288

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 128/275 (46%), Gaps = 22/275 (8%)
Query: 2   DWTRGQ-TIGRGSTATVSIGMSNRSSEVFAVKS------AELSNSEFLQREQRILSALAC 54
           D  +GQ  +G+GS   V +     + +  AVK        + ++ E L RE ++L  L  
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
           P I   K  +  E+ G   + L  E   GG L D I S     E       R VL G+ Y
Sbjct: 86  PNIX--KLYEFFEDKG--YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 141
Query: 115 LHSNGIVHCDIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
            H N IVH D+K +N+L+ SK  +   +I DFG +     ++  + K   GT   +APEV
Sbjct: 142 XHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK--IGTAYYIAPEV 199
Query: 174 ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY--MSKQ 231
             G       DVW+ G  +  + +G PP+ + A+    L ++     T E+P +  +S+ 
Sbjct: 200 LHGTYDE-KCDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKGKYTFELPQWKKVSES 257
Query: 232 AQDFLSKCLIRNPGERWSASELLEH----GFVKEQ 262
           A+D + K L   P  R SA + L+H     + KEQ
Sbjct: 258 AKDLIRKXLTYVPSXRISARDALDHEWIQTYTKEQ 292

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 114/252 (45%), Gaps = 19/252 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKS------AELSNSEFLQREQRILSALACP 55
           D+   +T+G GS   V +  S  +   +A+K         L   E    E+ +LS +  P
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G    ++  +I   + ++Y  GG L   +R          + +   V L L+YL
Sbjct: 67  FIIRMWGT--FQDAQQIF--MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  I++ D+K +NIL+ K+     KI DFG A+       D    +CGTP  +APEV  
Sbjct: 123 HSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYV----PDVTYXLCGTPDYIAPEVVS 176
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +      D W+ G  + EM  G  P+ D ++ +    +I   +     P + ++  +D 
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKI--LNAELRFPPFFNEDVKDL 233
Query: 236 LSKCLIRNPGER 247
           LS+ + R+  +R
Sbjct: 234 LSRLITRDLSQR 245

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 19/261 (7%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEF---LQREQRILSALACPQIVAY 60
           +T+G GS   V +     + +  A+K      L+ S+    ++RE   L  L  P I+  
Sbjct: 20  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHII-- 77
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           K  D+ +   +I+  + +EYA G  L D I     + E   R   + ++  ++Y H + I
Sbjct: 78  KLYDVIKSKDEII--MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 134
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           VH D+K +N+L+  D     KIADFG +    + + +  K  CG+P   APEV  G+   
Sbjct: 135 VHRDLKPENLLL--DEHLNVKIADFGLSN--IMTDGNFLKTSCGSPNYAAPEVISGKLYA 190
Query: 181 FP-ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
            P  DVW+ G  +  M   R P+ D + P+  L +   S+    +P ++S  A   + + 
Sbjct: 191 GPEVDVWSCGVILYVMLCRRLPFDDESIPV--LFK-NISNGVYTLPKFLSPGAAGLIKRM 247
Query: 240 LIRNPGERWSASELLEHGFVK 260
           LI NP  R S  E+++  + K
Sbjct: 248 LIVNPLNRISIHEIMQDDWFK 268

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 19/261 (7%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEF---LQREQRILSALACPQIVAY 60
           +T+G GS   V +     + +  A+K      L+ S+    ++RE   L  L  P I+  
Sbjct: 19  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHII-- 76
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           K  D+ +   +I+  + +EYA G  L D I     + E   R   + ++  ++Y H + I
Sbjct: 77  KLYDVIKSKDEII--MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 133
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           VH D+K +N+L+  D     KIADFG +    + + +  K  CG+P   APEV  G+   
Sbjct: 134 VHRDLKPENLLL--DEHLNVKIADFGLSN--IMTDGNFLKTSCGSPNYAAPEVISGKLYA 189
Query: 181 FP-ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
            P  DVW+ G  +  M   R P+ D + P+  L +   S+    +P ++S  A   + + 
Sbjct: 190 GPEVDVWSCGVILYVMLCRRLPFDDESIPV--LFK-NISNGVYTLPKFLSPGAAGLIKRM 246
Query: 240 LIRNPGERWSASELLEHGFVK 260
           LI NP  R S  E+++  + K
Sbjct: 247 LIVNPLNRISIHEIMQDDWFK 267

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 124/275 (45%), Gaps = 21/275 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE----LSNSEFLQR--EQRILSALACP 55
           D+   + +G+G+   V +     +   +A+K       ++  E      E R+L     P
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            + A K     + + ++ +   +EYA GG L   +       E R R +   ++  L+YL
Sbjct: 66  FLTALKYA--FQTHDRLCF--VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  +V+ DIK +N+++ KD     KI DFG  +   +++    K  CGTP  +APEV  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEG-ISDGATMKXFCGTPEYLAPEVLE 178
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
             + G   D W LG  + EM  GR P+ +  D       I    +    P  +S +A+  
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELI--LMEEIRFPRTLSPEAKSL 235
Query: 236 LSKCLIRNPGERW-----SASELLEHGFVKEQNFK 265
           L+  L ++P +R       A E++EH F    N++
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 122/273 (44%), Gaps = 21/273 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE----LSNSEFLQR--EQRILSALACP 55
           D+   + +G+G+   V +     +   +A+K       ++  E      E R+L     P
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            + A K     + + ++ +   +EYA GG L   +       E R R +   ++  L+YL
Sbjct: 66  FLTALKYA--FQTHDRLCF--VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  +V+ DIK +N+++ KD     KI DFG  +   +++    K  CGTP  +APEV  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLE 178
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
             + G   D W LG  + EM  GR P+ +  D       I    +    P  +S +A+  
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELI--LMEEIRFPRTLSPEAKSL 235
Query: 236 LSKCLIRNPGERW-----SASELLEHGFVKEQN 263
           L+  L ++P +R       A E++EH F    N
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 19/261 (7%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEF---LQREQRILSALACPQIVAY 60
           +T+G GS   V +     + +  A+K      L+ S+    ++RE   L  L  P I+  
Sbjct: 10  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHII-- 67
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           K  D+ +   +I+  + +EYA G  L D I     + E   R   + ++  ++Y H + I
Sbjct: 68  KLYDVIKSKDEII--MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 124
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           VH D+K +N+L+  D     KIADFG +    + + +  K  CG+P   APEV  G+   
Sbjct: 125 VHRDLKPENLLL--DEHLNVKIADFGLSN--IMTDGNFLKTSCGSPNYAAPEVISGKLYA 180
Query: 181 FP-ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
            P  DVW+ G  +  M   R P+ D + P+  L +   S+    +P ++S  A   + + 
Sbjct: 181 GPEVDVWSCGVILYVMLCRRLPFDDESIPV--LFK-NISNGVYTLPKFLSPGAAGLIKRM 237
Query: 240 LIRNPGERWSASELLEHGFVK 260
           LI NP  R S  E+++  + K
Sbjct: 238 LIVNPLNRISIHEIMQDDWFK 258

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 124/275 (45%), Gaps = 21/275 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE----LSNSEFLQR--EQRILSALACP 55
           D+   + +G+G+   V +     +   +A+K       ++  E      E R+L     P
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            + A K     + + ++ +   +EYA GG L   +       E R R +   ++  L+YL
Sbjct: 66  FLTALKYA--FQTHDRLCF--VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  +V+ DIK +N+++ KD     KI DFG  +   +++    K  CGTP  +APEV  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLE 178
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
             + G   D W LG  + EM  GR P+ +  D       I    +    P  +S +A+  
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELI--LMEEIRFPRTLSPEAKSL 235
Query: 236 LSKCLIRNPGERW-----SASELLEHGFVKEQNFK 265
           L+  L ++P +R       A E++EH F    N++
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 11/221 (4%)
Query: 40  EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEG 99
           E ++RE  IL  +    ++     D+ E    ++  L LE   GG L D +     L E 
Sbjct: 60  EEIEREVSILRQVLHHNVITLH--DVYENRTDVV--LILELVSGGELFDFLAQKESLSEE 115
Query: 100 RIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNEDD 157
              S  + +L G+ YLH+  I H D+K +NI++   N      K+ DFG A    + +  
Sbjct: 116 EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGV 173
Query: 158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRI 215
           E K I GTP  +APE+   E  G  AD+W++G     + +G  P+      + ++ +  +
Sbjct: 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233
Query: 216 GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
            +  D  E     S+ A+DF+ K L++   +R +  E L H
Sbjct: 234 SYDFD-EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 11/219 (5%)
Query: 42  LQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRI 101
           ++RE  IL  +    ++     D+ E    ++  L LE   GG L D +     L E   
Sbjct: 62  IEREVSILRQVLHHNVITLH--DVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEA 117
Query: 102 RSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRARVNEDDEG 159
            S  + +L G+ YLH+  I H D+K +NI++   N      K+ DFG A    + +  E 
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEF 175
Query: 160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRIGF 217
           K I GTP  +APE+   E  G  AD+W++G     + +G  P+      + ++ +  + +
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY 235
Query: 218 SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
             D  E     S+ A+DF+ K L++   +R +  E L H
Sbjct: 236 DFD-EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 122/271 (45%), Gaps = 13/271 (4%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSN--SEFLQ--REQRILSALACPQ 56
           +  G+ +G G  + V +    R     AVK   A+L+   S +L+  RE +  +AL  P 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IVA      +E     L  + +EY  G TL D + +   +   R           L + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV--NEDDEGKPICGTPICMAPEVA 174
            NGI+H D+K  NI++S  N    K+ DFG AR      N   +   + GT   ++PE A
Sbjct: 134 QNGIIHRDVKPANIMISATN--AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY--MSKQA 232
           RG+     +DV++LGC + E+ TG PP+   + P+S  ++       P    +  +S   
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-PVSVAYQHVREDPIPPSARHEGLSADL 250
Query: 233 QDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
              + K L +NP  R+  +  +    V+  N
Sbjct: 251 DAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 124/275 (45%), Gaps = 21/275 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE----LSNSEFLQR--EQRILSALACP 55
           D+   + +G+G+   V +     +   +A+K       ++  E      E R+L     P
Sbjct: 11  DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 70
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            + A K     + + ++ +   +EYA GG L   +       E R R +   ++  L+YL
Sbjct: 71  FLTALKYA--FQTHDRLCF--VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 126
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  +V+ DIK +N+++ KD     KI DFG  +   +++    K  CGTP  +APEV  
Sbjct: 127 HSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEG-ISDGATMKXFCGTPEYLAPEVLE 183
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
             + G   D W LG  + EM  GR P+ +  D       I    +    P  +S +A+  
Sbjct: 184 DNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELI--LMEEIRFPRTLSPEAKSL 240
Query: 236 LSKCLIRNPGERW-----SASELLEHGFVKEQNFK 265
           L+  L ++P +R       A E++EH F    N++
Sbjct: 241 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 275

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 122/273 (44%), Gaps = 21/273 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE----LSNSEFLQR--EQRILSALACP 55
           D+   + +G+G+   V +     +   +A+K       ++  E      E R+L     P
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            + A K     + + ++ +   +EYA GG L   +       E R R +   ++  L+YL
Sbjct: 66  FLTALKYA--FQTHDRLCF--VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  +V+ DIK +N+++ KD     KI DFG  +   +++    K  CGTP  +APEV  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEG-ISDGATMKXFCGTPEYLAPEVLE 178
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
             + G   D W LG  + EM  GR P+ +  D       I    +    P  +S +A+  
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELI--LMEEIRFPRTLSPEAKSL 235
Query: 236 LSKCLIRNPGERW-----SASELLEHGFVKEQN 263
           L+  L ++P +R       A E++EH F    N
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 122/273 (44%), Gaps = 21/273 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE----LSNSEFLQR--EQRILSALACP 55
           D+   + +G+G+   V +     +   +A+K       ++  E      E R+L     P
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            + A K     + + ++ +   +EYA GG L   +       E R R +   ++  L+YL
Sbjct: 66  FLTALKYA--FQTHDRLCF--VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  +V+ DIK +N+++ KD     KI DFG  +   +++    K  CGTP  +APEV  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEG-ISDGATMKXFCGTPEYLAPEVLE 178
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
             + G   D W LG  + EM  GR P+ +  D       I    +    P  +S +A+  
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELI--LMEEIRFPRTLSPEAKSL 235
Query: 236 LSKCLIRNPGERW-----SASELLEHGFVKEQN 263
           L+  L ++P +R       A E++EH F    N
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 19/261 (7%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEF---LQREQRILSALACPQIVAY 60
           +T+G GS   V +     + +  A+K      L+ S+    ++RE   L  L  P I+  
Sbjct: 14  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHII-- 71
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           K  D+ +   +I+  + +EYA G  L D I     + E   R   + ++  ++Y H + I
Sbjct: 72  KLYDVIKSKDEII--MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 128
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           VH D+K +N+L+  D     KIADFG +    + + +  K  CG+P   APEV  G+   
Sbjct: 129 VHRDLKPENLLL--DEHLNVKIADFGLSN--IMTDGNFLKTSCGSPNYAAPEVISGKLYA 184
Query: 181 FP-ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
            P  DVW+ G  +  M   R P+ D + P+  L +   S+    +P ++S  A   + + 
Sbjct: 185 GPEVDVWSCGVILYVMLCRRLPFDDESIPV--LFK-NISNGVYTLPKFLSPGAAGLIKRM 241
Query: 240 LIRNPGERWSASELLEHGFVK 260
           LI NP  R S  E+++  + K
Sbjct: 242 LIVNPLNRISIHEIMQDDWFK 262

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 122/273 (44%), Gaps = 21/273 (7%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE----LSNSEFLQR--EQRILSALACP 55
           D+   + +G+G+   V +     +   +A+K       ++  E      E R+L     P
Sbjct: 9   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 68
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            + A K     + + ++ +   +EYA GG L   +       E R R +   ++  L+YL
Sbjct: 69  FLTALKYA--FQTHDRLCF--VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 124
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  +V+ DIK +N+++ KD     KI DFG  +   +++    K  CGTP  +APEV  
Sbjct: 125 HSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLE 181
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
             + G   D W LG  + EM  GR P+ +  D       I    +    P  +S +A+  
Sbjct: 182 DNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELI--LMEEIRFPRTLSPEAKSL 238
Query: 236 LSKCLIRNPGERW-----SASELLEHGFVKEQN 263
           L+  L ++P +R       A E++EH F    N
Sbjct: 239 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 271

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 122/271 (45%), Gaps = 13/271 (4%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSN--SEFLQ--REQRILSALACPQ 56
           +  G+ +G G  + V +    R     AVK   A+L+   S +L+  RE +  +AL  P 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IVA      +E     L  + +EY  G TL D + +   +   R           L + H
Sbjct: 74  IVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV--NEDDEGKPICGTPICMAPEVA 174
            NGI+H D+K  NI++S  N    K+ DFG AR      N   +   + GT   ++PE A
Sbjct: 134 QNGIIHRDVKPANIMISATN--AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY--MSKQA 232
           RG+     +DV++LGC + E+ TG PP+   + P+S  ++       P    +  +S   
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-PVSVAYQHVREDPIPPSARHEGLSADL 250
Query: 233 QDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
              + K L +NP  R+  +  +    V+  N
Sbjct: 251 DAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 84/320 (26%), Positives = 145/320 (45%), Gaps = 41/320 (12%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILS--ALACPQIVAYKGCD 64
           + IG G+     +    +S+E+ AVK  E         ++ I++  +L  P IV +K   
Sbjct: 25  KDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVI 84
Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           ++  +  I+    +EYA GG L + I +     E   R   + ++ G+ Y H+  + H D
Sbjct: 85  LTPTHLAIV----MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 140
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV-ARGEEQGFPA 183
           +K +N L+        KI DFG ++ + ++   + K   GTP  +APEV  + E  G  A
Sbjct: 141 LKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYDGKVA 198
Query: 184 DVWALGCTVLEMATGRPPWPDVADPIS---ALHRIGFSSDTPEIPGY--MSKQAQDFLSK 238
           DVW+ G T+  M  G  P+ D  +P +    +HRI   +    IP Y  +S + +  +S+
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI--LNVQYAIPDYVHISPECRHLISR 256
Query: 239 CLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLTSCSS 298
             + +P +R S  E+  H                E +    P  ++N    D+T+T+   
Sbjct: 257 IFVADPAKRISIPEIRNH----------------EWFLKNLPADLMN----DNTMTTQFD 296
Query: 299 ASAK-----ERIRQLIGEGS 313
            S +     E I Q+I E +
Sbjct: 297 ESDQPGQSIEEIMQIIAEAT 316

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 146/307 (47%), Gaps = 30/307 (9%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALACPQIVAYKGC 63
           +G+GS   V       + + +AVK     SA+  ++  + RE  +L  L  P I+  K  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM--KLF 87
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
           +I E++    + +  E   GG L D I       E       + V  G+ Y+H + IVH 
Sbjct: 88  EILEDSSS--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHR 145
Query: 124 DIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFP 182
           D+K +NIL+ SK+ +   KI DFG +      ++ + K   GT   +APEV RG      
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLS--TCFQQNTKMKDRIGTAYYIAPEVLRGTYDE-K 202
Query: 183 ADVWALGCTVLEMATGRPPW--PDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCL 240
            DVW+ G  +  + +G PP+   +  D +  +    ++ D P+    +S  A+D + K L
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT-ISDDAKDLIRKML 261
Query: 241 IRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLTSCSSAS 300
             +P  R +A++ LEH ++++             Y+SE+PT + +    +S +T+     
Sbjct: 262 TFHPSLRITATQCLEHPWIQK-------------YSSETPT-ISDLPSLESAMTNIRQFQ 307
Query: 301 AKERIRQ 307
           A++++ Q
Sbjct: 308 AEKKLAQ 314

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 118/237 (49%), Gaps = 10/237 (4%)
Query: 31  VKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTD-A 89
           +K+  + + E ++ E  +++ L    ++     D  E    I+  L +EY  GG L D  
Sbjct: 122 IKTRGMKDKEEVKNEISVMNQLDHANLIQL--YDAFESKNDIV--LVMEYVDGGELFDRI 177
Query: 90  IRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR 149
           I     L E       + +  G++++H   I+H D+K +NIL    + +  KI DFG AR
Sbjct: 178 IDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLAR 237
Query: 150 RARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVAD 207
           R +  E  + K   GTP  +APEV   +   FP D+W++G     + +G  P+   + A+
Sbjct: 238 RYKPRE--KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE 295
Query: 208 PISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
            ++ +    +  +  E    +S++A++F+SK LI+    R SASE L+H ++ +   
Sbjct: 296 TLNNILACRWDLEDEEFQD-ISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKL 351

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 108/222 (48%), Gaps = 14/222 (6%)
Query: 39  SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGT--C 95
           +EFL RE  I+  L  P IV + G      N  I+     EY   G+L   + +SG    
Sbjct: 79  NEFL-REVAIMKRLRHPNIVLFMGAVTQPPNLSIV----TEYLSRGSLYRLLHKSGAREQ 133
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNG--IVHCDIKGQNILVSKDNEQGAKIADFGCARRARV 153
           L+E R  S    V  G+ YLH+    IVH D+K  N+LV  D +   K+ DFG +R  + 
Sbjct: 134 LDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLV--DKKYTVKVCDFGLSR-LKA 190
Query: 154 NEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALH 213
           +     K   GTP  MAPEV R E     +DV++ G  + E+AT + PW ++ +P   + 
Sbjct: 191 SXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL-NPAQVVA 249
Query: 214 RIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
            +GF     EIP  ++ Q    +  C    P +R S + +++
Sbjct: 250 AVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           + IG GS +     +   ++  FAVK  + S  +  +  + +L     P I+  K     
Sbjct: 28  EDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDV--- 84
Query: 67  EENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIK 126
            ++GK +Y +  E   GG L D I       E    +    +   ++YLH+ G+VH D+K
Sbjct: 85  YDDGKYVY-VVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLK 143
Query: 127 GQNILVSKD--NEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPA- 183
             NIL   +  N +  +I DFG A++ R        P C T   +APEV   E QG+ A 
Sbjct: 144 PSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTP-CYTANFVAPEVL--ERQGYDAA 200
Query: 184 -DVWALGCTVLEMATGRPPWPDVAD--PISALHRIGFSSDTPEIPGY---MSKQAQDFLS 237
            D+W+LG  +    TG  P+ +  D  P   L RIG S       GY   +S  A+D +S
Sbjct: 201 CDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIG-SGKFSLSGGYWNSVSDTAKDLVS 259
Query: 238 KCLIRNPGERWSASELLEHGFV 259
           K L  +P +R +A+ +L H ++
Sbjct: 260 KXLHVDPHQRLTAALVLRHPWI 281

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 122/271 (45%), Gaps = 13/271 (4%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSN--SEFLQ--REQRILSALACPQ 56
           +  G+ +G G  + V +    R     AVK   A+L+   S +L+  RE +  +AL  P 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IVA      +E     L  + +EY  G TL D + +   +   R           L + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV--NEDDEGKPICGTPICMAPEVA 174
            NGI+H D+K  NI++S  N    K+ DFG AR      N   +   + GT   ++PE A
Sbjct: 134 QNGIIHRDVKPANIMISATN--AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY--MSKQA 232
           RG+     +DV++LGC + E+ TG PP+   + P+S  ++       P    +  +S   
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-PVSVAYQHVREDPIPPSARHEGLSADL 250
Query: 233 QDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
              + K L +NP  R+  +  +    V+  N
Sbjct: 251 DAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 75  NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSK 134
           +L L+Y  GG L   +       E  ++ +   ++L L++LH  GI++ DIK +NIL+  
Sbjct: 135 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL-- 192
Query: 135 DNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF--PADVWALGCTV 192
           D+     + DFG ++    +E +     CGT   MAP++ RG + G     D W+LG  +
Sbjct: 193 DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLM 252
Query: 193 LEMATGRPPWPDVADPISA--LHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERW-- 248
            E+ TG  P+    +  S   + R    S+ P  P  MS  A+D + + L+++P +R   
Sbjct: 253 YELLTGASPFTVDGEKNSQAEISRRILKSEPP-YPQEMSALAKDLIQRLLMKDPKKRLGC 311
Query: 249 ---SASELLEHGFVKEQN 263
               A E+ EH F ++ N
Sbjct: 312 GPRDADEIKEHLFFQKIN 329

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 128/279 (45%), Gaps = 16/279 (5%)
Query: 7   QTIGRGSTATVS-----IGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           + +G+G+ + V      +     ++ +   K     + + L+RE RI   L  P IV   
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
              ISEE     + L  +   GG L + I +     E       + +L  + + H  G+V
Sbjct: 77  D-SISEEGH---HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVV 132
Query: 122 HCDIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           H ++K +N+L+ SK      K+ADFG A      E        GTP  ++PEV R +  G
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGYLSPEVLRKDPYG 191
Query: 181 FPADVWALGCTVLEMATGRPPWPDVADPISALHRI---GFSSDTPEIPGYMSKQAQDFLS 237
            P D+WA G  +  +  G PP+ D  D      +I    +   +PE    ++ +A+D ++
Sbjct: 192 KPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDT-VTPEAKDLIN 249
Query: 238 KCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYN 276
           K L  NP +R +A+E L+H ++  ++   S +   ET +
Sbjct: 250 KMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVD 288

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 121/262 (46%), Gaps = 20/262 (7%)
Query: 8   TIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSE-FLQREQRILSALACPQIVAYKGC 63
            +G G+ + V +    R+ ++ A+K      L   E  ++ E  +L  +  P IVA    
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD-- 82
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
           DI E  G +   L ++   GG L D I       E         VL  ++YLH  GIVH 
Sbjct: 83  DIYESGGHLY--LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 140
Query: 124 DIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPI---CGTPICMAPEVARGEEQ 179
           D+K +N+L  S D +    I+DFG ++      +D G  +   CGTP  +APEV   +  
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSKM-----EDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADP--ISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
               D W++G     +  G PP+ D  D      + +  +  D+P     +S  A+DF+ 
Sbjct: 196 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD-ISDSAKDFIR 254
Query: 238 KCLIRNPGERWSASELLEHGFV 259
             + ++P +R++  + L+H ++
Sbjct: 255 HLMEKDPEKRFTCEQALQHPWI 276

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 125/282 (44%), Gaps = 35/282 (12%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSN--SEFLQ--REQRILSALACPQ 56
           +  G+ +G G  + V +    R     AVK   A+L+   S +L+  RE +  +AL  P 
Sbjct: 31  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 90
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IVA      +E     L  + +EY  G TL D + +   +   R           L + H
Sbjct: 91  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 150
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV--NEDDEGKPICGTPICMAPEVA 174
            NGI+H D+K  NI++S  N    K+ DFG AR      N   +   + GT   ++PE A
Sbjct: 151 QNGIIHRDVKPANIMISATN--AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 208
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWP-----DVA------DPI--SALHRIGFSSDT 221
           RG+     +DV++LGC + E+ TG PP+       VA      DPI  SA H  G S+D 
Sbjct: 209 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE-GLSADL 267
Query: 222 PEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
             +           + K L +NP  R+  +  +    V+  N
Sbjct: 268 DAV-----------VLKALAKNPENRYQTAAEMRADLVRVHN 298

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 121/262 (46%), Gaps = 20/262 (7%)
Query: 8   TIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSE-FLQREQRILSALACPQIVAYKGC 63
            +G G+ + V +    R+ ++ A+K      L   E  ++ E  +L  +  P IVA    
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD-- 82
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
           DI E  G +   L ++   GG L D I       E         VL  ++YLH  GIVH 
Sbjct: 83  DIYESGGHLY--LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 140
Query: 124 DIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPI---CGTPICMAPEVARGEEQ 179
           D+K +N+L  S D +    I+DFG ++      +D G  +   CGTP  +APEV   +  
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSKM-----EDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADP--ISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
               D W++G     +  G PP+ D  D      + +  +  D+P     +S  A+DF+ 
Sbjct: 196 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD-ISDSAKDFIR 254
Query: 238 KCLIRNPGERWSASELLEHGFV 259
             + ++P +R++  + L+H ++
Sbjct: 255 HLMEKDPEKRFTCEQALQHPWI 276

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 123/254 (48%), Gaps = 19/254 (7%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEF---LQREQRILSALACPQIVAY 60
           +T+G GS   V +    ++ +  A+K      L  S+    ++RE   L  L  P I+  
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII-- 72
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           K  D+      I+  + +EYA GG L D I     + E   R   + ++  ++Y H + I
Sbjct: 73  KLYDVITTPTDIV--MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI 129
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           VH D+K +N+L+  D+    KIADFG +    + + +  K  CG+P   APEV  G+   
Sbjct: 130 VHRDLKPENLLL--DDNLNVKIADFGLSN--IMTDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 181 FP-ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
            P  DVW+ G  +  M  GR P+ D   P +   ++  +S    +P ++S  AQ  + + 
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIP-NLFKKV--NSCVYVMPDFLSPGAQSLIRRM 242
Query: 240 LIRNPGERWSASEL 253
           ++ +P +R +  E+
Sbjct: 243 IVADPMQRITIQEI 256

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 121/262 (46%), Gaps = 20/262 (7%)
Query: 8   TIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSE-FLQREQRILSALACPQIVAYKGC 63
            +G G+ + V +    R+ ++ A+K      L   E  ++ E  +L  +  P IVA    
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD-- 82
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
           DI E  G +   L ++   GG L D I       E         VL  ++YLH  GIVH 
Sbjct: 83  DIYESGGHLY--LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 140
Query: 124 DIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPI---CGTPICMAPEVARGEEQ 179
           D+K +N+L  S D +    I+DFG ++      +D G  +   CGTP  +APEV   +  
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSKM-----EDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADP--ISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
               D W++G     +  G PP+ D  D      + +  +  D+P     +S  A+DF+ 
Sbjct: 196 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD-ISDSAKDFIR 254
Query: 238 KCLIRNPGERWSASELLEHGFV 259
             + ++P +R++  + L+H ++
Sbjct: 255 HLMEKDPEKRFTCEQALQHPWI 276

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 119/265 (44%), Gaps = 18/265 (6%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF------LQREQRILSALACP 55
           D+   + +G+G    V +    ++  + A+K    S  E       L+RE  I S L  P
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+  +  +   +  +I   L LE+AP G L   ++     +E R  +    +   L Y 
Sbjct: 75  NIL--RMYNYFHDRKRIY--LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYC 130
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           H   ++H DIK +N+L+    E   KIADFG +  A        + +CGT   + PE+  
Sbjct: 131 HERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHA---PSLRRRXMCGTLDYLPPEMIE 185
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
           G+      D+W  G    E   G PP+   +   +  HR   + D  + P ++S  ++D 
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--TETHRRIVNVDL-KFPPFLSDGSKDL 242
Query: 236 LSKCLIRNPGERWSASELLEHGFVK 260
           +SK L  +P +R     ++EH +VK
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHPWVK 267

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 121/262 (46%), Gaps = 20/262 (7%)
Query: 8   TIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSE-FLQREQRILSALACPQIVAYKGC 63
            +G G+ + V +    R+ ++ A+K      L   E  ++ E  +L  +  P IVA    
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD-- 82
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
           DI E  G +   L ++   GG L D I       E         VL  ++YLH  GIVH 
Sbjct: 83  DIYESGGHLY--LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 140
Query: 124 DIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPI---CGTPICMAPEVARGEEQ 179
           D+K +N+L  S D +    I+DFG ++      +D G  +   CGTP  +APEV   +  
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSKM-----EDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADP--ISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
               D W++G     +  G PP+ D  D      + +  +  D+P     +S  A+DF+ 
Sbjct: 196 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD-ISDSAKDFIR 254
Query: 238 KCLIRNPGERWSASELLEHGFV 259
             + ++P +R++  + L+H ++
Sbjct: 255 HLMEKDPEKRFTCEQALQHPWI 276

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 116/262 (44%), Gaps = 20/262 (7%)
Query: 1   MDWTRGQT-IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVA 59
           + W   Q  +GRGS   V      ++    AVK   L    F   E    + L  P+IV 
Sbjct: 73  VHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEV--FRAEELMACAGLTSPRIVP 130
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
             G   +   G  + N+F+E   GG+L   ++   CL E R   +    L GL+YLHS  
Sbjct: 131 LYG---AVREGPWV-NIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR 186
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG---CARRARVNED-DEGKPICGTPICMAPEVAR 175
           I+H D+K  N+L+S D    A + DFG   C +   + +D   G  I GT   MAPEV  
Sbjct: 187 ILHGDVKADNVLLSSDGSHAA-LCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVL 245
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPD-VADPISALHRIGFSSDTP---EIPGYMSKQ 231
           G       DVW+  C +L M  G  PW      P+     +  +S+ P   EIP   +  
Sbjct: 246 GRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLC----LKIASEPPPVREIPPSCAPL 301
Query: 232 AQDFLSKCLIRNPGERWSASEL 253
               + + L + P  R SA+EL
Sbjct: 302 TAQAIQEGLRKEPIHRVSAAEL 323

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/320 (26%), Positives = 144/320 (45%), Gaps = 41/320 (12%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS--EFLQREQRILSALACPQIVAYKGCD 64
           + IG G+     +    +S+E+ AVK  E      E ++RE     +L  P IV +K   
Sbjct: 25  KDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVI 84
Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           ++  +  I+    +EYA GG L + I +     E   R   + ++ G+ Y H+  + H D
Sbjct: 85  LTPTHLAIV----MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 140
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV-ARGEEQGFPA 183
           +K +N L+        KI  FG ++ + ++   + K   GTP  +APEV  + E  G  A
Sbjct: 141 LKLENTLLDGSPAPRLKICAFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYDGKVA 198
Query: 184 DVWALGCTVLEMATGRPPWPDVADPIS---ALHRIGFSSDTPEIPGY--MSKQAQDFLSK 238
           DVW+ G T+  M  G  P+ D  +P +    +HRI   +    IP Y  +S + +  +S+
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI--LNVQYAIPDYVHISPECRHLISR 256
Query: 239 CLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLTSCSS 298
             + +P +R S  E+  H                E +    P  ++N    D+T+T+   
Sbjct: 257 IFVADPAKRISIPEIRNH----------------EWFLKNLPADLMN----DNTMTTQFD 296
Query: 299 ASAK-----ERIRQLIGEGS 313
            S +     E I Q+I E +
Sbjct: 297 ESDQPGQSIEEIMQIIAEAT 316

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 125/270 (46%), Gaps = 31/270 (11%)
Query: 7   QTIGRGSTATVSIGMS---NRSSEVFAVKSAELSNSEFLQR-----EQRILSALACPQIV 58
           + +G+GS   V +      + + +++A+K  + +  +   R     E+ IL  +  P IV
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
                  +E  GK+   L L++  GG L   +       E  ++ +   + L L +LHS 
Sbjct: 90  KLHYAFQTE--GKLY--LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 145
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA--RG 176
           GI++ D+K +NIL+  D E   K+ DFG ++ + ++ + +    CGT   MAPEV   RG
Sbjct: 146 GIIYRDLKPENILL--DEEGHIKLTDFGLSKES-IDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 177 EEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRIGFSSDTPEIPGYMSKQAQD 234
             Q   AD W+ G  + EM TG  P+   D  + ++ + +         +P ++S +AQ 
Sbjct: 203 HTQS--ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG-----MPQFLSPEAQS 255
Query: 235 FLSKCLIRNPGERWSA-----SELLEHGFV 259
            L     RNP  R  A      E+  H F 
Sbjct: 256 LLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/320 (26%), Positives = 144/320 (45%), Gaps = 41/320 (12%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS--EFLQREQRILSALACPQIVAYKGCD 64
           + IG G+     +    +S+E+ AVK  E      E ++RE     +L  P IV +K   
Sbjct: 25  KDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVI 84
Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           ++  +  I+    +EYA GG L + I +     E   R   + ++ G+ Y H+  + H D
Sbjct: 85  LTPTHLAIV----MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 140
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV-ARGEEQGFPA 183
           +K +N L+        KI  FG ++ + ++   + K   GTP  +APEV  + E  G  A
Sbjct: 141 LKLENTLLDGSPAPRLKICAFGYSKSSVLHS--QPKDTVGTPAYIAPEVLLKKEYDGKVA 198
Query: 184 DVWALGCTVLEMATGRPPWPDVADPIS---ALHRIGFSSDTPEIPGY--MSKQAQDFLSK 238
           DVW+ G T+  M  G  P+ D  +P +    +HRI   +    IP Y  +S + +  +S+
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI--LNVQYAIPDYVHISPECRHLISR 256
Query: 239 CLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLTSCSS 298
             + +P +R S  E+  H                E +    P  ++N    D+T+T+   
Sbjct: 257 IFVADPAKRISIPEIRNH----------------EWFLKNLPADLMN----DNTMTTQFD 296
Query: 299 ASAK-----ERIRQLIGEGS 313
            S +     E I Q+I E +
Sbjct: 297 ESDQPGQSIEEIMQIIAEAT 316

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 108/222 (48%), Gaps = 14/222 (6%)
Query: 39  SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGT--C 95
           +EFL RE  I+  L  P IV + G      N  I+     EY   G+L   + +SG    
Sbjct: 79  NEFL-REVAIMKRLRHPNIVLFMGAVTQPPNLSIV----TEYLSRGSLYRLLHKSGAREQ 133
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNG--IVHCDIKGQNILVSKDNEQGAKIADFGCARRARV 153
           L+E R  S    V  G+ YLH+    IVH ++K  N+LV  D +   K+ DFG +R  + 
Sbjct: 134 LDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV--DKKYTVKVCDFGLSR-LKA 190
Query: 154 NEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALH 213
           +     K   GTP  MAPEV R E     +DV++ G  + E+AT + PW ++ +P   + 
Sbjct: 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL-NPAQVVA 249
Query: 214 RIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
            +GF     EIP  ++ Q    +  C    P +R S + +++
Sbjct: 250 AVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 125/269 (46%), Gaps = 31/269 (11%)
Query: 7   QTIGRGSTATVSIGMS---NRSSEVFAVKSAELSNSEFLQR-----EQRILSALACPQIV 58
           + +G+GS   V +      + + +++A+K  + +  +   R     E+ IL  +  P IV
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 90
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
                  +E  GK+   L L++  GG L   +       E  ++ +   + L L +LHS 
Sbjct: 91  KLHYAFQTE--GKLY--LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 146
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA--RG 176
           GI++ D+K +NIL+  D E   K+ DFG ++ + ++ + +    CGT   MAPEV   RG
Sbjct: 147 GIIYRDLKPENILL--DEEGHIKLTDFGLSKES-IDHEKKAYSFCGTVEYMAPEVVNRRG 203
Query: 177 EEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRIGFSSDTPEIPGYMSKQAQD 234
             Q   AD W+ G  + EM TG  P+   D  + ++ + +         +P ++S +AQ 
Sbjct: 204 HTQS--ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG-----MPQFLSPEAQS 256
Query: 235 FLSKCLIRNPGERWSA-----SELLEHGF 258
            L     RNP  R  A      E+  H F
Sbjct: 257 LLRMLFKRNPANRLGAGPDGVEEIKRHSF 285

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 125/269 (46%), Gaps = 31/269 (11%)
Query: 7   QTIGRGSTATVSIGMS---NRSSEVFAVKSAELSNSEFLQR-----EQRILSALACPQIV 58
           + +G+GS   V +      + + +++A+K  + +  +   R     E+ IL  +  P IV
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
                  +E  GK+   L L++  GG L   +       E  ++ +   + L L +LHS 
Sbjct: 90  KLHYAFQTE--GKLY--LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 145
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA--RG 176
           GI++ D+K +NIL+  D E   K+ DFG ++ + ++ + +    CGT   MAPEV   RG
Sbjct: 146 GIIYRDLKPENILL--DEEGHIKLTDFGLSKES-IDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 177 EEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRIGFSSDTPEIPGYMSKQAQD 234
             Q   AD W+ G  + EM TG  P+   D  + ++ + +         +P ++S +AQ 
Sbjct: 203 HTQS--ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG-----MPQFLSPEAQS 255
Query: 235 FLSKCLIRNPGERWSA-----SELLEHGF 258
            L     RNP  R  A      E+  H F
Sbjct: 256 LLRMLFKRNPANRLGAGPDGVEEIKRHSF 284

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 129/278 (46%), Gaps = 18/278 (6%)
Query: 7   QTIGRGSTATVSIGMS-----NRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           + IG+G+ + V   +        ++++   K     + + L+RE RI   L    IV   
Sbjct: 10  EDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLH 69
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
              ISEE     + L  +   GG L + I +     E       + +L  + + H  G+V
Sbjct: 70  D-SISEEG---FHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVV 125
Query: 122 HCDIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEG-KPICGTPICMAPEVARGEEQ 179
           H D+K +N+L+ SK      K+ADFG A    V  D +      GTP  ++PEV R E  
Sbjct: 126 HRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPEVLRKEAY 183
Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI---GFSSDTPEIPGYMSKQAQDFL 236
           G P D+WA G  +  +  G PP+ D  D      +I    +   +PE    ++ +A++ +
Sbjct: 184 GKPVDIWACGVILYILLVGYPPFWD-EDQHKLYQQIKAGAYDFPSPEWDT-VTPEAKNLI 241
Query: 237 SKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPET 274
           ++ L  NP +R +A E L+H +V +++   S +   ET
Sbjct: 242 NQMLTINPAKRITAHEALKHPWVCQRSTVASMMHRQET 279

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 115/264 (43%), Gaps = 24/264 (9%)
Query: 1   MDWTRGQT-IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVA 59
           + W   Q  +GRGS   V      ++    AVK   L    F   E    + L  P+IV 
Sbjct: 92  VHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEV--FRAEELMACAGLTSPRIVP 149
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
             G   +   G  + N+F+E   GG+L   ++   CL E R   +    L GL+YLHS  
Sbjct: 150 LYG---AVREGPWV-NIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR 205
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP------ICGTPICMAPEV 173
           I+H D+K  N+L+S D    A + DFG A    +  D  GK       I GT   MAPEV
Sbjct: 206 ILHGDVKADNVLLSSDGSHAA-LCDFGHA--VCLQPDGLGKSLLTGDYIPGTETHMAPEV 262
Query: 174 ARGEEQGFPADVWALGCTVLEMATGRPPWPD-VADPISALHRIGFSSDTP---EIPGYMS 229
             G       DVW+  C +L M  G  PW      P+     +  +S+ P   EIP   +
Sbjct: 263 VLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLC----LKIASEPPPVREIPPSCA 318
Query: 230 KQAQDFLSKCLIRNPGERWSASEL 253
                 + + L + P  R SA+EL
Sbjct: 319 PLTAQAIQEGLRKEPIHRVSAAEL 342

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 84/309 (27%), Positives = 133/309 (43%), Gaps = 59/309 (19%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQI 57
           D+ R   +G G+   V+      S  + A K   L     ++    RE ++L     P I
Sbjct: 17  DFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 76
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH- 116
           V + G   S  +G+I  ++ +E+  GG+L   ++    + E  +   + AVL GL YL  
Sbjct: 77  VGFYGAFYS--DGEI--SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE 132
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
            + I+H D+K  NILV+   E   K+ DFG + +     D       GT   MAPE  +G
Sbjct: 133 KHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI---DSMANSFVGTRSYMAPERLQG 187
Query: 177 EEQGFPADVWALGCTVLEMATGRPPWPDV-ADPISAL-------------HRI------- 215
                 +D+W++G +++E+A GR P P   A  + A+             H I       
Sbjct: 188 THYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 247
Query: 216 -----GFSSDT------------------PEIP-GYMSKQAQDFLSKCLIRNPGERWSAS 251
                G   D+                  P++P G  +   Q+F++KCLI+NP ER    
Sbjct: 248 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLK 307
Query: 252 ELLEHGFVK 260
            L  H F+K
Sbjct: 308 MLTNHTFIK 316

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 126/261 (48%), Gaps = 16/261 (6%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALACPQIVAYKGC 63
           +G+GS   V       + + +AVK     SA+  ++  + RE  +L  L  P I+  K  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM--KLF 87
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
           +I E++    + +  E   GG L D I       E       + V  G+ Y+H + IVH 
Sbjct: 88  EILEDSSS--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHR 145
Query: 124 DIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFP 182
           D+K +NIL+ SK+ +   KI DFG +      ++ + K   GT   +APEV RG      
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLS--TCFQQNTKMKDRIGTAYYIAPEVLRGTYDE-K 202
Query: 183 ADVWALGCTVLEMATGRPPW--PDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCL 240
            DVW+ G  +  + +G PP+   +  D +  +    ++ D P+    +S  A+D + K L
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT-ISDDAKDLIRKML 261
Query: 241 IRNPGERWSASELLEHGFVKE 261
             +P  R +A++ LEH ++++
Sbjct: 262 TFHPSLRITATQCLEHPWIQK 282

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 126/261 (48%), Gaps = 16/261 (6%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALACPQIVAYKGC 63
           +G+GS   V       + + +AVK     SA+  ++  + RE  +L  L  P I+  K  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM--KLF 87
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
           +I E++    + +  E   GG L D I       E       + V  G+ Y+H + IVH 
Sbjct: 88  EILEDSSS--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHR 145
Query: 124 DIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFP 182
           D+K +NIL+ SK+ +   KI DFG +      ++ + K   GT   +APEV RG      
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLS--TCFQQNTKMKDRIGTAYYIAPEVLRGTYDE-K 202
Query: 183 ADVWALGCTVLEMATGRPPW--PDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCL 240
            DVW+ G  +  + +G PP+   +  D +  +    ++ D P+    +S  A+D + K L
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT-ISDDAKDLIRKML 261
Query: 241 IRNPGERWSASELLEHGFVKE 261
             +P  R +A++ LEH ++++
Sbjct: 262 TFHPSLRITATQCLEHPWIQK 282

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 122/266 (45%), Gaps = 23/266 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE--LSNSEFLQREQRILSALACPQIVAYKGCD 64
           + IG G+     +     + E+ AVK  E   +  E +QRE     +L  P IV +K   
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           ++  +  I+    +EYA GG L + I +     E   R   + +L G+ Y HS  I H D
Sbjct: 86  LTPTHLAII----MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRD 141
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV-ARGEEQGFPA 183
           +K +N L+        KI DFG ++ + ++   + K   GTP  +APEV  R E  G  A
Sbjct: 142 LKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIA 199
Query: 184 DVWALGCTVLEMATGRPPWPDVADP------ISALHRIGFSSDTPEIPG--YMSKQAQDF 235
           DVW+ G T+  M  G  P+ D  +P      I  +  + +S     IP    +S +    
Sbjct: 200 DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS-----IPDDIRISPECCHL 254
Query: 236 LSKCLIRNPGERWSASELLEHG-FVK 260
           +S+  + +P  R S  E+  H  F+K
Sbjct: 255 ISRIFVADPATRISIPEIKTHSWFLK 280

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 127/274 (46%), Gaps = 31/274 (11%)
Query: 8   TIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----------EFLQREQRILSALA-CP 55
            IGRG ++ V   +   +   FAVK  E++             E  +RE  IL  +A  P
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+       S E+   ++ +F +    G L D +     L E   RS  R++L  + +L
Sbjct: 161 HIITLID---SYESSSFMFLVF-DLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFL 216
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           H+N IVH D+K +NIL+  D+    +++DFG +    +   ++ + +CGTP  +APE+ +
Sbjct: 217 HANNIVHRDLKPENILL--DDNMQIRLSDFGFS--CHLEPGEKLRELCGTPGYLAPEILK 272
Query: 176 -GEEQGFP-----ADVWALGCTVLEMATGRPPWPDVADPISALHRI---GFSSDTPEIPG 226
              ++  P      D+WA G  +  +  G PP+      I  L  I    +   +PE   
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-ILMLRMIMEGQYQFSSPEWDD 331
Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
             S   +D +S+ L  +P  R +A + L+H F +
Sbjct: 332 -RSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 124/267 (46%), Gaps = 11/267 (4%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKG 62
           +   +TIG GS +     +   ++  +AVK  + S  +  +  + +L     P I+  K 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
                ++GK +Y L  E   GG L D I       E         +   ++YLHS G+VH
Sbjct: 89  V---YDDGKHVY-LVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVH 144
Query: 123 CDIKGQNILVSKD--NEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
            D+K  NIL   +  N +  +I DFG A++ R        P C T   +APEV + +   
Sbjct: 145 RDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP-CYTANFVAPEVLKRQGYD 203
Query: 181 FPADVWALGCTVLEMATGRPPWPD--VADPISALHRIGFSSDTPEIPGY--MSKQAQDFL 236
              D+W+LG  +  M  G  P+ +     P   L RIG    T     +  +S+ A+D +
Sbjct: 204 EGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLV 263
Query: 237 SKCLIRNPGERWSASELLEHGFVKEQN 263
           SK L  +P +R +A ++L+H +V +++
Sbjct: 264 SKMLHVDPHQRLTAKQVLQHPWVTQKD 290

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 121/267 (45%), Gaps = 26/267 (9%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGC 63
           +G G+   V      ++  V AVK    S     N   L     +L +  CP IV   G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYL-HSNGI 120
            I+  +      +F+     GT  + +  R    + E  +   T A++  L YL   +G+
Sbjct: 93  FITNTD------VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGV 146
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           +H D+K  NIL+  D     K+ DFG +   R+ +D       G    MAPE     +  
Sbjct: 147 IHRDVKPSNILL--DERGQIKLCDFGIS--GRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 181 FP-----ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM--SKQAQ 233
            P     ADVW+LG +++E+ATG+ P+ +       L ++    + P +PG+M  S   Q
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV-LQEEPPLLPGHMGFSGDFQ 261
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVK 260
            F+  CL ++  +R   ++LLEH F+K
Sbjct: 262 SFVKDCLTKDHRKRPKYNKLLEHSFIK 288

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 116/265 (43%), Gaps = 18/265 (6%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF------LQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    S  E       L+RE  I + L  P
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+  +  +   +  +I   L LEYAP G L   ++     +E R  +    +   L Y 
Sbjct: 84  NIL--RLYNYFYDRRRIY--LILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYC 139
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           H   ++H DIK +N  +    +   KIADFG +  A        K +CGT   + PE+  
Sbjct: 140 HGKKVIHRDIKPEN--LLLGLKGELKIADFGWSVHA---PSLRRKTMCGTLDYLPPEMIE 194
Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
           G       D+W +G    E+  G PP+   +   +  +R     D  + P  +   AQD 
Sbjct: 195 GRMHNEKVDLWCIGVLCYELLVGNPPFESASH--NETYRRIVKVDL-KFPASVPTGAQDL 251
Query: 236 LSKCLIRNPGERWSASELLEHGFVK 260
           +SK L  NP ER   +++  H +V+
Sbjct: 252 ISKLLRHNPSERLPLAQVSAHPWVR 276

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 90/326 (27%), Positives = 142/326 (43%), Gaps = 33/326 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKG 62
           +   +TIG GS +     +   ++  +AVK  + S  +  +  + +L     P I+  K 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
                ++GK +Y L  E   GG L D I       E         +   ++YLHS G+VH
Sbjct: 89  V---YDDGKHVY-LVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVH 144
Query: 123 CDIKGQNILVSKD--NEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
            D+K  NIL   +  N +  +I DFG A++ R        P C T   +APEV + +   
Sbjct: 145 RDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP-CYTANFVAPEVLKRQGYD 203
Query: 181 FPADVWALGCTVLEMATGRPPWPD--VADPISALHRIGFSSDTPEIPGY--MSKQAQDFL 236
              D+W+LG  +  M  G  P+ +     P   L RIG    T     +  +S+ A+D +
Sbjct: 204 EGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLV 263
Query: 237 SKCLIRNPGERWSASELLEHGFVKE-----------QNFKLSTLTEPETY---NSESPTS 282
           SK L  +P +R +A ++L+H +V +           Q+ +L       TY   NS  PT 
Sbjct: 264 SKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQLVKGAMAATYSALNSSKPTP 323
Query: 283 VLNQQLWDSTLTSCSSASAKERIRQL 308
            L            SS  A+ R+R+L
Sbjct: 324 QLK--------PIESSILAQRRVRKL 341

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 123/261 (47%), Gaps = 17/261 (6%)
Query: 4   TRGQTIGRGSTATVSIG--MSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           T GQ IG GS  TV  G    + + ++  V +      +  + E  +L       I+ + 
Sbjct: 27  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           G   + +       +  ++  G +L   +  S T  E  ++    R    G+ YLH+  I
Sbjct: 87  GYSTAPQ-----LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCA-RRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           +H D+K  NI + +DN    KI DFG A  ++R +   + + + G+ + MAPEV R ++ 
Sbjct: 142 IHRDLKSNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 180 G---FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS---KQAQ 233
               F +DV+A G  + E+ TG+ P+ ++ +    +  +G  S +P++    S   K+ +
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 259
Query: 234 DFLSKCLIRNPGERWSASELL 254
             +++CL +   ER S   +L
Sbjct: 260 RLMAECLKKKRDERPSFPRIL 280

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 119/270 (44%), Gaps = 27/270 (10%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILS-ALACPQIVA 59
           + +G+GS   V +     + +++AVK  +        + E    E+RILS A   P +  
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
              C   +   ++ +   +E+  GG L   I+     +E R R +   ++  L +LH  G
Sbjct: 89  LFCC--FQTPDRLFF--VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG 144
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           I++ D+K  N+L+  D+E   K+ADFG  +    N        CGTP  +APE+ +    
Sbjct: 145 IIYRDLKLDNVLL--DHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAPEILQEMLY 201
Query: 180 GFPADVWALGCTVLEMATGRPPW--PDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
           G   D WA+G  + EM  G  P+   +  D   A+      +D    P ++ + A   L 
Sbjct: 202 GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI-----LNDEVVYPTWLHEDATGILK 256
Query: 238 KCLIRNPGERWSA------SELLEHGFVKE 261
             + +NP  R  +        +L H F KE
Sbjct: 257 SFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 122/261 (46%), Gaps = 17/261 (6%)
Query: 4   TRGQTIGRGSTATVSIG--MSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           T GQ IG GS  TV  G    + + ++  V +      +  + E  +L       I+ + 
Sbjct: 27  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           G     +       +  ++  G +L   +  S T  E  ++    R    G+ YLH+  I
Sbjct: 87  GYSTKPQ-----LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCA-RRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           +H D+K  NI + +DN    KI DFG A  ++R +   + + + G+ + MAPEV R ++ 
Sbjct: 142 IHRDLKSNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 180 G---FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS---KQAQ 233
               F +DV+A G  + E+ TG+ P+ ++ +    +  +G  S +P++    S   K+ +
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 259
Query: 234 DFLSKCLIRNPGERWSASELL 254
             +++CL +   ER S   +L
Sbjct: 260 RLMAECLKKKRDERPSFPRIL 280

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 131/313 (41%), Gaps = 52/313 (16%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELS--------NSEFLQREQRILSALACPQIV-- 58
           IG+GS   V + + N++  + A+K    +        + E ++ E R++  L  P I   
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 59  --AYKG----CDISE--ENGKIL--YNLFLEYAPGGTLTDAIRSGTC------------- 95
              Y+     C + E    G +L   N+F++ + G    D +++  C             
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 96  -----------LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIAD 144
                        E  I +  R +   L YLH+ GI H DIK +N L S +     K+ D
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVD 213
Query: 145 FGCARRARVNEDDEGKPI---CGTPICMAPEVAR--GEEQGFPADVWALGCTVLEMATGR 199
           FG ++      + E   +    GTP  +APEV     E  G   D W+ G  +  +  G 
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
Query: 200 PPWPDV--ADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHG 257
            P+P V  AD IS +       + P     +S  A+D LS  L RN  ER+ A   L+H 
Sbjct: 274 VPFPGVNDADTISQVLNKKLCFENPNY-NVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332
Query: 258 FVKEQNFKLSTLT 270
           ++ + + K+  ++
Sbjct: 333 WISQFSDKIYKMS 345

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 122/261 (46%), Gaps = 17/261 (6%)
Query: 4   TRGQTIGRGSTATVSIG--MSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           T GQ IG GS  TV  G    + + ++  V +      +  + E  +L       I+ + 
Sbjct: 15  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 74
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           G     +       +  ++  G +L   +  S T  E  ++    R    G+ YLH+  I
Sbjct: 75  GYSTKPQ-----LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 129
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           +H D+K  NI + +DN    KI DFG A  ++R +   + + + G+ + MAPEV R ++ 
Sbjct: 130 IHRDLKSNNIFLHEDNT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 187
Query: 180 G---FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS---KQAQ 233
               F +DV+A G  + E+ TG+ P+ ++ +    +  +G  S +P++    S   K+ +
Sbjct: 188 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 247
Query: 234 DFLSKCLIRNPGERWSASELL 254
             +++CL +   ER S   +L
Sbjct: 248 RLMAECLKKKRDERPSFPRIL 268

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 119/259 (45%), Gaps = 14/259 (5%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELS---NSEFLQREQRILSALACPQIVAYKGC 63
           + +G G+ + V +     + ++FA+K  + S       L+ E  +L  +    IV  +  
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE-- 72
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
           DI E      Y L ++   GG L D I       E       + VL  ++YLH NGIVH 
Sbjct: 73  DIYESTTH--YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHR 130
Query: 124 DIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFP 182
           D+K +N+L ++ +      I DFG    +++ ++      CGTP  +APEV   +     
Sbjct: 131 DLKPENLLYLTPEENSKIMITDFGL---SKMEQNGIMSTACGTPGYVAPEVLAQKPYSKA 187
Query: 183 ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY--MSKQAQDFLSKCL 240
            D W++G     +  G PP+ +  +      +I       E P +  +S+ A+DF+   L
Sbjct: 188 VDCWSIGVITYILLCGYPPFYEETES-KLFEKIKEGYYEFESPFWDDISESAKDFICHLL 246
Query: 241 IRNPGERWSASELLEHGFV 259
            ++P ER++  + L H ++
Sbjct: 247 EKDPNERYTCEKALSHPWI 265

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSA-LACPQIVAYKG 62
           T    +GRGS   V      ++    AVK   L   E  + E+ +  A L+ P+IV   G
Sbjct: 61  THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL---EVFRVEELVACAGLSSPRIVPLYG 117
Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
              +   G  + N+F+E   GG+L   I+   CL E R   +    L GL+YLH+  I+H
Sbjct: 118 ---AVREGPWV-NIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 173
Query: 123 CDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP------ICGTPICMAPEVARG 176
            D+K  N+L+S D  + A + DFG A    +  D  GK       I GT   MAPEV  G
Sbjct: 174 GDVKADNVLLSSDGSRAA-LCDFGHA--LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 177 EEQGFPADVWALGCTVLEMATGRPPW 202
           +      D+W+  C +L M  G  PW
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSA-LACPQIVAYKG 62
           T    +GRGS   V      ++    AVK   L   E  + E+ +  A L+ P+IV   G
Sbjct: 77  THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL---EVFRVEELVACAGLSSPRIVPLYG 133
Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
              +   G  + N+F+E   GG+L   I+   CL E R   +    L GL+YLH+  I+H
Sbjct: 134 ---AVREGPWV-NIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 189
Query: 123 CDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP------ICGTPICMAPEVARG 176
            D+K  N+L+S D  + A + DFG A    +  D  GK       I GT   MAPEV  G
Sbjct: 190 GDVKADNVLLSSDGSRAA-LCDFGHA--LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 246
Query: 177 EEQGFPADVWALGCTVLEMATGRPPW 202
           +      D+W+  C +L M  G  PW
Sbjct: 247 KPCDAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 92/349 (26%), Positives = 138/349 (39%), Gaps = 50/349 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAV-----KSAELSNSE---FLQREQRILSALA 53
           D+   + IG+GS   V +   +++ EVF       K A L   E    +     +L  + 
Sbjct: 39  DFHFLKVIGKGSFGKVLLA-RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
            P +V   G   S +    LY   L+Y  GG L   ++   C  E R R +   +   L 
Sbjct: 98  HPFLV---GLHFSFQTADKLY-FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153
Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
           YLHS  IV+ D+K +NIL+  D++    + DFG  +   +  +      CGTP  +APEV
Sbjct: 154 YLHSLNIVYRDLKPENILL--DSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYLAPEV 210
Query: 174 ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
              +      D W LG  + EM  G PP+              +S +T E+         
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGLPPF--------------YSRNTAEM-------YD 249
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTL 293
           + L+K L   P    SA  LLE    K++  +L    +     S    S++N   WD  +
Sbjct: 250 NILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN---WDDLI 306
Query: 294 TS------CSSASAKERIRQLIGEGSSEMV----NWAWDETWVTVRSKE 332
                     + S    +R    E + E V      A D   VT   KE
Sbjct: 307 NKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKAPDSVLVTASVKE 355

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSA-LACPQIVAYKG 62
           T    +GRGS   V      ++    AVK   L   E  + E+ +  A L+ P+IV   G
Sbjct: 75  THQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRL---EVFRVEELVACAGLSSPRIVPLYG 131
Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
              +   G  + N+F+E   GG+L   I+   CL E R   +    L GL+YLH+  I+H
Sbjct: 132 ---AVREGPWV-NIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 187
Query: 123 CDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP------ICGTPICMAPEVARG 176
            D+K  N+L+S D  + A + DFG A    +  D  GK       I GT   MAPEV  G
Sbjct: 188 GDVKADNVLLSSDGSRAA-LCDFGHA--LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 244
Query: 177 EEQGFPADVWALGCTVLEMATGRPPW 202
           +      D+W+  C +L M  G  PW
Sbjct: 245 KPCDAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 120/271 (44%), Gaps = 22/271 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACP 55
           D+     +G+GS   V +     + E++A+K        +  + E    E+R+L+ L  P
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKP 79
Query: 56  QIVA-YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
             +     C  + +    LY   +EY  GG L   I+     +E +   +   + +GL +
Sbjct: 80  PFLTQLHSCFQTVDR---LY-FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFF 135
Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           LH  GI++ D+K  N+++  D+E   KIADFG  +   + +    +  CGTP  +APE+ 
Sbjct: 136 LHKRGIIYRDLKLDNVML--DSEGHIKIADFGMCKE-HMMDGVTTREFCGTPDYIAPEII 192
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD 234
             +  G   D WA G  + EM  G+PP+ D  D       I         P  +SK+A  
Sbjct: 193 AYQPYGKSVDWWAYGVLLYEMLAGQPPF-DGEDEDELFQSI--MEHNVSYPKSLSKEAVS 249
Query: 235 FLSKCLIRNPGERWSA-----SELLEHGFVK 260
                + ++P +R         ++ EH F +
Sbjct: 250 ICKGLMTKHPAKRLGCGPEGERDVREHAFFR 280

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 125/291 (42%), Gaps = 44/291 (15%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQREQRILSALACPQIVAYK 61
           + IG G+   V    +N   E FA+K   L   +        RE  IL  L    IV  K
Sbjct: 8   EKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV--K 64
Query: 62  GCDISEENGKILYNLFLEYAPGG--TLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
             D+     +++  L  E+       L D    G  LE    +S    +L G+ Y H   
Sbjct: 65  LYDVIHTKKRLV--LVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHDRR 120
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           ++H D+K QN+L++++ E   KIADFG AR   +        I  T    AP+V  G ++
Sbjct: 121 VLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKK 177
Query: 180 -GFPADVWALGCTVLEMATGRPPWPDV--ADPISALHRIGFSSDTP------EIPGY--- 227
                D+W++GC   EM  G P +P V  AD +  + RI  + ++       E+P Y   
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 228 ---------------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
                          + +   D LSK L  +P +R +A + LEH + KE N
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 116/266 (43%), Gaps = 18/266 (6%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFL------QREQRILSALACPQ 56
           +  G T+G G+   V IG    +    AVK         L      +RE + L     P 
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           I+       +  +    + + +EY  GG L D I     +EE   R   + +L  + Y H
Sbjct: 73  IIKLYQVISTPTD----FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH 128
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
            + +VH D+K +N+L+  D    AKIADFG +    +++ +  +  CG+P   APEV  G
Sbjct: 129 RHMVVHRDLKPENVLL--DAHMNAKIADFGLSN--MMSDGEFLRTSCGSPNYAAPEVISG 184
Query: 177 EEQGFP-ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
                P  D+W+ G  +  +  G  P+ D   P +   +I        IP Y+++     
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP-TLFKKI--RGGVFYIPEYLNRSVATL 241
Query: 236 LSKCLIRNPGERWSASELLEHGFVKE 261
           L   L  +P +R +  ++ EH + K+
Sbjct: 242 LMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 116/266 (43%), Gaps = 18/266 (6%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFL------QREQRILSALACPQ 56
           +  G T+G G+   V IG    +    AVK         L      +RE + L     P 
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           I+       +  +    + + +EY  GG L D I     +EE   R   + +L  + Y H
Sbjct: 73  IIKLYQVISTPTD----FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH 128
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
            + +VH D+K +N+L+  D    AKIADFG +    +++ +  +  CG+P   APEV  G
Sbjct: 129 RHMVVHRDLKPENVLL--DAHMNAKIADFGLSN--MMSDGEFLRDSCGSPNYAAPEVISG 184
Query: 177 EEQGFP-ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
                P  D+W+ G  +  +  G  P+ D   P +   +I        IP Y+++     
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP-TLFKKI--RGGVFYIPEYLNRSVATL 241
Query: 236 LSKCLIRNPGERWSASELLEHGFVKE 261
           L   L  +P +R +  ++ EH + K+
Sbjct: 242 LMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 89/189 (47%), Gaps = 23/189 (12%)
Query: 102 RSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR-----VNED 156
           +S+ + +L  +  +H +GIVH D+K  N L+    +   K+ DFG A + +     V +D
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKD 186
Query: 157 DEGKPICGTPICMAPEVAR----GEEQGFPA-------DVWALGCTVLEMATGRPPWPDV 205
            +     GT   M PE  +      E G          DVW+LGC +  M  G+ P+  +
Sbjct: 187 SQ----VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242
Query: 206 ADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK 265
            + IS LH I   +   E P    K  QD L  CL R+P +R S  ELL H +V+ Q   
Sbjct: 243 INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302
Query: 266 LSTLTEPET 274
           ++ + +  T
Sbjct: 303 VNQMAKGTT 311

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 89/189 (47%), Gaps = 23/189 (12%)
Query: 102 RSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR-----VNED 156
           +S+ + +L  +  +H +GIVH D+K  N L+    +   K+ DFG A + +     V +D
Sbjct: 111 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKD 167
Query: 157 DEGKPICGTPICMAPEVAR----GEEQGFPA-------DVWALGCTVLEMATGRPPWPDV 205
            +     GT   M PE  +      E G          DVW+LGC +  M  G+ P+  +
Sbjct: 168 SQ----VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223
Query: 206 ADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK 265
            + IS LH I   +   E P    K  QD L  CL R+P +R S  ELL H +V+ Q   
Sbjct: 224 INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283
Query: 266 LSTLTEPET 274
           ++ + +  T
Sbjct: 284 VNQMAKGTT 292

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 89/189 (47%), Gaps = 23/189 (12%)
Query: 102 RSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR-----VNED 156
           +S+ + +L  +  +H +GIVH D+K  N L+    +   K+ DFG A + +     V +D
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDXXXVVKD 186
Query: 157 DEGKPICGTPICMAPEVAR----GEEQGFPA-------DVWALGCTVLEMATGRPPWPDV 205
            +     GT   M PE  +      E G          DVW+LGC +  M  G+ P+  +
Sbjct: 187 SQ----VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242
Query: 206 ADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK 265
            + IS LH I   +   E P    K  QD L  CL R+P +R S  ELL H +V+ Q   
Sbjct: 243 INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302
Query: 266 LSTLTEPET 274
           ++ + +  T
Sbjct: 303 VNQMAKGTT 311

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 120/263 (45%), Gaps = 13/263 (4%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEFLQREQRILSALACPQIVAYKGC 63
           + +G G+   V       +   FA K   +   S+ E +++E + +S L  P +V     
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH-- 220
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
           D  E++ +++  +  E+  GG L + +      + E     + R V  GL ++H N  VH
Sbjct: 221 DAFEDDNEMV--MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVH 278
Query: 123 CDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFP 182
            D+K +NI+ +       K+ DFG    A ++     K   GT    APEVA G+  G+ 
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLT--AHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 336
Query: 183 ADVWALGCTVLEMATGRPPWPDVAD--PISALHRIGFSSDTPEIPGYMSKQAQDFLSKCL 240
            D+W++G     + +G  P+    D   +  +    ++ D     G +S+  +DF+ K L
Sbjct: 337 TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG-ISEDGKDFIRKLL 395
Query: 241 IRNPGERWSASELLEHGFVKEQN 263
           + +P  R +  + LEH ++   N
Sbjct: 396 LADPNTRMTIHQALEHPWLTPGN 418

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 89/189 (47%), Gaps = 23/189 (12%)
Query: 102 RSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR-----VNED 156
           +S+ + +L  +  +H +GIVH D+K  N L+    +   K+ DFG A + +     V +D
Sbjct: 110 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKD 166
Query: 157 DEGKPICGTPICMAPEVAR----GEEQGFPA-------DVWALGCTVLEMATGRPPWPDV 205
            +     GT   M PE  +      E G          DVW+LGC +  M  G+ P+  +
Sbjct: 167 SQ----VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 222
Query: 206 ADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK 265
            + IS LH I   +   E P    K  QD L  CL R+P +R S  ELL H +V+ Q   
Sbjct: 223 INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 282
Query: 266 LSTLTEPET 274
           ++ + +  T
Sbjct: 283 VNQMAKGTT 291

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 89/189 (47%), Gaps = 23/189 (12%)
Query: 102 RSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR-----VNED 156
           +S+ + +L  +  +H +GIVH D+K  N L+    +   K+ DFG A + +     V +D
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 157 DEGKPICGTPICMAPEVAR----GEEQGFPA-------DVWALGCTVLEMATGRPPWPDV 205
            +     GT   M PE  +      E G          DVW+LGC +  M  G+ P+  +
Sbjct: 215 SQ----VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270
Query: 206 ADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK 265
            + IS LH I   +   E P    K  QD L  CL R+P +R S  ELL H +V+ Q   
Sbjct: 271 INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330
Query: 266 LSTLTEPET 274
           ++ + +  T
Sbjct: 331 VNQMAKGTT 339

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 89/189 (47%), Gaps = 23/189 (12%)
Query: 102 RSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR-----VNED 156
           +S+ + +L  +  +H +GIVH D+K  N L+    +   K+ DFG A + +     V +D
Sbjct: 114 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKD 170
Query: 157 DEGKPICGTPICMAPEVAR----GEEQGFPA-------DVWALGCTVLEMATGRPPWPDV 205
            +     GT   M PE  +      E G          DVW+LGC +  M  G+ P+  +
Sbjct: 171 SQ----VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 226
Query: 206 ADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK 265
            + IS LH I   +   E P    K  QD L  CL R+P +R S  ELL H +V+ Q   
Sbjct: 227 INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 286
Query: 266 LSTLTEPET 274
           ++ + +  T
Sbjct: 287 VNQMAKGTT 295

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 125/291 (42%), Gaps = 44/291 (15%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQREQRILSALACPQIVAYK 61
           + IG G+   V    +N   E FA+K   L   +        RE  IL  L    IV  K
Sbjct: 8   EKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV--K 64
Query: 62  GCDISEENGKILYNLFLEYAPGG--TLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
             D+     +++  L  E+       L D    G  LE    +S    +L G+ Y H   
Sbjct: 65  LYDVIHTKKRLV--LVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHDRR 120
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           ++H D+K QN+L++++ E   KIADFG AR   +        +  T    AP+V  G ++
Sbjct: 121 VLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKK 177
Query: 180 -GFPADVWALGCTVLEMATGRPPWPDV--ADPISALHRIGFSSDTP------EIPGY--- 227
                D+W++GC   EM  G P +P V  AD +  + RI  + ++       E+P Y   
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 228 ---------------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
                          + +   D LSK L  +P +R +A + LEH + KE N
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 23/231 (9%)
Query: 78  LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSKDN 136
           +EYA GG L   +       E R R +   ++  L YLHS   +V+ D+K +N+++ KD 
Sbjct: 87  MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG 146
Query: 137 EQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMA 196
               KI DFG  +   + +    K  CGTP  +APEV    + G   D W LG  + EM 
Sbjct: 147 H--IKITDFGLCKEG-IKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 203
Query: 197 TGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERW-----SAS 251
            GR P+ +  D       I    +    P  +  +A+  LS  L ++P +R       A 
Sbjct: 204 CGRLPFYN-QDHEKLFELI--LMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAK 260
Query: 252 ELLEHGF--------VKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLT 294
           E+++H F        V E+  KLS   +P+   SE+ T   +++     +T
Sbjct: 261 EIMQHRFFAGIVWQHVYEK--KLSPPFKPQV-TSETDTRYFDEEFTAQMIT 308

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 23/231 (9%)
Query: 78  LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSKDN 136
           +EYA GG L   +       E R R +   ++  L YLHS   +V+ D+K +N+++ KD 
Sbjct: 88  MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG 147
Query: 137 EQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMA 196
               KI DFG  +   + +    K  CGTP  +APEV    + G   D W LG  + EM 
Sbjct: 148 H--IKITDFGLCKEG-IKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 204
Query: 197 TGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERW-----SAS 251
            GR P+ +  D       I    +    P  +  +A+  LS  L ++P +R       A 
Sbjct: 205 CGRLPFYN-QDHEKLFELI--LMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAK 261
Query: 252 ELLEHGF--------VKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLT 294
           E+++H F        V E+  KLS   +P+   SE+ T   +++     +T
Sbjct: 262 EIMQHRFFAGIVWQHVYEK--KLSPPFKPQV-TSETDTRYFDEEFTAQMIT 309

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 121/282 (42%), Gaps = 19/282 (6%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFL------QREQRILSALACPQ 56
           +  G T+G G+   V +G    +    AVK         L      +RE + L     P 
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           I+  K   +      I   + +EY  GG L D I     L+E   R   + +L G+ Y H
Sbjct: 78  II--KLYQVISTPSDIF--MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH 133
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
            + +VH D+K +N+L+  D    AKIADFG +    +++ +  +  CG+P   APEV  G
Sbjct: 134 RHMVVHRDLKPENVLL--DAHMNAKIADFGLSN--MMSDGEFLRXSCGSPNYAAPEVISG 189
Query: 177 EEQGFP-ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
                P  D+W+ G  +  +  G  P+ D  D +  L +          P Y++      
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPFDD--DHVPTLFK-KICDGIFYTPQYLNPSVISL 246
Query: 236 LSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNS 277
           L   L  +P +R +  ++ EH + K Q+       E  +Y+S
Sbjct: 247 LKHMLQVDPMKRATIKDIREHEWFK-QDLPKYLFPEDPSYSS 287

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 89/189 (47%), Gaps = 23/189 (12%)
Query: 102 RSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR-----VNED 156
           +S+ + +L  +  +H +GIVH D+K  N L+    +   K+ DFG A + +     V +D
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 157 DEGKPICGTPICMAPEVAR----GEEQGFPA-------DVWALGCTVLEMATGRPPWPDV 205
            +     GT   M PE  +      E G          DVW+LGC +  M  G+ P+  +
Sbjct: 215 SQ----VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270
Query: 206 ADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK 265
            + IS LH I   +   E P    K  QD L  CL R+P +R S  ELL H +V+ Q   
Sbjct: 271 INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330
Query: 266 LSTLTEPET 274
           ++ + +  T
Sbjct: 331 VNQMAKGTT 339

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 125/291 (42%), Gaps = 44/291 (15%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQREQRILSALACPQIVAYK 61
           + IG G+   V    +N   E FA+K   L   +        RE  IL  L    IV  K
Sbjct: 8   EKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV--K 64
Query: 62  GCDISEENGKILYNLFLEYAPGG--TLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
             D+     +++  L  E+       L D    G  LE    +S    +L G+ Y H   
Sbjct: 65  LYDVIHTKKRLV--LVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHDRR 120
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           ++H D+K QN+L++++ E   KIADFG AR   +        +  T    AP+V  G ++
Sbjct: 121 VLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKK 177
Query: 180 -GFPADVWALGCTVLEMATGRPPWPDV--ADPISALHRIGFSSDTP------EIPGY--- 227
                D+W++GC   EM  G P +P V  AD +  + RI  + ++       E+P Y   
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 228 ---------------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
                          + +   D LSK L  +P +R +A + LEH + KE N
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 23/231 (9%)
Query: 78  LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSKDN 136
           +EYA GG L   +       E R R +   ++  L YLHS   +V+ D+K +N+++ KD 
Sbjct: 89  MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG 148
Query: 137 EQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMA 196
               KI DFG  +   + +    K  CGTP  +APEV    + G   D W LG  + EM 
Sbjct: 149 H--IKITDFGLCKEG-IKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 205
Query: 197 TGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERW-----SAS 251
            GR P+ +  D       I    +    P  +  +A+  LS  L ++P +R       A 
Sbjct: 206 CGRLPFYN-QDHEKLFELI--LMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAK 262
Query: 252 ELLEHGF--------VKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLT 294
           E+++H F        V E+  KLS   +P+   SE+ T   +++     +T
Sbjct: 263 EIMQHRFFAGIVWQHVYEK--KLSPPFKPQV-TSETDTRYFDEEFTAQMIT 310

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 103/225 (45%), Gaps = 23/225 (10%)
Query: 78  LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSKDN 136
           +EYA GG L   +       E R R +   ++  L YLHS   +V+ D+K +N+++ KD 
Sbjct: 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG 286
Query: 137 EQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMA 196
               KI DFG  +   + +    K  CGTP  +APEV    + G   D W LG  + EM 
Sbjct: 287 H--IKITDFGLCKEG-IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 343
Query: 197 TGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERW-----SAS 251
            GR P+ +  D       I    +    P  +  +A+  LS  L ++P +R       A 
Sbjct: 344 CGRLPFYN-QDHEKLFELI--LMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAK 400
Query: 252 ELLEHGF--------VKEQNFKLSTLTEPETYNSESPTSVLNQQL 288
           E+++H F        V E+  KLS   +P+   SE+ T   +++ 
Sbjct: 401 EIMQHRFFAGIVWQHVYEK--KLSPPFKPQV-TSETDTRYFDEEF 442

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 88/185 (47%), Gaps = 15/185 (8%)
Query: 102 RSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR-----VNED 156
           +S+ + +L  +  +H +GIVH D+K  N L+    +   K+ DFG A + +     V +D
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 157 DEGKPICGTPICMAPEVARGEEQGFPA-------DVWALGCTVLEMATGRPPWPDVADPI 209
            +   +   P     +++   E G          DVW+LGC +  M  G+ P+  + + I
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274
Query: 210 SALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTL 269
           S LH I   +   E P    K  QD L  CL R+P +R S  ELL H +V+ Q   ++ +
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 334
Query: 270 TEPET 274
            +  T
Sbjct: 335 AKGTT 339

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 117/256 (45%), Gaps = 13/256 (5%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEFLQREQRILSALACPQIVAYKGC 63
           + +G G+   V       +   FA K   +   S+ E +++E + +S L  P +V     
Sbjct: 57  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH-- 114
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
           D  E++ +++  +  E+  GG L + +      + E     + R V  GL ++H N  VH
Sbjct: 115 DAFEDDNEMV--MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVH 172
Query: 123 CDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFP 182
            D+K +NI+ +       K+ DFG    A ++     K   GT    APEVA G+  G+ 
Sbjct: 173 LDLKPENIMFTTKRSNELKLIDFGLT--AHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 230
Query: 183 ADVWALGCTVLEMATGRPPWPDVADP--ISALHRIGFSSDTPEIPGYMSKQAQDFLSKCL 240
            D+W++G     + +G  P+    D   +  +    ++ D     G +S+  +DF+ K L
Sbjct: 231 TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG-ISEDGKDFIRKLL 289
Query: 241 IRNPGERWSASELLEH 256
           + +P  R +  + LEH
Sbjct: 290 LADPNTRMTIHQALEH 305

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 103/225 (45%), Gaps = 23/225 (10%)
Query: 78  LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSKDN 136
           +EYA GG L   +       E R R +   ++  L YLHS   +V+ D+K +N+++ KD 
Sbjct: 230 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG 289
Query: 137 EQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMA 196
               KI DFG  +   + +    K  CGTP  +APEV    + G   D W LG  + EM 
Sbjct: 290 H--IKITDFGLCKEG-IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 346
Query: 197 TGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERW-----SAS 251
            GR P+ +  D       I    +    P  +  +A+  LS  L ++P +R       A 
Sbjct: 347 CGRLPFYN-QDHEKLFELI--LMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAK 403
Query: 252 ELLEHGF--------VKEQNFKLSTLTEPETYNSESPTSVLNQQL 288
           E+++H F        V E+  KLS   +P+   SE+ T   +++ 
Sbjct: 404 EIMQHRFFAGIVWQHVYEK--KLSPPFKPQV-TSETDTRYFDEEF 445

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR-------EQRILSALAC 54
           D+   + IGRG+   V +     S +V+A+K   LS  E ++R       E+R + A A 
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKL--LSKFEMIKRSDSAFFWEERDIMAFAN 133
Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
              V    C   ++  K LY + +EY PGG L + + S   + E   + +T  V+L L  
Sbjct: 134 SPWVVQLFCAFQDD--KYLY-MVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDA 189
Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPIC----GTPICMA 170
           +HS G++H D+K  N+L+ K      K+ADFG   +     D+ G   C    GTP  ++
Sbjct: 190 IHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKM----DETGMVHCDTAVGTPDYIS 243
Query: 171 PEVARGE----EQGFPADVWALGCTVLEMATGRPPW 202
           PEV + +      G   D W++G  + EM  G  P+
Sbjct: 244 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 131/282 (46%), Gaps = 32/282 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQ-------REQRIL 49
           ++   + +GRG ++ V   +   + + +AVK  +++     ++E +Q       +E  IL
Sbjct: 5   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 64
Query: 50  SALA-CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAV 108
             ++  P I+  K  D  E N    + L  +    G L D +     L E   R   RA+
Sbjct: 65  RKVSGHPNIIQLK--DTYETN--TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 120
Query: 109 LLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC 168
           L  +  LH   IVH D+K +NIL+  D++   K+ DFG +   +++  ++ + +CGTP  
Sbjct: 121 LEVICALHKLNIVHRDLKPENILL--DDDMNIKLTDFGFS--CQLDPGEKLREVCGTPSY 176
Query: 169 MAPEVARGEEQ------GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI---GFSS 219
           +APE+            G   D+W+ G  +  +  G PP+      +  L  I    +  
Sbjct: 177 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQF 235
Query: 220 DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
            +PE   Y S   +D +S+ L+  P +R++A E L H F ++
Sbjct: 236 GSPEWDDY-SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 42  LQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRI 101
            +RE    S L+   IV+    D+ EE+    Y L +EY  G TL++ I S   L     
Sbjct: 58  FEREVHNSSQLSHQNIVSM--IDVDEEDD--CYYLVMEYIEGPTLSEYIESHGPLSVDTA 113
Query: 102 RSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP 161
            + T  +L G+++ H   IVH DIK QNIL+  D+ +  KI DFG A+        +   
Sbjct: 114 INFTNQILDGIKHAHDMRIVHRDIKPQNILI--DSNKTLKIFDFGIAKALSETSLTQTNH 171
Query: 162 ICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWP-DVADPISALHRIGFSSD 220
           + GT    +PE A+GE      D++++G  + EM  G PP+  + A  I+  H       
Sbjct: 172 VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH---IQDS 228
Query: 221 TPEIPGYMSKQAQDFLSKCLIR 242
            P +   + K     LS  ++R
Sbjct: 229 VPNVTTDVRKDIPQSLSNVILR 250

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 131/282 (46%), Gaps = 32/282 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQ-------REQRIL 49
           ++   + +GRG ++ V   +   + + +AVK  +++     ++E +Q       +E  IL
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 50  SALA-CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAV 108
             ++  P I+  K  D  E N    + L  +    G L D +     L E   R   RA+
Sbjct: 78  RKVSGHPNIIQLK--DTYETN--TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 109 LLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC 168
           L  +  LH   IVH D+K +NIL+  D++   K+ DFG +   +++  ++ + +CGTP  
Sbjct: 134 LEVICALHKLNIVHRDLKPENILL--DDDMNIKLTDFGFS--CQLDPGEKLRSVCGTPSY 189
Query: 169 MAPEVARGEEQ------GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI---GFSS 219
           +APE+            G   D+W+ G  +  +  G PP+      +  L  I    +  
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQF 248
Query: 220 DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
            +PE   Y S   +D +S+ L+  P +R++A E L H F ++
Sbjct: 249 GSPEWDDY-SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 131/282 (46%), Gaps = 32/282 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQ-------REQRIL 49
           ++   + +GRG ++ V   +   + + +AVK  +++     ++E +Q       +E  IL
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 50  SALA-CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAV 108
             ++  P I+  K  D  E N    + L  +    G L D +     L E   R   RA+
Sbjct: 78  RKVSGHPNIIQLK--DTYETN--TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 109 LLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC 168
           L  +  LH   IVH D+K +NIL+  D++   K+ DFG +   +++  ++ + +CGTP  
Sbjct: 134 LEVICALHKLNIVHRDLKPENILL--DDDMNIKLTDFGFS--CQLDPGEKLREVCGTPSY 189
Query: 169 MAPEVARGEEQ------GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI---GFSS 219
           +APE+            G   D+W+ G  +  +  G PP+      +  L  I    +  
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQF 248
Query: 220 DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
            +PE   Y S   +D +S+ L+  P +R++A E L H F ++
Sbjct: 249 GSPEWDDY-SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ------REQRILSALACPQ 56
           W     +G+G+TA V  G   ++ ++FA+K    +N  FL+      RE  +L  L    
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKV--FNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIR---SGTCLEEGRIRSHTRAVLLGLQ 113
           IV  K   I EE       L +E+ P G+L   +    +   L E       R V+ G+ 
Sbjct: 69  IV--KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 114 YLHSNGIVHCDIKGQNIL--VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAP 171
           +L  NGIVH +IK  NI+  + +D +   K+ DFG AR   + +D++   + GT   + P
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR--ELEDDEQFVSLYGTEEYLHP 184
Query: 172 E-----VARGEEQ---GFPADVWALGCTVLEMATGRPPWPDVADP 208
           +     V R + Q   G   D+W++G T    ATG  P+     P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 124/280 (44%), Gaps = 30/280 (10%)
Query: 10  GRGSTATVSIGMSNRSSEVFAVKSAELS-------NSEFLQREQRILSALACPQIVAYKG 62
           G G    V       + ++FA+K  + +       ++   + E+ IL  +  P IV    
Sbjct: 29  GYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV---D 85
Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
              + + G  LY L LEY  GG L   +       E     +   + + L +LH  GI++
Sbjct: 86  LIYAFQTGGKLY-LILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIY 144
Query: 123 CDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF 181
            D+K +NI++   N QG  K+ DFG  + + +++       CGT   MAPE+        
Sbjct: 145 RDLKPENIML---NHQGHVKLTDFGLCKES-IHDGTVTHTFCGTIEYMAPEILMRSGHNR 200
Query: 182 PADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
             D W+LG  + +M TG PP+   +    I  + +   +     +P Y++++A+D L K 
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN-----LPPYLTQEARDLLKKL 255
Query: 240 LIRNPGERW-----SASELLEHGFVKEQNFK--LSTLTEP 272
           L RN   R       A E+  H F +  N++  L+   EP
Sbjct: 256 LKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEP 295

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 131/289 (45%), Gaps = 32/289 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACP 55
           D+   + IGRG+   V +     + +V+A+K        + S+S F   E+ I++    P
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            +V       + ++ + LY + +EY PGG L + + S   + E   R +T  V+L L  +
Sbjct: 130 WVVQ---LFYAFQDDRYLY-MVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAI 184
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPIC----GTPICMAP 171
           HS G +H D+K  N+L+ K      K+ADFG   +     + EG   C    GTP  ++P
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKM----NKEGMVRCDTAVGTPDYISP 238
Query: 172 EVARGE----EQGFPADVWALGCTVLEMATGRPPWPDVADPISALH-RIGFSSDTPEIP- 225
           EV + +      G   D W++G  + EM  G  P+   AD +   + +I    ++   P 
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF--YADSLVGTYSKIMNHKNSLTFPD 296
Query: 226 -GYMSKQAQDFLSKCLIRNPGE--RWSASELLEHGFVKEQNFKLSTLTE 271
              +SK+A++ +   L        R    E+  H F K   +   TL +
Sbjct: 297 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRD 345

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 124/280 (44%), Gaps = 30/280 (10%)
Query: 10  GRGSTATVSIGMSNRSSEVFAVKSAELS-------NSEFLQREQRILSALACPQIVAYKG 62
           G G    V       + ++FA+K  + +       ++   + E+ IL  +  P IV    
Sbjct: 29  GYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV---D 85
Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
              + + G  LY L LEY  GG L   +       E     +   + + L +LH  GI++
Sbjct: 86  LIYAFQTGGKLY-LILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIY 144
Query: 123 CDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF 181
            D+K +NI++   N QG  K+ DFG  + + +++       CGT   MAPE+        
Sbjct: 145 RDLKPENIML---NHQGHVKLTDFGLCKES-IHDGTVTHXFCGTIEYMAPEILMRSGHNR 200
Query: 182 PADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
             D W+LG  + +M TG PP+   +    I  + +   +     +P Y++++A+D L K 
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN-----LPPYLTQEARDLLKKL 255
Query: 240 LIRNPGERW-----SASELLEHGFVKEQNFK--LSTLTEP 272
           L RN   R       A E+  H F +  N++  L+   EP
Sbjct: 256 LKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEP 295

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 131/289 (45%), Gaps = 32/289 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACP 55
           D+   + IGRG+   V +     + +V+A+K        + S+S F   E+ I++    P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            +V       + ++ + LY + +EY PGG L + + S   + E   R +T  V+L L  +
Sbjct: 135 WVVQ---LFYAFQDDRYLY-MVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAI 189
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPIC----GTPICMAP 171
           HS G +H D+K  N+L+ K      K+ADFG   +     + EG   C    GTP  ++P
Sbjct: 190 HSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKM----NKEGMVRCDTAVGTPDYISP 243
Query: 172 EVARGE----EQGFPADVWALGCTVLEMATGRPPWPDVADPISALH-RIGFSSDTPEIP- 225
           EV + +      G   D W++G  + EM  G  P+   AD +   + +I    ++   P 
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF--YADSLVGTYSKIMNHKNSLTFPD 301
Query: 226 -GYMSKQAQDFLSKCLIRNPGE--RWSASELLEHGFVKEQNFKLSTLTE 271
              +SK+A++ +   L        R    E+  H F K   +   TL +
Sbjct: 302 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRD 350

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 131/289 (45%), Gaps = 32/289 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACP 55
           D+   + IGRG+   V +     + +V+A+K        + S+S F   E+ I++    P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            +V       + ++ + LY + +EY PGG L + + S   + E   R +T  V+L L  +
Sbjct: 135 WVVQ---LFYAFQDDRYLY-MVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAI 189
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPIC----GTPICMAP 171
           HS G +H D+K  N+L+ K      K+ADFG   +     + EG   C    GTP  ++P
Sbjct: 190 HSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKM----NKEGMVRCDTAVGTPDYISP 243
Query: 172 EVARGE----EQGFPADVWALGCTVLEMATGRPPWPDVADPISALH-RIGFSSDTPEIP- 225
           EV + +      G   D W++G  + EM  G  P+   AD +   + +I    ++   P 
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF--YADSLVGTYSKIMNHKNSLTFPD 301
Query: 226 -GYMSKQAQDFLSKCLIRNPGE--RWSASELLEHGFVKEQNFKLSTLTE 271
              +SK+A++ +   L        R    E+  H F K   +   TL +
Sbjct: 302 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRD 350

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 30/275 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACP 55
           D+     +G+GS   V +     + E++AVK        +  + E    E+R+L+    P
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 56  QIVA-YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
             +     C  + +    LY   +EY  GG L   I+     +E     +   + +GL +
Sbjct: 81  PFLTQLHSCFQTMDR---LY-FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 136
Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           L S GI++ D+K  N+++  D+E   KIADFG  +   + +    K  CGTP  +APE+ 
Sbjct: 137 LQSKGIIYRDLKLDNVML--DSEGHIKIADFGMCKE-NIWDGVTTKXFCGTPDYIAPEII 193
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISAL--HRIGFSSDTPEIPGYMSK 230
             +  G   D WA G  + EM  G+ P+   D  +   ++  H + +       P  MSK
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY-------PKSMSK 246
Query: 231 QAQDFLSKCLIRNPGERWSAS-----ELLEHGFVK 260
           +A       + ++PG+R         ++ EH F +
Sbjct: 247 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 110/233 (47%), Gaps = 24/233 (10%)
Query: 40  EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS----GTC 95
           E ++ E  +L +L  P I+  K  ++ E+   +   + +E   GG L + I S    G  
Sbjct: 65  EQIEAEIEVLKSLDHPNII--KIFEVFEDYHNMY--IVMETCEGGELLERIVSAQARGKA 120
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVN 154
           L EG +    + ++  L Y HS  +VH D+K +NIL    +     KI DFG A   +  
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-- 178
Query: 155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHR 214
            D+      GT + MAPEV +  +  F  D+W+ G  +  + TG  P+       ++L  
Sbjct: 179 SDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG-----TSLEE 232
Query: 215 IGFSSDTPEIPGY------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
           +   +   E P Y      ++ QA D L + L ++P  R SA+++L H + K+
Sbjct: 233 VQQKATYKE-PNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ------REQRILSALACPQ 56
           W     +G+G+TA V  G   ++ ++FA+K    +N  FL+      RE  +L  L    
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKV--FNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIR---SGTCLEEGRIRSHTRAVLLGLQ 113
           IV  K   I EE       L +E+ P G+L   +    +   L E       R V+ G+ 
Sbjct: 69  IV--KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 114 YLHSNGIVHCDIKGQNIL--VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAP 171
           +L  NGIVH +IK  NI+  + +D +   K+ DFG AR   + +D++   + GT   + P
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR--ELEDDEQFVXLYGTEEYLHP 184
Query: 172 E-----VARGEEQ---GFPADVWALGCTVLEMATGRPPWPDVADP 208
           +     V R + Q   G   D+W++G T    ATG  P+     P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 30/275 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACP 55
           D+     +G+GS   V +     + E++AVK        +  + E    E+R+L+    P
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 56  QIVA-YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
             +     C  + +    LY   +EY  GG L   I+     +E     +   + +GL +
Sbjct: 402 PFLTQLHSCFQTMDR---LY-FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 457
Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           L S GI++ D+K  N+++  D+E   KIADFG  +   + +    K  CGTP  +APE+ 
Sbjct: 458 LQSKGIIYRDLKLDNVML--DSEGHIKIADFGMCKE-NIWDGVTTKXFCGTPDYIAPEII 514
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISAL--HRIGFSSDTPEIPGYMSK 230
             +  G   D WA G  + EM  G+ P+   D  +   ++  H + +       P  MSK
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY-------PKSMSK 567
Query: 231 QAQDFLSKCLIRNPGERWSAS-----ELLEHGFVK 260
           +A       + ++PG+R         ++ EH F +
Sbjct: 568 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 123/264 (46%), Gaps = 23/264 (8%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALA-------CPQIVAYK 61
           +GRG+   V       S ++ AVK    + +   Q ++R+L  L        CP  V + 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS--QEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN-GI 120
           G    E +  I   L ++ +        I  G  + E  +     +++  L++LHS   +
Sbjct: 73  GALFREGDVWICMEL-MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI-CGTPICMAPEVARGE-- 177
           +H D+K  N+L++   +   K+ DFG +       DD  K I  G    MAPE    E  
Sbjct: 132 IHRDVKPSNVLINALGQ--VKMCDFGISGYLV---DDVAKDIDAGCKPYMAPERINPELN 186
Query: 178 EQGF--PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPG-YMSKQAQD 234
           ++G+   +D+W+LG T++E+A  R P+     P   L ++     +P++P    S +  D
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPSPQLPADKFSAEFVD 245
Query: 235 FLSKCLIRNPGERWSASELLEHGF 258
           F S+CL +N  ER +  EL++H F
Sbjct: 246 FTSQCLKKNSKERPTYPELMQHPF 269

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 126/293 (43%), Gaps = 41/293 (13%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKG 62
           +T  + IG GS   V       S EV A+K   L +  F  RE +I+  +  P +V  K 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEV-AIKKV-LQDKRFKNRELQIMRIVKHPNVVDLKA 99
Query: 63  CDIS--EENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGR----IRSHTRAVLLGLQYLH 116
              S  ++  ++  NL LEY P  T+  A R    L++      I+ +   +L  L Y+H
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH 158
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S GI H DIK QN+L+  D   G  K+ DFG A+     E +    IC      APE+  
Sbjct: 159 SIGICHRDIKPQNLLL--DPPSGVLKLIDFGSAKILIAGEPNVSX-ICSR-YYRAPELIF 214
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVA--DPISALHRIGFSSDTPEI----PGYM 228
           G        D+W+ GC + E+  G+P +P  +  D +  + ++  +    +I    P YM
Sbjct: 215 GATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM 274
Query: 229 SKQ--------------------AQDFLSKCLIRNPGERWSASELLEHGFVKE 261
             +                    A D +S+ L   P  R +A E L H F  E
Sbjct: 275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 112/229 (48%), Gaps = 30/229 (13%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAYKGCD 64
           QTIG+G    V +G   R ++V AVK    + +   FL  E  +++ L    +V   G  
Sbjct: 27  QTIGKGEFGDVMLG-DYRGNKV-AVKCIKNDATAQAFLA-EASVMTQLRHSNLVQLLGVI 83
Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRS-------GTCLEEGRIRSHTRAVLLGLQYLHS 117
           + E+ G  LY +  EY   G+L D +RS       G CL        +  V   ++YL  
Sbjct: 84  VEEKGG--LY-IVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEG 135
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
           N  VH D+  +N+LVS+DN   AK++DFG  + A   +D    P+  T    APE  R +
Sbjct: 136 NNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASSTQDTGKLPVKWT----APEALREK 189
Query: 178 EQGFPADVWALGCTVLEMAT-GRPPWPDV--ADPISALHRIGFSSDTPE 223
           +    +DVW+ G  + E+ + GR P+P +   D +  + + G+  D P+
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPD 237

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/174 (34%), Positives = 81/174 (46%), Gaps = 10/174 (5%)
Query: 98  EGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD 157
           E R   +   +  GL+ LH   IV+ D+K +NIL+  D+    +I+D G A    V E  
Sbjct: 285 EARAVFYAAEICCGLEDLHRERIVYRDLKPENILL--DDHGHIRISDLGLA--VHVPEGQ 340
Query: 158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF 217
             K   GT   MAPEV + E   F  D WALGC + EM  G+ P+      I        
Sbjct: 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL 400
Query: 218 SSDTP-EIPGYMSKQAQDFLSKCLIRNPGERW-----SASELLEHGFVKEQNFK 265
             + P E     S QA+   S+ L ++P ER      SA E+ EH   K+ NFK
Sbjct: 401 VKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 112/229 (48%), Gaps = 30/229 (13%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAYKGCD 64
           QTIG+G    V +G   R ++V AVK    + +   FL  E  +++ L    +V   G  
Sbjct: 12  QTIGKGEFGDVMLG-DYRGNKV-AVKCIKNDATAQAFLA-EASVMTQLRHSNLVQLLGVI 68
Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRS-------GTCLEEGRIRSHTRAVLLGLQYLHS 117
           + E+ G  LY +  EY   G+L D +RS       G CL        +  V   ++YL  
Sbjct: 69  VEEKGG--LY-IVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEG 120
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
           N  VH D+  +N+LVS+DN   AK++DFG  + A   +D    P+  T    APE  R +
Sbjct: 121 NNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASSTQDTGKLPVKWT----APEALREK 174
Query: 178 EQGFPADVWALGCTVLEMAT-GRPPWPDV--ADPISALHRIGFSSDTPE 223
           +    +DVW+ G  + E+ + GR P+P +   D +  + + G+  D P+
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPD 222

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/174 (34%), Positives = 81/174 (46%), Gaps = 10/174 (5%)
Query: 98  EGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD 157
           E R   +   +  GL+ LH   IV+ D+K +NIL+  D+    +I+D G A    V E  
Sbjct: 285 EARAVFYAAEICCGLEDLHRERIVYRDLKPENILL--DDHGHIRISDLGLA--VHVPEGQ 340
Query: 158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF 217
             K   GT   MAPEV + E   F  D WALGC + EM  G+ P+      I        
Sbjct: 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL 400
Query: 218 SSDTP-EIPGYMSKQAQDFLSKCLIRNPGERW-----SASELLEHGFVKEQNFK 265
             + P E     S QA+   S+ L ++P ER      SA E+ EH   K+ NFK
Sbjct: 401 VKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 111/252 (44%), Gaps = 17/252 (6%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKS------AELSNSEFLQREQRILSALACPQIVAY 60
           + IG+GS   V I   N + +++A+K        E +    + +E +I+  L  P +V  
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
                 EE+  ++ +L L    GG L   ++     +E  ++     +++ L YL +  I
Sbjct: 81  WYSFQDEEDMFMVVDLLL----GGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRI 136
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV---ARGE 177
           +H D+K  NIL+  D      I DF  A  A +  + +   + GT   MAPE+    +G 
Sbjct: 137 IHRDMKPDNILL--DEHGHVHITDFNIA--AMLPRETQITTMAGTKPYMAPEMFSSRKGA 192
Query: 178 EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
              F  D W+LG T  E+  GR P+   +   S      F +     P   S++    L 
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLK 252
Query: 238 KCLIRNPGERWS 249
           K L  NP +R+S
Sbjct: 253 KLLEPNPDQRFS 264

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 109/227 (48%), Gaps = 26/227 (11%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           QTIG+G    V +G   R ++V        + ++    E  +++ L    +V   G  + 
Sbjct: 199 QTIGKGEFGDVMLG-DYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 67  EENGKILYNLFLEYAPGGTLTDAIRS-------GTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           E+ G  LY +  EY   G+L D +RS       G CL +  +      V   ++YL  N 
Sbjct: 258 EKGG--LY-IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD-----VCEAMEYLEGNN 309
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
            VH D+  +N+LVS+DN   AK++DFG  + A   +D    P+  T    APE  R ++ 
Sbjct: 310 FVHRDLAARNVLVSEDNV--AKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKF 363
Query: 180 GFPADVWALGCTVLEMAT-GRPPWPDV--ADPISALHRIGFSSDTPE 223
              +DVW+ G  + E+ + GR P+P +   D +  + + G+  D P+
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPD 409

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 131/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV  K  D+     K+       +    T  DA  + T +    I+S+   +L GL + H
Sbjct: 67  IV--KLLDVIHTENKLYLVFEFLHQDLKTFMDA-SALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 124 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 179
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 238
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 239 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 99/223 (44%), Gaps = 11/223 (4%)
Query: 37  SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCL 96
           SNS  L  E  +L  L  P I+        + N    Y L +E   GG L D I      
Sbjct: 46  SNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRN----YYLVMEVYRGGELFDEIILRQKF 101
Query: 97  EEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV-SKDNEQGAKIADFGCARRARVNE 155
            E       + VL G  YLH + IVH D+K +N+L+ SK  +   KI DFG +    V  
Sbjct: 102 SEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG- 160
Query: 156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADP--ISALH 213
             + K   GT   +APEV R ++     DVW+ G  +  +  G PP+    D   +  + 
Sbjct: 161 -GKMKERLGTAYYIAPEVLR-KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVE 218
Query: 214 RIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
           +  FS D P+    +S +A+  +   L   P +R SA E L H
Sbjct: 219 KGKFSFDPPDWTQ-VSDEAKQLVKLMLTYEPSKRISAEEALNH 260

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 103/226 (45%), Gaps = 11/226 (4%)
Query: 37  SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCL 96
           SNS  L  E  +L  L  P I+  K  +  E+     Y L +E   GG L D I      
Sbjct: 63  SNSGALLDEVAVLKQLDHPNIM--KLYEFFEDKRN--YYLVMEVYRGGELFDEIILRQKF 118
Query: 97  EEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV-SKDNEQGAKIADFGCARRARVNE 155
            E       + VL G  YLH + IVH D+K +N+L+ SK  +   KI DFG +    V  
Sbjct: 119 SEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG- 177
Query: 156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADP--ISALH 213
             + K   GT   +APEV R ++     DVW+ G  +  +  G PP+    D   +  + 
Sbjct: 178 -GKMKERLGTAYYIAPEVLR-KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVE 235
Query: 214 RIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV 259
           +  FS D P+    +S +A+  +   L   P +R SA E L H ++
Sbjct: 236 KGKFSFDPPDWTQ-VSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 280

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 7   QTIGRGSTATVSI----GMSNRSSEVFAVKSAELSNSEFL---QREQRILSALACPQIVA 59
           Q +G+G+  +V +     + + + EV AVK  + S  E L   +RE  IL +L    IV 
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSN 118
           YKG   S   G+    L +EY P G+L D +++    ++  ++  +T  +  G++YL + 
Sbjct: 79  YKGVCYSA--GRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTK 136
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPIC-MAPEVARG 176
             +H D+  +NILV  +NE   KI DFG  +   +  E  + K    +PI   APE    
Sbjct: 137 RYIHRDLATRNILV--ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 177 EEQGFPADVWALGCTVLEMAT 197
            +    +DVW+ G  + E+ T
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 7   QTIGRGSTATVSI----GMSNRSSEVFAVKSAELSNSEFL---QREQRILSALACPQIVA 59
           Q +G+G+  +V +     + + + EV AVK  + S  E L   +RE  IL +L    IV 
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
           YKG   S   G+    L +EY P G+L D + +    ++  ++  +T  +  G++YL + 
Sbjct: 82  YKGVCYSA--GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 139
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPIC-MAPEVARG 176
             +H D+  +NILV  +NE   KI DFG  +   +  E  + K    +PI   APE    
Sbjct: 140 RYIHRDLATRNILV--ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 197
Query: 177 EEQGFPADVWALGCTVLEMAT 197
            +    +DVW+ G  + E+ T
Sbjct: 198 SKFSVASDVWSFGVVLYELFT 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 7   QTIGRGSTATVSI----GMSNRSSEVFAVKSAELSNSEFL---QREQRILSALACPQIVA 59
           Q +G+G+  +V +     + + + EV AVK  + S  E L   +RE  IL +L    IV 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
           YKG   S   G+    L +EY P G+L D + +    ++  ++  +T  +  G++YL + 
Sbjct: 76  YKGVCYSA--GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPIC-MAPEVARG 176
             +H D+  +NILV  +NE   KI DFG  +   +  E  + K    +PI   APE    
Sbjct: 134 RYIHRDLATRNILV--ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 177 EEQGFPADVWALGCTVLEMAT 197
            +    +DVW+ G  + E+ T
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 7   QTIGRGSTATVSI----GMSNRSSEVFAVKSAELSNSEFL---QREQRILSALACPQIVA 59
           Q +G+G+  +V +     + + + EV AVK  + S  E L   +RE  IL +L    IV 
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
           YKG   S   G+    L +EY P G+L D + +    ++  ++  +T  +  G++YL + 
Sbjct: 107 YKGVCYSA--GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPIC-MAPEVARG 176
             +H D+  +NILV  +NE   KI DFG  +   +  E  + K    +PI   APE    
Sbjct: 165 RYIHRDLATRNILV--ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 222
Query: 177 EEQGFPADVWALGCTVLEMAT 197
            +    +DVW+ G  + E+ T
Sbjct: 223 SKFSVASDVWSFGVVLYELFT 243

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 7   QTIGRGSTATVSI----GMSNRSSEVFAVKSAELSNSEFL---QREQRILSALACPQIVA 59
           Q +G+G+  +V +     + + + EV AVK  + S  E L   +RE  IL +L    IV 
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
           YKG   S   G+    L +EY P G+L D + +    ++  ++  +T  +  G++YL + 
Sbjct: 83  YKGVCYSA--GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 140
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPIC-MAPEVARG 176
             +H D+  +NILV  +NE   KI DFG  +   +  E  + K    +PI   APE    
Sbjct: 141 RYIHRDLATRNILV--ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 198
Query: 177 EEQGFPADVWALGCTVLEMAT 197
            +    +DVW+ G  + E+ T
Sbjct: 199 SKFSVASDVWSFGVVLYELFT 219

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 7   QTIGRGSTATVSI----GMSNRSSEVFAVKSAELSNSEFL---QREQRILSALACPQIVA 59
           Q +G+G+  +V +     + + + EV AVK  + S  E L   +RE  IL +L    IV 
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
           YKG   S   G+    L +EY P G+L D + +    ++  ++  +T  +  G++YL + 
Sbjct: 80  YKGVCYSA--GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 137
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPIC-MAPEVARG 176
             +H D+  +NILV  +NE   KI DFG  +   +  E  + K    +PI   APE    
Sbjct: 138 RYIHRDLATRNILV--ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 195
Query: 177 EEQGFPADVWALGCTVLEMAT 197
            +    +DVW+ G  + E+ T
Sbjct: 196 SKFSVASDVWSFGVVLYELFT 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 7   QTIGRGSTATVSI----GMSNRSSEVFAVKSAELSNSEFL---QREQRILSALACPQIVA 59
           Q +G+G+  +V +     + + + EV AVK  + S  E L   +RE  IL +L    IV 
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
           YKG   S   G+    L +EY P G+L D + +    ++  ++  +T  +  G++YL + 
Sbjct: 79  YKGVCYSA--GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 136
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPIC-MAPEVARG 176
             +H D+  +NILV  +NE   KI DFG  +   +  E  + K    +PI   APE    
Sbjct: 137 RYIHRDLATRNILV--ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 177 EEQGFPADVWALGCTVLEMAT 197
            +    +DVW+ G  + E+ T
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 7   QTIGRGSTATVSI----GMSNRSSEVFAVKSAELSNSEFL---QREQRILSALACPQIVA 59
           Q +G+G+  +V +     + + + EV AVK  + S  E L   +RE  IL +L    IV 
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
           YKG   S   G+    L +EY P G+L D + +    ++  ++  +T  +  G++YL + 
Sbjct: 74  YKGVCYSA--GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 131
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPIC-MAPEVARG 176
             +H D+  +NILV  +NE   KI DFG  +   +  E  + K    +PI   APE    
Sbjct: 132 RYIHRDLATRNILV--ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 189
Query: 177 EEQGFPADVWALGCTVLEMAT 197
            +    +DVW+ G  + E+ T
Sbjct: 190 SKFSVASDVWSFGVVLYELFT 210

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 7   QTIGRGSTATVSI----GMSNRSSEVFAVKSAELSNSEFL---QREQRILSALACPQIVA 59
           Q +G+G+  +V +     + + + EV AVK  + S  E L   +RE  IL +L    IV 
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
           YKG   S   G+    L +EY P G+L D + +    ++  ++  +T  +  G++YL + 
Sbjct: 81  YKGVCYSA--GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 138
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPIC-MAPEVARG 176
             +H D+  +NILV  +NE   KI DFG  +   +  E  + K    +PI   APE    
Sbjct: 139 RYIHRDLATRNILV--ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 196
Query: 177 EEQGFPADVWALGCTVLEMAT 197
            +    +DVW+ G  + E+ T
Sbjct: 197 SKFSVASDVWSFGVVLYELFT 217

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 7   QTIGRGSTATVSI----GMSNRSSEVFAVKSAELSNSEFL---QREQRILSALACPQIVA 59
           Q +G+G+  +V +     + + + EV AVK  + S  E L   +RE  IL +L    IV 
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
           YKG   S   G+    L +EY P G+L D + +    ++  ++  +T  +  G++YL + 
Sbjct: 75  YKGVCYSA--GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 132
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPIC-MAPEVARG 176
             +H D+  +NILV  +NE   KI DFG  +   +  E  + K    +PI   APE    
Sbjct: 133 RYIHRDLATRNILV--ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 190
Query: 177 EEQGFPADVWALGCTVLEMAT 197
            +    +DVW+ G  + E+ T
Sbjct: 191 SKFSVASDVWSFGVVLYELFT 211

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 131/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 64  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 120
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 121 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 176 GEEQGFPA-DVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +    A D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 177 GXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 235
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 7   QTIGRGSTATVSI----GMSNRSSEVFAVKSAELSNSEFL---QREQRILSALACPQIVA 59
           Q +G+G+  +V +     + + + EV AVK  + S  E L   +RE  IL +L    IV 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
           YKG   S   G+    L +EY P G+L D + +    ++  ++  +T  +  G++YL + 
Sbjct: 76  YKGVCYSA--GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPIC-MAPEVARG 176
             +H D+  +NILV  +NE   KI DFG  +   +  E  + K    +PI   APE    
Sbjct: 134 RYIHRDLATRNILV--ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 177 EEQGFPADVWALGCTVLEMAT 197
            +    +DVW+ G  + E+ T
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 7   QTIGRGSTATVSI----GMSNRSSEVFAVKSAELSNSEFL---QREQRILSALACPQIVA 59
           Q +G+G+  +V +     + + + EV AVK  + S  E L   +RE  IL +L    IV 
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
           YKG   S   G+    L +EY P G+L D + +    ++  ++  +T  +  G++YL + 
Sbjct: 94  YKGVCYSA--GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 151
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPIC-MAPEVARG 176
             +H D+  +NILV  +NE   KI DFG  +   +  E  + K    +PI   APE    
Sbjct: 152 RYIHRDLATRNILV--ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 177 EEQGFPADVWALGCTVLEMAT 197
            +    +DVW+ G  + E+ T
Sbjct: 210 SKFSVASDVWSFGVVLYELFT 230

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 107/227 (47%), Gaps = 26/227 (11%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           QTIG+G    V +G   R ++V        + ++    E  +++ L    +V   G  + 
Sbjct: 18  QTIGKGEFGDVMLG-DYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 67  EENGKILYNLFLEYAPGGTLTDAIRS-------GTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           E+ G  LY +  EY   G+L D +RS       G CL +      +  V   ++YL  N 
Sbjct: 77  EKGG--LY-IVTEYMAKGSLVDYLRSRGRSVLGGDCLLK-----FSLDVCEAMEYLEGNN 128
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
            VH D+  +N+LVS+DN   AK++DFG  + A   +D    P+  T    APE  R    
Sbjct: 129 FVHRDLAARNVLVSEDNV--AKVSDFGLTKEASSTQDTGKLPVKWT----APEALREAAF 182
Query: 180 GFPADVWALGCTVLEMAT-GRPPWPDV--ADPISALHRIGFSSDTPE 223
              +DVW+ G  + E+ + GR P+P +   D +  + + G+  D P+
Sbjct: 183 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPD 228

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 131/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 71  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 127
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 128 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 183
Query: 176 GEEQGFPA-DVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +    A D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 184 GXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 242
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 243 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 7   QTIGRGSTATVSI----GMSNRSSEVFAVKSAELSNSEFL---QREQRILSALACPQIVA 59
           Q +G+G+  +V +     + + + EV AVK  + S  E L   +RE  IL +L    IV 
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
           YKG   S   G+    L +EY P G+L D + +    ++  ++  +T  +  G++YL + 
Sbjct: 94  YKGVCYSA--GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 151
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPIC-MAPEVARG 176
             +H D+  +NILV  +NE   KI DFG  +   +  E  + K    +PI   APE    
Sbjct: 152 RYIHRDLATRNILV--ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 177 EEQGFPADVWALGCTVLEMAT 197
            +    +DVW+ G  + E+ T
Sbjct: 210 SKFSVASDVWSFGVVLYELFT 230

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 125/271 (46%), Gaps = 12/271 (4%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE--FLQREQRILSALACPQIVAY 60
           +   + +GRG    V   +   S + +  K  ++  ++   +++E  IL+      I+  
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTC-LEEGRIRSHTRAVLLGLQYLHSNG 119
                S E   +++    E+  G  + + I +    L E  I S+   V   LQ+LHS+ 
Sbjct: 67  HESFESMEELVMIF----EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           I H DI+ +NI+         KI +FG AR+ +    D  + +   P   APEV + +  
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--PGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADP--ISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
               D+W+LG  V  + +G  P+    +   I  +    ++ D  E    +S +A DF+ 
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD-EEAFKEISIEAMDFVD 239
Query: 238 KCLIRNPGERWSASELLEHGFVKEQNFKLST 268
           + L++    R +ASE L+H ++K++  ++ST
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIERVST 270

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 122/264 (46%), Gaps = 23/264 (8%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALA-------CPQIVAYK 61
           +GRG+   V       S ++ AVK    + +   Q ++R+L  L        CP  V + 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS--QEQKRLLMDLDISMRTVDCPFTVTFY 116
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN-GI 120
           G    E +  I   L ++ +        I  G  + E  +     +++  L++LHS   +
Sbjct: 117 GALFREGDVWICMEL-MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 175
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI-CGTPICMAPEVARGE-- 177
           +H D+K  N+L++   +   K+ DFG +       D   K I  G    MAPE    E  
Sbjct: 176 IHRDVKPSNVLINALGQ--VKMCDFGISGYLV---DSVAKTIDAGCKPYMAPERINPELN 230
Query: 178 EQGF--PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPG-YMSKQAQD 234
           ++G+   +D+W+LG T++E+A  R P+     P   L ++     +P++P    S +  D
Sbjct: 231 QKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPSPQLPADKFSAEFVD 289
Query: 235 FLSKCLIRNPGERWSASELLEHGF 258
           F S+CL +N  ER +  EL++H F
Sbjct: 290 FTSQCLKKNSKERPTYPELMQHPF 313

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 134/295 (45%), Gaps = 44/295 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 57  IVAYKGCDISEENGKILYNLFLE-YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
           IV  K  D+     K LY +F   +    T  DA  + T +    I+S+   +L GL + 
Sbjct: 63  IV--KLLDVIHTENK-LYLVFEHVHQDLKTFMDA-SALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           HS+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+ 
Sbjct: 119 HSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 174
Query: 175 RG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------I 224
            G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 225 PGY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
           P Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 64  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 120
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 121 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 176
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 235
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 66  IVKLLDV-IHTENKLYLVFEFLSMDLKDFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 122
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 123 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 178
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 237
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 238 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 64  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLSFCH 120
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 121 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 235
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 64  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 120
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 121 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 176
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 235
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 64  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 120
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 121 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 176
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 235
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 66  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 122
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 123 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 178
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 237
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 238 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 63  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 119
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 120 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 175
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 65  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 121
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 122 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 177
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 236
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 237 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 65  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 121
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 122 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 177
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 236
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 237 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 64  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 120
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 121 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 176
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 235
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 65  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 121
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 122 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 177
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 236
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 237 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 67  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 123
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 124 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 179
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 238
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 239 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 66  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 122
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 123 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 178
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 237
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 238 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 67  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 123
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 124 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 179
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 238
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 239 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 63  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 119
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 120 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 175
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 67  IVKLLDV-IHTENKLYLVFEFLSMDLKDFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 123
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 124 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 179
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 238
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 239 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 71  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 127
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 128 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 183
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 184 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 242
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 243 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 64  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 120
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 121 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 235
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 63  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 119
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 120 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 175
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 68  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 124
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 125 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 180
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 239
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 240 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 293

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 64  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 120
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 121 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 235
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 63  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 119
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 120 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 175
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 7   QTIGRGSTATVSI----GMSNRSSEVFAVKSAELSNSEFL---QREQRILSALACPQIVA 59
           Q +G+G+  +V +     + + + EV AVK  + S  E L   +RE  IL +L    IV 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
           YKG   S   G+    L +EY P G+L D + +    ++  ++  +T  +  G++YL + 
Sbjct: 76  YKGVCYSA--GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPIC-MAPEVARG 176
             +H D+  +NILV  +NE   KI DFG  +   +  E  + K    +PI   APE    
Sbjct: 134 RYIHRDLATRNILV--ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 177 EEQGFPADVWALGCTVLEMAT 197
            +    +DVW+ G  + E+ T
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 68  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 124
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 125 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 180
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 239
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 240 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 293

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 115/275 (41%), Gaps = 23/275 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-----SNSEFLQREQRILSALACPQ 56
           D+    TIG GS             ++   K  +      +  + L  E  +L  L  P 
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT----CLEEGRIRSHTRAVLLGL 112
           IV Y    I   N  +   + +EY  GG L   I  GT     L+E  +      + L L
Sbjct: 67  IVRYYDRIIDRTNTTLY--IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 113 QYLH--SNG---IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI 167
           +  H  S+G   ++H D+K  N+ +  D +Q  K+ DFG AR    +++D  K   GTP 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFL--DGKQNVKLGDFGLARILN-HDEDFAKEFVGTPY 181
Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADP-ISALHRIGFSSDTPEIPG 226
            M+PE          +D+W+LGC + E+    PP+   +   ++   R G       IP 
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG---KFRRIPY 238
Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
             S +  + +++ L      R S  E+LE+  + E
Sbjct: 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 120/287 (41%), Gaps = 43/287 (14%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQREQRILSALACPQIVAYKGC 63
           IG GS   V    +  + ++ A+K    S  +        RE R+L  L  P +V     
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNL--L 68
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
           ++     ++  +L  EY     L +  R    + E  ++S T   L  + + H +  +H 
Sbjct: 69  EVFRRKRRL--HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHR 126
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ-GFP 182
           D+K +NIL++K +    K+ DFG AR      D     +  T    +PE+  G+ Q G P
Sbjct: 127 DVKPENILITKHS--VIKLCDFGFARLLTGPSDYYDDEV-ATRWYRSPELLVGDTQYGPP 183
Query: 183 ADVWALGCTVLEMATGRPPWPDVAD------------PISALHRIGFSSDT--------- 221
            DVWA+GC   E+ +G P WP  +D             +   H+  FS++          
Sbjct: 184 VDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPD 243
Query: 222 PE--------IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
           PE         P  +S  A   L  CL  +P ER +  +LL H + +
Sbjct: 244 PEDMEPLELKFPN-ISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 54/105 (51%), Gaps = 8/105 (7%)
Query: 101 IRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG--CARRARVNEDDE 158
           +R    ++L  L  LH N I+HCD+K +NIL+ +    G K+ DFG  C    RV    +
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQ 261
Query: 159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWP 203
            +         APEV  G   G P D+W+LGC + E+ TG P  P
Sbjct: 262 SR------FYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 54/105 (51%), Gaps = 8/105 (7%)
Query: 101 IRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG--CARRARVNEDDE 158
           +R    ++L  L  LH N I+HCD+K +NIL+ +    G K+ DFG  C    RV    +
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXIQ 261
Query: 159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWP 203
            +         APEV  G   G P D+W+LGC + E+ TG P  P
Sbjct: 262 SR------FYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 120/272 (44%), Gaps = 33/272 (12%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSA-----ELSNSEFLQREQRILSALACPQIVAYKG- 62
           IGRG+  +V+  +   S ++ AVK       E    + L     ++ +  CP IV + G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 63  ------CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
                 C I  E     ++ F +Y     L D I        G+I   T A +  L +L 
Sbjct: 90  LFREGDCWICMELMSTSFDKFYKYV-YSVLDDVIPEEIL---GKI---TLATVKALNHLK 142
Query: 117 SN-GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV-- 173
            N  I+H DIK  NIL+  D     K+ DFG +   ++ +        G    MAPE   
Sbjct: 143 ENLKIIHRDIKPSNILL--DRSGNIKLCDFGIS--GQLVDSIAKTRDAGCRPYMAPERID 198
Query: 174 ARGEEQGFP--ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQ 231
                QG+   +DVW+LG T+ E+ATGR P+P        L ++    D P++     ++
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDPPQLSNSEERE 257
Query: 232 AQ----DFLSKCLIRNPGERWSASELLEHGFV 259
                 +F++ CL ++  +R    ELL+H F+
Sbjct: 258 FSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 54/105 (51%), Gaps = 8/105 (7%)
Query: 101 IRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG--CARRARVNEDDE 158
           +R    ++L  L  LH N I+HCD+K +NIL+ +    G K+ DFG  C    RV    +
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQ 261
Query: 159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWP 203
            +         APEV  G   G P D+W+LGC + E+ TG P  P
Sbjct: 262 SR------FYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 118/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKS-----AELSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      R  +  AVK        L ++    RE R+L  L    ++     
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +    ++L     G   + I     L +  ++     +L GL+Y+HS GI+H 
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAGIIHR 155
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D+E   +I DFG AR+A    D+E      T    APE+          
Sbjct: 156 DLKPSNVAVNEDSE--LRILDFGLARQA----DEEMTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 183 ADVWALGCTVLEMATGRP--------------------PWPDVADPISALHRIGFSSDTP 222
            D+W++GC + E+  G+                     P P+V   IS+ H   +    P
Sbjct: 210 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 269
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            +P           +  A D L + L+ +  +R SA+E L H +  + +
Sbjct: 270 PMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYH 318

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 109/240 (45%), Gaps = 22/240 (9%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE----FLQREQRILSALACPQIV 58
           + +   +G G+ ATV  G S  +  + A+K   L + E       RE  +L  L    IV
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
                  +E++  +++  +L+      L D    G  +    ++     +L GL Y H  
Sbjct: 64  TLHDIIHTEKSLTLVFE-YLDKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 119 GIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARV---NEDDEGKPICGTPICMAPEVA 174
            ++H D+K QN+L+   NE+G  K+ADFG AR   +     D+E   +   P    P++ 
Sbjct: 120 KVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNEVVTLWYRP----PDIL 172
Query: 175 RGE-EQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQ 231
            G  +     D+W +GC   EMATGRP +P   V + +  + RI  +      PG +S +
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 65  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 121
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K +N+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 122 SHRVLHRDLKPENLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 177
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 236
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 237 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 64  IVKLLDV-IHTENKLYLVFEFLHQDLKDFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 120
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K +N+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 121 SHRVLHRDLKPENLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 176
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 235
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 67  IVKLLDV-IHTENKLYLVFEFLSMDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 123
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K +N+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 124 SHRVLHRDLKPENLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 179
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 238
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 239 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 65  IVKLLDV-IHTENKLYLVFEFLSMDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 121
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K +N+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 122 SHRVLHRDLKPENLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 177
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 236
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 237 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 66  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 122
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K +N+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 123 SHRVLHRDLKPENLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 178
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 237
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 238 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 10/209 (4%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           + +T  + IG GS   V       S E+ A+K   L +  F  RE +I+  L    IV  
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 78
Query: 61  KGCDIS--EENGKILYNLFLEYAPGGTLTDA---IRSGTCLEEGRIRSHTRAVLLGLQYL 115
           +    S  E+  ++  NL L+Y P      A    R+   L    ++ +   +   L Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS GI H DIK QN+L+  D     K+ DFG A++    E +    IC      APE+  
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSX-ICSR-YYRAPELIF 195
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWP 203
           G  +     DVW+ GC + E+  G+P +P
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFP 224

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 116/254 (45%), Gaps = 17/254 (6%)
Query: 4   TRGQTIGRGSTATVSIG--MSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           T GQ IG GS  TV  G    + + ++  V +      +  + E  +L       I+ + 
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           G     +       +  ++  G +L   +    T  E  ++    R    G+ YLH+  I
Sbjct: 71  GYSTKPQLA-----IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCA-RRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           +H D+K  NI + +D     KI DFG A  ++R +   + + + G+ + MAPEV R +++
Sbjct: 126 IHRDLKSNNIFLHED--LTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 180 G---FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS---KQAQ 233
               F +DV+A G  + E+ TG+ P+ ++ +    +  +G    +P++    S   K  +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243
Query: 234 DFLSKCLIRNPGER 247
             +++CL +   ER
Sbjct: 244 RLMAECLKKKRDER 257

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 10/209 (4%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           + +T  + IG GS   V       S E+ A+K   L +  F  RE +I+  L    IV  
Sbjct: 21  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 79
Query: 61  KGCDIS--EENGKILYNLFLEYAPGGTLTDA---IRSGTCLEEGRIRSHTRAVLLGLQYL 115
           +    S  E+  ++  NL L+Y P      A    R+   L    ++ +   +   L Y+
Sbjct: 80  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 139
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS GI H DIK QN+L+  D     K+ DFG A++    E +    IC      APE+  
Sbjct: 140 HSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSX-ICSR-YYRAPELIF 196
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWP 203
           G  +     DVW+ GC + E+  G+P +P
Sbjct: 197 GATDYTSSIDVWSAGCVLAELLLGQPIFP 225

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 10/209 (4%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           + +T  + IG GS   V       S E+ A+K   L +  F  RE +I+  L    IV  
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 78
Query: 61  KGCDIS--EENGKILYNLFLEYAPGGTLTDA---IRSGTCLEEGRIRSHTRAVLLGLQYL 115
           +    S  E+  ++  NL L+Y P      A    R+   L    ++ +   +   L Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS GI H DIK QN+L+  D     K+ DFG A++    E +    IC      APE+  
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSX-ICSR-YYRAPELIF 195
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWP 203
           G  +     DVW+ GC + E+  G+P +P
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFP 224

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 10/209 (4%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           + +T  + IG GS   V       S E+ A+K   L +  F  RE +I+  L    IV  
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 78
Query: 61  KGCDIS--EENGKILYNLFLEYAPGGTLTDA---IRSGTCLEEGRIRSHTRAVLLGLQYL 115
           +    S  E+  ++  NL L+Y P      A    R+   L    ++ +   +   L Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS GI H DIK QN+L+  D     K+ DFG A++    E +    IC      APE+  
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSY-ICSR-YYRAPELIF 195
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWP 203
           G  +     DVW+ GC + E+  G+P +P
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFP 224

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 10/209 (4%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           + +T  + IG GS   V       S E+ A+K   L +  F  RE +I+  L    IV  
Sbjct: 39  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 97
Query: 61  KGCDIS--EENGKILYNLFLEYAPGGTLTDA---IRSGTCLEEGRIRSHTRAVLLGLQYL 115
           +    S  E+  ++  NL L+Y P      A    R+   L    ++ +   +   L Y+
Sbjct: 98  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 157
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS GI H DIK QN+L+  D     K+ DFG A++    E +    IC      APE+  
Sbjct: 158 HSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSX-ICSR-YYRAPELIF 214
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWP 203
           G  +     DVW+ GC + E+  G+P +P
Sbjct: 215 GATDYTSSIDVWSAGCVLAELLLGQPIFP 243

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 10/209 (4%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           + +T  + IG GS   V       S E+ A+K   L +  F  RE +I+  L    IV  
Sbjct: 28  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 86
Query: 61  KGCDIS--EENGKILYNLFLEYAPGGTLTDA---IRSGTCLEEGRIRSHTRAVLLGLQYL 115
           +    S  E+  ++  NL L+Y P      A    R+   L    ++ +   +   L Y+
Sbjct: 87  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 146
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS GI H DIK QN+L+  D     K+ DFG A++    E +    IC      APE+  
Sbjct: 147 HSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSX-ICSR-YYRAPELIF 203
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWP 203
           G  +     DVW+ GC + E+  G+P +P
Sbjct: 204 GATDYTSSIDVWSAGCVLAELLLGQPIFP 232

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 117/254 (46%), Gaps = 17/254 (6%)
Query: 4   TRGQTIGRGSTATVSIG--MSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           T GQ IG GS  TV  G    + + ++  V +      +  + E  +L       I+ + 
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           G   + +       +  ++  G +L   +    T  E  ++    R    G+ YLH+  I
Sbjct: 71  GYSTAPQLA-----IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           +H D+K  NI + +D     KI DFG A  ++R +   + + + G+ + MAPEV R +++
Sbjct: 126 IHRDLKSNNIFLHED--LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 180 G---FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS---KQAQ 233
               F +DV+A G  + E+ TG+ P+ ++ +    +  +G    +P++    S   K  +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243
Query: 234 DFLSKCLIRNPGER 247
             +++CL +   ER
Sbjct: 244 RLMAECLKKKRDER 257

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 10/209 (4%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           + +T  + IG GS   V       S E+ A+K   L +  F  RE +I+  L    IV  
Sbjct: 24  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 82
Query: 61  KGCDIS--EENGKILYNLFLEYAPGGTLTDA---IRSGTCLEEGRIRSHTRAVLLGLQYL 115
           +    S  E+  ++  NL L+Y P      A    R+   L    ++ +   +   L Y+
Sbjct: 83  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 142
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS GI H DIK QN+L+  D     K+ DFG A++    E +    IC      APE+  
Sbjct: 143 HSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSX-ICSR-YYRAPELIF 199
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWP 203
           G  +     DVW+ GC + E+  G+P +P
Sbjct: 200 GATDYTSSIDVWSAGCVLAELLLGQPIFP 228

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 10/209 (4%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           + +T  + IG GS   V       S E+ A+K   L +  F  RE +I+  L    IV  
Sbjct: 32  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 90
Query: 61  KGCDIS--EENGKILYNLFLEYAPGGTLTDA---IRSGTCLEEGRIRSHTRAVLLGLQYL 115
           +    S  E+  ++  NL L+Y P      A    R+   L    ++ +   +   L Y+
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS GI H DIK QN+L+  D     K+ DFG A++    E +    IC      APE+  
Sbjct: 151 HSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSX-ICSR-YYRAPELIF 207
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWP 203
           G  +     DVW+ GC + E+  G+P +P
Sbjct: 208 GATDYTSSIDVWSAGCVLAELLLGQPIFP 236

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 10/209 (4%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           + +T  + IG GS   V       S E+ A+K   L +  F  RE +I+  L    IV  
Sbjct: 32  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 90
Query: 61  KGCDIS--EENGKILYNLFLEYAPGGTLTDA---IRSGTCLEEGRIRSHTRAVLLGLQYL 115
           +    S  E+  ++  NL L+Y P      A    R+   L    ++ +   +   L Y+
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS GI H DIK QN+L+  D     K+ DFG A++    E +    IC      APE+  
Sbjct: 151 HSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSX-ICSR-YYRAPELIF 207
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWP 203
           G  +     DVW+ GC + E+  G+P +P
Sbjct: 208 GATDYTSSIDVWSAGCVLAELLLGQPIFP 236

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 10/209 (4%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           + +T  + IG GS   V       S E+ A+K   L +  F  RE +I+  L    IV  
Sbjct: 33  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 91
Query: 61  KGCDIS--EENGKILYNLFLEYAPGGTLTDA---IRSGTCLEEGRIRSHTRAVLLGLQYL 115
           +    S  E+  ++  NL L+Y P      A    R+   L    ++ +   +   L Y+
Sbjct: 92  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 151
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS GI H DIK QN+L+  D     K+ DFG A++    E +    IC      APE+  
Sbjct: 152 HSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSY-ICSR-YYRAPELIF 208
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWP 203
           G  +     DVW+ GC + E+  G+P +P
Sbjct: 209 GATDYTSSIDVWSAGCVLAELLLGQPIFP 237

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 116/254 (45%), Gaps = 17/254 (6%)
Query: 4   TRGQTIGRGSTATVSIG--MSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           T GQ IG GS  TV  G    + + ++  V +      +  + E  +L       I+ + 
Sbjct: 31  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 90
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           G     +       +  ++  G +L   +    T  E  ++    R    G+ YLH+  I
Sbjct: 91  GYSTKPQLA-----IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 145
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCA-RRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           +H D+K  NI + +D     KI DFG A  ++R +   + + + G+ + MAPEV R +++
Sbjct: 146 IHRDLKSNNIFLHED--LTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 203
Query: 180 G---FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS---KQAQ 233
               F +DV+A G  + E+ TG+ P+ ++ +    +  +G    +P++    S   K  +
Sbjct: 204 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 263
Query: 234 DFLSKCLIRNPGER 247
             +++CL +   ER
Sbjct: 264 RLMAECLKKKRDER 277

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 116/254 (45%), Gaps = 17/254 (6%)
Query: 4   TRGQTIGRGSTATVSIG--MSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           T GQ IG GS  TV  G    + + ++  V +      +  + E  +L       I+ + 
Sbjct: 39  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           G     +       +  ++  G +L   +    T  E  ++    R    G+ YLH+  I
Sbjct: 99  GYSTKPQ-----LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 153
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCA-RRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           +H D+K  NI + +D     KI DFG A  ++R +   + + + G+ + MAPEV R +++
Sbjct: 154 IHRDLKSNNIFLHED--LTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 211
Query: 180 G---FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS---KQAQ 233
               F +DV+A G  + E+ TG+ P+ ++ +    +  +G    +P++    S   K  +
Sbjct: 212 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 271
Query: 234 DFLSKCLIRNPGER 247
             +++CL +   ER
Sbjct: 272 RLMAECLKKKRDER 285

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 7   QTIGRGSTATVSI----GMSNRSSEVFAVKSAELSNSEFL---QREQRILSALACPQIVA 59
           Q +G+G+  +V +     + + + EV AVK  + S  E L   +RE  IL +L    IV 
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
           YKG   S   G+    L +EY P G+L D + +    ++  ++  +T  +  G++YL + 
Sbjct: 77  YKGVCYSA--GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 134
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPIC-MAPEVARG 176
             +H ++  +NILV  +NE   KI DFG  +   +  E  + K    +PI   APE    
Sbjct: 135 RYIHRNLATRNILV--ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 192
Query: 177 EEQGFPADVWALGCTVLEMAT 197
            +    +DVW+ G  + E+ T
Sbjct: 193 SKFSVASDVWSFGVVLYELFT 213

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 116/254 (45%), Gaps = 17/254 (6%)
Query: 4   TRGQTIGRGSTATVSIG--MSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           T GQ IG GS  TV  G    + + ++  V +      +  + E  +L       I+ + 
Sbjct: 13  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 72
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           G     +       +  ++  G +L   +    T  E  ++    R    G+ YLH+  I
Sbjct: 73  GYSTKPQLA-----IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 127
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           +H D+K  NI + +D     KI DFG A  ++R +   + + + G+ + MAPEV R +++
Sbjct: 128 IHRDLKSNNIFLHED--LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 185
Query: 180 G---FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS---KQAQ 233
               F +DV+A G  + E+ TG+ P+ ++ +    +  +G    +P++    S   K  +
Sbjct: 186 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 245
Query: 234 DFLSKCLIRNPGER 247
             +++CL +   ER
Sbjct: 246 RLMAECLKKKRDER 259

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 116/254 (45%), Gaps = 17/254 (6%)
Query: 4   TRGQTIGRGSTATVSIG--MSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           T GQ IG GS  TV  G    + + ++  V +      +  + E  +L       I+ + 
Sbjct: 16  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           G     +       +  ++  G +L   +    T  E  ++    R    G+ YLH+  I
Sbjct: 76  GYSTKPQLA-----IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 130
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           +H D+K  NI + +D     KI DFG A  ++R +   + + + G+ + MAPEV R +++
Sbjct: 131 IHRDLKSNNIFLHED--LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 188
Query: 180 G---FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS---KQAQ 233
               F +DV+A G  + E+ TG+ P+ ++ +    +  +G    +P++    S   K  +
Sbjct: 189 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 248
Query: 234 DFLSKCLIRNPGER 247
             +++CL +   ER
Sbjct: 249 RLMAECLKKKRDER 262

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 10/209 (4%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           + +T  + IG GS   V       S E+ A+K   L    F  RE +I+  L    IV  
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFKNRELQIMRKLDHCNIVRL 78
Query: 61  KGCDIS--EENGKILYNLFLEYAPGGTLTDA---IRSGTCLEEGRIRSHTRAVLLGLQYL 115
           +    S  E+  ++  NL L+Y P      A    R+   L    ++ +   +   L Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS GI H DIK QN+L+  D     K+ DFG A++    E +    IC      APE+  
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSX-ICSR-YYRAPELIF 195
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWP 203
           G  +     DVW+ GC + E+  G+P +P
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFP 224

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 116/254 (45%), Gaps = 17/254 (6%)
Query: 4   TRGQTIGRGSTATVSIG--MSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           T GQ IG GS  TV  G    + + ++  V +      +  + E  +L       I+ + 
Sbjct: 16  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           G     +       +  ++  G +L   +    T  E  ++    R    G+ YLH+  I
Sbjct: 76  GYSTKPQLA-----IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 130
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           +H D+K  NI + +D     KI DFG A  ++R +   + + + G+ + MAPEV R +++
Sbjct: 131 IHRDLKSNNIFLHED--LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 188
Query: 180 G---FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS---KQAQ 233
               F +DV+A G  + E+ TG+ P+ ++ +    +  +G    +P++    S   K  +
Sbjct: 189 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 248
Query: 234 DFLSKCLIRNPGER 247
             +++CL +   ER
Sbjct: 249 RLMAECLKKKRDER 262

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 10/209 (4%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           + +T  + IG GS   V       S E+ A+K   L +  F  RE +I+  L    IV  
Sbjct: 54  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 112
Query: 61  KGCDIS--EENGKILYNLFLEYAPGGTLTDA---IRSGTCLEEGRIRSHTRAVLLGLQYL 115
           +    S  E+  ++  NL L+Y P      A    R+   L    ++ +   +   L Y+
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS GI H DIK QN+L+  D     K+ DFG A++    E +    IC      APE+  
Sbjct: 173 HSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSX-ICSR-YYRAPELIF 229
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWP 203
           G  +     DVW+ GC + E+  G+P +P
Sbjct: 230 GATDYTSSIDVWSAGCVLAELLLGQPIFP 258

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 116/254 (45%), Gaps = 17/254 (6%)
Query: 4   TRGQTIGRGSTATVSIG--MSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           T GQ IG GS  TV  G    + + ++  V +      +  + E  +L       I+ + 
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           G     +       +  ++  G +L   +    T  E  ++    R    G+ YLH+  I
Sbjct: 71  GYSTKPQLA-----IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           +H D+K  NI + +D     KI DFG A  ++R +   + + + G+ + MAPEV R +++
Sbjct: 126 IHRDLKSNNIFLHED--LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 180 G---FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS---KQAQ 233
               F +DV+A G  + E+ TG+ P+ ++ +    +  +G    +P++    S   K  +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243
Query: 234 DFLSKCLIRNPGER 247
             +++CL +   ER
Sbjct: 244 RLMAECLKKKRDER 257

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 10/209 (4%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           + +T  + IG GS   V       S E+ A+K   L +  F  RE +I+  L    IV  
Sbjct: 25  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 83
Query: 61  KGCDIS--EENGKILYNLFLEYAPGGTLTDA---IRSGTCLEEGRIRSHTRAVLLGLQYL 115
           +    S  E+  ++  NL L+Y P      A    R+   L    ++ +   +   L Y+
Sbjct: 84  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 143
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS GI H DIK QN+L+  D     K+ DFG A++    E +    IC      APE+  
Sbjct: 144 HSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSY-ICSR-YYRAPELIF 200
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWP 203
           G  +     DVW+ GC + E+  G+P +P
Sbjct: 201 GATDYTSSIDVWSAGCVLAELLLGQPIFP 229

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 10/209 (4%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           + +T  + IG GS   V       S E+ A+K   L +  F  RE +I+  L    IV  
Sbjct: 48  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 106
Query: 61  KGCDIS--EENGKILYNLFLEYAPGGTLTDA---IRSGTCLEEGRIRSHTRAVLLGLQYL 115
           +    S  E+  ++  NL L+Y P      A    R+   L    ++ +   +   L Y+
Sbjct: 107 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 166
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS GI H DIK QN+L+  D     K+ DFG A++    E +    IC      APE+  
Sbjct: 167 HSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSY-ICSR-YYRAPELIF 223
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWP 203
           G  +     DVW+ GC + E+  G+P +P
Sbjct: 224 GATDYTSSIDVWSAGCVLAELLLGQPIFP 252

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 98/249 (39%), Gaps = 46/249 (18%)
Query: 47  RILSALACPQIV-AYKGCDISEENGKILYNLFLEYAPGG--TLTDAIRSGTCLEEGRIRS 103
           R L     P +V  +  C +S  + +    L  E+      T  D +       E  I+ 
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET-IKD 124
Query: 104 HTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPIC 163
               +L GL +LHS+ +VH D+K QNILV+   +   K+ADFG AR            + 
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQM--ALTSVV 180
Query: 164 GTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRP----------------------- 200
            T    APEV        P D+W++GC   EM   +P                       
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 201 -PWP-DVADPISALHRIG------FSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASE 252
             WP DVA P  A H         F +D  E+        +D L KCL  NP +R SA  
Sbjct: 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL-------GKDLLLKCLTFNPAKRISAYS 293
Query: 253 LLEHGFVKE 261
            L H + ++
Sbjct: 294 ALSHPYFQD 302

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 129/294 (43%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+    L + +E +     RE  +L  L  P 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 64  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 120
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 121 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 235
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 129/294 (43%), Gaps = 42/294 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+    L + +E +     RE  +L  L  P 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV      I  EN   L   FL       +  +  +G  L    I+S+   +L GL + H
Sbjct: 63  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLFQLLQGLAFCH 119
Query: 117 SNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+  
Sbjct: 120 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 175
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE---------IP 225
           G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         +P
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 226 GY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
            Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 10/209 (4%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           + +T  + IG GS   V       S E+ A+K   L +  F  RE +I+  L    IV  
Sbjct: 54  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 112
Query: 61  KGCDIS--EENGKILYNLFLEYAPGGTLTDA---IRSGTCLEEGRIRSHTRAVLLGLQYL 115
           +    S  E+  ++  NL L+Y P      A    R+   L    ++ +   +   L Y+
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS GI H DIK QN+L+  D     K+ DFG A++    E +    IC      APE+  
Sbjct: 173 HSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSY-ICSR-YYRAPELIF 229
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWP 203
           G  +     DVW+ GC + E+  G+P +P
Sbjct: 230 GATDYTSSIDVWSAGCVLAELLLGQPIFP 258

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 116/254 (45%), Gaps = 17/254 (6%)
Query: 4   TRGQTIGRGSTATVSIG--MSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           T GQ IG GS  TV  G    + + ++  V +      +  + E  +L       I+ + 
Sbjct: 38  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 97
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           G     +       +  ++  G +L   +    T  E  ++    R    G+ YLH+  I
Sbjct: 98  GYSTKPQLA-----IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 152
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           +H D+K  NI + +D     KI DFG A  ++R +   + + + G+ + MAPEV R +++
Sbjct: 153 IHRDLKSNNIFLHED--LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 210
Query: 180 G---FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS---KQAQ 233
               F +DV+A G  + E+ TG+ P+ ++ +    +  +G    +P++    S   K  +
Sbjct: 211 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 270
Query: 234 DFLSKCLIRNPGER 247
             +++CL +   ER
Sbjct: 271 RLMAECLKKKRDER 284

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 114/291 (39%), Gaps = 46/291 (15%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQRE---QRILSALACPQIVAY 60
           IG G+  TV       S    A+KS  + N E        RE    R L A   P +V  
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 61  KG-CDISEENGKILYNLFLEYAPGGTLTDAIRSGTC-LEEGRIRSHTRAVLLGLQYLHSN 118
              C  S  + +I   L  E+      T   ++    L    I+   R  L GL +LH+N
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN 131
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
            IVH D+K +NILV+       K+ADFG AR        +  P+  T    APEV     
Sbjct: 132 CIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALD--PVVVTLWYRAPEVLLQST 187
Query: 179 QGFPADVWALGCTVLEM---------------------ATGRPP---WP-DVADPISALH 213
              P D+W++GC   EM                       G PP   WP DV+ P  A  
Sbjct: 188 YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFP 247
Query: 214 RIG---FSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
             G     S  PE    M +     L + L  NP +R SA   L+H ++ +
Sbjct: 248 PRGPRPVQSVVPE----MEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 294

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 10/209 (4%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           + +T  + IG GS   V       S E+ A+K   L +  F  RE +I+  L    IV  
Sbjct: 58  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 116
Query: 61  KGCDIS--EENGKILYNLFLEYAPGGTLTDA---IRSGTCLEEGRIRSHTRAVLLGLQYL 115
           +    S  E+  ++  NL L+Y P      A    R+   L    ++ +   +   L Y+
Sbjct: 117 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 176
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS GI H DIK QN+L+  D     K+ DFG A++    E +    IC      APE+  
Sbjct: 177 HSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSY-ICSR-YYRAPELIF 233
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWP 203
           G  +     DVW+ GC + E+  G+P +P
Sbjct: 234 GATDYTSSIDVWSAGCVLAELLLGQPIFP 262

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 116/254 (45%), Gaps = 17/254 (6%)
Query: 4   TRGQTIGRGSTATVSIG--MSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           T GQ IG GS  TV  G    + + ++  V +      +  + E  +L       I+ + 
Sbjct: 39  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           G     +       +  ++  G +L   +    T  E  ++    R    G+ YLH+  I
Sbjct: 99  GYSTKPQ-----LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 153
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           +H D+K  NI + +D     KI DFG A  ++R +   + + + G+ + MAPEV R +++
Sbjct: 154 IHRDLKSNNIFLHED--LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 211
Query: 180 G---FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS---KQAQ 233
               F +DV+A G  + E+ TG+ P+ ++ +    +  +G    +P++    S   K  +
Sbjct: 212 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 271
Query: 234 DFLSKCLIRNPGER 247
             +++CL +   ER
Sbjct: 272 RLMAECLKKKRDER 285

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 10/209 (4%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           + +T  + IG GS   V       S E+ A+K   L +  F  RE +I+  L    IV  
Sbjct: 56  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 114
Query: 61  KGCDIS--EENGKILYNLFLEYAPGGTLTDA---IRSGTCLEEGRIRSHTRAVLLGLQYL 115
           +    S  E+  ++  NL L+Y P      A    R+   L    ++ +   +   L Y+
Sbjct: 115 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 174
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS GI H DIK QN+L+  D     K+ DFG A++    E +    IC      APE+  
Sbjct: 175 HSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSY-ICSR-YYRAPELIF 231
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWP 203
           G  +     DVW+ GC + E+  G+P +P
Sbjct: 232 GATDYTSSIDVWSAGCVLAELLLGQPIFP 260

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 10/209 (4%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           + +T  + IG GS   V       S E+ A+K   L +  F  RE +I+  L    IV  
Sbjct: 99  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 157
Query: 61  KGCDIS--EENGKILYNLFLEYAPGGTLTDA---IRSGTCLEEGRIRSHTRAVLLGLQYL 115
           +    S  E+  ++  NL L+Y P      A    R+   L    ++ +   +   L Y+
Sbjct: 158 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 217
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS GI H DIK QN+L+  D     K+ DFG A++    E +    IC      APE+  
Sbjct: 218 HSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSY-ICSR-YYRAPELIF 274
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWP 203
           G  +     DVW+ GC + E+  G+P +P
Sbjct: 275 GATDYTSSIDVWSAGCVLAELLLGQPIFP 303

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 123/293 (41%), Gaps = 47/293 (16%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR------------------ 44
           +T    IG+GS   V +  +   +  +A+K   LS  + +++                  
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKV--LSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 45  -------------EQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIR 91
                        E  IL  L  P +V      + + N   LY +F E    G + + + 
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEV-LDDPNEDHLYMVF-ELVNQGPVME-VP 129
Query: 92  SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA 151
           +   L E + R + + ++ G++YLH   I+H DIK  N+LV +D     KIADFG +   
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH--IKIADFGVSNEF 187
Query: 152 RVNEDDEGKPICGTPICMAPEV---ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADP 208
           +   D       GTP  MAPE     R    G   DVWA+G T+     G+ P+ D  + 
Sbjct: 188 K-GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD--ER 244
Query: 209 ISALHRIGFSSDTPEIPGY--MSKQAQDFLSKCLIRNPGERWSASELLEHGFV 259
           I  LH     S   E P    +++  +D +++ L +NP  R    E+  H +V
Sbjct: 245 IMCLHS-KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 118/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKS-----AELSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      R  +  AVK        L ++    RE R+L  L    ++     
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +    ++L     G   + I     L +  ++     +L GL+Y+HS GI+H 
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHR 155
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D+E   +I DFG AR+A    D+E      T    APE+          
Sbjct: 156 DLKPSNVAVNEDSE--LRILDFGLARQA----DEEMTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 183 ADVWALGCTVLEMATGRP--------------------PWPDVADPISALHRIGFSSDTP 222
            D+W++GC + E+  G+                     P P+V   IS+ H   +    P
Sbjct: 210 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 269
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            +P           +  A D L + L+ +  +R SA+E L H +  + +
Sbjct: 270 PMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYH 318

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 116/265 (43%), Gaps = 12/265 (4%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIVA 59
           +T   TIGRGS   V I +   +    A K      + + +  ++E  I+ +L  P I+ 
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII- 69
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
            +  +  E+N  I   L +E   GG L + +       E       + VL  + Y H   
Sbjct: 70  -RLYETFEDNTDIY--LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 120 IVHCDIKGQNILVSKDN-EQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           + H D+K +N L   D+ +   K+ DFG A  AR       +   GTP  ++P+V  G  
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLA--ARFKPGKMMRTKVGTPYYVSPQVLEG-L 183
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY-MSKQAQDFLS 237
            G   D W+ G  +  +  G PP+    D    L     +   PE     +S QA+  + 
Sbjct: 184 YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIR 243
Query: 238 KCLIRNPGERWSASELLEHGFVKEQ 262
           + L ++P +R ++ + LEH + ++Q
Sbjct: 244 RLLTKSPKQRITSLQALEHEWFEKQ 268

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 110/248 (44%), Gaps = 39/248 (15%)
Query: 44  REQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRS 103
           RE  +L  L  P IV+      SE    +++  F+E      L +   + T L++ +I+ 
Sbjct: 68  REISLLKELHHPNIVSLIDVIHSERCLTLVFE-FMEKDLKKVLDE---NKTGLQDSQIKI 123
Query: 104 HTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPIC 163
           +   +L G+ + H + I+H D+K QN+L++ D     K+ADFG AR   +        + 
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG--ALKLADFGLARAFGIPVRSYTHEVV 181
Query: 164 GTPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP 222
            T    AP+V  G ++     D+W++GC   EM TG+P +P V D    L +I     TP
Sbjct: 182 -TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD-DQLPKIFSILGTP 239
Query: 223 E-----------------------------IPGYMSKQAQDFLSKCLIRNPGERWSASEL 253
                                         IPG+  ++  D LS  L  +P +R SA + 
Sbjct: 240 NPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGF-CQEGIDLLSNMLCFDPNKRISARDA 298
Query: 254 LEHGFVKE 261
           + H + K+
Sbjct: 299 MNHPYFKD 306

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 116/265 (43%), Gaps = 12/265 (4%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIVA 59
           +T   TIGRGS   V I +   +    A K      + + +  ++E  I+ +L  P I+ 
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII- 86
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
            +  +  E+N  I   L +E   GG L + +       E       + VL  + Y H   
Sbjct: 87  -RLYETFEDNTDIY--LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 143
Query: 120 IVHCDIKGQNILVSKDN-EQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           + H D+K +N L   D+ +   K+ DFG A  AR       +   GTP  ++P+V  G  
Sbjct: 144 VAHRDLKPENFLFLTDSPDSPLKLIDFGLA--ARFKPGKMMRTKVGTPYYVSPQVLEG-L 200
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY-MSKQAQDFLS 237
            G   D W+ G  +  +  G PP+    D    L     +   PE     +S QA+  + 
Sbjct: 201 YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIR 260
Query: 238 KCLIRNPGERWSASELLEHGFVKEQ 262
           + L ++P +R ++ + LEH + ++Q
Sbjct: 261 RLLTKSPKQRITSLQALEHEWFEKQ 285

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 10/209 (4%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           + +T  + IG GS   V       S E+ A+K   L +  F  RE +I+  L    IV  
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 78
Query: 61  KGCDIS--EENGKILYNLFLEYAPGGTLTDA---IRSGTCLEEGRIRSHTRAVLLGLQYL 115
           +    S  E+   +  NL L+Y P      A    R+   L    ++ +   +   L Y+
Sbjct: 79  RYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS GI H DIK QN+L+  D     K+ DFG A++    E +    IC      APE+  
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSX-ICSR-YYRAPELIF 195
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWP 203
           G  +     DVW+ GC + E+  G+P +P
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFP 224

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 9   IGRGSTATVSIG----MSNRSSEVFAVKSAELSNSEFL----QREQRILSALACPQIVAY 60
           +G G    VS+      ++ + E+ AVK+ +      L    QRE  IL  L    IV Y
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           KGC   E+ G+    L +EY P G+L D +    C+   ++    + +  G+ YLH+   
Sbjct: 76  KGC--CEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGLAQLLLFAQQICEGMAYLHAQHY 132
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRA-------RVNEDDEGKPICGTPICMAPEV 173
           +H  +  +N+L+  DN++  KI DFG A+         RV ED +  P+       APE 
Sbjct: 133 IHRALAARNVLL--DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS-PV----FWYAPEC 185
Query: 174 ARGEEQGFPADVWALGCTVLEMAT 197
            +  +  + +DVW+ G T+ E+ T
Sbjct: 186 LKECKFYYASDVWSFGVTLYELLT 209

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 110/248 (44%), Gaps = 39/248 (15%)
Query: 44  REQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRS 103
           RE  +L  L  P IV+      SE    +++  F+E      L +   + T L++ +I+ 
Sbjct: 68  REISLLKELHHPNIVSLIDVIHSERCLTLVFE-FMEKDLKKVLDE---NKTGLQDSQIKI 123
Query: 104 HTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPIC 163
           +   +L G+ + H + I+H D+K QN+L++ D     K+ADFG AR   +        + 
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG--ALKLADFGLARAFGIPVRSYTHEVV 181
Query: 164 GTPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP 222
            T    AP+V  G ++     D+W++GC   EM TG+P +P V D    L +I     TP
Sbjct: 182 -TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD-DQLPKIFSILGTP 239
Query: 223 E-----------------------------IPGYMSKQAQDFLSKCLIRNPGERWSASEL 253
                                         IPG+  ++  D LS  L  +P +R SA + 
Sbjct: 240 NPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGF-CQEGIDLLSNMLCFDPNKRISARDA 298
Query: 254 LEHGFVKE 261
           + H + K+
Sbjct: 299 MNHPYFKD 306

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 98/249 (39%), Gaps = 46/249 (18%)
Query: 47  RILSALACPQIV-AYKGCDISEENGKILYNLFLEYAPGG--TLTDAIRSGTCLEEGRIRS 103
           R L     P +V  +  C +S  + +    L  E+      T  D +       E  I+ 
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET-IKD 124
Query: 104 HTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPIC 163
               +L GL +LHS+ +VH D+K QNILV+   +   K+ADFG AR            + 
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQM--ALTSVV 180
Query: 164 GTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRP----------------------- 200
            T    APEV        P D+W++GC   EM   +P                       
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 201 -PWP-DVADPISALHRIG------FSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASE 252
             WP DVA P  A H         F +D  E+        +D L KCL  NP +R SA  
Sbjct: 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL-------GKDLLLKCLTFNPAKRISAYS 293
Query: 253 LLEHGFVKE 261
            L H + ++
Sbjct: 294 ALSHPYFQD 302

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 114/276 (41%), Gaps = 25/276 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-----SNSEFLQREQRILSALACPQ 56
           D+    TIG GS             ++   K  +      +  + L  E  +L  L  P 
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT----CLEEGRIRSHTRAVLLGL 112
           IV Y    I   N  +   + +EY  GG L   I  GT     L+E  +      + L L
Sbjct: 67  IVRYYDRIIDRTNTTLY--IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 113 QYLH--SNG---IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTP 166
           +  H  S+G   ++H D+K  N+ +  D +Q  K+ DFG AR   +N D    K   GTP
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFL--DGKQNVKLGDFGLARI--LNHDTSFAKTFVGTP 180
Query: 167 ICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADP-ISALHRIGFSSDTPEIP 225
             M+PE          +D+W+LGC + E+    PP+   +   ++   R G       IP
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG---KFRRIP 237
Query: 226 GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
              S +  + +++ L      R S  E+LE+  + E
Sbjct: 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 114/276 (41%), Gaps = 25/276 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-----SNSEFLQREQRILSALACPQ 56
           D+    TIG GS             ++   K  +      +  + L  E  +L  L  P 
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT----CLEEGRIRSHTRAVLLGL 112
           IV Y    I   N  +   + +EY  GG L   I  GT     L+E  +      + L L
Sbjct: 67  IVRYYDRIIDRTNTTLY--IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 113 QYLH--SNG---IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTP 166
           +  H  S+G   ++H D+K  N+ +  D +Q  K+ DFG AR   +N D    K   GTP
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFL--DGKQNVKLGDFGLARI--LNHDTSFAKAFVGTP 180
Query: 167 ICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADP-ISALHRIGFSSDTPEIP 225
             M+PE          +D+W+LGC + E+    PP+   +   ++   R G       IP
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG---KFRRIP 237
Query: 226 GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
              S +  + +++ L      R S  E+LE+  + E
Sbjct: 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 9   IGRGSTATVSIG----MSNRSSEVFAVKSAELSNSEFL----QREQRILSALACPQIVAY 60
           +G G    VS+      ++ + E+ AVK+ +      L    QRE  IL  L    IV Y
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           KGC   E+ G+    L +EY P G+L D +    C+   ++    + +  G+ YLH+   
Sbjct: 77  KGC--CEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGLAQLLLFAQQICEGMAYLHAQHY 133
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRA-------RVNEDDEGKPICGTPICMAPEV 173
           +H  +  +N+L+  DN++  KI DFG A+         RV ED +  P+       APE 
Sbjct: 134 IHRALAARNVLL--DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS-PV----FWYAPEC 186
Query: 174 ARGEEQGFPADVWALGCTVLEMAT 197
            +  +  + +DVW+ G T+ E+ T
Sbjct: 187 LKECKFYYASDVWSFGVTLYELLT 210

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 46/296 (15%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQ----REQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L + +E +     RE  +L  L  P 
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGG--TLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
           IV  K  D+     K LY +F E+         DA  + T +    I+S+   +L GL +
Sbjct: 67  IV--KLLDVIHTENK-LYLVF-EHVDQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAF 121
Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
            HS+ ++H D+K QN+L+   N +GA K+ADFG AR   V        +  T    APE+
Sbjct: 122 CHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEI 177
Query: 174 ARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE--------- 223
             G +      D+W+LGC   EM T R  +P  ++ I  L RI  +  TP+         
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTS 236
Query: 224 IPGY---MSKQA-QDF--------------LSKCLIRNPGERWSASELLEHGFVKE 261
           +P Y     K A QDF              LS+ L  +P +R SA   L H F ++
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 114/291 (39%), Gaps = 46/291 (15%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQRE---QRILSALACPQIVAY 60
           IG G+  TV       S    A+KS  + N E        RE    R L A   P +V  
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 61  KG-CDISEENGKILYNLFLEYAPGGTLTDAIRSGTC-LEEGRIRSHTRAVLLGLQYLHSN 118
              C  S  + +I   L  E+      T   ++    L    I+   R  L GL +LH+N
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN 131
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
            IVH D+K +NILV+       K+ADFG AR    +      P+  T    APEV     
Sbjct: 132 CIVHRDLKPENILVTSGGT--VKLADFGLAR--IYSYQMALAPVVVTLWYRAPEVLLQST 187
Query: 179 QGFPADVWALGCTVLEM---------------------ATGRPP---WP-DVADPISALH 213
              P D+W++GC   EM                       G PP   WP DV+ P  A  
Sbjct: 188 YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFP 247
Query: 214 RIG---FSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
             G     S  PE    M +     L + L  NP +R SA   L+H ++ +
Sbjct: 248 PRGPRPVQSVVPE----MEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 294

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 10/209 (4%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           + +T  + IG GS   V       S E+ A+K   L    F  RE +I+  L    IV  
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFKNRELQIMRKLDHCNIVRL 78
Query: 61  KGCDIS--EENGKILYNLFLEYAPGGTLTDA---IRSGTCLEEGRIRSHTRAVLLGLQYL 115
           +    S  E+  ++  NL L+Y P      A    R+   L    ++ +   +   L Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS GI H DIK QN+L+  D     K+ DFG A++    E +    IC      APE+  
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSY-ICSR-YYRAPELIF 195
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWP 203
           G  +     DVW+ GC + E+  G+P +P
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFP 224

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 97/248 (39%), Gaps = 46/248 (18%)
Query: 47  RILSALACPQIV-AYKGCDISEENGKILYNLFLEYAPGG--TLTDAIRSGTCLEEGRIRS 103
           R L     P +V  +  C +S  + +    L  E+      T  D +       E  I+ 
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET-IKD 124
Query: 104 HTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPIC 163
               +L GL +LHS+ +VH D+K QNILV+   +   K+ADFG AR            + 
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQM--ALTSVV 180
Query: 164 GTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRP----------------------- 200
            T    APEV        P D+W++GC   EM   +P                       
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 201 -PWP-DVADPISALHRIG------FSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASE 252
             WP DVA P  A H         F +D  E+        +D L KCL  NP +R SA  
Sbjct: 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL-------GKDLLLKCLTFNPAKRISAYS 293
Query: 253 LLEHGFVK 260
            L H + +
Sbjct: 294 ALSHPYFQ 301

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 114/291 (39%), Gaps = 46/291 (15%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQRE---QRILSALACPQIVAY 60
           IG G+  TV       S    A+KS  + N E        RE    R L A   P +V  
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 61  KG-CDISEENGKILYNLFLEYAPGGTLTDAIRSGTC-LEEGRIRSHTRAVLLGLQYLHSN 118
              C  S  + +I   L  E+      T   ++    L    I+   R  L GL +LH+N
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN 131
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
            IVH D+K +NILV+       K+ADFG AR    +      P+  T    APEV     
Sbjct: 132 CIVHRDLKPENILVTSGGT--VKLADFGLAR--IYSYQMALFPVVVTLWYRAPEVLLQST 187
Query: 179 QGFPADVWALGCTVLEM---------------------ATGRPP---WP-DVADPISALH 213
              P D+W++GC   EM                       G PP   WP DV+ P  A  
Sbjct: 188 YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFP 247
Query: 214 RIG---FSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
             G     S  PE    M +     L + L  NP +R SA   L+H ++ +
Sbjct: 248 PRGPRPVQSVVPE----MEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 294

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 10/209 (4%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           + +T  + IG GS   V       S E+ A+K   L    F  RE +I+  L    IV  
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFKNRELQIMRKLDHCNIVRL 78
Query: 61  KGCDIS--EENGKILYNLFLEYAPGGTLTDA---IRSGTCLEEGRIRSHTRAVLLGLQYL 115
           +    S  E+  ++  NL L+Y P      A    R+   L    ++ +   +   L Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS GI H DIK QN+L+  D     K+ DFG A++    E +    IC      APE+  
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSY-ICSR-YYRAPELIF 195
Query: 176 G-EEQGFPADVWALGCTVLEMATGRPPWP 203
           G  +     DVW+ GC + E+  G+P +P
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFP 224

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 112/223 (50%), Gaps = 11/223 (4%)
Query: 42  LQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRI 101
           +  E  +L +L  P I+  K  D+ E+  K  + L  E+  GG L + I +    +E   
Sbjct: 93  IYNEISLLKSLDHPNII--KLFDVFED--KKYFYLVTEFYEGGELFEQIINRHKFDECDA 148
Query: 102 RSHTRAVLLGLQYLHSNGIVHCDIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGK 160
            +  + +L G+ YLH + IVH DIK +NIL+ +K++    KI DFG +  +  ++D + +
Sbjct: 149 ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS--SFFSKDYKLR 206
Query: 161 PICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRIGFS 218
              GT   +APEV + ++     DVW+ G  +  +  G PP+   +  D I  + +  + 
Sbjct: 207 DRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265
Query: 219 SDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
            D  +    +S +A++ +   L  +  +R +A E L   ++K+
Sbjct: 266 FDFNDWKN-ISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 123/297 (41%), Gaps = 45/297 (15%)
Query: 5   RGQT---IGRGSTATVSIGMSNRSSEVFAVKS-----AELSNSEFLQREQRILSALACPQ 56
           R QT   +G G+  +V      +S    AVK        + +++   RE R+L  +    
Sbjct: 52  RYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 111
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           ++          + +   +++L     G   + I     L +  ++     +L GL+Y+H
Sbjct: 112 VIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 171
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
           S  I+H D+K  N+ V++D E   KI DFG AR      DDE      T    APE+   
Sbjct: 172 SADIIHRDLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLN 225
Query: 177 -EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP------EIPGYMS 229
                   D+W++GC + E+ TGR  +P   D I+ L +I   + TP       +P + +
Sbjct: 226 WMHYNMTVDIWSVGCIMAELLTGRTLFPG-TDHINQLQQIMRLTGTPPASVISRMPSHEA 284
Query: 230 KQ-----------------------AQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           +                        A D L K L+ +  +R +ASE L H +  + +
Sbjct: 285 RNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYH 341

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 124/294 (42%), Gaps = 49/294 (16%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFL-----QREQRILSALACPQIVAYKGC 63
           +G GS   V    +  +  + A+K    S+ + +      RE ++L  L    +V     
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNL--L 90
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
           ++ ++  +  + L  E+     L D       L+   ++ +   ++ G+ + HS+ I+H 
Sbjct: 91  EVCKKKKR--WYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHR 148
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVN---EDDEGKPICGTPICMAPEVARGE-EQ 179
           DIK +NILVS+      K+ DFG AR         DDE      T    APE+  G+ + 
Sbjct: 149 DIKPENILVSQSG--VVKLCDFGFARTLAAPGEVYDDE----VATRWYRAPELLVGDVKY 202
Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG-------------FSSD------ 220
           G   DVWA+GC V EM  G P +P  +D I  L+ I              F+ +      
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSD-IDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261
Query: 221 -TPEIPG---------YMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
             PEI            +S+   D   KCL  +P +R   +ELL H F +   F
Sbjct: 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGF 315

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 8   TIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISE 67
            +G G+ A V   ++  +S+ +AVK  E        R  R +  L   Q        I  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 68  ENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKG 127
              +  + L  E   GG++   I       E       + V   L +LH+ GI H D+K 
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKP 139
Query: 128 QNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPI--------CGTPICMAPEV--ARG 176
           +NIL    N+    KI DFG     ++N D    PI        CG+   MAPEV  A  
Sbjct: 140 ENILCEHPNQVSPVKICDFGLGSGIKLNGD--CSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 177 EEQGF---PADVWALGCTVLEMATGRPPWP---------DVADPISALHRIGFSS---DT 221
           EE        D+W+LG  +  + +G PP+          D  +   A   + F S     
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK 257
Query: 222 PEIP----GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
            E P     ++S  A+D +SK L+R+  +R SA+++L+H +V+
Sbjct: 258 YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 9   IGRGSTATVSI----GMSNRSSEVFAVKSAELSNSEF---LQREQRILSALACPQIVAYK 61
           +G+G+  +V +     + + +  + AVK  + S  +     QRE +IL AL    IV Y+
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           G  +S   G+    L +EY P G L D + R    L+  R+  ++  +  G++YL S   
Sbjct: 75  G--VSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 132
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG-TPIC-MAPEVARGEE 178
           VH D+  +NILV  ++E   KIADFG A+   +++D       G +PI   APE      
Sbjct: 133 VHRDLAARNILV--ESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNI 190
Query: 179 QGFPADVWALGCTVLEMAT 197
               +DVW+ G  + E+ T
Sbjct: 191 FSRQSDVWSFGVVLYELFT 209

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 135/311 (43%), Gaps = 25/311 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRIL-SALACPQIVAYKGCDI 65
           Q +G G    V    + R+ E FA+K   L +    +RE  +   A  CP IV  +  D+
Sbjct: 22  QVLGLGINGKVLQIFNKRTQEKFALKM--LQDCPKARREVELHWRASQCPHIV--RIVDV 77
Query: 66  SEE--NGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            E    G+    + +E   GG L   I  R      E       +++   +QYLHS  I 
Sbjct: 78  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 137
Query: 122 HCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           H D+K +N+L  SK      K+ DFG A+    + +   +P C TP  +APEV   E+  
Sbjct: 138 HRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTEP-CYTPYYVAPEVLGPEKYD 195
Query: 181 FPADVWALGCTVLEMATGRPPWPD-----VADPISALHRIG-FSSDTPEIPGYMSKQAQD 234
              D+W+LG  +  +  G PP+       ++  +    R+G +    PE    +S++ + 
Sbjct: 196 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW-SEVSEEVKM 254
Query: 235 FLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLT 294
            +   L   P +R + +E + H ++      + +   P+T    S     +++ W+    
Sbjct: 255 LIRNLLKTEPTQRMTITEFMNHPWI------MQSTKVPQTPLHTSRVLKEDKERWEDVKE 308
Query: 295 SCSSASAKERI 305
             +SA A  R+
Sbjct: 309 EMTSALATMRV 319

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 9   IGRGSTATVSI----GMSNRSSEVFAVKSAELSNSEF---LQREQRILSALACPQIVAYK 61
           +G+G+  +V +     + + +  + AVK  + S  +     QRE +IL AL    IV Y+
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           G  +S   G+    L +EY P G L D + R    L+  R+  ++  +  G++YL S   
Sbjct: 78  G--VSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 135
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED-----DEGKPICGTPIC-MAPEVA 174
           VH D+  +NILV  ++E   KIADFG A+   +++D     + G+    +PI   APE  
Sbjct: 136 VHRDLAARNILV--ESEAHVKIADFGLAKLLPLDKDYYVVREPGQ----SPIFWYAPESL 189
Query: 175 RGEEQGFPADVWALGCTVLEMAT 197
                   +DVW+ G  + E+ T
Sbjct: 190 SDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKS-----AELSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      R  +  AVK        L ++    RE R+L  L    ++     
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +    ++L     G   + I     L +  ++     +L GL+Y+HS GI+H 
Sbjct: 88  FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHR 147
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   +I DFG AR+A    D+E      T    APE+          
Sbjct: 148 DLKPSNVAVNEDCE--LRILDFGLARQA----DEEMTGYVATRWYRAPEIMLNWMHYNQT 201
Query: 183 ADVWALGCTVLEMATGRP--------------------PWPDVADPISALHRIGFSSDTP 222
            D+W++GC + E+  G+                     P P+V   IS+ H   +    P
Sbjct: 202 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 261
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            +P           +  A D L + L+ +  +R SA+E L H +  + +
Sbjct: 262 PMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYH 310

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 18/226 (7%)
Query: 40  EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEG 99
           E +++E ++ + L  P I+A +G  + E N      L +E+A GG L + + SG  +   
Sbjct: 51  ENVRQEAKLFAMLKHPNIIALRGVCLKEPN----LCLVMEFARGGPL-NRVLSGKRIPPD 105
Query: 100 RIRSHTRAVLLGLQYLHSNGIV---HCDIKGQNILVSKDNEQG------AKIADFGCARR 150
            + +    +  G+ YLH   IV   H D+K  NIL+ +  E G       KI DFG AR 
Sbjct: 106 ILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165
Query: 151 ARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS 210
                        G    MAPEV R       +DVW+ G  + E+ TG  P+  + D ++
Sbjct: 166 WHRTTKMSA---AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI-DGLA 221
Query: 211 ALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
             + +  +     IP    +     +  C   +P  R S + +L+ 
Sbjct: 222 VAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 117/284 (41%), Gaps = 41/284 (14%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQR---ILSALACPQIVAYKGC 63
           +G G+  +V   +  RS E  A+K  S    +  F +R  R   +L  +    ++     
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +  Y+ +L      T    I  G    E +I+     +L GL+Y+HS G+VH 
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKI-MGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHR 150
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR A    D E      T    APEV          
Sbjct: 151 DLKPGNLAVNEDCE--LKILDFGLARHA----DAEMTGYVVTRWYRAPEVILSWMHYNQT 204
Query: 183 ADVWALGCTVLEMATGRPPW--PDVADPISALHRI------------------GFSSDTP 222
            D+W++GC + EM TG+  +   D  D ++ + ++                   +    P
Sbjct: 205 VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLP 264
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGF 258
           + P           S QA D L K L  +  +R +A++ L H F
Sbjct: 265 QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 7   QTIGRGSTATVSI----GMSNRSSEVFAVKSAELSNSEFL---QREQRILSALACPQIVA 59
           + +G+G+  +V +     + + + EV AVK  + S  E L   +RE  IL +L    IV 
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
           YKG   S   G+    L +E+ P G+L + + +    ++  ++  +T  +  G++YL + 
Sbjct: 79  YKGVCYSA--GRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 136
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPIC-MAPEVARG 176
             +H D+  +NILV  +NE   KI DFG  +   +  E  + K    +PI   APE    
Sbjct: 137 RYIHRDLATRNILV--ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 177 EEQGFPADVWALGCTVLEMAT 197
            +    +DVW+ G  + E+ T
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 9   IGRGSTATVSI----GMSNRSSEVFAVKSAELSNSEF---LQREQRILSALACPQIVAYK 61
           +G+G+  +V +     + + +  + AVK  + S  +     QRE +IL AL    IV Y+
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           G  +S   G+    L +EY P G L D + R    L+  R+  ++  +  G++YL S   
Sbjct: 79  G--VSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 136
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED-----DEGKPICGTPIC-MAPEVA 174
           VH D+  +NILV  ++E   KIADFG A+   +++D     + G+    +PI   APE  
Sbjct: 137 VHRDLAARNILV--ESEAHVKIADFGLAKLLPLDKDYYVVREPGQ----SPIFWYAPESL 190
Query: 175 RGEEQGFPADVWALGCTVLEMAT 197
                   +DVW+ G  + E+ T
Sbjct: 191 SDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 79/312 (25%), Positives = 134/312 (42%), Gaps = 25/312 (8%)
Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRIL-SALACPQIVAYKGCD 64
            Q +G G    V    + R+ E FA+K   L +    +RE  +   A  CP IV  +  D
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKM--LQDCPKARREVELHWRASQCPHIV--RIVD 78
Query: 65  ISEE--NGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           + E    G+    + +E   GG L   I  R      E       +++   +QYLHS  I
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 138
Query: 121 VHCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
            H D+K +N+L  SK      K+ DFG A+    + +    P C TP  +APEV   E+ 
Sbjct: 139 AHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTP-CYTPYYVAPEVLGPEKY 196
Query: 180 GFPADVWALGCTVLEMATGRPPWPD-----VADPISALHRIG-FSSDTPEIPGYMSKQAQ 233
               D+W+LG  +  +  G PP+       ++  +    R+G +    PE    +S++ +
Sbjct: 197 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW-SEVSEEVK 255
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTL 293
             +   L   P +R + +E + H ++      + +   P+T    S     +++ W+   
Sbjct: 256 MLIRNLLKTEPTQRMTITEFMNHPWI------MQSTKVPQTPLHTSRVLKEDKERWEDVK 309
Query: 294 TSCSSASAKERI 305
              +SA A  R+
Sbjct: 310 EEMTSALATMRV 321

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 9   IGRGSTATVSI----GMSNRSSEVFAVKSAELSNSEF---LQREQRILSALACPQIVAYK 61
           +G+G+  +V +     + + +  + AVK  + S  +     QRE +IL AL    IV Y+
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           G  +S   G+    L +EY P G L D + R    L+  R+  ++  +  G++YL S   
Sbjct: 91  G--VSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 148
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED-----DEGKPICGTPIC-MAPEVA 174
           VH D+  +NILV  ++E   KIADFG A+   +++D     + G+    +PI   APE  
Sbjct: 149 VHRDLAARNILV--ESEAHVKIADFGLAKLLPLDKDYYVVREPGQ----SPIFWYAPESL 202
Query: 175 RGEEQGFPADVWALGCTVLEMAT 197
                   +DVW+ G  + E+ T
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFT 225

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/312 (25%), Positives = 134/312 (42%), Gaps = 25/312 (8%)
Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRIL-SALACPQIVAYKGCD 64
            Q +G G    V    + R+ E FA+K   L +    +RE  +   A  CP IV  +  D
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKM--LQDCPKARREVELHWRASQCPHIV--RIVD 122
Query: 65  ISEE--NGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           + E    G+    + +E   GG L   I  R      E       +++   +QYLHS  I
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 182
Query: 121 VHCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
            H D+K +N+L  SK      K+ DFG A+    + +    P C TP  +APEV   E+ 
Sbjct: 183 AHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTP-CYTPYYVAPEVLGPEKY 240
Query: 180 GFPADVWALGCTVLEMATGRPPWPD-----VADPISALHRIG-FSSDTPEIPGYMSKQAQ 233
               D+W+LG  +  +  G PP+       ++  +    R+G +    PE    +S++ +
Sbjct: 241 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW-SEVSEEVK 299
Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTL 293
             +   L   P +R + +E + H ++      + +   P+T    S     +++ W+   
Sbjct: 300 MLIRNLLKTEPTQRMTITEFMNHPWI------MQSTKVPQTPLHTSRVLKEDKERWEDVK 353
Query: 294 TSCSSASAKERI 305
              +SA A  R+
Sbjct: 354 EEMTSALATMRV 365

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 118/264 (44%), Gaps = 23/264 (8%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALA-------CPQIVAYK 61
           +GRG+   V       S ++ AVK    + +   Q ++R+L  L        CP  V + 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNS--QEQKRLLXDLDISXRTVDCPFTVTFY 99
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN-GI 120
           G    E +  I   L  + +        I  G  + E  +     +++  L++LHS   +
Sbjct: 100 GALFREGDVWICXEL-XDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 158
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI-CGTPICMAPEVARGE-- 177
           +H D+K  N+L++   +   K  DFG +       DD  K I  G     APE    E  
Sbjct: 159 IHRDVKPSNVLINALGQ--VKXCDFGISGYLV---DDVAKDIDAGCKPYXAPERINPELN 213
Query: 178 EQGF--PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPG-YMSKQAQD 234
           ++G+   +D+W+LG T +E+A  R P+     P   L ++     +P++P    S +  D
Sbjct: 214 QKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQV-VEEPSPQLPADKFSAEFVD 272
Query: 235 FLSKCLIRNPGERWSASELLEHGF 258
           F S+CL +N  ER +  EL +H F
Sbjct: 273 FTSQCLKKNSKERPTYPELXQHPF 296

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 114/262 (43%), Gaps = 23/262 (8%)
Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGL 112
           P IV       +  +GK    + +E   GG L   I  R      E       R +   +
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 113 QYLHSNGIVHCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAP 171
           Q+LHS+ I H D+K +N+L  SK+ +   K+ DFG A+    N     +  C TP  +AP
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPCYTPYYVAP 198
Query: 172 EVARGEEQGFPADVWALGCTVLEMATGRPP-WPDVADPISA-------LHRIGFSSDTPE 223
           EV   E+     D+W+LG  +  +  G PP + +    IS        L + GF +  PE
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN--PE 256
Query: 224 IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSV 283
               +S+ A+  +   L  +P ER + ++ + H ++ +      ++  P+T    +    
Sbjct: 257 W-SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ------SMVVPQTPLHTARVLQ 309
Query: 284 LNQQLWDSTLTSCSSASAKERI 305
            ++  WD      +SA A  R+
Sbjct: 310 EDKDHWDEVKEEMTSALATMRV 331

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 118/286 (41%), Gaps = 41/286 (14%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQR---ILSALACPQIVAYKGC 63
           +G G+  +V   +  RS E  A+K  S    +  F +R  R   +L  +    ++     
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +  Y+ +L      T    I  G    E +I+     +L GL+Y+HS G+VH 
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKI-MGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHR 168
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR A    D E      T    APEV          
Sbjct: 169 DLKPGNLAVNEDCE--LKILDFGLARHA----DAEMTGYVVTRWYRAPEVILSWMHYNQT 222
Query: 183 ADVWALGCTVLEMATGRPPW--PDVADPISALHRI------------------GFSSDTP 222
            D+W++GC + EM TG+  +   D  D ++ + ++                   +    P
Sbjct: 223 VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLP 282
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
           + P           S QA D L K L  +  +R +A++ L H F +
Sbjct: 283 QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 84/294 (28%), Positives = 113/294 (38%), Gaps = 49/294 (16%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ--------RE---QRILSALACPQI 57
           IG G+  TV       S    A+KS  + N             RE    R L A   P +
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 58  VAYKG-CDISEENGKILYNLFLEYAPGGTLTDAIRSGTC-LEEGRIRSHTRAVLLGLQYL 115
           V     C  S  + +I   L  E+      T   ++    L    I+   R  L GL +L
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 136
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           H+N IVH D+K +NILV+       K+ADFG AR    +      P+  T    APEV  
Sbjct: 137 HANCIVHRDLKPENILVTSGGT--VKLADFGLAR--IYSYQMALTPVVVTLWYRAPEVLL 192
Query: 176 GEEQGFPADVWALGCTVLEM---------------------ATGRPP---WP-DVADPIS 210
                 P D+W++GC   EM                       G PP   WP DV+ P  
Sbjct: 193 QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRG 252
Query: 211 ALHRIG---FSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
           A    G     S  PE    M +     L + L  NP +R SA   L+H ++ +
Sbjct: 253 AFPPRGPRPVQSVVPE----MEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 134/311 (43%), Gaps = 25/311 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRIL-SALACPQIVAYKGCDI 65
           Q +G G    V    + R+ E FA+K   L +    +RE  +   A  CP IV  +  D+
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKM--LQDCPKARREVELHWRASQCPHIV--RIVDV 79
Query: 66  SEE--NGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            E    G+    + +E   GG L   I  R      E       +++   +QYLHS  I 
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 139
Query: 122 HCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           H D+K +N+L  SK      K+ DFG A+    + +    P C TP  +APEV   E+  
Sbjct: 140 HRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTP-CYTPYYVAPEVLGPEKYD 197
Query: 181 FPADVWALGCTVLEMATGRPPWPD-----VADPISALHRIG-FSSDTPEIPGYMSKQAQD 234
              D+W+LG  +  +  G PP+       ++  +    R+G +    PE    +S++ + 
Sbjct: 198 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW-SEVSEEVKM 256
Query: 235 FLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLT 294
            +   L   P +R + +E + H ++      + +   P+T    S     +++ W+    
Sbjct: 257 LIRNLLKTEPTQRMTITEFMNHPWI------MQSTKVPQTPLHTSRVLKEDKERWEDVKE 310
Query: 295 SCSSASAKERI 305
             +SA A  R+
Sbjct: 311 EMTSALATMRV 321

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 134/311 (43%), Gaps = 25/311 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRIL-SALACPQIVAYKGCDI 65
           Q +G G    V    + R+ E FA+K   L +    +RE  +   A  CP IV  +  D+
Sbjct: 74  QVLGLGINGKVLQIFNKRTQEKFALKM--LQDCPKARREVELHWRASQCPHIV--RIVDV 129
Query: 66  SEE--NGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            E    G+    + +E   GG L   I  R      E       +++   +QYLHS  I 
Sbjct: 130 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 189
Query: 122 HCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           H D+K +N+L  SK      K+ DFG A+    + +    P C TP  +APEV   E+  
Sbjct: 190 HRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTP-CYTPYYVAPEVLGPEKYD 247
Query: 181 FPADVWALGCTVLEMATGRPPWPD-----VADPISALHRIG-FSSDTPEIPGYMSKQAQD 234
              D+W+LG  +  +  G PP+       ++  +    R+G +    PE    +S++ + 
Sbjct: 248 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW-SEVSEEVKM 306
Query: 235 FLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLT 294
            +   L   P +R + +E + H ++      + +   P+T    S     +++ W+    
Sbjct: 307 LIRNLLKTEPTQRMTITEFMNHPWI------MQSTKVPQTPLHTSRVLKEDKERWEDVKE 360
Query: 295 SCSSASAKERI 305
             +SA A  R+
Sbjct: 361 EMTSALATMRV 371

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 126/290 (43%), Gaps = 40/290 (13%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE----LSNSEFLQREQRILSALACPQIVAYKG 62
           + +G G+ A V   +S ++ + +AVK  E     S S   +  + +        I+    
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILEL-- 76
Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
            +  E++ +  + L  E   GG++   I+      E       R V   L +LH+ GI H
Sbjct: 77  IEFFEDDTR--FYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAH 134
Query: 123 CDIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPI--------CGTPICMAPEV 173
            D+K +NIL  S +     KI DF      ++N  +   PI        CG+   MAPEV
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLN--NSCTPITTPELTTPCGSAEYMAPEV 192
Query: 174 AR--GEEQGF---PADVWALGCTVLEMATGRPPWP---------DVADPISALHRIGFSS 219
                ++  F     D+W+LG  +  M +G PP+          D  +         F S
Sbjct: 193 VEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 252
Query: 220 ---DTPEIP----GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ 262
                 E P     ++S +A+D +SK L+R+  +R SA+++L+H +V+ Q
Sbjct: 253 IQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQ 302

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 125/313 (39%), Gaps = 64/313 (20%)
Query: 8   TIGRG--STATVSIGMSNRSSEVFAVKSAEL---SNS--EFLQREQRILSALACPQIVAY 60
            IG+G     TV++     + E   V+   L   SN    FLQ E  +      P IV Y
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTC--LEEGRIRSHTRAVLLGLQYLHSN 118
           +   I++    ++ + F+ Y   G+  D I +     + E  I    + VL  L Y+H  
Sbjct: 92  RATFIADNELWVVTS-FMAY---GSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM 147
Query: 119 GIVHCDIKGQNILVSKDNE-----QGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
           G VH  +K  +IL+S D +       + ++     +R RV  D     +   P  ++PEV
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP-WLSPEV 206
Query: 174 ARGEEQGFPA--DVWALGCTVLEMATGRPPWPDV-------------------------- 205
            +   QG+ A  D++++G T  E+A G  P+ D+                          
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 266
Query: 206 ---ADPISALHRIGFSS------------DTPEIPGY--MSKQAQDFLSKCLIRNPGERW 248
                P  ++   G S             D+P  P +   S     F+ +CL RNP  R 
Sbjct: 267 ELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 326
Query: 249 SASELLEHGFVKE 261
           SAS LL H F K+
Sbjct: 327 SASTLLNHSFFKQ 339

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 124/313 (39%), Gaps = 64/313 (20%)
Query: 8   TIGRG--STATVSIGMSNRSSEVFAVKSAEL---SNS--EFLQREQRILSALACPQIVAY 60
            IG+G     TV++     + E   V+   L   SN    FLQ E  +      P IV Y
Sbjct: 16  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 75
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTC--LEEGRIRSHTRAVLLGLQYLHSN 118
           +   I++ N   +   F+ Y   G+  D I +     + E  I    + VL  L Y+H  
Sbjct: 76  RATFIAD-NELWVVTSFMAY---GSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM 131
Query: 119 GIVHCDIKGQNILVSKDNE-----QGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
           G VH  +K  +IL+S D +       + ++     +R RV  D     +   P  ++PEV
Sbjct: 132 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP-WLSPEV 190
Query: 174 ARGEEQGFPA--DVWALGCTVLEMATGRPPWPDV-------------------------- 205
            +   QG+ A  D++++G T  E+A G  P+ D+                          
Sbjct: 191 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 250
Query: 206 ---ADPISALHRIGFSS------------DTPEIPGY--MSKQAQDFLSKCLIRNPGERW 248
                P  ++   G S             D+P  P +   S     F+ +CL RNP  R 
Sbjct: 251 ELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 310
Query: 249 SASELLEHGFVKE 261
           SAS LL H F K+
Sbjct: 311 SASTLLNHSFFKQ 323

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 114/262 (43%), Gaps = 23/262 (8%)
Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGL 112
           P IV       +  +GK    + +E   GG L   I  R      E       R +   +
Sbjct: 63  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 122
Query: 113 QYLHSNGIVHCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAP 171
           Q+LHS+ I H D+K +N+L  SK+ +   K+ DFG A+    N     +  C TP  +AP
Sbjct: 123 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPCYTPYYVAP 179
Query: 172 EVARGEEQGFPADVWALGCTVLEMATGRPP-WPDVADPISA-------LHRIGFSSDTPE 223
           EV   E+     D+W+LG  +  +  G PP + +    IS        L + GF +  PE
Sbjct: 180 EVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN--PE 237
Query: 224 IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSV 283
               +S+ A+  +   L  +P ER + ++ + H ++ +      ++  P+T    +    
Sbjct: 238 W-SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ------SMVVPQTPLHTARVLQ 290
Query: 284 LNQQLWDSTLTSCSSASAKERI 305
            ++  WD      +SA A  R+
Sbjct: 291 EDKDHWDEVKEEMTSALATMRV 312

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 133/310 (42%), Gaps = 25/310 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRIL-SALACPQIVAYKGCDI 65
           Q +G G    V    + R+ E FA+K   L +    +RE  +   A  CP IV  +  D+
Sbjct: 38  QVLGLGINGKVLQIFNKRTQEKFALKM--LQDCPKARREVELHWRASQCPHIV--RIVDV 93
Query: 66  SEE--NGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            E    G+    + +E   GG L   I  R      E       +++   +QYLHS  I 
Sbjct: 94  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 153
Query: 122 HCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           H D+K +N+L  SK      K+ DFG A+    + +    P C TP  +APEV   E+  
Sbjct: 154 HRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTP-CYTPYYVAPEVLGPEKYD 211
Query: 181 FPADVWALGCTVLEMATGRPPWPD-----VADPISALHRIG-FSSDTPEIPGYMSKQAQD 234
              D+W+LG  +  +  G PP+       ++  +    R+G +    PE    +S++ + 
Sbjct: 212 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW-SEVSEEVKM 270
Query: 235 FLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLT 294
            +   L   P +R + +E + H ++      + +   P+T    S     +++ W+    
Sbjct: 271 LIRNLLKTEPTQRMTITEFMNHPWI------MQSTKVPQTPLHTSRVLKEDKERWEDVKE 324
Query: 295 SCSSASAKER 304
             +SA A  R
Sbjct: 325 EMTSALATMR 334

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 133/310 (42%), Gaps = 25/310 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRIL-SALACPQIVAYKGCDI 65
           Q +G G    V    + R+ E FA+K   L +    +RE  +   A  CP IV  +  D+
Sbjct: 29  QVLGLGINGKVLQIFNKRTQEKFALKM--LQDCPKARREVELHWRASQCPHIV--RIVDV 84
Query: 66  SEE--NGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            E    G+    + +E   GG L   I  R      E       +++   +QYLHS  I 
Sbjct: 85  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 144
Query: 122 HCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           H D+K +N+L  SK      K+ DFG A+    + +    P C TP  +APEV   E+  
Sbjct: 145 HRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTP-CYTPYYVAPEVLGPEKYD 202
Query: 181 FPADVWALGCTVLEMATGRPPWPD-----VADPISALHRIG-FSSDTPEIPGYMSKQAQD 234
              D+W+LG  +  +  G PP+       ++  +    R+G +    PE    +S++ + 
Sbjct: 203 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW-SEVSEEVKM 261
Query: 235 FLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLT 294
            +   L   P +R + +E + H ++      + +   P+T    S     +++ W+    
Sbjct: 262 LIRNLLKTEPTQRMTITEFMNHPWI------MQSTKVPQTPLHTSRVLKEDKERWEDVKE 315
Query: 295 SCSSASAKER 304
             +SA A  R
Sbjct: 316 EMTSALATMR 325

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 133/310 (42%), Gaps = 25/310 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRIL-SALACPQIVAYKGCDI 65
           Q +G G    V    + R+ E FA+K   L +    +RE  +   A  CP IV  +  D+
Sbjct: 30  QVLGLGINGKVLQIFNKRTQEKFALKM--LQDCPKARREVELHWRASQCPHIV--RIVDV 85
Query: 66  SEE--NGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            E    G+    + +E   GG L   I  R      E       +++   +QYLHS  I 
Sbjct: 86  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 145
Query: 122 HCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           H D+K +N+L  SK      K+ DFG A+    + +    P C TP  +APEV   E+  
Sbjct: 146 HRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTP-CYTPYYVAPEVLGPEKYD 203
Query: 181 FPADVWALGCTVLEMATGRPPWPD-----VADPISALHRIG-FSSDTPEIPGYMSKQAQD 234
              D+W+LG  +  +  G PP+       ++  +    R+G +    PE    +S++ + 
Sbjct: 204 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW-SEVSEEVKM 262
Query: 235 FLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLT 294
            +   L   P +R + +E + H ++      + +   P+T    S     +++ W+    
Sbjct: 263 LIRNLLKTEPTQRMTITEFMNHPWI------MQSTKVPQTPLHTSRVLKEDKERWEDVKE 316
Query: 295 SCSSASAKER 304
             +SA A  R
Sbjct: 317 EMTSALATMR 326

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 133/310 (42%), Gaps = 25/310 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRIL-SALACPQIVAYKGCDI 65
           Q +G G    V    + R+ E FA+K   L +    +RE  +   A  CP IV  +  D+
Sbjct: 28  QVLGLGINGKVLQIFNKRTQEKFALKM--LQDCPKARREVELHWRASQCPHIV--RIVDV 83
Query: 66  SEE--NGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            E    G+    + +E   GG L   I  R      E       +++   +QYLHS  I 
Sbjct: 84  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 143
Query: 122 HCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           H D+K +N+L  SK      K+ DFG A+    + +    P C TP  +APEV   E+  
Sbjct: 144 HRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTP-CYTPYYVAPEVLGPEKYD 201
Query: 181 FPADVWALGCTVLEMATGRPPWPD-----VADPISALHRIG-FSSDTPEIPGYMSKQAQD 234
              D+W+LG  +  +  G PP+       ++  +    R+G +    PE    +S++ + 
Sbjct: 202 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW-SEVSEEVKM 260
Query: 235 FLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLT 294
            +   L   P +R + +E + H ++      + +   P+T    S     +++ W+    
Sbjct: 261 LIRNLLKTEPTQRMTITEFMNHPWI------MQSTKVPQTPLHTSRVLKEDKERWEDVKE 314
Query: 295 SCSSASAKER 304
             +SA A  R
Sbjct: 315 EMTSALATMR 324

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 133/310 (42%), Gaps = 25/310 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRI-LSALACPQIVAYKGCDI 65
           Q +G G    V    + R+ E FA+K   L +    +RE  +   A  CP IV  +  D+
Sbjct: 22  QVLGLGINGKVLQIFNKRTQEKFALKM--LQDCPKARREVELHWRASQCPHIV--RIVDV 77
Query: 66  SEE--NGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            E    G+    + +E   GG L   I  R      E       +++   +QYLHS  I 
Sbjct: 78  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 137
Query: 122 HCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           H D+K +N+L  SK      K+ DFG A+    + +    P C TP  +APEV   E+  
Sbjct: 138 HRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTP-CYTPYYVAPEVLGPEKYD 195
Query: 181 FPADVWALGCTVLEMATGRPPWPD-----VADPISALHRIG-FSSDTPEIPGYMSKQAQD 234
              D+W+LG  +  +  G PP+       ++  +    R+G +    PE    +S++ + 
Sbjct: 196 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW-SEVSEEVKM 254
Query: 235 FLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLT 294
            +   L   P +R + +E + H ++      + +   P+T    S     +++ W+    
Sbjct: 255 LIRNLLKTEPTQRMTITEFMNHPWI------MQSTKVPQTPLHTSRVLKEDKERWEDVKE 308
Query: 295 SCSSASAKER 304
             +SA A  R
Sbjct: 309 EMTSALATMR 318

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 133/310 (42%), Gaps = 25/310 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRI-LSALACPQIVAYKGCDI 65
           Q +G G    V    + R+ E FA+K   L +    +RE  +   A  CP IV  +  D+
Sbjct: 23  QVLGLGINGKVLQIFNKRTQEKFALKM--LQDCPKARREVELHWRASQCPHIV--RIVDV 78
Query: 66  SEE--NGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            E    G+    + +E   GG L   I  R      E       +++   +QYLHS  I 
Sbjct: 79  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 138
Query: 122 HCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           H D+K +N+L  SK      K+ DFG A+    + +    P C TP  +APEV   E+  
Sbjct: 139 HRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTP-CYTPYYVAPEVLGPEKYD 196
Query: 181 FPADVWALGCTVLEMATGRPPWPD-----VADPISALHRIG-FSSDTPEIPGYMSKQAQD 234
              D+W+LG  +  +  G PP+       ++  +    R+G +    PE    +S++ + 
Sbjct: 197 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW-SEVSEEVKM 255
Query: 235 FLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLT 294
            +   L   P +R + +E + H ++      + +   P+T    S     +++ W+    
Sbjct: 256 LIRNLLKTEPTQRMTITEFMNHPWI------MQSTKVPQTPLHTSRVLKEDKERWEDVKE 309
Query: 295 SCSSASAKER 304
             +SA A  R
Sbjct: 310 EMTSALATMR 319

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 29/206 (14%)
Query: 9   IGRGSTATVSI----GMSNRSSEVFAVKS----AELSNSEFLQREQRILSALACPQIVAY 60
           +G G    VS+      ++ + E+ AVK+    A   +    ++E  IL  L    I+ Y
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           KGC   E+ G     L +EY P G+L D + R    L   ++    + +  G+ YLH+  
Sbjct: 99  KGC--CEDAGAASLQLVMEYVPLGSLRDYLPRHSIGL--AQLLLFAQQICEGMAYLHAQH 154
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRA-------RVNEDDEGKPICGTPIC-MAP 171
            +H D+  +N+L+  DN++  KI DFG A+         RV ED +      +P+   AP
Sbjct: 155 YIHRDLAARNVLL--DNDRLVKIGDFGLAKAVPEGHEXYRVREDGD------SPVFWYAP 206
Query: 172 EVARGEEQGFPADVWALGCTVLEMAT 197
           E  +  +  + +DVW+ G T+ E+ T
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 79/155 (50%), Gaps = 8/155 (5%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
            +E R   +T  ++ GL++LH   I++ D+K +N+L+  D++   +I+D G A   +  +
Sbjct: 286 FQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL--DDDGNVRISDLGLAVELKAGQ 343
Query: 156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPI---SAL 212
             + K   GTP  MAPE+  GEE  F  D +ALG T+ EM   R P+    + +      
Sbjct: 344 T-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
Query: 213 HRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGER 247
            R+   + T   P   S  ++DF    L ++P +R
Sbjct: 403 QRVLEQAVT--YPDKFSPASKDFCEALLQKDPEKR 435

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 27/207 (13%)
Query: 7   QTIGRGSTATVSIG----MSNRSSEVFAVKSAEL----SNSEFLQREQRILSALACPQIV 58
           + +G G    VS+      ++ + E+ AVK+ +      +    ++E  IL  L    I+
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
            YKGC   E+ G+    L +EY P G+L D +   + +   ++    + +  G+ YLHS 
Sbjct: 80  KYKGC--CEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHSQ 136
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRA-------RVNEDDEGKPICGTPIC-MA 170
             +H ++  +N+L+  DN++  KI DFG A+         RV ED +      +P+   A
Sbjct: 137 HYIHRNLAARNVLL--DNDRLVKIGDFGLAKAVPEGHEYYRVREDGD------SPVFWYA 188
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT 197
           PE  +  +  + +DVW+ G T+ E+ T
Sbjct: 189 PECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 79/155 (50%), Gaps = 8/155 (5%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
            +E R   +T  ++ GL++LH   I++ D+K +N+L+  D++   +I+D G A   +  +
Sbjct: 286 FQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL--DDDGNVRISDLGLAVELKAGQ 343
Query: 156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPI---SAL 212
             + K   GTP  MAPE+  GEE  F  D +ALG T+ EM   R P+    + +      
Sbjct: 344 T-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
Query: 213 HRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGER 247
            R+   + T   P   S  ++DF    L ++P +R
Sbjct: 403 QRVLEQAVT--YPDKFSPASKDFCEALLQKDPEKR 435

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 79/155 (50%), Gaps = 8/155 (5%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
            +E R   +T  ++ GL++LH   I++ D+K +N+L+  D++   +I+D G A   +  +
Sbjct: 286 FQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL--DDDGNVRISDLGLAVELKAGQ 343
Query: 156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPI---SAL 212
             + K   GTP  MAPE+  GEE  F  D +ALG T+ EM   R P+    + +      
Sbjct: 344 T-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
Query: 213 HRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGER 247
            R+   + T   P   S  ++DF    L ++P +R
Sbjct: 403 QRVLEQAVT--YPDKFSPASKDFCEALLQKDPEKR 435

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 116/289 (40%), Gaps = 42/289 (14%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFL----QREQRILSALACPQIVAYK 61
           Q +G G+   V   +  R+    A+K       SE       RE R+L  +    ++   
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
                +E      + +L     GT    +     L E RI+     +L GL+Y+H+ GI+
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII 150
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQG 180
           H D+K  N+ V++D E   KI DFG AR+A    D E      T    APEV        
Sbjct: 151 HRDLKPGNLAVNEDCE--LKILDFGLARQA----DSEMXGXVVTRWYRAPEVILNWMRYT 204
Query: 181 FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP-----------EIPGYM- 228
              D+W++GC + EM TG+  +   +D +  L  I   + TP           E   YM 
Sbjct: 205 QTVDIWSVGCIMAEMITGKTLFKG-SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 263
Query: 229 -----------------SKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
                            S  A + L K L+ +  +R +A E L H + +
Sbjct: 264 GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 99/238 (41%), Gaps = 46/238 (19%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVA--- 59
           ++ G+T+G GS   V       S + FA+K   L +  +  RE  I+  L    I+    
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKV-LQDPRYKNRELDIMKVLDHVNIIKLVD 67
Query: 60  --------------------------------YKGCDISEENGKILYNLFLEYAPG---G 84
                                           +K   ++    K L N+ +EY P     
Sbjct: 68  YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL-NVIMEYVPDTLHK 126
Query: 85  TLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV-SKDNEQGAKIA 143
            L   IRSG  +    I  +   +   + ++HS GI H DIK QN+LV SKDN    K+ 
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT--LKLC 184
Query: 144 DFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPA-DVWALGCTVLEMATGRP 200
           DFG A++   +E      IC      APE+  G  +  P+ D+W++GC   E+  G+P
Sbjct: 185 DFGSAKKLIPSEPSVAX-ICSR-FYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 79/155 (50%), Gaps = 8/155 (5%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
            +E R   +T  ++ GL++LH   I++ D+K +N+L+  D++   +I+D G A   +  +
Sbjct: 286 FQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL--DDDGNVRISDLGLAVELKAGQ 343
Query: 156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPI---SAL 212
             + K   GTP  MAPE+  GEE  F  D +ALG T+ EM   R P+    + +      
Sbjct: 344 T-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
Query: 213 HRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGER 247
            R+   + T   P   S  ++DF    L ++P +R
Sbjct: 403 QRVLEQAVT--YPDKFSPASKDFCEALLQKDPEKR 435

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 118/297 (39%), Gaps = 50/297 (16%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQIVAYKG 62
           + +G G+ ATV  G++  +    A+K  +L + E       RE  ++  L    IV    
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 63  CDISEENGKILYNLFLE-----YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
             I  EN   L   F++     Y    T+ +  R    LE   ++     +L GL + H 
Sbjct: 71  V-IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRG---LELNLVKYFQWQLLQGLAFCHE 126
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
           N I+H D+K QN+L++K  +   K+ DFG AR   +  +     +  T    AP+V  G 
Sbjct: 127 NKILHRDLKPQNLLINKRGQ--LKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMGS 183
Query: 178 E-QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP---------EIPGY 227
                  D+W+ GC + EM TG+P +P   D    L  I     TP         ++P Y
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-EQLKLIFDIMGTPNESLWPSVTKLPKY 242
Query: 228 -----------------------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                                  +     DFL   L  NP  R SA + L H +  E
Sbjct: 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 119/283 (42%), Gaps = 32/283 (11%)
Query: 8   TIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISE 67
            +G G+ A V   ++  +S+ +AVK  E        R  R +  L   Q        I  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 68  ENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKG 127
              +  + L  E   GG++   I       E       + V   L +LH+ GI H D+K 
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKP 139
Query: 128 QNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPI--------CGTPICMAPEV--ARG 176
           +NIL    N+    KI DF      ++N D    PI        CG+   MAPEV  A  
Sbjct: 140 ENILCEHPNQVSPVKICDFDLGSGIKLNGD--CSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 177 EEQGF---PADVWALGCTVLEMATGRPPWP---------DVADPISALHRIGFSS---DT 221
           EE        D+W+LG  +  + +G PP+          D  +   A   + F S     
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK 257
Query: 222 PEIP----GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
            E P     ++S  A+D +SK L+R+  +R SA+++L+H +V+
Sbjct: 258 YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 119/310 (38%), Gaps = 67/310 (21%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAY 60
           + + + IG G+   V            AVK  S    N    +R  R L  L C      
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKC------ 77
Query: 61  KGCDISEENGKILYNLFL------EYAPGGTLTDAIRSGTC------LEEGRIRSHTRAV 108
               ++ +N   L N+F       E+     + + + +  C      L+  R+      +
Sbjct: 78  ----VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQM 133
Query: 109 LLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC 168
           L G+++LHS GI+H D+K  NI+V  D     KI DFG AR A  N      P   T   
Sbjct: 134 LCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTASTNF--MMTPYVVTRYY 189
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGR---------PPWPDV--------ADPISA 211
            APEV  G       D+W++GC + E+  G            W  V        A+ ++A
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAA 249
Query: 212 LHRI--GFSSDTPEIPGYM--------------------SKQAQDFLSKCLIRNPGERWS 249
           L      +  + P  PG                      + QA+D LSK L+ +P +R S
Sbjct: 250 LQPTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRIS 309
Query: 250 ASELLEHGFV 259
             E L H ++
Sbjct: 310 VDEALRHPYI 319

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 120/310 (38%), Gaps = 67/310 (21%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAY 60
           + + + IG G+   V            AVK  S    N    +R  R L  L C      
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKC------ 79
Query: 61  KGCDISEENGKILYNLFL------EYAPGGTLTDAIRSGTC------LEEGRIRSHTRAV 108
               ++ +N   L N+F       E+     + + + +  C      L+  R+      +
Sbjct: 80  ----VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQM 135
Query: 109 LLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC 168
           L G+++LHS GI+H D+K  NI+V  D     KI DFG AR A  N      P   T   
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTACTNF--MMTPYVVTRYY 191
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATG---------RPPWPDV--------ADPISA 211
            APEV  G       D+W++GC + E+  G            W  V        A+ ++A
Sbjct: 192 RAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAA 251
Query: 212 LHRI--GFSSDTPEIPGYM--------------------SKQAQDFLSKCLIRNPGERWS 249
           L      +  + P+ PG                      + QA+D LSK L+ +P +R S
Sbjct: 252 LQPTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRIS 311
Query: 250 ASELLEHGFV 259
             E L H ++
Sbjct: 312 VDEALRHPYI 321

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 27/207 (13%)
Query: 7   QTIGRGSTATVSIG----MSNRSSEVFAVKSAEL----SNSEFLQREQRILSALACPQIV 58
           + +G G    VS+      ++ + E+ AVK+ +      +    ++E  IL  L    I+
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
            YKGC   E+ G+    L +EY P G+L D +   + +   ++    + +  G+ YLH+ 
Sbjct: 80  KYKGC--CEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQ 136
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRA-------RVNEDDEGKPICGTPIC-MA 170
             +H ++  +N+L+  DN++  KI DFG A+         RV ED +      +P+   A
Sbjct: 137 HYIHRNLAARNVLL--DNDRLVKIGDFGLAKAVPEGHEYYRVREDGD------SPVFWYA 188
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT 197
           PE  +  +  + +DVW+ G T+ E+ T
Sbjct: 189 PECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 44/291 (15%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 150 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMAGFVATRWYRAPEIMLNWMHYNQT 203
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI----------GFSSDTPEIPGYMSK 230
            D+W++GC + E+ TGR  +P  D  D +  + R+            SS++     Y+  
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR--NYIQS 261
Query: 231 QAQ------------------DFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            AQ                  D L K L+ +  +R +A++ L H +  + +
Sbjct: 262 LAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/291 (23%), Positives = 120/291 (41%), Gaps = 44/291 (15%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 145
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR    + DDE      T    APE+          
Sbjct: 146 DLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMAGFVATRWYRAPEIMLNWMHYNQT 199
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI----------GFSSDTPEIPGYMSK 230
            D+W++GC + E+ TGR  +P  D  D +  + R+            SS++     Y+  
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR--NYIQS 257
Query: 231 QAQ------------------DFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            AQ                  D L K L+ +  +R +A++ L H +  + +
Sbjct: 258 LAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 123/292 (42%), Gaps = 46/292 (15%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 64  DISEENGKILYNLFL-EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
                + +   +++L  +  G  L + ++    L +  ++     +L GL+Y+HS  I+H
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCAK-LTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 123 CDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGF 181
            D+K  N+ V++D E   KI DFG AR    + DDE      T    APE+         
Sbjct: 145 RDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQ 198
Query: 182 PADVWALGCTVLEMATGRPPWP--DVADPISALHRI----------GFSSDTPEIPGYMS 229
             D+W++GC + E+ TGR  +P  D  D +  + R+            SS++     Y+ 
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR--NYIQ 256
Query: 230 KQAQ------------------DFLSKCLIRNPGERWSASELLEHGFVKEQN 263
             AQ                  D L K L+ +  +R +A++ L H +  + +
Sbjct: 257 SLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 44/291 (15%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 150 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI----------GFSSDTPEIPGYMSK 230
            D+W++GC + E+ TGR  +P  D  D +  + R+            SS++     Y+  
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR--NYIQS 261
Query: 231 QAQ------------------DFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            AQ                  D L K L+ +  +R +A++ L H +  + +
Sbjct: 262 LAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 44/291 (15%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 159
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 160 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 213
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI----------GFSSDTPEIPGYMSK 230
            D+W++GC + E+ TGR  +P  D  D +  + R+            SS++     Y+  
Sbjct: 214 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR--NYIQS 271
Query: 231 QAQ------------------DFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            AQ                  D L K L+ +  +R +A++ L H +  + +
Sbjct: 272 LAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 322

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/291 (23%), Positives = 120/291 (41%), Gaps = 44/291 (15%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 145
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR    + DDE      T    APE+          
Sbjct: 146 DLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 199
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI----------GFSSDTPEIPGYMSK 230
            D+W++GC + E+ TGR  +P  D  D +  + R+            SS++     Y+  
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR--NYIQS 257
Query: 231 QAQ------------------DFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            AQ                  D L K L+ +  +R +A++ L H +  + +
Sbjct: 258 LAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 44/291 (15%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 155
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 156 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI----------GFSSDTPEIPGYMSK 230
            D+W++GC + E+ TGR  +P  D  D +  + R+            SS++     Y+  
Sbjct: 210 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR--NYIQS 267
Query: 231 QAQ------------------DFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            AQ                  D L K L+ +  +R +A++ L H +  + +
Sbjct: 268 LAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 318

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 44/291 (15%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 169
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 170 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 223
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI----------GFSSDTPEIPGYMSK 230
            D+W++GC + E+ TGR  +P  D  D +  + R+            SS++     Y+  
Sbjct: 224 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR--NYIQS 281
Query: 231 QAQ------------------DFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            AQ                  D L K L+ +  +R +A++ L H +  + +
Sbjct: 282 LAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 332

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 44/291 (15%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 169
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 170 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMXGXVATRWYRAPEIMLNWMHYNQT 223
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI----------GFSSDTPEIPGYMSK 230
            D+W++GC + E+ TGR  +P  D  D +  + R+            SS++     Y+  
Sbjct: 224 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR--NYIQS 281
Query: 231 QAQ------------------DFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            AQ                  D L K L+ +  +R +A++ L H +  + +
Sbjct: 282 LAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 332

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 44/291 (15%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 168
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 169 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 222
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI----------GFSSDTPEIPGYMSK 230
            D+W++GC + E+ TGR  +P  D  D +  + R+            SS++     Y+  
Sbjct: 223 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR--NYIQS 280
Query: 231 QAQ------------------DFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            AQ                  D L K L+ +  +R +A++ L H +  + +
Sbjct: 281 LAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 331

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           IG G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 154
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 155 DLKPSNLAVNEDXE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 208
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 268
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 269 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 317

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 150 DLKPSNLAVNEDXE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 118/296 (39%), Gaps = 52/296 (17%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQREQRILSALACPQIVAY--- 60
           IG+G+   V      ++ +  A+K   + N +        RE +IL  L    +V     
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 61  ---KGCDISEENGKILYNL-FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
              K    +   G I     F E+   G L++ +   T  E  R+    + +L GL Y+H
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV---MQMLLNGLYYIH 142
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEV 173
            N I+H D+K  N+L+++D     K+ADFG AR   + ++ +        + +    PE+
Sbjct: 143 RNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 200
Query: 174 ARGE-EQGFPADVWALGCTVLEMATGRP------------------------PWPDVADP 208
             GE + G P D+W  GC + EM T  P                         WP+V D 
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV-DN 259
Query: 209 ISALHRIGFSSDTP-----EIPGYMSK-QAQDFLSKCLIRNPGERWSASELLEHGF 258
                ++             +  Y+    A D + K L+ +P +R  + + L H F
Sbjct: 260 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 315

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 118/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 151
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D+E   KI DFG AR      DDE      T    APE+          
Sbjct: 152 DLKPSNLAVNEDSE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 205
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 265
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 266 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 314

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 150 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMAGFVATRWYRAPEIMLNWMHYNQT 203
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 118/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 155
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D+E   KI DFG AR      DDE      T    APE+          
Sbjct: 156 DLKPSNLAVNEDSE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 210 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 269
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 270 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 318

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/302 (23%), Positives = 120/302 (39%), Gaps = 52/302 (17%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQREQRILSALACPQI 57
           + +   IG+G+   V      ++ +  A+K   + N +        RE +IL  L    +
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 78
Query: 58  VAY------KGCDISEENGKILYNL-FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL 110
           V        K    +   G I     F E+   G L++ +   T  E  R+    + +L 
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV---MQMLLN 135
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM- 169
           GL Y+H N I+H D+K  N+L+++D     K+ADFG AR   + ++ +        + + 
Sbjct: 136 GLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 193
Query: 170 --APEVARGE-EQGFPADVWALGCTVLEMATGRP------------------------PW 202
              PE+  GE + G P D+W  GC + EM T  P                         W
Sbjct: 194 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253
Query: 203 PDVADPISALHRIGFSSDTP-----EIPGYMSK-QAQDFLSKCLIRNPGERWSASELLEH 256
           P+V D      ++             +  Y+    A D + K L+ +P +R  + + L H
Sbjct: 254 PNV-DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312
Query: 257 GF 258
            F
Sbjct: 313 DF 314

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/290 (22%), Positives = 121/290 (41%), Gaps = 42/290 (14%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DISEENGKILYNLFL-EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
                + +   +++L  +  G  L + ++S   L +  ++     +L GL+Y+HS  I+H
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKSQK-LTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 123 CDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGF 181
            D+K  N+ V++D+E   KI DFG  R      DDE      T    APE+         
Sbjct: 149 RDLKPSNLAVNEDSE--LKILDFGLCRHT----DDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 182 PADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDT 221
             D+W++GC + E+ TGR  +P  D  D +  + R+                   +    
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 222 PEIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 160
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 161 DLKPSNLAVNEDXE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 214
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 215 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 274
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 275 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 323

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/302 (23%), Positives = 120/302 (39%), Gaps = 52/302 (17%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQREQRILSALACPQI 57
           + +   IG+G+   V      ++ +  A+K   + N +        RE +IL  L    +
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 58  VAY------KGCDISEENGKILYNL-FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL 110
           V        K    +   G I     F E+   G L++ +   T  E  R+    + +L 
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV---MQMLLN 136
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM- 169
           GL Y+H N I+H D+K  N+L+++D     K+ADFG AR   + ++ +        + + 
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 194
Query: 170 --APEVARGE-EQGFPADVWALGCTVLEMATGRP------------------------PW 202
              PE+  GE + G P D+W  GC + EM T  P                         W
Sbjct: 195 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 254
Query: 203 PDVADPISALHRIGFSSDTP-----EIPGYMSK-QAQDFLSKCLIRNPGERWSASELLEH 256
           P+V D      ++             +  Y+    A D + K L+ +P +R  + + L H
Sbjct: 255 PNV-DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 313
Query: 257 GF 258
            F
Sbjct: 314 DF 315

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 114/252 (45%), Gaps = 31/252 (12%)
Query: 9   IGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +G+G    V +G  N ++ V    +K   +S   FLQ E +++  L   ++V      +S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYAV-VS 83
Query: 67  EENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           EE   I+    +EY   G+L D ++   G  L   ++      +  G+ Y+     VH D
Sbjct: 84  EEPIYIV----IEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEEQGF 181
           ++  NILV ++     K+ADFG    AR+ ED+E     G    +   APE A       
Sbjct: 140 LRAANILVGEN--LVCKVADFGL---ARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 182 PADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +DVW+ G  + E+ T GR P+P     +V D +   +R+    + PE          D 
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE-------SLHDL 247
Query: 236 LSKCLIRNPGER 247
           + +C  ++P ER
Sbjct: 248 MCQCWRKDPEER 259

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 106/231 (45%), Gaps = 21/231 (9%)
Query: 42  LQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGT--LTDAI---RSGTCL 96
           +++E ++L  L    ++       +EE  K+   + +EY   G   + D++   R   C 
Sbjct: 53  VKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY--MVMEYCVCGMQEMLDSVPEKRFPVCQ 110
Query: 97  EEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR-VNE 155
             G    +   ++ GL+YLHS GIVH DIK  N+L++       KI+  G A        
Sbjct: 111 AHG----YFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALHPFAA 164
Query: 156 DDEGKPICGTPICMAPEVARGEE--QGFPADVWALGCTVLEMATGRPPWPDVADPISAL- 212
           DD  +   G+P    PE+A G +   GF  D+W+ G T+  + TG   +P   D I  L 
Sbjct: 165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL--YPFEGDNIYKLF 222
Query: 213 HRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
             IG  S    IPG       D L   L   P +R+S  ++ +H + ++++
Sbjct: 223 ENIGKGSYA--IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 154
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 155 DLKPSNLAVNEDXE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 208
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 268
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 269 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 317

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 114/252 (45%), Gaps = 31/252 (12%)
Query: 9   IGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +G+G    V +G  N ++ V    +K   +S   FLQ E +++  L   ++V      +S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYAV-VS 83
Query: 67  EENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           EE   I+    +EY   G+L D ++   G  L   ++      +  G+ Y+     VH D
Sbjct: 84  EEPIYIV----IEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEEQGF 181
           ++  NILV ++     K+ADFG    AR+ ED+E     G    +   APE A       
Sbjct: 140 LRAANILVGEN--LVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 182 PADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +DVW+ G  + E+ T GR P+P     +V D +   +R+    + PE          D 
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE-------SLHDL 247
Query: 236 LSKCLIRNPGER 247
           + +C  ++P ER
Sbjct: 248 MCQCWRKDPEER 259

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 150 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 55/209 (26%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L+  R+      +L+G+++LHS GI+H D+K  NI+V  D     KI DFG AR A    
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSD--ATLKILDFGLARTA---- 176
Query: 156 DDEGKPICGTPICM-----APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS 210
              G     TP  +     APEV  G       D+W++GC + EM  G   +P   D I 
Sbjct: 177 ---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG-TDHID 232
Query: 211 ALHRI--------------------GFSSDTPEIPGY--------------------MSK 230
             +++                     +  + P+  GY                     + 
Sbjct: 233 QWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKAS 292
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGFV 259
           QA+D LSK L+ +  +R S  E L+H ++
Sbjct: 293 QARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 120/306 (39%), Gaps = 60/306 (19%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQREQRILSALACPQI 57
           + +   IG+G+   V      ++ +  A+K   + N +        RE +IL  L    +
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 58  V-----------AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTR 106
           V            Y  C  S      L   F E+   G L++ +   T  E  R+    +
Sbjct: 80  VNLIEICRTKASPYNRCKAS----IYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV---MQ 132
Query: 107 AVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTP 166
            +L GL Y+H N I+H D+K  N+L+++D     K+ADFG AR   + ++ +        
Sbjct: 133 MLLNGLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 167 ICM---APEVARGE-EQGFPADVWALGCTVLEMATGRP---------------------- 200
           + +    PE+  GE + G P D+W  GC + EM T  P                      
Sbjct: 191 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 250
Query: 201 --PWPDVADPISALHRIGFSSDTP-----EIPGYMSK-QAQDFLSKCLIRNPGERWSASE 252
              WP+V D      ++             +  Y+    A D + K L+ +P +R  + +
Sbjct: 251 PEVWPNV-DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 309
Query: 253 LLEHGF 258
            L H F
Sbjct: 310 ALNHDF 315

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 113/252 (44%), Gaps = 31/252 (12%)
Query: 9   IGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +G+G    V +G  N ++ V    +K   +S   FLQ E +++  L   ++V      +S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYAV-VS 249
Query: 67  EENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           EE   I+     EY   G+L D ++  +G  L   ++      +  G+ Y+     VH D
Sbjct: 250 EEPIYIV----TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEEQGF 181
           ++  NILV ++     K+ADFG    AR+ ED+E     G    +   APE A       
Sbjct: 306 LRAANILVGEN--LVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 182 PADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +DVW+ G  + E+ T GR P+P     +V D +   +R+    + PE          D 
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE-------SLHDL 413
Query: 236 LSKCLIRNPGER 247
           + +C  + P ER
Sbjct: 414 MCQCWRKEPEER 425

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA-RGEEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 150 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNAMHYNQT 203
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 86/210 (40%), Gaps = 57/210 (27%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L+  R+      +L G+++LHS GI+H D+K  NI+V  D     KI DFG AR A    
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSD--XTLKILDFGLARTA---- 176
Query: 156 DDEGKPICGTPICM-----APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS 210
              G     TP  +     APEV  G       D+W++GC + EM   +  +P   D I 
Sbjct: 177 ---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG-RDYID 232
Query: 211 ALHRIGFSSDTPEIPGYMSK---------------------------------------- 230
             +++     TP  P +M K                                        
Sbjct: 233 QWNKVIEQLGTP-CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKA 291
Query: 231 -QAQDFLSKCLIRNPGERWSASELLEHGFV 259
            QA+D LSK L+ +P +R S  + L+H ++
Sbjct: 292 SQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 113/252 (44%), Gaps = 31/252 (12%)
Query: 9   IGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +G+G    V +G  N ++ V    +K   +S   FLQ E +++  L   ++V      +S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYAV-VS 249
Query: 67  EENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           EE   I+     EY   G+L D ++  +G  L   ++      +  G+ Y+     VH D
Sbjct: 250 EEPIYIV----TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEEQGF 181
           ++  NILV ++     K+ADFG    AR+ ED+E     G    +   APE A       
Sbjct: 306 LRAANILVGEN--LVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 182 PADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +DVW+ G  + E+ T GR P+P     +V D +   +R+    + PE          D 
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE-------SLHDL 413
Query: 236 LSKCLIRNPGER 247
           + +C  + P ER
Sbjct: 414 MCQCWRKEPEER 425

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 115/271 (42%), Gaps = 32/271 (11%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           MD+   + IG G    V         + + +K  + +N E  +RE + L+ L    IV Y
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKLDHVNIVHY 69
Query: 61  KGC-------------DISEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHT 105
            GC             + S    K L+ + +E+   GTL   I  R G  L++       
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLF-IQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 106 RAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT 165
             +  G+ Y+HS  +++ D+K  NI +  D +Q  KI DFG      +  D +     GT
Sbjct: 129 EQITKGVDYIHSKKLINRDLKPSNIFLV-DTKQ-VKIGDFGLV--TSLKNDGKRXRSKGT 184
Query: 166 PICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE-- 223
              M+PE    ++ G   D++ALG  + E+         V D  +A     F +D  +  
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELL-------HVCD--TAFETSKFFTDLRDGI 235
Query: 224 IPGYMSKQAQDFLSKCLIRNPGERWSASELL 254
           I     K+ +  L K L + P +R + SE+L
Sbjct: 236 ISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 266

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 172
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 173 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMXGYVATRWYRAPEIMLNWMHYNQT 226
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 227 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 286
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 287 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 335

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 86/210 (40%), Gaps = 57/210 (27%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L+  R+      +L G+++LHS GI+H D+K  NI+V  D     KI DFG AR A    
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSD--XTLKILDFGLARTA---- 176
Query: 156 DDEGKPICGTPICM-----APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS 210
              G     TP  +     APEV  G       D+W++GC + EM   +  +P   D I 
Sbjct: 177 ---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG-RDYID 232
Query: 211 ALHRIGFSSDTPEIPGYMSK---------------------------------------- 230
             +++     TP  P +M K                                        
Sbjct: 233 QWNKVIEQLGTP-CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKA 291
Query: 231 -QAQDFLSKCLIRNPGERWSASELLEHGFV 259
            QA+D LSK L+ +P +R S  + L+H ++
Sbjct: 292 SQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 161
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 162 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 215
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 216 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 275
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 276 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 324

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 161
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 162 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 215
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 216 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 275
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 276 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 324

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 161
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 162 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 215
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 216 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 275
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 276 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 324

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 151
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 152 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 205
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 265
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 266 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 314

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 150 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 150 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 113/252 (44%), Gaps = 31/252 (12%)
Query: 9   IGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +G+G    V +G  N ++ V    +K   +S   FLQ E +++  L   ++V      +S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYAV-VS 83
Query: 67  EENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           EE   I+    +EY   G L D ++   G  L   ++      +  G+ Y+     VH D
Sbjct: 84  EEPIYIV----MEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEEQGF 181
           ++  NILV ++     K+ADFG    AR+ ED+E     G    +   APE A       
Sbjct: 140 LRAANILVGEN--LVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 182 PADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +DVW+ G  + E+ T GR P+P     +V D +   +R+    + PE          D 
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE-------SLHDL 247
Query: 236 LSKCLIRNPGER 247
           + +C  ++P ER
Sbjct: 248 MCQCWRKDPEER 259

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 86/210 (40%), Gaps = 57/210 (27%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L+  R+      +L G+++LHS GI+H D+K  NI+V  D     KI DFG AR A    
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD--XTLKILDFGLARTA---- 176
Query: 156 DDEGKPICGTPICM-----APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS 210
              G     TP  +     APEV  G       D+W++GC + EM   +  +P   D I 
Sbjct: 177 ---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG-RDYID 232
Query: 211 ALHRIGFSSDTPEIPGYMSK---------------------------------------- 230
             +++     TP  P +M K                                        
Sbjct: 233 QWNKVIEQLGTP-CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKA 291
Query: 231 -QAQDFLSKCLIRNPGERWSASELLEHGFV 259
            QA+D LSK L+ +P +R S  + L+H ++
Sbjct: 292 SQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 156
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 157 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 210
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 211 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 270
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 271 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 150 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 113/252 (44%), Gaps = 31/252 (12%)
Query: 9   IGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +G+G    V +G  N ++ V    +K   +S   FLQ E +++  L   ++V      +S
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYAV-VS 73
Query: 67  EENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           EE   I+     EY   G+L D ++  +G  L   ++      +  G+ Y+     VH D
Sbjct: 74  EEPIXIV----TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 129
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEEQGF 181
           ++  NILV ++     K+ADFG    AR+ ED+E     G    +   APE A       
Sbjct: 130 LRAANILVGEN--LVCKVADFGL---ARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTI 184
Query: 182 PADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +DVW+ G  + E+ T GR P+P     +V D +   +R+    + PE          D 
Sbjct: 185 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE-------SLHDL 237
Query: 236 LSKCLIRNPGER 247
           + +C  + P ER
Sbjct: 238 MCQCWRKEPEER 249

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 114/252 (45%), Gaps = 31/252 (12%)
Query: 9   IGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +G+G    V +G  N ++ V    +K   +S   FLQ E +++  L   ++V      +S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYAV-VS 80
Query: 67  EENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           EE   I+     EY   G+L D ++  +G  L   ++   +  +  G+ Y+     VH D
Sbjct: 81  EEPIYIV----TEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEEQGF 181
           ++  NILV ++     K+ADFG    AR+ ED+E     G    +   APE A       
Sbjct: 137 LRAANILVGEN--LVCKVADFGL---ARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTI 191
Query: 182 PADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +DVW+ G  + E+ T GR P+P     +V D +   +R+    + PE          D 
Sbjct: 192 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE-------SLHDL 244
Query: 236 LSKCLIRNPGER 247
           + +C  + P ER
Sbjct: 245 MCQCWRKEPEER 256

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 146
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 147 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 200
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 201 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 260
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 261 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 309

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 151
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 152 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 205
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 265
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 266 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 314

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 155
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 156 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 210 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 269
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 270 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 318

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 118/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 88  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 147
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR    + DDE      T    APE+          
Sbjct: 148 DLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 201
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 202 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 261
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 262 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 310

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 118/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 145
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR    + DDE      T    APE+          
Sbjct: 146 DLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 199
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 259
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 260 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 86/210 (40%), Gaps = 57/210 (27%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L+  R+      +L G+++LHS GI+H D+K  NI+V  D     KI DFG AR A    
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD--XTLKILDFGLARTA---- 176
Query: 156 DDEGKPICGTPICM-----APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS 210
              G     TP  +     APEV  G       D+W++GC + EM   +  +P   D I 
Sbjct: 177 ---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG-RDYID 232
Query: 211 ALHRIGFSSDTPEIPGYMSK---------------------------------------- 230
             +++     TP  P +M K                                        
Sbjct: 233 QWNKVIEQLGTP-CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKA 291
Query: 231 -QAQDFLSKCLIRNPGERWSASELLEHGFV 259
            QA+D LSK L+ +P +R S  + L+H ++
Sbjct: 292 SQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 172
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 173 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 226
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 227 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 286
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 287 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 335

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 150 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 154
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 155 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 208
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 268
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 269 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 317

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 150 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 160
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 161 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 214
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 215 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 274
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 275 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 323

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 86/210 (40%), Gaps = 57/210 (27%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L+  R+      +L G+++LHS GI+H D+K  NI+V  D     KI DFG AR A    
Sbjct: 116 LDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSD--XTLKILDFGLARTA---- 169
Query: 156 DDEGKPICGTPICM-----APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS 210
              G     TP  +     APEV  G       D+W++GC + EM   +  +P   D I 
Sbjct: 170 ---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG-RDYID 225
Query: 211 ALHRIGFSSDTPEIPGYMSK---------------------------------------- 230
             +++     TP  P +M K                                        
Sbjct: 226 QWNKVIEQLGTP-CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKA 284
Query: 231 -QAQDFLSKCLIRNPGERWSASELLEHGFV 259
            QA+D LSK L+ +P +R S  + L+H ++
Sbjct: 285 SQARDLLSKMLVIDPAKRISVDDALQHPYI 314

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 150 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 129/310 (41%), Gaps = 23/310 (7%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRIL-SALACPQIVAYKGCDI 65
           Q +G G    V    + R+ E FA+K   L +    +RE  +   A  CP IV  +  D+
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKX--LQDCPKARREVELHWRASQCPHIV--RIVDV 123
Query: 66  SEE--NGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            E    G+    +  E   GG L   I  R      E       +++   +QYLHS  I 
Sbjct: 124 YENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIA 183
Query: 122 HCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           H D+K +N+L  SK      K+ DFG A+    + +    P C TP  +APEV   E+  
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTP-CYTPYYVAPEVLGPEKYD 241
Query: 181 FPADVWALGCTVLEMATGRPP-WPDVADPISALHRIGFSSDTPEIPG----YMSKQAQDF 235
              D W+LG     +  G PP + +    IS   +        E P      +S++ +  
Sbjct: 242 KSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEVSEEVKXL 301
Query: 236 LSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLTS 295
           +   L   P +R + +E   H ++  Q+ K+     P+T    S     +++ W+     
Sbjct: 302 IRNLLKTEPTQRXTITEFXNHPWIX-QSTKV-----PQTPLHTSRVLKEDKERWEDVKEE 355
Query: 296 CSSASAKERI 305
            +SA A  R+
Sbjct: 356 XTSALATMRV 365

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 168
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 169 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 222
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 223 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 282
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 283 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 331

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 154
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 155 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 208
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 268
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 269 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 317

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 89  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 148
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 149 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 202
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 203 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 262
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 263 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 311

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 150 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 169
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 170 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 223
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 224 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 283
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 284 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 332

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 151
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 152 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 205
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 265
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 266 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 314

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 114/252 (45%), Gaps = 31/252 (12%)
Query: 9   IGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +G+G    V +G  N ++ V    +K   +S   FLQ E +++  L   ++V      +S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYAV-VS 80
Query: 67  EENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           EE   I+     EY   G+L D ++  +G  L   ++   +  +  G+ Y+     VH D
Sbjct: 81  EEPIYIV----TEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEEQGF 181
           ++  NILV ++     K+ADFG    AR+ ED+E     G    +   APE A       
Sbjct: 137 LRAANILVGEN--LVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 191
Query: 182 PADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +DVW+ G  + E+ T GR P+P     +V D +   +R+    + PE          D 
Sbjct: 192 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE-------SLHDL 244
Query: 236 LSKCLIRNPGER 247
           + +C  + P ER
Sbjct: 245 MCQCWRKEPEER 256

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 113/252 (44%), Gaps = 31/252 (12%)
Query: 9   IGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +G+G    V +G  N ++ V    +K   +S   FLQ E +++  L   ++V      +S
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYAV-VS 76
Query: 67  EENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           EE   I+     EY   G+L D ++  +G  L   ++      +  G+ Y+     VH D
Sbjct: 77  EEPIYIV----TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 132
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEEQGF 181
           ++  NILV ++     K+ADFG    AR+ ED+E     G    +   APE A       
Sbjct: 133 LRAANILVGEN--LVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 187
Query: 182 PADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +DVW+ G  + E+ T GR P+P     +V D +   +R+    + PE          D 
Sbjct: 188 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE-------SLHDL 240
Query: 236 LSKCLIRNPGER 247
           + +C  + P ER
Sbjct: 241 MCQCWRKEPEER 252

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/254 (22%), Positives = 115/254 (45%), Gaps = 22/254 (8%)
Query: 7   QTIGRGSTATVS--------IGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIV 58
           + IGRG  + V         + ++ +  ++F +  A+ + ++ + +E  +L  L  P ++
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK-ARADCI-KEIDLLKQLNHPNVI 95
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIR----SGTCLEEGRIRSHTRAVLLGLQY 114
            Y    I +       N+ LE A  G L+  I+        + E  +  +   +   L++
Sbjct: 96  KYYASFIEDNE----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           +HS  ++H DIK  N+ ++       K+ D G  R    ++      + GTP  M+PE  
Sbjct: 152 MHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 208
Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPG-YMSKQAQ 233
                 F +D+W+LGC + EMA  + P+      + +L +     D P +P  + S++ +
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 268
Query: 234 DFLSKCLIRNPGER 247
             ++ C+  +P +R
Sbjct: 269 QLVNMCINPDPEKR 282

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 150 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGXVATRWYRAPEIMLNWMHYNQT 203
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 155
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 156 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 210 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 269
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 270 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 318

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 146
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR      DDE      T    APE+          
Sbjct: 147 DLKPSNLAVNEDCE--LKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 200
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 201 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 260
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 261 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 309

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 113/252 (44%), Gaps = 31/252 (12%)
Query: 9   IGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +G+G    V +G  N ++ V    +K   +S   FLQ E +++  L   ++V      +S
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYAV-VS 72
Query: 67  EENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           EE   I+     EY   G+L D ++   G  L   ++      +  G+ Y+     VH D
Sbjct: 73  EEPIYIV----TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 128
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEEQGF 181
           ++  NILV ++     K+ADFG    AR+ ED+E     G    +   APE A       
Sbjct: 129 LRAANILVGEN--LVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 183
Query: 182 PADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +DVW+ G  + E+ T GR P+P     +V D +   +R+    + PE          D 
Sbjct: 184 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE-------SLHDL 236
Query: 236 LSKCLIRNPGER 247
           + +C  ++P ER
Sbjct: 237 MCQCWRKDPEER 248

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 113/252 (44%), Gaps = 31/252 (12%)
Query: 9   IGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +G+G    V +G  N ++ V    +K   +S   FLQ E +++  L   ++V      +S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYAV-VS 83
Query: 67  EENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           EE   I+     EY   G+L D ++   G  L   ++      +  G+ Y+     VH D
Sbjct: 84  EEPIYIV----TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEEQGF 181
           ++  NILV ++     K+ADFG    AR+ ED+E     G    +   APE A       
Sbjct: 140 LRAANILVGEN--LVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 182 PADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +DVW+ G  + E+ T GR P+P     +V D +   +R+    + PE          D 
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE-------SLHDL 247
Query: 236 LSKCLIRNPGER 247
           + +C  ++P ER
Sbjct: 248 MCQCWRKDPEER 259

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 113/252 (44%), Gaps = 31/252 (12%)
Query: 9   IGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +G+G    V +G  N ++ V    +K   +S   FLQ E +++  L   ++V      +S
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYAV-VS 74
Query: 67  EENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           EE   I+     EY   G+L D ++   G  L   ++      +  G+ Y+     VH D
Sbjct: 75  EEPIYIV----TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 130
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEEQGF 181
           ++  NILV ++     K+ADFG    AR+ ED+E     G    +   APE A       
Sbjct: 131 LRAANILVGEN--LVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 185
Query: 182 PADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +DVW+ G  + E+ T GR P+P     +V D +   +R+    + PE          D 
Sbjct: 186 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE-------SLHDL 238
Query: 236 LSKCLIRNPGER 247
           + +C  ++P ER
Sbjct: 239 MCQCWRKDPEER 250

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 133/324 (41%), Gaps = 77/324 (23%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSA--ELSNSEFLQREQR---ILSALACPQIVAYK 61
           + +G+G+   V   +  R+ EV AVK       NS   QR  R   IL+ L+  + +   
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
              +  +N + +Y L  +Y    T   A+     LE    +     ++  ++YLHS G++
Sbjct: 75  LNVLRADNDRDVY-LVFDYME--TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLL 131
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARR------------ARVNED----DEGKPICGT 165
           H D+K  NIL++   E   K+ADFG +R               +NE+    D+ +PI   
Sbjct: 132 HRDMKPSNILLNA--ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 166 PICM----APEVARGEEQGFPA-DVWALGCTVLEMATGRPPWPDVADPISALHR----IG 216
            +      APE+  G  +     D+W+LGC + E+  G+P +P  +  ++ L R    I 
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG-SSTMNQLERIIGVID 248
Query: 217 FSS--DTPEIPGYMSK---------------------------------------QAQDF 235
           F S  D   I    +K                                       +A D 
Sbjct: 249 FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDL 308
Query: 236 LSKCLIRNPGERWSASELLEHGFV 259
           L K L  NP +R SA++ L+H FV
Sbjct: 309 LDKLLQFNPNKRISANDALKHPFV 332

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 106/235 (45%), Gaps = 29/235 (12%)
Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVFA--VKSAELSNSEFLQREQRILSALACPQIVAYK 61
           T  + +G G    V +G      +V    +K   +S  EF Q  Q ++  L+ P++V + 
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMK-LSHPKLVKFY 69
Query: 62  GCDISEENGKILYNLFL--EYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSN 118
           G    E      Y +++  EY   G L + +RS G  LE  ++      V  G+ +L S+
Sbjct: 70  GVCSKE------YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH 123
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVAR 175
             +H D+  +N LV +D     K++DFG  R      DD+     GT   +   APEV  
Sbjct: 124 QFIHRDLAARNCLVDRD--LCVKVSDFGMTRYVL---DDQYVSSVGTKFPVKWSAPEVFH 178
Query: 176 GEEQGFPADVWALGCTVLEM-ATGRPPW-----PDVADPISALHRI---GFSSDT 221
             +    +DVWA G  + E+ + G+ P+      +V   +S  HR+     +SDT
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDT 233

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 113/252 (44%), Gaps = 31/252 (12%)
Query: 9   IGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +G+G    V +G  N ++ V    +K   +S   FLQ E +++  L   ++V      +S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYAV-VS 83
Query: 67  EENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           EE   I+     EY   G+L D ++   G  L   ++      +  G+ Y+     VH D
Sbjct: 84  EEPIYIV----CEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEEQGF 181
           ++  NILV ++     K+ADFG    AR+ ED+E     G    +   APE A       
Sbjct: 140 LRAANILVGEN--LVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 182 PADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +DVW+ G  + E+ T GR P+P     +V D +   +R+    + PE          D 
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE-------SLHDL 247
Query: 236 LSKCLIRNPGER 247
           + +C  ++P ER
Sbjct: 248 MCQCWRKDPEER 259

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 113/252 (44%), Gaps = 31/252 (12%)
Query: 9   IGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +G+G    V +G  N ++ V    +K   +S   FLQ E +++  L   ++V      +S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYAV-VS 249
Query: 67  EENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           EE   I+     EY   G+L D ++  +G  L   ++      +  G+ Y+     VH D
Sbjct: 250 EEPIYIV----GEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEEQGF 181
           ++  NILV ++     K+ADFG    AR+ ED+E     G    +   APE A       
Sbjct: 306 LRAANILVGEN--LVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 182 PADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +DVW+ G  + E+ T GR P+P     +V D +   +R+    + PE          D 
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE-------SLHDL 413
Query: 236 LSKCLIRNPGER 247
           + +C  + P ER
Sbjct: 414 MCQCWRKEPEER 425

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 113/252 (44%), Gaps = 31/252 (12%)
Query: 9   IGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +G+G    V +G  N ++ V    +K   +S   FLQ E +++  L   ++V      +S
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYAV-VS 332
Query: 67  EENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           EE   I+     EY   G+L D ++  +G  L   ++      +  G+ Y+     VH D
Sbjct: 333 EEPIYIV----TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 388
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEEQGF 181
           ++  NILV ++     K+ADFG    AR+ ED+E     G    +   APE A       
Sbjct: 389 LRAANILVGEN--LVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 182 PADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +DVW+ G  + E+ T GR P+P     +V D +   +R+    + PE          D 
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE-------SLHDL 496
Query: 236 LSKCLIRNPGER 247
           + +C  + P ER
Sbjct: 497 MCQCWRKEPEER 508

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 120/268 (44%), Gaps = 23/268 (8%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF--LQREQRILSALACPQIVAYKGCDIS 66
           IG GS  TV  G  +    V  +K  + +  +F   + E  +L       I+ + G  ++
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY-MT 102
Query: 67  EENGKILYNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDI 125
           ++N  I+     ++  G +L   +    T  +  ++    R    G+ YLH+  I+H D+
Sbjct: 103 KDNLAIV----TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDM 158
Query: 126 KGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPICMAPEVARGEEQG---F 181
           K  NI + +      KI DFG A  ++R +   + +   G+ + MAPEV R ++     F
Sbjct: 159 KSNNIFLHEG--LTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSF 216
Query: 182 PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS---KQAQDFLSK 238
            +DV++ G  + E+ TG  P+  + +    +  +G    +P++        K  +  ++ 
Sbjct: 217 QSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVAD 276
Query: 239 CLIRNPGER------WSASELLEHGFVK 260
           C+ +   ER       S+ ELL+H   K
Sbjct: 277 CVKKVKEERPLFPQILSSIELLQHSLPK 304

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 55/209 (26%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L+  R+      +L G+++LHS GI+H D+K  NI+V  D     KI DFG AR A    
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD--ATLKILDFGLARTA---- 176
Query: 156 DDEGKPICGTPICM-----APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS 210
              G     TP  +     APEV  G       D+W++GC + EM  G   +P   D I 
Sbjct: 177 ---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG-TDHID 232
Query: 211 ALHRI--------------------GFSSDTPEIPGY--------------------MSK 230
             +++                     +  + P+  GY                     + 
Sbjct: 233 QWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKAS 292
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGFV 259
           QA+D LSK L+ +  +R S  E L+H ++
Sbjct: 293 QARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 118/313 (37%), Gaps = 81/313 (25%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAYKGCD 64
           + IG G+   V            A+K  S    N    +R  R L  + C          
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC---------- 79
Query: 65  ISEENGKILYNLFL------EYAPGGTLTDAIRSGTC------LEEGRIRSHTRAVLLGL 112
           ++ +N   L N+F       E+     + + + +  C      L+  R+      +L G+
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM--- 169
           ++LHS GI+H D+K  NI+V  D     KI DFG AR A       G     TP  +   
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTA-------GTSFMMTPYVVTRY 190
Query: 170 --APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY 227
             APEV  G       D+W++GC + EM   +  +P   D I   +++     TP  P +
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP-CPEF 248
Query: 228 MSK-----------------------------------------QAQDFLSKCLIRNPGE 246
           M K                                         QA+D LSK L+ +P +
Sbjct: 249 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 308
Query: 247 RWSASELLEHGFV 259
           R S  + L+H ++
Sbjct: 309 RISVDDALQHPYI 321

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS----AELSNSEFLQR---EQRILSALACPQIV 58
           G  +G G    V  G  N ++   AVK      +++  E  Q+   E ++++      +V
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRS-HTRAVLL-----GL 112
              G     ++  ++Y     Y P G+L D +   +CL+     S H R  +      G+
Sbjct: 94  ELLGFSSDGDDLCLVY----VYMPNGSLLDRL---SCLDGTPPLSWHMRCKIAQGAANGI 146
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA-RVNEDDEGKPICGTPICMAP 171
            +LH N  +H DIK  NIL+  D    AKI+DFG AR + +  +      I GT   MAP
Sbjct: 147 NFLHENHHIHRDIKSANILL--DEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAP 204
Query: 172 EVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADP 208
           E  RGE     +D+++ G  +LE+ TG P   +  +P
Sbjct: 205 EALRGEITP-KSDIYSFGVVLLEIITGLPAVDEHREP 240

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 55/209 (26%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L+  R+      +L G+++LHS GI+H D+K  NI+V  D     KI DFG AR A    
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD--ATLKILDFGLARTA---- 176
Query: 156 DDEGKPICGTPICM-----APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS 210
              G     TP  +     APEV  G       D+W++GC + EM  G   +P   D I 
Sbjct: 177 ---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG-TDHID 232
Query: 211 ALHRI--------------------GFSSDTPEIPGY--------------------MSK 230
             +++                     +  + P+  GY                     + 
Sbjct: 233 QWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKAS 292
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGFV 259
           QA+D LSK L+ +  +R S  E L+H ++
Sbjct: 293 QARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 118/313 (37%), Gaps = 81/313 (25%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAYKGCD 64
           + IG G+   V            A+K  S    N    +R  R L  + C          
Sbjct: 31  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC---------- 80
Query: 65  ISEENGKILYNLFL------EYAPGGTLTDAIRSGTC------LEEGRIRSHTRAVLLGL 112
           ++ +N   L N+F       E+     + + + +  C      L+  R+      +L G+
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM--- 169
           ++LHS GI+H D+K  NI+V  D     KI DFG AR A       G     TP  +   
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTA-------GTSFMMTPYVVTRY 191
Query: 170 --APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY 227
             APEV  G       D+W++GC + EM   +  +P   D I   +++     TP  P +
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP-CPEF 249
Query: 228 MSK-----------------------------------------QAQDFLSKCLIRNPGE 246
           M K                                         QA+D LSK L+ +P +
Sbjct: 250 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 309
Query: 247 RWSASELLEHGFV 259
           R S  + L+H ++
Sbjct: 310 RISVDDALQHPYI 322

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 118/313 (37%), Gaps = 81/313 (25%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAYKGCD 64
           + IG G+   V            A+K  S    N    +R  R L  + C          
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC---------- 117
Query: 65  ISEENGKILYNLFL------EYAPGGTLTDAIRSGTC------LEEGRIRSHTRAVLLGL 112
           ++ +N   L N+F       E+     + + + +  C      L+  R+      +L G+
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 177
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM--- 169
           ++LHS GI+H D+K  NI+V  D     KI DFG AR A       G     TP  +   
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTA-------GTSFMMTPYVVTRY 228
Query: 170 --APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY 227
             APEV  G       D+W++GC + EM   +  +P   D I   +++     TP  P +
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP-CPEF 286
Query: 228 MSK-----------------------------------------QAQDFLSKCLIRNPGE 246
           M K                                         QA+D LSK L+ +P +
Sbjct: 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 346
Query: 247 RWSASELLEHGFV 259
           R S  + L+H ++
Sbjct: 347 RISVDDALQHPYI 359

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS----AELSNSEFLQR---EQRILSALACPQIV 58
           G  +G G    V  G  N ++   AVK      +++  E  Q+   E ++++      +V
Sbjct: 30  GNKMGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 87
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRS-HTRAVLL-----GL 112
              G     ++  ++Y     Y P G+L D +   +CL+     S H R  +      G+
Sbjct: 88  ELLGFSSDGDDLCLVY----VYMPNGSLLDRL---SCLDGTPPLSWHMRCKIAQGAANGI 140
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA-RVNEDDEGKPICGTPICMAP 171
            +LH N  +H DIK  NIL+  D    AKI+DFG AR + +  +      I GT   MAP
Sbjct: 141 NFLHENHHIHRDIKSANILL--DEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAP 198
Query: 172 EVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADP 208
           E  RGE     +D+++ G  +LE+ TG P   +  +P
Sbjct: 199 EALRGEITP-KSDIYSFGVVLLEIITGLPAVDEHREP 234

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 118/313 (37%), Gaps = 81/313 (25%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAYKGCD 64
           + IG G+   V            A+K  S    N    +R  R L  + C          
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC---------- 117
Query: 65  ISEENGKILYNLFL------EYAPGGTLTDAIRSGTC------LEEGRIRSHTRAVLLGL 112
           ++ +N   L N+F       E+     + + + +  C      L+  R+      +L G+
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 177
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM--- 169
           ++LHS GI+H D+K  NI+V  D     KI DFG AR A       G     TP  +   
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTA-------GTSFMMTPYVVTRY 228
Query: 170 --APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY 227
             APEV  G       D+W++GC + EM   +  +P   D I   +++     TP  P +
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP-CPEF 286
Query: 228 MSK-----------------------------------------QAQDFLSKCLIRNPGE 246
           M K                                         QA+D LSK L+ +P +
Sbjct: 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 346
Query: 247 RWSASELLEHGFV 259
           R S  + L+H ++
Sbjct: 347 RISVDDALQHPYI 359

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/289 (21%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI D+G AR      DDE      T    APE+          
Sbjct: 150 DLKPSNLAVNEDCE--LKILDYGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS----AELSNSEFLQR---EQRILSALACPQIV 58
           G  +G G    V  G  N ++   AVK      +++  E  Q+   E ++++      +V
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRS-HTRAVLL-----GL 112
              G     ++  ++Y     Y P G+L D +   +CL+     S H R  +      G+
Sbjct: 94  ELLGFSSDGDDLCLVY----VYMPNGSLLDRL---SCLDGTPPLSWHMRCKIAQGAANGI 146
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA-RVNEDDEGKPICGTPICMAP 171
            +LH N  +H DIK  NIL+  D    AKI+DFG AR + +  +      I GT   MAP
Sbjct: 147 NFLHENHHIHRDIKSANILL--DEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAP 204
Query: 172 EVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADP 208
           E  RGE     +D+++ G  +LE+ TG P   +  +P
Sbjct: 205 EALRGEITP-KSDIYSFGVVLLEIITGLPAVDEHREP 240

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 118/313 (37%), Gaps = 81/313 (25%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAYKGCD 64
           + IG G+   V            A+K  S    N    +R  R L  + C          
Sbjct: 31  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC---------- 80
Query: 65  ISEENGKILYNLFL------EYAPGGTLTDAIRSGTC------LEEGRIRSHTRAVLLGL 112
           ++ +N   L N+F       E+     + + + +  C      L+  R+      +L G+
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM--- 169
           ++LHS GI+H D+K  NI+V  D     KI DFG AR A       G     TP  +   
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTA-------GTSFMMTPYVVTRY 191
Query: 170 --APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY 227
             APEV  G       D+W++GC + EM   +  +P   D I   +++     TP  P +
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP-CPEF 249
Query: 228 MSK-----------------------------------------QAQDFLSKCLIRNPGE 246
           M K                                         QA+D LSK L+ +P +
Sbjct: 250 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 309
Query: 247 RWSASELLEHGFV 259
           R S  + L+H ++
Sbjct: 310 RISVDDALQHPYI 322

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 118/313 (37%), Gaps = 81/313 (25%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAYKGCD 64
           + IG G+   V            A+K  S    N    +R  R L  + C          
Sbjct: 29  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC---------- 78
Query: 65  ISEENGKILYNLFL------EYAPGGTLTDAIRSGTC------LEEGRIRSHTRAVLLGL 112
           ++ +N   L N+F       E+     + + + +  C      L+  R+      +L G+
Sbjct: 79  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 138
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM--- 169
           ++LHS GI+H D+K  NI+V  D     KI DFG AR A       G     TP  +   
Sbjct: 139 KHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTA-------GTSFMMTPYVVTRY 189
Query: 170 --APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY 227
             APEV  G       D+W++GC + EM   +  +P   D I   +++     TP  P +
Sbjct: 190 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP-CPEF 247
Query: 228 MSK-----------------------------------------QAQDFLSKCLIRNPGE 246
           M K                                         QA+D LSK L+ +P +
Sbjct: 248 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 307
Query: 247 RWSASELLEHGFV 259
           R S  + L+H ++
Sbjct: 308 RISVDDALQHPYI 320

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 116/284 (40%), Gaps = 45/284 (15%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           MD+   + IG G    V         + + ++  + +N E  +RE + L+ L    IV Y
Sbjct: 12  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN-EKAEREVKALAKLDHVNIVHY 70
Query: 61  KGC------------------DISEENGK--------ILYNLFLEYAPGGTLTDAI--RS 92
            GC                  D   EN K         L+ + +E+   GTL   I  R 
Sbjct: 71  NGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLF-IQMEFCDKGTLEQWIEKRR 129
Query: 93  GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR 152
           G  L++         +  G+ Y+HS  ++H D+K  NI +  D +Q  KI DFG      
Sbjct: 130 GEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLV-DTKQ-VKIGDFGLV--TS 185
Query: 153 VNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISAL 212
           +  D +     GT   M+PE    ++ G   D++ALG  + E+         V D  +A 
Sbjct: 186 LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH-------VCD--TAF 236
Query: 213 HRIGFSSDTPE--IPGYMSKQAQDFLSKCLIRNPGERWSASELL 254
               F +D  +  I     K+ +  L K L + P +R + SE+L
Sbjct: 237 ETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 280

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 118/313 (37%), Gaps = 81/313 (25%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAYKGCD 64
           + IG G+   V            A+K  S    N    +R  R L  + C          
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC---------- 79
Query: 65  ISEENGKILYNLFL------EYAPGGTLTDAIRSGTC------LEEGRIRSHTRAVLLGL 112
           ++ +N   L N+F       E+     + + + +  C      L+  R+      +L G+
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM--- 169
           ++LHS GI+H D+K  NI+V  D     KI DFG AR A       G     TP  +   
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTA-------GTSFMMTPYVVTRY 190
Query: 170 --APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY 227
             APEV  G       D+W++GC + EM   +  +P   D I   +++     TP  P +
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP-CPEF 248
Query: 228 MSK-----------------------------------------QAQDFLSKCLIRNPGE 246
           M K                                         QA+D LSK L+ +P +
Sbjct: 249 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 308
Query: 247 RWSASELLEHGFV 259
           R S  + L+H ++
Sbjct: 309 RISVDDALQHPYI 321

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 118/313 (37%), Gaps = 81/313 (25%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAYKGCD 64
           + IG G+   V            A+K  S    N    +R  R L  + C          
Sbjct: 24  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC---------- 73
Query: 65  ISEENGKILYNLFL------EYAPGGTLTDAIRSGTC------LEEGRIRSHTRAVLLGL 112
           ++ +N   L N+F       E+     + + + +  C      L+  R+      +L G+
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 133
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM--- 169
           ++LHS GI+H D+K  NI+V  D     KI DFG AR A       G     TP  +   
Sbjct: 134 KHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTA-------GTSFMMTPYVVTRY 184
Query: 170 --APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY 227
             APEV  G       D+W++GC + EM   +  +P   D I   +++     TP  P +
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP-CPEF 242
Query: 228 MSK-----------------------------------------QAQDFLSKCLIRNPGE 246
           M K                                         QA+D LSK L+ +P +
Sbjct: 243 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 302
Query: 247 RWSASELLEHGFV 259
           R S  + L+H ++
Sbjct: 303 RISVDDALQHPYI 315

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 118/313 (37%), Gaps = 81/313 (25%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAYKGCD 64
           + IG G+   V            A+K  S    N    +R  R L  + C          
Sbjct: 24  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC---------- 73
Query: 65  ISEENGKILYNLFL------EYAPGGTLTDAIRSGTC------LEEGRIRSHTRAVLLGL 112
           ++ +N   L N+F       E+     + + + +  C      L+  R+      +L G+
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 133
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM--- 169
           ++LHS GI+H D+K  NI+V  D     KI DFG AR A       G     TP  +   
Sbjct: 134 KHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTA-------GTSFMMTPYVVTRY 184
Query: 170 --APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY 227
             APEV  G       D+W++GC + EM   +  +P   D I   +++     TP  P +
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP-CPEF 242
Query: 228 MSK-----------------------------------------QAQDFLSKCLIRNPGE 246
           M K                                         QA+D LSK L+ +P +
Sbjct: 243 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 302
Query: 247 RWSASELLEHGFV 259
           R S  + L+H ++
Sbjct: 303 RISVDDALQHPYI 315

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 112/252 (44%), Gaps = 31/252 (12%)
Query: 9   IGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +G+G    V +G  N ++ V    +K   +S   FLQ E +++  L   ++V      +S
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQ-EAQVMKKLRHEKLVQLYAV-VS 250
Query: 67  EENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           EE   I+     EY   G+L D ++   G  L   ++      +  G+ Y+     VH D
Sbjct: 251 EEPIYIV----TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 306
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEEQGF 181
           ++  NILV ++     K+ADFG     R+ ED+E     G    +   APE A       
Sbjct: 307 LRAANILVGEN--LVCKVADFGL---GRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 361
Query: 182 PADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +DVW+ G  + E+ T GR P+P     +V D +   +R+    + PE          D 
Sbjct: 362 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE-------SLHDL 414
Query: 236 LSKCLIRNPGER 247
           + +C  ++P ER
Sbjct: 415 MCQCWRKDPEER 426

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 118/313 (37%), Gaps = 81/313 (25%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAYKGCD 64
           + IG G+   V            A+K  S    N    +R  R L  + C          
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC---------- 72
Query: 65  ISEENGKILYNLFL------EYAPGGTLTDAIRSGTC------LEEGRIRSHTRAVLLGL 112
           ++ +N   L N+F       E+     + + + +  C      L+  R+      +L G+
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM--- 169
           ++LHS GI+H D+K  NI+V  D     KI DFG AR A       G     TP  +   
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTA-------GTSFMMTPYVVTRY 183
Query: 170 --APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY 227
             APEV  G       D+W++GC + EM   +  +P   D I   +++     TP  P +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP-CPEF 241
Query: 228 MSK-----------------------------------------QAQDFLSKCLIRNPGE 246
           M K                                         QA+D LSK L+ +P +
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 247 RWSASELLEHGFV 259
           R S  + L+H ++
Sbjct: 302 RISVDDALQHPYI 314

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 113/252 (44%), Gaps = 31/252 (12%)
Query: 9   IGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +G+G    V +G  N ++ V    +K   +S   FLQ E +++  +   ++V      +S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKIRHEKLVQLYAV-VS 83
Query: 67  EENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           EE   I+     EY   G+L D ++   G  L   ++      +  G+ Y+     VH D
Sbjct: 84  EEPIYIV----TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEEQGF 181
           ++  NILV ++     K+ADFG    AR+ ED+E     G    +   APE A       
Sbjct: 140 LRAANILVGEN--LVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 182 PADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +DVW+ G  + E+ T GR P+P     +V D +   +R+    + PE          D 
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE-------SLHDL 247
Query: 236 LSKCLIRNPGER 247
           + +C  ++P ER
Sbjct: 248 MCQCWRKDPEER 259

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/312 (23%), Positives = 131/312 (41%), Gaps = 29/312 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILSALA 53
           D+   + IGRG+   V++     +  ++A+K   L+  E L+R        E+ +L    
Sbjct: 75  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKI--LNKWEMLKRAETACFREERDVLVNGD 132
Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
           C  I A       +EN   LY +   Y  G  LT   +    L E   R +   ++L + 
Sbjct: 133 CQWITALHYA-FQDENH--LYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAID 189
Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
            +H    VH DIK  N+L+  D     ++ADFG   +   +   +     GTP  ++PE+
Sbjct: 190 SIHQLHYVHRDIKPDNVLL--DVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEI 247
Query: 174 ARGEEQGF-----PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY- 227
            +  E G        D W+LG  + EM  G  P+      +    +I    +  + P + 
Sbjct: 248 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHEERFQFPSHV 306
Query: 228 --MSKQAQDFLSKCLI---RNPGERWSASELLEHGFVKEQNFK-LSTLTEPETYNSESPT 281
             +S++A+D + + +    R  G+     +  +H F +  N++ +  L  P   +  SP+
Sbjct: 307 TDVSEEAKDLIQRLICSRERRLGQN-GIEDFKKHAFFEGLNWENIRNLEAPYIPDVSSPS 365
Query: 282 SVLNQQLWDSTL 293
              N  + D  L
Sbjct: 366 DTSNFDVDDDVL 377

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/312 (23%), Positives = 131/312 (41%), Gaps = 29/312 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILSALA 53
           D+   + IGRG+   V++     +  ++A+K   L+  E L+R        E+ +L    
Sbjct: 91  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKI--LNKWEMLKRAETACFREERDVLVNGD 148
Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
           C  I A       +EN   LY +   Y  G  LT   +    L E   R +   ++L + 
Sbjct: 149 CQWITALHYA-FQDENH--LYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAID 205
Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
            +H    VH DIK  N+L+  D     ++ADFG   +   +   +     GTP  ++PE+
Sbjct: 206 SIHQLHYVHRDIKPDNVLL--DVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEI 263
Query: 174 ARGEEQGF-----PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY- 227
            +  E G        D W+LG  + EM  G  P+      +    +I    +  + P + 
Sbjct: 264 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHEERFQFPSHV 322
Query: 228 --MSKQAQDFLSKCLI---RNPGERWSASELLEHGFVKEQNFK-LSTLTEPETYNSESPT 281
             +S++A+D + + +    R  G+     +  +H F +  N++ +  L  P   +  SP+
Sbjct: 323 TDVSEEAKDLIQRLICSRERRLGQN-GIEDFKKHAFFEGLNWENIRNLEAPYIPDVSSPS 381
Query: 282 SVLNQQLWDSTL 293
              N  + D  L
Sbjct: 382 DTSNFDVDDDVL 393

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 112/252 (44%), Gaps = 31/252 (12%)
Query: 9   IGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +G+G    V +G  N ++ V    +K   +S   FLQ E +++  L   ++V      +S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYAV-VS 83
Query: 67  EENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           EE   I+     EY   G L D ++   G  L   ++      +  G+ Y+     VH D
Sbjct: 84  EEPIYIV----TEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEEQGF 181
           ++  NILV ++     K+ADFG    AR+ ED+E     G    +   APE A       
Sbjct: 140 LRAANILVGEN--LVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 182 PADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +DVW+ G  + E+ T GR P+P     +V D +   +R+    + PE          D 
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE-------SLHDL 247
Query: 236 LSKCLIRNPGER 247
           + +C  ++P ER
Sbjct: 248 MCQCWRKDPEER 259

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 29/235 (12%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--------SEFLQREQRILSALAC 54
           + +   +G G  ATV       ++++ A+K  +L +        +    RE ++L  L+ 
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
           P I+        + N  ++++ F+E      + D   +   L    I+++    L GL+Y
Sbjct: 72  PNIIGLLDAFGHKSNISLVFD-FMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEY 127
Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR------RARVNEDDEGKPICGTPIC 168
           LH + I+H D+K  N+L+  D     K+ADFG A+      RA  ++         T   
Sbjct: 128 LHQHWILHRDLKPNNLLL--DENGVLKLADFGLAKSFGSPNRAYXHQ-------VVTRWY 178
Query: 169 MAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP 222
            APE+  G    G   D+WA+GC + E+    P  P  +D +  L RI  +  TP
Sbjct: 179 RAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLGTP 232

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/289 (21%), Positives = 116/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DF  AR      DDE      T    APE+          
Sbjct: 150 DLKPSNLAVNEDCE--LKILDFYLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 112/252 (44%), Gaps = 31/252 (12%)
Query: 9   IGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +G+G    V +G  N ++ V    +K   +S   FLQ E +++  L   ++V      +S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYAV-VS 83
Query: 67  EENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           EE   I+     EY   G+L D ++   G  L   ++      +  G+ Y+     VH D
Sbjct: 84  EEPIYIV----TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 125 IKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEEQGF 181
           +   NILV ++     K+ADFG    AR+ ED+E     G    +   APE A       
Sbjct: 140 LAAANILVGEN--LVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 182 PADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +DVW+ G  + E+ T GR P+P     +V D +   +R+    + PE          D 
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE-------SLHDL 247
Query: 236 LSKCLIRNPGER 247
           + +C  ++P ER
Sbjct: 248 MCQCWRKDPEER 259

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 84/185 (45%), Gaps = 19/185 (10%)
Query: 74  YNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           + L LE   P   L D I     L EG  R     V+  +Q+ HS G+VH DIK +NIL+
Sbjct: 113 FMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILI 172
Query: 133 SKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICMAPE-VARGEEQGFPADVWALGC 190
             D  +G AK+ DFG      +  D+      GT +   PE ++R +    PA VW+LG 
Sbjct: 173 --DLRRGCAKLIDFGS---GALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGI 227
Query: 191 TVLEMATGRPPWPDVADPISA-LHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWS 249
            + +M  G  P+    + + A LH           P ++S      + +CL   P  R S
Sbjct: 228 LLYDMVCGDIPFERDQEILEAELH----------FPAHVSPDCCALIRRCLAPKPSSRPS 277
Query: 250 ASELL 254
             E+L
Sbjct: 278 LEEIL 282

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 125/304 (41%), Gaps = 64/304 (21%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQREQRILSALACPQI 57
           + + + IG G+  TV    +  + E+ A+K   L + +        RE  +L  L    I
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V     D+   + K+   L  E+               L+   ++S    +L GL + HS
Sbjct: 64  VRLH--DVLHSDKKL--TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMAPEVA-- 174
             ++H D+K QN+L++++ E   K+A+FG AR              G P+ C + EV   
Sbjct: 120 RNVLHRDLKPQNLLINRNGE--LKLANFGLARAF------------GIPVRCYSAEVVTL 165
Query: 175 --RGEEQGFPA-------DVWALGCTVLEMAT-GRPPWP--DVADPISALHRIGFSSDTP 222
             R  +  F A       D+W+ GC   E+A  GRP +P  DV D +  + R+   + T 
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL-LGTPTE 224
Query: 223 E-------IPGY------------------MSKQAQDFLSKCLIRNPGERWSASELLEHG 257
           E       +P Y                  ++   +D L   L  NP +R SA E L+H 
Sbjct: 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284
Query: 258 FVKE 261
           +  +
Sbjct: 285 YFSD 288

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 55/209 (26%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L+  R+      +L G+++LHS GI+H D+K  NI+V  D     KI DFG AR A    
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTA---- 176
Query: 156 DDEGKPICGTPICM-----APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS 210
              G     TP  +     APEV  G       D+W++GC + EM  G   +P   D I 
Sbjct: 177 ---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG-TDHID 232
Query: 211 ALHRI--------------------GFSSDTPEIPGY--------------------MSK 230
             +++                     +  + P+  GY                     + 
Sbjct: 233 QWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKAS 292
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGFV 259
           QA+D LSK L+ +  +R S  E L+H ++
Sbjct: 293 QARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 55/209 (26%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L+  R+      +L+G+++LHS GI+H D+K  NI+V  D     KI DFG AR A    
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSD--ATLKILDFGLARTA---- 176
Query: 156 DDEGKPICGTPICM-----APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS 210
              G     TP  +     APEV  G       D+W++G  + EM  G   +P   D I 
Sbjct: 177 ---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPG-TDHID 232
Query: 211 ALHRI--------------------GFSSDTPEIPGY--------------------MSK 230
             +++                     +  + P+  GY                     + 
Sbjct: 233 QWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKAS 292
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGFV 259
           QA+D LSK L+ +  +R S  E L+H ++
Sbjct: 293 QARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 55/209 (26%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L+  R+      +L G+++LHS GI+H D+K  NI+V  D     KI DFG AR A    
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTA---- 176
Query: 156 DDEGKPICGTPICM-----APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS 210
              G     TP  +     APEV  G       D+W++GC + EM  G   +P   D I 
Sbjct: 177 ---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG-TDHID 232
Query: 211 ALHRI--------------------GFSSDTPEIPGY--------------------MSK 230
             +++                     +  + P+  GY                     + 
Sbjct: 233 QWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKAS 292
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGFV 259
           QA+D LSK L+ +  +R S  E L+H ++
Sbjct: 293 QARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 55/209 (26%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L+  R+      +L+G+++LHS GI+H D+K  NI+V  D     KI DFG AR A    
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSD--ATLKILDFGLARTA---- 176
Query: 156 DDEGKPICGTPICM-----APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS 210
              G     TP  +     APEV  G       D+W++G  + EM  G   +P   D I 
Sbjct: 177 ---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPG-TDHID 232
Query: 211 ALHRI--------------------GFSSDTPEIPGY--------------------MSK 230
             +++                     +  + P+  GY                     + 
Sbjct: 233 QWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKAS 292
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGFV 259
           QA+D LSK L+ +  +R S  E L+H ++
Sbjct: 293 QARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 124/304 (40%), Gaps = 64/304 (21%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQREQRILSALACPQI 57
           + + + IG G+  TV    +  + E+ A+K   L + +        RE  +L  L    I
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V     D+   + K+   L  E+               L+   ++S    +L GL + HS
Sbjct: 64  VRLH--DVLHSDKKL--TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMAPEVA-- 174
             ++H D+K QN+L++++ E   K+ADFG AR              G P+ C + EV   
Sbjct: 120 RNVLHRDLKPQNLLINRNGE--LKLADFGLARAF------------GIPVRCYSAEVVTL 165
Query: 175 --RGEEQGFPA-------DVWALGCTVLEMAT-GRPPWP--DVADPISALHRIGFSSDTP 222
             R  +  F A       D+W+ GC   E+A   RP +P  DV D +  + R+   + T 
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRL-LGTPTE 224
Query: 223 E-------IPGY------------------MSKQAQDFLSKCLIRNPGERWSASELLEHG 257
           E       +P Y                  ++   +D L   L  NP +R SA E L+H 
Sbjct: 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284
Query: 258 FVKE 261
           +  +
Sbjct: 285 YFSD 288

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 33/216 (15%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSS-EVFAVKSA----ELSNSEFLQREQRILSALACPQ 56
           D   G+ +G+G     +I +++R + EV  +K      E +   FL +E +++  L  P 
Sbjct: 11  DLIHGEVLGKGCFGQ-AIKVTHRETGEVMVMKELIRFDEETQRTFL-KEVKVMRCLEHPN 68
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIR-SHTRAVLLGLQYL 115
           ++ + G    ++      N   EY  GGTL   I+S         R S  + +  G+ YL
Sbjct: 69  VLKFIGVLYKDKR----LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP-------------- 161
           HS  I+H D+   N LV ++  +   +ADFG    AR+  D++ +P              
Sbjct: 125 HSMNIIHRDLNSHNCLVREN--KNVVVADFGL---ARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 162 --ICGTPICMAPEVARGEEQGFPADVWALGCTVLEM 195
             + G P  MAPE+  G       DV++ G  + E+
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 86/203 (42%), Gaps = 43/203 (21%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L+  R+      +L G+++LHS GI+H D+K  NI+V  D     KI DFG AR A  + 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSF 180
Query: 156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWP--DVAD------ 207
             E  P   T    APEV  G       D+W++GC + EM   +  +P  D  D      
Sbjct: 181 MME--PEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVI 238
Query: 208 -----PISALHRI------GFSSDTPEIPGY--------------------MSKQAQDFL 236
                P  A  +        +  + P+  GY                     + QA+D L
Sbjct: 239 EQLGTPCPAFMKKLQPTVRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298
Query: 237 SKCLIRNPGERWSASELLEHGFV 259
           SK L+ +  +R S  E L+H ++
Sbjct: 299 SKMLVIDASKRISVDEALQHPYI 321

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 55/209 (26%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L+  R+      +L G+++LHS GI+H D+K  NI+V  D     KI DFG AR A    
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTA---- 176
Query: 156 DDEGKPICGTPICM-----APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS 210
              G     TP  +     APEV  G       D+W++GC + EM  G   +P   D I 
Sbjct: 177 ---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG-TDHID 232
Query: 211 ALHRI--------------------GFSSDTPEIPGY--------------------MSK 230
             +++                     +  + P+  GY                     + 
Sbjct: 233 QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKAS 292
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGFV 259
           QA+D LSK L+ +  +R S  E L+H ++
Sbjct: 293 QARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 55/209 (26%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L+  R+      +L G+++LHS GI+H D+K  NI+V  D     KI DFG AR A    
Sbjct: 124 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTA---- 177
Query: 156 DDEGKPICGTPICM-----APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS 210
              G     TP  +     APEV  G       D+W++GC + EM  G   +P   D I 
Sbjct: 178 ---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG-TDHID 233
Query: 211 ALHRI--------------------GFSSDTPEIPGY--------------------MSK 230
             +++                     +  + P+  GY                     + 
Sbjct: 234 QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKAS 293
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGFV 259
           QA+D LSK L+ +  +R S  E L+H ++
Sbjct: 294 QARDLLSKMLVIDASKRISVDEALQHPYI 322

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 115/252 (45%), Gaps = 27/252 (10%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIVAYKGC 63
           + +G G    V +   N+ ++V AVK+ +   +S   FL  E  ++  L   ++V     
Sbjct: 21  KKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAFLA-EANVMKTLQHDKLVKLHAV 78
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
              E     +Y +  E+   G+L D ++S  G+     ++   +  +  G+ ++     +
Sbjct: 79  VTKEP----IY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 133
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEE 178
           H D++  NILVS       KIADFG    ARV ED+E     G    +   APE      
Sbjct: 134 HRDLRAANILVSAS--LVCKIADFGL---ARVIEDNEYTAREGAKFPIKWTAPEAINFGS 188
Query: 179 QGFPADVWALGCTVLEMAT-GRPPWPDVADP--ISALHRIGFSSDTPEIPGYMSKQAQDF 235
               +DVW+ G  ++E+ T GR P+P +++P  I AL R G+    PE      ++  + 
Sbjct: 189 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRPE---NCPEELYNI 244
Query: 236 LSKCLIRNPGER 247
           + +C    P ER
Sbjct: 245 MMRCWKNRPEER 256

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 84/204 (41%), Gaps = 45/204 (22%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L+  R+      +L G+++LHS GI+H D+K  NI+V  D     KI DFG AR A    
Sbjct: 125 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTA--GT 180
Query: 156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI 215
                P   T    APEV  G       D+W++GC + EM  G   +P   D I   +++
Sbjct: 181 SFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG-TDHIDQWNKV 239
Query: 216 --------------------GFSSDTPEIPGY--------------------MSKQAQDF 235
                                +  + P+  GY                     + QA+D 
Sbjct: 240 IEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 299
Query: 236 LSKCLIRNPGERWSASELLEHGFV 259
           LSK L+ +  +R S  E L+H ++
Sbjct: 300 LSKMLVIDASKRISVDEALQHPYI 323

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 80/170 (47%), Gaps = 15/170 (8%)
Query: 44  REQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGT--------LTDAIRSGTC 95
           RE  +L  L  P +++ +   +S  + K+   L  +YA             + A +    
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVW--LLFDYAEHDLWHIIKFHRASKANKKPVQ 124
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN-EQG-AKIADFGCAR--RA 151
           L  G ++S    +L G+ YLH+N ++H D+K  NILV  +  E+G  KIAD G AR   +
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 152 RVNEDDEGKPICGTPICMAPEVARGEEQGFPA-DVWALGCTVLEMATGRP 200
            +    +  P+  T    APE+  G      A D+WA+GC   E+ T  P
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 234

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/289 (21%), Positives = 116/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 156
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR       DE      T    APE+          
Sbjct: 157 DLKPSNLAVNEDCE--LKILDFGLARHTA----DEMTGYVATRWYRAPEIMLNWMHYNQT 210
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 211 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 270
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 271 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 115/252 (45%), Gaps = 27/252 (10%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIVAYKGC 63
           + +G G    V +   N+ ++V AVK+ +   +S   FL  E  ++  L   ++V     
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAFLA-EANVMKTLQHDKLVKLHAV 251
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
              E     +Y +  E+   G+L D ++S  G+     ++   +  +  G+ ++     +
Sbjct: 252 VTKEP----IY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 306
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEE 178
           H D++  NILVS       KIADFG    ARV ED+E     G    +   APE      
Sbjct: 307 HRDLRAANILVSAS--LVCKIADFGL---ARVIEDNEYTAREGAKFPIKWTAPEAINFGS 361
Query: 179 QGFPADVWALGCTVLEMAT-GRPPWPDVADP--ISALHRIGFSSDTPEIPGYMSKQAQDF 235
               +DVW+ G  ++E+ T GR P+P +++P  I AL R G+    PE      ++  + 
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRPE---NCPEELYNI 417
Query: 236 LSKCLIRNPGER 247
           + +C    P ER
Sbjct: 418 MMRCWKNRPEER 429

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/289 (21%), Positives = 116/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 156
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR       DE      T    APE+          
Sbjct: 157 DLKPSNLAVNEDCE--LKILDFGLARHTA----DEMTGYVATRWYRAPEIMLNWMHYNQT 210
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 211 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 270
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 271 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/289 (21%), Positives = 116/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 156
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI DFG AR       DE      T    APE+          
Sbjct: 157 DLKPSNLAVNEDCE--LKILDFGLARHTA----DEMTGYVATRWYRAPEIMLNWMHYNQT 210
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 211 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 270
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 271 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/289 (21%), Positives = 116/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI  FG AR      DDE      T    APE+          
Sbjct: 150 DLKPSNLAVNEDCE--LKILGFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/298 (22%), Positives = 120/298 (40%), Gaps = 50/298 (16%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF----LQREQRILSALACPQI 57
           D+   Q +GRG    V    +      +A+K   L N E     + RE + L+ L  P I
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 58  VAYKGC--------DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVL 109
           V Y            +   + K+   + ++      L D + +G C  E R RS    + 
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM-NGRCTIEERERSVCLHIF 124
Query: 110 L----GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI--- 162
           L     +++LHS G++H D+K  NI  + D+    K+ DFG      +++D+E + +   
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLV--TAMDQDEEEQTVLTP 180
Query: 163 ----------CGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISAL 212
                      GT + M+PE   G       D+++LG  + E+        +    ++ +
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDV 240
Query: 213 HRIGFSSDTPEIPGYMSK------QAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF 264
             + F       P +  K        QD LS     +P ER  A  ++E+   ++ +F
Sbjct: 241 RNLKFP------PLFTQKYPCEYVMVQDMLSP----SPMERPEAINIIENAVFEDLDF 288

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 53/208 (25%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L+  R+      +L G+++LHS GI+H D+K  NI+V  D     KI DFG AR A    
Sbjct: 117 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTA---- 170
Query: 156 DDEGKPICGTPICM-----APEVARGEEQGFPADVWALGCTVLEMATGRPPWP--DVADP 208
              G     TP  +     APEV  G       D+W++GC + EM   +  +P  D  D 
Sbjct: 171 ---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQ 227
Query: 209 IS-ALHRIG----------------FSSDTPEIPGY--------------------MSKQ 231
            +  + ++G                +  + P+  GY                     + Q
Sbjct: 228 WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQ 287
Query: 232 AQDFLSKCLIRNPGERWSASELLEHGFV 259
           A+D LSK L+ +  +R S  E L+H ++
Sbjct: 288 ARDLLSKMLVIDASKRISVDEALQHPYI 315

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKG 62
           + R   +G GS   V    S     ++AVK + +S     +   R L+ +   + V    
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRS-MSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 63  CDI----SEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHS 117
           C +    + E G ILY L  E   G +L     + G  L E ++  + R  LL L +LHS
Sbjct: 118 CCVRLEQAWEEGGILY-LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
            G+VH D+K  NI +        K+ DFG      +     G+   G P  MAPE+ +G 
Sbjct: 176 QGLVHLDVKPANIFLGPRGR--CKLGDFGLL--VELGTAGAGEVQEGDPRYMAPELLQG- 230
Query: 178 EQGFPADVWALGCTVLEMA 196
             G  ADV++LG T+LE+A
Sbjct: 231 SYGTAADVFSLGLTILEVA 249

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 94/216 (43%), Gaps = 35/216 (16%)
Query: 66  SEENGKILYNLFLEYAPGGTLTDAI----RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
           +E++  ++ N   EY  GG+L DAI    R  +  +E  ++     V  GL+Y+HS  +V
Sbjct: 77  AEDDHMLIQN---EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV 133
Query: 122 HCDIKGQNILVSK-----------------DNEQGAKIADFGCARRARVNEDDEGKPICG 164
           H DIK  NI +S+                  N+   KI D G   R    + +E     G
Sbjct: 134 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-----G 188
Query: 165 TPICMAPEVARGEEQGFP-ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE 223
               +A EV +      P AD++AL  TV+  A G  P P   D     H I      P 
Sbjct: 189 DSRFLANEVLQENYTHLPKADIFALALTVV-XAAGAEPLPRNGD---QWHEIR-QGRLPR 243
Query: 224 IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV 259
           IP  +S++  + L   +  +P  R SA  L++H  +
Sbjct: 244 IPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 279

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 111/254 (43%), Gaps = 31/254 (12%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVAYKGCD 64
           + +G G    V +G  N +++V    +K   +S   FL+ E +I+  L   ++V      
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLE-EAQIMKKLKHDKLVQLYAV- 72
Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
           +SEE   I+     EY   G+L D ++ G    L+   +      V  G+ Y+     +H
Sbjct: 73  VSEEPIYIV----TEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIH 128
Query: 123 CDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEEQ 179
            D++  NILV   N    KIADFG    AR+ ED+E     G    +   APE A     
Sbjct: 129 RDLRSANILVG--NGLICKIADFGL---ARLIEDNEXTARQGAKFPIKWTAPEAALYGRF 183
Query: 180 GFPADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
              +DVW+ G  + E+ T GR P+P     +V + +   +R+    D P           
Sbjct: 184 TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCP-------ISLH 236
Query: 234 DFLSKCLIRNPGER 247
           + +  C  ++P ER
Sbjct: 237 ELMIHCWKKDPEER 250

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/289 (21%), Positives = 116/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI D G AR      DDE      T    APE+          
Sbjct: 150 DLKPSNLAVNEDCE--LKILDAGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 53/208 (25%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L+  R+      +L G+++LHS GI+H D+K  NI+V  D     KI DFG AR A    
Sbjct: 128 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTA---- 181
Query: 156 DDEGKPICGTPICM-----APEVARGEEQGFPADVWALGCTVLEMATGRPPWP--DVADP 208
              G     TP  +     APEV  G       D+W++GC + EM   +  +P  D  D 
Sbjct: 182 ---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQ 238
Query: 209 IS-ALHRIG----------------FSSDTPEIPGY--------------------MSKQ 231
            +  + ++G                +  + P+  GY                     + Q
Sbjct: 239 WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQ 298
Query: 232 AQDFLSKCLIRNPGERWSASELLEHGFV 259
           A+D LSK L+ +  +R S  E L+H ++
Sbjct: 299 ARDLLSKMLVIDASKRISVDEALQHPYI 326

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 55/209 (26%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L+  R+      +L G+++LHS GI+H D+K  NI+V  D     KI DFG AR A    
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTA---- 176
Query: 156 DDEGKPICGTPICM-----APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS 210
              G     TP  +     APEV  G       D+W++GC + EM  G   +P   D I 
Sbjct: 177 ---GTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG-TDHID 232
Query: 211 ALHRI--------------------GFSSDTPEIPGY--------------------MSK 230
             +++                     +  + P+  GY                     + 
Sbjct: 233 QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKAS 292
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGFV 259
           QA+D LSK L+ +  +R S  E L+H ++
Sbjct: 293 QARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 88/203 (43%), Gaps = 43/203 (21%)
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L+  R+      +L G+++LHS GI+H D+K  NI+V  D     KI DFG AR A  + 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSF 180
Query: 156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWP--DVADPIS-AL 212
             E  P   T    APEV  G       D+W++GC + EM   +  +P  D  D  +  +
Sbjct: 181 MME--PEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVI 238
Query: 213 HRIG----------------FSSDTPEIPGY--------------------MSKQAQDFL 236
            ++G                +  + P+  GY                     + QA+D L
Sbjct: 239 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298
Query: 237 SKCLIRNPGERWSASELLEHGFV 259
           SK L+ +  +R S  E L+H ++
Sbjct: 299 SKMLVIDASKRISVDEALQHPYI 321

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/289 (21%), Positives = 116/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI D G AR      DDE      T    APE+          
Sbjct: 150 DLKPSNLAVNEDCE--LKILDRGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 116/264 (43%), Gaps = 25/264 (9%)
Query: 5   RGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALAC----PQIVAY 60
           + + +G GS +     +  +S++ FAVK   + +       Q+ ++AL      P IV  
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVK---IISKRMEANTQKEITALKLCEGHPNIVK- 70
Query: 61  KGCDISEENGKILYN-LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
               + E     L+  L +E   GG L + I+      E       R ++  + ++H  G
Sbjct: 71  ----LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG 126
Query: 120 IVHCDIKGQNILVSKDNEQ-GAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           +VH D+K +N+L + +N+    KI DFG A R +  ++   K  C T    APE+     
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFA-RLKPPDNQPLKTPCFTLHYAAPELLNQNG 185
Query: 179 QGFPADVWALGCTVLEMATGRPPW---------PDVADPISALHRIGFSSDTPEIPGYMS 229
                D+W+LG  +  M +G+ P+             + +  + +  FS +  E    +S
Sbjct: 186 YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG-EAWKNVS 244
Query: 230 KQAQDFLSKCLIRNPGERWSASEL 253
           ++A+D +   L  +P +R   S L
Sbjct: 245 QEAKDLIQGLLTVDPNKRLKMSGL 268

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 111/268 (41%), Gaps = 37/268 (13%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V +G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 91
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E      + +  EY P G L D +R          R    AV+L        
Sbjct: 92  QLLGVCTLEPP----FYIVTEYMPYGNLLDYLRECN-------REEVTAVVLLYMATQIS 140
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-C 168
             ++YL     +H D+  +N LV +++    K+ADFG +R     +          PI  
Sbjct: 141 SAMEYLEKKNFIHRDLAARNCLVGENHV--VKVADFGLSR-LMTGDTYTAHAGAKFPIKW 197
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWP--DVADPISALHRIGFSSDTPE-I 224
            APE          +DVWA G  + E+AT G  P+P  D++     L + G+  + PE  
Sbjct: 198 TAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEK-GYRMEQPEGC 256
Query: 225 PGYMSKQAQDFLSKCLIRNPGERWSASE 252
           P     +  + +  C   +P +R S +E
Sbjct: 257 P----PKVYELMRACWKWSPADRPSFAE 280

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKS--AELS--NSEFLQREQRILSALACPQIV 58
           W   + +G G    V   +   + E  A+K    ELS  N E    E +I+  L  P +V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 59  AYKGCDISEENGKILYN----LFLEYAPGGTLTDAIRS--GTC-LEEGRIRSHTRAVLLG 111
           + +  ++ +   K+  N    L +EY  GG L   +      C L+EG IR+    +   
Sbjct: 77  SAR--EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 134
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGK---PICGTPI 167
           L+YLH N I+H D+K +NI++    ++   KI D G A+     E D+G+      GT  
Sbjct: 135 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK-----ELDQGELCTEFVGTLQ 189
Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMATG-RPPWPD 204
            +APE+   ++     D W+ G    E  TG RP  P+
Sbjct: 190 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 227

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKS--AELS--NSEFLQREQRILSALACPQIV 58
           W   + +G G    V   +   + E  A+K    ELS  N E    E +I+  L  P +V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 59  AYKGCDISEENGKILYN----LFLEYAPGGTLTDAIRS--GTC-LEEGRIRSHTRAVLLG 111
           + +  ++ +   K+  N    L +EY  GG L   +      C L+EG IR+    +   
Sbjct: 76  SAR--EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGK---PICGTPI 167
           L+YLH N I+H D+K +NI++    ++   KI D G A+     E D+G+      GT  
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK-----ELDQGELCTEFVGTLQ 188
Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMATG-RPPWPD 204
            +APE+   ++     D W+ G    E  TG RP  P+
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 94/216 (43%), Gaps = 35/216 (16%)
Query: 66  SEENGKILYNLFLEYAPGGTLTDAI----RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
           +E++  ++ N   EY  GG+L DAI    R  +  +E  ++     V  GL+Y+HS  +V
Sbjct: 79  AEDDHMLIQN---EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV 135
Query: 122 HCDIKGQNILVSK-----------------DNEQGAKIADFGCARRARVNEDDEGKPICG 164
           H DIK  NI +S+                  N+   KI D G   R    + +E     G
Sbjct: 136 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-----G 190
Query: 165 TPICMAPEVARGEEQGFP-ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE 223
               +A EV +      P AD++AL  TV+  A G  P P   D     H I      P 
Sbjct: 191 DSRFLANEVLQENYTHLPKADIFALALTVV-CAAGAEPLPRNGD---QWHEIR-QGRLPR 245
Query: 224 IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV 259
           IP  +S++  + L   +  +P  R SA  L++H  +
Sbjct: 246 IPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 281

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 132/304 (43%), Gaps = 48/304 (15%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ---REQRILSALACPQIVAY--- 60
           + +G G    V   + N   +  A+K   L++ + ++   RE +I+  L    IV     
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 61  ---KGCDISEENGKI--LYNLFL--EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
               G  ++++ G +  L ++++  EY     L + +  G  LEE   R     +L GL+
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEYMETD-LANVLEQGPLLEE-HARLFMYQLLRGLK 134
Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG--TPICMAP 171
           Y+HS  ++H D+K  N+ ++ ++    KI DFG AR    +   +G    G  T    +P
Sbjct: 135 YIHSANVLHRDLKPANLFINTED-LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSP 193
Query: 172 EVARGEEQGFPA-DVWALGCTVLEMATGRPPWPD---------VADPISALHR------- 214
            +         A D+WA GC   EM TG+  +           + + I  +H        
Sbjct: 194 RLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELL 253
Query: 215 ----IGFSSDTPE--------IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ 262
               +   +D  E        +PG +S++A DFL + L  +P +R +A E L H ++   
Sbjct: 254 SVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312
Query: 263 NFKL 266
           +F +
Sbjct: 313 SFPM 316

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 94/216 (43%), Gaps = 35/216 (16%)
Query: 66  SEENGKILYNLFLEYAPGGTLTDAI----RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
           +E++  ++ N   EY  GG+L DAI    R  +  +E  ++     V  GL+Y+HS  +V
Sbjct: 81  AEDDHMLIQN---EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV 137
Query: 122 HCDIKGQNILVSK-----------------DNEQGAKIADFGCARRARVNEDDEGKPICG 164
           H DIK  NI +S+                  N+   KI D G   R    + +E     G
Sbjct: 138 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-----G 192
Query: 165 TPICMAPEVARGEEQGFP-ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE 223
               +A EV +      P AD++AL  TV+  A G  P P   D     H I      P 
Sbjct: 193 DSRFLANEVLQENYTHLPKADIFALALTVV-CAAGAEPLPRNGD---QWHEIR-QGRLPR 247
Query: 224 IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV 259
           IP  +S++  + L   +  +P  R SA  L++H  +
Sbjct: 248 IPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 94/216 (43%), Gaps = 35/216 (16%)
Query: 66  SEENGKILYNLFLEYAPGGTLTDAI----RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
           +E++  ++ N   EY  GG+L DAI    R  +  +E  ++     V  GL+Y+HS  +V
Sbjct: 79  AEDDHMLIQN---EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV 135
Query: 122 HCDIKGQNILVSK-----------------DNEQGAKIADFGCARRARVNEDDEGKPICG 164
           H DIK  NI +S+                  N+   KI D G   R    + +E     G
Sbjct: 136 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-----G 190
Query: 165 TPICMAPEVARGEEQGFP-ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE 223
               +A EV +      P AD++AL  TV+  A G  P P   D     H I      P 
Sbjct: 191 DSRFLANEVLQENYTHLPKADIFALALTVV-CAAGAEPLPRNGD---QWHEIR-QGRLPR 245
Query: 224 IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV 259
           IP  +S++  + L   +  +P  R SA  L++H  +
Sbjct: 246 IPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 281

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/289 (21%), Positives = 116/289 (40%), Gaps = 40/289 (13%)
Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYKGC 63
           +G G+  +V      ++    AVK        + +++   RE R+L  +    ++     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
                + +   +++L     G   + I     L +  ++     +L GL+Y+HS  I+H 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 149
Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFP 182
           D+K  N+ V++D E   KI D G AR      DDE      T    APE+          
Sbjct: 150 DLKPSNLAVNEDCE--LKILDGGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 183 ADVWALGCTVLEMATGRPPWP--DVADPISALHRI------------------GFSSDTP 222
            D+W++GC + E+ TGR  +P  D  D +  + R+                   +     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 223 EIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           ++P           +  A D L K L+ +  +R +A++ L H +  + +
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 105/229 (45%), Gaps = 26/229 (11%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIVAYKGC 63
           + +G G    V +G  N  ++V AVKS +   +S   FL  E  ++  L   ++V     
Sbjct: 20  ERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRLYAV 77
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            +++E   I+     EY   G+L D ++  SG  L   ++      +  G+ ++     +
Sbjct: 78  -VTQEPIYII----TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 132
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD--EGK--PICGTPICMAPEVARGE 177
           H D++  NILVS  +    KIADFG AR    NE    EG   PI  T    APE     
Sbjct: 133 HRDLRAANILVS--DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT----APEAINYG 186
Query: 178 EQGFPADVWALGCTVLEMAT-GRPPWPDVADP--ISALHRIGFSSDTPE 223
                +DVW+ G  + E+ T GR P+P + +P  I  L R G+    P+
Sbjct: 187 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 234

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 105/229 (45%), Gaps = 26/229 (11%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIVAYKGC 63
           + +G G    V +G  N  ++V AVKS +   +S   FL  E  ++  L   ++V     
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRLYAV 76
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            +++E   I+     EY   G+L D ++  SG  L   ++      +  G+ ++     +
Sbjct: 77  -VTQEPIYII----TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD--EGK--PICGTPICMAPEVARGE 177
           H D++  NILVS  +    KIADFG AR    NE    EG   PI  T    APE     
Sbjct: 132 HRDLRAANILVS--DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT----APEAINYG 185
Query: 178 EQGFPADVWALGCTVLEMAT-GRPPWPDVADP--ISALHRIGFSSDTPE 223
                +DVW+ G  + E+ T GR P+P + +P  I  L R G+    P+
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 233

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 105/229 (45%), Gaps = 26/229 (11%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIVAYKGC 63
           + +G G    V +G  N  ++V AVKS +   +S   FL  E  ++  L   ++V     
Sbjct: 21  ERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRLYAV 78
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            +++E   I+     EY   G+L D ++  SG  L   ++      +  G+ ++     +
Sbjct: 79  -VTQEPIYII----TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 133
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD--EGK--PICGTPICMAPEVARGE 177
           H D++  NILVS  +    KIADFG AR    NE    EG   PI  T    APE     
Sbjct: 134 HRDLRAANILVS--DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT----APEAINYG 187
Query: 178 EQGFPADVWALGCTVLEMAT-GRPPWPDVADP--ISALHRIGFSSDTPE 223
                +DVW+ G  + E+ T GR P+P + +P  I  L R G+    P+
Sbjct: 188 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 235

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/140 (34%), Positives = 69/140 (49%), Gaps = 13/140 (9%)
Query: 76  LFLEYAPGGTLTDAIRSGTCLEEGRIRS-HTRAVLL-----GLQYLHSNGIVHCDIKGQN 129
           L   Y P G+L D +   +CL+     S H R  +      G+ +LH N  +H DIK  N
Sbjct: 98  LVYVYXPNGSLLDRL---SCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIHRDIKSAN 154
Query: 130 ILVSKDNEQGAKIADFGCARRA-RVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWAL 188
           IL+  D    AKI+DFG AR + +  +      I GT    APE  RGE     +D+++ 
Sbjct: 155 ILL--DEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGEITP-KSDIYSF 211
Query: 189 GCTVLEMATGRPPWPDVADP 208
           G  +LE+ TG P   +  +P
Sbjct: 212 GVVLLEIITGLPAVDEHREP 231

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 105/229 (45%), Gaps = 26/229 (11%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIVAYKGC 63
           + +G G    V +G  N  ++V AVKS +   +S   FL  E  ++  L   ++V     
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRLYAV 76
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            +++E   I+     EY   G+L D ++  SG  L   ++      +  G+ ++     +
Sbjct: 77  -VTQEPIYII----TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD--EGK--PICGTPICMAPEVARGE 177
           H D++  NILVS  +    KIADFG AR    NE    EG   PI  T    APE     
Sbjct: 132 HRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINYG 185
Query: 178 EQGFPADVWALGCTVLEMAT-GRPPWPDVADP--ISALHRIGFSSDTPE 223
                +DVW+ G  + E+ T GR P+P + +P  I  L R G+    P+
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 233

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 113/257 (43%), Gaps = 22/257 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQREQRILSALACPQIVAYKGCDI 65
           + +GRG+   V      R+ +V A+K  E  S  +    E R LS +  P IV   G  +
Sbjct: 15  EVVGRGAFGVVCKA-KWRAKDV-AIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL 72
Query: 66  SEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL----GLQYLHS---N 118
           +         L +EYA GG+L + +     L      +H  +  L    G+ YLHS    
Sbjct: 73  NP------VCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQPK 125
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
            ++H D+K  N+L+        KI DFG A   + +  +      G+   MAPEV  G  
Sbjct: 126 ALIHRDLKPPNLLLVAGGTV-LKICDFGTACDIQTHMTNNK----GSAAWMAPEVFEGSN 180
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK 238
                DV++ G  + E+ T R P+ ++  P   +     +   P +   + K  +  +++
Sbjct: 181 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTR 240
Query: 239 CLIRNPGERWSASELLE 255
           C  ++P +R S  E+++
Sbjct: 241 CWSKDPSQRPSMEEIVK 257

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 105/229 (45%), Gaps = 26/229 (11%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIVAYKGC 63
           + +G G    V +G  N  ++V AVKS +   +S   FL  E  ++  L   ++V     
Sbjct: 28  ERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRLYAV 85
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            +++E   I+     EY   G+L D ++  SG  L   ++      +  G+ ++     +
Sbjct: 86  -VTQEPIYII----TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 140
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD--EGK--PICGTPICMAPEVARGE 177
           H D++  NILVS  +    KIADFG AR    NE    EG   PI  T    APE     
Sbjct: 141 HRDLRAANILVS--DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT----APEAINYG 194
Query: 178 EQGFPADVWALGCTVLEMAT-GRPPWPDVADP--ISALHRIGFSSDTPE 223
                +DVW+ G  + E+ T GR P+P + +P  I  L R G+    P+
Sbjct: 195 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 242

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 105/229 (45%), Gaps = 26/229 (11%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIVAYKGC 63
           + +G G    V +G  N  ++V AVKS +   +S   FL  E  ++  L   ++V     
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRLYAV 76
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            +++E   I+     EY   G+L D ++  SG  L   ++      +  G+ ++     +
Sbjct: 77  -VTQEPIYII----TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD--EGK--PICGTPICMAPEVARGE 177
           H D++  NILVS  +    KIADFG AR    NE    EG   PI  T    APE     
Sbjct: 132 HRDLRAANILVS--DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT----APEAINYG 185
Query: 178 EQGFPADVWALGCTVLEMAT-GRPPWPDVADP--ISALHRIGFSSDTPE 223
                +DVW+ G  + E+ T GR P+P + +P  I  L R G+    P+
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 233

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 113/257 (43%), Gaps = 22/257 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQREQRILSALACPQIVAYKGCDI 65
           + +GRG+   V      R+ +V A+K  E  S  +    E R LS +  P IV   G  +
Sbjct: 14  EVVGRGAFGVVCKA-KWRAKDV-AIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 66  SEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL----GLQYLHS---N 118
           +         L +EYA GG+L + +     L      +H  +  L    G+ YLHS    
Sbjct: 72  NP------VCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
            ++H D+K  N+L+        KI DFG A   + +  +      G+   MAPEV  G  
Sbjct: 125 ALIHRDLKPPNLLLVAGGTV-LKICDFGTACDIQTHMTNNK----GSAAWMAPEVFEGSN 179
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK 238
                DV++ G  + E+ T R P+ ++  P   +     +   P +   + K  +  +++
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTR 239
Query: 239 CLIRNPGERWSASELLE 255
           C  ++P +R S  E+++
Sbjct: 240 CWSKDPSQRPSMEEIVK 256

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 105/229 (45%), Gaps = 26/229 (11%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIVAYKGC 63
           + +G G    V +G  N  ++V AVKS +   +S   FL  E  ++  L   ++V     
Sbjct: 27  ERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRLYAV 84
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            +++E   I+     EY   G+L D ++  SG  L   ++      +  G+ ++     +
Sbjct: 85  -VTQEPIYII----TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 139
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD--EGK--PICGTPICMAPEVARGE 177
           H D++  NILVS  +    KIADFG AR    NE    EG   PI  T    APE     
Sbjct: 140 HRDLRAANILVS--DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT----APEAINYG 193
Query: 178 EQGFPADVWALGCTVLEMAT-GRPPWPDVADP--ISALHRIGFSSDTPE 223
                +DVW+ G  + E+ T GR P+P + +P  I  L R G+    P+
Sbjct: 194 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 241

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 105/229 (45%), Gaps = 26/229 (11%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIVAYKGC 63
           + +G G    V +G  N  ++V AVKS +   +S   FL  E  ++  L   ++V     
Sbjct: 24  ERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRLYAV 81
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            +++E   I+     EY   G+L D ++  SG  L   ++      +  G+ ++     +
Sbjct: 82  -VTQEPIYII----TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 136
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD--EGK--PICGTPICMAPEVARGE 177
           H D++  NILVS  +    KIADFG AR    NE    EG   PI  T    APE     
Sbjct: 137 HRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINYG 190
Query: 178 EQGFPADVWALGCTVLEMAT-GRPPWPDVADP--ISALHRIGFSSDTPE 223
                +DVW+ G  + E+ T GR P+P + +P  I  L R G+    P+
Sbjct: 191 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 238

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 105/229 (45%), Gaps = 26/229 (11%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIVAYKGC 63
           + +G G    V +G  N  ++V AVKS +   +S   FL  E  ++  L   ++V     
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRLYAV 82
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            +++E   I+     EY   G+L D ++  SG  L   ++      +  G+ ++     +
Sbjct: 83  -VTQEPIYII----TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 137
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD--EGK--PICGTPICMAPEVARGE 177
           H D++  NILVS  +    KIADFG AR    NE    EG   PI  T    APE     
Sbjct: 138 HRDLRAANILVS--DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT----APEAINYG 191
Query: 178 EQGFPADVWALGCTVLEMAT-GRPPWPDVADP--ISALHRIGFSSDTPE 223
                +DVW+ G  + E+ T GR P+P + +P  I  L R G+    P+
Sbjct: 192 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 239

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 105/229 (45%), Gaps = 26/229 (11%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIVAYKGC 63
           + +G G    V +G  N  ++V AVKS +   +S   FL  E  ++  L   ++V     
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRLYAV 82
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            +++E   I+     EY   G+L D ++  SG  L   ++      +  G+ ++     +
Sbjct: 83  -VTQEPIYII----TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 137
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD--EGK--PICGTPICMAPEVARGE 177
           H D++  NILVS  +    KIADFG AR    NE    EG   PI  T    APE     
Sbjct: 138 HRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINYG 191
Query: 178 EQGFPADVWALGCTVLEMAT-GRPPWPDVADP--ISALHRIGFSSDTPE 223
                +DVW+ G  + E+ T GR P+P + +P  I  L R G+    P+
Sbjct: 192 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 239

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 111/266 (41%), Gaps = 31/266 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 70
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E      + + +E+   G L D +R          R    AV+L        
Sbjct: 71  QLLGVCTREPP----FYIIIEFMTYGNLLDYLRECN-------RQEVSAVVLLYMATQIS 119
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-C 168
             ++YL     +H D+  +N LV +++    K+ADFG +R     +          PI  
Sbjct: 120 SAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSR-LMTGDTXTAHAGAKFPIKW 176
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
            APE     +    +DVWA G  + E+AT G  P+P + DP S ++ +       E P  
Sbjct: 177 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DP-SQVYELLEKDYRMERPEG 234
Query: 228 MSKQAQDFLSKCLIRNPGERWSASEL 253
             ++  + +  C   NP +R S +E+
Sbjct: 235 CPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 105/229 (45%), Gaps = 26/229 (11%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIVAYKGC 63
           + +G G    V +G  N  ++V AVKS +   +S   FL  E  ++  L   ++V     
Sbjct: 29  ERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRLYAV 86
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            +++E   I+     EY   G+L D ++  SG  L   ++      +  G+ ++     +
Sbjct: 87  -VTQEPIYII----TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 141
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD--EGK--PICGTPICMAPEVARGE 177
           H D++  NILVS  +    KIADFG AR    NE    EG   PI  T    APE     
Sbjct: 142 HRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINYG 195
Query: 178 EQGFPADVWALGCTVLEMAT-GRPPWPDVADP--ISALHRIGFSSDTPE 223
                +DVW+ G  + E+ T GR P+P + +P  I  L R G+    P+
Sbjct: 196 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 243

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 105/229 (45%), Gaps = 26/229 (11%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIVAYKGC 63
           + +G G    V +G  N  ++V AVKS +   +S   FL  E  ++  L   ++V     
Sbjct: 14  ERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRLYAV 71
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            +++E   I+     EY   G+L D ++  SG  L   ++      +  G+ ++     +
Sbjct: 72  -VTQEPIYII----TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 126
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD--EGK--PICGTPICMAPEVARGE 177
           H D++  NILVS  +    KIADFG AR    NE    EG   PI  T    APE     
Sbjct: 127 HRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINYG 180
Query: 178 EQGFPADVWALGCTVLEMAT-GRPPWPDVADP--ISALHRIGFSSDTPE 223
                +DVW+ G  + E+ T GR P+P + +P  I  L R G+    P+
Sbjct: 181 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 228

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 15/163 (9%)
Query: 42  LQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGR 100
           L++E  IL  L    IV YKG  I  E+G     L +E+ P G+L + + ++   +   +
Sbjct: 70  LKKEIEILRNLYHENIVKYKG--ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127
Query: 101 IRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN------ 154
              +   +  G+ YL S   VH D+  +N+LV  ++E   KI DFG  +    +      
Sbjct: 128 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLV--ESEHQVKIGDFGLTKAIETDKEXXTV 185
Query: 155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT 197
           +DD   P+       APE     +    +DVW+ G T+ E+ T
Sbjct: 186 KDDRDSPV----FWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 15/163 (9%)
Query: 42  LQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGR 100
           L++E  IL  L    IV YKG  I  E+G     L +E+ P G+L + + ++   +   +
Sbjct: 58  LKKEIEILRNLYHENIVKYKG--ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 115
Query: 101 IRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN------ 154
              +   +  G+ YL S   VH D+  +N+LV  ++E   KI DFG  +    +      
Sbjct: 116 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLV--ESEHQVKIGDFGLTKAIETDKEXXTV 173
Query: 155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT 197
           +DD   P+       APE     +    +DVW+ G T+ E+ T
Sbjct: 174 KDDRDSPV----FWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 110/266 (41%), Gaps = 31/266 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 73
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E      + + +E+   G L D +R          R    AV+L        
Sbjct: 74  QLLGVCTREPP----FYIIIEFMTYGNLLDYLRECN-------RQEVNAVVLLYMATQIS 122
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-C 168
             ++YL     +H D+  +N LV +++    K+ADFG +R     +          PI  
Sbjct: 123 SAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSR-LMTGDTXTAHAGAKFPIKW 179
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
            APE     +    +DVWA G  + E+AT G  P+P +   +S ++ +       E P  
Sbjct: 180 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEG 237
Query: 228 MSKQAQDFLSKCLIRNPGERWSASEL 253
             ++  + +  C   NP +R S +E+
Sbjct: 238 CPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 112/255 (43%), Gaps = 32/255 (12%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIVAYKGC 63
           + +G G    V +G  N S++V AVK+ +   +S   FL+ E  ++  L   ++V     
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSVQAFLE-EANLMKTLQHDKLVRLYAV 76
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
              EE   I+     EY   G+L D ++S  G  +   ++   +  +  G+ Y+     +
Sbjct: 77  VTREEPIYII----TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 132
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEE 178
           H D++  N+LVS+      KIADFG    ARV ED+E     G    +   APE      
Sbjct: 133 HRDLRAANVLVSES--LMCKIADFGL---ARVIEDNEYTAREGAKFPIKWTAPEAINFGC 187
Query: 179 QGFPADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQA 232
               +DVW+ G  + E+ T G+ P+P     DV   +S  +R+    + P+       + 
Sbjct: 188 FTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCPD-------EL 240
Query: 233 QDFLSKCLIRNPGER 247
            D +  C      ER
Sbjct: 241 YDIMKMCWKEKAEER 255

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/294 (22%), Positives = 115/294 (39%), Gaps = 45/294 (15%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL-ACPQIVAY 60
           D+   + +GRG  + V   ++  ++E   VK  +      ++RE +IL  L   P I+  
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRGGPNIITL 97
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
              DI ++       L  E+      TD  +    L +  IR +   +L  L Y HS GI
Sbjct: 98  --ADIVKDPVSRTPALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGI 152
Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPE-VARGEEQ 179
           +H D+K  N+++  ++ +  ++ D+G A      +  E      +     PE +   +  
Sbjct: 153 MHRDVKPHNVMIDHEHRK-LRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMY 209
Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK--------- 230
            +  D+W+LGC +  M   + P+    D    L RI     T ++  Y+ K         
Sbjct: 210 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 269
Query: 231 --------------------------QAQDFLSKCLIRNPGERWSASELLEHGF 258
                                     +A DFL K L  +   R +A E +EH +
Sbjct: 270 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 116/292 (39%), Gaps = 35/292 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF--LQREQRILSALACPQIVA 59
           D+     +G+G+   V    +   S  +A+K    +  +   +  E  +L++L    +V 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 60  YKGCDISEENG-------KILYNLF--LEYAPGGTLTDAIRSGTCLEE-GRIRSHTRAVL 109
           Y    +   N        K    LF  +EY   GTL D I S    ++        R +L
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 110 LGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED------------- 156
             L Y+HS GI+H D+K  NI +  D  +  KI DFG A+    + D             
Sbjct: 127 EALSYIHSQGIIHRDLKPMNIFI--DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 157 DEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI 215
           D      GT + +A EV  G        D+++LG    EM     P+    + ++ L ++
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKL 241
Query: 216 GFSSDT--PEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGF--VKEQN 263
              S    P+      K  +  +   +  +P +R  A  LL  G+  VK Q+
Sbjct: 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD 293

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 123/289 (42%), Gaps = 32/289 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALA--- 53
           D++  + IGRG    V       + +++A+K       ++   E L   +RI+ +L    
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 54  -CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGL 112
            CP IV       + +      +  L+   GG L   +       E  +R +   ++LGL
Sbjct: 250 DCPFIVCMSYAFHTPDK----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI--CGTPICMA 170
           +++H+  +V+ D+K  NIL+  D     +I+D G A      +  + KP    GT   MA
Sbjct: 306 EHMHNRFVVYRDLKPANILL--DEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMA 358
Query: 171 PEV-ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDT--PEIPGY 227
           PEV  +G      AD ++LGC + ++  G  P+          H I   + T   E+P  
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ--HKTKDKHEIDRMTLTMAVELPDS 416
Query: 228 MSKQAQDFLSKCLIRNPGERW-----SASELLEHGFVKEQNFKLSTLTE 271
            S + +  L   L R+   R       A E+ E  F +  ++++  L +
Sbjct: 417 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQK 465

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 123/289 (42%), Gaps = 32/289 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALA--- 53
           D++  + IGRG    V       + +++A+K       ++   E L   +RI+ +L    
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 54  -CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGL 112
            CP IV       + +      +  L+   GG L   +       E  +R +   ++LGL
Sbjct: 250 DCPFIVCMSYAFHTPDK----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI--CGTPICMA 170
           +++H+  +V+ D+K  NIL+  D     +I+D G A      +  + KP    GT   MA
Sbjct: 306 EHMHNRFVVYRDLKPANILL--DEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMA 358
Query: 171 PEV-ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDT--PEIPGY 227
           PEV  +G      AD ++LGC + ++  G  P+          H I   + T   E+P  
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ--HKTKDKHEIDRMTLTMAVELPDS 416
Query: 228 MSKQAQDFLSKCLIRNPGERW-----SASELLEHGFVKEQNFKLSTLTE 271
            S + +  L   L R+   R       A E+ E  F +  ++++  L +
Sbjct: 417 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQK 465

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 123/289 (42%), Gaps = 32/289 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALA--- 53
           D++  + IGRG    V       + +++A+K       ++   E L   +RI+ +L    
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 54  -CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGL 112
            CP IV       + +      +  L+   GG L   +       E  +R +   ++LGL
Sbjct: 250 DCPFIVCMSYAFHTPDK----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI--CGTPICMA 170
           +++H+  +V+ D+K  NIL+  D     +I+D G A      +  + KP    GT   MA
Sbjct: 306 EHMHNRFVVYRDLKPANILL--DEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMA 358
Query: 171 PEV-ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDT--PEIPGY 227
           PEV  +G      AD ++LGC + ++  G  P+          H I   + T   E+P  
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ--HKTKDKHEIDRMTLTMAVELPDS 416
Query: 228 MSKQAQDFLSKCLIRNPGERW-----SASELLEHGFVKEQNFKLSTLTE 271
            S + +  L   L R+   R       A E+ E  F +  ++++  L +
Sbjct: 417 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQK 465

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 110/266 (41%), Gaps = 31/266 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 77
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E    I+    +E+   G L D +R          R    AV+L        
Sbjct: 78  QLLGVCTREPPFYII----IEFMTYGNLLDYLRECN-------RQEVNAVVLLYMATQIS 126
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-C 168
             ++YL     +H D+  +N LV +++    K+ADFG +R     +          PI  
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSR-LMTGDTYTAHAGAKFPIKW 183
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
            APE     +    +DVWA G  + E+AT G  P+P +   +S ++ +       E P  
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEG 241
Query: 228 MSKQAQDFLSKCLIRNPGERWSASEL 253
             ++  + +  C   NP +R S +E+
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 123/289 (42%), Gaps = 32/289 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALA--- 53
           D++  + IGRG    V       + +++A+K       ++   E L   +RI+ +L    
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 248
Query: 54  -CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGL 112
            CP IV    C     +     +  L+   GG L   +       E  +R +   ++LGL
Sbjct: 249 DCPFIV----CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 304
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI--CGTPICMA 170
           +++H+  +V+ D+K  NIL+  D     +I+D G A      +  + KP    GT   MA
Sbjct: 305 EHMHNRFVVYRDLKPANILL--DEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMA 357
Query: 171 PEV-ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDT--PEIPGY 227
           PEV  +G      AD ++LGC + ++  G  P+          H I   + T   E+P  
Sbjct: 358 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ--HKTKDKHEIDRMTLTMAVELPDS 415
Query: 228 MSKQAQDFLSKCLIRNPGERW-----SASELLEHGFVKEQNFKLSTLTE 271
            S + +  L   L R+   R       A E+ E  F +  ++++  L +
Sbjct: 416 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQK 464

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 23/218 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQ 56
           D   G+ IGRG+   V  G     + + AVKS   +      ++FLQ E RIL   + P 
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQ-EARILKQYSHPN 173
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLG----- 111
           IV   G    ++   I+    +E   GG     +R+    E  R+R  T   ++G     
Sbjct: 174 IVRLIGVCTQKQPIYIV----MELVQGGDFLTFLRT----EGARLRVKTLLQMVGDAAAG 225
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           ++YL S   +H D+  +N LV++ N    KI+DFG +R            +   P+   A
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSREEADGVXAASGGLRQVPVKWTA 283
Query: 171 PEVARGEEQGFPADVWALGCTVLE-MATGRPPWPDVAD 207
           PE          +DVW+ G  + E  + G  P+P++++
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN 321

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 104/228 (45%), Gaps = 24/228 (10%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIVAYKGC 63
           + +G G    V +G  N  ++V AVKS +   +S   FL  E  ++  L   ++V     
Sbjct: 19  ERLGAGQAGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRLYAV 76
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            +++E   I+     EY   G+L D ++  SG  L   ++      +  G+ ++     +
Sbjct: 77  -VTQEPIYII----TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEE 178
           H D++  NILVS  +    KIADFG    AR+ ED E     G    +   APE      
Sbjct: 132 HRDLRAANILVS--DTLSCKIADFGL---ARLIEDAEXTAREGAKFPIKWTAPEAINYGT 186
Query: 179 QGFPADVWALGCTVLEMAT-GRPPWPDVADP--ISALHRIGFSSDTPE 223
               +DVW+ G  + E+ T GR P+P + +P  I  L R G+    P+
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 233

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/323 (23%), Positives = 135/323 (41%), Gaps = 31/323 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR-------EQRILSALAC 54
           D+   + IGRG+ + V++    ++ +V+A+K   ++  + L+R       E+R +     
Sbjct: 62  DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKI--MNKWDMLKRGEVSCFREERDVLVNGD 119
Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQ 113
            + +        +EN   LY L +EY  GG L   + + G  +     R +   +++ + 
Sbjct: 120 RRWITQLHFAFQDEN--YLY-LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID 176
Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
            +H  G VH DIK  NIL+ +      ++ADFG   + R +         GTP  ++PE+
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234
Query: 174 ARGEEQGFPA-------DVWALGCTVLEMATGRPPW--PDVADPISALHRIGFSSDTPEI 224
            +    G          D WALG    EM  G+ P+     A+    +         P +
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV 294
Query: 225 PGYMSKQAQDFLSKCLIRNPGE----RWSASELLEHGFVKEQNFK-LSTLTEPETYNSES 279
              + ++A+DF+ + L   P E    R  A +   H F    ++  L     P T + E 
Sbjct: 295 DEGVPEEARDFIQRLLC--PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFEG 352
Query: 280 PTSVLNQQLWDSTLTSCSSASAK 302
            T   N  L +  LT+  S   +
Sbjct: 353 ATDTCNFDLVEDGLTAMVSGGGE 375

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 110/266 (41%), Gaps = 31/266 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 72
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E      + + +E+   G L D +R          R    AV+L        
Sbjct: 73  QLLGVCTREPP----FYIIIEFMTYGNLLDYLRECN-------RQEVSAVVLLYMATQIS 121
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-C 168
             ++YL     +H D+  +N LV +++    K+ADFG +R     +          PI  
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSR-LMTGDTYTAHAGAKFPIKW 178
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
            APE     +    +DVWA G  + E+AT G  P+P +   +S ++ +       E P  
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEG 236
Query: 228 MSKQAQDFLSKCLIRNPGERWSASEL 253
             ++  + +  C   NP +R S +E+
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 110/266 (41%), Gaps = 31/266 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 72
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E      + + +E+   G L D +R          R    AV+L        
Sbjct: 73  QLLGVCTREPP----FYIIIEFMTYGNLLDYLRECN-------RQEVSAVVLLYMATQIS 121
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-C 168
             ++YL     +H D+  +N LV +++    K+ADFG +R     +          PI  
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSR-LMTGDTYTAHAGAKFPIKW 178
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
            APE     +    +DVWA G  + E+AT G  P+P +   +S ++ +       E P  
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEG 236
Query: 228 MSKQAQDFLSKCLIRNPGERWSASEL 253
             ++  + +  C   NP +R S +E+
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 111/267 (41%), Gaps = 33/267 (12%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 74
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E      + +  E+   G L D +R          R    AV+L        
Sbjct: 75  QLLGVCTREPP----FYIITEFMTYGNLLDYLRECN-------RQEVNAVVLLYMATQIS 123
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI-CGTPI- 167
             ++YL     +H D+  +N LV +++    K+ADFG +R   +  D    P     PI 
Sbjct: 124 SAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRL--MTGDTYTAPAGAKFPIK 179
Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPG 226
             APE     +    +DVWA G  + E+AT G  P+P +   +S ++ +       E P 
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPE 237
Query: 227 YMSKQAQDFLSKCLIRNPGERWSASEL 253
              ++  + +  C   NP +R S +E+
Sbjct: 238 GCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 111/267 (41%), Gaps = 33/267 (12%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 73
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E      + +  E+   G L D +R          R    AV+L        
Sbjct: 74  QLLGVCTREPP----FYIITEFMTYGNLLDYLRECN-------RQEVNAVVLLYMATQIS 122
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI-CGTPI- 167
             ++YL     +H D+  +N LV +++    K+ADFG +R   +  D    P     PI 
Sbjct: 123 SAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRL--MTGDTYTAPAGAKFPIK 178
Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPG 226
             APE     +    +DVWA G  + E+AT G  P+P +   +S ++ +       E P 
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPE 236
Query: 227 YMSKQAQDFLSKCLIRNPGERWSASEL 253
              ++  + +  C   NP +R S +E+
Sbjct: 237 GCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 110/266 (41%), Gaps = 31/266 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 70
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E      + +  E+   G L D +R          R    AV+L        
Sbjct: 71  QLLGVCTREPP----FYIITEFMTYGNLLDYLRECN-------RQEVSAVVLLYMATQIS 119
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-C 168
             ++YL     +H D+  +N LV +++    K+ADFG +R     +          PI  
Sbjct: 120 SAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSR-LMTGDTXTAHAGAKFPIKW 176
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
            APE     +    +DVWA G  + E+AT G  P+P + DP S ++ +       E P  
Sbjct: 177 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DP-SQVYELLEKDYRMERPEG 234
Query: 228 MSKQAQDFLSKCLIRNPGERWSASEL 253
             ++  + +  C   NP +R S +E+
Sbjct: 235 CPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 80/180 (44%), Gaps = 7/180 (3%)
Query: 79  EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQ 138
           E+ P  T  D  +    LE   +  ++  V  G+++L S   +H D+  +NIL+S+ N  
Sbjct: 130 EFVPYKTPEDLYKDFLTLEH--LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV- 186
Query: 139 GAKIADFGCARRARVNEDDEGKPICGTPI-CMAPEVARGEEQGFPADVWALGCTVLEM-A 196
             KI DFG AR    + D   K     P+  MAPE          +DVW+ G  + E+ +
Sbjct: 187 -VKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
Query: 197 TGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
            G  P+P V        R+   +     P Y + +    +  C    P +R + SEL+EH
Sbjct: 246 LGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 103 SHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI 162
           S++  V  G+++L S   +H D+  +NIL+S++N    KI DFG AR    N D   K  
Sbjct: 203 SYSFQVARGMEFLSSRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKNPDYVRKGD 260
Query: 163 CGTPIC-MAPEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVA--DPISALHRIGFS 218
              P+  MAPE    +     +DVW+ G  + E+ + G  P+P V   +   +  R G  
Sbjct: 261 TRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREGMR 320
Query: 219 SDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
              PE   Y + +    +  C  R+P ER   +EL+E
Sbjct: 321 MRAPE---YSTPEIYQIMLDCWHRDPKERPRFAELVE 354

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 23/218 (10%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQ 56
           D   G+ IGRG+   V  G     + + AVKS   +      ++FLQ E RIL   + P 
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQ-EARILKQYSHPN 173
Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLG----- 111
           IV   G    ++   I+    +E   GG     +R+    E  R+R  T   ++G     
Sbjct: 174 IVRLIGVCTQKQPIYIV----MELVQGGDFLTFLRT----EGARLRVKTLLQMVGDAAAG 225
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           ++YL S   +H D+  +N LV++ N    KI+DFG +R            +   P+   A
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSREEADGVYAASGGLRQVPVKWTA 283
Query: 171 PEVARGEEQGFPADVWALGCTVLE-MATGRPPWPDVAD 207
           PE          +DVW+ G  + E  + G  P+P++++
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN 321

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 121/295 (41%), Gaps = 40/295 (13%)
Query: 3   WTRGQTIGRGSTATVSIGMSN-RSSEVFAVKSAELSNSEFLQR---EQRILSALACPQIV 58
           +T+ Q IG G+   VS    + R + V   K +   +  + QR   E +IL       ++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
             +   +     + + ++++      T    +     L    I      +L GL+Y+HS 
Sbjct: 105 GIRDI-LRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSA 163
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG--KPICGTPICMAPEVARG 176
            ++H D+K  N+L++   +   KI DFG AR A    D  G       T    APE+   
Sbjct: 164 NVLHRDLKPSNLLINTTCD--LKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLN 221
Query: 177 EEQGFPA--DVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGYMSKQA 232
             +G+    D+W++GC + EM + RP +P     D ++ +  I  S    ++   ++ +A
Sbjct: 222 -SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKA 280
Query: 233 Q--------------------------DFLSKCLIRNPGERWSASELLEHGFVKE 261
           +                          D L + L  NP +R +  E L H ++++
Sbjct: 281 RNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQ 335

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 110/266 (41%), Gaps = 31/266 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 70
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E      + +  E+   G L D +R          R    AV+L        
Sbjct: 71  QLLGVCTREPP----FYIITEFMTYGNLLDYLRECN-------RQEVSAVVLLYMATQIS 119
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-C 168
             ++YL     +H D+  +N LV +++    K+ADFG +R     +          PI  
Sbjct: 120 SAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSR-LMTGDTFTAHAGAKFPIKW 176
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
            APE     +    +DVWA G  + E+AT G  P+P + DP S ++ +       E P  
Sbjct: 177 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DP-SQVYELLEKDYRMERPEG 234
Query: 228 MSKQAQDFLSKCLIRNPGERWSASEL 253
             ++  + +  C   NP +R S +E+
Sbjct: 235 CPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKS-AELSNSEFLQR---EQRILSALACPQIV 58
           +T    IG G+   V     N +    A+K  +   +  + QR   E +IL       I+
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 59  AYKGCDI----SEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
                DI    + E  K +Y   + +  G  L   +++   L    I      +L GL+Y
Sbjct: 105 GIN--DIIRAPTIEQMKDVY--LVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKY 159
Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG--KPICGTPICMAPE 172
           +HS  ++H D+K  N+L++   +   KI DFG AR A  + D  G       T    APE
Sbjct: 160 IHSANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 217
Query: 173 VARGEEQGFPA--DVWALGCTVLEMATGRPPWP 203
           +     +G+    D+W++GC + EM + RP +P
Sbjct: 218 IMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFP 249

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 115/273 (42%), Gaps = 49/273 (17%)
Query: 4   TRGQTIGRGSTATVSIG--MSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           T  Q IG G    V +G  ++     +  +K   +S  +F++ E  ++  L+ P++V   
Sbjct: 30  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIE-EAEVMMKLSHPKLVQLY 88
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS-----------GTCLEEGRIRSHTRAVLL 110
           G  +  E   I   L  E+   G L+D +R+           G CL+          V  
Sbjct: 89  G--VCLEQAPIC--LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD----------VCE 134
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PIC 168
           G+ YL    ++H D+  +N LV ++  Q  K++DFG  R      DD+     GT  P+ 
Sbjct: 135 GMAYLEEACVIHRDLAARNCLVGEN--QVIKVSDFGMTRFVL---DDQYTSSTGTKFPVK 189
Query: 169 MA-PEVARGEEQGFPADVWALGCTVLEMAT-GRPPW-----PDVADPISALHRIGFSSDT 221
            A PEV         +DVW+ G  + E+ + G+ P+      +V + IS     GF    
Sbjct: 190 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----GFRLYK 245
Query: 222 PEIPGYMSKQAQDFLSKCLIRNPGERWSASELL 254
           P +    S      ++ C    P +R + S LL
Sbjct: 246 PRLA---STHVYQIMNHCWKERPEDRPAFSRLL 275

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG--KPICGT 165
           +L GL+Y+HS  ++H D+K  N+L++   +   KI DFG AR A  + D  G       T
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXD--LKIXDFGLARVADPDHDHTGFLTEYVAT 190
Query: 166 PICMAPEVARGEEQGFPA--DVWALGCTVLEMATGRPPWP 203
               APE+     +G+    D+W++GC + EM + RP +P
Sbjct: 191 RWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFP 229

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 105/229 (45%), Gaps = 26/229 (11%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIVAYKGC 63
           + +G G    V +G  N  ++V AVKS +   +S   FL  E  ++  L   ++V     
Sbjct: 15  ERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRLYAV 72
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            +++E   I+     EY   G+L D ++  SG  L   ++      +  G+ ++     +
Sbjct: 73  -VTQEPIYII----TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 127
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD--EGK--PICGTPICMAPEVARGE 177
           H +++  NILVS  +    KIADFG AR    NE    EG   PI  T    APE     
Sbjct: 128 HRNLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINYG 181
Query: 178 EQGFPADVWALGCTVLEMAT-GRPPWPDVADP--ISALHRIGFSSDTPE 223
                +DVW+ G  + E+ T GR P+P + +P  I  L R G+    P+
Sbjct: 182 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 229

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 109/266 (40%), Gaps = 31/266 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 77
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E    I+     E+   G L D +R          R    AV+L        
Sbjct: 78  QLLGVCTREPPFYII----TEFMTYGNLLDYLRECN-------RQEVNAVVLLYMATQIS 126
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-C 168
             ++YL     +H D+  +N LV +++    K+ADFG +R     +          PI  
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSR-LMTGDTXTAHAGAKFPIKW 183
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
            APE     +    +DVWA G  + E+AT G  P+P +   +S ++ +       E P  
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEG 241
Query: 228 MSKQAQDFLSKCLIRNPGERWSASEL 253
             ++  + +  C   NP +R S +E+
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 111/249 (44%), Gaps = 31/249 (12%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIVAYKGC 63
           + +G G    V +   N+ ++V AVK+ +   +S   FL  E  ++  L   ++V     
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAFLA-EANVMKTLQHDKLVKLHAV 245
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
              E     +Y +  E+   G+L D ++S  G+     ++   +  +  G+ ++     +
Sbjct: 246 VTKEP----IY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 300
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF 181
           H D++  NILVS       KIADFG AR           PI  T    APE         
Sbjct: 301 HRDLRAANILVSAS--LVCKIADFGLARVG------AKFPIKWT----APEAINFGSFTI 348
Query: 182 PADVWALGCTVLEMAT-GRPPWPDVADP--ISALHRIGFSSDTPEIPGYMSKQAQDFLSK 238
            +DVW+ G  ++E+ T GR P+P +++P  I AL R G+    PE      ++  + + +
Sbjct: 349 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRPE---NCPEELYNIMMR 404
Query: 239 CLIRNPGER 247
           C    P ER
Sbjct: 405 CWKNRPEER 413

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 115/273 (42%), Gaps = 49/273 (17%)
Query: 4   TRGQTIGRGSTATVSIG--MSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           T  Q IG G    V +G  ++     +  ++   +S  +F++ E  ++  L+ P++V   
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE-EAEVMMKLSHPKLVQLY 68
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS-----------GTCLEEGRIRSHTRAVLL 110
           G  +  E   I   L  E+   G L+D +R+           G CL+          V  
Sbjct: 69  G--VCLEQAPIC--LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD----------VCE 114
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PIC 168
           G+ YL    ++H D+  +N LV ++  Q  K++DFG  R      DD+     GT  P+ 
Sbjct: 115 GMAYLEEASVIHRDLAARNCLVGEN--QVIKVSDFGMTRFVL---DDQYTSSTGTKFPVK 169
Query: 169 MA-PEVARGEEQGFPADVWALGCTVLEMAT-GRPPW-----PDVADPISALHRIGFSSDT 221
            A PEV         +DVW+ G  + E+ + G+ P+      +V + IS     GF    
Sbjct: 170 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----GFRLYK 225
Query: 222 PEIPGYMSKQAQDFLSKCLIRNPGERWSASELL 254
           P +    S      ++ C    P +R + S LL
Sbjct: 226 PRLA---STHVYQIMNHCWKERPEDRPAFSRLL 255

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 109/266 (40%), Gaps = 31/266 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 77
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E    I+     E+   G L D +R          R    AV+L        
Sbjct: 78  QLLGVCTREPPFYII----TEFMTYGNLLDYLRECN-------RQEVNAVVLLYMATQIS 126
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-C 168
             ++YL     +H D+  +N LV +++    K+ADFG +R     +          PI  
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSR-LMTGDTYTAHAGAKFPIKW 183
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
            APE     +    +DVWA G  + E+AT G  P+P +   +S ++ +       E P  
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEG 241
Query: 228 MSKQAQDFLSKCLIRNPGERWSASEL 253
             ++  + +  C   NP +R S +E+
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 56/100 (56%), Gaps = 7/100 (7%)
Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG--KPICGT 165
           +L GL+Y+HS  ++H D+K  N+L++  ++   KI DFG AR A  + D  G       T
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTTSD--LKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 166 PICMAPEVARGEEQGFPA--DVWALGCTVLEMATGRPPWP 203
               APE+     +G+    D+W++GC + EM + RP +P
Sbjct: 193 RWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFP 231

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 109/266 (40%), Gaps = 31/266 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 27  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 85
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E    I+     E+   G L D +R          R    AV+L        
Sbjct: 86  QLLGVCTREPPFYII----TEFMTYGNLLDYLRECN-------RQEVNAVVLLYMATQIS 134
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-C 168
             ++YL     +H D+  +N LV +++    K+ADFG +R     +          PI  
Sbjct: 135 SAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSR-LMTGDTYTAHAGAKFPIKW 191
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
            APE     +    +DVWA G  + E+AT G  P+P +   +S ++ +       E P  
Sbjct: 192 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEG 249
Query: 228 MSKQAQDFLSKCLIRNPGERWSASEL 253
             ++  + +  C   NP +R S +E+
Sbjct: 250 CPEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 109/266 (40%), Gaps = 31/266 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 74
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E      + +  E+   G L D +R          R    AV+L        
Sbjct: 75  QLLGVCTREPP----FYIITEFMTYGNLLDYLRECN-------RQEVNAVVLLYMATQIS 123
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-C 168
             ++YL     +H D+  +N LV +++    K+ADFG +R     +          PI  
Sbjct: 124 SAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSR-LMTGDTYTAHAGAKFPIKW 180
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
            APE     +    +DVWA G  + E+AT G  P+P +   +S ++ +       E P  
Sbjct: 181 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEG 238
Query: 228 MSKQAQDFLSKCLIRNPGERWSASEL 253
             ++  + +  C   NP +R S +E+
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 109/266 (40%), Gaps = 31/266 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 74
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E    I+     E+   G L D +R          R    AV+L        
Sbjct: 75  QLLGVCTREPPFYII----TEFMTYGNLLDYLRECN-------RQEVNAVVLLYMATQIS 123
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-C 168
             ++YL     +H D+  +N LV +++    K+ADFG +R     +          PI  
Sbjct: 124 SAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSR-LMTGDTYTAHAGAKFPIKW 180
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
            APE     +    +DVWA G  + E+AT G  P+P +   +S ++ +       E P  
Sbjct: 181 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEG 238
Query: 228 MSKQAQDFLSKCLIRNPGERWSASEL 253
             ++  + +  C   NP +R S +E+
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 109/266 (40%), Gaps = 31/266 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 72
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E    I+     E+   G L D +R          R    AV+L        
Sbjct: 73  QLLGVCTREPPFYII----TEFMTYGNLLDYLRECN-------RQEVNAVVLLYMATQIS 121
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-C 168
             ++YL     +H D+  +N LV +++    K+ADFG +R     +          PI  
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSR-LMTGDTYTAHAGAKFPIKW 178
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
            APE     +    +DVWA G  + E+AT G  P+P +   +S ++ +       E P  
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEG 236
Query: 228 MSKQAQDFLSKCLIRNPGERWSASEL 253
             ++  + +  C   NP +R S +E+
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG--KPICGT 165
           +L GL+Y+HS  ++H D+K  N+L++   +   KI DFG AR A  + D  G       T
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 166 PICMAPEVARGEEQGFPA--DVWALGCTVLEMATGRPPWP 203
               APE+     +G+    D+W++GC + EM + RP +P
Sbjct: 191 RWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFP 229

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 109/266 (40%), Gaps = 31/266 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 72
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E    I+     E+   G L D +R          R    AV+L        
Sbjct: 73  QLLGVCTREPPFYII----TEFMTYGNLLDYLRECN-------RQEVNAVVLLYMATQIS 121
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-C 168
             ++YL     +H D+  +N LV +++    K+ADFG +R     +          PI  
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSR-LMTGDTYTAHAGAKFPIKW 178
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
            APE     +    +DVWA G  + E+AT G  P+P +   +S ++ +       E P  
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEG 236
Query: 228 MSKQAQDFLSKCLIRNPGERWSASEL 253
             ++  + +  C   NP +R S +E+
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG--KPICGT 165
           +L GL+Y+HS  ++H D+K  N+L++   +   KI DFG AR A  + D  G       T
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 166 PICMAPEVARGEEQGFPA--DVWALGCTVLEMATGRPPWP 203
               APE+     +G+    D+W++GC + EM + RP +P
Sbjct: 195 RWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFP 233

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 109/266 (40%), Gaps = 31/266 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 77
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E      + +  E+   G L D +R          R    AV+L        
Sbjct: 78  QLLGVCTREPP----FYIITEFMTYGNLLDYLRECN-------RQEVNAVVLLYMATQIS 126
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-C 168
             ++YL     +H D+  +N LV +++    K+ADFG +R     +          PI  
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSR-LMTGDTYTAHAGAKFPIKW 183
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
            APE     +    +DVWA G  + E+AT G  P+P +   +S ++ +       E P  
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEG 241
Query: 228 MSKQAQDFLSKCLIRNPGERWSASEL 253
             ++  + +  C   NP +R S +E+
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 109/266 (40%), Gaps = 31/266 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 76
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E    I+     E+   G L D +R          R    AV+L        
Sbjct: 77  QLLGVCTREPPFYII----TEFMTYGNLLDYLRECN-------RQEVNAVVLLYMATQIS 125
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-C 168
             ++YL     +H D+  +N LV +++    K+ADFG +R     +          PI  
Sbjct: 126 SAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSR-LMTGDTYTAHAGAKFPIKW 182
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
            APE     +    +DVWA G  + E+AT G  P+P +   +S ++ +       E P  
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEG 240
Query: 228 MSKQAQDFLSKCLIRNPGERWSASEL 253
             ++  + +  C   NP +R S +E+
Sbjct: 241 CPEKVYELMRACWQWNPSDRPSFAEI 266

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 109/266 (40%), Gaps = 31/266 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 72
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E      + +  E+   G L D +R          R    AV+L        
Sbjct: 73  QLLGVCTREPP----FYIITEFMTYGNLLDYLRECN-------RQEVSAVVLLYMATQIS 121
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-C 168
             ++YL     +H D+  +N LV +++    K+ADFG +R     +          PI  
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSR-LMTGDTYTAHAGAKFPIKW 178
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
            APE     +    +DVWA G  + E+AT G  P+P +   +S ++ +       E P  
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEG 236
Query: 228 MSKQAQDFLSKCLIRNPGERWSASEL 253
             ++  + +  C   NP +R S +E+
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG--KPICGT 165
           +L GL+Y+HS  ++H D+K  N+L++   +   KI DFG AR A  + D  G       T
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 166 PICMAPEVARGEEQGFPA--DVWALGCTVLEMATGRPPWP 203
               APE+     +G+    D+W++GC + EM + RP +P
Sbjct: 191 RWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFP 229

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 109/266 (40%), Gaps = 31/266 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 72
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E      + +  E+   G L D +R          R    AV+L        
Sbjct: 73  QLLGVCTREPP----FYIITEFMTYGNLLDYLRECN-------RQEVSAVVLLYMATQIS 121
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-C 168
             ++YL     +H D+  +N LV +++    K+ADFG +R     +          PI  
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSR-LMTGDTYTAHAGAKFPIKW 178
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
            APE     +    +DVWA G  + E+AT G  P+P +   +S ++ +       E P  
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEG 236
Query: 228 MSKQAQDFLSKCLIRNPGERWSASEL 253
             ++  + +  C   NP +R S +E+
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG--KPICGT 165
           +L GL+Y+HS  ++H D+K  N+L++   +   KI DFG AR A  + D  G       T
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 166 PICMAPEVARGEEQGFPA--DVWALGCTVLEMATGRPPWP 203
               APE+     +G+    D+W++GC + EM + RP +P
Sbjct: 195 RWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFP 233

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 109/266 (40%), Gaps = 31/266 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 77
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E      + +  E+   G L D +R          R    AV+L        
Sbjct: 78  QLLGVCTREPP----FYIITEFMTYGNLLDYLRECN-------RQEVSAVVLLYMATQIS 126
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-C 168
             ++YL     +H D+  +N LV +++    K+ADFG +R     +          PI  
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSR-LMTGDTYTAHAGAKFPIKW 183
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
            APE     +    +DVWA G  + E+AT G  P+P +   +S ++ +       E P  
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEG 241
Query: 228 MSKQAQDFLSKCLIRNPGERWSASEL 253
             ++  + +  C   NP +R S +E+
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 84/216 (38%), Gaps = 43/216 (19%)
Query: 87  TDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG 146
           TD  +    L +  IR +   +L  L Y HS GI+H D+K  N+++    ++  ++ D+G
Sbjct: 120 TDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDH-QQKKLRLIDWG 178
Query: 147 CARRARVNEDDEGKPICGTPICMAPE-VARGEEQGFPADVWALGCTVLEMATGRPPWPDV 205
            A      +  E      +     PE +   +   +  D+W+LGC +  M   R P+   
Sbjct: 179 LAEFYHPAQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHG 236
Query: 206 ADPISALHRIGFSSDTPEIPGYMSK----------------------------------- 230
            D    L RI     T E+ GY+ K                                   
Sbjct: 237 QDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSP 296
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGF----VKEQ 262
           +A D L K L  +  +R +A E +EH +    VKEQ
Sbjct: 297 EALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQ 332

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 115/273 (42%), Gaps = 49/273 (17%)
Query: 4   TRGQTIGRGSTATVSIG--MSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           T  Q IG G    V +G  ++     +  ++   +S  +F++ E  ++  L+ P++V   
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE-EAEVMMKLSHPKLVQLY 66
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS-----------GTCLEEGRIRSHTRAVLL 110
           G  +  E   I   L  E+   G L+D +R+           G CL+          V  
Sbjct: 67  G--VCLEQAPIC--LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD----------VCE 112
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PIC 168
           G+ YL    ++H D+  +N LV ++  Q  K++DFG  R      DD+     GT  P+ 
Sbjct: 113 GMAYLEEACVIHRDLAARNCLVGEN--QVIKVSDFGMTRFVL---DDQYTSSTGTKFPVK 167
Query: 169 MA-PEVARGEEQGFPADVWALGCTVLEMAT-GRPPW-----PDVADPISALHRIGFSSDT 221
            A PEV         +DVW+ G  + E+ + G+ P+      +V + IS     GF    
Sbjct: 168 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----GFRLYK 223
Query: 222 PEIPGYMSKQAQDFLSKCLIRNPGERWSASELL 254
           P +    S      ++ C    P +R + S LL
Sbjct: 224 PRLA---STHVYQIMNHCWKERPEDRPAFSRLL 253

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 115/273 (42%), Gaps = 49/273 (17%)
Query: 4   TRGQTIGRGSTATVSIG--MSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           T  Q IG G    V +G  ++     +  ++   +S  +F++ E  ++  L+ P++V   
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE-EAEVMMKLSHPKLVQLY 68
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS-----------GTCLEEGRIRSHTRAVLL 110
           G  +  E   I   L  E+   G L+D +R+           G CL+          V  
Sbjct: 69  G--VCLEQAPIC--LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD----------VCE 114
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PIC 168
           G+ YL    ++H D+  +N LV ++  Q  K++DFG  R      DD+     GT  P+ 
Sbjct: 115 GMAYLEEACVIHRDLAARNCLVGEN--QVIKVSDFGMTRFVL---DDQYTSSTGTKFPVK 169
Query: 169 MA-PEVARGEEQGFPADVWALGCTVLEMAT-GRPPW-----PDVADPISALHRIGFSSDT 221
            A PEV         +DVW+ G  + E+ + G+ P+      +V + IS     GF    
Sbjct: 170 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----GFRLYK 225
Query: 222 PEIPGYMSKQAQDFLSKCLIRNPGERWSASELL 254
           P +    S      ++ C    P +R + S LL
Sbjct: 226 PRLA---STHVYQIMNHCWKERPEDRPAFSRLL 255

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 115/273 (42%), Gaps = 49/273 (17%)
Query: 4   TRGQTIGRGSTATVSIG--MSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           T  Q IG G    V +G  ++     +  ++   +S  +F++ E  ++  L+ P++V   
Sbjct: 13  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE-EAEVMMKLSHPKLVQLY 71
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS-----------GTCLEEGRIRSHTRAVLL 110
           G  +  E   I   L  E+   G L+D +R+           G CL+          V  
Sbjct: 72  G--VCLEQAPIC--LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD----------VCE 117
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PIC 168
           G+ YL    ++H D+  +N LV ++  Q  K++DFG  R      DD+     GT  P+ 
Sbjct: 118 GMAYLEEACVIHRDLAARNCLVGEN--QVIKVSDFGMTRFVL---DDQYTSSTGTKFPVK 172
Query: 169 MA-PEVARGEEQGFPADVWALGCTVLEMAT-GRPPW-----PDVADPISALHRIGFSSDT 221
            A PEV         +DVW+ G  + E+ + G+ P+      +V + IS     GF    
Sbjct: 173 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----GFRLYK 228
Query: 222 PEIPGYMSKQAQDFLSKCLIRNPGERWSASELL 254
           P +    S      ++ C    P +R + S LL
Sbjct: 229 PRLA---STHVYQIMNHCWRERPEDRPAFSRLL 258

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 84/216 (38%), Gaps = 43/216 (19%)
Query: 87  TDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG 146
           TD  +    L +  IR +   +L  L Y HS GI+H D+K  N+++    ++  ++ D+G
Sbjct: 125 TDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDH-QQKKLRLIDWG 183
Query: 147 CARRARVNEDDEGKPICGTPICMAPE-VARGEEQGFPADVWALGCTVLEMATGRPPWPDV 205
            A      +  E      +     PE +   +   +  D+W+LGC +  M   R P+   
Sbjct: 184 LAEFYHPAQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHG 241
Query: 206 ADPISALHRIGFSSDTPEIPGYMSK----------------------------------- 230
            D    L RI     T E+ GY+ K                                   
Sbjct: 242 QDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSP 301
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGF----VKEQ 262
           +A D L K L  +  +R +A E +EH +    VKEQ
Sbjct: 302 EALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQ 337

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 11/184 (5%)
Query: 75  NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSK 134
           N F+ Y P     D  +    LE   +  ++  V  G+++L S   +H D+  +NIL+S+
Sbjct: 130 NEFVPYKP----EDLYKDFLTLEH--LIXYSFQVAKGMEFLASRKXIHRDLAARNILLSE 183
Query: 135 DNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMAPEVARGEEQGFPADVWALGCTVL 193
            N    KI DFG AR    + D   K     P+  MAPE          +DVW+ G  + 
Sbjct: 184 KNV--VKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 241
Query: 194 EM-ATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASE 252
           E+ + G  P+P V        R+   +     P Y + +    +  C    P +R + SE
Sbjct: 242 EIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 300
Query: 253 LLEH 256
           L+EH
Sbjct: 301 LVEH 304

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 61/123 (49%), Gaps = 9/123 (7%)
Query: 87  TDAIRSGTC--LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIAD 144
           TD  +   C  L    I      +L GL+Y+HS  ++H D+K  N+L++   +   KI D
Sbjct: 114 TDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICD 171
Query: 145 FGCARRARVNEDDEG--KPICGTPICMAPEVARGEEQGFPA--DVWALGCTVLEMATGRP 200
           FG AR A  + D  G       T    APE+     +G+    D+W++GC + EM + RP
Sbjct: 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRP 230
Query: 201 PWP 203
            +P
Sbjct: 231 IFP 233

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 112/255 (43%), Gaps = 32/255 (12%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIVAYKGC 63
           + +G G    V +G  N S++V AVK+ +   +S   FL+ E  ++  L   ++V     
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSVQAFLE-EANLMKTLQHDKLVRLYAV 75
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
              EE   I+     E+   G+L D ++S  G  +   ++   +  +  G+ Y+     +
Sbjct: 76  VTKEEPIYII----TEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 131
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---APEVARGEE 178
           H D++  N+LVS+      KIADFG    ARV ED+E     G    +   APE      
Sbjct: 132 HRDLRAANVLVSES--LMCKIADFGL---ARVIEDNEYTAREGAKFPIKWTAPEAINFGC 186
Query: 179 QGFPADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQA 232
               ++VW+ G  + E+ T G+ P+P     DV   +S  +R+    + P+       + 
Sbjct: 187 FTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCPD-------EL 239
Query: 233 QDFLSKCLIRNPGER 247
            D +  C      ER
Sbjct: 240 YDIMKMCWKEKAEER 254

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 117/295 (39%), Gaps = 41/295 (13%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF--LQREQRILSALACPQIVA 59
           D+     +G+G+   V    +   S  +A+K    +  +   +  E  +L++L    +V 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 60  YKGCDISEENG-------KILYNLF--LEYAPGGTLTDAIRSGTCLEEG----RIRSHTR 106
           Y    +   N        K    LF  +EY    TL D I S    ++     R+    R
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRL---FR 123
Query: 107 AVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED---------- 156
            +L  L Y+HS GI+H D+K  NI +  D  +  KI DFG A+    + D          
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFI--DESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 157 ---DEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISAL 212
              D      GT + +A EV  G        D+++LG    EM     P+    + ++ L
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238
Query: 213 HRIGFSSDT--PEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGF--VKEQN 263
            ++   S    P+      K  +  +   +  +P +R  A  LL  G+  VK Q+
Sbjct: 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD 293

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 12/209 (5%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKS-AELSNSEFLQR---EQRILSALACPQIV 58
           +T    IG G+   V     N +    A+K  +   +  + QR   E +IL A     I+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
                 I     + + ++++      T    +     L    I      +L GL+Y+HS 
Sbjct: 87  GINDI-IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 145
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG--KPICGTPICMAPEVARG 176
            ++H D+K  N+L++   +   KI DFG AR A  + D  G       T    APE+   
Sbjct: 146 NVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 177 EEQGFPA--DVWALGCTVLEMATGRPPWP 203
             +G+    D+W++GC + EM + RP +P
Sbjct: 204 -SKGYTKSIDIWSVGCILAEMLSNRPIFP 231

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG--KPICGT 165
           +L GL+Y+HS  ++H D+K  N+L++   +   KI DFG AR A  + D  G       T
Sbjct: 141 ILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVAT 198
Query: 166 PICMAPEVARGEEQGFPA--DVWALGCTVLEMATGRPPWP 203
               APE+     +G+    D+W++GC + EM + RP +P
Sbjct: 199 RWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFP 237

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG--KPICGT 165
           +L GL+Y+HS  ++H D+K  N+L++   +   KI DFG AR A  + D  G       T
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 166 PICMAPEVARGEEQGFPA--DVWALGCTVLEMATGRPPWP 203
               APE+     +G+    D+W++GC + EM + RP +P
Sbjct: 191 RWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFP 229

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG--KPICGT 165
           +L GL+Y+HS  ++H D+K  N+L++   +   KI DFG AR A  + D  G       T
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 166 PICMAPEVARGEEQGFPA--DVWALGCTVLEMATGRPPWP 203
               APE+     +G+    D+W++GC + EM + RP +P
Sbjct: 195 RWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFP 233

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG--KPICGT 165
           +L GL+Y+HS  ++H D+K  N+L++   +   KI DFG AR A  + D  G       T
Sbjct: 138 ILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVAT 195
Query: 166 PICMAPEVARGEEQGFPA--DVWALGCTVLEMATGRPPWP 203
               APE+     +G+    D+W++GC + EM + RP +P
Sbjct: 196 RWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFP 234

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG--KPICGT 165
           +L GL+Y+HS  ++H D+K  N+L++   +   KI DFG AR A  + D  G       T
Sbjct: 139 ILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVAT 196
Query: 166 PICMAPEVARGEEQGFPA--DVWALGCTVLEMATGRPPWP 203
               APE+     +G+    D+W++GC + EM + RP +P
Sbjct: 197 RWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFP 235

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG--KPICGT 165
           +L GL+Y+HS  ++H D+K  N+L++   +   KI DFG AR A  + D  G       T
Sbjct: 130 ILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVAT 187
Query: 166 PICMAPEVARGEEQGFPA--DVWALGCTVLEMATGRPPWP 203
               APE+     +G+    D+W++GC + EM + RP +P
Sbjct: 188 RWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFP 226

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG--KPICGT 165
           +L GL+Y+HS  ++H D+K  N+L++   +   KI DFG AR A  + D  G       T
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 166 PICMAPEVARGEEQGFPA--DVWALGCTVLEMATGRPPWP 203
               APE+     +G+    D+W++GC + EM + RP +P
Sbjct: 195 RWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFP 233

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG--KPICGT 165
           +L GL+Y+HS  ++H D+K  N+L++   +   KI DFG AR A  + D  G       T
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 166 PICMAPEVARGEEQGFPA--DVWALGCTVLEMATGRPPWP 203
               APE+     +G+    D+W++GC + EM + RP +P
Sbjct: 191 RWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFP 229

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG--KPICGT 165
           +L GL+Y+HS  ++H D+K  N+L++   +   KI DFG AR A  + D  G       T
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 166 PICMAPEVARGEEQGFPA--DVWALGCTVLEMATGRPPWP 203
               APE+     +G+    D+W++GC + EM + RP +P
Sbjct: 193 RWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFP 231

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG--KPICGT 165
           +L GL+Y+HS  ++H D+K  N+L++   +   KI DFG AR A  + D  G       T
Sbjct: 153 ILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 166 PICMAPEVARGEEQGFPA--DVWALGCTVLEMATGRPPWP 203
               APE+     +G+    D+W++GC + EM + RP +P
Sbjct: 211 RWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFP 249

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG--KPICGT 165
           +L GL+Y+HS  ++H D+K  N+L++   +   KI DFG AR A  + D  G       T
Sbjct: 131 ILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 166 PICMAPEVARGEEQGFPA--DVWALGCTVLEMATGRPPWP 203
               APE+     +G+    D+W++GC + EM + RP +P
Sbjct: 189 RWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFP 227

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG--KPICGT 165
           +L GL+Y+HS  ++H D+K  N+L++   +   KI DFG AR A  + D  G       T
Sbjct: 131 ILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 166 PICMAPEVARGEEQGFPA--DVWALGCTVLEMATGRPPWP 203
               APE+     +G+    D+W++GC + EM + RP +P
Sbjct: 189 RWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFP 227

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 115/273 (42%), Gaps = 49/273 (17%)
Query: 4   TRGQTIGRGSTATVSIG--MSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           T  Q IG G    V +G  ++     +  ++   +S  +F++ E  ++  L+ P++V   
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE-EAEVMMKLSHPKLVQLY 69
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS-----------GTCLEEGRIRSHTRAVLL 110
           G  +  E   I   L  E+   G L+D +R+           G CL+          V  
Sbjct: 70  G--VCLEQAPIC--LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD----------VCE 115
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PIC 168
           G+ YL    ++H D+  +N LV ++  Q  K++DFG  R      DD+     GT  P+ 
Sbjct: 116 GMAYLEEACVIHRDLAARNCLVGEN--QVIKVSDFGMTRFVL---DDQYTSSTGTKFPVK 170
Query: 169 MA-PEVARGEEQGFPADVWALGCTVLEMAT-GRPPW-----PDVADPISALHRIGFSSDT 221
            A PEV         +DVW+ G  + E+ + G+ P+      +V + IS     GF    
Sbjct: 171 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----GFRLYK 226
Query: 222 PEIPGYMSKQAQDFLSKCLIRNPGERWSASELL 254
           P +    S      ++ C    P +R + S LL
Sbjct: 227 PRLA---STHVYQIMNHCWRERPEDRPAFSRLL 256

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG--KPICGT 165
           +L GL+Y+HS  ++H D+K  N+L++   +   KI DFG AR A  + D  G       T
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLXEXVAT 194
Query: 166 PICMAPEVARGEEQGFPA--DVWALGCTVLEMATGRPPWP 203
               APE+     +G+    D+W++GC + EM + RP +P
Sbjct: 195 RWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFP 233

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG--KPICGT 165
           +L GL+Y+HS  ++H D+K  N+L++   +   KI DFG AR A  + D  G       T
Sbjct: 138 ILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLXEXVAT 195
Query: 166 PICMAPEVARGEEQGFPA--DVWALGCTVLEMATGRPPWP 203
               APE+     +G+    D+W++GC + EM + RP +P
Sbjct: 196 RWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFP 234

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 11/162 (6%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA-----ELSNSEFLQREQRILSALACPQ 56
           ++     IGRGS   V +     +++  A+K       +L + + + RE  IL+ L    
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 88
Query: 57  IVAYKGCDISEENGKI--LYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
           I+      I E+  K   LY + LE A    L    ++   L E  +++    +LLG ++
Sbjct: 89  IIRLHDLIIPEDLLKFDELY-IVLEIA-DSDLKKLFKTPIFLTEQHVKTILYNLLLGEKF 146
Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED 156
           +H +GI+H D+K  N L+++D     KI DFG AR    ++D
Sbjct: 147 IHESGIIHRDLKPANCLLNQD--CSVKICDFGLARTINSDKD 186

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CM 169
           G+++L S   +H D+  +NIL+S+ N    KI DFG AR    + D   K     P+  M
Sbjct: 156 GMEFLASRKXIHRDLAARNILLSEKNV--VKIXDFGLARDIYKDPDYVRKGDARLPLKWM 213
Query: 170 APEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           APE          +DVW+ G  + E+ + G  P+P V        R+   +     P Y 
Sbjct: 214 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRM-RAPDYT 272
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEH 256
           + +    +  C    P +R + SEL+EH
Sbjct: 273 TPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 7   QTIGRGSTATVSIG--MSNRSSEVF-AVKSAELSN-----SEFLQREQRILSALACPQIV 58
           + IGRG    V  G  + N   ++  AVKS          S+FL  E  I+   + P ++
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT-EGIIMKDFSHPNVL 92
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGR-IRSHTRAVLLGLQYLHS 117
           +  G  +  E   ++    L Y   G L + IR+ T     + +      V  G+++L S
Sbjct: 93  SLLGICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 149
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC---MAPEVA 174
              VH D+  +N ++  D +   K+ADFG AR     E D      G  +    MA E  
Sbjct: 150 KKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 207
Query: 175 RGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
           + ++    +DVW+ G  + E+ T G PP+PDV
Sbjct: 208 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 239

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 7   QTIGRGSTATVSIG--MSNRSSEVF-AVKSAELSN-----SEFLQREQRILSALACPQIV 58
           + IGRG    V  G  + N   ++  AVKS          S+FL  E  I+   + P ++
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT-EGIIMKDFSHPNVL 95
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGR-IRSHTRAVLLGLQYLHS 117
           +  G  +  E   ++    L Y   G L + IR+ T     + +      V  G+++L S
Sbjct: 96  SLLGICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 152
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC---MAPEVA 174
              VH D+  +N ++  D +   K+ADFG AR     E D      G  +    MA E  
Sbjct: 153 KKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 175 RGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
           + ++    +DVW+ G  + E+ T G PP+PDV
Sbjct: 211 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 242

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 7   QTIGRGSTATVSIG--MSNRSSEVF-AVKSAELSN-----SEFLQREQRILSALACPQIV 58
           + IGRG    V  G  + N   ++  AVKS          S+FL  E  I+   + P ++
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT-EGIIMKDFSHPNVL 94
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGR-IRSHTRAVLLGLQYLHS 117
           +  G  +  E   ++    L Y   G L + IR+ T     + +      V  G+++L S
Sbjct: 95  SLLGICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 151
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC---MAPEVA 174
              VH D+  +N ++  D +   K+ADFG AR     E D      G  +    MA E  
Sbjct: 152 KKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 175 RGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
           + ++    +DVW+ G  + E+ T G PP+PDV
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 241

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 7   QTIGRGSTATVSIG--MSNRSSEVF-AVKSAELSN-----SEFLQREQRILSALACPQIV 58
           + IGRG    V  G  + N   ++  AVKS          S+FL  E  I+   + P ++
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT-EGIIMKDFSHPNVL 99
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGR-IRSHTRAVLLGLQYLHS 117
           +  G  +  E   ++    L Y   G L + IR+ T     + +      V  G+++L S
Sbjct: 100 SLLGICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 156
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC---MAPEVA 174
              VH D+  +N ++  D +   K+ADFG AR     E D      G  +    MA E  
Sbjct: 157 KKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 214
Query: 175 RGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
           + ++    +DVW+ G  + E+ T G PP+PDV
Sbjct: 215 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 246

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 7   QTIGRGSTATVSIG--MSNRSSEVF-AVKSAELSN-----SEFLQREQRILSALACPQIV 58
           + IGRG    V  G  + N   ++  AVKS          S+FL  E  I+   + P ++
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT-EGIIMKDFSHPNVL 94
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGR-IRSHTRAVLLGLQYLHS 117
           +  G  +  E   ++    L Y   G L + IR+ T     + +      V  G+++L S
Sbjct: 95  SLLGICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 151
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC---MAPEVA 174
              VH D+  +N ++  D +   K+ADFG AR     E D      G  +    MA E  
Sbjct: 152 KKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 175 RGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
           + ++    +DVW+ G  + E+ T G PP+PDV
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 241

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR-------EQRILSALAC 54
           D+   + IGRG+   V++     + +VFA+K   L+  E L+R       E+R +     
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGD 132
Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
            + +        ++N   LY +   Y  G  LT   +    L E   R +   +++ +  
Sbjct: 133 SKWITTLHYAFQDDNN--LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDS 190
Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           +H    VH DIK  NIL+  D     ++ADFG   +   +   +     GTP  ++PE+ 
Sbjct: 191 VHQLHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248
Query: 175 RGEE-----QGFPADVWALGCTVLEMATGRPPW 202
           +  E      G   D W+LG  + EM  G  P+
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 116/271 (42%), Gaps = 35/271 (12%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE----------FLQREQRILSALACPQ 56
           + IG+G    V  G   +   V A+KS  L +SE            QRE  I+S L  P 
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 57  IVAYKGCDISEENGKILYN---LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRA-VLLGL 112
           IV   G         +++N   + +E+ P G L   +       +  ++      + LG+
Sbjct: 85  IVKLYG---------LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 113 QYLHSNG--IVHCDIKGQNILVSKDNEQG---AKIADFGCARRARVNEDDEGKPICGTPI 167
           +Y+ +    IVH D++  NI +   +E     AK+ADFG ++++  +       + G   
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSG----LLGNFQ 191
Query: 168 CMAPEVARGEEQGF--PADVWALGCTVLEMATGRPPWPDVA-DPISALHRIGFSSDTPEI 224
            MAPE    EE+ +   AD ++    +  + TG  P+ + +   I  ++ I      P I
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251
Query: 225 PGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
           P     + ++ +  C   +P +R   S +++
Sbjct: 252 PEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 7   QTIGRGSTATVSIG--MSNRSSEVF-AVKSAELSN-----SEFLQREQRILSALACPQIV 58
           + IGRG    V  G  + N   ++  AVKS          S+FL  E  I+   + P ++
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT-EGIIMKDFSHPNVL 153
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGR-IRSHTRAVLLGLQYLHS 117
           +  G  +  E   ++    L Y   G L + IR+ T     + +      V  G+++L S
Sbjct: 154 SLLGICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC---MAPEVA 174
              VH D+  +N ++  D +   K+ADFG AR     E D      G  +    MA E  
Sbjct: 211 KKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 175 RGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
           + ++    +DVW+ G  + E+ T G PP+PDV
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 7   QTIGRGSTATVSIG--MSNRSSEVF-AVKSAELSN-----SEFLQREQRILSALACPQIV 58
           + IGRG    V  G  + N   ++  AVKS          S+FL  E  I+   + P ++
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT-EGIIMKDFSHPNVL 95
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGR-IRSHTRAVLLGLQYLHS 117
           +  G  +  E   ++    L Y   G L + IR+ T     + +      V  G+++L S
Sbjct: 96  SLLGICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 152
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC---MAPEVA 174
              VH D+  +N ++  D +   K+ADFG AR     E D      G  +    MA E  
Sbjct: 153 KKFVHRDLAARNCML--DEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 175 RGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
           + ++    +DVW+ G  + E+ T G PP+PDV
Sbjct: 211 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 242

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 116/271 (42%), Gaps = 35/271 (12%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE----------FLQREQRILSALACPQ 56
           + IG+G    V  G   +   V A+KS  L +SE            QRE  I+S L  P 
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 57  IVAYKGCDISEENGKILYN---LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRA-VLLGL 112
           IV   G         +++N   + +E+ P G L   +       +  ++      + LG+
Sbjct: 85  IVKLYG---------LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 113 QYLHSNG--IVHCDIKGQNILVSKDNEQG---AKIADFGCARRARVNEDDEGKPICGTPI 167
           +Y+ +    IVH D++  NI +   +E     AK+ADFG ++++  +       + G   
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSG----LLGNFQ 191
Query: 168 CMAPEVARGEEQGF--PADVWALGCTVLEMATGRPPWPDVA-DPISALHRIGFSSDTPEI 224
            MAPE    EE+ +   AD ++    +  + TG  P+ + +   I  ++ I      P I
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251
Query: 225 PGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
           P     + ++ +  C   +P +R   S +++
Sbjct: 252 PEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 10  GRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALAC---PQIVAYKGC--D 64
           G+G+  TV +G    +    A+K   + +  F  RE +I+  LA    P IV  +     
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYT 90
Query: 65  ISEENGKILY-NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVL------LGLQYLHS 117
           + E + + +Y N+ +EY P  TL    R+    +        +  L      +G  +L S
Sbjct: 91  LGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS 149
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
             + H DIK  N+LV+ + +   K+ DFG A++   +E +    IC      APE+  G 
Sbjct: 150 VNVCHRDIKPHNVLVN-EADGTLKLCDFGSAKKLSPSEPNVAY-ICSR-YYRAPELIFGN 206
Query: 178 EQGFPA-DVWALGCTVLEMATGRP 200
           +    A D+W++GC   EM  G P
Sbjct: 207 QHYTTAVDIWSVGCIFAEMMLGEP 230

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CM 169
           G+++L S   +H D+  +NIL+S+ N    KI DFG AR    + D   K     P+  M
Sbjct: 151 GMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIXKDPDXVRKGDARLPLKWM 208
Query: 170 APEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           APE          +DVW+ G  + E+ + G  P+P V        R+   +     P Y 
Sbjct: 209 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYT 267
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEH 256
           + +    +  C    P +R + SEL+EH
Sbjct: 268 TPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CM 169
           G+++L S   +H D+  +NIL+S+ N    KI DFG AR    + D   K     P+  M
Sbjct: 151 GMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIXKDPDXVRKGDARLPLKWM 208
Query: 170 APEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           APE          +DVW+ G  + E+ + G  P+P V        R+   +     P Y 
Sbjct: 209 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYT 267
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEH 256
           + +    +  C    P +R + SEL+EH
Sbjct: 268 TPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CM 169
           G+++L S   +H D+  +NIL+S+ N    KI DFG AR    + D   K     P+  M
Sbjct: 151 GMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWM 208
Query: 170 APEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           APE          +DVW+ G  + E+ + G  P+P V        R+   +     P Y 
Sbjct: 209 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYT 267
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEH 256
           + +    +  C    P +R + SEL+EH
Sbjct: 268 TPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 109/266 (40%), Gaps = 31/266 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 318
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E    I+     E+   G L D +R          R    AV+L        
Sbjct: 319 QLLGVCTREPPFYII----TEFMTYGNLLDYLRECN-------RQEVNAVVLLYMATQIS 367
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-C 168
             ++YL     +H ++  +N LV +++    K+ADFG +R     +          PI  
Sbjct: 368 SAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSR-LMTGDTYTAHAGAKFPIKW 424
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
            APE     +    +DVWA G  + E+AT G  P+P +   +S ++ +       E P  
Sbjct: 425 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKDYRMERPEG 482
Query: 228 MSKQAQDFLSKCLIRNPGERWSASEL 253
             ++  + +  C   NP +R S +E+
Sbjct: 483 CPEKVYELMRACWQWNPSDRPSFAEI 508

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 109/266 (40%), Gaps = 31/266 (11%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAE---LSNSEFLQREQRILSALACPQIV 58
           D T    +G G    V  G+  + S   AVK+ +   +   EFL +E  ++  +  P +V
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 279
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------- 110
              G    E      + +  E+   G L D +R          R    AV+L        
Sbjct: 280 QLLGVCTREPP----FYIITEFMTYGNLLDYLRECN-------RQEVSAVVLLYMATQIS 328
Query: 111 -GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-C 168
             ++YL     +H ++  +N LV +++    K+ADFG +R     +          PI  
Sbjct: 329 SAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSR-LMTGDTYTAHAGAKFPIKW 385
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
            APE     +    +DVWA G  + E+AT G  P+P +   +S ++ +       E P  
Sbjct: 386 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKDYRMERPEG 443
Query: 228 MSKQAQDFLSKCLIRNPGERWSASEL 253
             ++  + +  C   NP +R S +E+
Sbjct: 444 CPEKVYELMRACWQWNPSDRPSFAEI 469

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CM 169
           G+++L S   +H D+  +NIL+S+ N    KI DFG AR    + D   K     P+  M
Sbjct: 160 GMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIXKDPDXVRKGDARLPLKWM 217
Query: 170 APEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           APE          +DVW+ G  + E+ + G  P+P V        R+   +     P Y 
Sbjct: 218 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYT 276
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEH 256
           + +    +  C    P +R + SEL+EH
Sbjct: 277 TPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CM 169
           G+++L S   +H D+  +NIL+S+ N    KI DFG AR    + D   K     P+  M
Sbjct: 160 GMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDXVRKGDARLPLKWM 217
Query: 170 APEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           APE          +DVW+ G  + E+ + G  P+P V        R+   +     P Y 
Sbjct: 218 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYT 276
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEH 256
           + +    +  C    P +R + SEL+EH
Sbjct: 277 TPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CM 169
           G+++L S   +H D+  +NIL+S+ N    KI DFG AR    + D   K     P+  M
Sbjct: 156 GMEFLASRKXIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWM 213
Query: 170 APEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           APE          +DVW+ G  + E+ + G  P+P V        R+   +     P Y 
Sbjct: 214 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYT 272
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEH 256
           + +    +  C    P +R + SEL+EH
Sbjct: 273 TPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CM 169
           G+++L S   +H D+  +NIL+S+ N    KI DFG AR    + D   K     P+  M
Sbjct: 203 GMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWM 260
Query: 170 APEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           APE          +DVW+ G  + E+ + G  P+P V        R+   +     P Y 
Sbjct: 261 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYT 319
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEH 256
           + +    +  C    P +R + SEL+EH
Sbjct: 320 TPEMYQTMLDCWHGEPSQRPTFSELVEH 347

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CM 169
           G+++L S   +H D+  +NIL+S+ N    KI DFG AR    + D   K     P+  M
Sbjct: 151 GMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWM 208
Query: 170 APEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           APE          +DVW+ G  + E+ + G  P+P V        R+   +     P Y 
Sbjct: 209 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYT 267
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEH 256
           + +    +  C    P +R + SEL+EH
Sbjct: 268 TPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CM 169
           G+++L S   +H D+  +NIL+S+ N    KI DFG AR    + D   K     P+  M
Sbjct: 205 GMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWM 262
Query: 170 APEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           APE          +DVW+ G  + E+ + G  P+P V        R+   +     P Y 
Sbjct: 263 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYT 321
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEH 256
           + +    +  C    P +R + SEL+EH
Sbjct: 322 TPEMYQTMLDCWHGEPSQRPTFSELVEH 349

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CM 169
           G+++L S   +H D+  +NIL+S+ N    KI DFG AR    + D   K     P+  M
Sbjct: 197 GMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWM 254
Query: 170 APEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           APE          +DVW+ G  + E+ + G  P+P V        R+   +     P Y 
Sbjct: 255 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYT 313
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEH 256
           + +    +  C    P +R + SEL+EH
Sbjct: 314 TPEMYQTMLDCWHGEPSQRPTFSELVEH 341

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 7   QTIGRGSTATVSIG--MSNRSSEVF-AVKSAELSN-----SEFLQREQRILSALACPQIV 58
           + IGRG    V  G  + N   ++  AVKS          S+FL  E  I+   + P ++
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT-EGIIMKDFSHPNVL 93
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGR-IRSHTRAVLLGLQYLHS 117
           +  G  +  E   ++    L Y   G L + IR+ T     + +      V  G++YL S
Sbjct: 94  SLLGICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 150
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC---MAPEVA 174
              VH D+  +N ++  D +   K+ADFG AR     E        G  +    MA E  
Sbjct: 151 KKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESL 208
Query: 175 RGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
           + ++    +DVW+ G  + E+ T G PP+PDV
Sbjct: 209 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 240

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CM 169
           G+++L S   +H D+  +NIL+S+ N    KI DFG AR    + D   K     P+  M
Sbjct: 210 GMEFLASRKCIHRDLAARNILLSEKN--VVKICDFGLARDIYKDPDYVRKGDARLPLKWM 267
Query: 170 APEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           APE          +DVW+ G  + E+ + G  P+P V        R+   +     P Y 
Sbjct: 268 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYT 326
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEH 256
           + +    +  C    P +R + SEL+EH
Sbjct: 327 TPEMYQTMLDCWHGEPSQRPTFSELVEH 354

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC-M 169
           G+++L S   +H D+  +NIL+S+ N    KI DFG AR    + D   K     P+  M
Sbjct: 212 GMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWM 269
Query: 170 APEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           APE          +DVW+ G  + E+ + G  P+P V        R+   +     P Y 
Sbjct: 270 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYT 328
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEH 256
           + +    +  C    P +R + SEL+EH
Sbjct: 329 TPEMYQTMLDCWHGEPSQRPTFSELVEH 356

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 113/300 (37%), Gaps = 50/300 (16%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYK 61
           +TIG G+   VS      + +  A+K        ++N++   RE +IL       I+A K
Sbjct: 61  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIK 120
Query: 62  GC---DISEENGKILYNLF--LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
                 +     K +Y +   +E      L   I S   L    +R     +L GL+Y+H
Sbjct: 121 DILRPTVPYGEFKSVYVVLDLME----SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH 176
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR---RARVNEDDEGKPICGTPICMAPEV 173
           S  ++H D+K  N+LV+++ E   KI DFG AR    +             T    APE+
Sbjct: 177 SAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 234
Query: 174 ARG-EEQGFPADVWALGCTVLEMATGR--------------------PPWPDVADPISAL 212
                E     D+W++GC   EM   R                     P P V   + A 
Sbjct: 235 MLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAE 294
Query: 213 HRIGFSSDTPE---------IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
               +    P           PG   +QA   L + L   P  R SA+  L H F+ + +
Sbjct: 295 RVRAYIQSLPPRQPVPWETVYPG-ADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 353

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 7   QTIGRGSTATVSIG--MSNRSSEVF-AVKSAELSN-----SEFLQREQRILSALACPQIV 58
           + IGRG    V  G  + N   ++  AVKS          S+FL  E  I+   + P ++
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT-EGIIMKDFSHPNVL 89
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGR-IRSHTRAVLLGLQYLHS 117
           +  G  +  E   ++    L Y   G L + IR+ T     + +      V  G++YL S
Sbjct: 90  SLLGICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE--DDEGKPICGTPI-CMAPEVA 174
              VH D+  +N ++  D +   K+ADFG AR     E      K     P+  MA E  
Sbjct: 147 KKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 175 RGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
           + ++    +DVW+ G  + E+ T G PP+PDV
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 7   QTIGRGSTATVSIG--MSNRSSEVF-AVKSAELSN-----SEFLQREQRILSALACPQIV 58
           + IGRG    V  G  + N   ++  AVKS          S+FL  E  I+   + P ++
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT-EGIIMKDFSHPNVL 91
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGR-IRSHTRAVLLGLQYLHS 117
           +  G  +  E   ++    L Y   G L + IR+ T     + +      V  G++YL S
Sbjct: 92  SLLGICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 148
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE--DDEGKPICGTPI-CMAPEVA 174
              VH D+  +N ++  D +   K+ADFG AR     E      K     P+  MA E  
Sbjct: 149 KKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 206
Query: 175 RGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
           + ++    +DVW+ G  + E+ T G PP+PDV
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 7   QTIGRGSTATVSIG--MSNRSSEVF-AVKSAELSN-----SEFLQREQRILSALACPQIV 58
           + IGRG    V  G  + N   ++  AVKS          S+FL  E  I+   + P ++
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT-EGIIMKDFSHPNVL 94
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGR-IRSHTRAVLLGLQYLHS 117
           +  G  +  E   ++    L Y   G L + IR+ T     + +      V  G++YL S
Sbjct: 95  SLLGICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 151
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE--DDEGKPICGTPI-CMAPEVA 174
              VH D+  +N ++  D +   K+ADFG AR     E      K     P+  MA E  
Sbjct: 152 KKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 175 RGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
           + ++    +DVW+ G  + E+ T G PP+PDV
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 241

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 33/223 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA-----ELSNSEFLQREQRILSALACPQ 56
           ++     IGRGS   V +     + +  A+K       +L + + + RE  IL+ L    
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 57  IVAYKGCDISEENGKI--LYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
           I+      I ++  K   LY + LE A    L    ++   L E  I++    +LLG  +
Sbjct: 87  IIRLYDLIIPDDLLKFDELY-IVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR-------VNEDDEG-------- 159
           +H +GI+H D+K  N L+++D     K+ DFG AR          VN+ +E         
Sbjct: 145 IHESGIIHRDLKPANCLLNQD--CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 160 ---KPICGTPIC---MAPEVARGEEQGFPA-DVWALGCTVLEM 195
              K +    +     APE+   +E    + D+W+ GC   E+
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 115/300 (38%), Gaps = 50/300 (16%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAE-----LSNSEFLQREQRILSALACPQIVAYK 61
           +TIG G+   VS      + +  A+K        ++N++   RE +IL       I+A K
Sbjct: 60  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIK 119
Query: 62  GC---DISEENGKILYNLF--LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
                 +     K +Y +   +E      L   I S   L    +R     +L GL+Y+H
Sbjct: 120 DILRPTVPYGEFKSVYVVLDLME----SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH 175
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR---RARVNEDDEGKPICGTPICMAPEV 173
           S  ++H D+K  N+LV+++ E   KI DFG AR    +             T    APE+
Sbjct: 176 SAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 233
Query: 174 ARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP---------- 222
                E     D+W++GC   EM   R  +P   + +  L  I     TP          
Sbjct: 234 MLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG-KNYVHQLQLIMMVLGTPSPAVIQAVGA 292
Query: 223 -EIPGYMS------------------KQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
             +  Y+                   +QA   L + L   P  R SA+  L H F+ + +
Sbjct: 293 ERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CM 169
           G+++L S   +H D+  +NIL+S+ N    KI DFG AR    + D   K     P+  M
Sbjct: 162 GMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWM 219
Query: 170 APEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           APE          +DVW+ G  + E+ + G  P+P V        R+   +     P Y 
Sbjct: 220 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYT 278
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEH 256
           + +    +  C    P +R + SEL+EH
Sbjct: 279 TPEMYQTMLDCWHGEPSQRPTFSELVEH 306

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CM 169
           G+++L S   +H D+  +NIL+S+ N    KI DFG AR    + D   K     P+  M
Sbjct: 160 GMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWM 217
Query: 170 APEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           APE          +DVW+ G  + E+ + G  P+P V        R+   +     P Y 
Sbjct: 218 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYT 276
Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEH 256
           + +    +  C    P +R + SEL+EH
Sbjct: 277 TPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 7   QTIGRGSTATVSIG--MSNRSSEVF-AVKSAELSN-----SEFLQREQRILSALACPQIV 58
           + IGRG    V  G  + N   ++  AVKS          S+FL  E  I+   + P ++
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT-EGIIMKDFSHPNVL 112
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGR-IRSHTRAVLLGLQYLHS 117
           +  G  +  E   ++    L Y   G L + IR+ T     + +      V  G++YL S
Sbjct: 113 SLLGICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 169
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE--DDEGKPICGTPI-CMAPEVA 174
              VH D+  +N ++  D +   K+ADFG AR     E      K     P+  MA E  
Sbjct: 170 KKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 227
Query: 175 RGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
           + ++    +DVW+ G  + E+ T G PP+PDV
Sbjct: 228 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 259

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 7   QTIGRGSTATVSIG--MSNRSSEVF-AVKSAELSN-----SEFLQREQRILSALACPQIV 58
           + IGRG    V  G  + N   ++  AVKS          S+FL  E  I+   + P ++
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT-EGIIMKDFSHPNVL 93
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGR-IRSHTRAVLLGLQYLHS 117
           +  G  +  E   ++    L Y   G L + IR+ T     + +      V  G++YL S
Sbjct: 94  SLLGICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 150
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE--DDEGKPICGTPI-CMAPEVA 174
              VH D+  +N ++  D +   K+ADFG AR     E      K     P+  MA E  
Sbjct: 151 KKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 208
Query: 175 RGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
           + ++    +DVW+ G  + E+ T G PP+PDV
Sbjct: 209 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 240

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 7   QTIGRGSTATVSIG--MSNRSSEVF-AVKSAELSN-----SEFLQREQRILSALACPQIV 58
           + IGRG    V  G  + N   ++  AVKS          S+FL  E  I+   + P ++
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT-EGIIMKDFSHPNVL 94
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGR-IRSHTRAVLLGLQYLHS 117
           +  G  +  E   ++    L Y   G L + IR+ T     + +      V  G++YL S
Sbjct: 95  SLLGICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 151
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE--DDEGKPICGTPI-CMAPEVA 174
              VH D+  +N ++  D +   K+ADFG AR     E      K     P+  MA E  
Sbjct: 152 KKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 175 RGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
           + ++    +DVW+ G  + E+ T G PP+PDV
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 241

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 7   QTIGRGSTATVSIG--MSNRSSEVF-AVKSAELSN-----SEFLQREQRILSALACPQIV 58
           + IGRG    V  G  + N   ++  AVKS          S+FL  E  I+   + P ++
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT-EGIIMKDFSHPNVL 92
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGR-IRSHTRAVLLGLQYLHS 117
           +  G  +  E   ++    L Y   G L + IR+ T     + +      V  G++YL S
Sbjct: 93  SLLGICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 149
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE--DDEGKPICGTPI-CMAPEVA 174
              VH D+  +N ++  D +   K+ADFG AR     E      K     P+  MA E  
Sbjct: 150 KKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 207
Query: 175 RGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
           + ++    +DVW+ G  + E+ T G PP+PDV
Sbjct: 208 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 239

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 107/265 (40%), Gaps = 24/265 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGM-SNRSSEVFAV------KSAELSNSEFLQREQRILSALAC 54
           D    + +G G    V  G+ +N   E   V      K   L N E    E  I+  L  
Sbjct: 13  DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72
Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQ 113
           P IV   G  I EE   I+  L+    P G L   + R+   L+   +  ++  +   + 
Sbjct: 73  PHIVKLIGI-IEEEPTWIIMELY----PYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMAPE 172
           YL S   VH DI  +NILV+  + +  K+ DFG +R    +ED     +   PI  M+PE
Sbjct: 128 YLESINCVHRDIAVRNILVA--SPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPE 184
Query: 173 VARGEEQGFPADVWALGCTVLE-MATGRPP--WPDVADPISALHRIGFSSDTPEIPGYMS 229
                     +DVW     + E ++ G+ P  W +  D I  L +     D    P    
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK----GDRLPKPDLCP 240
Query: 230 KQAQDFLSKCLIRNPGERWSASELL 254
                 +++C   +P +R   +EL+
Sbjct: 241 PVLYTLMTRCWDYDPSDRPRFTELV 265

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 7   QTIGRGSTATVSIG--MSNRSSEVF-AVKSAELSN-----SEFLQREQRILSALACPQIV 58
           + IGRG    V  G  + N   ++  AVKS          S+FL  E  I+   + P ++
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT-EGIIMKDFSHPNVL 86
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGR-IRSHTRAVLLGLQYLHS 117
           +  G  +  E   ++    L Y   G L + IR+ T     + +      V  G++YL S
Sbjct: 87  SLLGICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 143
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE--DDEGKPICGTPI-CMAPEVA 174
              VH D+  +N ++  D +   K+ADFG AR     E      K     P+  MA E  
Sbjct: 144 KKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 201
Query: 175 RGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
           + ++    +DVW+ G  + E+ T G PP+PDV
Sbjct: 202 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 233

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 42/83 (50%), Gaps = 8/83 (9%)
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG--CARRARVNEDDEGKPICGTPICMAPEVARGE 177
           I+HCD+K +NIL+        KI DFG  C    R+ +  + +         +PEV  G 
Sbjct: 180 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSR------FYRSPEVLLGM 233
Query: 178 EQGFPADVWALGCTVLEMATGRP 200
                 D+W+LGC ++EM TG P
Sbjct: 234 PYDLAIDMWSLGCILVEMHTGEP 256

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 107/265 (40%), Gaps = 24/265 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGM-SNRSSEVFAV------KSAELSNSEFLQREQRILSALAC 54
           D    + +G G    V  G+ +N   E   V      K   L N E    E  I+  L  
Sbjct: 9   DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 68
Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQ 113
           P IV   G  I EE   I+  L+    P G L   + R+   L+   +  ++  +   + 
Sbjct: 69  PHIVKLIGI-IEEEPTWIIMELY----PYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 123
Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMAPE 172
           YL S   VH DI  +NILV+  + +  K+ DFG +R    +ED     +   PI  M+PE
Sbjct: 124 YLESINCVHRDIAVRNILVA--SPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPE 180
Query: 173 VARGEEQGFPADVWALGCTVLE-MATGRPP--WPDVADPISALHRIGFSSDTPEIPGYMS 229
                     +DVW     + E ++ G+ P  W +  D I  L +     D    P    
Sbjct: 181 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK----GDRLPKPDLCP 236
Query: 230 KQAQDFLSKCLIRNPGERWSASELL 254
                 +++C   +P +R   +EL+
Sbjct: 237 PVLYTLMTRCWDYDPSDRPRFTELV 261

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 42/83 (50%), Gaps = 8/83 (9%)
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG--CARRARVNEDDEGKPICGTPICMAPEVARGE 177
           I+HCD+K +NIL+        KI DFG  C    R+ +  + +         +PEV  G 
Sbjct: 180 IIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQXIQSR------FYRSPEVLLGM 233
Query: 178 EQGFPADVWALGCTVLEMATGRP 200
                 D+W+LGC ++EM TG P
Sbjct: 234 PYDLAIDMWSLGCILVEMHTGEP 256

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 7   QTIGRGSTATVSIG--MSNRSSEVF-AVKSAELSN-----SEFLQREQRILSALACPQIV 58
           + IGRG    V  G  + N   ++  AVKS          S+FL  E  I+   + P ++
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT-EGIIMKDFSHPNVL 113
Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGR-IRSHTRAVLLGLQYLHS 117
           +  G  +  E   ++    L Y   G L + IR+ T     + +      V  G++YL S
Sbjct: 114 SLLGICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 170
Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE--DDEGKPICGTPI-CMAPEVA 174
              VH D+  +N ++  D +   K+ADFG AR     E      K     P+  MA E  
Sbjct: 171 KKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 228
Query: 175 RGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
           + ++    +DVW+ G  + E+ T G PP+PDV
Sbjct: 229 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 260

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 107/265 (40%), Gaps = 24/265 (9%)
Query: 2   DWTRGQTIGRGSTATVSIGM-SNRSSEVFAV------KSAELSNSEFLQREQRILSALAC 54
           D    + +G G    V  G+ +N   E   V      K   L N E    E  I+  L  
Sbjct: 25  DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 84
Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQ 113
           P IV   G  I EE   I+  L+    P G L   + R+   L+   +  ++  +   + 
Sbjct: 85  PHIVKLIGI-IEEEPTWIIMELY----PYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 139
Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMAPE 172
           YL S   VH DI  +NILV+  + +  K+ DFG +R    +ED     +   PI  M+PE
Sbjct: 140 YLESINCVHRDIAVRNILVA--SPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPE 196
Query: 173 VARGEEQGFPADVWALGCTVLE-MATGRPP--WPDVADPISALHRIGFSSDTPEIPGYMS 229
                     +DVW     + E ++ G+ P  W +  D I  L +     D    P    
Sbjct: 197 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK----GDRLPKPDLCP 252
Query: 230 KQAQDFLSKCLIRNPGERWSASELL 254
                 +++C   +P +R   +EL+
Sbjct: 253 PVLYTLMTRCWDYDPSDRPRFTELV 277

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 42/83 (50%), Gaps = 8/83 (9%)
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG--CARRARVNEDDEGKPICGTPICMAPEVARGE 177
           I+HCD+K +NIL+        KI DFG  C    R+ +  + +         +PEV  G 
Sbjct: 161 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSR------FYRSPEVLLGM 214
Query: 178 EQGFPADVWALGCTVLEMATGRP 200
                 D+W+LGC ++EM TG P
Sbjct: 215 PYDLAIDMWSLGCILVEMHTGEP 237

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/310 (23%), Positives = 123/310 (39%), Gaps = 46/310 (14%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRI-LSALACPQIVAYKGCDI 65
           Q +G G    V    + R+ E FA+K   L +    +RE  +   A  CP IV  +  D+
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKM--LQDCPKARREVELHWRASQCPHIV--RIVDV 79
Query: 66  SEE--NGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            E    G+    + +E   GG L   I  R      E       +++   +QYLHS  I 
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 139
Query: 122 HCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           H D+K +N+L  SK      K+ DFG A+                          GE+  
Sbjct: 140 HRDVKPENLLYTSKRPNAILKLTDFGFAKE-----------------------TTGEKYD 176
Query: 181 FPADVWALGCTVLEMATGRPPWPD-----VADPISALHRIG-FSSDTPEIPGYMSKQAQD 234
              D+W+LG  +  +  G PP+       ++  +    R+G +    PE    +S++ + 
Sbjct: 177 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW-SEVSEEVKM 235
Query: 235 FLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLT 294
            +   L   P +R + +E + H ++      + +   P+T    S     +++ W+    
Sbjct: 236 LIRNLLKTEPTQRMTITEFMNHPWI------MQSTKVPQTPLHTSRVLKEDKERWEDVKE 289
Query: 295 SCSSASAKER 304
             +SA A  R
Sbjct: 290 EMTSALATMR 299

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 8/148 (5%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG-TPIC- 168
           G++YL S   +H D+  +N+LV++DN    KIADFG AR    + D   K   G  P+  
Sbjct: 162 GMEYLASKKCIHRDLAARNVLVTEDNVM--KIADFGLARDIH-HIDXXKKTTNGRLPVKW 218
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
           MAPE          +DVW+ G  + E+ T G  P+P V  P+  L ++       + P  
Sbjct: 219 MAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPSN 276
Query: 228 MSKQAQDFLSKCLIRNPGERWSASELLE 255
            + +    +  C    P +R +  +L+E
Sbjct: 277 CTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 71/148 (47%), Gaps = 8/148 (5%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG-TPIC- 168
           G++YL S   +H D+  +N+LV+++N    KIADFG AR    N D   K   G  P+  
Sbjct: 169 GMEYLASQKCIHRDLAARNVLVTENN--VMKIADFGLARDIN-NIDXXKKTTNGRLPVKW 225
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
           MAPE          +DVW+ G  + E+ T G  P+P +  P+  L ++       + P  
Sbjct: 226 MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHRMDKPAN 283
Query: 228 MSKQAQDFLSKCLIRNPGERWSASELLE 255
            + +    +  C    P +R +  +L+E
Sbjct: 284 CTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 71/148 (47%), Gaps = 8/148 (5%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG-TPIC- 168
           G++YL S   +H D+  +N+LV+++N    KIADFG AR    N D   K   G  P+  
Sbjct: 169 GMEYLASQKCIHRDLAARNVLVTENN--VMKIADFGLARDIN-NIDXXKKTTNGRLPVKW 225
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
           MAPE          +DVW+ G  + E+ T G  P+P +  P+  L ++       + P  
Sbjct: 226 MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHRMDKPAN 283
Query: 228 MSKQAQDFLSKCLIRNPGERWSASELLE 255
            + +    +  C    P +R +  +L+E
Sbjct: 284 CTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 31/226 (13%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVA 59
           D T  + +G G    V  G      +V    +K   +S  EF++ E +++  L+  ++V 
Sbjct: 9   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQ 67
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------GL 112
             G    +    I+     EY   G L + +R      E R R  T+ +L         +
Sbjct: 68  LYGVCTKQRPIFII----TEYMANGCLLNYLR------EMRHRFQTQQLLEMCKDVCEAM 117
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICM-- 169
           +YL S   +H D+  +N LV   N+QG  K++DFG +R      DDE     G+   +  
Sbjct: 118 EYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVL---DDEYTSSVGSKFPVRW 171
Query: 170 -APEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALH 213
             PEV    +    +D+WA G  + E+ + G+ P+    +  +A H
Sbjct: 172 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 217

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 8/148 (5%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG-TPI-C 168
           G++YL S   +H D+  +N+LV++DN    KIADFG AR    + D   K   G  P+  
Sbjct: 203 GMEYLASKKCIHRDLAARNVLVTEDNVM--KIADFGLARDIH-HIDYYKKTTNGRLPVKW 259
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
           MAPE          +DVW+ G  + E+ T G  P+P V  P+  L ++       + P  
Sbjct: 260 MAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPSN 317
Query: 228 MSKQAQDFLSKCLIRNPGERWSASELLE 255
            + +    +  C    P +R +  +L+E
Sbjct: 318 CTNELYMMMRDCWHAVPSQRPTFKQLVE 345

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 84/216 (38%), Gaps = 43/216 (19%)
Query: 87  TDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG 146
           TD  +    L +  IR +   +L  L Y HS GI+H D+K  N+++  ++ +  ++ D+G
Sbjct: 119 TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK-LRLIDWG 177
Query: 147 CARRARVNEDDEGKPICGTPICMAPE-VARGEEQGFPADVWALGCTVLEMATGRPPWPDV 205
            A      +  E      +     PE +   +   +  D+W+LGC +  M   + P+   
Sbjct: 178 LAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 235
Query: 206 ADPISALHRIGFSSDTPEIPGYMSK----------------------------------- 230
            D    L RI     T ++  Y+ K                                   
Sbjct: 236 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 295
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGF----VKEQ 262
           +A DFL K L  +   R +A E +EH +    VKEQ
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPYFYPVVKEQ 331

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG--TPI- 167
           G++YL S   +H D+  +N+LV++DN    KIADFG AR   ++  D  K       P+ 
Sbjct: 162 GMEYLASKKCIHRDLAARNVLVTEDNVM--KIADFGLAR--DIHHIDYYKKTTNGRLPVK 217
Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPG 226
            MAPE          +DVW+ G  + E+ T G  P+P V  P+  L ++       + P 
Sbjct: 218 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPS 275
Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLE 255
             + +    +  C    P +R +  +L+E
Sbjct: 276 NCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG--TPI- 167
           G++YL S   +H D+  +N+LV++DN    KIADFG AR   ++  D  K       P+ 
Sbjct: 155 GMEYLASKKCIHRDLAARNVLVTEDNVM--KIADFGLAR--DIHHIDYYKKTTNGRLPVK 210
Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPG 226
            MAPE          +DVW+ G  + E+ T G  P+P V  P+  L ++       + P 
Sbjct: 211 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPS 268
Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLE 255
             + +    +  C    P +R +  +L+E
Sbjct: 269 NCTNELYMMMRDCWHAVPSQRPTFKQLVE 297

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG--TPI- 167
           G++YL S   +H D+  +N+LV++DN    KIADFG AR   ++  D  K       P+ 
Sbjct: 162 GMEYLASKKCIHRDLAARNVLVTEDNVM--KIADFGLAR--DIHHIDYYKKTTNGRLPVK 217
Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPG 226
            MAPE          +DVW+ G  + E+ T G  P+P V  P+  L ++       + P 
Sbjct: 218 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPS 275
Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLE 255
             + +    +  C    P +R +  +L+E
Sbjct: 276 NCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 31/226 (13%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVA 59
           D T  + +G G    V  G      +V    +K   +S  EF++ E +++  L+  ++V 
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQ 63
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------GL 112
             G    +    I+     EY   G L + +R      E R R  T+ +L         +
Sbjct: 64  LYGVCTKQRPIFII----TEYMANGCLLNYLR------EMRHRFQTQQLLEMCKDVCEAM 113
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICM-- 169
           +YL S   +H D+  +N LV   N+QG  K++DFG +R      DDE     G+   +  
Sbjct: 114 EYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVL---DDEYTSSVGSKFPVRW 167
Query: 170 -APEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALH 213
             PEV    +    +D+WA G  + E+ + G+ P+    +  +A H
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 213

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG--TPI- 167
           G++YL S   +H D+  +N+LV++DN    KIADFG AR   ++  D  K       P+ 
Sbjct: 154 GMEYLASKKCIHRDLAARNVLVTEDNVM--KIADFGLAR--DIHHIDYYKKTTNGRLPVK 209
Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPG 226
            MAPE          +DVW+ G  + E+ T G  P+P V  P+  L ++       + P 
Sbjct: 210 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPS 267
Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLE 255
             + +    +  C    P +R +  +L+E
Sbjct: 268 NCTNELYMMMRDCWHAVPSQRPTFKQLVE 296

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 31/226 (13%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVA 59
           D T  + +G G    V  G      +V    +K   +S  EF++ E +++  L+  ++V 
Sbjct: 10  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQ 68
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------GL 112
             G    +    I+     EY   G L + +R      E R R  T+ +L         +
Sbjct: 69  LYGVCTKQRPIFII----TEYMANGCLLNYLR------EMRHRFQTQQLLEMCKDVCEAM 118
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICM-- 169
           +YL S   +H D+  +N LV   N+QG  K++DFG +R      DDE     G+   +  
Sbjct: 119 EYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVL---DDEYTSSVGSKFPVRW 172
Query: 170 -APEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALH 213
             PEV    +    +D+WA G  + E+ + G+ P+    +  +A H
Sbjct: 173 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 218

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG--TPI- 167
           G++YL S   +H D+  +N+LV++DN    KIADFG AR   ++  D  K       P+ 
Sbjct: 151 GMEYLASKKCIHRDLAARNVLVTEDNVM--KIADFGLAR--DIHHIDYYKKTTNGRLPVK 206
Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPG 226
            MAPE          +DVW+ G  + E+ T G  P+P V  P+  L ++       + P 
Sbjct: 207 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPS 264
Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLE 255
             + +    +  C    P +R +  +L+E
Sbjct: 265 NCTNELYMMMRDCWHAVPSQRPTFKQLVE 293

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 31/226 (13%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVA 59
           D T  + +G G    V  G      +V    +K   +S  EF++ E +++  L+  ++V 
Sbjct: 16  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQ 74
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------GL 112
             G    +    I+     EY   G L + +R      E R R  T+ +L         +
Sbjct: 75  LYGVCTKQRPIFII----TEYMANGCLLNYLR------EMRHRFQTQQLLEMCKDVCEAM 124
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICM-- 169
           +YL S   +H D+  +N LV   N+QG  K++DFG +R      DDE     G+   +  
Sbjct: 125 EYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVL---DDEYTSSVGSKFPVRW 178
Query: 170 -APEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALH 213
             PEV    +    +D+WA G  + E+ + G+ P+    +  +A H
Sbjct: 179 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 224

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 84/216 (38%), Gaps = 43/216 (19%)
Query: 87  TDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG 146
           TD  +    L +  IR +   +L  L Y HS GI+H D+K  N+L+  ++ +  ++ D+G
Sbjct: 119 TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRK-LRLIDWG 177
Query: 147 CARRARVNEDDEGKPICGTPICMAPE-VARGEEQGFPADVWALGCTVLEMATGRPPWPDV 205
            A      +  E      +     PE +   +   +  D+W+LGC +  M   + P+   
Sbjct: 178 LAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 235
Query: 206 ADPISALHRIGFSSDTPEIPGYMSK----------------------------------- 230
            D    L RI     T ++  Y+ K                                   
Sbjct: 236 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 295
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGF----VKEQ 262
           +A DFL K L  +   R +A E +EH +    VK+Q
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG--TPI- 167
           G++YL S   +H D+  +N+LV++DN    KIADFG AR   ++  D  K       P+ 
Sbjct: 162 GMEYLASKKCIHRDLAARNVLVTEDNVM--KIADFGLAR--DIHHIDYYKKTTNGRLPVK 217
Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPG 226
            MAPE          +DVW+ G  + E+ T G  P+P V  P+  L ++       + P 
Sbjct: 218 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPS 275
Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLE 255
             + +    +  C    P +R +  +L+E
Sbjct: 276 NCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 14/214 (6%)
Query: 44  REQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGT-LTDAIRSG-TCLEEGRI 101
           RE R+L+    P I+  +   +  E    ++ L+L      T L   I      +    I
Sbjct: 78  REIRLLNHFHHPNILGLRDIFVHFEEPA-MHKLYLVTELMRTDLAQVIHDQRIVISPQHI 136
Query: 102 RSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP 161
           +     +LLGL  LH  G+VH D+   NIL++ +N+    I DF  AR      D     
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITICDFNLARED--TADANKTH 192
Query: 162 ICGTPICMAPEVARGEEQGFP--ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS 219
                   APE+   + +GF    D+W+ GC + EM   +  +   +   + L++I    
Sbjct: 193 YVTHRWYRAPELVM-QFKGFTKLVDMWSAGCVMAEMFNRKALFRG-STFYNQLNKIVEVV 250
Query: 220 DTPEIPG---YMSKQAQDFLSKCLIRNPGERWSA 250
            TP+I     + S  A+D+L   L   P   W+A
Sbjct: 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTA 284

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG--TPI- 167
           G++YL S   +H D+  +N+LV++DN    KIADFG AR   ++  D  K       P+ 
Sbjct: 147 GMEYLASKKCIHRDLAARNVLVTEDNVM--KIADFGLAR--DIHHIDYYKKTTNGRLPVK 202
Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPG 226
            MAPE          +DVW+ G  + E+ T G  P+P V  P+  L ++       + P 
Sbjct: 203 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPS 260
Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLE 255
             + +    +  C    P +R +  +L+E
Sbjct: 261 NCTNELYMMMRDCWHAVPSQRPTFKQLVE 289

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/271 (23%), Positives = 115/271 (42%), Gaps = 35/271 (12%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE----------FLQREQRILSALACPQ 56
           + IG+G    V  G   +   V A+KS  L +SE            QRE  I+S L  P 
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 57  IVAYKGCDISEENGKILYN---LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRA-VLLGL 112
           IV   G         +++N   + +E+ P G L   +       +  ++      + LG+
Sbjct: 85  IVKLYG---------LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 113 QYLHSNG--IVHCDIKGQNILVSKDNEQG---AKIADFGCARRARVNEDDEGKPICGTPI 167
           +Y+ +    IVH D++  NI +   +E     AK+ADF  ++++  +       + G   
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSG----LLGNFQ 191
Query: 168 CMAPEVARGEEQGF--PADVWALGCTVLEMATGRPPWPDVA-DPISALHRIGFSSDTPEI 224
            MAPE    EE+ +   AD ++    +  + TG  P+ + +   I  ++ I      P I
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251
Query: 225 PGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
           P     + ++ +  C   +P +R   S +++
Sbjct: 252 PEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG--TPI- 167
           G++YL S   +H D+  +N+LV+++N    KIADFG AR   +N  D  K       P+ 
Sbjct: 169 GMEYLASQKCIHRDLAARNVLVTENNVM--KIADFGLAR--DINNIDYYKKTTNGRLPVK 224
Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPG 226
            MAPE          +DVW+ G  + E+ T G  P+P +  P+  L ++       + P 
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHRMDKPA 282
Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLE 255
             + +    +  C    P +R +  +L+E
Sbjct: 283 NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG--TPI- 167
           G++YL S   +H D+  +N+LV+++N    KIADFG AR   +N  D  K       P+ 
Sbjct: 169 GMEYLASQKCIHRDLAARNVLVTENNVM--KIADFGLAR--DINNIDYYKKTTNGRLPVK 224
Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPG 226
            MAPE          +DVW+ G  + E+ T G  P+P +  P+  L ++       + P 
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHRMDKPA 282
Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLE 255
             + +    +  C    P +R +  +L+E
Sbjct: 283 NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG--TPI- 167
           G++YL S   +H D+  +N+LV+++N    KIADFG AR   +N  D  K       P+ 
Sbjct: 158 GMEYLASQKCIHRDLAARNVLVTENNVM--KIADFGLAR--DINNIDYYKKTTNGRLPVK 213
Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPG 226
            MAPE          +DVW+ G  + E+ T G  P+P +  P+  L ++       + P 
Sbjct: 214 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHRMDKPA 271
Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLE 255
             + +    +  C    P +R +  +L+E
Sbjct: 272 NCTNELYMMMRDCWHAVPSQRPTFKQLVE 300

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG--TPI- 167
           G++YL S   +H D+  +N+LV+++N    KIADFG AR   +N  D  K       P+ 
Sbjct: 156 GMEYLASQKCIHRDLTARNVLVTENNVM--KIADFGLAR--DINNIDYYKKTTNGRLPVK 211
Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPG 226
            MAPE          +DVW+ G  + E+ T G  P+P +  P+  L ++       + P 
Sbjct: 212 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHRMDKPA 269
Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLE 255
             + +    +  C    P +R +  +L+E
Sbjct: 270 NCTNELYMMMRDCWHAVPSQRPTFKQLVE 298

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG--TPI- 167
           G++YL S   +H D+  +N+LV+++N    KIADFG AR   +N  D  K       P+ 
Sbjct: 169 GMEYLASQKCIHRDLAARNVLVTENNVM--KIADFGLAR--DINNIDYYKKTTNGRLPVK 224
Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPG 226
            MAPE          +DVW+ G  + E+ T G  P+P +  P+  L ++       + P 
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHRMDKPA 282
Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLE 255
             + +    +  C    P +R +  +L+E
Sbjct: 283 NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG--TPI- 167
           G++YL S   +H D+  +N+LV+++N    KIADFG AR   +N  D  K       P+ 
Sbjct: 169 GMEYLASQKCIHRDLAARNVLVTENNVM--KIADFGLAR--DINNIDYYKKTTNGRLPVK 224
Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPG 226
            MAPE          +DVW+ G  + E+ T G  P+P +  P+  L ++       + P 
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHRMDKPA 282
Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLE 255
             + +    +  C    P +R +  +L+E
Sbjct: 283 NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 31/226 (13%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVA 59
           D T  + +G G    V  G      +V    +K   +S  EF++ E +++  L+  ++V 
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQ 83
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------GL 112
             G    +    I+     EY   G L + +R      E R R  T+ +L         +
Sbjct: 84  LYGVCTKQRPIFII----TEYMANGCLLNYLR------EMRHRFQTQQLLEMCKDVCEAM 133
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICM-- 169
           +YL S   +H D+  +N LV   N+QG  K++DFG +R      DDE     G+   +  
Sbjct: 134 EYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVL---DDEETSSVGSKFPVRW 187
Query: 170 -APEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALH 213
             PEV    +    +D+WA G  + E+ + G+ P+    +  +A H
Sbjct: 188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 31/226 (13%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVA 59
           D T  + +G G    V  G      +V    +K   +S  EF++ E +++  L+  ++V 
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQ 83
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------GL 112
             G    +    I+     EY   G L + +R      E R R  T+ +L         +
Sbjct: 84  LYGVCTKQRPIFII----TEYMANGCLLNYLR------EMRHRFQTQQLLEMCKDVCEAM 133
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICM-- 169
           +YL S   +H D+  +N LV   N+QG  K++DFG +R      DDE     G+   +  
Sbjct: 134 EYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVL---DDEYTSSVGSKFPVRW 187
Query: 170 -APEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALH 213
             PEV    +    +D+WA G  + E+ + G+ P+    +  +A H
Sbjct: 188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 87/188 (46%), Gaps = 20/188 (10%)
Query: 101 IRSHTRAVLLGLQYLHSN-GIVHCDIKGQNILV----SKDNEQGAKIADFGCARRARVNE 155
           ++  ++ +LLGL Y+H   GI+H DIK +N+L+    S +N    KIAD G A       
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWY 188
Query: 156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW-PDVADPISA--L 212
           D+       T    +PEV  G   G  AD+W+  C + E+ TG   + PD     +    
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248
Query: 213 HRIGFSSDTPEIPGYMSKQAQD----FLSKCLIRNPGER--WSASELL--EHGFVKEQNF 264
           H         E+P Y+ +  +     F S+ L+RN  +   W   ++L  ++ F K++  
Sbjct: 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 308
Query: 265 KLSTLTEP 272
           ++S    P
Sbjct: 309 EISDFLSP 316

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 14/214 (6%)
Query: 44  REQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGT-LTDAIRSG-TCLEEGRI 101
           RE R+L+    P I+  +   +  E    ++ L+L      T L   I      +    I
Sbjct: 78  REIRLLNHFHHPNILGLRDIFVHFEEPA-MHKLYLVTELMRTDLAQVIHDQRIVISPQHI 136
Query: 102 RSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP 161
           +     +LLGL  LH  G+VH D+   NIL++ +N+    I DF  AR      D     
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITICDFNLARED--TADANKTH 192
Query: 162 ICGTPICMAPEVARGEEQGFP--ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS 219
                   APE+   + +GF    D+W+ GC + EM   +  +   +   + L++I    
Sbjct: 193 YVTHRWYRAPELVM-QFKGFTKLVDMWSAGCVMAEMFNRKALFRG-STFYNQLNKIVEVV 250
Query: 220 DTPEIPG---YMSKQAQDFLSKCLIRNPGERWSA 250
            TP+I     + S  A+D+L   L   P   W+A
Sbjct: 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTA 284

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG--TPIC 168
           G++YL S   +H D+  +N+LV+++N    KIADFG AR   +N  D  K       P+ 
Sbjct: 215 GMEYLASQKCIHRDLAARNVLVTENNVM--KIADFGLAR--DINNIDYYKKTTNGRLPVK 270
Query: 169 -MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPG 226
            MAPE          +DVW+ G  + E+ T G  P+P +  P+  L ++       + P 
Sbjct: 271 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHRMDKPA 328
Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLE 255
             + +    +  C    P +R +  +L+E
Sbjct: 329 NCTNELYMMMRDCWHAVPSQRPTFKQLVE 357

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 87/188 (46%), Gaps = 20/188 (10%)
Query: 101 IRSHTRAVLLGLQYLHSN-GIVHCDIKGQNILV----SKDNEQGAKIADFGCARRARVNE 155
           ++  ++ +LLGL Y+H   GI+H DIK +N+L+    S +N    KIAD G A       
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWY 188
Query: 156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW-PDVADPISA--L 212
           D+       T    +PEV  G   G  AD+W+  C + E+ TG   + PD     +    
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248
Query: 213 HRIGFSSDTPEIPGYMSKQAQD----FLSKCLIRNPGER--WSASELL--EHGFVKEQNF 264
           H         E+P Y+ +  +     F S+ L+RN  +   W   ++L  ++ F K++  
Sbjct: 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 308
Query: 265 KLSTLTEP 272
           ++S    P
Sbjct: 309 EISDFLSP 316

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 71/148 (47%), Gaps = 8/148 (5%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG-TPI-C 168
           G++YL S   +H D+  +N+LV+++N    KIADFG AR    N D   K   G  P+  
Sbjct: 169 GMEYLASQKCIHRDLAARNVLVTENNVM--KIADFGLARDIN-NIDYYKKTTNGRLPVKW 225
Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGY 227
           MAPE          +DVW+ G  + E+ T G  P+P +  P+  L ++       + P  
Sbjct: 226 MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHRMDKPAN 283
Query: 228 MSKQAQDFLSKCLIRNPGERWSASELLE 255
            + +    +  C    P +R +  +L+E
Sbjct: 284 CTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG--TPI- 167
           G++YL S   +H D+  +N+LV+++N    KIADFG AR   +N  D  K       P+ 
Sbjct: 161 GMEYLASQKCIHRDLAARNVLVTENNVM--KIADFGLAR--DINNIDYYKKTTNGRLPVK 216
Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPG 226
            MAPE          +DVW+ G  + E+ T G  P+P +  P+  L ++       + P 
Sbjct: 217 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHRMDKPA 274
Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLE 255
             + +    +  C    P +R +  +L+E
Sbjct: 275 NCTNELYMMMRDCWHAVPSQRPTFKQLVE 303

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 104/241 (43%), Gaps = 22/241 (9%)
Query: 45  EQRILSALACPQIVAYKGCDISEENGKILYNLFLE-YAPGGTLTDAIRSGTCLEEGRIRS 103
           E  ILS +    I+  K  DI E  G   + L +E +  G  L   I     L+E     
Sbjct: 79  EIAILSRVEHANII--KVLDIFENQG--FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134
Query: 104 HTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPIC 163
             R ++  + YL    I+H DIK +NI++++D     K+ DFG A  A +         C
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF--TIKLIDFGSA--AYLERGKLFYTFC 190
Query: 164 GTPICMAPEVARGEE-QGFPADVWALGCTVLEMATGRPPWPDVADPI-SALHRIGFSSDT 221
           GT    APEV  G   +G   ++W+LG T+  +     P+ ++ + + +A+H        
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHP------- 243
Query: 222 PEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPT 281
              P  +SK+    +S  L   P  R +  +L+   +V  Q   L+  T  E +    P 
Sbjct: 244 ---PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVT-QPVNLADYTWEEVFRVNKPE 299
Query: 282 S 282
           S
Sbjct: 300 S 300

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 33/227 (14%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVF--AVKSAELSNSEFLQREQRILSALACPQIVA 59
           D T  + +G G    V  G      +V    +K   +S  EF++ E +++  L+  ++V 
Sbjct: 10  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQ 68
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-------GL 112
             G    +    I+     EY   G L + +R      E R R  T+ +L         +
Sbjct: 69  LYGVCTKQRPIFII----TEYMANGCLLNYLR------EMRHRFQTQQLLEMCKDVCEAM 118
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGK----PICGTPI 167
           +YL S   +H D+  +N LV   N+QG  K++DFG +R    +E    +    P+  +P 
Sbjct: 119 EYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSP- 174
Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALH 213
              PEV    +    +D+WA G  + E+ + G+ P+    +  +A H
Sbjct: 175 ---PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 218

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 84/216 (38%), Gaps = 43/216 (19%)
Query: 87  TDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG 146
           TD  +    L +  IR +   +L  L Y HS GI+H D+K  N+++  ++ +  ++ D+G
Sbjct: 119 TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK-LRLIDWG 177
Query: 147 CARRARVNEDDEGKPICGTPICMAPE-VARGEEQGFPADVWALGCTVLEMATGRPPWPDV 205
            A      +  E      +     PE +   +   +  D+W+LGC +  M   + P+   
Sbjct: 178 LAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 235
Query: 206 ADPISALHRIGFSSDTPEIPGYMSK----------------------------------- 230
            D    L RI     T ++  Y+ K                                   
Sbjct: 236 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 295
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGF----VKEQ 262
           +A DFL K L  +   R +A E +EH +    VK+Q
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 84/216 (38%), Gaps = 43/216 (19%)
Query: 87  TDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG 146
           TD  +    L +  IR +   +L  L Y HS GI+H D+K  N+++  ++ +  ++ D+G
Sbjct: 118 TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK-LRLIDWG 176
Query: 147 CARRARVNEDDEGKPICGTPICMAPE-VARGEEQGFPADVWALGCTVLEMATGRPPWPDV 205
            A      +  E      +     PE +   +   +  D+W+LGC +  M   + P+   
Sbjct: 177 LAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234
Query: 206 ADPISALHRIGFSSDTPEIPGYMSK----------------------------------- 230
            D    L RI     T ++  Y+ K                                   
Sbjct: 235 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 294
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGF----VKEQ 262
           +A DFL K L  +   R +A E +EH +    VK+Q
Sbjct: 295 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 330

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG--TPI- 167
           G++YL S   +H D+  +N+LV+++N    KIADFG AR   +N  D  K       P+ 
Sbjct: 169 GMEYLASQKCIHRDLAARNVLVTENNVM--KIADFGLAR--DINNIDYYKNTTNGRLPVK 224
Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPG 226
            MAPE          +DVW+ G  + E+ T G  P+P +  P+  L ++       + P 
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHRMDKPA 282
Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLE 255
             + +    +  C    P +R +  +L+E
Sbjct: 283 NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 92/223 (41%), Gaps = 38/223 (17%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSA-----ELSNSEFLQREQRILSALACPQIVAYK 61
             IG GS   V          V A+K       +L + + + RE  IL+ L    +V   
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 62  GCDISEENGKI--LYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
              I ++  K   LY + LE A         R+   L E  I++    +L+G++Y+HS G
Sbjct: 119 DIVIPKDVEKFDELY-VVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG 176
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARV------------NEDDEG-------- 159
           I+H D+K  N LV++D     K+ DFG AR                 EDD          
Sbjct: 177 ILHRDLKPANCLVNQDC--SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTK 234
Query: 160 ---KPICGTPIC---MAPEVARGEEQGFPA-DVWALGCTVLEM 195
              + + G  +     APE+   +E    A DVW++GC   E+
Sbjct: 235 NLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 84/216 (38%), Gaps = 43/216 (19%)
Query: 87  TDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG 146
           TD  +    L +  IR +   +L  L Y HS GI+H D+K  N+++  ++ +  ++ D+G
Sbjct: 119 TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK-LRLIDWG 177
Query: 147 CARRARVNEDDEGKPICGTPICMAPE-VARGEEQGFPADVWALGCTVLEMATGRPPWPDV 205
            A      +  E      +     PE +   +   +  D+W+LGC +  M   + P+   
Sbjct: 178 LAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 235
Query: 206 ADPISALHRIGFSSDTPEIPGYMSK----------------------------------- 230
            D    L RI     T ++  Y+ K                                   
Sbjct: 236 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 295
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGF----VKEQ 262
           +A DFL K L  +   R +A E +EH +    VK+Q
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 84/216 (38%), Gaps = 43/216 (19%)
Query: 87  TDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG 146
           TD  +    L +  IR +   +L  L Y HS GI+H D+K  N+++  ++ +  ++ D+G
Sbjct: 119 TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK-LRLIDWG 177
Query: 147 CARRARVNEDDEGKPICGTPICMAPE-VARGEEQGFPADVWALGCTVLEMATGRPPWPDV 205
            A      +  E      +     PE +   +   +  D+W+LGC +  M   + P+   
Sbjct: 178 LAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 235
Query: 206 ADPISALHRIGFSSDTPEIPGYMSK----------------------------------- 230
            D    L RI     T ++  Y+ K                                   
Sbjct: 236 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 295
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGF----VKEQ 262
           +A DFL K L  +   R +A E +EH +    VK+Q
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 84/216 (38%), Gaps = 43/216 (19%)
Query: 87  TDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG 146
           TD  +    L +  IR +   +L  L Y HS GI+H D+K  N+++  ++ +  ++ D+G
Sbjct: 119 TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK-LRLIDWG 177
Query: 147 CARRARVNEDDEGKPICGTPICMAPE-VARGEEQGFPADVWALGCTVLEMATGRPPWPDV 205
            A      +  E      +     PE +   +   +  D+W+LGC +  M   + P+   
Sbjct: 178 LAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 235
Query: 206 ADPISALHRIGFSSDTPEIPGYMSK----------------------------------- 230
            D    L RI     T ++  Y+ K                                   
Sbjct: 236 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 295
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGF----VKEQ 262
           +A DFL K L  +   R +A E +EH +    VK+Q
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 78/181 (43%), Gaps = 14/181 (7%)
Query: 82  PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAK 141
           P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+   N    K
Sbjct: 93  PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDL-NRGELK 151
Query: 142 IADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCTVLEMATGRP 200
           + DFG     +   D       GT +   PE  R     G  A VW+LG  + +M  G  
Sbjct: 152 LIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 208
Query: 201 PWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
           P+    + I    ++ F          +S + Q  +  CL   P +R +  E+  H +++
Sbjct: 209 PFEHDEEIIRG--QVFFRQR-------VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259
Query: 261 E 261
           +
Sbjct: 260 D 260

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 84/216 (38%), Gaps = 43/216 (19%)
Query: 87  TDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG 146
           TD  +    L +  IR +   +L  L Y HS GI+H D+K  N+++  ++ +  ++ D+G
Sbjct: 119 TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK-LRLIDWG 177
Query: 147 CARRARVNEDDEGKPICGTPICMAPE-VARGEEQGFPADVWALGCTVLEMATGRPPWPDV 205
            A      +  E      +     PE +   +   +  D+W+LGC +  M   + P+   
Sbjct: 178 LAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 235
Query: 206 ADPISALHRIGFSSDTPEIPGYMSK----------------------------------- 230
            D    L RI     T ++  Y+ K                                   
Sbjct: 236 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 295
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGF----VKEQ 262
           +A DFL K L  +   R +A E +EH +    VK+Q
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 84/216 (38%), Gaps = 43/216 (19%)
Query: 87  TDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG 146
           TD  +    L +  IR +   +L  L Y HS GI+H D+K  N+++  ++ +  ++ D+G
Sbjct: 119 TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK-LRLIDWG 177
Query: 147 CARRARVNEDDEGKPICGTPICMAPE-VARGEEQGFPADVWALGCTVLEMATGRPPWPDV 205
            A      +  E      +     PE +   +   +  D+W+LGC +  M   + P+   
Sbjct: 178 LAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 235
Query: 206 ADPISALHRIGFSSDTPEIPGYMSK----------------------------------- 230
            D    L RI     T ++  Y+ K                                   
Sbjct: 236 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 295
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGF----VKEQ 262
           +A DFL K L  +   R +A E +EH +    VK+Q
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 84/216 (38%), Gaps = 43/216 (19%)
Query: 87  TDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG 146
           TD  +    L +  IR +   +L  L Y HS GI+H D+K  N+++  ++ +  ++ D+G
Sbjct: 119 TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK-LRLIDWG 177
Query: 147 CARRARVNEDDEGKPICGTPICMAPE-VARGEEQGFPADVWALGCTVLEMATGRPPWPDV 205
            A      +  E      +     PE +   +   +  D+W+LGC +  M   + P+   
Sbjct: 178 LAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 235
Query: 206 ADPISALHRIGFSSDTPEIPGYMSK----------------------------------- 230
            D    L RI     T ++  Y+ K                                   
Sbjct: 236 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 295
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGF----VKEQ 262
           +A DFL K L  +   R +A E +EH +    VK+Q
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 84/216 (38%), Gaps = 43/216 (19%)
Query: 87  TDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG 146
           TD  +    L +  IR +   +L  L Y HS GI+H D+K  N+++  ++ +  ++ D+G
Sbjct: 118 TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK-LRLIDWG 176
Query: 147 CARRARVNEDDEGKPICGTPICMAPE-VARGEEQGFPADVWALGCTVLEMATGRPPWPDV 205
            A      +  E      +     PE +   +   +  D+W+LGC +  M   + P+   
Sbjct: 177 LAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234
Query: 206 ADPISALHRIGFSSDTPEIPGYMSK----------------------------------- 230
            D    L RI     T ++  Y+ K                                   
Sbjct: 235 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 294
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGF----VKEQ 262
           +A DFL K L  +   R +A E +EH +    VK+Q
Sbjct: 295 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 330

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 84/216 (38%), Gaps = 43/216 (19%)
Query: 87  TDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG 146
           TD  +    L +  IR +   +L  L Y HS GI+H D+K  N+++  ++ +  ++ D+G
Sbjct: 119 TDFKQLRQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK-LRLIDWG 177
Query: 147 CARRARVNEDDEGKPICGTPICMAPE-VARGEEQGFPADVWALGCTVLEMATGRPPWPDV 205
            A      +  E      +     PE +   +   +  D+W+LGC +  M   + P+   
Sbjct: 178 LAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 235
Query: 206 ADPISALHRIGFSSDTPEIPGYMSK----------------------------------- 230
            D    L RI     T ++  Y+ K                                   
Sbjct: 236 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 295
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGF----VKEQ 262
           +A DFL K L  +   R +A E +EH +    VK+Q
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 331

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 17/206 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-------SEFLQREQRILSALACPQIVA 59
           + +G G+  TV  G       V  V    L N        + L  E  ++  L  P IV 
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
             G   +E      + L +E A  G L   ++    +++  I      V +G++YL  + 
Sbjct: 77  MIGICEAES-----WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 131
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT-PI-CMAPEVARGE 177
            VH D+  +N+L+    +  AKI+DFG ++  R +E+       G  P+   APE     
Sbjct: 132 FVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYY 189
Query: 178 EQGFPADVWALGCTVLE-MATGRPPW 202
           +    +DVW+ G  + E  + G+ P+
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKPY 215

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/298 (22%), Positives = 111/298 (37%), Gaps = 42/298 (14%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQREQRILSALACPQI 57
           + R   +G G+   V   +   ++E  A+K   L + E        RE  +L  L    I
Sbjct: 36  YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           +  K   +   N ++  +L  EYA    L   +     +    I+S    ++ G+ + HS
Sbjct: 96  IELKS--VIHHNHRL--HLIFEYAEND-LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 118 NGIVHCDIKGQNILVSKDNEQGA---KIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
              +H D+K QN+L+S  +       KI DFG AR   +        I  T     PE+ 
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEIL 209
Query: 175 RGEEQ-GFPADVWALGCTVLEMATGRPPWP---DVADPISALHRIGFSSDT--------P 222
            G        D+W++ C   EM    P +P   ++         +G   DT        P
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP 269
Query: 223 E----IPGYMSKQAQDFL------------SKCLIRNPGERWSASELLEHGFVKEQNF 264
           +     P +  K  +  L            +  L  +P +R SA   LEH +    +F
Sbjct: 270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 84/216 (38%), Gaps = 43/216 (19%)
Query: 87  TDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG 146
           TD  +    L +  IR +   +L  L Y HS GI+H D+K  N+++  ++ +  ++ D+G
Sbjct: 124 TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK-LRLIDWG 182
Query: 147 CARRARVNEDDEGKPICGTPICMAPE-VARGEEQGFPADVWALGCTVLEMATGRPPWPDV 205
            A      +  E      +     PE +   +   +  D+W+LGC +  M   + P+   
Sbjct: 183 LAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 240
Query: 206 ADPISALHRIGFSSDTPEIPGYMSK----------------------------------- 230
            D    L RI     T ++  Y+ K                                   
Sbjct: 241 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 300
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGF----VKEQ 262
           +A DFL K L  +   R +A E +EH +    VK+Q
Sbjct: 301 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 336

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG--TPI- 167
           G++YL S   +H D+  +N+LV+++N    +IADFG AR   +N  D  K       P+ 
Sbjct: 169 GMEYLASQKCIHRDLAARNVLVTENNVM--RIADFGLAR--DINNIDYYKKTTNGRLPVK 224
Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPG 226
            MAPE          +DVW+ G  + E+ T G  P+P +  P+  L ++       + P 
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHRMDKPA 282
Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLE 255
             + +    +  C    P +R +  +L+E
Sbjct: 283 NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 67/304 (22%), Positives = 116/304 (38%), Gaps = 50/304 (16%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQI 57
           D+     +G G+   V       + E+ A+K  E  +         RE +IL       I
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 58  VAYKGCDISEENGKILYN-LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +     +I   +    +N +++      T    + S   L +  I+      L  ++ LH
Sbjct: 72  ITI--FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP---------ICGTPI 167
            + ++H D+K  N+L++ + +   K+ DFG AR    +  D  +P            T  
Sbjct: 130 GSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW 187
Query: 168 CMAPEVARGEEQGFPA-DVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE--- 223
             APEV     +   A DVW+ GC + E+   RP +P   D    L  I     TP    
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG-RDYRHQLLLIFGIIGTPHSDN 246
Query: 224 ----------------IPGY-----------MSKQAQDFLSKCLIRNPGERWSASELLEH 256
                           +P Y           ++ +  D L + L+ +P +R +A E LEH
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306
Query: 257 GFVK 260
            +++
Sbjct: 307 PYLQ 310

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 74  YNLFLE-YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           + L LE   P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+
Sbjct: 88  FVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 147
Query: 133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCT 191
              N    K+ DFG     +   D       GT +   PE  R     G  A VW+LG  
Sbjct: 148 DL-NRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 203
Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS 251
           + +M  G  P+    + I    ++ F          +S + Q  +  CL   P +R +  
Sbjct: 204 LYDMVCGDIPFEHDEEIIRG--QVFFRQR-------VSSECQHLIRWCLALRPSDRPTFE 254
Query: 252 ELLEHGFVKE 261
           E+  H ++++
Sbjct: 255 EIQNHPWMQD 264

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 17/206 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-------SEFLQREQRILSALACPQIVA 59
           + +G G+  TV  G       V  V    L N        + L  E  ++  L  P IV 
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
             G   +E      + L +E A  G L   ++    +++  I      V +G++YL  + 
Sbjct: 77  MIGICEAES-----WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 131
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT-PI-CMAPEVARGE 177
            VH D+  +N+L+    +  AKI+DFG ++  R +E+       G  P+   APE     
Sbjct: 132 FVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 189
Query: 178 EQGFPADVWALGCTVLE-MATGRPPW 202
           +    +DVW+ G  + E  + G+ P+
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKPY 215

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 17/206 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-------SEFLQREQRILSALACPQIVA 59
           + +G G+  TV  G       V  V    L N        + L  E  ++  L  P IV 
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
             G   +E      + L +E A  G L   ++    +++  I      V +G++YL  + 
Sbjct: 93  MIGICEAES-----WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 147
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT-PI-CMAPEVARGE 177
            VH D+  +N+L+    +  AKI+DFG ++  R +E+       G  P+   APE     
Sbjct: 148 FVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 178 EQGFPADVWALGCTVLE-MATGRPPW 202
           +    +DVW+ G  + E  + G+ P+
Sbjct: 206 KFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 17/206 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-------SEFLQREQRILSALACPQIVA 59
           + +G G+  TV  G       V  V    L N        + L  E  ++  L  P IV 
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
             G   +E      + L +E A  G L   ++    +++  I      V +G++YL  + 
Sbjct: 93  MIGICEAES-----WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 147
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT-PI-CMAPEVARGE 177
            VH D+  +N+L+    +  AKI+DFG ++  R +E+       G  P+   APE     
Sbjct: 148 FVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 178 EQGFPADVWALGCTVLE-MATGRPPW 202
           +    +DVW+ G  + E  + G+ P+
Sbjct: 206 KFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 80/208 (38%), Gaps = 39/208 (18%)
Query: 87  TDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG 146
           TD  +    L +  IR +   +L  L Y HS GI+H D+K  N+++  ++ +  ++ D+G
Sbjct: 117 TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK-LRLIDWG 175
Query: 147 CARRARVNEDDEGKPICGTPICMAPE-VARGEEQGFPADVWALGCTVLEMATGRPPWPDV 205
            A      +  E      +     PE +   +   +  D+W+LGC +  M   + P+   
Sbjct: 176 LAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233
Query: 206 ADPISALHRIGFSSDTPEIPGYMSK----------------------------------- 230
            D    L RI     T ++  Y+ K                                   
Sbjct: 234 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 293
Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGF 258
           +A DFL K L  +   R +A E +EH +
Sbjct: 294 EALDFLDKLLRYDHQSRLTAREAMEHPY 321

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 17/206 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-------SEFLQREQRILSALACPQIVA 59
           + +G G+  TV  G       V  V    L N        + L  E  ++  L  P IV 
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
             G   +E      + L +E A  G L   ++    +++  I      V +G++YL  + 
Sbjct: 91  MIGICEAES-----WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 145
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT-PI-CMAPEVARGE 177
            VH D+  +N+L+    +  AKI+DFG ++  R +E+       G  P+   APE     
Sbjct: 146 FVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 203
Query: 178 EQGFPADVWALGCTVLE-MATGRPPW 202
           +    +DVW+ G  + E  + G+ P+
Sbjct: 204 KFSSKSDVWSFGVLMWEAFSYGQKPY 229

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 78/181 (43%), Gaps = 14/181 (7%)
Query: 82  PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAK 141
           P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+   N    K
Sbjct: 93  PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELK 151
Query: 142 IADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCTVLEMATGRP 200
           + DFG     +   D       GT +   PE  R     G  A VW+LG  + +M  G  
Sbjct: 152 LIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 208
Query: 201 PWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
           P+    + I    ++ F          +S + Q  +  CL   P +R +  E+  H +++
Sbjct: 209 PFEHDEEIIRG--QVFFRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259
Query: 261 E 261
           +
Sbjct: 260 D 260

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 78/181 (43%), Gaps = 14/181 (7%)
Query: 82  PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAK 141
           P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+   N    K
Sbjct: 96  PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELK 154
Query: 142 IADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCTVLEMATGRP 200
           + DFG     +   D       GT +   PE  R     G  A VW+LG  + +M  G  
Sbjct: 155 LIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 211
Query: 201 PWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
           P+    + I    ++ F          +S + Q  +  CL   P +R +  E+  H +++
Sbjct: 212 PFEHDEEIIRG--QVFFRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 262
Query: 261 E 261
           +
Sbjct: 263 D 263

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 17/206 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-------SEFLQREQRILSALACPQIVA 59
           + +G G+  TV  G       V  V    L N        + L  E  ++  L  P IV 
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
             G   +E      + L +E A  G L   ++    +++  I      V +G++YL  + 
Sbjct: 71  MIGICEAES-----WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 125
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT-PI-CMAPEVARGE 177
            VH D+  +N+L+    +  AKI+DFG ++  R +E+       G  P+   APE     
Sbjct: 126 FVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 183
Query: 178 EQGFPADVWALGCTVLE-MATGRPPW 202
           +    +DVW+ G  + E  + G+ P+
Sbjct: 184 KFSSKSDVWSFGVLMWEAFSYGQKPY 209

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 17/206 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-------SEFLQREQRILSALACPQIVA 59
           + +G G+  TV  G       V  V    L N        + L  E  ++  L  P IV 
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
             G   +E      + L +E A  G L   ++    +++  I      V +G++YL  + 
Sbjct: 73  MIGICEAES-----WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT-PI-CMAPEVARGE 177
            VH D+  +N+L+    +  AKI+DFG ++  R +E+       G  P+   APE     
Sbjct: 128 FVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 178 EQGFPADVWALGCTVLE-MATGRPPW 202
           +    +DVW+ G  + E  + G+ P+
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPY 211

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 78/181 (43%), Gaps = 14/181 (7%)
Query: 82  PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAK 141
           P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+   N    K
Sbjct: 93  PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELK 151
Query: 142 IADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCTVLEMATGRP 200
           + DFG     +   D       GT +   PE  R     G  A VW+LG  + +M  G  
Sbjct: 152 LIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 208
Query: 201 PWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
           P+    + I    ++ F          +S + Q  +  CL   P +R +  E+  H +++
Sbjct: 209 PFEHDEEIIGG--QVFFRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259
Query: 261 E 261
           +
Sbjct: 260 D 260

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 17/206 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-------SEFLQREQRILSALACPQIVA 59
           + +G G+  TV  G       V  V    L N        + L  E  ++  L  P IV 
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
             G   +E      + L +E A  G L   ++    +++  I      V +G++YL  + 
Sbjct: 83  MIGICEAES-----WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 137
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT-PI-CMAPEVARGE 177
            VH D+  +N+L+    +  AKI+DFG ++  R +E+       G  P+   APE     
Sbjct: 138 FVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 178 EQGFPADVWALGCTVLE-MATGRPPW 202
           +    +DVW+ G  + E  + G+ P+
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKPY 221

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 74  YNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           + L LE   P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+
Sbjct: 89  FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 148
Query: 133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCT 191
              N    K+ DFG     +   D       GT +   PE  R     G  A VW+LG  
Sbjct: 149 DL-NRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 204
Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS 251
           + +M  G  P+    + I    ++ F          +S + Q  +  CL   P +R +  
Sbjct: 205 LYDMVCGDIPFEHDEEIIRG--QVFFRQR-------VSSECQHLIRWCLALRPSDRPTFE 255
Query: 252 ELLEHGFVKE 261
           E+  H ++++
Sbjct: 256 EIQNHPWMQD 265

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 74  YNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           + L LE   P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+
Sbjct: 88  FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 147
Query: 133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCT 191
              N    K+ DFG     +   D       GT +   PE  R     G  A VW+LG  
Sbjct: 148 DL-NRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 203
Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS 251
           + +M  G  P+    + I    ++ F          +S + Q  +  CL   P +R +  
Sbjct: 204 LYDMVCGDIPFEHDEEIIRG--QVFFRQR-------VSSECQHLIRWCLALRPSDRPTFE 254
Query: 252 ELLEHGFVKE 261
           E+  H ++++
Sbjct: 255 EIQNHPWMQD 264

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 74  YNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           + L LE   P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+
Sbjct: 89  FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 148
Query: 133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCT 191
              N    K+ DFG     +   D       GT +   PE  R     G  A VW+LG  
Sbjct: 149 DL-NRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 204
Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS 251
           + +M  G  P+    + I    ++ F          +S + Q  +  CL   P +R +  
Sbjct: 205 LYDMVCGDIPFEHDEEIIRG--QVFFRQR-------VSSECQHLIRWCLALRPSDRPTFE 255
Query: 252 ELLEHGFVKE 261
           E+  H ++++
Sbjct: 256 EIQNHPWMQD 265

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 78/181 (43%), Gaps = 14/181 (7%)
Query: 82  PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAK 141
           P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+   N    K
Sbjct: 98  PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELK 156
Query: 142 IADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCTVLEMATGRP 200
           + DFG     +   D       GT +   PE  R     G  A VW+LG  + +M  G  
Sbjct: 157 LIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 213
Query: 201 PWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
           P+    + I    ++ F          +S + Q  +  CL   P +R +  E+  H +++
Sbjct: 214 PFEHDEEIIRG--QVFFRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 264
Query: 261 E 261
           +
Sbjct: 265 D 265

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 67/304 (22%), Positives = 116/304 (38%), Gaps = 50/304 (16%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQI 57
           D+     +G G+   V       + E+ A+K  E  +         RE +IL       I
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 58  VAYKGCDISEENGKILYN-LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +     +I   +    +N +++      T    + S   L +  I+      L  ++ LH
Sbjct: 72  ITI--FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP---------ICGTPI 167
            + ++H D+K  N+L++ + +   K+ DFG AR    +  D  +P            T  
Sbjct: 130 GSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRW 187
Query: 168 CMAPEVARGEEQGFPA-DVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE--- 223
             APEV     +   A DVW+ GC + E+   RP +P   D    L  I     TP    
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG-RDYRHQLLLIFGIIGTPHSDN 246
Query: 224 ----------------IPGY-----------MSKQAQDFLSKCLIRNPGERWSASELLEH 256
                           +P Y           ++ +  D L + L+ +P +R +A E LEH
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306
Query: 257 GFVK 260
            +++
Sbjct: 307 PYLQ 310

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 74  YNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           + L LE   P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+
Sbjct: 131 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 190
Query: 133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCT 191
              N    K+ DFG     +   D       GT +   PE  R     G  A VW+LG  
Sbjct: 191 DL-NRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 246
Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS 251
           + +M  G  P+    + I    ++ F          +S + Q  +  CL   P +R +  
Sbjct: 247 LYDMVCGDIPFEHDEEIIRG--QVFFRQR-------VSSECQHLIRWCLALRPSDRPTFE 297
Query: 252 ELLEHGFVKE 261
           E+  H ++++
Sbjct: 298 EIQNHPWMQD 307

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 67/304 (22%), Positives = 116/304 (38%), Gaps = 50/304 (16%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQI 57
           D+     +G G+   V       + E+ A+K  E  +         RE +IL       I
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 58  VAYKGCDISEENGKILYN-LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           +     +I   +    +N +++      T    + S   L +  I+      L  ++ LH
Sbjct: 72  ITI--FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI---------CGTPI 167
            + ++H D+K  N+L++ + +   K+ DFG AR    +  D  +P            T  
Sbjct: 130 GSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRW 187
Query: 168 CMAPEVARGEEQGFPA-DVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE--- 223
             APEV     +   A DVW+ GC + E+   RP +P   D    L  I     TP    
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG-RDYRHQLLLIFGIIGTPHSDN 246
Query: 224 ----------------IPGY-----------MSKQAQDFLSKCLIRNPGERWSASELLEH 256
                           +P Y           ++ +  D L + L+ +P +R +A E LEH
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306
Query: 257 GFVK 260
            +++
Sbjct: 307 PYLQ 310

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 78/181 (43%), Gaps = 14/181 (7%)
Query: 82  PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAK 141
           P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+   N    K
Sbjct: 140 PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELK 198
Query: 142 IADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCTVLEMATGRP 200
           + DFG     +   D       GT +   PE  R     G  A VW+LG  + +M  G  
Sbjct: 199 LIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 255
Query: 201 PWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
           P+    + I    ++ F          +S + Q  +  CL   P +R +  E+  H +++
Sbjct: 256 PFEHDEEIIRG--QVFFRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 306
Query: 261 E 261
           +
Sbjct: 307 D 307

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 74  YNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           + L LE   P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+
Sbjct: 117 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 176
Query: 133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCT 191
              N    K+ DFG     +   D       GT +   PE  R     G  A VW+LG  
Sbjct: 177 DL-NRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 232
Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS 251
           + +M  G  P+    + I    ++ F          +S + Q  +  CL   P +R +  
Sbjct: 233 LYDMVCGDIPFEHDEEIIGG--QVFFRQR-------VSSECQHLIRWCLALRPSDRPTFE 283
Query: 252 ELLEHGFVKE 261
           E+  H ++++
Sbjct: 284 EIQNHPWMQD 293

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 74  YNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           + L LE   P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+
Sbjct: 103 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 162
Query: 133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCT 191
              N    K+ DFG     +   D       GT +   PE  R     G  A VW+LG  
Sbjct: 163 DL-NRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 218
Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS 251
           + +M  G  P+    + I    ++ F          +S + Q  +  CL   P +R +  
Sbjct: 219 LYDMVCGDIPFEHDEEIIRG--QVFFRQR-------VSSECQHLIRWCLALRPSDRPTFE 269
Query: 252 ELLEHGFVKE 261
           E+  H ++++
Sbjct: 270 EIQNHPWMQD 279

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 74  YNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           + L LE   P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+
Sbjct: 116 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 175
Query: 133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCT 191
              N    K+ DFG     +   D       GT +   PE  R     G  A VW+LG  
Sbjct: 176 DL-NRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 231
Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS 251
           + +M  G  P+    + I    ++ F          +S + Q  +  CL   P +R +  
Sbjct: 232 LYDMVCGDIPFEHDEEIIGG--QVFFRQR-------VSSECQHLIRWCLALRPSDRPTFE 282
Query: 252 ELLEHGFVKE 261
           E+  H ++++
Sbjct: 283 EIQNHPWMQD 292

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 74  YNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           + L LE   P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+
Sbjct: 117 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 176
Query: 133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCT 191
              N    K+ DFG     +   D       GT +   PE  R     G  A VW+LG  
Sbjct: 177 DL-NRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 232
Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS 251
           + +M  G  P+    + I    ++ F          +S + Q  +  CL   P +R +  
Sbjct: 233 LYDMVCGDIPFEHDEEIIGG--QVFFRQR-------VSSECQHLIRWCLALRPSDRPTFE 283
Query: 252 ELLEHGFVKE 261
           E+  H ++++
Sbjct: 284 EIQNHPWMQD 293

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 74  YNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           + L LE   P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+
Sbjct: 117 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 176
Query: 133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCT 191
              N    K+ DFG     +   D       GT +   PE  R     G  A VW+LG  
Sbjct: 177 DL-NRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 232
Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS 251
           + +M  G  P+    + I    ++ F          +S + Q  +  CL   P +R +  
Sbjct: 233 LYDMVCGDIPFEHDEEIIGG--QVFFRQR-------VSXECQHLIRWCLALRPSDRPTFE 283
Query: 252 ELLEHGFVKE 261
           E+  H ++++
Sbjct: 284 EIQNHPWMQD 293

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 74  YNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           + L LE   P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+
Sbjct: 116 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 175
Query: 133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCT 191
              N    K+ DFG     +   D       GT +   PE  R     G  A VW+LG  
Sbjct: 176 DL-NRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 231
Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS 251
           + +M  G  P+    + I    ++ F          +S + Q  +  CL   P +R +  
Sbjct: 232 LYDMVCGDIPFEHDEEIIGG--QVFFRQR-------VSSECQHLIRWCLALRPSDRPTFE 282
Query: 252 ELLEHGFVKE 261
           E+  H ++++
Sbjct: 283 EIQNHPWMQD 292

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 74  YNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           + L LE   P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+
Sbjct: 116 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 175
Query: 133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCT 191
              N    K+ DFG     +   D       GT +   PE  R     G  A VW+LG  
Sbjct: 176 DL-NRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 231
Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS 251
           + +M  G  P+    + I    ++ F          +S + Q  +  CL   P +R +  
Sbjct: 232 LYDMVCGDIPFEHDEEIIRG--QVFFRQR-------VSSECQHLIRWCLALRPSDRPTFE 282
Query: 252 ELLEHGFVKE 261
           E+  H ++++
Sbjct: 283 EIQNHPWMQD 292

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 17/206 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-------SEFLQREQRILSALACPQIVA 59
           + +G G+  TV  G       V  V    L N        + L  E  ++  L  P IV 
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 434
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
             G   +E      + L +E A  G L   ++    +++  I      V +G++YL  + 
Sbjct: 435 MIGICEAES-----WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 489
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT-PI-CMAPEVARGE 177
            VH D+  +N+L+    +  AKI+DFG ++  R +E+       G  P+   APE     
Sbjct: 490 FVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 547
Query: 178 EQGFPADVWALGCTVLE-MATGRPPW 202
           +    +DVW+ G  + E  + G+ P+
Sbjct: 548 KFSSKSDVWSFGVLMWEAFSYGQKPY 573

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 74  YNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           + L LE   P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+
Sbjct: 117 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 176
Query: 133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCT 191
              N    K+ DFG     +   D       GT +   PE  R     G  A VW+LG  
Sbjct: 177 DL-NRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 232
Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS 251
           + +M  G  P+    + I    ++ F          +S + Q  +  CL   P +R +  
Sbjct: 233 LYDMVCGDIPFEHDEEIIGG--QVFFRQR-------VSXECQHLIRWCLALRPSDRPTFE 283
Query: 252 ELLEHGFVKE 261
           E+  H ++++
Sbjct: 284 EIQNHPWMQD 293

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 74  YNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           + L LE   P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+
Sbjct: 116 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 175
Query: 133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCT 191
              N    K+ DFG     +   D       GT +   PE  R     G  A VW+LG  
Sbjct: 176 DL-NRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 231
Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS 251
           + +M  G  P+    + I    ++ F          +S + Q  +  CL   P +R +  
Sbjct: 232 LYDMVCGDIPFEHDEEIIGG--QVFFRQR-------VSXECQHLIRWCLALRPSDRPTFE 282
Query: 252 ELLEHGFVKE 261
           E+  H ++++
Sbjct: 283 EIQNHPWMQD 292

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 74  YNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           + L LE   P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+
Sbjct: 103 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 162
Query: 133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCT 191
              N    K+ DFG     +   D       GT +   PE  R     G  A VW+LG  
Sbjct: 163 DL-NRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 218
Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS 251
           + +M  G  P+    + I    ++ F          +S + Q  +  CL   P +R +  
Sbjct: 219 LYDMVCGDIPFEHDEEIIRG--QVFFRQR-------VSXECQHLIRWCLALRPSDRPTFE 269
Query: 252 ELLEHGFVKE 261
           E+  H ++++
Sbjct: 270 EIQNHPWMQD 279

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 74  YNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           + L LE   P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+
Sbjct: 104 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 163
Query: 133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCT 191
              N    K+ DFG     +   D       GT +   PE  R     G  A VW+LG  
Sbjct: 164 DL-NRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 219
Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS 251
           + +M  G  P+    + I    ++ F          +S + Q  +  CL   P +R +  
Sbjct: 220 LYDMVCGDIPFEHDEEIIRG--QVFFRQR-------VSSECQHLIRWCLALRPSDRPTFE 270
Query: 252 ELLEHGFVKE 261
           E+  H ++++
Sbjct: 271 EIQNHPWMQD 280

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 74  YNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           + L LE   P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+
Sbjct: 131 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 190
Query: 133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCT 191
              N    K+ DFG     +   D       GT +   PE  R     G  A VW+LG  
Sbjct: 191 DL-NRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 246
Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS 251
           + +M  G  P+    + I    ++ F          +S + Q  +  CL   P +R +  
Sbjct: 247 LYDMVCGDIPFEHDEEIIRG--QVFFRQR-------VSXECQHLIRWCLALRPSDRPTFE 297
Query: 252 ELLEHGFVKE 261
           E+  H ++++
Sbjct: 298 EIQNHPWMQD 307

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 74  YNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           + L LE   P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+
Sbjct: 111 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 170
Query: 133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCT 191
              N    K+ DFG     +   D       GT +   PE  R     G  A VW+LG  
Sbjct: 171 DL-NRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 226
Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS 251
           + +M  G  P+    + I    ++ F          +S + Q  +  CL   P +R +  
Sbjct: 227 LYDMVCGDIPFEHDEEIIRG--QVFFRQR-------VSXECQHLIRWCLALRPSDRPTFE 277
Query: 252 ELLEHGFVKE 261
           E+  H ++++
Sbjct: 278 EIQNHPWMQD 287

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 74  YNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           + L LE   P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+
Sbjct: 104 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 163
Query: 133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCT 191
              N    K+ DFG     +   D       GT +   PE  R     G  A VW+LG  
Sbjct: 164 DL-NRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 219
Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS 251
           + +M  G  P+    + I    ++ F          +S + Q  +  CL   P +R +  
Sbjct: 220 LYDMVCGDIPFEHDEEIIRG--QVFFRQR-------VSXECQHLIRWCLALRPSDRPTFE 270
Query: 252 ELLEHGFVKE 261
           E+  H ++++
Sbjct: 271 EIQNHPWMQD 280

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 74  YNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           + L LE   P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+
Sbjct: 123 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 182
Query: 133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCT 191
              N    K+ DFG     +   D       GT +   PE  R     G  A VW+LG  
Sbjct: 183 DL-NRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 238
Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS 251
           + +M  G  P+    + I    ++ F          +S + Q  +  CL   P +R +  
Sbjct: 239 LYDMVCGDIPFEHDEEIIRG--QVFFRQR-------VSSECQHLIRWCLALRPSDRPTFE 289
Query: 252 ELLEHGFVKE 261
           E+  H ++++
Sbjct: 290 EIQNHPWMQD 299

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 17/206 (8%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-------SEFLQREQRILSALACPQIVA 59
           + +G G+  TV  G       V  V    L N        + L  E  ++  L  P IV 
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 435
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
             G   +E      + L +E A  G L   ++    +++  I      V +G++YL  + 
Sbjct: 436 MIGICEAES-----WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 490
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT-PI-CMAPEVARGE 177
            VH D+  +N+L+    +  AKI+DFG ++  R +E+       G  P+   APE     
Sbjct: 491 FVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 548
Query: 178 EQGFPADVWALGCTVLE-MATGRPPW 202
           +    +DVW+ G  + E  + G+ P+
Sbjct: 549 KFSSKSDVWSFGVLMWEAFSYGQKPY 574

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 77/185 (41%), Gaps = 29/185 (15%)
Query: 101 IRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG 159
           I+   ++VL    Y+H+   I H D+K  NIL+ K+     K++DFG    +    D + 
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR--VKLSDFG---ESEYMVDKKI 207
Query: 160 KPICGTPICMAPEVARGEE--QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF 217
           K   GT   M PE    E    G   D+W+LG  +  M     P+      +   + I  
Sbjct: 208 KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI-- 265
Query: 218 SSDTPEIP-------------------GYMSKQAQDFLSKCLIRNPGERWSASELLEHGF 258
            +   E P                    ++S +  DFL   L +NP ER ++ + L+H +
Sbjct: 266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325
Query: 259 VKEQN 263
           + + N
Sbjct: 326 LADTN 330

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 82/314 (26%), Positives = 139/314 (44%), Gaps = 46/314 (14%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILS-ALACPQIVAYKGCDI 65
           + +G GS+ TV    S +   V AVK   +   +    E ++L+ +   P ++ Y  C  
Sbjct: 39  KILGYGSSGTVVFQGSFQGRPV-AVKRMLIDFCDIALMEIKLLTESDDHPNVIRYY-C-- 94
Query: 66  SEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEG-RIR------SHTRAVLLGLQYLHSN 118
           SE   + LY + LE      L D + S    +E  +++      S  R +  G+ +LHS 
Sbjct: 95  SETTDRFLY-IALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 152
Query: 119 GIVHCDIKGQNILVSK------DNEQGAK-----IADFGCARRA-------RVNEDDEGK 160
            I+H D+K QNILVS       D + GA+     I+DFG  ++        R N ++   
Sbjct: 153 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPS- 211
Query: 161 PICGTPICMAPEV---ARGEEQGFPADVWALGCTVLE-MATGRPPWPDVADPISALHRIG 216
              GT    APE+   +         D++++GC     ++ G+ P+ D     S + R  
Sbjct: 212 ---GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGI 268
Query: 217 FSSDTPEIPGYMS--KQAQDFLSKCLIRNPGERWSASELLEHGFV----KEQNFKLSTLT 270
           FS D  +     S   +A D +S+ +  +P +R +A ++L H       K+  F L    
Sbjct: 269 FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSD 328
Query: 271 EPETYNSESPTSVL 284
             E  N + P+++L
Sbjct: 329 RLEIENRDPPSALL 342

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 74  YNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           + L LE   P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+
Sbjct: 136 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 195
Query: 133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCT 191
              N    K+ DFG     +   D       GT +   PE  R     G  A VW+LG  
Sbjct: 196 DL-NRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 251
Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS 251
           + +M  G  P+    + I    ++ F          +S + Q  +  CL   P +R +  
Sbjct: 252 LYDMVCGDIPFEHDEEIIRG--QVFFRQR-------VSXECQHLIRWCLALRPSDRPTFE 302
Query: 252 ELLEHGFVKE 261
           E+  H ++++
Sbjct: 303 EIQNHPWMQD 312

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 74  YNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV 132
           + L LE   P   L D I     L+E   RS    VL  +++ H+ G++H DIK +NIL+
Sbjct: 104 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 163
Query: 133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCT 191
              N    K+ DFG     +   D       GT +   PE  R     G  A VW+LG  
Sbjct: 164 DL-NRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 219
Query: 192 VLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSAS 251
           + +M  G  P+    + I    ++ F          +S + Q  +  CL   P +R +  
Sbjct: 220 LYDMVCGDIPFEHDEEIIRG--QVFFRQR-------VSXECQHLIRWCLALRPXDRPTFE 270
Query: 252 ELLEHGFVKE 261
           E+  H ++++
Sbjct: 271 EIQNHPWMQD 280

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 82/314 (26%), Positives = 139/314 (44%), Gaps = 46/314 (14%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILS-ALACPQIVAYKGCDI 65
           + +G GS+ TV    S +   V AVK   +   +    E ++L+ +   P ++ Y  C  
Sbjct: 39  KILGYGSSGTVVFQGSFQGRPV-AVKRMLIDFCDIALMEIKLLTESDDHPNVIRYY-C-- 94
Query: 66  SEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEG-RIR------SHTRAVLLGLQYLHSN 118
           SE   + LY + LE      L D + S    +E  +++      S  R +  G+ +LHS 
Sbjct: 95  SETTDRFLY-IALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 152
Query: 119 GIVHCDIKGQNILVSK------DNEQGAK-----IADFGCARRA-------RVNEDDEGK 160
            I+H D+K QNILVS       D + GA+     I+DFG  ++        R N ++   
Sbjct: 153 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPS- 211
Query: 161 PICGTPICMAPEV---ARGEEQGFPADVWALGCTVLE-MATGRPPWPDVADPISALHRIG 216
              GT    APE+   +         D++++GC     ++ G+ P+ D     S + R  
Sbjct: 212 ---GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGI 268
Query: 217 FSSDTPEIPGYMS--KQAQDFLSKCLIRNPGERWSASELLEHGFV----KEQNFKLSTLT 270
           FS D  +     S   +A D +S+ +  +P +R +A ++L H       K+  F L    
Sbjct: 269 FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSD 328
Query: 271 EPETYNSESPTSVL 284
             E  N + P+++L
Sbjct: 329 RLEIENRDPPSALL 342

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 114/295 (38%), Gaps = 41/295 (13%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF--LQREQRILSALACPQIVA 59
           D+     +G+G+   V    +   S  +A+K    +  +   +  E  +L++L    +V 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVR 66
Query: 60  YKGCDISEENG-------KILYNLFL--EYAPGGTLTDAIRSGTCLEEG----RIRSHTR 106
           Y    +   N        K    LF+  EY    TL D I S    ++     R+    R
Sbjct: 67  YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRL---FR 123
Query: 107 AVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED---------- 156
            +L  L Y+HS GI+H ++K  NI +  D  +  KI DFG A+    + D          
Sbjct: 124 QILEALSYIHSQGIIHRNLKPXNIFI--DESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 157 ---DEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISAL 212
              D      GT   +A EV  G        D ++LG    E      P+    + ++ L
Sbjct: 182 GSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY---PFSTGXERVNIL 238
Query: 213 HRIGFSSDT--PEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGF--VKEQN 263
            ++   S    P+      K  +  +   +  +P +R  A  LL  G+  VK Q+
Sbjct: 239 KKLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD 293

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 9/157 (5%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQG---AKIADFGCARRARVNEDDEGKP--ICGT 165
           GL +LHS  IVH D+K  NIL+S  N  G   A I+DFG  ++  V      +   + GT
Sbjct: 130 GLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
Query: 166 PICMAPEVAR---GEEQGFPADVWALGCTVLE-MATGRPPWPDVADPISALHRIGFSSDT 221
              +APE+      E   +  D+++ GC     ++ G  P+       + +     S D 
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC 249
Query: 222 PEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGF 258
                +    A++ + K +  +P +R SA  +L+H F
Sbjct: 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 57/135 (42%), Gaps = 23/135 (17%)
Query: 100 RIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGA-----------------KI 142
            IR     +   + +LHSN + H D+K +NIL  + +   A                 K+
Sbjct: 119 HIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 143 ADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW 202
            DFG A      +D+    +  T    APEV        P DVW++GC ++E   G   +
Sbjct: 179 VDFGSA----TYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234
Query: 203 P--DVADPISALHRI 215
           P  D  + ++ + RI
Sbjct: 235 PTHDSKEHLAMMERI 249

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 111/265 (41%), Gaps = 44/265 (16%)
Query: 10  GRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEEN 69
           GR    TV++ M   ++       +EL +   L  E  +L  +  P ++   G     ++
Sbjct: 49  GRAGYTTVAVKMLKENAS-----PSELRD---LLSEFNVLKQVNHPHVIKLYGA--CSQD 98
Query: 70  GKILYNLFLEYAPGGTLTDAIRSGTCLEEGRI----------------RSHTRAVLL--- 110
           G +L  L +EYA  G+L   +R    +  G +                R+ T   L+   
Sbjct: 99  GPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFA 156
Query: 111 -----GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG- 164
                G+QYL    +VH D+  +NILV++  +   KI+DFG +R     ED   K   G 
Sbjct: 157 WQISQGMQYLAEMSLVHRDLAARNILVAEGRKM--KISDFGLSRDV-YEEDSXVKRSQGR 213
Query: 165 TPI-CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTP 222
            P+  MA E          +DVW+ G  + E+ T G  P+P +  P   L  +  +    
Sbjct: 214 IPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI--PPERLFNLLKTGHRM 271
Query: 223 EIPGYMSKQAQDFLSKCLIRNPGER 247
           E P   S++    + +C  + P +R
Sbjct: 272 ERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 89/217 (41%), Gaps = 33/217 (15%)
Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQREQRILSALA----CPQIVAY 60
           G+ IG G+   + +G +  ++E  A+K   + S +  L  E R    L      PQ+  +
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ------Y 114
             C      GK  YN  +    G +L D      C    R  S    +++ +Q      Y
Sbjct: 74  GPC------GK--YNAMVLELLGPSLEDLF--DLC---DRTFSLKTVLMIAIQLISRMEY 120
Query: 115 LHSNGIVHCDIKGQNILVSK---DNEQGAKIADFGCARRARVNEDD------EGKPICGT 165
           +HS  +++ D+K +N L+ +     +Q   I DFG A+     E        E K + GT
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGT 180
Query: 166 PICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW 202
              M+     G+EQ    D+ ALG   +    G  PW
Sbjct: 181 ARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW 217

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 117/292 (40%), Gaps = 54/292 (18%)
Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQ---IVAYKG 62
           G+ IG+G    V  G  +    +  +   E  N + L+  +R + A    +   +V + G
Sbjct: 38  GELIGKGRFGQVYHGRWHGEVAIRLI-DIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSG-TCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
             +S  +  I+ +L      G TL   +R     L+  + R   + ++ G+ YLH+ GI+
Sbjct: 97  ACMSPPHLAIITSL----CKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGIL 152
Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARV----NEDDEGKPICGTPICMAPEVAR-- 175
           H D+K +N+    DN +   I DFG    + V      +D+ +   G    +APE+ R  
Sbjct: 153 HKDLKSKNVFY--DNGK-VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 176 ---GEEQGFP----ADVWALGCTVLEMATGRPPWPDVADPISA------------LHRIG 216
               EE   P    +DV+ALG    E+      WP    P  A            L +IG
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHARE--WPFKTQPAEAIIWQMGTGMKPNLSQIG 267
Query: 217 FSSDTPEIPGY----------MSKQAQDFLSKCLIRN-----PGERWSASEL 253
              +  +I  +             +  D L K   RN     PG  W ++EL
Sbjct: 268 MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKSAEL 319

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 111/265 (41%), Gaps = 44/265 (16%)
Query: 10  GRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEEN 69
           GR    TV++ M   ++       +EL +   L  E  +L  +  P ++   G     ++
Sbjct: 49  GRAGYTTVAVKMLKENAS-----PSELRD---LLSEFNVLKQVNHPHVIKLYGA--CSQD 98
Query: 70  GKILYNLFLEYAPGGTLTDAIRSGTCLEEGRI----------------RSHTRAVLL--- 110
           G +L  L +EYA  G+L   +R    +  G +                R+ T   L+   
Sbjct: 99  GPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFA 156
Query: 111 -----GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG- 164
                G+QYL    +VH D+  +NILV++  +   KI+DFG +R     ED   K   G 
Sbjct: 157 WQISQGMQYLAEMKLVHRDLAARNILVAEGRKM--KISDFGLSRDV-YEEDSXVKRSQGR 213
Query: 165 TPI-CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTP 222
            P+  MA E          +DVW+ G  + E+ T G  P+P +  P   L  +  +    
Sbjct: 214 IPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI--PPERLFNLLKTGHRM 271
Query: 223 EIPGYMSKQAQDFLSKCLIRNPGER 247
           E P   S++    + +C  + P +R
Sbjct: 272 ERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 111/265 (41%), Gaps = 44/265 (16%)
Query: 10  GRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEEN 69
           GR    TV++ M   ++       +EL +   L  E  +L  +  P ++   G     ++
Sbjct: 49  GRAGYTTVAVKMLKENAS-----PSELRD---LLSEFNVLKQVNHPHVIKLYGA--CSQD 98
Query: 70  GKILYNLFLEYAPGGTLTDAIRSGTCLEEGRI----------------RSHTRAVLL--- 110
           G +L  L +EYA  G+L   +R    +  G +                R+ T   L+   
Sbjct: 99  GPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFA 156
Query: 111 -----GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG- 164
                G+QYL    +VH D+  +NILV++  +   KI+DFG +R     ED   K   G 
Sbjct: 157 WQISQGMQYLAEMKLVHRDLAARNILVAEGRKM--KISDFGLSRDV-YEEDSYVKRSQGR 213
Query: 165 TPI-CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTP 222
            P+  MA E          +DVW+ G  + E+ T G  P+P +  P   L  +  +    
Sbjct: 214 IPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI--PPERLFNLLKTGHRM 271
Query: 223 EIPGYMSKQAQDFLSKCLIRNPGER 247
           E P   S++    + +C  + P +R
Sbjct: 272 ERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 82/318 (25%), Positives = 138/318 (43%), Gaps = 50/318 (15%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILS-ALACPQIVAYKGCDI 65
           + +G GS+ TV    S +   V AVK   +   +    E ++L+ +   P ++ Y  C  
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPV-AVKRMLIDFCDIALMEIKLLTESDDHPNVIRYY-C-- 76
Query: 66  SEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEG-RIR------SHTRAVLLGLQYLHSN 118
           SE   + LY + LE      L D + S    +E  +++      S  R +  G+ +LHS 
Sbjct: 77  SETTDRFLY-IALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134
Query: 119 GIVHCDIKGQNILVSK------DNEQGAK-----IADFGCARRA-------RVNEDDEGK 160
            I+H D+K QNILVS       D + GA+     I+DFG  ++        R N ++   
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS- 193
Query: 161 PICGTPICMAPEVAR-------GEEQGFPADVWALGCTVLE-MATGRPPWPDVADPISAL 212
              GT    APE+                 D++++GC     ++ G+ P+ D     S +
Sbjct: 194 ---GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 213 HRIGFSSDTPEIPGYMS--KQAQDFLSKCLIRNPGERWSASELLEHGFV----KEQNFKL 266
            R  FS D  +     S   +A D +S+ +  +P +R +A ++L H       K+  F L
Sbjct: 251 IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLL 310
Query: 267 STLTEPETYNSESPTSVL 284
                 E  N + P+++L
Sbjct: 311 KVSDRLEIENRDPPSALL 328

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 76/177 (42%), Gaps = 15/177 (8%)
Query: 79  EYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN 136
           E AP G+L D +R   G  L  G +  +   V  G+ YL S   +H D+  +N+L++   
Sbjct: 94  ELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA--T 150
Query: 137 EQGAKIADFGCARRARVNED----DEGKPICGTPICM-APEVARGEEQGFPADVWALGCT 191
               KI DFG  R    N+D     E + +   P    APE  +       +D W  G T
Sbjct: 151 RDLVKIGDFGLMRALPQNDDHYVMQEHRKV---PFAWCAPESLKTRTFSHASDTWMFGVT 207
Query: 192 VLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGER 247
           + EM T G+ PW  + +    LH+I    +    P    +   + + +C    P +R
Sbjct: 208 LWEMFTYGQEPWIGL-NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 263

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 21/209 (10%)
Query: 5   RGQTIGRGSTATVSIGMSNRSSEVFAVKSA---------ELSNSEFLQREQRILSALACP 55
           R + +G G+  TV  G+     E   +  A           +N EF+  E  I++++  P
Sbjct: 19  RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMD-EALIMASMDHP 77
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLGLQY 114
            +V   G  +S         L  +  P G L + +      +    + +    +  G+ Y
Sbjct: 78  HLVRLLGVCLSPT-----IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMY 132
Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMAPEV 173
           L    +VH D+  +N+LV   N    KI DFG AR    +E +        PI  MA E 
Sbjct: 133 LEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 190
Query: 174 ARGEEQGFPADVWALGCTVLEMAT--GRP 200
               +    +DVW+ G T+ E+ T  G+P
Sbjct: 191 IHYRKFTHQSDVWSYGVTIWELMTFGGKP 219

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 21/209 (10%)
Query: 5   RGQTIGRGSTATVSIGMSNRSSEVFAVKSA---------ELSNSEFLQREQRILSALACP 55
           R + +G G+  TV  G+     E   +  A           +N EF+  E  I++++  P
Sbjct: 42  RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMD-EALIMASMDHP 100
Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLGLQY 114
            +V   G  +S         L  +  P G L + +      +    + +    +  G+ Y
Sbjct: 101 HLVRLLGVCLSPT-----IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMY 155
Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMAPEV 173
           L    +VH D+  +N+LV   N    KI DFG AR    +E +        PI  MA E 
Sbjct: 156 LEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 213
Query: 174 ARGEEQGFPADVWALGCTVLEMAT--GRP 200
               +    +DVW+ G T+ E+ T  G+P
Sbjct: 214 IHYRKFTHQSDVWSYGVTIWELMTFGGKP 242

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 82/318 (25%), Positives = 138/318 (43%), Gaps = 50/318 (15%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILS-ALACPQIVAYKGCDI 65
           + +G GS+ TV    S +   V AVK   +   +    E ++L+ +   P ++ Y  C  
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPV-AVKRMLIDFCDIALMEIKLLTESDDHPNVIRYY-C-- 76
Query: 66  SEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEG-RIR------SHTRAVLLGLQYLHSN 118
           SE   + LY + LE      L D + S    +E  +++      S  R +  G+ +LHS 
Sbjct: 77  SETTDRFLY-IALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134
Query: 119 GIVHCDIKGQNILVSK------DNEQGAK-----IADFGCARRA-------RVNEDDEGK 160
            I+H D+K QNILVS       D + GA+     I+DFG  ++        R N ++   
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPS- 193
Query: 161 PICGTPICMAPEVAR-------GEEQGFPADVWALGCTVLE-MATGRPPWPDVADPISAL 212
              GT    APE+                 D++++GC     ++ G+ P+ D     S +
Sbjct: 194 ---GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 213 HRIGFSSDTPEIPGYMS--KQAQDFLSKCLIRNPGERWSASELLEHGFV----KEQNFKL 266
            R  FS D  +     S   +A D +S+ +  +P +R +A ++L H       K+  F L
Sbjct: 251 IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLL 310
Query: 267 STLTEPETYNSESPTSVL 284
                 E  N + P+++L
Sbjct: 311 KVSDRLEIENRDPPSALL 328

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 76/177 (42%), Gaps = 15/177 (8%)
Query: 79  EYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN 136
           E AP G+L D +R   G  L  G +  +   V  G+ YL S   +H D+  +N+L++   
Sbjct: 94  ELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA--T 150
Query: 137 EQGAKIADFGCARRARVNED----DEGKPICGTPICM-APEVARGEEQGFPADVWALGCT 191
               KI DFG  R    N+D     E + +   P    APE  +       +D W  G T
Sbjct: 151 RDLVKIGDFGLMRALPQNDDHYVMQEHRKV---PFAWCAPESLKTRTFSHASDTWMFGVT 207
Query: 192 VLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGER 247
           + EM T G+ PW  + +    LH+I    +    P    +   + + +C    P +R
Sbjct: 208 LWEMFTYGQEPWIGL-NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 263

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 76/177 (42%), Gaps = 15/177 (8%)
Query: 79  EYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN 136
           E AP G+L D +R   G  L  G +  +   V  G+ YL S   +H D+  +N+L++   
Sbjct: 90  ELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA--T 146
Query: 137 EQGAKIADFGCARRARVNED----DEGKPICGTPICM-APEVARGEEQGFPADVWALGCT 191
               KI DFG  R    N+D     E + +   P    APE  +       +D W  G T
Sbjct: 147 RDLVKIGDFGLMRALPQNDDHYVMQEHRKV---PFAWCAPESLKTRTFSHASDTWMFGVT 203
Query: 192 VLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGER 247
           + EM T G+ PW  + +    LH+I    +    P    +   + + +C    P +R
Sbjct: 204 LWEMFTYGQEPWIGL-NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 259

>pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 96/236 (40%), Gaps = 31/236 (13%)
Query: 3   WTRGQTIGRGSTATVSIGMSNRSSE-----VFAVKSAE----LSNSEFLQR--------- 44
           W  G+ IG G    + +       E     V  V+  E     S  +F QR         
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98
Query: 45  --EQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIR 102
             E++ L  L  P    + G  ++E  G+    + +E         + ++GT  +   ++
Sbjct: 99  WIERKQLDYLGIP---LFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQ 155
Query: 103 SHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN------ED 156
              R +L  L+Y+H N  VH DIK  N+L+   N     +AD+G + R   N      ++
Sbjct: 156 LGIR-MLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214
Query: 157 DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW-PDVADPISA 211
           +  K   GT    + +  +G      +DV  LG  +L    G+ PW  ++ DP++ 
Sbjct: 215 NPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 9/157 (5%)
Query: 103 SHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI 162
           S +  V  G+ +L S   +H D+  +NIL++  + +  KI DFG AR  + + +   K  
Sbjct: 172 SFSYQVAKGMAFLASKNCIHRDLAARNILLT--HGRITKICDFGLARHIKNDSNYVVKGN 229
Query: 163 CGTPI-CMAPEVARGEEQGFPADVWALGCTVLEM-ATGRPPWP--DVADPISALHRIGFS 218
              P+  MAPE        F +DVW+ G  + E+ + G  P+P   V      + + GF 
Sbjct: 230 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 289
Query: 219 SDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
             +PE   +   +  D +  C   +P +R +  ++++
Sbjct: 290 MLSPE---HAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 76/177 (42%), Gaps = 15/177 (8%)
Query: 79  EYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN 136
           E AP G+L D +R   G  L  G +  +   V  G+ YL S   +H D+  +N+L++   
Sbjct: 90  ELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA--T 146
Query: 137 EQGAKIADFGCARRARVNED----DEGKPICGTPICM-APEVARGEEQGFPADVWALGCT 191
               KI DFG  R    N+D     E + +   P    APE  +       +D W  G T
Sbjct: 147 RDLVKIGDFGLMRALPQNDDHXVMQEHRKV---PFAWCAPESLKTRTFSHASDTWMFGVT 203
Query: 192 VLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGER 247
           + EM T G+ PW  + +    LH+I    +    P    +   + + +C    P +R
Sbjct: 204 LWEMFTYGQEPWIGL-NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 259

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 108/285 (37%), Gaps = 39/285 (13%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
           D T  + +G+G    V  G     +    + S+    S F + E      L    I+ + 
Sbjct: 9   DITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH----- 116
             D++  +      L   Y   G+L D ++  T L+         ++  GL +LH     
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 117 ---SNGIVHCDIKGQNILVSKDNEQGAKIADFGCA--RRARVNEDDEG-KPICGTPICMA 170
                 I H D+K +NILV K+ +    IAD G A       N+ D G  P  GT   MA
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQ--CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 171 PEVARGEEQ------GFPADVWALGCTVLEMA----------TGRPPWPDVA--DPISAL 212
           PEV     Q          D+WA G  + E+A            +PP+ DV   DP    
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 213 HR--IGFSSDTPEIPG-YMSKQAQDFLSK----CLIRNPGERWSA 250
            R  +      P IP  + S      L+K    C  +NP  R +A
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA 290

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 76/177 (42%), Gaps = 15/177 (8%)
Query: 79  EYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN 136
           E AP G+L D +R   G  L  G +  +   V  G+ YL S   +H D+  +N+L++   
Sbjct: 100 ELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA--T 156
Query: 137 EQGAKIADFGCARRARVNED----DEGKPICGTPICM-APEVARGEEQGFPADVWALGCT 191
               KI DFG  R    N+D     E + +   P    APE  +       +D W  G T
Sbjct: 157 RDLVKIGDFGLMRALPQNDDHXVMQEHRKV---PFAWCAPESLKTRTFSHASDTWMFGVT 213
Query: 192 VLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGER 247
           + EM T G+ PW  + +    LH+I    +    P    +   + + +C    P +R
Sbjct: 214 LWEMFTYGQEPWIGL-NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 269

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 76/177 (42%), Gaps = 15/177 (8%)
Query: 79  EYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN 136
           E AP G+L D +R   G  L  G +  +   V  G+ YL S   +H D+  +N+L++   
Sbjct: 100 ELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA--T 156
Query: 137 EQGAKIADFGCARRARVNED----DEGKPICGTPICM-APEVARGEEQGFPADVWALGCT 191
               KI DFG  R    N+D     E + +   P    APE  +       +D W  G T
Sbjct: 157 RDLVKIGDFGLMRALPQNDDHYVMQEHRKV---PFAWCAPESLKTRTFSHASDTWMFGVT 213
Query: 192 VLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGER 247
           + EM T G+ PW  + +    LH+I    +    P    +   + + +C    P +R
Sbjct: 214 LWEMFTYGQEPWIGL-NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 269

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 76/177 (42%), Gaps = 15/177 (8%)
Query: 79  EYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN 136
           E AP G+L D +R   G  L  G +  +   V  G+ YL S   +H D+  +N+L++   
Sbjct: 90  ELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA--T 146
Query: 137 EQGAKIADFGCARRARVNED----DEGKPICGTPICM-APEVARGEEQGFPADVWALGCT 191
               KI DFG  R    N+D     E + +   P    APE  +       +D W  G T
Sbjct: 147 RDLVKIGDFGLMRALPQNDDHYVMQEHRKV---PFAWCAPESLKTRTFSHASDTWMFGVT 203
Query: 192 VLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGER 247
           + EM T G+ PW  + +    LH+I    +    P    +   + + +C    P +R
Sbjct: 204 LWEMFTYGQEPWIGL-NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 259

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 102/259 (39%), Gaps = 31/259 (11%)
Query: 7   QTIGRGSTATVSIG-----MSNRSSEVFAVKS----AELSNSEFLQREQRILSALACPQI 57
           + IG+G    V  G       NR     A+KS     E+   E   RE  ++  L  P +
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQ--CAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGR-IRSHTRAVLLGLQYLH 116
           +A  G  +  E    L ++ L Y   G L   IRS       + + S    V  G++YL 
Sbjct: 85  LALIGIMLPPEG---LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR------RARVNEDDEGK-PICGTPICM 169
               VH D+  +N ++  D     K+ADFG AR         V +    + P+  T    
Sbjct: 142 EQKFVHRDLAARNCML--DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT---- 195
Query: 170 APEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           A E  +       +DVW+ G  + E+ T G PP+  + DP    H +      P+ P Y 
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-DPFDLTHFLAQGRRLPQ-PEYC 253
Query: 229 SKQAQDFLSKCLIRNPGER 247
                  + +C   +P  R
Sbjct: 254 PDSLYQVMQQCWEADPAVR 272

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 96/234 (41%), Gaps = 39/234 (16%)
Query: 68  ENGKILYNLFLEYAPGGTLTDAIRSGTCLEEG----------------RIRSHTRAVLLG 111
           E+   LY L +EYAP G L D +R    LE                  ++      V  G
Sbjct: 86  EHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 144
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL     +H D+  +NILV ++    AKIADFG +R   V      K +   P+  MA
Sbjct: 145 MDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSRGQEVYVK---KTMGRLPVRWMA 199
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPW-----PDVADPISALHRIGFSSDTPEI 224
            E          +DVW+ G  + E+ + G  P+      ++ + +   +R+       E 
Sbjct: 200 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL-------EK 252
Query: 225 PGYMSKQAQDFLSKCLIRNPGERWSASEL---LEHGFVKEQNFKLSTLTEPETY 275
           P     +  D + +C    P ER S +++   L     + + +  +TL E  TY
Sbjct: 253 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTY 306

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 104/270 (38%), Gaps = 49/270 (18%)
Query: 17  VSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL 76
           V++ + +   E    +  EL N+  L+ E           I+ +   D++  +      L
Sbjct: 63  VAVKIFSSRDEKSWFRETELYNTVMLRHEN----------ILGFIASDMTSRHSSTQLWL 112
Query: 77  FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH--------SNGIVHCDIKGQ 128
              Y   G+L D ++  T L+         ++  GL +LH           I H D+K +
Sbjct: 113 ITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSK 171
Query: 129 NILVSKDNEQGAKIADFGCA--RRARVNEDDEG-KPICGTPICMAPEVARGEEQ------ 179
           NILV K+ +    IAD G A       N+ D G  P  GT   MAPEV     Q      
Sbjct: 172 NILVKKNGQ--CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDS 229
Query: 180 GFPADVWALGCTVLEMA----------TGRPPWPDVA--DPISALHR--IGFSSDTPEIP 225
               D+WA G  + E+A            +PP+ DV   DP     R  +      P IP
Sbjct: 230 YKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIP 289
Query: 226 G-YMSKQAQDFLSK----CLIRNPGERWSA 250
             + S      L+K    C  +NP  R +A
Sbjct: 290 NRWFSDPTLTSLAKLMKECWYQNPSARLTA 319

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 46  QRILSALACPQIV-AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSH 104
           ++ L+ +  P IV  +   + ++ +G  +  + +EY  G +L  +   G  L      ++
Sbjct: 130 RQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRS--KGQKLPVAEAIAY 187
Query: 105 TRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG 164
              +L  L YLHS G+V+ D+K +NI+++   E+  K+ D G    +R+N       + G
Sbjct: 188 LLEILPALSYLHSIGLVYNDLKPENIMLT---EEQLKLIDLGAV--SRINSFGY---LYG 239
Query: 165 TPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI 224
           TP   APE+ R        D++ +G T+  +    P         +  +  G   D P +
Sbjct: 240 TPGFQAPEIVRTGPT-VATDIYTVGRTLAALTLDLPTR-------NGRYVDGLPEDDPVL 291
Query: 225 PGYMSKQAQDFLSKCLIRNPGERWSASE 252
             Y S      L + +  +P +R++ +E
Sbjct: 292 KTYDSYGR--LLRRAIDPDPRQRFTTAE 317

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 96/234 (41%), Gaps = 39/234 (16%)
Query: 68  ENGKILYNLFLEYAPGGTLTDAIRSGTCLEEG----------------RIRSHTRAVLLG 111
           E+   LY L +EYAP G L D +R    LE                  ++      V  G
Sbjct: 96  EHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 154
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL     +H D+  +NILV ++    AKIADFG +R   V      K +   P+  MA
Sbjct: 155 MDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSRGQEVYVK---KTMGRLPVRWMA 209
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPW-----PDVADPISALHRIGFSSDTPEI 224
            E          +DVW+ G  + E+ + G  P+      ++ + +   +R+       E 
Sbjct: 210 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL-------EK 262
Query: 225 PGYMSKQAQDFLSKCLIRNPGERWSASEL---LEHGFVKEQNFKLSTLTEPETY 275
           P     +  D + +C    P ER S +++   L     + + +  +TL E  TY
Sbjct: 263 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTY 316

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 104/276 (37%), Gaps = 51/276 (18%)
Query: 11  RGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENG 70
           +G    V I  S      F  +  EL N+  L+ E           I+ +   D++  + 
Sbjct: 30  QGENVAVKIFSSRDEKSWF--RETELYNTVMLRHEN----------ILGFIASDMTSRHS 77
Query: 71  KILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH--------SNGIVH 122
                L   Y   G+L D ++  T L+         ++  GL +LH           I H
Sbjct: 78  STQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAH 136
Query: 123 CDIKGQNILVSKDNEQGAKIADFGCA--RRARVNEDDEG-KPICGTPICMAPEVARGEEQ 179
            D+K +NILV K+ +    IAD G A       N+ D G  P  GT   MAPEV     Q
Sbjct: 137 RDLKSKNILVKKNGQ--CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQ 194
Query: 180 ------GFPADVWALGCTVLEMA----------TGRPPWPDVA--DPISALHR--IGFSS 219
                     D+WA G  + E+A            +PP+ DV   DP     R  +    
Sbjct: 195 VDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQ 254
Query: 220 DTPEIPG-YMSKQAQDFLSK----CLIRNPGERWSA 250
             P IP  + S      L+K    C  +NP  R +A
Sbjct: 255 QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA 290

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 15/180 (8%)
Query: 35  ELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT 94
           E +++E + RE +I+  L  P IV   G   +E        L +E A GG L   +    
Sbjct: 50  EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-----LMLVMEMAGGGPLHKFLVGKR 104
Query: 95  CLEE---GRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA 151
             EE     +      V +G++YL     VH D+  +N+L+   N   AKI+DFG ++  
Sbjct: 105 --EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV--NRHYAKISDFGLSKAL 160
Query: 152 RVNEDDEGKPICGT-PI-CMAPEVARGEEQGFPADVWALGCTVLE-MATGRPPWPDVADP 208
             ++        G  P+   APE     +    +DVW+ G T+ E ++ G+ P+  +  P
Sbjct: 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 220

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 70/298 (23%), Positives = 120/298 (40%), Gaps = 47/298 (15%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL-ACPQIVAY 60
           D+   + +GRG  + V  G++  ++E   +K  +    + ++RE +IL  L   P IV  
Sbjct: 53  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGPNIV-- 110
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           K  DI  +      +L  EY      TD       L +  IR +   +L  L Y HS GI
Sbjct: 111 KLLDIVRDQHSKTPSLIFEYVNN---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 167
Query: 121 VHCDIKGQNILVSKDNE-QGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EE 178
           +H D+K  N+++  D+E +  ++ D+G A      +  E      +     PE+    ++
Sbjct: 168 MHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQD 223
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK-------- 230
             +  D+W+LGC    M   + P+    D    L +I     T  +  Y++K        
Sbjct: 224 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRIELDPQ 283
Query: 231 ---------------------------QAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                                      +A DFL K L  +  ER +A E + H + ++
Sbjct: 284 LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 341

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 121/283 (42%), Gaps = 43/283 (15%)
Query: 6   GQTIGRGST-----ATVSIGMSNRSSEVFAVK----SAELSNSEFLQREQRILSALACPQ 56
           G+T+G G+      AT    + + ++   AVK    SA L+  E L  E ++LS L    
Sbjct: 46  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 105
Query: 57  -IVAYKG-CDISEENGKILYNLFLEYAPGGTLTDAIR----SGTCLEEG----------- 99
            IV   G C I    G  L  +  EY   G L + +R    S  C +             
Sbjct: 106 NIVNLLGACTIG---GPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 100 ---RIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED 156
               + S +  V  G+ +L S   +H D+  +NIL++  + +  KI DFG AR  + + +
Sbjct: 161 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT--HGRITKICDFGLARDIKNDSN 218
Query: 157 DEGKPICGTPI-CMAPEVARGEEQGFPADVWALGCTVLEM-ATGRPPWP--DVADPISAL 212
              K     P+  MAPE        F +DVW+ G  + E+ + G  P+P   V      +
Sbjct: 219 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 278
Query: 213 HRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
            + GF   +PE   +   +  D +  C   +P +R +  ++++
Sbjct: 279 IKEGFRMLSPE---HAPAEMYDIMKTCWDADPLKRPTFKQIVQ 318

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 64/298 (21%), Positives = 115/298 (38%), Gaps = 47/298 (15%)
Query: 2   DWTRGQTIGRGSTATVSIGMS-NRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           D+   + +GRG  + V  G++ N + +        +   +  +  + + + +  P IV  
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLMGGPNIV-- 89
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           K  DI  +      +L  EY      TD       L +  IR +   +L  L Y HS GI
Sbjct: 90  KLLDIVRDQHSKTPSLIFEYVNN---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 121 VHCDIKGQNILVSKDNE-QGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EE 178
           +H D+K  N+++  D+E +  ++ D+G A      +  E      +     PE+    ++
Sbjct: 147 MHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQD 202
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK-------- 230
             +  D+W+LGC    M   + P+    D    L +I     T  +  Y++K        
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 231 ---------------------------QAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                                      +A DFL K L  +  ER +A E + H + ++
Sbjct: 263 LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 121/283 (42%), Gaps = 43/283 (15%)
Query: 6   GQTIGRGST-----ATVSIGMSNRSSEVFAVK----SAELSNSEFLQREQRILSALACPQ 56
           G+T+G G+      AT    + + ++   AVK    SA L+  E L  E ++LS L    
Sbjct: 44  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 103
Query: 57  -IVAYKG-CDISEENGKILYNLFLEYAPGGTLTDAIR----SGTCLEEG----------- 99
            IV   G C I    G  L  +  EY   G L + +R    S  C +             
Sbjct: 104 NIVNLLGACTIG---GPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 100 ---RIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED 156
               + S +  V  G+ +L S   +H D+  +NIL++  + +  KI DFG AR  + + +
Sbjct: 159 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT--HGRITKICDFGLARDIKNDSN 216
Query: 157 DEGKPICGTPI-CMAPEVARGEEQGFPADVWALGCTVLEM-ATGRPPWP--DVADPISAL 212
              K     P+  MAPE        F +DVW+ G  + E+ + G  P+P   V      +
Sbjct: 217 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 276
Query: 213 HRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
            + GF   +PE   +   +  D +  C   +P +R +  ++++
Sbjct: 277 IKEGFRMLSPE---HAPAEMYDIMKTCWDADPLKRPTFKQIVQ 316

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 85/212 (40%), Gaps = 28/212 (13%)
Query: 7   QTIGRGSTATVSIGMSNRSSE---------VFAVKSAELSNSEFLQREQRILSALACPQI 57
           + +G G+  TV  G+     E         V    ++  +N E L  E  +++ +  P +
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD-EAYVMAGVGSPYV 81
Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHT-----RAVLLGL 112
               G  ++         L  +  P G L D +R       GR+ S         +  G+
Sbjct: 82  SRLLGICLTST-----VQLVTQLMPYGCLLDHVREN----RGRLGSQDLLNWCMQIAKGM 132
Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMAP 171
            YL    +VH D+  +N+LV   N    KI DFG AR   ++E +        PI  MA 
Sbjct: 133 SYLEDVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDIDETEYHADGGKVPIKWMAL 190
Query: 172 EVARGEEQGFPADVWALGCTVLEMAT-GRPPW 202
           E          +DVW+ G TV E+ T G  P+
Sbjct: 191 ESILRRRFTHQSDVWSYGVTVWELMTFGAKPY 222

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 37/163 (22%), Positives = 71/163 (43%), Gaps = 21/163 (12%)
Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI-------- 162
            +++LHS G++H D+K  NI  + D+    K+ DFG      +++D+E + +        
Sbjct: 176 AVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLV--TAMDQDEEEQTVLTPMPAYA 231
Query: 163 -----CGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF 217
                 GT + M+PE   G       D+++LG  + E+        +    I+ +  + F
Sbjct: 232 THXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKF 291
Query: 218 SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
                +         QD LS     +P ER  A++++E+   +
Sbjct: 292 PLLFTQKYPQEHMMVQDMLSP----SPTERPEATDIIENAIFE 330

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 114/279 (40%), Gaps = 31/279 (11%)
Query: 6   GQTIGRGSTATV----SIGMSNRSSEV-FAVK----SAELSNSEFLQREQRILSALACPQ 56
           G+T+G G+   V    + G+    + +  AVK    +A     E L  E +I+S L   +
Sbjct: 43  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 102
Query: 57  -IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIR----------SGTCLEEGRIRSHT 105
            IV   G       G +L  +  EY   G L + +R           G  LE   +   +
Sbjct: 103 NIVNLLGA--CTHGGPVL--VITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 158
Query: 106 RAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT 165
             V  G+ +L S   +H D+  +N+L++  N   AKI DFG AR    + +   K     
Sbjct: 159 SQVAQGMAFLASKNCIHRDVAARNVLLT--NGHVAKIGDFGLARDIMNDSNYIVKGNARL 216
Query: 166 PI-CMAPEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVADPISALHRIGFSSDTPE 223
           P+  MAPE          +DVW+ G  + E+ + G  P+P +    S  +++        
Sbjct: 217 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-SKFYKLVKDGYQMA 275
Query: 224 IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ 262
            P +  K     +  C    P  R +  ++    F++EQ
Sbjct: 276 QPAFAPKNIYSIMQACWALEPTHRPTFQQIC--SFLQEQ 312

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 9/157 (5%)
Query: 103 SHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI 162
           S +  V  G+ +L S   +H D+  +NIL++  + +  KI DFG AR  + + +   K  
Sbjct: 172 SFSYQVAKGMAFLASKNCIHRDLAARNILLT--HGRITKICDFGLARDIKNDSNYVVKGN 229
Query: 163 CGTPI-CMAPEVARGEEQGFPADVWALGCTVLEM-ATGRPPWP--DVADPISALHRIGFS 218
              P+  MAPE        F +DVW+ G  + E+ + G  P+P   V      + + GF 
Sbjct: 230 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 289
Query: 219 SDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
             +PE   +   +  D +  C   +P +R +  ++++
Sbjct: 290 MLSPE---HAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 88/217 (40%), Gaps = 33/217 (15%)
Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQREQRILSALA----CPQIVAY 60
           G+ IG G+   + +G +  ++E  A+K   + S +  L  E R    L      PQ+  +
Sbjct: 35  GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 94
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ------Y 114
             C      GK  YN  +    G +L D      C    R  S    +++ +Q      Y
Sbjct: 95  GPC------GK--YNAMVLELLGPSLEDLF--DLC---DRTFSLKTVLMIAIQLISRMEY 141
Query: 115 LHSNGIVHCDIKGQNILVSK---DNEQGAKIADFGCARRARVNEDD------EGKPICGT 165
           +HS  +++ D+K +N L+ +     +Q   I DF  A+     E        E K + GT
Sbjct: 142 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT 201
Query: 166 PICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW 202
              M+     G+EQ    D+ ALG   +    G  PW
Sbjct: 202 ARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW 238

>pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 88/217 (40%), Gaps = 33/217 (15%)
Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQREQRILSALA----CPQIVAY 60
           G+ IG G+   + +G +  ++E  A+K   + S +  L  E R    L      PQ+  +
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ------Y 114
             C      GK  YN  +    G +L D      C    R  S    +++ +Q      Y
Sbjct: 74  GPC------GK--YNAMVLELLGPSLEDLF--DLC---DRTFSLKTVLMIAIQLISRMEY 120
Query: 115 LHSNGIVHCDIKGQNILVSK---DNEQGAKIADFGCARRARVNEDD------EGKPICGT 165
           +HS  +++ D+K +N L+ +     +Q   I DF  A+     E        E K + GT
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT 180
Query: 166 PICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW 202
              M+     G+EQ    D+ ALG   +    G  PW
Sbjct: 181 ARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW 217

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 69/160 (43%), Gaps = 6/160 (3%)
Query: 43  QREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIR 102
           QRE R    L  P +V     D  E +G++  +  L    G  L   +R    L   R  
Sbjct: 82  QREARTAGRLQEPHVVPIH--DFGEIDGQLYVDXRL--INGVDLAAXLRRQGPLAPPRAV 137
Query: 103 SHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI 162
           +  R +   L   H+ G  H D+K +NILVS D+   A + DFG A      +  +    
Sbjct: 138 AIVRQIGSALDAAHAAGATHRDVKPENILVSADD--FAYLVDFGIASATTDEKLTQLGNT 195
Query: 163 CGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW 202
            GT    APE        + AD++AL C + E  TG PP+
Sbjct: 196 VGTLYYXAPERFSESHATYRADIYALTCVLYECLTGSPPY 235

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 9/157 (5%)
Query: 103 SHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI 162
           S +  V  G+ +L S   +H D+  +NIL++  + +  KI DFG AR  + + +   K  
Sbjct: 149 SFSYQVAKGMAFLASKNCIHRDLAARNILLT--HGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 163 CGTPI-CMAPEVARGEEQGFPADVWALGCTVLEM-ATGRPPWP--DVADPISALHRIGFS 218
              P+  MAPE        F +DVW+ G  + E+ + G  P+P   V      + + GF 
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 266
Query: 219 SDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
             +PE   +   +  D +  C   +P +R +  ++++
Sbjct: 267 MLSPE---HAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 114/279 (40%), Gaps = 31/279 (11%)
Query: 6   GQTIGRGSTATV----SIGMSNRSSEV-FAVK----SAELSNSEFLQREQRILSALACPQ 56
           G+T+G G+   V    + G+    + +  AVK    +A     E L  E +I+S L   +
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 57  -IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIR----------SGTCLEEGRIRSHT 105
            IV   G       G +L  +  EY   G L + +R           G  LE   +   +
Sbjct: 111 NIVNLLGA--CTHGGPVL--VITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 166
Query: 106 RAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT 165
             V  G+ +L S   +H D+  +N+L++  N   AKI DFG AR    + +   K     
Sbjct: 167 SQVAQGMAFLASKNCIHRDVAARNVLLT--NGHVAKIGDFGLARDIMNDSNYIVKGNARL 224
Query: 166 PI-CMAPEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVADPISALHRIGFSSDTPE 223
           P+  MAPE          +DVW+ G  + E+ + G  P+P +    S  +++        
Sbjct: 225 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-SKFYKLVKDGYQMA 283
Query: 224 IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ 262
            P +  K     +  C    P  R +  ++    F++EQ
Sbjct: 284 QPAFAPKNIYSIMQACWALEPTHRPTFQQIC--SFLQEQ 320

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 70/298 (23%), Positives = 120/298 (40%), Gaps = 47/298 (15%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL-ACPQIVAY 60
           D+   + +GRG  + V  G++  ++E   +K  +    + ++RE +IL  L   P IV  
Sbjct: 33  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGPNIV-- 90
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           K  DI  +      +L  EY      TD       L +  IR +   +L  L Y HS GI
Sbjct: 91  KLLDIVRDQHSKTPSLIFEYVNN---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 147
Query: 121 VHCDIKGQNILVSKDNE-QGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EE 178
           +H D+K  N+++  D+E +  ++ D+G A      +  E      +     PE+    ++
Sbjct: 148 MHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQD 203
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK-------- 230
             +  D+W+LGC    M   + P+    D    L +I     T  +  Y++K        
Sbjct: 204 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 263
Query: 231 ---------------------------QAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                                      +A DFL K L  +  ER +A E + H + ++
Sbjct: 264 LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 321

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 56/135 (41%), Gaps = 23/135 (17%)
Query: 100 RIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGA-----------------KI 142
            IR     +   + +LHSN + H D+K +NIL  + +   A                 K+
Sbjct: 119 HIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 143 ADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW 202
            DFG A      +D+    +       APEV        P DVW++GC ++E   G   +
Sbjct: 179 VDFGSA----TYDDEHHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234
Query: 203 P--DVADPISALHRI 215
           P  D  + ++ + RI
Sbjct: 235 PTHDSKEHLAMMERI 249

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 70/298 (23%), Positives = 120/298 (40%), Gaps = 47/298 (15%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL-ACPQIVAY 60
           D+   + +GRG  + V  G++  ++E   +K  +    + ++RE +IL  L   P IV  
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV-- 89
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           K  DI  +      +L  EY      TD       L +  IR +   +L  L Y HS GI
Sbjct: 90  KLLDIVRDQHSKTPSLIFEYVNN---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 121 VHCDIKGQNILVSKDNE-QGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EE 178
           +H D+K  N+++  D+E +  ++ D+G A      +  E      +     PE+    ++
Sbjct: 147 MHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQD 202
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK-------- 230
             +  D+W+LGC    M   + P+    D    L +I     T  +  Y++K        
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 231 ---------------------------QAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                                      +A DFL K L  +  ER +A E + H + ++
Sbjct: 263 LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 70/298 (23%), Positives = 120/298 (40%), Gaps = 47/298 (15%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL-ACPQIVAY 60
           D+   + +GRG  + V  G++  ++E   +K  +    + ++RE +IL  L   P IV  
Sbjct: 33  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV-- 90
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           K  DI  +      +L  EY      TD       L +  IR +   +L  L Y HS GI
Sbjct: 91  KLLDIVRDQHSKTPSLIFEYVNN---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 147
Query: 121 VHCDIKGQNILVSKDNE-QGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EE 178
           +H D+K  N+++  D+E +  ++ D+G A      +  E      +     PE+    ++
Sbjct: 148 MHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQD 203
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK-------- 230
             +  D+W+LGC    M   + P+    D    L +I     T  +  Y++K        
Sbjct: 204 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 263
Query: 231 ---------------------------QAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                                      +A DFL K L  +  ER +A E + H + ++
Sbjct: 264 LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 321

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/298 (23%), Positives = 120/298 (40%), Gaps = 47/298 (15%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL-ACPQIVAY 60
           D+   + +GRG  + V  G++  ++E   +K  +    + ++RE +IL  L   P IV  
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGPNIV-- 89
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           K  DI  +      +L  EY      TD       L +  IR +   +L  L Y HS GI
Sbjct: 90  KLLDIVRDQHSKTPSLIFEYVNN---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 121 VHCDIKGQNILVSKDNE-QGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EE 178
           +H D+K  N+++  D+E +  ++ D+G A      +  E      +     PE+    ++
Sbjct: 147 MHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQD 202
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK-------- 230
             +  D+W+LGC    M   + P+    D    L +I     T  +  Y++K        
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 231 ---------------------------QAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                                      +A DFL K L  +  ER +A E + H + ++
Sbjct: 263 LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/298 (23%), Positives = 120/298 (40%), Gaps = 47/298 (15%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL-ACPQIVAY 60
           D+   + +GRG  + V  G++  ++E   +K  +    + ++RE +IL  L   P IV  
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV-- 89
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           K  DI  +      +L  EY      TD       L +  IR +   +L  L Y HS GI
Sbjct: 90  KLLDIVRDQHSKTPSLIFEYVNN---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 121 VHCDIKGQNILVSKDNE-QGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EE 178
           +H D+K  N+++  D+E +  ++ D+G A      +  E      +     PE+    ++
Sbjct: 147 MHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQD 202
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK-------- 230
             +  D+W+LGC    M   + P+    D    L +I     T  +  Y++K        
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 231 ---------------------------QAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                                      +A DFL K L  +  ER +A E + H + ++
Sbjct: 263 LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/298 (23%), Positives = 120/298 (40%), Gaps = 47/298 (15%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL-ACPQIVAY 60
           D+   + +GRG  + V  G++  ++E   +K  +    + ++RE +IL  L   P IV  
Sbjct: 34  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV-- 91
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           K  DI  +      +L  EY      TD       L +  IR +   +L  L Y HS GI
Sbjct: 92  KLLDIVRDQHSKTPSLIFEYVNN---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 148
Query: 121 VHCDIKGQNILVSKDNE-QGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EE 178
           +H D+K  N+++  D+E +  ++ D+G A      +  E      +     PE+    ++
Sbjct: 149 MHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQD 204
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK-------- 230
             +  D+W+LGC    M   + P+    D    L +I     T  +  Y++K        
Sbjct: 205 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 264
Query: 231 ---------------------------QAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                                      +A DFL K L  +  ER +A E + H + ++
Sbjct: 265 LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 322

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/298 (23%), Positives = 120/298 (40%), Gaps = 47/298 (15%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL-ACPQIVAY 60
           D+   + +GRG  + V  G++  ++E   +K  +    + ++RE +IL  L   P IV  
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGPNIV-- 89
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           K  DI  +      +L  EY      TD       L +  IR +   +L  L Y HS GI
Sbjct: 90  KLLDIVRDQHSKTPSLIFEYVNN---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 121 VHCDIKGQNILVSKDNE-QGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EE 178
           +H D+K  N+++  D+E +  ++ D+G A      +  E      +     PE+    ++
Sbjct: 147 MHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQD 202
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK-------- 230
             +  D+W+LGC    M   + P+    D    L +I     T  +  Y++K        
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 231 ---------------------------QAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                                      +A DFL K L  +  ER +A E + H + ++
Sbjct: 263 LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/298 (23%), Positives = 120/298 (40%), Gaps = 47/298 (15%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL-ACPQIVAY 60
           D+   + +GRG  + V  G++  ++E   +K  +    + ++RE +IL  L   P IV  
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGPNIV-- 89
Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           K  DI  +      +L  EY      TD       L +  IR +   +L  L Y HS GI
Sbjct: 90  KLLDIVRDQHSKTPSLIFEYVNN---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 121 VHCDIKGQNILVSKDNE-QGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG-EE 178
           +H D+K  N+++  D+E +  ++ D+G A      +  E      +     PE+    ++
Sbjct: 147 MHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQD 202
Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK-------- 230
             +  D+W+LGC    M   + P+    D    L +I     T  +  Y++K        
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 231 ---------------------------QAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                                      +A DFL K L  +  ER +A E + H + ++
Sbjct: 263 LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 6   GQTIGRGSTATV---SIGMSNRSSEVFAVKSAELSNSEFLQRE-QRILSALAC------P 55
           G+ +G G   +V   ++   + +S   AVK+ +L NS   QRE +  LS  AC      P
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS--QREIEEFLSEAACMKDFSHP 96
Query: 56  QIVAYKGCDISEENGKILYNL----FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVL-- 109
            ++   G  I   +  I   +    F++Y    T     R  T  +   +++  + ++  
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 110 -LGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC 168
            LG++YL +   +H D+  +N ++  D      +ADFG +++    +      I   P+ 
Sbjct: 157 ALGMEYLSNRNFLHRDLAARNCMLRDD--MTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 169 -MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVAD 207
            +A E          +DVWA G T+ E+AT G  P+P V +
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN 255

>pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 21/216 (9%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVK-SAELSNSEFLQREQRILSALA-CPQI- 57
           + +  G+ IG GS   +  G +  +++  A+K     S++  L+ E R    LA C  I 
Sbjct: 9   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 68
Query: 58  -VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYL 115
            V Y G     + G  L+N+ +    G +L D +   G       +    + +L  +Q +
Sbjct: 69  NVYYFG-----QEG--LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 121
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAK---IADFGCARRAR--VNEDD----EGKPICGTP 166
           H   +V+ DIK  N L+ + N + A    + DFG  +  R  V +      E K + GT 
Sbjct: 122 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 181
Query: 167 ICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW 202
             M+     G EQ    D+ ALG   +    G  PW
Sbjct: 182 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 217

>pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 21/216 (9%)
Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVK-SAELSNSEFLQREQRILSALA-CPQI- 57
           + +  G+ IG GS   +  G +  +++  A+K     S++  L+ E R    LA C  I 
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 69
Query: 58  -VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYL 115
            V Y G     + G  L+N+ +    G +L D +   G       +    + +L  +Q +
Sbjct: 70  NVYYFG-----QEG--LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAK---IADFGCARRAR--VNEDD----EGKPICGTP 166
           H   +V+ DIK  N L+ + N + A    + DFG  +  R  V +      E K + GT 
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 167 ICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW 202
             M+     G EQ    D+ ALG   +    G  PW
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 96/234 (41%), Gaps = 39/234 (16%)
Query: 68  ENGKILYNLFLEYAPGGTLTDAIRSGTCLEEG----------------RIRSHTRAVLLG 111
           E+   LY L +EYAP G L D +R    LE                  ++      V  G
Sbjct: 93  EHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 151
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL     +H ++  +NILV ++    AKIADFG +R   V      K +   P+  MA
Sbjct: 152 MDYLSQKQFIHRNLAARNILVGEN--YVAKIADFGLSRGQEVYVK---KTMGRLPVRWMA 206
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPW-----PDVADPISALHRIGFSSDTPEI 224
            E          +DVW+ G  + E+ + G  P+      ++ + +   +R+       E 
Sbjct: 207 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL-------EK 259
Query: 225 PGYMSKQAQDFLSKCLIRNPGERWSASEL---LEHGFVKEQNFKLSTLTEPETY 275
           P     +  D + +C    P ER S +++   L     + + +  +TL E  TY
Sbjct: 260 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTY 313

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 97/236 (41%), Gaps = 21/236 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA--EL-------SNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A  EL       +N E L  E  +++++
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASV 75
Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLG 111
             P +    G  ++         L ++  P G L D +R     +    + +    +  G
Sbjct: 76  DNPHVCRLLGICLTST-----VQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKG 130
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL    +VH D+  +N+LV     Q  KI DFG A+     E +        PI  MA
Sbjct: 131 MNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEI 224
            E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P I
Sbjct: 189 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 244

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 101/240 (42%), Gaps = 35/240 (14%)
Query: 4   TRGQTIGRGSTATVSIGMSNRSS---EV-FAVKSAELSNSE-----FLQREQRILSALAC 54
           TR + IG G    V  GM   SS   EV  A+K+ +   +E     FL  E  I+   + 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG-EAGIMGQFSH 105
Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTC-LEEGRIRSHTRAVLLGLQ 113
             I+  +G  IS+    ++     EY   G L   +R         ++    R +  G++
Sbjct: 106 HNIIRLEGV-ISKYKPMMIIT---EYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 161
Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE--------GK-PICG 164
           YL +   VH D+  +NILV  ++    K++DFG    +RV EDD         GK PI  
Sbjct: 162 YLANMNYVHRDLAARNILV--NSNLVCKVSDFGL---SRVLEDDPEATYTTSGGKIPIRW 216
Query: 165 TPICMAPEVARGEEQGFPADVWALGCTVLEMATG--RPPWPDVADPISALHRIGFSSDTP 222
           T    APE     +    +DVW+ G  + E+ T   RP W      +      GF   TP
Sbjct: 217 T----APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 272

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 7   QTIGRGSTATVSIG---MSNRSSEVFAVKSAELSNSEFLQR----EQRILSALACPQIVA 59
           + IG G +  V  G   +  +     A+K+ +   +E  +R    E  I+     P I+ 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSG----TCLEEGRIRSHTRAVLLGLQYL 115
            +G       G+ L  +  EY   G+L   +R+     T ++   +    R V  G++YL
Sbjct: 115 LEGV---VTRGR-LAMIVTEYMENGSLDTFLRTHDGQFTIMQ---LVGMLRGVGAGMRYL 167
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT----PI-CMA 170
              G VH D+  +N+LV  D+    K++DFG    +RV EDD       T    PI   A
Sbjct: 168 SDLGYVHRDLAARNVLV--DSNLVCKVSDFGL---SRVLEDDPDAAYTTTGGKIPIRWTA 222
Query: 171 PEVARGEEQGFPADVWALGCTVLE-MATG-RPPW 202
           PE          +DVW+ G  + E +A G RP W
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW 256

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 102/237 (43%), Gaps = 30/237 (12%)
Query: 7   QTIGRGSTATVSIGMSNR--SSEVF-AVKSAELSNSEFLQR----EQRILSALACPQIVA 59
           Q IG G    V  G        E+F A+K+ +   +E  +R    E  I+     P ++ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTC-LEEGRIRSHTRAVLLGLQYLHSN 118
            +G  +++    ++   F+E    G+L   +R         ++    R +  G++YL   
Sbjct: 99  LEGV-VTKSTPVMIITEFME---NGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 154
Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT------PI-CMAP 171
             VH D+  +NILV+ +     K++DFG +R     EDD   P   +      PI   AP
Sbjct: 155 NYVHRDLAARNILVNSN--LVCKVSDFGLSRFL---EDDTSDPTYTSALGGKIPIRWTAP 209
Query: 172 EVARGEEQGFPADVWALGCTVLE-MATG-RPPWP----DVADPISALHRIGFSSDTP 222
           E  +  +    +DVW+ G  + E M+ G RP W     DV + I   +R+    D P
Sbjct: 210 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP 266

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 7   QTIGRGSTATVSIG---MSNRSSEVFAVKSAELSNSEFLQR----EQRILSALACPQIVA 59
           + IG G +  V  G   +  +     A+K+ +   +E  +R    E  I+     P I+ 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSG----TCLEEGRIRSHTRAVLLGLQYL 115
            +G       G+ L  +  EY   G+L   +R+     T ++   +    R V  G++YL
Sbjct: 115 LEGV---VTRGR-LAMIVTEYMENGSLDTFLRTHDGQFTIMQ---LVGMLRGVGAGMRYL 167
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT----PI-CMA 170
              G VH D+  +N+LV  D+    K++DFG    +RV EDD       T    PI   A
Sbjct: 168 SDLGYVHRDLAARNVLV--DSNLVCKVSDFGL---SRVLEDDPDAAXTTTGGKIPIRWTA 222
Query: 171 PEVARGEEQGFPADVWALGCTVLE-MATG-RPPW 202
           PE          +DVW+ G  + E +A G RP W
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW 256

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 61/143 (42%), Gaps = 29/143 (20%)
Query: 101 IRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR-------- 152
           +R +   +   L+ +H  GIVH D+K  N L ++  ++ A + DFG A+           
Sbjct: 119 VREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYA-LVDFGLAQGTHDTKIELLK 177
Query: 153 -------------------VNEDDEGKPICGTPICMAPEV-ARGEEQGFPADVWALGCTV 192
                              ++   +  P  GTP   APEV  +   Q    D+W+ G   
Sbjct: 178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIF 237
Query: 193 LEMATGRPPWPDVADPISALHRI 215
           L + +GR P+   +D ++AL +I
Sbjct: 238 LSLLSGRYPFYKASDDLTALAQI 260

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 82/195 (42%), Gaps = 21/195 (10%)
Query: 28  VFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLT 87
           V  +K A  +  +   RE  +L+ L    IV + G  +    G  L  +F EY   G L 
Sbjct: 48  VKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE---GDPLIMVF-EYMKHGDLN 103
Query: 88  DAIRSG-------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSK 134
             +R+              T L + ++    + +  G+ YL S   VH D+  +N LV +
Sbjct: 104 KFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 163
Query: 135 DNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMAPEVARGEEQGFPADVWALGCTVL 193
           +     KI DFG +R     +          PI  M PE     +    +DVW+LG  + 
Sbjct: 164 N--LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLW 221
Query: 194 EMAT-GRPPWPDVAD 207
           E+ T G+ PW  +++
Sbjct: 222 EIFTYGKQPWYQLSN 236

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 97/236 (41%), Gaps = 21/236 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA--EL-------SNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A  EL       +N E L  E  +++++
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASV 74
Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLG 111
             P +    G  ++         L ++  P G L D +R     +    + +    +  G
Sbjct: 75  DNPHVCRLLGICLTST-----VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL    +VH D+  +N+LV     Q  KI DFG A+     E +        PI  MA
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEI 224
            E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P I
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 243

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 87/217 (40%), Gaps = 35/217 (16%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSA--LACPQIVAY-KGC 63
           + IGRG    V  G  +      AVK    +N +    E+ I     +    I  +  G 
Sbjct: 19  ELIGRGRYGAVYKGSLDERP--VAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGD 76
Query: 64  DISEENGKILYNLFLEYAPGGTLTD--AIRSGTCLEEGRIRSHTRAVLLGLQYLHSN--- 118
           +    +G++ Y L +EY P G+L    ++ +   +   R+     +V  GL YLH+    
Sbjct: 77  ERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL---AHSVTRGLAYLHTELPR 133
Query: 119 ------GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN-------EDDEGKPICGT 165
                  I H D+  +N+LV  D      I+DFG + R   N       ED+      GT
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDG--TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191
Query: 166 PICMAPEVARG-------EEQGFPADVWALGCTVLEM 195
              MAPEV  G       E      D++ALG    E+
Sbjct: 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 97/236 (41%), Gaps = 21/236 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA--EL-------SNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A  EL       +N E L  E  +++++
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASV 75
Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLG 111
             P +    G  ++         L ++  P G L D +R     +    + +    +  G
Sbjct: 76  DNPHVCRLLGICLTST-----VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 130
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL    +VH D+  +N+LV     Q  KI DFG A+     E +        PI  MA
Sbjct: 131 MNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEI 224
            E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P I
Sbjct: 189 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 244

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 97/236 (41%), Gaps = 21/236 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA--EL-------SNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A  EL       +N E L  E  +++++
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASV 76
Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLG 111
             P +    G  ++         L ++  P G L D +R     +    + +    +  G
Sbjct: 77  DNPHVCRLLGICLTST-----VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 131
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL    +VH D+  +N+LV     Q  KI DFG A+     E +        PI  MA
Sbjct: 132 MNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEI 224
            E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P I
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 245

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 97/236 (41%), Gaps = 21/236 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA--EL-------SNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A  EL       +N E L  E  +++++
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASV 77
Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLG 111
             P +    G  ++         L ++  P G L D +R     +    + +    +  G
Sbjct: 78  DNPHVCRLLGICLTST-----VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 132
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL    +VH D+  +N+LV     Q  KI DFG A+     E +        PI  MA
Sbjct: 133 MNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEI 224
            E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P I
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 246

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 97/236 (41%), Gaps = 21/236 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA--EL-------SNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A  EL       +N E L  E  +++++
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASV 78
Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLG 111
             P +    G  ++         L ++  P G L D +R     +    + +    +  G
Sbjct: 79  DNPHVCRLLGICLTST-----VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 133
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL    +VH D+  +N+LV     Q  KI DFG A+     E +        PI  MA
Sbjct: 134 MNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 191
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEI 224
            E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P I
Sbjct: 192 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 247

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 5/92 (5%)
Query: 111 GLQYLHSN---GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI 167
           GL YLH +    I+H D+K  NIL+  D E  A + DFG A+     +      + GT  
Sbjct: 151 GLAYLHDHCDPKIIHRDVKAANILL--DEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIG 208
Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMATGR 199
            +APE     +     DV+  G  +LE+ TG+
Sbjct: 209 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 240

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 104/252 (41%), Gaps = 52/252 (20%)
Query: 30  AVKSAELSNSEFLQR----EQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGT 85
           A+K+ ++  +E  +R    E  I+     P I+  +G     +   I+     EY   G+
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV----TEYMENGS 132
Query: 86  LTDAIRSGTC-LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIAD 144
           L   +R         ++    R +  G++YL   G VH D+  +NIL+  ++    K++D
Sbjct: 133 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI--NSNLVCKVSD 190
Query: 145 FGCARRARVNEDDE--------GK-PICGTPICMAPEVARGEEQGFPADVWALGCTVLE- 194
           FG    ARV EDD         GK PI  T    +PE     +    +DVW+ G  + E 
Sbjct: 191 FGL---ARVLEDDPEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 195 MATG-RPPWP----DVADPISALHRIGFSSDTPEI----------------PGYMSKQAQ 233
           M+ G RP W     DV   +   +R+    D P                  P +  +Q  
Sbjct: 244 MSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF--EQIV 301
Query: 234 DFLSKCLIRNPG 245
             L K LIRNPG
Sbjct: 302 SILDK-LIRNPG 312

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 102/238 (42%), Gaps = 34/238 (14%)
Query: 7   QTIGRGSTATVSIG---MSNRSSEVFAVKSAELSNSEFLQR----EQRILSALACPQIVA 59
           + IG G    V  G   +  +     A+K+ ++  +E  +R    E  I+     P +V 
Sbjct: 49  RVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVH 108
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSG----TCLEEGRIRSHTRAVLLGLQYL 115
            +G       GK +  + +E+   G L   +R      T ++   +    R +  G++YL
Sbjct: 109 LEGV---VTRGKPVM-IVIEFMENGALDAFLRKHDGQFTVIQ---LVGMLRGIAAGMRYL 161
Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT----PI-CMA 170
              G VH D+  +NILV+ +     K++DFG    +RV EDD       T    P+   A
Sbjct: 162 ADMGYVHRDLAARNILVNSN--LVCKVSDFGL---SRVIEDDPEAVYTTTGGKIPVRWTA 216
Query: 171 PEVARGEEQGFPADVWALGCTVLE-MATG-RPPWP----DVADPISALHRIGFSSDTP 222
           PE  +  +    +DVW+ G  + E M+ G RP W     DV   I   +R+    D P
Sbjct: 217 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPMDCP 274

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 84/217 (38%), Gaps = 20/217 (9%)
Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSA---ELSNSEFLQREQRILSALACPQIVAYKGC 63
           Q +G G  + V +         +A+K     E  + E  QRE  +      P I+     
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIR----SGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
            + E   K    L L +   GTL + I      G  L E +I      +  GL+ +H+ G
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154
Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPIC--------GTPICMAP 171
             H D+K  NIL+  + +    + D G   +A ++ +   + +          T    AP
Sbjct: 155 YAHRDLKPTNILLGDEGQ--PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 172 EVARGEEQGF---PADVWALGCTVLEMATGRPPWPDV 205
           E+   +         DVW+LGC +  M  G  P+  V
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV 249

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 104/252 (41%), Gaps = 52/252 (20%)
Query: 30  AVKSAELSNSEFLQR----EQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGT 85
           A+K+ ++  +E  +R    E  I+     P I+  +G     +   I+     EY   G+
Sbjct: 48  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV----TEYMENGS 103
Query: 86  LTDAIRSGTC-LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIAD 144
           L   +R         ++    R +  G++YL   G VH D+  +NIL+  ++    K++D
Sbjct: 104 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI--NSNLVCKVSD 161
Query: 145 FGCARRARVNEDDE--------GK-PICGTPICMAPEVARGEEQGFPADVWALGCTVLE- 194
           FG    +RV EDD         GK PI  T    +PE     +    +DVW+ G  + E 
Sbjct: 162 FGL---SRVLEDDPEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEV 214
Query: 195 MATG-RPPWP----DVADPISALHRIGFSSDTPEI----------------PGYMSKQAQ 233
           M+ G RP W     DV   +   +R+    D P                  P +  +Q  
Sbjct: 215 MSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF--EQIV 272
Query: 234 DFLSKCLIRNPG 245
             L K LIRNPG
Sbjct: 273 SILDK-LIRNPG 283

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 97/236 (41%), Gaps = 21/236 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA--EL-------SNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A  EL       +N E L  E  +++++
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASV 76
Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLG 111
             P +    G  ++         L ++  P G L D +R     +    + +    +  G
Sbjct: 77  DNPHVCRLLGICLTST-----VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 131
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL    +VH D+  +N+LV     Q  KI DFG A+     E +        PI  MA
Sbjct: 132 MNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEI 224
            E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P I
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 245

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 104/252 (41%), Gaps = 52/252 (20%)
Query: 30  AVKSAELSNSEFLQR----EQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGT 85
           A+K+ ++  +E  +R    E  I+     P I+  +G     +   I+     EY   G+
Sbjct: 65  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV----TEYMENGS 120
Query: 86  LTDAIRSGTC-LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIAD 144
           L   +R         ++    R +  G++YL   G VH D+  +NIL+  ++    K++D
Sbjct: 121 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI--NSNLVCKVSD 178
Query: 145 FGCARRARVNEDDE--------GK-PICGTPICMAPEVARGEEQGFPADVWALGCTVLE- 194
           FG    +RV EDD         GK PI  T    +PE     +    +DVW+ G  + E 
Sbjct: 179 FGL---SRVLEDDPEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEV 231
Query: 195 MATG-RPPW----PDVADPISALHRIGFSSDTPEI----------------PGYMSKQAQ 233
           M+ G RP W     DV   +   +R+    D P                  P +  +Q  
Sbjct: 232 MSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF--EQIV 289
Query: 234 DFLSKCLIRNPG 245
             L K LIRNPG
Sbjct: 290 SILDK-LIRNPG 300

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 104/252 (41%), Gaps = 52/252 (20%)
Query: 30  AVKSAELSNSEFLQR----EQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGT 85
           A+K+ ++  +E  +R    E  I+     P I+  +G     +   I+     EY   G+
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV----TEYMENGS 132
Query: 86  LTDAIRSGTC-LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIAD 144
           L   +R         ++    R +  G++YL   G VH D+  +NIL+  ++    K++D
Sbjct: 133 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILI--NSNLVCKVSD 190
Query: 145 FGCARRARVNEDDE--------GK-PICGTPICMAPEVARGEEQGFPADVWALGCTVLE- 194
           FG    +RV EDD         GK PI  T    +PE     +    +DVW+ G  + E 
Sbjct: 191 FGL---SRVLEDDPEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 195 MATG-RPPW----PDVADPISALHRIGFSSDTPEI----------------PGYMSKQAQ 233
           M+ G RP W     DV   +   +R+    D P                  P +  +Q  
Sbjct: 244 MSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF--EQIV 301
Query: 234 DFLSKCLIRNPG 245
             L K LIRNPG
Sbjct: 302 SILDK-LIRNPG 312

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 31/216 (14%)
Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQREQRILSALA----CPQIVAY 60
           G+ IG G+   + +G +  ++E  A+K   + S +  L  E R    L+     PQ+  +
Sbjct: 9   GKKIGCGNFGELRLGKNLYTNEYVAIKLEPIKSRAPQLHLEYRFYKQLSATEGVPQVYYF 68
Query: 61  -----KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
                    + E  G  L +LF        L D   +   +    I+  TR     ++Y+
Sbjct: 69  GPXGKYNAMVLELLGPSLEDLF-------DLCDRTFTLKTVLMIAIQLITR-----MEYV 116
Query: 116 HSNGIVHCDIKGQNILVSK---DNEQGAKIADFGCARRARVNEDD------EGKPICGTP 166
           H+  +++ D+K +N LV +     +    I DFG A+     E        E K + GT 
Sbjct: 117 HTKSLIYRDVKPENFLVGRPGTKRQHAIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTA 176
Query: 167 ICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW 202
             M+     G+EQ    D+ ALG   +    G  PW
Sbjct: 177 RYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW 212

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 96/236 (40%), Gaps = 21/236 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA--EL-------SNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A  EL       +N E L  E  +++++
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASV 74
Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLG 111
             P +    G  ++         L  +  P G L D +R     +    + +    +  G
Sbjct: 75  DNPHVCRLLGICLTST-----VQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL    +VH D+  +N+LV     Q  KI DFG A+     E +        PI  MA
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEI 224
            E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P I
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 243

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 67/160 (41%), Gaps = 36/160 (22%)
Query: 69  NGKILY--NLFLEYAP-GGTLTDAI----RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
           +GK +Y  ++ L + P G +L + I     +G  +E+  I+ +   +L  L YL    + 
Sbjct: 102 HGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIED--IKLYCIEILKALNYLRKMSLT 159
Query: 122 HCDIKGQNIL-----------------------VSKDNEQGAKIADFGCARRARVNEDDE 158
           H D+K +NIL                       + +    G K+ DFGCA      + D 
Sbjct: 160 HTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA----TFKSDY 215
Query: 159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATG 198
              I  T    APEV         +D+W+ GC + E+ TG
Sbjct: 216 HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 97/236 (41%), Gaps = 21/236 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA--EL-------SNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A  EL       +N E L  E  +++++
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASV 76
Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLG 111
             P +    G  ++         L ++  P G L D +R     +    + +    +  G
Sbjct: 77  DNPHVCRLLGICLTST-----VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 131
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL    +VH D+  +N+LV     Q  KI DFG A+     E +        PI  MA
Sbjct: 132 MNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEI 224
            E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P I
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 245

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 114/283 (40%), Gaps = 35/283 (12%)
Query: 6   GQTIGRGSTATV----SIGMSNRSSEV-FAVK----SAELSNSEFLQREQRILSALACPQ 56
           G+T+G G+   V    + G+    + +  AVK    +A     E L  E +I+S L   +
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 57  -IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIR--------------SGTCLEEGRI 101
            IV   G       G +L  +  EY   G L + +R              + + L    +
Sbjct: 111 NIVNLLGA--CTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDL 166
Query: 102 RSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP 161
              +  V  G+ +L S   +H D+  +N+L++  N   AKI DFG AR    + +   K 
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLT--NGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 162 ICGTPI-CMAPEVARGEEQGFPADVWALGCTVLEM-ATGRPPWPDVADPISALHRIGFSS 219
               P+  MAPE          +DVW+ G  + E+ + G  P+P +    S  +++    
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-SKFYKLVKDG 283
Query: 220 DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ 262
                P +  K     +  C    P  R +  ++    F++EQ
Sbjct: 284 YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQIC--SFLQEQ 324

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 97/236 (41%), Gaps = 21/236 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA--EL-------SNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A  EL       +N E L  E  +++++
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASV 78
Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLG 111
             P +    G  ++         L ++  P G L D +R     +    + +    +  G
Sbjct: 79  DNPHVCRLLGICLTST-----VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 133
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL    +VH D+  +N+LV     Q  KI DFG A+     E +        PI  MA
Sbjct: 134 MNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 191
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEI 224
            E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P I
Sbjct: 192 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 247

>pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 99/247 (40%), Gaps = 54/247 (21%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFA----VKSAELSNS-------EFLQR----EQ 46
           +W  G  IG+G    + +   N S  V +    V   E S++       +F QR    EQ
Sbjct: 36  EWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 47  -------RILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLE-- 97
                  R L  L  P+   Y G  + ++NGK    + ++           R G+ L+  
Sbjct: 96  IQKWIRTRKLKYLGVPK---YWGSGLHDKNGKSYRFMIMD-----------RFGSDLQKI 141
Query: 98  -EGRIRSHTRAVLLGL--------QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA 148
            E   +  +R  +L L        +Y+H +  VH DIK  N+L++  N     + D+G A
Sbjct: 142 YEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
Query: 149 RR------ARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW 202
            R       +  ++D  +   GT    + +   G       D+  LG  +++  TG  PW
Sbjct: 202 YRYCPEGVHKEYKEDPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261
Query: 203 PD-VADP 208
            D + DP
Sbjct: 262 EDNLKDP 268

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 81/181 (44%), Gaps = 11/181 (6%)
Query: 32  KSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTD-AI 90
           +  E +++E + RE +I+  L  P IV   G   +E        L +E A GG L    +
Sbjct: 373 QGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-----LMLVMEMAGGGPLHKFLV 427
Query: 91  RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR 150
                +    +      V +G++YL     VH ++  +N+L+   N   AKI+DFG ++ 
Sbjct: 428 GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV--NRHYAKISDFGLSKA 485
Query: 151 ARVNEDDEGKPICGT-PI-CMAPEVARGEEQGFPADVWALGCTVLE-MATGRPPWPDVAD 207
              ++        G  P+   APE     +    +DVW+ G T+ E ++ G+ P+  +  
Sbjct: 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545
Query: 208 P 208
           P
Sbjct: 546 P 546

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 44/199 (22%)
Query: 111 GLQYLHSNG--IVHCDIKGQNILVSKDNEQGAKIADFGCA--------------RRARVN 154
            +Q++H     I+H D+K +N+L+S  N+   K+ DFG A              RRA V 
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLS--NQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 155 ED--DEGKPICGTP--ICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS 210
           E+      P+  TP  I +      GE+Q    D+WALGC +  +   + P+ D A    
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQ----DIWALGCILYLLCFRQHPFEDGA---- 257
Query: 211 ALHRIGFSSDTPEIPGYMSKQA--QDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLST 268
              ++   +    IP + ++       +   L  NP ER S +E++          +L  
Sbjct: 258 ---KLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVH---------QLQE 305
Query: 269 LTEPETYNSESPTSVLNQQ 287
           +      N +SP + L +Q
Sbjct: 306 IAAARNVNPKSPITELLEQ 324

>pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 99/247 (40%), Gaps = 54/247 (21%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFA----VKSAELSNS-------EFLQR----EQ 46
           +W  G  IG+G    + +   N S  V +    V   E S++       +F QR    EQ
Sbjct: 36  EWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 47  -------RILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLE-- 97
                  R L  L  P+   Y G  + ++NGK    + ++           R G+ L+  
Sbjct: 96  IQKWIRTRKLKYLGVPK---YWGSGLHDKNGKSYRFMIMD-----------RFGSDLQKI 141
Query: 98  -EGRIRSHTRAVLLGL--------QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA 148
            E   +  +R  +L L        +Y+H +  VH DIK  N+L++  N     + D+G A
Sbjct: 142 YEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
Query: 149 RR------ARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW 202
            R       +  ++D  +   GT    + +   G       D+  LG  +++  TG  PW
Sbjct: 202 YRYCPEGVHKEYKEDPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261
Query: 203 PD-VADP 208
            D + DP
Sbjct: 262 EDNLKDP 268

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 12/192 (6%)
Query: 37  SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-C 95
           +N E L  E  +++++  P +    G  ++         L ++  P G L D +R     
Sbjct: 67  ANKEILD-EAYVMASVDNPHVCRLLGICLTST-----VQLIMQLMPFGCLLDYVREHKDN 120
Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           +    + +    +  G+ YL    +VH D+  +N+LV     Q  KI DFG A+     E
Sbjct: 121 IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGLAKLLGAEE 178
Query: 156 DDEGKPICGTPI-CMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISAL 212
            +        PI  MA E          +DVW+ G TV E+ T G  P+  + A  IS++
Sbjct: 179 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 238
Query: 213 HRIGFSSDTPEI 224
              G     P I
Sbjct: 239 LEKGERLPQPPI 250

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 88/216 (40%), Gaps = 30/216 (13%)
Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-SNSEFLQREQRILSALA-----CPQIVA 59
           G+ IG G+   + +G +  ++E  A+K   + S +  L  E R    L       PQ V 
Sbjct: 5   GKKIGCGNFGELRLGKNLYTNEYVAIKLEPIKSRAPQLHLEYRFYKQLGSAGEGLPQ-VY 63
Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI----RSGTCLEEGRIRSHTRAVLLGLQYL 115
           Y G       GK  YN  +    G +L D      R+ T      I      +L  ++Y+
Sbjct: 64  YFG-----PXGK--YNAMVLELLGPSLEDLFDLCDRTFTLKTVLMI---AIQLLSRMEYV 113
Query: 116 HSNGIVHCDIKGQNILVSKD---NEQGAKIADFGCARRARVNEDD------EGKPICGTP 166
           HS  +++ D+K +N L+ +     E    I DFG A+     E        E K + GT 
Sbjct: 114 HSKNLIYRDVKPENFLIGRQGNKKEHVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTA 173
Query: 167 ICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW 202
             M+     G+EQ    D+ ALG   +    G  PW
Sbjct: 174 RYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW 209

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 96/236 (40%), Gaps = 21/236 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA--EL-------SNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A  EL       +N E L  E  +++++
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASV 99
Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLG 111
             P +    G  ++         L  +  P G L D +R     +    + +    +  G
Sbjct: 100 DNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 154
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL    +VH D+  +N+LV     Q  KI DFG A+     E +        PI  MA
Sbjct: 155 MNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 212
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEI 224
            E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P I
Sbjct: 213 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 268

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 96/236 (40%), Gaps = 21/236 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA--EL-------SNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A  EL       +N E L  E  +++++
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASV 81
Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLG 111
             P +    G  ++         L  +  P G L D +R     +    + +    +  G
Sbjct: 82  DNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 136
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL    +VH D+  +N+LV     Q  KI DFG A+     E +        PI  MA
Sbjct: 137 MNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEI 224
            E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P I
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 250

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/133 (26%), Positives = 59/133 (44%), Gaps = 13/133 (9%)
Query: 68  ENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKG 127
           ENG +  +L+    P  +++   R   C+   R          GL YLH+  I+H D+K 
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR----------GLHYLHTRAIIHRDVKS 167
Query: 128 QNILVSKDNEQGAKIADFGCARR-ARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVW 186
            NIL+  D     KI DFG +++   +++      + GT   + PE          +DV+
Sbjct: 168 INILL--DENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVY 225
Query: 187 ALGCTVLEMATGR 199
           + G  + E+   R
Sbjct: 226 SFGVVLFEVLCAR 238

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 96/236 (40%), Gaps = 21/236 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA--EL-------SNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A  EL       +N E L  E  +++++
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASV 74
Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLG 111
             P +    G  ++         L  +  P G L D +R     +    + +    +  G
Sbjct: 75  DNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL    +VH D+  +N+LV     Q  KI DFG A+     E +        PI  MA
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEI 224
            E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P I
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 243

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 104/252 (41%), Gaps = 52/252 (20%)
Query: 30  AVKSAELSNSEFLQR----EQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGT 85
           A+K+ ++  +E  +R    E  I+     P I+  +G     +   I+     EY   G+
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV----TEYMENGS 132
Query: 86  LTDAIRSGTC-LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIAD 144
           L   +R         ++    R +  G++YL   G VH D+  +NIL+  ++    K++D
Sbjct: 133 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI--NSNLVCKVSD 190
Query: 145 FGCARRARVNEDDE--------GK-PICGTPICMAPEVARGEEQGFPADVWALGCTVLE- 194
           FG    +RV EDD         GK PI  T    +PE     +    +DVW+ G  + E 
Sbjct: 191 FGL---SRVLEDDPEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 195 MATG-RPPWP----DVADPISALHRIGFSSDTPEI----------------PGYMSKQAQ 233
           M+ G RP W     DV   +   +R+    D P                  P +  +Q  
Sbjct: 244 MSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF--EQIV 301
Query: 234 DFLSKCLIRNPG 245
             L K LIRNPG
Sbjct: 302 SILDK-LIRNPG 312

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 96/236 (40%), Gaps = 21/236 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA--EL-------SNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A  EL       +N E L  E  +++++
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASV 74
Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLG 111
             P +    G  ++         L  +  P G L D +R     +    + +    +  G
Sbjct: 75  DNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL    +VH D+  +N+LV     Q  KI DFG A+     E +        PI  MA
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEI 224
            E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P I
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 243

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 104/252 (41%), Gaps = 52/252 (20%)
Query: 30  AVKSAELSNSEFLQR----EQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGT 85
           A+K+ ++  +E  +R    E  I+     P I+  +G     +   I+     EY   G+
Sbjct: 75  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV----TEYMENGS 130
Query: 86  LTDAIRSGTC-LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIAD 144
           L   +R         ++    R +  G++YL   G VH D+  +NIL+  ++    K++D
Sbjct: 131 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI--NSNLVCKVSD 188
Query: 145 FGCARRARVNEDDE--------GK-PICGTPICMAPEVARGEEQGFPADVWALGCTVLE- 194
           FG    +RV EDD         GK PI  T    +PE     +    +DVW+ G  + E 
Sbjct: 189 FGL---SRVLEDDPEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEV 241
Query: 195 MATG-RPPWP----DVADPISALHRIGFSSDTPEI----------------PGYMSKQAQ 233
           M+ G RP W     DV   +   +R+    D P                  P +  +Q  
Sbjct: 242 MSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF--EQIV 299
Query: 234 DFLSKCLIRNPG 245
             L K LIRNPG
Sbjct: 300 SILDK-LIRNPG 310

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 104/252 (41%), Gaps = 52/252 (20%)
Query: 30  AVKSAELSNSEFLQR----EQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGT 85
           A+K+ ++  +E  +R    E  I+     P I+  +G     +   I+     EY   G+
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV----TEYMENGS 132
Query: 86  LTDAIRSGTC-LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIAD 144
           L   +R         ++    R +  G++YL   G VH D+  +NIL+  ++    K++D
Sbjct: 133 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI--NSNLVCKVSD 190
Query: 145 FGCARRARVNEDDE--------GK-PICGTPICMAPEVARGEEQGFPADVWALGCTVLE- 194
           FG    +RV EDD         GK PI  T    +PE     +    +DVW+ G  + E 
Sbjct: 191 FGL---SRVLEDDPEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 195 MATG-RPPW----PDVADPISALHRIGFSSDTPEI----------------PGYMSKQAQ 233
           M+ G RP W     DV   +   +R+    D P                  P +  +Q  
Sbjct: 244 MSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF--EQIV 301
Query: 234 DFLSKCLIRNPG 245
             L K LIRNPG
Sbjct: 302 SILDK-LIRNPG 312

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 104/252 (41%), Gaps = 52/252 (20%)
Query: 30  AVKSAELSNSEFLQR----EQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGT 85
           A+K+ ++  +E  +R    E  I+     P I+  +G     +   I+     EY   G+
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV----TEYMENGS 132
Query: 86  LTDAIRSGTC-LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIAD 144
           L   +R         ++    R +  G++YL   G VH D+  +NIL+  ++    K++D
Sbjct: 133 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI--NSNLVCKVSD 190
Query: 145 FGCARRARVNEDDE--------GK-PICGTPICMAPEVARGEEQGFPADVWALGCTVLE- 194
           FG    +RV EDD         GK PI  T    +PE     +    +DVW+ G  + E 
Sbjct: 191 FGL---SRVLEDDPEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 195 MATG-RPPW----PDVADPISALHRIGFSSDTPEI----------------PGYMSKQAQ 233
           M+ G RP W     DV   +   +R+    D P                  P +  +Q  
Sbjct: 244 MSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF--EQIV 301
Query: 234 DFLSKCLIRNPG 245
             L K LIRNPG
Sbjct: 302 SILDK-LIRNPG 312

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 104/252 (41%), Gaps = 52/252 (20%)
Query: 30  AVKSAELSNSEFLQR----EQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGT 85
           A+K+ ++  +E  +R    E  I+     P I+  +G     +   I+     EY   G+
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV----TEYMENGS 132
Query: 86  LTDAIRSGTC-LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIAD 144
           L   +R         ++    R +  G++YL   G VH D+  +NIL+  ++    K++D
Sbjct: 133 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI--NSNLVCKVSD 190
Query: 145 FGCARRARVNEDDE--------GK-PICGTPICMAPEVARGEEQGFPADVWALGCTVLE- 194
           FG    +RV EDD         GK PI  T    +PE     +    +DVW+ G  + E 
Sbjct: 191 FGL---SRVLEDDPEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 195 MATG-RPPW----PDVADPISALHRIGFSSDTPEI----------------PGYMSKQAQ 233
           M+ G RP W     DV   +   +R+    D P                  P +  +Q  
Sbjct: 244 MSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF--EQIV 301
Query: 234 DFLSKCLIRNPG 245
             L K LIRNPG
Sbjct: 302 SILDK-LIRNPG 312

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 96/236 (40%), Gaps = 21/236 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA--EL-------SNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A  EL       +N E L  E  +++++
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASV 84
Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLG 111
             P +    G  ++         L  +  P G L D +R     +    + +    +  G
Sbjct: 85  DNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 139
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL    +VH D+  +N+LV     Q  KI DFG A+     E +        PI  MA
Sbjct: 140 MNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 197
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEI 224
            E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P I
Sbjct: 198 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 253

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 96/236 (40%), Gaps = 21/236 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA--EL-------SNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A  EL       +N E L  E  +++++
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASV 68
Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLG 111
             P +    G  ++         L  +  P G L D +R     +    + +    +  G
Sbjct: 69  DNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL    +VH D+  +N+LV     Q  KI DFG A+     E +        PI  MA
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEI 224
            E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P I
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 237

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 96/236 (40%), Gaps = 21/236 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA--EL-------SNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A  EL       +N E L  E  +++++
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASV 77
Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLG 111
             P +    G  ++         L  +  P G L D +R     +    + +    +  G
Sbjct: 78  DNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 132
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL    +VH D+  +N+LV     Q  KI DFG A+     E +        PI  MA
Sbjct: 133 MNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEI 224
            E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P I
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 246

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 96/236 (40%), Gaps = 21/236 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA--EL-------SNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A  EL       +N E L  E  +++++
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASV 80
Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLG 111
             P +    G  ++         L  +  P G L D +R     +    + +    +  G
Sbjct: 81  DNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 135
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL    +VH D+  +N+LV     Q  KI DFG A+     E +        PI  MA
Sbjct: 136 MNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 193
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEI 224
            E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P I
Sbjct: 194 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 249

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 96/236 (40%), Gaps = 21/236 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA--EL-------SNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A  EL       +N E L  E  +++++
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASV 76
Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLG 111
             P +    G  ++         L  +  P G L D +R     +    + +    +  G
Sbjct: 77  DNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 131
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL    +VH D+  +N+LV     Q  KI DFG A+     E +        PI  MA
Sbjct: 132 MNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEI 224
            E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P I
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 245

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 95/236 (40%), Gaps = 21/236 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL---------SNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A +         +N E L  E  +++++
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILD-EAYVMASV 108
Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLG 111
             P +    G  ++         L  +  P G L D +R     +    + +    +  G
Sbjct: 109 DNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 163
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL    +VH D+  +N+LV     Q  KI DFG A+     E +        PI  MA
Sbjct: 164 MNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 221
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEI 224
            E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P I
Sbjct: 222 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 277

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 96/236 (40%), Gaps = 21/236 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA--EL-------SNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A  EL       +N E L  E  +++++
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASV 77
Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLG 111
             P +    G  ++         L  +  P G L D +R     +    + +    +  G
Sbjct: 78  DNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 132
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL    +VH D+  +N+LV     Q  KI DFG A+     E +        PI  MA
Sbjct: 133 MNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEI 224
            E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P I
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 246

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 96/236 (40%), Gaps = 21/236 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA--EL-------SNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A  EL       +N E L  E  +++++
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASV 77
Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLG 111
             P +    G  ++         L  +  P G L D +R     +    + +    +  G
Sbjct: 78  DNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 132
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL    +VH D+  +N+LV     Q  KI DFG A+     E +        PI  MA
Sbjct: 133 MNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEI 224
            E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P I
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 246

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 59/125 (47%), Gaps = 4/125 (3%)
Query: 75  NLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVS 133
            L  +Y P G+L D +R     L    + +    +  G+ YL  +G+VH ++  +N+L+ 
Sbjct: 90  QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK 149
Query: 134 KDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMAPEVARGEEQGFPADVWALGCTV 192
             ++   ++ADFG A     ++         TPI  MA E     +    +DVW+ G TV
Sbjct: 150 SPSQ--VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTV 207
Query: 193 LEMAT 197
            E+ T
Sbjct: 208 WELMT 212

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 59/125 (47%), Gaps = 4/125 (3%)
Query: 75  NLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVS 133
            L  +Y P G+L D +R     L    + +    +  G+ YL  +G+VH ++  +N+L+ 
Sbjct: 108 QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK 167
Query: 134 KDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMAPEVARGEEQGFPADVWALGCTV 192
             ++   ++ADFG A     ++         TPI  MA E     +    +DVW+ G TV
Sbjct: 168 SPSQ--VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTV 225
Query: 193 LEMAT 197
            E+ T
Sbjct: 226 WELMT 230

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 96/236 (40%), Gaps = 21/236 (8%)
Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA--EL-------SNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A  EL       +N E L  E  +++++
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASV 71
Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLG 111
             P +    G  ++         L  +  P G L D +R     +    + +    +  G
Sbjct: 72  DNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEG 126
Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CMA 170
           + YL    +VH D+  +N+LV     Q  KI DFG A+     E +        PI  MA
Sbjct: 127 MNYLEDRRLVHRDLAARNVLVK--TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 184
Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV-ADPISALHRIGFSSDTPEI 224
            E          +DVW+ G TV E+ T G  P+  + A  IS++   G     P I
Sbjct: 185 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 240

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 103/252 (40%), Gaps = 52/252 (20%)
Query: 30  AVKSAELSNSEFLQR----EQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGT 85
           A+K+ ++  +E  +R    E  I+     P I+  +G     +   I+     EY   G+
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV----TEYMENGS 132
Query: 86  LTDAIRSGTC-LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIAD 144
           L   +R         ++    R +  G++YL   G VH D+  +NIL+  ++    K++D
Sbjct: 133 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI--NSNLVCKVSD 190
Query: 145 FGCARRARVNEDDE--------GK-PICGTPICMAPEVARGEEQGFPADVWALGCTVLE- 194
           FG     RV EDD         GK PI  T    +PE     +    +DVW+ G  + E 
Sbjct: 191 FGL---GRVLEDDPEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 195 MATG-RPPW----PDVADPISALHRIGFSSDTPEI----------------PGYMSKQAQ 233
           M+ G RP W     DV   +   +R+    D P                  P +  +Q  
Sbjct: 244 MSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF--EQIV 301
Query: 234 DFLSKCLIRNPG 245
             L K LIRNPG
Sbjct: 302 SILDK-LIRNPG 312
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	385
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-100
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-92
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-82
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-82
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-80
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-79
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-74
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-72
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-70
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-70
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-67
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-67
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-67
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-66
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-65
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-63
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-63
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-63
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-62
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-62
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-62
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-61
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-60
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-59
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-57
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-56
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-56
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-55
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-55
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-54
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-54
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-53
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-53
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-51
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-51
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-49
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-49
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-49
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-48
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-48
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-48
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-48
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-47
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-47
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-47
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-47
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-47
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-47
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-47
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-47
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-46
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-46
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-46
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-46
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-46
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-46
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-46
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-46
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-46
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-45
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-45
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-45
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-45
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-44
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-44
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-44
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-44
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-44
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-44
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-44
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-43
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-43
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-43
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-43
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-42
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-42
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-42
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-42
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-42
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-42
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-42
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-41
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-41
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-41
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-41
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-41
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-41
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-41
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-40
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-40
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-40
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-40
3ork_A	311	Serine/threonine protein kinase; structural genomi	9e-40
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-39
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-39
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-39
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-39
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-39
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-39
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-39
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-39
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-39
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-39
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-39
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-39
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-39
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	9e-39
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-38
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-38
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-38
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-38
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-38
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-37
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-37
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-37
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-37
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	7e-37
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-36
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-36
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-36
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-36
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-35
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-35
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-34
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-34
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-33
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-33
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-33
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-33
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-33
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-33
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-33
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-31
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-31
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-31
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-29
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-29
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-29
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-29
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-29
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-29
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-28
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-28
3o0g_A	292	Cell division protein kinase 5; kinase activator c	9e-28
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-27
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-27
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-27
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-26
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-26
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-26
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-26
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-25
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-25
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-25
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-24
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-24
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-24
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-24
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-24
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-23
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-23
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-23
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	9e-23
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-21
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-21
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-21
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-21
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-21
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-20
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-20
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-20
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-20
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-20
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-20
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	9e-20
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-19
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-19
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-19
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-19
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-18
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-18
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-18
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-05
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-18
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-18
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-18
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-18
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-18
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-17
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-17
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-17
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-17
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	8e-17
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	9e-17
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-16
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-16
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-16
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-16
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-16
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-16
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-16
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-16
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-16
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-16
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-15
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-15
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-15
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-15
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-15
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-15
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-15
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	7e-15
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-14
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-14
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-14
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-14
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-14
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-13
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-13
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-13
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-13
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-13
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-13
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-13
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-13
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-12
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-12
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-12
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-12
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-11
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-11
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-05

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  297 bits (762), Expect = e-100
 Identities = 89/270 (32%), Positives = 138/270 (51%), Gaps = 16/270 (5%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF---LQREQRILSALACPQIV 58
           +      +G+G+   V  G    +    A+K     +S +   L  E  +   L    IV
Sbjct: 23  ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV 82

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT---CLEEGRIRSHTRAVLLGLQYL 115
            Y G             +F+E  PGG+L+  +RS        E  I  +T+ +L GL+YL
Sbjct: 83  QYLGSFSENGF----IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL 138

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           H N IVH DIKG N+L+  +   G  KI+DFG ++R     +   +   GT   MAPE+ 
Sbjct: 139 HDNQIVHRDIKGDNVLI--NTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEII 195

Query: 175 RGEEQG--FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA 232
               +G    AD+W+LGCT++EMATG+PP+ ++ +P +A+ ++G     PEIP  MS +A
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA 255

Query: 233 QDFLSKCLIRNPGERWSASELLEHGFVKEQ 262
           + F+ KC   +P +R  A++LL   F+K  
Sbjct: 256 KAFILKCFEPDPDKRACANDLLVDEFLKVS 285

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  280 bits (717), Expect = 1e-92
 Identities = 78/276 (28%), Positives = 108/276 (39%), Gaps = 15/276 (5%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
             T    +GRGS   V      ++    AVK   L        E    + L+ P+IV   
Sbjct: 59  WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--VEELVACAGLSSPRIVPLY 116

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
           G            N+F+E   GG+L   I+   CL E R   +    L GL+YLH+  I+
Sbjct: 117 GAVREGPW----VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRIL 172

Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARR----ARVNEDDEGKPICGTPICMAPEVARGE 177
           H D+K  N+L+S D  + A + DFG A              G  I GT   MAPEV  G+
Sbjct: 173 HGDVKADNVLLSSDGSR-AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231

Query: 178 EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS-DTPEIPGYMSKQAQDFL 236
                 D+W+  C +L M  G  PW           +I        EIP   +      +
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQY-FRGPLCLKIASEPPPIREIPPSCAPLTAQAI 290

Query: 237 SKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEP 272
            + L + P  R SA EL        Q  ++  L  P
Sbjct: 291 QEGLRKEPVHRASAMELRRKVGKALQ--EVGGLKSP 324

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  255 bits (654), Expect = 2e-82
 Identities = 76/333 (22%), Positives = 138/333 (41%), Gaps = 31/333 (9%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----EFLQREQRILSALA--C 54
            ++  + IG G ++ V   + N   +++A+K   L  +     +  + E   L+ L    
Sbjct: 57  IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
            +I+     +I+++       + +E      L   ++    ++    +S+ + +L  +  
Sbjct: 116 DKIIRLYDYEITDQY----IYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP-ICGTPICMAPEV 173
           +H +GIVH D+K  N L+        K+ DFG A + + +     K    G    M PE 
Sbjct: 171 IHQHGIVHSDLKPANFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227

Query: 174 -----------ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP 222
                          +    +DVW+LGC +  M  G+ P+  + + IS LH I   +   
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287

Query: 223 EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTS 282
           E P    K  QD L  CL R+P +R S  ELL H +V+ Q   ++ + +     +E    
Sbjct: 288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG---TTEEMKY 344

Query: 283 VLNQQLWDSTLTSCSSASAKERIRQLIGEGSSE 315
           VL Q +  ++  S   A+         GE  + 
Sbjct: 345 VLGQLVGLNSPNSILKAAKTLYEHYSGGESHNS 377

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  253 bits (649), Expect = 4e-82
 Identities = 77/333 (23%), Positives = 139/333 (41%), Gaps = 31/333 (9%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----EFLQREQRILSALA--C 54
            ++  + IG G ++ V   + N   +++A+K   L  +     +  + E   L+ L    
Sbjct: 10  IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
            +I+     +I+++       + +E      L   ++    ++    +S+ + +L  +  
Sbjct: 69  DKIIRLYDYEITDQY----IYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 123

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP-ICGTPICMAPEV 173
           +H +GIVH D+K  N L+        K+ DFG A + + +     K    GT   M PE 
Sbjct: 124 IHQHGIVHSDLKPANFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180

Query: 174 -----------ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP 222
                          +    +DVW+LGC +  M  G+ P+  + + IS LH I   +   
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240

Query: 223 EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTS 282
           E P    K  QD L  CL R+P +R S  ELL H +V+ Q   ++ + +     +E    
Sbjct: 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG---TTEEMKY 297

Query: 283 VLNQQLWDSTLTSCSSASAKERIRQLIGEGSSE 315
           VL Q +  ++  S   A+         GE  + 
Sbjct: 298 VLGQLVGLNSPNSILKAAKTLYEHYSGGESHNS 330

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  247 bits (633), Expect = 4e-80
 Identities = 70/292 (23%), Positives = 126/292 (43%), Gaps = 28/292 (9%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----EFLQREQRILSALA--C 54
            ++  + IG G ++ V   + N   +++A+K   L  +     +  + E   L+ L    
Sbjct: 29  IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
            +I+     +I+++       + +E      L   ++    ++    +S+ + +L  +  
Sbjct: 88  DKIIRLYDYEITDQY----IYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 142

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP-ICGTPICMAPEV 173
           +H +GIVH D+K  N L+        K+ DFG A + + +     K    GT   M PE 
Sbjct: 143 IHQHGIVHSDLKPANFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199

Query: 174 -----------ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP 222
                          +    +DVW+LGC +  M  G+ P+  + + IS LH I   +   
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 259

Query: 223 EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPET 274
           E P    K  QD L  CL R+P +R S  ELL H +V+ Q   ++ + +  T
Sbjct: 260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 311

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  244 bits (624), Expect = 4e-79
 Identities = 76/269 (28%), Positives = 116/269 (43%), Gaps = 16/269 (5%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----EFLQREQRILSALACPQI 57
                 IGRGS  TV  G+   ++   A    +         +  + E  +L  L  P I
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87

Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V +     S   GK    L  E    GTL   ++    ++   +RS  R +L GLQ+LH+
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147

Query: 118 NG--IVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
               I+H D+K  NI +      G  KI D G A    +      K + GTP  MAPE+ 
Sbjct: 148 RTPPIIHRDLKCDNIFI--TGPTGSVKIGDLGLAT---LKRASFAKAVIGTPEFMAPEMY 202

Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE-IPGYMSKQAQ 233
             E+     DV+A G  +LEMAT   P+ +     + ++R   S   P         + +
Sbjct: 203 E-EKYDESVDVYAFGMCMLEMATSEYPYSEC-QNAAQIYRRVTSGVKPASFDKVAIPEVK 260

Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQ 262
           + +  C+ +N  ER+S  +LL H F +E+
Sbjct: 261 EIIEGCIRQNKDERYSIKDLLNHAFFQEE 289

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  231 bits (592), Expect = 5e-74
 Identities = 70/267 (26%), Positives = 105/267 (39%), Gaps = 21/267 (7%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALA-CP 55
            + R   +G GS   V    S     ++AVK          +      E      +   P
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQY 114
             V  +    + E G ILY L  E   G +L       G  L E ++  + R  LL L +
Sbjct: 118 CCVRLEQ---AWEEGGILY-LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           LHS G+VH D+K  NI +        K+ DFG      +     G+   G P  MAPE+ 
Sbjct: 173 LHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLV--ELGTAGAGEVQEGDPRYMAPELL 228

Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD 234
           +G   G  ADV++LG T+LE+A                 ++      PE    +S + + 
Sbjct: 229 QGSY-GTAADVFSLGLTILEVACNMELPHGGEG----WQQLRQGYLPPEFTAGLSSELRS 283

Query: 235 FLSKCLIRNPGERWSASELLEHGFVKE 261
            L   L  +P  R +A  LL    +++
Sbjct: 284 VLVMMLEPDPKLRATAEALLALPVLRQ 310

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  227 bits (581), Expect = 1e-72
 Identities = 67/287 (23%), Positives = 108/287 (37%), Gaps = 42/287 (14%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALA-CP 55
           ++   + IG G   +V   +      ++A+K      A   + +   RE    + L    
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAI----RSGTCLEEGRIRSHTRAVLLG 111
            +V Y       E+  +   +  EY  GG+L DAI    R  +  +E  ++     V  G
Sbjct: 72  HVVRYFSAW--AEDDHM--LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQG-----------------AKIADFGCARRARVN 154
           L+Y+HS  +VH DIK  NI +S+ +                     KI D G   R    
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI--- 184

Query: 155 EDDEGKPICGTPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALH 213
                +   G    +A EV +        AD++AL  TV+  A   P            H
Sbjct: 185 --SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP----RNGDQWH 238

Query: 214 RIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
            I      P IP  +S++  + L   +  +P  R SA  L++H  + 
Sbjct: 239 EI-RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  221 bits (566), Expect = 4e-70
 Identities = 59/283 (20%), Positives = 114/283 (40%), Gaps = 19/283 (6%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS------EFLQREQRILSALACP 55
           ++   + IGRG  + V            A+K  ++ +           +E  +L  L  P
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAI----RSGTCLEEGRIRSHTRAVLLG 111
            ++ Y     S      L  + LE A  G L+  I    +    + E  +  +   +   
Sbjct: 93  NVIKYYA---SFIEDNELN-IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAP 171
           L+++HS  ++H DIK  N+ ++       K+ D G  R    ++      + GTP  M+P
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSP 205

Query: 172 EVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP-GYMSK 230
           E        F +D+W+LGC + EMA  + P+      + +L +     D P +P  + S+
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265

Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPE 273
           + +  ++ C+  +P +R   + + +           S+L    
Sbjct: 266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRM-HACTASSLEHHH 307

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  221 bits (564), Expect = 6e-70
 Identities = 96/279 (34%), Positives = 145/279 (51%), Gaps = 24/279 (8%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
            +T+ + IG+GS   V  G+ NR+ +V A+K  +L  +    E +Q+E  +LS    P +
Sbjct: 23  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82

Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
             Y G  + +    I+    +EY  GG+  D +  G  L+E +I +  R +L GL YLHS
Sbjct: 83  TKYYGSYLKDTKLWII----MEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHS 137

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCA-----RRARVNEDDEGKPICGTPICMAPE 172
              +H DIK  N+L+S+  E   K+ADFG A      + + N         GTP  MAPE
Sbjct: 138 EKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNT------FVGTPFWMAPE 189

Query: 173 VARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA 232
           V +       AD+W+LG T +E+A G PP  ++  P+  L  I   ++ P + G  SK  
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIP-KNNPPTLEGNYSKPL 247

Query: 233 QDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTE 271
           ++F+  CL + P  R +A ELL+H F+     K S LTE
Sbjct: 248 KEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTE 286

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  214 bits (546), Expect = 3e-67
 Identities = 95/277 (34%), Positives = 149/277 (53%), Gaps = 22/277 (7%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS---EFLQREQRILSALACPQIVA 59
           +TR + IG+G++ TV   M   + +  A++   L      E +  E  ++     P IV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           Y    +  +   ++    +EY  GG+LTD +   TC++EG+I +  R  L  L++LHSN 
Sbjct: 82  YLDSYLVGDELWVV----MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKP--ICGTPICMAPEVARG 176
           ++H DIK  NIL+  D     K+ DFG CA+       ++ K   + GTP  MAPEV   
Sbjct: 137 VIHRDIKSDNILLGMDGS--VKLTDFGFCAQ----ITPEQSKRSTMVGTPYWMAPEVVTR 190

Query: 177 EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMSKQAQD 234
           +  G   D+W+LG   +EM  G PP+ +  +P+ AL+ I  ++ TPE+  P  +S   +D
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNE-NPLRALYLIA-TNGTPELQNPEKLSAIFRD 248

Query: 235 FLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTE 271
           FL++CL  +  +R SA ELL+H F+K     LS+LT 
Sbjct: 249 FLNRCLEMDVEKRGSAKELLQHQFLK-IAKPLSSLTP 284

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  214 bits (546), Expect = 4e-67
 Identities = 89/277 (32%), Positives = 129/277 (46%), Gaps = 22/277 (7%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS---EFLQREQRILSALACPQIVA 59
                 IG GST  V +     S    AVK  +L      E L  E  I+       +V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
                +  E    L+ + +E+  GG LTD +     L E +I +   AVL  L YLH+ G
Sbjct: 107 MYKSYLVGEE---LW-VLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG 161

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKP--ICGTPICMAPEVARG 176
           ++H DIK  +IL++ D     K++DFG CA+       D  K   + GTP  MAPEV   
Sbjct: 162 VIHRDIKSDSILLTLDGR--VKLSDFGFCAQ----ISKDVPKRKSLVGTPYWMAPEVISR 215

Query: 177 EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMSKQAQD 234
                  D+W+LG  V+EM  G PP+     P+ A+ R+   S  P++     +S   +D
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLR-DSPPPKLKNSHKVSPVLRD 273

Query: 235 FLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTE 271
           FL + L+R+P ER +A ELL+H F+ +       L  
Sbjct: 274 FLERMLVRDPQERATAQELLDHPFLLQTG-LPECLVP 309

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  214 bits (546), Expect = 9e-67
 Identities = 80/321 (24%), Positives = 141/321 (43%), Gaps = 16/321 (4%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----EFLQREQRILSALACPQ 56
            + R Q IG GS     +  S      + +K   +S       E  +RE  +L+ +  P 
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84

Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQY 114
           IV Y+     EENG +   + ++Y  GG L   I  + G   +E +I      + L L++
Sbjct: 85  IVQYRES--FEENGSL--YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           +H   I+H DIK QNI ++KD     ++ DFG AR    +  +  +   GTP  ++PE+ 
Sbjct: 141 VHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLN-STVELARACIGTPYYLSPEIC 197

Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD 234
             +     +D+WALGC + E+ T +  + +     + + +I  S   P +  + S   + 
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKII-SGSFPPVSLHYSYDLRS 255

Query: 235 FLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLT 294
            +S+   RNP +R S + +LE GF+ ++  K  +             S    Q   +   
Sbjct: 256 LVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRP 315

Query: 295 SCSSASAKERIRQLIGEGSSE 315
           +    S      Q I + +++
Sbjct: 316 ASGQNSISVMPAQKITKPAAK 336

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  211 bits (540), Expect = 1e-66
 Identities = 65/277 (23%), Positives = 112/277 (40%), Gaps = 28/277 (10%)

Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAY 60
           MD+   + IG G    V         + + +K  + +N +  +RE + L+ L    IV Y
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK-AEREVKALAKLDHVNIVHY 69

Query: 61  KGC-------------DISEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHT 105
            GC             + S    K L+ + +E+   GTL   I  R G  L++       
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLF-IQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128

Query: 106 RAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT 165
             +  G+ Y+HS  +++ D+K  NI +    +   KI DFG      +  D +     GT
Sbjct: 129 EQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIGDFGLVTS--LKNDGKRTRSKGT 184

Query: 166 PICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP 225
              M+PE    ++ G   D++ALG  + E+        + +   + L           I 
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRD-------GIIS 237

Query: 226 GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ 262
               K+ +  L K L + P +R + SE+L    V ++
Sbjct: 238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  209 bits (533), Expect = 3e-65
 Identities = 82/274 (29%), Positives = 141/274 (51%), Gaps = 16/274 (5%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-EFLQREQRILSALACPQIVAYK 61
           +   + +G GS  +V   +   + ++ A+K   + +  + + +E  I+     P +V Y 
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           G      +  I+    +EY   G+++D IR     L E  I +  ++ L GL+YLH    
Sbjct: 91  GSYFKNTDLWIV----MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           +H DIK  NIL++ +    AK+ADFG   +    +   +   + GTP  MAPEV +    
Sbjct: 147 IHRDIKAGNILLNTEGH--AKLADFGVAGQLT--DTMAKRNTVIGTPFWMAPEVIQEIGY 202

Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMSKQAQDFLS 237
              AD+W+LG T +EMA G+PP+ D+  P+ A+  I  ++  P    P   S    DF+ 
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPYADI-HPMRAIFMIP-TNPPPTFRKPELWSDNFTDFVK 260

Query: 238 KCLIRNPGERWSASELLEHGFVKEQNFKLSTLTE 271
           +CL+++P +R +A++LL+H FV+     +S L +
Sbjct: 261 QCLVKSPEQRATATQLLQHPFVRSAK-GVSILRD 293

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  204 bits (522), Expect = 1e-63
 Identities = 87/283 (30%), Positives = 130/283 (45%), Gaps = 27/283 (9%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS---EFLQREQRILSALACPQIVA 59
           W     +G G+   V    +  +  + A K  E  +    E    E  IL+    P IV 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSN 118
             G    +    I+    +E+ PGG +   +      L E +I+   R +L  L +LHS 
Sbjct: 81  LLGAYYHDGKLWIM----IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGK--PICGTPICMAPEVAR 175
            I+H D+K  N+L++ + +   ++ADFG  A+    N     K     GTP  MAPEV  
Sbjct: 137 RIIHRDLKAGNVLMTLEGD--IRLADFGVSAK----NLKTLQKRDSFIGTPYWMAPEVVM 190

Query: 176 GEEQ-----GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYM 228
            E        + AD+W+LG T++EMA   PP  ++ +P+  L +I   SD P +  P   
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIA-KSDPPTLLTPSKW 248

Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTE 271
           S + +DFL   L +NP  R SA++LLEH FV         L E
Sbjct: 249 SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT-SNKALRE 290

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  205 bits (523), Expect = 2e-63
 Identities = 83/280 (29%), Positives = 136/280 (48%), Gaps = 26/280 (9%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS------EFLQREQRILSALACPQ 56
           ++  + IG GS   V      R+SEV A+K    S        + + +E R L  L  P 
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
            + Y+GC + E    ++    +EY  G            L+E  I + T   L GL YLH
Sbjct: 116 TIQYRGCYLREHTAWLV----MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVAR 175
           S+ ++H D+K  NIL+S+      K+ DFG  +  A  N         GTP  MAPEV  
Sbjct: 172 SHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAPANS------FVGTPYWMAPEVIL 223

Query: 176 GEEQ---GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI-PGYMSKQ 231
             ++       DVW+LG T +E+A  +PP  ++ + +SAL+ I   +++P +  G+ S+ 
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIA-QNESPALQSGHWSEY 281

Query: 232 AQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTE 271
            ++F+  CL + P +R ++  LL+H FV  +    + + +
Sbjct: 282 FRNFVDSCLQKIPQDRPTSEVLLKHRFVL-RERPPTVIMD 320

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  204 bits (521), Expect = 3e-63
 Identities = 83/275 (30%), Positives = 145/275 (52%), Gaps = 22/275 (8%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF--LQREQRILSALA-CPQIVA 59
           +   + +G G+   V  G   ++ ++ A+K  +++  E   +++E  +L   +    I  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 60  YKGCDISEENGKILYNLFL--EYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYL 115
           Y G  I +    +   L+L  E+   G++TD I++  G  L+E  I    R +L GL +L
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGK--PICGTPICMAPEV 173
           H + ++H DIKGQN+L++++ E   K+ DFG + +    +   G+     GTP  MAPEV
Sbjct: 146 HQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQ---LDRTVGRRNTFIGTPYWMAPEV 200

Query: 174 ARGEEQ-----GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI-PGY 227
              +E       F +D+W+LG T +EMA G PP  D+  P+ AL  I   +  P +    
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIP-RNPAPRLKSKK 258

Query: 228 MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ 262
            SK+ Q F+  CL++N  +R +  +L++H F+++Q
Sbjct: 259 WSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  202 bits (515), Expect = 1e-62
 Identities = 89/296 (30%), Positives = 135/296 (45%), Gaps = 35/296 (11%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           D+   + IG G+TA V         E  A+K   L       + L +E + +S    P I
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75

Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT--------CLEEGRIRSHTRAVL 109
           V+Y    + ++    L+ L ++   GG++ D I+            L+E  I +  R VL
Sbjct: 76  VSYYTSFVVKDE---LW-LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 110 LGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKP---ICGT 165
            GL+YLH NG +H D+K  NIL+ +D     +IADFG  A  A   +    K      GT
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGT 189

Query: 166 PICMAPEV-ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI 224
           P  MAPEV  +     F AD+W+ G T +E+ATG  P+     P+  L      +D P +
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY-PPMKVLMLTL-QNDPPSL 247

Query: 225 PGYM---------SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTE 271
              +          K  +  +S CL ++P +R +A+ELL H F + +      L E
Sbjct: 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ-KAKNKEFLQE 302

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  199 bits (509), Expect = 5e-62
 Identities = 66/275 (24%), Positives = 105/275 (38%), Gaps = 21/275 (7%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKS---AELSNSE--FLQREQRILSALACPQ 56
           D+    TIG GS             ++   K      ++ +E   L  E  +L  L  P 
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66

Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAI----RSGTCLEEGRIRSHTRAVLLGL 112
           IV Y    I   N  +   + +EY  GG L   I    +    L+E  +      + L L
Sbjct: 67  IVRYYDRIIDRTNTTL--YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 113 QYLHS-----NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI 167
           +  H      + ++H D+K  N+ +        K+ DFG AR    ++    K   GTP 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILN-HDTSFAKTFVGTPY 181

Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY 227
            M+PE          +D+W+LGC + E+    PP+   A     L           IP  
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF--TAFSQKELAGKIREGKFRRIPYR 239

Query: 228 MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ 262
            S +  + +++ L      R S  E+LE+  + E 
Sbjct: 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  200 bits (510), Expect = 7e-62
 Identities = 63/297 (21%), Positives = 110/297 (37%), Gaps = 32/297 (10%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF--LQREQRILSALACPQIVA 59
           D+     +G+G+   V    +   S  +A+K    +  +   +  E  +L++L    +V 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVR 66

Query: 60  YKGCDISEEN----------GKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAV 108
           Y    +   N             L+ + +EY   GTL D I S     +        R +
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLF-IQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125

Query: 109 LLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR-------------RARVNE 155
           L  L Y+HS GI+H D+K  NI + +      KI DFG A+             +     
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 156 DDEGKPICGTPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHR 214
            D      GT + +A EV  G        D+++LG    EM        +  + +  L  
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRS 243

Query: 215 IGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTE 271
           +      P+      K  +  +   +  +P +R  A  LL  G++  +  +   + E
Sbjct: 244 VSIEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK-HQDEVIKE 298

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  203 bits (518), Expect = 1e-61
 Identities = 61/280 (21%), Positives = 113/280 (40%), Gaps = 17/280 (6%)

Query: 1   MDWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL-ACPQIVA 59
           + +     +G G+  T+ +      +   AVK        F  RE ++L      P ++ 
Sbjct: 24  ISFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
           Y     +E++ +  Y + +E     TL + + +           +  +    GL +LHS 
Sbjct: 83  YFC---TEKDRQFQY-IAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137

Query: 119 GIVHCDIKGQNILVSKDNEQG---AKIADFGCARRARVNEDDEG--KPICGTPICMAPEV 173
            IVH D+K  NIL+S  N  G   A I+DFG  ++  V          + GT   +APE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197

Query: 174 ARGEEQ---GFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMS 229
              + +    +  D+++ GC    + + G  P+       + +     S D      +  
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHED 257

Query: 230 KQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTL 269
             A++ + K +  +P +R SA  +L+H F      +L   
Sbjct: 258 VIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFF 297

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  192 bits (489), Expect = 6e-59
 Identities = 74/278 (26%), Positives = 119/278 (42%), Gaps = 27/278 (9%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEF--LQREQRI-LSALACPQ 56
           D      +GRG+   V       S ++ AVK   A +++ E   L  +  I +  + CP 
Sbjct: 8   DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPF 67

Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGT---LTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
            V + G    E +  I     +E             I  G  + E  +     +++  L+
Sbjct: 68  TVTFYGALFREGDVWIC----MELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123

Query: 114 YLHSNG-IVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPI-CGTPICMA 170
           +LHS   ++H D+K  N+L+   N  G  K+ DFG +       DD  K I  G    MA
Sbjct: 124 HLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGISGY---LVDDVAKDIDAGCKPYMA 177

Query: 171 PEVARGEEQG----FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP- 225
           PE    E         +D+W+LG T++E+A  R P+     P   L ++     +P++P 
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPSPQLPA 236

Query: 226 GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
              S +  DF S+CL +N  ER +  EL++H F     
Sbjct: 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  188 bits (479), Expect = 3e-57
 Identities = 59/300 (19%), Positives = 108/300 (36%), Gaps = 34/300 (11%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF----LQREQRILSALACPQI 57
           D+   Q +GRG    V    +      +A+K   L N E     + RE + L+ L  P I
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65

Query: 58  VAYKGCDISEEN---------GKILYNLFLEYAPGGTLTDAI---RSGTCLEEGRIRSHT 105
           V Y    + +              LY + ++      L D +    +    E        
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLY-IQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 106 RAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR-----------ARVN 154
             +   +++LHS G++H D+K  NI  + D+    K+ DFG                 + 
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMP 182

Query: 155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHR 214
                    GT + M+PE   G       D+++LG  + E+     P+    + +  L  
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD 239

Query: 215 IGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPET 274
           +  +   P +           +   L  +P ER  A  ++E+   ++ +F   T+    +
Sbjct: 240 VR-NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRS 298

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  185 bits (471), Expect = 5e-56
 Identities = 71/283 (25%), Positives = 118/283 (41%), Gaps = 40/283 (14%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEF--LQREQRIL-SALACPQ 56
           D      +G G+   V      ++  V AVK      +  E   +  +  ++  +  CP 
Sbjct: 26  DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPY 85

Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV   G  I+  +  I     +E           R    + E  +   T A++  L YL 
Sbjct: 86  IVQCFGTFITNTDVFIA----MELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK 141

Query: 117 S-NGIVHCDIKGQNILVSKDNEQG-AKIADFG--------CARRARVNEDDEGKPICGTP 166
             +G++H D+K  NIL+   +E+G  K+ DFG         A+              G  
Sbjct: 142 EKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDKAKDRSA----------GCA 188

Query: 167 ICMAPEV-----ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDT 221
             MAPE          +    ADVW+LG +++E+ATG+ P+ +       L ++    + 
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV-LQEEP 247

Query: 222 PEIPGYM--SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ 262
           P +PG+M  S   Q F+  CL ++  +R   ++LLEH F+K  
Sbjct: 248 PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  185 bits (471), Expect = 6e-56
 Identities = 69/298 (23%), Positives = 116/298 (38%), Gaps = 47/298 (15%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK----SAELSNSEFLQREQRILSALACPQI 57
            W     +G+G+TA V  G   ++ ++FA+K     + L   +   RE  +L  L    I
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIR---SGTCLEEGRIRSHTRAVLLGLQY 114
           V  K   I EE       L +E+ P G+L   +    +   L E       R V+ G+ +
Sbjct: 70  V--KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 115 LHSNGIVHCDIKGQNIL--VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPE 172
           L  NGIVH +IK  NI+  + +D +   K+ DFG AR   + +D++   + GT   + P+
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR--ELEDDEQFVSLYGTEEYLHPD 185

Query: 173 V--------ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADP---------------- 208
           +           ++ G   D+W++G T    ATG  P+     P                
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245

Query: 209 -------ISALHRIGFSSDTP---EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
                   +    I +S D P    +   +       L+  L  +  + W   +    
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  184 bits (470), Expect = 1e-55
 Identities = 70/283 (24%), Positives = 113/283 (39%), Gaps = 47/283 (16%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEF--LQREQRI-LSALACPQIVAYKGC 63
           IGRG+  +V+  +   S ++ AVK   + +   E   L  +  + + +  CP IV + G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRS-----GTCLEEGRIRSHTRAVLLGLQYLHSN 118
              E +  I     +E     +     +         + E  +   T A +  L +L  N
Sbjct: 90  LFREGDCWIC----MELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144

Query: 119 G-IVHCDIKGQNILVSKDNEQG-AKIADFG--------CARRARVNEDDEGKPICGTPIC 168
             I+H DIK  NIL+   +  G  K+ DFG         A+              G    
Sbjct: 145 LKIIHRDIKPSNILL---DRSGNIKLCDFGISGQLVDSIAKTRDA----------GCRPY 191

Query: 169 MAPEVARGEEQGFP----ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI 224
           MAPE              +DVW+LG T+ E+ATGR P+P        L ++    D P++
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDPPQL 250

Query: 225 PGYM----SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
                   S    +F++ CL ++  +R    ELL+H F+    
Sbjct: 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  185 bits (472), Expect = 2e-55
 Identities = 70/321 (21%), Positives = 111/321 (34%), Gaps = 70/321 (21%)

Query: 2   DWTRGQTIGRG--STATVSIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALAC 54
            +     IG+G     TV++     + E   V+     +       FLQ E  +      
Sbjct: 26  CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNH 85

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTC--LEEGRIRSHTRAVLLGL 112
           P IV Y+   I++     L+ +   +   G+  D I +     + E  I    + VL  L
Sbjct: 86  PNIVPYRATFIADNE---LW-VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141

Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA-------RRARVNEDDEGKPICGT 165
            Y+H  G VH  +K  +IL+S D +    ++            +R RV  D     +   
Sbjct: 142 DYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSV-KV 198

Query: 166 PICMAPEVARGEEQG--FPADVWALGCTVLEMATGRPPWPDVADPISALHRI-------- 215
              ++PEV +   QG    +D++++G T  E+A G  P+ D+      L           
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM-PATQMLLEKLNGTVPCL 257

Query: 216 ------------------------------------GFSSDTPEIPGYMSKQAQDFLSKC 239
                                                  S +       S     F+ +C
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317

Query: 240 LIRNPGERWSASELLEHGFVK 260
           L RNP  R SAS LL H F K
Sbjct: 318 LQRNPDARPSASTLLNHSFFK 338

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  183 bits (466), Expect = 1e-54
 Identities = 78/308 (25%), Positives = 121/308 (39%), Gaps = 55/308 (17%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEF--LQREQRILSALACPQI 57
           D+ +   +G G+   V       S  V A K    E+  +    + RE ++L     P I
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93

Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G   S+    I     +E+  GG+L   ++    + E  +   + AV+ GL YL  
Sbjct: 94  VGFYGAFYSDGEISIC----MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149

Query: 118 NG-IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
              I+H D+K  NILV+   E   K+ DFG + +     D       GT   M+PE  +G
Sbjct: 150 KHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG 204

Query: 177 EEQGFPADVWALGCTVLEMATGRPPWPDVAD----------------------------- 207
                 +D+W++G +++EMA GR P P                                 
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264

Query: 208 ------------PISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
                           L  I          G  S + QDF++KCLI+NP ER    +L+ 
Sbjct: 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324

Query: 256 HGFVKEQN 263
           H F+K  +
Sbjct: 325 HAFIKRSD 332

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  181 bits (460), Expect = 2e-54
 Identities = 58/273 (21%), Positives = 98/273 (35%), Gaps = 20/273 (7%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEFLQREQRILSALACPQIV 58
            +   Q +G G  + V +         +A+K     E  + E  QRE  +      P I+
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAI----RSGTCLEEGRIRSHTRAVLLGLQY 114
                 + E   K    L L +   GTL + I      G  L E +I      +  GL+ 
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI--------CGTP 166
           +H+ G  H D+K  NIL+  + +    + D G   +A ++ +   + +          T 
Sbjct: 150 IHAKGYAHRDLKPTNILLGDEGQ--PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207

Query: 167 ICMAPEV---ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE 223
              APE+             DVW+LGC +  M  G  P+  V     ++     +  +  
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIP 267

Query: 224 IPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
                S      L+  +  +P +R     LL  
Sbjct: 268 QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  181 bits (461), Expect = 1e-53
 Identities = 75/335 (22%), Positives = 128/335 (38%), Gaps = 52/335 (15%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK----SAELSNSEFLQREQRILSALACPQI 57
            W     +G+G+TA V  G   ++ ++FA+K     + L   +   RE  +L  L    I
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAI---RSGTCLEEGRIRSHTRAVLLGLQY 114
           V  K   I EE       L +E+ P G+L   +    +   L E       R V+ G+ +
Sbjct: 70  V--KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 115 LHSNGIVHCDIKGQNIL--VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPE 172
           L  NGIVH +IK  NI+  + +D +   K+ DFG AR   + +D++   + GT   + P+
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR--ELEDDEQFVSLYGTEEYLHPD 185

Query: 173 V--------ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADP---------------- 208
           +           ++ G   D+W++G T    ATG  P+     P                
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245

Query: 209 -------ISALHRIGFSSDTP---EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH-- 256
                   +    I +S D P    +   +       L+  L  +  + W   +      
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305

Query: 257 ---GFVKEQNFKLSTLTEPETYNSESPTSVLNQQL 288
                +    F L  +T  + Y     T+ +  +L
Sbjct: 306 DILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHEL 340

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  181 bits (462), Expect = 2e-53
 Identities = 72/317 (22%), Positives = 128/317 (40%), Gaps = 42/317 (13%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL-ACPQIVAYKGCD 64
            + +G GS+ TV +   +      AVK   +   +    E ++L+     P ++ Y    
Sbjct: 20  EKILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYC-- 76

Query: 65  ISEENGKILYNLFLEYAPGGTLTDAI-------RSGTCLEEGRIRSHTRAVLLGLQYLHS 117
            SE   + LY + LE      L D +        +    +E    S  R +  G+ +LHS
Sbjct: 77  -SETTDRFLY-IALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133

Query: 118 NGIVHCDIKGQNILVSKDNEQG-----------AKIADFGCARRARVNEDDEG---KPIC 163
             I+H D+K QNILVS  +                I+DFG  ++    +           
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193

Query: 164 GTPICMAPEVARGEEQ-------GFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRI 215
           GT    APE+                 D++++GC    + + G+ P+ D     S + R 
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRG 253

Query: 216 GFSSDTPEIPG--YMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEP- 272
            FS D  +      +  +A D +S+ +  +P +R +A ++L H     ++ KL  L +  
Sbjct: 254 IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVS 313

Query: 273 ---ETYNSESPTSVLNQ 286
              E  N + P+++L +
Sbjct: 314 DRLEIENRDPPSALLMK 330

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  172 bits (439), Expect = 1e-51
 Identities = 80/281 (28%), Positives = 128/281 (45%), Gaps = 18/281 (6%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKS---AELSNS---EFLQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G          +Y L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 70  NILRLYGYFHDATR---VY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A          +CGT   + PE+  
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHA---PSSRRTDLCGTLDYLPPEMIE 180

Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
           G       D+W+LG    E   G+PP+           RI  S      P ++++ A+D 
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRI--SRVEFTFPDFVTEGARDL 237

Query: 236 LSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYN 276
           +S+ L  NP +R    E+LEH ++   + K S     E+ +
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 278

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  170 bits (434), Expect = 9e-51
 Identities = 80/283 (28%), Positives = 128/283 (45%), Gaps = 24/283 (8%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEF---LQREQRILSALACP 55
            + RG+ +G+G  A         + EVFA K    + L        +  E  I  +LA  
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            +V + G     +    ++ + LE     +L +  +    L E   R + R ++LG QYL
Sbjct: 76  HVVGFHGFFEDNDF---VF-VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 131

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP-ICGTPICMAPEVA 174
           H N ++H D+K  N+ +++D E   KI DFG A   +V  D E K  +CGTP  +APEV 
Sbjct: 132 HRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLA--TKVEYDGERKKVLCGTPNYIAPEVL 187

Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISAL-HRIGFSSDTPEIPGYMSKQAQ 233
             +   F  DVW++GC +  +  G+PP+      +     RI    +   IP +++  A 
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPPFET--SCLKETYLRI--KKNEYSIPKHINPVAA 243

Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKE----QNFKLSTLTEP 272
             + K L  +P  R + +ELL   F           ++ LT P
Sbjct: 244 SLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIP 286

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  167 bits (426), Expect = 1e-49
 Identities = 77/268 (28%), Positives = 126/268 (47%), Gaps = 19/268 (7%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEF---LQREQRILSALACP 55
           D+  G  +G+GS A V    S  +    A+K      +  +     +Q E +I   L  P
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQY 114
            I+              +Y L LE    G +   +++      E   R     ++ G+ Y
Sbjct: 72  SILELYNYFEDSNY---VY-LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP-ICGTPICMAPEV 173
           LHS+GI+H D+   N+L++++     KIADFG A   ++    E    +CGTP  ++PE+
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMN--IKIADFGLA--TQLKMPHEKHYTLCGTPNYISPEI 183

Query: 174 ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           A     G  +DVW+LGC    +  GRPP+    D +         +D  E+P ++S +A+
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPPFDT--DTVKNTLNKVVLADY-EMPSFLSIEAK 240

Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKE 261
           D + + L RNP +R S S +L+H F+  
Sbjct: 241 DLIHQLLRRNPADRLSLSSVLDHPFMSR 268

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  168 bits (427), Expect = 4e-49
 Identities = 81/297 (27%), Positives = 131/297 (44%), Gaps = 27/297 (9%)

Query: 5   RGQTIGRGSTATVSIGMSNRSSEVFAVKS---AELSNSEF---LQREQRILSALACPQIV 58
           RG+ +G+G  A         + EVFA K    + L        +  E  I  +LA   +V
Sbjct: 45  RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 104

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
            + G     +    ++ + LE     +L +  +    L E   R + R ++LG QYLH N
Sbjct: 105 GFHGFFEDNDF---VF-VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP-ICGTPICMAPEVARGE 177
            ++H D+K  N+ +++D E   KI DFG A   +V  D E K  +CGTP  +APEV   +
Sbjct: 161 RVIHRDLKLGNLFLNEDLE--VKIGDFGLA--TKVEYDGERKKVLCGTPNYIAPEVLSKK 216

Query: 178 EQGFPADVWALGCTVLEMATGRPPWPDVADPISAL-HRIGFSSDTPEIPGYMSKQAQDFL 236
              F  DVW++GC +  +  G+PP+      +     RI    +   IP +++  A   +
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPFET--SCLKETYLRI--KKNEYSIPKHINPVAASLI 272

Query: 237 SKCLIRNPGERWSASELLEHGFVKEQNFKLSTL------TEPETYNSESPTSVLNQQ 287
            K L  +P  R + +ELL   F     +  + L        P    + S     N++
Sbjct: 273 QKMLQTDPTARPTINELLNDEFFT-SGYIPARLPITCLTIPPRFSIAPSSLDPSNRK 328

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  165 bits (420), Expect = 8e-49
 Identities = 69/262 (26%), Positives = 114/262 (43%), Gaps = 18/262 (6%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNS---EFLQREQRILSALACPQIVA 59
           G+ +G+G    V +    ++  + A+K    ++L        L+RE  I S L  P I+ 
Sbjct: 19  GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
                   +    +Y L LE+AP G L   ++     +E R  +    +   L Y H   
Sbjct: 79  MYNYFHDRKR---IY-LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 134

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           ++H DIK +N+L+    E   KIADFG +  A        + +CGT   + PE+  G+  
Sbjct: 135 VIHRDIKPENLLMGYKGE--LKIADFGWSVHA---PSLRRRTMCGTLDYLPPEMIEGKTH 189

Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
               D+W  G    E   G PP+           RI   +   + P ++S  ++D +SK 
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFDS-PSHTETHRRI--VNVDLKFPPFLSDGSKDLISKL 246

Query: 240 LIRNPGERWSASELLEHGFVKE 261
           L  +P +R     ++EH +VK 
Sbjct: 247 LRYHPPQRLPLKGVMEHPWVKA 268

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  168 bits (428), Expect = 1e-48
 Identities = 71/278 (25%), Positives = 130/278 (46%), Gaps = 26/278 (9%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS-----------AELSNSEFLQREQRILSALAC 54
            +T+G G+   V +    ++ +  A++             E   +  ++ E  IL  L  
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
           P I+  K  +  +      Y + LE   GG L D +     L+E   + +   +LL +QY
Sbjct: 200 PCIIKIK--NFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254

Query: 115 LHSNGIVHCDIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
           LH NGI+H D+K +N+L+ S++ +   KI DFG ++   + E    + +CGTP  +APEV
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLCGTPTYLAPEV 312

Query: 174 ARGEEQ---GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI---GFSSDTPEIPGY 227
                        D W+LG  +    +G PP+ +    +S   +I    ++         
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE- 371

Query: 228 MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK 265
           +S++A D + K L+ +P  R++  E L H ++++++ K
Sbjct: 372 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 409

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  165 bits (419), Expect = 3e-48
 Identities = 69/279 (24%), Positives = 121/279 (43%), Gaps = 26/279 (9%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILSALA 53
           D+  G+ +G GS +TV +     +S  +A+K   L     ++         E+ ++S L 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLD 88

Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
            P  V        +E    LY   L YA  G L   IR     +E   R +T  ++  L+
Sbjct: 89  HPFFVKLYFTFQDDEK---LY-FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 144

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR-ARVNEDDEGKPICGTPICMAPE 172
           YLH  GI+H D+K +NIL+  + +   +I DFG A+  +  ++        GT   ++PE
Sbjct: 145 YLHGKGIIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202

Query: 173 VARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA 232
           +   +     +D+WALGC + ++  G PP+    +      +I       + P     +A
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKI--IKLEYDFPEKFFPKA 259

Query: 233 QDFLSKCLIRNPGERW------SASELLEHGFVKEQNFK 265
           +D + K L+ +  +R           L  H F +   ++
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 298

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  164 bits (418), Expect = 3e-48
 Identities = 68/268 (25%), Positives = 117/268 (43%), Gaps = 22/268 (8%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS---AELSNSEFLQREQRILSALACPQIVAYKG 62
            + +G G+ + V +     + ++FA+K    +       L+ E  +L  +    IV  + 
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE- 72

Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
            DI E      Y L ++   GG L D I       E       + VL  ++YLH NGIVH
Sbjct: 73  -DIYESTTH--YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVH 129

Query: 123 CDIKGQNILV-SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF 181
            D+K +N+L  + +      I DFG    +++ ++      CGTP  +APEV   +    
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGL---SKMEQNGIMSTACGTPGYVAPEVLAQKPYSK 186

Query: 182 PADVWALGCTVLEMATGRPP-W----PDVADPISALHRIGFSSDT-PEIPGYMSKQAQDF 235
             D W++G     +  G PP +      + + I   +   F S    +I    S+ A+DF
Sbjct: 187 AVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY-YEFESPFWDDI----SESAKDF 241

Query: 236 LSKCLIRNPGERWSASELLEHGFVKEQN 263
           +   L ++P ER++  + L H ++    
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWIDGNT 269

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  164 bits (417), Expect = 7e-48
 Identities = 73/275 (26%), Positives = 122/275 (44%), Gaps = 28/275 (10%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS---------AELSNSEFLQREQRILSALACPQ 56
           G+ +G G  A V       +   +A K              + E ++RE  IL  +  P 
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75

Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           ++         EN   +  L LE   GG L D +     L E       + +L G+ YLH
Sbjct: 76  VITLHE---VYENKTDVI-LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131

Query: 117 SNGIVHCDIKGQNILVSKDNEQGA--KIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           S  I H D+K +NI++   N      KI DFG A   +++  +E K I GTP  +APE+ 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIFGTPEFVAPEIV 189

Query: 175 RGEEQGFPADVWALGCTVLEMATGRPP-W----PDVADPISALHRIGFSSDT-PEIPGYM 228
             E  G  AD+W++G     + +G  P       +    +SA++   F  +         
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN-YEFEDEYFSNT---- 244

Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           S  A+DF+ + L+++P +R +  + L+H ++K ++
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  164 bits (417), Expect = 1e-47
 Identities = 76/320 (23%), Positives = 121/320 (37%), Gaps = 60/320 (18%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS--------AELSNSEFLQREQRILSALACPQI 57
              IG+GS   V + + N++  + A+K             + E ++ E R++  L  P I
Sbjct: 31  KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90

Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS------------------------- 92
                 ++ E+   I   L +E   GG L D +                           
Sbjct: 91  ARLY--EVYEDEQYI--CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146

Query: 93  ---------------GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE 137
                               E  I +  R +   L YLH+ GI H DIK +N L S +  
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206

Query: 138 QGAKIADFGCARRARVNEDDEGKP---ICGTPICMAPEVARGEEQ--GFPADVWALGCTV 192
              K+ DFG ++      + E        GTP  +APEV     +  G   D W+ G  +
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

Query: 193 LEMATGRPPWPDVADP--ISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSA 250
             +  G  P+P V D   IS +       + P     +S  A+D LS  L RN  ER+ A
Sbjct: 267 HLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNV-LSPLARDLLSNLLNRNVDERFDA 325

Query: 251 SELLEHGFVKEQNFKLSTLT 270
              L+H ++ + + K+  ++
Sbjct: 326 MRALQHPWISQFSDKIYKMS 345

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  163 bits (416), Expect = 1e-47
 Identities = 72/290 (24%), Positives = 122/290 (42%), Gaps = 28/290 (9%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS---------AELSNSEFLQREQRILSALACPQ 56
           G+ +G G  A V       +   +A K              + E ++RE  IL  +    
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76

Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           ++     D+ E    +   L LE   GG L D +     L E    S  + +L G+ YLH
Sbjct: 77  VITLH--DVYENRTDV--VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132

Query: 117 SNGIVHCDIKGQNIL-VSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           +  I H D+K +NI+ + K+      K+ DFG A    + +  E K I GTP  +APE+ 
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKNIFGTPEFVAPEIV 190

Query: 175 RGEEQGFPADVWALGCTVLEMATGRPP-W----PDVADPISALHRIGFSSDT-PEIPGYM 228
             E  G  AD+W++G     + +G  P       +    I+++    F  +         
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS-YDFDEEFFSHT---- 245

Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSE 278
           S+ A+DF+ K L++   +R +  E L H ++   + + + +      N E
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLE 295

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  162 bits (413), Expect = 1e-47
 Identities = 75/283 (26%), Positives = 124/283 (43%), Gaps = 23/283 (8%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS---AELSNSEF--LQREQRILSALACPQIVAY 60
            + +G+G+ + V   +   +   FA K     +LS  +F  L+RE RI   L  P IV  
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
              D  +E     + L  +   GG L + I +     E       + +L  + Y HSNGI
Sbjct: 71  H--DSIQEESF--HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 126

Query: 121 VHCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           VH ++K +N+L  SK      K+ADFG A    VN+ +      GTP  ++PEV + +  
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAI--EVNDSEAWHGFAGTPGYLSPEVLKKDPY 184

Query: 180 GFPADVWALGCTVLEMATGRPP-W----PDVADPISALHRIGFSSDT-PEIPGYMSKQAQ 233
             P D+WA G  +  +  G PP W      +   I A     + S     +    + +A+
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA-YDYPSPEWDTV----TPEAK 239

Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYN 276
             +   L  NP +R +A + L+  ++  +    S +   +T +
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVD 282

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  169 bits (430), Expect = 3e-47
 Identities = 62/293 (21%), Positives = 112/293 (38%), Gaps = 37/293 (12%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK----SAELSNSEFLQREQRILSALACPQI 57
            W   + +G G    V   +   + E  A+K         N E    E +I+  L  P +
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 58  VAYKGCDISEENGKILYN----LFLEYAPGGTLTDAIRS---GTCLEEGRIRSHTRAVLL 110
           V     ++ +   K+  N    L +EY  GG L   +        L+EG IR+    +  
Sbjct: 75  V--SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132

Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICM 169
            L+YLH N I+H D+K +NI++    ++   KI D G A+   +++ +      GT   +
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTEFVGTLQYL 190

Query: 170 APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPI-------------------- 209
           APE+   ++     D W+ G    E  TG  P+     P+                    
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250

Query: 210 -SALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
             A+           + G ++ + + +L   L+ +  +R +  +    G  + 
Sbjct: 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  161 bits (409), Expect = 4e-47
 Identities = 75/277 (27%), Positives = 123/277 (44%), Gaps = 28/277 (10%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS---------AELSNSEFLQREQRILSALACPQ 56
           G+ +G G  A V       + + +A K              + E ++RE  IL  +  P 
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69

Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           I+         EN   +  L LE   GG L D +     L E       + +L G+ YLH
Sbjct: 70  IITLHD---IFENKTDVV-LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125

Query: 117 SNGIVHCDIKGQNIL-VSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           S  I H D+K +NI+ + K+      K+ DFG A   ++   +E K I GTP  +APE+ 
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH--KIEAGNEFKNIFGTPEFVAPEIV 183

Query: 175 RGEEQGFPADVWALGCTVLEMATGRPP-WPD----VADPISALHRIGFSSDT-PEIPGYM 228
             E  G  AD+W++G     + +G  P   +        ISA++   F  +         
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVN-YDFDEEYFSNT---- 238

Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK 265
           S+ A+DF+ + L+++P  R + ++ LEH ++K    +
Sbjct: 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  163 bits (413), Expect = 6e-47
 Identities = 47/306 (15%), Positives = 79/306 (25%), Gaps = 60/306 (19%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSAL--- 52
              RG  +G+             + E F V           +  + ++ E   L  L   
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 53  -------------------ACPQIVAYKGCDISEENGKILYNLFLEYAP-------GGTL 86
                                PQ        + E +  +L   FL           G  L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 87  TDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG 146
                +   L        T  V+  L  LH  G+VH  ++  +I++ +       +  F 
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG--VFLTGFE 251

Query: 147 CARRARVNEDDEGKPICGTPICMAPEV-----------ARGEEQGFPADVWALGCTVLEM 195
              R     D        +     PE+            R     F  D WALG  +  +
Sbjct: 252 HLVR-----DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306

Query: 196 ATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
                P     D         F S        + +  +  L   L     +R    + +E
Sbjct: 307 WCADLPITK--DAALGGSEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359

Query: 256 HGFVKE 261
               ++
Sbjct: 360 TPEYEQ 365

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  162 bits (413), Expect = 7e-47
 Identities = 75/290 (25%), Positives = 123/290 (42%), Gaps = 28/290 (9%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS---------AELSNSEFLQREQRILSALACPQ 56
           G+ +G G  A V       +   +A K                E ++RE  IL  +  P 
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76

Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           I+     D+ E    +   L LE   GG L D +     L E    S  + +L G+ YLH
Sbjct: 77  IITLH--DVYENRTDV--VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132

Query: 117 SNGIVHCDIKGQNIL-VSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           +  I H D+K +NI+ + K+      K+ DFG A    + +  E K I GTP  +APE+ 
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKNIFGTPEFVAPEIV 190

Query: 175 RGEEQGFPADVWALGCTVLEMATGRPP-W----PDVADPISALHRIGFSSDT-PEIPGYM 228
             E  G  AD+W++G     + +G  P       +    I+A+    F  +   +     
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS-YDFDEEFFSQT---- 245

Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSE 278
           S+ A+DF+ K L++   +R +  E L H ++   + + + +      N E
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLE 295

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  162 bits (412), Expect = 8e-47
 Identities = 40/302 (13%), Positives = 69/302 (22%), Gaps = 48/302 (15%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACP 55
                + +  G  + V +       E FA+K          S  E L       + L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 56  QIVAYKGC-------DISEENGK-------------ILYNLFL--EYAPG------GTLT 87
                +         D      +              + N  L    A         TL 
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 88  DAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGC 147
                        +   T  ++     L S G+VH      N+ +  D      + D   
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR--LMLGDVSA 240

Query: 148 ARRARVNEDDEGKPICGTPICMAPEVARGEEQ--GFPADVWALGCTVLEMATGRPPWPDV 205
             +        G            E             + W LG ++  +     P+  V
Sbjct: 241 LWK----VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296

Query: 206 ADPISA------LHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFV 259
              I        L   G  S        +    +  + + L  +   R    E +E    
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356

Query: 260 KE 261
            +
Sbjct: 357 LQ 358

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  162 bits (411), Expect = 2e-46
 Identities = 74/313 (23%), Positives = 129/313 (41%), Gaps = 21/313 (6%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS---AELSNSEFLQREQRILSALACPQIVAYKG 62
            + +G G+   V   +   +  VF  K        +   ++ E  I++ L  P+++    
Sbjct: 56  LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH- 114

Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            D  E+  ++   L LE+  GG L D I      + E  + ++ R    GL+++H + IV
Sbjct: 115 -DAFEDKYEM--VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 171

Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF 181
           H DIK +NI+         KI DFG A   ++N D+  K    T    APE+   E  GF
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLAT--KLNPDEIVKVTTATAEFAAPEIVDREPVGF 229

Query: 182 PADVWALGCTVLEMATGRPPWPDVADP-----ISALHRIGFSSDT-PEIPGYMSKQAQDF 235
             D+WA+G     + +G  P+    D      +       F  D    +    S +A+DF
Sbjct: 230 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD-WEFDEDAFSSV----SPEAKDF 284

Query: 236 LSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLTS 295
           +   L + P +R +  + LEH ++K  +  L++      YN            W +   +
Sbjct: 285 IKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPA 344

Query: 296 CSSASAKERIRQL 308
               +    +R+ 
Sbjct: 345 IGRIANFSSLRKH 357

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  160 bits (406), Expect = 3e-46
 Identities = 73/292 (25%), Positives = 131/292 (44%), Gaps = 26/292 (8%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS-----------AELSNSEFLQREQRILSALAC 54
            +T+G G+   V +    ++ +  A+K             E   +  ++ E  IL  L  
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
           P I+  K  +  +      Y + LE   GG L D +     L+E   + +   +LL +QY
Sbjct: 75  PCIIKIK--NFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129

Query: 115 LHSNGIVHCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
           LH NGI+H D+K +N+L  S++ +   KI DFG ++   + E    + +CGTP  +APEV
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLCGTPTYLAPEV 187

Query: 174 ARGEEQ---GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI---GFSSDTPEIPGY 227
                        D W+LG  +    +G PP+ +    +S   +I    ++         
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA-E 246

Query: 228 MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSES 279
           +S++A D + K L+ +P  R++  E L H ++++++ K          N  +
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENEST 298

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  160 bits (406), Expect = 3e-46
 Identities = 73/278 (26%), Positives = 125/278 (44%), Gaps = 30/278 (10%)

Query: 5   RGQTIGRGSTATVSIGMSNRSSEVFAVKS-----AELSNSEFLQREQRILSALA-CPQIV 58
             + +GRG  A V   +S  + + +A K              +  E  +L     CP+++
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLH 116
                ++ E   +I   L LEYA GG +           + E  +    + +L G+ YLH
Sbjct: 93  NLH--EVYENTSEI--ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148

Query: 117 SNGIVHCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
            N IVH D+K QNIL  S       KI DFG +R  ++    E + I GTP  +APE+  
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR--KIGHACELREIMGTPEYLAPEILN 206

Query: 176 GEEQGFPADVWALGCTVLE--MATGRPP-W----PDVADPISALHRIGFSSDT-PEIPGY 227
            +      D+W +G  ++   + T   P       +    IS ++ + +S +T   +   
Sbjct: 207 YDPITTATDMWNIG--IIAYMLLTHTSPFVGEDNQETYLNISQVN-VDYSEETFSSV--- 260

Query: 228 MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK 265
            S+ A DF+   L++NP +R +A   L H ++++ +F+
Sbjct: 261 -SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  160 bits (408), Expect = 4e-46
 Identities = 75/281 (26%), Positives = 123/281 (43%), Gaps = 23/281 (8%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS---AELSNSEF--LQREQRILSALACPQIVAY 60
            + +G+G+ + V   +   +   FA K     +LS  +F  L+RE RI   L  P IV  
Sbjct: 34  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 93

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
              D  +E     + L  +   GG L + I +     E       + +L  + Y HSNGI
Sbjct: 94  H--DSIQEESF--HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 149

Query: 121 VHCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           VH ++K +N+L  SK      K+ADFG A    VN+ +      GTP  ++PEV + +  
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAI--EVNDSEAWHGFAGTPGYLSPEVLKKDPY 207

Query: 180 GFPADVWALGCTVLEMATGRPP-W----PDVADPISALHRIGFSSDT-PEIPGYMSKQAQ 233
             P D+WA G  +  +  G PP W      +   I A     + S     +    + +A+
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA-YDYPSPEWDTV----TPEAK 262

Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPET 274
             +   L  NP +R +A + L+  ++  +    S +   +T
Sbjct: 263 SLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDT 303

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  163 bits (415), Expect = 4e-46
 Identities = 74/266 (27%), Positives = 117/266 (43%), Gaps = 16/266 (6%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS---AELSNSEF--LQREQRILSALACPQIVAY 60
            + +G G+   V +     +    A+K      +S S    L  E  +L  L  P I+  
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
                 + N    Y L +E   GG L D I       E       + VL G+ YLH + I
Sbjct: 102 YDFFEDKRN----YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNI 157

Query: 121 VHCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           VH D+K +N+L  SK+ +   KI DFG +         + K   GT   +APEV R  + 
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSA--VFENQKKMKERLGTAYYIAPEVLRK-KY 214

Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADP--ISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
               DVW++G  +  +  G PP+    D   +  + +  ++ D+PE    +S+ A+D + 
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKN-VSEGAKDLIK 273

Query: 238 KCLIRNPGERWSASELLEHGFVKEQN 263
           + L  +   R SA + LEH ++KE  
Sbjct: 274 QMLQFDSQRRISAQQALEHPWIKEMC 299

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  163 bits (414), Expect = 5e-46
 Identities = 74/276 (26%), Positives = 123/276 (44%), Gaps = 17/276 (6%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS---AELSNS---EFLQREQRILSALACPQIVA 59
            + +G+GS   V +     + +  AVK     ++      E L RE ++L  L  P I+ 
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
               +  E+ G   + L  E   GG L D I S     E       R VL G+ Y+H N 
Sbjct: 91  LY--EFFEDKGY--FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146

Query: 120 IVHCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           IVH D+K +N+L  SK  +   +I DFG +         + K   GT   +APEV  G  
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLST--HFEASKKMKDKIGTAYYIAPEVLHG-T 203

Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADP--ISALHRIGFSSDTPEIPGYMSKQAQDFL 236
                DVW+ G  +  + +G PP+    +   +  + +  ++ + P+    +S+ A+D +
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK-VSESAKDLI 262

Query: 237 SKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEP 272
            K L   P  R SA + L+H +++    +  ++  P
Sbjct: 263 RKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 298

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  157 bits (400), Expect = 6e-46
 Identities = 64/264 (24%), Positives = 112/264 (42%), Gaps = 14/264 (5%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS---AELSNSEFLQREQRILSALACPQIVAYKG 62
             TIGRGS   V I +   +    A K      + + +  ++E  I+ +L  P I+    
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73

Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
              + E+   +Y L +E   GG L + +       E       + VL  + Y H   + H
Sbjct: 74  ---TFEDNTDIY-LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAH 129

Query: 123 CDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF 181
            D+K +N L ++   +   K+ DFG A   R       +   GTP  ++P+V  G   G 
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAA--RFKPGKMMRTKVGTPYYVSPQVLEG-LYGP 186

Query: 182 PADVWALGCTVLEMATGRPP-WPDVADPISALHRIG-FSSDTPEIPGYMSKQAQDFLSKC 239
             D W+ G  +  +  G PP        +    R G F+    +    +S QA+  + + 
Sbjct: 187 ECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLN-VSPQAESLIRRL 245

Query: 240 LIRNPGERWSASELLEHGFVKEQN 263
           L ++P +R ++ + LEH + ++Q 
Sbjct: 246 LTKSPKQRITSLQALEHEWFEKQL 269

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  159 bits (404), Expect = 6e-46
 Identities = 68/272 (25%), Positives = 122/272 (44%), Gaps = 20/272 (7%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS--EFLQREQRILSALACPQIVAYKGC 63
            + +GRG    V   +   S + +  K  ++  +    +++E  IL+      I+     
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLH-- 67

Query: 64  DISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
           +  E   ++   +  E+  G  + + I  S   L E  I S+   V   LQ+LHS+ I H
Sbjct: 68  ESFESMEEL--VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGH 125

Query: 123 CDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFP 182
            DI+ +NI+         KI +FG AR  ++   D  + +   P   APEV + +     
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQAR--QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183

Query: 183 ADVWALGCTVLEMATGRPP-WPD----VADPISALHRIGFSSDT-PEIPGYMSKQAQDFL 236
            D+W+LG  V  + +G  P   +    + + I       F  +   EI    S +A DF+
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE-YTFDEEAFKEI----SIEAMDFV 238

Query: 237 SKCLIRNPGERWSASELLEHGFVKEQNFKLST 268
            + L++    R +ASE L+H ++K++  ++ST
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLKQKIERVST 270

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  158 bits (401), Expect = 7e-46
 Identities = 74/266 (27%), Positives = 121/266 (45%), Gaps = 16/266 (6%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS---AELSNSEF--LQREQRILSALACPQIVAY 60
              +G+GS   V       + + +AVK    A   N +   + RE  +L  L  P I+  
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
              +I E++    + +  E   GG L D I       E       + V  G+ Y+H + I
Sbjct: 87  F--EILEDSSS--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142

Query: 121 VHCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           VH D+K +NIL  SK+ +   KI DFG +      ++ + K   GT   +APEV RG   
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLST--CFQQNTKMKDRIGTAYYIAPEVLRG-TY 199

Query: 180 GFPADVWALGCTVLEMATGRPP-WPDVADPISALHRIG-FSSDTPEIPGYMSKQAQDFLS 237
               DVW+ G  +  + +G PP +      I      G ++ D P+    +S  A+D + 
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT-ISDDAKDLIR 258

Query: 238 KCLIRNPGERWSASELLEHGFVKEQN 263
           K L  +P  R +A++ LEH ++++ +
Sbjct: 259 KMLTFHPSLRITATQCLEHPWIQKYS 284

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  158 bits (402), Expect = 2e-45
 Identities = 74/277 (26%), Positives = 119/277 (42%), Gaps = 30/277 (10%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS--------AELSNSEFLQREQRILSALACPQI 57
            + IG+G  + V   ++  + + FAVK         +   ++E L+RE  I   L  P I
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88

Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAI----RSGTCLEEGRIRSHTRAVLLGLQ 113
           V     +    +G     +  E+  G  L   I     +G    E     + R +L  L+
Sbjct: 89  VELL--ETYSSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144

Query: 114 YLHSNGIVHCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEG-KPICGTPICMAP 171
           Y H N I+H D+K   +L  SK+N    K+  FG A   ++ E         GTP  MAP
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI--QLGESGLVAGGRVGTPHFMAP 202

Query: 172 EVARGEEQGFPADVWALGCTVLEMATGRPP-W---PDVADPISALHRIGFSSDT-PEIPG 226
           EV + E  G P DVW  G  +  + +G  P +     + + I        +      I  
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGK-YKMNPRQWSHI-- 259

Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
             S+ A+D + + L+ +P ER +  E L H ++KE++
Sbjct: 260 --SESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  157 bits (399), Expect = 3e-45
 Identities = 64/297 (21%), Positives = 115/297 (38%), Gaps = 23/297 (7%)

Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALA-CPQIVAYKG 62
            + + +G GS +     +  +S++ FAVK          Q+E   L      P IV    
Sbjct: 14  LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHE 73

Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
                 +    + L +E   GG L + I+      E       R ++  + ++H  G+VH
Sbjct: 74  ---VFHDQLHTF-LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVH 129

Query: 123 CDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKP---ICGTPICMAPEVARGEE 178
            D+K +N+L   +++    KI DFG AR        + +P    C T    APE+     
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKP----PDNQPLKTPCFTLHYAAPELLNQNG 185

Query: 179 QGFPADVWALGCTVLEMATGRPP-WPDVADPISA-----LHRIG---FSSDTPEIPGYMS 229
                D+W+LG  +  M +G+ P                + +I    FS +       +S
Sbjct: 186 YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN-VS 244

Query: 230 KQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQ 286
           ++A+D +   L  +P +R   S L  + ++++ +   S           S  +V   
Sbjct: 245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTC 301

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  161 bits (408), Expect = 4e-45
 Identities = 74/289 (25%), Positives = 123/289 (42%), Gaps = 21/289 (7%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS---AELSNSEF--LQREQRILSALACPQIVAY 60
              +G+GS   V       + + +AVK    A   N +   + RE  +L  L  P I+  
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
                   +    + +  E   GG L D I       E       + V  G+ Y+H + I
Sbjct: 87  FEILEDSSS----FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142

Query: 121 VHCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           VH D+K +NIL  SK+ +   KI DFG +      ++ + K   GT   +APEV RG   
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLST--CFQQNTKMKDRIGTAYYIAPEVLRG-TY 199

Query: 180 GFPADVWALGCTVLEMATGRPP-WPDVADPI-SALHRIGFSSDTPEIPGYMSKQAQDFLS 237
               DVW+ G  +  + +G PP +      I   +    ++ D P+    +S  A+D + 
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT-ISDDAKDLIR 258

Query: 238 KCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQ 286
           K L  +P  R +A++ LEH ++++ + +      P   +  S  S +  
Sbjct: 259 KMLTFHPSLRITATQCLEHPWIQKYSSE-----TPTISDLPSLESAMTN 302

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  156 bits (397), Expect = 8e-45
 Identities = 76/309 (24%), Positives = 128/309 (41%), Gaps = 22/309 (7%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALA-CPQIVAYKGCDI 65
           Q +G G    V      R+ +  A+K   L +S   ++E       +  P IV       
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKL--LYDSPKARQEVDHHWQASGGPHIVCILDVYE 92

Query: 66  SEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
           +  +GK    + +E   GG L   I  R      E       R +   +Q+LHS+ I H 
Sbjct: 93  NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHR 152

Query: 124 DIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFP 182
           D+K +N+L  SK+ +   K+ DFG A+       +  +  C TP  +APEV   E+    
Sbjct: 153 DVKPENLLYTSKEKDAVLKLTDFGFAKET---TQNALQTPCYTPYYVAPEVLGPEKYDKS 209

Query: 183 ADVWALGCTVLEMATGRPP-WPDVADPISA--LHRIG---FSSDTPEIPGYMSKQAQDFL 236
            D+W+LG  +  +  G PP + +    IS     RI    +    PE    +S+ A+  +
Sbjct: 210 CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE-VSEDAKQLI 268

Query: 237 SKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLTSC 296
              L  +P ER + ++ + H ++ +          P+T    +     ++  WD      
Sbjct: 269 RLLLKTDPTERLTITQFMNHPWINQSM------VVPQTPLHTARVLQEDKDHWDEVKEEM 322

Query: 297 SSASAKERI 305
           +SA A  R+
Sbjct: 323 TSALATMRV 331

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  157 bits (398), Expect = 1e-44
 Identities = 69/273 (25%), Positives = 121/273 (44%), Gaps = 25/273 (9%)

Query: 5   RGQTIGRGSTATVSIGMSNRSSEVFAVKS---AELSNSEFLQREQRILSALACPQIVAYK 61
           + + +G G    V       +    A K      + + E ++ E  +++ L    ++   
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLY 152

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
               + E+   +  L +EY  GG L D I      L E       + +  G++++H   I
Sbjct: 153 D---AFESKNDIV-LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYI 208

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           +H D+K +NIL    + +  KI DFG AR  R    ++ K   GTP  +APEV   +   
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLAR--RYKPREKLKVNFGTPEFLAPEVVNYDFVS 266

Query: 181 FPADVWALGCTVLE--MATGRPP-W----PDVADPISALHRIGFSSDT-PEIPGYMSKQA 232
           FP D+W++G  V+   + +G  P       +  + I A        +   +I    S++A
Sbjct: 267 FPTDMWSVG--VIAYMLLSGLSPFLGDNDAETLNNILACR-WDLEDEEFQDI----SEEA 319

Query: 233 QDFLSKCLIRNPGERWSASELLEHGFVKEQNFK 265
           ++F+SK LI+    R SASE L+H ++ +    
Sbjct: 320 KEFISKLLIKEKSWRISASEALKHPWLSDHKLH 352

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  156 bits (396), Expect = 2e-44
 Identities = 75/262 (28%), Positives = 120/262 (45%), Gaps = 24/262 (9%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS-AELSNSEFLQREQRILSALACPQIVAYKGCD 64
              +GRG+T+ V       + + +A+K   +  + + ++ E  +L  L+ P I+  K  +
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLK--E 115

Query: 65  ISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCD 124
           I E   +   +L LE   GG L D I       E       + +L  + YLH NGIVH D
Sbjct: 116 IFETPTE--ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRD 173

Query: 125 IKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPA 183
           +K +N+L  +   +   KIADFG ++   V      K +CGTP   APE+ RG   G   
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSK--IVEHQVLMKTVCGTPGYCAPEILRGCAYGPEV 231

Query: 184 DVWALG---CTVLEMATGRPPWPDVADPISALHRI-----GFSSDT-PEIPGYMSKQAQD 234
           D+W++G     +L    G  P+ D         RI      F S    E+    S  A+D
Sbjct: 232 DMWSVGIITYILL---CGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV----SLNAKD 284

Query: 235 FLSKCLIRNPGERWSASELLEH 256
            + K ++ +P +R +  + L+H
Sbjct: 285 LVRKLIVLDPKKRLTTFQALQH 306

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  157 bits (398), Expect = 2e-44
 Identities = 63/271 (23%), Positives = 116/271 (42%), Gaps = 26/271 (9%)

Query: 8   TIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILSALACPQIVA 59
            IG+GS   V I   N + +++A+K   ++  + ++R        E +I+  L  P +V 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMK--YMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
                  EE+   ++ + ++   GG L   ++     +E  ++     +++ L YL +  
Sbjct: 80  LWYSFQDEED---MF-MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR 135

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           I+H D+K  NIL+  D      I DF  A    +  + +   + GT   MAPE+    + 
Sbjct: 136 IIHRDMKPDNILL--DEHGHVHITDFNIAA--MLPRETQITTMAGTKPYMAPEMFSSRKG 191

Query: 180 ---GFPADVWALGCTVLEMATGRPPW--PDVADPISALHRIGFSSDTPEIPGYMSKQAQD 234
               F  D W+LG T  E+  GR P+           +H     +     P   S++   
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--ETTVVTYPSAWSQEMVS 249

Query: 235 FLSKCLIRNPGERW-SASELLEHGFVKEQNF 264
            L K L  NP +R+   S++    ++ + N+
Sbjct: 250 LLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  157 bits (400), Expect = 3e-44
 Identities = 74/290 (25%), Positives = 121/290 (41%), Gaps = 36/290 (12%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS-----AELSNSEFLQREQRILSALACPQIVAY 60
            + +G+G+ + V   +   + + +A            + + L+RE RI   L  P IV  
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
              D   E G   + L  +   GG L + I +     E       + +L  + + H  G+
Sbjct: 76  H--DSISEEGH--HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 131

Query: 121 VHCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           VH ++K +N+L  SK      K+ADFG A      E        GTP  ++PEV R +  
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGYLSPEVLRKDPY 190

Query: 180 GFPADVWALG-------CTVLEMATGRPP-W----PDVADPISALHRIGFSSDT-PEIPG 226
           G P D+WA G               G PP W      +   I A     F S     +  
Sbjct: 191 GKPVDLWACGVILYILLV-------GYPPFWDEDQHRLYQQIKAGA-YDFPSPEWDTV-- 240

Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYN 276
             + +A+D ++K L  NP +R +A+E L+H ++  ++   S +   ET +
Sbjct: 241 --TPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVD 288

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  153 bits (389), Expect = 4e-44
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 26/270 (9%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS----AELSNSEFLQREQRILSALACPQIVAYK 61
            + +G G+   V +     S     +K+          E ++ E  +L +L  P I+   
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAI----RSGTCLEEGRIRSHTRAVLLGLQYLHS 117
                 E+   +Y + +E   GG L + I      G  L EG +    + ++  L Y HS
Sbjct: 87  EV---FEDYHNMY-IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142

Query: 118 NGIVHCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
             +VH D+K +NIL          KI DFG A       D+      GT + MAPEV + 
Sbjct: 143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHSTNAAGTALYMAPEVFKR 200

Query: 177 EEQGFPADVWALGCTVLEMATGRPP-W----PDVADPISALHRIGFSSDTPEIPGYMSKQ 231
           +   F  D+W+ G  +  + TG  P       +V    +      ++ +       ++ Q
Sbjct: 201 DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE-PNYAVE----CRPLTPQ 254

Query: 232 AQDFLSKCLIRNPGERWSASELLEHGFVKE 261
           A D L + L ++P  R SA+++L H + K+
Sbjct: 255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  152 bits (387), Expect = 6e-44
 Identities = 74/261 (28%), Positives = 109/261 (41%), Gaps = 14/261 (5%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK----SAELSNSEFLQREQRILSALACPQIV 58
           W   QT+G G+   V + ++  + E  AVK       +   E +++E  I   L    +V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
            +       E     Y LFLEY  GG L D I     + E   +     ++ G+ YLH  
Sbjct: 69  KFY--GHRREGNIQ-Y-LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG-KPICGTPICMAPEVARGE 177
           GI H DIK +N+L+  D     KI+DFG A   R N  +     +CGT   +APE+ +  
Sbjct: 125 GITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 178 E-QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP-GYMSKQAQDF 235
           E    P DVW+ G  +  M  G  PW   +D             T   P   +       
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-KEKKTYLNPWKKIDSAPLAL 241

Query: 236 LSKCLIRNPGERWSASELLEH 256
           L K L+ NP  R +  ++ + 
Sbjct: 242 LHKILVENPSARITIPDIKKD 262

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  158 bits (401), Expect = 6e-44
 Identities = 63/286 (22%), Positives = 118/286 (41%), Gaps = 27/286 (9%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS----------------AELSNSEFLQREQRIL 49
            + +G G+   V +          A+K                       E +  E  +L
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100

Query: 50  SALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVL 109
            +L  P I+        ++     + L  E+  GG L + I +    +E    +  + +L
Sbjct: 101 KSLDHPNIIKLFDVFEDKKY----FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156

Query: 110 LGLQYLHSNGIVHCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC 168
            G+ YLH + IVH DIK +NIL  +K++    KI DFG +     ++D + +   GT   
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS--FFSKDYKLRDRLGTAYY 214

Query: 169 MAPEVARGEEQGFPADVWALGCTVLEMATGRPP-W-PDVADPISALHRIGFSSDTPEIPG 226
           +APEV +  +     DVW+ G  +  +  G PP    +  D I  + +  +  D  +   
Sbjct: 215 IAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKN 273

Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEP 272
            +S +A++ +   L  +  +R +A E L   ++K+    ++   + 
Sbjct: 274 -ISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQK 318

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  152 bits (387), Expect = 2e-43
 Identities = 84/321 (26%), Positives = 124/321 (38%), Gaps = 21/321 (6%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK----SAELSNSEFLQREQRILSALACPQIV 58
           W   QT+G G+   V + ++  + E  AVK       +   E +++E  I   L    +V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
            +       E     Y LFLEY  GG L D I     + E   +     ++ G+ YLH  
Sbjct: 69  KFY--GHRREGNIQ-Y-LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG-KPICGTPICMAPEVARGE 177
           GI H DIK +N+L+  D     KI+DFG A   R N  +     +CGT   +APE+ +  
Sbjct: 125 GITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 178 E-QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP-GYMSKQAQDF 235
           E    P DVW+ G  +  M  G  PW   +D             T   P   +       
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-KEKKTYLNPWKKIDSAPLAL 241

Query: 236 LSKCLIRNPGERWSASELLEHG-FVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLT 294
           L K L+ NP  R +  ++ +   + K                SESP+           + 
Sbjct: 242 LHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGF------SKHIQ 295

Query: 295 SCSSASAKERIRQLIGEGSSE 315
           S    S      +  G G S+
Sbjct: 296 SNLDFSPVNSASRTPGSGWSK 316

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  152 bits (386), Expect = 2e-43
 Identities = 44/238 (18%), Positives = 86/238 (36%), Gaps = 24/238 (10%)

Query: 37  SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSG--- 93
           S  +    + R +   +    V              LY + ++      L D +      
Sbjct: 103 SPMDAPSVKIRRMDPFSTKNTVGQ---LQPSSPKVYLY-IQMQLCRKENLKDWMNRRCSL 158

Query: 94  TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV 153
              E G        +   +++LHS G++H D+K  NI  + D+    K+ DFG       
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQ 216

Query: 154 NEDDEGKPI-----------CGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW 202
           +E+++                GT + M+PE   G       D+++LG  + E+       
Sbjct: 217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276

Query: 203 PDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
            +    I+ +  + F    P +      Q    +   L  +P ER  A++++E+   +
Sbjct: 277 MERVRIITDVRNLKF----PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  152 bits (386), Expect = 4e-43
 Identities = 69/268 (25%), Positives = 115/268 (42%), Gaps = 19/268 (7%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDI 65
            + IG GS +     +   ++  FAVK  + S  +  +  + +L     P I+  K  D+
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLK--DV 84

Query: 66  SEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDI 125
            ++   +   +  E   GG L D I       E    +    +   ++YLH+ G+VH D+
Sbjct: 85  YDDGKYVY--VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDL 142

Query: 126 KGQNILVSKDNEQGA--KIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPA 183
           K  NIL   ++      +I DFG A++ R  E+      C T   +APEV   +      
Sbjct: 143 KPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLMTPCYTANFVAPEVLERQGYDAAC 201

Query: 184 DVWALGCTVLEMATGRPP-WPDVADPISAL-HRIG-----FSSDT-PEIPGYMSKQAQDF 235
           D+W+LG  +  M TG  P      D    +  RIG      S      +    S  A+D 
Sbjct: 202 DIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV----SDTAKDL 257

Query: 236 LSKCLIRNPGERWSASELLEHGFVKEQN 263
           +SK L  +P +R +A+ +L H ++   +
Sbjct: 258 VSKMLHVDPHQRLTAALVLRHPWIVHWD 285

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  156 bits (397), Expect = 5e-43
 Identities = 70/333 (21%), Positives = 126/333 (37%), Gaps = 38/333 (11%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS---AELSNSEFLQREQRILSALACPQIVAYKG 62
            + +G G+   V       +   FA K       S+ E +++E + +S L  P +V    
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 221

Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
              + E+   +  +  E+  GG L + +      + E     + R V  GL ++H N  V
Sbjct: 222 ---AFEDDNEMV-MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 277

Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF 181
           H D+K +NI+ +       K+ DFG      ++     K   GT    APEVA G+  G+
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTA--HLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 335

Query: 182 PADVWALGCTVLEMATGRPP-W----PDVADPISALHRIGFSSDT-PEIPGYMSKQAQDF 235
             D+W++G     + +G  P       +    + +             I    S+  +DF
Sbjct: 336 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS-CDWNMDDSAFSGI----SEDGKDF 390

Query: 236 LSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQ--------- 286
           + K L+ +P  R +  + LEH ++   N            +S+ P+S   +         
Sbjct: 391 IRKLLLADPNTRMTIHQALEHPWLTPGNAPGR--------DSQIPSSRYTKIRDSIKTKY 442

Query: 287 QLWDSTLTSCSSASAKERIRQLIGEGSSEMVNW 319
             W   L      S    +R+   +  S    +
Sbjct: 443 DAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAF 475

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  150 bits (380), Expect = 2e-42
 Identities = 75/272 (27%), Positives = 121/272 (44%), Gaps = 29/272 (10%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILSALACPQIVAY 60
           +G+G+   V +     +   +A+K   L     + +        E R+L     P + A 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           K    + +    L    +EYA GG L   +       E R R +   ++  L+YLHS  +
Sbjct: 71  KYAFQTHDR---LC-FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126

Query: 121 VHCDIKGQNILVSKDNEQG-AKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           V+ DIK +N+++ KD   G  KI DFG C  +  +++    K  CGTP  +APEV    +
Sbjct: 127 VYRDIKLENLMLDKD---GHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK 238
            G   D W LG  + EM  GR P+ +  D       I    +    P  +S +A+  L+ 
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELI--LMEEIRFPRTLSPEAKSLLAG 238

Query: 239 CLIRNPGER-----WSASELLEHGFVKEQNFK 265
            L ++P +R       A E++EH F    N++
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  151 bits (384), Expect = 3e-42
 Identities = 71/272 (26%), Positives = 112/272 (41%), Gaps = 19/272 (6%)

Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALA-CPQIVAYKG 62
              Q +G G    V    + R+ E FA+K   L +    +RE  +    + CP IV    
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALKM--LQDCPKARREVELHWRASQCPHIVRIV- 121

Query: 63  CDISEENGKILYNLFL--EYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
            D+ E        L +  E   GG L   I  R      E       +++   +QYLHS 
Sbjct: 122 -DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 180

Query: 119 GIVHCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
            I H D+K +N+L  SK      K+ DFG A+       +     C TP  +APEV   E
Sbjct: 181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPE 238

Query: 178 EQGFPADVWALGCTVLEMATGRPP-WPDVADPISA--LHRIG---FSSDTPEIPGYMSKQ 231
           +     D+W+LG  +  +  G PP + +    IS     RI    +    PE    +S++
Sbjct: 239 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE-VSEE 297

Query: 232 AQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
            +  +   L   P +R + +E + H ++ +  
Sbjct: 298 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  152 bits (384), Expect = 3e-42
 Identities = 45/298 (15%), Positives = 77/298 (25%), Gaps = 49/298 (16%)

Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALA---- 53
            RG  +G+             + E F V           +  + ++ E   L  L     
Sbjct: 81  VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 140

Query: 54  ------------------CPQIVAYKGCDISEENGKILYNLFLEYAP-------GGTLTD 88
                              PQ        + E +  +L   FL           G  L  
Sbjct: 141 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 200

Query: 89  AIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA 148
              +   L        T  V+  L  LH  G+VH  ++  +I++ +       +  F   
Sbjct: 201 HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG--VFLTGFEHL 258

Query: 149 RRARVNEDDEGKPICGTPICMAPEVARGEEQG-----FPADVWALGCTVLEMATGRPPWP 203
            R   +           P   A  +    +       F  D W LG  +  +     P  
Sbjct: 259 VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318

Query: 204 DVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
           D    +     I        IP       +  L   L     +R    + +E    ++
Sbjct: 319 D-DAALGGSEWI--FRSCKNIPQP----VRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  150 bits (380), Expect = 3e-42
 Identities = 71/277 (25%), Positives = 121/277 (43%), Gaps = 28/277 (10%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILSALA 53
            + R +T+G GS   V +     S   +A+K   L   + ++         E+RIL A+ 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVN 99

Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
            P +V  +       N   LY + +EY  GG +   +R      E   R +   ++L  +
Sbjct: 100 FPFLVKLEFSFKDNSN---LY-MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
           YLHS  +++ D+K +N+L+  D +   ++ DFG A+R           +CGTP  +APE+
Sbjct: 156 YLHSLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKR----VKGRTWTLCGTPEALAPEI 209

Query: 174 ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
              +      D WALG  + EMA G PP+     PI    +I   S     P + S   +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKI--VSGKVRFPSHFSSDLK 266

Query: 234 DFLSKCLIRNPGERW-----SASELLEHGFVKEQNFK 265
           D L   L  +  +R+       +++  H +    ++ 
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  149 bits (379), Expect = 4e-42
 Identities = 77/281 (27%), Positives = 121/281 (43%), Gaps = 36/281 (12%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILS-ALACPQIVA 59
           IGRGS A V +    ++  ++A+K   +                E+ +   A   P +V 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
              C  +E     L+   +EY  GG L   ++    L E   R ++  + L L YLH  G
Sbjct: 75  LHSCFQTESR---LF-FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           I++ D+K  N+L+  D+E   K+ D+G C  +  +   D     CGTP  +APE+ RGE+
Sbjct: 131 IIYRDLKLDNVLL--DSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGED 186

Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISA--------LHRIGFSSDTPEIPGYMSK 230
            GF  D WALG  + EM  GR P+  V    +            I        IP  +S 
Sbjct: 187 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPRSLSV 244

Query: 231 QAQDFLSKCLIRNPGER------WSASELLEHGFVKEQNFK 265
           +A   L   L ++P ER         +++  H F +  ++ 
Sbjct: 245 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 285

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  148 bits (375), Expect = 5e-42
 Identities = 70/280 (25%), Positives = 121/280 (43%), Gaps = 34/280 (12%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS------------EFLQREQRILSALA 53
            + +GRG ++ V   +   + + +AVK  +++              E   +E  IL  ++
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81

Query: 54  C-PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGL 112
             P I+  K    + E     + L  +    G L D +     L E   R   RA+L  +
Sbjct: 82  GHPNIIQLKD---TYETNTFFF-LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137

Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPE 172
             LH   IVH D+K +NIL+  D     K+ DFG +   +++  ++ + +CGTP  +APE
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSC--QLDPGEKLREVCGTPSYLAPE 193

Query: 173 VARGEEQ------GFPADVWALGCTVLEMATGRPP-WPDVADPISALHRIG---FSSDTP 222
           +            G   D+W+ G  +  +  G PP W      +  L  I    +   +P
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--KQMLMLRMIMSGNYQFGSP 251

Query: 223 EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ 262
           E     S   +D +S+ L+  P +R++A E L H F ++ 
Sbjct: 252 EWDD-YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  148 bits (377), Expect = 6e-42
 Identities = 79/287 (27%), Positives = 137/287 (47%), Gaps = 23/287 (8%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALACPQ 56
           ++   +TIG+G+ A V +     +    A+K         ++ + L RE RI+  L  P 
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 57  IVA-YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
           IV  +   ++ E    + Y L +EYA GG + D + +   ++E   RS  R ++  +QY 
Sbjct: 76  IVKLF---EVIETEKTL-Y-LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           H   IVH D+K +N+L+  D +   KIADFG +         +    CG P   APE+ +
Sbjct: 131 HQKRIVHRDLKAENLLL--DADMNIKIADFGFS--NEFTVGGKLDAFCGAPPYAAPELFQ 186

Query: 176 GEE-QGFPADVWALGCTVLEMATGRPPWPDVADPISALH-RIGFSSDTPEIPGYMSKQAQ 233
           G++  G   DVW+LG  +  + +G  P+      +  L  R+        IP YMS   +
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QNLKELRERV--LRGKYRIPFYMSTDCE 242

Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKE--QNFKLSTLTEPETYNSE 278
           + L + L+ NP +R +  ++++  ++    +  +L    EPE   S+
Sbjct: 243 NLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISD 289

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  147 bits (374), Expect = 1e-41
 Identities = 69/278 (24%), Positives = 123/278 (44%), Gaps = 30/278 (10%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILSALA 53
           D+   +T+G GS   V +  S  +   +A+K   L     ++         E+ +LS + 
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIVT 64

Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
            P I+   G     +    ++ + ++Y  GG L   +R          + +   V L L+
Sbjct: 65  HPFIIRMWGTFQDAQQ---IF-MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 120

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICMAPE 172
           YLHS  I++ D+K +NIL+ K+   G  KI DFG A+       D    +CGTP  +APE
Sbjct: 121 YLHSKDIIYRDLKPENILLDKN---GHIKITDFGFAKY----VPDVTYTLCGTPDYIAPE 173

Query: 173 VARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA 232
           V   +      D W+ G  + EM  G  P+ D ++ +    +I   +     P + ++  
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKI--LNAELRFPPFFNEDV 230

Query: 233 QDFLSKCLIRNPGERW-----SASELLEHGFVKEQNFK 265
           +D LS+ + R+  +R         ++  H + KE  ++
Sbjct: 231 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  151 bits (384), Expect = 2e-41
 Identities = 66/277 (23%), Positives = 117/277 (42%), Gaps = 31/277 (11%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILSALACPQIVAY 60
           +GRG    V       + +++A K   L+     +R        E++IL+ +    IV+ 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKK--LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250

Query: 61  KGCDISEENGKILYNLFLEYAPGGTL----TDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
                ++ +   L  L +    GG +     +        +E R   +T  ++ GL++LH
Sbjct: 251 AYAFETKTD---LC-LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
              I++ D+K +N+L+  D++   +I+D G A         + K   GTP  MAPE+  G
Sbjct: 307 QRNIIYRDLKPENVLL--DDDGNVRISDLGLAVEL-KAGQTKTKGYAGTPGFMAPELLLG 363

Query: 177 EEQGFPADVWALGCTVLEMATGRPPWPD---VADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           EE  F  D +ALG T+ EM   R P+       +      R+         P   S  ++
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV--LEQAVTYPDKFSPASK 421

Query: 234 DFLSKCLIRNPGER-----WSASELLEHGFVKEQNFK 265
           DF    L ++P +R      S   L  H   ++ +++
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  146 bits (372), Expect = 5e-41
 Identities = 82/267 (30%), Positives = 130/267 (48%), Gaps = 24/267 (8%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILS-ALACPQIVA 59
           +G+GS   V +    ++++ FA+K+  L     L          E+R+LS A   P +  
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
                 ++EN   L+   +EY  GG L   I+S    +  R   +   ++LGLQ+LHS G
Sbjct: 83  MFCTFQTKEN---LF-FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 138

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           IV+ D+K  NIL+  D +   KIADFG C  +  +  D +    CGTP  +APE+  G++
Sbjct: 139 IVYRDLKLDNILL--DKDGHIKIADFGMC--KENMLGDAKTNTFCGTPDYIAPEILLGQK 194

Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK 238
                D W+ G  + EM  G+ P+    D     H I    D P  P ++ K+A+D L K
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSI--RMDNPFYPRWLEKEAKDLLVK 251

Query: 239 CLIRNPGERW-SASELLEHGFVKEQNF 264
             +R P +R     ++ +H   +E N+
Sbjct: 252 LFVREPEKRLGVRGDIRQHPLFREINW 278

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  151 bits (382), Expect = 6e-41
 Identities = 77/274 (28%), Positives = 113/274 (41%), Gaps = 28/274 (10%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILSALACPQIVAY 60
           +G+G    V       + +++A K   L      +R        E++IL  +    +V+ 
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGT-CLEEGRIRSHTRAVLLGLQYLHSN 118
                +++    L  L L    GG L   I   G     E R   +   +  GL+ LH  
Sbjct: 250 AYAYETKDA---LC-LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
            IV+ D+K +NIL+  D+    +I+D G A    V E    K   GT   MAPEV + E 
Sbjct: 306 RIVYRDLKPENILL--DDHGHIRISDLGLAVH--VPEGQTIKGRVGTVGYMAPEVVKNER 361

Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS--SDTPEIPGYMSKQAQDFL 236
             F  D WALGC + EM  G+ P+            +         E     S QA+   
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVPEEYSERFSPQARSLC 420

Query: 237 SKCLIRNPGER-----WSASELLEHGFVKEQNFK 265
           S+ L ++P ER      SA E+ EH   K+ NFK
Sbjct: 421 SQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  147 bits (374), Expect = 7e-41
 Identities = 76/281 (27%), Positives = 121/281 (43%), Gaps = 36/281 (12%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILS-ALACPQIVA 59
           IGRGS A V +    ++  ++A++   +                E+ +   A   P +V 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
              C  +E     L+   +EY  GG L   ++    L E   R ++  + L L YLH  G
Sbjct: 118 LHSCFQTESR---LF-FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           I++ D+K  N+L+  D+E   K+ D+G C  +  +   D     CGTP  +APE+ RGE+
Sbjct: 174 IIYRDLKLDNVLL--DSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGED 229

Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISA--------LHRIGFSSDTPEIPGYMSK 230
            GF  D WALG  + EM  GR P+  V    +            I        IP  +S 
Sbjct: 230 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPRSLSV 287

Query: 231 QAQDFLSKCLIRNPGER------WSASELLEHGFVKEQNFK 265
           +A   L   L ++P ER         +++  H F +  ++ 
Sbjct: 288 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 328

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  145 bits (367), Expect = 7e-41
 Identities = 67/263 (25%), Positives = 113/263 (42%), Gaps = 23/263 (8%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSN-SEFL---QREQRILSALACPQIVA 59
              +G G  +TV +      +   A+K          E L   +RE    S L+   IV+
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 60  -YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
                D+ EE+    Y L +EY  G TL++ I S   L      + T  +L G+++ H  
Sbjct: 76  MI---DVDEEDD--CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
            IVH DIK QNIL+  +     KI DFG A+        +   + GT    +PE A+GE 
Sbjct: 131 RIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188

Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPIS-ALHRIGFSSDTPEIPGYM----SKQAQ 233
                D++++G  + EM  G PP+ +    +S A+  I      P +   +     +   
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPF-NGETAVSIAIKHI--QDSVPNVTTDVRKDIPQSLS 245

Query: 234 DFLSKCLIRNPGERW-SASELLE 255
           + + +   ++   R+ +  E+ +
Sbjct: 246 NVILRATEKDKANRYKTIQEMKD 268

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  146 bits (370), Expect = 8e-41
 Identities = 56/311 (18%), Positives = 110/311 (35%), Gaps = 57/311 (18%)

Query: 2   DWTRGQTIGRGSTATV------------------SIGMSNRSSEVFAVKSAELSNSEFLQ 43
           D+   +T+ +G    +                   +      ++    K +  S  +  +
Sbjct: 32  DYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFK 91

Query: 44  REQRILSALACPQIVA-YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIR 102
            E +I++ +     +       I     ++ Y +  EY    ++         L++    
Sbjct: 92  NELQIITDIKNEYCLTCE---GIITNYDEV-Y-IIYEYMENDSILKFDEYFFVLDKNYTC 146

Query: 103 SHT--------RAVLLGLQYLHS-NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV 153
                      ++VL    Y+H+   I H D+K  NIL+ K+     K++DFG +     
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR--VKLSDFGESEYM-- 202

Query: 154 NEDDEGKPICGTPICMAPEVARGEEQ--GFPADVWALGCTVLEMATGRPPWPDVADPISA 211
             D + K   GT   M PE    E    G   D+W+LG  +  M     P+      +  
Sbjct: 203 -VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261

Query: 212 LHRI-----------------GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELL 254
            + I                   +  +     ++S +  DFL   L +NP ER ++ + L
Sbjct: 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDAL 321

Query: 255 EHGFVKEQNFK 265
           +H ++ + N +
Sbjct: 322 KHEWLADTNIE 332

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  145 bits (367), Expect = 1e-40
 Identities = 69/295 (23%), Positives = 110/295 (37%), Gaps = 34/295 (11%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---------SAELSNSEFLQREQRILSAL 52
            +  G  +G G   +V  G+    +   A+K           EL N   +  E  +L  +
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 53  --ACPQIVA-YKGCDISEENGKILYNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRAV 108
                 ++      D  E     +  L LE   P   L D I     L+E   RS    V
Sbjct: 104 SSGFSGVIRLL---DWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQV 158

Query: 109 LLGLQYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPI 167
           L  +++ H+ G++H DIK +NIL+  D  +G  K+ DFG      + +D       GT +
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGS---GALLKDTVYTDFDGTRV 213

Query: 168 CMAPEVARGEE-QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPG 226
              PE  R     G  A VW+LG  + +M  G  P+            I           
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------EEI--IRGQVFFRQ 264

Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPT 281
            +S + Q  +  CL   P +R +  E+  H ++++      T        S  P+
Sbjct: 265 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPS 319

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  144 bits (365), Expect = 1e-40
 Identities = 74/296 (25%), Positives = 118/296 (39%), Gaps = 51/296 (17%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK-----------------------------S 33
           +T    IG+GS   V +  +   +  +A+K                              
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 34  AELSNSEFLQREQRILSALACPQIVA-YKGCDISEENGKILYNLFLEYAPGGTLTDAIRS 92
                 E + +E  IL  L  P +V       + + N   LY +  E    G + +    
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKLV--EVLDDPNEDHLY-MVFELVNQGPVMEVPTL 131

Query: 93  GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR 152
              L E + R + + ++ G++YLH   I+H DIK  N+LV +D     KIADFG    + 
Sbjct: 132 K-PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH--IKIADFGV---SN 185

Query: 153 VNEDDEG--KPICGTPICMAPEVARGEEQ---GFPADVWALGCTVLEMATGRPPWPDVAD 207
             +  +       GTP  MAPE      +   G   DVWA+G T+     G+ P+ D  +
Sbjct: 186 EFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD--E 243

Query: 208 PISALHR-IGFSSDTPEIPGY--MSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
            I  LH  I   S   E P    +++  +D +++ L +NP  R    E+  H +V 
Sbjct: 244 RIMCLHSKI--KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  144 bits (366), Expect = 3e-40
 Identities = 75/322 (23%), Positives = 120/322 (37%), Gaps = 39/322 (12%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVK-----------SAELSNSEFLQREQRILSALAC 54
              +G G+   V   +    ++   VK             E      +  E  ILS +  
Sbjct: 29  MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88

Query: 55  PQIVAYKGCDISEENGKILYNLFLE-YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
             I+  K  DI E  G     L +E +  G  L   I     L+E       R ++  + 
Sbjct: 89  ANII--KVLDIFENQGFFQ--LVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI---CGTPICMA 170
           YL    I+H DIK +NI++    +   K+ DFG A        + GK     CGT    A
Sbjct: 145 YLRLKDIIHRDIKDENIVI--AEDFTIKLIDFGSA-----AYLERGKLFYTFCGTIEYCA 197

Query: 171 PEVARGEE-QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS 229
           PEV  G   +G   ++W+LG T+  +     P+ ++ + + A             P  +S
Sbjct: 198 PEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIH---------PPYLVS 248

Query: 230 KQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLW 289
           K+    +S  L   P  R +  +L+   +V  Q   L+  T  E +    P S +     
Sbjct: 249 KELMSLVSGLLQPVPERRTTLEKLVTDPWVT-QPVNLADYTWEEVFRVNKPESGVLSAA- 306

Query: 290 DSTLTSCSSASAKERIRQLIGE 311
            S      S S   + ++L G 
Sbjct: 307 -SLEMGNRSLSDVAQAQELCGG 327

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  144 bits (365), Expect = 5e-40
 Identities = 43/286 (15%), Positives = 81/286 (28%), Gaps = 38/286 (13%)

Query: 6   GQTIGRGSTATV-----SIGMSNRSSEVFAVK---SAELSNSEFLQREQRILSALACPQI 57
              +G G+ A V           ++ + F +K    A         +    L        
Sbjct: 70  HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMF 129

Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIR-----SGTCLEEGRIRSHTRAVLLGL 112
           + +    + +        L  E    GTL +AI          + +G + S    +L  +
Sbjct: 130 MKFYSAHLFQNG---SV-LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185

Query: 113 QYLHSNGIVHCDIKGQNILVS---------KDNEQGAKIADFGCARRARVNEDDEG-KPI 162
           + +H   I+H DIK  N ++           D   G  + D G +   ++          
Sbjct: 186 EQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245

Query: 163 CGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP 222
           C T      E+   +   +  D + +  TV  M  G                +       
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL------- 298

Query: 223 EIPGYMSKQA-QDFLSKCLIRNPGERWSASELLEHGFVK--EQNFK 265
                       +F    L         + +LL     K  +Q++ 
Sbjct: 299 -FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  142 bits (361), Expect = 9e-40
 Identities = 79/299 (26%), Positives = 127/299 (42%), Gaps = 31/299 (10%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVK--SAELS-NSEFL---QREQRILSALACPQIVA 59
           G+ +G G  + V +    R     AVK   A+L+ +  F    +RE +  +AL  P IVA
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 60  -YKGCDISEENGKILYNLFL--EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
            Y   D  E         ++  EY  G TL D + +   +   R           L + H
Sbjct: 77  VY---DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD--EGKPICGTPICMAPEVA 174
            NGI+H D+K  NI++S  N    K+ DFG AR    + +   +   + GT   ++PE A
Sbjct: 134 QNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191

Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS-ALHRIG-----FSSDTPEIPGYM 228
           RG+     +DV++LGC + E+ TG PP+     P+S A   +       S+    +    
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQHVREDPIPPSARHEGLS--- 247

Query: 229 SKQAQDFLSKCLIRNPGERW-SASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQ 286
                  + K L +NP  R+ +A+E+        +         P+       TS+L+ 
Sbjct: 248 -ADLDAVVLKALAKNPENRYQTAAEMRAD---LVRVHNGEPPEAPKVLTDAERTSLLSS 302

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  142 bits (360), Expect = 1e-39
 Identities = 65/286 (22%), Positives = 108/286 (37%), Gaps = 36/286 (12%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKS---AELSNSEFLQREQRILSALA-CPQIVAYKG 62
             +G G+ A V   ++  +S+ +AVK            + RE  +L        ++    
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78

Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
                E     Y L  E   GG++   I       E       + V   L +LH+ GI H
Sbjct: 79  F---FEEEDRFY-LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAH 134

Query: 123 CDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEG------KPICGTPICMAPEVAR 175
            D+K +NIL    +     KI DF      ++N D            CG+   MAPEV  
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194

Query: 176 GEEQ-----GFPADVWALGCTVLEMATGRPP-WPDVADPISALHRIGFSSDTPEI----- 224
              +         D+W+LG  +  + +G PP                  +    +     
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQ 254

Query: 225 ------PG----YMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
                 P     ++S  A+D +SK L+R+  +R SA+++L+H +V+
Sbjct: 255 EGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  143 bits (363), Expect = 1e-39
 Identities = 73/273 (26%), Positives = 118/273 (43%), Gaps = 29/273 (10%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILS-ALACPQIVA 59
           +G+GS   V +     + +++AVK   L     LQ         E+RILS A   P +  
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
              C  + +    L+   +E+  GG L   I+     +E R R +   ++  L +LH  G
Sbjct: 89  LFCCFQTPDR---LF-FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG 144

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           I++ D+K  N+L+  D+E   K+ADFG C  +  +         CGTP  +APE+ +   
Sbjct: 145 IIYRDLKLDNVLL--DHEGHCKLADFGMC--KEGICNGVTTATFCGTPDYIAPEILQEML 200

Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK 238
            G   D WA+G  + EM  G  P+    +       I   +D    P ++ + A   L  
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAI--LNDEVVYPTWLHEDATGILKS 257

Query: 239 CLIRNPGER------WSASELLEHGFVKEQNFK 265
            + +NP  R           +L H F KE ++ 
Sbjct: 258 FMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA 290

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  142 bits (360), Expect = 1e-39
 Identities = 70/271 (25%), Positives = 106/271 (39%), Gaps = 34/271 (12%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---------SAELSNSEFLQREQRIL--- 49
           ++  G  +G+G   TV  G         A+K          + LS+S     E  +L   
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 50  -SALACPQIVAYKGCDISEENGKILYNLFLEYA-PGGTLTDAIRSGTCLEEGRIRSHTRA 107
            +    P ++  +  D  E     +  L LE   P   L D I     L EG  R     
Sbjct: 92  GAGGGHPGVI--RLLDWFETQEGFM--LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQ 147

Query: 108 VLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTP 166
           V+  +Q+ HS G+VH DIK +NIL+  D  +G  K+ DFG      +  D+      GT 
Sbjct: 148 VVAAIQHCHSRGVVHRDIKDENILI--DLRRGCAKLIDFGS---GALLHDEPYTDFDGTR 202

Query: 167 ICMAPEVARGEE-QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP 225
           +   PE     +    PA VW+LG  + +M  G  P+    + + A             P
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELH---------FP 253

Query: 226 GYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
            ++S      + +CL   P  R S  E+L  
Sbjct: 254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  145 bits (367), Expect = 1e-39
 Identities = 69/271 (25%), Positives = 115/271 (42%), Gaps = 26/271 (9%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILSALACPQIVAY 60
           +G+G+   V +     +   +A+K   L     + +        E R+L     P + A 
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKI--LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS-NG 119
           K    + +    L    +EYA GG L   +       E R R +   ++  L YLHS   
Sbjct: 214 KYSFQTHDR---LC-FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 269

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           +V+ D+K +N+++  D +   KI DFG  +   + +    K  CGTP  +APEV    + 
Sbjct: 270 VVYRDLKLENLML--DKDGHIKITDFGLCKEG-IKDGATMKTFCGTPEYLAPEVLEDNDY 326

Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
           G   D W LG  + EM  GR P+ +  D       I    +    P  +  +A+  LS  
Sbjct: 327 GRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELI--LMEEIRFPRTLGPEAKSLLSGL 383

Query: 240 LIRNPGER-----WSASELLEHGFVKEQNFK 265
           L ++P +R       A E+++H F     ++
Sbjct: 384 LKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ 414

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  141 bits (357), Expect = 3e-39
 Identities = 68/271 (25%), Positives = 114/271 (42%), Gaps = 26/271 (9%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVK-------SAELSNSEFLQREQRILSALACPQIV 58
           G  +G GS   V   + + +    AVK           +    +++E ++L  L    ++
Sbjct: 10  GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69

Query: 59  A-YKGCD-ISEENGKILYNLFLEYAPGGT--LTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
                 D +  E  + +Y + +EY   G   + D++         +   +   ++ GL+Y
Sbjct: 70  QLV---DVLYNEEKQKMY-MVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFCQLIDGLEY 124

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEV 173
           LHS GIVH DIK  N+L+        KI+  G          DD  +   G+P    PE+
Sbjct: 125 LHSQGIVHKDIKPGNLLL--TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182

Query: 174 ARGEEQ--GFPADVWALGCTVLEMATGRPPWPDVADPISAL-HRIGFSSDTPEIPGYMSK 230
           A G +   GF  D+W+ G T+  + TG  P+    D I  L   IG    +  IPG    
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG--DNIYKLFENIG--KGSYAIPGDCGP 238

Query: 231 QAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
              D L   L   P +R+S  ++ +H + ++
Sbjct: 239 PLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  140 bits (356), Expect = 4e-39
 Identities = 79/263 (30%), Positives = 118/263 (44%), Gaps = 24/263 (9%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVA 59
            + IG GS  TV        S+V AVK     +      +EF  RE  I+  L  P IV 
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDV-AVKILMEQDFHAERVNEF-LREVAIMKRLRHPNIVL 98

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTC---LEEGRIRSHTRAVLLGLQYLH 116
           + G      N     ++  EY   G+L   +        L+E R  S    V  G+ YLH
Sbjct: 99  FMGAVTQPPN----LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154

Query: 117 SNG--IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           +    IVH ++K  N+LV K      K+ DFG +R  + +     K   GTP  MAPEV 
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVL 211

Query: 175 RGEEQGFPADVWALGCTVL-EMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           R E     +DV++ G  +L E+AT + PW ++ +P   +  +GF     EIP  ++ Q  
Sbjct: 212 RDEPSNEKSDVYSFG-VILWELATLQQPWGNL-NPAQVVAAVGFKCKRLEIPRNLNPQVA 269

Query: 234 DFLSKCLIRNPGERWSASELLEH 256
             +  C    P +R S + +++ 
Sbjct: 270 AIIEGCWTNEPWKRPSFATIMDL 292

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  140 bits (355), Expect = 5e-39
 Identities = 65/266 (24%), Positives = 111/266 (41%), Gaps = 28/266 (10%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVA 59
           +    + +GRG+   V      R+ +V A+K   +E     F   E R LS +  P IV 
Sbjct: 9   EIEVEEVVGRGAFGVVCKA-KWRAKDV-AIKQIESESERKAF-IVELRQLSRVNHPNIVK 65

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL------GLQ 113
             G  ++         L +EYA GG+L + +      E     +   A+        G+ 
Sbjct: 66  LYGACLNP------VCLVMEYAEGGSLYNVLHGA---EPLPYYTAAHAMSWCLQCSQGVA 116

Query: 114 YLHS---NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMA 170
           YLHS     ++H D+K  N+L+        KI DFG A     +         G+   MA
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTV-LKICDFGTAC----DIQTHMTNNKGSAAWMA 171

Query: 171 PEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK 230
           PEV  G       DV++ G  + E+ T R P+ ++  P   +     +   P +   + K
Sbjct: 172 PEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK 231

Query: 231 QAQDFLSKCLIRNPGERWSASELLEH 256
             +  +++C  ++P +R S  E+++ 
Sbjct: 232 PIESLMTRCWSKDPSQRPSMEEIVKI 257

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  141 bits (357), Expect = 5e-39
 Identities = 68/274 (24%), Positives = 118/274 (43%), Gaps = 29/274 (10%)

Query: 9   IGRGSTATV---SIGMSNRSSEVFAVKSAELSNSEFLQR---------EQRILSALACPQ 56
           +G+G    V          + ++FA+K   L  +  ++          E+ IL  +  P 
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKV--LKKAMIVRNAKDTAHTKAERNILEEVKHPF 82

Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV       +      LY L LEY  GG L   +       E     +   + + L +LH
Sbjct: 83  IVDLIYAFQTGGK---LY-LILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
             GI++ D+K +NI++  +++   K+ DFG  + + +++       CGT   MAPE+   
Sbjct: 139 QKGIIYRDLKPENIML--NHQGHVKLTDFGLCKES-IHDGTVTHTFCGTIEYMAPEILMR 195

Query: 177 EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL 236
                  D W+LG  + +M TG PP+    +    + +I        +P Y++++A+D L
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKI--LKCKLNLPPYLTQEARDLL 252

Query: 237 SKCLIRNPGER-----WSASELLEHGFVKEQNFK 265
            K L RN   R       A E+  H F +  N++
Sbjct: 253 KKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE 286

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  141 bits (357), Expect = 5e-39
 Identities = 72/273 (26%), Positives = 115/273 (42%), Gaps = 29/273 (10%)

Query: 9   IGRGSTATVSI---GMSNRSSEVFAVKSAELSNSEFLQR-------EQRILSALACPQIV 58
           +G+GS   V +      + + +++A+K   L  +    R       E+ IL  +  P IV
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKV--LKKATLKVRDRVRTKMERDILVEVNHPFIV 89

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
                  +E     LY L L++  GG L   +       E  ++ +   + L L +LHS 
Sbjct: 90  KLHYAFQTEGK---LY-LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 145

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGE 177
           GI++ D+K +NIL+  D E   K+ DFG    +  ++ + +    CGT   MAPEV    
Sbjct: 146 GIIYRDLKPENILL--DEEGHIKLTDFGLS--KESIDHEKKAYSFCGTVEYMAPEVVNRR 201

Query: 178 EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
                AD W+ G  + EM TG  P+    D    +  I        +P ++S +AQ  L 
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMI--LKAKLGMPQFLSPEAQSLLR 258

Query: 238 KCLIRNPGER-----WSASELLEHGFVKEQNFK 265
               RNP  R         E+  H F    ++ 
Sbjct: 259 MLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN 291

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  141 bits (357), Expect = 5e-39
 Identities = 66/324 (20%), Positives = 109/324 (33%), Gaps = 46/324 (14%)

Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEFLQREQRILSALA-CPQIVA 59
              + +  G  A V       S   +A+K   S E   +  + +E   +  L+  P IV 
Sbjct: 31  RVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ 90

Query: 60  YKGCDISE----ENGKILYNLFLEYAPGGTLTD--AIRSGTCLEEGRIRSHTRAVLLGLQ 113
           +           + G+  + L  E   G  +     + S   L    +          +Q
Sbjct: 91  FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQ 150

Query: 114 YLHSNG--IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI--------- 162
           ++H     I+H D+K +N+L+S       K+ DFG A       D               
Sbjct: 151 HMHRQKPPIIHRDLKVENLLLSNQGT--IKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208

Query: 163 --CGTPICMAPEV---ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF 217
               TP+   PE+         G   D+WALGC +  +   + P+ D      A  RI  
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED-----GAKLRI-- 261

Query: 218 SSDTPEIPGY--MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETY 275
            +    IP +          +   L  NP ER S +E++           L  +      
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ---------LQEIAAARNV 312

Query: 276 NSESPTSVLNQQLWDSTLTSCSSA 299
           N +SP + L +Q       + S  
Sbjct: 313 NPKSPITELLEQNGGYGSATLSRG 336

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  142 bits (360), Expect = 5e-39
 Identities = 67/270 (24%), Positives = 109/270 (40%), Gaps = 25/270 (9%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILS-ALACPQIVA 59
           IG+GS   V +         +AVK   L     L++        E+ +L   +  P +V 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
                 + +    LY   L+Y  GG L   ++   C  E R R +   +   L YLHS  
Sbjct: 104 LHFSFQTADK---LY-FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN 159

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           IV+ D+K +NIL+  D++    + DFG  +   +  +      CGTP  +APEV   +  
Sbjct: 160 IVYRDLKPENILL--DSQGHIVLTDFGLCKEN-IEHNSTTSTFCGTPEYLAPEVLHKQPY 216

Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKC 239
               D W LG  + EM  G PP+    +       I   +   ++   ++  A+  L   
Sbjct: 217 DRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNI--LNKPLQLKPNITNSARHLLEGL 273

Query: 240 LIRNPGER----WSASELLEHGFVKEQNFK 265
           L ++  +R        E+  H F    N+ 
Sbjct: 274 LQKDRTKRLGAKDDFMEIKSHVFFSLINWD 303

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  141 bits (358), Expect = 5e-39
 Identities = 72/272 (26%), Positives = 119/272 (43%), Gaps = 28/272 (10%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILS-ALACPQIVA 59
           +G+GS   V +     + E++AVK   L     +Q         E+R+L+     P +  
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
              C  + +    LY   +EY  GG L   I+     +E     +   + +GL +L S G
Sbjct: 86  LHSCFQTMDR---LY-FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 141

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           I++ D+K  N+++  D+E   KIADFG C  +  + +    K  CGTP  +APE+   + 
Sbjct: 142 IIYRDLKLDNVML--DSEGHIKIADFGMC--KENIWDGVTTKTFCGTPDYIAPEIIAYQP 197

Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK 238
            G   D WA G  + EM  G+ P+    D       I         P  MSK+A      
Sbjct: 198 YGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSI--MEHNVAYPKSMSKEAVAICKG 254

Query: 239 CLIRNPGER-----WSASELLEHGFVKEQNFK 265
            + ++PG+R         ++ EH F +  +++
Sbjct: 255 LMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 286

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  141 bits (358), Expect = 7e-39
 Identities = 73/279 (26%), Positives = 120/279 (43%), Gaps = 37/279 (13%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS-----------AELSNSEFLQREQRILSALAC 54
              IGRG ++ V   +   +   FAVK                  E  +RE  IL  +A 
Sbjct: 99  KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158

Query: 55  -PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
            P I+     D  E +  + + L  +    G L D +     L E   RS  R++L  + 
Sbjct: 159 HPHIITLI--DSYESSSFM-F-LVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
           +LH+N IVH D+K +NIL+  + +   +++DFG +    +   ++ + +CGTP  +APE+
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSC--HLEPGEKLRELCGTPGYLAPEI 270

Query: 174 ARGEEQ------GFPADVWALGCTVLEMATGRPP-W----PDVADPISALHRIGFSSDT- 221
            +          G   D+WA G  +  +  G PP W      +   I       FSS   
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ-YQFSSPEW 329

Query: 222 PEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
            +     S   +D +S+ L  +P  R +A + L+H F +
Sbjct: 330 DDR----SSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  139 bits (352), Expect = 9e-39
 Identities = 60/275 (21%), Positives = 107/275 (38%), Gaps = 31/275 (11%)

Query: 2   DWTRGQTIGRGSTATVSIGM-SNRSSEVFAVK----------SAELSNSEFLQREQRILS 50
           +    + IG+G    V  G      S V A+K          +  +   +  QRE  I+S
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVV-AIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 51  ALACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVL 109
            L  P IV   G   +         + +E+ P G L   +      ++          + 
Sbjct: 79  NLNHPNIVKLYGLMHNP------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132

Query: 110 LGLQYLHSNG--IVHCDIKGQNILVSKDNEQG---AKIADFGCARRARVNEDDEGKPICG 164
           LG++Y+ +    IVH D++  NI +   +E     AK+ADFG ++            + G
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLG 188

Query: 165 TPICMAPEVARGEEQGF--PADVWALGCTVLEMATGRPPWPDV-ADPISALHRIGFSSDT 221
               MAPE    EE+ +   AD ++    +  + TG  P+ +     I  ++ I      
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248

Query: 222 PEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
           P IP     + ++ +  C   +P +R   S +++ 
Sbjct: 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  145 bits (368), Expect = 1e-38
 Identities = 66/279 (23%), Positives = 111/279 (39%), Gaps = 36/279 (12%)

Query: 8   TIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRIL---SALACPQ 56
            IGRG    V       + +++A+K   L       +        E+ +L   S   CP 
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253

Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV       + +    L    L+   GG L   +       E  +R +   ++LGL+++H
Sbjct: 254 IVCMSYAFHTPDK---LS-FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 309

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEV- 173
           +  +V+ D+K  NIL+  D     +I+D G A      +  + KP    GT   MAPEV 
Sbjct: 310 NRFVVYRDLKPANILL--DEHGHVRISDLGLAC-----DFSKKKPHASVGTHGYMAPEVL 362

Query: 174 ARGEEQGFPADVWALGCTVLEMATGRPPW--PDVADPISALHRIGFSSDTPEIPGYMSKQ 231
            +G      AD ++LGC + ++  G  P+      D           +   E+P   S +
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPE 420

Query: 232 AQDFLSKCLIRNPGER-----WSASELLEHGFVKEQNFK 265
            +  L   L R+   R       A E+ E  F +  +++
Sbjct: 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 459

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  138 bits (351), Expect = 1e-38
 Identities = 71/268 (26%), Positives = 117/268 (43%), Gaps = 22/268 (8%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQ 56
           +  G T+G G+   V IG    +    AVK         L     ++RE + L     P 
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72

Query: 57  IVA-YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
           I+  Y    +          + +EY  GG L D I     +EE   R   + +L  + Y 
Sbjct: 73  IIKLY---QVISTPTDFF--MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYC 127

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           H + +VH D+K +N+L+  D    AKIADFG +    +++ +  +  CG+P   APEV  
Sbjct: 128 HRHMVVHRDLKPENVLL--DAHMNAKIADFGLS--NMMSDGEFLRTSCGSPNYAAPEVIS 183

Query: 176 GEE-QGFPADVWALGCTVLEMATGRPPWPDVADPISALHR-IGFSSDTPEIPGYMSKQAQ 233
           G    G   D+W+ G  +  +  G  P+ D  + +  L + I        IP Y+++   
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDD--EHVPTLFKKI--RGGVFYIPEYLNRSVA 239

Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKE 261
             L   L  +P +R +  ++ EH + K+
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHEWFKQ 267

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  142 bits (359), Expect = 1e-38
 Identities = 66/281 (23%), Positives = 116/281 (41%), Gaps = 32/281 (11%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILSALACPQIV 58
           + IGRG+ + V++    ++ +V+A+K   ++  + L+R        E+ +L       I 
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKI--MNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHS 117
                   E     LY L +EY  GG L   + + G  +     R +   +++ +  +H 
Sbjct: 125 QLHFAFQDENY---LY-LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
            G VH DIK  NIL+  D     ++ADFG   + R +         GTP  ++PE+ +  
Sbjct: 181 LGYVHRDIKPDNILL--DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAV 238

Query: 178 EQ-------GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDT---PEIPGY 227
                    G   D WALG    EM  G+ P+           +I    +    P +   
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSLPLVDEG 297

Query: 228 MSKQAQDFLSKCLIRNPGER---WSASELLEHGFVKEQNFK 265
           + ++A+DF+ + L+  P  R     A +   H F    ++ 
Sbjct: 298 VPEEARDFIQR-LLCPPETRLGRGGAGDFRTHPFFFGLDWD 337

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  139 bits (352), Expect = 2e-38
 Identities = 74/268 (27%), Positives = 108/268 (40%), Gaps = 35/268 (13%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSN-SEFL---QREQRILSALACPQIVA 59
            + +GRG    V          + A+K  S  LS+   F    QRE R    L  P +V 
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 60  -YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
            +   D  E +G  LY + +    G  L   +R    L   R  +  R +   L   H+ 
Sbjct: 99  IH---DFGEIDG-QLY-VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA 153

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG----KPICGTPICMAPEVA 174
           G  H D+K +NILVS D+   A + DFG A        DE         GT   MAPE  
Sbjct: 154 GATHRDVKPENILVSADDF--AYLVDFGIASAT----TDEKLTQLGNTVGTLYYMAPERF 207

Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS-ALHRIGF-----SSDTPEIPGYM 228
                 + AD++AL C + E  TG PP+    D +S     I       S+  P IP   
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPPYQ--GDQLSVMGAHINQAIPRPSTVRPGIP--- 262

Query: 229 SKQAQDFLSKCLIRNPGERW-SASELLE 255
                  +++ + +NP +R+ +  +L  
Sbjct: 263 -VAFDAVIARGMAKNPEDRYVTCGDLSA 289

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  137 bits (348), Expect = 2e-38
 Identities = 69/267 (25%), Positives = 109/267 (40%), Gaps = 27/267 (10%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFL-------QREQRILSALACPQIV 58
            + IG G    V         EV AVK+A     E +       ++E ++ + L  P I+
Sbjct: 12  EEIIGIGGFGKVYRAF-WIGDEV-AVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
           A +G  + E N      L +E+A GG L   +  G  +    + +    +  G+ YLH  
Sbjct: 70  ALRGVCLKEPN----LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDE 124

Query: 119 G---IVHCDIKGQNILVSKDNEQG------AKIADFGCARRARVNEDDEGKPICGTPICM 169
               I+H D+K  NIL+ +  E G       KI DFG AR              G    M
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAAGAYAWM 181

Query: 170 APEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS 229
           APEV R       +DVW+ G  + E+ TG  P+  + D ++  + +  +     IP    
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI-DGLAVAYGVAMNKLALPIPSTCP 240

Query: 230 KQAQDFLSKCLIRNPGERWSASELLEH 256
           +     +  C   +P  R S + +L+ 
Sbjct: 241 EPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  137 bits (348), Expect = 1e-37
 Identities = 70/281 (24%), Positives = 125/281 (44%), Gaps = 33/281 (11%)

Query: 8   TIGRGSTATV---SIGMSNRSSEVFAVKSAELSNSEFLQR---------EQRILSALA-C 54
            +G G+   V        + + +++A+K   L  +  +Q+         E+++L  +   
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKV--LKKATIVQKAKTTEHTRTERQVLEHIRQS 118

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
           P +V       +E     L+ L L+Y  GG L   +       E  ++ +   ++L L++
Sbjct: 119 PFLVTLHYAFQTETK---LH-LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 174

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           LH  GI++ DIK +NIL+  D+     + DFG ++    +E +     CGT   MAP++ 
Sbjct: 175 LHKLGIIYRDIKLENILL--DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232

Query: 175 RGEEQGF--PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS---DTPEIPGYMS 229
           RG + G     D W+LG  + E+ TG  P+    D                 P  P  MS
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPF--TVDGEKNSQAEISRRILKSEPPYPQEMS 290

Query: 230 KQAQDFLSKCLIRNPGER-----WSASELLEHGFVKEQNFK 265
             A+D + + L+++P +R       A E+ EH F ++ N+ 
Sbjct: 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 331

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  142 bits (359), Expect = 2e-37
 Identities = 72/272 (26%), Positives = 119/272 (43%), Gaps = 28/272 (10%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILSALA-CPQIVA 59
           +G+GS   V +     + E++AVK   L     +Q         E+R+L+     P +  
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
              C  + +    LY   +EY  GG L   I+     +E     +   + +GL +L S G
Sbjct: 407 LHSCFQTMDR---LY-FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 462

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFG-CARRARVNEDDEGKPICGTPICMAPEVARGEE 178
           I++ D+K  N+++  D+E   KIADFG C  +  + +    K  CGTP  +APE+   + 
Sbjct: 463 IIYRDLKLDNVML--DSEGHIKIADFGMC--KENIWDGVTTKTFCGTPDYIAPEIIAYQP 518

Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK 238
            G   D WA G  + EM  G+ P+    D       I         P  MSK+A      
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSI--MEHNVAYPKSMSKEAVAICKG 575

Query: 239 CLIRNPGER-----WSASELLEHGFVKEQNFK 265
            + ++PG+R         ++ EH F +  +++
Sbjct: 576 LMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 607

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  137 bits (347), Expect = 6e-37
 Identities = 68/279 (24%), Positives = 119/279 (42%), Gaps = 24/279 (8%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKS------AELSNSEFLQREQRILSALACP 55
           D+   + IGRG+   V +     + +V+A+K        + S+S F   E+ I++    P
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            +V        +     LY + +EY PGG L + + +   + E   R +T  V+L L  +
Sbjct: 130 WVVQLFYAFQDDRY---LY-MVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAI 184

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS G +H D+K  N+L+  D     K+ADFG   +             GTP  ++PEV +
Sbjct: 185 HSMGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242

Query: 176 GEEQ----GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPG--YMS 229
            +      G   D W++G  + EM  G  P+      +    +I    ++   P    +S
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDIS 301

Query: 230 KQAQDFLSKCLIRNPGER---WSASELLEHGFVKEQNFK 265
           K+A++ +    + +   R       E+  H F K   + 
Sbjct: 302 KEAKNLICA-FLTDREVRLGRNGVEEIKRHLFFKNDQWA 339

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  135 bits (342), Expect = 7e-37
 Identities = 74/292 (25%), Positives = 130/292 (44%), Gaps = 22/292 (7%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKS------AELSNSEFLQREQRILSALACPQ 56
           +   +T+G GS   V +    ++ +  A+K        +      ++RE   L  L  P 
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70

Query: 57  IVA-YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
           I+  Y   D+      I   + +EYA GG L D I     + E   R   + ++  ++Y 
Sbjct: 71  IIKLY---DVITTPTDI-V-MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           H + IVH D+K +N+L+  D+    KIADFG +    + + +  K  CG+P   APEV  
Sbjct: 125 HRHKIVHRDLKPENLLL--DDNLNVKIADFGLS--NIMTDGNFLKTSCGSPNYAAPEVIN 180

Query: 176 GEE-QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD 234
           G+   G   DVW+ G  +  M  GR P+ D  + I  L +   S     +P ++S  AQ 
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDD--EFIPNLFKKVNSCV-YVMPDFLSPGAQS 237

Query: 235 FLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQ 286
            + + ++ +P +R +  E+    +    N         E   S + + ++++
Sbjct: 238 LIRRMIVADPMQRITIQEIRRDPWFN-VNLPDYLRPMEEVQGSYADSRIVSK 288

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  133 bits (338), Expect = 1e-36
 Identities = 71/266 (26%), Positives = 120/266 (45%), Gaps = 27/266 (10%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACPQIVA 59
           GQ IG GS  TV  G  +   +V AVK              F   E  +L       I+ 
Sbjct: 29  GQRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNILL 84

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSN 118
           + G   +     I+     ++  G +L   + +  T  E  ++    R    G+ YLH+ 
Sbjct: 85  FMGY-STAPQLAIV----TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK 139

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPICMAPEVARGE 177
            I+H D+K  NI + +DN    KI DFG A  ++R +   + + + G+ + MAPEV R +
Sbjct: 140 SIIHRDLKSNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197

Query: 178 EQG---FPADVWALGCTVL-EMATGRPPWPDVADPISALHRIGFSS---DTPEIPGYMSK 230
           +     F +DV+A G  VL E+ TG+ P+ ++ +    +  +G  S   D  ++     K
Sbjct: 198 DSNPYSFQSDVYAFG-IVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK 256

Query: 231 QAQDFLSKCLIRNPGERWSASELLEH 256
           + +  +++CL +   ER S   +L  
Sbjct: 257 RMKRLMAECLKKKRDERPSFPRILAE 282

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  134 bits (339), Expect = 3e-36
 Identities = 78/289 (26%), Positives = 123/289 (42%), Gaps = 17/289 (5%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAYKGC 63
            + IG G+     +     + E+ AVK      +  E +QRE     +L  P IV +K  
Sbjct: 25  VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFK-- 82

Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC 123
           ++      +   + +EYA GG L + I +     E   R   + +L G+ Y HS  I H 
Sbjct: 83  EVILTPTHL-A-IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHR 140

Query: 124 DIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QGFP 182
           D+K +N L+        KI DFG ++ +      + K   GTP  +APEV   +E  G  
Sbjct: 141 DLKLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKSTVGTPAYIAPEVLLRQEYDGKI 198

Query: 183 ADVWALGCTVLEMATGRPPWPDVADPI---SALHRIGFSSDTPEIPG--YMSKQAQDFLS 237
           ADVW+ G T+  M  G  P+ D  +P      + RI   S    IP    +S +    +S
Sbjct: 199 ADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI--LSVKYSIPDDIRISPECCHLIS 256

Query: 238 KCLIRNPGERWSASELLEHG-FVKEQNFKLSTLTEPETYNSESPTSVLN 285
           +  + +P  R S  E+  H  F+K     L   +   +   E    + +
Sbjct: 257 RIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQS 305

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  136 bits (344), Expect = 3e-36
 Identities = 71/267 (26%), Positives = 117/267 (43%), Gaps = 20/267 (7%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKS------AELSNSEFLQREQRILSALACPQ 56
           +  G T+G G+   V +G    +    AVK         L     ++RE + L     P 
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77

Query: 57  IVA-YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
           I+  Y    +      I + + +EY  GG L D I     L+E   R   + +L G+ Y 
Sbjct: 78  IIKLY---QVISTPSDI-F-MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYC 132

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           H + +VH D+K +N+L+  D    AKIADFG +    +++ +  +  CG+P   APEV  
Sbjct: 133 HRHMVVHRDLKPENVLL--DAHMNAKIADFGLS--NMMSDGEFLRTSCGSPNYAAPEVIS 188

Query: 176 GEE-QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD 234
           G    G   D+W+ G  +  +  G  P+ D  D +  L +          P Y++     
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLPFDD--DHVPTLFKKICDGIF-YTPQYLNPSVIS 245

Query: 235 FLSKCLIRNPGERWSASELLEHGFVKE 261
            L   L  +P +R +  ++ EH + K+
Sbjct: 246 LLKHMLQVDPMKRATIKDIREHEWFKQ 272

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  135 bits (342), Expect = 4e-36
 Identities = 65/279 (23%), Positives = 114/279 (40%), Gaps = 30/279 (10%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--------EQRILSALACPQIV 58
           + IGRG+   V++     + +VFA+K   L+  E L+R        E+ +L       I 
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDSKWIT 137

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTL-TDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
                   + N   LY L ++Y  GG L T   +    L E   R +   +++ +  +H 
Sbjct: 138 TLHYAFQDDNN---LY-LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
              VH DIK  NIL+  D     ++ADFG   +   +   +     GTP  ++PE+ +  
Sbjct: 194 LHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 251

Query: 178 EQ-----GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY---MS 229
           E      G   D W+LG  + EM  G  P+      +    +I    +  + P     +S
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPTQVTDVS 310

Query: 230 KQAQDFLSKCLIRNP---GERWSASELLEHGFVKEQNFK 265
           + A+D + + +       G+     +  +H F    ++ 
Sbjct: 311 ENAKDLIRRLICSREHRLGQN-GIEDFKKHPFFSGIDWD 348

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  130 bits (330), Expect = 1e-35
 Identities = 42/267 (15%), Positives = 100/267 (37%), Gaps = 33/267 (12%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVA 59
              +    +  +  G   + +++  VK  ++ +       +F   E   L   + P ++ 
Sbjct: 15  LTKLNENHSGELWKG-RWQGNDI-VVKVLKVRDWSTRKSRDF-NEECPRLRIFSHPNVLP 71

Query: 60  YKGCDISEENGKILYNLFL--EYAPGGTLTDAIRSGTC--LEEGRIRSHTRAVLLGLQYL 115
             G   S        +  L   + P G+L + +  GT   +++ +       +  G+ +L
Sbjct: 72  VLGACQSPPAP----HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127

Query: 116 HS--NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
           H+    I    +  +++++ +D    A+I+          +    G+     P  +APE 
Sbjct: 128 HTLEPLIPRHALNSRSVMIDEDMT--ARISMADVKF----SFQSPGR--MYAPAWVAPEA 179

Query: 174 ARGEEQGFP---ADVWALGCTVL-EMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS 229
            + + +      AD+W+    +L E+ T   P+ D+   +    ++      P IP  +S
Sbjct: 180 LQKKPEDTNRRSADMWSFA-VLLWELVTREVPFADL-SNMEIGMKVALEGLRPTIPPGIS 237

Query: 230 KQAQDFLSKCLIRNPGERWSASELLEH 256
                 +  C+  +P +R     ++  
Sbjct: 238 PHVSKLMKICMNEDPAKRPKFDMIVPI 264

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  131 bits (331), Expect = 1e-35
 Identities = 66/275 (24%), Positives = 104/275 (37%), Gaps = 46/275 (16%)

Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALA-CPQIVAYKG 62
              Q +G G    V    + R+ E FA+K   L +    +RE  +    + CP IV    
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALKM--LQDCPKARREVELHWRASQCPHIVRIV- 77

Query: 63  CDISEENGKILYNLFL--EYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
            D+ E        L +  E   GG L   I  R      E       +++   +QYLHS 
Sbjct: 78  -DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 136

Query: 119 GIVHCDIKGQNIL-VSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
            I H D+K +N+L  SK      K+ DFG                       A E   GE
Sbjct: 137 NIAHRDVKPENLLYTSKRPNAILKLTDFG----------------------FAKET-TGE 173

Query: 178 EQGFPADVWALGCTVLEMATGRPP-WPDVADPISA--LHRIG-----FSSDT-PEIPGYM 228
           +     D+W+LG  +  +  G PP + +    IS     RI      F +    E+    
Sbjct: 174 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV---- 229

Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN 263
           S++ +  +   L   P +R + +E + H ++ +  
Sbjct: 230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  134 bits (338), Expect = 1e-34
 Identities = 59/267 (22%), Positives = 106/267 (39%), Gaps = 47/267 (17%)

Query: 6   GQTIGRGSTATVSIG----MSNRSSEVFAVKSAELSNS---EFL---QREQRILSALACP 55
              I  G    + +     ++ R   V  +K   L +S   E       E++ L+ +  P
Sbjct: 85  KGCIAHGGLGWIYLALDRNVNGR--PV-VLK--GLVHSGDAEAQAMAMAERQFLAEVVHP 139

Query: 56  QIVA-YKGCDISEENGK----ILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL 110
            IV  +   +  E   +    + Y + +EY  G +L  +      L      ++   +L 
Sbjct: 140 SIVQIF---NFVEHTDRHGDPVGY-IVMEYVGGQSLKRSKGQK--LPVAEAIAYLLEILP 193

Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMA 170
            L YLHS G+V+ D+K +NI+++++     K+ D G   R     +  G  + GTP   A
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRI----NSFG-YLYGTPGFQA 245

Query: 171 PEVARGEEQGFPA-DVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS 229
           PE+ R       A D++ +G T+  +    P               G   D P +  Y S
Sbjct: 246 PEIVRTGPT--VATDIYTVGRTLAALTLDLPTRNGRYVD-------GLPEDDPVLKTYDS 296

Query: 230 KQAQDFLSKCLIRNPGERW-SASELLE 255
                 L + +  +P +R+ +A E+  
Sbjct: 297 YGR--LLRRAIDPDPRQRFTTAEEMSA 321

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  126 bits (320), Expect = 6e-34
 Identities = 75/335 (22%), Positives = 130/335 (38%), Gaps = 74/335 (22%)

Query: 1   MD-WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQREQRILSALAC 54
           M+ + +   IG GS   V    +  + ++ A+K    S  +        RE R+L  L  
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQ 113
           P +V     ++     ++  +L  EY    T+   + R    + E  ++S T   L  + 
Sbjct: 62  PNLVNLL--EVFRRKRRL--HLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVN 116

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---- 169
           + H +  +H D+K +NIL++K +    K+ DFG AR            +   P       
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSV--IKLCDFGFAR------------LLTGPSDYYDDE 162

Query: 170 -------APEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI------ 215
                  +PE+  G+ Q G P DVWA+GC   E+ +G P WP  +D +  L+ I      
Sbjct: 163 VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD-VDQLYLIRKTLGD 221

Query: 216 -------GFSSDTPEIPGY-----------------MSKQAQDFLSKCLIRNPGERWSAS 251
                   FS++     G                  +S  A   L  CL  +P ER +  
Sbjct: 222 LIPRHQQVFSTN-QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCE 280

Query: 252 ELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQ 286
           +LL H + +        + +    + +   ++  Q
Sbjct: 281 QLLHHPYFENIRE----IEDLAKEHDKPAENLYFQ 311

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  125 bits (316), Expect = 3e-33
 Identities = 58/271 (21%), Positives = 103/271 (38%), Gaps = 32/271 (11%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVA 59
           G+ IG+G    V  G  +   EV A++  ++          F +RE           +V 
Sbjct: 38  GELIGKGRFGQVYHGRWH--GEV-AIRLIDIERDNEDQLKAF-KREVMAYRQTRHENVVL 93

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSN 118
           + G  +S  +      +      G TL   +R     L+  + R   + ++ G+ YLH+ 
Sbjct: 94  FMGACMSPPH----LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV----NEDDEGKPICGTPICMAPEVA 174
           GI+H D+K +N+           I DFG    + V      +D+ +   G    +APE+ 
Sbjct: 150 GILHKDLKSKNVFYDNGK---VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206

Query: 175 RGEEQGFP---------ADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP 225
           R                +DV+ALG    E+     P+       + + ++G         
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ-PAEAIIWQMGTGMKPNLSQ 265

Query: 226 GYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
             M K+  D L  C      ER + ++L++ 
Sbjct: 266 IGMGKEISDILLFCWAFEQEERPTFTKLMDM 296

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  125 bits (315), Expect = 3e-33
 Identities = 50/223 (22%), Positives = 81/223 (36%), Gaps = 23/223 (10%)

Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAYK 61
              +   RG    V       +  V AVK    +   S   + E   L  +    I+ + 
Sbjct: 27  QLLEVKARGRFGCVWKAQL-LNEYV-AVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFI 84

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN--- 118
           G +    +  +   L   +   G+L+D +++               +  GL YLH +   
Sbjct: 85  GAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHI-AETMARGLAYLHEDIPG 143

Query: 119 -------GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG-KPICGTPICMA 170
                   I H DIK +N+L+  +    A IADFG A +    +         GT   MA
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLKNNLT--ACIADFGLALKFEAGKSAGDTHGQVGTRRYMA 201

Query: 171 PEVARG----EEQGFP-ADVWALGCTVLEMATGRPPWPDVADP 208
           PEV  G    +   F   D++A+G  + E+A+         D 
Sbjct: 202 PEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  125 bits (316), Expect = 4e-33
 Identities = 77/321 (23%), Positives = 126/321 (39%), Gaps = 68/321 (21%)

Query: 1   MD-WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE-----FLQREQRILSALAC 54
           M+ +     +G GS   V    +  +  + A+K    S+ +        RE ++L  L  
Sbjct: 24  MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 83

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQ 113
             +V     ++ ++  +    L  E+    T+ D +      L+   ++ +   ++ G+ 
Sbjct: 84  ENLVNLL--EVCKKKKRW--YLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIG 138

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM---- 169
           + HS+ I+H DIK +NILVS+      K+ DFG AR                P  +    
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFAR------------TLAAPGEVYDDE 184

Query: 170 -------APEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI------ 215
                  APE+  G+ + G   DVWA+GC V EM  G P +P  +D I  L+ I      
Sbjct: 185 VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD-IDQLYHIMMCLGN 243

Query: 216 -------GFSS-------DTPEIPG---------YMSKQAQDFLSKCLIRNPGERWSASE 252
                   F+          PEI            +S+   D   KCL  +P +R   +E
Sbjct: 244 LIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAE 303

Query: 253 LLEHGFVKEQNFKLSTLTEPE 273
           LL H F +   F      E +
Sbjct: 304 LLHHDFFQMDGFAERFSQELQ 324

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  124 bits (314), Expect = 4e-33
 Identities = 59/269 (21%), Positives = 100/269 (37%), Gaps = 27/269 (10%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQIVAYK 61
           G+ +G+G            + EV  +K     +      FL+ E +++  L  P ++ + 
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK-EVKVMRCLEHPNVLKFI 73

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           G    ++      N   EY  GGTL   I+S  +     +  S  + +  G+ YLHS  I
Sbjct: 74  GVLYKDKR----LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCAR-------------RARVNEDDEGKPICGTPI 167
           +H D+   N LV ++      +ADFG AR               +  +  +   + G P 
Sbjct: 130 IHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187

Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDT-PEIPG 226
            MAPE+  G       DV++ G  + E+       PD   P +    +          P 
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY-LPRTMDFGLNVRGFLDRYCPP 246

Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLE 255
                      +C   +P +R S  +L  
Sbjct: 247 NCPPSFFPITVRCCDLDPEKRPSFVKLEH 275

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  124 bits (312), Expect = 6e-33
 Identities = 71/289 (24%), Positives = 106/289 (36%), Gaps = 45/289 (15%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAYKGC 63
            + +G+G    V  G S +   V AVK  S+    S F + E      L    I+ +   
Sbjct: 13  LECVGKGRYGEVWRG-SWQGENV-AVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS------ 117
           D++  +      L   Y   G+L D ++  T      +R    ++  GL +LH       
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR-IVLSIASGLAHLHIEIFGTQ 129

Query: 118 --NGIVHCDIKGQNILVSKDNEQGAKIADFGCARR---ARVNEDDEGKPICGTPICMAPE 172
               I H D+K +NILV K+ +    IAD G A     +    D    P  GT   MAPE
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQ--CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 173 VARGEEQGFP------ADVWALGCTVL-EMATG----------RPPWPDVADPISALHRI 215
           V     Q          D+WA G  VL E+A            +PP+ DV     +   +
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFG-LVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246

Query: 216 ----GFSSDTPEIPGYMSKQA-----QDFLSKCLIRNPGERWSASELLE 255
                     P IP               + +C  +NP  R +A  + +
Sbjct: 247 RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  121 bits (305), Expect = 1e-31
 Identities = 69/302 (22%), Positives = 110/302 (36%), Gaps = 47/302 (15%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAYKGC 63
            + IG+G    V +G   R  +V AVK        S F + E      +    I+ +   
Sbjct: 42  VKQIGKGRYGEVWMGKW-RGEKV-AVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS------ 117
           DI          L  +Y   G+L D ++S T   +  ++    + + GL +LH+      
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLK-LAYSSVSGLCHLHTEIFSTQ 158

Query: 118 --NGIVHCDIKGQNILVSKDNEQGAKIADFGCARR---ARVNEDDEGKPICGTPICMAPE 172
               I H D+K +NILV K+      IAD G A +        D       GT   M PE
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216

Query: 173 VARGEE--QGFP----ADVWALGCTVL-EMATG----------RPPWPDVADPISALHRI 215
           V         F     AD+++ G  +L E+A            + P+ D+     +   +
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGL-ILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275

Query: 216 ----GFSSDTPEIP-GYMSKQAQDFLSK----CLIRNPGERWSASELLEH--GFVKEQNF 264
                     P  P  + S +    + K    C   NP  R +A  + +      + Q+ 
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI 335

Query: 265 KL 266
           KL
Sbjct: 336 KL 337

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  119 bits (300), Expect = 6e-31
 Identities = 69/308 (22%), Positives = 114/308 (37%), Gaps = 58/308 (18%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF------LQREQRILSALACP 55
            + R   +G G+   V   +   ++E  A+K   L + E       + RE  +L  L   
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI-REVSLLKELQHR 93

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+  K   +   N ++  +L  EYA    L   +     +    I+S    ++ G+ + 
Sbjct: 94  NIIELK--SVIHHNHRL--HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFC 148

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGA---KIADFGCARRARVNEDDEGKPI-CGTPICM-- 169
           HS   +H D+K QN+L+S  +       KI DFG AR         G PI   T   +  
Sbjct: 149 HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-------GIPIRQFTHEIITL 201

Query: 170 ---APEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI---------- 215
               PE+  G        D+W++ C   EM    P +P  ++ I  L +I          
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE-IDQLFKIFEVLGLPDDT 260

Query: 216 ---------GFSSDTP---------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHG 257
                     +    P          +   +  +  D L+  L  +P +R SA   LEH 
Sbjct: 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320

Query: 258 FVKEQNFK 265
           +    +F 
Sbjct: 321 YFSHNDFD 328

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  119 bits (300), Expect = 6e-31
 Identities = 70/288 (24%), Positives = 104/288 (36%), Gaps = 43/288 (14%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAYKGC 63
            ++IG+G    V  G   R  EV AVK  S+    S F + E      L    I+ +   
Sbjct: 47  QESIGKGRFGEVWRG-KWRGEEV-AVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN----- 118
           D  +        L  +Y   G+L D +   T   EG I+    +   GL +LH       
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAHLHMEIVGTQ 163

Query: 119 ---GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN---EDDEGKPICGTPICMAPE 172
               I H D+K +NILV K+      IAD G A R        D       GT   MAPE
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221

Query: 173 VARGE--EQGFP----ADVWALGCTVLEMATG----------RPPWPDVADPISALHRI- 215
           V       + F     AD++A+G    E+A            + P+ D+     ++  + 
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281

Query: 216 ---GFSSDTPEIPGYMSKQAQDFLSKCLIR-----NPGERWSASELLE 255
                    P IP          +   ++R     N   R +A  + +
Sbjct: 282 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  115 bits (290), Expect = 2e-29
 Identities = 77/314 (24%), Positives = 115/314 (36%), Gaps = 56/314 (17%)

Query: 1   MD-WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACP 55
           M+ + +   +G G+ ATV  G S  +  + A+K   L + E       RE  +L  L   
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQY 114
            IV     DI      +   L  EY     L   +   G  +    ++     +L GL Y
Sbjct: 61  NIVTLH--DIIHTEKSL--TLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI-CGTPICM---- 169
            H   ++H D+K QN+L+++  E   K+ADFG AR           P        +    
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAK-------SIPTKTYDNEVVTLWY 166

Query: 170 -APEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI------------ 215
             P++  G        D+W +GC   EMATGRP +P        LH I            
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV-EEQLHFIFRILGTPTEETW 225

Query: 216 -GFSS----DTPEIPGY-----------MSKQAQDFLSKCLIRNPGERWSASELLEHGFV 259
            G  S     T   P Y           +     D L+K L      R SA + ++H F 
Sbjct: 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285

Query: 260 KEQNFKLSTLTEPE 273
                ++  L +  
Sbjct: 286 LSLGERIHKLPDTT 299

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  117 bits (294), Expect = 2e-29
 Identities = 76/297 (25%), Positives = 113/297 (38%), Gaps = 56/297 (18%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           + IG GS   V       S E+ A+K   L +  F  RE +I+  L    IV  +    S
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRLRYFFYS 118

Query: 67  --EENGKILYNLFLEYAPGGTLTDAIR----SGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
             E+  ++  NL L+Y P  T+    R    +   L    ++ +   +   L Y+HS GI
Sbjct: 119 SGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 177

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTP----ICM----APE 172
            H DIK QN+L+  D     K+ DFG A++    E          P    IC     APE
Sbjct: 178 CHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGE----------PNVSYICSRYYRAPE 226

Query: 173 VARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI-------------GFS 218
           +  G        DVW+ GC + E+  G+P +P     +  L  I               +
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG-DSGVDQLVEIIKVLGTPTREQIREMN 285

Query: 219 SDT-----PEIPGY---------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
            +      P+I  +            +A    S+ L   P  R +  E   H F  E
Sbjct: 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  114 bits (287), Expect = 3e-29
 Identities = 77/306 (25%), Positives = 109/306 (35%), Gaps = 59/306 (19%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ--------REQRILSALA 53
            +     IG G+  TV       S    A+KS  + N             RE  +L  L 
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69

Query: 54  C---PQIVAYKGCDI-SEENGKILYNLFL--EYAPG--GTLTDAIRSGTCLEEGRIRSHT 105
               P +V     D+ +         + L  E+      T  D       L    I+   
Sbjct: 70  AFEHPNVVRLM--DVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLM 126

Query: 106 RAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT 165
           R  L GL +LH+N IVH D+K +NILV+       K+ADFG AR            +  T
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIY-------SYQMALT 177

Query: 166 PICM-----APEVARGEEQGFPADVWALGCTVLEMATGRP-------------------- 200
           P+ +     APEV        P D+W++GC   EM   +P                    
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237

Query: 201 P----WPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
           P    WP     P  A    G       +P  M +     L + L  NP +R SA   L+
Sbjct: 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVP-EMEESGAQLLLEMLTFNPHKRISAFRALQ 296

Query: 256 HGFVKE 261
           H ++ +
Sbjct: 297 HSYLHK 302

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  113 bits (285), Expect = 4e-29
 Identities = 80/306 (26%), Positives = 122/306 (39%), Gaps = 61/306 (19%)

Query: 1   MD-WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE------FLQREQRILSALA 53
           M+ +   + IG G+   V     N   E FA+K   L   +       + RE  IL  L 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTI-REISILKELK 58

Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPG--GTLTDAIRSGTCLEEGRIRSHTRAVLLG 111
              IV     D+     ++   L  E+       L D    G  LE    +S    +L G
Sbjct: 59  HSNIVKLY--DVIHTKKRL--VLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNG 112

Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI-CGTPICM- 169
           + Y H   ++H D+K QN+L++++ E   KIADFG AR         G P+   T   + 
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAF-------GIPVRKYTHEIVT 163

Query: 170 ----APEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI--------- 215
               AP+V  G ++     D+W++GC   EM  G P +P V++    L RI         
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTPNS 222

Query: 216 ----GFSS------DTPEIPG--------YMSKQAQDFLSKCLIRNPGERWSASELLEHG 257
                 +       +               + +   D LSK L  +P +R +A + LEH 
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282

Query: 258 FVKEQN 263
           + KE N
Sbjct: 283 YFKENN 288

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  113 bits (286), Expect = 5e-29
 Identities = 74/306 (24%), Positives = 114/306 (37%), Gaps = 68/306 (22%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ----REQRILSALACPQI 57
            + + + +G G+ ATV  G++  +    A+K  +L + E       RE  ++  L    I
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI 65

Query: 58  VAYKGCDISEENGKILYNLFLEYAPG--GTLTDAIRSGTC---LEEGRIRSHTRAVLLGL 112
           V     D+     K+   L  E+         D+   G     LE   ++     +L GL
Sbjct: 66  VRLY--DVIHTENKL--TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121

Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI-CGTPICM-- 169
            + H N I+H D+K QN+L++K  +   K+ DFG AR         G P+   +   +  
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRGQ--LKLGDFGLARAF-------GIPVNTFSSEVVTL 172

Query: 170 ---APEVARGEEQ-GFPADVWALGCTVLEMATGRP--------------------P---- 201
              AP+V  G        D+W+ GC + EM TG+P                    P    
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232

Query: 202 WPDVAD-----------PISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSA 250
           WP V             P   L ++            +     DFL   L  NP  R SA
Sbjct: 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKE----PLDGNLMDFLHGLLQLNPDMRLSA 288

Query: 251 SELLEH 256
            + L H
Sbjct: 289 KQALHH 294

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  112 bits (283), Expect = 2e-28
 Identities = 67/311 (21%), Positives = 115/311 (36%), Gaps = 75/311 (24%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ--------REQRILSALA 53
            + +   +G G  ATV       ++++ A+K  +L +    +        RE ++L  L+
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70

Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGL 112
            P I+     D       I  +L  ++     L   I+     L    I+++    L GL
Sbjct: 71  HPNIIGLL--DAFGHKSNI--SLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMTLQGL 125

Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI-CM-- 169
           +YLH + I+H D+K  N+L+ ++     K+ADFG A+              G+P      
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAK------------SFGSPNRAYTH 171

Query: 170 --------APEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI----- 215
                   APE+  G    G   D+WA+GC + E+    P  P  +D +  L RI     
Sbjct: 172 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLG 230

Query: 216 --------GFSSDTPEIPGY-----------------MSKQAQDFLSKCLIRNPGERWSA 250
                      S    +P Y                       D +    + NP  R +A
Sbjct: 231 TPTEEQWPDMCS----LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 286

Query: 251 SELLEHGFVKE 261
           ++ L+  +   
Sbjct: 287 TQALKMKYFSN 297

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  111 bits (280), Expect = 3e-28
 Identities = 70/307 (22%), Positives = 124/307 (40%), Gaps = 69/307 (22%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE------FLQREQRILSALACP 55
            + + + +G G+   V     +    + A+K   L   +       + RE  +L  L  P
Sbjct: 22  KYQKLEKVGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAI-REISLLKELHHP 79

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPG--GTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ 113
            IV+    D+      +   L  E+       + D  ++G  L++ +I+ +   +L G+ 
Sbjct: 80  NIVSLI--DVIHSERCL--TLVFEFMEKDLKKVLDENKTG--LQDSQIKIYLYQLLRGVA 133

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI-CGTPICM--- 169
           + H + I+H D+K QN+L++ D     K+ADFG AR         G P+   T   +   
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARAF-------GIPVRSYTHEVVTLW 184

Query: 170 --APEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI----------- 215
             AP+V  G ++     D+W++GC   EM TG+P +P V D    L +I           
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD-DDQLPKIFSILGTPNPRE 243

Query: 216 --GFSSDTPEIPGY-------------------MSKQAQDFLSKCLIRNPGERWSASELL 254
                     +P +                     ++  D LS  L  +P +R SA + +
Sbjct: 244 WPQVQE----LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM 299

Query: 255 EHGFVKE 261
            H + K+
Sbjct: 300 NHPYFKD 306

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  109 bits (276), Expect = 9e-28
 Identities = 72/299 (24%), Positives = 117/299 (39%), Gaps = 59/299 (19%)

Query: 1   MD-WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE------FLQREQRILSALA 53
           M  + + + IG G+  TV    +  + E+ A+K   L + +       L RE  +L  L 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-REICLLKELK 59

Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPG--GTLTDAIRSGTCLEEGRIRSHTRAVLLG 111
              IV     D+   + K+   L  E+         D+      L+   ++S    +L G
Sbjct: 60  HKNIVRLH--DVLHSDKKL--TLVFEFCDQDLKKYFDSCNGD--LDPEIVKSFLFQLLKG 113

Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI-CGTPICM- 169
           L + HS  ++H D+K QN+L++++ E   K+A+FG AR         G P+ C +   + 
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAF-------GIPVRCYSAEVVT 164

Query: 170 ----APEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI--------- 215
                P+V  G +      D+W+ GC   E+A    P     D    L RI         
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224

Query: 216 ----GFSS-----DTPEIPGY---------MSKQAQDFLSKCLIRNPGERWSASELLEH 256
                 +        P  P           ++   +D L   L  NP +R SA E L+H
Sbjct: 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  109 bits (276), Expect = 1e-27
 Identities = 54/196 (27%), Positives = 79/196 (40%), Gaps = 40/196 (20%)

Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           +    I+     +L GL +LHS+ +VH D+K QNILV+   +   K+ADFG AR      
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIY---- 170

Query: 156 DDEGKPICGTPICM-----APEVARGEEQGFPADVWALGCTVLEMATGRP---------- 200
                 +  T + +     APEV        P D+W++GC   EM   +P          
Sbjct: 171 ---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 227

Query: 201 ----------P----WPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPG 245
                     P    WP     P  A H          +   + +  +D L KCL  NP 
Sbjct: 228 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVT-DIDELGKDLLLKCLTFNPA 286

Query: 246 ERWSASELLEHGFVKE 261
           +R SA   L H + ++
Sbjct: 287 KRISAYSALSHPYFQD 302

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  110 bits (278), Expect = 2e-27
 Identities = 82/299 (27%), Positives = 115/299 (38%), Gaps = 61/299 (20%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           + IG GS   V       S EV A+K   L +  F  RE +I+  +  P +V  K    S
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEV-AIKKV-LQDKRFKNRELQIMRIVKHPNVVDLKAFFYS 103

Query: 67  --EENGKILYNLFLEYAPGGTLTDAIRS----GTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
             ++  ++  NL LEY P  T+  A R        +    I+ +   +L  L Y+HS GI
Sbjct: 104 NGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGI 162

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED--DEGKPICGTPICM----APEVA 174
            H DIK QN+L+   +    K+ DFG A+     E             IC     APE+ 
Sbjct: 163 CHRDIKPQNLLLDPPSGV-LKLIDFGSAKILIAGEPNVSY--------ICSRYYRAPELI 213

Query: 175 RGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI----GFSSDTP---EIPG 226
            G        D+W+ GC + E+  G+P +P     I  L  I    G    TP   +I  
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQPLFPG-ESGIDQLVEIIKVLG----TPSREQIKT 268

Query: 227 ------------------------YMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                                        A D +S+ L   P  R +A E L H F  E
Sbjct: 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  110 bits (276), Expect = 4e-27
 Identities = 69/320 (21%), Positives = 117/320 (36%), Gaps = 70/320 (21%)

Query: 6   GQTIGRGSTATV--SIGMSNRSSEVFAVKSAELSN-SEFLQREQRILSALACPQIVAYKG 62
           G  +GRG+   V  +     +  + +A+K  E +  S    RE  +L  L  P +++ + 
Sbjct: 26  GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQK 85

Query: 63  CDISEENGKILYNLFLEYAP--------GGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
             +S  + K+   L  +YA             + A +    L  G ++S    +L G+ Y
Sbjct: 86  VFLSHADRKV--WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143

Query: 115 LHSNGIVHCDIKGQNILVSKD-NEQGA-KIADFGCARRARVNEDDEGKPICGTPICM--- 169
           LH+N ++H D+K  NILV  +  E+G  KIAD G AR      +   KP+      +   
Sbjct: 144 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF----NSPLKPLADLDPVVVTF 199

Query: 170 ---APEVARGEEQ-GFPADVWALGCTVLEMATGRP------------------------- 200
              APE+  G        D+WA+GC   E+ T  P                         
Sbjct: 200 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259

Query: 201 ----P----WPDVAD-----------PISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLI 241
               P    W D+               +            +       +A   L K L 
Sbjct: 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLT 319

Query: 242 RNPGERWSASELLEHGFVKE 261
            +P +R ++ + ++  +  E
Sbjct: 320 MDPIKRITSEQAMQDPYFLE 339

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  107 bits (270), Expect = 1e-26
 Identities = 74/305 (24%), Positives = 116/305 (38%), Gaps = 63/305 (20%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALAC---PQIVAYKGC 63
           +  G+G+  TV +G    +    A+K   + +  F  RE +I+  LA    P IV  +  
Sbjct: 29  RMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLAVLHHPNIVQLQ-- 85

Query: 64  DI----SEENGKILY-NLFLEYAPGGTLTDAIRS----GTCLEEGRIRSHTRAVLLGLQY 114
                  E + + +Y N+ +EY P  TL    R+            I+     ++  +  
Sbjct: 86  SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGC 144

Query: 115 LH--SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED--DEGKPICGTPICM- 169
           LH  S  + H DIK  N+LV++ +    K+ DFG A++   +E             IC  
Sbjct: 145 LHLPSVNVCHRDIKPHNVLVNEADGT-LKLCDFGSAKKLSPSEPNVAY--------ICSR 195

Query: 170 ---APEVARGEEQ-GFPADVWALGCTVLEMATGRP--------------------P---- 201
              APE+  G +      D+W++GC   EM  G P                    P    
Sbjct: 196 YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255

Query: 202 ----WPDVAD-PISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
                P   D  +     I +S+   +     +K+A D LS  L   P ER    E L H
Sbjct: 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315

Query: 257 GFVKE 261
            +  E
Sbjct: 316 PYFDE 320

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  106 bits (268), Expect = 3e-26
 Identities = 69/302 (22%), Positives = 116/302 (38%), Gaps = 58/302 (19%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELSNSE--F---LQREQRILSALACPQIVAYKGC 63
           IG+G+   V      ++ +  A+K   + N +  F     RE +IL  L    +V     
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84

Query: 64  DISE--ENGKILYNLFL--EYAP---GGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
             ++     +   +++L  ++      G L++            I+   + +L GL Y+H
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIH 141

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM-----AP 171
            N I+H D+K  N+L+++D     K+ADFG AR   + ++ +      T   +      P
Sbjct: 142 RNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRY--TNRVVTLWYRPP 197

Query: 172 EVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS---SDTPEI-PG 226
           E+  GE   G P D+W  GC + EM T  P      +    L  I      S TPE+ P 
Sbjct: 198 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-QHQLALI-SQLCGSITPEVWPN 255

Query: 227 Y---------------------------MSKQAQDFLSKCLIRNPGERWSASELLEHGFV 259
                                           A D + K L+ +P +R  + + L H F 
Sbjct: 256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315

Query: 260 KE 261
             
Sbjct: 316 WS 317

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  105 bits (264), Expect = 7e-26
 Identities = 59/219 (26%), Positives = 83/219 (37%), Gaps = 31/219 (14%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRI--LSALACPQIVAYKGC 63
            + IGRG    V  G       V AVK    +N +    E+ I  +  +    I  +   
Sbjct: 18  LELIGRGRYGAVYKGSL-DERPV-AVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75

Query: 64  DI-SEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS----- 117
           D     +G++ Y L +EY P G+L   +   T       R    +V  GL YLH+     
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCR-LAHSVTRGLAYLHTELPRG 134

Query: 118 ----NGIVHCDIKGQNILVSKDNEQGAKIADFGCARR-------ARVNEDDEGKPICGTP 166
                 I H D+  +N+LV  D      I+DFG + R           ED+      GT 
Sbjct: 135 DHYKPAISHRDLNSRNVLVKNDGT--CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTI 192

Query: 167 ICMAPEVARG-------EEQGFPADVWALGCTVLEMATG 198
             MAPEV  G       E      D++ALG    E+   
Sbjct: 193 RYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  105 bits (265), Expect = 8e-26
 Identities = 72/304 (23%), Positives = 109/304 (35%), Gaps = 59/304 (19%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQ---REQRILSALACPQIVAYK 61
           + IG G+   V            A+K  S    N    +   RE  ++  +    I+   
Sbjct: 31  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90

Query: 62  GCDI-----SEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
             ++     S E  + +Y + +E      L   I+    L+  R+      +L G+++LH
Sbjct: 91  --NVFTPQKSLEEFQDVY-IVMELM-DANLCQVIQME--LDHERMSYLLYQMLCGIKHLH 144

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
           S GI+H D+K  NI+V  D     KI DFG AR A         P   T    APEV  G
Sbjct: 145 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILG 200

Query: 177 EEQGFPADVWALGCTVLEMATGRPPWP--DVAD--------------------------- 207
                  D+W++GC + EM  G   +P  D  D                           
Sbjct: 201 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 260

Query: 208 ----------PISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHG 257
                         L          E     + QA+D LSK L+ +  +R S  E L+H 
Sbjct: 261 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320

Query: 258 FVKE 261
           ++  
Sbjct: 321 YINV 324

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  105 bits (263), Expect = 1e-25
 Identities = 68/306 (22%), Positives = 113/306 (36%), Gaps = 62/306 (20%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQ---REQRILSALACPQIVAYK 61
             +G G+   V       + E+ A+K          F     RE +IL       I+   
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEP-FDKPLFALRTLREIKILKHFKHENIITIF 75

Query: 62  GCDI----SEENGKILYNLFLEYAPGGTLTD--AIRSGTCLEEGRIRSHTRAVLLGLQYL 115
             +I    S EN   +Y +  E       TD   + S   L +  I+      L  ++ L
Sbjct: 76  --NIQRPDSFENFNEVY-IIQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAVKVL 128

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM------ 169
           H + ++H D+K  N+L++ + +   K+ DFG AR    +  D  +P       M      
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSG-MVEFVAT 185

Query: 170 ----APEVARGEEQ-GFPADVWALGCTVLEMATGRPPWP--DVAD-------------PI 209
               APEV     +     DVW+ GC + E+   RP +P  D                  
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245

Query: 210 SALHRIG------FSSDTPEIPG--------YMSKQAQDFLSKCLIRNPGERWSASELLE 255
           + L  I       +    P  P          ++ +  D L + L+ +P +R +A E LE
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305

Query: 256 HGFVKE 261
           H +++ 
Sbjct: 306 HPYLQT 311

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  104 bits (261), Expect = 2e-25
 Identities = 65/311 (20%), Positives = 112/311 (36%), Gaps = 72/311 (23%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ---REQRILSAL----------- 52
           + +G G    V   + N   +  A+K   L++ + ++   RE +I+  L           
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76

Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTD---AIRSGTCLEEGRIRSHTRAVL 109
             P          S      +Y +  EY      TD    +  G  L E   R     +L
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVY-IVQEYME----TDLANVLEQGP-LLEEHARLFMYQLL 130

Query: 110 LGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM 169
            GL+Y+HS  ++H D+K  N+ ++ ++    KI DFG AR    +   +G         +
Sbjct: 131 RGLKYIHSANVLHRDLKPANLFINTEDLV-LKIGDFGLARIMDPHYSHKGH--------L 181

Query: 170 ----------APEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI--- 215
                     +P +           D+WA GC   EM TG+  +   A  +  +  I   
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAG-AHELEQMQLILES 240

Query: 216 -----------------GFSSDTPEIPGY--------MSKQAQDFLSKCLIRNPGERWSA 250
                             +  +    P          +S++A DFL + L  +P +R +A
Sbjct: 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300

Query: 251 SELLEHGFVKE 261
            E L H ++  
Sbjct: 301 EEALSHPYMSI 311

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  103 bits (258), Expect = 7e-25
 Identities = 74/294 (25%), Positives = 122/294 (41%), Gaps = 50/294 (17%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQ---REQRILSALACPQIVAYK 61
           Q +G G+   V   +  R+    A+K       +  F +   RE R+L  +    ++   
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90

Query: 62  GCDI-----SEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
             D+     + ++    Y L + +  G  L   ++    L E RI+     +L GL+Y+H
Sbjct: 91  --DVFTPDETLDDFTDFY-LVMPFM-GTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRYIH 145

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
           + GI+H D+K  N+ V++D E   KI DFG AR+A    D E      T    APEV   
Sbjct: 146 AAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQA----DSEMTGYVVTRWYRAPEVILN 199

Query: 177 EEQ-GFPADVWALGCTVLEMATGRPPWP--DVAD------------PISALHRIG----- 216
             +     D+W++GC + EM TG+  +   D  D            P   + R+      
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259

Query: 217 -FSSDTPEIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
            +    PE+            S  A + L K L+ +  +R +A E L H + + 
Sbjct: 260 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  101 bits (255), Expect = 1e-24
 Identities = 76/295 (25%), Positives = 117/295 (39%), Gaps = 53/295 (17%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQ---REQRILSALACPQIVAYK 61
             +G G+  +V   +  RS E  A+K  S    +  F +   RE  +L  +    ++   
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89

Query: 62  GCDI-----SEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
             D+     S  N    Y L + +     L   +       E +I+     +L GL+Y+H
Sbjct: 90  --DVFTPASSLRNFYDFY-LVMPFM-QTDLQKIMGLK--FSEEKIQYLVYQMLKGLKYIH 143

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
           S G+VH D+K  N+ V++D E   KI DFG AR A    D E      T    APEV   
Sbjct: 144 SAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHA----DAEMTGYVVTRWYRAPEVILS 197

Query: 177 EEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI-------------GFSSDT- 221
                   D+W++GC + EM TG+  +    D +  L +I               +    
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGKTLFKG-KDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256

Query: 222 -------PEIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                  P+ P           S QA D L K L  +  +R +A++ L H F + 
Sbjct: 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  102 bits (256), Expect = 2e-24
 Identities = 70/306 (22%), Positives = 114/306 (37%), Gaps = 70/306 (22%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQ---REQRILSALACPQIVAYK 61
             IG G+   V     N +    A+K  S    +  + Q   RE +IL       I+   
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISP-FEHQTYCQRTLREIKILLRFRHENIIGIN 91

Query: 62  GCDI----SEENGKILYNLFLEYAPGGTLTD---AIRSGTCLEEGRIRSHTRAVLLGLQY 114
             DI    + E  K +Y +  +       TD    +++   L    I      +L GL+Y
Sbjct: 92  --DIIRAPTIEQMKDVY-IVQDLME----TDLYKLLKTQH-LSNDHICYFLYQILRGLKY 143

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM----- 169
           +HS  ++H D+K  N+L++   +   KI DFG AR A  + D  G         +     
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTG--------FLTEYVA 193

Query: 170 -----APEVARGEEQGFPA-DVWALGCTVLEMATGRPPWP--DVAD------------PI 209
                APE+    +    + D+W++GC + EM + RP +P     D              
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253

Query: 210 SALHRIG------FSSDTPEIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLE 255
             L+ I       +    P                +A D L K L  NP +R    + L 
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313

Query: 256 HGFVKE 261
           H ++++
Sbjct: 314 HPYLEQ 319

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  102 bits (255), Expect = 2e-24
 Identities = 71/295 (24%), Positives = 118/295 (40%), Gaps = 52/295 (17%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQ---REQRILSALACPQIVAYK 61
             +G G+  +V      ++    AVK  S    +    +   RE R+L  +    ++   
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94

Query: 62  GCDI-----SEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
             D+     S E    +Y L      G  L + ++    L +  ++     +L GL+Y+H
Sbjct: 95  --DVFTPARSLEEFNDVY-LVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIH 149

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
           S  I+H D+K  N+ V++D E   KI DFG AR       DE      T    APE+   
Sbjct: 150 SADIIHRDLKPSNLAVNEDCE--LKILDFGLARHT----ADEMTGYVATRWYRAPEIMLN 203

Query: 177 EEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI-------------GFSSDT- 221
                   D+W++GC + E+ TGR  +P   D I  L  I               SS++ 
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPG-TDHIDQLKLILRLVGTPGAELLKKISSESA 262

Query: 222 -------PEIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                   ++P           +  A D L K L+ +  +R +A++ L H +  +
Sbjct: 263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  101 bits (254), Expect = 2e-24
 Identities = 71/308 (23%), Positives = 107/308 (34%), Gaps = 66/308 (21%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK-----------SAELSNSEFLQ---REQRILSAL 52
           + I  GS   V     +      A+K              LS+S   +   RE R+L+  
Sbjct: 28  RFISSGSYGAV-CAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86

Query: 53  ACPQIVAYKGCDI----SEENGKILYNLFLEYAPGGTLTD---AIRSG-TCLEEGRIRSH 104
             P I+  +  DI     E     LY L  E       TD    I      +    I+  
Sbjct: 87  HHPNILGLR--DIFVHFEEPAMHKLY-LVTELMR----TDLAQVIHDQRIVISPQHIQYF 139

Query: 105 TRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG 164
              +LLGL  LH  G+VH D+   NIL++ +N+    I DF  AR      D        
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITICDFNLARED--TADANKTHYVT 195

Query: 165 TPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI-------- 215
                APE+    +      D+W+ GC + EM   +  +   +   + L++I        
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG-STFYNQLNKIVEVVGTPK 254

Query: 216 -----GFSSDT---------PEIPGY--------MSKQAQDFLSKCLIRNPGERWSASEL 253
                 FSS +           +P              A D ++K L  NP  R S  + 
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA 314

Query: 254 LEHGFVKE 261
           L H + + 
Sbjct: 315 LRHPYFES 322

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  100 bits (252), Expect = 5e-24
 Identities = 51/216 (23%), Positives = 78/216 (36%), Gaps = 54/216 (25%)

Query: 100 RIRSHTRAVLLGLQYLHSN-GIVHCDIKGQNILVSKDNEQGA----KIADFGCARRARVN 154
            ++  ++ +LLGL Y+H   GI+H DIK +N+L+   +        KIAD G A      
Sbjct: 132 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---- 187

Query: 155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRP-------------- 200
            D+       T    +PEV  G   G  AD+W+  C + E+ TG                
Sbjct: 188 YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247

Query: 201 -----------PWPD-----------------VADPISALHRIGFSSDTPEIPGYMSKQA 232
                        P                  +   IS L          E   +   +A
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 307

Query: 233 Q---DFLSKCLIRNPGERWSASELLEHGFVKEQNFK 265
           +   DFLS  L  +P +R  A  L+ H ++K+    
Sbjct: 308 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGM 343

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 98.3 bits (245), Expect = 1e-23
 Identities = 36/262 (13%), Positives = 70/262 (26%), Gaps = 57/262 (21%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEFLQR---EQRILSALACPQIVA-YK 61
            G          +        A+       +   + LQ        LS +  P +     
Sbjct: 39  HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL- 97

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
             D+          +  E+  GG+L +   +             +++       H  G+ 
Sbjct: 98  --DVVHTRA-GGL-VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVA 151

Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF 181
                   + VS D +    +A                         M     +      
Sbjct: 152 LSIDHPSRVRVSIDGD--VVLAYPA---------------------TMPDANPQ------ 182

Query: 182 PADVWALGCTVLEMATGRPPWP--DVADPISALHRIGF------SSDTPEIPGYMSKQAQ 233
             D+  +G ++  +   R P P   V   ++   R         +    +IP  +S    
Sbjct: 183 -DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS---- 237

Query: 234 DFLSKCLIRNPGERWSASELLE 255
              ++ +  + G R SAS LL 
Sbjct: 238 AVAARSVQGDGGIR-SASTLLN 258

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 70/327 (21%), Positives = 112/327 (34%), Gaps = 84/327 (25%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +T+G GS   V       S + FA+K   L +  +  RE  I+  L    I+       +
Sbjct: 13  KTLGTGSFGIVCEVFDIESGKRFALKKV-LQDPRYKNRELDIMKVLDHVNIIKLVDYFYT 71

Query: 67  EENGKILY----------------------------------NLFLEYAPGGTLTDAIR- 91
             + +                                     N+ +EY P  TL   ++ 
Sbjct: 72  TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKS 130

Query: 92  ---SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGA-KIADFGC 147
              SG  +    I  +   +   + ++HS GI H DIK QN+LV  +++    K+ DFG 
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV--NSKDNTLKLCDFGS 188

Query: 148 ARRARVNEDDEGKPICGTP-ICM----APEVARGEEQ-GFPADVWALGCTVLEMATGRPP 201
           A++   +E            IC     APE+  G  +     D+W++GC   E+  G+P 
Sbjct: 189 AKKLIPSEP-------SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPL 241

Query: 202 WPDVADPISALHRI-------------GFSSDTPE--------------IPGYMSKQAQD 234
           +      I  L RI               +    E              +P      A D
Sbjct: 242 FSG-ETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID 300

Query: 235 FLSKCLIRNPGERWSASELLEHGFVKE 261
            L + L   P  R +  E + H F   
Sbjct: 301 LLEQILRYEPDLRINPYEAMAHPFFDH 327

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  100 bits (251), Expect = 2e-23
 Identities = 71/304 (23%), Positives = 111/304 (36%), Gaps = 59/304 (19%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQ---REQRILSALACPQIVAYK 61
           + IG G+   V            A+K  S    N    +   RE  ++  +    I++  
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127

Query: 62  GCDI-----SEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
             ++     + E  + +Y L +E      L   I+    L+  R+      +L G+++LH
Sbjct: 128 --NVFTPQKTLEEFQDVY-LVMELM-DANLCQVIQME--LDHERMSYLLYQMLCGIKHLH 181

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
           S GI+H D+K  NI+V  D     KI DFG AR A         P   T    APEV  G
Sbjct: 182 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILG 237

Query: 177 EEQGFPADVWALGCTVLEMATGRPPWP--DVAD--------------------------- 207
                  D+W++GC + EM   +  +P  D  D                           
Sbjct: 238 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297

Query: 208 ----------PISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHG 257
                         L          E     + QA+D LSK L+ +P +R S  + L+H 
Sbjct: 298 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357

Query: 258 FVKE 261
           ++  
Sbjct: 358 YINV 361

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 96.6 bits (241), Expect = 9e-23
 Identities = 63/303 (20%), Positives = 110/303 (36%), Gaps = 67/303 (22%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALAC-PQIVAY 60
           D+   + +GRG  + V   ++  ++E   VK  +    + ++RE +IL  L   P I+  
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 96

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
              DI ++       L  E+          ++   L +  IR +   +L  L Y HS GI
Sbjct: 97  A--DIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGI 151

Query: 121 VHCDIKGQNILVSKDNEQGA-KIADFGCARRARVNEDDEGKPICGTPICM---------- 169
           +H D+K  N+++  D+E    ++ D+G A      ++                       
Sbjct: 152 MHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQE------------YNVRVASRYFK 197

Query: 170 APEVARGEEQ-GFPADVWALGCTVLEMATGRPP--------------------------- 201
            PE+    +   +  D+W+LGC +  M   + P                           
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 257

Query: 202 -------WPDVADPISALHRIGFSSDTP-EIPGYMSKQAQDFLSKCLIRNPGERWSASEL 253
                   P   D +    R  +      E    +S +A DFL K L  +   R +A E 
Sbjct: 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 317

Query: 254 LEH 256
           +EH
Sbjct: 318 MEH 320

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 94.9 bits (236), Expect = 1e-21
 Identities = 77/353 (21%), Positives = 112/353 (31%), Gaps = 107/353 (30%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQ---REQRILSALACPQIVAYK 61
             IG GS   V          V A+K       +    +   RE  IL+ L    +V   
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118

Query: 62  GCDI----SEENGKILYNLFLEYAPGGTLTD---AIRSGTCLEEGRIRSHTRAVLLGLQY 114
             DI      E    LY + LE A     +D     R+   L E  I++    +L+G++Y
Sbjct: 119 --DIVIPKDVEKFDELY-VVLEIAD----SDFKKLFRTPVYLTELHIKTLLYNLLVGVKY 171

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM----- 169
           +HS GI+H D+K  N LV++D     K+ DFG AR     E+   +              
Sbjct: 172 VHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229

Query: 170 ---------------------APEVARGEEQ-GFPADVWALGCTVLEM-----------A 196
                                APE+   +E      DVW++GC   E+           A
Sbjct: 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289

Query: 197 TGRP-------------------PWPDVADPISALHRI-------------GFSSDT--- 221
              P                              L+ I                 +    
Sbjct: 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKR 349

Query: 222 -----PEIPG--------YMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                P+  G          S  A   L + L+ NP +R + +E L H F KE
Sbjct: 350 YIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 64/345 (18%), Positives = 108/345 (31%), Gaps = 99/345 (28%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQ---REQRILSALACPQIVAYK 61
             IGRGS   V +     + +  A+K  +    +    +   RE  IL+ L    I+   
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91

Query: 62  GCDI----SEENGKILYNLFLEYAPGGTLTD---AIRSGTCLEEGRIRSHTRAVLLGLQY 114
             D+           LY + LE A     +D     ++   L E  I++    +LLG  +
Sbjct: 92  --DLIIPDDLLKFDELY-IVLEIAD----SDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM----- 169
           +H +GI+H D+K  N L+++D     K+ DFG AR     +D                  
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCS--VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202

Query: 170 ----------------APEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVA------ 206
                           APE+   +E      D+W+ GC   E+        +        
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262

Query: 207 ---------------------DPISALHRI-------------GFSSDT--------PEI 224
                                     L+ I               +           P  
Sbjct: 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHR 322

Query: 225 PG--------YMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                      +S    + L   L  NP +R +  + L+H ++K+
Sbjct: 323 KPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 93.2 bits (232), Expect = 3e-21
 Identities = 75/330 (22%), Positives = 120/330 (36%), Gaps = 85/330 (25%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQ---REQRILSALAC-PQIVAY 60
           + +G+G+   V   +  R+ EV AVK       NS   Q   RE  IL+ L+    IV  
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74

Query: 61  KGCDI-SEENGKILYNLFLEYAPGGTLTD---AIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
              ++   +N + +Y L  +Y      TD    IR+   LE    +     ++  ++YLH
Sbjct: 75  L--NVLRADNDRDVY-LVFDYME----TDLHAVIRANI-LEPVHKQYVVYQLIKVIKYLH 126

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICM------- 169
           S G++H D+K  NIL++ +     K+ADFG +R                           
Sbjct: 127 SGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184

Query: 170 -------------APEVARGEEQ-GFPADVWALGCTVLEMATGRPPWP--DVAD------ 207
                        APE+  G  +     D+W+LGC + E+  G+P +P     +      
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244

Query: 208 ------PISALHRIG------FSSDTPEIPGY------------------------MSKQ 231
                     +  I             E                             +++
Sbjct: 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEE 304

Query: 232 AQDFLSKCLIRNPGERWSASELLEHGFVKE 261
           A D L K L  NP +R SA++ L+H FV  
Sbjct: 305 ALDLLDKLLQFNPNKRISANDALKHPFVSI 334

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 92.4 bits (230), Expect = 3e-21
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 43/232 (18%)

Query: 4   TRGQTIGRGSTATVSIG----MSNRSSEVFAVK----SAELSNSEFLQREQRILSALACP 55
                +G+G+  +V +     + + +  + AVK    S      +F  RE +IL AL   
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ-REIQILKALHSD 84

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL----- 110
            IV Y+G        + L  L +EY P G L D ++        R+ +     LL     
Sbjct: 85  FIVKYRGV-SYGPGRQSLR-LVMEYLPSGCLRDFLQR----HRARLDASR---LLLYSSQ 135

Query: 111 ---GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED-----DEGKPI 162
              G++YL S   VH D+  +NILV  +     KIADFG A+   +++D     + G+  
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAH--VKIADFGLAKLLPLDKDYYVVREPGQ-- 191

Query: 163 CGTPIC-MAPEVARGEEQGFPA--DVWALGCTVLEMAT-GRPPWPDVADPIS 210
             +PI   APE     +  F    DVW+ G  + E+ T         A+ + 
Sbjct: 192 --SPIFWYAPESLS--DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR 239

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 93.3 bits (232), Expect = 5e-21
 Identities = 70/272 (25%), Positives = 113/272 (41%), Gaps = 45/272 (16%)

Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEFLQREQRILSALACPQIVAY 60
                +G+G    V +G  N ++ V A+K      +S   FLQ E +++  L   ++V  
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQL 244

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL--------GL 112
               +SEE   I+     EY   G+L D ++          +      L+        G+
Sbjct: 245 YAV-VSEEPIYIV----TEYMSKGSLLDFLKGE------TGKYLRLPQLVDMAAQIASGM 293

Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE--GKPICGTPI-CM 169
            Y+     VH D++  NILV ++     K+ADFG    AR+ ED+E   +     PI   
Sbjct: 294 AYVERMNYVHRDLRAANILVGENLV--CKVADFG---LARLIEDNEYTARQGAKFPIKWT 348

Query: 170 APEVARGEEQGFPADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPE 223
           APE A        +DVW+ G  + E+ T GR P+P     +V D +   +R+        
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------P 401

Query: 224 IPGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
            P    +   D + +C  + P ER +   L  
Sbjct: 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 56/235 (23%), Positives = 95/235 (40%), Gaps = 44/235 (18%)

Query: 4   TRGQTIGRGSTATVSIGM----SNRSSEVFAVK-----SAELSNSEFLQREQRILSALAC 54
            R + +G G    V +       + + E  AVK     S     ++   +E  IL  L  
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-KEIEILRNLYH 82

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL---- 110
             IV YKG   +E+ G  +  L +E+ P G+L + +       + +I        L    
Sbjct: 83  ENIVKYKGI-CTEDGGNGIK-LIMEFLPSGSLKEYLPK----NKNKINLKQ---QLKYAV 133

Query: 111 ----GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED-----DEGKP 161
               G+ YL S   VH D+  +N+LV  +++   KI DFG  +    +++     D+   
Sbjct: 134 QICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKEYYTVKDDRD- 190

Query: 162 ICGTPIC-MAPEVARGEEQGFPA--DVWALGCTVLEMAT-GRPPWPDVADPISAL 212
              +P+   APE     +  F    DVW+ G T+ E+ T        +A  +  +
Sbjct: 191 ---SPVFWYAPECLM--QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI 240

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 89.7 bits (223), Expect = 2e-20
 Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 44/235 (18%)

Query: 4   TRGQTIGRGSTATVSIG----MSNRSSEVFAVK----SAELSNSEFLQREQRILSALACP 55
              Q +G+G+  +V +     + + + EV AVK    S E    +F  RE  IL +L   
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE-REIEILKSLQHD 71

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQY 114
            IV YKG        + L  L +EY P G+L D ++     ++  ++  +T  +  G++Y
Sbjct: 72  NIVKYKGV-CYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 129

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED-----DEGKPICGTPIC- 168
           L +   +H D+  +NILV  +N    KI DFG  +    +++     + G+    +PI  
Sbjct: 130 LGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQDKEFFKVKEPGE----SPIFW 183

Query: 169 MAPEVARGEEQGFPA--DVWALGCTVLEMAT----------------GRPPWPDV 205
            APE     E  F    DVW+ G  + E+ T                G      +
Sbjct: 184 YAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 90.1 bits (224), Expect = 3e-20
 Identities = 45/239 (18%), Positives = 71/239 (29%), Gaps = 67/239 (28%)

Query: 101 IRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGA-----------------KIA 143
           +R     +   L++LH N + H D+K +NIL      +                   ++A
Sbjct: 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184

Query: 144 DFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRP--- 200
           DFG A      + +    I  T     PEV        P DVW++GC + E   G     
Sbjct: 185 DFGSA----TFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240

Query: 201 -------------------------------------PWPDVA-DPISALHRIGFSSDTP 222
                                                 W + + D               
Sbjct: 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYM 300

Query: 223 EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPT 281
                   Q  D + + L  +P +R + +E L H F     F   T  E   + S +P+
Sbjct: 301 LQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPF-----FAGLTPEERSFHTSRNPS 354

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 89.4 bits (222), Expect = 4e-20
 Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 44/235 (18%)

Query: 4   TRGQTIGRGSTATVSIG----MSNRSSEVFAVK----SAELSNSEFLQREQRILSALACP 55
              Q +G+G+  +V +     + + + EV AVK    S E    +F  RE  IL +L   
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE-REIEILKSLQHD 102

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQY 114
            IV YKG        + L  L +EY P G+L D ++     ++  ++  +T  +  G++Y
Sbjct: 103 NIVKYKGV-CYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 160

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED-----DEGKPICGTPIC- 168
           L +   +H D+  +NILV  +N    KI DFG  +    +++     + G+    +PI  
Sbjct: 161 LGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQDKEYYKVKEPGE----SPIFW 214

Query: 169 MAPEVARGEEQGFPA--DVWALGCTVLEMAT----------------GRPPWPDV 205
            APE     E  F    DVW+ G  + E+ T                G      +
Sbjct: 215 YAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 267

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 91.1 bits (226), Expect = 4e-20
 Identities = 70/272 (25%), Positives = 113/272 (41%), Gaps = 45/272 (16%)

Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEFLQREQRILSALACPQIVAY 60
                +G+G    V +G  N ++ V A+K      +S   FLQ E +++  L   ++V  
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQL 327

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL--------GL 112
               +SEE   I+     EY   G+L D ++          +      L+        G+
Sbjct: 328 YAV-VSEEPIYIV----TEYMSKGSLLDFLKGE------TGKYLRLPQLVDMAAQIASGM 376

Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE--GKPICGTPI-CM 169
            Y+     VH D++  NILV ++     K+ADFG    AR+ ED+E   +     PI   
Sbjct: 377 AYVERMNYVHRDLRAANILVGENLV--CKVADFG---LARLIEDNEYTARQGAKFPIKWT 431

Query: 170 APEVARGEEQGFPADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPE 223
           APE A        +DVW+ G  + E+ T GR P+P     +V D +   +R+        
Sbjct: 432 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------P 484

Query: 224 IPGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
            P    +   D + +C  + P ER +   L  
Sbjct: 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 89.6 bits (223), Expect = 4e-20
 Identities = 67/267 (25%), Positives = 105/267 (39%), Gaps = 35/267 (13%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----EFLQREQRILSALACPQIVAY 60
           G+ IGRG+   V  G     + + AVKS   +       +FL +E RIL   + P IV  
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL-QEARILKQYSHPNIVRL 177

Query: 61  KG-CDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSN 118
            G C   +     +Y + +E   GG     +R+ G  L    +         G++YL S 
Sbjct: 178 IGVCTQKQP----IY-IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT---PIC-MAPEVA 174
             +H D+  +N LV++ N    KI+DFG    +R   D       G    P+   APE  
Sbjct: 233 CCIHRDLAARNCLVTEKNV--LKISDFG---MSREEADGVYAASGGLRQVPVKWTAPEAL 287

Query: 175 RGEEQGFPADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYM 228
                   +DVW+ G  + E  + G  P+P        + +    R+         P   
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL-------PCPELC 340

Query: 229 SKQAQDFLSKCLIRNPGERWSASELLE 255
                  + +C    PG+R S S + +
Sbjct: 341 PDAVFRLMEQCWAYEPGQRPSFSTIYQ 367

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 88.2 bits (219), Expect = 9e-20
 Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 30/225 (13%)

Query: 4   TRGQTIGRGSTATVSIGM----SNRSSEVFAVK-----SAELSNSEFLQREQRILSALAC 54
            + + +G G    VS+      ++ + E+ AVK     +     S +  +E  IL  L  
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK-QEIDILRTLYH 92

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
             I+ YKGC   +     L  L +EY P G+L D +   + +   ++    + +  G+ Y
Sbjct: 93  EHIIKYKGC-CEDAGAASLQ-LVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAY 149

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED-----DEGKPICGTPIC- 168
           LH+   +H D+  +N+L+  D     KI DFG A+      +     ++G     +P+  
Sbjct: 150 LHAQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGD----SPVFW 203

Query: 169 MAPEVARGEEQGFPA--DVWALGCTVLEMAT-GRPPWPDVADPIS 210
            APE  +  E  F    DVW+ G T+ E+ T            + 
Sbjct: 204 YAPECLK--EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE 246

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 48/228 (21%), Positives = 76/228 (33%), Gaps = 74/228 (32%)

Query: 101 IRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGA-------------------- 140
           I+ +   +L  L YL    + H D+K +NIL+     + +                    
Sbjct: 139 IKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198

Query: 141 ---KIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT 197
              K+ DFGCA      + D    I  T    APEV         +D+W+ GC + E+ T
Sbjct: 199 TGIKLIDFGCA----TFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254

Query: 198 GRP---------------------------------------------PWPDVADPISAL 212
           G                                                WP+ A  I+++
Sbjct: 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSI 314

Query: 213 HRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
             +       +I     +   DFL   L  +P  R S +ELL+H F++
Sbjct: 315 KHVKKCLPLYKI--IKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 89.1 bits (221), Expect = 1e-19
 Identities = 63/267 (23%), Positives = 108/267 (40%), Gaps = 31/267 (11%)

Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEFLQREQRILSALACPQIVAY 60
           T    +G G    V  G+  + S   AVK      +   EFL+ E  ++  +  P +V  
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQL 281

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSN 118
            G   + E     Y +  E+   G L D +R      +    +      +   ++YL   
Sbjct: 282 LGV-CTRE--PPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PIC-MAPEVAR 175
             +H ++  +N LV +++    K+ADFG    +R+   D      G   PI   APE   
Sbjct: 338 NFIHRNLAARNCLVGENHL--VKVADFG---LSRLMTGDTYTAHAGAKFPIKWTAPESLA 392

Query: 176 GEEQGFPADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMS 229
             +    +DVWA G  + E+AT G  P+P      V + +   +R+       E P    
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-------ERPEGCP 445

Query: 230 KQAQDFLSKCLIRNPGERWSASELLEH 256
           ++  + +  C   NP +R S +E+ + 
Sbjct: 446 EKVYELMRACWQWNPSDRPSFAEIHQA 472

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 87.3 bits (216), Expect = 4e-19
 Identities = 68/362 (18%), Positives = 105/362 (29%), Gaps = 124/362 (34%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAYKGCDIS 66
           +G G  +TV +    +  +  A+K   +    +E    E R+L ++           D +
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVR--------NSDPN 96

Query: 67  EENGK---ILYNLFLEYAPGGT------------LTDAIRS--GTCLEEGRIRSHTRAVL 109
           + N +    L + F      GT            L   I       L    ++   + VL
Sbjct: 97  DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156

Query: 110 LGLQYLHS-NGIVHCDIKGQNILVSKDN-------------------------------- 136
            GL YLH+   I+H DIK +NIL+S +                                 
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216

Query: 137 ---------------EQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF 181
                          +   KIAD G A                T    + EV  G     
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWV----HKHFTEDIQTRQYRSLEVLIGSGYNT 272

Query: 182 PADVWALGCTVLEMATGRPP--------WPDVAD------------PISALHRIGFSSD- 220
           PAD+W+  C   E+ATG           +    D            P   +    +S + 
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332

Query: 221 ------------------------TPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
                                     E     +    DFL   L   P +R +A+E L H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392

Query: 257 GF 258
            +
Sbjct: 393 PW 394

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 86.7 bits (215), Expect = 7e-19
 Identities = 39/108 (36%), Positives = 55/108 (50%), Gaps = 12/108 (11%)

Query: 100 RIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG 159
            +R    ++L  L  LH N I+HCD+K +NIL+ +    G K+ DFG +         E 
Sbjct: 201 LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC-------YEH 253

Query: 160 KPICGTPICM----APEVARGEEQGFPADVWALGCTVLEMATGRPPWP 203
           + +  T I      APEV  G   G P D+W+LGC + E+ TG P  P
Sbjct: 254 QRVY-TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 11/38 (28%), Positives = 20/38 (52%)

Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTE 271
           DFL +CL  +P  R +  + L H +++ +  K  T  +
Sbjct: 387 DFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEK 424

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 46/237 (19%), Positives = 68/237 (28%), Gaps = 100/237 (42%)

Query: 101 IRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGA-----------------KIA 143
           IR     +   + +LHSN + H D+K +NIL  + +   A                 K+ 
Sbjct: 120 IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179

Query: 144 DFGCA-------------RRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGC 190
           DFG A             R  R                 APEV        P DVW++GC
Sbjct: 180 DFGSATYDDEHHSTLVSTRHYR-----------------APEVILALGWSQPCDVWSIGC 222

Query: 191 TVLEMATGRP----------------------------------------PWPD------ 204
            ++E   G                                           W +      
Sbjct: 223 ILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGR 282

Query: 205 -VADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK 260
            V+     L     S D         ++  D + K L  +P +R +  E L+H F  
Sbjct: 283 YVSRACKPLKEFMLSQDVEH------ERLFDLIQKMLEYDPAKRITLREALKHPFFD 333

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 21/214 (9%)

Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEFLQREQRILSALACPQIVAY 60
              + +G G    V +   N+ ++V AVK      +S   FL  E  ++  L   ++V  
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAFLA-EANVMKTLQHDKLVKL 248

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSN 118
               +++E   I+     E+   G+L D ++S  G+     ++   +  +  G+ ++   
Sbjct: 249 HAV-VTKEPIYII----TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC---MAPEVAR 175
             +H D++  NILVS       KIADFG    ARV ED+E     G        APE   
Sbjct: 304 NYIHRDLRAANILVSASLV--CKIADFGL---ARVIEDNEYTAREGAKFPIKWTAPEAIN 358

Query: 176 GEEQGFPADVWALGCTVLEMAT-GRPPWPDVADP 208
                  +DVW+ G  ++E+ T GR P+P +++P
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 392

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 30/102 (29%), Positives = 45/102 (44%), Gaps = 6/102 (5%)

Query: 101 IRSHTRAVLLGLQYLHSN--GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE 158
            R   + +   L +L +    I+HCD+K +NIL+        KI DFG +          
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQR 214

Query: 159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRP 200
                 +    +PEV  G       D+W+LGC ++EM TG P
Sbjct: 215 IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 16/79 (20%), Positives = 24/79 (30%), Gaps = 3/79 (3%)

Query: 186 WALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ---DFLSKCLIR 242
           W L  T       +PP       I  +   G         G+         D + + L  
Sbjct: 300 WNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY 359

Query: 243 NPGERWSASELLEHGFVKE 261
           +P  R      L+H F K+
Sbjct: 360 DPKTRIQPYYALQHSFFKK 378

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 83.0 bits (206), Expect = 3e-18
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 23/212 (10%)

Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEFLQREQRILSALACPQIVAY 60
           T  + +G G    V +G      +V AVK      +S  EF Q E + +  L+ P++V +
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSMSEDEFFQ-EAQTMMKLSHPKLVKF 68

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNG 119
            G    E    I+     EY   G L + +RS G  LE  ++      V  G+ +L S+ 
Sbjct: 69  YGVCSKEYPIYIV----TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PIC-MAPEVARG 176
            +H D+  +N LV +D     K++DFG     R   DD+     GT  P+   APEV   
Sbjct: 125 FIHRDLAARNCLVDRDLC--VKVSDFG---MTRYVLDDQYVSSVGTKFPVKWSAPEVFH- 178

Query: 177 EEQGF--PADVWALGCTVLEMAT-GRPPWPDV 205
               +   +DVWA G  + E+ + G+ P+   
Sbjct: 179 -YFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 82.6 bits (205), Expect = 3e-18
 Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 37/219 (16%)

Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVFAVKS---AELSNSEFLQREQRILSALACPQIVAY 60
           T  Q IG G    V +G      +V A+K+     +S  +F++ E  ++  L+ P++V  
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE-EAEVMMKLSHPKLVQL 68

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL--------GL 112
            G  + +    ++     E+   G L+D +R+      G         LL        G+
Sbjct: 69  YGVCLEQAPICLV----TEFMEHGCLSDYLRTQ----RGLF---AAETLLGMCLDVCEGM 117

Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PIC-M 169
            YL    ++H D+  +N LV ++     K++DFG     R   DD+     GT  P+   
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQV--IKVSDFG---MTRFVLDDQYTSSTGTKFPVKWA 172

Query: 170 APEVARGEEQGF--PADVWALGCTVLEMAT-GRPPWPDV 205
           +PEV       +   +DVW+ G  + E+ + G+ P+ + 
Sbjct: 173 SPEVFS--FSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 83.9 bits (208), Expect = 7e-18
 Identities = 69/263 (26%), Positives = 116/263 (44%), Gaps = 31/263 (11%)

Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVFAVKS--AELSNSEFLQREQRILSALACPQIVAYK 61
              QTIG+G    V +G     ++V AVK    + +   FL  E  +++ L    +V   
Sbjct: 196 KLLQTIGKGEFGDVMLGDYR-GNKV-AVKCIKNDATAQAFLA-EASVMTQLRHSNLVQLL 252

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           G  I EE G +   +  EY   G+L D +RS   + L    +   +  V   ++YL  N 
Sbjct: 253 GV-IVEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC-MAPEVARGEE 178
            VH D+  +N+LVS+DN   AK++DFG  +    +   +   +   P+   APE  R ++
Sbjct: 310 FVHRDLAARNVLVSEDNV--AKVSDFGLTK--EASSTQDTGKL---PVKWTAPEALREKK 362

Query: 179 QGFPADVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQA 232
               +DVW+ G  + E+ + GR P+P     DV   +   +++       + P       
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-------DAPDGCPPAV 415

Query: 233 QDFLSKCLIRNPGERWSASELLE 255
            D +  C   +   R +  +L E
Sbjct: 416 YDVMKNCWHLDAATRPTFLQLRE 438

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 81.9 bits (203), Expect = 7e-18
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 23/208 (11%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKS--AELSNSEFLQREQRILSALACPQIVAYKGC 63
            QTIG+G    V +G     ++V AVK    + +   FL  E  +++ L    +V   G 
Sbjct: 26  LQTIGKGEFGDVMLGDYR-GNKV-AVKCIKNDATAQAFLA-EASVMTQLRHSNLVQLLGV 82

Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
            I EE G +   +  EY   G+L D +RS   + L    +   +  V   ++YL  N  V
Sbjct: 83  -IVEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 139

Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC-MAPEVARGEEQG 180
           H D+  +N+LVS+DN   AK++DFG  +    +   +   +   P+   APE  R  E+ 
Sbjct: 140 HRDLAARNVLVSEDNV--AKVSDFGLTK--EASSTQDTGKL---PVKWTAPEALR--EKK 190

Query: 181 F--PADVWALGCTVLEMAT-GRPPWPDV 205
           F   +DVW+ G  + E+ + GR P+P +
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRVPYPRI 218

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 82.3 bits (204), Expect = 8e-18
 Identities = 55/223 (24%), Positives = 88/223 (39%), Gaps = 38/223 (17%)

Query: 4   TRGQTIGRGSTATVSIG-----MSNRSSEVFAVK-----SAELSNSEFLQREQRILSALA 53
            + + +G G+  TV  G            V A+K     ++  +N E L  E  +++++ 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANKEIL-DEAYVMASVD 75

Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHT-----RAV 108
            P +    G  ++      +  L  +  P G L D +R      +  I S         +
Sbjct: 76  NPHVCRLLGICLTST----VQ-LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQI 126

Query: 109 LLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED----DEGKPICG 164
             G+ YL    +VH D+  +N+LV        KI DFG A+     E     + GK    
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKEYHAEGGK---- 180

Query: 165 TPIC-MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
            PI  MA E          +DVW+ G TV E+ T G  P+  +
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 79.9 bits (198), Expect = 3e-17
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 25/213 (11%)

Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEFLQREQRILSALACPQIVAY 60
              + +G G    V +G  N  ++V AVK      +S   FL  E  ++  L   ++V  
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRL 73

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSN 118
               +++E   I+     EY   G+L D +++  G  L   ++      +  G+ ++   
Sbjct: 74  YAV-VTQEPIYII----TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PIC-MAPEVAR 175
             +H D++  NILVS       KIADFG    AR+ ED+E     G   PI   APE   
Sbjct: 129 NYIHRDLRAANILVSDTLS--CKIADFG---LARLIEDNEYTAREGAKFPIKWTAPEAIN 183

Query: 176 GEEQGF--PADVWALGCTVLEMAT-GRPPWPDV 205
                F   +DVW+ G  + E+ T GR P+P +
Sbjct: 184 --YGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 59/239 (24%), Positives = 95/239 (39%), Gaps = 42/239 (17%)

Query: 4   TRGQTIGRGSTATVSIGM----SNRSSEVFAVK-------SAELSNSEFLQREQRILSAL 52
              + +G GS   V  G     S ++  V AVK       S   +  +F+ RE   + +L
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFI-REVNAMHSL 78

Query: 53  ACPQIVAYKG-CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHT-----R 106
               ++   G         K++     E AP G+L D +R      +G     T      
Sbjct: 79  DHRNLIRLYGVV--LTPPMKMV----TELAPLGSLLDRLRKH----QGHFLLGTLSRYAV 128

Query: 107 AVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED----DEGKPI 162
            V  G+ YL S   +H D+  +N+L++  +    KI DFG  R    N+D     E + +
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDDHYVMQEHRKV 186

Query: 163 CGTPIC-MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV--ADPISALHRIGF 217
              P    APE  +       +D W  G T+ EM T G+ PW  +  +  +  + + G 
Sbjct: 187 ---PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 242

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 80.5 bits (199), Expect = 4e-17
 Identities = 57/279 (20%), Positives = 104/279 (37%), Gaps = 42/279 (15%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVF---AVK------SAELSNSEFLQREQRILSALACPQ 56
           G+ +G+G   +V      +    F   AVK       A     EFL RE   +     P 
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL-REAACMKEFDHPH 86

Query: 57  IVAYKGCDISEENGKILYNLF--LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ- 113
           +    G  +       L      L +   G L   + +    E          V   +  
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 114 -----YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--P 166
                YL S   +H D+  +N ++++D      +ADFG +R  ++   D  +  C +  P
Sbjct: 147 ACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSR--KIYSGDYYRQGCASKLP 202

Query: 167 IC-MAPEVARGEEQGFPA--DVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGF 217
           +  +A E     +  +    DVWA G T+ E+ T G+ P+      ++ + +   +R+  
Sbjct: 203 VKWLALESLA--DNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL-- 258

Query: 218 SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
                + P    ++  D + +C   +P +R S + L   
Sbjct: 259 -----KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRME 292

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 79.7 bits (197), Expect = 7e-17
 Identities = 50/221 (22%), Positives = 86/221 (38%), Gaps = 34/221 (15%)

Query: 4   TRGQTIGRGSTATVSIG-----MSNRSSEVFAVK-----SAELSNSEFLQREQRILSALA 53
            + + +G G   TV  G       +    V  +K     S   S           + +L 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPV-CIKVIEDKSGRQSFQAVT-DHMLAIGSLD 73

Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHT-----RAV 108
              IV   G      + +++     +Y P G+L D +R       G +           +
Sbjct: 74  HAHIVRLLGL-CPGSSLQLV----TQYLPLGSLLDHVRQ----HRGALGPQLLLNWGVQI 124

Query: 109 LLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--P 166
             G+ YL  +G+VH ++  +N+L+   ++   ++ADFG A    +  DD+         P
Sbjct: 125 AKGMYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVAD--LLPPDDKQLLYSEAKTP 180

Query: 167 IC-MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
           I  MA E     +    +DVW+ G TV E+ T G  P+  +
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 79.2 bits (196), Expect = 8e-17
 Identities = 53/219 (24%), Positives = 88/219 (40%), Gaps = 37/219 (16%)

Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEFLQREQRILSALACPQIVAY 60
           T  + +G G    V  G      +V A+K      +S  EF++ E +++  L+  ++V  
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQL 84

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL--------GL 112
            G    +    I+     EY   G L + +R        R        LL         +
Sbjct: 85  YGVCTKQRPIFII----TEYMANGCLLNYLREM----RHRF---QTQQLLEMCKDVCEAM 133

Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PIC-M 169
           +YL S   +H D+  +N LV+       K++DFG    +R   DDE     G+  P+   
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGV--VKVSDFG---LSRYVLDDEYTSSVGSKFPVRWS 188

Query: 170 APEVARGEEQGF--PADVWALGCTVLEMAT-GRPPWPDV 205
            PEV       F   +D+WA G  + E+ + G+ P+   
Sbjct: 189 PPEVLM--YSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 81.1 bits (200), Expect = 9e-17
 Identities = 57/219 (26%), Positives = 87/219 (39%), Gaps = 32/219 (14%)

Query: 4   TRGQTIGRGSTATVSIGM----SNRSSEVFAVK-----SAELSNSEFLQREQRILSALAC 54
             G+ IG G    V  G+     N +  V A+K     +++    +FLQ E   +     
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAV-AIKTCKNCTSDSVREKFLQ-EALTMRQFDH 450

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHT-----RAVL 109
           P IV   G  I+E    I+    +E    G L   ++      +  +   +       + 
Sbjct: 451 PHIVKLIGV-ITENPVWII----MELCTLGELRSFLQV----RKFSLDLASLILYAYQLS 501

Query: 110 LGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG-TPIC 168
             L YL S   VH DI  +N+LVS ++    K+ DFG +R   + +    K   G  PI 
Sbjct: 502 TALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSR--YMEDSTYYKASKGKLPIK 557

Query: 169 -MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
            MAPE          +DVW  G  + E+   G  P+  V
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 31/214 (14%)

Query: 9   IGRGSTATVSIG---MSNRSSEVFAVK-----SAELSNSEFLQREQRILSALACPQIVAY 60
           +G G+  +V  G   M  +  +V A+K     + +    E + RE +I+  L  P IV  
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDV-AIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRL 401

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL-----GLQYL 115
            G     E   ++    +E A GG L   +      +   I     A LL     G++YL
Sbjct: 402 IGV-CQAEALMLV----MEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYL 452

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PIC-MAPE 172
                VH ++  +N+L+   +   AKI+DFG + +A   +D           P+   APE
Sbjct: 453 EEKNFVHRNLAARNVLLVNRHY--AKISDFGLS-KALGADDSYYTARSAGKWPLKWYAPE 509

Query: 173 VARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
                +    +DVW+ G T+ E  + G+ P+  +
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 55/213 (25%), Positives = 87/213 (40%), Gaps = 23/213 (10%)

Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEFLQREQRILSALACPQIVAY 60
           T    +G G    V  G+  + S   AVK      +   EFL+ E  ++  +  P +V  
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQL 74

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSN 118
            G   + E     Y +  E+   G L D +R      +    +      +   ++YL   
Sbjct: 75  LGV-CTRE--PPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PIC-MAPEVAR 175
             +H D+  +N LV +++    K+ADFG    +R+   D      G   PI   APE   
Sbjct: 131 NFIHRDLAARNCLVGENHL--VKVADFG---LSRLMTGDTYTAHAGAKFPIKWTAPESLA 185

Query: 176 GEEQGF--PADVWALGCTVLEMAT-GRPPWPDV 205
                F   +DVWA G  + E+AT G  P+P +
Sbjct: 186 --YNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 53/225 (23%), Positives = 85/225 (37%), Gaps = 44/225 (19%)

Query: 4   TRGQTIGRGSTATVSIGM----SNRSSEVFAVK-----SAELSNSEFLQREQRILSALAC 54
              + +G G    V  G+          V AVK         +  +F+  E  I+  L  
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINV-AVKTCKKDCTLDNKEKFM-SEAVIMKNLDH 72

Query: 55  PQIVAYKG-CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHT-----RAV 108
           P IV   G     EE   I+    +E  P G L   +       +  ++  T       +
Sbjct: 73  PHIVKLIGII--EEEPTWII----MELYPYGELGHYLERN----KNSLKVLTLVLYSLQI 122

Query: 109 LLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD----EGKPICG 164
              + YL S   VH DI  +NILV+       K+ DFG +R   + ++D        +  
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSR--YIEDEDYYKASVTRL-- 176

Query: 165 TPIC-MAPEVARGEEQGF--PADVWALGCTVLEMAT-GRPPWPDV 205
            PI  M+PE      + F   +DVW     + E+ + G+ P+  +
Sbjct: 177 -PIKWMSPESIN--FRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 77.3 bits (191), Expect = 3e-16
 Identities = 60/226 (26%), Positives = 89/226 (39%), Gaps = 46/226 (20%)

Query: 4   TRGQTIGRGSTATVSIGM----SNRSSEVFAVK-----SAELSNSEFLQREQRILSALAC 54
             G+ IG G    V  G+     N +  V A+K     +++    +FLQ E   +     
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAV-AIKTCKNCTSDSVREKFLQ-EALTMRQFDH 75

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHT-----RAVL 109
           P IV   G  I+E    I+    +E    G L   ++      +  +   +       + 
Sbjct: 76  PHIVKLIGV-ITENPVWII----MELCTLGELRSFLQVR----KYSLDLASLILYAYQLS 126

Query: 110 LGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE------GKPIC 163
             L YL S   VH DI  +N+LVS ++    K+ DFG    +R  ED        GK   
Sbjct: 127 TALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFG---LSRYMEDSTYYKASKGK--- 178

Query: 164 GTPIC-MAPEVARGEEQGF--PADVWALGCTVLEMAT-GRPPWPDV 205
             PI  MAPE      + F   +DVW  G  + E+   G  P+  V
Sbjct: 179 -LPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 57/224 (25%), Positives = 88/224 (39%), Gaps = 39/224 (17%)

Query: 4   TRGQTIGRGSTATVSIGM----SNRSSEVFAVK-----SAELSNSEFLQREQRILSALAC 54
              + IG G +  V  G       R   V A+K       E    +FL  E  I+     
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPV-AIKALKAGYTERQRRDFLS-EASIMGQFDH 109

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHT-----RAVL 109
           P I+  +G         I+     EY   G+L   +R+     +G+          R V 
Sbjct: 110 PNIIRLEGVVTRGRLAMIV----TEYMENGSLDTFLRTH----DGQFTIMQLVGMLRGVG 161

Query: 110 LGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD----EGKPICGT 165
            G++YL   G VH D+  +N+LV  +     K++DFG +R    + D      G  I   
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGKI--- 216

Query: 166 PIC-MAPEVARGEEQGF--PADVWALGCTVLEMAT-GRPPWPDV 205
           PI   APE      + F   +DVW+ G  + E+   G  P+ ++
Sbjct: 217 PIRWTAPEAIA--FRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 77.4 bits (191), Expect = 4e-16
 Identities = 55/223 (24%), Positives = 88/223 (39%), Gaps = 38/223 (17%)

Query: 4   TRGQTIGRGSTATVSIG-----MSNRSSEVFAVK-----SAELSNSEFLQREQRILSALA 53
            + + +G G+  TV  G            V A+K     ++  +N E L  E  +++++ 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANKEIL-DEAYVMASVD 75

Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHT-----RAV 108
            P +    G  ++      +  L  +  P G L D +R      +  I S         +
Sbjct: 76  NPHVCRLLGICLTST----VQ-LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQI 126

Query: 109 LLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED----DEGKPICG 164
             G+ YL    +VH D+  +N+LV        KI DFG A+     E     + GK    
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKEYHAEGGK---- 180

Query: 165 TPIC-MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
            PI  MA E          +DVW+ G TV E+ T G  P+  +
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 76.9 bits (190), Expect = 5e-16
 Identities = 52/220 (23%), Positives = 83/220 (37%), Gaps = 29/220 (13%)

Query: 4   TRGQTIGRGSTATV----SIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALAC 54
              + IG+G    V     I  +    +  A+K     +       FL RE  ++  L  
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQC-AIKSLSRITEMQQVEAFL-REGLLMRGLNH 81

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQ 113
           P ++A  G  +    G     + L Y   G L   IRS         + S    V  G++
Sbjct: 82  PNVLALIGI-MLPPEGLPH--VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGME 138

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT----PIC- 168
           YL     VH D+  +N ++ +      K+ADFG AR   + + +            P+  
Sbjct: 139 YLAEQKFVHRDLAARNCMLDESFT--VKVADFGLAR--DILDREYYSVQQHRHARLPVKW 194

Query: 169 MAPEVARGEEQGFPA--DVWALGCTVLEMAT-GRPPWPDV 205
            A E  +     F    DVW+ G  + E+ T G PP+  +
Sbjct: 195 TALESLQ--TYRFTTKSDVWSFGVLLWELLTRGAPPYRHI 232

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 76.9 bits (190), Expect = 5e-16
 Identities = 60/227 (26%), Positives = 91/227 (40%), Gaps = 43/227 (18%)

Query: 4   TRGQTIGRGSTATVSIG----MSNRSSEVFAVK-----SAELSNSEFLQREQRILSALAC 54
              + IGRG    V  G       +     AVK     +     S+FL  E  I+   + 
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHC-AVKSLNRITDIGEVSQFL-TEGIIMKDFSH 85

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL---- 110
           P +++  G       G  L  + L Y   G L + IR+          + T   L+    
Sbjct: 86  PNVLSLLGI-CLRSEGSPL--VVLPYMKHGDLRNFIRN-------ETHNPTVKDLIGFGL 135

Query: 111 ----GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD----EGKPI 162
               G++YL S   VH D+  +N ++ +      K+ADFG AR   + + +      K  
Sbjct: 136 QVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLAR--DMYDKEYYSVHNKTG 191

Query: 163 CGTPIC-MAPEVARGEEQGFPA--DVWALGCTVLEMAT-GRPPWPDV 205
              P+  MA E  +   Q F    DVW+ G  + E+ T G PP+PDV
Sbjct: 192 AKLPVKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 76.6 bits (189), Expect = 5e-16
 Identities = 55/222 (24%), Positives = 84/222 (37%), Gaps = 33/222 (14%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF--LQREQRILSALA----CPQIVA 59
           G+ IG GS   + +G    + E  A+K  E   ++   L  E +I   +      P I  
Sbjct: 14  GRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPTIR- 71

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ------ 113
           + G   +E +    YN+ +    G +L D      C    R  S    +LL  Q      
Sbjct: 72  WCG---AEGD----YNVMVMELLGPSLEDLFNF--C---SRKFSLKTVLLLADQMISRIE 119

Query: 114 YLHSNGIVHCDIKGQNILVSK-DNEQGAKIADFGCARRARVNED------DEGKPICGTP 166
           Y+HS   +H D+K  N L+          I DFG A++ R           E K + GT 
Sbjct: 120 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179

Query: 167 ICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADP 208
              +     G EQ    D+ +LG  ++    G  PW  +   
Sbjct: 180 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 221

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 76.5 bits (189), Expect = 6e-16
 Identities = 53/222 (23%), Positives = 90/222 (40%), Gaps = 39/222 (17%)

Query: 5   RGQTIGRGSTATVSIG---MSNRSSEVFAVK------SAELSNSEFLQREQRILSALACP 55
             + +G G+  TV  G   M      V AVK      +      E L  E  ++  L  P
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTV-AVKILKNEANDPALKDELL-AEANVMQQLDNP 78

Query: 56  QIVAYKG-CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
            IV   G C+      +    L +E A  G L   ++    +++  I      V +G++Y
Sbjct: 79  YIVRMIGICE-----AESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 132

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED----DEGKPICGTPIC-M 169
           L  +  VH D+  +N+L+   +   AKI+DFG ++  R +E+             P+   
Sbjct: 133 LEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTHGKW---PVKWY 187

Query: 170 APEVARGEEQGF-----PADVWALGCTVLEMAT-GRPPWPDV 205
           APE        +      +DVW+ G  + E  + G+ P+  +
Sbjct: 188 APECIN-----YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 37/225 (16%), Positives = 83/225 (36%), Gaps = 36/225 (16%)

Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVF-------AVK----SAELSNSEFLQREQRILSAL 52
              +++G+G+   +  G+     +          +K    +    +  F      ++S L
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFF-EAASMMSKL 69

Query: 53  ACPQIVAYKG-CDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLL 110
           +   +V   G C   +E       L  E+   G+L   ++    C+         + +  
Sbjct: 70  SHKHLVLNYGVCVCGDE----NI-LVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124

Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQG------AKIADFGCARRARVNEDDEGKPICG 164
            + +L  N ++H ++  +NIL+ ++ ++        K++D G +    V   D  +    
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI--TVLPKDILQ---- 178

Query: 165 TPIC-MAPEVARGEEQGF--PADVWALGCTVLEMAT-GRPPWPDV 205
             I  + PE      +      D W+ G T+ E+ + G  P   +
Sbjct: 179 ERIPWVPPECIE-NPKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 51/224 (22%), Positives = 88/224 (39%), Gaps = 33/224 (14%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVF---AVK------SAELSNSEFLQREQRILSALACPQ 56
           G+ +G G   +V  G   +        AVK      S++    EFL  E   +   + P 
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFL-SEAACMKDFSHPN 97

Query: 57  IVAYKG-CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL----- 110
           ++   G C      G     + L +   G L   +       E   +      LL     
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLY--SRLETGPKHIPLQTLLKFMVD 155

Query: 111 ---GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT-- 165
              G++YL +   +H D+  +N ++  D      +ADFG ++  ++   D  +       
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADFGLSK--KIYSGDYYRQGRIAKM 211

Query: 166 PIC-MAPEVARGEEQGFPA--DVWALGCTVLEMAT-GRPPWPDV 205
           P+  +A E     ++ + +  DVWA G T+ E+AT G  P+P V
Sbjct: 212 PVKWIAIESLA--DRVYTSKSDVWAFGVTMWEIATRGMTPYPGV 253

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 58/220 (26%), Positives = 89/220 (40%), Gaps = 29/220 (13%)

Query: 4   TRGQTIGRGSTATVSIG----MSNRSSEVFAVK-----SAELSNSEFLQREQRILSALAC 54
              + IGRG    V  G       +     AVK     +     S+FL  E  I+   + 
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHC-AVKSLNRITDIGEVSQFL-TEGIIMKDFSH 149

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQ 113
           P +++  G       G  L  + L Y   G L + IR+         +      V  G++
Sbjct: 150 PNVLSLLGI-CLRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 206

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT----PIC- 168
           +L S   VH D+  +N ++ +      K+ADFG AR   + + +       T    P+  
Sbjct: 207 FLASKKFVHRDLAARNCMLDEKFT--VKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKW 262

Query: 169 MAPEVARGEEQGFPA--DVWALGCTVLEMAT-GRPPWPDV 205
           MA E  +   Q F    DVW+ G  + E+ T G PP+PDV
Sbjct: 263 MALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 57/225 (25%), Positives = 90/225 (40%), Gaps = 40/225 (17%)

Query: 4   TRGQTIGRGSTATVSIGMSNRSSEVF----AVK-----SAELSNSEFLQREQRILSALAC 54
           TR + IG G    V  GM   SS       A+K       E    +FL  E  I+   + 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG-EAGIMGQFSH 105

Query: 55  PQIVAYKG-CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHT-----RAV 108
             I+  +G     +     +  +  EY   G L   +R      +G           R +
Sbjct: 106 HNIIRLEGVISKYKP----MM-IITEYMENGALDKFLREK----DGEFSVLQLVGMLRGI 156

Query: 109 LLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD----EGKPICG 164
             G++YL +   VH D+  +NILV+ +     K++DFG +R    + +      G  I  
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKI-- 212

Query: 165 TPIC-MAPEVARGEEQGF--PADVWALGCTVLEMAT-GRPPWPDV 205
            PI   APE      + F   +DVW+ G  + E+ T G  P+ ++
Sbjct: 213 -PIRWTAPEAIS--YRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 74.6 bits (184), Expect = 3e-15
 Identities = 49/220 (22%), Positives = 87/220 (39%), Gaps = 43/220 (19%)

Query: 9   IGRGSTATVSIGMSNRSSEVF--AVK-----SAELSNSEFLQREQRILSALACPQIVAYK 61
           +G G+  +V  G+     +    A+K     + +    E ++ E +I+  L  P IV   
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR-EAQIMHQLDNPYIVRLI 76

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHT-----RAVLLGLQYLH 116
           G     E   ++    +E A GG L   +      +   I           V +G++YL 
Sbjct: 77  GV-CQAEALMLV----MEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLE 127

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED----DEGKPICGTPIC-MAP 171
               VH D+  +N+L+   +   AKI+DFG ++    ++              P+   AP
Sbjct: 128 EKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGADDSYYTARSAGKW---PLKWYAP 182

Query: 172 EVARGEEQGF-----PADVWALGCTVLEMAT-GRPPWPDV 205
           E        F      +DVW+ G T+ E  + G+ P+  +
Sbjct: 183 ECIN-----FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 74.3 bits (183), Expect = 3e-15
 Identities = 59/217 (27%), Positives = 84/217 (38%), Gaps = 33/217 (15%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF--LQREQRILSALA-CPQI--VAY 60
           G+ IG GS   +  G +  +++  A+K  E   S+   L+ E R    LA C  I  V Y
Sbjct: 15  GRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYY 73

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ------Y 114
            G    E    +L    L    G +L D +    C   GR  S     +   Q       
Sbjct: 74  FG---QEGLHNVLVIDLL----GPSLEDLLDL--C---GRKFSVKTVAMAAKQMLARVQS 121

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAK---IADFGCARRARVNED------DEGKPICGT 165
           +H   +V+ DIK  N L+ + N + A    + DFG  +  R           E K + GT
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181

Query: 166 PICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW 202
              M+     G EQ    D+ ALG   +    G  PW
Sbjct: 182 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 75.0 bits (184), Expect = 5e-15
 Identities = 52/213 (24%), Positives = 83/213 (38%), Gaps = 27/213 (12%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF--LQREQRILSALA-CPQIVAYKG 62
           G+ IG GS   + +G + +++E  A+K  E   ++   L  E +I   L     I   + 
Sbjct: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGIPNVRW 70

Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ------YLH 116
             +  +     YN+ +    G +L D      C    R  S    ++L  Q      ++H
Sbjct: 71  FGVEGD-----YNVLVMDLLGPSLEDLFNF--C---SRKLSLKTVLMLADQMINRVEFVH 120

Query: 117 SNGIVHCDIKGQNILVSKDNEQ-GAKIADFGCARRARVNED------DEGKPICGTPICM 169
           S   +H DIK  N L+          I DFG A++ R           E K + GT    
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180

Query: 170 APEVARGEEQGFPADVWALGCTVLEMATGRPPW 202
           +     G EQ    D+ +LG  ++    G  PW
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 74.3 bits (183), Expect = 6e-15
 Identities = 51/222 (22%), Positives = 88/222 (39%), Gaps = 35/222 (15%)

Query: 4   TRGQTIGRGSTATVSIGM----SNRSSEVFAVK-----SAELSNSEFLQREQRILSALAC 54
           +  + +G G    V  G     S +   V A+K       E    +FL  E  I+     
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISV-AIKTLKVGYTEKQRRDFLG-EASIMGQFDH 105

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHT-----RAVL 109
           P I+  +G     +   I+     EY   G+L   +R      + +          R + 
Sbjct: 106 PNIIRLEGVVTKSKPVMIV----TEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIA 157

Query: 110 LGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD----EGKPICGT 165
            G++YL   G VH D+  +NIL++ +     K++DFG  R    + +      G  I   
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGRVLEDDPEAAYTTRGGKI--- 212

Query: 166 PIC-MAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDV 205
           PI   +PE     +    +DVW+ G  + E+ + G  P+ ++
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 74.0 bits (182), Expect = 7e-15
 Identities = 51/233 (21%), Positives = 85/233 (36%), Gaps = 44/233 (18%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF--LQREQRILSALACPQIVA- 59
           W  G+ IG G    + +       E  A    ++   E   L  E +    +A    +  
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98

Query: 60  --------------YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHT 105
                         + G  ++E  G+    + +E           R G  L++   ++ T
Sbjct: 99  WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVME-----------RLGIDLQKISGQNGT 147

Query: 106 ---RAVL-LGLQ------YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
                VL LG++      Y+H N  VH DIK  N+L+   N     +AD+G + R   N 
Sbjct: 148 FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207

Query: 156 D------DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW 202
           +      +  K   GT    + +  +G      +DV  LG  +L    G+ PW
Sbjct: 208 NHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPW 260

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 56/211 (26%), Positives = 85/211 (40%), Gaps = 35/211 (16%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVKSAELS----NSEFLQREQRILSALACPQIVAYKG-C 63
           IG G    V  G+    ++V A+K           EF + E   LS    P +V+  G C
Sbjct: 47  IGHGVFGKVYKGVLRDGAKV-ALKRRTPESSQGIEEF-ETEIETLSFCRHPHLVSLIGFC 104

Query: 64  DISEENGKIL-YNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTR-------AVLLGLQYL 115
           D  E N  IL Y    +Y   G L   +  G+ L    +    R       A   GL YL
Sbjct: 105 D--ERNEMILIY----KYMENGNLKRHL-YGSDLPTMSMSWEQRLEICIGAA--RGLHYL 155

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP-----ICGTPICMA 170
           H+  I+H D+K  NIL+ ++     KI DFG +++      +  +      + GT   + 
Sbjct: 156 HTRAIIHRDVKSINILLDENFV--PKITDFGISKKG----TELDQTHLSTVVKGTLGYID 209

Query: 171 PEVARGEEQGFPADVWALGCTVLEMATGRPP 201
           PE          +DV++ G  + E+   R  
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 68/287 (23%), Positives = 117/287 (40%), Gaps = 50/287 (17%)

Query: 6   GQTIGRGSTATV------SIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALAC 54
           G+ +GRG+   V       I  +     V AVK     +    +   +  E +IL  +  
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTV-AVKMLKEGATHSEHRALM-SELKILIHIGH 89

Query: 55  -PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS--------GTCLEEGRIRSHT 105
              +V   G   ++  G ++  + +E+   G L+  +RS            E+      T
Sbjct: 90  HLNVVNLLGA-CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 106 RAVLL--------GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD 157
              L+        G+++L S   +H D+  +NIL+S+ N    KI DFG AR   + +D 
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLAR--DIYKDP 202

Query: 158 EGKPICGT--PIC-MAPEVARGEEQGFPA--DVWALGCTVLEMAT-GRPPWPDVADPISA 211
           +         P+  MAPE     ++ +    DVW+ G  + E+ + G  P+P V      
Sbjct: 203 DYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260

Query: 212 LHRI--GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
             R+  G     P+   Y + +    +  C    P +R + SEL+EH
Sbjct: 261 CRRLKEGTRMRAPD---YTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 53/216 (24%), Positives = 84/216 (38%), Gaps = 31/216 (14%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF--LQREQRILSALA-CPQIVAYKG 62
           G+ IG G+   + +G +  ++E  A+K  E   S    L  E R    L     I     
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYY 72

Query: 63  CDISEENGKILYN-LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQ------YL 115
                +     YN + LE   G +L D      C    R  S    +++ +Q      Y+
Sbjct: 73  FGPCGK-----YNAMVLELL-GPSLEDLFDL--C---DRTFSLKTVLMIAIQLISRMEYV 121

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAK---IADFGCARRARVNED------DEGKPICGTP 166
           HS  +++ D+K +N L+ +   +  +   I DF  A+     E        E K + GT 
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181

Query: 167 ICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW 202
             M+     G+EQ    D+ ALG   +    G  PW
Sbjct: 182 RYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW 217

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 71.1 bits (175), Expect = 5e-14
 Identities = 70/288 (24%), Positives = 111/288 (38%), Gaps = 51/288 (17%)

Query: 6   GQTIGRGSTATV------SIGMSNRSSEVFAVK----SAELSNSEFLQREQRILSALAC- 54
           G+T+G G+   V       +  S+ +  V AVK    SA L+  E L  E ++LS L   
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTV-AVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS----------GTCLEEGRIRSH 104
             IV   G       G  L  +  EY   G L + +R              + E    + 
Sbjct: 87  MNIVNLLGA--CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 105 TRAVLL--------GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED 156
               LL        G+ +L S   +H D+  +NIL++       KI DFG AR   +  D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFGLAR--DIKND 198

Query: 157 DEGKPICGT--PIC-MAPEVARGEEQGFPA--DVWALGCTVLEMAT-GRPPWPDVADPIS 210
                      P+  MAPE        +    DVW+ G  + E+ + G  P+P +     
Sbjct: 199 SNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256

Query: 211 ALHRI--GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
               I  GF   +PE   +   +  D +  C   +P +R +  ++++ 
Sbjct: 257 FYKMIKEGFRMLSPE---HAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 71.7 bits (176), Expect = 5e-14
 Identities = 26/97 (26%), Positives = 41/97 (42%), Gaps = 6/97 (6%)

Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED------DEGKPICGT 165
           L+Y+H +  VH DIK  N+L++  N     + D+G A R            D  +   GT
Sbjct: 165 LEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGT 224

Query: 166 PICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW 202
               + +   G       D+  LG  +++  TG  PW
Sbjct: 225 IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 71.2 bits (175), Expect = 6e-14
 Identities = 51/228 (22%), Positives = 91/228 (39%), Gaps = 39/228 (17%)

Query: 6   GQTIGRGSTATV------SIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALAC 54
            + +G+GS   V       +      + V A+K     ++     EFL  E  ++    C
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL-NEASVMKEFNC 87

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLL-- 110
             +V   G     +    L  + +E    G L   +RS          +   + + ++  
Sbjct: 88  HHVVRLLGV--VSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143

Query: 111 ------GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICG 164
                 G+ YL++N  VH D+  +N +V++D     KI DFG  R   + E D  +    
Sbjct: 144 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDFGMTR--DIYETDYYRKGGK 199

Query: 165 T--PIC-MAPEVARGEEQGFPA--DVWALGCTVLEMAT-GRPPWPDVA 206
              P+  M+PE  +  +  F    DVW+ G  + E+AT    P+  ++
Sbjct: 200 GLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 65/320 (20%), Positives = 122/320 (38%), Gaps = 61/320 (19%)

Query: 6   GQTIGRGS-------TATVSIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALA 53
           G+ +G G+        A              AVK     + E   S+ +  E  ++  + 
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIG 132

Query: 54  C-PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS--------GTCLEEGRIRSH 104
               I+   G     ++G +   + +EYA  G L + +++                    
Sbjct: 133 KHKNIINLLGA--CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 105 TRAVLL--------GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED 156
           +   L+        G++YL S   +H D+  +N+LV++DN    KIADFG AR   ++  
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLAR--DIHHI 244

Query: 157 DEGKPICGT--PIC-MAPEVARGEEQGFPA--DVWALGCTVLEMAT-GRPPWP-----DV 205
           D  K       P+  MAPE     ++ +    DVW+ G  + E+ T G  P+P     ++
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302

Query: 206 ADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASEL---LEHGFVKEQ 262
              +   HR+       + P   + +    +  C    P +R +  +L   L+       
Sbjct: 303 FKLLKEGHRM-------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355

Query: 263 NFKLSTLTEPETYNSESPTS 282
           N ++        ++ + PT+
Sbjct: 356 NQEMGYYHHHHHHDYDIPTT 375

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 54/201 (26%), Positives = 74/201 (36%), Gaps = 38/201 (18%)

Query: 30  AVK-----SAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGG 84
           AVK      +E    +FL  E  I+S      IV   G  +      IL    +E   GG
Sbjct: 64  AVKTLPEVCSEQDELDFL-MEALIISKFNHQNIVRCIGVSLQSLPRFIL----MELMAGG 118

Query: 85  TLTDAIRSGTCLEEGRIRSHTRAVLL--------GLQYLHSNGIVHCDIKGQNILVSKDN 136
            L   +R  T     +  S     LL        G QYL  N  +H DI  +N L++   
Sbjct: 119 DLKSFLRE-TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 177

Query: 137 EQG-AKIADFGCARRARVNEDD------EGKPICGTPIC-MAPEVARGEEQGFPA--DVW 186
               AKI DFG AR   +                  P+  M PE     E  F +  D W
Sbjct: 178 PGRVAKIGDFGMAR--DIYRASYYRKGGCAM----LPVKWMPPEAFM--EGIFTSKTDTW 229

Query: 187 ALGCTVLEMAT-GRPPWPDVA 206
           + G  + E+ + G  P+P  +
Sbjct: 230 SFGVLLWEIFSLGYMPYPSKS 250

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 69.2 bits (169), Expect = 3e-13
 Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 13/152 (8%)

Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC-M 169
           G+++L S   +H D+  +NIL+S+ N    KI DFG AR    + D   K     P+  M
Sbjct: 205 GMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWM 262

Query: 170 APEVARGEEQGFPA--DVWALGCTVLEMAT-GRPPWPDVADPISALHRI--GFSSDTPEI 224
           APE     ++ +    DVW+ G  + E+ + G  P+P V        R+  G     P+ 
Sbjct: 263 APET--IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD- 319

Query: 225 PGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
             Y + +    +  C    P +R + SEL+EH
Sbjct: 320 --YTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 23/97 (23%), Positives = 45/97 (46%), Gaps = 6/97 (6%)

Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN------EDDEGKPICGT 165
           L++LH N  VH ++  +NI V  +++    +A +G A R   +       +    P  G 
Sbjct: 172 LEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGD 231

Query: 166 PICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPW 202
              ++ ++ +G      +D+ +LG  +L+   G  PW
Sbjct: 232 LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 63/232 (27%), Positives = 86/232 (37%), Gaps = 43/232 (18%)

Query: 4   TRGQTIGRGSTATV----SIGMSNRSSEVF-AVK-----SAELSNSEFLQREQRILSALA 53
           T  + +G G+   V      GM N  S +  AVK      +E    +FL  E  I+S   
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFN 132

Query: 54  CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL--- 110
              IV   G  +      IL    LE   GG L   +R  T     +  S     LL   
Sbjct: 133 HQNIVRCIGVSLQSLPRFIL----LELMAGGDLKSFLRE-TRPRPSQPSSLAMLDLLHVA 187

Query: 111 -----GLQYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDD------E 158
                G QYL  N  +H DI  +N L++       AKI DFG AR   +           
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGC 245

Query: 159 GKPICGTPIC-MAPEVARGEEQGFPA--DVWALGCTVLEMAT-GRPPWPDVA 206
                  P+  M PE     E  F +  D W+ G  + E+ + G  P+P  +
Sbjct: 246 AM----LPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 68.0 bits (167), Expect = 5e-13
 Identities = 51/182 (28%), Positives = 78/182 (42%), Gaps = 40/182 (21%)

Query: 38  NSEFLQREQRILSALACPQIVAYKGCDISEENGKIL-YNLFLEYAPGGTLTDAIRSGTCL 96
             +F Q E ++++      +V   G    + +   L Y     Y P G+L D +      
Sbjct: 74  KQQFDQ-EIKVMAKCQHENLVELLGFSS-DGDDLCLVY----VYMPNGSLLDRLS----- 122

Query: 97  EEGRIRS-----HTR-AVLL----GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG 146
                 +     H R  +      G+ +LH N  +H DIK  NIL+  D    AKI+DFG
Sbjct: 123 --CLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL--DEAFTAKISDFG 178

Query: 147 CARRARVNEDDEGKP-----ICGTPICMAPEVARGE--EQGFPADVWALGCTVLEMATGR 199
            AR +    +   +      I GT   MAPE  RGE   +   +D+++ G  +LE+ TG 
Sbjct: 179 LARAS----EKFAQTVMTSRIVGTTAYMAPEALRGEITPK---SDIYSFGVVLLEIITGL 231

Query: 200 PP 201
           P 
Sbjct: 232 PA 233

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 68.5 bits (168), Expect = 5e-13
 Identities = 63/291 (21%), Positives = 113/291 (38%), Gaps = 58/291 (19%)

Query: 6   GQTIGRGS-------TATVSIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALA 53
           G+ +G G+        A        + +   AVK     + E   S+ +  E  ++  + 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEMMKMIG 98

Query: 54  C-PQIVAYKGCDISEENGKILYNLFLEYAPGGTL--------TDAIRSGTCLEEGRIRSH 104
               I+   G     ++G +   + +EYA  G L           +     +        
Sbjct: 99  KHKNIINLLGA--CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 105 TRAVLL--------GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED 156
           T   L+        G++YL S   +H D+  +N+LV+++N    KIADFG AR   +N  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR--DINNI 210

Query: 157 DEGKPICGT--PIC-MAPEVARGEEQGFPA--DVWALGCTVLEMAT-GRPPWP-----DV 205
           D  K       P+  MAPE     ++ +    DVW+ G  + E+ T G  P+P     ++
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268

Query: 206 ADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
              +   HR+       + P   + +    +  C    P +R +  +L+E 
Sbjct: 269 FKLLKEGHRM-------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 68.2 bits (167), Expect = 7e-13
 Identities = 63/291 (21%), Positives = 112/291 (38%), Gaps = 58/291 (19%)

Query: 6   GQTIGRGS-------TATVSIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALA 53
           G+ +G G         A        + +   AVK     + E   S+ +  E  ++  + 
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEMMKMIG 144

Query: 54  C-PQIVAYKGCDISEENGKILYNLFLEYAPGGTL--------TDAIRSGTCLEEGRIRSH 104
               I+   G     ++G +   + +EYA  G L           +     +        
Sbjct: 145 KHKNIINLLGA--CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 105 TRAVLL--------GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED 156
           T   L+        G++YL S   +H D+  +N+LV+++N    KIADFG AR   +N  
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR--DINNI 256

Query: 157 DEGKPICGT--PIC-MAPEVARGEEQGFPA--DVWALGCTVLEMAT-GRPPWP-----DV 205
           D  K       P+  MAPE     ++ +    DVW+ G  + E+ T G  P+P     ++
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314

Query: 206 ADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
              +   HR+       + P   + +    +  C    P +R +  +L+E 
Sbjct: 315 FKLLKEGHRM-------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 67.6 bits (166), Expect = 7e-13
 Identities = 60/242 (24%), Positives = 99/242 (40%), Gaps = 53/242 (21%)

Query: 6   GQTIGRGSTATV------SIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALAC 54
           G+T+G G    V       +      + V AVK     ++     + L  E  +L  +  
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTV-AVKMLKENASPSELRDLL-SEFNVLKQVNH 85

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS----------------GTCLEE 98
           P ++   G     ++G +L  L +EYA  G+L   +R                  + L+ 
Sbjct: 86  PHVIKLYGA--CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141

Query: 99  GRIRSHTRAVLL--------GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR 150
              R+ T   L+        G+QYL    +VH D+  +NILV++  +   KI+DFG +R 
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK--MKISDFGLSR- 198

Query: 151 ARVNEDDEGKPICGT--PIC-MAPEVARGEEQGFPA--DVWALGCTVLEMAT-GRPPWPD 204
             V E+D          P+  MA E     +  +    DVW+ G  + E+ T G  P+P 
Sbjct: 199 -DVYEEDSYVKRSQGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255

Query: 205 VA 206
           + 
Sbjct: 256 IP 257

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 67.7 bits (166), Expect = 8e-13
 Identities = 61/287 (21%), Positives = 103/287 (35%), Gaps = 53/287 (18%)

Query: 6   GQTIGRGSTATV------SIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALAC 54
           G+T+G G+   V       +G  +   +V AVK     +        +  E +I+S L  
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKV-AVKMLKSTAHADEKEALM-SELKIMSHLGQ 108

Query: 55  -PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL--- 110
              IV   G       G +L  +  EY   G L + +R  + + E               
Sbjct: 109 HENIVNLLGA--CTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164

Query: 111 -----------GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG 159
                      G+ +L S   +H D+  +N+L++  +   AKI DFG AR   +  D   
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV--AKIGDFGLAR--DIMNDSNY 220

Query: 160 KPICGT--PIC-MAPEVARGEEQGFPA--DVWALGCTVL--EMAT-GRPPWPDVADPISA 211
                   P+  MAPE     +  +    DVW+ G  +L  E+ + G  P+P +      
Sbjct: 221 IVKGNARLPVKWMAPESIF--DCVYTVQSDVWSYG--ILLWEIFSLGLNPYPGILVNSKF 276

Query: 212 LHRI--GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
              +  G+    P    +  K     +  C    P  R +  ++   
Sbjct: 277 YKLVKDGYQMAQPA---FAPKNIYSIMQACWALEPTHRPTFQQICSF 320

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 66.9 bits (164), Expect = 1e-12
 Identities = 73/293 (24%), Positives = 110/293 (37%), Gaps = 56/293 (19%)

Query: 6   GQTIGRGSTATV------SIGMSNRSSEVFAVK----SAELSNSEFLQREQRILSALAC- 54
           G+ +G G+   V       I  +  S +V AVK     A+ S  E L  E ++++ L   
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQV-AVKMLKEKADSSEREALMSELKMMTQLGSH 108

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS---------------GTCLEEG 99
             IV   G      +G I   L  EY   G L + +RS                   EE 
Sbjct: 109 ENIVNLLGA--CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 100 RIRSHTRAVLL--------GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA 151
            +   T   LL        G+++L     VH D+  +N+LV+       KI DFG AR  
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFGLAR-- 220

Query: 152 RVNEDDEGKPICGT--PIC-MAPEVARGEEQGFPA--DVWALGCTVLEMAT-GRPPWPDV 205
            +  D           P+  MAPE     E  +    DVW+ G  + E+ + G  P+P +
Sbjct: 221 DIMSDSNYVVRGNARLPVKWMAPESLF--EGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278

Query: 206 ADPISALHRI--GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
               +    I  GF  D P    Y +++    +  C   +  +R S   L   
Sbjct: 279 PVDANFYKLIQNGFKMDQPF---YATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 51/204 (25%), Positives = 78/204 (38%), Gaps = 37/204 (18%)

Query: 30  AVKS----AELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGT 85
           AVK+       +  +F  RE  +L+ L    IV + G     +   ++     EY   G 
Sbjct: 49  AVKALKDPTLAARKDFQ-REAELLTNLQHEHIVKFYGVCGDGDPLIMV----FEYMKHGD 103

Query: 86  LTDAIRS--------GTCLEEGRIRSHTRAVLL--------GLQYLHSNGIVHCDIKGQN 129
           L   +R+                      + +L        G+ YL S   VH D+  +N
Sbjct: 104 LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRN 163

Query: 130 ILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PIC-MAPEVARGEEQGFPA--D 184
            LV  +     KI DFG +R   V   D  +    T  PI  M PE      + F    D
Sbjct: 164 CLVGANLL--VKIGDFGMSR--DVYSTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESD 217

Query: 185 VWALGCTVLEMAT-GRPPWPDVAD 207
           VW+ G  + E+ T G+ PW  +++
Sbjct: 218 VWSFGVILWEIFTYGKQPWFQLSN 241

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 66.1 bits (162), Expect = 3e-12
 Identities = 46/191 (24%), Positives = 77/191 (40%), Gaps = 33/191 (17%)

Query: 30  AVK-----SAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKIL-YNLFLEYAPG 83
           AVK       +    +F Q E  ++S      ++  +G  +     ++L Y     Y   
Sbjct: 58  AVKRLKEERTQGGELQF-QTEVEMISMAVHRNLLRLRGFCM-TPTERLLVY----PYMAN 111

Query: 84  GTLTDAIRSGTCLEEGRIRSHTR-AVLLG----LQYLH--SN-GIVHCDIKGQNILVSKD 135
           G++   +R      +  +    R  + LG    L YLH   +  I+H D+K  NIL+ ++
Sbjct: 112 GSVASCLR-ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 170

Query: 136 NEQGAKIADFGCARRARVNEDDEGKP-----ICGTPICMAPEVARGEEQGFPADVWALGC 190
            E  A + DFG A+       D         + GT   +APE     +     DV+  G 
Sbjct: 171 FE--AVVGDFGLAK-----LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 223

Query: 191 TVLEMATGRPP 201
            +LE+ TG+  
Sbjct: 224 MLLELITGQRA 234

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 61/261 (23%), Positives = 91/261 (34%), Gaps = 56/261 (21%)

Query: 30  AVKS----AELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGGT 85
           AVK+    +E +  +F  RE  +L+ L    IV + G         ++     EY   G 
Sbjct: 75  AVKALKEASESARQDFQ-REAELLTMLQHQHIVRFFGVCTEGRPLLMV----FEYMRHGD 129

Query: 86  LTDAIRS-------GTCLEEGRIRSHTRAVLL--------GLQYLHSNGIVHCDIKGQNI 130
           L   +RS           E+          LL        G+ YL     VH D+  +N 
Sbjct: 130 LNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNC 189

Query: 131 LVSKDNEQGAKIADFGCARRARVNEDD------EGKPICGTPIC-MAPEVARGEEQGFPA 183
           LV +      KI DFG +R   +   D              PI  M PE      + F  
Sbjct: 190 LVGQGLV--VKIGDFGMSR--DIYSTDYYRVGGRTM----LPIRWMPPESIL--YRKFTT 239

Query: 184 --DVWALGCTVLEMAT-GRPPWP-----DVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
             DVW+ G  + E+ T G+ PW      +  D I+    +       E P     +    
Sbjct: 240 ESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL-------ERPRACPPEVYAI 292

Query: 236 LSKCLIRNPGERWSASELLEH 256
           +  C  R P +R S  ++   
Sbjct: 293 MRGCWQREPQQRHSIKDVHAR 313

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 47/235 (20%), Positives = 83/235 (35%), Gaps = 45/235 (19%)

Query: 6   GQTIGRGSTATV------SIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALAC 54
            + +G      V            ++  V A+K     +      EF   E  + + L  
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAV-AIKTLKDKAEGPLREEFR-HEAMLRARLQH 71

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS--------GTCLEEGRIRSHTR 106
           P +V   G    ++   ++      Y   G L + +           T  +     +   
Sbjct: 72  PNVVCLLGVVTKDQPLSMI----FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 127

Query: 107 AVLL--------GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE 158
              +        G++YL S+ +VH D+  +N+LV        KI+D G  R   V   D 
Sbjct: 128 PDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN--VKISDLGLFR--EVYAADY 183

Query: 159 GKPICGT--PIC-MAPEVARGEEQGFPA--DVWALGCTVLEMAT-GRPPWPDVAD 207
            K +  +  PI  MAPE        F    D+W+ G  + E+ + G  P+   ++
Sbjct: 184 YKLLGNSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 236

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 54/231 (23%), Positives = 87/231 (37%), Gaps = 46/231 (19%)

Query: 6   GQTIGRGSTATVSIGM---SNRSSEVFAVK-----SAELSNSEFLQREQRILSALAC-PQ 56
              IG G+   V            +  A+K     +++  + +F   E  +L  L   P 
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKDDHRDFA-GELEVLCKLGHHPN 87

Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS--------GTCLEEGRIRSHTRAV 108
           I+   G    E  G +   L +EYAP G L D +R            +      + +   
Sbjct: 88  IINLLGA--CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143

Query: 109 LL--------GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGK 160
           LL        G+ YL     +H D+  +NILV ++    AKIADFG +R       +   
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSR-----GQEVYV 196

Query: 161 PICGT--PIC-MAPEVARGEEQGF--PADVWALGCTVLEMAT-GRPPWPDV 205
                  P+  MA E        +   +DVW+ G  + E+ + G  P+  +
Sbjct: 197 KKTMGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 245

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 51/213 (23%), Positives = 76/213 (35%), Gaps = 46/213 (21%)

Query: 30  AVK-----SAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAPGG 84
           AVK     ++    ++F  RE  +++    P IV   G         +   L  EY   G
Sbjct: 81  AVKMLKEEASADMQADFQ-REAALMAEFDNPNIVKLLGV--CAVGKPMC--LLFEYMAYG 135

Query: 85  TLTDAIRS----------------GTCLEEGRIRSHTRAVLL--------GLQYLHSNGI 120
            L + +RS                   +        + A  L        G+ YL     
Sbjct: 136 DLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF 195

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGT--PIC-MAPEVARGE 177
           VH D+  +N LV ++     KIADFG +R   +   D  K       PI  M PE     
Sbjct: 196 VHRDLATRNCLVGENMV--VKIADFGLSR--NIYSADYYKADGNDAIPIRWMPPESIF-- 249

Query: 178 EQGFPA--DVWALGCTVLEMAT-GRPPWPDVAD 207
              +    DVWA G  + E+ + G  P+  +A 
Sbjct: 250 YNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.0 bits (108), Expect = 2e-05
 Identities = 57/357 (15%), Positives = 96/357 (26%), Gaps = 127/357 (35%)

Query: 23  NRSSEVFAVKSAELSNSEFLQREQRI------------LSALAC---------PQIVAY- 60
           +R      ++ A L     L+  + +            ++   C            + + 
Sbjct: 132 SRLQPYLKLRQA-LLE---LRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWL 187

Query: 61  --KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
             K C+  E   ++L  L  +  P  T      S   L    I++  R +L    Y    
Sbjct: 188 NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY---- 243

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIAD-FGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
              +C +    +L    N Q AK  + F                                
Sbjct: 244 --ENCLL----VL---LNVQNAKAWNAFN------------------------------- 263

Query: 178 EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
                     L C +L   T R     V D +SA      S D          + +  L 
Sbjct: 264 ----------LSCKIL--LTTRF--KQVTDFLSAATTTHISLD-HHSMTLTPDEVKSLLL 308

Query: 238 KCL-IRN---PGERWSAS--------ELLEHGFVKEQNFK--------------LSTLTE 271
           K L  R    P E  + +        E +  G     N+K              L+ L  
Sbjct: 309 KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEP 368

Query: 272 PET---YNS-----ES---PTSVLNQQLWDSTLTSCSSASAKERIRQ-LIGEGSSEM 316
            E    ++       S   PT +L   +W   + S       +  +  L+ +   E 
Sbjct: 369 AEYRKMFDRLSVFPPSAHIPTILL-SLIWFDVIKSDVMVVVNKLHKYSLVEKQPKES 424

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	385
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.88
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.76
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.43
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.22
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.12
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.92
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.66
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.64
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.45
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.41
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.29
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.2
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.14
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.85
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.85
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.83
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.78
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.54
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.44
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.38
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.37
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.28
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.23
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.98
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.89
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.88
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.86
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.28
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.06
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	83.28

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.1e-65  Score=490.15  Aligned_cols=255  Identities=27%  Similarity=0.445  Sum_probs=224.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      ||++++.||+|+||+||+|+++.+|+.||||++.+      ...+.+.+|+++|++|+|||||++++++.+...    +|
T Consensus        33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~----~y  108 (311)
T 4aw0_A           33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK----LY  108 (311)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE----EE
T ss_pred             ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE----EE
Confidence            59999999999999999999999999999999863      345678999999999999999999999876543    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      ||||||+||+|.+++++.+.++|..++.|++||+.||+|||++||+||||||+|||++.++.  +||+|||+|+......
T Consensus       109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~--vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPES  186 (311)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTT
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC--EEEEEcCCceecCCCC
Confidence            99999999999999998888999999999999999999999999999999999999987776  9999999999875332


Q ss_pred             -CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          156 -DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       156 -~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                       .....+.+||+.|||||++.+..|+.++|||||||++|+|++|++||... +......++..  ..+.+|..+|+++++
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-~~~~~~~~i~~--~~~~~p~~~s~~~~d  263 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEGLIFAKIIK--LEYDFPEKFFPKARD  263 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHH--TCCCCCTTCCHHHHH
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHc--CCCCCCcccCHHHHH
Confidence             22345679999999999999999999999999999999999999999764 45555555432  234567789999999


Q ss_pred             HHHHhhhcCCCCCCCHHH------HHhCccccccccc
Q 040569          235 FLSKCLIRNPGERWSASE------LLEHGFVKEQNFK  265 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~e------lL~hp~~~~~~~~  265 (385)
                      ||.+||++||.+|||++|      +++||||+..++.
T Consensus       264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~  300 (311)
T 4aw0_A          264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE  300 (311)
T ss_dssp             HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred             HHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence            999999999999999987      5899999987654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.7e-64  Score=478.55  Aligned_cols=252  Identities=29%  Similarity=0.432  Sum_probs=219.1

Q ss_pred             eeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            4 TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +..+.||+|+||+||+|+++.+++.||+|.+...     ..+.+.+|+++|++|+|||||++++++.+...+...++|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            5677899999999999999999999999988532     13567899999999999999999999877655556678999


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEeec-CCCCCeEEeecCceeeecccC
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG--IVHCDIKGQNILVSK-DNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~g--ivHrDlKp~NILi~~-~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |||+||+|.+++++.+.+++..++.+++||+.||+|||++|  |+||||||+||||+. ++.  +||+|||+|+...   
T Consensus       109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~--vKl~DFGla~~~~---  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKR---  183 (290)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSC--EEECCTTGGGGCC---
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCC--EEEEeCcCCEeCC---
Confidence            99999999999998888999999999999999999999998  999999999999974 444  9999999997542   


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                      .....+.+|||.|||||++.+ .|+.++|||||||++|||+||++||.+..+.......+......+.++...++++++|
T Consensus       184 ~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  262 (290)
T 3fpq_A          184 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI  262 (290)
T ss_dssp             TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred             CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHH
Confidence            223456789999999999875 5999999999999999999999999876666666666654444455677789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      |.+||++||.+|||++|+|+||||++
T Consensus       263 i~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          263 IEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHccCChhHCcCHHHHhcCccccC
Confidence            99999999999999999999999975

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.7e-64  Score=488.58  Aligned_cols=252  Identities=31%  Similarity=0.493  Sum_probs=219.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC---CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL---SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      .|++++.||+|+||+||+|+++.+|+.||||++..   ...+.+.+|+++|++++|||||++++++.+...    +||||
T Consensus        75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~----~~ivm  150 (346)
T 4fih_A           75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE----LWVVM  150 (346)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTE----EEEEE
T ss_pred             hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE----EEEEE
Confidence            48999999999999999999999999999999864   335678899999999999999999999877654    77999


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      |||+||+|.+++.++ +++|..++.+++||+.||+|||++||+||||||+||||+.++.  +||+|||+|+..... ...
T Consensus       151 Ey~~gg~L~~~l~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~-~~~  226 (346)
T 4fih_A          151 EFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKE-VPR  226 (346)
T ss_dssp             CCCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSS-SCC
T ss_pred             eCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC--EEEecCcCceecCCC-CCc
Confidence            999999999999865 5999999999999999999999999999999999999988776  999999999986432 223


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC-CCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS-SDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~ll~  237 (385)
                      ..+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+. +....+..+... ......+..+|+++++||.
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~  305 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-PPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD  305 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-CHHHHHHHHHcCCCCCCCccccCCHHHHHHHH
Confidence            45678999999999999999999999999999999999999999874 455555544322 1222334568999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCcccccc
Q 040569          238 KCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +||++||.+|||++|+|+||||++.
T Consensus       306 ~~L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          306 RLLVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHcCCChhHCcCHHHHhcCHhhcCC
Confidence            9999999999999999999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.9e-64  Score=471.27  Aligned_cols=248  Identities=27%  Similarity=0.416  Sum_probs=205.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||++.+.      ..+.+.+|+++|++++|||||++++++.+...    +|
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~----~~   89 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDE----II   89 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE----EE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE----EE
Confidence            699999999999999999999999999999998643      23568899999999999999999999876543    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||| +|+|.+++.+.+++++..++.+++||+.||+|||++||+||||||+|||++.++.  +||+|||+|+....  
T Consensus        90 ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~--  164 (275)
T 3hyh_A           90 MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN--VKIADFGLSNIMTD--  164 (275)
T ss_dssp             EEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC--EEECCSSCC-------
T ss_pred             EEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC--EEEeecCCCeecCC--
Confidence            999999 6799999998888999999999999999999999999999999999999987766  99999999987532  


Q ss_pred             CCCCCccccCCcccChhhhcCCCC-CCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                      .....+.+||+.|||||++.+..+ +.++|||||||++|+|+||+.||... +.......+..  ..+.+|..+|+++++
T Consensus       165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-~~~~~~~~i~~--~~~~~p~~~s~~~~~  241 (275)
T 3hyh_A          165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-SIPVLFKNISN--GVYTLPKFLSPGAAG  241 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHH--TCCCCCTTSCHHHHH
T ss_pred             CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHc--CCCCCCCCCCHHHHH
Confidence            223456789999999999998876 57999999999999999999999764 44444444422  335567889999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          235 FLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      ||.+||++||.+|||++|+|+||||+.
T Consensus       242 li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          242 LIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HHHHHccCChhHCcCHHHHHcCccccc
Confidence            999999999999999999999999964

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.5e-64  Score=489.72  Aligned_cols=252  Identities=27%  Similarity=0.467  Sum_probs=213.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||++.+..     .+.+.+|+++|++|+|||||++++++.+...    +||
T Consensus        25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~----~yi  100 (350)
T 4b9d_A           25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGS----LYI  100 (350)
T ss_dssp             CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE----EEE
T ss_pred             ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCE----EEE
Confidence            6999999999999999999999999999999987542     3567899999999999999999999876543    679


Q ss_pred             EEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           77 FLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      |||||+||+|.++|..  +..++|..++.|+.||+.||+|||++||+||||||+||||+.++.  +||+|||+|+.....
T Consensus       101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNST  178 (350)
T ss_dssp             EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC--EEECSTTEESCCCHH
T ss_pred             EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC--EEEcccccceeecCC
Confidence            9999999999999973  345799999999999999999999999999999999999988776  999999999876322


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                      . ......+||+.|||||++.+..|+.++|||||||++|||++|++||... +....+.++.. ...+.++..+|+++++
T Consensus       179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~-~~~~~~~~i~~-~~~~~~~~~~s~~~~~  255 (350)
T 4b9d_A          179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-SMKNLVLKIIS-GSFPPVSLHYSYDLRS  255 (350)
T ss_dssp             H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHH-TCCCCCCTTSCHHHHH
T ss_pred             c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-CHHHHHHHHHc-CCCCCCCccCCHHHHH
Confidence            1 1123568999999999999999999999999999999999999999874 45555555533 3445667789999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          235 FLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ||.+||++||.+|||++|+|+||||+..
T Consensus       256 li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          256 LVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence            9999999999999999999999999754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.2e-63  Score=491.05  Aligned_cols=252  Identities=31%  Similarity=0.493  Sum_probs=220.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC---CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~---~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      .|++++.||+|+||+||+|+++.+|+.||||++...   ..+.+.+|+.+|++|+|||||++++++.....    +||||
T Consensus       152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~----~~iVm  227 (423)
T 4fie_A          152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE----LWVVM  227 (423)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTE----EEEEE
T ss_pred             hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCE----EEEEE
Confidence            489999999999999999999999999999998643   35678899999999999999999999877553    77999


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      |||+||+|.++++.+ +++|..++.+++||+.||+|||++|||||||||+||||+.++.  +||+|||+|+..... ...
T Consensus       228 Ey~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~--vKl~DFGla~~~~~~-~~~  303 (423)
T 4fie_A          228 EFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKE-VPR  303 (423)
T ss_dssp             ECCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC--EEECCCTTCEECCSS-CCC
T ss_pred             eCCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEecCccceECCCC-Ccc
Confidence            999999999999865 5999999999999999999999999999999999999988776  999999999976432 223


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC-CCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS-SDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~ll~  237 (385)
                      ....+||+.|||||++.+..|+.++|||||||++|||++|++||.+. +....+..+... ......+..+|+++++||.
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~  382 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-PPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD  382 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-CHHHHHHHHHcCCCCCCcccccCCHHHHHHHH
Confidence            45678999999999999999999999999999999999999999874 455555554322 2223345568999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCcccccc
Q 040569          238 KCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +||++||.+|||+.|+|+||||+..
T Consensus       383 ~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          383 RLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHcCCChhHCcCHHHHhcCHHhcCC
Confidence            9999999999999999999999754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.5e-64  Score=477.24  Aligned_cols=254  Identities=26%  Similarity=0.416  Sum_probs=214.2

Q ss_pred             CceeeceeeccCceEEEEEEEC---CCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN---RSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~---~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|++++.||+|+||+||+|++.   .+++.||||++.+.     ....+.+|+++|++++|||||++++++.+...    
T Consensus        25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~----  100 (304)
T 3ubd_A           25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK----  100 (304)
T ss_dssp             GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE----
T ss_pred             ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE----
Confidence            5999999999999999999874   46899999988643     23467889999999999999999999876543    


Q ss_pred             EEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           74 YNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      +|||||||+||+|.+++++.+.++|..++.+++||+.||+|||++||+||||||+|||++.++.  +||+|||+|+....
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~  178 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESID  178 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC--EEEESSEEEEC---
T ss_pred             EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC--EEecccccceeccC
Confidence            7799999999999999998888999999999999999999999999999999999999988776  99999999987532


Q ss_pred             cCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHH
Q 040569          154 NEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ  233 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  233 (385)
                      . .....+.+||+.|||||++.+..|+.++|||||||++|||+||++||... +....+.++..  ..+.+|..+|++++
T Consensus       179 ~-~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~-~~~~~~~~i~~--~~~~~p~~~s~~~~  254 (304)
T 3ubd_A          179 H-EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK-DRKETMTMILK--AKLGMPQFLSPEAQ  254 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHH--CCCCCCTTSCHHHH
T ss_pred             C-CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc-CHHHHHHHHHc--CCCCCCCcCCHHHH
Confidence            2 22345678999999999999999999999999999999999999999874 45555555432  23456778999999


Q ss_pred             HHHHHhhhcCCCCCCC-----HHHHHhCccccccccc
Q 040569          234 DFLSKCLIRNPGERWS-----ASELLEHGFVKEQNFK  265 (385)
Q Consensus       234 ~ll~~cL~~dP~~Rps-----~~elL~hp~~~~~~~~  265 (385)
                      +||.+||++||.+|||     ++|+++||||+..++.
T Consensus       255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~  291 (304)
T 3ubd_A          255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN  291 (304)
T ss_dssp             HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             HHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence            9999999999999998     5799999999987653

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.9e-63  Score=477.64  Aligned_cols=244  Identities=31%  Similarity=0.421  Sum_probs=205.8

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeecC
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYAP   82 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (385)
                      |++.+.||+|+||+||+|+++.+|+.||||+++...  ...+|+.+|++|+|||||++++++.+...    +|||||||+
T Consensus        60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~--~~~~E~~il~~l~HpnIV~l~~~~~~~~~----~~ivmEy~~  133 (336)
T 4g3f_A           60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGLSSPRIVPLYGAVREGPW----VNIFMELLE  133 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCTHHHHTTTTCCCTTBCCEEEEEEETTE----EEEEECCCT
T ss_pred             eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH--hHHHHHHHHHhCCCCCCCcEEEEEEECCE----EEEEEeccC
Confidence            678889999999999999999999999999997643  23579999999999999999999876543    679999999


Q ss_pred             CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC----C
Q 040569           83 GGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD----E  158 (385)
Q Consensus        83 ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~----~  158 (385)
                      ||+|.++|++.+++++..++.|+.||+.||+|||++||+||||||+||||+.++. .+||+|||+|+........    .
T Consensus       134 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~~~~~~  212 (336)
T 4g3f_A          134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKSLLT  212 (336)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC-----------
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcccceec
Confidence            9999999998788999999999999999999999999999999999999987652 3999999999976433221    2


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc-CCCCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG-FSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      ....+||+.|||||++.+..|+.++|||||||++|||+||++||....... ...++. .......++..+|+++++||.
T Consensus       213 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~s~~~~~li~  291 (336)
T 4g3f_A          213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-LCLKIASEPPPIREIPPSCAPLTAQAIQ  291 (336)
T ss_dssp             -CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-CHHHHHHSCCGGGGSCTTSCHHHHHHHH
T ss_pred             CCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHcCCCCchhcCccCCHHHHHHHH
Confidence            234689999999999999999999999999999999999999997643322 222222 222234567789999999999


Q ss_pred             HhhhcCCCCCCCHHHHH
Q 040569          238 KCLIRNPGERWSASELL  254 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL  254 (385)
                      +||++||.+|||+.|++
T Consensus       292 ~~L~~dP~~R~sa~el~  308 (336)
T 4g3f_A          292 EGLRKEPVHRASAMELR  308 (336)
T ss_dssp             HHTCSSGGGSCCHHHHH
T ss_pred             HHccCCHhHCcCHHHHH
Confidence            99999999999999984

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.4e-61  Score=458.69  Aligned_cols=256  Identities=22%  Similarity=0.352  Sum_probs=201.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCC-------
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENG-------   70 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~-------   70 (385)
                      ||++++.||+|+||+||+|+++.+|+.||||.+....    .+.+.+|+++|++|+|||||++++++......       
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            5899999999999999999999999999999986543    24678999999999999999999998765432       


Q ss_pred             -eEEEEEEEeecCCCCHHHHHHcCCCC---CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecC
Q 040569           71 -KILYNLFLEYAPGGTLTDAIRSGTCL---EEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG  146 (385)
Q Consensus        71 -~~~~~lv~Ey~~ggsL~~~l~~~~~l---~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG  146 (385)
                       ..++|+|||||+||+|.+++...+.+   ++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DFG  163 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFG  163 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc--EEEccCc
Confidence             23467999999999999999866544   45668999999999999999999999999999999988766  9999999


Q ss_pred             ceeeecccCCC-----------CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh
Q 040569          147 CARRARVNEDD-----------EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI  215 (385)
Q Consensus       147 ~a~~~~~~~~~-----------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~  215 (385)
                      +|+........           .....+||+.|||||++.+..|+.++|||||||++|||++   ||....+....+..+
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~  240 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV  240 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHH
Confidence            99876433221           1234589999999999999999999999999999999996   786433333333333


Q ss_pred             cCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          216 GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       216 ~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      . ....|..+...++.+++||.+||++||.+|||+.|+|+||||++.+
T Consensus       241 ~-~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          241 R-NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             H-TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             h-cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            2 2233333344677889999999999999999999999999998654

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-59  Score=460.46  Aligned_cols=257  Identities=27%  Similarity=0.332  Sum_probs=211.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccC--CeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEEN--GKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~~~~   74 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||++....     .+.+.+|+++|++|+|||||++++++.....  ....+
T Consensus        55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~  134 (398)
T 4b99_A           55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV  134 (398)
T ss_dssp             SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred             CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence            4899999999999999999999999999999986432     2456789999999999999999998754321  11226


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      |||||||. |+|.+++.+.+++++..++.+++||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.....
T Consensus       135 ~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          135 YVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLCTS  211 (398)
T ss_dssp             EEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC---
T ss_pred             EEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeecccC
Confidence            79999996 689999998889999999999999999999999999999999999999987766  999999999876432


Q ss_pred             C---CCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCC---------
Q 040569          155 E---DDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDT---------  221 (385)
Q Consensus       155 ~---~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~---------  221 (385)
                      .   .....+.+||+.|||||++.+. .++.++||||+||++|||++|++||.+. +....+..+......         
T Consensus       212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~-~~~~~l~~I~~~~g~p~~~~~~~~  290 (398)
T 4b99_A          212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK-NYVHQLQLIMMVLGTPSPAVIQAV  290 (398)
T ss_dssp             ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS-SHHHHHHHHHHHHCCCCGGGTC--
T ss_pred             ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC-CHHHHHHHHHHhcCCCChHHhhhh
Confidence            1   2234567999999999998875 5699999999999999999999999874 333333332110000         


Q ss_pred             -------------CC-------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          222 -------------PE-------IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       222 -------------~~-------~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                   +.       +...+|+++++||.+||++||.+|||+.|+|+||||++.
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence                         00       112478999999999999999999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-58  Score=439.91  Aligned_cols=245  Identities=23%  Similarity=0.360  Sum_probs=200.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      ++++++.||+|+||+||+|+++.   .+|||+++...     .+.+.+|+++|++++|||||++++++.. ..    ++|
T Consensus        37 ~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~----~~i  108 (307)
T 3omv_A           37 EVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN----LAI  108 (307)
T ss_dssp             SCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS----CEE
T ss_pred             HeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce----EEE
Confidence            46788999999999999998753   48999886432     3567899999999999999999997643 22    569


Q ss_pred             EEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |||||+||+|.+++.. .+++++..+..++.||+.||+|||++|||||||||+||||+.++.  +||+|||+|+......
T Consensus       109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSRWS  186 (307)
T ss_dssp             EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE--EEECCCSSCBC-----
T ss_pred             EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc--EEEeeccCceecccCC
Confidence            9999999999999974 567999999999999999999999999999999999999997766  9999999998754322


Q ss_pred             -CCCCCccccCCcccChhhhcCC---CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC---CCCCCCCCcC
Q 040569          156 -DDEGKPICGTPICMAPEVARGE---EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS---SDTPEIPGYM  228 (385)
Q Consensus       156 -~~~~~~~~Gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~---~~~~~~~~~~  228 (385)
                       .......+||+.|||||++.+.   .|+.++|||||||++|||+||+.||.+..+.......+...   ...+.++..+
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  266 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC  266 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTS
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccc
Confidence             2234566899999999999754   58889999999999999999999998876655444444322   2334566778


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          229 SKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       229 s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      |+++.+|+.+||++||.+|||+.|++++
T Consensus       267 ~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          267 PKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             CHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999988654

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.8e-58  Score=447.44  Aligned_cols=253  Identities=26%  Similarity=0.350  Sum_probs=205.9

Q ss_pred             CceeeceeeccCceEEEEEEEC---CCCcEEEEEeccCC-CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN---RSSEVFAVKSAELS-NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~---~~~~~~AvK~~~~~-~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      .|++++.||+|+||+||+|+++   .+++.||+|.+... ....+.+|+++|+.+ .||||+++++++.....    +|+
T Consensus        22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~----~~l   97 (361)
T 4f9c_A           22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH----VVI   97 (361)
T ss_dssp             TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE----EEE
T ss_pred             cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE----EEE
Confidence            4999999999999999999875   46789999987644 456788999999998 79999999999876543    679


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |||||+||+|.++++   .+++..++.+++||+.||+|||++||+||||||+|||++.+. ..+||+|||+|+.......
T Consensus        98 vmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~-~~~kl~DFGla~~~~~~~~  173 (361)
T 4f9c_A           98 AMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL-KKYALVDFGLAQGTHDTKI  173 (361)
T ss_dssp             EEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECTTCSC
T ss_pred             EEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC-CeEEECcCCCCcccCCccc
Confidence            999999999999985   499999999999999999999999999999999999998652 2389999999986532211


Q ss_pred             ---------------------------CCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCCh
Q 040569          157 ---------------------------DEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADP  208 (385)
Q Consensus       157 ---------------------------~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~  208 (385)
                                                 ....+.+||+.|||||++.+. .|+.++||||+||++|||++|+.||....+.
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~  253 (361)
T 4f9c_A          174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD  253 (361)
T ss_dssp             GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence                                       122345899999999999875 5899999999999999999999999765554


Q ss_pred             HHHHHHhcC---------------------------------------CCCC-------------CCCCCcCCHHHHHHH
Q 040569          209 ISALHRIGF---------------------------------------SSDT-------------PEIPGYMSKQAQDFL  236 (385)
Q Consensus       209 ~~~~~~~~~---------------------------------------~~~~-------------~~~~~~~s~~~~~ll  236 (385)
                      ...+.++..                                       ....             ......+|++++|||
T Consensus       254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl  333 (361)
T 4f9c_A          254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL  333 (361)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence            444332210                                       0000             011235799999999


Q ss_pred             HHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          237 SKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      .+||++||.+|||++|+|+||||++.
T Consensus       334 ~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          334 DKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             HHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHCcCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999864

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.1e-58  Score=476.91  Aligned_cols=253  Identities=24%  Similarity=0.363  Sum_probs=215.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHH---HHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQRE---QRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E---~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      ||++++.||+|+||+||+|+++.+|+.||||++.+.      ....+.+|   +.+++.++|||||++++++.+...   
T Consensus       190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~---  266 (689)
T 3v5w_A          190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK---  266 (689)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE---
T ss_pred             HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE---
Confidence            699999999999999999999999999999998642      23344444   566677899999999999876654   


Q ss_pred             EEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           73 LYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                       +|||||||+||+|.++|.+.+.++|..++.|+.||+.||+|||++|||||||||+||||+.++.  +||+|||+|+...
T Consensus       267 -lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~--vKL~DFGlA~~~~  343 (689)
T 3v5w_A          267 -LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFS  343 (689)
T ss_dssp             -EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC--EEECCCTTCEECS
T ss_pred             -EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC--EEecccceeeecC
Confidence             7799999999999999998888999999999999999999999999999999999999998776  9999999998764


Q ss_pred             ccCCCCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHhcCCCCCCCCCCcCC
Q 040569          153 VNEDDEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVA--DPISALHRIGFSSDTPEIPGYMS  229 (385)
Q Consensus       153 ~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~s  229 (385)
                      .   ....+.+|||.|||||++.+ ..|+.++|||||||++|||++|++||....  +.......+.  ...+.+|..+|
T Consensus       344 ~---~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~--~~~~~~p~~~S  418 (689)
T 3v5w_A          344 K---KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TMAVELPDSFS  418 (689)
T ss_dssp             S---CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH--HCCCCCCTTSC
T ss_pred             C---CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc--CCCCCCCccCC
Confidence            2   23456799999999999964 579999999999999999999999997532  2333333321  23345677899


Q ss_pred             HHHHHHHHHhhhcCCCCCCC-----HHHHHhCccccccccc
Q 040569          230 KQAQDFLSKCLIRNPGERWS-----ASELLEHGFVKEQNFK  265 (385)
Q Consensus       230 ~~~~~ll~~cL~~dP~~Rps-----~~elL~hp~~~~~~~~  265 (385)
                      +++++||.+||++||.+|++     ++|+++||||+..++.
T Consensus       419 ~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~  459 (689)
T 3v5w_A          419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  459 (689)
T ss_dssp             HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred             HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence            99999999999999999998     7999999999988654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.1e-58  Score=441.24  Aligned_cols=250  Identities=22%  Similarity=0.359  Sum_probs=209.7

Q ss_pred             CceeeceeeccCceEEEEEEEC-----CCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN-----RSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|++.+.||+|+||+||+|++.     .++..||||++....   .+.+.+|+++|++|+|||||++++++.+...    
T Consensus        14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~----   89 (299)
T 4asz_A           14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP----   89 (299)
T ss_dssp             GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS----
T ss_pred             HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE----
Confidence            5788999999999999999875     468899999997654   3567899999999999999999999876554    


Q ss_pred             EEEEEeecCCCCHHHHHHcC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCe
Q 040569           74 YNLFLEYAPGGTLTDAIRSG-------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGA  140 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~-------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~  140 (385)
                      ++||||||+||+|.++|++.             ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.  +
T Consensus        90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~--~  167 (299)
T 4asz_A           90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--V  167 (299)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--E
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--E
Confidence            67999999999999999743             36999999999999999999999999999999999999988766  9


Q ss_pred             EEeecCceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCC
Q 040569          141 KIADFGCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFS  218 (385)
Q Consensus       141 kL~DFG~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~  218 (385)
                      ||+|||+|+........ .....+||+.|||||++.+..|+.++|||||||++|||+| |+.||.... ....+..+. .
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~-~~~~~~~i~-~  245 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-NNEVIECIT-Q  245 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-HHHHHHHHH-H
T ss_pred             EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHH-c
Confidence            99999999865432221 2334579999999999999999999999999999999998 999998753 444444443 2


Q ss_pred             CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          219 SDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       219 ~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      ...+..|..+|+++.+|+.+||++||++|||+.|++  ++++.
T Consensus       246 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~  286 (299)
T 4asz_A          246 GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN  286 (299)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred             CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence            345667888999999999999999999999999995  35543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.6e-58  Score=440.57  Aligned_cols=247  Identities=25%  Similarity=0.357  Sum_probs=202.7

Q ss_pred             CceeeceeeccCceEEEEEEEC-----CCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN-----RSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      |+++.+.||+|+||+||+|+++     .+++.||||++....   .+.+.+|+++|++|+|||||++++++.....    
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~----  117 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP----  117 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS----
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE----
Confidence            4677899999999999999865     468999999997654   3568899999999999999999999876554    


Q ss_pred             EEEEEeecCCCCHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCC
Q 040569           74 YNLFLEYAPGGTLTDAIRSG---------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQ  138 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~---------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~  138 (385)
                      ++||||||+||+|.+++++.               +++++..+..++.||+.||+|||+++|+||||||+||||+.++. 
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~-  196 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV-  196 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE-
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc-
Confidence            67999999999999999742               35899999999999999999999999999999999999997766 


Q ss_pred             CeEEeecCceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhc
Q 040569          139 GAKIADFGCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIG  216 (385)
Q Consensus       139 ~~kL~DFG~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~  216 (385)
                       +||+|||+|+....... ......+||+.|||||++.+..++.++|||||||++|||+| |+.||.... ....+..+.
T Consensus       197 -~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~-~~~~~~~i~  274 (329)
T 4aoj_A          197 -VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS-NTEAIDCIT  274 (329)
T ss_dssp             -EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC-HHHHHHHHH
T ss_pred             -EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC-HHHHHHHHH
Confidence             99999999987643322 22345679999999999999999999999999999999999 999998754 344444442


Q ss_pred             CCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          217 FSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       217 ~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                       ....+..|..+|+++.+|+.+||++||++|||+.|++++
T Consensus       275 -~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          275 -QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             -HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             -cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence             234566778899999999999999999999999999874

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.1e-57  Score=434.08  Aligned_cols=247  Identities=19%  Similarity=0.261  Sum_probs=209.7

Q ss_pred             CceeeceeeccCceEEEEEEEC-----CCCcEEEEEeccCC----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN-----RSSEVFAVKSAELS----NSEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~~AvK~~~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      ++++.+.||+|+||+||+|+..     .+++.||||.+...    ..+.+.+|+.+|++++|||||+++|++.....   
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~---  103 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP---  103 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS---
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE---
Confidence            3567899999999999999863     46789999998642    24678999999999999999999999876554   


Q ss_pred             EEEEEEeecCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC
Q 040569           73 LYNLFLEYAPGGTLTDAIRSG----------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN  136 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~----------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~  136 (385)
                       ++||||||++|+|.++|...                ..+++..+..++.||++||+|||+++||||||||+||||+.++
T Consensus       104 -~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          104 -LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             -CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             -EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC
Confidence             66999999999999999632                3589999999999999999999999999999999999998876


Q ss_pred             CCCeEEeecCceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHH
Q 040569          137 EQGAKIADFGCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHR  214 (385)
Q Consensus       137 ~~~~kL~DFG~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~  214 (385)
                      .  +||+|||+|+....... ......+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.. ....+..
T Consensus       183 ~--~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~-~~~~~~~  259 (308)
T 4gt4_A          183 N--VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-NQDVVEM  259 (308)
T ss_dssp             C--EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC-HHHHHHH
T ss_pred             C--EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-HHHHHHH
Confidence            6  99999999987643322 23345689999999999999999999999999999999998 899998753 4444444


Q ss_pred             hcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          215 IGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       215 ~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      +. ....+..|..+|+++.+|+.+||+.||.+|||+.|++++
T Consensus       260 i~-~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          260 IR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HH-cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            43 344556778899999999999999999999999999874

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.3e-57  Score=468.12  Aligned_cols=255  Identities=24%  Similarity=0.377  Sum_probs=220.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|++++.||+|+||+||+|+++.+|+.||+|.+....   .+.+++|+++|+.|+|||||++++++.+...    +||||
T Consensus       158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~----~~iv~  233 (573)
T 3uto_A          158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE----MVMIY  233 (573)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE----EEEEE
T ss_pred             ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE----EEEEE
Confidence            5899999999999999999999999999999987654   3567899999999999999999999876543    67999


Q ss_pred             eecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           79 EYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        79 Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |||+||+|.++|. +.+.++|..++.|++||+.||+|||++||+||||||+|||++.+..+.+||+|||+|+....  ..
T Consensus       234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~--~~  311 (573)
T 3uto_A          234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--KQ  311 (573)
T ss_dssp             ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT--TS
T ss_pred             eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC--CC
Confidence            9999999999997 45679999999999999999999999999999999999999876445599999999998742  22


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCC--CCCCCCcCCHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSD--TPEIPGYMSKQAQDF  235 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~l  235 (385)
                      .....+||+.|||||++.+..|+.++|||||||++|+|++|++||.+. +....+..+.....  .+..+..+|+++++|
T Consensus       312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dl  390 (573)
T 3uto_A          312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-NDDETLRNVKSCDWNMDDSAFSGISEDGKDF  390 (573)
T ss_dssp             EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred             ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-CHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence            345668999999999999999999999999999999999999999874 44455555433221  223345689999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      |.+||++||.+|||+.|+|+||||+...
T Consensus       391 i~~~L~~dp~~R~t~~e~l~Hpw~~~~~  418 (573)
T 3uto_A          391 IRKLLLADPNTRMTIHQALEHPWLTPGN  418 (573)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred             HHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence            9999999999999999999999998654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.2e-56  Score=436.28  Aligned_cols=249  Identities=25%  Similarity=0.341  Sum_probs=209.4

Q ss_pred             CceeeceeeccCceEEEEEEECCC-----CcEEEEEeccCCC----HHHHHHHHHHHHhcCC-CCeeeeeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRS-----SEVFAVKSAELSN----SEFLQREQRILSALAC-PQIVAYKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~~AvK~~~~~~----~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~   71 (385)
                      +|++++.||+|+||+||+|.++.+     ++.||||.+....    .+.+.+|+++|+++.| ||||++++++..... .
T Consensus        65 ~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~-~  143 (353)
T 4ase_A           65 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG-P  143 (353)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS-C
T ss_pred             HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC-E
Confidence            478899999999999999997654     3689999986543    3457899999999965 999999998765432 1


Q ss_pred             EEEEEEEeecCCCCHHHHHHc----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecC
Q 040569           72 ILYNLFLEYAPGGTLTDAIRS----------------GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKD  135 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~----------------~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~  135 (385)
                        ++||||||++|+|.++|++                ...+++..+..++.||++||+|||+++||||||||+|||++.+
T Consensus       144 --~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~  221 (353)
T 4ase_A          144 --LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  221 (353)
T ss_dssp             --CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             --EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC
Confidence              5699999999999999974                2348999999999999999999999999999999999999887


Q ss_pred             CCCCeEEeecCceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 040569          136 NEQGAKIADFGCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALH  213 (385)
Q Consensus       136 ~~~~~kL~DFG~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~  213 (385)
                      +.  +||+|||+|+........ .....+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.........
T Consensus       222 ~~--vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~  299 (353)
T 4ase_A          222 NV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  299 (353)
T ss_dssp             GC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred             CC--EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            76  999999999876433221 2345679999999999999999999999999999999998 9999987654444333


Q ss_pred             HhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          214 RIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       214 ~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      .+ .....+..|..+++++.+||.+||++||.+|||+.|+++|
T Consensus       300 ~i-~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          300 RL-KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HH-HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HH-HcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            33 2344566788899999999999999999999999999987

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.5e-54  Score=413.86  Aligned_cols=250  Identities=24%  Similarity=0.239  Sum_probs=196.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHH--HHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQR--EQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~--E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|.+.+.||+|+||+||+|++  +|+.||||++.......+.+  |+..+.+++|||||++++++.........++||||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            578899999999999999987  48999999998766554444  55555678999999999998876654445779999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN--------GIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~--------givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      ||+||+|.++++.. .+++..+..++.|++.||+|||++        +|+||||||+||||+.++.  +||+|||+|+..
T Consensus        82 y~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~  158 (303)
T 3hmm_A           82 YHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRH  158 (303)
T ss_dssp             CCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEEE
T ss_pred             CCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCCccc
Confidence            99999999999865 489999999999999999999987        9999999999999988776  999999999876


Q ss_pred             cccCCC---CCCccccCCcccChhhhcCC------CCCCCCChHHHHHHHHHHHhCCCCCCCCC--------------Ch
Q 040569          152 RVNEDD---EGKPICGTPICMAPEVARGE------EQGFPADVWALGCTVLEMATGRPPWPDVA--------------DP  208 (385)
Q Consensus       152 ~~~~~~---~~~~~~Gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltG~~Pf~~~~--------------~~  208 (385)
                      ......   .....+||+.|||||++.+.      .++.++|||||||++|||+||++||....              ..
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            433221   22345799999999999764      36778999999999999999987664211              11


Q ss_pred             HHHHHHhcCCCCCCCCCCc-----CCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          209 ISALHRIGFSSDTPEIPGY-----MSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~-----~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ......+......|.+|..     .++.+.+|+.+||+.||.+|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            2222223233334555543     23578899999999999999999999874

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.7e-53  Score=412.34  Aligned_cols=254  Identities=28%  Similarity=0.455  Sum_probs=220.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+||+|+++.+|+.||+|.+..      ...+.+.+|..+|++++||||+++++++.....    ++
T Consensus         6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~----~~   81 (337)
T 1o6l_A            6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR----LC   81 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE----EE
T ss_pred             HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCE----EE
Confidence            68999999999999999999999999999998853      345678899999999999999999998876543    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++..... 
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~-  158 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISD-  158 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCT-
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC--EEEeeccchhhcccC-
Confidence            99999999999999998778999999999999999999999999999999999999987776  999999999864322 


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||... +.......+..  ....+|..+|+++++|
T Consensus       159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-~~~~~~~~i~~--~~~~~p~~~s~~~~~l  235 (337)
T 1o6l_A          159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHERLFELILM--EEIRFPRTLSPEAKSL  235 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHH--CCCCCCTTSCHHHHHH
T ss_pred             CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC-CHHHHHHHHHc--CCCCCCCCCCHHHHHH
Confidence            22345678999999999999999999999999999999999999999764 33343333322  2345677899999999


Q ss_pred             HHHhhhcCCCCCC-----CHHHHHhCccccccccc
Q 040569          236 LSKCLIRNPGERW-----SASELLEHGFVKEQNFK  265 (385)
Q Consensus       236 l~~cL~~dP~~Rp-----s~~elL~hp~~~~~~~~  265 (385)
                      |.+||++||.+||     ++.|+++||||...++.
T Consensus       236 i~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~  270 (337)
T 1o6l_A          236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             HHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence            9999999999999     99999999999987553

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.8e-53  Score=408.33  Aligned_cols=250  Identities=29%  Similarity=0.470  Sum_probs=216.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--C---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--N---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++++.||+|+||+||+|++..+|+.||||++...  .   .+.+.+|+++|+.++||||+++++++.....    +++
T Consensus        16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----~~l   91 (328)
T 3fe3_A           16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT----LYL   91 (328)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE----EEE
T ss_pred             CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE----EEE
Confidence            699999999999999999999999999999988643  1   3457789999999999999999998765443    679


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      ||||++||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.....  
T Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~--  167 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVG--  167 (328)
T ss_dssp             EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSS--
T ss_pred             EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCC--
Confidence            9999999999999987778999999999999999999999999999999999999987766  999999999765322  


Q ss_pred             CCCCccccCCcccChhhhcCCCCC-CCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          157 DEGKPICGTPICMAPEVARGEEQG-FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                      ......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||... +.......+..  ....+|..+|+++.+|
T Consensus       168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~--~~~~~p~~~s~~~~~l  244 (328)
T 3fe3_A          168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ-NLKELRERVLR--GKYRIPFYMSTDCENL  244 (328)
T ss_dssp             CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHH--CCCCCCTTSCHHHHHH
T ss_pred             CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHHh--CCCCCCCCCCHHHHHH
Confidence            233456899999999999988775 7899999999999999999999874 34444444322  2345667789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      |.+||..||.+|||++|+|+||||+..
T Consensus       245 i~~~L~~dP~~R~t~~eil~h~~~~~~  271 (328)
T 3fe3_A          245 LKRFLVLNPIKRGTLEQIMKDRWINAG  271 (328)
T ss_dssp             HHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred             HHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence            999999999999999999999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6.9e-53  Score=400.31  Aligned_cols=253  Identities=32%  Similarity=0.543  Sum_probs=217.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC---CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL---SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|++.+.||+|+||+||+|++..+++.||+|.+..   ...+.+.+|+.++++++||||+++++++.....    +++||
T Consensus        21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~----~~lv~   96 (297)
T 3fxz_A           21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDE----LWVVM   96 (297)
T ss_dssp             TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE----EEEEE
T ss_pred             ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCE----EEEEE
Confidence            59999999999999999999999999999998753   346778899999999999999999998876543    67999


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      ||++||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||++........ .
T Consensus        97 e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~-~  172 (297)
T 3fxz_A           97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS-K  172 (297)
T ss_dssp             ECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTC-C
T ss_pred             ECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC--EEEeeCCCceecCCccc-c
Confidence            999999999999865 5999999999999999999999999999999999999987766  99999999987643322 2


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK  238 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~  238 (385)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||......................+..+++.+++||.+
T Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  252 (297)
T 3fxz_A          173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR  252 (297)
T ss_dssp             BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHH
T ss_pred             cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHH
Confidence            34567999999999999999999999999999999999999999875333222222222223334466789999999999


Q ss_pred             hhhcCCCCCCCHHHHHhCcccccc
Q 040569          239 CLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       239 cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ||+.||.+|||+.|+|+||||+..
T Consensus       253 ~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          253 CLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             HSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HccCChhHCcCHHHHhhChhhccc
Confidence            999999999999999999999753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.9e-53  Score=414.56  Aligned_cols=254  Identities=26%  Similarity=0.458  Sum_probs=216.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++++.||+|+||+||+|+++.+++.||||++..      ...+.+.+|..+|+.+ +||||+++++++.....    +
T Consensus        24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~----~   99 (353)
T 3txo_A           24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR----L   99 (353)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE----E
T ss_pred             heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE----E
Confidence            69999999999999999999999999999998864      2346678899999998 79999999998866543    6


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus       100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~--ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCC-
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC--EEEccccceeecccC
Confidence            799999999999999998788999999999999999999999999999999999999987766  999999999864222


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                       .......+||+.|||||++.+..++.++|||||||++|||++|+.||... +.......+..  ....+|..+++++++
T Consensus       178 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-~~~~~~~~i~~--~~~~~p~~~~~~~~~  253 (353)
T 3txo_A          178 -GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE-NEDDLFEAILN--DEVVYPTWLHEDATG  253 (353)
T ss_dssp             ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred             -CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC-CHHHHHHHHHc--CCCCCCCCCCHHHHH
Confidence             22345668999999999999999999999999999999999999999874 44444444422  234567779999999


Q ss_pred             HHHHhhhcCCCCCCCH------HHHHhCccccccccc
Q 040569          235 FLSKCLIRNPGERWSA------SELLEHGFVKEQNFK  265 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~------~elL~hp~~~~~~~~  265 (385)
                      ||.+||++||.+||++      .|+++||||+..++.
T Consensus       254 li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~  290 (353)
T 3txo_A          254 ILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA  290 (353)
T ss_dssp             HHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred             HHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence            9999999999999998      899999999987653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=8.1e-53  Score=411.34  Aligned_cols=255  Identities=28%  Similarity=0.416  Sum_probs=217.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---------SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|++++.||+|+||+||+|+++.+|+.||+|.+....         .+.+.+|+.+|+++.||||+++++++.....   
T Consensus        13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~---   89 (361)
T 2yab_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD---   89 (361)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE---
T ss_pred             ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE---
Confidence            4899999999999999999999999999999886432         4678899999999999999999998765433   


Q ss_pred             EEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCC--CCeEEeecCceee
Q 040569           73 LYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE--QGAKIADFGCARR  150 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~--~~~kL~DFG~a~~  150 (385)
                       +++||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  ..+||+|||+++.
T Consensus        90 -~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~  168 (361)
T 2yab_A           90 -VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (361)
T ss_dssp             -EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred             -EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence             6799999999999999998888999999999999999999999999999999999999976652  1489999999987


Q ss_pred             ecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCC--CCCCCCcC
Q 040569          151 ARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSD--TPEIPGYM  228 (385)
Q Consensus       151 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~  228 (385)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||... +....+..+.....  .+..+..+
T Consensus       169 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~  245 (361)
T 2yab_A          169 IEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-TKQETLANITAVSYDFDEEFFSQT  245 (361)
T ss_dssp             CCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred             cCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCchhccCC
Confidence            6432  2334567999999999999999999999999999999999999999774 34444444322211  11223568


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       229 s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      |+++++||.+||.+||.+|||+.|+|+||||....
T Consensus       246 s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence            99999999999999999999999999999998653

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6.8e-53  Score=416.54  Aligned_cols=255  Identities=29%  Similarity=0.524  Sum_probs=217.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++++.||+|+||+||+|+++.+++.||+|++.+.      ..+.+.+|..+|+++ +||||+++++++.....    +
T Consensus        53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~----~  128 (396)
T 4dc2_A           53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR----L  128 (396)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE----E
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE----E
Confidence            589999999999999999999999999999988642      124577899999987 89999999998876543    6


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... 
T Consensus       129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFGla~~~~~-  205 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLR-  205 (396)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCC-
T ss_pred             EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC--EEEeecceeeeccc-
Confidence            799999999999999998778999999999999999999999999999999999999988776  99999999986322 


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCC-------hHH-HHHHhcCCCCCCCCCC
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-------PIS-ALHRIGFSSDTPEIPG  226 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-------~~~-~~~~~~~~~~~~~~~~  226 (385)
                      ........+||+.|||||++.+..++.++|||||||++|||++|+.||.....       ... ....+.  .....+|.
T Consensus       206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~--~~~~~~p~  283 (396)
T 4dc2_A          206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--EKQIRIPR  283 (396)
T ss_dssp             TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH--HCCCCCCT
T ss_pred             CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh--ccccCCCC
Confidence            22334567899999999999999999999999999999999999999964311       111 222221  23445677


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCCCH------HHHHhCccccccccc
Q 040569          227 YMSKQAQDFLSKCLIRNPGERWSA------SELLEHGFVKEQNFK  265 (385)
Q Consensus       227 ~~s~~~~~ll~~cL~~dP~~Rps~------~elL~hp~~~~~~~~  265 (385)
                      .+|+++++||.+||++||.+||++      +|+++||||+..++.
T Consensus       284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~  328 (396)
T 4dc2_A          284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  328 (396)
T ss_dssp             TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred             cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence            899999999999999999999985      799999999987654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-52  Score=400.94  Aligned_cols=251  Identities=27%  Similarity=0.443  Sum_probs=219.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+|+++.+|+.||+|.+..      ...+.+.+|..+|+.+.||||+++++++.....    ++
T Consensus         7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~----~~   82 (318)
T 1fot_A            7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ----IF   82 (318)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE----EE
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCE----EE
Confidence            68999999999999999999999999999998853      345678899999999999999999998865443    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....  
T Consensus        83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~Dfg~a~~~~~--  158 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD--  158 (318)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC--EEEeecCcceecCC--
Confidence            99999999999999998888999999999999999999999999999999999999987766  99999999987532  


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                        .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+..  ....+|..+++++++|
T Consensus       159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~--~~~~~p~~~~~~~~~l  233 (318)
T 1fot_A          159 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-NTMKTYEKILN--AELRFPPFFNEDVKDL  233 (318)
T ss_dssp             --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHH--CCCCCCTTSCHHHHHH
T ss_pred             --ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHHh--CCCCCCCCCCHHHHHH
Confidence              234568999999999999999999999999999999999999999764 34444444322  2345667799999999


Q ss_pred             HHHhhhcCCCCCC-----CHHHHHhCccccccccc
Q 040569          236 LSKCLIRNPGERW-----SASELLEHGFVKEQNFK  265 (385)
Q Consensus       236 l~~cL~~dP~~Rp-----s~~elL~hp~~~~~~~~  265 (385)
                      |.+||.+||.+||     +++++++||||+..++.
T Consensus       234 i~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~  268 (318)
T 1fot_A          234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  268 (318)
T ss_dssp             HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             HHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence            9999999999999     89999999999977543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=7.9e-53  Score=408.96  Aligned_cols=254  Identities=31%  Similarity=0.541  Sum_probs=220.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++.+.||+|+||+||+|+++.+++.||+|.+..      ...+.+.+|..+|+.+ +||||+++++++.....    +
T Consensus        18 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~----~   93 (345)
T 1xjd_A           18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN----L   93 (345)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE----E
T ss_pred             HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE----E
Confidence            69999999999999999999999999999998864      3456778899999987 99999999998866543    6


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCT
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC--EEEeEChhhhhcccC
Confidence            799999999999999997778999999999999999999999999999999999999987766  999999999864322


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                       .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+..  ..+.+|..+|+++++
T Consensus       172 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-~~~~~~~~i~~--~~~~~p~~~s~~~~~  247 (345)
T 1xjd_A          172 -DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-DEEELFHSIRM--DNPFYPRWLEKEAKD  247 (345)
T ss_dssp             -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred             -CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHh--CCCCCCcccCHHHHH
Confidence             22345668999999999999999999999999999999999999999764 44444444432  235567789999999


Q ss_pred             HHHHhhhcCCCCCCCHH-HHHhCccccccccc
Q 040569          235 FLSKCLIRNPGERWSAS-ELLEHGFVKEQNFK  265 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~-elL~hp~~~~~~~~  265 (385)
                      ||.+||++||.+||++. ++++||||+..++.
T Consensus       248 li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~  279 (345)
T 1xjd_A          248 LLVKLFVREPEKRLGVRGDIRQHPLFREINWE  279 (345)
T ss_dssp             HHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred             HHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence            99999999999999998 99999999987653

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=8.6e-53  Score=417.72  Aligned_cols=256  Identities=26%  Similarity=0.400  Sum_probs=215.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+||+|+++.+++.||+|++.+      ...+.+.+|..+|+.++||||+++++++.+...    ++
T Consensus        70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~----~~  145 (410)
T 3v8s_A           70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY----LY  145 (410)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE----EE
T ss_pred             ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE----EE
Confidence            58999999999999999999999999999998854      233457789999999999999999998875443    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++||+|.++++.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+......
T Consensus       146 lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFG~a~~~~~~~  222 (410)
T 3v8s_A          146 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEG  222 (410)
T ss_dssp             EEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTS
T ss_pred             EEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC--EEEeccceeEeeccCC
Confidence            999999999999999865 5999999999999999999999999999999999999987776  9999999998764333


Q ss_pred             CCCCCccccCCcccChhhhcCCC----CCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCC--CCcCC
Q 040569          156 DDEGKPICGTPICMAPEVARGEE----QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMS  229 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~s  229 (385)
                      .......+||+.|||||++.+..    ++.++|||||||++|||++|+.||... +.......+........+  ...+|
T Consensus       223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~s  301 (410)
T 3v8s_A          223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-SLVGTYSKIMNHKNSLTFPDDNDIS  301 (410)
T ss_dssp             EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred             cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC-ChhhHHHHHHhccccccCCCccccc
Confidence            22344678999999999998765    789999999999999999999999864 444444443221111112  23589


Q ss_pred             HHHHHHHHHhhhcCCCC--CCCHHHHHhCccccccccc
Q 040569          230 KQAQDFLSKCLIRNPGE--RWSASELLEHGFVKEQNFK  265 (385)
Q Consensus       230 ~~~~~ll~~cL~~dP~~--Rps~~elL~hp~~~~~~~~  265 (385)
                      +++++||.+||..+|.+  ||+++|+++||||+..++.
T Consensus       302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~  339 (410)
T 3v8s_A          302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA  339 (410)
T ss_dssp             HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred             HHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence            99999999999999988  9999999999999987543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1e-52  Score=420.30  Aligned_cols=257  Identities=22%  Similarity=0.331  Sum_probs=218.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+||+|+++.+++.||+|++.+.      ..+.+.+|..+|..++||||+++++++.....    ++
T Consensus        75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~----~~  150 (437)
T 4aw2_A           75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN----LY  150 (437)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE----EE
T ss_pred             heEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE----EE
Confidence            589999999999999999999999999999988642      22347889999999999999999998866543    67


Q ss_pred             EEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           76 LFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +||||++||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.....
T Consensus       151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMED  228 (437)
T ss_dssp             EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTT
T ss_pred             EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC--EEEcchhhhhhcccC
Confidence            99999999999999986 578999999999999999999999999999999999999987776  999999999876443


Q ss_pred             CCCCCCccccCCcccChhhhc-----CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC---CCCCCCCCC
Q 040569          155 EDDEGKPICGTPICMAPEVAR-----GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF---SSDTPEIPG  226 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~---~~~~~~~~~  226 (385)
                      ........+||+.|||||++.     ...++.++|||||||++|||++|+.||... +.......+..   ....|....
T Consensus       229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~  307 (437)
T 4aw2_A          229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYGKIMNHKERFQFPTQVT  307 (437)
T ss_dssp             SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHTHHHHCCCCSSCC
T ss_pred             CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC-ChhHHHHhhhhccccccCCcccc
Confidence            333344568999999999997     567899999999999999999999999864 34443333321   123344445


Q ss_pred             cCCHHHHHHHHHhhhcCCCC--CCCHHHHHhCccccccccc
Q 040569          227 YMSKQAQDFLSKCLIRNPGE--RWSASELLEHGFVKEQNFK  265 (385)
Q Consensus       227 ~~s~~~~~ll~~cL~~dP~~--Rps~~elL~hp~~~~~~~~  265 (385)
                      .+|+++++||++||..+|++  |++++|+++||||+..++.
T Consensus       308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~  348 (437)
T 4aw2_A          308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD  348 (437)
T ss_dssp             CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred             cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence            58999999999999988888  9999999999999987654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.3e-52  Score=409.34  Aligned_cols=253  Identities=25%  Similarity=0.406  Sum_probs=218.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+||+|+++.+++.||+|.+..      .....+.+|+++|++++||||+++++++.....    ++
T Consensus        16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~----~~   91 (384)
T 4fr4_A           16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED----MF   91 (384)
T ss_dssp             GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE----EE
T ss_pred             HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE----EE
Confidence            58999999999999999999999999999998753      345678899999999999999999998876543    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++....  
T Consensus        92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~--  167 (384)
T 4fr4_A           92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIAAMLPR--  167 (384)
T ss_dssp             EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCT--
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC--EEEeccceeeeccC--
Confidence            99999999999999998888999999999999999999999999999999999999987766  99999999987632  


Q ss_pred             CCCCCccccCCcccChhhhcC---CCCCCCCChHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          156 DDEGKPICGTPICMAPEVARG---EEQGFPADVWALGCTVLEMATGRPPWPDVA--DPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      .......+||+.|+|||++.+   ..++.++|||||||++|+|++|+.||....  ........+  ......+|..+|+
T Consensus       168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~p~~~s~  245 (384)
T 4fr4_A          168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--ETTVVTYPSAWSQ  245 (384)
T ss_dssp             TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH--HHCCCCCCTTSCH
T ss_pred             CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH--hhcccCCCCcCCH
Confidence            233456789999999999974   458999999999999999999999997532  222222322  2234456777999


Q ss_pred             HHHHHHHHhhhcCCCCCCC-HHHHHhCcccccccc
Q 040569          231 QAQDFLSKCLIRNPGERWS-ASELLEHGFVKEQNF  264 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps-~~elL~hp~~~~~~~  264 (385)
                      ++.+||.+||++||.+||+ ++++++||||...++
T Consensus       246 ~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w  280 (384)
T 4fr4_A          246 EMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW  280 (384)
T ss_dssp             HHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred             HHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence            9999999999999999998 899999999998754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.4e-52  Score=404.39  Aligned_cols=254  Identities=29%  Similarity=0.519  Sum_probs=216.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC---C---HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---N---SEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~---~---~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++++.||+|+||+||+|+++.+++.||+|++.+.   .   .+.+.+|..+|+++ +||||+++++++.....    +
T Consensus        10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~----~   85 (345)
T 3a8x_A           10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR----L   85 (345)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE----E
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE----E
Confidence            589999999999999999999999999999998643   2   24577899999998 89999999998866443    6


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCGGGCBCSCCT
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEEeccccccccCC
Confidence            799999999999999997778999999999999999999999999999999999999987766  999999999864222


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCC--------ChHHHHHHhcCCCCCCCCCC
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVA--------DPISALHRIGFSSDTPEIPG  226 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~--------~~~~~~~~~~~~~~~~~~~~  226 (385)
                       .......+||+.|+|||++.+..++.++|||||||++|||++|+.||....        ........+.  .....+|.
T Consensus       164 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~--~~~~~~p~  240 (345)
T 3a8x_A          164 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--EKQIRIPR  240 (345)
T ss_dssp             -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH--HCCCCCCT
T ss_pred             -CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH--cCCCCCCC
Confidence             223455689999999999999999999999999999999999999996421        1112222221  12345677


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCCCH------HHHHhCcccccccc
Q 040569          227 YMSKQAQDFLSKCLIRNPGERWSA------SELLEHGFVKEQNF  264 (385)
Q Consensus       227 ~~s~~~~~ll~~cL~~dP~~Rps~------~elL~hp~~~~~~~  264 (385)
                      .+|+++++||.+||++||.+||++      .|+++||||+..++
T Consensus       241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w  284 (345)
T 3a8x_A          241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  284 (345)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred             CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence            899999999999999999999995      89999999998764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.1e-52  Score=404.01  Aligned_cols=250  Identities=27%  Similarity=0.456  Sum_probs=219.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+||+|+++.+|+.||+|.+..      ...+.+.+|+++|++++||||+++++++.....    ++
T Consensus        42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~----~~  117 (350)
T 1rdq_E           42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN----LY  117 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE----EE
T ss_pred             HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE----EE
Confidence            58999999999999999999999999999998853      345678899999999999999999998765443    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....  
T Consensus       118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFg~a~~~~~--  193 (350)
T 1rdq_E          118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKG--  193 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS--
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC--EEEcccccceeccC--
Confidence            99999999999999997778999999999999999999999999999999999999987766  99999999987632  


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                        .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+...  ...+|..+++++++|
T Consensus       194 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-~~~~~~~~i~~~--~~~~p~~~~~~~~~l  268 (350)
T 1rdq_E          194 --RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-QPIQIYEKIVSG--KVRFPSHFSSDLKDL  268 (350)
T ss_dssp             --CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHC--CCCCCTTCCHHHHHH
T ss_pred             --CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC-CHHHHHHHHHcC--CCCCCCCCCHHHHHH
Confidence              234568999999999999999999999999999999999999999764 444444444222  345677799999999


Q ss_pred             HHHhhhcCCCCCCC-----HHHHHhCcccccccc
Q 040569          236 LSKCLIRNPGERWS-----ASELLEHGFVKEQNF  264 (385)
Q Consensus       236 l~~cL~~dP~~Rps-----~~elL~hp~~~~~~~  264 (385)
                      |.+||++||.+||+     ++|+++||||...++
T Consensus       269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w  302 (350)
T 1rdq_E          269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             HHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence            99999999999998     999999999998765

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2e-52  Score=402.11  Aligned_cols=255  Identities=28%  Similarity=0.449  Sum_probs=215.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++++.||+|+||+||+|+++.+++.||||.+....    .+.+.+|+.+++.++||||+++++++.....    .++|
T Consensus         8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----~~lv   83 (323)
T 3tki_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI----QYLF   83 (323)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSE----EEEE
T ss_pred             hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe----EEEE
Confidence            6999999999999999999999999999999986433    3567899999999999999999998765432    6699


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC-
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED-  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~-  156 (385)
                      |||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....... 
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEE
T ss_pred             EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC--EEEEEeeccceeccCCcc
Confidence            999999999999998878999999999999999999999999999999999999987766  99999999986543221 


Q ss_pred             CCCCccccCCcccChhhhcCCCC-CCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          157 DEGKPICGTPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                      ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.........................+++.+.+|
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  241 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence            22345679999999999988775 77899999999999999999999865544333333322222223345689999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      |.+||+.||.+|||+.|+|+||||+..
T Consensus       242 i~~~L~~dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          242 LHKILVENPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHHHccCChhhCcCHHHHhhChhhccc
Confidence            999999999999999999999999864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.8e-52  Score=404.08  Aligned_cols=254  Identities=26%  Similarity=0.437  Sum_probs=219.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++++.||+|+||+||+|+++.+++.||+|++..      ...+.+.+|..+|..+ .||||+++++++.....    +
T Consensus        21 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~----~   96 (353)
T 2i0e_A           21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR----L   96 (353)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE----E
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE----E
Confidence            69999999999999999999999999999998864      3456778999999988 89999999998866443    6


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus        97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCT
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc--EEEEeCCcccccccC
Confidence            799999999999999997778999999999999999999999999999999999999987766  999999999864322


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                       .......+||+.|+|||++.+..++.++|||||||++|||++|+.||... +.......+..  ....+|..+|+++++
T Consensus       175 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-~~~~~~~~i~~--~~~~~p~~~s~~~~~  250 (353)
T 2i0e_A          175 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-DEDELFQSIME--HNVAYPKSMSKEAVA  250 (353)
T ss_dssp             -TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred             -CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC-CHHHHHHHHHh--CCCCCCCCCCHHHHH
Confidence             22345668999999999999999999999999999999999999999764 44444444422  234567789999999


Q ss_pred             HHHHhhhcCCCCCCC-----HHHHHhCccccccccc
Q 040569          235 FLSKCLIRNPGERWS-----ASELLEHGFVKEQNFK  265 (385)
Q Consensus       235 ll~~cL~~dP~~Rps-----~~elL~hp~~~~~~~~  265 (385)
                      ||.+||.+||.+||+     +.++++||||+..++.
T Consensus       251 li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~  286 (353)
T 2i0e_A          251 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  286 (353)
T ss_dssp             HHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence            999999999999994     6999999999987553

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-51  Score=396.58  Aligned_cols=254  Identities=28%  Similarity=0.438  Sum_probs=215.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC---------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---------NSEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~---------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      .|++++.||+|+||+||+|+++.+++.||+|.+...         ..+.+.+|+.+|++++||||+++++++.....   
T Consensus        12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~---   88 (326)
T 2y0a_A           12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD---   88 (326)
T ss_dssp             HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE---
T ss_pred             ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE---
Confidence            388999999999999999999999999999988643         25678899999999999999999998765433   


Q ss_pred             EEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCC--CCeEEeecCceee
Q 040569           73 LYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE--QGAKIADFGCARR  150 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~--~~~kL~DFG~a~~  150 (385)
                       +++||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  ..+||+|||+++.
T Consensus        89 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  167 (326)
T 2y0a_A           89 -VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  167 (326)
T ss_dssp             -EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             -EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence             6799999999999999998888999999999999999999999999999999999999987651  2489999999987


Q ss_pred             ecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC--CCCCCCCcC
Q 040569          151 ARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS--DTPEIPGYM  228 (385)
Q Consensus       151 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~  228 (385)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ....+..+....  .....+..+
T Consensus       168 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~  244 (326)
T 2y0a_A          168 IDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-KQETLANVSAVNYEFEDEYFSNT  244 (326)
T ss_dssp             CCTT--SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-HHHHHHHHHHTCCCCCHHHHTTS
T ss_pred             CCCC--CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC-HHHHHHHHHhcCCCcCccccccC
Confidence            6432  22345679999999999999999999999999999999999999997643 333333322111  111223457


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       229 s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      |+.+++||.+||.+||.+|||+.|+|+||||+..
T Consensus       245 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            9999999999999999999999999999999754

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2e-51  Score=388.27  Aligned_cols=253  Identities=26%  Similarity=0.358  Sum_probs=208.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++++.||+|+||+||+|+++.+++.||+|.+....     ...+.+|+.++++++||||+++++++.....    +++
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~l   78 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK----LTL   78 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE----EEE
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCE----EEE
Confidence            6999999999999999999999999999999886432     3567899999999999999999999876543    679


Q ss_pred             EEeecCCCCHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l-~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      ||||+++ +|.+.+ ...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++..... 
T Consensus        79 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~-  154 (292)
T 3o0g_A           79 VFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIP-  154 (292)
T ss_dssp             EEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCSC-
T ss_pred             EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecCCc-
Confidence            9999987 555555 45678999999999999999999999999999999999999987766  999999999876422 


Q ss_pred             CCCCCccccCCcccChhhhcCCC-CCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC---C-------------
Q 040569          156 DDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF---S-------------  218 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~---~-------------  218 (385)
                      ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||....+....+..+..   .             
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (292)
T 3o0g_A          155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence            22334557899999999998766 799999999999999999988886544454444433210   0             


Q ss_pred             -----------CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          219 -----------SDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       219 -----------~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                 .........+++++++||.+||+.||.+|||++|+|+||||++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence                       00111223578999999999999999999999999999999753

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-52  Score=398.98  Aligned_cols=254  Identities=26%  Similarity=0.372  Sum_probs=215.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++++.||+|+||+||+|.++.+++.+|+|.+....  .+.+++|+.+|+.++||||+++++++.....    +++|||
T Consensus         6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----~~lv~e   81 (321)
T 1tki_A            6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEE----LVMIFE   81 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE----EEEEEC
T ss_pred             ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCE----EEEEEE
Confidence            6999999999999999999999999999999987654  3467899999999999999999999866543    679999


Q ss_pred             ecCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           80 YAPGGTLTDAIRSG-TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        80 y~~ggsL~~~l~~~-~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      |++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+....+||+|||+++.....  ..
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~--~~  159 (321)
T 1tki_A           82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DN  159 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--CE
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC--Cc
Confidence            99999999999854 4799999999999999999999999999999999999998744455999999999876422  22


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCC--CCCCCcCCHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDT--PEIPGYMSKQAQDFL  236 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~~ll  236 (385)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.... ....+..+......  +.....+|+++++||
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  238 (321)
T 1tki_A          160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-NQQIIENIMNAEYTFDEEAFKEISIEAMDFV  238 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred             cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC-HHHHHHHHHcCCCCCChhhhccCCHHHHHHH
Confidence            344579999999999999989999999999999999999999997743 33333333221111  111235899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          237 SKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      .+||.+||.+|||+.|+|+||||++.
T Consensus       239 ~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          239 DRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHcCCChhHCcCHHHHhcChhhccC
Confidence            99999999999999999999999754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.3e-51  Score=411.55  Aligned_cols=255  Identities=25%  Similarity=0.382  Sum_probs=213.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++++.||+|+||+||+|.++.+|+.+|+|.+....     .+.+.+|+.+|++++||||+++++++.....    +++
T Consensus        12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----~~l   87 (444)
T 3soa_A           12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGH----HYL   87 (444)
T ss_dssp             HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE----EEE
T ss_pred             CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE----EEE
Confidence            4899999999999999999999999999999987543     3467899999999999999999998765443    679


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC-CCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN-EQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~-~~~~kL~DFG~a~~~~~~~  155 (385)
                      ||||++||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.+. ...+||+|||+++..... 
T Consensus        88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~-  166 (444)
T 3soa_A           88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-  166 (444)
T ss_dssp             EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT-
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC-
Confidence            999999999999999888899999999999999999999999999999999999998542 234899999999876432 


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC--CCCCCCCcCCHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS--DTPEIPGYMSKQAQ  233 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~  233 (385)
                      .......+||+.|+|||++.+..++.++|||||||++|+|++|++||... +.......+....  ........+|++++
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  245 (444)
T 3soa_A          167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE-DQHRLYQQIKAGAYDFPSPEWDTVTPEAK  245 (444)
T ss_dssp             CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence            22234567999999999999999999999999999999999999999764 3334333332221  11122245899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          234 DFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       234 ~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +||.+||++||.+|||+.|+|+|||+...
T Consensus       246 ~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          246 DLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             HHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            99999999999999999999999999754

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.1e-51  Score=402.95  Aligned_cols=255  Identities=27%  Similarity=0.389  Sum_probs=205.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++.+.||+|+||+||+|+++.+++.||||.+....  .+.+++|+.++++++||||+++++++.....    +++|||
T Consensus        21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----~~lv~e   96 (361)
T 3uc3_A           21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTH----LAIIME   96 (361)
T ss_dssp             TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSE----EEEEEE
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCE----EEEEEE
Confidence            5999999999999999999999999999999987543  4678899999999999999999999876543    679999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      |++||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++...+||+|||+++.....  ...
T Consensus        97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--~~~  174 (361)
T 3uc3_A           97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQP  174 (361)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred             eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--CCC
Confidence            999999999998777899999999999999999999999999999999999998766656999999999854222  223


Q ss_pred             CccccCCcccChhhhcCCCCCCC-CChHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          160 KPICGTPICMAPEVARGEEQGFP-ADVWALGCTVLEMATGRPPWPDVAD---PISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltG~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                      ...+||+.|+|||++.+..+..+ +|||||||++|+|++|+.||.....   ....+..+............+++++++|
T Consensus       175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  254 (361)
T 3uc3_A          175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHL  254 (361)
T ss_dssp             ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHH
T ss_pred             CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHH
Confidence            44579999999999988877655 8999999999999999999976432   2233333322222222233579999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      |.+||++||.+|||+.|+|+||||...
T Consensus       255 i~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          255 ISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             HHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             HHHHccCChhHCcCHHHHHhCcchhcC
Confidence            999999999999999999999999653

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-52  Score=411.92  Aligned_cols=256  Identities=24%  Similarity=0.365  Sum_probs=214.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+||+|+++.+++.||+|++.+..      .+.+.+|..+|..++||||+++++++.+...    +|
T Consensus        62 ~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~----~~  137 (412)
T 2vd5_A           62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY----LY  137 (412)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE----EE
T ss_pred             hEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE----EE
Confidence            5899999999999999999999999999999986422      2347789999999999999999998876543    67


Q ss_pred             EEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           76 LFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +||||++||+|.+++.+ +..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus       138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~--vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRAD  215 (412)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTT
T ss_pred             EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC--EEEeechhheeccCC
Confidence            99999999999999985 457999999999999999999999999999999999999987766  999999999876543


Q ss_pred             CCCCCCccccCCcccChhhhc-------CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC---CCCCCCC
Q 040569          155 EDDEGKPICGTPICMAPEVAR-------GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF---SSDTPEI  224 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~---~~~~~~~  224 (385)
                      ........+||+.|||||++.       +..++.++|||||||++|||++|+.||... +......++..   ....|..
T Consensus       216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~  294 (412)
T 2vd5_A          216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD-STAETYGKIVHYKEHLSLPLV  294 (412)
T ss_dssp             SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHTHHHHCCCC--
T ss_pred             CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC-CHHHHHHHHHhcccCcCCCcc
Confidence            332334568999999999997       457899999999999999999999999764 33333333321   1233444


Q ss_pred             CCcCCHHHHHHHHHhhhcCCCCC---CCHHHHHhCccccccccc
Q 040569          225 PGYMSKQAQDFLSKCLIRNPGER---WSASELLEHGFVKEQNFK  265 (385)
Q Consensus       225 ~~~~s~~~~~ll~~cL~~dP~~R---ps~~elL~hp~~~~~~~~  265 (385)
                      +..+|+++++||.+||. +|.+|   ++++|+++||||+..++.
T Consensus       295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~  337 (412)
T 2vd5_A          295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWD  337 (412)
T ss_dssp             --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred             ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            56799999999999999 99998   599999999999987664

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.7e-51  Score=396.02  Aligned_cols=253  Identities=26%  Similarity=0.405  Sum_probs=208.9

Q ss_pred             CceeeceeeccCceEEEEEEEC---CCCcEEEEEeccCCC-------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN---RSSEVFAVKSAELSN-------SEFLQREQRILSALACPQIVAYKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~---~~~~~~AvK~~~~~~-------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   71 (385)
                      +|++.+.||+|+||+||+|++.   .+++.||+|++....       ...+.+|+.+|++++||||+++++++.....  
T Consensus        18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~--   95 (327)
T 3a62_A           18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK--   95 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC--
T ss_pred             HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE--
Confidence            5899999999999999999985   689999999986532       3456789999999999999999998876544  


Q ss_pred             EEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           72 ILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                        +++||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..
T Consensus        96 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 --LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLCKES  171 (327)
T ss_dssp             --EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC--EEECCCSCC---
T ss_pred             --EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc--EEEEeCCccccc
Confidence              6799999999999999997778999999999999999999999999999999999999987766  999999999864


Q ss_pred             cccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHH
Q 040569          152 RVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQ  231 (385)
Q Consensus       152 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  231 (385)
                      .... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+..  ....+|..++++
T Consensus       172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~i~~--~~~~~p~~~~~~  247 (327)
T 3a62_A          172 IHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE-NRKKTIDKILK--CKLNLPPYLTQE  247 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHH--TCCCCCTTSCHH
T ss_pred             ccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHh--CCCCCCCCCCHH
Confidence            3221 2234567999999999999999999999999999999999999999864 33333333321  233456678999


Q ss_pred             HHHHHHHhhhcCCCCCC-----CHHHHHhCcccccccc
Q 040569          232 AQDFLSKCLIRNPGERW-----SASELLEHGFVKEQNF  264 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rp-----s~~elL~hp~~~~~~~  264 (385)
                      +++||.+||.+||.+||     ++.|+++||||+..++
T Consensus       248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~  285 (327)
T 3a62_A          248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW  285 (327)
T ss_dssp             HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred             HHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence            99999999999999999     8999999999987654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.2e-51  Score=401.16  Aligned_cols=254  Identities=25%  Similarity=0.392  Sum_probs=215.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++++.||+|+||+||+|.++.+++.||+|.+....     .+.+.+|+.+|++++||||+++++++.....    +++
T Consensus        30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~----~~l  105 (362)
T 2bdw_A           30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF----HYL  105 (362)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE----EEE
T ss_pred             CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE----EEE
Confidence            4899999999999999999999999999999986532     2567899999999999999999998765443    679


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCC-CCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE-QGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~-~~~kL~DFG~a~~~~~~~  155 (385)
                      ||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++. ..+||+|||++...... 
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-  184 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-  184 (362)
T ss_dssp             EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-
Confidence            9999999999999998888999999999999999999999999999999999999976543 34899999999876422 


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCC--CCCCCCcCCHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSD--TPEIPGYMSKQAQ  233 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~  233 (385)
                       ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+.....  .......++++++
T Consensus       185 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  262 (362)
T 2bdw_A          185 -EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-DQHRLYAQIKAGAYDYPSPEWDTVTPEAK  262 (362)
T ss_dssp             -CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred             -cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence             2334568999999999999999999999999999999999999999764 33333333322211  1112245799999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          234 DFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       234 ~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +||.+||.+||.+|||+.|+|+|||+...
T Consensus       263 ~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          263 SLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999754

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.5e-51  Score=400.32  Aligned_cols=254  Identities=28%  Similarity=0.408  Sum_probs=212.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--------NSEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|++.+.||+|+||+||+|+++.+++.||||++...        ..+.+.+|+.++++++||||+++++++.....    
T Consensus        25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----  100 (351)
T 3c0i_A           25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM----  100 (351)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE----
T ss_pred             ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE----
Confidence            489999999999999999999999999999987531        35778999999999999999999998876543    


Q ss_pred             EEEEEeecCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCC-CCeEEeecCce
Q 040569           74 YNLFLEYAPGGTLTDAIRS----GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE-QGAKIADFGCA  148 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~----~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~-~~~kL~DFG~a  148 (385)
                      +++||||++||+|.+++..    +..+++..++.++.||+.||+|||++||+||||||+|||++.++. ..+||+|||++
T Consensus       101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            6799999999999988852    345899999999999999999999999999999999999976543 33899999999


Q ss_pred             eeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC--CCCCCCC
Q 040569          149 RRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS--DTPEIPG  226 (385)
Q Consensus       149 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~  226 (385)
                      +...... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...  .......+....  ..+....
T Consensus       181 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~i~~~~~~~~~~~~~  257 (351)
T 3c0i_A          181 IQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT--KERLFEGIIKGKYKMNPRQWS  257 (351)
T ss_dssp             EECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS--HHHHHHHHHHTCCCCCHHHHT
T ss_pred             eEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc--HHHHHHHHHcCCCCCCccccc
Confidence            8764322 1234557999999999999999999999999999999999999999763  223333222111  1111224


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          227 YMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       227 ~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      .+|+++++||.+||.+||.+|||+.|+|+||||+..
T Consensus       258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            579999999999999999999999999999999864

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7.7e-52  Score=414.92  Aligned_cols=254  Identities=27%  Similarity=0.442  Sum_probs=210.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+||+|+++.+++.||||.+...      ....+.+|+.+|++++||||+++++++.....    ++
T Consensus       149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~----~~  224 (446)
T 4ejn_A          149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR----LC  224 (446)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE----EE
T ss_pred             HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE----EE
Confidence            489999999999999999999999999999988632      23456789999999999999999998876543    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~-~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +||||++||+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.  +||+|||+++.....
T Consensus       225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKD  302 (446)
T ss_dssp             EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC--EEECCCCCCCTTCC-
T ss_pred             EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC--EEEccCCCceeccCC
Confidence            999999999999999977789999999999999999999998 99999999999999987766  999999999854222


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                       .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+..  ....+|..+++++++
T Consensus       303 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-~~~~~~~~i~~--~~~~~p~~~~~~~~~  378 (446)
T 4ejn_A          303 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELILM--EEIRFPRTLGPEAKS  378 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred             -CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC-CHHHHHHHHHh--CCCCCCccCCHHHHH
Confidence             22344568999999999999999999999999999999999999999764 33333333322  234466779999999


Q ss_pred             HHHHhhhcCCCCCC-----CHHHHHhCccccccccc
Q 040569          235 FLSKCLIRNPGERW-----SASELLEHGFVKEQNFK  265 (385)
Q Consensus       235 ll~~cL~~dP~~Rp-----s~~elL~hp~~~~~~~~  265 (385)
                      ||.+||++||.+||     ++.|+|+||||...++.
T Consensus       379 li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~  414 (446)
T 4ejn_A          379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ  414 (446)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             HHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence            99999999999999     99999999999987543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-51  Score=389.17  Aligned_cols=252  Identities=26%  Similarity=0.379  Sum_probs=206.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----------------------------HHHHHHHHHHHHhc
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----------------------------SEFLQREQRILSAL   52 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----------------------------~~~~~~E~~il~~l   52 (385)
                      +|++.+.||+|+||+||+|+++.+++.||||.+....                             .+.+.+|+++|+++
T Consensus        14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   93 (298)
T 2zv2_A           14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL   93 (298)
T ss_dssp             TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred             ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence            6999999999999999999999999999999886432                             24578999999999


Q ss_pred             CCCCeeeeeeeeeeccCCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEe
Q 040569           53 ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV  132 (385)
Q Consensus        53 ~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi  132 (385)
                      +||||+++++++.......  +++||||+++++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus        94 ~h~~iv~~~~~~~~~~~~~--~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           94 DHPNVVKLVEVLDDPNEDH--LYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV  170 (298)
T ss_dssp             CCTTBCCEEEEEECSSSSE--EEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             CCCCCCeEEEEEEcCCCCE--EEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            9999999999887643332  5699999999999886653 469999999999999999999999999999999999999


Q ss_pred             ecCCCCCeEEeecCceeeecccCCCCCCccccCCcccChhhhcCCC---CCCCCChHHHHHHHHHHHhCCCCCCCCCChH
Q 040569          133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE---QGFPADVWALGCTVLEMATGRPPWPDVADPI  209 (385)
Q Consensus       133 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltG~~Pf~~~~~~~  209 (385)
                      +.++.  +||+|||+++...... .......||+.|+|||++.+..   ++.++|||||||++|+|++|+.||... +..
T Consensus       171 ~~~~~--~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~  246 (298)
T 2zv2_A          171 GEDGH--IKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE-RIM  246 (298)
T ss_dssp             CTTSC--EEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS-SHH
T ss_pred             CCCCC--EEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc-cHH
Confidence            87766  9999999998764322 1223457999999999998765   377899999999999999999999764 333


Q ss_pred             HHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 040569          210 SALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK  260 (385)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~  260 (385)
                      .....+............+++++++||.+||++||.+|||+.|+|+||||+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            333333222222222345899999999999999999999999999999985

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-51  Score=401.70  Aligned_cols=254  Identities=25%  Similarity=0.396  Sum_probs=215.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|++++.||+|+||+||+|+++.+++.+|+|.+....   ...+.+|+.+|++++||||+++++++.....    +++||
T Consensus        52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~----~~lv~  127 (387)
T 1kob_A           52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE----MVLIL  127 (387)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE----EEEEE
T ss_pred             ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE----EEEEE
Confidence            5899999999999999999999999999999987653   3467899999999999999999998865433    67999


Q ss_pred             eecCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           79 EYAPGGTLTDAIRSG-TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~-~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      ||++||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++...+||+|||+++.....  .
T Consensus       128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~--~  205 (387)
T 1kob_A          128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--E  205 (387)
T ss_dssp             ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--S
T ss_pred             EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC--c
Confidence            999999999999854 4799999999999999999999999999999999999998655556999999999876422  2


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC--CCCCCCCCcCCHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS--SDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~l  235 (385)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +....+..+...  ...+.....+++++++|
T Consensus       206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  284 (387)
T 1kob_A          206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-DDLETLQNVKRCDWEFDEDAFSSVSPEAKDF  284 (387)
T ss_dssp             CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred             ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence            233457999999999999999999999999999999999999999874 333333333221  12233345689999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      |.+||++||.+|||+.|+|+||||...
T Consensus       285 i~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          285 IKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             HHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHcCCChhHCcCHHHHhhCccccCC
Confidence            999999999999999999999999764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.3e-51  Score=397.32  Aligned_cols=249  Identities=27%  Similarity=0.426  Sum_probs=213.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+||+|++..+++.||+|.+...      ....+.+|+.+|+.++||||+++++++.....    ++
T Consensus        10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----~~   85 (336)
T 3h4j_B           10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD----IV   85 (336)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE----EE
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE----EE
Confidence            699999999999999999999999999999988532      24578899999999999999999998766543    66


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++...... 
T Consensus        86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~DFG~s~~~~~~-  161 (336)
T 3h4j_B           86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDG-  161 (336)
T ss_dssp             EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC--EEECCSSCTBTTTTS-
T ss_pred             EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC--EEEEEeccceeccCC-
Confidence            999999 7799999987778999999999999999999999999999999999999987765  999999999865322 


Q ss_pred             CCCCCccccCCcccChhhhcCCCC-CCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                       ......+||+.|+|||++.+..+ ++++|||||||++|+|++|+.||...... .....  .......+|..+|+++++
T Consensus       162 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~~~~~--i~~~~~~~p~~~s~~~~~  237 (336)
T 3h4j_B          162 -NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-NLFKK--VNSCVYVMPDFLSPGAQS  237 (336)
T ss_dssp             -BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-TCBCC--CCSSCCCCCTTSCHHHHH
T ss_pred             -cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-HHHHH--HHcCCCCCcccCCHHHHH
Confidence             23345689999999999988876 78999999999999999999999764221 11111  123344567789999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          235 FLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ||.+||+.||.+|||++|+++||||+..
T Consensus       238 li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          238 LIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             HHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            9999999999999999999999999753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.2e-50  Score=398.75  Aligned_cols=256  Identities=26%  Similarity=0.375  Sum_probs=209.4

Q ss_pred             Cceeeceeecc--CceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRG--STATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G--~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++++.||+|  +||+||+|+++.+++.||||.+....     .+.+++|+.+|++++||||+++++++.....    +
T Consensus        26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~  101 (389)
T 3gni_B           26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE----L  101 (389)
T ss_dssp             GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE----E
T ss_pred             cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE----E
Confidence            58999999999  99999999999999999999986432     3567789999999999999999999876543    6


Q ss_pred             EEEEeecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           75 NLFLEYAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      ++||||+++|+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++....
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~--~kl~dfg~~~~~~  179 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCGGGCEECE
T ss_pred             EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccccceeec
Confidence            7999999999999999854  67999999999999999999999999999999999999987765  9999999987543


Q ss_pred             ccC------CCCCCccccCCcccChhhhcC--CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC------
Q 040569          153 VNE------DDEGKPICGTPICMAPEVARG--EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS------  218 (385)
Q Consensus       153 ~~~------~~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~------  218 (385)
                      ...      .......+||+.|+|||++.+  ..++.++|||||||++|+|++|+.||................      
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence            221      112234479999999999987  578999999999999999999999998654333222211000      


Q ss_pred             -------------------------------------CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          219 -------------------------------------SDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       219 -------------------------------------~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                                                           ......+..+++++++||.+||+.||.+|||+.|+|+||||+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~  339 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  339 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence                                                 0011234557899999999999999999999999999999987


Q ss_pred             cc
Q 040569          262 QN  263 (385)
Q Consensus       262 ~~  263 (385)
                      ..
T Consensus       340 ~~  341 (389)
T 3gni_B          340 IK  341 (389)
T ss_dssp             C-
T ss_pred             Hh
Confidence            54

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=7.9e-51  Score=395.10  Aligned_cols=255  Identities=27%  Similarity=0.396  Sum_probs=201.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +|++.+.||+|+||+||+|+++.+++.||||.+... ..+.+.+|+.+|++++||||+++++++.....    +++||||
T Consensus        54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~lv~e~  129 (349)
T 2w4o_A           54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE----ISLVLEL  129 (349)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSE----EEEEECC
T ss_pred             cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCe----EEEEEEe
Confidence            488999999999999999999999999999998754 34567899999999999999999998865433    6699999


Q ss_pred             cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeec-CCCCCeEEeecCceeeecccCCCCC
Q 040569           81 APGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSK-DNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        81 ~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~-~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      ++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. +....+||+|||+++.....  ...
T Consensus       130 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~  207 (349)
T 2w4o_A          130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLM  207 (349)
T ss_dssp             CCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc--ccc
Confidence            999999999998888999999999999999999999999999999999999975 22334999999999875322  223


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC--CCCCCCCcCCHHHHHHHH
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS--DTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~ll~  237 (385)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||............+....  ........+++++++||.
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  287 (349)
T 2w4o_A          208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVR  287 (349)
T ss_dssp             -----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHH
T ss_pred             ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHH
Confidence            456799999999999999999999999999999999999999987655544444432221  122233568999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCcccccc
Q 040569          238 KCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +||+.||.+|||+.|+|+||||...
T Consensus       288 ~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          288 KLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             TTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             HHccCChhhCcCHHHHhcCcccCCC
Confidence            9999999999999999999999754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-50  Score=385.43  Aligned_cols=255  Identities=29%  Similarity=0.404  Sum_probs=208.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--------HHHHHHHHHHHHhcC---CCCeeeeeeeeeeccC-
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--------SEFLQREQRILSALA---CPQIVAYKGCDISEEN-   69 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--------~~~~~~E~~il~~l~---hpnIv~~~~~~~~~~~-   69 (385)
                      +|++.+.||+|+||+||+|+++.+++.||||.+....        ...+.+|+.+++++.   ||||+++++++..... 
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~   89 (308)
T 3g33_A           10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD   89 (308)
T ss_dssp             CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSS
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCC
Confidence            6999999999999999999999999999999886321        346778888888774   9999999999876543 


Q ss_pred             CeEEEEEEEeecCCCCHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCc
Q 040569           70 GKILYNLFLEYAPGGTLTDAIRSGTC--LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGC  147 (385)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~l~~~~~--l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~  147 (385)
                      ....++++|||+. |+|.+++.....  +++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~  166 (308)
T 3g33_A           90 REIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGL  166 (308)
T ss_dssp             SEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC--EEECSCSC
T ss_pred             CceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEEeeCcc
Confidence            3445779999997 599999985543  999999999999999999999999999999999999987766  99999999


Q ss_pred             eeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh----cCCCC--C
Q 040569          148 ARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI----GFSSD--T  221 (385)
Q Consensus       148 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~----~~~~~--~  221 (385)
                      ++...  ........+||+.|+|||++.+..++.++|||||||++|+|++|++||..... ...+..+    +....  .
T Consensus       167 a~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~  243 (308)
T 3g33_A          167 ARIYS--YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-ADQLGKIFDLIGLPPEDDW  243 (308)
T ss_dssp             TTTST--TCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH-HHHHHHHHHHHCCCCTTTS
T ss_pred             ccccC--CCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChhhc
Confidence            98653  22234556899999999999999999999999999999999999999987533 2222222    11000  0


Q ss_pred             C-------------------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          222 P-------------------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       222 ~-------------------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +                   .....+++++.+||.+||++||.+|||+.|+|+||||+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            0                   0113478999999999999999999999999999999864

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.4e-51  Score=401.53  Aligned_cols=254  Identities=25%  Similarity=0.399  Sum_probs=210.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHH-HHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRI-LSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~i-l~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++++.||+|+||+||+|+++.+++.||+|++.+..      ...+.+|..+ ++.++||||+++++++.....    +
T Consensus        39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~----~  114 (373)
T 2r5t_A           39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK----L  114 (373)
T ss_dssp             GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE----E
T ss_pred             heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE----E
Confidence            5899999999999999999999999999999886432      2345567776 567899999999998876543    6


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      |+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... 
T Consensus       115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--ikL~DFG~a~~~~~-  191 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIE-  191 (373)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCBCGGGBC-
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEeeCcccccccc-
Confidence            799999999999999998778999999999999999999999999999999999999987776  99999999986422 


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                      ........+||+.|+|||++.+..++.++|||||||++|||++|+.||... +.......+..  ....++..+++++++
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-~~~~~~~~i~~--~~~~~~~~~~~~~~~  268 (373)
T 2r5t_A          192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-NTAEMYDNILN--KPLQLKPNITNSARH  268 (373)
T ss_dssp             CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS-BHHHHHHHHHH--SCCCCCSSSCHHHHH
T ss_pred             CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHh--cccCCCCCCCHHHHH
Confidence            223345678999999999999999999999999999999999999999764 34444444322  233456679999999


Q ss_pred             HHHHhhhcCCCCCCCH----HHHHhCccccccccc
Q 040569          235 FLSKCLIRNPGERWSA----SELLEHGFVKEQNFK  265 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~----~elL~hp~~~~~~~~  265 (385)
                      ||.+||++||.+||++    .++++||||+..++.
T Consensus       269 li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~  303 (373)
T 2r5t_A          269 LLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD  303 (373)
T ss_dssp             HHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred             HHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence            9999999999999986    699999999987653

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=9.5e-51  Score=388.02  Aligned_cols=253  Identities=27%  Similarity=0.410  Sum_probs=204.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++++.||+|+||+||+|++. +++.||+|.+....     ...+.+|+++|++++||||+++++++.....    +++
T Consensus        22 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~----~~l   96 (311)
T 3niz_A           22 KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC----LTL   96 (311)
T ss_dssp             EEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC----EEE
T ss_pred             hhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE----EEE
Confidence            5899999999999999999985 58999999886432     2567899999999999999999998765543    679


Q ss_pred             EEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      ||||+++ +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus        97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A           97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPV  173 (311)
T ss_dssp             EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEETTSCC
T ss_pred             EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC--EEEccCcCceecCCCc
Confidence            9999985 88888874 456999999999999999999999999999999999999987766  9999999998764222


Q ss_pred             CCCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHH--HHHhcCCCCCC----------
Q 040569          156 DDEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISA--LHRIGFSSDTP----------  222 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~--~~~~~~~~~~~----------  222 (385)
                       .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....+....  +..........          
T Consensus       174 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  252 (311)
T 3niz_A          174 -RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL  252 (311)
T ss_dssp             -C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred             -ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence             22344578999999999976 56899999999999999999999999865433222  21111111110          


Q ss_pred             ---------------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          223 ---------------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       223 ---------------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                                     .+...+++++++||.+||++||.+|||+.|+|+||||++.+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence                           01234688999999999999999999999999999998653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.3e-50  Score=386.07  Aligned_cols=251  Identities=33%  Similarity=0.517  Sum_probs=213.4

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCC---CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~---~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      |+..+.||+|+||+||+|+++.+|+.||||.+...   ..+.+.+|+.++++++||||+++++++.....    +++|||
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~lv~e  122 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE----LWVLME  122 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE----EEEEEC
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCE----EEEEEe
Confidence            67788999999999999999999999999988643   35678899999999999999999998876543    669999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      |++||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||++........ ..
T Consensus       123 ~~~~~~L~~~l~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~-~~  198 (321)
T 2c30_A          123 FLQGGALTDIVSQV-RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVP-KR  198 (321)
T ss_dssp             CCCSCBHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSC-CB
T ss_pred             cCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc--EEEeeeeeeeecccCcc-cc
Confidence            99999999998754 5999999999999999999999999999999999999987766  99999999987643222 23


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC-CCCCCCCCcCCHHHHHHHHH
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS-SDTPEIPGYMSKQAQDFLSK  238 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~ll~~  238 (385)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+... ......+..+++++++||.+
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  277 (321)
T 2c30_A          199 KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLER  277 (321)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHH
T ss_pred             ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCCCcCccccCCHHHHHHHHH
Confidence            4557999999999999999999999999999999999999999764 333433333222 11222344589999999999


Q ss_pred             hhhcCCCCCCCHHHHHhCcccccc
Q 040569          239 CLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       239 cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ||++||.+|||+.|+|+||||.+.
T Consensus       278 ~l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          278 MLVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             HSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             HccCChhhCcCHHHHhcChhhccC
Confidence            999999999999999999999754

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.4e-50  Score=381.91  Aligned_cols=251  Identities=29%  Similarity=0.398  Sum_probs=203.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++++.||+|+||+||+|++ .+++.+|+|.+....     .+.+.+|++++++++||||+++++++.....    +++
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~l   77 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR----LVL   77 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC----EEE
T ss_pred             cchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe----EEE
Confidence            699999999999999999998 678999999886432     3577899999999999999999999876544    679


Q ss_pred             EEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      ||||+++ +|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPV  154 (288)
T ss_dssp             EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC--
T ss_pred             EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEeECccccccCccc
Confidence            9999986 99999984 467999999999999999999999999999999999999987766  9999999997653221


Q ss_pred             CCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc---CCCC-----------
Q 040569          156 DDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG---FSSD-----------  220 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~---~~~~-----------  220 (385)
                       .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... .+.++.   ....           
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T 1ob3_A          155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELP  232 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCCChhhchhhhccc
Confidence             122345789999999999764 58999999999999999999999998754332 222210   0000           


Q ss_pred             -------------CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          221 -------------TPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       221 -------------~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                   .......+++++++||.+||++||.+|||+.|+|+||||++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                         001224579999999999999999999999999999999753

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.7e-51  Score=395.33  Aligned_cols=254  Identities=27%  Similarity=0.382  Sum_probs=212.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +|++++.||+|+||+||+|+++.+++.||||.+..... ...+|+++|.++ .||||+++++++.....    +++||||
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~----~~lv~E~   97 (342)
T 2qr7_A           23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-DPTEEIEILLRYGQHPNIITLKDVYDDGKY----VYVVTEL   97 (342)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-CCHHHHHHHHHHTTSTTBCCEEEEEECSSE----EEEEECC
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-ChHHHHHHHHHhcCCCCcCeEEEEEEcCCE----EEEEEeC
Confidence            48899999999999999999999999999999976432 345789999988 79999999998765432    6799999


Q ss_pred             cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCC--CCeEEeecCceeeecccCCCC
Q 040569           81 APGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE--QGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        81 ~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~--~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      ++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+..+..  ..+||+|||+++...... ..
T Consensus        98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~  176 (342)
T 2qr7_A           98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GL  176 (342)
T ss_dssp             CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT-CC
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC-Cc
Confidence            999999999998888999999999999999999999999999999999999854322  238999999998764322 23


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCC--CChHHHHHHhcCCC--CCCCCCCcCCHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDV--ADPISALHRIGFSS--DTPEIPGYMSKQAQD  234 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~--~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~  234 (385)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...  .........+....  .....+..+|+++++
T Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  256 (342)
T 2qr7_A          177 LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKD  256 (342)
T ss_dssp             BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHH
T ss_pred             eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHH
Confidence            34568999999999999888999999999999999999999999753  23333444432221  122234568999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          235 FLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      ||.+||.+||.+|||+.|+|+||||..
T Consensus       257 li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          257 LVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             HHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            999999999999999999999999965

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.2e-50  Score=380.40  Aligned_cols=253  Identities=29%  Similarity=0.430  Sum_probs=217.9

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      |++.+.||+|+||+||+|.+..++..+|+|.+...     ..+.+.+|+.+|++++||||+++++++.....+...+++|
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            77889999999999999999999999999987532     2356789999999999999999999987665555567899


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEee-cCCCCCeEEeecCceeeeccc
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG--IVHCDIKGQNILVS-KDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~g--ivHrDlKp~NILi~-~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      |||+++|+|.+++...+.+++..+..++.||+.||.|||++|  |+||||||+|||++ .++.  +||+|||++....  
T Consensus       108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~--~kl~Dfg~~~~~~--  183 (290)
T 1t4h_A          108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKR--  183 (290)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGGGCC--
T ss_pred             EEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCC--EEEeeCCCccccc--
Confidence            999999999999997778999999999999999999999999  99999999999997 4444  9999999996542  


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                       ........||+.|+|||++.+ .++.++|||||||++|+|++|+.||....+.......+.........+...++++.+
T Consensus       184 -~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  261 (290)
T 1t4h_A          184 -ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE  261 (290)
T ss_dssp             -TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred             -ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHH
Confidence             122334579999999998875 589999999999999999999999988766666666655444455566678899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          235 FLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      ||.+||+.||.+|||+.|+|+||||++
T Consensus       262 li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          262 IIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHccCChhhCCCHHHHhhCccccc
Confidence            999999999999999999999999975

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.8e-51  Score=394.40  Aligned_cols=252  Identities=24%  Similarity=0.352  Sum_probs=194.1

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccCCeEEEEEEEeecCCC
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALA-CPQIVAYKGCDISEENGKILYNLFLEYAPGG   84 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~gg   84 (385)
                      ++.||+|+||+||+|+++.+++.||||.+.......+++|+.+++.+. ||||+++++++.....    +++||||++||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~----~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLH----TFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE----EEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE----EEEEEEccCCC
Confidence            478999999999999999999999999998777788899999999996 9999999999865433    67999999999


Q ss_pred             CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCC-CeEEeecCceeeecccCCCCCCccc
Q 040569           85 TLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQ-GAKIADFGCARRARVNEDDEGKPIC  163 (385)
Q Consensus        85 sL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~  163 (385)
                      +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.. .+||+|||+++..... .......+
T Consensus        92 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~  170 (325)
T 3kn6_A           92 ELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKTPC  170 (325)
T ss_dssp             BHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC-CCcccccC
Confidence            999999988889999999999999999999999999999999999999865422 3899999999865422 22334567


Q ss_pred             cCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCC------ChHHHHHHhcCCCCCCC--CCCcCCHHHHHH
Q 040569          164 GTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVA------DPISALHRIGFSSDTPE--IPGYMSKQAQDF  235 (385)
Q Consensus       164 Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~------~~~~~~~~~~~~~~~~~--~~~~~s~~~~~l  235 (385)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||....      .....+..+........  ....+|+++++|
T Consensus       171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  250 (325)
T 3kn6_A          171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL  250 (325)
T ss_dssp             -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHH
T ss_pred             CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHH
Confidence            9999999999999999999999999999999999999997532      22334444432221111  113479999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      |.+||.+||.+|||+.|+++||||+..
T Consensus       251 i~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          251 IQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             HHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             HHHHCCCChhHCCCHHHHhcChhhccC
Confidence            999999999999999999999999754

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.9e-50  Score=405.70  Aligned_cols=250  Identities=26%  Similarity=0.410  Sum_probs=217.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|.+++.||+|+||+||+|+++.+|+.||||++...      ..+.+.+|+.+|+.++||||+++++++.....    ++
T Consensus        17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~----~~   92 (476)
T 2y94_A           17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD----IF   92 (476)
T ss_dssp             TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE----EE
T ss_pred             CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE----EE
Confidence            589999999999999999999999999999988632      34678899999999999999999998765443    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++..... 
T Consensus        93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~~~-  169 (476)
T 2y94_A           93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDG-  169 (476)
T ss_dssp             EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEECCTT-
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC--eEEEeccchhhcccc-
Confidence            99999999999999998888999999999999999999999999999999999999987766  999999999876432 


Q ss_pred             CCCCCccccCCcccChhhhcCCCC-CCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                       ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... ......+..  .....|..+++++++
T Consensus       170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~--~~~~~p~~~s~~~~~  245 (476)
T 2y94_A          170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-PTLFKKICD--GIFYTPQYLNPSVIS  245 (476)
T ss_dssp             -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-HHHHHHHHT--TCCCCCTTCCHHHHH
T ss_pred             -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-HHHHHHHhc--CCcCCCccCCHHHHH
Confidence             23345689999999999988765 6899999999999999999999987543 333333322  234456778999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          235 FLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ||.+||+.||.+|||+.|+++||||+..
T Consensus       246 Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          246 LLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             HHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            9999999999999999999999999864

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4e-50  Score=384.79  Aligned_cols=254  Identities=28%  Similarity=0.399  Sum_probs=215.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC---------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---------NSEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~---------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|++++.||+|+||+||+|+++.+++.+|+|.+...         ..+.+.+|+.+|+++.||||+++++++.....   
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---   89 (321)
T 2a2a_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD---   89 (321)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE---
T ss_pred             cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE---
Confidence            489999999999999999999999999999988643         25678899999999999999999998765433   


Q ss_pred             EEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCC--CeEEeecCceee
Q 040569           73 LYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQ--GAKIADFGCARR  150 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~--~~kL~DFG~a~~  150 (385)
                       +++||||++|++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++..  .+||+|||+++.
T Consensus        90 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~  168 (321)
T 2a2a_A           90 -VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (321)
T ss_dssp             -EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred             -EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence             67999999999999999988889999999999999999999999999999999999999876521  489999999987


Q ss_pred             ecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC--CCCCCCCcC
Q 040569          151 ARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS--DTPEIPGYM  228 (385)
Q Consensus       151 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~  228 (385)
                      ....  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||... .....+..+....  ..+..+..+
T Consensus       169 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~  245 (321)
T 2a2a_A          169 IEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-TKQETLANITSVSYDFDEEFFSHT  245 (321)
T ss_dssp             CCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred             cCcc--ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhcccccChhhhccc
Confidence            6432  2234557999999999999999999999999999999999999999764 3333333332211  111223468


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       229 s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ++.+++||.+||.+||.+|||+.|+|+||||...
T Consensus       246 ~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             CHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence            9999999999999999999999999999999764

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.8e-50  Score=398.45  Aligned_cols=256  Identities=23%  Similarity=0.352  Sum_probs=203.9

Q ss_pred             Cceee-ceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHh-cCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRG-QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSA-LACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~-~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~-l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|.+. +.||+|+||+||+|+++.+++.||||++..  ...+.+|+.++.+ .+||||+++++++.....+...++||||
T Consensus        62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E  139 (400)
T 1nxk_A           62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME  139 (400)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEE
Confidence            46665 789999999999999999999999999863  4567789999855 4899999999988764444556789999


Q ss_pred             ecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC-CCCeEEeecCceeeecccCC
Q 040569           80 YAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN-EQGAKIADFGCARRARVNED  156 (385)
Q Consensus        80 y~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~-~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++.....  
T Consensus       140 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~--  217 (400)
T 1nxk_A          140 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--  217 (400)
T ss_dssp             CCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred             eCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC--
Confidence            99999999999854  3599999999999999999999999999999999999998632 234899999999875322  


Q ss_pred             CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCC------hHHHHHHhcCCCCCCCCCCcCCH
Q 040569          157 DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVAD------PISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~------~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.....      ....+..-.+.... .....+|+
T Consensus       218 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~  296 (400)
T 1nxk_A          218 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN-PEWSEVSE  296 (400)
T ss_dssp             ---------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT-TTTTTSCH
T ss_pred             CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC-cccccCCH
Confidence            223456899999999999999999999999999999999999999975422      11222221111111 12245899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ++++||.+||++||.+|||+.|+|+||||...
T Consensus       297 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          297 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            99999999999999999999999999999753

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8e-50  Score=374.92  Aligned_cols=255  Identities=25%  Similarity=0.385  Sum_probs=214.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++.+.||+|+||+||+|.++.+++.||+|.+....     .+.+.+|+.++++++||||+++++++.....    .++
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~~   82 (284)
T 3kk8_A            7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF----HYL   82 (284)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE----EEE
T ss_pred             hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCE----EEE
Confidence            6999999999999999999999999999999885432     3567799999999999999999998765432    569


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCC-CCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE-QGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~-~~~kL~DFG~a~~~~~~~  155 (385)
                      ||||++|++|.+.+.....+++..+..++.||+.||.|||++||+||||||+||+++.++. ..+||+|||++...... 
T Consensus        83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~-  161 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-  161 (284)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-
T ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-
Confidence            9999999999999987778999999999999999999999999999999999999976543 33899999999876422 


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC--CCCCCCCCcCCHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS--SDTPEIPGYMSKQAQ  233 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~  233 (385)
                       .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+...  .........+++++.
T Consensus       162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T 3kk8_A          162 -EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-QHRLYAQIKAGAYDYPSPEWDTVTPEAK  239 (284)
T ss_dssp             -CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             -ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc-hhHHHHHHHhccccCCchhhcccCHHHH
Confidence             22344679999999999999999999999999999999999999997643 33333333211  112222346899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          234 DFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       234 ~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      +||.+||++||.+|||+.|+|+||||....
T Consensus       240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (284)
T 3kk8_A          240 SLIDSMLTVNPKKRITADQALKVPWICNRE  269 (284)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred             HHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence            999999999999999999999999998654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.3e-50  Score=378.28  Aligned_cols=249  Identities=29%  Similarity=0.472  Sum_probs=212.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+||+|.++.+++.+|+|.+..      .....+.+|+.++++++||||+++++++.....    ++
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~   85 (279)
T 3fdn_A           10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR----VY   85 (279)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE----EE
T ss_pred             cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE----EE
Confidence            58999999999999999999999999999998853      234568899999999999999999998765433    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||+++|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||++...... 
T Consensus        86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~~~-  162 (279)
T 3fdn_A           86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPSS-  162 (279)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC--EEECSCCEESCC----
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC--EEEEeccccccCCcc-
Confidence            99999999999999997778999999999999999999999999999999999999987766  999999998654322 


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                        ......||+.|+|||++.+..++.++||||||+++|+|++|+.||... +.......+.  .....++..+++.+++|
T Consensus       163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~~l  237 (279)
T 3fdn_A          163 --RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-TYQETYKRIS--RVEFTFPDFVTEGARDL  237 (279)
T ss_dssp             -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHH--HTCCCCCTTSCHHHHHH
T ss_pred             --cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC-cHHHHHHHHH--hCCCCCCCcCCHHHHHH
Confidence              223457999999999999999999999999999999999999999864 3333333332  12334566789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      |.+||+.||.+|||+.|+|+||||+..
T Consensus       238 i~~~l~~~p~~Rps~~e~l~h~~~~~~  264 (279)
T 3fdn_A          238 ISRLLKHNPSQRPMLREVLEHPWITAN  264 (279)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             HHHHhccChhhCCCHHHHhhCccccCC
Confidence            999999999999999999999999864

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.8e-50  Score=386.88  Aligned_cols=253  Identities=28%  Similarity=0.426  Sum_probs=196.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++++.||+|+||+||+|+++.+++.||+|.+....    .+.+.+|+.+|++++||||+++++++.....    +++|
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~----~~lv   81 (317)
T 2pmi_A            6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENK----LTLV   81 (317)
T ss_dssp             -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTE----EEEE
T ss_pred             ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCe----EEEE
Confidence            6899999999999999999999999999999886432    3678899999999999999999998765432    6799


Q ss_pred             EeecCCCCHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           78 LEYAPGGTLTDAIRSG------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      |||++ |+|.+++...      ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..
T Consensus        82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~  158 (317)
T 2pmi_A           82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ--LKLGDFGLARAF  158 (317)
T ss_dssp             EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCSSCEET
T ss_pred             EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC--EEECcCccceec
Confidence            99998 5999998632      35899999999999999999999999999999999999987766  999999999876


Q ss_pred             cccCCCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh----cCCC-------
Q 040569          152 RVNEDDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI----GFSS-------  219 (385)
Q Consensus       152 ~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~----~~~~-------  219 (385)
                      .... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... ...+..+    +...       
T Consensus       159 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          159 GIPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-EEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             TSCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCSCCTTTCGGG
T ss_pred             CCCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChhHhhhh
Confidence            4222 223445799999999999764 689999999999999999999999987533 2222221    1000       


Q ss_pred             --------C-------------CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          220 --------D-------------TPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       220 --------~-------------~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                              .             .+..+..+++++++||.+||++||.+|||+.|+|+||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence                    0             0011235789999999999999999999999999999998653

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.4e-50  Score=396.63  Aligned_cols=254  Identities=29%  Similarity=0.397  Sum_probs=199.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--C---HHHHHHHHHHHHhcC-CCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--N---SEFLQREQRILSALA-CPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~---~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+||+|+++.+++.||||.+...  .   ...+.+|+.+|+++. ||||+++++++.......  ++
T Consensus        10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~--~~   87 (388)
T 3oz6_A           10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD--VY   87 (388)
T ss_dssp             TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC--EE
T ss_pred             ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE--EE
Confidence            699999999999999999999999999999988532  1   345668999999996 999999999987654323  56


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++ |+|.++++.+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+......
T Consensus        88 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIR  163 (388)
T ss_dssp             EEEECCS-EEHHHHHHHT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEESSSCC
T ss_pred             EEecccC-cCHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC--EEecCCcccccccccc
Confidence            9999997 5999999864 6999999999999999999999999999999999999987766  9999999998653210


Q ss_pred             --------------------CCCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHH
Q 040569          156 --------------------DDEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHR  214 (385)
Q Consensus       156 --------------------~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~  214 (385)
                                          .......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.. ....+.+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~  242 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS-TMNQLER  242 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHH
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHH
Confidence                                112234589999999999987 678999999999999999999999998753 3333332


Q ss_pred             hcCCCCCC---------------------------------------------CCCCcCCHHHHHHHHHhhhcCCCCCCC
Q 040569          215 IGFSSDTP---------------------------------------------EIPGYMSKQAQDFLSKCLIRNPGERWS  249 (385)
Q Consensus       215 ~~~~~~~~---------------------------------------------~~~~~~s~~~~~ll~~cL~~dP~~Rps  249 (385)
                      +......|                                             ..+..+++++.+||.+||+.||.+|||
T Consensus       243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t  322 (388)
T 3oz6_A          243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS  322 (388)
T ss_dssp             HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence            21000000                                             011257899999999999999999999


Q ss_pred             HHHHHhCcccccc
Q 040569          250 ASELLEHGFVKEQ  262 (385)
Q Consensus       250 ~~elL~hp~~~~~  262 (385)
                      ++|+|+||||+..
T Consensus       323 ~~e~l~Hp~~~~~  335 (388)
T 3oz6_A          323 ANDALKHPFVSIF  335 (388)
T ss_dssp             HHHHTTSTTTTTT
T ss_pred             HHHHhCCHHHHHh
Confidence            9999999999764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7.3e-50  Score=376.70  Aligned_cols=252  Identities=25%  Similarity=0.401  Sum_probs=204.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++.+.||+|+||+||+|.++.+++.+|+|.+...    ..+.+.+|+++|++++||||+++++++.....    +++|
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~----~~lv   98 (285)
T 3is5_A           23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN----MYIV   98 (285)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE----EEEE
T ss_pred             heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCe----EEEE
Confidence            488999999999999999999999999999988542    35788999999999999999999998765433    6799


Q ss_pred             EeecCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC-CCCeEEeecCceeeec
Q 040569           78 LEYAPGGTLTDAIR----SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN-EQGAKIADFGCARRAR  152 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~----~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~-~~~~kL~DFG~a~~~~  152 (385)
                      |||++||+|.+++.    .+..+++..+..++.||+.||+|||++||+||||||+|||++.+. ...+||+|||++....
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            99999999999985    346799999999999999999999999999999999999995432 2348999999998653


Q ss_pred             ccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC-CCCCCCCCCcCCHH
Q 040569          153 VNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF-SSDTPEIPGYMSKQ  231 (385)
Q Consensus       153 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~  231 (385)
                      ..  .......||+.|+|||++. ..++.++|||||||++|+|++|+.||.... .......... ....+.....++++
T Consensus       179 ~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  254 (285)
T 3is5_A          179 SD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS-LEEVQQKATYKEPNYAVECRPLTPQ  254 (285)
T ss_dssp             ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCCCCC--CCCCHH
T ss_pred             Cc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC-HHHHHhhhccCCcccccccCcCCHH
Confidence            22  2234557999999999986 467889999999999999999999998753 3333222222 22222223347999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          232 AQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      +.+||.+||+.||.+|||+.|+|+||||++
T Consensus       255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            999999999999999999999999999975

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.2e-50  Score=402.67  Aligned_cols=260  Identities=28%  Similarity=0.377  Sum_probs=195.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--C---HHHHHHHHHHHHhcCCCCeeeeeeeeeecc-CCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--N---SEFLQREQRILSALACPQIVAYKGCDISEE-NGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~~~~~   75 (385)
                      +|++++.||+|+||+||+|+++.+++.||||++...  .   .+.+.+|+.+|++++||||+++++++.... .....+|
T Consensus        54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  133 (458)
T 3rp9_A           54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY  133 (458)
T ss_dssp             TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence            589999999999999999999999999999988642  1   356779999999999999999999886543 2222367


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||+ +|+|.+++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.  +||+|||+|+......
T Consensus       134 lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~~~~~  210 (458)
T 3rp9_A          134 VVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVDYPE  210 (458)
T ss_dssp             EEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCTTSCT
T ss_pred             EEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC--EeecccccchhccCcc
Confidence            999998 4699999998888999999999999999999999999999999999999988766  9999999998754221


Q ss_pred             C--------------------------CCCCccccCCcccChhhh-cCCCCCCCCChHHHHHHHHHHHh-----------
Q 040569          156 D--------------------------DEGKPICGTPICMAPEVA-RGEEQGFPADVWALGCTVLEMAT-----------  197 (385)
Q Consensus       156 ~--------------------------~~~~~~~Gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~ellt-----------  197 (385)
                      .                          ......+||+.|+|||++ .+..++.++|||||||++|||++           
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~  290 (458)
T 3rp9_A          211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD  290 (458)
T ss_dssp             TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred             ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence            1                          123445789999999986 56679999999999999999999           


Q ss_pred             CCCCCCCCCC-------------------hHHHHHHh----cC---------------------C----CCCCCCCCcCC
Q 040569          198 GRPPWPDVAD-------------------PISALHRI----GF---------------------S----SDTPEIPGYMS  229 (385)
Q Consensus       198 G~~Pf~~~~~-------------------~~~~~~~~----~~---------------------~----~~~~~~~~~~s  229 (385)
                      |+++|.+...                   ....+..+    +.                     .    ..........+
T Consensus       291 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  370 (458)
T 3rp9_A          291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASS  370 (458)
T ss_dssp             CCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSC
T ss_pred             ccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCC
Confidence            6777765321                   01111110    00                     0    00011123468


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHhCcccccccc
Q 040569          230 KQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF  264 (385)
Q Consensus       230 ~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~~  264 (385)
                      +++.+||.+||.+||.+|||++|+|+||||+....
T Consensus       371 ~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~  405 (458)
T 3rp9_A          371 ADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI  405 (458)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred             HHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence            99999999999999999999999999999987643

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=8.2e-51  Score=389.06  Aligned_cols=254  Identities=22%  Similarity=0.333  Sum_probs=206.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccC--------
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEEN--------   69 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--------   69 (385)
                      +|++++.||+|+||+||+|+++.+++.||||++....    .+.+.+|+++|++++||||+++++++.....        
T Consensus         7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~   86 (332)
T 3qd2_B            7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD   86 (332)
T ss_dssp             HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred             cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence            5899999999999999999999999999999986432    3678899999999999999999998765432        


Q ss_pred             ---------------------------------------------CeEEEEEEEeecCCCCHHHHHHcCCC---CCHHHH
Q 040569           70 ---------------------------------------------GKILYNLFLEYAPGGTLTDAIRSGTC---LEEGRI  101 (385)
Q Consensus        70 ---------------------------------------------~~~~~~lv~Ey~~ggsL~~~l~~~~~---l~e~~~  101 (385)
                                                                   ...++++|||||+||+|.++++....   .++..+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~  166 (332)
T 3qd2_B           87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC  166 (332)
T ss_dssp             C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHH
T ss_pred             hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHH
Confidence                                                         11236799999999999999986543   456678


Q ss_pred             HHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC-----------CCCCccccCCcccC
Q 040569          102 RSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED-----------DEGKPICGTPICMA  170 (385)
Q Consensus       102 ~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~-----------~~~~~~~Gt~~y~a  170 (385)
                      ..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.......           ......+||+.|+|
T Consensus       167 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  244 (332)
T 3qd2_B          167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS  244 (332)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred             HHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC--EEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence            999999999999999999999999999999987765  99999999987643321           12234579999999


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCH
Q 040569          171 PEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSA  250 (385)
Q Consensus       171 PE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~  250 (385)
                      ||++.+..++.++|||||||++|+|++|..|+..   ........ .....+..+...++++++||.+||++||.+|||+
T Consensus       245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  320 (332)
T 3qd2_B          245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---RVRIITDV-RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA  320 (332)
T ss_dssp             HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHH-HTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCH
T ss_pred             hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHHh-hccCCCcccccCChhHHHHHHHHccCCCCcCCCH
Confidence            9999999999999999999999999999877632   22222222 1223333334467889999999999999999999


Q ss_pred             HHHHhCccccc
Q 040569          251 SELLEHGFVKE  261 (385)
Q Consensus       251 ~elL~hp~~~~  261 (385)
                      .|+|+||||++
T Consensus       321 ~~~l~~~~f~~  331 (332)
T 3qd2_B          321 TDIIENAIFEN  331 (332)
T ss_dssp             HHHHHSTTCCC
T ss_pred             HHHhhchhhhc
Confidence            99999999974

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4e-50  Score=412.54  Aligned_cols=254  Identities=28%  Similarity=0.385  Sum_probs=216.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+|+++.+|+.||+|.+..      .....+.+|+++|++++||||+++++++.....    ++
T Consensus       185 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~----l~  260 (576)
T 2acx_A          185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA----LC  260 (576)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE----EE
T ss_pred             ceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE----EE
Confidence            48899999999999999999999999999998853      234667899999999999999999998765443    67


Q ss_pred             EEEeecCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           76 LFLEYAPGGTLTDAIRSGT--CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~--~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      +||||++||+|.+++...+  .+++..++.++.||+.||+|||++||+||||||+||||+.++.  +||+|||+++....
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~--vKL~DFGla~~~~~  338 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPE  338 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCT
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC--eEEEecccceeccc
Confidence            9999999999999998543  4999999999999999999999999999999999999987766  99999999987642


Q ss_pred             cCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHhcCCCCCCCCCCcCCH
Q 040569          154 NEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVAD---PISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      .  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....   .......+.  .....++..+|+
T Consensus       339 ~--~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~--~~~~~~p~~~s~  414 (576)
T 2acx_A          339 G--QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK--EVPEEYSERFSP  414 (576)
T ss_dssp             T--CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH--HCCCCCCTTSCH
T ss_pred             C--ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh--cccccCCccCCH
Confidence            2  222345899999999999999999999999999999999999999976432   222222221  223455677999


Q ss_pred             HHHHHHHHhhhcCCCCCC-----CHHHHHhCccccccccc
Q 040569          231 QAQDFLSKCLIRNPGERW-----SASELLEHGFVKEQNFK  265 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rp-----s~~elL~hp~~~~~~~~  265 (385)
                      ++++||.+||++||.+||     +++|+++||||+..++.
T Consensus       415 ~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~  454 (576)
T 2acx_A          415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK  454 (576)
T ss_dssp             HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred             HHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence            999999999999999999     79999999999987553

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.8e-50  Score=420.09  Aligned_cols=254  Identities=26%  Similarity=0.438  Sum_probs=221.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++++.||+|+||+||+|+++.+++.||||++.+      ...+.+.+|..+|..+ .||+|+++++++.....    +
T Consensus       342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~----~  417 (674)
T 3pfq_A          342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR----L  417 (674)
T ss_dssp             TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE----E
T ss_pred             ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE----E
Confidence            68999999999999999999999999999998863      2346677899999988 79999999988765443    6


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ||||||++||+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+||||+.++.  +||+|||+|+.....
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWD  495 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC--EEECCCTTCEECCCT
T ss_pred             EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc--EEEeecceeeccccC
Confidence            799999999999999997778999999999999999999999999999999999999988776  999999999864322


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                       .......+||+.|||||++.+..++.++|||||||++|||++|+.||... +.......+..  ....+|..+|+++++
T Consensus       496 -~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~-~~~~~~~~i~~--~~~~~p~~~s~~~~~  571 (674)
T 3pfq_A          496 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-DEDELFQSIME--HNVAYPKSMSKEAVA  571 (674)
T ss_dssp             -TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHS--SCCCCCTTSCHHHHH
T ss_pred             -CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC-CHHHHHHHHHh--CCCCCCccCCHHHHH
Confidence             22345678999999999999999999999999999999999999999874 44444445432  335567789999999


Q ss_pred             HHHHhhhcCCCCCCCH-----HHHHhCccccccccc
Q 040569          235 FLSKCLIRNPGERWSA-----SELLEHGFVKEQNFK  265 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~-----~elL~hp~~~~~~~~  265 (385)
                      ||.+||++||.+||++     +|+++||||+..++.
T Consensus       572 li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~  607 (674)
T 3pfq_A          572 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  607 (674)
T ss_dssp             HHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred             HHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence            9999999999999997     999999999987654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-50  Score=388.96  Aligned_cols=257  Identities=28%  Similarity=0.414  Sum_probs=208.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC--------CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL--------SNSEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~--------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|++++.||+|+||+||+|+++.+++.+|+|.+..        ...+.+.+|+++|++++||||+++++++.....    
T Consensus        27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----  102 (345)
T 3hko_A           27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY----  102 (345)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE----
T ss_pred             heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe----
Confidence            48999999999999999999999999999998753        224678899999999999999999999865432    


Q ss_pred             EEEEEeecCCCCHHHHHHc----------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 040569           74 YNLFLEYAPGGTLTDAIRS----------------------------------------GTCLEEGRIRSHTRAVLLGLQ  113 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~----------------------------------------~~~l~e~~~~~i~~qil~gL~  113 (385)
                      +++||||++||+|.+++..                                        ...+++..++.++.||+.||+
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  182 (345)
T 3hko_A          103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH  182 (345)
T ss_dssp             EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence            6799999999999999852                                        112467889999999999999


Q ss_pred             HHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC---CCCccccCCcccChhhhcC--CCCCCCCChHHH
Q 040569          114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD---EGKPICGTPICMAPEVARG--EEQGFPADVWAL  188 (385)
Q Consensus       114 yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~---~~~~~~Gt~~y~aPE~~~~--~~~~~~~DiwSl  188 (385)
                      |||++||+||||||+|||++.++...+||+|||+++........   ......||+.|+|||++.+  ..++.++|||||
T Consensus       183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl  262 (345)
T 3hko_A          183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA  262 (345)
T ss_dssp             HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred             HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence            99999999999999999998766445999999999876432221   2345679999999999975  678899999999


Q ss_pred             HHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCC--CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          189 GCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE--IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       189 G~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      ||++|+|++|+.||...... .....+........  ....+++++++||.+||++||.+|||+.|+|+||||++..
T Consensus       263 G~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          263 GVLLHLLLMGAVPFPGVNDA-DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             HHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             HHHHHHHHHCCCCCCCCChH-HHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            99999999999999875433 33333322221111  1234799999999999999999999999999999998654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.7e-50  Score=381.63  Aligned_cols=254  Identities=28%  Similarity=0.413  Sum_probs=206.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++++.||+|+||+||+|+++.+++.||+|.+....     .+.+.+|++++++++||||+++++++.....    +++
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~l   79 (311)
T 4agu_A            4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR----LHL   79 (311)
T ss_dssp             CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE----EEE
T ss_pred             cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCe----EEE
Confidence            6999999999999999999999999999999885433     2456789999999999999999999865443    669


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      ||||+++++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||++....... 
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~-  156 (311)
T 4agu_A           80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV--IKLCDFGFARLLTGPS-  156 (311)
T ss_dssp             EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECC----
T ss_pred             EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC--EEEeeCCCchhccCcc-
Confidence            9999999999999998888999999999999999999999999999999999999987765  9999999998764222 


Q ss_pred             CCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc-------------------
Q 040569          157 DEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG-------------------  216 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~-------------------  216 (385)
                      ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ...+.                   
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhcccccccccccccccc
Confidence            22344579999999999976 5679999999999999999999999987533222 21110                   


Q ss_pred             -CCCCCCCC---------CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          217 -FSSDTPEI---------PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       217 -~~~~~~~~---------~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                       .....+..         ...+++++.+||.+||+.||.+|||++|+|+||||+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  292 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR  292 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence             00000100         134789999999999999999999999999999998753

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2e-50  Score=388.64  Aligned_cols=256  Identities=25%  Similarity=0.395  Sum_probs=203.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++++.||+|+||+||+|+++.+++.||||.+....     .+.+.+|+.+|++++||||+++++++.....    +++
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~l  110 (329)
T 3gbz_A           35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR----LHL  110 (329)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTE----EEE
T ss_pred             hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE----EEE
Confidence            5899999999999999999999999999999986543     2346689999999999999999999876543    679


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC---CCCeEEeecCceeeecc
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN---EQGAKIADFGCARRARV  153 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~---~~~~kL~DFG~a~~~~~  153 (385)
                      ||||++| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++   ...+||+|||+++....
T Consensus       111 v~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~  189 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI  189 (329)
T ss_dssp             EEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred             EEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence            9999985 9999999888899999999999999999999999999999999999996432   22389999999986532


Q ss_pred             cCCCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh----cCCCC--------
Q 040569          154 NEDDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI----GFSSD--------  220 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~----~~~~~--------  220 (385)
                      .. ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... ..+..+    +....        
T Consensus       190 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  267 (329)
T 3gbz_A          190 PI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-DQLFKIFEVLGLPDDTTWPGVTA  267 (329)
T ss_dssp             -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             cc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH-HHHHHHHHHhCCCchhhhhhhhh
Confidence            22 223445789999999999875 4799999999999999999999999875433 222222    11000        


Q ss_pred             -------CCC---------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccccc
Q 040569          221 -------TPE---------IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF  264 (385)
Q Consensus       221 -------~~~---------~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~~  264 (385)
                             .+.         ++..+++++++||.+||++||.+|||+.|+|+||||+..++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence                   000         01126899999999999999999999999999999987543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1e-49  Score=374.73  Aligned_cols=250  Identities=27%  Similarity=0.451  Sum_probs=215.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+||+|++..+++.+|+|.+..      .....+.+|++++++++||||+++++++.....    ++
T Consensus        15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~   90 (284)
T 2vgo_A           15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR----IY   90 (284)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE----EE
T ss_pred             hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE----EE
Confidence            58999999999999999999999999999998853      234678899999999999999999998765432    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.  +||+|||++...... 
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPSL-  167 (284)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC--EEECCCTTCEECSSS-
T ss_pred             EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC--EEEecccccccCccc-
Confidence            99999999999999987778999999999999999999999999999999999999987766  999999999765321 


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+.  .....++..+++++++|
T Consensus       168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~~~--~~~~~~~~~~~~~~~~l  242 (284)
T 2vgo_A          168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS-HTETHRRIV--NVDLKFPPFLSDGSKDL  242 (284)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHH--TTCCCCCTTSCHHHHHH
T ss_pred             --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC-HhHHHHHHh--ccccCCCCcCCHHHHHH
Confidence              2334579999999999999999999999999999999999999997643 333333332  12334567789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      |.+||..||.+|||+.|+++||||+...
T Consensus       243 i~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          243 ISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             HHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence            9999999999999999999999998643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.5e-50  Score=375.52  Aligned_cols=255  Identities=28%  Similarity=0.446  Sum_probs=214.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++++.||+|+||+||+|.++.+++.+|+|.+...    ..+.+.+|+.++++++||||+++++++.....    +++|
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv   83 (276)
T 2yex_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI----QYLF   83 (276)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE----EEEE
T ss_pred             ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCE----EEEE
Confidence            589999999999999999999999999999988532    24678899999999999999999998765432    6699


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC-
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED-  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~-  156 (385)
                      |||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+||+++.++.  +||+|||++........ 
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEE
T ss_pred             EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC--EEEeeCCCccccCCCcch
Confidence            999999999999987778999999999999999999999999999999999999987766  99999999986543221 


Q ss_pred             CCCCccccCCcccChhhhcCCCC-CCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          157 DEGKPICGTPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                      .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||............+............+++.+++|
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  241 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHH
Confidence            12345579999999999987765 77899999999999999999999865443333333222222222234689999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      |.+||+.||.+|||+.|+++||||+..
T Consensus       242 i~~~l~~~p~~Rps~~~il~~~~~~~~  268 (276)
T 2yex_A          242 LHKILVENPSARITIPDIKKDRWYNKP  268 (276)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHHHCCCCchhCCCHHHHhcCccccCh
Confidence            999999999999999999999999764

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.6e-49  Score=380.96  Aligned_cols=253  Identities=24%  Similarity=0.342  Sum_probs=212.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALA-CPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +|++++.||+|+||+||+|++..+++.||||.+.....+.+.+|+.+|+++. ||||+++++++.......  .++||||
T Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~--~~lv~e~  114 (330)
T 3nsz_A           37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRT--PALVFEH  114 (330)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC--EEEEEEC
T ss_pred             ceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc--eEEEEec
Confidence            5899999999999999999999999999999999888899999999999996 999999999887643333  5689999


Q ss_pred             cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCC
Q 040569           81 APGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGK  160 (385)
Q Consensus        81 ~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~  160 (385)
                      +++++|.++++.   +++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+++.....  ....
T Consensus       115 ~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~--~~~~  188 (330)
T 3nsz_A          115 VNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPG--QEYN  188 (330)
T ss_dssp             CCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCTT--CCCC
T ss_pred             cCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCC--Cccc
Confidence            999999999864   899999999999999999999999999999999999986552 3899999999876432  2334


Q ss_pred             ccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC----------------CC----
Q 040569          161 PICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF----------------SS----  219 (385)
Q Consensus       161 ~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~----------------~~----  219 (385)
                      ...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....+....+..+..                ..    
T Consensus       189 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (330)
T 3nsz_A          189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF  268 (330)
T ss_dssp             SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHH
T ss_pred             cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccch
Confidence            5579999999999987 67899999999999999999999999654443332221100                00    


Q ss_pred             ---------------CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          220 ---------------DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       220 ---------------~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                     .....+..+++++++||.+||++||.+|||++|+|+||||+..
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          269 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             HHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             hhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence                           0111223379999999999999999999999999999999864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4e-50  Score=385.67  Aligned_cols=255  Identities=27%  Similarity=0.401  Sum_probs=202.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHH----HHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE----FLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~----~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++++.||+|+||+||+|+++.+++.||+|.+......    .+.+|+++|++++||||+++++++.....    +++|
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv   78 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS----LTLV   78 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSC----EEEE
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCE----EEEE
Confidence            699999999999999999999999999999998754332    34479999999999999999999876544    6799


Q ss_pred             EeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           78 LEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |||++| +|.+++.. +..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...... 
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~-  154 (324)
T 3mtl_A           79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPT-  154 (324)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC--EEECSSSEEECC-----
T ss_pred             eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC--EEEccCcccccccCCc-
Confidence            999975 99998874 556999999999999999999999999999999999999987766  9999999998653222 


Q ss_pred             CCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh---cCCCCCCC---------
Q 040569          157 DEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI---GFSSDTPE---------  223 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---~~~~~~~~---------  223 (385)
                      ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ....+..+   ........         
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST-VEEQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChHhchhhhcchh
Confidence            22334578999999999977 568999999999999999999999998753 22222221   11111111         


Q ss_pred             ----------------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccc
Q 040569          224 ----------------IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK  265 (385)
Q Consensus       224 ----------------~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~~~  265 (385)
                                      ....+++++++||.+||+.||.+|||++|+|+||||......
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence                            112468999999999999999999999999999999876433

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.1e-49  Score=372.91  Aligned_cols=251  Identities=25%  Similarity=0.400  Sum_probs=211.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC---CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL---SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|++.+.||+|+||+||+|.++.++..+|+|.+..   ...+.+.+|++++++++||||+++++++.....    +++||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~   85 (277)
T 3f3z_A           10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD----IYLVM   85 (277)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE----EEEEE
T ss_pred             hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe----EEEEE
Confidence            48999999999999999999999999999998853   456788999999999999999999998765433    67999


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecC-CCCCeEEeecCceeeecccCCC
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKD-NEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~-~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      ||++|++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+..+ ....+||+|||++......  .
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~--~  163 (277)
T 3f3z_A           86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--K  163 (277)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT--S
T ss_pred             eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc--c
Confidence            999999999999877789999999999999999999999999999999999999321 1233999999999876432  2


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCC----CcCCHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP----GYMSKQAQ  233 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~  233 (385)
                      ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||..... ......+....  ...+    ..+++++.
T Consensus       164 ~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~~~~  239 (277)
T 3f3z_A          164 MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD-SEVMLKIREGT--FTFPEKDWLNVSPQAE  239 (277)
T ss_dssp             CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCC--CCCCHHHHTTSCHHHH
T ss_pred             chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhCC--CCCCchhhhcCCHHHH
Confidence            33455799999999998765 89999999999999999999999987533 33333332211  1122    25799999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          234 DFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       234 ~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +||.+||++||.+|||+.|+|+||||++.
T Consensus       240 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          240 SLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence            99999999999999999999999999764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2e-50  Score=396.04  Aligned_cols=252  Identities=27%  Similarity=0.376  Sum_probs=206.5

Q ss_pred             eeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            4 TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      ...+.||+|+||+||+|.++.+|+.||+|++....   .+.+.+|+++|++++||||+++++++.....    +++||||
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----~~lv~E~  167 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKND----IVLVMEY  167 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE----EEEEEEC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE----EEEEEeC
Confidence            34678999999999999999999999999987653   4568899999999999999999998765443    6799999


Q ss_pred             cCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           81 APGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        81 ~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      ++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+..+....+||+|||+++.....  ...
T Consensus       168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~--~~~  245 (373)
T 2x4f_A          168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EKL  245 (373)
T ss_dssp             CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT--CBC
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc--ccc
Confidence            999999998864 45699999999999999999999999999999999999996544445999999999876432  223


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC--CCCCCCCcCCHHHHHHHH
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS--DTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~ll~  237 (385)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ....+..+....  ..+.....+++++++||.
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  324 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN-DAETLNNILACRWDLEDEEFQDISEEAKEFIS  324 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHH
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCCCChhhhccCCHHHHHHHH
Confidence            44579999999999999999999999999999999999999998753 333333332111  112223458999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCcccccc
Q 040569          238 KCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +||++||.+|||+.|+|+||||...
T Consensus       325 ~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          325 KLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             TTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHcCCChhhCCCHHHHhcCcCcCCC
Confidence            9999999999999999999999865

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.3e-49  Score=407.08  Aligned_cols=255  Identities=25%  Similarity=0.370  Sum_probs=216.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+|+++.+|+.||+|++..      ...+.+.+|.++|++++||||+++++++.....    +|
T Consensus       186 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~----l~  261 (543)
T 3c4z_A          186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD----LC  261 (543)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE----EE
T ss_pred             heEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE----EE
Confidence            58889999999999999999999999999998853      234667899999999999999999998765443    67


Q ss_pred             EEEeecCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           76 LFLEYAPGGTLTDAIRS----GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~----~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      +||||++||+|.+++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~--vkL~DFGla~~~  339 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAVEL  339 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEEC
T ss_pred             EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC--EEEeecceeeec
Confidence            99999999999999974    346999999999999999999999999999999999999988776  999999999876


Q ss_pred             cccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHhcCCCCCCCCCCcC
Q 040569          152 RVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVAD---PISALHRIGFSSDTPEIPGYM  228 (385)
Q Consensus       152 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~~  228 (385)
                      .... ......+||+.|||||++.+..++.++|||||||++|||++|+.||.....   .......+.  .....+|..+
T Consensus       340 ~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~--~~~~~~p~~~  416 (543)
T 3c4z_A          340 KAGQ-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL--EQAVTYPDKF  416 (543)
T ss_dssp             CTTC-CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH--HCCCCCCTTS
T ss_pred             cCCC-cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh--hcccCCCccc
Confidence            4322 123445899999999999999999999999999999999999999976432   223333332  2234566779


Q ss_pred             CHHHHHHHHHhhhcCCCCCCC-----HHHHHhCccccccccc
Q 040569          229 SKQAQDFLSKCLIRNPGERWS-----ASELLEHGFVKEQNFK  265 (385)
Q Consensus       229 s~~~~~ll~~cL~~dP~~Rps-----~~elL~hp~~~~~~~~  265 (385)
                      |+++++||.+||++||.+||+     ++++++||||+..++.
T Consensus       417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~  458 (543)
T 3c4z_A          417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR  458 (543)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred             CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence            999999999999999999996     5899999999987553

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.6e-50  Score=389.37  Aligned_cols=244  Identities=23%  Similarity=0.309  Sum_probs=210.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCC
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----------SEFLQREQRILSALACPQIVAYKGCDISEENG   70 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~   70 (385)
                      +|++.+.||+|+||+||+|+++.+++.||||.+....           .+.+.+|+.+|++++||||+++++++..... 
T Consensus        25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~-  103 (335)
T 3dls_A           25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF-  103 (335)
T ss_dssp             HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE-
T ss_pred             ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE-
Confidence            4899999999999999999999999999999886542           2356689999999999999999998765432 


Q ss_pred             eEEEEEEEeecCCC-CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCcee
Q 040569           71 KILYNLFLEYAPGG-TLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR  149 (385)
Q Consensus        71 ~~~~~lv~Ey~~gg-sL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~  149 (385)
                         +++||||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++
T Consensus       104 ---~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~  178 (335)
T 3dls_A          104 ---FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT--IKLIDFGSAA  178 (335)
T ss_dssp             ---EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCE
T ss_pred             ---EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc--EEEeecccce
Confidence               66999999776 99999998888999999999999999999999999999999999999987765  9999999998


Q ss_pred             eecccCCCCCCccccCCcccChhhhcCCCC-CCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcC
Q 040569          150 RARVNEDDEGKPICGTPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM  228 (385)
Q Consensus       150 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (385)
                      .....  ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......         .......+..+
T Consensus       179 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~~~~~~~~~~  247 (335)
T 3dls_A          179 YLERG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------VEAAIHPPYLV  247 (335)
T ss_dssp             ECCTT--CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------TTTCCCCSSCC
T ss_pred             ECCCC--CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------HhhccCCCccc
Confidence            76422  22345679999999999988876 78899999999999999999999753211         11223345568


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       229 s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ++++++||.+||++||.+|||+.|+|+||||++.
T Consensus       248 ~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          248 SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            9999999999999999999999999999999753

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.2e-49  Score=393.70  Aligned_cols=260  Identities=25%  Similarity=0.350  Sum_probs=203.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--C---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccC-CeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--N---SEFLQREQRILSALACPQIVAYKGCDISEEN-GKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~~~~~   75 (385)
                      +|++++.||+|+||+||+|+++.+++.||||++...  .   .+.+.+|+.+|++++||||+++++++..... ....+|
T Consensus        27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  106 (432)
T 3n9x_A           27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY  106 (432)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence            599999999999999999999999999999998643  1   3567799999999999999999998765431 112266


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||+. |+|.++++....+++..++.++.||+.||+|||++||+||||||+||||+.++.  +||+|||+|+......
T Consensus       107 lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--~kL~DFGla~~~~~~~  183 (432)
T 3n9x_A          107 IVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS--VKVCDFGLARTINSEK  183 (432)
T ss_dssp             EEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC----
T ss_pred             EEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC--EEEccCCCcccccccc
Confidence            9999996 599999998888999999999999999999999999999999999999987766  9999999998764322


Q ss_pred             C---------------------CCCCccccCCcccChhhh-cCCCCCCCCChHHHHHHHHHHHhCC-----------CCC
Q 040569          156 D---------------------DEGKPICGTPICMAPEVA-RGEEQGFPADVWALGCTVLEMATGR-----------PPW  202 (385)
Q Consensus       156 ~---------------------~~~~~~~Gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltG~-----------~Pf  202 (385)
                      .                     ......+||+.|+|||++ .+..++.++|||||||++|||++|.           ++|
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f  263 (432)
T 3n9x_A          184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF  263 (432)
T ss_dssp             ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSC
T ss_pred             cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccC
Confidence            1                     123566899999999986 5667999999999999999999854           444


Q ss_pred             CCCCC----------------hHHHHHHh------------------------cCCCCCCC-----CCCcCCHHHHHHHH
Q 040569          203 PDVAD----------------PISALHRI------------------------GFSSDTPE-----IPGYMSKQAQDFLS  237 (385)
Q Consensus       203 ~~~~~----------------~~~~~~~~------------------------~~~~~~~~-----~~~~~s~~~~~ll~  237 (385)
                      .+...                ....+..+                        ........     ....+++++.+||.
T Consensus       264 ~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~  343 (432)
T 3n9x_A          264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLE  343 (432)
T ss_dssp             CCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred             CCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH
Confidence            33210                01111110                        00000000     11347999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCcccccccc
Q 040569          238 KCLIRNPGERWSASELLEHGFVKEQNF  264 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~hp~~~~~~~  264 (385)
                      +||+.||.+|||++|+|+||||+....
T Consensus       344 ~mL~~dP~~R~ta~e~L~Hp~f~~~~~  370 (432)
T 3n9x_A          344 SMLKFNPNKRITIDQALDHPYLKDVRK  370 (432)
T ss_dssp             HHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred             HHhcCCcccCCCHHHHhcChhhhhccC
Confidence            999999999999999999999987643

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.7e-50  Score=387.58  Aligned_cols=252  Identities=27%  Similarity=0.440  Sum_probs=209.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCC--CCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALAC--PQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~h--pnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++++.||+|+||+||+|.+. +++.||||.+....     .+.+.+|+.+|+++.|  |||+++++++....    .+
T Consensus        10 ~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~----~~   84 (343)
T 3dbq_A           10 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ----YI   84 (343)
T ss_dssp             EEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----EE
T ss_pred             EEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC----EE
Confidence            4899999999999999999984 68999999886432     2567899999999976  99999999876544    26


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++|||| .+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.  +||+|||+++.....
T Consensus        85 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~--~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           85 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGM--LKLIDFGIANQMQPD  160 (343)
T ss_dssp             EEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTE--EEECCCSSSCCC---
T ss_pred             EEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCc--EEEeecccccccCcc
Confidence            799995 5789999999888899999999999999999999999999999999999997 333  999999999876433


Q ss_pred             CCC-CCCccccCCcccChhhhcC-----------CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCC
Q 040569          155 EDD-EGKPICGTPICMAPEVARG-----------EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP  222 (385)
Q Consensus       155 ~~~-~~~~~~Gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  222 (385)
                      ... .....+||+.|+|||++.+           ..++.++|||||||++|+|++|+.||....+....+..+.......
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  240 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI  240 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence            221 2335579999999999965           6678899999999999999999999987766666666655555556


Q ss_pred             CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          223 EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       223 ~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      .++...++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            6777788999999999999999999999999999999754

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-50  Score=390.12  Aligned_cols=255  Identities=26%  Similarity=0.458  Sum_probs=213.6

Q ss_pred             CceeeceeeccCceEEEEEEEC---CCCcEEEEEeccCC-------CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCC
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN---RSSEVFAVKSAELS-------NSEFLQREQRILSAL-ACPQIVAYKGCDISEENG   70 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~---~~~~~~AvK~~~~~-------~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~   70 (385)
                      +|++++.||+|+||+||+|++.   .+++.||||++...       ..+.+.+|+++|+++ .||||+++++++..... 
T Consensus        55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~-  133 (355)
T 1vzo_A           55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK-  133 (355)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE-
T ss_pred             ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce-
Confidence            5899999999999999999984   58999999988532       345677899999999 79999999998766543 


Q ss_pred             eEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569           71 KILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus        71 ~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                         +++||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.
T Consensus       134 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~  208 (355)
T 1vzo_A          134 ---LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKE  208 (355)
T ss_dssp             ---EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEE
T ss_pred             ---EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc--EEEeeCCCCee
Confidence               6799999999999999997778999999999999999999999999999999999999987766  99999999987


Q ss_pred             ecccCCCCCCccccCCcccChhhhcCC--CCCCCCChHHHHHHHHHHHhCCCCCCCCC---ChHHHHHHhcCCCCCCCCC
Q 040569          151 ARVNEDDEGKPICGTPICMAPEVARGE--EQGFPADVWALGCTVLEMATGRPPWPDVA---DPISALHRIGFSSDTPEIP  225 (385)
Q Consensus       151 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~---~~~~~~~~~~~~~~~~~~~  225 (385)
                      ............+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||....   ........+.  ...+.++
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~  286 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL--KSEPPYP  286 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH--HCCCCCC
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh--ccCCCCC
Confidence            644333334456899999999999863  47889999999999999999999997432   2222222221  2234566


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCcccccccc
Q 040569          226 GYMSKQAQDFLSKCLIRNPGERW-----SASELLEHGFVKEQNF  264 (385)
Q Consensus       226 ~~~s~~~~~ll~~cL~~dP~~Rp-----s~~elL~hp~~~~~~~  264 (385)
                      ..+++.+++||.+||.+||.+||     |+.|+++||||...++
T Consensus       287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~  330 (355)
T 1vzo_A          287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  330 (355)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence            77899999999999999999999     9999999999987654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1e-49  Score=393.18  Aligned_cols=252  Identities=27%  Similarity=0.442  Sum_probs=209.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcC--CCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALA--CPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~--hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++++.||+|+||+||+|.+.. ++.||||.+....     .+.+.+|+.+|+++.  ||||+++++++.....    +
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~----~  131 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY----I  131 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE----E
T ss_pred             ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE----E
Confidence            38999999999999999999865 9999999886432     256789999999996  5999999998765443    6


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||| +.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++  .+||+|||+++.....
T Consensus       132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~--~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG--MLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SS--CEEECCCSSSCCC---
T ss_pred             EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CC--eEEEEecCccccccCC
Confidence            79999 56789999999888899999999999999999999999999999999999995 33  3999999999876433


Q ss_pred             CCC-CCCccccCCcccChhhhcC-----------CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCC
Q 040569          155 EDD-EGKPICGTPICMAPEVARG-----------EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP  222 (385)
Q Consensus       155 ~~~-~~~~~~Gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  222 (385)
                      ... .....+||+.|||||++.+           ..++.++|||||||++|+|++|+.||....+....+..+.......
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~  287 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI  287 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence            221 2345679999999999975           3678899999999999999999999987666655555554444455


Q ss_pred             CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          223 EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       223 ~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      .++...++++++||.+||++||.+|||+.|+|+||||+..
T Consensus       288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            5677779999999999999999999999999999999754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.5e-50  Score=384.55  Aligned_cols=258  Identities=27%  Similarity=0.410  Sum_probs=210.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+||+|+++.+++.||||.+....      ...+.+|+.++++++||||+++++++..........+
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   92 (311)
T 3ork_A           13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY   92 (311)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence            5999999999999999999999999999999986532      2357799999999999999999999877666555568


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus        93 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~  170 (311)
T 3ork_A           93 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSG  170 (311)
T ss_dssp             EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC-------
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCcccccccc
Confidence            99999999999999997778999999999999999999999999999999999999987766  9999999998754322


Q ss_pred             C--CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCC--CCCCcCCHH
Q 040569          156 D--DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP--EIPGYMSKQ  231 (385)
Q Consensus       156 ~--~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~  231 (385)
                      .  ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..............+  ..+..++++
T Consensus       171 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (311)
T 3ork_A          171 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-PVSVAYQHVREDPIPPSARHEGLSAD  249 (311)
T ss_dssp             -----------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHCCCCCHHHHSTTCCHH
T ss_pred             cccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHhcCCCCCcccccCCCCHH
Confidence            2  12334579999999999999999999999999999999999999998753 333322222222111  123458999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          232 AQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +.+||.+||++||.+||++.++|.|+|++..
T Consensus       250 l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          250 LDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            9999999999999999999999999998753

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.7e-49  Score=404.03  Aligned_cols=253  Identities=24%  Similarity=0.342  Sum_probs=212.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC----------------CHHHHHHHHHHHHhcCCCCeeeeeeeee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS----------------NSEFLQREQRILSALACPQIVAYKGCDI   65 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~----------------~~~~~~~E~~il~~l~hpnIv~~~~~~~   65 (385)
                      +|++++.||+|+||+||+|+++.+++.+|+|.+...                ..+.+.+|+.+|++++||||+++++++.
T Consensus        37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  116 (504)
T 3q5i_A           37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE  116 (504)
T ss_dssp             TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            589999999999999999999999999999988642                2356889999999999999999999986


Q ss_pred             eccCCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCC-CeEEee
Q 040569           66 SEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQ-GAKIAD  144 (385)
Q Consensus        66 ~~~~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~-~~kL~D  144 (385)
                      ....    +++|||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.. .+||+|
T Consensus       117 ~~~~----~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  192 (504)
T 3q5i_A          117 DKKY----FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD  192 (504)
T ss_dssp             CSSE----EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred             cCCE----EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence            5433    67999999999999999877789999999999999999999999999999999999999876532 489999


Q ss_pred             cCceeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCC-
Q 040569          145 FGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE-  223 (385)
Q Consensus       145 FG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-  223 (385)
                      ||+++.....  ......+||+.|+|||++.+ .++.++|||||||++|+|++|++||... +....+..+........ 
T Consensus       193 fg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~  268 (504)
T 3q5i_A          193 FGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQ-NDQDIIKKVEKGKYYFDF  268 (504)
T ss_dssp             CTTCEECCTT--SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCCCCH
T ss_pred             CCCCEEcCCC--CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCCCc
Confidence            9999876432  23345679999999999874 5899999999999999999999999874 34444444432221111 


Q ss_pred             -CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          224 -IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       224 -~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                       ....+|+++++||.+||++||.+|||+.|+|+||||+..
T Consensus       269 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  308 (504)
T 3q5i_A          269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY  308 (504)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred             cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence             124589999999999999999999999999999999764

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.4e-49  Score=403.51  Aligned_cols=253  Identities=27%  Similarity=0.366  Sum_probs=210.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      .|++++.||+|+||+||+|+++.++..+|+|.+...     ....+.+|+.+|++++||||+++++++.....    +++
T Consensus        38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----~~l  113 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN----YYL  113 (494)
T ss_dssp             HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSE----EEE
T ss_pred             CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE----EEE
Confidence            389999999999999999999999999999988643     34678899999999999999999999865443    679


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCC-CCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE-QGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~-~~~kL~DFG~a~~~~~~~  155 (385)
                      |||||+||+|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++..+. ..+||+|||+++..... 
T Consensus       114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-  192 (494)
T 3lij_A          114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-  192 (494)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-
Confidence            9999999999999987778999999999999999999999999999999999999976432 34899999999876432 


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCC--CCCCcCCHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP--EIPGYMSKQAQ  233 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~  233 (385)
                       ......+||+.|+|||++. ..++.++|||||||++|+|++|++||... .....+..+.......  .....+|++++
T Consensus       193 -~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  269 (494)
T 3lij_A          193 -KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ-TDQEILRKVEKGKYTFDSPEWKNVSEGAK  269 (494)
T ss_dssp             -BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred             -ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence             2334567999999999986 46899999999999999999999999875 3344444432222111  12245899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          234 DFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       234 ~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +||.+||++||.+|||+.|+|+||||+..
T Consensus       270 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          270 DLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            99999999999999999999999999864

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1e-49  Score=373.37  Aligned_cols=251  Identities=29%  Similarity=0.530  Sum_probs=190.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+||+|.+..+++.||+|.+...      ..+.+.+|+.++++++||||+++++++.....    .+
T Consensus        12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~   87 (278)
T 3cok_A           12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY----VY   87 (278)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE----EE
T ss_pred             cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe----EE
Confidence            589999999999999999999999999999988532      24678899999999999999999998765432    66


Q ss_pred             EEEeecCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           76 LFLEYAPGGTLTDAIRSG-TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~-~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.  +||+|||++......
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMP  165 (278)
T ss_dssp             EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC--EEECCCTTCEECC--
T ss_pred             EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEEeecceeeccCC
Confidence            999999999999999854 67999999999999999999999999999999999999987766  999999999876422


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                      .. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..+..+.  ......+..++.++++
T Consensus       166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~~~  241 (278)
T 3cok_A          166 HE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK-NTLNKVV--LADYEMPSFLSIEAKD  241 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CC--SSCCCCCTTSCHHHHH
T ss_pred             CC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH-HHHHHHh--hcccCCccccCHHHHH
Confidence            22 223457999999999999999999999999999999999999999764322 2222221  1223456678999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          235 FLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ||.+||+.||.+|||+.++|+||||...
T Consensus       242 li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          242 LIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             HHHHHcccCHhhCCCHHHHhcCccccCC
Confidence            9999999999999999999999999754

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.4e-50  Score=403.84  Aligned_cols=253  Identities=26%  Similarity=0.365  Sum_probs=200.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccC--CeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEEN--GKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~~~~   74 (385)
                      +|++++.||+|+||+||+|+++.+++.||||++...     ..+.+.+|+.+|+.++||||+++++++.....  ....+
T Consensus        63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~  142 (464)
T 3ttj_A           63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV  142 (464)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred             CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence            588999999999999999999999999999998643     23567799999999999999999999865432  12236


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||||+.+ +|.+.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.... 
T Consensus       143 ~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~-  216 (464)
T 3ttj_A          143 YLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGT-  216 (464)
T ss_dssp             EEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCCC------
T ss_pred             EEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC--EEEEEEEeeeecCC-
Confidence            799999976 57777754  3899999999999999999999999999999999999998766  99999999987632 


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC--C-------------
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS--S-------------  219 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~-------------  219 (385)
                       .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. ....+..+...  .             
T Consensus       217 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~-~~~~~~~i~~~lg~p~~~~~~~~~~~~  294 (464)
T 3ttj_A          217 -SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-YIDQWNKVIEQLGTPCPEFMKKLQPTV  294 (464)
T ss_dssp             -CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred             -CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence             223455689999999999999999999999999999999999999998753 33322222100  0             


Q ss_pred             -----CCCCC---------CCc-----------CCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          220 -----DTPEI---------PGY-----------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       220 -----~~~~~---------~~~-----------~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                           ..+..         +..           .++++++||.+||++||.+|||++|+|+||||+..
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~  362 (464)
T 3ttj_A          295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  362 (464)
T ss_dssp             HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence                 00000         000           15679999999999999999999999999999853

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.1e-50  Score=405.46  Aligned_cols=253  Identities=28%  Similarity=0.410  Sum_probs=214.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+|+++.+++.||||++..      ...+.+.+|+.+|++++||||+++++++.....    ++
T Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----~~  102 (484)
T 3nyv_A           27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY----FY  102 (484)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE----EE
T ss_pred             ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE----EE
Confidence            48899999999999999999999999999998853      245778899999999999999999998765432    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecC-CCCCeEEeecCceeeeccc
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKD-NEQGAKIADFGCARRARVN  154 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~-~~~~~kL~DFG~a~~~~~~  154 (385)
                      +||||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.. ....+||+|||+++.....
T Consensus       103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            999999999999999988889999999999999999999999999999999999999532 2234899999999865322


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCC--CCcCCHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMSKQA  232 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~  232 (385)
                        ......+||+.|+|||++.+ .++.++|||||||++|+|++|++||... +....+..+.........  ...+|+++
T Consensus       183 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~  258 (484)
T 3nyv_A          183 --KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA-NEYDILKKVEKGKYTFELPQWKKVSESA  258 (484)
T ss_dssp             --CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred             --cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence              22344579999999999977 6899999999999999999999999874 444444444333222222  24589999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          233 QDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ++||.+||++||.+|||+.|+|+||||+..
T Consensus       259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          259 KDLIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             HHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence            999999999999999999999999999864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.7e-50  Score=402.37  Aligned_cols=255  Identities=28%  Similarity=0.479  Sum_probs=204.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCC
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----------SEFLQREQRILSALACPQIVAYKGCDISEENG   70 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~   70 (385)
                      +|++.+.||+|+||+||+|.++.+++.||||.+....           ...+.+|+.+|++++||||+++++++...   
T Consensus       136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---  212 (419)
T 3i6u_A          136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE---  212 (419)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS---
T ss_pred             cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence            5899999999999999999999999999999875421           12477999999999999999999986322   


Q ss_pred             eEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCC-CCeEEeecCcee
Q 040569           71 KILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE-QGAKIADFGCAR  149 (385)
Q Consensus        71 ~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~-~~~kL~DFG~a~  149 (385)
                      .  +++||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. ..+||+|||+++
T Consensus       213 ~--~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~  290 (419)
T 3i6u_A          213 D--YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  290 (419)
T ss_dssp             E--EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred             c--eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence            2  5699999999999999988888999999999999999999999999999999999999975432 348999999998


Q ss_pred             eecccCCCCCCccccCCcccChhhhcC---CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC--CCCCCCC
Q 040569          150 RARVNEDDEGKPICGTPICMAPEVARG---EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF--SSDTPEI  224 (385)
Q Consensus       150 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~  224 (385)
                      ....  .......+||+.|+|||++.+   ..++.++|||||||++|+|++|+.||............+..  ....+..
T Consensus       291 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~  368 (419)
T 3i6u_A          291 ILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV  368 (419)
T ss_dssp             SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred             ecCC--CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence            7632  223345689999999999864   56778999999999999999999999765433222222211  1122223


Q ss_pred             CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          225 PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       225 ~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      ...+++.+++||.+||++||.+|||++|+|+||||+...
T Consensus       369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  407 (419)
T 3i6u_A          369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  407 (419)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred             hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence            345899999999999999999999999999999998653

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1e-49  Score=403.76  Aligned_cols=253  Identities=26%  Similarity=0.393  Sum_probs=212.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC-----CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-----SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~-----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++++.||+|+||+||+|+++.+++.||||++..     .....+.+|+++|++++||||+++++++.....    +++
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----~~l   98 (486)
T 3mwu_A           23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS----FYI   98 (486)
T ss_dssp             HEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE----EEE
T ss_pred             ceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE----EEE
Confidence            48999999999999999999999999999998742     346778899999999999999999998765433    679


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC-CCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN-EQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~-~~~~kL~DFG~a~~~~~~~  155 (385)
                      ||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++..+ ...+||+|||+++..... 
T Consensus        99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-  177 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-  177 (486)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred             EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-
Confidence            999999999999998777899999999999999999999999999999999999996533 234899999999865322 


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCC--CCcCCHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMSKQAQ  233 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~  233 (385)
                       ......+||+.|+|||++.+ .++.++|||||||++|+|++|++||... +....+..+.........  ...+|++++
T Consensus       178 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  254 (486)
T 3mwu_A          178 -TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK-NEYDILKRVETGKYAFDLPQWRTISDDAK  254 (486)
T ss_dssp             -----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCSCSGGGGGSCHHHH
T ss_pred             -CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCCCcccCCCCHHHH
Confidence             23345579999999999986 4889999999999999999999999874 344444444322222222  245899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          234 DFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       234 ~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +||.+||++||.+|||+.|+|+||||+..
T Consensus       255 ~li~~~L~~dp~~R~t~~~~l~hp~~~~~  283 (486)
T 3mwu_A          255 DLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (486)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence            99999999999999999999999999764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.3e-49  Score=384.90  Aligned_cols=249  Identities=25%  Similarity=0.336  Sum_probs=204.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcC-----CCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALA-----CPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~-----hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++.+.||+|+||+||+|++..+++.||||++....  .....+|+.+++.+.     ||||+++++++.....    +
T Consensus        36 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~----~  111 (360)
T 3llt_A           36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH----M  111 (360)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE----E
T ss_pred             EEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe----e
Confidence            5899999999999999999999999999999987533  346678999999996     9999999998876543    6


Q ss_pred             EEEEeecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecC-----------------
Q 040569           75 NLFLEYAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKD-----------------  135 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~-----------------  135 (385)
                      ++||||+ +++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++..                 
T Consensus       112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~  190 (360)
T 3llt_A          112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK  190 (360)
T ss_dssp             EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred             EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence            7999999 89999999854  359999999999999999999999999999999999999751                 


Q ss_pred             ------CCCCeEEeecCceeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChH
Q 040569          136 ------NEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPI  209 (385)
Q Consensus       136 ------~~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~  209 (385)
                            ....+||+|||+++....    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... 
T Consensus       191 ~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-  265 (360)
T 3llt_A          191 IQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM-  265 (360)
T ss_dssp             EEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-
T ss_pred             ccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHH-
Confidence                  133499999999986432    234557999999999999999999999999999999999999999764322 


Q ss_pred             HHHHHh-cCCCCCC-------------------------------------------CCCCcCCHHHHHHHHHhhhcCCC
Q 040569          210 SALHRI-GFSSDTP-------------------------------------------EIPGYMSKQAQDFLSKCLIRNPG  245 (385)
Q Consensus       210 ~~~~~~-~~~~~~~-------------------------------------------~~~~~~s~~~~~ll~~cL~~dP~  245 (385)
                      ..+..+ ......+                                           ..+...++.+.+||.+||++||.
T Consensus       266 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  345 (360)
T 3llt_A          266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPT  345 (360)
T ss_dssp             HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChh
Confidence            222111 0000000                                           00112347888999999999999


Q ss_pred             CCCCHHHHHhCcccc
Q 040569          246 ERWSASELLEHGFVK  260 (385)
Q Consensus       246 ~Rps~~elL~hp~~~  260 (385)
                      +|||+.|+|+||||+
T Consensus       346 ~Rpta~elL~hp~f~  360 (360)
T 3llt_A          346 LRPSPAELLKHKFLE  360 (360)
T ss_dssp             GSCCHHHHTTSGGGC
T ss_pred             hCCCHHHHhcCcccC
Confidence            999999999999985

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-49  Score=387.46  Aligned_cols=252  Identities=27%  Similarity=0.384  Sum_probs=203.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccC--CeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEEN--GKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~~~~   74 (385)
                      +|++.+.||+|+||+||+|+++.+|+.||||.+....     .+.+.+|+++|++++||||+++++++.....  ....+
T Consensus        26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~  105 (367)
T 1cm8_A           26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF  105 (367)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred             eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence            5899999999999999999999999999999985421     3456799999999999999999998865432  11225


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||||+ |++|.++++.+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... 
T Consensus       106 ~lv~e~~-~~~L~~~~~~~-~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~-  180 (367)
T 1cm8_A          106 YLVMPFM-GTDLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQADS-  180 (367)
T ss_dssp             EEEEECC-SEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCS-
T ss_pred             EEEEecC-CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC--EEEEeeeccccccc-
Confidence            6999999 88999999874 5999999999999999999999999999999999999987766  99999999987532 


Q ss_pred             CCCCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC----------------
Q 040569          155 EDDEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF----------------  217 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~----------------  217 (385)
                         .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ....+..+..                
T Consensus       181 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~l~~i~~~~g~~~~~~~~~~~~~  256 (367)
T 1cm8_A          181 ---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD-HLDQLKEIMKVTGTPPAEFVQRLQSD  256 (367)
T ss_dssp             ---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             ---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence               2345679999999999987 678999999999999999999999998643 2222222100                


Q ss_pred             -------------CCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          218 -------------SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       218 -------------~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                   ......+....++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence                         011112334579999999999999999999999999999999864

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.8e-49  Score=378.39  Aligned_cols=255  Identities=27%  Similarity=0.398  Sum_probs=203.8

Q ss_pred             Cceee-ceeeccCceEEEEEEECCCCcEEEEEeccCC---CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRG-QTIGRGSTATVSIGMSNRSSEVFAVKSAELS---NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~-~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~---~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      .|++. +.||+|+||+||+|+++.+++.||||++...   ..+.+.+|+++|+++ .||||+++++++.....    +++
T Consensus        13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~----~~l   88 (316)
T 2ac3_A           13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR----FYL   88 (316)
T ss_dssp             SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE----EEE
T ss_pred             eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE----EEE
Confidence            37774 7899999999999999999999999998653   356788999999995 79999999999876543    679


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCC-CCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE-QGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~-~~~kL~DFG~a~~~~~~~  155 (385)
                      ||||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++. ..+||+|||++.......
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  168 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG  168 (316)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred             EEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence            9999999999999987778999999999999999999999999999999999999986543 238999999987653221


Q ss_pred             C------CCCCccccCCcccChhhhcC-----CCCCCCCChHHHHHHHHHHHhCCCCCCCCCCh--------------HH
Q 040569          156 D------DEGKPICGTPICMAPEVARG-----EEQGFPADVWALGCTVLEMATGRPPWPDVADP--------------IS  210 (385)
Q Consensus       156 ~------~~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--------------~~  210 (385)
                      .      ......+||+.|+|||++.+     ..++.++|||||||++|+|++|+.||......              ..
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  248 (316)
T 2ac3_A          169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM  248 (316)
T ss_dssp             -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred             ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence            1      11234569999999999975     56889999999999999999999999764321              11


Q ss_pred             HHHHhcCCCCCCCCC----CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          211 ALHRIGFSSDTPEIP----GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       211 ~~~~~~~~~~~~~~~----~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ....+...  ...++    ..+++++++||.+||++||.+|||+.|+|+||||+..
T Consensus       249 ~~~~i~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          249 LFESIQEG--KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             HHHHHHHC--CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             HHHHHhcc--CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence            12222111  11222    3478999999999999999999999999999999864

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-49  Score=377.78  Aligned_cols=246  Identities=26%  Similarity=0.314  Sum_probs=199.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--H---HHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--S---EFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~---~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+|+++.+++.||||++....  .   ....+|+..+.++ .||||+++++++.....    ++
T Consensus        58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~----~~  133 (311)
T 3p1a_A           58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI----LY  133 (311)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE----EE
T ss_pred             heeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE----EE
Confidence            3889999999999999999999999999999875422  1   2333455555555 99999999998865433    67


Q ss_pred             EEEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           76 LFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +||||+ +++|.+++. .+..+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||++......
T Consensus       134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTA  210 (311)
T ss_dssp             EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC--
T ss_pred             EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEccceeeeecccC
Confidence            999999 669999887 4557999999999999999999999999999999999999987766  999999999876322


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                        .......||+.|+|||++.+ .++.++|||||||++|||++|..|+... +.   ...+......+.++..+++++.+
T Consensus       211 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-~~---~~~~~~~~~~~~~~~~~~~~l~~  283 (311)
T 3p1a_A          211 --GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-EG---WQQLRQGYLPPEFTAGLSSELRS  283 (311)
T ss_dssp             ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-HH---HHHHTTTCCCHHHHTTSCHHHHH
T ss_pred             --CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-cH---HHHHhccCCCcccccCCCHHHHH
Confidence              22344569999999999986 6899999999999999999997766432 11   22222222333455668999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          235 FLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      ||.+||++||.+|||+.|+|+||||++
T Consensus       284 li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          284 VLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHcCCChhhCcCHHHHHhCccccC
Confidence            999999999999999999999999974

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.5e-49  Score=372.93  Aligned_cols=255  Identities=28%  Similarity=0.455  Sum_probs=212.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC---------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---------NSEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~---------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|++++.||+|+||+||+|+++.+++.+|+|.+...         ..+.+.+|+.++++++||||+++++++.....   
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---   82 (283)
T 3bhy_A            6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD---   82 (283)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE---
T ss_pred             hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe---
Confidence            489999999999999999999999999999987643         25778999999999999999999998765432   


Q ss_pred             EEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCC--CCeEEeecCceee
Q 040569           73 LYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE--QGAKIADFGCARR  150 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~--~~~kL~DFG~a~~  150 (385)
                       +++||||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+||+++.++.  ..+||+|||++..
T Consensus        83 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           83 -VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             -EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             -EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence             6799999999999999987778999999999999999999999999999999999999986652  2489999999987


Q ss_pred             ecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC--CCCCCCCcC
Q 040569          151 ARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS--DTPEIPGYM  228 (385)
Q Consensus       151 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~  228 (385)
                      .....  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ....+..+....  ..+..+..+
T Consensus       162 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T 3bhy_A          162 IEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET-KQETLTNISAVNYDFDEEYFSNT  238 (283)
T ss_dssp             CC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHTTCCCCCHHHHTTC
T ss_pred             ccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc-hHHHHHHhHhcccCCcchhcccC
Confidence            63322  2334569999999999999999999999999999999999999998743 333333332211  111223457


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       229 s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      ++.+.+||.+||..||.+|||+.|+|+||||+...
T Consensus       239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            89999999999999999999999999999998653

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.8e-50  Score=392.87  Aligned_cols=255  Identities=27%  Similarity=0.410  Sum_probs=206.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcCCCCeeeeeeeeeecc-------------
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEE-------------   68 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-------------   68 (385)
                      +|++++.||+|+||+||+|++..+|+.||||++..+ .....+|+++|+.++||||+++++++....             
T Consensus         8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~   86 (383)
T 3eb0_A            8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH   86 (383)
T ss_dssp             TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHTTCCCTTBCCEEEEEEEC--------------
T ss_pred             eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHHcCCCCccchhheeeecCccccccccccccc
Confidence            699999999999999999999999999999988643 333458999999999999999999886543             


Q ss_pred             ---------------------CCeEEEEEEEeecCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 040569           69 ---------------------NGKILYNLFLEYAPGGTLTDAIR----SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHC  123 (385)
Q Consensus        69 ---------------------~~~~~~~lv~Ey~~ggsL~~~l~----~~~~l~e~~~~~i~~qil~gL~yLH~~givHr  123 (385)
                                           ....++++||||++| +|.+.+.    .+..+++..++.++.||+.||+|||++||+||
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~  165 (383)
T 3eb0_A           87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHR  165 (383)
T ss_dssp             -----------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECS
T ss_pred             ccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccC
Confidence                                 223346799999985 7776664    46779999999999999999999999999999


Q ss_pred             cCCCCCEEeec-CCCCCeEEeecCceeeecccCCCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCC
Q 040569          124 DIKGQNILVSK-DNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPP  201 (385)
Q Consensus       124 DlKp~NILi~~-~~~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~P  201 (385)
                      ||||+|||++. ++.  +||+|||+++.....  .......||+.|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus       166 Dikp~Nil~~~~~~~--~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  241 (383)
T 3eb0_A          166 DIKPQNLLVNSKDNT--LKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPL  241 (383)
T ss_dssp             CCCGGGEEEETTTTE--EEECCCTTCEECCTT--SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCHHHEEEcCCCCc--EEEEECCCCcccCCC--CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCC
Confidence            99999999974 443  999999999876432  233455789999999999875 489999999999999999999999


Q ss_pred             CCCCCChHHHHHHhcC------------------CCCCC---------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 040569          202 WPDVADPISALHRIGF------------------SSDTP---------EIPGYMSKQAQDFLSKCLIRNPGERWSASELL  254 (385)
Q Consensus       202 f~~~~~~~~~~~~~~~------------------~~~~~---------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL  254 (385)
                      |...... ..+..+..                  ....+         .++..+++++.+||.+||+.||.+|||+.|+|
T Consensus       242 f~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l  320 (383)
T 3eb0_A          242 FSGETSI-DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAM  320 (383)
T ss_dssp             SCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             CCCCChH-HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence            9875332 22222210                  00001         13456899999999999999999999999999


Q ss_pred             hCccccccc
Q 040569          255 EHGFVKEQN  263 (385)
Q Consensus       255 ~hp~~~~~~  263 (385)
                      +||||+...
T Consensus       321 ~hp~f~~~~  329 (383)
T 3eb0_A          321 AHPFFDHLR  329 (383)
T ss_dssp             TSGGGHHHH
T ss_pred             cCHHHHHHH
Confidence            999998653

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.5e-49  Score=372.20  Aligned_cols=251  Identities=30%  Similarity=0.483  Sum_probs=215.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+||+|.++.+++.+|+|.+...      ..+.+.+|+.+++++.||||+++++++.....    ++
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~   91 (294)
T 2rku_A           16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF----VF   91 (294)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE----EE
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCE----EE
Confidence            489999999999999999999999999999987543      23567889999999999999999998765432    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||+++++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||++.......
T Consensus        92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSTT
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC--EEEEeccCceecccCc
Confidence            99999999999999987778999999999999999999999999999999999999987766  9999999998764222


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                       .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... .......+.  .....++..+++.+.+|
T Consensus       170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~~~l  245 (294)
T 2rku_A          170 -ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-LKETYLRIK--KNEYSIPKHINPVAASL  245 (294)
T ss_dssp             -CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHH--TTCCCCCTTSCHHHHHH
T ss_pred             -cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHh--hccCCCccccCHHHHHH
Confidence             22344579999999999999999999999999999999999999997643 333333332  22344567789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      |.+||+.||.+|||+.|+++||||...
T Consensus       246 i~~~l~~~p~~Rps~~~ll~~~~~~~~  272 (294)
T 2rku_A          246 IQKMLQTDPTARPTINELLNDEFFTSG  272 (294)
T ss_dssp             HHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             HHHHcccChhhCcCHHHHhhChheecC
Confidence            999999999999999999999999754

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.3e-49  Score=385.13  Aligned_cols=250  Identities=28%  Similarity=0.435  Sum_probs=210.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----------HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccC
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----------SEFLQREQRILSAL-ACPQIVAYKGCDISEEN   69 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----------~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~   69 (385)
                      +|++.+.||+|+||+||+|+++.+|+.||||++....           .+.+.+|+.+++++ .||||+++++++.....
T Consensus        95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  174 (365)
T 2y7j_A           95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF  174 (365)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred             hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence            4888999999999999999999999999999886543           34577899999999 89999999998765432


Q ss_pred             CeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCcee
Q 040569           70 GKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR  149 (385)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~  149 (385)
                          .++||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.
T Consensus       175 ----~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~--ikl~DfG~~~  248 (365)
T 2y7j_A          175 ----MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSC  248 (365)
T ss_dssp             ----EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCE
T ss_pred             ----EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEecCccc
Confidence                6699999999999999997778999999999999999999999999999999999999987766  9999999998


Q ss_pred             eecccCCCCCCccccCCcccChhhhcC------CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCC
Q 040569          150 RARVNEDDEGKPICGTPICMAPEVARG------EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE  223 (385)
Q Consensus       150 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  223 (385)
                      .....  ......+||+.|+|||++.+      ..++.++|||||||++|+|++|+.||... +....+..+........
T Consensus       249 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~  325 (365)
T 2y7j_A          249 HLEPG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR-RQILMLRMIMEGQYQFS  325 (365)
T ss_dssp             ECCTT--CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCCC
T ss_pred             ccCCC--cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhCCCCCC
Confidence            76432  23345679999999999863      35788999999999999999999999764 33333333322211111


Q ss_pred             --CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 040569          224 --IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK  260 (385)
Q Consensus       224 --~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~  260 (385)
                        ....+++.+.+||.+||+.||.+|||+.|+|+||||+
T Consensus       326 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          326 SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence              1235789999999999999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.5e-49  Score=380.88  Aligned_cols=251  Identities=30%  Similarity=0.479  Sum_probs=215.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+||++.++.+++.+|+|.+...      ..+.+.+|+.+++++.||||+++++++.....    ++
T Consensus        42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~  117 (335)
T 2owb_A           42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF----VF  117 (335)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE----EE
T ss_pred             ceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe----EE
Confidence            589999999999999999999999999999988543      23567899999999999999999998765432    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus       118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDG  195 (335)
T ss_dssp             EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSTT
T ss_pred             EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC--EEEeeccCceecccCc
Confidence            99999999999999987778999999999999999999999999999999999999987766  9999999998764222


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                       .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+..  ....++..+++++.+|
T Consensus       196 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~l  271 (335)
T 2owb_A          196 -ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-LKETYLRIKK--NEYSIPKHINPVAASL  271 (335)
T ss_dssp             -CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHH--TCCCCCTTSCHHHHHH
T ss_pred             -ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC-HHHHHHHHhc--CCCCCCccCCHHHHHH
Confidence             22345579999999999999999999999999999999999999997643 3333333221  2234566789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      |.+||+.||.+|||+.|+|+||||...
T Consensus       272 i~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          272 IQKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             HHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             HHHHccCChhHCcCHHHHhcCccccCC
Confidence            999999999999999999999999764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.4e-49  Score=374.30  Aligned_cols=253  Identities=31%  Similarity=0.544  Sum_probs=212.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +|++.+.||+|+||+||+|+++.+|+.||+|.+... ..+.+.+|+.+++++.||||+++++++.....    +++||||
T Consensus        30 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~  105 (314)
T 3com_A           30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTD----LWIVMEY  105 (314)
T ss_dssp             CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTE----EEEEEEC
T ss_pred             hhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE----EEEEeec
Confidence            589999999999999999999999999999988654 35678899999999999999999998876443    6799999


Q ss_pred             cCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCC
Q 040569           81 APGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEG  159 (385)
Q Consensus        81 ~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~  159 (385)
                      +++++|.+++. ....+++..+..++.||+.||.|||++|++||||||+||+++.++.  +||+|||++........ ..
T Consensus       106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~-~~  182 (314)
T 3com_A          106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGVAGQLTDTMA-KR  182 (314)
T ss_dssp             CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECBTTBS-CB
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC--EEEeecccchhhhhhcc-cc
Confidence            99999999997 5667999999999999999999999999999999999999987766  99999999987643222 23


Q ss_pred             CccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh-cCCCCCCCCCCcCCHHHHHHHHH
Q 040569          160 KPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI-GFSSDTPEIPGYMSKQAQDFLSK  238 (385)
Q Consensus       160 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~ll~~  238 (385)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+ .........+..+++.+.+||.+
T Consensus       183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  261 (314)
T 3com_A          183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-RAIFMIPTNPPPTFRKPELWSDNFTDFVKQ  261 (314)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSCCCCCSSGGGSCHHHHHHHHH
T ss_pred             CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhcCCCcccCCcccCCHHHHHHHHH
Confidence            3457999999999999999999999999999999999999999875433 322222 12222223455689999999999


Q ss_pred             hhhcCCCCCCCHHHHHhCcccccc
Q 040569          239 CLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       239 cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ||..||.+|||+.++|+||||+..
T Consensus       262 ~l~~dp~~Rpt~~~ll~~~~~~~~  285 (314)
T 3com_A          262 CLVKSPEQRATATQLLQHPFVRSA  285 (314)
T ss_dssp             HTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred             HccCChhhCcCHHHHHhCHHHhcC
Confidence            999999999999999999999764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.4e-49  Score=370.88  Aligned_cols=247  Identities=26%  Similarity=0.350  Sum_probs=205.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+|+++.+++.||+|.+...     ....+.+|+.++.++ +||||+++++++.....    ++
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~----~~   87 (289)
T 1x8b_A           12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH----ML   87 (289)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE----EE
T ss_pred             hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe----EE
Confidence            589999999999999999999999999999988643     234667899999999 99999999998866543    67


Q ss_pred             EEEeecCCCCHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC---------------
Q 040569           76 LFLEYAPGGTLTDAIRSG----TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN---------------  136 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~----~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~---------------  136 (385)
                      +||||++||+|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++               
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            999999999999999743    6799999999999999999999999999999999999997543               


Q ss_pred             --CCCeEEeecCceeeecccCCCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHH
Q 040569          137 --EQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALH  213 (385)
Q Consensus       137 --~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~  213 (385)
                        ...+||+|||++......     ....||+.|+|||++.+. .+++++|||||||++|+|++|.+|+... +....+ 
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-~~~~~~-  240 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-DQWHEI-  240 (289)
T ss_dssp             --CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-HHHHHH-
T ss_pred             CCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-hHHHHH-
Confidence              224899999999876422     233599999999999876 5567999999999999999999877542 222222 


Q ss_pred             HhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          214 RIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       214 ~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                         .....+.++..+++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus       241 ---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          241 ---RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             ---HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             ---HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence               1234566777899999999999999999999999999999999764

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.3e-49  Score=372.64  Aligned_cols=252  Identities=24%  Similarity=0.365  Sum_probs=199.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH-----HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----EFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~-----~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++.+.||+|+||+||+|++..+++.||+|.+.....     +.+.++...++.+.||||+++++++.....    +++
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~----~~l   83 (290)
T 3fme_A            8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD----VWI   83 (290)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS----EEE
T ss_pred             hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC----EEE
Confidence            58999999999999999999999999999999865421     234455556888899999999999876544    679


Q ss_pred             EEeecCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           77 FLEYAPGGTLTDAIR----SGTCLEEGRIRSHTRAVLLGLQYLHSN-GIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~----~~~~l~e~~~~~i~~qil~gL~yLH~~-givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      ||||++| +|.+++.    .+..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.  +||+|||+++..
T Consensus        84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~  160 (290)
T 3fme_A           84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ--VKMCDFGISGYL  160 (290)
T ss_dssp             EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCC--EEBCCC------
T ss_pred             EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecCCcccc
Confidence            9999975 8877765    466799999999999999999999998 9999999999999987665  999999999876


Q ss_pred             cccCCCCCCccccCCcccChhhh----cCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCc
Q 040569          152 RVNEDDEGKPICGTPICMAPEVA----RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY  227 (385)
Q Consensus       152 ~~~~~~~~~~~~Gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (385)
                      ....  ......||+.|+|||++    .+..++.++|||||||++|+|++|+.||.........+............+..
T Consensus       161 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (290)
T 3fme_A          161 VDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK  238 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTT
T ss_pred             cccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccccc
Confidence            4322  22334699999999996    45578889999999999999999999998766666555554333333334456


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          228 MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       228 ~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          239 FSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            89999999999999999999999999999999854

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.6e-49  Score=392.90  Aligned_cols=255  Identities=27%  Similarity=0.375  Sum_probs=207.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcCCCCeeeeeeeeeecc--CCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEE--NGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~~~~~lv~E   79 (385)
                      +|+.++.||+|+||+||+|+++.+++.||||.+... .....+|+++|++++||||+++++++....  ....++++|||
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e  133 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD  133 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc-chhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence            589999999999999999999999999999988653 334458999999999999999999886532  34556779999


Q ss_pred             ecCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           80 YAPGGTLTDAIR----SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        80 y~~ggsL~~~l~----~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |+++ +|.+.+.    ....+++..++.++.||+.||+|||++||+||||||+||||+.++. .+||+|||+++..... 
T Consensus       134 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-~~kl~DFG~a~~~~~~-  210 (420)
T 1j1b_A          134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRG-  210 (420)
T ss_dssp             CCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECCTT-
T ss_pred             cccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC-eEEeccchhhhhcccC-
Confidence            9986 6666654    4567999999999999999999999999999999999999986532 2799999999976432 


Q ss_pred             CCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC-----------------
Q 040569          156 DDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF-----------------  217 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-----------------  217 (385)
                       ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+..+..                 
T Consensus       211 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg~p~~~~~~~~~~~~  288 (420)
T 1j1b_A          211 -EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQIREMNPNY  288 (420)
T ss_dssp             -CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred             -CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHhhChhh
Confidence             223456799999999999765 7899999999999999999999999875332 22221100                 


Q ss_pred             -CCCCCC---------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          218 -SSDTPE---------IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       218 -~~~~~~---------~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                       ....+.         ++..+++++++||.+||.+||.+|||+.|+|+||||...
T Consensus       289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence             001111         234578999999999999999999999999999999764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.2e-49  Score=375.49  Aligned_cols=252  Identities=25%  Similarity=0.355  Sum_probs=203.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC---C---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---N---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~---~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+||+|++..+++.+|+|.+...   .   .+.+.+|+.++++++||||+++++++.....    ++
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~----~~   87 (294)
T 4eqm_A           12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC----YY   87 (294)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE----EE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe----EE
Confidence            599999999999999999999999999999987432   2   2467899999999999999999998755432    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++|++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus        88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETS  165 (294)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCSSSTTC----
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEEeCCCcccccccc
Confidence            99999999999999997778999999999999999999999999999999999999987766  9999999998664333


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCC--CCCCCCcCCHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSD--TPEIPGYMSKQAQ  233 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~  233 (385)
                      .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||............+.....  ....+..+++.+.
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  245 (294)
T 4eqm_A          166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS  245 (294)
T ss_dssp             ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred             ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence            33344567999999999999999999999999999999999999999875433333333321111  1223456899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          234 DFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       234 ~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      ++|.+||.+||.+||+..+.+.+.|.
T Consensus       246 ~li~~~l~~dp~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          246 NVILRATEKDKANRYKTIQEMKDDLS  271 (294)
T ss_dssp             HHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred             HHHHHHhcCCHhHccccHHHHHHHHH
Confidence            99999999999999966666665553

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4e-49  Score=379.20  Aligned_cols=257  Identities=27%  Similarity=0.403  Sum_probs=209.0

Q ss_pred             ceee-ceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEE
Q 040569            3 WTRG-QTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         3 y~~~-~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      |.+. +.||+|+||+||+|+++.+++.||+|.+...     ....+.+|+.+++++ .||||+++++++.....    ++
T Consensus        30 y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~----~~  105 (327)
T 3lm5_A           30 YILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE----II  105 (327)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE----EE
T ss_pred             EeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe----EE
Confidence            5555 8999999999999999999999999988642     356788999999999 56999999998765433    66


Q ss_pred             EEEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC-CCCeEEeecCceeeec
Q 040569           76 LFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN-EQGAKIADFGCARRAR  152 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~-~~~~kL~DFG~a~~~~  152 (385)
                      +||||++||+|.+++..  ...+++..++.++.||+.||+|||++||+||||||+|||++... ...+||+|||+++...
T Consensus       106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~  185 (327)
T 3lm5_A          106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG  185 (327)
T ss_dssp             EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred             EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence            99999999999999864  46799999999999999999999999999999999999998621 2349999999998764


Q ss_pred             ccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc-CCCCCCCCCCcCCHH
Q 040569          153 VNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG-FSSDTPEIPGYMSKQ  231 (385)
Q Consensus       153 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~  231 (385)
                      ..  ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.............. ...........+++.
T Consensus       186 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  263 (327)
T 3lm5_A          186 HA--CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL  263 (327)
T ss_dssp             ----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred             Cc--cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHH
Confidence            22  223445799999999999999999999999999999999999999987543322222111 122233344568999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCccccccccc
Q 040569          232 AQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK  265 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~~~  265 (385)
                      +++||.+||+.||.+|||++|+|+||||+..++.
T Consensus       264 ~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~  297 (327)
T 3lm5_A          264 ATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE  297 (327)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence            9999999999999999999999999999876543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5e-49  Score=382.47  Aligned_cols=246  Identities=34%  Similarity=0.526  Sum_probs=209.1

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      |+..+.||+|+||+||+|++..+++.||||.+....      .+.+.+|+++|++++||||+++++++.....    .++
T Consensus        56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----~~l  131 (348)
T 1u5q_A           56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT----AWL  131 (348)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE----EEE
T ss_pred             eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCe----EEE
Confidence            788999999999999999999999999999986432      2457799999999999999999998876543    679


Q ss_pred             EEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      ||||+. |+|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++....  
T Consensus       132 v~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~--  206 (348)
T 1u5q_A          132 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP--  206 (348)
T ss_dssp             EEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS--
T ss_pred             EEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEeeccCceecCC--
Confidence            999997 58888885 5667999999999999999999999999999999999999997765  99999999986532  


Q ss_pred             CCCCCccccCCcccChhhhc---CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHH
Q 040569          156 DDEGKPICGTPICMAPEVAR---GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA  232 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  232 (385)
                         ....+||+.|+|||++.   +..++.++|||||||++|+|++|+.||.... ....+..+.........+..+++.+
T Consensus       207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l  282 (348)
T 1u5q_A          207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPALQSGHWSEYF  282 (348)
T ss_dssp             ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred             ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCCCCCCHHH
Confidence               23457999999999985   5678999999999999999999999997753 3344444333333333455689999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          233 QDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      ++||.+||+.||.+|||+.++|+|||+..
T Consensus       283 ~~li~~~l~~dP~~Rps~~~ll~h~~~~~  311 (348)
T 1u5q_A          283 RNFVDSCLQKIPQDRPTSEVLLKHRFVLR  311 (348)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             HHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence            99999999999999999999999999864

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=8.8e-49  Score=382.24  Aligned_cols=257  Identities=24%  Similarity=0.323  Sum_probs=208.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeecc-CCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEE-NGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~~~~~l   76 (385)
                      +|++++.||+|+||+||+|+++.+++.||||.+....    .+.+.+|+++|++++||||+++++++.... .....+++
T Consensus        28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  107 (364)
T 3qyz_A           28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI  107 (364)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence            5999999999999999999999999999999986433    245779999999999999999999876543 12223669


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      ||||+.| +|.++++.+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.......
T Consensus       108 v~e~~~~-~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~  183 (364)
T 3qyz_A          108 VQDLMET-DLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHD  183 (364)
T ss_dssp             EEECCSE-EHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGGGC
T ss_pred             EEcccCc-CHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC--EEEEeCcceEecCCCCC
Confidence            9999975 999999865 4999999999999999999999999999999999999987766  99999999987653322


Q ss_pred             C--CCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc---C-------------
Q 040569          157 D--EGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG---F-------------  217 (385)
Q Consensus       157 ~--~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~---~-------------  217 (385)
                      .  .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||..............   .             
T Consensus       184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  263 (364)
T 3qyz_A          184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  263 (364)
T ss_dssp             BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence            2  23456899999999987654 589999999999999999999999976533222111110   0             


Q ss_pred             ------C-CCC-----CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          218 ------S-SDT-----PEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       218 ------~-~~~-----~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                            . ...     ..+...+++++.+||.+||++||.+|||+.|+|+||||++.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          264 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence                  0 000     01124578999999999999999999999999999999875

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.7e-49  Score=386.11  Aligned_cols=252  Identities=30%  Similarity=0.463  Sum_probs=210.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++.+.||+|+||+||+|.++.+++.+|+|.+....    .+.+.+|+.+|++++||||+++++++.....    +++|
T Consensus        34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv  109 (360)
T 3eqc_A           34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE----ISIC  109 (360)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE----EEEE
T ss_pred             cceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE----EEEE
Confidence            5899999999999999999999999999999987542    3567899999999999999999998876543    6799


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN-GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~-givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |||++||+|.+++...+.+++..+..++.||+.||.|||++ ||+||||||+|||++.++.  +||+|||++......  
T Consensus       110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHHH--
T ss_pred             EECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC--EEEEECCCCcccccc--
Confidence            99999999999999777899999999999999999999996 9999999999999987766  999999999765322  


Q ss_pred             CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHH--------------------------
Q 040569          157 DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS--------------------------  210 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--------------------------  210 (385)
                       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........                          
T Consensus       186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (360)
T 3eqc_A          186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  264 (360)
T ss_dssp             -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred             -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence             22345799999999999999999999999999999999999999975432111                          


Q ss_pred             ---------------HHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          211 ---------------ALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       211 ---------------~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                     .+..+.........+..+++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence                           1111111111122233478999999999999999999999999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.4e-48  Score=368.97  Aligned_cols=252  Identities=26%  Similarity=0.425  Sum_probs=211.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------------HHHHHHHHHHHHhcC-CCCeeeeeeeeeecc
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------------SEFLQREQRILSALA-CPQIVAYKGCDISEE   68 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------------~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~   68 (385)
                      +|++.+.||+|+||+||+|+++.+++.||||.+....            .+.+.+|+++|+++. ||||+++++++....
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (298)
T 1phk_A           18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT   97 (298)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence            6899999999999999999999999999999986542            245678999999995 999999999875543


Q ss_pred             CCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCce
Q 040569           69 NGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA  148 (385)
Q Consensus        69 ~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a  148 (385)
                      .    +++||||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+||+++.++.  +||+|||++
T Consensus        98 ~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~  171 (298)
T 1phk_A           98 F----FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFS  171 (298)
T ss_dssp             E----EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTC
T ss_pred             e----EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccch
Confidence            2    6799999999999999997778999999999999999999999999999999999999987766  999999999


Q ss_pred             eeecccCCCCCCccccCCcccChhhhc------CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCC-
Q 040569          149 RRARVNEDDEGKPICGTPICMAPEVAR------GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDT-  221 (385)
Q Consensus       149 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~-  221 (385)
                      ......  .......||+.|+|||++.      ...++.++|||||||++|+|++|+.||.... .......+...... 
T Consensus       172 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~  248 (298)
T 1phk_A          172 CQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-QMLMLRMIMSGNYQF  248 (298)
T ss_dssp             EECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCCCC
T ss_pred             hhcCCC--cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc-HHHHHHHHhcCCccc
Confidence            876432  2234457999999999985      4567889999999999999999999997643 33333332211111 


Q ss_pred             -CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          222 -PEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       222 -~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                       ......+++.+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus       249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (298)
T 1phk_A          249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  290 (298)
T ss_dssp             CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence             11224589999999999999999999999999999999864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.5e-49  Score=374.16  Aligned_cols=253  Identities=25%  Similarity=0.407  Sum_probs=211.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|++.+.||+|+||+||+|+++.+|+.||+|.+....   .+.+.+|+.++++++||||+++++++.....    +++||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~   85 (304)
T 2jam_A           10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTH----YYLVM   85 (304)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSE----EEEEE
T ss_pred             cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCE----EEEEE
Confidence            4889999999999999999999999999999987542   3567899999999999999999998765432    67999


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeec-CCCCCeEEeecCceeeecccCCC
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSK-DNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~-~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      ||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+.. +....+||+|||++.....   .
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~---~  162 (304)
T 2jam_A           86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---G  162 (304)
T ss_dssp             CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC---B
T ss_pred             EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC---C
Confidence            99999999999987778999999999999999999999999999999999999932 2233499999999876432   1


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC--CCCCCCCCcCCHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS--SDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~l  235 (385)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+...  ......+..+++++++|
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  241 (304)
T 2jam_A          163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET-ESKLFEKIKEGYYEFESPFWDDISESAKDF  241 (304)
T ss_dssp             TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHCCCCCCTTTTTTSCHHHHHH
T ss_pred             ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHcCCCCCCccccccCCHHHHHH
Confidence            2334579999999999999999999999999999999999999997643 33333333211  22233445689999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      |.+||..||.+|||+.|+|+||||...
T Consensus       242 i~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          242 ICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             HHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             HHHHcCCChhHCcCHHHHhcCccccCC
Confidence            999999999999999999999999753

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.2e-48  Score=373.34  Aligned_cols=244  Identities=31%  Similarity=0.464  Sum_probs=201.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++.+.||+|+||+||+|++  +++.+|||.+....     .+.+.+|+++|++++||||+++++++.....    +++
T Consensus        38 ~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~----~~l  111 (309)
T 3p86_A           38 DLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN----LSI  111 (309)
T ss_dssp             GEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC----CEE
T ss_pred             HceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc----eEE
Confidence            588999999999999999987  48899999886543     2467789999999999999999998866544    569


Q ss_pred             EEeecCCCCHHHHHHcCCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           77 FLEYAPGGTLTDAIRSGTC---LEEGRIRSHTRAVLLGLQYLHSNG--IVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~---l~e~~~~~i~~qil~gL~yLH~~g--ivHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      ||||++||+|.+++...+.   +++..+..++.||+.||+|||++|  |+||||||+|||++.++.  +||+|||+++..
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~  189 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGLSRLK  189 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC--EEECCCC-----
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc--EEECCCCCCccc
Confidence            9999999999999986553   999999999999999999999999  999999999999987765  999999999865


Q ss_pred             cccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHH
Q 040569          152 RVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQ  231 (385)
Q Consensus       152 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  231 (385)
                      ... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+........++..++++
T Consensus       190 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  267 (309)
T 3p86_A          190 AST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKCKRLEIPRNLNPQ  267 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS-CHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred             ccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCCCccCCHH
Confidence            322 12234567999999999999999999999999999999999999999875 4444445554455666778889999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          232 AQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      +.+||.+||..||.+|||+.++++
T Consensus       268 l~~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          268 VAAIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHHHH
Confidence            999999999999999999999987

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.3e-49  Score=368.44  Aligned_cols=250  Identities=27%  Similarity=0.421  Sum_probs=205.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+||+|.++.+++.+|||.+..      ...+.+.+|+.++++++||||+++++++.....    ++
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~   87 (276)
T 2h6d_A           12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD----FF   87 (276)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE----EE
T ss_pred             cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe----EE
Confidence            58999999999999999999999999999998853      234578899999999999999999998765432    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||+++++|.+++...+.+++..+..++.||+.||.|||++|++||||||+|||++.++.  +||+|||++...... 
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~-  164 (276)
T 2h6d_A           88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDG-  164 (276)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC--EEECCCCGGGCCCC--
T ss_pred             EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC--EEEeecccccccCCC-
Confidence            99999999999999987778999999999999999999999999999999999999987765  999999999875322 


Q ss_pred             CCCCCccccCCcccChhhhcCCCC-CCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                       .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||... +.......+..  ....++..+++.+.+
T Consensus       165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~--~~~~~~~~~~~~l~~  240 (276)
T 2h6d_A          165 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE-HVPTLFKKIRG--GVFYIPEYLNRSVAT  240 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred             -cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHhhc--CcccCchhcCHHHHH
Confidence             12234579999999999988765 68999999999999999999999764 33333333321  233456678999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          235 FLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ||.+||+.||.+|||+.|+++||||++.
T Consensus       241 li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          241 LLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHccCChhhCCCHHHHHhChhhccC
Confidence            9999999999999999999999999753

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.2e-49  Score=369.70  Aligned_cols=253  Identities=35%  Similarity=0.559  Sum_probs=210.3

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      |.....||+|+||+||+|.+..+++.||+|.+....   .+.+.+|+.++++++||||+++++++.....    +++|||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~e   99 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF----IKIFME   99 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE----EEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc----EEEEEE
Confidence            344559999999999999999999999999886543   4678899999999999999999998865442    669999


Q ss_pred             ecCCCCHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeec-CCCCCeEEeecCceeeecccC
Q 040569           80 YAPGGTLTDAIRSG---TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSK-DNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        80 y~~ggsL~~~l~~~---~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~-~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |+++++|.+++...   ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.  +||+|||++.......
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~--~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV--LKISDFGTSKRLAGIN  177 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCC--EEECCTTTCEESCC--
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCC--EEEeecccccccCCCC
Confidence            99999999999843   24679999999999999999999999999999999999986 444  9999999998764221


Q ss_pred             CCCCCccccCCcccChhhhcCCC--CCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEE--QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ  233 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  233 (385)
                       .......||+.|+|||++.+..  ++.++|||||||++|+|++|+.||...................+.++..+++++.
T Consensus       178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (295)
T 2clq_A          178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAK  256 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHH
T ss_pred             -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHH
Confidence             1234457999999999997653  7889999999999999999999997655554444333333445667778999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          234 DFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       234 ~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +||.+||..||.+|||+.|+|+||||+..
T Consensus       257 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          257 AFILKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             HHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             HHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence            99999999999999999999999999864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.8e-49  Score=372.25  Aligned_cols=253  Identities=30%  Similarity=0.476  Sum_probs=208.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC---CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~---~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|++.+.||+|+||+||+|.++.+++.+|+|.+...   ..+.+.+|+++++++.||||+++++++.....    +++||
T Consensus        20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~   95 (302)
T 2j7t_A           20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK----LWIMI   95 (302)
T ss_dssp             TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C----EEEEE
T ss_pred             ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe----EEEEE
Confidence            589999999999999999999999999999988643   35678899999999999999999998876543    67999


Q ss_pred             eecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           79 EYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        79 Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      ||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.  +||+|||++....... .
T Consensus        96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~-~  172 (302)
T 2j7t_A           96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFGVSAKNLKTL-Q  172 (302)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC--EEECCCHHHHHHHHHH-H
T ss_pred             EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC--EEEEECCCCccccccc-c
Confidence            99999999999874 567999999999999999999999999999999999999987766  9999999876432111 1


Q ss_pred             CCCccccCCcccChhhh-----cCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc-CCCCCCCCCCcCCHH
Q 040569          158 EGKPICGTPICMAPEVA-----RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG-FSSDTPEIPGYMSKQ  231 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~-----~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~  231 (385)
                      ......||+.|+|||++     .+..++.++|||||||++|+|++|+.||..... ......+. ........+..++.+
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  251 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSDPPTLLTPSKWSVE  251 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHSCCCCCSSGGGSCHH
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-HHHHHHHhccCCcccCCccccCHH
Confidence            12345799999999998     366788999999999999999999999987543 33333322 222222345668999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          232 AQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +.+||.+||..||.+|||+.|+++||||...
T Consensus       252 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  282 (302)
T 2j7t_A          252 FRDFLKIALDKNPETRPSAAQLLEHPFVSSI  282 (302)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred             HHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence            9999999999999999999999999999754

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-49  Score=379.57  Aligned_cols=252  Identities=25%  Similarity=0.386  Sum_probs=204.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--------SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||.+....        ...+.+|+.++++++||||+++++++.....    
T Consensus        11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----   86 (346)
T 1ua2_A           11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN----   86 (346)
T ss_dssp             --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC----
T ss_pred             ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc----
Confidence            5899999999999999999999999999999986432        1356789999999999999999998865544    


Q ss_pred             EEEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           74 YNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      +++||||+++ +|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFG  163 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTT
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC--EEEEecccceecc
Confidence            6689999986 89988874 456999999999999999999999999999999999999987766  9999999998753


Q ss_pred             ccCCCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC---CCCC-------
Q 040569          153 VNEDDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF---SSDT-------  221 (385)
Q Consensus       153 ~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~---~~~~-------  221 (385)
                      .. .......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.... ....+.++..   ....       
T Consensus       164 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~  241 (346)
T 1ua2_A          164 SP-NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-DLDQLTRIFETLGTPTEEQWPDMC  241 (346)
T ss_dssp             SC-CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             CC-cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC-HHHHHHHHHHHcCCCChhhhhhhc
Confidence            22 2233456799999999999764 47889999999999999999999998753 3333222210   0000       


Q ss_pred             -----------CCC-----CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          222 -----------PEI-----PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       222 -----------~~~-----~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                 +..     ...+++++++||.+||+.||.+|||+.|+|+||||...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~  298 (346)
T 1ua2_A          242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  298 (346)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence                       001     14467999999999999999999999999999999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.1e-48  Score=390.52  Aligned_cols=251  Identities=25%  Similarity=0.417  Sum_probs=206.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhc------CCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSAL------ACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l------~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|++++.||+|+||+||+|.+..+++.||||++....  ...+.+|+++++.+      .|+||+++++++.....    
T Consensus        98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~----  173 (429)
T 3kvw_A           98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH----  173 (429)
T ss_dssp             TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE----
T ss_pred             cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe----
Confidence            5899999999999999999999999999999997653  25667899999887      57799999998776543    


Q ss_pred             EEEEEeecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           74 YNLFLEYAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      +++||||+. ++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++...+||+|||+++..
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~  252 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE  252 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence            679999996 5999999843  3599999999999999999999999999999999999998876656999999999764


Q ss_pred             cccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc----C----------
Q 040569          152 RVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG----F----------  217 (385)
Q Consensus       152 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~----~----------  217 (385)
                      .    ......+||+.|+|||++.+..++.++|||||||++|+|++|++||....+. ..+..+.    .          
T Consensus       253 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~-~~l~~i~~~~~~p~~~~~~~~~  327 (429)
T 3kvw_A          253 H----QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG-DQLACMIELLGMPSQKLLDASK  327 (429)
T ss_dssp             T----CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHTBT
T ss_pred             C----CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHHhhh
Confidence            2    2234568999999999999999999999999999999999999999875332 2221110    0          


Q ss_pred             -------CCCCC------------------------------------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 040569          218 -------SSDTP------------------------------------EIPGYMSKQAQDFLSKCLIRNPGERWSASELL  254 (385)
Q Consensus       218 -------~~~~~------------------------------------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL  254 (385)
                             ....+                                    .++...++++.+||.+||+.||.+|||+.|+|
T Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L  407 (429)
T 3kvw_A          328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL  407 (429)
T ss_dssp             THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHh
Confidence                   00000                                    01223478899999999999999999999999


Q ss_pred             hCcccccc
Q 040569          255 EHGFVKEQ  262 (385)
Q Consensus       255 ~hp~~~~~  262 (385)
                      +||||+..
T Consensus       408 ~Hpw~~~~  415 (429)
T 3kvw_A          408 RHPWLRRR  415 (429)
T ss_dssp             TSTTTC--
T ss_pred             CChhhccC
Confidence            99999864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.6e-49  Score=378.06  Aligned_cols=255  Identities=29%  Similarity=0.490  Sum_probs=208.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCC
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----------SEFLQREQRILSALACPQIVAYKGCDISEENG   70 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~   70 (385)
                      +|++.+.||+|+||+||+|+++.+++.||||.+....           ...+.+|+++|++++||||+++++++... . 
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~-   88 (322)
T 2ycf_A           11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-D-   88 (322)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-S-
T ss_pred             ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-c-
Confidence            4899999999999999999999999999999886432           23477899999999999999999987543 2 


Q ss_pred             eEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCC-CCeEEeecCcee
Q 040569           71 KILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE-QGAKIADFGCAR  149 (385)
Q Consensus        71 ~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~-~~~kL~DFG~a~  149 (385)
                         +++||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++. ..+||+|||+++
T Consensus        89 ---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  165 (322)
T 2ycf_A           89 ---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  165 (322)
T ss_dssp             ---EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred             ---eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence               5699999999999999988888999999999999999999999999999999999999976542 248999999998


Q ss_pred             eecccCCCCCCccccCCcccChhhhc---CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh--cCCCCCCCC
Q 040569          150 RARVNEDDEGKPICGTPICMAPEVAR---GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI--GFSSDTPEI  224 (385)
Q Consensus       150 ~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~--~~~~~~~~~  224 (385)
                      .....  .......||+.|+|||++.   ...++.++|||||||++|+|++|+.||............+  ......+..
T Consensus       166 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (322)
T 2ycf_A          166 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV  243 (322)
T ss_dssp             ECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred             ecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence            75321  1122456999999999974   4568899999999999999999999997643322222222  111222233


Q ss_pred             CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          225 PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       225 ~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      +..+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus       244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~  282 (322)
T 2ycf_A          244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  282 (322)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred             hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence            345799999999999999999999999999999998653

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.5e-49  Score=375.83  Aligned_cols=253  Identities=23%  Similarity=0.365  Sum_probs=204.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC----CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL----SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++++.||+|+||+||+|+++.+++.||||++..    ...+.+.+|+++|++++||||+++++++.......  +++|
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~--~~lv   87 (319)
T 4euu_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH--KVLI   87 (319)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC--EEEE
T ss_pred             CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce--EEEE
Confidence            48999999999999999999999999999998864    34567789999999999999999999876654333  5689


Q ss_pred             EeecCCCCHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecC--CCCCeEEeecCceeeec
Q 040569           78 LEYAPGGTLTDAIRSGT---CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKD--NEQGAKIADFGCARRAR  152 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~---~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~--~~~~~kL~DFG~a~~~~  152 (385)
                      |||++||+|.+++....   .+++..+..++.||+.||+|||++||+||||||+|||+..+  +...+||+|||+++...
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~  167 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE  167 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence            99999999999998432   39999999999999999999999999999999999998321  22238999999998764


Q ss_pred             ccCCCCCCccccCCcccChhhhc--------CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHhcCCC--
Q 040569          153 VNEDDEGKPICGTPICMAPEVAR--------GEEQGFPADVWALGCTVLEMATGRPPWPDVADP---ISALHRIGFSS--  219 (385)
Q Consensus       153 ~~~~~~~~~~~Gt~~y~aPE~~~--------~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~---~~~~~~~~~~~--  219 (385)
                      ..  .......||+.|+|||++.        +..++.++|||||||++|+|++|+.||......   ...+..+....  
T Consensus       168 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~  245 (319)
T 4euu_A          168 DD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS  245 (319)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCT
T ss_pred             CC--CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCc
Confidence            32  2234457999999999986        577899999999999999999999999643322   22222221111  


Q ss_pred             ---------------------CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 040569          220 ---------------------DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGF  258 (385)
Q Consensus       220 ---------------------~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~  258 (385)
                                           ....++..+++.+.+||.+||+.||.+|||++|+|+||-
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence                                 011223345678899999999999999999999999975

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.3e-48  Score=378.63  Aligned_cols=257  Identities=25%  Similarity=0.353  Sum_probs=206.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCC----eE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENG----KI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~----~~   72 (385)
                      +|++++.||+|+||+||+|+++.+|+.||+|.+....     ...+.+|+.+|++++||||+++++++......    ..
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   97 (351)
T 3mi9_A           18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG   97 (351)
T ss_dssp             GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred             ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence            5899999999999999999999999999999885432     34677899999999999999999988764321    12


Q ss_pred             EEEEEEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           73 LYNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      .+++||||+++ +|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++..
T Consensus        98 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~  174 (351)
T 3mi9_A           98 SIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAF  174 (351)
T ss_dssp             EEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEEC
T ss_pred             eEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC--EEEccchhcccc
Confidence            36699999986 7777776 4467999999999999999999999999999999999999987766  999999999876


Q ss_pred             cccC---CCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh---cCCCCCCCC
Q 040569          152 RVNE---DDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI---GFSSDTPEI  224 (385)
Q Consensus       152 ~~~~---~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---~~~~~~~~~  224 (385)
                      ....   .......+||+.|+|||++.+. .++.++|||||||++|+|++|++||..... ...+..+   .........
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~  253 (351)
T 3mi9_A          175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-QHQLALISQLCGSITPEVW  253 (351)
T ss_dssp             CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTS
T ss_pred             cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChhhc
Confidence            4222   2223455789999999999764 579999999999999999999999987533 2222221   111111111


Q ss_pred             CCc---------------------------CCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          225 PGY---------------------------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       225 ~~~---------------------------~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +..                           .++++++||.+||++||.+|||+.|+|+||||...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  318 (351)
T 3mi9_A          254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  318 (351)
T ss_dssp             TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred             cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence            110                           27889999999999999999999999999999753

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.3e-49  Score=376.13  Aligned_cols=248  Identities=23%  Similarity=0.327  Sum_probs=203.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|++++.||+|+||+||+|.++.+++.+|+|.+....   .+.+.+|+++|++++||||+++++++.....    +++||
T Consensus        11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~----~~lv~   86 (310)
T 3s95_A           11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR----LNFIT   86 (310)
T ss_dssp             GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE----EEEEE
T ss_pred             HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCe----eEEEE
Confidence            5899999999999999999999999999999886544   3567799999999999999999999876543    66999


Q ss_pred             eecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           79 EYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        79 Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      ||++||+|.++++. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++........
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC--EEECCCTTCEECC-----
T ss_pred             EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC--EEEeecccceeccccccc
Confidence            99999999999985 667999999999999999999999999999999999999987766  999999999876432221


Q ss_pred             C-------------CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCC
Q 040569          158 E-------------GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI  224 (385)
Q Consensus       158 ~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  224 (385)
                      .             ....+||+.|+|||++.+..++.++|||||||++|+|++|..||......................
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC  244 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTC
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccC
Confidence            1             114579999999999999999999999999999999999999987532110000000000000123


Q ss_pred             CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          225 PGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       225 ~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      +..+++.+.+||.+||+.||.+|||+.++++
T Consensus       245 ~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            4557889999999999999999999999987

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.2e-49  Score=380.14  Aligned_cols=254  Identities=28%  Similarity=0.390  Sum_probs=205.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++++.||+|+||+||+|+++.+++.||+|.+....     .+.+.+|+.++++++||||+++++++.....    +++
T Consensus        26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~l  101 (331)
T 4aaa_A           26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR----WYL  101 (331)
T ss_dssp             GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE----EEE
T ss_pred             hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE----EEE
Confidence            5899999999999999999999999999999875432     2456789999999999999999998865443    679


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      ||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...... 
T Consensus       102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~-  178 (331)
T 4aaa_A          102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPG-  178 (331)
T ss_dssp             EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCTTC--------
T ss_pred             EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc--EEEEeCCCceeecCCc-
Confidence            9999999999999887778999999999999999999999999999999999999987765  9999999998654222 


Q ss_pred             CCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc-------------------
Q 040569          157 DEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG-------------------  216 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~-------------------  216 (385)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....+.........                   
T Consensus       179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T 4aaa_A          179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF  258 (331)
T ss_dssp             -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred             cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence            223345799999999999876 689999999999999999999999987543222211110                   


Q ss_pred             CCCCCCCC---------CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          217 FSSDTPEI---------PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       217 ~~~~~~~~---------~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      .....+.+         ...+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            00011111         12478999999999999999999999999999999864

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=8e-49  Score=387.17  Aligned_cols=255  Identities=28%  Similarity=0.387  Sum_probs=203.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcCCCCeeeeeeeeeecc--CCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEE--NGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~~~~~lv~E   79 (385)
                      +|++++.||+|+||+||+|+++.+++ +|+|++... .....+|+++|+.++||||+++++++....  ....++++|||
T Consensus        41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~-~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e  118 (394)
T 4e7w_A           41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQD-KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE  118 (394)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECC-TTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecC-cchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence            58999999999999999999987776 777766432 233457999999999999999999986644  34455779999


Q ss_pred             ecCCCCHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEee-cCCCCCeEEeecCceeeecccC
Q 040569           80 YAPGGTLTDAI---RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVS-KDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        80 y~~ggsL~~~l---~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~-~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |++++.+....   .....+++..++.++.||+.||+|||++||+||||||+|||++ .++.  +||+|||+++..... 
T Consensus       119 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~--~kL~DFG~a~~~~~~-  195 (394)
T 4e7w_A          119 YVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV--LKLIDFGSAKILIAG-  195 (394)
T ss_dssp             CCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE--EEECCCTTCEECCTT-
T ss_pred             ccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCc--EEEeeCCCcccccCC-
Confidence            99875433332   2466799999999999999999999999999999999999998 4544  899999999876332 


Q ss_pred             CCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC-----------------
Q 040569          156 DDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF-----------------  217 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-----------------  217 (385)
                       .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... ..+..+..                 
T Consensus       196 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~~~~~~~~  273 (394)
T 4e7w_A          196 -EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLGTPSREQIKTMNPNY  273 (394)
T ss_dssp             -CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred             -CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHhhChhh
Confidence             233456789999999999765 5899999999999999999999999875432 22221100                 


Q ss_pred             -CCCCC---------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          218 -SSDTP---------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       218 -~~~~~---------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                       ....+         .++..+++++.+||.+||++||.+|||+.|+|+||||+...
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence             00111         12334789999999999999999999999999999998753

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.1e-48  Score=369.13  Aligned_cols=251  Identities=35%  Similarity=0.597  Sum_probs=216.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      .|++++.||+|+||+||+|+++.+++.||+|.+...    ..+.+.+|+.+++++.||||+++++++.....    +++|
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv   98 (303)
T 3a7i_A           23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK----LWII   98 (303)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE----EEEE
T ss_pred             HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe----EEEE
Confidence            488999999999999999999999999999988643    35778899999999999999999998876543    6799


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |||++|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.  +||+|||++........ 
T Consensus        99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~~~~-  174 (303)
T 3a7i_A           99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQI-  174 (303)
T ss_dssp             EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECBTTBC-
T ss_pred             EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC--EEEeecccceecCcccc-
Confidence            999999999999975 46999999999999999999999999999999999999987766  99999999987643222 


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+. ....+.++..+++.+.+||.
T Consensus       175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~l~~li~  252 (303)
T 3a7i_A          175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH-PMKVLFLIP-KNNPPTLEGNYSKPLKEFVE  252 (303)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHH-HSCCCCCCSSCCHHHHHHHH
T ss_pred             ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC-HHHHHHHhh-cCCCCCCccccCHHHHHHHH
Confidence            2344579999999999999999999999999999999999999997643 333333332 23345567778999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCcccccc
Q 040569          238 KCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +||..||.+|||+.|+++||||...
T Consensus       253 ~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          253 ACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             HHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             HHcCCChhhCcCHHHHhhChhhhcC
Confidence            9999999999999999999998753

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-48  Score=372.14  Aligned_cols=257  Identities=31%  Similarity=0.515  Sum_probs=207.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccC--CeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSAL-ACPQIVAYKGCDISEEN--GKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~--~~~~~~l   76 (385)
                      +|++++.||+|+||+||+|++..+++.||||.+...  ..+.+.+|+.+++++ .||||+++++++.....  ....+++
T Consensus        25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l  104 (326)
T 2x7f_A           25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL  104 (326)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence            589999999999999999999999999999988643  457788999999999 89999999999876431  1123669


Q ss_pred             EEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           77 FLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ||||+++|+|.+++..  +..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++......
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~  182 (326)
T 2x7f_A          105 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRT  182 (326)
T ss_dssp             EEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCTTTC-----
T ss_pred             EEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC--EEEeeCcCceecCcC
Confidence            9999999999999984  357999999999999999999999999999999999999987766  999999998865322


Q ss_pred             CCCCCCccccCCcccChhhhc-----CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCC
Q 040569          155 EDDEGKPICGTPICMAPEVAR-----GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS  229 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s  229 (385)
                      . .......||+.|+|||++.     +..++.++|||||||++|+|++|+.||.... .......+.........+..++
T Consensus       183 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~  260 (326)
T 2x7f_A          183 V-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKWS  260 (326)
T ss_dssp             ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSCCCCCSCSCSC
T ss_pred             c-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHhhcCccccCCccccC
Confidence            1 1233457999999999997     5568899999999999999999999997653 3333333322333333456689


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          230 KQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       230 ~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +.+++||.+||..||.+|||+.|+++||||+..
T Consensus       261 ~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          261 KKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             HHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence            999999999999999999999999999999754

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.5e-48  Score=379.27  Aligned_cols=253  Identities=26%  Similarity=0.357  Sum_probs=197.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccC--CeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEEN--GKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~~~~   74 (385)
                      +|++++.||+|+||+||+|+++.+++.||||.+....     .+.+.+|+.+++.++||||+++++++.....  ....+
T Consensus        26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  105 (371)
T 2xrw_A           26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV  105 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred             heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence            5899999999999999999999999999999986431     2457789999999999999999998765431  12236


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||||+++ +|.+.+..  .+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus       106 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~  180 (371)
T 2xrw_A          106 YIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTS  180 (371)
T ss_dssp             EEEEECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC-------
T ss_pred             EEEEEcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEEEeecccccccc
Confidence            799999975 88888874  4899999999999999999999999999999999999987766  999999999875322


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCC-------------
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDT-------------  221 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~-------------  221 (385)
                        ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ....+..+......             
T Consensus       181 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~  257 (371)
T 2xrw_A          181 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD-HIDQWNKVIEQLGTPCPEFMKKLQPTV  257 (371)
T ss_dssp             -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred             --cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence              22345679999999999999999999999999999999999999998753 33333222111100             


Q ss_pred             -------CCC--------------C------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          222 -------PEI--------------P------GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       222 -------~~~--------------~------~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                             +..              |      ...++++++||.+||+.||.+|||++|+|+||||+..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence                   000              0      0125789999999999999999999999999999754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.6e-49  Score=383.93  Aligned_cols=252  Identities=25%  Similarity=0.366  Sum_probs=189.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccC--CeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEEN--GKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~~~~   74 (385)
                      +|++++.||+|+||+||+|++..+|+.||||++....     ...+.+|+.+|+.++||||+++++++.....  ....+
T Consensus        30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  109 (367)
T 2fst_X           30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV  109 (367)
T ss_dssp             TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred             ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence            5899999999999999999999999999999986431     3466789999999999999999998764321  11125


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++++||+ +++|.++++. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... 
T Consensus       110 ~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~~-  184 (367)
T 2fst_X          110 YLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTAD-  184 (367)
T ss_dssp             EEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC----------
T ss_pred             EEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC--EEEeeccccccccc-
Confidence            6899999 7899999986 46999999999999999999999999999999999999987766  99999999987532 


Q ss_pred             CCCCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC----C-----------
Q 040569          155 EDDEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF----S-----------  218 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~----~-----------  218 (385)
                         .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.. ....+..+..    .           
T Consensus       185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~l~~i~~~~g~p~~~~~~~~~~~  260 (367)
T 2fst_X          185 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-HIDQLKLILRLVGTPGAELLKKISSE  260 (367)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred             ---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence               2344579999999999987 678999999999999999999999998753 2222222100    0           


Q ss_pred             ---------CCCCC-----CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          219 ---------SDTPE-----IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       219 ---------~~~~~-----~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                               ...+.     .....++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~  318 (367)
T 2fst_X          261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  318 (367)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence                     00010     112468999999999999999999999999999999864

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=9e-49  Score=384.30  Aligned_cols=254  Identities=25%  Similarity=0.272  Sum_probs=204.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcC--------CCCeeeeeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALA--------CPQIVAYKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~--------hpnIv~~~~~~~~~~~~~   71 (385)
                      +|++.+.||+|+||+||+|++..+++.||||++....  .+.+.+|+++|+++.        ||||+++++++.......
T Consensus        38 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~  117 (397)
T 1wak_A           38 RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNG  117 (397)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTE
T ss_pred             eEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCC
Confidence            5899999999999999999999999999999997543  356789999999995        788999999887554444


Q ss_pred             EEEEEEEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEeecCCC-----------
Q 040569           72 ILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSN-GIVHCDIKGQNILVSKDNE-----------  137 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~-givHrDlKp~NILi~~~~~-----------  137 (385)
                      ..+++||||+ +++|.+.+..  .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++.           
T Consensus       118 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~  196 (397)
T 1wak_A          118 THICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATE  196 (397)
T ss_dssp             EEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC-
T ss_pred             ceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHH
Confidence            5578999999 5576666653  25699999999999999999999998 9999999999999986531           


Q ss_pred             ------------------------------------CCeEEeecCceeeecccCCCCCCccccCCcccChhhhcCCCCCC
Q 040569          138 ------------------------------------QGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF  181 (385)
Q Consensus       138 ------------------------------------~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~  181 (385)
                                                          ..+||+|||+++.....    ....+||+.|+|||++.+..++.
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~  272 (397)
T 1wak_A          197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSGYNT  272 (397)
T ss_dssp             --------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTSCCCT
T ss_pred             HhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCCCCCc
Confidence                                                24999999999876422    33457999999999999999999


Q ss_pred             CCChHHHHHHHHHHHhCCCCCCCCCC-----hHHHHHHh-cCCCC-----------------------------------
Q 040569          182 PADVWALGCTVLEMATGRPPWPDVAD-----PISALHRI-GFSSD-----------------------------------  220 (385)
Q Consensus       182 ~~DiwSlG~il~elltG~~Pf~~~~~-----~~~~~~~~-~~~~~-----------------------------------  220 (385)
                      ++|||||||++|+|++|+.||.....     ....+..+ .....                                   
T Consensus       273 ~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (397)
T 1wak_A          273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFE  352 (397)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHH
T ss_pred             HHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhH
Confidence            99999999999999999999975432     11111111 00000                                   


Q ss_pred             ----CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 040569          221 ----TPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK  260 (385)
Q Consensus       221 ----~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~  260 (385)
                          ....+...++.+++||.+||++||.+|||+.|+|+||||+
T Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          353 VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             HHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             hhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                0012233456789999999999999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.7e-48  Score=379.13  Aligned_cols=251  Identities=27%  Similarity=0.360  Sum_probs=202.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCC--eEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENG--KILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~--~~~~   74 (385)
                      +|++.+.||+|+||+||+|+++.+|+.||||.+....     ...+.+|+.++++++||||+++++++......  ...+
T Consensus        43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  122 (371)
T 4exu_A           43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF  122 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred             cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence            5889999999999999999999999999999986532     35677999999999999999999988655431  1123


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||||+. ++|.+++..  .+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... 
T Consensus       123 ~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~~-  196 (371)
T 4exu_A          123 YLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHADA-  196 (371)
T ss_dssp             EEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSTTCC------
T ss_pred             EEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC--EEEEecCccccccc-
Confidence            69999997 589888753  4999999999999999999999999999999999999987766  99999999986532 


Q ss_pred             CCCCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC----C-----------
Q 040569          155 EDDEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF----S-----------  218 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~----~-----------  218 (385)
                         .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ...+..+..    .           
T Consensus       197 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          197 ---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             ---CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCcHHHHHHhhhh
Confidence               2334578999999999987 6789999999999999999999999986432 222222100    0           


Q ss_pred             --------------CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          219 --------------SDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       219 --------------~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                    ......+..+++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  330 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  330 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence                          00011123478999999999999999999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=6.5e-48  Score=365.55  Aligned_cols=254  Identities=26%  Similarity=0.423  Sum_probs=210.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++++.||+|+||+||+|.++.+++.+|+|.+...       ..+.+.+|++++++++||||+++++++.......  +
T Consensus         6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~--~   83 (305)
T 2wtk_C            6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK--M   83 (305)
T ss_dssp             CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C--E
T ss_pred             ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe--E
Confidence            699999999999999999999999999999988642       2457889999999999999999999876443322  5


Q ss_pred             EEEEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           75 NLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      ++||||++++ |.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||++....
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~--~kl~dfg~~~~~~  160 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALH  160 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc--EEeeccccccccC
Confidence            6999999886 7777763  557999999999999999999999999999999999999987766  9999999998764


Q ss_pred             ccCC-CCCCccccCCcccChhhhcCCC--CCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCC
Q 040569          153 VNED-DEGKPICGTPICMAPEVARGEE--QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS  229 (385)
Q Consensus       153 ~~~~-~~~~~~~Gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s  229 (385)
                      .... .......||+.|+|||++.+..  ++.++|||||||++|+|++|+.||... +.......+..  ....++..++
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~i~~--~~~~~~~~~~  237 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD-NIYKLFENIGK--GSYAIPGDCG  237 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHH--CCCCCCSSSC
T ss_pred             ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc-hHHHHHHHHhc--CCCCCCCccC
Confidence            2211 1223456999999999998654  377999999999999999999999764 34444443322  2334566789


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          230 KQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       230 ~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      +.+.+||.+||..||.+|||+.|+++||||+...
T Consensus       238 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  271 (305)
T 2wtk_C          238 PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH  271 (305)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence            9999999999999999999999999999998653

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.3e-49  Score=371.13  Aligned_cols=255  Identities=32%  Similarity=0.520  Sum_probs=191.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++++.||+|+||+||+|.+..+++.||||.+....    .+.+.+|+.++++++||||+++++++.....    +++|
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv   91 (303)
T 2vwi_A           16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE----LWLV   91 (303)
T ss_dssp             CCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSC----EEEE
T ss_pred             hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC----cEEE
Confidence            6999999999999999999999999999999886432    3567789999999999999999998876654    6799


Q ss_pred             EeecCCCCHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCcee
Q 040569           78 LEYAPGGTLTDAIRS--------GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR  149 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~--------~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~  149 (385)
                      |||++|++|.+++..        .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.  +||+|||++.
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~  169 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSA  169 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCHHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC--EEEEeccchh
Confidence            999999999999973        456999999999999999999999999999999999999987766  9999999987


Q ss_pred             eecccCC----CCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC-----
Q 040569          150 RARVNED----DEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS-----  219 (385)
Q Consensus       150 ~~~~~~~----~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-----  219 (385)
                      .......    .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.................     
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  249 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET  249 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence            6532211    12234579999999999976 5689999999999999999999999987544333322221111     


Q ss_pred             --CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          220 --DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       220 --~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                        ..+.....+++++++||.+||+.||.+|||+.|+++||||+..
T Consensus       250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  294 (303)
T 2vwi_A          250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA  294 (303)
T ss_dssp             -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred             ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence              1123345688999999999999999999999999999999864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.5e-48  Score=362.44  Aligned_cols=246  Identities=22%  Similarity=0.332  Sum_probs=209.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++.+.||+|+||+||+|.+. +++.||+|.+...  ..+.+.+|++++++++||||+++++++.....    +++|||
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e   85 (269)
T 4hcu_A           11 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP----ICLVFE   85 (269)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS----EEEEEE
T ss_pred             hceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc----eEEEEE
Confidence            5889999999999999999987 5778999998754  35778999999999999999999998766544    679999


Q ss_pred             ecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           80 YAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        80 y~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      |+++++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+||+++.++.  +||+|||+++.........
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~  163 (269)
T 4hcu_A           86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTS  163 (269)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EEECCTTGGGGBCCHHHHS
T ss_pred             eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC--EEecccccccccccccccc
Confidence            9999999999974 556899999999999999999999999999999999999987765  9999999998654332223


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      .....||+.|+|||++.+..++.++|||||||++|+|++ |+.||... ........+. ....+..+...++.+.+|+.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~  241 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDIS-TGFRLYKPRLASTHVYQIMN  241 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHH-TTCCCCCCTTSCHHHHHHHH
T ss_pred             ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHh-cCccCCCCCcCCHHHHHHHH
Confidence            344567889999999999999999999999999999999 99999874 3344444432 23344556678999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhC
Q 040569          238 KCLIRNPGERWSASELLEH  256 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~h  256 (385)
                      +||+.||.+|||+.|+++|
T Consensus       242 ~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          242 HCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCCcccCcCHHHHHHH
Confidence            9999999999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.5e-48  Score=359.66  Aligned_cols=246  Identities=23%  Similarity=0.318  Sum_probs=208.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++.+.||+|+||+||+|.++ ++..+|+|.+...  ..+.+.+|++++++++||||+++++++.....    +++|||
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e   83 (268)
T 3sxs_A            9 EITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP----IYIVTE   83 (268)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS----EEEEEE
T ss_pred             heeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCc----eEEEEE
Confidence            5899999999999999999886 5678999998754  35678899999999999999999998765443    669999


Q ss_pred             ecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           80 YAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        80 y~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      |+++++|.+++.. +..+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||++..........
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~  161 (268)
T 3sxs_A           84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQYVS  161 (268)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC--EEECCTTCEEECCTTCEEE
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC--EEEccCccceecchhhhhc
Confidence            9999999999985 445999999999999999999999999999999999999987766  9999999998764333223


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      .....||+.|+|||++.+..++.++|||||||++|+|++ |+.||...... .....+. .......+...++.+.+||.
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~l~~li~  239 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-EVVLKVS-QGHRLYRPHLASDTIYQIMY  239 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHHHHHH-TTCCCCCCTTSCHHHHHHHH
T ss_pred             ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-HHHHHHH-cCCCCCCCCcChHHHHHHHH
Confidence            334457788999999999999999999999999999999 99999765433 3333332 23344456668999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhC
Q 040569          238 KCLIRNPGERWSASELLEH  256 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~h  256 (385)
                      +||+.||.+|||+.|++++
T Consensus       240 ~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          240 SCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HTTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCChhhCcCHHHHHHH
Confidence            9999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.6e-48  Score=377.08  Aligned_cols=256  Identities=25%  Similarity=0.343  Sum_probs=195.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcCCCCeeeeeeeeeecc---CCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALACPQIVAYKGCDISEE---NGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~hpnIv~~~~~~~~~~---~~~~~~~l   76 (385)
                      +|++.+.||+|+||+||+|+++.+++.||||.+....  .....+|++.++.++||||+++++++....   ....++++
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~l  103 (360)
T 3e3p_A           24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNV  103 (360)
T ss_dssp             TEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEE
Confidence            5899999999999999999999999999999875432  345567888889999999999999986533   23445779


Q ss_pred             EEeecCCCCHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCCEEeec-CCCCCeEEeecCcee
Q 040569           77 FLEYAPGGTLTDAI----RSGTCLEEGRIRSHTRAVLLGLQYLH--SNGIVHCDIKGQNILVSK-DNEQGAKIADFGCAR  149 (385)
Q Consensus        77 v~Ey~~ggsL~~~l----~~~~~l~e~~~~~i~~qil~gL~yLH--~~givHrDlKp~NILi~~-~~~~~~kL~DFG~a~  149 (385)
                      ||||+++ +|.+.+    .....+++..+..++.||+.||.|||  ++||+||||||+|||++. ++.  +||+|||+++
T Consensus       104 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~--~kl~Dfg~a~  180 (360)
T 3e3p_A          104 VMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT--LKLCDFGSAK  180 (360)
T ss_dssp             EEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE--EEECCCTTCB
T ss_pred             Eeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc--EEEeeCCCce
Confidence            9999987 554443    35667999999999999999999999  999999999999999986 444  9999999998


Q ss_pred             eecccCCCCCCccccCCcccChhhhcCCC-CCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC----------
Q 040569          150 RARVNEDDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS----------  218 (385)
Q Consensus       150 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~----------  218 (385)
                      .....  .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..... ...+..+...          
T Consensus       181 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~  257 (360)
T 3e3p_A          181 KLSPS--EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-AGQLHEIVRVLGCPSREVLR  257 (360)
T ss_dssp             CCCTT--SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHH
T ss_pred             ecCCC--CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-HHHHHHHHHHcCCCCHHHHH
Confidence            76432  2334557899999999997654 89999999999999999999999987533 2222221100          


Q ss_pred             --------------------CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          219 --------------------SDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       219 --------------------~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                                          ...+..+...++++++||.+||+.||.+|||+.|+|+||||+...
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             HHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             hcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence                                001122233678999999999999999999999999999998754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.2e-48  Score=366.09  Aligned_cols=254  Identities=25%  Similarity=0.397  Sum_probs=211.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++.+.||+|+||+||+|+++.+++.+|+|.+....     .+.+.+|+.++++++||||+++++++.......  +++
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~--~~l   84 (279)
T 2w5a_A            7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT--LYI   84 (279)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE--EEE
T ss_pred             heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce--EEE
Confidence            5899999999999999999999999999999986432     356789999999999999999999876544333  569


Q ss_pred             EEeecCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCCEEeecCCCCCeEEeecCc
Q 040569           77 FLEYAPGGTLTDAIRS----GTCLEEGRIRSHTRAVLLGLQYLHSNG-----IVHCDIKGQNILVSKDNEQGAKIADFGC  147 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~----~~~l~e~~~~~i~~qil~gL~yLH~~g-----ivHrDlKp~NILi~~~~~~~~kL~DFG~  147 (385)
                      ||||++|++|.+++..    ...+++..+..++.||+.||.|||++|     |+||||||+|||++.++.  +||+|||+
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~--~kl~dfg~  162 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGL  162 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC--EEECCCCH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC--EEEecCch
Confidence            9999999999999973    345999999999999999999999999     999999999999987765  99999999


Q ss_pred             eeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCc
Q 040569          148 ARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY  227 (385)
Q Consensus       148 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (385)
                      ++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+. ....+.++..
T Consensus       163 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~i~-~~~~~~~~~~  239 (279)
T 2w5a_A          163 ARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR-EGKFRRIPYR  239 (279)
T ss_dssp             HHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHH-HTCCCCCCTT
T ss_pred             heeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC-HHHHHHHHh-hcccccCCcc
Confidence            97653211 11123468999999999999999999999999999999999999998753 333333332 2334456777


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          228 MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       228 ~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +++++.+||.+||+.||.+|||+.|+|+|+|+...
T Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            89999999999999999999999999999998754

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.6e-48  Score=363.67  Aligned_cols=253  Identities=26%  Similarity=0.393  Sum_probs=211.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC-----CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL-----SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~-----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++.+.||+|+||+||+|+++.+++.||+|.+..     ...+.+.+|++++++++||||+++++++.....    +++
T Consensus        23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~l   98 (287)
T 2wei_A           23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS----FYI   98 (287)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE----EEE
T ss_pred             cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe----EEE
Confidence            48999999999999999999999999999998753     245778899999999999999999998765432    669


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC-CCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN-EQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~-~~~~kL~DFG~a~~~~~~~  155 (385)
                      ||||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+||+++.++ ...+||+|||++...... 
T Consensus        99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~-  177 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-  177 (287)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC-
T ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC-
Confidence            999999999999998767899999999999999999999999999999999999997644 234899999999865322 


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCC--CCcCCHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--PGYMSKQAQ  233 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~  233 (385)
                       .......||+.|+|||++.+. ++.++|||||||++|+|++|+.||... +.......+.........  ...+++++.
T Consensus       178 -~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (287)
T 2wei_A          178 -TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGK-NEYDILKRVETGKYAFDLPQWRTISDDAK  254 (287)
T ss_dssp             -SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred             -CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence             223445689999999998764 889999999999999999999999874 333333333222211112  245799999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          234 DFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       234 ~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +||.+||..||.+|||+.|+|+||||++.
T Consensus       255 ~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          255 DLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            99999999999999999999999999754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5.1e-48  Score=370.37  Aligned_cols=252  Identities=23%  Similarity=0.302  Sum_probs=204.3

Q ss_pred             CceeeceeeccCceEEEEEEE-CCCCcEEEEEeccCCC--HHHHHHHHHHHHhcCCC------CeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMS-NRSSEVFAVKSAELSN--SEFLQREQRILSALACP------QIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~-~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~hp------nIv~~~~~~~~~~~~~~   72 (385)
                      +|++.+.||+|+||+||+|.+ +.+++.||||++....  .+.+.+|+++++.++|+      +|+++++++.....   
T Consensus        15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~---   91 (339)
T 1z57_A           15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH---   91 (339)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE---
T ss_pred             ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc---
Confidence            699999999999999999998 5689999999987543  35678999999998665      48999988765543   


Q ss_pred             EEEEEEeecCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC--------------
Q 040569           73 LYNLFLEYAPGGTLTDAIRSGT--CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN--------------  136 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~~--~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~--------------  136 (385)
                       +++||||+ +++|.+++...+  .+++..+..++.||+.||+|||++||+||||||+|||++.++              
T Consensus        92 -~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~  169 (339)
T 1z57_A           92 -ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER  169 (339)
T ss_dssp             -EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred             -EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence             67999999 889999998544  689999999999999999999999999999999999997643              


Q ss_pred             ---CCCeEEeecCceeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHH--
Q 040569          137 ---EQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISA--  211 (385)
Q Consensus       137 ---~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~--  211 (385)
                         ...+||+|||+++....    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........  
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  245 (339)
T 1z57_A          170 TLINPDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM  245 (339)
T ss_dssp             EESCCCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH
T ss_pred             cccCCCceEeeCcccccCcc----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence               33489999999987432    234557999999999999999999999999999999999999999865332211  


Q ss_pred             HHHhcCCC---------------------------------------CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHH
Q 040569          212 LHRIGFSS---------------------------------------DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASE  252 (385)
Q Consensus       212 ~~~~~~~~---------------------------------------~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~e  252 (385)
                      +..+....                                       .....+...++++.+||.+||+.||.+|||+.|
T Consensus       246 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e  325 (339)
T 1z57_A          246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE  325 (339)
T ss_dssp             HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHH
Confidence            11110000                                       000111223578999999999999999999999


Q ss_pred             HHhCcccccc
Q 040569          253 LLEHGFVKEQ  262 (385)
Q Consensus       253 lL~hp~~~~~  262 (385)
                      +|+||||+..
T Consensus       326 ll~hp~f~~~  335 (339)
T 1z57_A          326 ALKHPFFDLL  335 (339)
T ss_dssp             HTTSGGGGGG
T ss_pred             HhcCHHHHHH
Confidence            9999999864

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.1e-47  Score=376.02  Aligned_cols=247  Identities=23%  Similarity=0.341  Sum_probs=206.8

Q ss_pred             CceeeceeeccCceEEEEEEEC-------CCCcEEEEEeccCCC----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccC
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN-------RSSEVFAVKSAELSN----SEFLQREQRILSAL-ACPQIVAYKGCDISEEN   69 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~-------~~~~~~AvK~~~~~~----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~   69 (385)
                      +|++++.||+|+||+||+|.+.       .++..||||.+....    .+.+.+|+.+|+++ +||||+++++++.....
T Consensus        82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  161 (370)
T 2psq_A           82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP  161 (370)
T ss_dssp             GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSS
T ss_pred             HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCC
Confidence            5889999999999999999874       346689999987543    24678999999999 89999999998766544


Q ss_pred             CeEEEEEEEeecCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEee
Q 040569           70 GKILYNLFLEYAPGGTLTDAIRSGT----------------CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVS  133 (385)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~l~~~~----------------~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~  133 (385)
                          +++||||++||+|.+++....                .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus       162 ----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          162 ----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT  237 (370)
T ss_dssp             ----CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred             ----EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence                668999999999999998532                478999999999999999999999999999999999998


Q ss_pred             cCCCCCeEEeecCceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHH
Q 040569          134 KDNEQGAKIADFGCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISA  211 (385)
Q Consensus       134 ~~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~  211 (385)
                      .++.  +||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.... ....
T Consensus       238 ~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~-~~~~  314 (370)
T 2psq_A          238 ENNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEEL  314 (370)
T ss_dssp             TTCC--EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-GGGH
T ss_pred             CCCC--EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC-HHHH
Confidence            7766  99999999987643222 12234467889999999999999999999999999999999 999998753 3333


Q ss_pred             HHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          212 LHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       212 ~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ...+ .....+..+..+++++.+||.+||..||.+|||+.|++++
T Consensus       315 ~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          315 FKLL-KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHH-HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHH-hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3333 2334456677899999999999999999999999999874

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=8.8e-50  Score=391.28  Aligned_cols=246  Identities=14%  Similarity=0.119  Sum_probs=194.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHH---HHHhcCCCCeeeee-------eeee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQR---ILSALACPQIVAYK-------GCDI   65 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~---il~~l~hpnIv~~~-------~~~~   65 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||++...      ..+.+.+|+.   +|+++.||||++++       +++.
T Consensus        74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~  153 (377)
T 3byv_A           74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  153 (377)
T ss_dssp             EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred             eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence            478899999999999999999999999999998632      2367889994   55555899999998       4333


Q ss_pred             eccC----------Ce---EEEEEEEeecCCCCHHHHHHcCCCCCH-------HHHHHHHHHHHHHHHHHHHCCceeccC
Q 040569           66 SEEN----------GK---ILYNLFLEYAPGGTLTDAIRSGTCLEE-------GRIRSHTRAVLLGLQYLHSNGIVHCDI  125 (385)
Q Consensus        66 ~~~~----------~~---~~~~lv~Ey~~ggsL~~~l~~~~~l~e-------~~~~~i~~qil~gL~yLH~~givHrDl  125 (385)
                      ....          +.   ...+++|||+ +|+|.+++...+.+++       ..+..++.||+.||+|||++||+||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDi  232 (377)
T 3byv_A          154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL  232 (377)
T ss_dssp             CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            2211          11   1256999999 6799999986555665       788889999999999999999999999


Q ss_pred             CCCCEEeecCCCCCeEEeecCceeeecccCCCCCCccccCCcccChhhhcCC-----------CCCCCCChHHHHHHHHH
Q 040569          126 KGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE-----------EQGFPADVWALGCTVLE  194 (385)
Q Consensus       126 Kp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-----------~~~~~~DiwSlG~il~e  194 (385)
                      ||+|||++.++.  +||+|||+++....    .....+| +.|+|||++.+.           .++.++|||||||++|+
T Consensus       233 kp~NIll~~~~~--~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e  305 (377)
T 3byv_A          233 RPVDIVLDQRGG--VFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW  305 (377)
T ss_dssp             CGGGEEECTTCC--EEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred             CHHHEEEcCCCC--EEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence            999999997765  99999999986421    2234568 999999999887           89999999999999999


Q ss_pred             HHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          195 MATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       195 lltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      |++|+.||...... .....+      ...+..+++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus       306 lltg~~Pf~~~~~~-~~~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  366 (377)
T 3byv_A          306 IWCADLPITKDAAL-GGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  366 (377)
T ss_dssp             HHHSSCCC-------CCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred             HHHCCCCCcccccc-cchhhh------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence            99999999754221 111111      11124579999999999999999999999999999999865

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=372.23  Aligned_cols=251  Identities=27%  Similarity=0.358  Sum_probs=203.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCC--eEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENG--KILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~--~~~~   74 (385)
                      +|++.+.||+|+||+||+|+++.+|+.||||.+....     ...+.+|+.+|++++||||+++++++......  ...+
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  104 (353)
T 3coi_A           25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF  104 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred             eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence            5899999999999999999999999999999986432     24667899999999999999999987654321  1124


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||||+. ++|.+++..  .+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... 
T Consensus       105 ~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~-  178 (353)
T 3coi_A          105 YLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHADA-  178 (353)
T ss_dssp             EEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC--EEECSTTCTTC----
T ss_pred             EEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc--EEEeecccccCCCC-
Confidence            69999997 588888754  4999999999999999999999999999999999999987766  99999999986532 


Q ss_pred             CCCCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc-----------------
Q 040569          155 EDDEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG-----------------  216 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~-----------------  216 (385)
                         ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ....+..+.                 
T Consensus       179 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~  254 (353)
T 3coi_A          179 ---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-YLDQLTQILKVTGVPGTEFVQKLNDK  254 (353)
T ss_dssp             --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC-HHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred             ---CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence               2234578999999999987 678999999999999999999999997643 222222110                 


Q ss_pred             ------------CCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          217 ------------FSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       217 ------------~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                  ...........+++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  312 (353)
T 3coi_A          255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  312 (353)
T ss_dssp             HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                        0111223345679999999999999999999999999999999864

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.4e-48  Score=377.09  Aligned_cols=249  Identities=25%  Similarity=0.345  Sum_probs=208.1

Q ss_pred             CceeeceeeccCceEEEEEE-----ECCCCcEEEEEeccCCC----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGM-----SNRSSEVFAVKSAELSN----SEFLQREQRILSAL-ACPQIVAYKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~-----~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~   71 (385)
                      +|++++.||+|+||+||+|+     +..+++.||||.+....    .+.+.+|+++|+++ +||||+++++++...... 
T Consensus        23 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~-  101 (359)
T 3vhe_A           23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP-  101 (359)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC-
T ss_pred             ceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc-
Confidence            58899999999999999999     56677999999987543    24578999999999 889999999987654331 


Q ss_pred             EEEEEEEeecCCCCHHHHHHcCCC--------------------------------------------------------
Q 040569           72 ILYNLFLEYAPGGTLTDAIRSGTC--------------------------------------------------------   95 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~~~~--------------------------------------------------------   95 (385)
                        +++||||++||+|.+++.....                                                        
T Consensus       102 --~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (359)
T 3vhe_A          102 --LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  179 (359)
T ss_dssp             --CEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred             --eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence              5589999999999999985432                                                        


Q ss_pred             ----------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC-CCCCcccc
Q 040569           96 ----------LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED-DEGKPICG  164 (385)
Q Consensus        96 ----------l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~G  164 (385)
                                +++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....... .......|
T Consensus       180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~  257 (359)
T 3vhe_A          180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARL  257 (359)
T ss_dssp             ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred             ccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc--EEEEeccceeeecccccchhccccCC
Confidence                      899999999999999999999999999999999999987766  99999999986532222 12334578


Q ss_pred             CCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcC
Q 040569          165 TPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRN  243 (385)
Q Consensus       165 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~d  243 (385)
                      |+.|+|||++.+..++.++|||||||++|+|++ |+.||............+ .....+..+..+++++.++|.+||++|
T Consensus       258 t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~d  336 (359)
T 3vhe_A          258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGTRMRAPDYTTPEMYQTMLDCWHGE  336 (359)
T ss_dssp             CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH-HHTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             CceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHccCC
Confidence            999999999999999999999999999999998 999998765444333333 223345567779999999999999999


Q ss_pred             CCCCCCHHHHHhC
Q 040569          244 PGERWSASELLEH  256 (385)
Q Consensus       244 P~~Rps~~elL~h  256 (385)
                      |.+|||+.|+++|
T Consensus       337 P~~Rps~~ell~~  349 (359)
T 3vhe_A          337 PSQRPTFSELVEH  349 (359)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             hhhCCCHHHHHHH
Confidence            9999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=9.2e-48  Score=372.18  Aligned_cols=258  Identities=23%  Similarity=0.347  Sum_probs=205.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeecc-CCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEE-NGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~~~~~l   76 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||.+....    ...+.+|+.+|++++||||+++++++.... .....+++
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   91 (353)
T 2b9h_A           12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI   91 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred             ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence            6899999999999999999999999999999986543    245678999999999999999999865431 11123669


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      ||||+. |+|.+++..+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.......
T Consensus        92 v~e~~~-~~L~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~  167 (353)
T 2b9h_A           92 IQELMQ-TDLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAA  167 (353)
T ss_dssp             EECCCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECC----
T ss_pred             EEeccC-ccHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc--EEEEecccccccccccc
Confidence            999997 5999999864 5999999999999999999999999999999999999987766  99999999987643221


Q ss_pred             C---------CCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh---cCCC----
Q 040569          157 D---------EGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI---GFSS----  219 (385)
Q Consensus       157 ~---------~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---~~~~----  219 (385)
                      .         .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.............   +...    
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
T 2b9h_A          168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND  247 (353)
T ss_dssp             ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTT
T ss_pred             cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcc
Confidence            1         1234578999999999865 678999999999999999999999998753222111110   0000    


Q ss_pred             --------------CCC--------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          220 --------------DTP--------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       220 --------------~~~--------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                                    ..+        .....+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             TTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             ccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence                          000        11235789999999999999999999999999999998653

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=9.5e-49  Score=382.99  Aligned_cols=256  Identities=14%  Similarity=0.099  Sum_probs=189.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhc--CCCCeeeeee-------eeee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSAL--ACPQIVAYKG-------CDIS   66 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l--~hpnIv~~~~-------~~~~   66 (385)
                      +|++++.||+|+||+||+|+++.+++.||||++....      .+.+++|+.+++.|  .||||++++.       ++..
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~  142 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV  142 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence            4889999999999999999999999999999987643      34567786555555  6999888553       2222


Q ss_pred             ccC-------------CeEEEEEEEeecCCCCHHHHHHc-CCCCCHHHH------HHHHHHHHHHHHHHHHCCceeccCC
Q 040569           67 EEN-------------GKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRI------RSHTRAVLLGLQYLHSNGIVHCDIK  126 (385)
Q Consensus        67 ~~~-------------~~~~~~lv~Ey~~ggsL~~~l~~-~~~l~e~~~------~~i~~qil~gL~yLH~~givHrDlK  126 (385)
                      ...             ....+++||||++ |+|.+++.. +..+++...      ..++.||+.||+|||++||+|||||
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik  221 (371)
T 3q60_A          143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT  221 (371)
T ss_dssp             TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence            111             0133679999998 799999984 334555555      5777999999999999999999999


Q ss_pred             CCCEEeecCCCCCeEEeecCceeeecccCCCCCCccccCCcccChhhhcC--CCCCCCCChHHHHHHHHHHHhCCCCCCC
Q 040569          127 GQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG--EEQGFPADVWALGCTVLEMATGRPPWPD  204 (385)
Q Consensus       127 p~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~Pf~~  204 (385)
                      |+|||++.++.  +||+|||+++.....    .....||+.|+|||++.+  ..++.++|||||||++|+|++|+.||..
T Consensus       222 p~NIll~~~~~--~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  295 (371)
T 3q60_A          222 PDNLFIMPDGR--LMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL  295 (371)
T ss_dssp             GGGEEECTTSC--EEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred             HHHEEECCCCC--EEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence            99999987766  999999999875321    113467799999999987  6789999999999999999999999976


Q ss_pred             CCChHHHHH-H---hcCCCCCC--CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccccc
Q 040569          205 VADPISALH-R---IGFSSDTP--EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNF  264 (385)
Q Consensus       205 ~~~~~~~~~-~---~~~~~~~~--~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~~  264 (385)
                      ......... .   ........  ..+..+++++++||.+||++||.+|||+.|+|+||||+....
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  361 (371)
T 3q60_A          296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN  361 (371)
T ss_dssp             CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred             cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence            522111000 0   00011111  122468999999999999999999999999999999987543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2e-48  Score=376.08  Aligned_cols=249  Identities=23%  Similarity=0.361  Sum_probs=211.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH--------------------HHHHHHHHHHHhcCCCCeeeee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS--------------------EFLQREQRILSALACPQIVAYK   61 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~--------------------~~~~~E~~il~~l~hpnIv~~~   61 (385)
                      +|++++.||+|+||+||+|.+  +++.||+|.+.....                    +.+.+|+.++++++||||++++
T Consensus        32 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           32 DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             TEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             ceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            699999999999999999998  899999998753211                    7888999999999999999999


Q ss_pred             eeeeeccCCeEEEEEEEeecCCCCHHHH------HHc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEe
Q 040569           62 GCDISEENGKILYNLFLEYAPGGTLTDA------IRS--GTCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILV  132 (385)
Q Consensus        62 ~~~~~~~~~~~~~~lv~Ey~~ggsL~~~------l~~--~~~l~e~~~~~i~~qil~gL~yLH~-~givHrDlKp~NILi  132 (385)
                      +++.....    +++||||++||+|.++      +..  ...+++..+..++.||+.||.|||+ +||+||||||+|||+
T Consensus       110 ~~~~~~~~----~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          110 GIITNYDE----VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM  185 (348)
T ss_dssp             EEEESSSE----EEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred             EEEeeCCe----EEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence            98766532    6799999999999998      665  6779999999999999999999999 999999999999999


Q ss_pred             ecCCCCCeEEeecCceeeecccCCCCCCccccCCcccChhhhcCC-CCCC-CCChHHHHHHHHHHHhCCCCCCCCCChHH
Q 040569          133 SKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE-EQGF-PADVWALGCTVLEMATGRPPWPDVADPIS  210 (385)
Q Consensus       133 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~-~~DiwSlG~il~elltG~~Pf~~~~~~~~  210 (385)
                      +.++.  +||+|||++......   ......||+.|+|||++.+. .++. ++|||||||++|+|++|+.||........
T Consensus       186 ~~~~~--~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          186 DKNGR--VKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             CTTSC--EEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             cCCCc--EEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            87765  999999999876322   23445799999999999887 5665 99999999999999999999987655445


Q ss_pred             HHHHhcCCCCCCCCC-------------------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          211 ALHRIGFSSDTPEIP-------------------GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       211 ~~~~~~~~~~~~~~~-------------------~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      ....+...  ...++                   ..+++++.+||.+||+.||.+|||+.|+|+||||....
T Consensus       261 ~~~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          261 LFNNIRTK--NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             HHHHHTSC--CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HHHHHhcc--CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            54444222  12222                   56899999999999999999999999999999998653

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=9.9e-48  Score=362.67  Aligned_cols=256  Identities=24%  Similarity=0.371  Sum_probs=203.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcCCCCeeeeeeeeeecc---------CC
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALACPQIVAYKGCDISEE---------NG   70 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~hpnIv~~~~~~~~~~---------~~   70 (385)
                      +|++++.||+|+||+||+|++..+++.||||.+....  .+.+.+|+.++++++||||+++++++....         ..
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   86 (303)
T 1zy4_A            7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKK   86 (303)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------C
T ss_pred             cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccccc
Confidence            5899999999999999999999999999999986532  356789999999999999999999876532         12


Q ss_pred             eEEEEEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCcee
Q 040569           71 KILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR  149 (385)
Q Consensus        71 ~~~~~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~  149 (385)
                      ...+++||||++||+|.+++.. +..+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||++.
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~  164 (303)
T 1zy4_A           87 KSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGLAK  164 (303)
T ss_dssp             EEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCCCS
T ss_pred             CCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC--EEEeeCcchh
Confidence            3457799999999999999984 446889999999999999999999999999999999999987766  9999999997


Q ss_pred             eecccC-------------CCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh
Q 040569          150 RARVNE-------------DDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI  215 (385)
Q Consensus       150 ~~~~~~-------------~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~  215 (385)
                      ......             ........||+.|+|||++.+. .++.++|||||||++|+|++   ||....+.......+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~  241 (303)
T 1zy4_A          165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKL  241 (303)
T ss_dssp             CTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred             hcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhc
Confidence            653211             1122345799999999999865 68999999999999999998   554322222233332


Q ss_pred             cC--CCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          216 GF--SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       216 ~~--~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ..  ....+.++...++.+++||.+||++||.+|||+.++++||||...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             cccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            11  122344566678899999999999999999999999999999754

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.5e-48  Score=372.97  Aligned_cols=257  Identities=25%  Similarity=0.348  Sum_probs=187.8

Q ss_pred             Cceee-ceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            2 DWTRG-QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         2 ~y~~~-~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +|.+. +.||+|+||+||+|+++.+++.||||++... ....++....++.+.||||+++++++.....+...+++||||
T Consensus        29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~  107 (336)
T 3fhr_A           29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMEC  107 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred             eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEec
Confidence            57785 4699999999999999999999999998653 333334444567779999999999987766656667899999


Q ss_pred             cCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC-CCCeEEeecCceeeecccCCC
Q 040569           81 APGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN-EQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        81 ~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~-~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      ++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++.....   
T Consensus       108 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~---  184 (336)
T 3fhr_A          108 MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---  184 (336)
T ss_dssp             CTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc---
Confidence            9999999999854  3699999999999999999999999999999999999997643 234899999999875422   


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHH---HHHhc--CCCCCCCCCCcCCHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISA---LHRIG--FSSDTPEIPGYMSKQA  232 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~---~~~~~--~~~~~~~~~~~~s~~~  232 (385)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.........   ...+.  ...........+++++
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (336)
T 3fhr_A          185 ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA  264 (336)
T ss_dssp             -------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHH
T ss_pred             ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHH
Confidence            234557899999999999888999999999999999999999999754322110   11111  1111122234689999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          233 QDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ++||.+||+.||.+|||+.|+|+||||++.
T Consensus       265 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          265 KQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             HHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            999999999999999999999999999763

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.7e-48  Score=380.28  Aligned_cols=257  Identities=28%  Similarity=0.400  Sum_probs=188.9

Q ss_pred             cee-eceeeccCceEEEEEEEC--CCCcEEEEEeccCCC-HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            3 WTR-GQTIGRGSTATVSIGMSN--RSSEVFAVKSAELSN-SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         3 y~~-~~~LG~G~~g~Vy~a~~~--~~~~~~AvK~~~~~~-~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      |.+ ++.||+|+||+||+|+++  .+++.||||.+.... ...+.+|+.+|++++||||+++++++.......  +++||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~--~~lv~   99 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRK--VWLLF   99 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE--EEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe--EEEEE
Confidence            444 668999999999999976  578999999987543 467889999999999999999999987654433  56999


Q ss_pred             eecCCCCHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecC--CCCCeEEeecCc
Q 040569           79 EYAPGGTLTDAIRS---------GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKD--NEQGAKIADFGC  147 (385)
Q Consensus        79 Ey~~ggsL~~~l~~---------~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~--~~~~~kL~DFG~  147 (385)
                      ||+.| +|.+++..         ...+++..++.++.||+.||+|||++||+||||||+||||..+  ....+||+|||+
T Consensus       100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  178 (405)
T 3rgf_A          100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  178 (405)
T ss_dssp             ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred             eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence            99975 88888752         1249999999999999999999999999999999999999432  223499999999


Q ss_pred             eeeecccCC--CCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHHh-
Q 040569          148 ARRARVNED--DEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADP--------ISALHRI-  215 (385)
Q Consensus       148 a~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--------~~~~~~~-  215 (385)
                      ++.......  ......+||+.|+|||++.+. .++.++|||||||++|+|++|++||......        ...+.++ 
T Consensus       179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~  258 (405)
T 3rgf_A          179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  258 (405)
T ss_dssp             CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHH
T ss_pred             ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHH
Confidence            987643211  223456899999999999874 5899999999999999999999999754321        1111111 


Q ss_pred             ---cCCCCC--C------------------------------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 040569          216 ---GFSSDT--P------------------------------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVK  260 (385)
Q Consensus       216 ---~~~~~~--~------------------------------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~  260 (385)
                         +.....  +                              ......++.+.+||.+||++||.+|||++|+|+||||.
T Consensus       259 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~  338 (405)
T 3rgf_A          259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL  338 (405)
T ss_dssp             HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhc
Confidence               111000  0                              00011277899999999999999999999999999998


Q ss_pred             cc
Q 040569          261 EQ  262 (385)
Q Consensus       261 ~~  262 (385)
                      ..
T Consensus       339 ~~  340 (405)
T 3rgf_A          339 ED  340 (405)
T ss_dssp             SS
T ss_pred             cC
Confidence            64

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.2e-48  Score=376.38  Aligned_cols=256  Identities=23%  Similarity=0.316  Sum_probs=207.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcC-----------CCCeeeeeeeeeecc
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALA-----------CPQIVAYKGCDISEE   68 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~-----------hpnIv~~~~~~~~~~   68 (385)
                      +|++++.||+|+||+||+|++..+++.||||.+....  .+.+.+|+.+++++.           ||||+++++++....
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~   99 (373)
T 1q8y_A           20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   99 (373)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccC
Confidence            5999999999999999999999999999999987543  356788999999886           899999999988766


Q ss_pred             CCeEEEEEEEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEeecCC----CCCeE
Q 040569           69 NGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSN-GIVHCDIKGQNILVSKDN----EQGAK  141 (385)
Q Consensus        69 ~~~~~~~lv~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~-givHrDlKp~NILi~~~~----~~~~k  141 (385)
                      .....++++|||+ +++|.+++..  ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++    ...+|
T Consensus       100 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~k  178 (373)
T 1q8y_A          100 PNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK  178 (373)
T ss_dssp             TTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred             CCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEE
Confidence            5555678999999 8899999984  45699999999999999999999998 999999999999996433    12389


Q ss_pred             EeecCceeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCC-----hHHHHHHh-
Q 040569          142 IADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-----PISALHRI-  215 (385)
Q Consensus       142 L~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-----~~~~~~~~-  215 (385)
                      |+|||+++....    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....     ....+..+ 
T Consensus       179 l~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (373)
T 1q8y_A          179 IADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII  254 (373)
T ss_dssp             ECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred             EcccccccccCC----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHH
Confidence            999999987632    22345799999999999999999999999999999999999999975321     11111110 


Q ss_pred             cCCC---------------------------------------CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          216 GFSS---------------------------------------DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       216 ~~~~---------------------------------------~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ....                                       ....++...++++.+||.+||+.||.+|||+.|+|+|
T Consensus       255 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  334 (373)
T 1q8y_A          255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  334 (373)
T ss_dssp             HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence            0000                                       0112334457789999999999999999999999999


Q ss_pred             cccccc
Q 040569          257 GFVKEQ  262 (385)
Q Consensus       257 p~~~~~  262 (385)
                      |||++.
T Consensus       335 p~f~~~  340 (373)
T 1q8y_A          335 PWLKDT  340 (373)
T ss_dssp             GGGTTC
T ss_pred             hhhhcc
Confidence            999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=6.6e-48  Score=361.94  Aligned_cols=246  Identities=20%  Similarity=0.283  Sum_probs=206.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++++.||+|+||+||+|.++ ++..||+|.+...  ..+.+.+|++++++++||||+++++++.....    +++|||
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e   99 (283)
T 3gen_A           25 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP----IFIITE   99 (283)
T ss_dssp             GEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS----EEEEEC
T ss_pred             HHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCC----eEEEEe
Confidence            5889999999999999999886 6778999998754  45778899999999999999999998765444    669999


Q ss_pred             ecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           80 YAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        80 y~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      |+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.........
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~  177 (283)
T 3gen_A          100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTS  177 (283)
T ss_dssp             CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC--EEECSTTGGGGBCCHHHHS
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC--EEEcccccccccccccccc
Confidence            9999999999985 567999999999999999999999999999999999999987765  9999999998653322223


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      .....||+.|+|||++.+..++.++|||||||++|+|++ |+.||.... .......+. .......+...++.+.+||.
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~l~~li~  255 (283)
T 3gen_A          178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIA-QGLRLYRPHLASEKVYTIMY  255 (283)
T ss_dssp             TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC-HHHHHHHHH-TTCCCCCCTTCCHHHHHHHH
T ss_pred             ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC-hhHHHHHHh-cccCCCCCCcCCHHHHHHHH
Confidence            334457889999999998899999999999999999998 999998753 333333332 23344456678999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhC
Q 040569          238 KCLIRNPGERWSASELLEH  256 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~h  256 (385)
                      +||+.||.+|||+.|+++|
T Consensus       256 ~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          256 SCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HTTCSSGGGSCCHHHHHHH
T ss_pred             HHccCChhHCcCHHHHHHH
Confidence            9999999999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=8.5e-48  Score=363.80  Aligned_cols=249  Identities=26%  Similarity=0.383  Sum_probs=204.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHh--cCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSA--LACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~--l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++++.||+|+||+||+|++  +++.||||++.......+.+|.+++..  ++||||+++++++.........+++|||
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e   86 (301)
T 3q4u_A            9 DITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH   86 (301)
T ss_dssp             GCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred             cEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence            589999999999999999987  589999999987777777788888887  7999999999988776555556789999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH--------SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH--------~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      |+++|+|.++++.. .+++..+..++.||+.||+|||        ++||+||||||+|||++.++.  +||+|||+++..
T Consensus        87 ~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~a~~~  163 (301)
T 3q4u_A           87 YHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ--CCIADLGLAVMH  163 (301)
T ss_dssp             CCTTCBHHHHHTTC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEEE
T ss_pred             hccCCCHHHHHhhc-ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC--EEEeeCCCeeec
Confidence            99999999999754 5999999999999999999999        999999999999999987765  999999999876


Q ss_pred             cccCCC---CCCccccCCcccChhhhcCC------CCCCCCChHHHHHHHHHHHhC----------CCCCCCCC---ChH
Q 040569          152 RVNEDD---EGKPICGTPICMAPEVARGE------EQGFPADVWALGCTVLEMATG----------RPPWPDVA---DPI  209 (385)
Q Consensus       152 ~~~~~~---~~~~~~Gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltG----------~~Pf~~~~---~~~  209 (385)
                      ......   .....+||+.|+|||++.+.      .++.++|||||||++|||++|          +.||....   ...
T Consensus       164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~  243 (301)
T 3q4u_A          164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF  243 (301)
T ss_dssp             ETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             ccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcch
Confidence            433221   12345799999999999877      445689999999999999999          88886432   112


Q ss_pred             H-HHHHhcCCCCCCCCCC-----cCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          210 S-ALHRIGFSSDTPEIPG-----YMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       210 ~-~~~~~~~~~~~~~~~~-----~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      . ...........+.++.     ..++++.+||.+||+.||.+|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             hhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            2 2222223333444432     25678999999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.9e-47  Score=365.76  Aligned_cols=256  Identities=26%  Similarity=0.361  Sum_probs=208.0

Q ss_pred             CceeeceeeccCceEEEEEEEC-CCCcEEEEEeccCC-----CHHHHHHHHHHHHhc---CCCCeeeeeeeeeecc-CCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN-RSSEVFAVKSAELS-----NSEFLQREQRILSAL---ACPQIVAYKGCDISEE-NGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~-~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l---~hpnIv~~~~~~~~~~-~~~   71 (385)
                      +|++.+.||+|+||+||+|++. .+++.||+|.+...     ....+.+|+.+++.+   .||||+++++++.... ...
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   91 (326)
T 1blx_A           12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   91 (326)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence            5899999999999999999995 67899999987532     123566888888777   8999999999876322 233


Q ss_pred             EEEEEEEeecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCcee
Q 040569           72 ILYNLFLEYAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR  149 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~  149 (385)
                      ..+++||||+. |+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++
T Consensus        92 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~--~kl~Dfg~~~  168 (326)
T 1blx_A           92 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLAR  168 (326)
T ss_dssp             EEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSCC
T ss_pred             ceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC--EEEecCcccc
Confidence            45779999998 5999999853  45999999999999999999999999999999999999987765  9999999998


Q ss_pred             eecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc----CC-------
Q 040569          150 RARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG----FS-------  218 (385)
Q Consensus       150 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~----~~-------  218 (385)
                      ......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..+..+.    ..       
T Consensus       169 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~  245 (326)
T 1blx_A          169 IYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEEDWPR  245 (326)
T ss_dssp             CCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCGGGSCT
T ss_pred             cccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCcccCcc
Confidence            754222  223457899999999999999999999999999999999999999875332 2222211    00       


Q ss_pred             --------------CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          219 --------------SDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       219 --------------~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                                    .....+...+++.+++||.+||..||.+|||+.|+|+||||+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  304 (326)
T 1blx_A          246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  304 (326)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence                          001123356899999999999999999999999999999998654

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6.7e-48  Score=374.91  Aligned_cols=254  Identities=24%  Similarity=0.325  Sum_probs=198.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--------------HHHHHHHHHHHHhcCCCCeeeeeeeeeec
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--------------SEFLQREQRILSALACPQIVAYKGCDISE   67 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--------------~~~~~~E~~il~~l~hpnIv~~~~~~~~~   67 (385)
                      +|++++.||+|+||+||+|.+.. ++.||||.+....              .+.+.+|+++|++++||||+++++++...
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  101 (362)
T 3pg1_A           23 PYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF  101 (362)
T ss_dssp             SCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred             ceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence            69999999999999999999865 9999999875321              16788999999999999999999988654


Q ss_pred             c-CCeEEEEEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeec
Q 040569           68 E-NGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADF  145 (385)
Q Consensus        68 ~-~~~~~~~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DF  145 (385)
                      . .....+++||||+. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+||
T Consensus       102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Df  178 (362)
T 3pg1_A          102 EEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITICDF  178 (362)
T ss_dssp             CTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCT
T ss_pred             cCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--EEEEec
Confidence            3 23334679999998 588888874 447999999999999999999999999999999999999987766  999999


Q ss_pred             CceeeecccCCCCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC-------
Q 040569          146 GCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF-------  217 (385)
Q Consensus       146 G~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-------  217 (385)
                      |+++.....  .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ....+..+..       
T Consensus       179 g~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          179 NLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST-FYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             TC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCH
T ss_pred             Ccccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHcCCCCh
Confidence            999864322  22345579999999999987 678999999999999999999999998643 2222221100       


Q ss_pred             ---------------CCCCC--------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          218 ---------------SSDTP--------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       218 ---------------~~~~~--------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                     .....        ..+...++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  323 (362)
T 3pg1_A          256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL  323 (362)
T ss_dssp             HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence                           00000        1123468899999999999999999999999999999865

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2e-47  Score=367.29  Aligned_cols=246  Identities=20%  Similarity=0.287  Sum_probs=204.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCc---EEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSE---VFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~---~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++.+.||+|+||+||+|+++.+++   .||||.+....    .+.+.+|+.+|++++||||+++++++.....    +
T Consensus        50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~  125 (325)
T 3kul_A           50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL----A  125 (325)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC----C
T ss_pred             HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc----c
Confidence            58899999999999999999986655   59999987542    3467889999999999999999998865544    6


Q ss_pred             EEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      ++||||++||+|.++++. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLED  203 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCSSCEECC-
T ss_pred             EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC--EEECCCCccccccc
Confidence            699999999999999974 467999999999999999999999999999999999999987665  99999999987643


Q ss_pred             cCCC--CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          154 NEDD--EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       154 ~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      ....  ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||.... .......+.. ......+..+++
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-~~~~~~~~~~-~~~~~~~~~~~~  281 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT-NRDVISSVEE-GYRLPAPMGCPH  281 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC-HHHHHHHHHT-TCCCCCCTTCCH
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC-HHHHHHHHHc-CCCCCCCCCcCH
Confidence            3221  1223346788999999999999999999999999999999 999997753 3333333322 334445667899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .+.+||.+||..||.+|||+.|+++
T Consensus       282 ~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          282 ALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHH
Confidence            9999999999999999999999987

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7.8e-48  Score=368.50  Aligned_cols=257  Identities=20%  Similarity=0.324  Sum_probs=193.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCc---EEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCe--
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSE---VFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEENGK--   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~---~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~--   71 (385)
                      +|++++.||+|+||+||+|.++.++.   .+|||.+...     ..+.+.+|++++++++||||+++++++.......  
T Consensus        24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (323)
T 3qup_A           24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL  103 (323)
T ss_dssp             -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred             HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence            58999999999999999999887775   8999988643     2356789999999999999999999887654321  


Q ss_pred             EEEEEEEeecCCCCHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeec
Q 040569           72 ILYNLFLEYAPGGTLTDAIRSG------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADF  145 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~~------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DF  145 (385)
                      ...++||||+++|+|.+++...      ..+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+||
T Consensus       104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~--~kl~Df  181 (323)
T 3qup_A          104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADF  181 (323)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCC
T ss_pred             CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC--EEEeec
Confidence            1236899999999999999632      15899999999999999999999999999999999999987765  999999


Q ss_pred             CceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCC
Q 040569          146 GCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPE  223 (385)
Q Consensus       146 G~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  223 (385)
                      |+++....... .......|++.|+|||++.+..++.++|||||||++|+|++ |+.||........ ...+ .....+.
T Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-~~~~-~~~~~~~  259 (323)
T 3qup_A          182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-YNYL-IGGNRLK  259 (323)
T ss_dssp             CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHH-HTTCCCC
T ss_pred             cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH-HHHH-hcCCCCC
Confidence            99987543222 12233457889999999999999999999999999999999 9999987544332 2222 2233445


Q ss_pred             CCCcCCHHHHHHHHHhhhcCCCCCCC-------HHHHHhCcccccc
Q 040569          224 IPGYMSKQAQDFLSKCLIRNPGERWS-------ASELLEHGFVKEQ  262 (385)
Q Consensus       224 ~~~~~s~~~~~ll~~cL~~dP~~Rps-------~~elL~hp~~~~~  262 (385)
                      .+..+++++.+||.+||+.||.+|||       ++++++|||+...
T Consensus       260 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          260 QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence            56678999999999999999999999       6778889998754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-48  Score=378.62  Aligned_cols=255  Identities=24%  Similarity=0.279  Sum_probs=210.0

Q ss_pred             CceeeceeeccCceEEEEEE-----ECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGM-----SNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~-----~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|++++.||+|+||+||+|+     +..+++.||||.+....    ...+.+|+.++++++||||+++++++.....   
T Consensus        72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---  148 (367)
T 3l9p_A           72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP---  148 (367)
T ss_dssp             GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS---
T ss_pred             HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC---
Confidence            48899999999999999999     55678899999986432    2357789999999999999999998866544   


Q ss_pred             EEEEEEeecCCCCHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCC-CCeEEee
Q 040569           73 LYNLFLEYAPGGTLTDAIRSG-------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE-QGAKIAD  144 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~-------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~-~~~kL~D  144 (385)
                       .++||||++||+|.+++...       ..+++..+..++.||+.||+|||++||+||||||+|||++.++. ..+||+|
T Consensus       149 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          149 -RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             -CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             -CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECC
Confidence             56899999999999999742       35899999999999999999999999999999999999985442 2389999


Q ss_pred             cCceeeecccC-CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCC
Q 040569          145 FGCARRARVNE-DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTP  222 (385)
Q Consensus       145 FG~a~~~~~~~-~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  222 (385)
                      ||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||... +.......+. ....+
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~-~~~~~~~~i~-~~~~~  305 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-SNQEVLEFVT-SGGRM  305 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHHHHH-TTCCC
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHH-cCCCC
Confidence            99998653322 223345578999999999999999999999999999999998 99999875 3344444332 33345


Q ss_pred             CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          223 EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       223 ~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ..+..+++.+.+||.+||+.||.+|||+.+++++.+....
T Consensus       306 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          306 DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            5567789999999999999999999999999999876543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.8e-47  Score=359.22  Aligned_cols=246  Identities=23%  Similarity=0.314  Sum_probs=194.3

Q ss_pred             CceeeceeeccCceEEEEEEECCC---CcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRS---SEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~---~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++++.||+|+||+||+|++..+   +..+|+|.+....    .+.+.+|+.++++++||||+++++++.. ..    +
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~----~   90 (281)
T 1mp8_A           16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP----V   90 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SS----C
T ss_pred             HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-Cc----c
Confidence            588999999999999999998654   5679999886532    3467789999999999999999998632 22    5


Q ss_pred             EEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      ++||||+++|+|.+++.. +..+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMED  168 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC---------
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC--EEECccccccccCc
Confidence            589999999999999984 446999999999999999999999999999999999999997766  99999999987644


Q ss_pred             cCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHH
Q 040569          154 NEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA  232 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  232 (385)
                      ..........||+.|+|||++.+..++.++|||||||++|+|++ |..||...... .....+. ....+..+..+++++
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-~~~~~i~-~~~~~~~~~~~~~~l  246 (281)
T 1mp8_A          169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIE-NGERLPMPPNCPPTL  246 (281)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHH-TTCCCCCCTTCCHHH
T ss_pred             ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-HHHHHHH-cCCCCCCCCCCCHHH
Confidence            33333334467889999999998899999999999999999997 99999875433 3333332 223345667799999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          233 QDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      .+||.+||..||.+|||+.|++++
T Consensus       247 ~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          247 YSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999874

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.5e-47  Score=363.59  Aligned_cols=252  Identities=27%  Similarity=0.435  Sum_probs=207.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcC--CCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALA--CPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~--hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++++.||+|+||+||+|.+. +++.||||.+....     .+.+.+|+.+++++.  ||||+++++++.....    +
T Consensus        29 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~----~  103 (313)
T 3cek_A           29 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY----I  103 (313)
T ss_dssp             EEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE----E
T ss_pred             eEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE----E
Confidence            4899999999999999999985 58999999886432     356789999999996  5999999998765432    6


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||| +.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. +  .+||+|||+++.....
T Consensus       104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~--~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPD  179 (313)
T ss_dssp             EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCC----
T ss_pred             EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C--eEEEeeccccccccCc
Confidence            79999 557899999998888999999999999999999999999999999999999963 3  3999999999876432


Q ss_pred             CCC-CCCccccCCcccChhhhcC-----------CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCC
Q 040569          155 EDD-EGKPICGTPICMAPEVARG-----------EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP  222 (385)
Q Consensus       155 ~~~-~~~~~~Gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  222 (385)
                      ... ......||+.|+|||++.+           ..++.++|||||||++|+|++|+.||....+....+..+.......
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  259 (313)
T 3cek_A          180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI  259 (313)
T ss_dssp             ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred             cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc
Confidence            221 1234579999999999976           4678899999999999999999999987666655555554444455


Q ss_pred             CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          223 EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       223 ~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      .++...++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus       260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence            6677789999999999999999999999999999999754

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.8e-48  Score=365.82  Aligned_cols=258  Identities=24%  Similarity=0.312  Sum_probs=200.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH---HHHHHHHHHHHhcCCCCeeeeeeeeeecc----------
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS---EFLQREQRILSALACPQIVAYKGCDISEE----------   68 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~---~~~~~E~~il~~l~hpnIv~~~~~~~~~~----------   68 (385)
                      +|++++.||+|+||+||+|.++.+++.||+|.+.....   +.+.+|++++++++||||+++++++....          
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   91 (320)
T 2i6l_A           12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL   91 (320)
T ss_dssp             TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred             ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence            58999999999999999999999999999998876543   45778999999999999999998864321          


Q ss_pred             CCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCce
Q 040569           69 NGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA  148 (385)
Q Consensus        69 ~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a  148 (385)
                      .....+++||||++ |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||++
T Consensus        92 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~kl~Dfg~~  168 (320)
T 2i6l_A           92 TELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED-LVLKIGDFGLA  168 (320)
T ss_dssp             CSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-TEEEECCCTTC
T ss_pred             cccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CeEEEccCccc
Confidence            11223679999998 599999975 4599999999999999999999999999999999999997432 23899999999


Q ss_pred             eeecccC--CCCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC------
Q 040569          149 RRARVNE--DDEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS------  219 (385)
Q Consensus       149 ~~~~~~~--~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~------  219 (385)
                      +......  ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+....      
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~  247 (320)
T 2i6l_A          169 RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE-LEQMQLILESIPVVHEE  247 (320)
T ss_dssp             BCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHSCCCCHH
T ss_pred             cccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCchh
Confidence            8753221  122344568999999999876 6788999999999999999999999987533 22222211000      


Q ss_pred             ----------------------CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          220 ----------------------DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       220 ----------------------~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                                            .....+..+++++++||.+||+.||.+|||+.|+|+||||+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (320)
T 2i6l_A          248 DRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS  313 (320)
T ss_dssp             HHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred             hhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence                                  00112245799999999999999999999999999999998643

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.4e-47  Score=363.78  Aligned_cols=247  Identities=23%  Similarity=0.311  Sum_probs=196.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+|.++.+++.||+|.+....      .+.+.+|+.++++++||||+++++++.....    ++
T Consensus        35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~----~~  110 (309)
T 2h34_A           35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ----LY  110 (309)
T ss_dssp             CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE----EE
T ss_pred             cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe----EE
Confidence            5999999999999999999999999999999986431      2567899999999999999999998866443    66


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.......
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF--AYLVDFGIASATTDEK  188 (309)
T ss_dssp             EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSCCC--------
T ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC--EEEecCccCccccccc
Confidence            99999999999999997778999999999999999999999999999999999999987765  9999999998764433


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC-CCCCCCCCcCCHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS-SDTPEIPGYMSKQAQD  234 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~  234 (385)
                      ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+... ......+..+|+++.+
T Consensus       189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~  267 (309)
T 2h34_A          189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGIPVAFDA  267 (309)
T ss_dssp             --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCCCGGGTSTTCCTHHHH
T ss_pred             cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCCCccccCCCCCHHHHH
Confidence            33334567999999999999999999999999999999999999999764322 222222211 2223445678999999


Q ss_pred             HHHHhhhcCCCCCC-CHHHHHh
Q 040569          235 FLSKCLIRNPGERW-SASELLE  255 (385)
Q Consensus       235 ll~~cL~~dP~~Rp-s~~elL~  255 (385)
                      ||.+||++||.+|| |++++++
T Consensus       268 li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          268 VIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHhccCCHHHHHHhHHHHHH
Confidence            99999999999999 8888775

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-47  Score=367.74  Aligned_cols=247  Identities=23%  Similarity=0.285  Sum_probs=207.5

Q ss_pred             CceeeceeeccCceEEEEEEEC-----CCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN-----RSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|++++.||+|+||+||+|+++     .+++.||||.+....    .+.+.+|+.++++++||||+++++++.....   
T Consensus        48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~---  124 (343)
T 1luf_A           48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP---  124 (343)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS---
T ss_pred             HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc---
Confidence            5899999999999999999987     456899999987543    3567899999999999999999998866444   


Q ss_pred             EEEEEEeecCCCCHHHHHHcC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 040569           73 LYNLFLEYAPGGTLTDAIRSG------------------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQ  128 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~------------------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~  128 (385)
                       +++||||+++|+|.+++...                        ..+++..+..++.||+.||.|||++||+||||||+
T Consensus       125 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~  203 (343)
T 1luf_A          125 -MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR  203 (343)
T ss_dssp             -CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             -eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence             66899999999999999752                        56999999999999999999999999999999999


Q ss_pred             CEEeecCCCCCeEEeecCceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCC
Q 040569          129 NILVSKDNEQGAKIADFGCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVA  206 (385)
Q Consensus       129 NILi~~~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~  206 (385)
                      |||++.++.  +||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||... 
T Consensus       204 NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-  280 (343)
T 1luf_A          204 NCLVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM-  280 (343)
T ss_dssp             GEEECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-
T ss_pred             eEEECCCCe--EEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC-
Confidence            999987766  99999999986532221 22334568999999999999899999999999999999999 99999874 


Q ss_pred             ChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          207 DPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ........+. ....+..+..+++++.+||.+||..||.+|||+.+++++
T Consensus       281 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          281 AHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             CHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ChHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            3333333332 334455677899999999999999999999999999874

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.1e-47  Score=362.95  Aligned_cols=250  Identities=24%  Similarity=0.343  Sum_probs=202.0

Q ss_pred             CceeeceeeccCceEEEEEE----ECCCCcEEEEEeccCCCH---HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGM----SNRSSEVFAVKSAELSNS---EFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~----~~~~~~~~AvK~~~~~~~---~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++++.||+|+||+||+|+    +..+++.||||.+.....   +.+.+|+++|++++||||+++++++.......  +
T Consensus        11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~--~   88 (295)
T 3ugc_A           11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN--L   88 (295)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS--C
T ss_pred             HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc--e
Confidence            58999999999999999998    667899999999876554   46779999999999999999999876543322  5


Q ss_pred             EEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      ++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~~~~~~~  166 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQ  166 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCSCC----
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe--EEEccCcccccccC
Confidence            589999999999999985 345999999999999999999999999999999999999998766  99999999987643


Q ss_pred             cCC--CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChH--------------HHHHHhcC
Q 040569          154 NED--DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPI--------------SALHRIGF  217 (385)
Q Consensus       154 ~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--------------~~~~~~~~  217 (385)
                      ...  .......|++.|+|||++.+..++.++|||||||++|+|++|..||.......              ........
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (295)
T 3ugc_A          167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK  246 (295)
T ss_dssp             ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred             CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence            221  12233457788999999999999999999999999999999999986421100              01111112


Q ss_pred             CCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          218 SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       218 ~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .......+..+++++.+||.+||+.||.+|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          247 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            23344557778999999999999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.7e-47  Score=362.45  Aligned_cols=247  Identities=23%  Similarity=0.346  Sum_probs=206.7

Q ss_pred             CceeeceeeccCceEEEEEEE-----CCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMS-----NRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|++++.||+|+||+||+|.+     +.+++.+|+|.+....    .+.+.+|+++|++++||||+++++++.....   
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~---  100 (314)
T 2ivs_A           24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP---  100 (314)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS---
T ss_pred             heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc---
Confidence            588999999999999999998     3456899999987543    2467789999999999999999998765544   


Q ss_pred             EEEEEEeecCCCCHHHHHHcCC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 040569           73 LYNLFLEYAPGGTLTDAIRSGT------------------------CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQ  128 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~~------------------------~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~  128 (385)
                       +++||||++||+|.+++....                        .+++..+..++.||+.||.|||++||+||||||+
T Consensus       101 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~  179 (314)
T 2ivs_A          101 -LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR  179 (314)
T ss_dssp             -CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             -eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchh
Confidence             668999999999999998543                        3899999999999999999999999999999999


Q ss_pred             CEEeecCCCCCeEEeecCceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCC
Q 040569          129 NILVSKDNEQGAKIADFGCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVA  206 (385)
Q Consensus       129 NILi~~~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~  206 (385)
                      |||++.++.  +||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||....
T Consensus       180 NIli~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          180 NILVAEGRK--MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GEEEETTTE--EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eEEEcCCCC--EEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999997765  999999999876432211 2234467889999999999999999999999999999999 999998653


Q ss_pred             ChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          207 DPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      . ......+ .....+..+..+++++.+||.+||+.||.+|||+.+++++
T Consensus       258 ~-~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          258 P-ERLFNLL-KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             G-GGHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             H-HHHHHHh-hcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            3 2222222 2233455677799999999999999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.6e-47  Score=356.34  Aligned_cols=244  Identities=25%  Similarity=0.351  Sum_probs=205.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH----------HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----------EFLQREQRILSALACPQIVAYKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~----------~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   71 (385)
                      +|++.+.||+|+||+||+|+++.+++.||+|.+.....          +.+.+|+.++++++||||+++++++....   
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---   96 (287)
T 4f0f_A           20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP---   96 (287)
T ss_dssp             TEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT---
T ss_pred             cceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC---
Confidence            58999999999999999999999999999998854321          57889999999999999999999864332   


Q ss_pred             EEEEEEEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEeecCCCC---CeEEeec
Q 040569           72 ILYNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNG--IVHCDIKGQNILVSKDNEQ---GAKIADF  145 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~g--ivHrDlKp~NILi~~~~~~---~~kL~DF  145 (385)
                         ++||||+++|+|.+.+. ....+++..+..++.||+.||+|||++|  |+||||||+|||++.++..   .+||+||
T Consensus        97 ---~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           97 ---RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             ---EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             ---eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence               38999999999999887 4457999999999999999999999999  9999999999999765432   2899999


Q ss_pred             CceeeecccCCCCCCccccCCcccChhhhc--CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChH-HHHHHhcCCCCCC
Q 040569          146 GCARRARVNEDDEGKPICGTPICMAPEVAR--GEEQGFPADVWALGCTVLEMATGRPPWPDVADPI-SALHRIGFSSDTP  222 (385)
Q Consensus       146 G~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~  222 (385)
                      |+++....    ......||+.|+|||++.  ...++.++|||||||++|+|++|+.||....... .....+......+
T Consensus       174 g~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  249 (287)
T 4f0f_A          174 GLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP  249 (287)
T ss_dssp             TTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC
T ss_pred             Cccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC
Confidence            99985422    233457999999999994  4557889999999999999999999997654332 2233333445556


Q ss_pred             CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          223 EIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       223 ~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .++..+++++.+||.+||+.||.+|||+.|+++
T Consensus       250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            677889999999999999999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.2e-47  Score=368.02  Aligned_cols=249  Identities=22%  Similarity=0.271  Sum_probs=201.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH--HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS--EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~--~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++++.||+|+||+||+|++.  ++.||||++.....  ...++|+.+|++++||||+++++++.........+++|||
T Consensus        25 ~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e  102 (322)
T 3soc_A           25 PLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA  102 (322)
T ss_dssp             EEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             hchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence            5899999999999999999876  89999999876544  3455688889999999999999998876554445679999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC----------CceeccCCCCCEEeecCCCCCeEEeecCcee
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN----------GIVHCDIKGQNILVSKDNEQGAKIADFGCAR  149 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~----------givHrDlKp~NILi~~~~~~~~kL~DFG~a~  149 (385)
                      |+++|+|.++++.+. +++..+..++.||+.||+|||++          ||+||||||+|||++.++.  +||+|||+++
T Consensus       103 ~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~--~kL~DFg~a~  179 (322)
T 3soc_A          103 FHEKGSLSDFLKANV-VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT--ACIADFGLAL  179 (322)
T ss_dssp             CCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC--EEECCCTTCE
T ss_pred             cCCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe--EEEccCCccc
Confidence            999999999998654 99999999999999999999999          9999999999999987765  9999999998


Q ss_pred             eecccCCC-CCCccccCCcccChhhhcCC-----CCCCCCChHHHHHHHHHHHhCCCCCCCCCC---------------h
Q 040569          150 RARVNEDD-EGKPICGTPICMAPEVARGE-----EQGFPADVWALGCTVLEMATGRPPWPDVAD---------------P  208 (385)
Q Consensus       150 ~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltG~~Pf~~~~~---------------~  208 (385)
                      ........ .....+||+.|+|||++.+.     .++.++|||||||++|+|++|+.||....+               .
T Consensus       180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  259 (322)
T 3soc_A          180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL  259 (322)
T ss_dssp             EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred             ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence            76543322 23346799999999999873     456688999999999999999999965321               1


Q ss_pred             HHHHHHhcCCCCCCCCCCc-----CCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          209 ISALHRIGFSSDTPEIPGY-----MSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~-----~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ......+......+.++..     .++++.+||.+||+.||.+|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          260 EDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            1222222222333333322     2456999999999999999999999987

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.1e-47  Score=368.66  Aligned_cols=253  Identities=20%  Similarity=0.254  Sum_probs=200.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCC-cEEEEEeccCCC--HHHHHHHHHHHHhcCCCC------eeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSS-EVFAVKSAELSN--SEFLQREQRILSALACPQ------IVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~-~~~AvK~~~~~~--~~~~~~E~~il~~l~hpn------Iv~~~~~~~~~~~~~~   72 (385)
                      +|++.+.||+|+||+||+|+++.++ +.||+|++....  .+.+.+|+.+++++.|++      ++.+++++.....   
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~---   96 (355)
T 2eu9_A           20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH---   96 (355)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE---
T ss_pred             cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe---
Confidence            5899999999999999999998877 789999987543  356778999999997665      8888887665443   


Q ss_pred             EEEEEEeecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecC---------------
Q 040569           73 LYNLFLEYAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKD---------------  135 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~---------------  135 (385)
                       +++||||+ +++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||+..+               
T Consensus        97 -~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~  174 (355)
T 2eu9_A           97 -MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK  174 (355)
T ss_dssp             -EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred             -EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence             67999999 56777777633  469999999999999999999999999999999999999432               


Q ss_pred             --CCCCeEEeecCceeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHH
Q 040569          136 --NEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALH  213 (385)
Q Consensus       136 --~~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~  213 (385)
                        ....+||+|||+++....    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........
T Consensus       175 ~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  250 (355)
T 2eu9_A          175 SVKNTSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM  250 (355)
T ss_dssp             EESCCCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ccCCCcEEEeecCccccccc----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence              233499999999986432    23455799999999999999999999999999999999999999986543222111


Q ss_pred             HhcCCCCCC-----------------------------------------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHH
Q 040569          214 RIGFSSDTP-----------------------------------------EIPGYMSKQAQDFLSKCLIRNPGERWSASE  252 (385)
Q Consensus       214 ~~~~~~~~~-----------------------------------------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~e  252 (385)
                      ........|                                         ......++++.+||.+||+.||.+|||+.|
T Consensus       251 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e  330 (355)
T 2eu9_A          251 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE  330 (355)
T ss_dssp             HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHH
Confidence            100000000                                         001122468899999999999999999999


Q ss_pred             HHhCccccccc
Q 040569          253 LLEHGFVKEQN  263 (385)
Q Consensus       253 lL~hp~~~~~~  263 (385)
                      +|+||||+...
T Consensus       331 ~l~hp~f~~~~  341 (355)
T 2eu9_A          331 ALLHPFFAGLT  341 (355)
T ss_dssp             HTTSGGGGGCC
T ss_pred             HhcChhhcCCC
Confidence            99999998754

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1e-47  Score=376.91  Aligned_cols=246  Identities=25%  Similarity=0.378  Sum_probs=206.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH----HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~----~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++++.||+|+||+||+|.++.+++.||||.+.....    +.+.+|+++|++++||||+++++++.....    +++|
T Consensus       115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----~~lv  190 (377)
T 3cbl_A          115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP----IYIV  190 (377)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS----CEEE
T ss_pred             HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC----cEEE
Confidence            47889999999999999999999999999999865422    346689999999999999999999865544    6699


Q ss_pred             EeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           78 LEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |||++||+|.++++. +..+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.......
T Consensus       191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~--~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSREEADGVY  268 (377)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECTTSEE
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc--EEECcCCCceecCCCce
Confidence            999999999999984 446999999999999999999999999999999999999987765  99999999986532211


Q ss_pred             C-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          157 D-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       157 ~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                      . ......+++.|+|||++.+..++.++|||||||++|||++ |..||..... ......+. .......|..+++++.+
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~l~~  346 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-QQTREFVE-KGGRLPCPELCPDAVFR  346 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-HHHHHHHH-TTCCCCCCTTCCHHHHH
T ss_pred             eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHH-cCCCCCCCCCCCHHHHH
Confidence            1 1122346778999999998899999999999999999998 9999987543 23332332 23344556778999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHh
Q 040569          235 FLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ||.+||+.||.+|||+.++++
T Consensus       347 li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          347 LMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCchhCcCHHHHHH
Confidence            999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.6e-47  Score=353.74  Aligned_cols=244  Identities=26%  Similarity=0.424  Sum_probs=198.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-------SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++.+.||+|+||+||+|.+.  ++.+|||.+....       .+.+++|+++++.++||||+++++++.....    +
T Consensus         8 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~   81 (271)
T 3dtc_A            8 ELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN----L   81 (271)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC------C
T ss_pred             heeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc----e
Confidence            6899999999999999999985  8899999886432       3568899999999999999999998765443    6


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCCEEeecCC------CCCeEEeec
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG---IVHCDIKGQNILVSKDN------EQGAKIADF  145 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~g---ivHrDlKp~NILi~~~~------~~~~kL~DF  145 (385)
                      ++||||++|++|.+++.. +.+++..+..++.||+.||.|||++|   |+||||||+|||++.+.      ...+||+||
T Consensus        82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            699999999999999874 46999999999999999999999999   89999999999997531      234899999


Q ss_pred             CceeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCC
Q 040569          146 GCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP  225 (385)
Q Consensus       146 G~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  225 (385)
                      |+++......   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+.........+
T Consensus       161 g~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~  236 (271)
T 3dtc_A          161 GLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID-GLAVAYGVAMNKLALPIP  236 (271)
T ss_dssp             CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC-HHHHHHHHHTSCCCCCCC
T ss_pred             Cccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHhhhcCCCCCCCC
Confidence            9998653222   234579999999999999999999999999999999999999998754 333344443444455667


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          226 GYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       226 ~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ..+++.+.+||.+||+.||.+|||+.|++++
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            7899999999999999999999999999975

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.3e-47  Score=374.80  Aligned_cols=251  Identities=25%  Similarity=0.366  Sum_probs=201.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcC-CC-----CeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALA-CP-----QIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~-hp-----nIv~~~~~~~~~~~~~~~   73 (385)
                      +|++.+.||+|+||+||+|+++.+++.||||++....  ...+++|+++++.+. |+     +|+++++++.....    
T Consensus        55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~----  130 (382)
T 2vx3_A           55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH----  130 (382)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE----
T ss_pred             eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc----
Confidence            5899999999999999999999999999999997543  356678999999884 55     48999888766543    


Q ss_pred             EEEEEeecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCCEEeecCCCCCeEEeecCcee
Q 040569           74 YNLFLEYAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLH--SNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR  149 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH--~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~  149 (385)
                      +++||||+.+ +|.+++...  +.+++..++.++.||+.||.|||  +.||+||||||+|||++.+....+||+|||+++
T Consensus       131 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~  209 (382)
T 2vx3_A          131 LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC  209 (382)
T ss_dssp             EEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             eEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence            6799999965 999999853  46999999999999999999999  469999999999999976555559999999998


Q ss_pred             eecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC-CCC-------
Q 040569          150 RARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS-SDT-------  221 (385)
Q Consensus       150 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~-------  221 (385)
                      ....    .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...+..+... ...       
T Consensus       210 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~  284 (382)
T 2vx3_A          210 QLGQ----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE-VDQMNKIVEVLGIPPAHILDQ  284 (382)
T ss_dssp             ETTC----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHHHHTT
T ss_pred             eccc----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHh
Confidence            7632    23456799999999999999999999999999999999999999986533 2222221100 000       


Q ss_pred             -----------C--------------CC--CC---------------------------cCCHHHHHHHHHhhhcCCCCC
Q 040569          222 -----------P--------------EI--PG---------------------------YMSKQAQDFLSKCLIRNPGER  247 (385)
Q Consensus       222 -----------~--------------~~--~~---------------------------~~s~~~~~ll~~cL~~dP~~R  247 (385)
                                 +              ..  +.                           ..++++++||.+||+.||.+|
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  364 (382)
T 2vx3_A          285 APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTR  364 (382)
T ss_dssp             CTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTS
T ss_pred             hHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhC
Confidence                       0              00  00                           001478999999999999999


Q ss_pred             CCHHHHHhCcccccc
Q 040569          248 WSASELLEHGFVKEQ  262 (385)
Q Consensus       248 ps~~elL~hp~~~~~  262 (385)
                      ||+.|+|+||||+..
T Consensus       365 pta~e~L~hp~f~~~  379 (382)
T 2vx3_A          365 IQPYYALQHSFFKKT  379 (382)
T ss_dssp             CCHHHHTTSGGGCC-
T ss_pred             CCHHHHhcCcccccC
Confidence            999999999999753

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.6e-47  Score=358.49  Aligned_cols=246  Identities=23%  Similarity=0.329  Sum_probs=209.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++.+.||+|+||+||+|.++.+++.+|+|.+....  .+.+.+|++++++++||||+++++++.....    +++|||
T Consensus        14 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~~v~e   89 (288)
T 3kfa_A           14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP----FYIITE   89 (288)
T ss_dssp             GEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS----EEEEEE
T ss_pred             ceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC----EEEEEE
Confidence            5889999999999999999999999999999987553  4678899999999999999999998765544    679999


Q ss_pred             ecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           80 YAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        80 y~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |++|++|.+++..  ...+++..+..++.||+.||+|||++||+||||||+||+++.++.  +||+|||++.........
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~  167 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYT  167 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC--EEECCCCGGGTSCSSSSE
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC--EEEccCccceeccCCccc
Confidence            9999999999985  345999999999999999999999999999999999999987765  999999999865433322


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      ......||+.|+|||++.+..++.++|||||||++|+|++ |..||...... .....+ .....+..+..+++.+.+||
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~l~~li  245 (288)
T 3kfa_A          168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELL-EKDYRMERPEGCPEKVYELM  245 (288)
T ss_dssp             EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHH-HTTCCCCCCTTCCHHHHHHH
T ss_pred             cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHH-hccCCCCCCCCCCHHHHHHH
Confidence            3344567889999999999999999999999999999999 99999865332 222222 12334455677899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 040569          237 SKCLIRNPGERWSASELLE  255 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~  255 (385)
                      .+||..||.+|||+.|+++
T Consensus       246 ~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          246 RACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhCCChhhCcCHHHHHH
Confidence            9999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.7e-47  Score=357.14  Aligned_cols=250  Identities=21%  Similarity=0.252  Sum_probs=206.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++++.||+|+||+||+|++..+++.||||.+... ..+.+.+|+.+++++ .|||++++++++.....    +++|||
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~----~~lv~e   86 (298)
T 1csn_A           11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH----NVLVID   86 (298)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE----EEEEEE
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCce----eEEEEE
Confidence            599999999999999999999999999999988643 345678999999999 89999999988755433    669999


Q ss_pred             ecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCC---CCeEEeecCceeeecccC
Q 040569           80 YAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE---QGAKIADFGCARRARVNE  155 (385)
Q Consensus        80 y~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~---~~~kL~DFG~a~~~~~~~  155 (385)
                      |+ |++|.+++.. +..+++..+..++.||+.||+|||++||+||||||+|||++.++.   ..+||+|||+++......
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~  165 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  165 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence            99 9999999985 446999999999999999999999999999999999999976542   238999999998765332


Q ss_pred             CC------CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHh---cCCCCCCCC
Q 040569          156 DD------EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVA--DPISALHRI---GFSSDTPEI  224 (385)
Q Consensus       156 ~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~--~~~~~~~~~---~~~~~~~~~  224 (385)
                      ..      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....  ........+   ......+..
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (298)
T 1csn_A          166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL  245 (298)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred             ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHH
Confidence            21      2345679999999999999999999999999999999999999997643  222222222   111222233


Q ss_pred             CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          225 PGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       225 ~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ...+++++.+||.+||..||.+|||+.++++.
T Consensus       246 ~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          246 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            44689999999999999999999999999863

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-47  Score=365.72  Aligned_cols=249  Identities=23%  Similarity=0.287  Sum_probs=207.1

Q ss_pred             CceeeceeeccCceEEEEEEE-----CCCCcEEEEEeccCC----CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMS-----NRSSEVFAVKSAELS----NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~~AvK~~~~~----~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~   71 (385)
                      +|++++.||+|+||+||+|.+     ..++..||+|.+...    ..+.+.+|+.+|+++ .||||+++++++.....  
T Consensus        46 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~--  123 (344)
T 1rjb_A           46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP--  123 (344)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--
T ss_pred             HceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc--
Confidence            578899999999999999997     346778999998643    235788999999999 99999999998866544  


Q ss_pred             EEEEEEEeecCCCCHHHHHHcCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 040569           72 ILYNLFLEYAPGGTLTDAIRSGT-----------------------CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQ  128 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~~~-----------------------~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~  128 (385)
                        +++||||++||+|.+++....                       .+++..+..++.||+.||.|||++||+||||||+
T Consensus       124 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~  201 (344)
T 1rjb_A          124 --IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  201 (344)
T ss_dssp             --CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             --cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence              669999999999999998532                       3799999999999999999999999999999999


Q ss_pred             CEEeecCCCCCeEEeecCceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCC
Q 040569          129 NILVSKDNEQGAKIADFGCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVA  206 (385)
Q Consensus       129 NILi~~~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~  206 (385)
                      |||++.++.  +||+|||++......... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus       202 NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          202 NVLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GEEEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hEEEcCCCc--EEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            999987765  999999999876433221 1234467889999999999999999999999999999998 999998765


Q ss_pred             ChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCc
Q 040569          207 DPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHG  257 (385)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp  257 (385)
                      ........+ .....+..+..+++++.+||.+||..||.+|||+.++++|.
T Consensus       280 ~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          280 VDANFYKLI-QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             CSHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cHHHHHHHH-hcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            443333222 23334556677899999999999999999999999999864

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.3e-47  Score=352.26  Aligned_cols=246  Identities=22%  Similarity=0.323  Sum_probs=208.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++.+.||+|+||+||+|.+. +++.+|+|.+...  ..+.+.+|++++++++||||+++++++.....    +++|||
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e   83 (267)
T 3t9t_A            9 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP----ICLVTE   83 (267)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS----CEEEEC
T ss_pred             heeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC----eEEEEe
Confidence            5889999999999999999986 6788999998754  45778999999999999999999998766544    668999


Q ss_pred             ecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           80 YAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        80 y~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      |+++++|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+||+++.++.  +||+|||++..........
T Consensus        84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~  161 (267)
T 3t9t_A           84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTS  161 (267)
T ss_dssp             CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC--EEECCTTGGGGBCCHHHHS
T ss_pred             CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC--EEEcccccccccccccccc
Confidence            9999999999985 456899999999999999999999999999999999999987766  9999999998653222222


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      .....|++.|+|||++.+..++.++||||||+++|+|++ |+.||... +.......+.. ...+..+...++.+.+|+.
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~  239 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDIST-GFRLYKPRLASTHVYQIMN  239 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHT-TCCCCCCTTSCHHHHHHHH
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC-CHHHHHHHHhc-CCcCCCCccCcHHHHHHHH
Confidence            334467889999999998889999999999999999999 89999764 33333333322 2334456678999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhC
Q 040569          238 KCLIRNPGERWSASELLEH  256 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~h  256 (385)
                      +||+.||.+|||+.+++++
T Consensus       240 ~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          240 HCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCChhhCcCHHHHHHH
Confidence            9999999999999999874

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.1e-47  Score=366.11  Aligned_cols=248  Identities=20%  Similarity=0.259  Sum_probs=202.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++++.||+|+||+||+|++..+++.||||.+... ..+.+.+|+++++++ .||||+++++++.....    .++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~----~~lv~e   85 (330)
T 2izr_A           10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY----NAMVLE   85 (330)
T ss_dssp             TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTE----EEEEEE
T ss_pred             CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCc----cEEEEE
Confidence            699999999999999999999999999999988643 345688999999999 99999999998766432    679999


Q ss_pred             ecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCC---CeEEeecCceeeecccC
Q 040569           80 YAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQ---GAKIADFGCARRARVNE  155 (385)
Q Consensus        80 y~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~---~~kL~DFG~a~~~~~~~  155 (385)
                      |+ |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++..   .+||+|||+++......
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~  164 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE  164 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence            99 9999999985 5679999999999999999999999999999999999999765432   28999999999764332


Q ss_pred             CC------CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHhc---CCCCCCCC
Q 040569          156 DD------EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVA--DPISALHRIG---FSSDTPEI  224 (385)
Q Consensus       156 ~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~--~~~~~~~~~~---~~~~~~~~  224 (385)
                      ..      .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||....  +.......+.   ........
T Consensus       165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  244 (330)
T 2izr_A          165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVL  244 (330)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred             CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHH
Confidence            21      1245689999999999999999999999999999999999999998643  2222222221   11111111


Q ss_pred             CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          225 PGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       225 ~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ....+ ++.+||.+||..||.+||++.++++
T Consensus       245 ~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          245 CENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            12234 9999999999999999999998876

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=369.47  Aligned_cols=247  Identities=23%  Similarity=0.334  Sum_probs=207.7

Q ss_pred             CceeeceeeccCceEEEEEEECCC-------CcEEEEEeccCCC----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccC
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRS-------SEVFAVKSAELSN----SEFLQREQRILSAL-ACPQIVAYKGCDISEEN   69 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~-------~~~~AvK~~~~~~----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~   69 (385)
                      +|++++.||+|+||+||+|.+..+       +..+|||++....    ...+.+|+++++++ +||||+++++++.....
T Consensus        70 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  149 (382)
T 3tt0_A           70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP  149 (382)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             heEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCc
Confidence            478899999999999999997543       3679999987543    24577999999999 99999999998866544


Q ss_pred             CeEEEEEEEeecCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEee
Q 040569           70 GKILYNLFLEYAPGGTLTDAIRSG----------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVS  133 (385)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~l~~~----------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~  133 (385)
                          +++||||++||+|.+++...                ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus       150 ----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  225 (382)
T 3tt0_A          150 ----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  225 (382)
T ss_dssp             ----CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             ----eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc
Confidence                56999999999999999853                3599999999999999999999999999999999999998


Q ss_pred             cCCCCCeEEeecCceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHH
Q 040569          134 KDNEQGAKIADFGCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISA  211 (385)
Q Consensus       134 ~~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~  211 (385)
                      .++.  +||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||... +....
T Consensus       226 ~~~~--~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~-~~~~~  302 (382)
T 3tt0_A          226 EDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEEL  302 (382)
T ss_dssp             TTCC--EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHH
T ss_pred             CCCc--EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHH
Confidence            7765  99999999986643221 22334467899999999999999999999999999999999 99999864 33333


Q ss_pred             HHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          212 LHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       212 ~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ...+ .....+..+..+++++.+||.+||+.||.+|||+.|++++
T Consensus       303 ~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          303 FKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHH-HcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3333 3344555677899999999999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=370.21  Aligned_cols=253  Identities=21%  Similarity=0.280  Sum_probs=199.3

Q ss_pred             CceeeceeeccCceEEEEEEECC---CCcEEEEEeccCCCH--------------HHHHHHHHHHHhcCCCCeeeeeeee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNR---SSEVFAVKSAELSNS--------------EFLQREQRILSALACPQIVAYKGCD   64 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~---~~~~~AvK~~~~~~~--------------~~~~~E~~il~~l~hpnIv~~~~~~   64 (385)
                      +|++++.||+|+||+||+|+++.   ++..+|+|.......              ..+.+|+.+++.+.||||+++++++
T Consensus        38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~  117 (345)
T 2v62_A           38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG  117 (345)
T ss_dssp             EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred             eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence            58999999999999999999987   889999998865431              2345688889999999999999998


Q ss_pred             eeccCCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEee
Q 040569           65 ISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIAD  144 (385)
Q Consensus        65 ~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~D  144 (385)
                      .....+...+++||||+ |++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++...+||+|
T Consensus       118 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~D  196 (345)
T 2v62_A          118 LTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLAD  196 (345)
T ss_dssp             EEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECC
T ss_pred             ccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEe
Confidence            77544445578999999 99999999876689999999999999999999999999999999999999887644599999


Q ss_pred             cCceeeecccCCCC------CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCC-ChHHHHHH-hc
Q 040569          145 FGCARRARVNEDDE------GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVA-DPISALHR-IG  216 (385)
Q Consensus       145 FG~a~~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~~-~~  216 (385)
                      ||+++.........      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... +....... ..
T Consensus       197 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  276 (345)
T 2v62_A          197 YGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTN  276 (345)
T ss_dssp             CTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHH
T ss_pred             CCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHh
Confidence            99998764332211      134579999999999999999999999999999999999999995422 22211111 11


Q ss_pred             CCCCCCC------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          217 FSSDTPE------IPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       217 ~~~~~~~------~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .....+.      ....+++++++||.+||..||.+|||+.++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          277 LLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             hcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            1111111      01258899999999999999999999999987

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.3e-48  Score=370.30  Aligned_cols=243  Identities=24%  Similarity=0.349  Sum_probs=206.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---------HHHHHHHHHHHHhcC--CCCeeeeeeeeeeccCC
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---------SEFLQREQRILSALA--CPQIVAYKGCDISEENG   70 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---------~~~~~~E~~il~~l~--hpnIv~~~~~~~~~~~~   70 (385)
                      +|++++.||+|+||+||+|+++.+++.||||.+....         .+.+.+|+.+++++.  ||||+++++++..... 
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~-  122 (320)
T 3a99_A           44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS-  122 (320)
T ss_dssp             TEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE-
T ss_pred             ceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc-
Confidence            5999999999999999999999999999999886431         245668999999996  5999999998765443 


Q ss_pred             eEEEEEEEeecCC-CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEee-cCCCCCeEEeecCce
Q 040569           71 KILYNLFLEYAPG-GTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVS-KDNEQGAKIADFGCA  148 (385)
Q Consensus        71 ~~~~~lv~Ey~~g-gsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~-~~~~~~~kL~DFG~a  148 (385)
                         +++||||+.+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.  +||+|||++
T Consensus       123 ---~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~--~kL~Dfg~~  197 (320)
T 3a99_A          123 ---FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSG  197 (320)
T ss_dssp             ---EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTE--EEECCCTTC
T ss_pred             ---EEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCC--EEEeeCccc
Confidence               6689999976 89999999777899999999999999999999999999999999999998 4444  999999999


Q ss_pred             eeecccCCCCCCccccCCcccChhhhcCCCC-CCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCc
Q 040569          149 RRARVNEDDEGKPICGTPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY  227 (385)
Q Consensus       149 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (385)
                      +.....   ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...   .... .     ....++..
T Consensus       198 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~---~~~~-~-----~~~~~~~~  265 (320)
T 3a99_A          198 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---EEII-R-----GQVFFRQR  265 (320)
T ss_dssp             EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HHHH-H-----CCCCCSSC
T ss_pred             cccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh---hhhh-c-----cccccccc
Confidence            876422   2234579999999999987665 67899999999999999999999642   1111 1     12234556


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          228 MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       228 ~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus       266 ~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  300 (320)
T 3a99_A          266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  300 (320)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence            89999999999999999999999999999999865

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.9e-47  Score=355.92  Aligned_cols=246  Identities=22%  Similarity=0.261  Sum_probs=200.7

Q ss_pred             CceeeceeeccCceEEEEEEECC---CCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNR---SSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~---~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++.+.||+|+||+||+|++..   ++..+|+|.+....    .+.+.+|+.++++++||||+++++++... .    .
T Consensus        13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~----~   87 (281)
T 3cc6_A           13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-P----T   87 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-S----C
T ss_pred             ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-C----C
Confidence            58999999999999999998653   34569999987542    45678999999999999999999986432 2    3


Q ss_pred             EEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      ++||||+++++|.+++.. +..+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.....
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSRYIED  165 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE--EEECCCCGGGCC--
T ss_pred             EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc--EEeCccCCCccccc
Confidence            589999999999999974 556999999999999999999999999999999999999987765  99999999987643


Q ss_pred             cCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHH
Q 040569          154 NEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA  232 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  232 (385)
                      ..........||+.|+|||++.+..++.++|||||||++|+|++ |+.||....... ....+.. ...+..+..+++.+
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~l  243 (281)
T 3cc6_A          166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-VIGVLEK-GDRLPKPDLCPPVL  243 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-HHHHHHH-TCCCCCCTTCCHHH
T ss_pred             ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-HHHHHhc-CCCCCCCCCCCHHH
Confidence            33333344567889999999998899999999999999999998 999997643322 2222211 22334566689999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          233 QDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      .+||.+||..||.+|||+.|++++
T Consensus       244 ~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          244 YTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCCchhCcCHHHHHHH
Confidence            999999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4e-47  Score=355.94  Aligned_cols=247  Identities=24%  Similarity=0.325  Sum_probs=208.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcCCCCeeeeeeeeeecc------------C
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEE------------N   69 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~------------~   69 (385)
                      +|++.+.||+|+||+||+|+++.+++.||+|.+.... +.+.+|++++++++||||+++++++....            .
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~   90 (284)
T 2a19_B           12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS   90 (284)
T ss_dssp             HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred             ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence            5899999999999999999999999999999987653 46778999999999999999999875421            1


Q ss_pred             CeEEEEEEEeecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCc
Q 040569           70 GKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGC  147 (385)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~  147 (385)
                      ....+++||||+++|+|.+++..  +..+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~  168 (284)
T 2a19_B           91 KTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIGDFGL  168 (284)
T ss_dssp             EEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTT
T ss_pred             CcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC--EEECcchh
Confidence            23346799999999999999973  457999999999999999999999999999999999999997766  99999999


Q ss_pred             eeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCc
Q 040569          148 ARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY  227 (385)
Q Consensus       148 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (385)
                      +.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..|+...   ......+..    ..++..
T Consensus       169 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~~~----~~~~~~  239 (284)
T 2a19_B          169 VTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---SKFFTDLRD----GIISDI  239 (284)
T ss_dssp             CEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---HHHHHHHHT----TCCCTT
T ss_pred             heeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---HHHHHHhhc----cccccc
Confidence            98764322  233457999999999999999999999999999999999999988432   112222211    223456


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 040569          228 MSKQAQDFLSKCLIRNPGERWSASELLEHGFVK  260 (385)
Q Consensus       228 ~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~  260 (385)
                      +++.+++||.+||..||.+|||+.|+++|++..
T Consensus       240 ~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          240 FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            889999999999999999999999999998754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1e-46  Score=350.37  Aligned_cols=241  Identities=17%  Similarity=0.294  Sum_probs=204.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++.+.||+|+||+||+|+++  ++.+|||.+....     .+.+.+|+.++++++||||+++++++.......  +++
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~--~~l   86 (271)
T 3kmu_A           11 QLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH--PTL   86 (271)
T ss_dssp             GCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS--CEE
T ss_pred             HhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC--eEe
Confidence            5899999999999999999986  8899999987543     346789999999999999999999876653332  568


Q ss_pred             EEeecCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           77 FLEYAPGGTLTDAIRSGT--CLEEGRIRSHTRAVLLGLQYLHSNG--IVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~--~l~e~~~~~i~~qil~gL~yLH~~g--ivHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      ||||++||+|.+++....  .+++..+..++.||+.||+|||++|  ++||||||+|||++.++.  ++|+|||++... 
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~l~~~~~~~~~-  163 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADVKFSF-  163 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC--EEEEGGGSCCTT-
T ss_pred             eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc--eeEEeccceeee-
Confidence            999999999999998654  4899999999999999999999999  999999999999987765  899988886543 


Q ss_pred             ccCCCCCCccccCCcccChhhhcCCCCCC---CCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCC
Q 040569          153 VNEDDEGKPICGTPICMAPEVARGEEQGF---PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS  229 (385)
Q Consensus       153 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~---~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s  229 (385)
                           ......||+.|+|||++.+..++.   ++|||||||++|+|++|+.||.... .......+......+.++..++
T Consensus       164 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~  237 (271)
T 3kmu_A          164 -----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-NMEIGMKVALEGLRPTIPPGIS  237 (271)
T ss_dssp             -----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC-HHHHHHHHHHSCCCCCCCTTCC
T ss_pred             -----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC-hHHHHHHHHhcCCCCCCCCCCC
Confidence                 123347899999999998876655   7999999999999999999998754 3333334434455667788899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          230 KQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       230 ~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      +++.+||.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          238 PHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999986

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.8e-47  Score=363.21  Aligned_cols=246  Identities=21%  Similarity=0.318  Sum_probs=199.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEE----EEEeccC----CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVF----AVKSAEL----SNSEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~----AvK~~~~----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|++.+.||+|+||+||+|++..+++.+    |+|.+..    ...+.+.+|+.++++++||||+++++++....     
T Consensus        16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----   90 (327)
T 3poz_A           16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-----   90 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-----
T ss_pred             HcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-----
Confidence            5899999999999999999998887765    7777643    23467889999999999999999999876532     


Q ss_pred             EEEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           74 YNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      .++++||+.+|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~  168 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLG  168 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTHHHHHT
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC--EEEccCcceeEcc
Confidence            4589999999999999984 567999999999999999999999999999999999999988766  9999999998764


Q ss_pred             ccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          153 VNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       153 ~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      ..... ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||...... .....+. .......+..++.
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~-~~~~~~~~~~~~~  246 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILE-KGERLPQPPICTI  246 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHH-TTCCCCCCTTBCH
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-HHHHHHH-cCCCCCCCccCCH
Confidence            32221 2233457889999999999999999999999999999999 99999865332 2222222 2333445666899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ++.+|+.+||+.||.+|||+.|++++
T Consensus       247 ~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          247 DVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999999999976

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.2e-46  Score=356.41  Aligned_cols=250  Identities=23%  Similarity=0.325  Sum_probs=205.1

Q ss_pred             CceeeceeeccCceEEEEEE----ECCCCcEEEEEeccCC----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGM----SNRSSEVFAVKSAELS----NSEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~----~~~~~~~~AvK~~~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      .|++++.||+|+||+||+|+    +..+++.||+|.+...    ..+.+.+|+++|++++||||+++++++.......  
T Consensus        22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~--   99 (302)
T 4e5w_A           22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG--   99 (302)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC--
T ss_pred             hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce--
Confidence            48899999999999999999    6778999999998643    3467889999999999999999999887653322  


Q ss_pred             EEEEEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           74 YNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      +++||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||++....
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECC
T ss_pred             EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC--EEECccccccccc
Confidence            568999999999999995 5567999999999999999999999999999999999999988766  9999999998764


Q ss_pred             ccCC--CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCC-------------ChHHHHHHhcC
Q 040569          153 VNED--DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVA-------------DPISALHRIGF  217 (385)
Q Consensus       153 ~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-------------~~~~~~~~~~~  217 (385)
                      ....  .......||+.|+|||++.+..++.++|||||||++|+|++|..|+....             .....+.....
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK  257 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence            3322  12334568889999999999999999999999999999999999864210             11111112122


Q ss_pred             CCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          218 SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       218 ~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .......+..+++++.+||.+||+.||.+|||+.++++
T Consensus       258 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          258 EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            33344566779999999999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-47  Score=363.30  Aligned_cols=244  Identities=27%  Similarity=0.380  Sum_probs=202.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---------HHHHHHHHHHHHhc----CCCCeeeeeeeeeecc
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---------SEFLQREQRILSAL----ACPQIVAYKGCDISEE   68 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---------~~~~~~E~~il~~l----~hpnIv~~~~~~~~~~   68 (385)
                      +|++++.||+|+||+||+|+++.+++.||||.+....         ...+.+|+.+++++    .||||+++++++....
T Consensus        32 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~  111 (312)
T 2iwi_A           32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQE  111 (312)
T ss_dssp             -CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC----
T ss_pred             ceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCC
Confidence            5999999999999999999999999999999986542         12345799999999    8999999999876554


Q ss_pred             CCeEEEEEEEee-cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEee-cCCCCCeEEeecC
Q 040569           69 NGKILYNLFLEY-APGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVS-KDNEQGAKIADFG  146 (385)
Q Consensus        69 ~~~~~~~lv~Ey-~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~-~~~~~~~kL~DFG  146 (385)
                      .    +++|+|| +.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.  +||+|||
T Consensus       112 ~----~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~--~kl~dfg  185 (312)
T 2iwi_A          112 G----FMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC--AKLIDFG  185 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTE--EEECCCS
T ss_pred             e----EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCe--EEEEEcc
Confidence            3    5689999 78999999999777899999999999999999999999999999999999998 4544  9999999


Q ss_pred             ceeeecccCCCCCCccccCCcccChhhhcCCCC-CCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCC
Q 040569          147 CARRARVNEDDEGKPICGTPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP  225 (385)
Q Consensus       147 ~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  225 (385)
                      ++......   ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...   .... .     ....++
T Consensus       186 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~~-~-----~~~~~~  253 (312)
T 2iwi_A          186 SGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD---QEIL-E-----AELHFP  253 (312)
T ss_dssp             SCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HHHH-H-----TCCCCC
T ss_pred             hhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh---HHHh-h-----hccCCc
Confidence            99876432   2334569999999999987666 45899999999999999999999642   1111 1     123355


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          226 GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       226 ~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      ..+++++++||.+||+.||.+|||+.|+++||||+...
T Consensus       254 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence            67899999999999999999999999999999998653

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-47  Score=380.61  Aligned_cols=256  Identities=22%  Similarity=0.294  Sum_probs=197.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +|...+.||+|+||+|+. ....+++.||||++.......+.+|+++|+++ +||||+++++++.....    +++||||
T Consensus        25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~----~~lv~E~   99 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQF----QYIAIEL   99 (432)
T ss_dssp             EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTE----EEEEEEC
T ss_pred             EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCE----EEEEEEC
Confidence            488899999999998763 34467999999999766656677999999999 89999999988765432    6799999


Q ss_pred             cCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeec---CCCCCeEEeecCceeeecccCC
Q 040569           81 APGGTLTDAIRSG-TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSK---DNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        81 ~~ggsL~~~l~~~-~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~---~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |. |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.   ++...+||+|||+++.......
T Consensus       100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~  178 (432)
T 3p23_A          100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH  178 (432)
T ss_dssp             CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred             CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence            96 5999999844 35667778899999999999999999999999999999954   3333478999999987643321


Q ss_pred             --CCCCccccCCcccChhhhc---CCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          157 --DEGKPICGTPICMAPEVAR---GEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       157 --~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                        ......+||+.|+|||++.   +..++.++|||||||++|+|++ |..||......................+...+.
T Consensus       179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (432)
T 3p23_A          179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDV  258 (432)
T ss_dssp             -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHH
T ss_pred             ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccH
Confidence              2234567999999999997   4567789999999999999999 999997643333322221111222222334566


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      .+++||.+||+.||.+|||+.|+|+||||....
T Consensus       259 ~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          259 IARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             HHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence            789999999999999999999999999997643

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5e-47  Score=360.45  Aligned_cols=248  Identities=24%  Similarity=0.304  Sum_probs=207.1

Q ss_pred             CceeeceeeccCceEEEEEEE-----CCCCcEEEEEeccCCC----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMS-----NRSSEVFAVKSAELSN----SEFLQREQRILSAL-ACPQIVAYKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~   71 (385)
                      +|++++.||+|+||+||+|.+     ..+++.+|+|.+....    .+.+.+|+.+|+++ +||||+++++++.....  
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~--  101 (313)
T 1t46_A           24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP--  101 (313)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--
T ss_pred             hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC--
Confidence            588999999999999999985     4578899999987543    35678999999999 99999999998866544  


Q ss_pred             EEEEEEEeecCCCCHHHHHHcCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEee
Q 040569           72 ILYNLFLEYAPGGTLTDAIRSGT------------------CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVS  133 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~~~------------------~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~  133 (385)
                        +++||||+++|+|.+++....                  .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus       102 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~  179 (313)
T 1t46_A          102 --TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT  179 (313)
T ss_dssp             --CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             --cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence              568999999999999998543                  489999999999999999999999999999999999998


Q ss_pred             cCCCCCeEEeecCceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHH
Q 040569          134 KDNEQGAKIADFGCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISA  211 (385)
Q Consensus       134 ~~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~  211 (385)
                      .++.  +||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||.........
T Consensus       180 ~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  257 (313)
T 1t46_A          180 HGRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (313)
T ss_dssp             TTTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             CCCC--EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence            7765  999999999876433221 1234467889999999999999999999999999999999 99999875443333


Q ss_pred             HHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          212 LHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       212 ~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ...+ .....+..+..+++++.+||.+||+.||.+|||+.|++++
T Consensus       258 ~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          258 YKMI-KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHH-HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHh-ccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            2222 1222344456789999999999999999999999999975

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.5e-47  Score=362.92  Aligned_cols=251  Identities=27%  Similarity=0.410  Sum_probs=184.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHH-HHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQR-ILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~-il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++++.||+|+||+||+|.++.+++.||||.+....    ...+.+|.. +++.+.||||+++++++.....    +++
T Consensus        23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~----~~l   98 (327)
T 3aln_A           23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD----CWI   98 (327)
T ss_dssp             SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE----EEE
T ss_pred             HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc----eEE
Confidence            5889999999999999999999999999999986542    123445555 6777899999999998876442    669


Q ss_pred             EEeecCCCCHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569           77 FLEYAPGGTLTDAIRS-----GTCLEEGRIRSHTRAVLLGLQYLHSN-GIVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~-----~~~l~e~~~~~i~~qil~gL~yLH~~-givHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                      ||||+++ +|.+++..     ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.  +||+|||+++.
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~  175 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN--IKLCDFGISGQ  175 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE--EEECCCSSSCC
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC--EEEccCCCcee
Confidence            9999986 88888762     56799999999999999999999999 9999999999999987766  99999999987


Q ss_pred             ecccCCCCCCccccCCcccChhhh----cCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCC--
Q 040569          151 ARVNEDDEGKPICGTPICMAPEVA----RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEI--  224 (385)
Q Consensus       151 ~~~~~~~~~~~~~Gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--  224 (385)
                      .....  ......||+.|+|||++    .+..++.++|||||||++|+|++|+.||.........+..+ .....+.+  
T Consensus       176 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~  252 (327)
T 3aln_A          176 LVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDPPQLSN  252 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC-CCSCCCCCCC
T ss_pred             ccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH-hcCCCCCCCC
Confidence            63221  22334799999999999    45678999999999999999999999998654333333222 12222222  


Q ss_pred             --CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          225 --PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       225 --~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                        ...+++++.+||.+||..||.+|||+.|+++||||...
T Consensus       253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence              23589999999999999999999999999999999754

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=7.2e-47  Score=368.74  Aligned_cols=253  Identities=19%  Similarity=0.258  Sum_probs=200.7

Q ss_pred             CceeeceeeccCceEEEEEEECCC-----CcEEEEEeccCCCHH--------------HHHHHHHHHHhcCCCCeeeeee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRS-----SEVFAVKSAELSNSE--------------FLQREQRILSALACPQIVAYKG   62 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~~AvK~~~~~~~~--------------~~~~E~~il~~l~hpnIv~~~~   62 (385)
                      +|++++.||+|+||+||+|.++.+     ++.||||.+......              ...+|+..++.+.||||+++++
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~  115 (364)
T 3op5_A           36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG  115 (364)
T ss_dssp             EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred             eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence            589999999999999999999765     588999998765421              1223455566778999999999


Q ss_pred             eeeeccCCeEEEEEEEeecCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeE
Q 040569           63 CDISEENGKILYNLFLEYAPGGTLTDAIRSG-TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAK  141 (385)
Q Consensus        63 ~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~-~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~k  141 (385)
                      ++.....+..+.++||||+ |++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.+....+|
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~k  194 (364)
T 3op5_A          116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVY  194 (364)
T ss_dssp             EEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEE
T ss_pred             eeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEE
Confidence            9888766666788999999 99999999854 679999999999999999999999999999999999999843344599


Q ss_pred             EeecCceeeecccCCC------CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHH--
Q 040569          142 IADFGCARRARVNEDD------EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALH--  213 (385)
Q Consensus       142 L~DFG~a~~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~--  213 (385)
                      |+|||+++........      .....+||+.|||||++.+..++.++|||||||++|+|++|+.||...........  
T Consensus       195 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~  274 (364)
T 3op5_A          195 LVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDS  274 (364)
T ss_dssp             ECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHH
T ss_pred             EEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHH
Confidence            9999999876433221      12345699999999999999999999999999999999999999985322222111  


Q ss_pred             HhcCCCCCCC------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          214 RIGFSSDTPE------IPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       214 ~~~~~~~~~~------~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ........+.      .+..+++++.+|+.+||..||.+||++.++++
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          275 KIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            1111011000      12457899999999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=9.7e-47  Score=383.03  Aligned_cols=246  Identities=22%  Similarity=0.331  Sum_probs=209.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++.+.||+|+||+||+|+++.++..||||.+...  ..+.+.+|+.+|++++||||+++++++.....    +++|||
T Consensus       221 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~~lv~E  296 (495)
T 1opk_A          221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP----FYIITE  296 (495)
T ss_dssp             GEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS----CEEEEE
T ss_pred             HceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc----EEEEEE
Confidence            478899999999999999999999999999998754  46788899999999999999999999866544    669999


Q ss_pred             ecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           80 YAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        80 y~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |+++|+|.++++.  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++........
T Consensus       297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~  374 (495)
T 1opk_A          297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYT  374 (495)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEECCTTCCEE
T ss_pred             ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc--EEEeecccceeccCCcee
Confidence            9999999999984  345899999999999999999999999999999999999987765  999999999876433222


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      ......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+. .......+..+++++.+||
T Consensus       375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~l~~li  452 (495)
T 1opk_A          375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLE-KDYRMERPEGCPEKVYELM  452 (495)
T ss_dssp             CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHHH-TTCCCCCCTTCCHHHHHHH
T ss_pred             ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH-cCCCCCCCCCCCHHHHHHH
Confidence            2334456789999999999999999999999999999999 99999875432 2222222 2334455677899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 040569          237 SKCLIRNPGERWSASELLE  255 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~  255 (385)
                      .+||+.||.+|||+.++++
T Consensus       453 ~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          453 RACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCcChhHCcCHHHHHH
Confidence            9999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.2e-47  Score=363.01  Aligned_cols=250  Identities=23%  Similarity=0.302  Sum_probs=202.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|++.+.||+|+||+||+|.++.+++.||||.+....   .+.+.+|+.++++++||||+++++++.........+++||
T Consensus        30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~  109 (317)
T 2buj_A           30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL  109 (317)
T ss_dssp             EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred             EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence            4899999999999999999999999999999886543   3567899999999999999999999876554455577999


Q ss_pred             eecCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           79 EYAPGGTLTDAIRS----GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        79 Ey~~ggsL~~~l~~----~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ||+++|+|.+++..    +..+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||++......
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~dfg~~~~~~~~  187 (317)
T 2buj_A          110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ--PVLMDLGSMNQACIH  187 (317)
T ss_dssp             ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCSSCEESCEE
T ss_pred             EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC--EEEEecCcchhcccc
Confidence            99999999999974    567999999999999999999999999999999999999987766  999999998765321


Q ss_pred             CCC--------CCCccccCCcccChhhhcCCC---CCCCCChHHHHHHHHHHHhCCCCCCCC---CChHHHHHHhcCCCC
Q 040569          155 EDD--------EGKPICGTPICMAPEVARGEE---QGFPADVWALGCTVLEMATGRPPWPDV---ADPISALHRIGFSSD  220 (385)
Q Consensus       155 ~~~--------~~~~~~Gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltG~~Pf~~~---~~~~~~~~~~~~~~~  220 (385)
                      ...        ......||+.|+|||++.+..   ++.++|||||||++|+|++|+.||...   .........  . ..
T Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~-~~  264 (317)
T 2buj_A          188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ--N-QL  264 (317)
T ss_dssp             EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH--C-C-
T ss_pred             cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh--c-cC
Confidence            111        012335799999999997654   688999999999999999999999531   111111111  1 11


Q ss_pred             CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          221 TPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       221 ~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ....+..+++++.+||.+||+.||.+|||+.+++++
T Consensus       265 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            122234579999999999999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-46  Score=356.43  Aligned_cols=242  Identities=25%  Similarity=0.398  Sum_probs=198.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +|++.+.||+|+||+||+|.++  ++.+|+|.+.... .+.+.+|+++|++++||||+++++++..  .    .++||||
T Consensus         9 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~----~~lv~e~   80 (307)
T 2eva_A            9 EIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--P----VCLVMEY   80 (307)
T ss_dssp             GEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--T----TEEEEEC
T ss_pred             HeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--C----cEEEEEc
Confidence            5889999999999999999985  7899999987544 4678899999999999999999997652  2    4589999


Q ss_pred             cCCCCHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           81 APGGTLTDAIRSGT---CLEEGRIRSHTRAVLLGLQYLHS---NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        81 ~~ggsL~~~l~~~~---~l~e~~~~~i~~qil~gL~yLH~---~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||+|.+++....   .+++..+..++.||++||+|||+   +||+||||||+|||++.++. .+||+|||++......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~~~  159 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQTH  159 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC-------
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEcccccccccccc
Confidence            99999999998654   37899999999999999999999   89999999999999986543 2699999999765322


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                          .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...................+..+..+++.+.+
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (307)
T 2eva_A          160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES  235 (307)
T ss_dssp             ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHH
T ss_pred             ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHH
Confidence                2334699999999999999999999999999999999999999986544333222222234455566778999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhC
Q 040569          235 FLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ||.+||+.||.+|||+.+++++
T Consensus       236 li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          236 LMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCChhhCcCHHHHHHH
Confidence            9999999999999999999874

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.2e-46  Score=352.90  Aligned_cols=248  Identities=21%  Similarity=0.273  Sum_probs=200.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +|++++.||+|+||+||+|++..+++.||||.+... ..+.+.+|+.+++.+.|++++..+..+.....   ..++||||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~---~~~lv~e~   86 (296)
T 4hgt_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGD---YNVMVMEL   86 (296)
T ss_dssp             -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETT---EEEEEEEC
T ss_pred             ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCC---ceEEEEEc
Confidence            599999999999999999999999999999986543 23467889999999999888877766544333   25699999


Q ss_pred             cCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEe---ecCCCCCeEEeecCceeeecccCC
Q 040569           81 APGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILV---SKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        81 ~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi---~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      + +++|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.  +||+|||+++.......
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~--~kL~Dfg~a~~~~~~~~  163 (296)
T 4hgt_A           87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDART  163 (296)
T ss_dssp             C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTC--EEECCCTTCEECBCTTT
T ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCe--EEEecCccceeccCccc
Confidence            9 899999998 45679999999999999999999999999999999999999   45444  99999999987654322


Q ss_pred             ------CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCC-----hHHHHHHhcCCCCCCCCC
Q 040569          157 ------DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-----PISALHRIGFSSDTPEIP  225 (385)
Q Consensus       157 ------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-----~~~~~~~~~~~~~~~~~~  225 (385)
                            .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....     ..............+...
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (296)
T 4hgt_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC  243 (296)
T ss_dssp             CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred             CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhh
Confidence                  122356799999999999999999999999999999999999999975422     111111111112222233


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          226 GYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       226 ~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ..+|+++.+||.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             TTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            457899999999999999999999999987

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2e-47  Score=366.15  Aligned_cols=250  Identities=22%  Similarity=0.290  Sum_probs=201.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH----HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~----~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++.+.||+|+||+||+|+++ +++.||||.+.....    ..+.+|++++++++||||+++++++.....    .++|
T Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~lv  105 (326)
T 3uim_A           31 NFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE----RLLV  105 (326)
T ss_dssp             SSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC----CEEE
T ss_pred             ccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCc----eEEE
Confidence            5899999999999999999854 689999999875432    267899999999999999999998876544    5689


Q ss_pred             EeecCCCCHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569           78 LEYAPGGTLTDAIRSG----TCLEEGRIRSHTRAVLLGLQYLHSN---GIVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~----~~l~e~~~~~i~~qil~gL~yLH~~---givHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                      |||+++|+|.+++...    ..+++..+..++.||+.||+|||++   ||+||||||+|||++.++.  +||+|||+++.
T Consensus       106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~~  183 (326)
T 3uim_A          106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAKL  183 (326)
T ss_dssp             EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC--EEECCCSSCEE
T ss_pred             EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC--EEeccCccccc
Confidence            9999999999999843    2489999999999999999999999   9999999999999987765  99999999987


Q ss_pred             ecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCC-----CC--hHHHHHHhcCCC----
Q 040569          151 ARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDV-----AD--PISALHRIGFSS----  219 (385)
Q Consensus       151 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~-----~~--~~~~~~~~~~~~----  219 (385)
                      .............||+.|+|||++.+..++.++|||||||++|+|++|+.||...     .+  ............    
T Consensus       184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (326)
T 3uim_A          184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA  263 (326)
T ss_dssp             CCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTT
T ss_pred             cCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhh
Confidence            6544433344556999999999999889999999999999999999999999511     11  111111110000    


Q ss_pred             -----CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 040569          220 -----DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGF  258 (385)
Q Consensus       220 -----~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~  258 (385)
                           ..+..+...++.+.+|+.+||+.||.+|||+.|+++|..
T Consensus       264 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence                 011122233578999999999999999999999999754

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.1e-46  Score=352.25  Aligned_cols=248  Identities=21%  Similarity=0.274  Sum_probs=202.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +|++++.||+|+||+||+|++..+++.||||.+... ..+.+.+|+.+++.+.|++++..+..+.....   ..++||||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~---~~~lv~e~   86 (296)
T 3uzp_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGD---YNVMVMEL   86 (296)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETT---EEEEEEEC
T ss_pred             EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCC---ceEEEEEe
Confidence            699999999999999999999999999999987643 34568899999999999887777665544332   25699999


Q ss_pred             cCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEee---cCCCCCeEEeecCceeeecccCC
Q 040569           81 APGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVS---KDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        81 ~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~---~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      + +++|.+++. ....+++..+..++.||+.||+|||++||+||||||+|||++   .++.  +||+|||+++.......
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~--~kl~Dfg~~~~~~~~~~  163 (296)
T 3uzp_A           87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDART  163 (296)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTTT
T ss_pred             c-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCe--EEEeeCCCccccccccc
Confidence            9 899999998 456799999999999999999999999999999999999994   4443  99999999987654322


Q ss_pred             C------CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCC-----hHHHHHHhcCCCCCCCCC
Q 040569          157 D------EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-----PISALHRIGFSSDTPEIP  225 (385)
Q Consensus       157 ~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-----~~~~~~~~~~~~~~~~~~  225 (385)
                      .      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....     ....+.........+..+
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (296)
T 3uzp_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC  243 (296)
T ss_dssp             CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred             ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHH
Confidence            1      12456799999999999999999999999999999999999999975422     122221111112222233


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          226 GYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       226 ~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ..+|+++.+||.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             TTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            558899999999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.4e-46  Score=353.24  Aligned_cols=245  Identities=22%  Similarity=0.307  Sum_probs=203.5

Q ss_pred             Cceeec-eeeccCceEEEEEE--ECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQ-TIGRGSTATVSIGM--SNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~-~LG~G~~g~Vy~a~--~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|++.+ .||+|+||+||+|.  .+.+++.+|||.+....     .+.+.+|++++++++||||+++++++. ...    
T Consensus        17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~----   91 (291)
T 1xbb_A           17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AES----   91 (291)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSS----
T ss_pred             hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-CCC----
Confidence            477777 99999999999994  46678999999986532     356889999999999999999999872 222    


Q ss_pred             EEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           74 YNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      +++||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.....
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRA  169 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCT
T ss_pred             cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc--EEEccCCcceeecc
Confidence            5699999999999999998888999999999999999999999999999999999999997765  99999999987643


Q ss_pred             cCCC--CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          154 NEDD--EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       154 ~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      ....  ......|++.|+|||++.+..++.++|||||||++|+|++ |+.||.... .......+ .....+..+..+++
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~~-~~~~~~~~~~~~~~  247 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-GSEVTAML-EKGERMGCPAGCPR  247 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHH-HTTCCCCCCTTCCH
T ss_pred             CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHH-HcCCCCCCCCCCCH
Confidence            2221  1222346789999999998889999999999999999999 999998753 33333333 23344566778999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ++.+||.+||+.||.+|||+.++++
T Consensus       248 ~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          248 EMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5.9e-47  Score=360.44  Aligned_cols=249  Identities=25%  Similarity=0.348  Sum_probs=207.2

Q ss_pred             CceeeceeeccCceEEEEEEE-----CCCCcEEEEEeccCCC----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMS-----NRSSEVFAVKSAELSN----SEFLQREQRILSAL-ACPQIVAYKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~   71 (385)
                      +|++++.||+|+||+||+|.+     ..+++.||||.+....    ...+.+|+.+++++ +||||+++++++.....  
T Consensus        28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~--  105 (316)
T 2xir_A           28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG--  105 (316)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS--
T ss_pred             heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC--
Confidence            588999999999999999985     4577999999987543    24577999999999 79999999998765432  


Q ss_pred             EEEEEEEeecCCCCHHHHHHcCCC----------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecC
Q 040569           72 ILYNLFLEYAPGGTLTDAIRSGTC----------------LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKD  135 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~~~~----------------l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~  135 (385)
                       .+++||||++||+|.+++.....                +++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus       106 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~  184 (316)
T 2xir_A          106 -PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  184 (316)
T ss_dssp             -CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             -ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC
Confidence             15689999999999999985443                8999999999999999999999999999999999999877


Q ss_pred             CCCCeEEeecCceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 040569          136 NEQGAKIADFGCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALH  213 (385)
Q Consensus       136 ~~~~~kL~DFG~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~  213 (385)
                      +.  +||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||...........
T Consensus       185 ~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~  262 (316)
T 2xir_A          185 NV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  262 (316)
T ss_dssp             GC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred             CC--EEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence            66  999999999865322211 1234568899999999999999999999999999999998 9999987654443333


Q ss_pred             HhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          214 RIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       214 ~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      .+. .......+..+++++.++|.+||+.||.+|||+.|+++|
T Consensus       263 ~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          263 RLK-EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             Hhc-cCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            332 223345566789999999999999999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.5e-47  Score=357.85  Aligned_cols=243  Identities=17%  Similarity=0.302  Sum_probs=200.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCC-------cEEEEEeccCC---CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSS-------EVFAVKSAELS---NSEFLQREQRILSALACPQIVAYKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~-------~~~AvK~~~~~---~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   71 (385)
                      +|++.+.||+|+||+||+|+++.++       ..+|+|.+...   ..+.+.+|+.++++++||||+++++++.....  
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--   86 (289)
T 4fvq_A            9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE--   86 (289)
T ss_dssp             GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC--
T ss_pred             HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC--
Confidence            5899999999999999999998877       46999988643   34678899999999999999999999876544  


Q ss_pred             EEEEEEEeecCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCC------CeEEee
Q 040569           72 ILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQ------GAKIAD  144 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~~~-~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~------~~kL~D  144 (385)
                        .++||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++..      .+||+|
T Consensus        87 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D  164 (289)
T 4fvq_A           87 --NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD  164 (289)
T ss_dssp             --CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred             --CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence              568999999999999998554 49999999999999999999999999999999999999876532      189999


Q ss_pred             cCceeeecccCCCCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCC
Q 040569          145 FGCARRARVNEDDEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE  223 (385)
Q Consensus       145 FG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  223 (385)
                      ||++....     ......||+.|+|||++.+ ..++.++|||||||++|+|++|..|+....+.........   ..+.
T Consensus       165 fg~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~---~~~~  236 (289)
T 4fvq_A          165 PGISITVL-----PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE---DRHQ  236 (289)
T ss_dssp             CCSCTTTS-----CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH---TTCC
T ss_pred             Cccccccc-----CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh---ccCC
Confidence            99986542     1223468999999999988 6789999999999999999995544433334433333322   2334


Q ss_pred             CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          224 IPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       224 ~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ++...++++.+||.+||++||.+|||+.|+++|
T Consensus       237 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          237 LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            455578899999999999999999999999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=356.95  Aligned_cols=251  Identities=27%  Similarity=0.422  Sum_probs=190.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH-----HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----EFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~-----~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++++.||+|+||+||+|+++.+++.||||.+.....     +.+.++..+++.+.||||+++++++.....    +++
T Consensus        26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~----~~l  101 (318)
T 2dyl_A           26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD----VFI  101 (318)
T ss_dssp             GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE----EEE
T ss_pred             cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc----EEE
Confidence            58889999999999999999999999999999865432     234455567888899999999998866442    679


Q ss_pred             EEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           77 FLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSN-GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~-givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ||||+ ++.+..+.. ..+.+++..+..++.||+.||.|||++ ||+||||||+|||++.++.  +||+|||++......
T Consensus       102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDFGISGRLVDD  178 (318)
T ss_dssp             EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC--EEECCCTTC------
T ss_pred             EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC--EEEEECCCchhccCC
Confidence            99999 556666665 366799999999999999999999995 9999999999999987766  999999999765332


Q ss_pred             CCCCCCccccCCcccChhhhc-----CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCC--Cc
Q 040569          155 EDDEGKPICGTPICMAPEVAR-----GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIP--GY  227 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~  227 (385)
                      .  ......||+.|+|||++.     +..++.++|||||||++|+|++|+.||.........+..+.. ...+.++  ..
T Consensus       179 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~  255 (318)
T 2dyl_A          179 K--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ-EEPPLLPGHMG  255 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH-SCCCCCCSSSC
T ss_pred             c--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc-cCCCCCCccCC
Confidence            2  233457999999999994     456788999999999999999999999875555554444322 2222222  35


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          228 MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       228 ~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      +++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus       256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            79999999999999999999999999999999754

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.5e-46  Score=350.47  Aligned_cols=244  Identities=23%  Similarity=0.329  Sum_probs=205.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++++.||+|+||+||+|.++ ++..+|+|.+...  ..+.+.+|+++|++++||||+++++++... .    .++|||
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~----~~~v~e   87 (279)
T 1qpc_A           14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-P----IYIITE   87 (279)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S----CEEEEE
T ss_pred             hhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCC-C----cEEEEe
Confidence            4888999999999999999976 5678999988654  467888999999999999999999986432 2    558999


Q ss_pred             ecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           80 YAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        80 y~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |++|++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||++.........
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~  165 (279)
T 1qpc_A           88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYT  165 (279)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEE
T ss_pred             cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC--EEECCCcccccccCcccc
Confidence            99999999999743  26999999999999999999999999999999999999987665  999999999876433322


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      ......|++.|+|||++.+..++.++|||||||++|+|++ |+.||.... .......+. ....+..+..+++++.+||
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~l~~li  243 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNLE-RGYRMVRPDNCPEELYQLM  243 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHH-TTCCCCCCTTCCHHHHHHH
T ss_pred             cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC-HHHHHHHHh-cccCCCCcccccHHHHHHH
Confidence            3334467889999999998889999999999999999999 999998753 333333332 2233455667899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 040569          237 SKCLIRNPGERWSASELLE  255 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~  255 (385)
                      .+||..||.+|||+.++++
T Consensus       244 ~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          244 RLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhccChhhCCCHHHHHH
Confidence            9999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.3e-46  Score=354.34  Aligned_cols=248  Identities=23%  Similarity=0.378  Sum_probs=195.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC---C---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---N---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~---~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+|.+..+++.+|+|.+...   .   .+.+.+|+.++++++||||+++++++.....    ++
T Consensus        33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~  108 (310)
T 2wqm_A           33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE----LN  108 (310)
T ss_dssp             GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE----EE
T ss_pred             ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc----EE
Confidence            589999999999999999999999999999988642   1   3467799999999999999999998876543    67


Q ss_pred             EEEeecCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           76 LFLEYAPGGTLTDAIRS----GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~----~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      +||||+++++|.+++..    ...+++..+..++.||+.||.|||++|++||||||+|||++.++.  +||+|||++...
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~--~kl~Dfg~~~~~  186 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFF  186 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCC------
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC--EEEEeccceeee
Confidence            99999999999999863    566999999999999999999999999999999999999987765  999999999865


Q ss_pred             cccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          152 RVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVA-DPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       152 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      .... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... +.......+......+..+..+++
T Consensus       187 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (310)
T 2wqm_A          187 SSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE  265 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred             cCCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence            4322 12234579999999999999999999999999999999999999997543 223333333322222333456899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ++.+||.+||..||.+|||+.+++++
T Consensus       266 ~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          266 ELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999999999973

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=9.8e-47  Score=361.94  Aligned_cols=251  Identities=26%  Similarity=0.364  Sum_probs=208.6

Q ss_pred             CceeeceeeccCceEEEEEE----ECCCCcEEEEEeccCCCH---HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGM----SNRSSEVFAVKSAELSNS---EFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~----~~~~~~~~AvK~~~~~~~---~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++++.||+|+||+||+|+    +..+++.||||.+.....   +.+.+|+++|++++||||+++++++.......  +
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~--~  101 (327)
T 3lxl_A           24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS--L  101 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE--E
T ss_pred             hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce--E
Confidence            58999999999999999999    577899999999976553   45789999999999999999999877544433  5


Q ss_pred             EEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      ++||||++|++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH--VKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCGGGCEECCT
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC--EEEcccccceeccc
Confidence            699999999999999984 456999999999999999999999999999999999999988766  99999999987643


Q ss_pred             cCCC--CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCC-------------hHHHHHHhcCC
Q 040569          154 NEDD--EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVAD-------------PISALHRIGFS  218 (385)
Q Consensus       154 ~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-------------~~~~~~~~~~~  218 (385)
                      ....  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....             ....+......
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE  259 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred             CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence            2211  23345688899999999999999999999999999999999999854211             11111222223


Q ss_pred             CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          219 SDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       219 ~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ...+..+..+++++.+||.+||++||.+|||+.|++++
T Consensus       260 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          260 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            33455577799999999999999999999999999764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=8e-47  Score=362.65  Aligned_cols=246  Identities=21%  Similarity=0.291  Sum_probs=202.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcE----EEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEV----FAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~----~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|++.+.||+|+||+||+|+++.+++.    +|+|.+....    ...+.+|+.++++++||||+++++++.. ..    
T Consensus        14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~----   88 (325)
T 3kex_A           14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SS----   88 (325)
T ss_dssp             TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SS----
T ss_pred             HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Cc----
Confidence            689999999999999999999888876    6777664322    2456689999999999999999998642 22    


Q ss_pred             EEEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           74 YNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      .++||||+++|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus        89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~  166 (325)
T 3kex_A           89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLLP  166 (325)
T ss_dssp             EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC--EEECSCSGGGGSC
T ss_pred             cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe--EEECCCCcccccC
Confidence            5689999999999999985 357999999999999999999999999999999999999987766  9999999998764


Q ss_pred             ccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          153 VNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       153 ~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      ..... ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||...... .....+ ........+..++.
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~-~~~~~~~~~~~~~~  244 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-EVPDLL-EKGERLAQPQICTI  244 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-HHHHHH-HTTCBCCCCTTBCT
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-HHHHHH-HcCCCCCCCCcCcH
Confidence            33222 2344568889999999999999999999999999999999 99999875432 222222 22334455666888


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ++.+||.+||..||.+|||+.|++++
T Consensus       245 ~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          245 DVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-46  Score=349.79  Aligned_cols=248  Identities=23%  Similarity=0.323  Sum_probs=205.8

Q ss_pred             Cceeec-eeeccCceEEEEEEEC--CCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQ-TIGRGSTATVSIGMSN--RSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~-~LG~G~~g~Vy~a~~~--~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|.+.+ .||+|+||+||+|.++  .++..+|+|.+....    .+.+.+|++++++++||||+++++++. ...    +
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~----~   84 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEA----L   84 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSS----E
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCC----c
Confidence            355655 9999999999999864  468889999987642    356789999999999999999999873 222    5


Q ss_pred             EEEEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      ++||||+++++|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.....
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           85 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGA  162 (287)
T ss_dssp             EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECTT
T ss_pred             EEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCC--EEECcccceeeecc
Confidence            69999999999999997 4456999999999999999999999999999999999999987765  99999999987643


Q ss_pred             cCC--CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          154 NED--DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       154 ~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      ...  .......||+.|+|||++.+..++.++|||||||++|+|++ |+.||...... .....+. ....+..+..+++
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~i~-~~~~~~~~~~~~~  240 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIE-QGKRMECPPECPP  240 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HHHHHHH-TTCCCCCCTTCCH
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHh-cCCcCCCCCCcCH
Confidence            222  12233457899999999998889999999999999999998 99999875443 3333332 2344566778999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLEHGF  258 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~hp~  258 (385)
                      ++.+||.+||..||.+|||+.+++++.+
T Consensus       241 ~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          241 ELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            9999999999999999999999998754

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.8e-46  Score=352.70  Aligned_cols=244  Identities=27%  Similarity=0.458  Sum_probs=191.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++++.||+|+||+||+|+++.   .+|+|.+....     .+.+.+|+.+|++++||||++++++... ..    +++
T Consensus        25 ~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~----~~l   96 (289)
T 3og7_A           25 QITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQ----LAI   96 (289)
T ss_dssp             SCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS----CEE
T ss_pred             ceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC-Cc----cEE
Confidence            58999999999999999998753   58999886432     3567899999999999999999986432 22    558


Q ss_pred             EEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      ||||++|++|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A           97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT--VKIGDFGLATEKSRWS  174 (289)
T ss_dssp             EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EEECCCC---------
T ss_pred             EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC--EEEccceecccccccc
Confidence            999999999999996 4567999999999999999999999999999999999999998765  9999999998653211


Q ss_pred             -CCCCCccccCCcccChhhhc---CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc---CCCCCCCCCCcC
Q 040569          156 -DDEGKPICGTPICMAPEVAR---GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG---FSSDTPEIPGYM  228 (385)
Q Consensus       156 -~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~---~~~~~~~~~~~~  228 (385)
                       ........||+.|+|||++.   +..++.++|||||||++|+|++|+.||....+.......+.   .......+...+
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC  254 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTS
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccC
Confidence             22234457999999999997   55678899999999999999999999987666554444332   223334455678


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          229 SKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       229 s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ++.+.+||.+||+.||.+|||+.++++
T Consensus       255 ~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          255 PKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            999999999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-46  Score=350.26  Aligned_cols=248  Identities=23%  Similarity=0.272  Sum_probs=203.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCc---EEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSE---VFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~---~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      .|..++.||+|+||+||+|.+..+++   .+|+|.+....    .+.+.+|+.++++++||||+++++++......   .
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~---~   98 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL---P   98 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC---C
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC---c
Confidence            46778999999999999999765544   79999887533    25677999999999999999999987655431   3


Q ss_pred             EEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      +++|||+.+|+|.+++.. +..+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~  176 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILD  176 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECCTTSSCTTTT
T ss_pred             EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEeCcCCCcccccC
Confidence            589999999999999985 567899999999999999999999999999999999999987765  99999999985432


Q ss_pred             c---CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          154 N---EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       154 ~---~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      .   .........||+.|+|||.+.+..++.++|||||||++|+|++|..|+....+.......+.. ......+..+++
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  255 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ-GRRLPQPEYCPD  255 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT-TCCCCCCTTCCH
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc-CCCCCCCccchH
Confidence            2   122234456899999999999999999999999999999999965554443444444444322 233445667899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .+.+||.+||+.||.+|||+.++++
T Consensus       256 ~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          256 SLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHH
Confidence            9999999999999999999999987

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4e-46  Score=358.61  Aligned_cols=246  Identities=21%  Similarity=0.319  Sum_probs=199.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEE----EEEeccC----CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVF----AVKSAEL----SNSEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~----AvK~~~~----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|++.+.||+|+||+||+|++..+++.+    |+|.+..    ...+.+.+|+.++++++||||+++++++....     
T Consensus        16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----   90 (327)
T 3lzb_A           16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-----   90 (327)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-----
T ss_pred             HceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-----
Confidence            6999999999999999999998888765    6666532    24577889999999999999999999876532     


Q ss_pred             EEEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           74 YNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      .++++||+.+|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kL~DfG~a~~~~  168 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLG  168 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTC-----
T ss_pred             ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC--EEEccCcceeEcc
Confidence            5589999999999999984 567999999999999999999999999999999999999987766  9999999998764


Q ss_pred             ccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          153 VNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       153 ~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      ..... ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||...... .....+. .......+..++.
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~~~~~~~-~~~~~~~~~~~~~  246 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILE-KGERLPQPPICTI  246 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHH-TTCCCCCCTTBCH
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHHHH-cCCCCCCCccCCH
Confidence            32221 2233457889999999999999999999999999999999 99999865332 2222222 2334445667899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ++.+||.+||..||.+|||+.|+++.
T Consensus       247 ~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          247 DVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            99999999999999999999999973

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.9e-46  Score=358.48  Aligned_cols=247  Identities=21%  Similarity=0.315  Sum_probs=206.2

Q ss_pred             CceeeceeeccCceEEEEEEEC-----CCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN-----RSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|++.+.||+|+||+||+|+++     .+++.||+|.+....    ...+.+|+.++++++||||+++++++.....   
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---  102 (322)
T 1p4o_A           26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP---  102 (322)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS---
T ss_pred             heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc---
Confidence            4889999999999999999886     467899999987543    2357799999999999999999998765443   


Q ss_pred             EEEEEEeecCCCCHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEE
Q 040569           73 LYNLFLEYAPGGTLTDAIRSG----------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKI  142 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~----------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL  142 (385)
                       +++||||++||+|.+++...          ..+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||
T Consensus       103 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~--~kl  179 (322)
T 1p4o_A          103 -TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKI  179 (322)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEE
T ss_pred             -cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe--EEE
Confidence             56899999999999999741          45799999999999999999999999999999999999987765  999


Q ss_pred             eecCceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCC
Q 040569          143 ADFGCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSD  220 (385)
Q Consensus       143 ~DFG~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  220 (385)
                      +|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||... +.......+ ....
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~~-~~~~  257 (322)
T 1p4o_A          180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-SNEQVLRFV-MEGG  257 (322)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CHHHHHHHH-HTTC
T ss_pred             CcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC-CHHHHHHHH-HcCC
Confidence            999999865332211 1223467899999999999999999999999999999999 89999765 333333333 2334


Q ss_pred             CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          221 TPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       221 ~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      .+..+..+++.+.+||.+||+.||.+|||+.|+++|
T Consensus       258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          258 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            455667799999999999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.5e-47  Score=362.74  Aligned_cols=249  Identities=21%  Similarity=0.243  Sum_probs=201.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|+..+.||+|+||+||+|+++ +++.||||.+....   .+.+.+|+.+|++++||||+++++++.....    +++||
T Consensus        40 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~  114 (321)
T 2qkw_B           40 NFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE----MILIY  114 (321)
T ss_dssp             CCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC----CEEEE
T ss_pred             ccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe----EEEEE
Confidence            5889999999999999999964 78999999886543   4678899999999999999999998765443    56899


Q ss_pred             eecCCCCHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           79 EYAPGGTLTDAIRSG----TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~----~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ||++||+|.+++...    ..+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~  192 (321)
T 2qkw_B          115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV--PKITDFGISKKGTEL  192 (321)
T ss_dssp             ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC--EEECCCTTCEECSSS
T ss_pred             EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC--EEEeecccccccccc
Confidence            999999999999743    25899999999999999999999999999999999999987665  999999999875422


Q ss_pred             CC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCCh-----HHHHH-HhcC--------CC
Q 040569          155 ED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADP-----ISALH-RIGF--------SS  219 (385)
Q Consensus       155 ~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-----~~~~~-~~~~--------~~  219 (385)
                      .. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......     ..... ....        ..
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (321)
T 2qkw_B          193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN  272 (321)
T ss_dssp             SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred             cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh
Confidence            22 2233456999999999999999999999999999999999999999653211     11000 0000        00


Q ss_pred             CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCc
Q 040569          220 DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHG  257 (385)
Q Consensus       220 ~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp  257 (385)
                      ....++...+..+.+++.+||+.||.+|||+.|++++.
T Consensus       273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            11122333567789999999999999999999999864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.4e-46  Score=361.38  Aligned_cols=248  Identities=22%  Similarity=0.297  Sum_probs=205.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCc-----EEEEEeccCCC----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSE-----VFAVKSAELSN----SEFLQREQRILSAL-ACPQIVAYKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~-----~~AvK~~~~~~----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~   71 (385)
                      +|++++.||+|+||+||+|.+..+++     .+|+|.+....    .+.+.+|+.+|+++ +||||+++++++.....  
T Consensus        47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~--  124 (333)
T 2i1m_A           47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP--  124 (333)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--
T ss_pred             HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc--
Confidence            58899999999999999999987664     79999987543    35678999999999 89999999998765544  


Q ss_pred             EEEEEEEeecCCCCHHHHHHc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCC
Q 040569           72 ILYNLFLEYAPGGTLTDAIRS--------------GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE  137 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~--------------~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~  137 (385)
                        +++||||+++|+|.+++..              ...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus       125 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~  202 (333)
T 2i1m_A          125 --VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV  202 (333)
T ss_dssp             --CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE
T ss_pred             --eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe
Confidence              6689999999999999973              345899999999999999999999999999999999999987765


Q ss_pred             CCeEEeecCceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHh
Q 040569          138 QGAKIADFGCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRI  215 (385)
Q Consensus       138 ~~~kL~DFG~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~  215 (385)
                        +||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|++ |..||............+
T Consensus       203 --~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  280 (333)
T 2i1m_A          203 --AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV  280 (333)
T ss_dssp             --EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred             --EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence              999999999865433221 1234467889999999999899999999999999999998 999998754433322222


Q ss_pred             cCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          216 GFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       216 ~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                       .....+..+...++.+.+||.+||+.||.+|||+.|++++
T Consensus       281 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          281 -KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             -HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -hcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence             1223344566689999999999999999999999999874

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.5e-46  Score=358.59  Aligned_cols=247  Identities=23%  Similarity=0.344  Sum_probs=204.6

Q ss_pred             CceeeceeeccCceEEEEEEEC-------CCCcEEEEEeccCCC----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccC
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN-------RSSEVFAVKSAELSN----SEFLQREQRILSAL-ACPQIVAYKGCDISEEN   69 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~-------~~~~~~AvK~~~~~~----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~   69 (385)
                      +|++++.||+|+||+||+|.+.       .+++.||+|.+....    .+.+.+|+.+++++ +||||+++++++.....
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  115 (334)
T 2pvf_A           36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP  115 (334)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred             HeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCc
Confidence            5889999999999999999986       467889999987543    24577999999999 99999999998765543


Q ss_pred             CeEEEEEEEeecCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEee
Q 040569           70 GKILYNLFLEYAPGGTLTDAIRSGT----------------CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVS  133 (385)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~l~~~~----------------~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~  133 (385)
                          +++||||+++|+|.+++....                .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus       116 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          116 ----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT  191 (334)
T ss_dssp             ----CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             ----eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc
Confidence                668999999999999998543                389999999999999999999999999999999999998


Q ss_pred             cCCCCCeEEeecCceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHH
Q 040569          134 KDNEQGAKIADFGCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISA  211 (385)
Q Consensus       134 ~~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~  211 (385)
                      .++.  +||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++ |+.||... .....
T Consensus       192 ~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~  268 (334)
T 2pvf_A          192 ENNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEEL  268 (334)
T ss_dssp             TTCC--EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHH
T ss_pred             CCCC--EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC-CHHHH
Confidence            7765  99999999987643221 12233457889999999998889999999999999999999 99999764 33333


Q ss_pred             HHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          212 LHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       212 ~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ...+. ....+..+..+++++.+||.+||..||.+|||+.|++++
T Consensus       269 ~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          269 FKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHh-cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            33322 223445667789999999999999999999999999975

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.7e-46  Score=358.90  Aligned_cols=245  Identities=25%  Similarity=0.327  Sum_probs=204.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEE--EEEeccCC----CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVF--AVKSAELS----NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~--AvK~~~~~----~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++.+.||+|+||+||+|+++.++..+  |+|.+...    ..+.+.+|+++|+++ +||||+++++++.....    +
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~----~  101 (327)
T 1fvr_A           26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY----L  101 (327)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE----E
T ss_pred             HccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc----e
Confidence            5899999999999999999999888866  89987642    234678999999999 99999999998865543    6


Q ss_pred             EEEEeecCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCC
Q 040569           75 NLFLEYAPGGTLTDAIRSGT----------------CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQ  138 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~----------------~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~  138 (385)
                      ++||||+++|+|.+++...+                .+++..++.++.||+.||.|||++||+||||||+|||++.++. 
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~-  180 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-  180 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC-
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe-
Confidence            79999999999999998543                6999999999999999999999999999999999999987765 


Q ss_pred             CeEEeecCceeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcC
Q 040569          139 GAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGF  217 (385)
Q Consensus       139 ~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~  217 (385)
                       +||+|||+++......  ......+++.|+|||++.+..++.++|||||||++|+|++ |+.||... +.......+. 
T Consensus       181 -~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~-~~~~~~~~~~-  255 (327)
T 1fvr_A          181 -AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKLP-  255 (327)
T ss_dssp             -EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHGG-
T ss_pred             -EEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC-cHHHHHHHhh-
Confidence             9999999998543221  2233457889999999998889999999999999999998 99999774 3333434432 


Q ss_pred             CCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          218 SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       218 ~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ....+..+..+++++.+||.+||..||.+|||+.|++++
T Consensus       256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            233445566789999999999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-46  Score=356.93  Aligned_cols=250  Identities=24%  Similarity=0.345  Sum_probs=201.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhc--CCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL--ACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l--~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++.+.||+|+||+||+|+++  ++.||||.+.........+|.+++..+  +||||+++++++.........+++|||
T Consensus        38 ~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e  115 (337)
T 3mdy_A           38 QIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD  115 (337)
T ss_dssp             HCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEEC
T ss_pred             ceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEe
Confidence            4899999999999999999986  899999999776666777777777765  999999999988766433334679999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN--------GIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~--------givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      |+++|+|.++++.. .+++..+..++.||+.||.|||++        ||+||||||+|||++.++.  +||+|||+++..
T Consensus       116 ~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~a~~~  192 (337)
T 3mdy_A          116 YHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVKF  192 (337)
T ss_dssp             CCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEEC
T ss_pred             ccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC--EEEEeCCCceee
Confidence            99999999999865 599999999999999999999999        9999999999999987765  999999999876


Q ss_pred             cccCCC---CCCccccCCcccChhhhcCCCCCCC------CChHHHHHHHHHHHhC----------CCCCCCCC---Ch-
Q 040569          152 RVNEDD---EGKPICGTPICMAPEVARGEEQGFP------ADVWALGCTVLEMATG----------RPPWPDVA---DP-  208 (385)
Q Consensus       152 ~~~~~~---~~~~~~Gt~~y~aPE~~~~~~~~~~------~DiwSlG~il~elltG----------~~Pf~~~~---~~-  208 (385)
                      ......   .....+||+.|+|||++.+......      +|||||||++|||++|          +.||....   .. 
T Consensus       193 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~  272 (337)
T 3mdy_A          193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY  272 (337)
T ss_dssp             C---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             ccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCch
Confidence            433222   1234579999999999988877665      9999999999999999          77775431   11 


Q ss_pred             HHHHHHhcCCCCCCCCCC-----cCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          209 ISALHRIGFSSDTPEIPG-----YMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~-----~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ......+......+.++.     .+++++.+||.+||+.||.+|||+.|+++|
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            122222223333444443     456779999999999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1e-45  Score=371.15  Aligned_cols=241  Identities=26%  Similarity=0.389  Sum_probs=202.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +|++.+.||+|+||+||+|.++  ++.||||.+... ..+.+.+|+++|++++||||+++++++......   +++||||
T Consensus       194 ~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---~~iv~e~  268 (450)
T 1k9a_A          194 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG---LYIVTEY  268 (450)
T ss_dssp             GEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC---EEEEEEC
T ss_pred             HeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc---eEEEEEe
Confidence            4788999999999999999986  789999998754 356788999999999999999999987654421   5699999


Q ss_pred             cCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           81 APGGTLTDAIRSGT--CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        81 ~~ggsL~~~l~~~~--~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      +++|+|.++++..+  .+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.....    
T Consensus       269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~----  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST----  342 (450)
T ss_dssp             CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC--EEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC--EEEeeCCCccccccc----
Confidence            99999999998533  3799999999999999999999999999999999999987765  999999999865322    


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      .....+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ....+. .......|..+++++.+||.
T Consensus       343 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-~~~~i~-~~~~~~~p~~~~~~l~~li~  420 (450)
T 1k9a_A          343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPRVE-KGYKMDAPDGCPPAVYDVMK  420 (450)
T ss_dssp             ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-HHHHHH-TTCCCCCCTTCCHHHHHHHH
T ss_pred             ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHH-cCCCCCCCCcCCHHHHHHHH
Confidence            122357889999999999999999999999999999998 999998754332 222322 23345567789999999999


Q ss_pred             HhhhcCCCCCCCHHHHHh
Q 040569          238 KCLIRNPGERWSASELLE  255 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~  255 (385)
                      +||+.||.+|||+.++++
T Consensus       421 ~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          421 NCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHcCCChhHCcCHHHHHH
Confidence            999999999999999976

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.1e-46  Score=374.44  Aligned_cols=254  Identities=24%  Similarity=0.320  Sum_probs=193.8

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEEeec
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFLEYA   81 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (385)
                      |...+.||+|+||+||.+ ...+|+.||||.+.....+.+.+|+.+|+++ +||||+++++++....    .+++|||||
T Consensus        17 ~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~----~~~lv~E~~   91 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDR----FLYIALELC   91 (434)
T ss_dssp             EEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSS----EEEEEECCC
T ss_pred             eeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCC----eEEEEEecC
Confidence            456789999999999875 4467999999998876677788999999987 8999999998875443    267999999


Q ss_pred             CCCCHHHHHHcCCCCC-------HHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC-----------CCCeEEe
Q 040569           82 PGGTLTDAIRSGTCLE-------EGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN-----------EQGAKIA  143 (385)
Q Consensus        82 ~ggsL~~~l~~~~~l~-------e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~-----------~~~~kL~  143 (385)
                      . |+|.+++.......       +..+..++.||+.||+|||++||+||||||+|||++.++           ...+||+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~  170 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS  170 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence            6 59999998654332       334578999999999999999999999999999997542           2348999


Q ss_pred             ecCceeeecccCCC---CCCccccCCcccChhhhcC-------CCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHH
Q 040569          144 DFGCARRARVNEDD---EGKPICGTPICMAPEVARG-------EEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISAL  212 (385)
Q Consensus       144 DFG~a~~~~~~~~~---~~~~~~Gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~  212 (385)
                      |||+++........   .....+||+.|+|||++.+       ..++.++|||||||++|+|++ |+.||.........+
T Consensus       171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~i  250 (434)
T 2rio_A          171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI  250 (434)
T ss_dssp             CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHHH
T ss_pred             ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHHH
Confidence            99999976433221   1234579999999999976       568899999999999999999 999997654443333


Q ss_pred             HHhcCCCCC-CC-CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          213 HRIGFSSDT-PE-IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       213 ~~~~~~~~~-~~-~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ......... +. .+..+++++++||.+||+.||.+|||+.|+|+||||...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          251 IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             HHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred             hcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence            222111111 11 122356889999999999999999999999999999754

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.8e-46  Score=366.42  Aligned_cols=246  Identities=18%  Similarity=0.296  Sum_probs=193.1

Q ss_pred             CceeeceeeccCceEEEEEEEC---CCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN---RSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~---~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++.+.||+|+||+||+|+++   .++..||||.+....    .+.+.+|+.+|++++||||+++++++.....    +
T Consensus        46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~  121 (373)
T 2qol_A           46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP----V  121 (373)
T ss_dssp             GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS----C
T ss_pred             hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc----e
Confidence            5889999999999999999987   567889999987542    3467899999999999999999998765543    5


Q ss_pred             EEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      ++||||++||+|.+++.. +..+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGRVLED  199 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC--------
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC--EEECcCcccccccc
Confidence            689999999999999985 447999999999999999999999999999999999999987765  99999999987643


Q ss_pred             cCCCC--CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          154 NEDDE--GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       154 ~~~~~--~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      .....  .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.... .......+.. ......+..++.
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~-~~~~~~~i~~-~~~~~~~~~~~~  277 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS-NQDVIKAVDE-GYRLPPPMDCPA  277 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC-HHHHHHHHHT-TEECCCCTTCBH
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHc-CCCCCCCccccH
Confidence            32211  122245778999999999999999999999999999998 999997753 3333333322 222334556899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .+.+||.+||++||.+||++.++++
T Consensus       278 ~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          278 ALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhCcChhhCcCHHHHHH
Confidence            9999999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=9.9e-46  Score=349.69  Aligned_cols=247  Identities=25%  Similarity=0.300  Sum_probs=199.4

Q ss_pred             CceeeceeeccCceEEEEEEECCC---CcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRS---SEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~---~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++.+.||+|+||+||+|.+..+   ...+|+|.+....    .+.+.+|+.++++++||||+++++++......   .
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~---~  102 (298)
T 3f66_A           26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS---P  102 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC---C
T ss_pred             ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc---e
Confidence            588999999999999999997543   3468999886533    25677999999999999999999986544332   5


Q ss_pred             EEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      ++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus       103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYD  180 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSCGGGCCCSC
T ss_pred             EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCC--EEECcccccccccc
Confidence            589999999999999984 556899999999999999999999999999999999999987665  99999999986533


Q ss_pred             cCC---CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCC
Q 040569          154 NED---DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMS  229 (385)
Q Consensus       154 ~~~---~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s  229 (385)
                      ...   .......||+.|+|||++.+..++.++|||||||++|+|++ |.+||......... ..+ .....+..+..++
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~  258 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT-VYL-LQGRRLLQPEYCP  258 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH-HHH-HTTCCCCCCTTCC
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH-HHH-hcCCCCCCCccCC
Confidence            221   12334567889999999999999999999999999999999 66777654333222 222 1233444566789


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          230 KQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       230 ~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      +.+.++|.+||..||.+|||+.|+++
T Consensus       259 ~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          259 DPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999987

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6.9e-46  Score=353.45  Aligned_cols=251  Identities=21%  Similarity=0.298  Sum_probs=196.6

Q ss_pred             CceeeceeeccCceEEEEEEECC---CCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCC-eE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNR---SSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENG-KI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~---~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~-~~   72 (385)
                      +|++++.||+|+||+||+|.+..   +++.||+|.+....     .+.+.+|+.++++++||||+++++++...... ..
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  114 (313)
T 3brb_A           35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP  114 (313)
T ss_dssp             GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------
T ss_pred             HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCc
Confidence            58899999999999999998765   56689999986432     24577899999999999999999988765432 12


Q ss_pred             EEEEEEeecCCCCHHHHHH------cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecC
Q 040569           73 LYNLFLEYAPGGTLTDAIR------SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFG  146 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~------~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG  146 (385)
                      ..++||||+++|+|.+++.      ....+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||
T Consensus       115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kl~Dfg  192 (313)
T 3brb_A          115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADFG  192 (313)
T ss_dssp             CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC--EEECSCS
T ss_pred             ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEEeecC
Confidence            3569999999999999994      3456999999999999999999999999999999999999987765  9999999


Q ss_pred             ceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCC
Q 040569          147 CARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEI  224 (385)
Q Consensus       147 ~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  224 (385)
                      +++....... .......|++.|+|||++.+..++.++|||||||++|+|++ |..||....... ....+ .....+..
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~~~-~~~~~~~~  270 (313)
T 3brb_A          193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-MYDYL-LHGHRLKQ  270 (313)
T ss_dssp             CC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HHHHH-HTTCCCCC
T ss_pred             cceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHH-HcCCCCCC
Confidence            9987643221 12234457889999999999999999999999999999999 999998754332 22222 22334556


Q ss_pred             CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          225 PGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       225 ~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      +..+++++.+||.+||..||.+|||+.+++++
T Consensus       271 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          271 PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            67789999999999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.4e-46  Score=359.24  Aligned_cols=255  Identities=24%  Similarity=0.278  Sum_probs=205.5

Q ss_pred             CceeeceeeccCceEEEEEE-----ECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGM-----SNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~-----~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|++++.||+|+||+||+|+     +..+++.||||.+....    ...+.+|+.++++++||||+++++++.....   
T Consensus        31 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---  107 (327)
T 2yfx_A           31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP---  107 (327)
T ss_dssp             GCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS---
T ss_pred             heEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC---
Confidence            58999999999999999999     56788999999986432    3467789999999999999999998776544   


Q ss_pred             EEEEEEeecCCCCHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC-CCCeEEee
Q 040569           73 LYNLFLEYAPGGTLTDAIRSG-------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN-EQGAKIAD  144 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~-------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~-~~~~kL~D  144 (385)
                       +++||||++||+|.+++...       ..+++..+..++.||+.||.|||++||+||||||+|||++.++ ...+||+|
T Consensus       108 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~D  186 (327)
T 2yfx_A          108 -RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD  186 (327)
T ss_dssp             -CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             -cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECc
Confidence             56899999999999999854       3489999999999999999999999999999999999998543 23489999


Q ss_pred             cCceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCC
Q 040569          145 FGCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTP  222 (385)
Q Consensus       145 FG~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  222 (385)
                      ||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++ |+.||... ........+. ....+
T Consensus       187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~~~~~~-~~~~~  264 (327)
T 2yfx_A          187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-SNQEVLEFVT-SGGRM  264 (327)
T ss_dssp             CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHHHHH-TTCCC
T ss_pred             cccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc-CHHHHHHHHh-cCCCC
Confidence            999975432221 22334568999999999998899999999999999999998 99999764 3333333332 33345


Q ss_pred             CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          223 EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       223 ~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ..+..+++.+.+||.+||+.||.+|||+.++++|.+....
T Consensus       265 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          265 DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            5667789999999999999999999999999999886543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.8e-47  Score=372.59  Aligned_cols=251  Identities=24%  Similarity=0.372  Sum_probs=201.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC----CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL----SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++.+.||+|+||+||+|+++.+++.||||++..    ...+.+.+|+++|++++||||+++++++.......  .++|
T Consensus        10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~--~~lv   87 (396)
T 4eut_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH--KVLI   87 (396)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC--EEEE
T ss_pred             ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe--eEEE
Confidence            48999999999999999999999999999999864    34567789999999999999999999877654333  5689


Q ss_pred             EeecCCCCHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeec--CCCCCeEEeecCceeeec
Q 040569           78 LEYAPGGTLTDAIRSGT---CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSK--DNEQGAKIADFGCARRAR  152 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~---~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~--~~~~~~kL~DFG~a~~~~  152 (385)
                      |||++||+|.+++....   .+++..++.++.||+.||+|||++||+||||||+|||+..  ++...+||+|||+++...
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~  167 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE  167 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence            99999999999997432   3999999999999999999999999999999999999832  222238999999998764


Q ss_pred             ccCCCCCCccccCCcccChhhhcC--------CCCCCCCChHHHHHHHHHHHhCCCCCCCCC---ChHHHHHHhcCCCC-
Q 040569          153 VNEDDEGKPICGTPICMAPEVARG--------EEQGFPADVWALGCTVLEMATGRPPWPDVA---DPISALHRIGFSSD-  220 (385)
Q Consensus       153 ~~~~~~~~~~~Gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltG~~Pf~~~~---~~~~~~~~~~~~~~-  220 (385)
                      ...  .....+||+.|+|||++.+        ..++.++|||||||++|+|++|+.||....   .....+..+..... 
T Consensus       168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~  245 (396)
T 4eut_A          168 DDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS  245 (396)
T ss_dssp             CGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCT
T ss_pred             CCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCc
Confidence            322  2334579999999999875        567789999999999999999999996432   22233333211111 


Q ss_pred             ----------------------CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          221 ----------------------TPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       221 ----------------------~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                                            ...++..+++.+.+||.+||+.||.+|||+.|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence                                  011223356788999999999999999999999764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.5e-46  Score=374.83  Aligned_cols=244  Identities=22%  Similarity=0.325  Sum_probs=203.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++.+.||+|+||+||+|.++ ++..||||.+...  ..+.+.+|+++|++++||||+++++++. ...    +++|||
T Consensus       189 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~----~~lv~e  262 (454)
T 1qcf_A          189 SLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP----IYIITE  262 (454)
T ss_dssp             GEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS----CEEEEC
T ss_pred             HeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc----cEEEEe
Confidence            4788999999999999999986 4678999998753  4678889999999999999999999864 222    568999


Q ss_pred             ecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           80 YAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        80 y~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |+++|+|.++++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++........
T Consensus       263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~~~  340 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYT  340 (454)
T ss_dssp             CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC--EEECSTTGGGGBCCHHHH
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc--EEEeeCCCceEcCCCcee
Confidence            99999999999843  36899999999999999999999999999999999999987765  999999999875332222


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      ......+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ......+.. ......|..+++++.+||
T Consensus       341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-~~~~~~i~~-~~~~~~~~~~~~~l~~li  418 (454)
T 1qcf_A          341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-PEVIRALER-GYRMPRPENCPEELYNIM  418 (454)
T ss_dssp             TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHH-TCCCCCCTTSCHHHHHHH
T ss_pred             ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHc-CCCCCCCCCCCHHHHHHH
Confidence            2233456789999999998999999999999999999999 9999987543 333333322 223344667899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 040569          237 SKCLIRNPGERWSASELLE  255 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~  255 (385)
                      .+||..||.+|||+.++++
T Consensus       419 ~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          419 MRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHccCChhHCcCHHHHHH
Confidence            9999999999999999976

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.6e-46  Score=362.99  Aligned_cols=244  Identities=16%  Similarity=0.148  Sum_probs=198.9

Q ss_pred             CceeeceeeccCceEEEEE-----EECCCCcEEEEEeccCCCHHHHHHHHHHHHhcC---CCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIG-----MSNRSSEVFAVKSAELSNSEFLQREQRILSALA---CPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a-----~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~---hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|++.+.||+|+||+||+|     .+..+++.||||.+.......+.+|.++++.+.   |+||+++++++.....    
T Consensus        66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~----  141 (365)
T 3e7e_A           66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG----  141 (365)
T ss_dssp             EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC----
T ss_pred             EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC----
Confidence            4889999999999999999     467889999999999888888999999999996   8999999998876554    


Q ss_pred             EEEEEeecCCCCHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeec-----------CCC
Q 040569           74 YNLFLEYAPGGTLTDAIR-----SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSK-----------DNE  137 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~-----~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~-----------~~~  137 (385)
                      .++||||++||+|.+++.     ....+++..+..++.||+.||+|||++||+||||||+|||++.           ++.
T Consensus       142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~  221 (365)
T 3e7e_A          142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG  221 (365)
T ss_dssp             EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTT
T ss_pred             cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCC
Confidence            669999999999999997     3567999999999999999999999999999999999999986           444


Q ss_pred             CCeEEeecCceeeecccC-CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc
Q 040569          138 QGAKIADFGCARRARVNE-DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG  216 (385)
Q Consensus       138 ~~~kL~DFG~a~~~~~~~-~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~  216 (385)
                        +||+|||+|+...... .......+||+.|||||++.+..++.++|||||||++|||++|+.||.......     ..
T Consensus       222 --~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----~~  294 (365)
T 3e7e_A          222 --LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-----CK  294 (365)
T ss_dssp             --EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----EE
T ss_pred             --EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----ee
Confidence              9999999998654222 222345679999999999999999999999999999999999999996432210     00


Q ss_pred             CCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 040569          217 FSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGF  258 (385)
Q Consensus       217 ~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~  258 (385)
                      ........  ..++.+.+++.+||+.+|.+|++..+.|.+.+
T Consensus       295 ~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l  334 (365)
T 3e7e_A          295 PEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL  334 (365)
T ss_dssp             ECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred             echhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence            11111222  25788999999999999999976655555433

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8.1e-46  Score=347.10  Aligned_cols=241  Identities=26%  Similarity=0.375  Sum_probs=197.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +|++.+.||+|+||+||+|.++  ++.+|+|.+... ..+.+.+|++++++++||||+++++++.....   .+++||||
T Consensus        22 ~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~lv~e~   96 (278)
T 1byg_A           22 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG---GLYIVTEY   96 (278)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC-----CCEEEECC
T ss_pred             hceEEeEEecCCCceEEEEEEc--CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC---ceEEEEec
Confidence            5899999999999999999875  889999998754 35678899999999999999999998654432   25689999


Q ss_pred             cCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           81 APGGTLTDAIRSGT--CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        81 ~~ggsL~~~l~~~~--~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      +++|+|.+++...+  .+++..+..++.||+.||.|||++|++||||||+||+++.++.  +||+|||++......    
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~----  170 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST----  170 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC-----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc--EEEeecccccccccc----
Confidence            99999999998543  3899999999999999999999999999999999999987765  999999999865322    


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      .....+++.|+|||++.+..++.++|||||||++|+|++ |+.||.... .......+. ....+..+..+++.+.++|.
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~l~~li~  248 (278)
T 1byg_A          171 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVE-KGYKMDAPDGCPPAVYEVMK  248 (278)
T ss_dssp             -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-GGGHHHHHT-TTCCCCCCTTCCHHHHHHHH
T ss_pred             ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHh-cCCCCCCcccCCHHHHHHHH
Confidence            223357899999999999899999999999999999998 999997653 233333332 23345567778999999999


Q ss_pred             HhhhcCCCCCCCHHHHHh
Q 040569          238 KCLIRNPGERWSASELLE  255 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~  255 (385)
                      +||..||.+|||+.|+++
T Consensus       249 ~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          249 NCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHhcCChhhCCCHHHHHH
Confidence            999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=354.81  Aligned_cols=249  Identities=25%  Similarity=0.311  Sum_probs=193.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHH--hcCCCCeeeeeeeeee-ccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILS--ALACPQIVAYKGCDIS-EENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~--~l~hpnIv~~~~~~~~-~~~~~~~~~lv~   78 (385)
                      +|++++.||+|+||+||+|++  +++.||||++.......+.+|.+++.  .++||||+++++.+.. ...+...+++||
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~   91 (336)
T 3g2f_A           14 NLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM   91 (336)
T ss_dssp             SEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred             HhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence            689999999999999999976  58999999998776666666666654  5899999999976543 223344467999


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCCEEeecCCCCCeEEeecCcee
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN---------GIVHCDIKGQNILVSKDNEQGAKIADFGCAR  149 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~---------givHrDlKp~NILi~~~~~~~~kL~DFG~a~  149 (385)
                      ||+++|+|.++++... +++..+..++.||+.||.|||++         ||+||||||+|||++.++.  +||+|||+++
T Consensus        92 e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kL~DFG~a~  168 (336)
T 3g2f_A           92 EYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT--CVISDFGLSM  168 (336)
T ss_dssp             CCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC--EEECCCTTCE
T ss_pred             ecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc--EEEeecccee
Confidence            9999999999998654 58999999999999999999999         9999999999999987765  9999999998


Q ss_pred             eecccCC-------CCCCccccCCcccChhhhcC-------CCCCCCCChHHHHHHHHHHHhCCCCCCCCCC--------
Q 040569          150 RARVNED-------DEGKPICGTPICMAPEVARG-------EEQGFPADVWALGCTVLEMATGRPPWPDVAD--------  207 (385)
Q Consensus       150 ~~~~~~~-------~~~~~~~Gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltG~~Pf~~~~~--------  207 (385)
                      .......       ......+||+.|+|||++.+       ..++.++|||||||++|||++|..||.....        
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~  248 (336)
T 3g2f_A          169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF  248 (336)
T ss_dssp             ECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTT
T ss_pred             ecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhh
Confidence            7643211       12234579999999999987       4566789999999999999999776632111        


Q ss_pred             ---------hHHHHHHhcCCCCCCCCCCc------CCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          208 ---------PISALHRIGFSSDTPEIPGY------MSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       208 ---------~~~~~~~~~~~~~~~~~~~~------~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                               ..............+.++..      .++++.+||.+||+.||.+|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          249 QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             HHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence                     01111112222333444433      3458999999999999999999999965

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-46  Score=362.48  Aligned_cols=248  Identities=19%  Similarity=0.264  Sum_probs=198.5

Q ss_pred             CceeeceeeccCceEEEEEEECCC--------CcEEEEEeccCCCHHHHHHHHHHHHhcCCCCeee--------------
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRS--------SEVFAVKSAELSNSEFLQREQRILSALACPQIVA--------------   59 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~--------~~~~AvK~~~~~~~~~~~~E~~il~~l~hpnIv~--------------   59 (385)
                      +|++.+.||+|+||+||+|+++.+        ++.||+|.+...  +.+.+|++++++++||||++              
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~  120 (352)
T 2jii_A           43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP  120 (352)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred             eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence            589999999999999999999874        899999998754  46779999999999999998              


Q ss_pred             -eeeeeeeccCCeEEEEEEEeecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC
Q 040569           60 -YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN  136 (385)
Q Consensus        60 -~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~  136 (385)
                       +++++.... .  .+++||||+ +++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus       121 ~~~~~~~~~~-~--~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~  196 (352)
T 2jii_A          121 TCMGFGVHQD-K--YRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPED  196 (352)
T ss_dssp             CCCEEEEETT-T--EEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTE
T ss_pred             chhhccccCC-c--EEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCC
Confidence             444443322 2  366999999 99999999864  6799999999999999999999999999999999999999766


Q ss_pred             CCCeEEeecCceeeecccCCC------CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCC-ChH
Q 040569          137 EQGAKIADFGCARRARVNEDD------EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVA-DPI  209 (385)
Q Consensus       137 ~~~~kL~DFG~a~~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~  209 (385)
                      ...+||+|||+++........      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... +..
T Consensus       197 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  276 (352)
T 2jii_A          197 QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTE  276 (352)
T ss_dssp             EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHH
Confidence            224999999999876433221      1234579999999999999999999999999999999999999998654 222


Q ss_pred             HHHHHh-cCCCCCCCCC------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          210 SALHRI-GFSSDTPEIP------GYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       210 ~~~~~~-~~~~~~~~~~------~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ...... ......+.++      ..+++++.+||.+||..||.+|||+.++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          277 DIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            221111 0111111111      246899999999999999999999999987

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-45  Score=353.30  Aligned_cols=247  Identities=21%  Similarity=0.274  Sum_probs=197.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCC----cEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSS----EVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~----~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      +|++.+.||+|+||+||+|.++.++    ..+|+|.+....    ...+.+|+.++++++||||+++++++.....    
T Consensus        45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----  120 (333)
T 1mqb_A           45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP----  120 (333)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS----
T ss_pred             HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC----
Confidence            5788999999999999999987553    459999987542    2457789999999999999999998765443    


Q ss_pred             EEEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           74 YNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      +++||||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLE  198 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-----
T ss_pred             cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc--EEECCCCcchhhc
Confidence            6699999999999999984 467999999999999999999999999999999999999987665  9999999998764


Q ss_pred             ccCCC--CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCC
Q 040569          153 VNEDD--EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMS  229 (385)
Q Consensus       153 ~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s  229 (385)
                      .....  ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||.... .......+.. ...+..+..++
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~-~~~~~~~~~~-~~~~~~~~~~~  276 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKAIND-GFRLPTPMDCP  276 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHHHT-TCCCCCCTTCB
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC-HHHHHHHHHC-CCcCCCcccCC
Confidence            32221  1122346789999999999999999999999999999999 999997653 3333333322 22344466789


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          230 KQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       230 ~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      +.+.++|.+||+.||.+||++.+++++
T Consensus       277 ~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          277 SAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999999874

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=8.9e-46  Score=371.76  Aligned_cols=244  Identities=24%  Similarity=0.357  Sum_probs=199.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++.+.||+|+||+||+|.++. +..||||.+...  ..+.+.+|+++|++++||||+++++++.. ..    +++|||
T Consensus       185 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~----~~iv~e  258 (452)
T 1fmk_A          185 SLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP----IYIVTE  258 (452)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS----CEEEEC
T ss_pred             HceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc----eEEEeh
Confidence            47889999999999999999975 467999998753  35778999999999999999999998754 22    568999


Q ss_pred             ecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           80 YAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        80 y~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |+++|+|.++++.  +..+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++........
T Consensus       259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~  336 (452)
T 1fmk_A          259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYT  336 (452)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC--------
T ss_pred             hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC--EEECCCccceecCCCcee
Confidence            9999999999973  456999999999999999999999999999999999999987665  999999999876433222


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.... ....+..+. .......|..+++.+.+||
T Consensus       337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~-~~~~~~~i~-~~~~~~~~~~~~~~l~~li  414 (452)
T 1fmk_A          337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVE-RGYRMPCPPECPESLHDLM  414 (452)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHH-TTCCCCCCTTSCHHHHHHH
T ss_pred             cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC-HHHHHHHHH-cCCCCCCCCCCCHHHHHHH
Confidence            2334457889999999999999999999999999999999 999998753 333333332 2333445667899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 040569          237 SKCLIRNPGERWSASELLE  255 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~  255 (385)
                      .+||+.||.+|||+.++++
T Consensus       415 ~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          415 CQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHH
Confidence            9999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=9.1e-46  Score=354.23  Aligned_cols=248  Identities=22%  Similarity=0.343  Sum_probs=202.5

Q ss_pred             ceeeceeeccCceEEEEEE----ECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            3 WTRGQTIGRGSTATVSIGM----SNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~----~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      |++++.||+|+||+||++.    +..+++.||||++....    .+.+.+|+++|++++||||+++++++.......  +
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~--~  110 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS--L  110 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE--E
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce--E
Confidence            4899999999999998775    44578999999987643    346789999999999999999999987654333  5


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||||+++|+|.+++.... +++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||++......
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          111 QLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EEEECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECCTT
T ss_pred             EEEEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC--EEECCcccccccccc
Confidence            69999999999999998654 999999999999999999999999999999999999987765  999999999876432


Q ss_pred             CC--CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChH-------------HHHHHhcCCC
Q 040569          155 ED--DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPI-------------SALHRIGFSS  219 (385)
Q Consensus       155 ~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-------------~~~~~~~~~~  219 (385)
                      ..  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......             ..+.......
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG  267 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence            21  12234468889999999999899999999999999999999999996421110             0111112233


Q ss_pred             CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          220 DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       220 ~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .....+..+++++.+||.+||+.||.+|||+.|+++
T Consensus       268 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          268 ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            445567778999999999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-45  Score=361.74  Aligned_cols=248  Identities=25%  Similarity=0.300  Sum_probs=193.1

Q ss_pred             CceeeceeeccCceEEEEEEECCC---CcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRS---SEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~---~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      .|++.+.||+|+||+||+|.+..+   +..+|+|.+....    .+.+.+|+.+|++++||||+++++++..... .  .
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~--~  166 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-S--P  166 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS-C--C
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC-C--e
Confidence            367889999999999999987543   3468999886432    3567899999999999999999998654432 1  4


Q ss_pred             EEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      ++||||+++|+|.++++. +..+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYD  244 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC--------
T ss_pred             EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC--EEEeeccccccccc
Confidence            589999999999999985 456899999999999999999999999999999999999987765  99999999986532


Q ss_pred             cCCC---CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCC
Q 040569          154 NEDD---EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMS  229 (385)
Q Consensus       154 ~~~~---~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s  229 (385)
                      ....   ......||+.|+|||++.+..++.++|||||||++|+|++ |.+||......... ..+ .....+..|..++
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~-~~~-~~~~~~~~p~~~~  322 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT-VYL-LQGRRLLQPEYCP  322 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH-HHH-HTTCCCCCCTTCC
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH-HHH-HcCCCCCCCCCCC
Confidence            2211   1233457889999999999999999999999999999999 78888765433222 222 1223344566789


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          230 KQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       230 ~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      +.+.++|.+||..||.+|||+.|++++
T Consensus       323 ~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          323 DPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999999874

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.1e-45  Score=353.77  Aligned_cols=250  Identities=25%  Similarity=0.288  Sum_probs=204.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHh--cCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSA--LACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~--l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++.+.||+|+||+||+|.+.  ++.||||.+.......+.+|.++++.  ++||||+++++++.........+++|||
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e  120 (342)
T 1b6c_B           43 TIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD  120 (342)
T ss_dssp             HCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEEC
T ss_pred             cEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEe
Confidence            4899999999999999999984  89999999987777788899999998  6999999999998766533233679999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH--------SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH--------~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      |+++|+|.+++.+. .+++..+..++.||+.||.|||        ++||+||||||+|||++.++.  +||+|||++...
T Consensus       121 ~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~  197 (342)
T 1b6c_B          121 YHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRH  197 (342)
T ss_dssp             CCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC--EEECCCTTCEEE
T ss_pred             ecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC--EEEEECCCceec
Confidence            99999999999865 5999999999999999999999        899999999999999987765  999999999876


Q ss_pred             cccCCC---CCCccccCCcccChhhhcCCC------CCCCCChHHHHHHHHHHHhC----------CCCCCCCC----Ch
Q 040569          152 RVNEDD---EGKPICGTPICMAPEVARGEE------QGFPADVWALGCTVLEMATG----------RPPWPDVA----DP  208 (385)
Q Consensus       152 ~~~~~~---~~~~~~Gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~elltG----------~~Pf~~~~----~~  208 (385)
                      ......   ......||+.|+|||++.+..      ++.++|||||||++|+|++|          +.||....    ..
T Consensus       198 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~  277 (342)
T 1b6c_B          198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  277 (342)
T ss_dssp             ETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccH
Confidence            433221   234557999999999998763      33689999999999999999          78886542    12


Q ss_pred             HHHHHHhcCCCCCCCCCC-----cCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          209 ISALHRIGFSSDTPEIPG-----YMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~-----~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ......+......+.++.     ..++.+.+||.+||+.||.+|||+.|+++|
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            222233322333344443     234679999999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.5e-45  Score=346.76  Aligned_cols=247  Identities=24%  Similarity=0.365  Sum_probs=197.8

Q ss_pred             CceeeceeeccCceEEEEEEECC-CCc--EEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNR-SSE--VFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~-~~~--~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|++++.||+|+||+||+|+++. +++  .||+|.+....      .+.+.+|++++++++||||+++++++....    
T Consensus        19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   94 (291)
T 1u46_A           19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP----   94 (291)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS----
T ss_pred             HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC----
Confidence            58999999999999999998643 333  68999886431      356789999999999999999999876532    


Q ss_pred             EEEEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           73 LYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                       .++||||+++++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||++...
T Consensus        95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~  171 (291)
T 1u46_A           95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRAL  171 (291)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEEC
T ss_pred             -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC--EEEccccccccc
Confidence             4589999999999999974 456999999999999999999999999999999999999987765  999999999876


Q ss_pred             cccCCC--CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcC
Q 040569          152 RVNEDD--EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYM  228 (385)
Q Consensus       152 ~~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (385)
                      ......  ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||... +.......+......+..+..+
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~  250 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEGERLPRPEDC  250 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHTSCCCCCCCTTC
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC-CHHHHHHHHHccCCCCCCCcCc
Confidence            432211  1233457889999999998889999999999999999999 99999875 4444445554444445566778


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          229 SKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       229 s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ++++.++|.+||..||.+|||+.+++++
T Consensus       251 ~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          251 PQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            9999999999999999999999999973

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=352.58  Aligned_cols=250  Identities=24%  Similarity=0.336  Sum_probs=202.9

Q ss_pred             CceeeceeeccCceEEEEEE----ECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGM----SNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~----~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++++.||+|+||+||+|+    +..+++.||||.+....   .+.+.+|+++|++++||||+++++++.......  +
T Consensus        42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~--~  119 (326)
T 2w1i_A           42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN--L  119 (326)
T ss_dssp             GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C--C
T ss_pred             HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc--e
Confidence            48899999999999999998    46789999999987644   346789999999999999999999876544222  5


Q ss_pred             EEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      ++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.....
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kL~Dfg~~~~~~~  197 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQ  197 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCS
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc--EEEecCcchhhccc
Confidence            689999999999999985 456999999999999999999999999999999999999987766  99999999987643


Q ss_pred             cCCC--CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChH--------------HHHHHhcC
Q 040569          154 NEDD--EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPI--------------SALHRIGF  217 (385)
Q Consensus       154 ~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--------------~~~~~~~~  217 (385)
                      ....  ......|++.|+|||++.+..++.++|||||||++|+|++|..||.......              ..+.....
T Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (326)
T 2w1i_A          198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK  277 (326)
T ss_dssp             SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred             cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence            2211  1233457888999999998889999999999999999999999985321000              01111111


Q ss_pred             CCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          218 SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       218 ~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ....+..+..+++++.+||.+||..||.+|||+.|+++
T Consensus       278 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          278 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            22234456778999999999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.9e-45  Score=351.29  Aligned_cols=249  Identities=22%  Similarity=0.285  Sum_probs=185.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcC-CCCeeeeeeeeeec----cCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALA-CPQIVAYKGCDISE----ENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~-hpnIv~~~~~~~~~----~~~~~~   73 (385)
                      +|++.+.||+|+||+||+|+++.+++.||||.+....   .+.+.+|+.+++++. ||||+++++++...    ......
T Consensus        29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~  108 (337)
T 3ll6_A           29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE  108 (337)
T ss_dssp             EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred             eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence            5899999999999999999999999999999885544   346778999999995 99999999987432    123344


Q ss_pred             EEEEEeecCCCCHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEeecCCCCCeEEeecCce
Q 040569           74 YNLFLEYAPGGTLTDAIRS---GTCLEEGRIRSHTRAVLLGLQYLHSNG--IVHCDIKGQNILVSKDNEQGAKIADFGCA  148 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~---~~~l~e~~~~~i~~qil~gL~yLH~~g--ivHrDlKp~NILi~~~~~~~~kL~DFG~a  148 (385)
                      ++++|||+. |+|.+++..   .+.+++..+..++.||+.||.|||++|  |+||||||+|||++.++.  +||+|||++
T Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~  185 (337)
T 3ll6_A          109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--IKLCDFGSA  185 (337)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC--EEBCCCTTC
T ss_pred             EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC--EEEecCccc
Confidence            679999996 699998863   567999999999999999999999999  999999999999987765  999999999


Q ss_pred             eeecccCCC-----------CCCccccCCcccChhhh---cCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHH
Q 040569          149 RRARVNEDD-----------EGKPICGTPICMAPEVA---RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHR  214 (385)
Q Consensus       149 ~~~~~~~~~-----------~~~~~~Gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~  214 (385)
                      +........           ......||+.|+|||++   .+..++.++|||||||++|+|++|+.||...... .....
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~  264 (337)
T 3ll6_A          186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-RIVNG  264 (337)
T ss_dssp             BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred             eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-HhhcC
Confidence            876432211           11245699999999998   5667888999999999999999999999754221 11111


Q ss_pred             hcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 040569          215 IGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGF  258 (385)
Q Consensus       215 ~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~  258 (385)
                          ......+...++.+.+||.+||+.||.+|||+.|+++|..
T Consensus       265 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          265 ----KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             -----CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             ----cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                1112223456788999999999999999999999998743

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.2e-44  Score=341.46  Aligned_cols=235  Identities=24%  Similarity=0.385  Sum_probs=189.9

Q ss_pred             Cceee-ceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHH-HhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRG-QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRIL-SALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~-~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il-~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|.+. +.||+|+||+||+|.++.+++.||+|.+..  .....+|+.++ +.+.||||+++++++.....+...+++|||
T Consensus        18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e   95 (299)
T 3m2w_A           18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME   95 (299)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred             chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEe
Confidence            46676 789999999999999999999999999864  45677899998 555999999999998764444555789999


Q ss_pred             ecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC-CCCeEEeecCceeeecccCC
Q 040569           80 YAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN-EQGAKIADFGCARRARVNED  156 (385)
Q Consensus        80 y~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~-~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |++||+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++ ...+||+|||++....    
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~----  171 (299)
T 3m2w_A           96 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----  171 (299)
T ss_dssp             CCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc----
Confidence            99999999999854  3699999999999999999999999999999999999998732 2348999999997642    


Q ss_pred             CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh--cCCCCCCCCC----CcCCH
Q 040569          157 DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI--GFSSDTPEIP----GYMSK  230 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~--~~~~~~~~~~----~~~s~  230 (385)
                                         +..++.++|||||||++|+|++|+.||....... .....  .........+    ..+++
T Consensus       172 -------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (299)
T 3m2w_A          172 -------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGMKTRIRMGQYEFPNPEWSEVSE  231 (299)
T ss_dssp             -------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCSSCTTCCSSCHHHHTTSCH
T ss_pred             -------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh-hhHHHHHHHhhccccCCchhcccCCH
Confidence                               1346778999999999999999999997542211 11111  1111112222    45799


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ++++||.+||+.||.+|||+.|+|+||||.+.
T Consensus       232 ~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          232 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             HHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence            99999999999999999999999999999764

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=7.2e-45  Score=345.19  Aligned_cols=245  Identities=24%  Similarity=0.357  Sum_probs=197.0

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-------NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      |..++.||+|+||+||+|.+  +++.+|+|.+...       ..+.+.+|+.++++++||||+++++++.....    ++
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~  106 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD----LC  106 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS----CE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCc----eE
Confidence            44569999999999999986  5889999987532       14678899999999999999999998766544    56


Q ss_pred             EEEeecCCCCHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           76 LFLEYAPGGTLTDAIR---SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~---~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      +||||+++|+|.+++.   ....+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~  184 (307)
T 2nru_A          107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT--AKISDFGLARASE  184 (307)
T ss_dssp             EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECC
T ss_pred             EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc--EEEeecccccccc
Confidence            8999999999999997   3456999999999999999999999999999999999999987665  9999999998764


Q ss_pred             ccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChH---HHHHHhc---------CCC
Q 040569          153 VNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPI---SALHRIG---------FSS  219 (385)
Q Consensus       153 ~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~---~~~~~~~---------~~~  219 (385)
                      ..... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.......   .....+.         ...
T Consensus       185 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (307)
T 2nru_A          185 KFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDK  263 (307)
T ss_dssp             SCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCS
T ss_pred             cccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccc
Confidence            32211 1234579999999999875 47899999999999999999999997543221   1111110         111


Q ss_pred             CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          220 DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       220 ~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ..+..+...++.+.+++.+||..||.+|||+.+++++
T Consensus       264 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          264 KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            2223344456789999999999999999999999874

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.6e-45  Score=379.83  Aligned_cols=241  Identities=22%  Similarity=0.332  Sum_probs=199.3

Q ss_pred             eceeeccCceEEEEEEE--CCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            6 GQTIGRGSTATVSIGMS--NRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~--~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      .+.||+|+||+||+|.+  +.+++.||||++....     .+.+.+|+++|++++||||+++++++.. ..    +++||
T Consensus       374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~----~~lv~  448 (635)
T 4fl3_A          374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ES----WMLVM  448 (635)
T ss_dssp             EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS----EEEEE
T ss_pred             CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CC----EEEEE
Confidence            35799999999999954  5677899999886422     4678899999999999999999998743 22    56999


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC--
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED--  156 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~--  156 (385)
                      ||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+||||+.++.  +||+|||+++.......  
T Consensus       449 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~--~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          449 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYY  526 (635)
T ss_dssp             ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCTTHHHHTTC-----
T ss_pred             EccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC--EEEEEcCCccccccCcccc
Confidence            99999999999998888999999999999999999999999999999999999997765  99999999986543222  


Q ss_pred             CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          157 DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                      .......||+.|+|||++.+..++.++|||||||++|||++ |+.||..... ......+. .......+..+++++.+|
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-~~~~~~i~-~~~~~~~p~~~~~~l~~l  604 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-SEVTAMLE-KGERMGCPAGCPREMYDL  604 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHH-TTCCCCCCTTCCHHHHHH
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHH-cCCCCCCCCCCCHHHHHH
Confidence            12233457889999999999999999999999999999998 9999987533 33333332 334455677899999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHh
Q 040569          236 LSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~  255 (385)
                      |.+||..||.+|||+.++++
T Consensus       605 i~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          605 MNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHH
Confidence            99999999999999999976

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-44  Score=374.45  Aligned_cols=239  Identities=23%  Similarity=0.337  Sum_probs=196.8

Q ss_pred             eeeccCceEEEEEEEC--CCCcEEEEEeccCC----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEeec
Q 040569            8 TIGRGSTATVSIGMSN--RSSEVFAVKSAELS----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEYA   81 (385)
Q Consensus         8 ~LG~G~~g~Vy~a~~~--~~~~~~AvK~~~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (385)
                      .||+|+||+||+|.++  .++..||||.+...    ..+.+.+|+++|++++||||+++++++.. +.    +++||||+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~----~~lv~E~~  417 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA----LMLVMEMA  417 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS----EEEEEECC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC----eEEEEEeC
Confidence            7999999999999875  35677999998653    35778899999999999999999998754 22    66999999


Q ss_pred             CCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC--
Q 040569           82 PGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE--  158 (385)
Q Consensus        82 ~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~--  158 (385)
                      ++|+|.+++. ....+++..+..++.||+.||+|||++||+||||||+||||+.++.  +||+|||+++.........  
T Consensus       418 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--vkL~DFGla~~~~~~~~~~~~  495 (613)
T 2ozo_A          418 GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY--AKISDFGLSKALGADDSYYTA  495 (613)
T ss_dssp             TTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCSTTTTCC--------
T ss_pred             CCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc--EEEeeccCcccccCCCceeee
Confidence            9999999997 4456999999999999999999999999999999999999997765  9999999998653322211  


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      .....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+. .......|..+++++.+||.
T Consensus       496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-~~~~~i~-~~~~~~~p~~~~~~l~~li~  573 (613)
T 2ozo_A          496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIE-QGKRMECPPECPPELYALMS  573 (613)
T ss_dssp             ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-HHHHHHH-TTCCCCCCTTCCHHHHHHHH
T ss_pred             ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHHHH-cCCCCCCCCcCCHHHHHHHH
Confidence            122346789999999999999999999999999999998 99999876543 3333332 23345567779999999999


Q ss_pred             HhhhcCCCCCCCHHHHHh
Q 040569          238 KCLIRNPGERWSASELLE  255 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~  255 (385)
                      +||..||.+|||+.++++
T Consensus       574 ~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          574 DCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HTTCSSTTTSCCHHHHHH
T ss_pred             HHcCCChhHCcCHHHHHH
Confidence            999999999999999864

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.4e-45  Score=373.55  Aligned_cols=244  Identities=24%  Similarity=0.357  Sum_probs=203.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++.+.||+|+||+||+|.++. +..||||.+...  ..+.+.+|+++|++++||||+++++++.. ..    ++||||
T Consensus       268 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~----~~lv~e  341 (535)
T 2h8h_A          268 SLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP----IYIVTE  341 (535)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS----CEEEEC
T ss_pred             hhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc----ceEeee
Confidence            47889999999999999999975 467999998753  35778899999999999999999998754 22    568999


Q ss_pred             ecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           80 YAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        80 y~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |+++|+|.++++.  +..+++..+..++.||+.||+|||++||+||||||+||||+.++.  +||+|||+++........
T Consensus       342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~  419 (535)
T 2h8h_A          342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYT  419 (535)
T ss_dssp             CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCTTSTTTCCCHHHH
T ss_pred             hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc--EEEcccccceecCCCcee
Confidence            9999999999973  456999999999999999999999999999999999999987665  999999999865322111


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      ......++..|+|||++.+..++.++|||||||++|||++ |+.||.... ....+..+. .......+..+++++.+||
T Consensus       420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~-~~~~~~~i~-~~~~~~~~~~~~~~l~~li  497 (535)
T 2h8h_A          420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVE-RGYRMPCPPECPESLHDLM  497 (535)
T ss_dssp             TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC-HHHHHHHHH-TTCCCCCCTTCCHHHHHHH
T ss_pred             cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHH-cCCCCCCCCCCCHHHHHHH
Confidence            2233457889999999999999999999999999999999 999998753 333333332 2233445667899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 040569          237 SKCLIRNPGERWSASELLE  255 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~  255 (385)
                      .+||+.||.+|||+.++++
T Consensus       498 ~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          498 CQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHH
Confidence            9999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.1e-44  Score=363.14  Aligned_cols=248  Identities=21%  Similarity=0.288  Sum_probs=198.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +|++++.||+|+||+||+|++..+++.||||++... ....+.+|+++++.|.|++++..+..+.....   ..+|||||
T Consensus         8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~---~~~lvme~   84 (483)
T 3sv0_A            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGD---YNVLVMDL   84 (483)
T ss_dssp             TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETT---EEEEEEEC
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCC---EEEEEEEC
Confidence            599999999999999999999999999999987643 33567899999999987554444333333222   25699999


Q ss_pred             cCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEee---cCCCCCeEEeecCceeeecccCC
Q 040569           81 APGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVS---KDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        81 ~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~---~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      + +++|.+++. ..+.+++..+..++.||+.||+|||++||+||||||+||||+   .++.  +||+|||+++.......
T Consensus        85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~--vkL~DFGla~~~~~~~~  161 (483)
T 3sv0_A           85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKKYRDTST  161 (483)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTTT
T ss_pred             C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCe--EEEEeCCcceeccCCcc
Confidence            9 899999998 366799999999999999999999999999999999999994   4444  99999999987653322


Q ss_pred             C------CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHh---cCCCCCCCCC
Q 040569          157 D------EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVAD--PISALHRI---GFSSDTPEIP  225 (385)
Q Consensus       157 ~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~--~~~~~~~~---~~~~~~~~~~  225 (385)
                      .      .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.....  ....+..+   ........++
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~  241 (483)
T 3sv0_A          162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALC  241 (483)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHH
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHh
Confidence            1      12356799999999999999999999999999999999999999986533  12222211   1111222233


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          226 GYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       226 ~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ..+++++.+||.+||..+|.+||++.++++
T Consensus       242 ~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          242 RGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             TTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            457899999999999999999999998765

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=345.14  Aligned_cols=243  Identities=23%  Similarity=0.335  Sum_probs=196.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++++.||+|+||+||+|.++.   .+|+|.+...     ..+.+.+|+.++++++||||+++++++.....    +++
T Consensus        34 ~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~i  106 (319)
T 2y4i_B           34 QLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH----LAI  106 (319)
T ss_dssp             CEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC----EEE
T ss_pred             HeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc----eEE
Confidence            58899999999999999999864   4899987643     23456789999999999999999999876554    679


Q ss_pred             EEeecCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIRSG-TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~-~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      ||||++|++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ ++  .+||+|||+++......
T Consensus       107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~--~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG--KVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----CCEECCCSCCC------
T ss_pred             EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC--CEEEeecCCcccccccc
Confidence            99999999999999854 4799999999999999999999999999999999999997 33  49999999987543211


Q ss_pred             ----CCCCCccccCCcccChhhhcC---------CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCC
Q 040569          156 ----DDEGKPICGTPICMAPEVARG---------EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP  222 (385)
Q Consensus       156 ----~~~~~~~~Gt~~y~aPE~~~~---------~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  222 (385)
                          ........||+.|+|||++.+         ..++.++|||||||++|+|++|+.||... ........+.......
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~  262 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ-PAEAIIWQMGTGMKPN  262 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC-CHHHHHHHHHTTCCCC
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhccCCCCC
Confidence                122334569999999999975         34688999999999999999999999764 3334444443333333


Q ss_pred             CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          223 EIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       223 ~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ..+..+++++.+||.+||..||.+|||+.++++
T Consensus       263 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            334468899999999999999999999999987

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.7e-46  Score=360.39  Aligned_cols=244  Identities=18%  Similarity=0.201  Sum_probs=188.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----------HHHHHHHHHHHHhcC---------CCCeeeee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----------SEFLQREQRILSALA---------CPQIVAYK   61 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----------~~~~~~E~~il~~l~---------hpnIv~~~   61 (385)
                      +|++++.||+|+||+||+|++  +|+.||||.+....           .+.+.+|+.+|+.++         ||||+++.
T Consensus        21 ~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             cchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            488899999999999999998  68999999986542           277889999999986         66666666


Q ss_pred             eeeeecc--------------------------CCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 040569           62 GCDISEE--------------------------NGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL  115 (385)
Q Consensus        62 ~~~~~~~--------------------------~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yL  115 (385)
                      +++....                          .....++|||||+++|++.+.+.+ +.+++..++.++.||+.||+||
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~l  177 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVA  177 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHH
Confidence            5543110                          001126799999999987777654 5689999999999999999999


Q ss_pred             H-HCCceeccCCCCCEEeecCCC------------------CCeEEeecCceeeecccCCCCCCccccCCcccChhhhcC
Q 040569          116 H-SNGIVHCDIKGQNILVSKDNE------------------QGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG  176 (385)
Q Consensus       116 H-~~givHrDlKp~NILi~~~~~------------------~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  176 (385)
                      | ++||+||||||+|||++.++.                  ..+||+|||+|+....      ...+||+.|||||++.+
T Consensus       178 H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTCSGGGCC
T ss_pred             HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccChhhhcC
Confidence            9 999999999999999987751                  1489999999997642      24589999999999987


Q ss_pred             CCCCCCCChHHHHHH-HHHHHhCCCCCCCCCC---hHHHHH-HhcCCC-CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCH
Q 040569          177 EEQGFPADVWALGCT-VLEMATGRPPWPDVAD---PISALH-RIGFSS-DTPEIPGYMSKQAQDFLSKCLIRNPGERWSA  250 (385)
Q Consensus       177 ~~~~~~~DiwSlG~i-l~elltG~~Pf~~~~~---~~~~~~-~~~~~~-~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~  250 (385)
                      .. +.++||||||++ .+++++|..||.....   ....+. ...... ..+..+..+|+++++||.+||++|     |+
T Consensus       252 ~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa  325 (336)
T 2vuw_A          252 DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SA  325 (336)
T ss_dssp             CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SH
T ss_pred             CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CH
Confidence            76 889999998877 7888899999953210   111111 111111 111123347889999999999987     99


Q ss_pred             HHHH-hCcccc
Q 040569          251 SELL-EHGFVK  260 (385)
Q Consensus       251 ~elL-~hp~~~  260 (385)
                      +|+| +||||+
T Consensus       326 ~e~l~~Hp~f~  336 (336)
T 2vuw_A          326 TDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHCGGGC
T ss_pred             HHHHhcCCCcC
Confidence            9999 999984

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.8e-45  Score=380.91  Aligned_cols=260  Identities=24%  Similarity=0.354  Sum_probs=205.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccC--CeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEEN--GKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~~~~~   75 (385)
                      +|++.+.||+|+||+||+|+++.+|+.||||.+....    .+.+.+|+++|++++||||+++++++.....  .....+
T Consensus        15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~   94 (676)
T 3qa8_A           15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL   94 (676)
T ss_dssp             --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCC
T ss_pred             CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEE
Confidence            5899999999999999999999999999999886532    3567789999999999999999988644110  011256


Q ss_pred             EEEeecCCCCHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCC-eEEeecCceeee
Q 040569           76 LFLEYAPGGTLTDAIRSGT---CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQG-AKIADFGCARRA  151 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~---~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~-~kL~DFG~a~~~  151 (385)
                      +||||++||+|.+++....   .+++..++.++.||+.||+|||++||+||||||+|||++.++... +||+|||++...
T Consensus        95 LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~  174 (676)
T 3qa8_A           95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL  174 (676)
T ss_dssp             CEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBT
T ss_pred             EEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccccc
Confidence            8999999999999998533   599999999999999999999999999999999999998765433 699999999876


Q ss_pred             cccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHH--------Hh--------
Q 040569          152 RVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALH--------RI--------  215 (385)
Q Consensus       152 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~--------~~--------  215 (385)
                      ...  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........        .+        
T Consensus       175 ~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g  252 (676)
T 3qa8_A          175 DQG--ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG  252 (676)
T ss_dssp             TSC--CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSS
T ss_pred             ccc--cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcc
Confidence            422  233456799999999999999999999999999999999999999965322111000        00        


Q ss_pred             --cCCC---CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          216 --GFSS---DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       216 --~~~~---~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                        .+..   ....++..+++.+.+||.+||..||.+|||+.|+|+||||....
T Consensus       253 ~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~  305 (676)
T 3qa8_A          253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD  305 (676)
T ss_dssp             SCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred             ccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence              0000   01123334678999999999999999999999999999998754

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.6e-44  Score=373.54  Aligned_cols=246  Identities=23%  Similarity=0.303  Sum_probs=201.5

Q ss_pred             CceeeceeeccCceEEEEEEECCC---CcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRS---SEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~---~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++++.||+|+||+||+|+++.+   +..+|+|.+....    .+.+.+|+.+|++++||||+++++++.. ..    +
T Consensus       391 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~----~  465 (656)
T 2j0j_A          391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP----V  465 (656)
T ss_dssp             GEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS----C
T ss_pred             cEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cc----e
Confidence            478899999999999999998654   5679999886533    2567789999999999999999998733 22    5


Q ss_pred             EEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      ++||||+++|+|.++++. +..+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~--vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMED  543 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCCCCSCCC
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC--EEEEecCCCeecCC
Confidence            689999999999999984 446999999999999999999999999999999999999998766  99999999987643


Q ss_pred             cCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHH
Q 040569          154 NEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA  232 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  232 (385)
                      ..........||+.|||||++.+..++.++|||||||++|||++ |..||.... .......+.. ...+..+..+++.+
T Consensus       544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~-~~~~~~~i~~-~~~~~~~~~~~~~l  621 (656)
T 2j0j_A          544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIEN-GERLPMPPNCPPTL  621 (656)
T ss_dssp             ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHHHH-TCCCCCCTTCCHHH
T ss_pred             CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHc-CCCCCCCccccHHH
Confidence            33323334467889999999998999999999999999999997 999998753 3333333322 23445677799999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          233 QDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      .+||.+||..||.+|||+.++++.
T Consensus       622 ~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          622 YSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHH
Confidence            999999999999999999999863

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-44  Score=358.41  Aligned_cols=246  Identities=17%  Similarity=0.154  Sum_probs=189.6

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHHHHHHHHhcCC-CCeeeee--------------
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQREQRILSALAC-PQIVAYK--------------   61 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~E~~il~~l~h-pnIv~~~--------------   61 (385)
                      |+.++.||+|+||+||+|++..+|+.||||++...      ..+.+++|+.+++.+.| +|+....              
T Consensus        80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  159 (413)
T 3dzo_A           80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD  159 (413)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred             EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence            67889999999999999999999999999988732      14678899999999977 3221111              


Q ss_pred             -------eeeeecc-CCeEEEEEEEeecCCCCHHHHHH-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 040569           62 -------GCDISEE-NGKILYNLFLEYAPGGTLTDAIR-------SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIK  126 (385)
Q Consensus        62 -------~~~~~~~-~~~~~~~lv~Ey~~ggsL~~~l~-------~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlK  126 (385)
                             .++.... .....++++|+++ +++|.++++       .+..+++..+..++.||+.||+|||++||+|||||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiK  238 (413)
T 3dzo_A          160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR  238 (413)
T ss_dssp             CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcc
Confidence                   1011100 0011245677766 579999985       13457888999999999999999999999999999


Q ss_pred             CCCEEeecCCCCCeEEeecCceeeecccCCCCCCccccCCcccChhhh----------cCCCCCCCCChHHHHHHHHHHH
Q 040569          127 GQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA----------RGEEQGFPADVWALGCTVLEMA  196 (385)
Q Consensus       127 p~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~----------~~~~~~~~~DiwSlG~il~ell  196 (385)
                      |+||||+.++.  +||+|||+++.....    ....+| +.|||||++          .+..++.++|||||||++|+|+
T Consensus       239 p~NILl~~~~~--~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          239 PVDIVLDQRGG--VFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             GGGEEECTTCC--EEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             cceEEEecCCe--EEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            99999998776  999999999875432    344578 999999999          5556888999999999999999


Q ss_pred             hCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          197 TGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       197 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      +|+.||...... .....+ +.     ....+|+++++||.+||++||.+|||+.|+|+||||+...
T Consensus       312 tg~~Pf~~~~~~-~~~~~~-~~-----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~  371 (413)
T 3dzo_A          312 CADLPNTDDAAL-GGSEWI-FR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  371 (413)
T ss_dssp             HSSCCCCTTGGG-SCSGGG-GS-----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             HCCCCCCCcchh-hhHHHH-Hh-----hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence            999999764221 111111 11     1124789999999999999999999999999999998653

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7e-43  Score=367.63  Aligned_cols=238  Identities=20%  Similarity=0.296  Sum_probs=196.3

Q ss_pred             CceeeceeeccCceEEEEEEECC-CCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccC-CeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNR-SSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEEN-GKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~-~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~~~~~   75 (385)
                      +|++.+.||+|+||+||+|.++. +++.||||.+....    .+.+.+|+++|++++||||+++++++..... +...+|
T Consensus        81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~  160 (681)
T 2pzi_A           81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY  160 (681)
T ss_dssp             TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeE
Confidence            58999999999999999999976 78999999886432    2456789999999999999999999876543 344457


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |||||++|++|.+++..  .+++..+..++.||+.||.|||++||+||||||+|||++.+   .+||+|||+++..... 
T Consensus       161 lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG~a~~~~~~-  234 (681)
T 2pzi_A          161 IVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRINSF-  234 (681)
T ss_dssp             EEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---CEEECCCTTCEETTCC-
T ss_pred             EEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC---cEEEEecccchhcccC-
Confidence            99999999999998775  69999999999999999999999999999999999999864   4999999999876322 


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCC--CCCcCCHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPE--IPGYMSKQAQ  233 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~  233 (385)
                          ...+||+.|||||++.+.. +.++|||||||++|+|++|.+||.....           ...+.  .....++.+.
T Consensus       235 ----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~-----------~~~~~~~~~~~~~~~l~  298 (681)
T 2pzi_A          235 ----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV-----------DGLPEDDPVLKTYDSYG  298 (681)
T ss_dssp             ----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC-----------SSCCTTCHHHHHCHHHH
T ss_pred             ----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc-----------ccccccccccccCHHHH
Confidence                4457999999999997654 8899999999999999999999864210           01111  0112467899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          234 DFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       234 ~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      +||.+||++||.+||+..+.+.|+|...
T Consensus       299 ~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          299 RLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             HHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            9999999999999999999999998753

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.7e-42  Score=325.18  Aligned_cols=218  Identities=14%  Similarity=0.098  Sum_probs=178.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++.+.||+|+||+||+|++..+++.||||.+....      .+.+.+|+.++++++||||+++++++.....    ++
T Consensus        32 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~----~~  107 (286)
T 3uqc_A           32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAG----GL  107 (286)
T ss_dssp             TEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE----EE
T ss_pred             cEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCc----EE
Confidence            4999999999999999999999999999999987542      1567899999999999999999998866533    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||++|++|.++++.+  ..+..+..++.||+.||+|||++||+||||||+|||++.++.  +||+++          
T Consensus       108 lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~--~kl~~~----------  173 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYP----------  173 (286)
T ss_dssp             EEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--EEECSC----------
T ss_pred             EEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--EEEEec----------
Confidence            999999999999999754  466678999999999999999999999999999999997766  888743          


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc-CCCCCC---CCCCcCCHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG-FSSDTP---EIPGYMSKQ  231 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~-~~~~~~---~~~~~~s~~  231 (385)
                                 .|++|       ++.++|||||||++|+|++|+.||.............. .....+   ..+..++++
T Consensus       174 -----------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T 3uqc_A          174 -----------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ  235 (286)
T ss_dssp             -----------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHH
T ss_pred             -----------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHH
Confidence                       34443       67899999999999999999999986432110000000 011111   233568999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          232 AQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      +++||.+||++||.+| |+.|+++.
T Consensus       236 l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          236 ISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHHHHcccCCccC-CHHHHHHH
Confidence            9999999999999999 99999873

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=5.7e-35  Score=300.97  Aligned_cols=226  Identities=14%  Similarity=0.093  Sum_probs=154.7

Q ss_pred             eeeccCceEEEEEEECCCCcEEEEEeccCCC-------------HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEE
Q 040569            8 TIGRGSTATVSIGMSNRSSEVFAVKSAELSN-------------SEFLQREQRILSAL-ACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         8 ~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-------------~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      .++.|+.|.+..++..-.|+.||+|.+.+..             .+.+++|+++|+++ .|+||+++++++.+...    
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~----  316 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS----  316 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE----
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE----
Confidence            3567888888888888889999999886431             24688999999999 79999999998866544    


Q ss_pred             EEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           74 YNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      +||||||++|++|.++|+.++++++.   .|++||+.||+|||++|||||||||+||||+.++.  +||+|||+|+....
T Consensus       317 ~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~--vKL~DFGlAr~~~~  391 (569)
T 4azs_A          317 GWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH--ARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC--EEECCCTTEESCC-
T ss_pred             EEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC--EEEeecccCeeCCC
Confidence            77999999999999999988888875   47899999999999999999999999999988776  99999999987643


Q ss_pred             cCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHH
Q 040569          154 NEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ  233 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  233 (385)
                      .. ....+.+||+.|||||++.+. +..++|+||+|+++++|.++..|+.      ..+.    .....      ...+.
T Consensus       392 ~~-~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~~------~~l~----~~~~~------~~~~~  453 (569)
T 4azs_A          392 DC-SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNWL------YAVW----QEPVE------RWNFV  453 (569)
T ss_dssp             ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHHH------HHHH----TSCGG------GCSHH
T ss_pred             CC-ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchhH------HHhh----cCCCC------CCcHH
Confidence            32 234567899999999999764 6778999999999998877654431      1111    11000      01245


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccc
Q 040569          234 DFLSKCLIRNPGERWSASELLEHGFVK  260 (385)
Q Consensus       234 ~ll~~cL~~dP~~Rps~~elL~hp~~~  260 (385)
                      .+...+...+|..|+.......++|..
T Consensus       454 ~l~~~l~~~~~~~~~~~~~~~~~~~~~  480 (569)
T 4azs_A          454 LLLALFEKKAKLPSAEQQRGATEQWII  480 (569)
T ss_dssp             HHHHHHHTGGGSCCGGGSSCCHHHHHH
T ss_pred             HHHHHHhCCCCCCCCChhhhccchhHH
Confidence            677777788888888776666666654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.5e-30  Score=266.53  Aligned_cols=181  Identities=20%  Similarity=0.219  Sum_probs=141.0

Q ss_pred             eeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            5 RGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----------SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      ..+.||+|+||+||+|.  ..++.+++|......           .+.+.+|+++|++++||||+++..++.....    
T Consensus       340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~----  413 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN----  413 (540)
T ss_dssp             --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT----
T ss_pred             CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc----
Confidence            35789999999999994  457888988753221           2346899999999999999965555554444    


Q ss_pred             EEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           74 YNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      .+|||||++|++|.++++.        +..++.||+.||+|||++||+||||||+|||++.    .+||+|||+++....
T Consensus       414 ~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~DFGla~~~~~  481 (540)
T 3en9_A          414 KRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIIDFGLGKISNL  481 (540)
T ss_dssp             TEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECCCTTCEECCC
T ss_pred             cEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEECccCEECCC
Confidence            4689999999999999886        6689999999999999999999999999999986    499999999998643


Q ss_pred             cCCCC------CCccccCCcccChhhhcC--CCCCCCCChHHHHHHHHHHHhCCCCCC
Q 040569          154 NEDDE------GKPICGTPICMAPEVARG--EEQGFPADVWALGCTVLEMATGRPPWP  203 (385)
Q Consensus       154 ~~~~~------~~~~~Gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~Pf~  203 (385)
                      .....      ....+||+.|||||++..  ..|+..+|+||..+-..+.+.++.+|.
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            21111      135689999999999987  567788999999999999988887763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=1e-26  Score=219.12  Aligned_cols=153  Identities=20%  Similarity=0.156  Sum_probs=122.5

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---------------------HHHHHHHHHHHHhcCCCCeeeee
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---------------------SEFLQREQRILSALACPQIVAYK   61 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---------------------~~~~~~E~~il~~l~hpnIv~~~   61 (385)
                      |.+++.||+|+||.||+|.+ .+|+.+|+|.+....                     ...+.+|+.+|++++  | +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            55679999999999999999 889999999886422                     245789999999999  4 5555


Q ss_pred             eeeeeccCCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeE
Q 040569           62 GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAK  141 (385)
Q Consensus        62 ~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~k  141 (385)
                      +++.. ..    .++||||++||+|.+ +..      .....++.||+.||.|||++||+||||||+|||++ ++.  +|
T Consensus       168 ~~~~~-~~----~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~--vk  232 (282)
T 1zar_A          168 KVYAW-EG----NAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG--IW  232 (282)
T ss_dssp             CEEEE-ET----TEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE--EE
T ss_pred             eEEec-cc----eEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc--EE
Confidence            54432 22    468999999999998 432      23557999999999999999999999999999999 555  99


Q ss_pred             EeecCceeeecccCCCCCCccccCCcccChhhhcC----------CCCCCCCChHHH
Q 040569          142 IADFGCARRARVNEDDEGKPICGTPICMAPEVARG----------EEQGFPADVWAL  188 (385)
Q Consensus       142 L~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~----------~~~~~~~DiwSl  188 (385)
                      |+|||+|+.              +..++|||++.+          ..++..+|+|.+
T Consensus       233 l~DFG~a~~--------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~  275 (282)
T 1zar_A          233 IIDFPQSVE--------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA  275 (282)
T ss_dssp             ECCCTTCEE--------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred             EEECCCCeE--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence            999999974              445899999864          346677777754

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.88  E-value=1.1e-22  Score=188.94  Aligned_cols=134  Identities=22%  Similarity=0.196  Sum_probs=106.5

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcE--EEEEeccCCCH---------------------------HHHHHHHHHHHhcC
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEV--FAVKSAELSNS---------------------------EFLQREQRILSALA   53 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~--~AvK~~~~~~~---------------------------~~~~~E~~il~~l~   53 (385)
                      |.+++.||+|+||.||+|.+..+|+.  ||||++.....                           ..+.+|+.+|+++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56889999999999999999778999  99998643211                           25778999999998


Q ss_pred             CCCe--eeeeeeeeeccCCeEEEEEEEeecCC-C----CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccC
Q 040569           54 CPQI--VAYKGCDISEENGKILYNLFLEYAPG-G----TLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH-SNGIVHCDI  125 (385)
Q Consensus        54 hpnI--v~~~~~~~~~~~~~~~~~lv~Ey~~g-g----sL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH-~~givHrDl  125 (385)
                      |+++  +..+..    ..    .+|||||+.+ |    +|.+....   .++..+..++.||+.||.||| ++||+||||
T Consensus       129 ~~~i~~p~~~~~----~~----~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDl  197 (258)
T 1zth_A          129 EAGVSVPQPYTY----MK----NVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADL  197 (258)
T ss_dssp             HTTCCCCCEEEE----ET----TEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred             hCCCCCCeEEEc----CC----CEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence            8764  333321    12    4589999942 3    67776543   346678899999999999999 999999999


Q ss_pred             CCCCEEeecCCCCCeEEeecCceeee
Q 040569          126 KGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus       126 Kp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      ||+|||++.    .++|+|||+|...
T Consensus       198 kp~NILl~~----~~~liDFG~a~~~  219 (258)
T 1zth_A          198 SEYNIMYID----KVYFIDMGQAVTL  219 (258)
T ss_dssp             STTSEEESS----SEEECCCTTCEET
T ss_pred             CHHHEEEcC----cEEEEECcccccC
Confidence            999999985    4999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.76  E-value=5.2e-19  Score=172.46  Aligned_cols=135  Identities=15%  Similarity=0.170  Sum_probs=99.5

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----------------HH--------HHHHHHHHHHhcCCCCe
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----------------SE--------FLQREQRILSALACPQI   57 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----------------~~--------~~~~E~~il~~l~hpnI   57 (385)
                      |.+++.||+|++|.||+|.+. +|+.+|||++....                 ..        ..++|...|.++.+..+
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            889999999999999999985 69999999764210                 01        12457777877755444


Q ss_pred             eeeeeeeeeccCCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCC
Q 040569           58 VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNE  137 (385)
Q Consensus        58 v~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~  137 (385)
                      ....-+ ....     .+|||||++|++|.++..      ...+..++.||+.+|.|||++|||||||||.|||++.++.
T Consensus       176 ~vp~p~-~~~~-----~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          176 PVPEPI-AQSR-----HTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             SCCCEE-EEET-----TEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred             CCCeee-eccC-----ceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence            221111 1112     248999999998876432      2345678899999999999999999999999999987653


Q ss_pred             C--------CeEEeecCceee
Q 040569          138 Q--------GAKIADFGCARR  150 (385)
Q Consensus       138 ~--------~~kL~DFG~a~~  150 (385)
                      .        .+.|+||+-+..
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEE
T ss_pred             cccccccccceEEEEeCCccc
Confidence            2        278999997654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.43  E-value=4.9e-13  Score=123.24  Aligned_cols=136  Identities=18%  Similarity=0.161  Sum_probs=105.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC---CCHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL---SNSEFLQREQRILSALA-CPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~---~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      .|+....++.|+.+.||++...  +..+++|....   .....+++|.++|+.+. +..+++++++....  +.  .++|
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~--~~lv   88 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GW--SNLL   88 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TE--EEEE
T ss_pred             cceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC--Cc--eEEE
Confidence            4777888888999999999754  68999998864   34456889999999994 66677787765543  22  5689


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS----------------------------------------  117 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~----------------------------------------  117 (385)
                      |||++|.+|.+.+.     +......++.++..+|..||+                                        
T Consensus        89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            99999999987632     222345788999999999998                                        


Q ss_pred             -------------------CCceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569          118 -------------------NGIVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus       118 -------------------~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                                         ..++|+|++|.|||++.+.  .+.|+||+.+..
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~--~~~lIDwe~a~~  213 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK--VSGFIDLGRSGR  213 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE--EEEECCCTTCEE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc--EEEEEEchhccc
Confidence                               4489999999999997432  146999998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.31  E-value=3.6e-12  Score=116.54  Aligned_cols=127  Identities=24%  Similarity=0.121  Sum_probs=91.0

Q ss_pred             eccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcCCCC--eeeeeeeeeeccCCeEEEEEEEeecCCCCHH
Q 040569           10 GRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQ--IVAYKGCDISEENGKILYNLFLEYAPGGTLT   87 (385)
Q Consensus        10 G~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~hpn--Iv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~   87 (385)
                      +.|..+.||++.. .+|..+++|.........+.+|+.+|+.+.+.+  +++++++......    .++||||++|.+|.
T Consensus        29 ~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~----~~~v~e~i~G~~l~  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGR----DWLLLGEVPGQDLL  103 (264)
T ss_dssp             CTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC----EEEEEECCSSEETT
T ss_pred             cCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC----CEEEEEecCCcccC
Confidence            4556699999964 467789999876554456789999999995434  4557666543322    56899999998884


Q ss_pred             HHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC------------------------------------------------
Q 040569           88 DAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG------------------------------------------------  119 (385)
Q Consensus        88 ~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~g------------------------------------------------  119 (385)
                        ...   .+   ...++.++...|..||+..                                                
T Consensus       104 --~~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  175 (264)
T 1nd4_A          104 --SSH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK  175 (264)
T ss_dssp             --TSC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred             --cCc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence              211   12   2356777778888888643                                                


Q ss_pred             ----------ceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569          120 ----------IVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus       120 ----------ivHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                                ++|+|++|.|||++.++  .+.|+|||.+...
T Consensus       176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~--~~~liD~~~a~~g  215 (264)
T 1nd4_A          176 ARMPDGEDLVVTHGDACLPNIMVENGR--FSGFIDCGRLGVA  215 (264)
T ss_dssp             HTCCSSCCEEEECSSCCGGGEEEETTE--EEEECCCTTCEEE
T ss_pred             HhcCCCCCeEEECCCCCCCcEEEECCc--EEEEEcchhcccC
Confidence                      99999999999997542  1469999988653

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.22  E-value=3.9e-11  Score=115.83  Aligned_cols=141  Identities=15%  Similarity=0.192  Sum_probs=104.0

Q ss_pred             eeceeeccCceEEEEEEECCCCcEEEEEecc--CCC----HHHHHHHHHHHHhcC--CCCeeeeeeeeeeccC-CeEEEE
Q 040569            5 RGQTIGRGSTATVSIGMSNRSSEVFAVKSAE--LSN----SEFLQREQRILSALA--CPQIVAYKGCDISEEN-GKILYN   75 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~--~~~----~~~~~~E~~il~~l~--hpnIv~~~~~~~~~~~-~~~~~~   75 (385)
                      ..+.|+.|.++.||++...  +..+++|...  ...    ...+.+|..+|+.|.  +..+++++.++..... +.  .+
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~--~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR--AF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS--CE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC--eE
Confidence            4678999999999998764  4678888776  322    356889999999996  3456777766543321 22  34


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS--------------------------------------  117 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~--------------------------------------  117 (385)
                      +||||++|..+.+..  -..+++.....++.++...|..||+                                      
T Consensus       118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            799999998875421  2237888889999999999999997                                      


Q ss_pred             --------------------CCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569          118 --------------------NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus       118 --------------------~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                                          ..++|+|++|.|||++.++...+.|+||+.+...
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                3689999999999998664332589999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.12  E-value=6.8e-11  Score=111.51  Aligned_cols=184  Identities=18%  Similarity=0.136  Sum_probs=121.2

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhc-CCCC--eeeeeeeeeeccCCeEEEEEEEeec
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSAL-ACPQ--IVAYKGCDISEENGKILYNLFLEYA   81 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l-~hpn--Iv~~~~~~~~~~~~~~~~~lv~Ey~   81 (385)
                      .+.++.|....||++.     ..+++|..... ....+.+|.++|+.+ .+..  +++.+..... .....+.|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~-~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP-SETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC-CSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCC-CCCCCcceEEEccc
Confidence            5678999999999863     46888976533 246788999999988 3322  2333332211 22122345799999


Q ss_pred             CCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 040569           82 PGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS--------------------------------------------  117 (385)
Q Consensus        82 ~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~--------------------------------------------  117 (385)
                      +|.+|.+....  .++..+...++.|+...|..||+                                            
T Consensus        99 ~G~~l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  176 (304)
T 3sg8_A           99 KGVPLTPLLLN--NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF  176 (304)
T ss_dssp             CCEECCHHHHH--TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred             CCeECCccccc--cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence            99988764432  37888888899999999999986                                            


Q ss_pred             --------------CCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCCccccCCcc---cChhhhcC--CC
Q 040569          118 --------------NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC---MAPEVARG--EE  178 (385)
Q Consensus       118 --------------~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y---~aPE~~~~--~~  178 (385)
                                    ..++|+|++|.||+++.+....+.|+||+.+.......+.     .....+   ..|+....  ..
T Consensus       177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-----~~~~~~~~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-----ISLMEDDEEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-----HTTCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-----HHHHhhccccCHHHHHHHHHH
Confidence                          1369999999999998642223689999998764211100     000111   23333211  01


Q ss_pred             CC------------CCCChHHHHHHHHHHHhCCCCC
Q 040569          179 QG------------FPADVWALGCTVLEMATGRPPW  202 (385)
Q Consensus       179 ~~------------~~~DiwSlG~il~elltG~~Pf  202 (385)
                      |+            ...+.|++|.+++.+.+|..+|
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            11            1258999999999999998876

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.66  E-value=1.7e-07  Score=88.41  Aligned_cols=137  Identities=15%  Similarity=0.161  Sum_probs=92.5

Q ss_pred             eeceeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhcCCC---CeeeeeeeeeeccCCeEEEEEEEee
Q 040569            5 RGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALACP---QIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l~hp---nIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      ..+.++.|....||+.     +..+++|..... ....+.+|.++|+.|.+.   .+++.+.+... ..+.  .+++|||
T Consensus        23 ~v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~--~~~v~e~   94 (306)
T 3tdw_A           23 SVESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGN--PFVGYRK   94 (306)
T ss_dssp             CEEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSC--EEEEEEC
T ss_pred             eeeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCc--eEEEEec
Confidence            3567888999999998     567888885432 235788999999999642   23444444322 2233  3489999


Q ss_pred             cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------------
Q 040569           81 APGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN------------------------------------------  118 (385)
Q Consensus        81 ~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~------------------------------------------  118 (385)
                      ++|.+|.+..-.  .+++.....++.++...|..||+.                                          
T Consensus        95 i~G~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           95 VQGQILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             CCSEECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             cCCeECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            999888764322  245555666666666666666642                                          


Q ss_pred             ------------------CceeccCCCCCEEeecCC-CCCe-EEeecCceeee
Q 040569          119 ------------------GIVHCDIKGQNILVSKDN-EQGA-KIADFGCARRA  151 (385)
Q Consensus       119 ------------------givHrDlKp~NILi~~~~-~~~~-kL~DFG~a~~~  151 (385)
                                        .++|+|++|.|||++.+. ...+ .|+||+.+...
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                              359999999999998621 1224 89999988764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.64  E-value=1.9e-07  Score=85.87  Aligned_cols=134  Identities=17%  Similarity=0.092  Sum_probs=92.1

Q ss_pred             eeeccCce-EEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccCCeEEEEEEEeecCCCC
Q 040569            8 TIGRGSTA-TVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALA-CPQIVAYKGCDISEENGKILYNLFLEYAPGGT   85 (385)
Q Consensus         8 ~LG~G~~g-~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggs   85 (385)
                      .+..|..+ .||+......+..+++|.........+.+|..+|+.|. +--+.+.+.+....+  .  .++|||+++|.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~--~--~~lvme~l~G~~  106 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD--D--AWLLTTAIPGKT  106 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT--E--EEEEEECCCSEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECC--e--EEEEEEeeCCcc
Confidence            45556555 79998887778889999887666778899999999884 222445555544332  2  458999999988


Q ss_pred             HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------------
Q 040569           86 LTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN-----------------------------------------------  118 (385)
Q Consensus        86 L~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~-----------------------------------------------  118 (385)
                      +.+.....    ......+..++...|.-||+.                                               
T Consensus       107 ~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          107 AFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             HHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             ccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence            87765432    122334555555666666531                                               


Q ss_pred             -----------CceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569          119 -----------GIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus       119 -----------givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                                 .++|+|+.|.|||++.++-  +-|+||+.+...
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~--~~viDwe~a~~g  224 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKL--IGCIDVGRVGIA  224 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEE--EEECCCTTCEEE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeE--EEEEECcccccC
Confidence                       1689999999999985431  469999988653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.29  E-value=2.8e-06  Score=82.76  Aligned_cols=74  Identities=16%  Similarity=0.028  Sum_probs=48.0

Q ss_pred             eeceeeccCceEEEEEEECCCCcEEEEEeccCC----------CHHHHHHHHHHHHhcCC--CC-eeeeeeeeeeccCCe
Q 040569            5 RGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS----------NSEFLQREQRILSALAC--PQ-IVAYKGCDISEENGK   71 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~----------~~~~~~~E~~il~~l~h--pn-Iv~~~~~~~~~~~~~   71 (385)
                      ..+.||.|..+.||++....+++.++||.....          ..+.+.+|.++|+.+..  |. +++++.+  +...  
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~--  109 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM--  109 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT--
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc--
Confidence            356899999999999987666788999975421          12356789999998732  33 3455543  2222  


Q ss_pred             EEEEEEEeecCCC
Q 040569           72 ILYNLFLEYAPGG   84 (385)
Q Consensus        72 ~~~~lv~Ey~~gg   84 (385)
                        .++||||++|.
T Consensus       110 --~~lvmE~l~g~  120 (397)
T 2olc_A          110 --AVTVMEDLSHL  120 (397)
T ss_dssp             --TEEEECCCTTS
T ss_pred             --cEEEEEeCCCc
Confidence              24899999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.20  E-value=1.7e-05  Score=74.84  Aligned_cols=77  Identities=17%  Similarity=0.097  Sum_probs=43.6

Q ss_pred             eeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcC-----CCCeeeee-eeeeeccCCeEEEEEEE
Q 040569            5 RGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALA-----CPQIVAYK-GCDISEENGKILYNLFL   78 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~-----hpnIv~~~-~~~~~~~~~~~~~~lv~   78 (385)
                      ..+.|+.|..+.||++...  +..+++|.... ..+.+..|..+++.|.     .|.++... +.......+.  .+++|
T Consensus        36 ~~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~-~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~--~~~l~  110 (346)
T 2q83_A           36 KIDVIQGNQMALVWKVHTD--SGAVCLKRIHR-PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSF--LFVVY  110 (346)
T ss_dssp             EEEECC----CEEEEEEET--TEEEEEEEECS-CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTE--EEEEE
T ss_pred             EeeeccccccCcEEEEEeC--CCCEEEEecCC-CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCE--EEEEE
Confidence            3456666778999998764  34589998876 3455666777777663     24444311 1111111222  45899


Q ss_pred             eecCCCCH
Q 040569           79 EYAPGGTL   86 (385)
Q Consensus        79 Ey~~ggsL   86 (385)
                      ||++|.++
T Consensus       111 ~~i~G~~~  118 (346)
T 2q83_A          111 DWIEGRPF  118 (346)
T ss_dssp             ECCCCBCC
T ss_pred             EeecCccC
Confidence            99998654

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.14  E-value=2.3e-06  Score=81.96  Aligned_cols=80  Identities=9%  Similarity=0.157  Sum_probs=51.8

Q ss_pred             ecee-eccCceEEEEEEEC--C----CCcEEEEEeccCCC------HHHHHHHHHHHHhcC-C--CCeeeeeeeeeeccC
Q 040569            6 GQTI-GRGSTATVSIGMSN--R----SSEVFAVKSAELSN------SEFLQREQRILSALA-C--PQIVAYKGCDISEEN   69 (385)
Q Consensus         6 ~~~L-G~G~~g~Vy~a~~~--~----~~~~~AvK~~~~~~------~~~~~~E~~il~~l~-h--pnIv~~~~~~~~~~~   69 (385)
                      .+.| +.|..+.+|+....  .    ++..+++|......      ...+.+|..+|+.|. +  -.+++++.+......
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4667 78888999988653  1    25678999765422      246788999999883 2  345666655433210


Q ss_pred             -CeEEEEEEEeecCCCCHH
Q 040569           70 -GKILYNLFLEYAPGGTLT   87 (385)
Q Consensus        70 -~~~~~~lv~Ey~~ggsL~   87 (385)
                       +.  .++||||++|.++.
T Consensus       105 ~g~--~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGT--PFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSS--CEEEEECCCCBCCC
T ss_pred             cCC--ceEEEEecCCCChh
Confidence             22  34799999986653

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.85  E-value=7.6e-05  Score=66.31  Aligned_cols=121  Identities=12%  Similarity=0.067  Sum_probs=78.5

Q ss_pred             CHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCCcc
Q 040569           85 TLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPI  162 (385)
Q Consensus        85 sL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~-~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~  162 (385)
                      ||.++++ .+.+++|++++.++.|.+..|.-+-. +.-..+=+.|..|++..+|.  |-..+ +.+.             
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~~-~~s~-------------   97 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLAP-AADD-------------   97 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEECC-C----------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eeccc-cccc-------------
Confidence            6999998 68899999999999999999877622 22223445578899988776  44332 1110             


Q ss_pred             ccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhc
Q 040569          163 CGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIR  242 (385)
Q Consensus       163 ~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~  242 (385)
                      .....+.|||... ...+.+.=|||||+++|.-+--..                    .+.-+..+|+++.+||..|..-
T Consensus        98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL--------------------~e~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A           98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL--------------------KENEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             ---------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC--------------------CTTEEECCCHHHHHHHHHHTTC
T ss_pred             ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC--------------------CcccchhhCHHHHHHHHHHHhc
Confidence            1233567888763 234456789999999999984221                    1222345899999999999865

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.85  E-value=9.5e-05  Score=69.83  Aligned_cols=76  Identities=20%  Similarity=0.148  Sum_probs=56.7

Q ss_pred             eeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcC---CCCeeeeeeeeeeccCCeEEEEEEEeec
Q 040569            5 RGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALA---CPQIVAYKGCDISEENGKILYNLFLEYA   81 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~---hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (385)
                      ..+.|+.|....+|+...  ++..+++|.........+.+|...|+.|.   ...+++.+.+....  +.  .++||||+
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~--~~lvme~l  113 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GH--SFLLLEAL  113 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SE--EEEEEECC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--Cc--eEEEEEec
Confidence            457789999999999875  46788899887666778899999999883   24556666554332  22  56899999


Q ss_pred             CCCCH
Q 040569           82 PGGTL   86 (385)
Q Consensus        82 ~ggsL   86 (385)
                      +|..+
T Consensus       114 ~G~~~  118 (312)
T 3jr1_A          114 NKSKN  118 (312)
T ss_dssp             CCCCC
T ss_pred             cCCCC
Confidence            99764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.83  E-value=8e-05  Score=69.53  Aligned_cols=72  Identities=15%  Similarity=0.057  Sum_probs=44.5

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHH--HHHHHHHHHHhcCCCCe-eeeeeeeeeccCCeEEEEEEEe
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE--FLQREQRILSALACPQI-VAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~--~~~~E~~il~~l~hpnI-v~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      |.-.+.|+.|....+|+.      ..+++|........  ..++|..+++.+..-.+ .++++.+  .+.+    ++++|
T Consensus        20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~----~~v~e   87 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATG----VMVTR   87 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTC----CEEEE
T ss_pred             ccceeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCC----EEEEe
Confidence            555788999999999998      46888877643222  23578888887732222 3444432  2222    26899


Q ss_pred             ec-CCCCH
Q 040569           80 YA-PGGTL   86 (385)
Q Consensus        80 y~-~ggsL   86 (385)
                      |+ +|.+|
T Consensus        88 ~i~~g~~l   95 (301)
T 3dxq_A           88 YIAGAQTM   95 (301)
T ss_dssp             CCTTCEEC
T ss_pred             ecCCCccC
Confidence            99 66544

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.78  E-value=0.0001  Score=72.23  Aligned_cols=32  Identities=16%  Similarity=0.390  Sum_probs=27.1

Q ss_pred             HCCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569          117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus       117 ~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      ...++|+|++|.|||++.++   ++|+||+.+...
T Consensus       231 ~~~liHGDl~~~Nil~~~~~---~~lID~e~a~~G  262 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS---TQVIDPEFSFYG  262 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC---EEECCCTTCEEE
T ss_pred             CCeEEecCCCCCcEEEeCCC---CEEEeCcccccC
Confidence            45799999999999997542   999999988764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.54  E-value=0.0003  Score=66.44  Aligned_cols=139  Identities=14%  Similarity=0.069  Sum_probs=72.6

Q ss_pred             eceeeccCceE-EEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcCC--CCeeeeeeeeeeccCCeEEEEEEEeecC
Q 040569            6 GQTIGRGSTAT-VSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALAC--PQIVAYKGCDISEENGKILYNLFLEYAP   82 (385)
Q Consensus         6 ~~~LG~G~~g~-Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~h--pnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (385)
                      .+.|+.|.... +|+... .++..+++|.......+.+..|+.+++.+..  -.+++++.+  +...+    +++||++.
T Consensus        23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~--d~~~g----~ll~e~l~   95 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAE--EHARG----LLLIEDLG   95 (333)
T ss_dssp             ECC--------CCEEEEC-TTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEE--ETTTT----EEEECCCC
T ss_pred             eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeee--cCCCC----EEEEeeCC
Confidence            45566665554 667653 2366788887654332455678888887732  224445543  22333    26899998


Q ss_pred             CCCHHHHHHcC--------------------------CCCCHHHHH-------H-HH------------HHHHHHHHHHH
Q 040569           83 GGTLTDAIRSG--------------------------TCLEEGRIR-------S-HT------------RAVLLGLQYLH  116 (385)
Q Consensus        83 ggsL~~~l~~~--------------------------~~l~e~~~~-------~-i~------------~qil~gL~yLH  116 (385)
                      +.++.+.+...                          ..++.....       . +.            ..+...++.+.
T Consensus        96 ~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~  175 (333)
T 3csv_A           96 DALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQIL  175 (333)
T ss_dssp             SCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred             CcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence            76665444211                          112221110       0 00            01111222221


Q ss_pred             ------HCCceeccCCCCCEEeecCC--CCCeEEeecCceeee
Q 040569          117 ------SNGIVHCDIKGQNILVSKDN--EQGAKIADFGCARRA  151 (385)
Q Consensus       117 ------~~givHrDlKp~NILi~~~~--~~~~kL~DFG~a~~~  151 (385)
                            ...++|||+.+.||+++.+.  ...+.|+||+.+...
T Consensus       176 ~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          176 SAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             HHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             HhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence                  24699999999999997541  134899999988764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.44  E-value=0.00033  Score=65.65  Aligned_cols=140  Identities=18%  Similarity=0.247  Sum_probs=76.4

Q ss_pred             eeceeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhcC-----CCCeeeee-eeeeeccCCeEEEEEE
Q 040569            5 RGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALA-----CPQIVAYK-GCDISEENGKILYNLF   77 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l~-----hpnIv~~~-~~~~~~~~~~~~~~lv   77 (385)
                      ..+.|+.|....+|+....  +..+++|..... ..+.+..|..+++.|.     .|.++... |.......+.  .+++
T Consensus        26 ~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~--~~~l  101 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR--PAAL  101 (322)
T ss_dssp             EEEEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE--EEEE
T ss_pred             EeeccCCCcccceEEEEeC--CccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE--EEEE
Confidence            3566777888999998764  336889988752 3456778899888773     23333211 1000011122  4579


Q ss_pred             EeecCCCCHH-----------HH---HH-cCCCC--------CHHHHHH---------------HHHHHHHHHHHHHH--
Q 040569           78 LEYAPGGTLT-----------DA---IR-SGTCL--------EEGRIRS---------------HTRAVLLGLQYLHS--  117 (385)
Q Consensus        78 ~Ey~~ggsL~-----------~~---l~-~~~~l--------~e~~~~~---------------i~~qil~gL~yLH~--  117 (385)
                      ++|++|..+.           ..   ++ ....+        ....-..               +...+...++.++.  
T Consensus       102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~  181 (322)
T 2ppq_A          102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW  181 (322)
T ss_dssp             EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred             EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence            9999986531           11   11 01011        1000000               00113444555553  


Q ss_pred             -----CCceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569          118 -----NGIVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus       118 -----~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                           .+++|+|+.+.|||++.++.  +.|+||+.+..
T Consensus       182 ~~~~~~~liHgDl~~~Nil~~~~~~--~~lIDf~~a~~  217 (322)
T 2ppq_A          182 PKDLPAGVIHADLFQDNVFFLGDEL--SGLIDFYFACN  217 (322)
T ss_dssp             CCSSCEEEECSCCCGGGEEEETTEE--EEECCCTTCEE
T ss_pred             cccCCcccCCCCCCccCEEEeCCce--EEEecchhccC
Confidence                 36999999999999985421  37999988764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.38  E-value=0.0019  Score=59.54  Aligned_cols=74  Identities=12%  Similarity=0.031  Sum_probs=51.8

Q ss_pred             eeeceeeccCceEEEEEEECCCCcEEEEEeccCC---CHHHHHHHHHHHHhcCCC---CeeeeeeeeeeccCCeEEEEEE
Q 040569            4 TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---NSEFLQREQRILSALACP---QIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~---~~~~~~~E~~il~~l~hp---nIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      ...+.+|.|..+.||+.... +|+.|.+|.....   ....+++|...|+.|..-   -+++.++.   . .    -++|
T Consensus        18 ~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~-~----~~lv   88 (288)
T 3f7w_A           18 AAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW---D-D----RTLA   88 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---E-T----TEEE
T ss_pred             EEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec---c-C----ceEE
Confidence            45678899999999999864 6889999986532   235788999999988321   23334332   1 1    1379


Q ss_pred             EeecCCCCH
Q 040569           78 LEYAPGGTL   86 (385)
Q Consensus        78 ~Ey~~ggsL   86 (385)
                      |||+.++..
T Consensus        89 ~e~l~~~~~   97 (288)
T 3f7w_A           89 MEWVDERPP   97 (288)
T ss_dssp             EECCCCCCC
T ss_pred             EEeecccCC
Confidence            999988653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.37  E-value=0.00053  Score=67.56  Aligned_cols=73  Identities=16%  Similarity=0.153  Sum_probs=49.6

Q ss_pred             eeceeeccCceEEEEEEECC-------CCcEEEEEeccC-CCHHHHHHHHHHHHhcCCCCe-eeeeeeeeeccCCeEEEE
Q 040569            5 RGQTIGRGSTATVSIGMSNR-------SSEVFAVKSAEL-SNSEFLQREQRILSALACPQI-VAYKGCDISEENGKILYN   75 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~-------~~~~~AvK~~~~-~~~~~~~~E~~il~~l~hpnI-v~~~~~~~~~~~~~~~~~   75 (385)
                      ..+.|+.|-...||++....       .+..+++|+... ...+.+.+|..+++.|...++ +++++.+   .++     
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~---~~g-----  148 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF---SGG-----  148 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE---TTE-----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe---CCC-----
Confidence            35678888889999998653       257889998854 232666689999998843333 4555543   221     


Q ss_pred             EEEeecCCCC
Q 040569           76 LFLEYAPGGT   85 (385)
Q Consensus        76 lv~Ey~~ggs   85 (385)
                      +|+||++|-+
T Consensus       149 ~v~e~l~G~~  158 (429)
T 1nw1_A          149 RLEEYIPSRP  158 (429)
T ss_dssp             EEECCCCEEE
T ss_pred             EEEEEeCCcc
Confidence            6899998744

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.28  E-value=0.0011  Score=62.27  Aligned_cols=76  Identities=13%  Similarity=0.104  Sum_probs=47.3

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEeccC--CCHHHHHHHHHHHHhcCCCC--eeeeeee---eeeccCCeEEEEEEE
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAEL--SNSEFLQREQRILSALACPQ--IVAYKGC---DISEENGKILYNLFL   78 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~--~~~~~~~~E~~il~~l~hpn--Iv~~~~~---~~~~~~~~~~~~lv~   78 (385)
                      ...|+ |....||++... +|+.+++|....  ...+.+.+|..+++.|....  +++.+..   ......+  ..++++
T Consensus        31 ~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g--~~~~l~  106 (328)
T 1zyl_A           31 LTPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQG--FYFAVF  106 (328)
T ss_dssp             CEEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETT--EEEEEE
T ss_pred             EEeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECC--EEEEEE
Confidence            34566 778899987543 466799998863  24677888999998883212  3333332   0001122  245799


Q ss_pred             eecCCCC
Q 040569           79 EYAPGGT   85 (385)
Q Consensus        79 Ey~~ggs   85 (385)
                      ||++|.+
T Consensus       107 ~~i~G~~  113 (328)
T 1zyl_A          107 PSVGGRQ  113 (328)
T ss_dssp             ECCCCEE
T ss_pred             EecCCCC
Confidence            9998854

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.23  E-value=0.00097  Score=64.60  Aligned_cols=137  Identities=16%  Similarity=0.146  Sum_probs=80.9

Q ss_pred             eceeeccCceEEEEEEECC-------CCcEEEEEeccC--CCHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccCCeEEEE
Q 040569            6 GQTIGRGSTATVSIGMSNR-------SSEVFAVKSAEL--SNSEFLQREQRILSALA-CPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~-------~~~~~AvK~~~~--~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      .+.|..|-...+|++....       .++.+++|+...  .....+.+|.++++.|. +.-..++++.+   .++     
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~---~~g-----  126 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF---PEG-----  126 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE---TTE-----
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc---CCc-----
Confidence            4566677788999987642       357899998643  23566779999999883 22234555443   221     


Q ss_pred             EEEeecCCCCHH--------------HHHH---c-----CCCCC--HHHHHHHHHHHHH-------------------HH
Q 040569           76 LFLEYAPGGTLT--------------DAIR---S-----GTCLE--EGRIRSHTRAVLL-------------------GL  112 (385)
Q Consensus        76 lv~Ey~~ggsL~--------------~~l~---~-----~~~l~--e~~~~~i~~qil~-------------------gL  112 (385)
                      +||||++|.+|.              +.++   .     +....  ...+..+..++-.                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            689999986542              1111   1     11111  3456666655422                   23


Q ss_pred             HHHH----HC----CceeccCCCCCEEeecC--CCCCeEEeecCceee
Q 040569          113 QYLH----SN----GIVHCDIKGQNILVSKD--NEQGAKIADFGCARR  150 (385)
Q Consensus       113 ~yLH----~~----givHrDlKp~NILi~~~--~~~~~kL~DFG~a~~  150 (385)
                      ..|.    ..    .++|+|+.+.||+++.+  ....+.|+||..|..
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            3332    22    48999999999999865  123489999998865

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.98  E-value=0.0022  Score=63.61  Aligned_cols=74  Identities=20%  Similarity=0.117  Sum_probs=48.5

Q ss_pred             eeceeeccCceEEEEEEECCCCcEEEEEeccCCCHH--HHHHHHHHHHhcCCCCe-eeeeeeeeeccCCeEEEEEEEeec
Q 040569            5 RGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSE--FLQREQRILSALACPQI-VAYKGCDISEENGKILYNLFLEYA   81 (385)
Q Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~--~~~~E~~il~~l~hpnI-v~~~~~~~~~~~~~~~~~lv~Ey~   81 (385)
                      ..+.|+.|-...+|++.....+..+++|+.......  ...+|..+|+.|...++ +++++.+   .++     +|+||+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~---~~G-----~v~e~I  183 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF---TNG-----RIEEFM  183 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE---TTE-----EEEECC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe---CCe-----EEEEee
Confidence            456788888899999987644578889987543222  12689999999965444 4566554   221     489999


Q ss_pred             CCCCH
Q 040569           82 PGGTL   86 (385)
Q Consensus        82 ~ggsL   86 (385)
                      +|-+|
T Consensus       184 ~G~~l  188 (458)
T 2qg7_A          184 DGYAL  188 (458)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            88543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.89  E-value=0.0019  Score=61.86  Aligned_cols=72  Identities=10%  Similarity=-0.081  Sum_probs=43.2

Q ss_pred             eceeeccCceEEEEEEECC--------CCcEEEEEeccCCCHH--HHHHHHHHHHhcCCCC-eeeeeeeeeeccCCeEEE
Q 040569            6 GQTIGRGSTATVSIGMSNR--------SSEVFAVKSAELSNSE--FLQREQRILSALACPQ-IVAYKGCDISEENGKILY   74 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~--------~~~~~AvK~~~~~~~~--~~~~E~~il~~l~hpn-Iv~~~~~~~~~~~~~~~~   74 (385)
                      .+.|+.|....+|++....        .+..+++|+.......  ...+|..+++.|...+ ++++++.+   ..     
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~---~~-----  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF---NG-----  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE---TT-----
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec---CC-----
Confidence            5677888888999997653        1367889987543221  2467899998884323 34555432   22     


Q ss_pred             EEEEeecCCCC
Q 040569           75 NLFLEYAPGGT   85 (385)
Q Consensus        75 ~lv~Ey~~ggs   85 (385)
                      ++||||++|.+
T Consensus       110 ~~v~e~i~G~~  120 (369)
T 3c5i_A          110 GRIEEWLYGDP  120 (369)
T ss_dssp             EEEEECCCSEE
T ss_pred             cEEEEEecCCc
Confidence            26899999854

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.88  E-value=0.0055  Score=58.14  Aligned_cols=31  Identities=29%  Similarity=0.412  Sum_probs=26.3

Q ss_pred             CceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569          119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus       119 givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      .++|+|+.+.||+++.++.  +.|+||+.+...
T Consensus       207 ~~~HgD~~~~N~l~~~~~~--~~~iD~e~~~~~  237 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEES--IYIIDWDEPMLA  237 (339)
T ss_dssp             EEECSCCCGGGEEECGGGC--EEECCCSSCEEE
T ss_pred             eeEeCCCCcCCEEEeCCCe--EEEEECCCCeeC
Confidence            5899999999999976544  899999887754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.28  E-value=0.024  Score=55.58  Aligned_cols=73  Identities=11%  Similarity=-0.065  Sum_probs=46.9

Q ss_pred             eceeeccCceEEEEEEECCC-------CcEEEEEeccCCCH--HHHHHHHHHHHhcC-CCCeeeeeeeeeeccCCeEEEE
Q 040569            6 GQTIGRGSTATVSIGMSNRS-------SEVFAVKSAELSNS--EFLQREQRILSALA-CPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~-------~~~~AvK~~~~~~~--~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      .+.|..|-...+|+......       ++.+++|+......  -..++|.++++.|. +.-.+++++.+   .+     +
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~---~~-----~  146 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF---PE-----G  146 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE---TT-----E
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc---CC-----C
Confidence            56677777889999987521       57889998754322  13468999999884 22234444422   22     2


Q ss_pred             EEEeecCCCCH
Q 040569           76 LFLEYAPGGTL   86 (385)
Q Consensus        76 lv~Ey~~ggsL   86 (385)
                      +|+||++|.+|
T Consensus       147 ~I~efI~G~~l  157 (424)
T 3mes_A          147 RIEEFIDGEPL  157 (424)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEeCCccC
Confidence            68999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.06  E-value=0.13  Score=49.64  Aligned_cols=31  Identities=26%  Similarity=0.366  Sum_probs=24.6

Q ss_pred             ceeccCCCCCEEeecC----CCCCeEEeecCceee
Q 040569          120 IVHCDIKGQNILVSKD----NEQGAKIADFGCARR  150 (385)
Q Consensus       120 ivHrDlKp~NILi~~~----~~~~~kL~DFG~a~~  150 (385)
                      ++|+|+.+.|||+..+    ....++++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999542    233489999998875

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=83.28  E-value=0.11  Score=51.40  Aligned_cols=57  Identities=11%  Similarity=0.063  Sum_probs=17.1

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEE------EeccC-----CCHHHHHHHHHHHHhcCCCCeeeeeeeee
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAV------KSAEL-----SNSEFLQREQRILSALACPQIVAYKGCDI   65 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~Av------K~~~~-----~~~~~~~~E~~il~~l~hpnIv~~~~~~~   65 (385)
                      .+.||   ||.||+|..+.....||+      |....     .....+.+|..+++.++|||+++.+++..
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            45666   999999998765567888      65432     12235667999999999999999987754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	385
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-69
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-69
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-69
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-68
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-68
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-68
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-67
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-67
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-65
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-65
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-64
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-64
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-63
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-62
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-61
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-60
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-58
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-58
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-56
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-56
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-55
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-54
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-54
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-53
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-52
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-52
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	9e-52
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-51
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-51
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-51
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-51
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-51
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-50
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-50
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-50
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-50
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-50
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-49
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	9e-49
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-48
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-48
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-48
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-48
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-48
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-47
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	7e-47
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-46
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-46
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-46
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-46
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-45
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-44
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-44
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-44
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-44
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-43
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-43
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-43
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-42
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-41
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-37
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-15

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (554), Expect = 1e-69
 Identities = 76/268 (28%), Positives = 121/268 (45%), Gaps = 18/268 (6%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEF---LQREQRILSALACP 55
           D+  G+ +G+G    V +    +S  + A+K    A+L  +     L+RE  I S L  P
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G             L LEYAP GT+   ++  +  +E R  ++   +   L Y 
Sbjct: 67  NILRLYGYFHDATR----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  ++H DIK +N+L+    E   KIADFG +  A          +CGT   + PE+  
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHA---PSSRRTTLCGTLDYLPPEMIE 177

Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
           G       D+W+LG    E   G+PP+           RI  S      P ++++ A+D 
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRI--SRVEFTFPDFVTEGARDL 234

Query: 236 LSKCLIRNPGERWSASELLEHGFVKEQN 263
           +S+ L  NP +R    E+LEH ++   +
Sbjct: 235 ISRLLKHNPSQRPMLREVLEHPWITANS 262

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  219 bits (559), Expect = 3e-69
 Identities = 69/282 (24%), Positives = 122/282 (43%), Gaps = 13/282 (4%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEFLQREQRILSALACPQIV 58
            +   + +G G+   V   +   +  VF  K   +    +   ++ E  I++ L  P+++
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHS 117
                   +        L LE+  GG L D I +    + E  + ++ R    GL+++H 
Sbjct: 90  NLHDAFEDKYE----MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
           + IVH DIK +NI+         KI DFG A   ++N D+  K    T    APE+   E
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLAT--KLNPDEIVKVTTATAEFAAPEIVDRE 203

Query: 178 EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI--GFSSDTPEIPGYMSKQAQDF 235
             GF  D+WA+G     + +G  P+    D +  L  +         +    +S +A+DF
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262

Query: 236 LSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNS 277
           +   L + P +R +  + LEH ++K  +  L++      YN 
Sbjct: 263 IKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNK 304

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  217 bits (553), Expect = 9e-69
 Identities = 83/266 (31%), Positives = 124/266 (46%), Gaps = 21/266 (7%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS------EFLQREQRILSALACPQIVAY 60
           + IG GS   V      R+SEV A+K    S        + + +E R L  L  P  + Y
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
           +GC + E        L +EY  G            L+E  I + T   L GL YLHS+ +
Sbjct: 81  RGCYLREHT----AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQG 180
           +H D+K  NIL+S+      K+ DFG A               GTP  MAPEV    ++G
Sbjct: 137 IHRDVKAGNILLSEPGL--VKLGDFGSASI-----MAPANSFVGTPYWMAPEVILAMDEG 189

Query: 181 ---FPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
                 DVW+LG T +E+A  +PP  +  + +SAL+ I  +       G+ S+  ++F+ 
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248

Query: 238 KCLIRNPGERWSASELLEHGFVKEQN 263
            CL + P +R ++  LL+H FV  + 
Sbjct: 249 SCLQKIPQDRPTSEVLLKHRFVLRER 274

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  217 bits (554), Expect = 2e-68
 Identities = 67/313 (21%), Positives = 123/313 (39%), Gaps = 14/313 (4%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEFLQREQRILSALACPQIV 58
            +   + +G G+   V       +   FA K   +   S+ E +++E + +S L  P +V
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHS 117
                   +        +  E+  GG L + +      + E     + R V  GL ++H 
Sbjct: 87  NLHDAFEDDNE----MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
           N  VH D+K +NI+ +       K+ DFG      ++     K   GT    APEVA G+
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTA--HLDPKQSVKVTTGTAEFAAPEVAEGK 200

Query: 178 EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI--GFSSDTPEIPGYMSKQAQDF 235
             G+  D+W++G     + +G  P+    +    L  +     +        +S+  +DF
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259

Query: 236 LSKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSV-LNQQLWDSTLT 294
           + K L+ +P  R +  + LEH ++   N        P +  ++   S+      W   L 
Sbjct: 260 IRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLP 319

Query: 295 SCSSASAKERIRQ 307
                S    +R+
Sbjct: 320 PLGRISNYSSLRK 332

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (546), Expect = 3e-68
 Identities = 71/266 (26%), Positives = 112/266 (42%), Gaps = 12/266 (4%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           DW   QT+G G+   V + ++  + E  AVK  ++  +    E +++E  I   L    +
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65

Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G             LFLEY  GG L D I     + E   +     ++ G+ YLH 
Sbjct: 66  VKFYGHRREGNI----QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPEVARG 176
            GI H DIK +N+L+ + +    KI+DFG A   R N  +     +CGT   +APE+ + 
Sbjct: 122 IGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179

Query: 177 EE-QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            E    P DVW+ G  +  M  G  PW   +D                    +       
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239

Query: 236 LSKCLIRNPGERWSASELLEHGFVKE 261
           L K L+ NP  R +  ++ +  +  +
Sbjct: 240 LHKILVENPSARITIPDIKKDRWYNK 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (546), Expect = 3e-68
 Identities = 72/259 (27%), Positives = 110/259 (42%), Gaps = 12/259 (4%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALACPQIVAYKGC 63
           IGRGS  TV  G+   ++   A           S  +  + E  +L  L  P IV +   
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG--IV 121
             S   GK    L  E    GTL   ++    ++   +RS  R +L GLQ+LH+    I+
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 136

Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF 181
           H D+K  NI ++       KI D G A    +      K + GTP  MAPE+   +    
Sbjct: 137 HRDLKCDNIFITGPTGS-VKIGDLGLAT---LKRASFAKAVIGTPEFMAPEMYEEK-YDE 191

Query: 182 PADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLI 241
             DV+A G  +LEMAT   P+ +  +      R+               + ++ +  C+ 
Sbjct: 192 SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 251

Query: 242 RNPGERWSASELLEHGFVK 260
           +N  ER+S  +LL H F +
Sbjct: 252 QNKDERYSIKDLLNHAFFQ 270

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 7e-67
 Identities = 86/274 (31%), Positives = 125/274 (45%), Gaps = 18/274 (6%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ---REQRILSALACPQIV 58
            W     +G G+   V    +  +S + A K  +  + E L+    E  IL++   P IV
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLGLQYLHS 117
                   E N      + +E+  GG +   +      L E +I+   +  L  L YLH 
Sbjct: 73  KLLDAFYYENN----LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
           N I+H D+K  NIL + D +   K+ADFG + +             GTP  MAPEV   E
Sbjct: 129 NKIIHRDLKAGNILFTLDGD--IKLADFGVSAKN-TRTIQRRDSFIGTPYWMAPEVVMCE 185

Query: 178 EQ-----GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS-DTPEIPGYMSKQ 231
                   + ADVW+LG T++EMA   PP  +  +P+  L +I  S   T   P   S  
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHE-LNPMRVLLKIAKSEPPTLAQPSRWSSN 244

Query: 232 AQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK 265
            +DFL KCL +N   RW+ S+LL+H FV   + K
Sbjct: 245 FKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNK 278

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 8e-67
 Identities = 72/314 (22%), Positives = 133/314 (42%), Gaps = 14/314 (4%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVA 59
            +   + +GRG    V   +   S + +  K    + ++   +++E  IL+      I+ 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILH 65

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSN 118
                 S E       +  E+  G  + + I +    L E  I S+   V   LQ+LHS+
Sbjct: 66  LHESFESMEE----LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
            I H DI+ +NI+         KI +FG AR  ++   D  + +   P   APEV + + 
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQAR--QLKPGDNFRLLFTAPEYYAPEVHQHDV 179

Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI--GFSSDTPEIPGYMSKQAQDFL 236
                D+W+LG  V  + +G  P+         +  I     +   E    +S +A DF+
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238

Query: 237 SKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLTSC 296
            + L++    R +ASE L+H ++K++  ++ST       +     +++ + L  + + S 
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDL--NMVVSA 296

Query: 297 SSASAKERIRQLIG 310
           +  S    IR   G
Sbjct: 297 ARISCGGAIRSQKG 310

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 5e-65
 Identities = 71/309 (22%), Positives = 124/309 (40%), Gaps = 19/309 (6%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALA-CPQIVAYKGCD 64
            Q +G G    V    + R+ E FA+K   L +    +RE  +    + CP IV      
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKARREVELHWRASQCPHIVRIVDVY 74

Query: 65  ISEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVH 122
            +   G+    + +E   GG L   I  R      E       +++   +QYLHS  I H
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 134

Query: 123 CDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGF 181
            D+K +N+L +        K+ DFG A+       +     C TP  +APEV   E+   
Sbjct: 135 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 192

Query: 182 PADVWALGCTVLEMATGRPPWPD-----VADPISALHRIGFSSDTPEIPGYMSKQAQDFL 236
             D+W+LG  +  +  G PP+       ++  +    R+G           +S++ +  +
Sbjct: 193 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLI 252

Query: 237 SKCLIRNPGERWSASELLEHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLTSC 296
              L   P +R + +E + H ++ +          P+T    S     +++ W+      
Sbjct: 253 RNLLKTEPTQRMTITEFMNHPWIMQS------TKVPQTPLHTSRVLKEDKERWEDVKEEM 306

Query: 297 SSASAKERI 305
           +SA A  R+
Sbjct: 307 TSALATMRV 315

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 7e-65
 Identities = 88/273 (32%), Positives = 139/273 (50%), Gaps = 14/273 (5%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS---EFLQREQRILSALACPQIVA 59
           +TR + IG+G++ TV   M   + +  A++   L      E +  E  ++     P IV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG 119
           Y    +  +       + +EY  GG+LTD +      +EG+I +  R  L  L++LHSN 
Sbjct: 82  YLDSYLVGDE----LWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQ 136

Query: 120 IVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ 179
           ++H DIK  NIL+  D     K+ DFG   +    E  +   + GTP  MAPEV   +  
Sbjct: 137 VIHRDIKSDNILLGMDGS--VKLTDFGFCAQIT-PEQSKRSTMVGTPYWMAPEVVTRKAY 193

Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS-SDTPEIPGYMSKQAQDFLSK 238
           G   D+W+LG   +EM  G PP+ +  +P+ AL+ I  + +   + P  +S   +DFL++
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252

Query: 239 CLIRNPGERWSASELLEHGFVKEQNFKLSTLTE 271
           CL  +  +R SA ELL+H F+K     LS+LT 
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLK-IAKPLSSLTP 284

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 3e-64
 Identities = 66/272 (24%), Positives = 104/272 (38%), Gaps = 21/272 (7%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALACPQ 56
           D+    TIG GS             ++   K     S   +  + L  E  +L  L  P 
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT----CLEEGRIRSHTRAVLLGL 112
           IV Y    I   N  +   + +EY  GG L   I  GT     L+E  +      + L L
Sbjct: 65  IVRYYDRIIDRTNTTLY--IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 113 QYLH-----SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPI 167
           +  H      + ++H D+K  N+ +        K+ DFG AR    ++    K   GTP 
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILN-HDTSFAKAFVGTPY 179

Query: 168 CMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY 227
            M+PE          +D+W+LGC + E+    PP+           +I        IP  
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKI-REGKFRRIPYR 237

Query: 228 MSKQAQDFLSKCLIRNPGERWSASELLEHGFV 259
            S +  + +++ L      R S  E+LE+  +
Sbjct: 238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 7e-64
 Identities = 72/270 (26%), Positives = 122/270 (45%), Gaps = 16/270 (5%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS------EFLQREQRILSALACP 55
           D+  G+ +G GS +TV +     +S  +A+K  E  +        ++ RE+ ++S L  P
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
             V        +E    LY   L YA  G L   IR     +E   R +T  ++  L+YL
Sbjct: 69  FFVKLYFTFQDDEK---LY-FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMAPEVA 174
           H  GI+H D+K +NIL+++D     +I DFG A+               GT   ++PE+ 
Sbjct: 125 HGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD 234
             +     +D+WALGC + ++  G PP+    +      +I       + P     +A+D
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKI--IKLEYDFPEKFFPKARD 239

Query: 235 FLSKCLIRNPGERWSASELLEHGFVKEQNF 264
            + K L+ +  +R    E+  +G +K   F
Sbjct: 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  202 bits (514), Expect = 2e-63
 Identities = 69/282 (24%), Positives = 123/282 (43%), Gaps = 32/282 (11%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS------------EFLQREQRIL 49
           ++   + +GRG ++ V   +   + + +AVK  +++              E   +E  IL
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 50  SALAC-PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAV 108
             ++  P I+  K    +       + L  +    G L D +     L E   R   RA+
Sbjct: 64  RKVSGHPNIIQLKDTYETNTF----FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119

Query: 109 LLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPIC 168
           L  +  LH   IVH D+K +NIL+  D     K+ DFG +   +++  ++ + +CGTP  
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSC--QLDPGEKLREVCGTPSY 175

Query: 169 MAPEVARGEEQ------GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI---GFSS 219
           +APE+            G   D+W+ G  +  +  G PP+      +  L  I    +  
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQF 234

Query: 220 DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
            +PE   Y S   +D +S+ L+  P +R++A E L H F ++
Sbjct: 235 GSPEWDDY-SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 7e-63
 Identities = 79/310 (25%), Positives = 126/310 (40%), Gaps = 55/310 (17%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQI 57
           D+ +   +G G+   V       S  V A K   L         + RE ++L     P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66

Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           V + G   S+       ++ +E+  GG+L   ++    + E  +   + AV+ GL YL  
Sbjct: 67  VGFYGAFYSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122

Query: 118 -NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
            + I+H D+K  NILV+   E   K+ DFG + +     D       GT   M+PE  +G
Sbjct: 123 KHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG 177

Query: 177 EEQGFPADVWALGCTVLEMATGRPPW-PDVADPISALHRIGFSSDTPEIP---------- 225
                 +D+W++G +++EMA GR P  P  A  +  +       D  E P          
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237

Query: 226 ------------------------------GYMSKQAQDFLSKCLIRNPGERWSASELLE 255
                                         G  S + QDF++KCLI+NP ER    +L+ 
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297

Query: 256 HGFVKEQNFK 265
           H F+K  + +
Sbjct: 298 HAFIKRSDAE 307

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 3e-62
 Identities = 85/295 (28%), Positives = 136/295 (46%), Gaps = 21/295 (7%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILS-ALAC 54
           D+   + +G+GS   V +    ++++ FA+K           + E    E+R+LS A   
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
           P +        ++EN        +EY  GG L   I+S    +  R   +   ++LGLQ+
Sbjct: 63  PFLTHMFCTFQTKEN----LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 118

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           LHS GIV+ D+K  NIL+ KD     KIADFG  +   +  D +    CGTP  +APE+ 
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHI--KIADFGMCKENMLG-DAKTNTFCGTPDYIAPEIL 175

Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD 234
            G++     D W+ G  + EM  G+ P+    D     H I    D P  P ++ K+A+D
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSI--RMDNPFYPRWLEKEAKD 232

Query: 235 FLSKCLIRNPGERWSA-SELLEHGFVKEQNFKL---STLTEPETYNSESPTSVLN 285
            L K  +R P +R     ++ +H   +E N++      +  P     +SP    N
Sbjct: 233 LLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSN 287

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  197 bits (503), Expect = 2e-61
 Identities = 65/269 (24%), Positives = 112/269 (41%), Gaps = 14/269 (5%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK----SAELSNSEFLQREQRILSALACPQI 57
            +     +G G+ + V +    R+ ++ A+K     A       ++ E  +L  +  P I
Sbjct: 10  IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI 69

Query: 58  VAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           VA      S  +   LY L ++   GG L D I       E         VL  ++YLH 
Sbjct: 70  VALDDIYESGGH---LY-LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD 125

Query: 118 NGIVHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
            GIVH D+K +N+L    +E     I+DFG ++    +        CGTP  +APEV   
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQ 183

Query: 177 EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI--GFSSDTPEIPGYMSKQAQD 234
           +      D W++G     +  G PP+ D  +      +I              +S  A+D
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242

Query: 235 FLSKCLIRNPGERWSASELLEHGFVKEQN 263
           F+   + ++P +R++  + L+H ++    
Sbjct: 243 FIRHLMEKDPEKRFTCEQALQHPWIAGDT 271

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 4e-60
 Identities = 64/265 (24%), Positives = 116/265 (43%), Gaps = 17/265 (6%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF--LQREQRILSALACPQIVA 59
             T GQ IG GS  TV  G  +    V  +     +  +    + E  +L       I+ 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSN 118
           + G          L  +  ++  G +L   +    T  E  ++    R    G+ YLH+ 
Sbjct: 69  FMGY----STAPQLA-IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCAR-RARVNEDDEGKPICGTPICMAPEVARGE 177
            I+H D+K  NI + +D     KI DFG A  ++R +   + + + G+ + MAPEV R +
Sbjct: 124 SIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 178 EQG---FPADVWALGCTVLEMATGRPPWPDVADPISALHRIG---FSSDTPEIPGYMSKQ 231
           ++    F +DV+A G  + E+ TG+ P+ ++ +    +  +G    S D  ++     K 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241

Query: 232 AQDFLSKCLIRNPGERWSASELLEH 256
            +  +++CL +   ER    ++L  
Sbjct: 242 MKRLMAECLKKKRDERPLFPQILAS 266

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  189 bits (482), Expect = 4e-58
 Identities = 74/298 (24%), Positives = 125/298 (41%), Gaps = 30/298 (10%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACP 55
           D+   +T+G GS   V +  S  +   +A+K         L   E    E+ +LS +  P
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            I+   G     +       + ++Y  GG L   +R          + +   V L L+YL
Sbjct: 65  FIIRMWGTFQDAQQ----IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  I++ D+K +NIL+ K+     KI DFG A+       D    +CGTP  +APEV  
Sbjct: 121 HSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVS 174

Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +      D W+ G  + EM  G  P+ D ++ +    +I   +     P + ++  +D 
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKI--LNAELRFPPFFNEDVKDL 231

Query: 236 LSKCLIRNPGERW-----SASELLEHGFVKEQNF------KLSTLTEPETYNSESPTS 282
           LS+ + R+  +R         ++  H + KE  +       + T  EP     +  TS
Sbjct: 232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTS 289

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 4e-58
 Identities = 71/277 (25%), Positives = 121/277 (43%), Gaps = 20/277 (7%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---------SAELSNSEFLQREQRILSAL 52
            +  G+ +G G  A V       +   +A K         S    + E ++RE  IL  +
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70

Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGL 112
             P ++       ++ +      L LE   GG L D +     L E       + +L G+
Sbjct: 71  QHPNVITLHEVYENKTD----VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126

Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQG--AKIADFGCARRARVNEDDEGKPICGTPICMA 170
            YLHS  I H D+K +NI++   N      KI DFG A +  ++  +E K I GTP  +A
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIFGTPEFVA 184

Query: 171 PEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI--GFSSDTPEIPGYM 228
           PE+   E  G  AD+W++G     + +G  P+         L  +         E     
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNT 243

Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFK 265
           S  A+DF+ + L+++P +R +  + L+H ++K ++ +
Sbjct: 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  184 bits (468), Expect = 1e-56
 Identities = 68/270 (25%), Positives = 110/270 (40%), Gaps = 9/270 (3%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACP 55
            +  G+ +G G  + V +    R     AVK      + + S     +RE +  +AL  P
Sbjct: 8   RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            IVA      +E     L  + +EY  G TL D + +   +   R           L + 
Sbjct: 68  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 127

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           H NGI+H D+K  NI++S  N           A     N   +   + GT   ++PE AR
Sbjct: 128 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187

Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP--EIPGYMSKQAQ 233
           G+     +DV++LGC + E+ TG PP+     P+S  ++       P       +S    
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQHVREDPIPPSARHEGLSADLD 246

Query: 234 DFLSKCLIRNPGERWSASELLEHGFVKEQN 263
             + K L +NP  R+  +  +    V+  N
Sbjct: 247 AVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 3e-56
 Identities = 59/272 (21%), Positives = 103/272 (37%), Gaps = 28/272 (10%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---------SAELSNSEFLQREQRILSAL 52
            +  G  +G G   +V  G+    +   A+K           EL N   +  E  +L  +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 53  --ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL 110
                 ++         ++      +     P   L D I     L+E   RS    VL 
Sbjct: 65  SSGFSGVIRLLDWFERPDS---FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121

Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMA 170
            +++ H+ G++H DIK +NIL+  +  +  K+ DFG      + +D       GT +   
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGE-LKLIDFGS---GALLKDTVYTDFDGTRVYSP 177

Query: 171 PEVARGEE-QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMS 229
           PE  R     G  A VW+LG  + +M  G  P+    + I                  +S
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG---------QVFFRQRVS 228

Query: 230 KQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
            + Q  +  CL   P +R +  E+  H ++++
Sbjct: 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  183 bits (466), Expect = 3e-55
 Identities = 61/280 (21%), Positives = 112/280 (40%), Gaps = 24/280 (8%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALA-- 53
           D++  + IGRG    V       + +++A+K                  E+ +LS ++  
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 54  -CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGL 112
            CP IV       + +      +  L+   GG L   +       E  +R +   ++LGL
Sbjct: 65  DCPFIVCMSYAFHTPDK----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120

Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPE 172
           +++H+  +V+ D+K  NIL+ +      +I+D G A         +     GT   MAPE
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDF---SKKKPHASVGTHGYMAPE 175

Query: 173 V-ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQ 231
           V  +G      AD ++LGC + ++  G  P+                +   E+P   S +
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235

Query: 232 AQDFLSKCLIRNPGERWS-----ASELLEHGFVKEQNFKL 266
            +  L   L R+   R       A E+ E  F +  ++++
Sbjct: 236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 275

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 1e-54
 Identities = 72/275 (26%), Positives = 117/275 (42%), Gaps = 21/275 (7%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACP 55
           D+   + +G+G+   V +     +   +A+K                  E R+L     P
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            + A K    + +         +EYA GG L   +       E R R +   ++  L+YL
Sbjct: 66  FLTALKYAFQTHDR----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  +V+ DIK +N+++ KD     KI DFG  +    ++    K  CGTP  +APEV  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGI-SDGATMKTFCGTPEYLAPEVLE 178

Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
             + G   D W LG  + EM  GR P+ +  D       I    +    P  +S +A+  
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELI--LMEEIRFPRTLSPEAKSL 235

Query: 236 LSKCLIRNPGERWS-----ASELLEHGFVKEQNFK 265
           L+  L ++P +R       A E++EH F    N++
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 4e-54
 Identities = 66/261 (25%), Positives = 108/261 (41%), Gaps = 21/261 (8%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQ---REQRILSALACPQIV 58
           +    QTIG+G    V +G         AVK   + N    Q    E  +++ L    +V
Sbjct: 8   ELKLLQTIGKGEFGDVMLGDYR--GNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLV 63

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLH 116
              G  + E+ G     +  EY   G+L D +RS   + L    +   +  V   ++YL 
Sbjct: 64  QLLGVIVEEKGG---LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
            N  VH D+  +N+LVS+DN   AK++DFG  + A   +D             APE  R 
Sbjct: 121 GNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASSTQDT----GKLPVKWTAPEALRE 174

Query: 177 EEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
           ++    +DVW+ G  + E+ + GR P+P +      + R+       + P        + 
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVE-KGYKMDAPDGCPPAVYEV 232

Query: 236 LSKCLIRNPGERWSASELLEH 256
           +  C   +   R S  +L E 
Sbjct: 233 MKNCWHLDAAMRPSFLQLREQ 253

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 4e-53
 Identities = 71/292 (24%), Positives = 106/292 (36%), Gaps = 36/292 (12%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYK 61
            +T  + IG GS   V       S E+ A+K   L +  F  RE +I+  L    IV  +
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRLR 79

Query: 62  GC--DISEENGKILYNLFLEYAPGGTLTDA---IRSGTCLEEGRIRSHTRAVLLGLQYLH 116
                  E+  ++  NL L+Y P      A    R+   L    ++ +   +   L Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
           S GI H DIK QN+L+  D     K+ DFG A++    E +    IC         +   
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNV-SYICSRYYRAPELIFGA 197

Query: 177 EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP-------------- 222
            +     DVW+ GC + E+  G+P +P     +  L  I     TP              
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPG-DSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256

Query: 223 -------------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                                +A    S+ L   P  R +  E   H F  E
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 5e-52
 Identities = 56/269 (20%), Positives = 105/269 (39%), Gaps = 22/269 (8%)

Query: 8   TIGRGSTATVSIGM--SNRSSEVFAVK-----SAELSNSEFLQREQRILSALACPQIVAY 60
            +G G+  TV  G     +  +  AVK     + + +  + L  E  ++  L  P IV  
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
            G   +E      + L +E A  G L   ++    +++  I      V +G++YL  +  
Sbjct: 74  IGICEAES-----WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCAR--RARVNEDDEGKPICGTPICMAPEVARGEE 178
           VH D+  +N+L+   +   AKI+DFG ++  RA  N               APE     +
Sbjct: 129 VHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 179 QGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
               +DVW+ G  + E  + G+ P+  +         +    +    P    ++  D ++
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGM-KGSEVTAMLE-KGERMGCPAGCPREMYDLMN 244

Query: 238 KCLIRNPGERWSASEL---LEHGFVKEQN 263
            C   +   R   + +   L + +    N
Sbjct: 245 LCWTYDVENRPGFAAVELRLRNYYYDVVN 273

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  173 bits (438), Expect = 6e-52
 Identities = 45/276 (16%), Positives = 92/276 (33%), Gaps = 21/276 (7%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAY 60
           +  G+ IG GS   + +G    + E  A+K    +  + +    E +I   +     +  
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL-HIESKIYKMMQGGVGIPT 67

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
                +E +  ++     E                     +      ++  ++Y+HS   
Sbjct: 68  IRWCGAEGDYNVMVM---ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124

Query: 121 VHCDIKGQNILVSKDNEQG-AKIADFGCARRARVNEDDEG------KPICGTPICMAPEV 173
           +H D+K  N L+    +     I DFG A++ R     +       K + GT    +   
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184

Query: 174 ARGEEQGFPADVWALGCTVLEMATGRPPWP-----DVADPISALHRIGFSSDTPEIPGYM 228
             G EQ    D+ +LG  ++    G  PW              +     S+    +    
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244

Query: 229 SKQAQDFLSKCLIRNPGERWSAS---ELLEHGFVKE 261
             +   +L+ C      ++   S   +L  + F ++
Sbjct: 245 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 9e-52
 Identities = 62/288 (21%), Positives = 108/288 (37%), Gaps = 43/288 (14%)

Query: 9   IGRGSTATVSIGMSNRSSEVFAVK--------SAELSNSEFLQREQRILSALACPQIVAY 60
           +G G  ATV       ++++ A+K         A+   +    RE ++L  L+ P I+  
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
                 + N     +L  ++           +   L    I+++    L GL+YLH + I
Sbjct: 66  LDAFGHKSN----ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 121

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ- 179
           +H D+K  N+L+ ++     K+ADFG A+    + +        T    APE+  G    
Sbjct: 122 LHRDLKPNNLLLDENGV--LKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLFGARMY 178

Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP----------------- 222
           G   D+WA+GC + E+    P  P     +  L RI  +  TP                 
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPG-DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237

Query: 223 ---------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                     I         D +    + NP  R +A++ L+  +   
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 2e-51
 Identities = 72/345 (20%), Positives = 124/345 (35%), Gaps = 56/345 (16%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS----EFLQREQRILSALACPQIV 58
           +T    IG G+   V     N +    A+K           +   RE +IL       I+
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSN 118
                  +    ++     + +  G  L   +++   L    I      +L GL+Y+HS 
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIHSA 128

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP--ICGTPICMAPEVA-R 175
            ++H D+K  N+L++   +   KI DFG AR A  + D  G       T    APE+   
Sbjct: 129 NVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186

Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP------------- 222
            +      D+W++GC + EM + RP +P     +  L+ I     +P             
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPSQEDLNCIINLKA 245

Query: 223 ----------------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKL 266
                            +      +A D L K L  NP +R    + L H ++++     
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ----- 300

Query: 267 STLTEPETYNSESPTSVLNQQLWDSTLTSCSSASAKERIRQLIGE 311
               +P            + +L D           KE++++LI E
Sbjct: 301 --YYDPSDEPIAEAPFKFDMELDDLP---------KEKLKELIFE 334

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 4e-51
 Identities = 53/258 (20%), Positives = 89/258 (34%), Gaps = 13/258 (5%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVA 59
                + +G G    V +G  N  ++V AVK       + +    E  ++  L   ++V 
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHS 117
                  E        +  EY   G+L D ++  SG  L   ++      +  G+ ++  
Sbjct: 73  LYAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
              +H D++  NILVS       KIADFG AR    NE    +         APE     
Sbjct: 128 RNYIHRDLRAANILVSDTLSC--KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185

Query: 178 EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
                +DVW+ G  + E+ T              +  +         P    ++    + 
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEELYQLMR 244

Query: 238 KCLIRNPGERWSASELLE 255
            C    P +R +   L  
Sbjct: 245 LCWKERPEDRPTFDYLRS 262

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  171 bits (435), Expect = 5e-51
 Identities = 62/297 (20%), Positives = 110/297 (37%), Gaps = 45/297 (15%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALAC-PQIVAY 60
           D+   + +GRG  + V   ++  ++E   VK  +    + ++RE +IL  L   P I+  
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 95

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
                   +      L  E+          ++   L +  IR +   +L  L Y HS GI
Sbjct: 96  ADIVKDPVSRTP--ALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGI 150

Query: 121 VHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQ- 179
           +H D+K  N+++  ++ +  ++ D+G A     +   E      +     PE+    +  
Sbjct: 151 MHRDVKPHNVMIDHEHRK-LRLIDWGLAEF--YHPGQEYNVRVASRYFKGPELLVDYQMY 207

Query: 180 GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP----------------- 222
            +  D+W+LGC +  M   + P+    D    L RI     T                  
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267

Query: 223 ------------------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                             E    +S +A DFL K L  +   R +A E +EH +   
Sbjct: 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  170 bits (430), Expect = 7e-51
 Identities = 74/294 (25%), Positives = 114/294 (38%), Gaps = 41/294 (13%)

Query: 1   MD-WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----EFLQREQRILSALAC 54
           M+ +   + IG G+   V     N   E FA+K   L            RE  IL  L  
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
             IV       +++       L  E+               LE    +S    +L G+ Y
Sbjct: 60  SNIVKLYDVIHTKKR----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
            H   ++H D+K QN+L++++ E   KIADFG AR        +      T    AP+V 
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFG-IPVRKYTHEIVTLWYRAPDVL 172

Query: 175 RGEEQ-GFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGFSSDTPEIPGY---- 227
            G ++     D+W++GC   EM  G P +P    AD +  + RI  + ++   P      
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 228 --------------------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                               + +   D LSK L  +P +R +A + LEH + KE
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 7e-51
 Identities = 53/258 (20%), Positives = 95/258 (36%), Gaps = 11/258 (4%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVA 59
           + T  Q IG G    V +G    + +  A+K       + E    E  ++  L+ P++V 
Sbjct: 6   ELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCL-EEGRIRSHTRAVLLGLQYLHSN 118
             G  + +        L  E+   G L+D +R+   L     +      V  G+ YL   
Sbjct: 65  LYGVCLEQAP----ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120

Query: 119 GIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE 178
            ++H D+  +N LV ++     K++DFG  R    ++              +PEV     
Sbjct: 121 CVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178

Query: 179 QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK 238
               +DVW+ G  + E+ +      +       +  I  +      P   S      ++ 
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIMNH 237

Query: 239 CLIRNPGERWSASELLEH 256
           C    P +R + S LL  
Sbjct: 238 CWKERPEDRPAFSRLLRQ 255

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 1e-50
 Identities = 62/268 (23%), Positives = 102/268 (38%), Gaps = 21/268 (7%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSS---EVFAVK---SAELSNSEFLQ---REQRILSAL 52
           D    + +G GS   V  G  +  S      AVK      LS  E +    RE   + +L
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTD-AIRSGTCLEEGRIRSHTRAVLLG 111
               ++   G  ++         +  E AP G+L D   +       G +  +   V  G
Sbjct: 69  DHRNLIRLYGVVLTPP-----MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE--GKPICGTPICM 169
           + YL S   +H D+  +N+L++  +    KI DFG  R    N+D     +         
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 170 APEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           APE  +       +D W  G T+ EM T G+ PW  + +    LH+I    +    P   
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEGERLPRPEDC 240

Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEH 256
            +   + + +C    P +R +   L + 
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 1e-50
 Identities = 58/281 (20%), Positives = 108/281 (38%), Gaps = 27/281 (9%)

Query: 9   IGRGSTATVSIGM--SNRSSEVFAVK----SAELSNSEFLQREQRILSALACPQIVAYKG 62
           +G G+  +V  G+    +     A+K      E +++E + RE +I+  L  P IV   G
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 63  CDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
              +E        L +E A GG L   +      +    +      V +G++YL     V
Sbjct: 77  VCQAEA-----LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131

Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGK--PICGTPICMAPEVARGEEQ 179
           H D+  +N+L+   +   AKI+DFG ++    ++                APE     + 
Sbjct: 132 HRDLAARNVLLVNRHY--AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189

Query: 180 GFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLSK 238
              +DVW+ G T+ E  + G+ P+  +      +  I       E P     +    +S 
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIE-QGKRMECPPECPPELYALMSD 247

Query: 239 CLIRNPGERWSASEL---LEHGFVKEQNFKLSTLTEPETYN 276
           C I    +R     +   +   +     + L++  E   ++
Sbjct: 248 CWIYKWEDRPDFLTVEQRMRACY-----YSLASKVEGHHHH 283

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 2e-50
 Identities = 54/260 (20%), Positives = 96/260 (36%), Gaps = 15/260 (5%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK---SAELSNSEFLQREQRILSALACPQIV 58
           D T  + +G G    V  G   R     A+K      +S  EF+  E +++  L+  ++V
Sbjct: 5   DLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFI-EEAKVMMNLSHEKLV 62

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHS 117
              G    +        +  EY   G L + +R      +  ++    + V   ++YL S
Sbjct: 63  QLYGVCTKQRP----IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
              +H D+  +N LV+       K++DFG +R    +E               PEV    
Sbjct: 119 KQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 178 EQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL 236
           +    +D+WA G  + E+ + G+ P+            I         P   S++    +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERF-TNSETAEHIA-QGLRLYRPHLASEKVYTIM 234

Query: 237 SKCLIRNPGERWSASELLEH 256
             C      ER +   LL +
Sbjct: 235 YSCWHEKADERPTFKILLSN 254

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 5e-50
 Identities = 56/258 (21%), Positives = 95/258 (36%), Gaps = 13/258 (5%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVA 59
                  +G+G    V +G  N ++ V A+K       + E   +E +++  L   ++V 
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHS 117
                  E        +  EY   G+L D ++   G  L   ++      +  G+ Y+  
Sbjct: 77  LYAVVSEEP-----IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
              VH D++  NILV ++     K+ADFG AR    NE    +         APE A   
Sbjct: 132 MNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189

Query: 178 EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
                +DVW+ G  + E+ T              L ++         P    +   D + 
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLMC 248

Query: 238 KCLIRNPGERWSASELLE 255
           +C  + P ER +   L  
Sbjct: 249 QCWRKEPEERPTFEYLQA 266

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 5e-50
 Identities = 67/284 (23%), Positives = 128/284 (45%), Gaps = 27/284 (9%)

Query: 2   DWTRGQTIGRGSTATVSIGM---SNRSSEVFAVK-------SAELSNSEFLQREQRILSA 51
           ++   + +G G+   V +      + + +++A+K         +   +E  + E+++L  
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 52  LA-CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLL 110
           +   P +V       +E       +L L+Y  GG L   +       E  ++ +   ++L
Sbjct: 85  IRQSPFLVTLHYAFQTETK----LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 140

Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMA 170
            L++LH  GI++ DIK +NIL+  +      + DFG ++    +E +     CGT   MA
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVADETERAYDFCGTIEYMA 198

Query: 171 PEVARGEEQGF--PADVWALGCTVLEMATGRPPWPDVADPISALHRI--GFSSDTPEIPG 226
           P++ RG + G     D W+LG  + E+ TG  P+       ++   I        P  P 
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV-DGEKNSQAEISRRILKSEPPYPQ 257

Query: 227 YMSKQAQDFLSKCLIRNPGERWS-----ASELLEHGFVKEQNFK 265
            MS  A+D + + L+++P +R       A E+ EH F ++ N+ 
Sbjct: 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 301

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 7e-49
 Identities = 69/296 (23%), Positives = 109/296 (36%), Gaps = 41/296 (13%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSS-EVFAVK-----SAELSNSEFLQREQRILSALAC- 54
            +     IG G+   V      ++     A+K     + E        RE  +L  L   
Sbjct: 8   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67

Query: 55  --PQIVAYKG-CDISEENGKILYNLFLEYAPGGTLT-DAIRSGTCLEEGRIRSHTRAVLL 110
             P +V     C +S  + +    L  E+      T         +    I+     +L 
Sbjct: 68  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127

Query: 111 GLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMA 170
           GL +LHS+ +VH D+K QNILV+   +   K+ADFG AR    +       +  T    A
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQI--KLADFGLAR--IYSFQMALTSVVVTLWYRA 183

Query: 171 PEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP-------- 222
           PEV        P D+W++GC   EM   +P +   +  +  L +I      P        
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG-SSDVDQLGKILDVIGLPGEEDWPRD 242

Query: 223 -----------------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                            +    + +  +D L KCL  NP +R SA   L H + ++
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (417), Expect = 9e-49
 Identities = 73/301 (24%), Positives = 116/301 (38%), Gaps = 40/301 (13%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----EFLQREQRILSALACPQ 56
           ++ + + IG G+   V    +  + EV A+K   L            RE  +L  L  P 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV       +E     LY +F              + T +    I+S+   +L GL + H
Sbjct: 63  IVKLLDVIHTENK---LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
           S+ ++H D+K QN+L++ +     K+ADFG AR               T    APE+  G
Sbjct: 120 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFG-VPVRTYTHEVVTLWYRAPEILLG 176

Query: 177 EEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP------------- 222
            +      D+W+LGC   EM T R  +P     I  L RI  +  TP             
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPG-DSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 223 --------------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQNFKLST 268
                         ++   + +  +  LS+ L  +P +R SA   L H F ++    +  
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 295

Query: 269 L 269
           L
Sbjct: 296 L 296

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  164 bits (415), Expect = 1e-48
 Identities = 55/270 (20%), Positives = 101/270 (37%), Gaps = 13/270 (4%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVA 59
           D T    +G G    V  G+  + S   AVK    +    E   +E  ++  +  P +V 
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 77

Query: 60  YKGCDISEENGKILYNLFLEYAPGGTLTDAI--RSGTCLEEGRIRSHTRAVLLGLQYLHS 117
             G    E      + +  E+   G L D +   +   +    +      +   ++YL  
Sbjct: 78  LLGVCTREPP----FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGE 177
              +H D+  +N LV +++    K+ADFG +R    +               APE     
Sbjct: 134 KNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 191

Query: 178 EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS 237
           +    +DVWA G  + E+AT     P     +S ++ +       E P    ++  + + 
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMS-PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 250

Query: 238 KCLIRNPGERWSASELLE--HGFVKEQNFK 265
            C   NP +R S +E+ +      +E +  
Sbjct: 251 ACWQWNPSDRPSFAEIHQAFETMFQESSIS 280

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 2e-48
 Identities = 59/290 (20%), Positives = 101/290 (34%), Gaps = 42/290 (14%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSE-----VFAVK----SAELSNSEFLQREQRILSAL 52
           +   G+ +G G+   V    +   S+       AVK     A+ S  E L  E ++++ L
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 53  A-CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS------------------- 92
                IV   G             L  EY   G L + +RS                   
Sbjct: 98  GSHENIVNLLGACTLSGP----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 93  ----GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA 148
                  L    +      V  G+++L     VH D+  +N+LV+       KI DFG A
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFGLA 211

Query: 149 RRARVNEDDE-GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVA 206
           R    + +             MAPE          +DVW+ G  + E+ + G  P+P + 
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI- 270

Query: 207 DPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
              +  +++  +    + P Y +++    +  C   +  +R S   L   
Sbjct: 271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  164 bits (417), Expect = 4e-48
 Identities = 69/275 (25%), Positives = 117/275 (42%), Gaps = 24/275 (8%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALACP 55
            + R +T+G GS   V +     S   +A+K        +L   E    E+RIL A+  P
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYL 115
            +V  +       N      + +EY  GG +   +R      E   R +   ++L  +YL
Sbjct: 102 FLVKLEFSFKDNSN----LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157

Query: 116 HSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVAR 175
           HS  +++ D+K +N+L+ +      ++ DFG A+R           +CGTP  +APE+  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR----VKGRTWTLCGTPEALAPEIIL 211

Query: 176 GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF 235
            +      D WALG  + EMA G PP+     PI    +I   S     P + S   +D 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKI--VSGKVRFPSHFSSDLKDL 268

Query: 236 LSKCLIRNPGERW-----SASELLEHGFVKEQNFK 265
           L   L  +  +R+       +++  H +    ++ 
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 8e-48
 Identities = 54/263 (20%), Positives = 89/263 (33%), Gaps = 16/263 (6%)

Query: 2   DWTRGQTIGRGSTATVSIGM---SNRSSEVFAVKSAELSNS----EFLQREQRILSALAC 54
               G+ IG G    V  G+       +   A+K+ +   S    E   +E   +     
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTC-LEEGRIRSHTRAVLLGLQ 113
           P IV   G             + +E    G L   ++     L+   +  +   +   L 
Sbjct: 68  PHIVKLIGVITENP-----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEV 173
           YL S   VH DI  +N+LVS ++    K+ DFG +R    +   +          MAPE 
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180

Query: 174 ARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
                    +DVW  G  + E+                + RI  + +   +P        
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPPTLY 239

Query: 234 DFLSKCLIRNPGERWSASELLEH 256
             ++KC   +P  R   +EL   
Sbjct: 240 SLMTKCWAYDPSRRPRFTELKAQ 262

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 8e-48
 Identities = 61/313 (19%), Positives = 115/313 (36%), Gaps = 29/313 (9%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSA---------ELSNSEFLQREQRILSAL 52
           ++ + + +G G+  TV  G+     E   +  A           +N E L  E  +++++
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASV 68

Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAI-RSGTCLEEGRIRSHTRAVLLG 111
             P +    G  ++         L  +  P G L D +      +    + +    +  G
Sbjct: 69  DNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123

Query: 112 LQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE-GKPICGTPICMA 170
           + YL    +VH D+  +N+LV        KI DFG A+     E +   +        MA
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181

Query: 171 PEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMS 229
            E          +DVW+ G TV E+ T G  P+     P S +  I    +    P   +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--IPASEISSILEKGERLPQPPICT 239

Query: 230 KQAQDFLSKCLIRNPGERWSASELLEH-GFVKEQNFKLSTLTEPETYNSESPT------S 282
                 + KC + +   R    EL+     +     +   +   E  +  SPT      +
Sbjct: 240 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRA 299

Query: 283 VLNQQLWDSTLTS 295
           +++++  D  + +
Sbjct: 300 LMDEEDMDDVVDA 312

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 1e-47
 Identities = 65/303 (21%), Positives = 107/303 (35%), Gaps = 46/303 (15%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----EFLQREQRILSALACPQ 56
            + +   IG+G+   V      ++ +  A+K   + N          RE +IL  L    
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70

Query: 57  IVAYKGCDISEENGKILYN----LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGL 112
           +V       ++ +          L  ++                    I+   + +L GL
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 130

Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP---ICGTPICM 169
            Y+H N I+H D+K  N+L+++D     K+ADFG AR   + ++ +         T    
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 170 APEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRI--GFSSDTPEIPG 226
            PE+  GE   G P D+W  GC + EM T  P           L  I     S TPE+  
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG-NTEQHQLALISQLCGSITPEVWP 247

Query: 227 YM----------------------------SKQAQDFLSKCLIRNPGERWSASELLEHGF 258
            +                               A D + K L+ +P +R  + + L H F
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307

Query: 259 VKE 261
              
Sbjct: 308 FWS 310

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 7e-47
 Identities = 69/289 (23%), Positives = 113/289 (39%), Gaps = 40/289 (13%)

Query: 7   QTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQ---REQRILSALACPQIVAYK 61
           Q +G G+   V   +  R+    A+K       +  F +   RE R+L  +    ++   
Sbjct: 24  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83

Query: 62  GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIV 121
                +E      + +L     GT    +     L E RI+     +L GL+Y+H+ GI+
Sbjct: 84  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII 143

Query: 122 HCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEE-QG 180
           H D+K  N+ V++D E   KI DFG AR+A    D E      T    APEV        
Sbjct: 144 HRDLKPGNLAVNEDCEL--KILDFGLARQA----DSEMTGYVVTRWYRAPEVILNWMRYT 197

Query: 181 FPADVWALGCTVLEMATGRPPW--------------------PDVADPISALHRIGFSSD 220
              D+W++GC + EM TG+  +                     +    + +     +   
Sbjct: 198 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257

Query: 221 TPEIPGY--------MSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
            PE+            S  A + L K L+ +  +R +A E L H + + 
Sbjct: 258 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 2e-46
 Identities = 59/263 (22%), Positives = 96/263 (36%), Gaps = 19/263 (7%)

Query: 6   GQTIGRGSTATVSIGM---SNRSSEVFAVK----SAELSNSEFLQREQRILSALACPQIV 58
            + IGRG    V  G    ++      AVK      ++        E  I+   + P ++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 59  AYKGCDISEENGKILYNLFLEYAPGGTLTD-AIRSGTCLEEGRIRSHTRAVLLGLQYLHS 117
           +  G  +  E   ++    L Y   G L +             +      V  G+++L S
Sbjct: 92  SLLGICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 148

Query: 118 NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP---ICGTPICMAPEVA 174
              VH D+  +N ++ +      K+ADFG AR     E D              MA E  
Sbjct: 149 KKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206

Query: 175 RGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ 233
           + ++    +DVW+ G  + E+ T G PP+PDV +       +         P Y      
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYL-LQGRRLLQPEYCPDPLY 264

Query: 234 DFLSKCLIRNPGERWSASELLEH 256
           + + KC       R S SEL+  
Sbjct: 265 EVMLKCWHPKAEMRPSFSELVSR 287

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 2e-46
 Identities = 60/279 (21%), Positives = 104/279 (37%), Gaps = 35/279 (12%)

Query: 6   GQTIGRGSTATVSIG-----MSNRSSEVFAVK----SAELSNSEFLQREQRILSALA-CP 55
           G+T+G G+   V        + + ++   AVK    SA L+  E L  E ++LS L    
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS------------------GTCLE 97
            IV   G             +  EY   G L + +R                      L+
Sbjct: 88  NIVNLLGACTIGGP----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 98  EGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD 157
              + S +  V  G+ +L S   +H D+  +NIL++       KI DFG AR  + + + 
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT--KICDFGLARDIKNDSNY 201

Query: 158 EGK-PICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG 216
             K         MAPE        F +DVW+ G  + E+ +            S  +++ 
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261

Query: 217 FSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
                   P +   +  D +  C   +P +R +  ++++
Sbjct: 262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 6e-46
 Identities = 66/308 (21%), Positives = 106/308 (34%), Gaps = 37/308 (12%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK------SAELSNSEFLQREQRILSALA-C 54
           D      IG G+   V      +               A   +      E  +L  L   
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIR----------------SGTCLEE 98
           P I+   G             L +EYAP G L D +R                + + L  
Sbjct: 71  PNIINLLGACEHRGY----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126

Query: 99  GRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE 158
            ++      V  G+ YL     +H D+  +NILV ++    AKIADFG +R        +
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSR--GQEVYVK 182

Query: 159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGF 217
                     MA E          +DVW+ G  + E+ + G  P+       + L+    
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--MTCAELYEKLP 240

Query: 218 SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH--GFVKEQNFKL-STLTEPET 274
                E P     +  D + +C    P ER S +++L      ++E+   + +TL E  T
Sbjct: 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFT 300

Query: 275 YNSESPTS 282
           Y     ++
Sbjct: 301 YAGIDCSA 308

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  157 bits (397), Expect = 7e-46
 Identities = 53/269 (19%), Positives = 90/269 (33%), Gaps = 20/269 (7%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVKS-AELSNSEFLQREQRILSALA-CPQIVAY 60
           +  G+ IG GS   +  G +  +++  A+K     S++  L+ E R    LA C  I   
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 61  KGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGI 120
                   +      L ++             G       +    + +L  +Q +H   +
Sbjct: 67  YYFGQEGLH----NVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 122

Query: 121 VHCDIKGQNILVSKDNEQG---AKIADFGCARRARVNEDDEG------KPICGTPICMAP 171
           V+ DIK  N L+ + N +      + DFG  +  R     +       K + GT   M+ 
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

Query: 172 EVARGEEQGFPADVWALGCTVLEMATGRPPWP--DVADPISALHRIGF---SSDTPEIPG 226
               G EQ    D+ ALG   +    G  PW     A       RIG    S+   E+  
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242

Query: 227 YMSKQAQDFLSKCLIRNPGERWSASELLE 255
              ++   ++                L  
Sbjct: 243 GFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 1e-45
 Identities = 62/292 (21%), Positives = 105/292 (35%), Gaps = 38/292 (13%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS-----EFLQREQRILSALACPQ 56
            + + + IG G+  TV    +  + E+ A+K   L +          RE  +L  L    
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           IV       S++       L  E+               L+   ++S    +L GL + H
Sbjct: 63  IVRLHDVLHSDKK----LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
           S  ++H D+K QN+L++++ E   K+A+FG AR   +        +          +   
Sbjct: 119 SRNVLHRDLKPQNLLINRNGEL--KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 177 EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP-------------- 222
           +      D+W+ GC   E+A    P     D    L RI     TP              
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236

Query: 223 -------------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE 261
                         +   ++   +D L   L  NP +R SA E L+H +  +
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (389), Expect = 1e-44
 Identities = 55/288 (19%), Positives = 88/288 (30%), Gaps = 41/288 (14%)

Query: 2   DWTRGQTIGRGSTATVSIG-----MSNRSSEVFAVK----SAELSNSEFLQREQRILSAL 52
           +    + IG G+   V        +      + AVK     A        QRE  +++  
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73

Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS-------------------- 92
             P IV   G     +       L  EY   G L + +RS                    
Sbjct: 74  DNPNIVKLLGVCAVGKP----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129

Query: 93  ----GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA 148
                  L         R V  G+ YL     VH D+  +N LV ++     KIADFG +
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFGLS 187

Query: 149 RRARVNEDDE-GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVAD 207
           R     +  +           M PE          +DVWA G  + E+ +          
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247

Query: 208 PISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE 255
               ++ +    +    P     +  + +  C  + P +R S   +  
Sbjct: 248 HEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 1e-44
 Identities = 77/364 (21%), Positives = 131/364 (35%), Gaps = 73/364 (20%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEF---LQREQRILSALACPQ 56
            +   + IG G+   V            A+K  S    N        RE  ++  +    
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77

Query: 57  IVAYKGCDISEENGKILYNLFL--EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQY 114
           I++       ++  +   +++L  E                L+  R+      +L G+++
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKH 134

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVA 174
           LHS GI+H D+K  NI+V  D     KI DFG AR           P   T    APEV 
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTL--KILDFGLART--AGTSFMMTPYVVTRYYRAPEVI 190

Query: 175 RGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP------------ 222
            G       D+W++GC + EM   +  +P   D I   +++     TP            
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 223 ----------------------------EIPGYMSKQAQDFLSKCLIRNPGERWSASELL 254
                                       E     + QA+D LSK L+ +P +R S  + L
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309

Query: 255 EHGFVKEQNFKLSTLTEPETYNSESPTSVLNQQLWDSTLTSCSSASAKERIRQLIGEGSS 314
           +H ++    +  + +  P       P  + ++QL +   T        E  ++LI +   
Sbjct: 310 QHPYINV-WYDPAEVEAP-------PPQIYDKQLDEREHT-------IEEWKELIYK--- 351

Query: 315 EMVN 318
           E++N
Sbjct: 352 EVMN 355

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 5e-44
 Identities = 57/282 (20%), Positives = 101/282 (35%), Gaps = 32/282 (11%)

Query: 2   DWTRGQTIGRGSTATVSIGMS-----NRSSEVFAVK-----SAELSNSEFLQREQRILSA 51
               G+ +GRG+   V    +       +    AVK     +    +   +   + ++  
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 52  LACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS----------------GTC 95
                +V   G   ++  G ++  + +E+   G L+  +RS                   
Sbjct: 74  GHHLNVVNLLGA-CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 96  LEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE 155
           L    +  ++  V  G+++L S   +H D+  +NIL+S+ N    KI DFG AR    + 
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDP 188

Query: 156 DDEGK-PICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHR 214
           D   K         MAPE          +DVW+ G  + E+ +                R
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248

Query: 215 IGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
                     P Y + +    +  C    P +R + SEL+EH
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 5e-44
 Identities = 67/328 (20%), Positives = 122/328 (37%), Gaps = 46/328 (14%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSEVFAVK-----SAELSNSEFLQREQRILSALACPQ 56
            +     +G G+  +V      ++    AVK        + +++   RE R+L  +    
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78

Query: 57  IVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLH 116
           ++          + +   +++L     G   + I     L +  ++     +L GL+Y+H
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 138

Query: 117 SNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARG 176
           S  I+H D+K  N+ V++D E   KI DFG AR      DDE      T    APE+   
Sbjct: 139 SADIIHRDLKPSNLAVNEDCEL--KILDFGLARH----TDDEMTGYVATRWYRAPEIMLN 192

Query: 177 EEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTP------------- 222
                   D+W++GC + E+ TGR  +P   D I  L  I     TP             
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPG-TDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 223 ----------------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE----Q 262
                            +    +  A D L K L+ +  +R +A++ L H +  +     
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

Query: 263 NFKLSTLTEPETYNSESPTSVLNQQLWD 290
           +  ++   +    + +          +D
Sbjct: 312 DEPVADPYDQSFESRDLLIDEWKSLTYD 339

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  151 bits (382), Expect = 1e-43
 Identities = 49/268 (18%), Positives = 93/268 (34%), Gaps = 21/268 (7%)

Query: 2   DWTRGQTIGRGSTATVSIG---MSNRSSEVFAVKSAELSNSE----FLQREQRILSALAC 54
                Q IG G    V  G   +  +     A+K+ +   +E        E  I+     
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86

Query: 55  PQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGT-CLEEGRIRSHTRAVLLGLQ 113
           P ++  +G             +  E+   G+L   +R         ++    R +  G++
Sbjct: 87  PNVIHLEGVVTKSTP----VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142

Query: 114 YLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE----GKPICGTPICM 169
           YL     VH D+  +NILV+ +     K++DFG +R    +  D                
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 200

Query: 170 APEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYM 228
           APE  +  +    +DVW+ G  + E+ + G  P+ D+      ++ I         P   
Sbjct: 201 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-TNQDVINAIE-QDYRLPPPMDC 258

Query: 229 SKQAQDFLSKCLIRNPGERWSASELLEH 256
                  +  C  ++   R    +++  
Sbjct: 259 PSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 2e-43
 Identities = 68/301 (22%), Positives = 102/301 (33%), Gaps = 45/301 (14%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAYKGC 63
            ++IG+G    V  G      E  AVK  S+    S F + E      L    I+ +   
Sbjct: 8   QESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 65

Query: 64  DISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS------ 117
           D  +        L  +Y   G+L D +   T   EG I+    +   GL +LH       
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAHLHMEIVGTQ 124

Query: 118 --NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKP---ICGTPICMAPE 172
               I H D+K +NILV K+      IAD G A R     D          GT   MAPE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 173 VARGEEQ------GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDT----- 221
           V               AD++A+G    E+A          D     + +  S  +     
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242

Query: 222 ---------PEIPGY-----MSKQAQDFLSKCLIRNPGERWSASELLE--HGFVKEQNFK 265
                    P IP         +     + +C   N   R +A  + +      +++  K
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302

Query: 266 L 266
           +
Sbjct: 303 M 303

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 3e-43
 Identities = 51/263 (19%), Positives = 91/263 (34%), Gaps = 18/263 (6%)

Query: 4   TRGQTIGRGSTATVSIGMSNRSSE----VFAVKSAELSNSE----FLQREQRILSALACP 55
           TR + IG G    V  GM   SS       A+K+ +   +E        E  I+   +  
Sbjct: 10  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 69

Query: 56  QIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQY 114
            I+  +G     +       +  EY   G L   +R         ++    R +  G++Y
Sbjct: 70  NIIRLEGVISKYKP----MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125

Query: 115 LHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD--EGKPICGTPICMAPE 172
           L +   VH D+  +NILV+ +     K++DFG +R    + +               APE
Sbjct: 126 LANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 173 VARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA 232
                +    +DVW+ G  + E+ T              +  I         P       
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDCPSAI 242

Query: 233 QDFLSKCLIRNPGERWSASELLE 255
              + +C  +    R   ++++ 
Sbjct: 243 YQLMMQCWQQERARRPKFADIVS 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 2e-42
 Identities = 55/292 (18%), Positives = 97/292 (33%), Gaps = 33/292 (11%)

Query: 2   DWTRGQTIGRGSTATVSIGM-----SNRSSEVFAVK----SAELSNSEFLQREQRILSAL 52
             T  + +G+GS   V  G+      +      A+K    +A +        E  ++   
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80

Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIR----------SGTCLEEGRIR 102
            C  +V   G     +       + +E    G L   +R                  ++ 
Sbjct: 81  NCHHVVRLLGVVSQGQP----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 103 SHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED-DEGKP 161
                +  G+ YL++N  VH D+  +N +V++D     KI DFG  R     +   +G  
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDIYETDYYRKGGK 194

Query: 162 ICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDT 221
                  M+PE  +       +DVW+ G  + E+AT              L  +      
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEGGL 253

Query: 222 PEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE------HGFVKEQNFKLS 267
            + P        + +  C   NP  R S  E++           +E +F  S
Sbjct: 254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 305

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 1e-41
 Identities = 60/285 (21%), Positives = 105/285 (36%), Gaps = 38/285 (13%)

Query: 2   DWTRGQTIGRGSTATVSIGMSNRSSE-------VFAVK----SAELSNSEFLQREQRILS 50
               G+ +G G+   V +  +    +         AVK     A   +   L  E  ++ 
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 51  ALA-CPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIR----------------SG 93
            +     I+   G    +        + +EYA  G L + ++                  
Sbjct: 74  MIGKHKNIINLLGACTQDGP----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 94  TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR-AR 152
             L    + S    V  G++YL S   +H D+  +N+LV++DN    KIADFG AR    
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM--KIADFGLARDIHH 187

Query: 153 VNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISA 211
           ++   +          MAPE          +DVW+ G  + E+ T G  P+P    P+  
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--VPVEE 245

Query: 212 LHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH 256
           L ++       + P   + +    +  C    P +R +  +L+E 
Sbjct: 246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  137 bits (344), Expect = 1e-37
 Identities = 64/351 (18%), Positives = 120/351 (34%), Gaps = 69/351 (19%)

Query: 3   WTRGQTIGRGSTATVSIGMSNRSSEVFAVK--SAELSNSEFLQREQRILSALACPQIVAY 60
           +   + +G G  +TV +     ++   A+K    +   +E  + E ++L  +        
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 61  KG------------CDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAV 108
                          +    NG  +  +F                  +    ++  ++ +
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 109 LLGLQYLHSN-GIVHCDIKGQNILVSKDNEQG----AKIADFGCARRARVNEDDEGKPIC 163
           LLGL Y+H   GI+H DIK +N+L+   +        KIAD G A       D+      
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW----YDEHYTNSI 190

Query: 164 GTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWP--------DVADPISALHRI 215
            T    +PEV  G   G  AD+W+  C + E+ TG   +            D I+ +  +
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250

Query: 216 -------------------------------------GFSSDTPEIPGYMSKQAQDFLSK 238
                                                   ++  +     +K+  DFLS 
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310

Query: 239 CLIRNPGERWSASELLEHGFVKEQ-NFKLSTLTEPETYNSESPTSVLNQQL 288
            L  +P +R  A  L+ H ++K+    +   + + E Y S S      +++
Sbjct: 311 MLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEEV 361

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 72.1 bits (176), Expect = 1e-15
 Identities = 30/207 (14%), Positives = 59/207 (28%), Gaps = 38/207 (18%)

Query: 6   GQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEF-------------LQREQRILSAL 52
           G+ +G G  + V    S +  E   VK  ++ ++ F                     +  
Sbjct: 5   GKLMGEGKESAVFNCYSEKFGEC-VVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 53  ACPQIVAYKGCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGL 112
               +   +G  + +        + +E                +           +L  +
Sbjct: 64  EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKE-------LYRVRVENPDEVLDMILEEV 116

Query: 113 QYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGKPICGTPICMAPE 172
              +  GIVH D+   N+LVS   E+G  I DF  +         E          +  +
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVS---EEGIWIIDFPQSVEVGEEGWRE---------ILERD 164

Query: 173 VAR-----GEEQGFPADVWALGCTVLE 194
           V               D+ +    +L+
Sbjct: 165 VRNIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	385
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.29
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.1
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.94
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.13
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.06
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.55

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-63  Score=467.02  Aligned_cols=254  Identities=28%  Similarity=0.451  Sum_probs=218.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||++....    .+.+++|+++|++++|||||++++++.+...    ++||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~----~~iv   81 (271)
T d1nvra_           6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI----QYLF   81 (271)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTE----EEEE
T ss_pred             ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCce----eEEE
Confidence            6999999999999999999999999999999986543    3457899999999999999999999876543    6799


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC-
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED-  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~-  156 (385)
                      ||||+||+|.++++..+.+++..++.+++||+.||+|||++||+||||||+|||++.++.  +||+|||+|+....... 
T Consensus        82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECEETTEE
T ss_pred             EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC--EEEccchhheeeccCCcc
Confidence            999999999999998888999999999999999999999999999999999999987766  99999999997643322 


Q ss_pred             CCCCccccCCcccChhhhcCCCC-CCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          157 DEGKPICGTPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                      ......+||+.|||||++.+..+ +.++|||||||++|||++|++||....+....................+|+++++|
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  239 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  239 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence            23455689999999999988876 57899999999999999999999766554444444433333334445689999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      |.+||++||++|||++|+|+||||++
T Consensus       240 i~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         240 LHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             HHHHcCCChhHCcCHHHHhcCHhhCc
Confidence            99999999999999999999999974

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-63  Score=458.89  Aligned_cols=248  Identities=29%  Similarity=0.473  Sum_probs=219.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+||+|+++.+++.||+|++.+      ...+.+.+|+++|++++|||||++++++.+...    ++
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~----~~   82 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR----VY   82 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE----EE
T ss_pred             HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCE----EE
Confidence            68999999999999999999999999999998753      335678899999999999999999999876543    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+....  
T Consensus        83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~~--  158 (263)
T d2j4za1          83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS--  158 (263)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCSCSCCCC--
T ss_pred             EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC--EeecccceeeecCC--
Confidence            99999999999999998778999999999999999999999999999999999999987766  99999999986532  


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                       ......+||+.|||||++.+..++.++|||||||++|+|++|+.||... +....+.++.  ...+.+|..+|+++++|
T Consensus       159 -~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-~~~~~~~~i~--~~~~~~p~~~s~~~~~l  234 (263)
T d2j4za1         159 -SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-TYQETYKRIS--RVEFTFPDFVTEGARDL  234 (263)
T ss_dssp             -CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHH--TTCCCCCTTSCHHHHHH
T ss_pred             -CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC-CHHHHHHHHH--cCCCCCCccCCHHHHHH
Confidence             2334568999999999999999999999999999999999999999764 4445555543  23345677899999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      |.+||++||.+|||++|+|+||||+.
T Consensus       235 i~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         235 ISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHHHccCCHhHCcCHHHHHcCcCcCC
Confidence            99999999999999999999999974

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-62  Score=462.97  Aligned_cols=251  Identities=33%  Similarity=0.582  Sum_probs=218.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC---CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL---SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|++.+.||+|+||+||+|+++.+|+.||||++..   ...+.+.+|+++|++++|||||++++++.+...    +|+||
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~----~~ivm   96 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDE----LWVVM   96 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE----EEEEE
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCE----EEEEE
Confidence            59999999999999999999999999999998853   345778999999999999999999999877553    67999


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      |||+||+|.+++.++ .+++..++.+++||+.||+|||++||+||||||+|||++.++.  +||+|||+|+...... ..
T Consensus        97 Ey~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--vkl~DFG~a~~~~~~~-~~  172 (293)
T d1yhwa1          97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQ-SK  172 (293)
T ss_dssp             ECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTT-CC
T ss_pred             EecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc--Eeeccchhheeecccc-cc
Confidence            999999999988765 5999999999999999999999999999999999999987766  9999999999864322 23


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh-cCCCCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI-GFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      ....+||+.|||||++.+..++.++|||||||++|+|++|+.||.+.. ....+..+ .........+..+|+++++||.
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  251 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-PLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHHCSCCCSSGGGSCHHHHHHHH
T ss_pred             ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC-HHHHHHHHHhCCCCCCCCcccCCHHHHHHHH
Confidence            345689999999999999999999999999999999999999998753 33333332 2223334456779999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCccccc
Q 040569          238 KCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      +||++||.+|||+.|+|+||||+.
T Consensus       252 ~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         252 RCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             HHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHccCChhHCcCHHHHhcCHhhCC
Confidence            999999999999999999999964

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-62  Score=454.61  Aligned_cols=251  Identities=29%  Similarity=0.429  Sum_probs=217.8

Q ss_pred             eeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            4 TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +..+.||+|+||+||+|+++.+++.||+|.+...     ..+.+.+|+++|++++|||||++++++.....+...+++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            5677899999999999999999999999987542     13567899999999999999999999876555555677999


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEeec-CCCCCeEEeecCceeeecccC
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNG--IVHCDIKGQNILVSK-DNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~g--ivHrDlKp~NILi~~-~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |||+||+|.+++.+.+.+++..++.++.||+.||+|||++|  |+||||||+|||++. ++.  +||+|||+|+...   
T Consensus        92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~--~Kl~DFGla~~~~---  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKR---  166 (270)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGGGCC---
T ss_pred             eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCC--EEEeecCcceecc---
Confidence            99999999999998778999999999999999999999998  999999999999964 444  9999999997542   


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                      .......+||+.|||||++.+ .++.++|||||||++|||++|+.||....+.......+......+.++...++++++|
T Consensus       167 ~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  245 (270)
T d1t4ha_         167 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI  245 (270)
T ss_dssp             TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred             CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHH
Confidence            223345689999999999976 5999999999999999999999999877666666666654444555667789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVK  260 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~  260 (385)
                      |.+||++||++|||++|+|+||||+
T Consensus       246 i~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         246 IEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHccCCHhHCcCHHHHhCCcccC
Confidence            9999999999999999999999985

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-62  Score=458.69  Aligned_cols=255  Identities=27%  Similarity=0.452  Sum_probs=219.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||++.+      ...+.+.+|+++|++++||||+++++++.+...    +|
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~----~~   84 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK----LY   84 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSE----EE
T ss_pred             CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCE----EE
Confidence            59999999999999999999999999999998753      345678899999999999999999999876543    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+......
T Consensus        85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPES  162 (288)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC---
T ss_pred             EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--EEecccccceecccCC
Confidence            99999999999999998788999999999999999999999999999999999999987766  9999999999764332


Q ss_pred             C-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          156 D-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       156 ~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                      . ......+||+.|||||++.+..++.++|||||||++|+|++|+.||... +......++..  ..+.+|..+|+++++
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-~~~~~~~~i~~--~~~~~p~~~s~~~~~  239 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIK--LEYDFPEKFFPKARD  239 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHT--TCCCCCTTCCHHHHH
T ss_pred             cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc-CHHHHHHHHHc--CCCCCCccCCHHHHH
Confidence            2 2334568999999999999999999999999999999999999999864 55555555432  234567789999999


Q ss_pred             HHHHhhhcCCCCCCCHHH------HHhCccccccccc
Q 040569          235 FLSKCLIRNPGERWSASE------LLEHGFVKEQNFK  265 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~e------lL~hp~~~~~~~~  265 (385)
                      ||.+||++||.+|||++|      +++||||+..++.
T Consensus       240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~  276 (288)
T d1uu3a_         240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE  276 (288)
T ss_dssp             HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred             HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence            999999999999999987      5889999887643

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-61  Score=453.35  Aligned_cols=251  Identities=25%  Similarity=0.397  Sum_probs=205.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      ||++.+.||+|+||+||+|+++.+|+.||||.+....     .+.+.+|+++|++++|||||++++++.+...+.  +|+
T Consensus         5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~--~~i   82 (269)
T d2java1           5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT--LYI   82 (269)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----C--EEE
T ss_pred             hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCE--EEE
Confidence            6999999999999999999999999999999986543     245779999999999999999999887544433  568


Q ss_pred             EEeecCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCCEEeecCCCCCeEEeecCc
Q 040569           77 FLEYAPGGTLTDAIR----SGTCLEEGRIRSHTRAVLLGLQYLHSNG-----IVHCDIKGQNILVSKDNEQGAKIADFGC  147 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~----~~~~l~e~~~~~i~~qil~gL~yLH~~g-----ivHrDlKp~NILi~~~~~~~~kL~DFG~  147 (385)
                      |||||+||+|.+++.    .++.+++..++.++.||+.||+|||++|     |+||||||+||||+.++.  +||+|||+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG~  160 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGL  160 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC--EEECCHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc--EEEeeccc
Confidence            999999999999986    3567999999999999999999999976     999999999999987766  99999999


Q ss_pred             eeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCc
Q 040569          148 ARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGY  227 (385)
Q Consensus       148 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (385)
                      |+...... ......+||+.|||||++.+..++.++|||||||++|||+||+.||... +.......+. ....+.+|..
T Consensus       161 a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~-~~~~~~~~i~-~~~~~~~~~~  237 (269)
T d2java1         161 ARILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-SQKELAGKIR-EGKFRRIPYR  237 (269)
T ss_dssp             HHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHH-HTCCCCCCTT
T ss_pred             eeecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC-CHHHHHHHHH-cCCCCCCCcc
Confidence            98764322 2334568999999999999999999999999999999999999999864 4444444442 2344567788


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 040569          228 MSKQAQDFLSKCLIRNPGERWSASELLEHGFV  259 (385)
Q Consensus       228 ~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~  259 (385)
                      +|+++++||.+||++||.+|||++|+|+|||+
T Consensus       238 ~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            99999999999999999999999999999996

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-61  Score=456.11  Aligned_cols=251  Identities=32%  Similarity=0.502  Sum_probs=214.2

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      |++++.||+|+||+||+|+++.+++.||||++....   .+.+.+|+++|++++|||||++++++.....    +++|||
T Consensus        14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~----~~lvmE   89 (288)
T d2jfla1          14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENN----LWILIE   89 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTE----EEEEEE
T ss_pred             eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCe----EEEEEe
Confidence            899999999999999999999999999999986532   3567899999999999999999999876553    679999


Q ss_pred             ecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           80 YAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        80 y~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      ||+||+|.+++. .++.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+....... .
T Consensus        90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~-~  166 (288)
T d2jfla1          90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQ-R  166 (288)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECHHHHH-H
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC--EEEEechhhhccCCCcc-c
Confidence            999999999976 4667999999999999999999999999999999999999998776  99999999987532211 1


Q ss_pred             CCccccCCcccChhhhc-----CCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC-CCCCCCCCCcCCHHH
Q 040569          159 GKPICGTPICMAPEVAR-----GEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF-SSDTPEIPGYMSKQA  232 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~  232 (385)
                      ....+||+.|||||++.     +..|+.++|||||||++|||++|+.||..... ...+.++.. .......+..+|+++
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~s~~~  245 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP-MRVLLKIAKSEPPTLAQPSRWSSNF  245 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG-GGHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH-HHHHHHHHcCCCCCCCccccCCHHH
Confidence            23457999999999984     45678999999999999999999999987543 333333322 223334466799999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          233 QDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      ++||.+||++||.+|||++|+|+||||+.
T Consensus       246 ~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         246 KDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            99999999999999999999999999964

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-60  Score=459.39  Aligned_cols=253  Identities=28%  Similarity=0.454  Sum_probs=222.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      ||++++.||+|+||+||+|+++.+|+.||||++.+      ...+.+.+|+.+|++++||||+++++++.+...    +|
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~----~~   81 (337)
T d1o6la_           6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR----LC   81 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE----EE
T ss_pred             hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccc----cc
Confidence            69999999999999999999999999999998863      345678899999999999999999999876554    77


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +|||||+||+|.+++.+.+.++|..++.+++||+.||+|||++||+||||||+|||++.++.  +||+|||+|+..... 
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~--vkl~DFG~a~~~~~~-  158 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISD-  158 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCT-
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC--EEEeecccccccccC-
Confidence            99999999999999998888999999999999999999999999999999999999988776  999999999875422 


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                      .......+||+.|||||++.+..|+.++|||||||++|||++|++||... +.......+..  ..+.+|..+|+++++|
T Consensus       159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~-~~~~~~~~i~~--~~~~~p~~~s~~~~dl  235 (337)
T d1o6la_         159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHERLFELILM--EEIRFPRTLSPEAKSL  235 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHH--CCCCCCTTSCHHHHHH
T ss_pred             CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc-CHHHHHHHHhc--CCCCCCccCCHHHHHH
Confidence            22345678999999999999999999999999999999999999999874 44444444422  2356788899999999


Q ss_pred             HHHhhhcCCCCCCC-----HHHHHhCcccccccc
Q 040569          236 LSKCLIRNPGERWS-----ASELLEHGFVKEQNF  264 (385)
Q Consensus       236 l~~cL~~dP~~Rps-----~~elL~hp~~~~~~~  264 (385)
                      |.+||++||.+|++     ++|+++||||+..++
T Consensus       236 i~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~  269 (337)
T d1o6la_         236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             HHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence            99999999999994     899999999987654

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-61  Score=461.24  Aligned_cols=251  Identities=31%  Similarity=0.503  Sum_probs=211.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++++.||+|+||+||+|+++.+|+.||+|++....    .+.+.+|+.+|++++|||||++++++.+...    +++|
T Consensus         7 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----~~iV   82 (322)
T d1s9ja_           7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE----ISIC   82 (322)
T ss_dssp             GEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSE----EEEE
T ss_pred             CCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE----EEEE
Confidence            5999999999999999999999999999999986432    3578899999999999999999999876553    6799


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~-~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+||||+.++.  +||+|||+|+.....  
T Consensus        83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~--  158 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS--  158 (322)
T ss_dssp             EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHHH--
T ss_pred             EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC--EEEeeCCCccccCCC--
Confidence            9999999999999877789999999999999999999997 59999999999999987766  999999999876432  


Q ss_pred             CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHH-----------------------
Q 040569          157 DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALH-----------------------  213 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~-----------------------  213 (385)
                       .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...........                       
T Consensus       159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (322)
T d1s9ja_         159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  237 (322)
T ss_dssp             -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred             -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence             23456899999999999999999999999999999999999999975432221111                       


Q ss_pred             ------------------HhcCCCCCCCCC-CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          214 ------------------RIGFSSDTPEIP-GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       214 ------------------~~~~~~~~~~~~-~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                        .+. ....+.++ ..+|+++++||.+||++||.+|||++|+|+||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         238 SSYGMDSRPPMAIFELLDYIV-NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             --------CCCCHHHHHHHHH-TSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cccccccccchhHHHHHhhhh-ccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                              000 11112222 2368999999999999999999999999999999754

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.9e-61  Score=456.07  Aligned_cols=253  Identities=24%  Similarity=0.378  Sum_probs=202.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      .|++++.||+|+||+||+|+++.+++.||||.+....    .+.+++|+.+|++++|||||++++++.+...    +|||
T Consensus        10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----~~lv   85 (307)
T d1a06a_          10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGH----LYLI   85 (307)
T ss_dssp             TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSE----EEEE
T ss_pred             ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE----EEEE
Confidence            3899999999999999999999999999999986532    3456799999999999999999998865543    6799


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecC-CCCCeEEeecCceeeecccCC
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKD-NEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~-~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      ||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+... .++.+||+|||+|+.....  
T Consensus        86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~--  163 (307)
T d1a06a_          86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--  163 (307)
T ss_dssp             ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC--
Confidence            9999999999999988889999999999999999999999999999999999999642 2334999999999876322  


Q ss_pred             CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC--CCCCCCCcCCHHHHH
Q 040569          157 DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS--DTPEIPGYMSKQAQD  234 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~  234 (385)
                      ......+||+.|||||++.+..++.++|||||||++|+|++|++||.+. ........+....  .....+..+|+++++
T Consensus       164 ~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  242 (307)
T d1a06a_         164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE-NDAKLFEQILKAEYEFDSPYWDDISDSAKD  242 (307)
T ss_dssp             ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred             CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC-CHHHHHHHHhccCCCCCCccccCCCHHHHH
Confidence            2334568999999999999999999999999999999999999999874 3344444432222  222344568999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          235 FLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      ||.+||++||.+|||++|+|+||||+.
T Consensus       243 li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         243 FIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             HHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            999999999999999999999999975

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.2e-60  Score=459.22  Aligned_cols=255  Identities=24%  Similarity=0.380  Sum_probs=219.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||++....   .+.+.+|+++|++++|||||++++++.+...    ++|||
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~----~~ivm  102 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE----MVMIY  102 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE----EEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE----EEEEE
Confidence            5999999999999999999999999999999987654   3567899999999999999999999876543    67999


Q ss_pred             eecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           79 EYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        79 Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |||+||+|.+++. ..+++++..++.++.||+.||+|||++||+||||||+|||++.+..+.+||+|||+|+....  ..
T Consensus       103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~--~~  180 (350)
T d1koaa2         103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--KQ  180 (350)
T ss_dssp             CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT--TS
T ss_pred             EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc--cc
Confidence            9999999999996 55679999999999999999999999999999999999999765555699999999987642  22


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC--CCCCCCCcCCHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS--DTPEIPGYMSKQAQDF  235 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~l  235 (385)
                      .....+||+.|||||++.+..++.++|||||||++|+|++|+.||.+. +....+..+....  ..+.....+|+++++|
T Consensus       181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  259 (350)
T d1koaa2         181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-NDDETLRNVKSCDWNMDDSAFSGISEDGKDF  259 (350)
T ss_dssp             CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred             ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence            334568999999999999999999999999999999999999999864 4445444443222  1223345689999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      |.+||++||.+|||++|+|+||||+...
T Consensus       260 i~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         260 IRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             HHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            9999999999999999999999998653

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-60  Score=453.35  Aligned_cols=247  Identities=33%  Similarity=0.503  Sum_probs=214.3

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      |+.++.||+|+||+||+|+++.+++.||||.+....      .+.+.+|+++|++++|||||++++++.+...    +++
T Consensus        17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~----~~i   92 (309)
T d1u5ra_          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT----AWL   92 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE----EEE
T ss_pred             cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCE----EEE
Confidence            899999999999999999999999999999986543      2457789999999999999999999876543    679


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      |||||.||+|..++...+++++..++.+++||+.||.|||++||+||||||+|||++.++.  +||+|||+|+....   
T Consensus        93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~~---  167 (309)
T d1u5ra_          93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---  167 (309)
T ss_dssp             EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---
T ss_pred             EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC--EEEeecccccccCC---
Confidence            9999999999888887788999999999999999999999999999999999999997766  99999999986532   


Q ss_pred             CCCCccccCCcccChhhhcC---CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHH
Q 040569          157 DEGKPICGTPICMAPEVARG---EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQ  233 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  233 (385)
                        ....+||+.|||||++.+   ..|+.++|||||||++|||++|+.||.+. +....+.++......+..+..+|++++
T Consensus       168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~s~~~~  244 (309)
T d1u5ra_         168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFR  244 (309)
T ss_dssp             --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCTTSCHHHH
T ss_pred             --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence              234579999999999964   35889999999999999999999999875 444445554333333344566899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          234 DFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       234 ~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      +||.+||++||.+|||++|+|+||||..
T Consensus       245 ~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         245 NFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             HHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence            9999999999999999999999999964

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-60  Score=447.13  Aligned_cols=255  Identities=27%  Similarity=0.440  Sum_probs=217.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC---------CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---------NSEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~---------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      .|++++.||+|+||+||+|+++.+|+.||||.+.+.         ..+.+++|+.+|++++|||||++++++.+...   
T Consensus        11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~---   87 (293)
T d1jksa_          11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD---   87 (293)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE---
T ss_pred             CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE---
Confidence            389999999999999999999999999999988532         24678999999999999999999999876543   


Q ss_pred             EEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCC--CeEEeecCceee
Q 040569           73 LYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQ--GAKIADFGCARR  150 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~--~~kL~DFG~a~~  150 (385)
                       ++||||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++..  .+||+|||+|+.
T Consensus        88 -~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~  166 (293)
T d1jksa_          88 -VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  166 (293)
T ss_dssp             -EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             -EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence             67999999999999999877789999999999999999999999999999999999999866532  489999999988


Q ss_pred             ecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCC--CCCCCCcC
Q 040569          151 ARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSD--TPEIPGYM  228 (385)
Q Consensus       151 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~  228 (385)
                      ....  .......||+.|||||++.+..++.++|||||||++|||++|+.||.+. +....+..+.....  .+..+..+
T Consensus       167 ~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~  243 (293)
T d1jksa_         167 IDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-TKQETLANVSAVNYEFEDEYFSNT  243 (293)
T ss_dssp             CTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred             cCCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC-CHHHHHHHHHhcCCCCCchhcCCC
Confidence            6432  2334567999999999999999999999999999999999999999874 44444444422211  22234568


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 040569          229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQN  263 (385)
Q Consensus       229 s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~~  263 (385)
                      |+++++||.+||++||.+|||++|+|+||||+..+
T Consensus       244 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999999999999998654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-59  Score=449.54  Aligned_cols=251  Identities=27%  Similarity=0.445  Sum_probs=221.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      ||++++.||+|+||+||+|+++.+|+.||||++.+      ...+.+.+|+.+|++++|||||++++++.+...    ++
T Consensus         5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~----~~   80 (316)
T d1fota_           5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ----IF   80 (316)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE----EE
T ss_pred             HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCe----ee
Confidence            69999999999999999999999999999998853      345678899999999999999999999876543    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +|||||+||+|..++..+..+++..++.++.||+.||+|||++||+||||||+||||+.++.  +||+|||+|+....  
T Consensus        81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~--vkL~DFG~a~~~~~--  156 (316)
T d1fota_          81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD--  156 (316)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--
T ss_pred             eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC--EEEecCccceEecc--
Confidence            99999999999999998888999999999999999999999999999999999999987766  99999999987642  


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                        .....+||+.|||||++.+..++.++|||||||++|+|++|+.||... +......++...  ...+|..+|++++++
T Consensus       157 --~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~-~~~~~~~~i~~~--~~~~p~~~s~~~~~l  231 (316)
T d1fota_         157 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-NTMKTYEKILNA--ELRFPPFFNEDVKDL  231 (316)
T ss_dssp             --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHC--CCCCCTTSCHHHHHH
T ss_pred             --ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc-CHHHHHHHHHcC--CCCCCCCCCHHHHHH
Confidence              234568999999999999999999999999999999999999999874 444554444322  345667799999999


Q ss_pred             HHHhhhcCCCCCC-----CHHHHHhCccccccccc
Q 040569          236 LSKCLIRNPGERW-----SASELLEHGFVKEQNFK  265 (385)
Q Consensus       236 l~~cL~~dP~~Rp-----s~~elL~hp~~~~~~~~  265 (385)
                      |.+||.+||.+|+     |++++|+||||++.++.
T Consensus       232 i~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~  266 (316)
T d1fota_         232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  266 (316)
T ss_dssp             HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             HHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence            9999999999996     89999999999987543

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-59  Score=453.45  Aligned_cols=250  Identities=27%  Similarity=0.455  Sum_probs=220.6

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||++.+      ...+.+.+|+++|++++|||||++++++.....    ++
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~----~~  117 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN----LY  117 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE----EE
T ss_pred             CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccc----cc
Confidence            59999999999999999999999999999998753      335678899999999999999999998866543    66


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+....  
T Consensus       118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~--ikL~DFG~a~~~~~--  193 (350)
T d1rdqe_         118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKG--  193 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS--
T ss_pred             cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC--EEeeeceeeeeccc--
Confidence            99999999999999997778999999999999999999999999999999999999987765  99999999998642  


Q ss_pred             CCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHH
Q 040569          156 DDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDF  235 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (385)
                        .....+||+.|||||++.+..++.++|||||||++|+|+||+.||... +....+.++..  ..+.+|..+|+++.+|
T Consensus       194 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-~~~~~~~~i~~--~~~~~p~~~s~~~~~l  268 (350)
T d1rdqe_         194 --RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-QPIQIYEKIVS--GKVRFPSHFSSDLKDL  268 (350)
T ss_dssp             --CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHH--CCCCCCTTCCHHHHHH
T ss_pred             --ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc-CHHHHHHHHhc--CCCCCCccCCHHHHHH
Confidence              234568999999999999999999999999999999999999999764 45555555532  2345677899999999


Q ss_pred             HHHhhhcCCCCCC-----CHHHHHhCcccccccc
Q 040569          236 LSKCLIRNPGERW-----SASELLEHGFVKEQNF  264 (385)
Q Consensus       236 l~~cL~~dP~~Rp-----s~~elL~hp~~~~~~~  264 (385)
                      |.+||++||.+|+     |++|+|+||||+..++
T Consensus       269 i~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~  302 (350)
T d1rdqe_         269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             HHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence            9999999999995     9999999999998754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.1e-59  Score=455.90  Aligned_cols=254  Identities=26%  Similarity=0.401  Sum_probs=218.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||++....   .+.+++|+++|++|+|||||++++++.....    ++|||
T Consensus        30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~----~~ivm  105 (352)
T d1koba_          30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE----MVLIL  105 (352)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE----EEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE----EEEEE
Confidence            4899999999999999999999999999999987654   3467799999999999999999999875543    67999


Q ss_pred             eecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           79 EYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        79 Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |||+||+|.+++.. +.++++..++.++.||+.||+|||++||+||||||+||||+....+.+||+|||+|+....  ..
T Consensus       106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~--~~  183 (352)
T d1koba_         106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DE  183 (352)
T ss_dssp             ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT--TS
T ss_pred             EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC--CC
Confidence            99999999998874 4579999999999999999999999999999999999999855455699999999998743  22


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCC--CCCCCCCcCCHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSS--DTPEIPGYMSKQAQDF  235 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~l  235 (385)
                      .....+||+.|||||++.+..++.++|||||||++|+|+||+.||.+. +....+..+....  .....+..+|+++++|
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  262 (352)
T d1koba_         184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-DDLETLQNVKRCDWEFDEDAFSSVSPEAKDF  262 (352)
T ss_dssp             CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred             ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence            344568999999999999999999999999999999999999999875 3444444442221  2233456789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          236 LSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       236 l~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      |.+||++||.+|||+.|+|+||||+..
T Consensus       263 i~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         263 IKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             HHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999754

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=7.4e-59  Score=451.99  Aligned_cols=253  Identities=23%  Similarity=0.370  Sum_probs=214.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC------CHHHHHH---HHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS------NSEFLQR---EQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~------~~~~~~~---E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||++.+.      ....+.+   |+++++.+.|||||++++++.....   
T Consensus         5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~---   81 (364)
T d1omwa3           5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK---   81 (364)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE---
T ss_pred             hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE---
Confidence            799999999999999999999999999999988532      2233444   4667777889999999998876543   


Q ss_pred             EEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           73 LYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                       +|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+...
T Consensus        82 -~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~  158 (364)
T d1omwa3          82 -LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFS  158 (364)
T ss_dssp             -EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC--EEECCCTTCEECS
T ss_pred             -EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc--EEEeeeceeeecC
Confidence             6799999999999999998888999999999999999999999999999999999999987766  9999999999764


Q ss_pred             ccCCCCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHhcCCCCCCCCCCcCCH
Q 040569          153 VNEDDEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADP-ISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       153 ~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      ..   .....+||+.|||||++.+ ..++.++|||||||++|||+||+.||...... ...+.+. .....+.+|..+|+
T Consensus       159 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~s~  234 (364)
T d1omwa3         159 KK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTMAVELPDSFSP  234 (364)
T ss_dssp             SS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH-SSSCCCCCCSSSCH
T ss_pred             CC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cccCCCCCCCCCCH
Confidence            32   3345689999999999964 56899999999999999999999999764322 2222222 23445566778999


Q ss_pred             HHHHHHHHhhhcCCCCCCC-----HHHHHhCcccccccc
Q 040569          231 QAQDFLSKCLIRNPGERWS-----ASELLEHGFVKEQNF  264 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps-----~~elL~hp~~~~~~~  264 (385)
                      ++++||.+||++||.+|||     ++|+++||||+..++
T Consensus       235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~  273 (364)
T d1omwa3         235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  273 (364)
T ss_dssp             HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred             HHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence            9999999999999999999     799999999998754

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-59  Score=446.01  Aligned_cols=253  Identities=32%  Similarity=0.543  Sum_probs=219.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccC------CCHHHHHHHHHHHH-hcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAEL------SNSEFLQREQRILS-ALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~------~~~~~~~~E~~il~-~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||++.+      ...+.+.+|..++. .++|||||++++++.+...    +
T Consensus         3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~----~   78 (320)
T d1xjda_           3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN----L   78 (320)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE----E
T ss_pred             CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCc----e
Confidence            79999999999999999999999999999999853      33455667777765 6899999999999876543    6


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      |+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.....
T Consensus        79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~--~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLG  156 (320)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCT
T ss_pred             eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc--eeccccchhhhcccc
Confidence            799999999999999998888999999999999999999999999999999999999987766  999999999876432


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                       .......+||+.|||||++.+..++.++|||||||++|+|++|+.||.+. +......++.  ...+.+|..+|+++++
T Consensus       157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~-~~~~~~~~i~--~~~~~~p~~~s~~~~d  232 (320)
T d1xjda_         157 -DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-DEEELFHSIR--MDNPFYPRWLEKEAKD  232 (320)
T ss_dssp             -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHH--HCCCCCCTTSCHHHHH
T ss_pred             -cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC-CHHHHHHHHH--cCCCCCCccCCHHHHH
Confidence             22344568999999999999999999999999999999999999999864 4555555543  2346678889999999


Q ss_pred             HHHHhhhcCCCCCCCHH-HHHhCcccccccc
Q 040569          235 FLSKCLIRNPGERWSAS-ELLEHGFVKEQNF  264 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~-elL~hp~~~~~~~  264 (385)
                      ||.+||++||.+|||+. |+++||||++.++
T Consensus       233 li~~~L~~dP~~R~s~~~~l~~hpff~~~~~  263 (320)
T d1xjda_         233 LLVKLFVREPEKRLGVRGDIRQHPLFREINW  263 (320)
T ss_dssp             HHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             HHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence            99999999999999995 8999999987643

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.5e-58  Score=430.45  Aligned_cols=251  Identities=26%  Similarity=0.428  Sum_probs=214.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------------HHHHHHHHHHHHhcC-CCCeeeeeeeeeecc
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------------SEFLQREQRILSALA-CPQIVAYKGCDISEE   68 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------------~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~   68 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||++.+..            .+.+.+|+.+|++++ ||||+++++++.+..
T Consensus         4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~   83 (277)
T d1phka_           4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT   83 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence            6999999999999999999999999999999986532            135778999999996 999999999987654


Q ss_pred             CCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCce
Q 040569           69 NGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCA  148 (385)
Q Consensus        69 ~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a  148 (385)
                      .    +|||||||+||+|.++++..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++
T Consensus        84 ~----~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a  157 (277)
T d1phka_          84 F----FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFS  157 (277)
T ss_dssp             E----EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTC
T ss_pred             c----eEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC--eEEccchhe
Confidence            3    6799999999999999997778999999999999999999999999999999999999987766  999999999


Q ss_pred             eeecccCCCCCCccccCCcccChhhhcC------CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCC--
Q 040569          149 RRARVNEDDEGKPICGTPICMAPEVARG------EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSD--  220 (385)
Q Consensus       149 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--  220 (385)
                      +.....  ......+||+.|+|||++.+      ..++.++||||+||++|+|++|+.||... +......++.....  
T Consensus       158 ~~~~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~-~~~~~~~~i~~~~~~~  234 (277)
T d1phka_         158 CQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-KQMLMLRMIMSGNYQF  234 (277)
T ss_dssp             EECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCC
T ss_pred             eEccCC--CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC-CHHHHHHHHHhCCCCC
Confidence            987432  23345679999999999863      34678999999999999999999999875 34444443322221  


Q ss_pred             CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          221 TPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       221 ~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      .......+|+++++||.+||++||.+|||++|+|+||||++
T Consensus       235 ~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            22233469999999999999999999999999999999975

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-58  Score=442.98  Aligned_cols=254  Identities=26%  Similarity=0.372  Sum_probs=218.1

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH--HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS--EFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~--~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++++.||+|+||+||+|+++.+++.||||.+.....  ..+++|+++|++++|||||++++++.+...    +|||||
T Consensus         6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~----~~lvmE   81 (321)
T d1tkia_           6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEE----LVMIFE   81 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE----EEEEEC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE----EEEEEe
Confidence            59999999999999999999999999999999987654  457799999999999999999999876543    779999


Q ss_pred             ecCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           80 YAPGGTLTDAIRSG-TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        80 y~~ggsL~~~l~~~-~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      ||+||+|.+++... ..++|..++.++.||+.||+|||++||+||||||+|||++.++...+||+|||+++....  ...
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~--~~~  159 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDN  159 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--TCE
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc--CCc
Confidence            99999999999854 479999999999999999999999999999999999999876666699999999987632  222


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCC--CCCCCcCCHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDT--PEIPGYMSKQAQDFL  236 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~~ll  236 (385)
                      ....+||+.|+|||.+.+..++.++|||||||++|+|++|+.||... +.......+......  ...+..+|+++++||
T Consensus       160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  238 (321)
T d1tkia_         160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE-TNQQIIENIMNAEYTFDEEAFKEISIEAMDFV  238 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred             ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCChhhccCCCHHHHHHH
Confidence            34567999999999999999999999999999999999999999874 444444444222211  112235899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          237 SKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      .+||++||.+|||+.|+|+||||++.
T Consensus       239 ~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         239 DRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHccCChhHCcCHHHHhcCHhhccC
Confidence            99999999999999999999999753

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-58  Score=433.43  Aligned_cols=251  Identities=24%  Similarity=0.354  Sum_probs=206.7

Q ss_pred             eeeceeeccCceEEEEEEECCCCcEEEEEeccCCCH--------HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            4 TRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNS--------EFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~--------~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      ++++.||+|+||+||+|+++.+|+.||||++.....        +.+.+|+.+|++++|||||++++++.....    ++
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~----~~   76 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN----IS   76 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC----CE
T ss_pred             CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCc----ee
Confidence            367899999999999999999999999999864321        357799999999999999999999877655    67


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      +||||+.|+++..++.....+++..++.+++||+.||+|||++||+||||||+|||++.++.  +||+|||+|+......
T Consensus        77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPN  154 (299)
T ss_dssp             EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCC
T ss_pred             ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc--cccccCccccccCCCc
Confidence            99999999888888777788999999999999999999999999999999999999987766  9999999998754322


Q ss_pred             CCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC---CC------------
Q 040569          156 DDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF---SS------------  219 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~---~~------------  219 (385)
                       ......+||+.|||||++.+. .++.++|||||||++|||++|++||.... ....+.++..   ..            
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~-~~~~l~~i~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ua2a_         155 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-DLDQLTRIFETLGTPTEEQWPDMCSLP  232 (299)
T ss_dssp             -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred             -ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC-HHHHHHHHHHhcCCCChhhccchhccc
Confidence             233456799999999998754 57999999999999999999999998753 3333332210   00            


Q ss_pred             ------CCCC-----CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          220 ------DTPE-----IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       220 ------~~~~-----~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                            ..+.     +...+|+++++||.+||++||++|||++|+|+||||++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence                  0000     112468999999999999999999999999999999754

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-58  Score=440.69  Aligned_cols=254  Identities=25%  Similarity=0.391  Sum_probs=211.2

Q ss_pred             Cceee-ceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRG-QTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~-~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|.+. +.||+|+||+||+|+++.+++.||||++..  ...+++|+.++.++ +|||||++++++.+.......+|+|||
T Consensus        12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmE   89 (335)
T d2ozaa1          12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME   89 (335)
T ss_dssp             TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEE
Confidence            58776 569999999999999999999999999863  56678999997665 899999999998765555556789999


Q ss_pred             ecCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC-CCCeEEeecCceeeecccCC
Q 040569           80 YAPGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN-EQGAKIADFGCARRARVNED  156 (385)
Q Consensus        80 y~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~-~~~~kL~DFG~a~~~~~~~~  156 (385)
                      ||+||+|.++|.+.  .+++|..++.++.||+.||+|||++||+||||||+|||++.+. ...+||+|||+|+.....  
T Consensus        90 y~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~--  167 (335)
T d2ozaa1          90 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--  167 (335)
T ss_dssp             CCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC--
T ss_pred             CCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCC--
Confidence            99999999999853  4699999999999999999999999999999999999998643 234899999999876432  


Q ss_pred             CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHH--HH-HHhcCCCCCCCCC----CcCC
Q 040569          157 DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPIS--AL-HRIGFSSDTPEIP----GYMS  229 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~-~~~~~~~~~~~~~----~~~s  229 (385)
                      ......+||+.|||||++.+..|+.++|||||||++|+|+||++||.+......  .+ .++.  .....+|    ..+|
T Consensus       168 ~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~--~~~~~~~~~~~~~~s  245 (335)
T d2ozaa1         168 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR--MGQYEFPNPEWSEVS  245 (335)
T ss_dssp             CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC--SCSSSCCTTHHHHSC
T ss_pred             CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHh--cCCCCCCCcccccCC
Confidence            234566899999999999999999999999999999999999999975432211  11 1221  1112222    3589


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          230 KQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       230 ~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                      +++++||.+||++||.+|||+.|+|+||||.+
T Consensus       246 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         246 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence            99999999999999999999999999999964

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.9e-57  Score=426.21  Aligned_cols=247  Identities=22%  Similarity=0.270  Sum_probs=212.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++++.||+|+||+||+|+++.+++.||||++..+  ..+.+.+|+++|++++|||||++++++.....    +++|||
T Consensus        18 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~----~~iv~E   93 (287)
T d1opja_          18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP----FYIITE   93 (287)
T ss_dssp             GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS----CEEEEE
T ss_pred             HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCe----eEEEee
Confidence            477899999999999999999999999999998643  45778999999999999999999999876554    669999


Q ss_pred             ecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           80 YAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        80 y~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      ||++|+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+||||+.++.  +||+|||+|+........
T Consensus        94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~~~  171 (287)
T d1opja_          94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYT  171 (287)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCCTTTCCSSSSE
T ss_pred             cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc--EEEccccceeecCCCCce
Confidence            9999999999974  457899999999999999999999999999999999999988766  999999999876433333


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      ......||+.|||||++.+..++.++|||||||++|||++|..||....+.......+ .....+..|..+|+++++||.
T Consensus       172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~  250 (287)
T d1opja_         172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPEKVYELMR  250 (287)
T ss_dssp             EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHH
T ss_pred             eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH-hcCCCCCCCccchHHHHHHHH
Confidence            3344568999999999999999999999999999999999777765544544443333 334456677889999999999


Q ss_pred             HhhhcCCCCCCCHHHHHh
Q 040569          238 KCLIRNPGERWSASELLE  255 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~  255 (385)
                      +||++||.+|||++|+++
T Consensus       251 ~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         251 ACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHH
Confidence            999999999999999976

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-56  Score=423.82  Aligned_cols=253  Identities=28%  Similarity=0.370  Sum_probs=206.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||++....     .+.+.+|+++|++++|||||++++++.+...    +++
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~----~~i   78 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK----LYL   78 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE----EEE
T ss_pred             CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc----eeE
Confidence            6999999999999999999999999999999986432     4578899999999999999999999877554    679


Q ss_pred             EEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      ||||+.++.+..... ....+++..++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+..... 
T Consensus        79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~-  155 (298)
T d1gz8a_          79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVP-  155 (298)
T ss_dssp             EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTHHHHHCCC-
T ss_pred             EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc--ceeccCCcceeccCC-
Confidence            999997654444433 4567999999999999999999999999999999999999987765  999999999876422 


Q ss_pred             CCCCCccccCCcccChhhhcCCC-CCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc----CC------------
Q 040569          156 DDEGKPICGTPICMAPEVARGEE-QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG----FS------------  218 (385)
Q Consensus       156 ~~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~----~~------------  218 (385)
                      .......+||+.|+|||++.... ++.++|||||||++|+|++|+.||...+ ....+.++.    ..            
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS-EIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC-HHHHHHHHHHhcCCCchhhcccccccc
Confidence            22344567999999999987765 4789999999999999999999998653 333333220    00            


Q ss_pred             CCCCCC-----------CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          219 SDTPEI-----------PGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       219 ~~~~~~-----------~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ......           ...+|+++++||++||++||.+|||+.|+|+||||++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            000001           12468999999999999999999999999999999765

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-57  Score=425.44  Aligned_cols=244  Identities=24%  Similarity=0.337  Sum_probs=207.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---------HHHHHHHHHHHHhcC--CCCeeeeeeeeeeccCC
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---------SEFLQREQRILSALA--CPQIVAYKGCDISEENG   70 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---------~~~~~~E~~il~~l~--hpnIv~~~~~~~~~~~~   70 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||.+....         ...+.+|+.+|++++  |||||++++++..... 
T Consensus         5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~-   83 (273)
T d1xwsa_           5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS-   83 (273)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE-
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe-
Confidence            6999999999999999999999999999999886421         133568999999996  8999999999876543 


Q ss_pred             eEEEEEEEeecCC-CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCcee
Q 040569           71 KILYNLFLEYAPG-GTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCAR  149 (385)
Q Consensus        71 ~~~~~lv~Ey~~g-gsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~  149 (385)
                         +++||||+.+ +++.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+. ..+||+|||+|+
T Consensus        84 ---~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~-~~vkl~DFG~a~  159 (273)
T d1xwsa_          84 ---FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGA  159 (273)
T ss_dssp             ---EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCE
T ss_pred             ---EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC-CeEEECccccce
Confidence               6799999976 68889998777899999999999999999999999999999999999998553 238999999998


Q ss_pred             eecccCCCCCCccccCCcccChhhhcCCCC-CCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcC
Q 040569          150 RARVNEDDEGKPICGTPICMAPEVARGEEQ-GFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYM  228 (385)
Q Consensus       150 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (385)
                      ....   ......+||+.|||||++.+..+ +.++|||||||++|+|++|+.||...   .. +.+     ....++..+
T Consensus       160 ~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~-i~~-----~~~~~~~~~  227 (273)
T d1xwsa_         160 LLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---EE-IIR-----GQVFFRQRV  227 (273)
T ss_dssp             ECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HH-HHH-----CCCCCSSCC
T ss_pred             eccc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc---hH-Hhh-----cccCCCCCC
Confidence            7532   22345689999999999987765 67799999999999999999999652   11 111     123456679


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          229 SKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       229 s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      |+++++||.+||++||.+|||++|+|+||||++.
T Consensus       228 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            9999999999999999999999999999999754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-57  Score=421.03  Aligned_cols=250  Identities=21%  Similarity=0.277  Sum_probs=211.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++++.||+|+||+||+|+++ ++..||||++...  ..+.+.+|+++|++++|||||++++++.. ..    +++|||
T Consensus        14 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~----~~iv~E   87 (272)
T d1qpca_          14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP----IYIITE   87 (272)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS----CEEEEE
T ss_pred             HeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CC----eEEEEE
Confidence            5788999999999999999986 6788999998653  45778999999999999999999997643 22    458999


Q ss_pred             ecCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           80 YAPGGTLTDAIRS--GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        80 y~~ggsL~~~l~~--~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      ||++|+|.+++..  +..+++..+..++.||+.||.|||++||+||||||+||||+.++.  +||+|||+|+........
T Consensus        88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~--~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEE
T ss_pred             eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc--eeeccccceEEccCCccc
Confidence            9999999998863  335999999999999999999999999999999999999987766  999999999987544433


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      ......||+.|||||++.+..++.++|||||||++|||+||..|+....+....+..+. ....+..|..+++++++||.
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~  244 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEELYQLMR  244 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHH
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCcccChHHHHHHHH
Confidence            44556799999999999999999999999999999999996555544445555555543 34456667889999999999


Q ss_pred             HhhhcCCCCCCCHHHHHh--Ccccc
Q 040569          238 KCLIRNPGERWSASELLE--HGFVK  260 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~--hp~~~  260 (385)
                      +||+.||++|||+.|+++  |+||.
T Consensus       245 ~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         245 LCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            999999999999999987  67764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-56  Score=416.36  Aligned_cols=246  Identities=22%  Similarity=0.320  Sum_probs=199.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++++.||+|+||+||+|+++ +++.||||.+...  ..+.+.+|++++++++|||||++++++.....    +++|||
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~----~~lv~E   80 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP----ICLVFE   80 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS----CEEEEE
T ss_pred             HcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCc----eEEEEE
Confidence            6899999999999999999986 5678999998753  35778999999999999999999999876554    669999


Q ss_pred             ecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           80 YAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        80 y~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      ||++|+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.  +||+|||+++.........
T Consensus        81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC--EEECSCC------------
T ss_pred             ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC--eEecccchheeccCCCcee
Confidence            9999999999874 456899999999999999999999999999999999999998766  9999999998765444444


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhC-CCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATG-RPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      .....||+.|||||++.+..++.++|||||||++|||+|+ ++||.. .+....+..+.. ...+..|...++++.+||.
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~-~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~  236 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDIST-GFRLYKPRLASTHVYQIMN  236 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-CCHHHHHHHHHH-TCCCCCCTTSCHHHHHHHH
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC-CCHHHHHHHHHh-cCCCCCccccCHHHHHHHH
Confidence            4456799999999999999999999999999999999995 555554 444444444432 3345567778999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhC
Q 040569          238 KCLIRNPGERWSASELLEH  256 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~h  256 (385)
                      +||++||.+|||++|+++|
T Consensus       237 ~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         237 HCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCCHhHCcCHHHHHHH
Confidence            9999999999999999986

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=420.66  Aligned_cols=245  Identities=26%  Similarity=0.414  Sum_probs=200.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++++.||+|+||+||+|+.+   ..||||++...     ..+.+++|+.+|++++|||||+++++.... .    +++
T Consensus         9 ~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~-~----~~l   80 (276)
T d1uwha_           9 QITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-Q----LAI   80 (276)
T ss_dssp             CCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-S----CEE
T ss_pred             cEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc-E----EEE
Confidence            5888999999999999999865   35999988642     236788999999999999999999975432 2    569


Q ss_pred             EEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           77 FLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |||||+||+|.+++. .+.++++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+......
T Consensus        81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWS  158 (276)
T ss_dssp             EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS--EEECCCCCSCC-----
T ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC--EEEccccceeeccccC
Confidence            999999999999997 4567999999999999999999999999999999999999987766  9999999998764322


Q ss_pred             C-CCCCccccCCcccChhhhcCC---CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCC---CCCCCCCCcC
Q 040569          156 D-DEGKPICGTPICMAPEVARGE---EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFS---SDTPEIPGYM  228 (385)
Q Consensus       156 ~-~~~~~~~Gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~---~~~~~~~~~~  228 (385)
                      . .......||+.|||||++.+.   .++.++|||||||++|||+||+.||.+..........+...   ...+.++..+
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  238 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC  238 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence            2 233456799999999999754   47889999999999999999999998876554443333222   2333566778


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          229 SKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       229 s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      |+++++||.+||++||.+|||+.|++++
T Consensus       239 ~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         239 PKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.7e-56  Score=419.51  Aligned_cols=256  Identities=27%  Similarity=0.400  Sum_probs=207.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKILYN   75 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~   75 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||++....      .+.+.+|+++|++++||||+++++++.........+|
T Consensus         8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~   87 (277)
T d1o6ya_           8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY   87 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence            4999999999999999999999999999999986432      2357899999999999999999999887766556678


Q ss_pred             EEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccC
Q 040569           76 LFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        76 lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~  155 (385)
                      ||||||+||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++.  .+|+|||.++......
T Consensus        88 lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~~~  165 (277)
T d1o6ya_          88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSG  165 (277)
T ss_dssp             EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC---
T ss_pred             EEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhcccc
Confidence            99999999999999988888999999999999999999999999999999999999998776  9999999987653322


Q ss_pred             C--CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCC--CCCCCcCCHH
Q 040569          156 D--DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDT--PEIPGYMSKQ  231 (385)
Q Consensus       156 ~--~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~  231 (385)
                      .  ......+||+.|||||++.+..+++++|||||||++|+|+||++||... +....+.++......  ......+|++
T Consensus       166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~  244 (277)
T d1o6ya_         166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-SPVSVAYQHVREDPIPPSARHEGLSAD  244 (277)
T ss_dssp             -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHCCCCCGGGTSSSCCHH
T ss_pred             ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc-CHHHHHHHHHhcCCCCCchhccCCCHH
Confidence            2  2345568999999999999999999999999999999999999999874 344443333222222  2344568999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 040569          232 AQDFLSKCLIRNPGERWSASELLEHGFVK  260 (385)
Q Consensus       232 ~~~ll~~cL~~dP~~Rps~~elL~hp~~~  260 (385)
                      +++||.+||++||.+||+..+.|.|+|.+
T Consensus       245 l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         245 LDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            99999999999999999544445566654

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-56  Score=420.58  Aligned_cols=256  Identities=25%  Similarity=0.353  Sum_probs=208.9

Q ss_pred             CceeeceeeccCceEEEEEEECCC-CcEEEEEeccCC-----CHHHHHHHHHHHHhc---CCCCeeeeeeeeeecc-CCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRS-SEVFAVKSAELS-----NSEFLQREQRILSAL---ACPQIVAYKGCDISEE-NGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~-~~~~AvK~~~~~-----~~~~~~~E~~il~~l---~hpnIv~~~~~~~~~~-~~~   71 (385)
                      +|++++.||+|+||+||+|++..+ ++.||||++...     ....+.+|+.+|+.|   +||||+++++++.... ...
T Consensus         8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~   87 (305)
T d1blxa_           8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   87 (305)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence            699999999999999999999765 678999987532     233566888888776   7999999999886432 334


Q ss_pred             EEEEEEEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569           72 ILYNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                      ..++++|||+.++.+..... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.
T Consensus        88 ~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg~~~~  165 (305)
T d1blxa_          88 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARI  165 (305)
T ss_dssp             EEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSCCC
T ss_pred             ceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC--eeecchhhhhh
Confidence            55779999999887765554 5567999999999999999999999999999999999999987766  99999999986


Q ss_pred             ecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc----C---------
Q 040569          151 ARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG----F---------  217 (385)
Q Consensus       151 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~----~---------  217 (385)
                      .....  .....+||+.|||||++.+..++.++|||||||++|||++|++||.... ....+.++.    .         
T Consensus       166 ~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~  242 (305)
T d1blxa_         166 YSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-DVDQLGKILDVIGLPGEEDWPRD  242 (305)
T ss_dssp             CCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             hcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC-HHHHHHHHHHhhCCCchhccccc
Confidence            53322  3345689999999999999999999999999999999999999998753 333333220    0         


Q ss_pred             ------------CCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          218 ------------SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       218 ------------~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                  ....+.++..+|+.+++||.+||++||++|||+.|+|+||||++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence                        011112345689999999999999999999999999999999864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=409.63  Aligned_cols=246  Identities=20%  Similarity=0.280  Sum_probs=215.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      ||++++.||+|+||+||+|+++ +++.||||.+...  ..+.+.+|+.++++++||||+++++++.....    +++|||
T Consensus         5 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~----~~iv~E   79 (258)
T d1k2pa_           5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP----IFIITE   79 (258)
T ss_dssp             CCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSS----EEEEEE
T ss_pred             HCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc----eEEEEE
Confidence            6899999999999999999985 7889999998653  45788999999999999999999998876544    679999


Q ss_pred             ecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           80 YAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        80 y~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      |+++|+|.+++. ....+++..+..++.||++||+|||++||+||||||+|||++.++.  +||+|||+++.........
T Consensus        80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC--EEECCCSSCCBCSSSSCCC
T ss_pred             ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc--EEECcchhheeccCCCcee
Confidence            999999999976 4567999999999999999999999999999999999999987665  9999999998765444444


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      .....||+.|||||++.+..++.++|||||||++|||+| |+.||.... .......+. ....+..|...++++++||.
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~-~~~~~~~i~-~~~~~~~p~~~~~~l~~li~  235 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIA-QGLRLYRPHLASEKVYTIMY  235 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-HHHHHHHHH-TTCCCCCCTTCCHHHHHHHH
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC-HHHHHHHHH-hCCCCCCcccccHHHHHHHH
Confidence            455679999999999999999999999999999999998 899998764 444444443 34456677889999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhC
Q 040569          238 KCLIRNPGERWSASELLEH  256 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~h  256 (385)
                      +||++||++|||++++|+|
T Consensus       236 ~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         236 SCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HTTCSSGGGSCCHHHHHHH
T ss_pred             HHccCCHhHCcCHHHHHHH
Confidence            9999999999999999987

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-56  Score=425.26  Aligned_cols=248  Identities=23%  Similarity=0.297  Sum_probs=207.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCc-----EEEEEeccCC----CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSE-----VFAVKSAELS----NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~-----~~AvK~~~~~----~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~   71 (385)
                      +|++++.||+|+||+||+|+++.+++     .||+|.+...    ....+.+|+.+|+++ +|||||++++++.....  
T Consensus        38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~--  115 (325)
T d1rjba_          38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP--  115 (325)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--
T ss_pred             HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe--
Confidence            47889999999999999999876554     6899987543    234678999999998 89999999999876655  


Q ss_pred             EEEEEEEeecCCCCHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 040569           72 ILYNLFLEYAPGGTLTDAIRSG-----------------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQ  128 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~~-----------------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~  128 (385)
                        +++|||||+||+|.++|+..                       ..+++..+..++.||+.||+|||++||+||||||+
T Consensus       116 --~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~  193 (325)
T d1rjba_         116 --IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  193 (325)
T ss_dssp             --CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             --EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence              66999999999999999743                       34899999999999999999999999999999999


Q ss_pred             CEEeecCCCCCeEEeecCceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCC
Q 040569          129 NILVSKDNEQGAKIADFGCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVA  206 (385)
Q Consensus       129 NILi~~~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~  206 (385)
                      |||++.++.  +||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |++||.+..
T Consensus       194 Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         194 NVLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GEEEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ccccccCCe--EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            999987766  999999999876433322 1234578999999999999999999999999999999998 899998754


Q ss_pred             ChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          207 DPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      .... +.++......+..|..+|+++++||.+||++||++|||++||++|
T Consensus       272 ~~~~-~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         272 VDAN-FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CSHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHH-HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4333 333333444566778899999999999999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-56  Score=415.85  Aligned_cols=245  Identities=22%  Similarity=0.331  Sum_probs=204.2

Q ss_pred             ceeeccCceEEEEEEEC--CCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            7 QTIGRGSTATVSIGMSN--RSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~--~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +.||+|+||+||+|.++  .+++.||||++....     .+.+.+|+++|++++|||||++++++.. +.    ++||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~----~~lvmE   87 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ES----WMLVME   87 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SS----EEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CC----EEEEEE
Confidence            47999999999999864  456889999886432     3468899999999999999999998743 22    569999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC--
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD--  157 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~--  157 (385)
                      ||++|+|.++++....+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++........  
T Consensus        88 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~--~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          88 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCSEEE
T ss_pred             cCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc--ccccchhhhhhccccccccc
Confidence            9999999999998888999999999999999999999999999999999999998766  999999999876433221  


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFL  236 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll  236 (385)
                      ......||+.|||||++.+..++.++|||||||++|||+| |+.||.+.. .......+ .....+..|..+|+++++||
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-~~~~~~~i-~~~~~~~~p~~~~~~~~~li  243 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-GSEVTAML-EKGERMGCPAGCPREMYDLM  243 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHH-HTTCCCCCCTTCCHHHHHHH
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC-HHHHHHHH-HcCCCCCCCcccCHHHHHHH
Confidence            2234568999999999999999999999999999999998 899998753 33333333 23456677888999999999


Q ss_pred             HHhhhcCCCCCCCHHHH---HhCcccc
Q 040569          237 SKCLIRNPGERWSASEL---LEHGFVK  260 (385)
Q Consensus       237 ~~cL~~dP~~Rps~~el---L~hp~~~  260 (385)
                      .+||++||.+|||++++   |+|+|+.
T Consensus       244 ~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         244 NLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            99999999999999998   4666643

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-55  Score=414.94  Aligned_cols=250  Identities=22%  Similarity=0.326  Sum_probs=208.0

Q ss_pred             Cceeece-eeccCceEEEEEEECCC--CcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQT-IGRGSTATVSIGMSNRS--SEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~-LG~G~~g~Vy~a~~~~~--~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|.+.+. ||+|+||+||+|.++.+  +..||||.+....    .+.+.+|+++|++++|||||++++++... .    +
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~----~   83 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-A----L   83 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S----E
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-e----E
Confidence            3556664 99999999999987644  5579999986532    35678999999999999999999987542 2    5


Q ss_pred             EEEEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      +||||||+||+|.+++. ..+.+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+....
T Consensus        84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~  161 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGA  161 (285)
T ss_dssp             EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECTT
T ss_pred             EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc--eeeccchhhhcccc
Confidence            69999999999999986 4567999999999999999999999999999999999999998776  99999999997643


Q ss_pred             cCC--CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          154 NED--DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       154 ~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      ...  ......+||+.|||||++.+..++.++|||||||++|||+| |+.||...... .....+ .....+..|..+|+
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-~~~~~i-~~~~~~~~p~~~~~  239 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFI-EQGKRMECPPECPP  239 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HHHHHH-HTTCCCCCCTTCCH
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-HHHHHH-HcCCCCCCCCcCCH
Confidence            322  22334578999999999999999999999999999999998 99999876543 333333 23455677888999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHH---HhCcccc
Q 040569          231 QAQDFLSKCLIRNPGERWSASEL---LEHGFVK  260 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~el---L~hp~~~  260 (385)
                      ++.+||.+||++||.+|||+.++   |+|+|+.
T Consensus       240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            99999999999999999999887   5677754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-55  Score=416.86  Aligned_cols=247  Identities=19%  Similarity=0.285  Sum_probs=196.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCc---EEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSE---VFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~---~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++.+.||+|+||+||+|+++.+++   .+|||.+....    .+.+.+|+++|++++|||||++++++.....    +
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~----~  102 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP----V  102 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS----C
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE----E
Confidence            47788999999999999999987764   68899876432    2467899999999999999999999866554    6


Q ss_pred             EEEEeecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      ++|||||+||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+||||+.++.  +||+|||+|+....
T Consensus       103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLED  180 (299)
T ss_dssp             EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC--------
T ss_pred             EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc--EEECCcccceEccC
Confidence            699999999999999885 557999999999999999999999999999999999999987766  99999999987643


Q ss_pred             cCCC----CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcC
Q 040569          154 NEDD----EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYM  228 (385)
Q Consensus       154 ~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (385)
                      ....    ......||+.|||||++.+..++.++|||||||++|||+| |+.||.+.. ....+..+. ....+..|..+
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~-~~~~~~~i~-~~~~~~~~~~~  258 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-NQDVINAIE-QDYRLPPPMDC  258 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHHH-TTCCCCCCTTC
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC-HHHHHHHHH-cCCCCCCCccc
Confidence            3221    1223458999999999999999999999999999999998 899998753 444444443 23345567779


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          229 SKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       229 s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ++++.+||.+||++||.+|||+.|++++
T Consensus       259 ~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         259 PSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999999874

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.3e-55  Score=413.36  Aligned_cols=251  Identities=29%  Similarity=0.372  Sum_probs=206.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++.+.||+|+||+||+|+++ +|+.||||++....     .+.+.+|+.+|++++||||+++++.+.....    +++
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~----~~i   77 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR----LVL   77 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC----EEE
T ss_pred             CceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc----eeE
Confidence            6999999999999999999986 88999999986532     4678899999999999999999999877665    678


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      ++||+.++.+..+.+..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|...... .
T Consensus        78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~-~  154 (286)
T d1ob3a_          78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIP-V  154 (286)
T ss_dssp             EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC---
T ss_pred             EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC--EEecccccceecccC-c
Confidence            9999998888887777888999999999999999999999999999999999999988766  999999999875422 2


Q ss_pred             CCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc---CC--------------
Q 040569          157 DEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG---FS--------------  218 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~---~~--------------  218 (385)
                      .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||....+ ...+.++.   ..              
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH-HHHHHHHHHhhCCCChhhccchhhhhh
Confidence            233445799999999999765 568999999999999999999999987533 33322210   00              


Q ss_pred             ----------CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          219 ----------SDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       219 ----------~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                                ...+..+..+|+.+++||++||++||++|||++|+|+||||++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                      0011233457899999999999999999999999999999974

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.9e-55  Score=417.90  Aligned_cols=253  Identities=24%  Similarity=0.337  Sum_probs=211.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALA-CPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||++.....+.+.+|+++|+++. ||||+++++++.......  +++||||
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~--~~~v~e~  113 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRT--PALVFEH  113 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS--EEEEEEC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc--eeEEEee
Confidence            5899999999999999999999999999999999888889999999999995 999999999887554433  5589999


Q ss_pred             cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCCCC
Q 040569           81 APGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDEGK  160 (385)
Q Consensus        81 ~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~~~  160 (385)
                      |.+++|.++.   +.+++..++.+++||+.||+|||++||+||||||+||||+.++. .+||+|||+|+.....  ....
T Consensus       114 ~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~--~~~~  187 (328)
T d3bqca1         114 VNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPG--QEYN  187 (328)
T ss_dssp             CCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTT--CCCC
T ss_pred             cCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCC--Cccc
Confidence            9999998764   35999999999999999999999999999999999999986543 3899999999876432  2345


Q ss_pred             ccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc----------------CCC----
Q 040569          161 PICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG----------------FSS----  219 (385)
Q Consensus       161 ~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~----------------~~~----  219 (385)
                      ..+||+.|+|||.+.+. .++.++|||||||++|+|++|+.||....+.......+.                ...    
T Consensus       188 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  267 (328)
T d3bqca1         188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF  267 (328)
T ss_dssp             SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGG
T ss_pred             ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCccc
Confidence            56799999999998775 479999999999999999999999976554433221110                000    


Q ss_pred             ---------------CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          220 ---------------DTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       220 ---------------~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                     ........+|+++++||++||++||.+|||++|+|+||||+..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v  325 (328)
T d3bqca1         268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  325 (328)
T ss_dssp             GGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred             chhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence                           0111223478999999999999999999999999999999865

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-55  Score=421.58  Aligned_cols=256  Identities=27%  Similarity=0.370  Sum_probs=206.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcCCCCeeeeeeeeeecc--CCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACPQIVAYKGCDISEE--NGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~~~~~lv~E   79 (385)
                      +|+.++.||+|+||+||+|+++.+|+.||||++.... ....+|+++|++++||||+++++++....  .+..+++||||
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E   99 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD   99 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence            5899999999999999999999999999999987543 34458999999999999999999986542  23345679999


Q ss_pred             ecCCCCHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           80 YAPGGTLTDAI---RSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        80 y~~ggsL~~~l---~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      ||+++.+..+.   .....+++..++.+++||+.||+|||++||+||||||+|||++.++. .+||+|||+++.....  
T Consensus       100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~DFG~a~~~~~~--  176 (350)
T d1q5ka_         100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRG--  176 (350)
T ss_dssp             CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECCCTTCEECCTT--
T ss_pred             ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEecccchhhccCC--
Confidence            99876433332   35667999999999999999999999999999999999999986642 3899999999876432  


Q ss_pred             CCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc------------------C
Q 040569          157 DEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG------------------F  217 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~------------------~  217 (385)
                      ......+||+.|+|||.+.+ ..++.++|||||||++|||++|++||..... ...+..+.                  .
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~-~~~l~~i~~~~g~~~~~~~~~~~~~~~  255 (350)
T d1q5ka_         177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQIREMNPNYT  255 (350)
T ss_dssp             SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHHHCC---
T ss_pred             cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH-HHHHHHHHHHhCCChHHhhhhhccchh
Confidence            23445689999999999875 4689999999999999999999999976533 22222210                  0


Q ss_pred             CCCCC---------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          218 SSDTP---------EIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       218 ~~~~~---------~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                      ....+         .....+++++++||.+||++||.+|||+.|+|+||||++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            00011         1123479999999999999999999999999999999865

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-55  Score=409.77  Aligned_cols=251  Identities=22%  Similarity=0.285  Sum_probs=205.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++++.||+|+||+||+|+++.+ +.||||++...  ..+.+.+|+.+|++++|||||++++++.. ..    +++|||
T Consensus        18 ~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~----~~lv~E   91 (285)
T d1fmka3          18 SLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP----IYIVTE   91 (285)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS----CEEEEC
T ss_pred             HEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CC----eEEEEE
Confidence            588999999999999999999755 56999998654  35778999999999999999999998743 22    458999


Q ss_pred             ecCCCCHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           80 YAPGGTLTDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        80 y~~ggsL~~~l~--~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |+++|+|..++.  ..+.+++..+..++.||+.||+|||++||+||||||+||||+.++.  +||+|||+|+........
T Consensus        92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~--~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC--------
T ss_pred             ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc--EEEcccchhhhccCCCce
Confidence            999999999886  3456999999999999999999999999999999999999987766  999999999876544433


Q ss_pred             CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          158 EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       158 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      ......||+.|||||++.+..++.++|||||||++|||++|..||.........+..+.. ...+..+..+|+++++||.
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~  248 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMC  248 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTSCHHHHHHHH
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh-cCCCCCCcccCHHHHHHHH
Confidence            444567999999999999999999999999999999999976666555555555555543 3345567789999999999


Q ss_pred             HhhhcCCCCCCCHHHHHh--Cccccc
Q 040569          238 KCLIRNPGERWSASELLE--HGFVKE  261 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~--hp~~~~  261 (385)
                      +||+.||++|||++++++  ++|+..
T Consensus       249 ~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         249 QCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            999999999999999987  777653

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-54  Score=404.09  Aligned_cols=253  Identities=25%  Similarity=0.342  Sum_probs=214.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      +|++++.||+|+||+||+|+++.+++.||||++....     .+.+++|+.+|++++||||+++++++.....    +++
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~----~~i   78 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK----LTL   78 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE----EEE
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc----eeE
Confidence            6999999999999999999999999999999985432     3678899999999999999999998876554    678


Q ss_pred             EEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC
Q 040569           77 FLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED  156 (385)
Q Consensus        77 v~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~  156 (385)
                      ++||+.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.  +||+|||.|+.......
T Consensus        79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVR  156 (292)
T ss_dssp             EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCS
T ss_pred             EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc--eeeeecchhhcccCCCc
Confidence            9999999999999998888999999999999999999999999999999999999987765  99999999998643322


Q ss_pred             CCCCccccCCcccChhhhcCCC-CCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcC------------------
Q 040569          157 DEGKPICGTPICMAPEVARGEE-QGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGF------------------  217 (385)
Q Consensus       157 ~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~------------------  217 (385)
                       ......+++.|+|||++.+.. ++.++|||||||++|||++|+.||....+....+..+..                  
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence             233446788999999997765 589999999999999999999998665555544443210                  


Q ss_pred             ---------CCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          218 ---------SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       218 ---------~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                               .......+..+++.+++||++||++||.+|||++|+|+||||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~  288 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence                     11122234457899999999999999999999999999999975

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-54  Score=415.94  Aligned_cols=252  Identities=27%  Similarity=0.382  Sum_probs=202.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccC--CeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEEN--GKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~~~~   74 (385)
                      .|++++.||+|+||+||+|+++.+|+.||||++....     .+.+.+|+++|++++|||||++++++.....  ....+
T Consensus        19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~   98 (346)
T d1cm8a_          19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF   98 (346)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred             cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence            5889999999999999999999999999999987532     3467799999999999999999999865442  22235


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      ++||||+ |.+|..+++.+ ++++..++.+++||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.... 
T Consensus        99 ~lv~e~~-~~~l~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~~~-  173 (346)
T d1cm8a_          99 YLVMPFM-GTDLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQADS-  173 (346)
T ss_dssp             EEEEECC-SEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCS-
T ss_pred             EEEEecc-cccHHHHHHhc-cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc--cccccccceeccCC-
Confidence            7999999 66888877754 5999999999999999999999999999999999999988766  99999999987632 


Q ss_pred             CCCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc-----------------
Q 040569          155 EDDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG-----------------  216 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~-----------------  216 (385)
                         ......||+.|+|||++.+. .++.++|||||||++|+|++|++||..... ...+..+.                 
T Consensus       174 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  249 (346)
T d1cm8a_         174 ---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEIMKVTGTPPAEFVQRLQSD  249 (346)
T ss_dssp             ---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             ---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh-HHHHHHHHhccCCCcHHHHhhhcch
Confidence               23456799999999998764 568999999999999999999999976532 22221110                 


Q ss_pred             ------------CCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          217 ------------FSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       217 ------------~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                                  .....+.....+++++++||.+||.+||.+|||+.|+|+||||+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence                        0111122345679999999999999999999999999999999864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=405.59  Aligned_cols=246  Identities=23%  Similarity=0.309  Sum_probs=196.8

Q ss_pred             CceeeceeeccCceEEEEEEECCC---CcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRS---SEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~---~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++++.||+|+||+||+|++..+   +..+|||.+....    .+.+.+|+++|++++|||||++++++.. ..    +
T Consensus         8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~----~   82 (273)
T d1mp8a_           8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP----V   82 (273)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SS----C
T ss_pred             HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-Ce----E
Confidence            588999999999999999998755   3568999886432    2467899999999999999999998743 22    5


Q ss_pred             EEEEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecc
Q 040569           75 NLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARV  153 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~  153 (385)
                      ++||||+++|+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||+|+....
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMED  160 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC---------
T ss_pred             EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--EEEccchhheeccC
Confidence            69999999999999876 4557999999999999999999999999999999999999998776  99999999987654


Q ss_pred             cCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHH
Q 040569          154 NEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQA  232 (385)
Q Consensus       154 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  232 (385)
                      ..........||+.|||||++.+..++.++|||||||++|||++ |.+||.... .......+. ....+.+|..+|+++
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~-~~~~~~~i~-~~~~~~~~~~~~~~~  238 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIE-NGERLPMPPNCPPTL  238 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-GGGHHHHHH-TTCCCCCCTTCCHHH
T ss_pred             CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC-HHHHHHHHH-cCCCCCCCCCCCHHH
Confidence            44444455678999999999999999999999999999999998 899998753 333444442 344556778899999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          233 QDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       233 ~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ++||.+||..||.+|||+.|+++|
T Consensus       239 ~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         239 YSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999986

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-54  Score=403.41  Aligned_cols=247  Identities=20%  Similarity=0.229  Sum_probs=200.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCC----cEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSS----EVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~----~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      .|++.+.||+|+||+||+|.++.++    ..||||.+....    ...+.+|+++|++++|||||++++++.....    
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~----   83 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP----   83 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS----
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc----
Confidence            4889999999999999999987665    479999986533    2357799999999999999999999876554    


Q ss_pred             EEEEEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           74 YNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      .++|||||.+|+|.+++. ..+.+++..+..++.||+.||+|||++||+||||||+||||+.++.  +||+|||+|+...
T Consensus        84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~  161 (283)
T d1mqba_          84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLE  161 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-----
T ss_pred             eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe--EEEcccchhhccc
Confidence            668999999999999887 4567999999999999999999999999999999999999987766  9999999998764


Q ss_pred             ccCCC--CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          153 VNEDD--EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       153 ~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      .....  ......||+.|||||++.+..++.++|||||||++|||++|..|+............+. ....+..|..+++
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~~~~  240 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDCPS  240 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTCBH
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh-ccCCCCCchhhHH
Confidence            33221  22345689999999999999999999999999999999997666655445555554443 3445667778999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ++.+||.+||+.||++|||+.|+++
T Consensus       241 ~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         241 AIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            9999999999999999999999987

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-54  Score=415.95  Aligned_cols=258  Identities=24%  Similarity=0.336  Sum_probs=204.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLF   77 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv   77 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||++....    .+.+.+|+++|++++||||+++++++..........+++
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l   88 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL   88 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence            4899999999999999999999999999999987543    235678999999999999999999886543221112245


Q ss_pred             EeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCC-
Q 040569           78 LEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNED-  156 (385)
Q Consensus        78 ~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~-  156 (385)
                      ++|+.||+|.++++.+ ++++..++.++.||++||+|||++||+||||||+|||++.++.  +||+|||+|+....... 
T Consensus        89 ~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~--~kl~DfG~a~~~~~~~~~  165 (345)
T d1pmea_          89 VTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDH  165 (345)
T ss_dssp             EEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGGGCB
T ss_pred             EEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC--EEEcccCceeeccCCCcc
Confidence            5677799999999865 5999999999999999999999999999999999999987665  99999999987644322 


Q ss_pred             -CCCCccccCCcccChhhhcC-CCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc------------------
Q 040569          157 -DEGKPICGTPICMAPEVARG-EEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG------------------  216 (385)
Q Consensus       157 -~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~------------------  216 (385)
                       ......+||+.|+|||++.. ..++.++||||+||++|+|++|+.||..............                  
T Consensus       166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (345)
T d1pmea_         166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA  245 (345)
T ss_dssp             CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred             ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhh
Confidence             22455679999999999854 4678899999999999999999999976432211111100                  


Q ss_pred             ------CC--CCC--CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          217 ------FS--SDT--PEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       217 ------~~--~~~--~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                            ..  ...  ......+|+++++||.+||++||.+|||+.|+|+||||++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence                  00  000  01223578999999999999999999999999999999854

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-54  Score=409.30  Aligned_cols=257  Identities=25%  Similarity=0.315  Sum_probs=204.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccC----CeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-----NSEFLQREQRILSALACPQIVAYKGCDISEEN----GKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~----~~~   72 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||++...     ....+.+|+.+|++++||||+++++++.....    ...
T Consensus        11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~   90 (318)
T d3blha1          11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG   90 (318)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred             CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence            589999999999999999999999999999988543     23567899999999999999999998755321    112


Q ss_pred             EEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           73 LYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      .+++||||+.++.+.........+++..++.+++||+.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus        91 ~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~dfg~~~~~~  168 (318)
T d3blha1          91 SIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFS  168 (318)
T ss_dssp             CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECC
T ss_pred             eEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--EEeeecceeeecc
Confidence            36799999988777766667778999999999999999999999999999999999999998776  9999999998764


Q ss_pred             ccC---CCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHh---cCCCCCCCCC
Q 040569          153 VNE---DDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRI---GFSSDTPEIP  225 (385)
Q Consensus       153 ~~~---~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---~~~~~~~~~~  225 (385)
                      ...   .......+||+.|+|||++.+. .+++++|||||||++|||++|+.||.+..+ ...+..+   ..........
T Consensus       169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~  247 (318)
T d3blha1         169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-QHQLALISQLCGSITPEVWP  247 (318)
T ss_dssp             C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTST
T ss_pred             cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH-HHHHHHHHHhcCCCChhhcc
Confidence            322   2233446799999999999765 689999999999999999999999986533 3322221   1111000000


Q ss_pred             ---------------------------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 040569          226 ---------------------------GYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKE  261 (385)
Q Consensus       226 ---------------------------~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~  261 (385)
                                                 ...++++++||.+||++||++|||++|+|+||||+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence                                       013778899999999999999999999999999974

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-54  Score=416.09  Aligned_cols=256  Identities=26%  Similarity=0.461  Sum_probs=215.0

Q ss_pred             CceeeceeeccCceEEEEEEE---CCCCcEEEEEeccCC-------CHHHHHHHHHHHHhcCC-CCeeeeeeeeeeccCC
Q 040569            2 DWTRGQTIGRGSTATVSIGMS---NRSSEVFAVKSAELS-------NSEFLQREQRILSALAC-PQIVAYKGCDISEENG   70 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~---~~~~~~~AvK~~~~~-------~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~   70 (385)
                      +|++++.||+|+||+||+|++   +.+|+.||||.+.+.       ..+.+.+|+++|++++| |||+++++++.+... 
T Consensus        25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~-  103 (322)
T d1vzoa_          25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK-  103 (322)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE-
T ss_pred             ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc-
Confidence            599999999999999999987   457999999987532       24567799999999966 899999998766553 


Q ss_pred             eEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceee
Q 040569           71 KILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARR  150 (385)
Q Consensus        71 ~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~  150 (385)
                         ++++|||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.
T Consensus       104 ---~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--vkL~DFG~a~~  178 (322)
T d1vzoa_         104 ---LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKE  178 (322)
T ss_dssp             ---EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEE
T ss_pred             ---eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC--EEEeeccchhh
Confidence               6789999999999999998888999999999999999999999999999999999999988766  99999999987


Q ss_pred             ecccCCCCCCccccCCcccChhhhcCC--CCCCCCChHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHhcCCCCCCCCCC
Q 040569          151 ARVNEDDEGKPICGTPICMAPEVARGE--EQGFPADVWALGCTVLEMATGRPPWPDVA--DPISALHRIGFSSDTPEIPG  226 (385)
Q Consensus       151 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~  226 (385)
                      .............|++.|+|||.+.+.  .++.++|||||||++|+|++|+.||....  +....+.+... ...+.+|.
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~  257 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-KSEPPYPQ  257 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-HCCCCCCT
T ss_pred             hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc-cCCCCCcc
Confidence            654444445566899999999999765  46789999999999999999999997543  22233322211 23455677


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCcccccccc
Q 040569          227 YMSKQAQDFLSKCLIRNPGERW-----SASELLEHGFVKEQNF  264 (385)
Q Consensus       227 ~~s~~~~~ll~~cL~~dP~~Rp-----s~~elL~hp~~~~~~~  264 (385)
                      .+|+++++||.+||++||.+||     |++|+|+||||++.++
T Consensus       258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~  300 (322)
T d1vzoa_         258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  300 (322)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence            7999999999999999999999     5899999999988654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-54  Score=410.39  Aligned_cols=247  Identities=21%  Similarity=0.304  Sum_probs=202.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCc----EEEEEeccCC----CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSE----VFAVKSAELS----NSEFLQREQRILSALACPQIVAYKGCDISEENGKIL   73 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~----~~AvK~~~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~   73 (385)
                      ||++++.||+|+||+||+|+++.+|+    .||+|.+...    ..+.+.+|+.+|++++|||||++++++.+..     
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-----   84 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-----   84 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-----
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----
Confidence            69999999999999999999988876    4788877532    3467889999999999999999999986532     


Q ss_pred             EEEEEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeec
Q 040569           74 YNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRAR  152 (385)
Q Consensus        74 ~~lv~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~  152 (385)
                      .++++||+.+|+|.+.+. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+...
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~  162 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLG  162 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTT
T ss_pred             eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC--eEeeccccceecc
Confidence            457899999999999887 4567999999999999999999999999999999999999998766  9999999998764


Q ss_pred             ccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCH
Q 040569          153 VNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSK  230 (385)
Q Consensus       153 ~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  230 (385)
                      ..... ......||+.|||||++.++.++.++|||||||++|||+| |++||..... ......+ .....+..|..+++
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-~~~~~~i-~~~~~~~~p~~~~~  240 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSIL-EKGERLPQPPICTI  240 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-GGHHHHH-HHTCCCCCCTTBCH
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-HHHHHHH-HcCCCCCCCcccCH
Confidence            33222 2234468999999999999999999999999999999998 8999976532 2222222 22344556778999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhCc
Q 040569          231 QAQDFLSKCLIRNPGERWSASELLEHG  257 (385)
Q Consensus       231 ~~~~ll~~cL~~dP~~Rps~~elL~hp  257 (385)
                      ++.+||.+||..||.+|||+.|+++|.
T Consensus       241 ~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         241 DVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence            999999999999999999999999884

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=404.05  Aligned_cols=249  Identities=25%  Similarity=0.328  Sum_probs=197.6

Q ss_pred             CceeeceeeccCceEEEEEEECC-----CCcEEEEEeccCCC----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNR-----SSEVFAVKSAELSN----SEFLQREQRILSAL-ACPQIVAYKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~~AvK~~~~~~----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~   71 (385)
                      +|++++.||+|+||+||+|+++.     +++.||||.+....    .+.+.+|..++.++ +||||+.+++++...... 
T Consensus        14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~-   92 (299)
T d1ywna1          14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP-   92 (299)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC-
T ss_pred             HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe-
Confidence            48899999999999999999754     45789999986432    23556777888777 789999999886554332 


Q ss_pred             EEEEEEEeecCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecC
Q 040569           72 ILYNLFLEYAPGGTLTDAIRSG----------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKD  135 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~~----------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~  135 (385)
                        +++|||||++|+|.+++...                ..+++..+..++.||+.||+|||++||+||||||+||||+.+
T Consensus        93 --~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~  170 (299)
T d1ywna1          93 --LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  170 (299)
T ss_dssp             --CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred             --EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence              56899999999999999732                348999999999999999999999999999999999999877


Q ss_pred             CCCCeEEeecCceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhC-CCCCCCCCChHHHHH
Q 040569          136 NEQGAKIADFGCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATG-RPPWPDVADPISALH  213 (385)
Q Consensus       136 ~~~~~kL~DFG~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG-~~Pf~~~~~~~~~~~  213 (385)
                      +.  +||+|||+|+....... ......+||+.|||||++.+..++.++|||||||++|||+|| .+||...........
T Consensus       171 ~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~  248 (299)
T d1ywna1         171 NV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  248 (299)
T ss_dssp             GC--EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred             Cc--EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            66  99999999987643322 233456799999999999999999999999999999999986 568876544443333


Q ss_pred             HhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          214 RIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       214 ~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      .+ .....+..|..+++++++||.+||++||.+|||+.|+++|
T Consensus       249 ~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         249 RL-KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HH-HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HH-hcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            33 2344566778899999999999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-53  Score=396.43  Aligned_cols=246  Identities=24%  Similarity=0.359  Sum_probs=200.0

Q ss_pred             CceeeceeeccCceEEEEEEECCC-C--cEEEEEeccCCC------HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRS-S--EVFAVKSAELSN------SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~-~--~~~AvK~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      ||++.+.||+|+||+||+|+++.+ +  ..||||.+....      .+.+.+|+.+|++++||||+++++++.+. .   
T Consensus         9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~---   84 (273)
T d1u46a_           9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-P---   84 (273)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S---
T ss_pred             HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-c---
Confidence            689999999999999999986533 2  368999886431      35678999999999999999999988543 2   


Q ss_pred             EEEEEEeecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           73 LYNLFLEYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                       +++||||+++|+|.+++. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..
T Consensus        85 -~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~--vkl~DfGl~~~~  161 (273)
T d1u46a_          85 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRAL  161 (273)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEEC
T ss_pred             -hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc--eeeccchhhhhc
Confidence             458999999999999876 4556999999999999999999999999999999999999998776  999999999986


Q ss_pred             cccCCC--CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcC
Q 040569          152 RVNEDD--EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYM  228 (385)
Q Consensus       152 ~~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (385)
                      ......  ......|++.|||||++.+..++.++|||||||++|||+| |++||... +.......+......+..+..+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~  240 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEGERLPRPEDC  240 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHTSCCCCCCCTTC
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc-CHHHHHHHHHhCCCCCCCcccc
Confidence            433221  2234568889999999999999999999999999999998 89999875 4555556665556666777889


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          229 SKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       229 s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      |+++++||.+||++||++|||+.|+++
T Consensus       241 ~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         241 PQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999975

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-53  Score=401.37  Aligned_cols=245  Identities=24%  Similarity=0.309  Sum_probs=206.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcE--EEEEeccCC----CHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEV--FAVKSAELS----NSEFLQREQRILSAL-ACPQIVAYKGCDISEENGKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~--~AvK~~~~~----~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~~~   74 (385)
                      +|++++.||+|+||+||+|+++.+|..  +|||.+...    ..+.+.+|+++|+++ +|||||++++++.....    +
T Consensus        11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~----~   86 (309)
T d1fvra_          11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY----L   86 (309)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE----E
T ss_pred             HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe----e
Confidence            588999999999999999999988875  667776432    234688999999999 79999999999876543    6


Q ss_pred             EEEEeecCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCC
Q 040569           75 NLFLEYAPGGTLTDAIRSG----------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQ  138 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~----------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~  138 (385)
                      ++||||++||+|.+++...                ..+++..+..++.||+.||.|||++||+||||||+|||++.++. 
T Consensus        87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~-  165 (309)
T d1fvra_          87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-  165 (309)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC-
T ss_pred             EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc-
Confidence            7999999999999999643                57999999999999999999999999999999999999988766 


Q ss_pred             CeEEeecCceeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCC-CCCCCCCChHHHHHHhcC
Q 040569          139 GAKIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGR-PPWPDVADPISALHRIGF  217 (385)
Q Consensus       139 ~~kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~-~Pf~~~~~~~~~~~~~~~  217 (385)
                       +||+|||+|+......  .....+||+.|+|||.+.+..++.++|||||||++|||++|. +||... +.......+. 
T Consensus       166 -~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-~~~~~~~~i~-  240 (309)
T d1fvra_         166 -AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKLP-  240 (309)
T ss_dssp             -EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHGG-
T ss_pred             -eEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC-CHHHHHHHHH-
Confidence             9999999998654332  223456999999999999999999999999999999999965 567653 5555555543 


Q ss_pred             CCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          218 SSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       218 ~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ....+..|..+++++++||.+||++||++|||+.|+++|
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            345667788899999999999999999999999999987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-53  Score=408.97  Aligned_cols=253  Identities=25%  Similarity=0.313  Sum_probs=194.0

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccC--CeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEEN--GKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~~~~   74 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||++....     ...+.+|+.+|++++||||+++++++.....  ....+
T Consensus        18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~   97 (355)
T d2b1pa1          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV   97 (355)
T ss_dssp             TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred             CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence            5899999999999999999999999999999986432     2357799999999999999999999865432  22346


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      |+|||||.|+.+ +.+.  ..+++..++.+++||+.||+|||++||+||||||+|||++.++.  +|++|||+++.....
T Consensus        98 ~iv~Ey~~~~l~-~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~~~  172 (355)
T d2b1pa1          98 YLVMELMDANLC-QVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTS  172 (355)
T ss_dssp             EEEEECCSEEHH-HHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-------
T ss_pred             EEEEeccchHHH-Hhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc--eeeechhhhhccccc
Confidence            799999977544 4443  35899999999999999999999999999999999999987766  999999998876432


Q ss_pred             CCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc---C--------------
Q 040569          155 EDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG---F--------------  217 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~---~--------------  217 (385)
                        ......+||+.|+|||++.+..+++++||||+||++++|++|++||...... ....++.   .              
T Consensus       173 --~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~  249 (355)
T d2b1pa1         173 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_dssp             ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred             --cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH-HHHHHHHHhccCCCHHHHHHhhhhH
Confidence              2344567999999999999999999999999999999999999999764322 2211110   0              


Q ss_pred             -----C-CCCCC-----------------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          218 -----S-SDTPE-----------------IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       218 -----~-~~~~~-----------------~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                           . .....                 .+...|+++++||++||.+||++|||++|+|+||||+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence                 0 00000                 011246789999999999999999999999999999863

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-53  Score=406.25  Aligned_cols=252  Identities=24%  Similarity=0.345  Sum_probs=201.4

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccC--CeEEE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-----SEFLQREQRILSALACPQIVAYKGCDISEEN--GKILY   74 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~~~~   74 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||++....     .+.+.+|+++|++++|||||++++++.....  ... .
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~-~   97 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN-D   97 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC-C
T ss_pred             CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc-e
Confidence            4899999999999999999999999999999987542     2457799999999999999999998764321  111 2


Q ss_pred             EEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeeccc
Q 040569           75 NLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVN  154 (385)
Q Consensus        75 ~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~  154 (385)
                      +++++|+.||+|.+++..+ ++++..++.+++||+.||+|||++||+||||||+|||++.++.  +|++|||++..... 
T Consensus        98 ~~i~~~~~gg~L~~~~~~~-~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~~~-  173 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTDD-  173 (348)
T ss_dssp             CEEEEECCSEEHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CCTG-
T ss_pred             EEEEEeecCCchhhhcccc-cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc--ccccccchhcccCc-
Confidence            3567888899999999754 6999999999999999999999999999999999999988766  99999999986532 


Q ss_pred             CCCCCCccccCCcccChhhhcCC-CCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhc---C-------------
Q 040569          155 EDDEGKPICGTPICMAPEVARGE-EQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIG---F-------------  217 (385)
Q Consensus       155 ~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~---~-------------  217 (385)
                         ......||+.|+|||++.+. .++.++|||||||++|+|++|++||...... .....+.   .             
T Consensus       174 ---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~  249 (348)
T d2gfsa1         174 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELLKKISSE  249 (348)
T ss_dssp             ---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred             ---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCChHHhhhccch
Confidence               23445799999999997765 4688999999999999999999999764322 2211110   0             


Q ss_pred             --------CCCCCC-----CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 040569          218 --------SSDTPE-----IPGYMSKQAQDFLSKCLIRNPGERWSASELLEHGFVKEQ  262 (385)
Q Consensus       218 --------~~~~~~-----~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~hp~~~~~  262 (385)
                              ....+.     ....+|+++++||.+||++||.+|||+.|+|+||||++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence                    000011     113478999999999999999999999999999999864

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=390.70  Aligned_cols=242  Identities=26%  Similarity=0.387  Sum_probs=200.7

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC-HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN-SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~-~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      ||+.++.||+|+||+||+|+++  |..||||.++.+. .+.+++|+++|++++||||+++++++......   +++||||
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~---~~lv~ey   82 (262)
T d1byga_           8 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG---LYIVTEY   82 (262)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--C---CEEEECC
T ss_pred             HeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCc---EEEEEec
Confidence            5889999999999999999985  7889999997654 56789999999999999999999987654322   5699999


Q ss_pred             cCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCCC
Q 040569           81 APGGTLTDAIRSG--TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDDE  158 (385)
Q Consensus        81 ~~ggsL~~~l~~~--~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~~  158 (385)
                      +++|+|.+++.+.  ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.  +||+|||+++.....    
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~s~~~~~~----  156 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST----  156 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC-----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC--EeecccccceecCCC----
Confidence            9999999999643  35899999999999999999999999999999999999998766  999999999875322    


Q ss_pred             CCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHHHHH
Q 040569          159 GKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQDFLS  237 (385)
Q Consensus       159 ~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  237 (385)
                      .....+|+.|||||++.+..+++++|||||||++|||+| |++||... +.......+ .....+.+|..+++++++||.
T Consensus       157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-~~~~~~~~i-~~~~~~~~~~~~~~~~~~li~  234 (262)
T d1byga_         157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRV-EKGYKMDAPDGCPPAVYEVMK  234 (262)
T ss_dssp             -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHHH-TTTCCCCCCTTCCHHHHHHHH
T ss_pred             CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC-CHHHHHHHH-HcCCCCCCCccCCHHHHHHHH
Confidence            234468999999999999999999999999999999998 78888764 344444444 334566778889999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhC
Q 040569          238 KCLIRNPGERWSASELLEH  256 (385)
Q Consensus       238 ~cL~~dP~~Rps~~elL~h  256 (385)
                      +||++||.+|||+.+++++
T Consensus       235 ~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         235 NCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHcccCHhHCcCHHHHHHH
Confidence            9999999999999999874

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.7e-52  Score=395.51  Aligned_cols=246  Identities=22%  Similarity=0.277  Sum_probs=207.0

Q ss_pred             CceeeceeeccCceEEEEEEEC-----CCCcEEEEEeccCCC----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN-----RSSEVFAVKSAELSN----SEFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~~AvK~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|++++.||+|+||+||+|+++     .+++.||||++....    .+.+.+|+++|++++||||+++++++.....   
T Consensus        14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~---   90 (301)
T d1lufa_          14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP---   90 (301)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS---
T ss_pred             HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc---
Confidence            4889999999999999999975     356899999987543    3467899999999999999999998876544   


Q ss_pred             EEEEEEeecCCCCHHHHHHcC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 040569           73 LYNLFLEYAPGGTLTDAIRSG------------------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQ  128 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~------------------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~  128 (385)
                       .+++|||+++|+|.+++...                        ..+++..+..++.||+.||+|||++||+||||||+
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~  169 (301)
T d1lufa_          91 -MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR  169 (301)
T ss_dssp             -CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             -eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence             56899999999999999632                        24889999999999999999999999999999999


Q ss_pred             CEEeecCCCCCeEEeecCceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCC-CCCCCCC
Q 040569          129 NILVSKDNEQGAKIADFGCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGR-PPWPDVA  206 (385)
Q Consensus       129 NILi~~~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~-~Pf~~~~  206 (385)
                      |||++.++.  +||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||++|. +||... 
T Consensus       170 NILld~~~~--~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~-  246 (301)
T d1lufa_         170 NCLVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM-  246 (301)
T ss_dssp             GEEECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-
T ss_pred             ceEECCCCc--EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC-
Confidence            999998766  99999999986543322 2234567899999999999999999999999999999999985 677664 


Q ss_pred             ChHHHHHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          207 DPISALHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      +.......+. ....+.+|..+++++.+||.+||+.||++|||+.|+++
T Consensus       247 ~~~e~~~~v~-~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         247 AHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             CHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            4455555543 34466778889999999999999999999999999975

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=390.91  Aligned_cols=246  Identities=24%  Similarity=0.332  Sum_probs=203.5

Q ss_pred             CceeeceeeccCceEEEEEEECCCC-------cEEEEEeccCCC----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccC
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSS-------EVFAVKSAELSN----SEFLQREQRILSAL-ACPQIVAYKGCDISEEN   69 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~-------~~~AvK~~~~~~----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~   69 (385)
                      +|++++.||+|+||+||+|++..++       ..||||.+....    ...+.+|..+++++ +|||||++++++.+...
T Consensus        14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~   93 (299)
T d1fgka_          14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP   93 (299)
T ss_dssp             GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence            4788999999999999999986554       479999986543    24567899999888 89999999999876544


Q ss_pred             CeEEEEEEEeecCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEee
Q 040569           70 GKILYNLFLEYAPGGTLTDAIRSG----------------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVS  133 (385)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~l~~~----------------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~  133 (385)
                          .++|||||++|+|.++|...                ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus        94 ----~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          94 ----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             ----CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             ----EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence                56899999999999999733                3589999999999999999999999999999999999998


Q ss_pred             cCCCCCeEEeecCceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHH
Q 040569          134 KDNEQGAKIADFGCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISA  211 (385)
Q Consensus       134 ~~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~  211 (385)
                      .++.  +||+|||+++........ .....+||+.|||||++.+..|+.++|||||||++|||++ |.+||... +....
T Consensus       170 ~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~-~~~~~  246 (299)
T d1fgka_         170 EDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEEL  246 (299)
T ss_dssp             TTCC--EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHH
T ss_pred             CCCC--eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC-CHHHH
Confidence            8766  999999999977543322 3445679999999999999999999999999999999998 78888764 33333


Q ss_pred             HHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          212 LHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       212 ~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      ...+ .....+..|..+|+++++||.+||++||.+|||+.|+++
T Consensus       247 ~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         247 FKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHH-HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            3333 345567778889999999999999999999999999987

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=393.20  Aligned_cols=247  Identities=24%  Similarity=0.305  Sum_probs=205.8

Q ss_pred             CceeeceeeccCceEEEEEEEC-----CCCcEEEEEeccCCC----HHHHHHHHHHHHhc-CCCCeeeeeeeeeeccCCe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSN-----RSSEVFAVKSAELSN----SEFLQREQRILSAL-ACPQIVAYKGCDISEENGK   71 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~~AvK~~~~~~----~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~   71 (385)
                      +|++++.||+|+||+||+|+++     .+++.||||++....    ...+.+|+.+++++ +|||||++++++.....  
T Consensus        24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~--  101 (311)
T d1t46a_          24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP--  101 (311)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--
T ss_pred             HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE--
Confidence            4677999999999999999863     467899999987543    24577899999999 79999999999876554  


Q ss_pred             EEEEEEEeecCCCCHHHHHHcCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEee
Q 040569           72 ILYNLFLEYAPGGTLTDAIRSGT------------------CLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVS  133 (385)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~l~~~~------------------~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~  133 (385)
                        ++++||||++|+|.+++....                  .+++..+..++.||+.||+|||++|++||||||+|||++
T Consensus       102 --~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         102 --TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT  179 (311)
T ss_dssp             --CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             --EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence              669999999999999997432                  589999999999999999999999999999999999998


Q ss_pred             cCCCCCeEEeecCceeeecccCC-CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHh-CCCCCCCCCChHHH
Q 040569          134 KDNEQGAKIADFGCARRARVNED-DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMAT-GRPPWPDVADPISA  211 (385)
Q Consensus       134 ~~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~  211 (385)
                      .++.  +||+|||+++....... ......+||+.|||||++.+..++.++|||||||++|||+| |.+||... +....
T Consensus       180 ~~~~--~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~-~~~~~  256 (311)
T d1t46a_         180 HGRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-PVDSK  256 (311)
T ss_dssp             TTTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CSSHH
T ss_pred             ccCc--ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC-CHHHH
Confidence            7765  89999999987643322 22345689999999999999999999999999999999999 55556554 33333


Q ss_pred             HHHhcCCCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          212 LHRIGFSSDTPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       212 ~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      +.++......+..+..+|+.+++||.+||++||.+|||++|+++
T Consensus       257 ~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            33333334556667789999999999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-51  Score=389.70  Aligned_cols=245  Identities=23%  Similarity=0.267  Sum_probs=200.3

Q ss_pred             eceeeccCceEEEEEEECCCC---cEEEEEeccCC-C---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            6 GQTIGRGSTATVSIGMSNRSS---EVFAVKSAELS-N---SEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~---~~~AvK~~~~~-~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      .+.||+|+||+||+|++..++   ..||||+++.. .   .+.+.+|+++|++++||||++++|++...+.   .+++||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~---~~~lv~  108 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLVVL  108 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTT---EEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCC---ceEEEE
Confidence            578999999999999986543   36899998643 2   2567899999999999999999998765443   256999


Q ss_pred             eecCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEEeecCceeeecccCCC
Q 040569           79 EYAPGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKIADFGCARRARVNEDD  157 (385)
Q Consensus        79 Ey~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~~~~~~~  157 (385)
                      |||++|+|.+++. ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.  +||+|||+++........
T Consensus       109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTCC
T ss_pred             EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC--EEEecccchhhccccccc
Confidence            9999999999998 4456788899999999999999999999999999999999987665  999999999876433222


Q ss_pred             ---CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHHHHHhcCCCCCCCCCCcCCHHHHH
Q 040569          158 ---EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISALHRIGFSSDTPEIPGYMSKQAQD  234 (385)
Q Consensus       158 ---~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (385)
                         ......||+.|+|||.+.+..++.++|||||||++|||+||..||....+.......+ .....+..|..+++++.+
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i-~~g~~~~~p~~~~~~l~~  265 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQPEYCPDPLYE  265 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH-HTTCCCCCCTTCCHHHHH
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCcccCcHHHHH
Confidence               2234568999999999999999999999999999999999888876544433333333 233456677889999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhC
Q 040569          235 FLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       235 ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      ||.+||++||++|||+.|+++|
T Consensus       266 li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         266 VMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-51  Score=389.69  Aligned_cols=246  Identities=22%  Similarity=0.305  Sum_probs=206.4

Q ss_pred             CceeeceeeccCceEEEEEEECC-----CCcEEEEEeccCCCH----HHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeE
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNR-----SSEVFAVKSAELSNS----EFLQREQRILSALACPQIVAYKGCDISEENGKI   72 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~~AvK~~~~~~~----~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~   72 (385)
                      +|+.++.||+|+||+||+|.++.     ++..||||+++....    ..+.+|++++++++||||+++++++.....   
T Consensus        21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~---   97 (308)
T d1p4oa_          21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP---   97 (308)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS---
T ss_pred             HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc---
Confidence            47889999999999999998863     357899999975432    357799999999999999999998866554   


Q ss_pred             EEEEEEeecCCCCHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeEE
Q 040569           73 LYNLFLEYAPGGTLTDAIRSG----------TCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAKI  142 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~l~~~----------~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~kL  142 (385)
                       .++||||+++|+|.+++...          ..+++..+..++.||++||.|||+++|+||||||+|||++.++.  +||
T Consensus        98 -~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~--~Kl  174 (308)
T d1p4oa_          98 -TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKI  174 (308)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEE
T ss_pred             -eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce--EEE
Confidence             56899999999999998521          24689999999999999999999999999999999999987766  999


Q ss_pred             eecCceeeecccCCC-CCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhC-CCCCCCCCChHHHHHHhcCCCC
Q 040569          143 ADFGCARRARVNEDD-EGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATG-RPPWPDVADPISALHRIGFSSD  220 (385)
Q Consensus       143 ~DFG~a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG-~~Pf~~~~~~~~~~~~~~~~~~  220 (385)
                      +|||+|+........ ......||+.|||||.+.+..++.++|||||||++|||+|| ++||... +....+..+. ...
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-~~~~~~~~i~-~~~  252 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-SNEQVLRFVM-EGG  252 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CHHHHHHHHH-TTC
T ss_pred             eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-CHHHHHHHHH-hCC
Confidence            999999865433221 22344689999999999999999999999999999999998 5778664 4444444443 445


Q ss_pred             CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          221 TPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       221 ~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      .+..|..+|+.+.++|.+||++||++|||+.|+++
T Consensus       253 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         253 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            56678889999999999999999999999999997

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-50  Score=381.31  Aligned_cols=254  Identities=19%  Similarity=0.250  Sum_probs=199.3

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhcCCCCeeeeeeeeeeccCCeEEEEEEEee
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALACPQIVAYKGCDISEENGKILYNLFLEY   80 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||++... ..+.+.+|+++++.++|+|++..+..+.....   .+++||||
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~---~~~ivme~   84 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGD---YNVMVMEL   84 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETT---EEEEEEEC
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCC---EEEEEEEE
Confidence            489999999999999999999999999999987653 33567889999999988776665544433332   26689999


Q ss_pred             cCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCC-CCCeEEeecCceeeecccCC--
Q 040569           81 APGGTLTDAIR-SGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDN-EQGAKIADFGCARRARVNED--  156 (385)
Q Consensus        81 ~~ggsL~~~l~-~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~-~~~~kL~DFG~a~~~~~~~~--  156 (385)
                      +. ++|.+.+. .++.+++..+..++.||+.||+|||++||+||||||+|||++..+ ...+||+|||+|+.......  
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~  163 (299)
T d1ckia_          85 LG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ  163 (299)
T ss_dssp             CC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred             cC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence            95 56666665 566899999999999999999999999999999999999986432 33489999999998653322  


Q ss_pred             ----CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCChHHH-----HHHhcCCCCCCCCCCc
Q 040569          157 ----DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADPISA-----LHRIGFSSDTPEIPGY  227 (385)
Q Consensus       157 ----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-----~~~~~~~~~~~~~~~~  227 (385)
                          ......+||+.|||||++.+..++.++|||||||++|||++|+.||.........     ..........+..+..
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (299)
T d1ckia_         164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG  243 (299)
T ss_dssp             BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTT
T ss_pred             ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccC
Confidence                1234567999999999999999999999999999999999999999764322111     1111112223334556


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHH---HHhCccc
Q 040569          228 MSKQAQDFLSKCLIRNPGERWSASE---LLEHGFV  259 (385)
Q Consensus       228 ~s~~~~~ll~~cL~~dP~~Rps~~e---lL~hp~~  259 (385)
                      +|+++.+||.+||+++|.+||++.+   +|+|+|.
T Consensus       244 ~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            8999999999999999999999875   4677664

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-50  Score=380.18  Aligned_cols=250  Identities=24%  Similarity=0.236  Sum_probs=196.8

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHH--HHhcCCCCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRI--LSALACPQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~i--l~~l~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|+..+.||+|+||+||+|++  +|+.||||.+..+......+|.++  +.+++|||||++++++.........+++|||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E   81 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence            578899999999999999986  589999999977666555455554  4577999999999999877665556779999


Q ss_pred             ecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH--------CCceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569           80 YAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS--------NGIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus        80 y~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~--------~givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                      ||++|+|.+++++. .+++.....++.|++.||+|||+        +||+||||||+||||+.++.  +||+|||+++..
T Consensus        82 y~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~--~Kl~DFGl~~~~  158 (303)
T d1vjya_          82 YHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRH  158 (303)
T ss_dssp             CCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEEE
T ss_pred             cccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC--eEEEecCccccc
Confidence            99999999999865 48999999999999999999996        59999999999999987766  999999999977


Q ss_pred             cccCC---CCCCccccCCcccChhhhcCCC------CCCCCChHHHHHHHHHHHhCCCCCCCCC--------------Ch
Q 040569          152 RVNED---DEGKPICGTPICMAPEVARGEE------QGFPADVWALGCTVLEMATGRPPWPDVA--------------DP  208 (385)
Q Consensus       152 ~~~~~---~~~~~~~Gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~elltG~~Pf~~~~--------------~~  208 (385)
                      .....   .......||+.|||||++.+..      ++.++|||||||++|||+||..||....              ..
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence            43322   1234567999999999997653      5668999999999999999988774211              11


Q ss_pred             HHHHHHhcCCCCCCCCCCc-----CCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 040569          209 ISALHRIGFSSDTPEIPGY-----MSKQAQDFLSKCLIRNPGERWSASELLEH  256 (385)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~-----~s~~~~~ll~~cL~~dP~~Rps~~elL~h  256 (385)
                      .............|.++..     ....+.+|+.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            1222222222333444332     23458999999999999999999999874

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.8e-49  Score=373.34  Aligned_cols=249  Identities=22%  Similarity=0.249  Sum_probs=202.9

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhcCC-CCeeeeeeeeeeccCCeEEEEEEEe
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALAC-PQIVAYKGCDISEENGKILYNLFLE   79 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~~~~~lv~E   79 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||++... ..+.+++|+++++.|.| +|++.+++++.....    +++|||
T Consensus         6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~----~~~vme   81 (293)
T d1csna_           6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH----NVLVID   81 (293)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE----EEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCc----cEEEEE
Confidence            599999999999999999999999999999987543 34567889999999965 899999888765443    668999


Q ss_pred             ecCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecC---CCCCeEEeecCceeeecccC
Q 040569           80 YAPGGTLTDAIRS-GTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKD---NEQGAKIADFGCARRARVNE  155 (385)
Q Consensus        80 y~~ggsL~~~l~~-~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~---~~~~~kL~DFG~a~~~~~~~  155 (385)
                      |+ |++|.+++.. +..+++..+..++.|++.||+|||++||+||||||+|||++..   ....+||+|||+|+......
T Consensus        82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~  160 (293)
T d1csna_          82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  160 (293)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence            99 6899999974 5579999999999999999999999999999999999999752   22348999999999764322


Q ss_pred             C------CCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHhc---CCCCCCCC
Q 040569          156 D------DEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVAD--PISALHRIG---FSSDTPEI  224 (385)
Q Consensus       156 ~------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~--~~~~~~~~~---~~~~~~~~  224 (385)
                      .      ......+||+.|||||++.+..+++++|||||||++|||++|+.||.....  ......++.   .....+.+
T Consensus       161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l  240 (293)
T d1csna_         161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL  240 (293)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred             cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh
Confidence            2      123456899999999999999999999999999999999999999975432  222222221   11222334


Q ss_pred             CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          225 PGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       225 ~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                      +..+|+++.+|+..|+..+|++||+++.+.+
T Consensus       241 ~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            4568899999999999999999999887654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.7e-47  Score=367.29  Aligned_cols=255  Identities=23%  Similarity=0.311  Sum_probs=196.2

Q ss_pred             CceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC--HHHHHHHHHHHHhcC-----------CCCeeeeeeeeeecc
Q 040569            2 DWTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN--SEFLQREQRILSALA-----------CPQIVAYKGCDISEE   68 (385)
Q Consensus         2 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~--~~~~~~E~~il~~l~-----------hpnIv~~~~~~~~~~   68 (385)
                      +|++++.||+|+||+||+|+++.+|+.||||+++...  .+.+++|+++|+.+.           ||||+++++++....
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            3999999999999999999999999999999998653  356788999998875           578999998876655


Q ss_pred             CCeEEEEEEEeecCCCCH-HHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEeecCCCC----Ce
Q 040569           69 NGKILYNLFLEYAPGGTL-TDAIR--SGTCLEEGRIRSHTRAVLLGLQYLHS-NGIVHCDIKGQNILVSKDNEQ----GA  140 (385)
Q Consensus        69 ~~~~~~~lv~Ey~~ggsL-~~~l~--~~~~l~e~~~~~i~~qil~gL~yLH~-~givHrDlKp~NILi~~~~~~----~~  140 (385)
                      .....  ++++++..+.. .....  ....+++..++.+++||+.||+|||+ +||+||||||+||||+.++..    .+
T Consensus        94 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~  171 (362)
T d1q8ya_          94 PNGVH--VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI  171 (362)
T ss_dssp             TTEEE--EEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             cccee--eeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence            54444  45555544432 22222  45678999999999999999999998 899999999999999765432    27


Q ss_pred             EEeecCceeeecccCCCCCCccccCCcccChhhhcCCCCCCCCChHHHHHHHHHHHhCCCCCCCCCCh-----HHHHHH-
Q 040569          141 KIADFGCARRARVNEDDEGKPICGTPICMAPEVARGEEQGFPADVWALGCTVLEMATGRPPWPDVADP-----ISALHR-  214 (385)
Q Consensus       141 kL~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-----~~~~~~-  214 (385)
                      |++|||.+.....    .....+||+.|+|||++.+..++.++||||+||++++|++|+.||......     ...+.. 
T Consensus       172 kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~  247 (362)
T d1q8ya_         172 KIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI  247 (362)
T ss_dssp             EECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred             eEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence            9999999986532    234557999999999999999999999999999999999999999643211     001100 


Q ss_pred             ---hcC------------------C---CC---------------CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 040569          215 ---IGF------------------S---SD---------------TPEIPGYMSKQAQDFLSKCLIRNPGERWSASELLE  255 (385)
Q Consensus       215 ---~~~------------------~---~~---------------~~~~~~~~s~~~~~ll~~cL~~dP~~Rps~~elL~  255 (385)
                         .+.                  .   ..               ....+...++++++||.+||++||.+|||++|+|+
T Consensus       248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               000                  0   00               11122234678999999999999999999999999


Q ss_pred             Ccccccc
Q 040569          256 HGFVKEQ  262 (385)
Q Consensus       256 hp~~~~~  262 (385)
                      ||||++.
T Consensus       328 Hp~f~~~  334 (362)
T d1q8ya_         328 HPWLKDT  334 (362)
T ss_dssp             CGGGTTC
T ss_pred             CcccCCC
Confidence            9999854

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=2.4e-26  Score=201.90  Aligned_cols=163  Identities=18%  Similarity=0.150  Sum_probs=121.5

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCCC---------------------HHHHHHHHHHHHhcCCCCeeeee
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELSN---------------------SEFLQREQRILSALACPQIVAYK   61 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~~---------------------~~~~~~E~~il~~l~hpnIv~~~   61 (385)
                      +.+++.||+|+||+||+|++. +|+.||||++....                     .....+|..++.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            568999999999999999985 78999999764211                     12345689999999999999877


Q ss_pred             eeeeeccCCeEEEEEEEeecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEeecCCCCCeE
Q 040569           62 GCDISEENGKILYNLFLEYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHSNGIVHCDIKGQNILVSKDNEQGAK  141 (385)
Q Consensus        62 ~~~~~~~~~~~~~~lv~Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~~givHrDlKp~NILi~~~~~~~~k  141 (385)
                      ++.    .    .+++|||+++..+.+       +++..+..++.||+.+|+|||++||+||||||+|||++++   +++
T Consensus        81 ~~~----~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~---~~~  142 (191)
T d1zara2          81 AWE----G----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE---GIW  142 (191)
T ss_dssp             EEE----T----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT---EEE
T ss_pred             Eec----C----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC---CEE
Confidence            542    1    238999999866543       5666678899999999999999999999999999999843   399


Q ss_pred             EeecCceeeecccCCCCCCccccCCcccChhh-----hcCCCCCCCCChHHHHHHHH
Q 040569          142 IADFGCARRARVNEDDEGKPICGTPICMAPEV-----ARGEEQGFPADVWALGCTVL  193 (385)
Q Consensus       142 L~DFG~a~~~~~~~~~~~~~~~Gt~~y~aPE~-----~~~~~~~~~~DiwSlG~il~  193 (385)
                      |+|||+|.......         ...|....+     +....|+.++|+||+.--+.
T Consensus       143 liDFG~a~~~~~~~---------~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         143 IIDFPQSVEVGEEG---------WREILERDVRNIITYFSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             ECCCTTCEETTSTT---------HHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred             EEECCCcccCCCCC---------cHHHHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence            99999997652110         011221110     11356788999999865443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.29  E-value=2e-06  Score=76.34  Aligned_cols=136  Identities=18%  Similarity=0.159  Sum_probs=81.5

Q ss_pred             ceeeceeeccCceEEEEEEECCCCcEEEEEeccCC---CHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccCCeEEEEEEE
Q 040569            3 WTRGQTIGRGSTATVSIGMSNRSSEVFAVKSAELS---NSEFLQREQRILSALA-CPQIVAYKGCDISEENGKILYNLFL   78 (385)
Q Consensus         3 y~~~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~---~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~~~~lv~   78 (385)
                      |+..+..+-++.+.||+..  ..++.+++|.....   ....+.+|..+++.+. +--+.+++.+....  +.  .++||
T Consensus        16 ~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~~--~~lv~   89 (263)
T d1j7la_          16 YRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GW--SNLLM   89 (263)
T ss_dssp             SEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TE--EEEEE
T ss_pred             eEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecC--Cc--eEEEE
Confidence            4555554444557899876  34667788876532   2345778999988873 22234444433322  22  45899


Q ss_pred             eecCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 040569           79 EYAPGGTLTDAIRSGTCLEEGRIRSHTRAVLLGLQYLHS-----------------------------------------  117 (385)
Q Consensus        79 Ey~~ggsL~~~l~~~~~l~e~~~~~i~~qil~gL~yLH~-----------------------------------------  117 (385)
                      ++++|.++.+......     ....++.++...|..||+                                         
T Consensus        90 ~~l~G~~~~~~~~~~~-----~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T d1j7la_          90 SEADGVLCSEEYEDEQ-----SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             ECCSSEEHHHHTTTCS-----CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred             Eecccccccccccccc-----cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence            9999988765432111     112223333333333432                                         


Q ss_pred             ------------C------CceeccCCCCCEEeecCCCCCeEEeecCceeee
Q 040569          118 ------------N------GIVHCDIKGQNILVSKDNEQGAKIADFGCARRA  151 (385)
Q Consensus       118 ------------~------givHrDlKp~NILi~~~~~~~~kL~DFG~a~~~  151 (385)
                                  .      .++|+|+.|.|||+++++.  +-|+||+.+...
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~--~~lIDwe~a~~g  214 (263)
T d1j7la_         165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV--SGFIDLGRSGRA  214 (263)
T ss_dssp             SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEE--EEECCCTTCEEE
T ss_pred             hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCce--EEEeechhcccC
Confidence                        1      2789999999999985432  369999988753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.10  E-value=3.7e-06  Score=74.14  Aligned_cols=74  Identities=26%  Similarity=0.142  Sum_probs=50.6

Q ss_pred             eeeccCc-eEEEEEEECCCCcEEEEEeccCCCHHHHHHHHHHHHhcCCC--CeeeeeeeeeeccCCeEEEEEEEeecCCC
Q 040569            8 TIGRGST-ATVSIGMSNRSSEVFAVKSAELSNSEFLQREQRILSALACP--QIVAYKGCDISEENGKILYNLFLEYAPGG   84 (385)
Q Consensus         8 ~LG~G~~-g~Vy~a~~~~~~~~~AvK~~~~~~~~~~~~E~~il~~l~hp--nIv~~~~~~~~~~~~~~~~~lv~Ey~~gg   84 (385)
                      .+..|.. +.||+... .++..+++|.........+.+|...|+.|...  .+++++.+..+..  .  .++||||++|.
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~--~--~~~v~~~i~G~   91 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAG--R--DWLLLGEVPGQ   91 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS--C--EEEEEECCSSE
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeeccccc--c--eEEEEEeeecc
Confidence            4455554 68998875 35677899988776667788999999988332  2455555443332  2  55899999986


Q ss_pred             CH
Q 040569           85 TL   86 (385)
Q Consensus        85 sL   86 (385)
                      ++
T Consensus        92 ~~   93 (255)
T d1nd4a_          92 DL   93 (255)
T ss_dssp             ET
T ss_pred             cc
Confidence            65

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.94  E-value=1.8e-05  Score=74.77  Aligned_cols=75  Identities=15%  Similarity=-0.005  Sum_probs=47.7

Q ss_pred             eceeeccCceEEEEEEECCCCcEEEEEeccC----------CCHHHHHHHHHHHHhc-CC--CCeeeeeeeeeeccCCeE
Q 040569            6 GQTIGRGSTATVSIGMSNRSSEVFAVKSAEL----------SNSEFLQREQRILSAL-AC--PQIVAYKGCDISEENGKI   72 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~----------~~~~~~~~E~~il~~l-~h--pnIv~~~~~~~~~~~~~~   72 (385)
                      .+.||.|....||++.+..+++.++||....          ...+...+|.+.|+.+ .+  ..+++++.+  +...   
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~---  105 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM---  105 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT---
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCC---
Confidence            4578999999999999887888999996431          0123456789888877 22  345555543  2333   


Q ss_pred             EEEEEEeecCCCCH
Q 040569           73 LYNLFLEYAPGGTL   86 (385)
Q Consensus        73 ~~~lv~Ey~~ggsL   86 (385)
                       ..+|||++.+..+
T Consensus       106 -~~lvmE~L~~~~~  118 (392)
T d2pula1         106 -AVTVMEDLSHLKI  118 (392)
T ss_dssp             -TEEEECCCTTSEE
T ss_pred             -CEEEEeccCCccc
Confidence             2379999987553

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.13  E-value=0.001  Score=60.52  Aligned_cols=68  Identities=18%  Similarity=0.202  Sum_probs=42.9

Q ss_pred             eEEEEEEECCCCcEEEEEeccCC--CHHHHHHHHHHHHhcCC-----CCeeeeeeeeeeccCCeEEEEEEEeecCCCC
Q 040569           15 ATVSIGMSNRSSEVFAVKSAELS--NSEFLQREQRILSALAC-----PQIVAYKGCDISEENGKILYNLFLEYAPGGT   85 (385)
Q Consensus        15 g~Vy~a~~~~~~~~~AvK~~~~~--~~~~~~~E~~il~~l~h-----pnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggs   85 (385)
                      -.||++.. .+|..|++|+....  ..+.+..|...|..|..     |..+..-+-......+  .++.++++++|..
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~--~~~~l~~~~~G~~  110 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQG--FYFAVFPSVGGRQ  110 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETT--EEEEEEECCCCEE
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeee--EEEEEEeecCCcC
Confidence            58999987 46888999988653  46788889999988832     2222221111111122  2557899998744

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.06  E-value=0.0012  Score=61.84  Aligned_cols=73  Identities=15%  Similarity=0.079  Sum_probs=48.7

Q ss_pred             eceeeccCceEEEEEEECC-------CCcEEEEEeccC-CCHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccCCeEEEEE
Q 040569            6 GQTIGRGSTATVSIGMSNR-------SSEVFAVKSAEL-SNSEFLQREQRILSALA-CPQIVAYKGCDISEENGKILYNL   76 (385)
Q Consensus         6 ~~~LG~G~~g~Vy~a~~~~-------~~~~~AvK~~~~-~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~~~~l   76 (385)
                      .+.|+.|-.-.+|++....       ..+.+.+++... ...-...+|..+++.+. +.-.+++++++   .+     .+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~---~~-----g~  118 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF---SG-----GR  118 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE---TT-----EE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc---CC-----ce
Confidence            5678888888999998653       345677777652 23445678999999984 33334666654   22     15


Q ss_pred             EEeecCCCCH
Q 040569           77 FLEYAPGGTL   86 (385)
Q Consensus        77 v~Ey~~ggsL   86 (385)
                      |+||++|.+|
T Consensus       119 I~efi~g~~l  128 (395)
T d1nw1a_         119 LEEYIPSRPL  128 (395)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeccccC
Confidence            8999988544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.55  E-value=0.0026  Score=57.15  Aligned_cols=45  Identities=13%  Similarity=0.077  Sum_probs=29.1

Q ss_pred             ceeeccCceEEEEEEECCCCcEEEEEeccCC-CHHHHHHHHHHHHhcC
Q 040569            7 QTIGRGSTATVSIGMSNRSSEVFAVKSAELS-NSEFLQREQRILSALA   53 (385)
Q Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~AvK~~~~~-~~~~~~~E~~il~~l~   53 (385)
                      +.|..|---+.|+....  +..|++|+.+.. ..+.+..|+++|..|.
T Consensus        24 ~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~~~~~l~~~~~~l~~L~   69 (316)
T d2ppqa1          24 KGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLA   69 (316)
T ss_dssp             EEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHH
T ss_pred             ecCCCCcccCeEEEEEC--CCcEEEEEcCCCCCHHHHHHHHHHHHhhh
Confidence            34456666889998765  345899998653 4466777888888873